PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, L; Wang, P; Qin, Y; Cong, Q; Shao, C; Du, Z; Ni, X; Li, P; Ding, K				Zhang, L.; Wang, P.; Qin, Y.; Cong, Q.; Shao, C.; Du, Z.; Ni, X.; Li, P.; Ding, K.			RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEIN-2; CLINICOPATHOLOGICAL SIGNIFICANCE; ACTIVATOR PROTEIN-1; FACTOR RECEPTOR; EXPRESSION; TRANSDUCTION; ANGIOGENESIS; METASTASIS; APOPTOSIS; GCS-100	Galectin-3 (Gal-3) has been implicated in pancreatic ductal adenocarcinoma (PDAC), and its candidacy as a therapeutic target has been evaluated. Gal-3 is widely upregulated in tumors, and its expression is associated with the development and malignancy of PDAC. In the present study, we demonstrate that a polysaccharide, RN1, purified from the flower of Panax notoginseng binds to Gal-3 and suppresses its expression. In addition, RN1 markedly inhibits PDAC cells growth in vitro, in vivo and in patient-derived xenografts. Mechanistically, RN1 binds to epidermal growth factor receptor (EGFR) and Gal-3, thereby disrupting the interaction between Gal-3 and EGFR and downregulating extracellular-related kinase (ERK) phosphorylation and the transcription factor of Gal-3, Runx1 expression. Inhibiting the expression of Runx1 by RN1, suppresses Gal-3 expression and inactivates Gal-3-associated signaling pathways, including the EGFR/ERK/Runx1, BMP/smad/Id-3 and integrin/FAK/JNK signaling pathways. In addition, RN1 can also bind to bone morphogenetic protein receptors (BMPR1A and BMPR2) and block the interaction between Gal-3 and the BMPRs. Thus, our results suggest that a novel Gal-3 inhibitor RN1 may be a potential candidate for human PDAC treatment via multiple targets and multiple signaling pathways.	[Zhang, L.; Wang, P.; Qin, Y.; Cong, Q.; Du, Z.; Ni, X.; Ding, K.] Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China; [Zhang, L.; Li, P.] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia Lane, Nanjing 210009, Jiangsu, Peoples R China; [Shao, C.] Second Mil Med Univ, Changzheng Hosp, Dept Gen Surg, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; China Pharmaceutical University; Naval Medical University	Ding, K (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, 555 Zu Chong Zhi Rd, Shanghai 201203, Peoples R China.; Li, P (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjia Lane, Nanjing 210009, Jiangsu, Peoples R China.	liping2004@126.com; dingkan@simm.ac.cn	Li, Ping/GYV-4914-2022	Cong, Qifei/0000-0002-4446-7222; Ding, Kan/0000-0002-8140-9259	National Natural Science Foundation of China [31230022]; New Drug Creation and Manufacturing Program [2012ZX09301001-003]; National Science Foundation of China [81421005]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12010302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Drug Creation and Manufacturing Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from National Natural Science Foundation of China (31230022), New Drug Creation and Manufacturing Program (2012ZX09301001-003), Innovative Research Groups of the National Science Foundation of China (81421005), Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Strategic Priority Research Program of the Chinese Academy of Sciences (XDA12010302).	Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Berberat PO, 2001, J HISTOCHEM CYTOCHEM, V49, P539, DOI 10.1177/002215540104900414; Blanchard H, 2014, EXPERT OPIN THER PAT, V24, DOI 10.1517/13543776.2014.947961; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; Deng HY, 2007, EXP CELL RES, V313, P1033, DOI 10.1016/j.yexcr.2006.12.020; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Friedman AD, 2009, J CELL PHYSIOL, V219, P520, DOI 10.1002/jcp.21738; Fukushi J, 2004, MOL BIOL CELL, V15, P3580, DOI 10.1091/mbc.E04-03-0236; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7; Kobayashi T, 2011, INT J CANCER, V129, P2775, DOI 10.1002/ijc.25946; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu W, 2012, J INVEST DERMATOL, V132, P2828, DOI 10.1038/jid.2012.211; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Mendelsohn J, 2000, CLIN CANCER RES, V6, P747; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Shimamura T, 2002, CLIN CANCER RES, V8, P2570; Shin S, 2009, MOL CANCER RES, V7, P745, DOI 10.1158/1541-7786.MCR-08-0462; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Stegmayr J, 2016, J BIOL CHEM, V291, P13318, DOI 10.1074/jbc.M116.721464; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; Tellez-Sanz R, 2013, CURR MED CHEM, V20, P2979, DOI 10.2174/09298673113209990163; Tobita K, 2003, INT J MOL MED, V11, P305; Uegaki K, 1997, ANTICANCER RES, V17, P3841; Wang PP, 2015, CARBOHYD POLYM, V121, P328, DOI 10.1016/j.carbpol.2014.11.073; Xiao F, 2013, GLYCOBIOLOGY, V23, P524, DOI 10.1093/glycob/cwt004; YAMANAKA Y, 1993, ANTICANCER RES, V13, P565; Zhang HY, 2009, ENDOCRINE, V35, P101, DOI 10.1007/s12020-008-9129-z	44	45	46	5	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1297	1308		10.1038/onc.2016.306	http://dx.doi.org/10.1038/onc.2016.306			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27617577				2022-12-26	WOS:000395861300013
J	Mustafi, SB; Aznar, N; Dwivedi, SKD; Chakraborty, PK; Basak, R; Mukherjee, P; Ghosh, P; Bhattacharya, R				Mustafi, Soumyajit Banerjee; Aznar, Nicolas; Dwivedi, Shailendra Kumar Dhar; Chakraborty, Prabir Kumar; Basak, Rumki; Mukherjee, Priyabrata; Ghosh, Pradipta; Bhattacharya, Resham			Mitochondrial BMI1 maintains bioenergetic homeostasis in cells	FASEB JOURNAL			English	Article						electron transport chain; mitochondrial mRNA; PNPase	HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; SELF-RENEWAL; MEDIATED PHOSPHORYLATION; RNA-POLYMERASE; CANCER GROWTH; DNA-DAMAGE; STEM-CELLS; STAT3; TRANSFORMATION; P53	The polycomb complex proto-oncogene BMI1 [B lymphoma Mo-MLV insertion region 1 homolog (mouse)] is essential for self-renewal of normal and cancer stem cells. BMI1-nullmice show severe defects ingrowth, development, and survival. Although BMI1 is known to exert its effect in the nucleus via repression of 2 potent cell-cycle regulators that are encoded by the Ink4a/Arf locus, deletion of this locus only partially rescues BMI1-null phenotypes, which is indicative of alternate mechanisms of action of BMI1. Here, we show that an extranuclear pool of BMI1 localizes to inner mitochondrial membrane and directly regulates mitochondrial RNA (mtRNA) homeostasis and bioenergetics. These mitochondrial functions of BMI1 are independent of its previously described nuclear functions because a nuclear localization-defective mutant BMI1 rescued several bioenergetic defects that we observed in BMI1-depleted cells, for example, mitochondrial respiration, cytochrome c oxidase activity, and ATP production. Mechanistically, BMI1 coprecipitated with polynucleotide phosphorylase, a ribonuclease that is responsible for decay of mtRNA transcripts. Loss of BMI1 enhanced ribonuclease activity of polynucleotide phosphorylase and reduced mtRNA stability. These findings not only establish a novel extranuclear role ofBMI1 in the regulation of mitochondrial bioenergetics, but also provide new mechanistic insights into the role of this protooncogene in stem cell differentiation, neuronal aging, and cancer.	[Mustafi, Soumyajit Banerjee; Dwivedi, Shailendra Kumar Dhar; Basak, Rumki; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Stephenson Canc Ctr, Oklahoma City, OK 73190 USA; [Chakraborty, Prabir Kumar; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Stephenson Canc Ctr, Oklahoma City, OK USA; [Aznar, Nicolas] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bhattacharya, Resham] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Diego; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhattacharya, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 1409B, Oklahoma City, OK 73104 USA.	resham-bhattacharya@ouhsc.edu	Dwivedi, Shailendra Kumar Dhar/Q-2204-2019	Aznar, Nicolas/0000-0003-3338-9932	U.S. National Institutes of Health (NIH) National Cancer Institute [CA157481, CA160911]; NIH National Heart, Lung, and Blood Institute [HL120585]; NATIONAL CANCER INSTITUTE [R01CA160911, R01CA100768, R01CA157481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Timo Meerloo and Dr. Marilyn G. Farquhar (University of California, San Diego Electron Microscopy Core Facility). The Stephenson Cancer Functional Genomics Core of Oklahoma University Health Science Center assisted in the mitostress (XF) assay. This study was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute Grants CA157481 (to R.Bh.) and CA160911 (to P.G.), and NIH National Heart, Lung, and Blood Institute Grant HL120585 (to P.M.).	Abd El Hafez A, 2014, ANN DIAGN PATHOL, V18, P58, DOI 10.1016/j.anndiagpath.2013.11.004; Allegra E, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-206; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P895, DOI 10.1101/pdb.prot5641; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Cohen KJ, 1996, MOL CELL BIOL, V16, P5527; Demaria M, 2011, CELL CYCLE, V10, P3221, DOI 10.4161/cc.10.19.17379; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300; Honig A, 2010, ANTICANCER RES, V30, P1559; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Ishiwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042118; Ismail IH, 2012, NUCLEIC ACIDS RES, V40, P5497, DOI 10.1093/nar/gks222; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marcu R, 2012, JOVE-J VIS EXP, DOI 10.3791/4131; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Mourgues L, 2015, LEUKEMIA, V29, P1993, DOI 10.1038/leu.2015.112; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Mustafi SB, 2014, ANTIOXID REDOX SIGN, V20, P2891, DOI 10.1089/ars.2013.5340; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Piwowarski J, 2003, J MOL BIOL, V329, P853, DOI 10.1016/S0022-2836(03)00528-X; Proctor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055820; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tao Zhou, 2009, PROGR NATURAL SCI, V01, P1, DOI DOI 10.1371/J0URNAL.PBI0.1000139; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vaseva Angelina V, 2013, Methods Mol Biol, V962, P75, DOI 10.1007/978-1-62703-236-0_6; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang DDH, 2014, J BIOL CHEM, V289, P16727, DOI 10.1074/jbc.M113.536540; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Wang G, 2012, BBA-GENE REGUL MECH, V1819, P998, DOI 10.1016/j.bbagrm.2011.10.001; Wang RL, 2015, J BIOMOL SCREEN, V20, P422, DOI 10.1177/1087057114557621; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yin CQ, 2012, CRIT REV EUKAR GENE, V22, P17, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.20; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851; Zhang QF, 2013, J BIOL CHEM, V288, P31280, DOI 10.1074/jbc.M113.505057	78	16	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4042	4055		10.1096/fj.201600321R	http://dx.doi.org/10.1096/fj.201600321R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27613804	Green Published			2022-12-26	WOS:000388201500012
J	Tillgren, V; Morgelin, M; Onnerfjord, P; Kalamajski, S; Aspberg, A				Tillgren, Viveka; Morgelin, Matthias; Onnerfjord, Patrik; Kalamajski, Sebastian; Aspberg, Anders			The Tyrosine Sulfate Domain of Fibromodulin Binds Collagen and Enhances Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix; fibromodulin; post-translational modification (PTM); protein assembly; tyrosine sulfation; fibrillogenesis	RICH REPEAT PROTEIN; MATRIX PROTEIN; EXTRACELLULAR-MATRIX; DEFICIENT MICE; I COLLAGEN; ELECTRON-MICROSCOPY; CONNECTIVE TISSUES; CROSS-LINKING; PRELP BINDS; LUMICAN	Small leucine-rich proteoglycans interact with other extracellular matrix proteins and are important regulators of matrix assembly. Fibromodulin has a key role in connective tissues, binding collagen through two identified binding sites in its leucine-rich repeat domain and regulating collagen fibril formation in vitro and in vivo. Some nine tyrosine residues in the fibromodulin N-terminal domain are O-sulfated, a posttranslational modification often involved in protein interactions. The N-terminal domain mimics heparin, binding proteins with clustered basic amino acid residues. Because heparin affects collagen fibril formation, we investigated whether tyrosine sulfate is involved in fibromodulin interactions with collagen. Using full-length fibromodulin and its N-terminal tyrosine-sulfated domain purified from tissue, as well as recombinant fibromodulin fragments, we found that the N-terminal domain binds collagen. The tyrosine-sulfated domain and the leucine-rich repeat domain both bound to three specific sites along the collagen type I molecule, at the N terminus and at 100 and 220 nm from the N terminus. The N-terminal domain shortened the collagen fibril formation lag phase and tyrosine sulfation was required for this effect. The isolated leucine-rich repeat domain inhibited the fibril formation rate, and full-length fibromodulin showed a combination of these effects. The fibrils formed in the presence of fibromodulin or its fragments showed more organized structure. Fibromodulin and its tyrosine sulfate domain remained bound on the formed fiber. Taken together, this suggests a novel, regulatory function for tyrosine sulfation in collagen interaction and control of fibril formation.	[Tillgren, Viveka; Onnerfjord, Patrik; Kalamajski, Sebastian; Aspberg, Anders] Lund Univ, Dept Clin Sci Lund Rheumatol & Mol Skeletal Biol, SE-22184 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci Lund, Div Infect Med BMC BMC B14, SE-22184 Lund, Sweden; [Kalamajski, Sebastian] Lund Univ, Div Translat Canc Res, Dept Lab Med, Medicon Village 406-3, SE-22363 Lund, Sweden	Lund University; Lund University; Lund University	Aspberg, A (corresponding author), Lund Univ, Dept Clin Sci Lund Rheumatol & Mol Skeletal Biol, SE-22184 Lund, Sweden.	Anders.Aspberg@med.lu.se	Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937; Kalamajski, Sebastian/0000-0002-6600-9302; Aspberg, Anders/0000-0002-6588-6944; Tillgren, Viveka/0000-0003-2869-9477	Swedish Research Council; King Gustaf V's 80-years fund; Crafoord Foundation; Swedish Rheumatism association; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V's 80-years fund; Crafoord Foundation; Swedish Rheumatism association; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	This work was supported by grants from the Swedish Research Council, King Gustaf V's 80-years fund, the Crafoord Foundation, the Swedish Rheumatism association, the Greta and Johan Kock Foundation, and the Alfred Osterlund Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	ANTONSSON P, 1991, J BIOL CHEM, V266, P16859; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; FORBES EG, 1994, FEBS LETT, V351, P433, DOI 10.1016/0014-5793(94)00907-4; FREIBERGER H, 1980, J INVEST DERMATOL, V75, P425, DOI 10.1111/1523-1747.ep12524080; Geng H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4022; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Keene DR, 2000, J BIOL CHEM, V275, P21801, DOI 10.1074/jbc.C000278200; Kvist AJ, 2006, J BIOL CHEM, V281, P33127, DOI 10.1074/jbc.M607892200; Liu CY, 2003, J BIOL CHEM, V278, P21672, DOI 10.1074/jbc.M301169200; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; MACBEATH JRE, 1993, J BIOL CHEM, V268, P19826; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Muller C, 2014, MATRIX BIOL, V40, P34, DOI 10.1016/j.matbio.2014.08.013; OBRINK B, 1973, EUR J BIOCHEM, V34, P129, DOI 10.1111/j.1432-1033.1973.tb02739.x; OLSEN BR, 1963, Z ZELLFORSCH MIK ANA, V59, P199, DOI 10.1007/BF00320445; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Park H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-599; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; SANANTONIO JD, 1994, GLYCOBIOLOGY, V4, P327; SCHONHERR E, 1995, J BIOL CHEM, V270, P8877, DOI 10.1074/jbc.270.15.8877; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; Viola M, 2007, CONNECT TISSUE RES, V48, P141, DOI 10.1080/03008200701276133	47	15	15	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23744	23755		10.1074/jbc.M116.730325	http://dx.doi.org/10.1074/jbc.M116.730325			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634037	Green Published, hybrid			2022-12-26	WOS:000387884400034
J	Albracht, CD; Guzik-Lendrum, S; Rayment, I; Gilbert, SP				Albracht, Clayton D.; Guzik-Lendrum, Stephanie; Rayment, Ivan; Gilbert, Susan P.			Heterodimerization of Kinesin-2 KIF3AB Modulates Entry into the Processive Run	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATPASE PATHWAY; INTRAFLAGELLAR TRANSPORT; INTRACELLULAR-TRANSPORT; CONVENTIONAL KINESIN; SUPERFAMILY PROTEIN; MICROTUBULE MOTOR; ACCESSORY SUBUNIT; AXONAL-TRANSPORT; COILED-COIL; NECK-LINKER	Mammalian KIF3AB is an N-terminal processive kinesin-2 that is best known for its roles in intracellular transport. There has been significant interest in KIF3AB to define the key principles that underlie its processivity but also to define the mechanistic basis of its sensitivity to force. In this study, the kinetics for entry into the processive run were quantified. The results show for KIF3AB that the kinetics of microtubule association at 7 mu M-1 s(-1) is less than the rates observed for KIF3AA at 13 mu M-1 s(-1) or KIF3BB at 11.9 mu M-1 s(-1). ADP release after microtubule association for KIF3AB is 33 s(-1) and is significantly slower than ADP release from homodimeric KIF3AA and KIF3BB, which reach 80-90 s(-1). To explore the interhead communication implied by the rate differences at these first steps, we compared the kinetics of KIF3AB microtubule association followed by ADP release with the kinetics for mixtures of KIF3AA plus KIF3BB. Surprisingly, the kinetics of KIF3AB are not equivalent to any of the mixtures of KIF3AA + KIF3BB. In fact, the transients for each of the mixtures overlay the transients for KIF3AA and KIF3BB. These results reveal that intermolecular communication within the KIF3AB heterodimer modulates entry into the processive run, and the results suggest that it is the high rate of microtubule association that drives rebinding to the microtubule after force-dependent motor detachment.	[Albracht, Clayton D.; Guzik-Lendrum, Stephanie; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Albracht, Clayton D.; Guzik-Lendrum, Stephanie; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Albracht, Clayton D.] NIH, Lab Mol Physiol, Bldg 50,Rm 3523, Bethesda, MD 20814 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.; Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	sgilbert@rpi.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [R37-GM054141]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141, R01GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R37-GM054141 (to S. P. G). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Arpag G, 2014, BIOPHYS J, V107, P1896, DOI 10.1016/j.bpj.2014.09.009; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Brown JM, 1999, MOL BIOL CELL, V10, P3081, DOI 10.1091/mbc.10.10.3081; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Bu W, 2003, J BIOL CHEM, V278, P49721, DOI 10.1074/jbc.M306194200; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Chen CJ, 2012, J BIOL CHEM, V287, P36673, DOI 10.1074/jbc.M112.395590; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Dogan MY, 2015, CELL REP, V10, P1967, DOI 10.1016/j.celrep.2015.02.061; Doodhi H, 2009, BIOCHEMISTRY-US, V48, P2248, DOI 10.1021/bi8018338; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gindhart JG, 1996, TRENDS CELL BIOL, V6, P415, DOI 10.1016/S0962-8924(96)20037-6; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P2175, DOI 10.1073/pnas.0610939104; Kallipolitou A, 2001, EMBO J, V20, P6226, DOI 10.1093/emboj/20.22.6226; Komaki S, 2010, J CELL SCI, V123, P451, DOI 10.1242/jcs.062703; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; LOCKHART A, 1995, FEBS LETT, V368, P531, DOI 10.1016/0014-5793(95)00723-M; Lockhart A, 1996, BIOCHEMISTRY-US, V35, P2365, DOI 10.1021/bi952318n; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; Phillips RK, 2016, J BIOL CHEM, V291, P20372, DOI 10.1074/jbc.M116.737577; Prevo B, 2015, NAT CELL BIOL, V17, P1536, DOI 10.1038/ncb3263; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2002, J BIOL CHEM, V277, P36731, DOI 10.1074/jbc.M205261200; Rosenfeld SS, 2009, J BIOL CHEM, V284, P32858, DOI 10.1074/jbc.M109.041210; SADHU A, 1992, J BIOL CHEM, V267, P11352; Sardar HS, 2012, J BIOL CHEM, V287, P24894, DOI 10.1074/jbc.M112.376830; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Sen I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074448; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970; Zhang PW, 2015, P NATL ACAD SCI USA, V112, P6359, DOI 10.1073/pnas.1505531112	74	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23248	23256		10.1074/jbc.M116.752196	http://dx.doi.org/10.1074/jbc.M116.752196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637334	Green Published, hybrid			2022-12-26	WOS:000387224800033
J	Dao, TT; Sehgal, P; Tung, TT; Moller, JV; Nielsen, J; Palmgren, M; Christensen, SB; Fuglsang, AT				Dao, Trong Tuan; Sehgal, Pankaj; Tung, Truong Thanh; Moller, Jesper Vuust; Nielsen, John; Palmgren, Michael; Christensen, Soren Brogger; Fuglsang, Anja Thoe			DemethoxycurcuminIs A Potent Inhibitor of P-Type ATPases from Diverse Kingdoms of Life	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; PLANT PLASMA-MEMBRANE; SARCOPLASMIC-RETICULUM; ANTIFUNGAL TARGET; REGULATORY DOMAIN; DELETION ANALYSIS; INNATE IMMUNITY; CURCUMA-LONGA; CALCIUM-PUMP; YEAST	P-type ATPases catalyze the active transport of cations and phospholipids across biological membranes. Members of this large family are involved in a range of fundamental cellular processes. To date, a substantial number of P-type ATPase inhibitors have been characterized, some of which are used as drugs. In this work a library of natural compounds was screened and we first identified curcuminoids as plasma membrane H+-ATPases inhibitors in plant and fungal cells. We also found that some of the commercial curcumins contain several curcuminoids. Three of these were purified and, among the curcuminoids, demethoxycurcumin was the most potent inhibitor of all tested P-type ATPases from fungal (Pma1p; H+-ATPase), plant (AHA2; H+-ATPase) and animal (SERCA; Ca2+-ATPase) cells. All three curcuminoids acted as non-competitive antagonist to ATP and hence may bind to a highly conserved allosteric site of these pumps. Future research on biological effects of commercial preparations of curcumin should consider the heterogeneity of the material.	[Dao, Trong Tuan; Palmgren, Michael; Fuglsang, Anja Thoe] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Dao, Trong Tuan; Tung, Truong Thanh; Nielsen, John; Christensen, Soren Brogger] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Sehgal, Pankaj; Moller, Jesper Vuust] Univ Aarhus, Dept Biomed, Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University	Fuglsang, AT (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark.	atf@plen.ku.dk	Palmgren, Michael/A-9808-2013; Fuglsang, Anja Thoe/A-6733-2015; Truong, Tung/L-2664-2019; Christensen, Søren Brøgger/H-4526-2019	Palmgren, Michael/0000-0002-9982-6114; Fuglsang, Anja Thoe/0000-0003-1153-8394; Truong, Tung/0000-0002-5263-203X; Christensen, Søren Brøgger/0000-0002-5773-6874; Nielsen, John/0000-0002-2854-8188; Dao, Trong Tuan/0000-0003-4741-1678	University of Copenhagen's Excellency Program KU; Danish National Research Foundation [DNRF85]	University of Copenhagen's Excellency Program KU; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the University of Copenhagen's Excellency Program KU2016 "Plants for a changing world" (SBC, MP) and the Danish National Research Foundation through the "PUMPKIN Center of Excellence" (DNRF85) (JVM, ATF, MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Apell HJ, 2004, BIOELECTROCHEMISTRY, V63, P149, DOI 10.1016/j.bioelechem.2003.09.021; Ashraf K, 2015, J CHROMATOGR SCI; Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baunsgaard L, 1998, PLANT J, V13, P661, DOI 10.1046/j.1365-313X.1998.00083.x; Bayet-Robert M, 2010, CANCER BIOL THER, V9, P8, DOI 10.4161/cbt.9.1.10392; Billack B, 2010, J ENZYM INHIB MED CH, V25, P312, DOI 10.3109/14756360903179419; Bilmen JG, 2001, EUR J BIOCHEM, V268, P6318, DOI 10.1046/j.0014-2956.2001.02589.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brini M, 2013, FEBS J, V280, P5385, DOI 10.1111/febs.12193; BRISKIN DP, 1986, ARCH BIOCHEM BIOPHYS, V248, P106, DOI 10.1016/0003-9861(86)90406-6; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Bublitz M, 2010, CURR OPIN STRUC BIOL, V20, P431, DOI 10.1016/j.sbi.2010.06.007; Buch-Pedersen MJ, 2006, J BIOL CHEM, V281, P38285, DOI 10.1074/jbc.M604781200; Chauhan S. K., 1999, Indian Journal of Pharmaceutical Sciences, V61, P58; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Dao TT, 2012, FOOD CHEM, V134, P21, DOI 10.1016/j.foodchem.2012.02.015; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Falhof J, 2016, MOL PLANT, V9, P323, DOI 10.1016/j.molp.2015.11.002; Fan L, 2014, BIOMED PHARMACOTHER, V68, P1141, DOI 10.1016/j.biopha.2014.10.014; Fournet A., 2002, TOP MED CHEM, V2, P1215, DOI DOI 10.2174/1568026023393011; Ganiger S, 2007, FOOD CHEM TOXICOL, V45, P64, DOI 10.1016/j.fct.2006.07.016; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Huang K.C., 1998, PHARM CHINESE HERBS; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Kang S, 2016, J BIOL CHEM, V291, P5185, DOI 10.1074/jbc.M115.705012; Kim MK, 2003, J AGR FOOD CHEM, V51, P1578, DOI 10.1021/jf0210369; KIUCHI F, 1993, CHEM PHARM BULL, V41, P1640, DOI 10.1248/cpb.41.1640; Kongstad KT, 2015, FITOTERAPIA, V105, P102, DOI 10.1016/j.fitote.2015.06.013; Kongstad KT, 2014, J AGR FOOD CHEM, V62, P5595, DOI 10.1021/jf501605z; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200; Lund Anette, 2012, Methods Mol Biol, V913, P217, DOI 10.1007/978-1-61779-986-0_14; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Mahmmoud YA, 2005, BRIT J PHARMACOL, V145, P236, DOI 10.1038/sj.bjp.0706185; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Moller JV, 2016, METHODS MOL BIOL, V1377, P11, DOI 10.1007/978-1-4939-3179-8_3; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MONK BC, 1994, CRIT REV MICROBIOL, V20, P209, DOI 10.3109/10408419409114555; Neelofar K, 2011, CAN J MICROBIOL, V57, P204, DOI 10.1139/W10-117; Doan NTQ, 2015, CURR PHARM DESIGN, V21, P5501, DOI 10.2174/1381612821666151002112824; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Ostrowski W, 2013, J SPECTROSC, V2013, DOI 10.1155/2013/749641; Padhye S, 2010, MINI-REV MED CHEM, V10, P372, DOI 10.2174/138955710791330891; PALMGREN MG, 1993, FEBS LETT, V317, P216, DOI 10.1016/0014-5793(93)81279-9; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Palmgren MG, 2011, PLANT CELL MONOGR, V19, P177, DOI 10.1007/978-3-642-13431-9_7; Pedersen CNS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00031; Pfeiffer E, 2003, J FOOD ENG, V56, P257, DOI 10.1016/S0260-8774(02)00264-9; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; Priyadarsini KI, 2014, MOLECULES, V19, P20091, DOI 10.3390/molecules191220091; RASICALDOGNO F, 1995, PLANT PHYSIOL, V108, P105, DOI 10.1104/pp.108.1.105; Rasmussen HB, 2000, PLANTA MED, V66, P396, DOI 10.1055/s-2000-8533; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Rudashevskaya EL, 2012, J BIOL CHEM, V287, P4904, DOI 10.1074/jbc.M111.307264; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SCHULTHEIS PJ, 1993, J BIOL CHEM, V268, P22686; Sehgal P, 2016, METHODS MOL BIOL, V1377, P105, DOI 10.1007/978-1-4939-3179-8_11; SetoYoung D, 1997, BBA-BIOMEMBRANES, V1326, P249, DOI 10.1016/S0005-2736(97)00028-X; Sharma M, 2010, FEMS YEAST RES, V10, P570, DOI 10.1111/j.1567-1364.2010.00637.x; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Shukla A, 2012, CELL MOL BIOL, V58, P182, DOI 10.1170/T939; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Soteropoulos P, 2000, ANTIMICROB AGENTS CH, V44, P2349, DOI 10.1128/AAC.44.9.2349-2355.2000; Sumbilla C, 2002, J BIOL CHEM, V277, P13900, DOI 10.1074/jbc.M111155200; Takeuchi T, 2006, GENES CELLS, V11, P223, DOI 10.1111/j.1365-2443.2006.00937.x; Tao Zhou, 2009, PROGR NATURAL SCI, V01, P1, DOI DOI 10.1371/J0URNAL.PBI0.1000139; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsao SM, 2000, J FOOD DRUG ANAL, V8, P208; Underwood W, 2007, CELL MICROBIOL, V9, P1621, DOI 10.1111/j.1462-5822.2007.00938.x; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019	86	13	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163260	10.1371/journal.pone.0163260	http://dx.doi.org/10.1371/journal.pone.0163260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27644036	Green Published, gold, Green Submitted			2022-12-26	WOS:000383891900039
J	Boswihi, SS; Udo, EE; Al-Sweih, N				Boswihi, Samar S.; Udo, Edet E.; Al-Sweih, Noura			Shifts in the Clonal Distribution of Methicillin-Resistant Staphylococcus aureus in Kuwait Hospitals: 1992-2010	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; ASIAN COUNTRIES; COMMUNITY; MRSA; STRAINS; SEQUENCE; EPIDEMIOLOGY; EMERGENCE	Background As the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) is constantly changing globally, determining the prevailing MRSA clones in a local healthcare facility is important for better management of infections. This study investigated clonal composition and distribution of MRSA isolates in Kuwait's hospitals using a combination of molecular typing methods. Materials and Methods In total, 400 non-repeatMRSA isolates were obtained between 1992 and 2010 in 13 public hospitals and were characterized using antibiogram, SCCmec typing, spa typing, and multilocus-sequence typing. Clonal assignment and detection of virulence factors and antibiotic resistance genes were performed by DNA microarray. Results The isolates were resistant to kanamycin (74.2%), erythromycin (69.5%), tetracycline (66.7%), gentamicin (61%), ciprofloxacin, (61%), fusidic acid (53.5%), clindamycin (41.5%), high-level mupirocin resistance (5.2%) and carried aphA3, aacA-aphD, ermA, ermC, mupA, tetK, tetM, fusC and far1. Molecular typing revealed 31 different MRSA clones consisting of ST239-MRSA-III (52.2%), ST22-MRSA-IV (9.2%), ST80-MRSA-IV (7.5%), ST5-MRSA-II/IV/V/VI (6.5%), ST30-MRSA-IV (3.5%), ST241-MRSA-III (2.7%), ST6-MRSA-IV (2.2%), ST36-MRSA-II (2%) and ST772-MRSA-V (1.75%). The isolates differed in the carriage of genes for enterotoxins, Panton-Valentine leukocidin (PVL), toxic shock syndrome toxin (tst-1), arginine catabolic mobile element (ACME) and exfoliative toxins. The number of clones increased from one (ST239-III-t037) in 1992 to 30 in 2010 including ST8-IV-t008 [PVL+] [ACME+] (USA300), ST772-V (Bengal Bay clone) and ST2816 identified for the first time in Kuwait. Conclusion The study revealed that the MRSA isolates belonged to diverse clones that changed in numbers and diversity overtime. Although ST239-MRSA-III, a healthcare-associated clone remained the dominant MRSA clone overtime, the newly emerged clones consisted mostly of community-associated.	[Boswihi, Samar S.; Udo, Edet E.; Al-Sweih, Noura] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait	Kuwait University	Udo, EE (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	EDET@hsc.edu.kw	Udo, Edet E/H-7367-2016	Udo, Edet E/0000-0002-7269-7949	Kuwait University Research Sector [YM 02/12, SRUL02/13]; College of Graduate Studies, Kuwait University, Kuwait	Kuwait University Research Sector; College of Graduate Studies, Kuwait University, Kuwait	This study was supported by grant YM 02/12 and Research Core Facility project no. SRUL02/13 from Kuwait University Research Sector. S. Boswihi received a graduate student fellowship from the College of Graduate Studies, Kuwait University, Kuwait.	Adhikari RP, 2002, J ANTIMICROB CHEMOTH, V50, P825, DOI 10.1093/jac/dkf242; Afroz S, 2008, JPN J INFECT DIS, V61, P393; Ahmad N, 2009, J MED MICROBIOL, V58, P1213, DOI 10.1099/jmm.0.011353-0; Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Al-Haddad AM, 2001, J MED MICROBIOL, V50, P558, DOI 10.1099/0022-1317-50-6-558; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Baranovich T, 2010, CLIN MICROBIOL INFEC, V16, P575, DOI 10.1111/j.1469-0691.2009.02891.x; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chatterjee S.S., 2013, CLIN EPIDEMIOL, V5, P205, DOI [10.2147/CLEP.S37071, DOI 10.2147/CLEP.S37071]; Chen HJ, 2010, ANTIMICROB AGENTS CH, V54, P4985, DOI 10.1128/AAC.00523-10; Chongtrakool P, 2006, ANTIMICROB AGENTS CH, V50, P1001, DOI 10.1128/AAC.50.3.1001-1012.2006; CLSI, 2012, CLSI DOCUMENT M100 S; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Ellington MJ, 2008, J ANTIMICROB CHEMOTH, V61, P73, DOI 10.1093/jac/dkm422; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P46, DOI 10.1093/jac/dkp386; Enany S, 2010, MICROBIOL RES, V165, P152, DOI 10.1016/j.micres.2009.03.005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Espedido BA, 2012, ANTIMICROB AGENTS CH, V56, P3380, DOI 10.1128/AAC.00013-12; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harastani HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103715; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Hon PY, 2013, ANTIMICROB AGENTS CH, V57, P1563, DOI 10.1128/AAC.02518-12; Hsu LY, 2005, CLIN INFECT DIS, V40, P486, DOI 10.1086/427033; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Hudson LO, 2013, J CLIN MICROBIOL, V51, P3788, DOI 10.1128/JCM.01708-13; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Kawaguchiya M, 2013, J MED MICROBIOL, V62, P1852, DOI 10.1099/jmm.0.062125-0; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Melter O, 2006, EUROSURVEILLANCE, P1; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; O'Hara FP, 2012, MICROB DRUG RESIST, V18, P555, DOI 10.1089/mdr.2012.0056; Oksuz L, 2013, INT J MED SCI, V10, P1740, DOI 10.7150/ijms.6438; Que Y.A., 2010, MANDELL DOUGLAS BENN, P2543; RICHARDSON JF, 1993, J HOSP INFECT, V25, P45, DOI 10.1016/0195-6701(93)90007-M; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P1896, DOI 10.1128/AAC.01756-10; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Sonnevend A, 2012, J CLIN PATHOL, V65, P178, DOI 10.1136/jclinpath-2011-200436; Spoor LE, 2013, MBIO, V4, DOI 10.1128/mBio.00356-13; Stegger M, 2014, MBIO, V5, DOI 10.1128/mBio.01044-14; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Udo EE, 2008, J CLIN MICROBIOL, V46, P3514, DOI 10.1128/JCM.00966-08; Udo E E, 2014, New Microbes New Infect, V2, P100, DOI 10.1002/nmi2.47; Udo EE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-168; Udo EE, 2011, J MED MICROBIOL, V60, P600, DOI 10.1099/jmm.0.028381-0; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Udo EE, 2000, J MED MICROBIOL, V49, P419, DOI 10.1099/0022-1317-49-5-419; Udo EE, 2016, HIGH PREVALENCE TOXI; Wang SH, 2012, EMERG INFECT DIS, V18, P1557, DOI 10.3201/eid1810.120468; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	70	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162744	10.1371/journal.pone.0162744	http://dx.doi.org/10.1371/journal.pone.0162744			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631623	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900072
J	Kaluzny, J; Purta, P; Poskin, Z; Rogers, JD; Fawzi, AA				Kaluzny, Joel; Purta, Patryk; Poskin, Zach; Rogers, Jeremy D.; Fawzi, Amani A.			Ex Vivo Confocal Spectroscopy of Autofluorescence in Age-Related Macular Degeneration	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; QUANTITATIVE FUNDUS AUTOFLUORESCENCE; BRUCHS MEMBRANE; MORPHOMETRIC-ANALYSIS; HUMAN RPE; LIPOFUSCIN; FLUORESCENCE; DISEASE; DRUSEN; EYES	Purpose We investigated the autofluorescence (AF) signature of the microscopic features of retina with age-related macular degeneration (AMD) using 488 nm excitation. Methods The globes of four donors with AMD and four age-matched controls were embedded in paraffin and sectioned through the macula. Sections were excited using a 488 nm argon laser, and the AF emission was captured using a laser scanning confocal microscope (496-610 nm, 6 nm resolution). The data cubes were then analyzed to compare peak emission spectra between the AMD and the controls. Microscopic features, including individual lipofuscin and melanolipofuscin granules, Bruch's Membrane, as well macroscopic features, were considered. Results Overall, the AMD eyes showed a trend of blue-shifted emission peaks compared with the controls. These differences were statistically significant when considering the emission of the combined RPE/Bruch's Membrane across all the tissue cross-sections (p = 0.02). Conclusions The AF signatures of ex vivo AMD RPE/BrM show blue-shifted emission spectra (488 nm excitation) compared with the control tissue. The magnitude of these differences is small (similar to 4 nm) and highlights the potential challenges of detecting these subtle spectral differences in vivo.	[Kaluzny, Joel; Purta, Patryk; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Poskin, Zach; Rogers, Jeremy D.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA	Northwestern University; Feinberg School of Medicine; University of Wisconsin System; University of Wisconsin Madison	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.; Rogers, JD (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	jdrogers5@wisc.edu; amani.fawzi@northwestern.edu	fawzi, amani/AAA-9199-2021; Rogers, Jeremy/A-4572-2008	fawzi, amani/0000-0002-9568-3558; Rogers, Jeremy/0000-0003-3049-2803	National Institutes of Health [NIH-EY021470]; Illinois Society for the Prevention of Blindness; Edwin and Dorothy Gamewell Professorship, Retina Research Foundation; National Cancer Institute (Northwestern University) [NCI-CCSG-P30-CA060553]; NCI CCSG [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK108248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Society for the Prevention of Blindness; Edwin and Dorothy Gamewell Professorship, Retina Research Foundation; National Cancer Institute (Northwestern University); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (http://www.nih.gov/; NIH-EY021470; AAF), Illinois Society for the Prevention of Blindness (http://www.eyehealthillinois.org/; JK), and the Edwin and Dorothy Gamewell Professorship, Retina Research Foundation (http://retinaresearchfnd.org/; JDR), National Cancer Institute (http://www.cancer.gov/; NCI-CCSG-P30-CA060553; Northwestern University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Confocal microscopy was performed at the Northwestern University Center for Advanced Microscopy generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center.	Ach T, 2012, BRIT J OPHTHALMOL, V96, P1141, DOI 10.1136/bjophthalmol-2012-301547; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Biesemeier A, 2011, EXP EYE RES, V93, P29, DOI 10.1016/j.exer.2011.04.004; Bourg-Heckly G, 2008, IN VIVO ENDOSCOPIC A; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Cucio CA, 2010, J LIPID RES, V51, P451, DOI [10.1194/jlr.R002238, DOI 10.1194/JLR.R002238]; Cummings TJ., 2013, OPHTHALMIC PATHOLOGY; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P2327; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; FEENEY L, 1978, INVEST OPHTH VIS SCI, V17, P583; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Feldman TB, 2015, ANAL BIOANAL CHEM, V407, P1075, DOI 10.1007/s00216-014-8353-z; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Greenberg JP, 2013, INVEST OPHTH VIS SCI, V54, P5684, DOI 10.1167/iovs.13-12445; Hussain AA, 2011, INVEST OPHTH VIS SCI, V52, P4459, DOI 10.1167/iovs.10-6678; Jonasson F, 2011, OPHTHALMOLOGY, V118, P825, DOI 10.1016/j.ophtha.2010.08.044; Kamei M, 1999, INVEST OPHTH VIS SCI, V40, P2367; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Marmorstein AD, 2002, INVEST OPHTH VIS SCI, V43, P2435; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; NEWSOME DA, 1987, CURR EYE RES, V6, P1211, DOI 10.3109/02713688709025231; Nita M, 2014, MED SCI MONITOR, V20, P1003, DOI 10.12659/MSM.889887; Okubo A, 1999, INVEST OPHTH VIS SCI, V40, P443; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Rocha R, 2008, PHOTOMED LASER SURG, V26, P329, DOI 10.1089/pho.2007.2208; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Schweitzer D, 2009, OPHTHALMOLOGE, V106, P714, DOI 10.1007/s00347-009-1975-4; Schweitzer D, 2012, INVEST OPHTH VIS SCI, V53, P3376, DOI 10.1167/iovs.11-8970; SISKEN JE, 1989, METHOD CELL BIOL, V30, P113; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Thiberville L, 2007, AM J RESP CRIT CARE, V175, P22, DOI 10.1164/rccm.200605-684OC; VONRUCKMANN A, 1995, BRIT J OPHTHALMOL, V79, P407, DOI 10.1136/bjo.79.5.407; vonRuckmann A, 1997, INVEST OPHTH VIS SCI, V38, P478; Warburton S, 2005, MOL VIS, V11, P1122; Warburton S, 2007, MOL VIS, V13, P318; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107	46	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162869	10.1371/journal.pone.0162869	http://dx.doi.org/10.1371/journal.pone.0162869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631087	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900089
J	Kuznetsova, IS; Labutina, EV; Hunter, N				Kuznetsova, Irina S.; Labutina, Elena V.; Hunter, Nezahat			Radiation Risks of Leukemia, Lymphoma and Multiple Myeloma Incidence in the Mayak Cohort: 1948-2004	PLOS ONE			English	Article							CANCER INCIDENCE; WORKERS; MORTALITY; PLUTONIUM; LUNG	Incidence of all types of lymphatic and hematopoietic cancers, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiplemyeloma, acute and chronicmyeloid leukemia (AML and CML respectively), chronic lymphocytic leukemia (CLL) and other forms of leukemia have been studied in a cohort of 22,373 workers employed at the Mayak Production Association (PA) main facilities during 536,126 person-years of follow-up from the start of employment between 1948 and 1982 to the end of 2004. Risk assessment was performed for both external gamma-radiation and internal alpha-exposure of red bone marrow due to incorporated Pu-239 using Mayak Workers Dosimetry System 2008 taking into account non-radiation factors. The incidence of leukemia excluding CLL showed a non-linear dose response relationship for external gamma exposure with exponential effect modifiers based on time since exposure and age at exposure. Among the major subtypes of leukemia, the excess risk of AML was the highest within the first 2-5 years of external exposure (ERR per Gy: 38.40; 90% CI: 13.92-121.4) and decreased substantially thereafter, but the risks remained statistically significant (ERR per Gy: 2.63; 90% CI: 0.07-12.55). In comparison, excess CML first occurred 5 years after exposure and decreased about 10 years after exposure, although the association was not statistically significant (ERR per Gy: 1.39; 90% CI: -0.22-7.32). The study found no evidence of an association between leukemia and occupational exposure to internal plutonium ERR per Gy 2.13; 90% CI: < 0-9.45). There was also no indication of any relationship with either external gamma or internal plutonium radiation exposure for either incidence of Hodgkin or non-Hodgkin lymphoma or multiplemyeloma.	[Kuznetsova, Irina S.; Labutina, Elena V.] SUBI, Ozyorsk, Chelyabinsk Reg, Russia; [Hunter, Nezahat] Ctr Radiat Chem & Environm Hazards CRCE, PHE, Chilton, Oxon, England	Southern Urals Biophysics Institute	Kuznetsova, IS (corresponding author), SUBI, Ozyorsk, Chelyabinsk Reg, Russia.	Kuznetsova@subi.su	Kuznetsova, Irina S./L-5569-2019; Kuznetsova, Irina S/D-3847-2019	Kuznetsova, Irina S./0000-0002-1214-295X; Kuznetsova, Irina S/0000-0002-1214-295X	European Commission though EC-SOLO project under EC SEVENTH FRAMEWORK PROGRAMME THEME: Radiation Protection Quantification of Risks for Low and Protracted Exposures [CP-IP: 249675]	European Commission though EC-SOLO project under EC SEVENTH FRAMEWORK PROGRAMME THEME: Radiation Protection Quantification of Risks for Low and Protracted Exposures	This work was supported by the European Commission though EC-SOLO project (CP-IP: 249675) under EC SEVENTH FRAMEWORK PROGRAMME THEME: Radiation Protection Quantification of Risks for Low and Protracted Exposures.	Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; Daniels RD, 2013, OCCUP ENVIRON MED, V70, P41, DOI 10.1136/oemed-2012-100906; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1; Hunter N, 2013, BRIT J CANCER, V109, P1989, DOI 10.1038/bjc.2013.543; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Krestinina LY, 2013, BRIT J CANCER, V109, P2886, DOI 10.1038/bjc.2013.614; Labutina EV, 2013, HEALTH PHYS, V105, P165, DOI 10.1097/HP.0b013e31828f57df; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Preston DL, 1998, EPICURE RELEASE 2 10; Richardson DB, 2007, AM J EPIDEMIOL, V166, P1015, DOI 10.1093/aje/kwm176; Richardson DB, 2009, AM J EPIDEMIOL, V169, P969, DOI 10.1093/aje/kwp018; Shilnikova NS, 2003, RADIAT RES, V159, P787, DOI 10.1667/0033-7587(2003)159[0787:CMRAWA]2.0.CO;2; Sokolnikov ME, 2013, INT J CANCER, V123, P905; United Nations Scientific Committee on the Effects of Atomic Radiation, 2011, SOURC EFF ION RAD UN; Vasilenko EK, AAHP SPEC SESS HLTH; *WHO, 1977, INT CLASS DIS INJ CA	19	22	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162710	10.1371/journal.pone.0162710	http://dx.doi.org/10.1371/journal.pone.0162710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631102	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900069
J	Lleo, A; Bian, ZL; Zhang, HY; Miao, Q; Yang, F; Peng, YS; Chen, XY; Tang, RQ; Wang, QX; Qiu, DK; Fang, JY; Sobacchi, C; Villa, A; Di Tommaso, L; Roncalli, M; Gershwin, ME; Ma, X; Invernizzi, P				Lleo, Ana; Bian, Zhaolian; Zhang, Haiyan; Miao, Qi; Yang, Fang; Peng, Yanshen; Chen, Xiaoyu; Tang, Ruqi; Wang, Qixia; Qiu, Dekai; Fang, Jingyuan; Sobacchi, Cristina; Villa, Anna; Di Tommaso, Luca; Roncalli, Massimo; Gershwin, M. Eric; Ma, Xiong; Invernizzi, Pietro			Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis	PLOS ONE			English	Article							KAPPA-B LIGAND; CELL IMMUNE-RESPONSES; RECEPTOR ACTIVATOR; AUTOIMMUNE CHOLANGITIS; DIFFERENTIATION FACTOR; OSTEOCLAST FORMATION; OSTEOPROTEGERIN; BONE; CIRRHOSIS; INFLAMMATION	There is substantial data that suggests an abnormality of innate immunity in patients with primary biliary cholangitis (PBC) which includes the transcription factor nuclear factor-kB (NF-kB) and well as downstream inflammatory signaling pathways. In addition, Immuno-Chip analysis has identified a novel PBC-associated locus near the receptor activator of NF-kB ligand (RANKL) gene. Based on these observations, we investigated the role of the RANKL axis in the liver of patients with PBC compared to controls. We used immunohistochemistry to quantitate liver expression of RANKL, its receptor (RANK), and importantly the decoy receptor osteoprotegerin (OPG), including a total of 122 liver samples (PBC = 37, primary sclerosing cholangitis = 20, autoimmune hepatitis = 26, chronic hepatitis B = 32 and unaffected controls = 7). In addition, we studied RANKL-RANK-OPG co-localization in CD4 and CD8 T cells, B cells, dendritic cells, macrophages, NK, NKT cells, hepatocytes, and cholangiocytes. We report herein that RANK is constitutively expressed by cholangiocytes in both unaffected and diseased liver. However, cholangiocytes from PBC express significantly higher levers of RANK than either the unaffected controls or liver diseased controls. CD4, CD8 and CD19 cells with in the portal areas around bile ducts in PBC express significantly higher levels of RANKL compared to controls. Importantly, the overall hepatic RANKL level and the ratio of hepatic RANKL/OPG correlated with disease severity in PBC. In conclusion, our data indicate a role of RANK-RANKL axis in the innate immune activation in PBC and we hypothesize that the damaged cholangiocytes, which express high levels of RANK, lead to the recruitment of RANKL positive cells and ultimately the classic portal tract infiltrates.	[Lleo, Ana; Invernizzi, Pietro] Humanitas Clin & Res Ctr, Liver Unit, Milan, Italy; [Lleo, Ana; Invernizzi, Pietro] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Milan, Italy; [Bian, Zhaolian; Zhang, Haiyan; Miao, Qi; Yang, Fang; Peng, Yanshen; Chen, Xiaoyu; Tang, Ruqi; Wang, Qixia; Qiu, Dekai; Fang, Jingyuan; Ma, Xiong] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Key Lab Gastroenterol & Hepatol,Shanghai Canc Ins, Div Gastroenterol & Hepatol,Ren Ji Hosp,Sch Med,M, Shanghai, Peoples R China; [Sobacchi, Cristina; Villa, Anna] CNR, Ist Ric Genet & Biomed, Milan, Italy; [Sobacchi, Cristina; Villa, Anna] Humanitas Clin & Res Ctr, Milan, Italy; [Di Tommaso, Luca; Roncalli, Massimo] Humanitas Clin & Res Ctr, Pathol Unit, Milan, Italy; [Di Tommaso, Luca; Roncalli, Massimo] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Gershwin, M. Eric; Invernizzi, Pietro] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Invernizzi, Pietro] Univ Milano Bicocca, Int Ctr Digest Hlth, Dept Med & Surg, Milan, Italy	Shanghai Jiao Tong University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Humanitas University; University of California System; University of California Davis; University of Milano-Bicocca	Invernizzi, P (corresponding author), Humanitas Clin & Res Ctr, Liver Unit, Milan, Italy.; Invernizzi, P (corresponding author), Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Milan, Italy.; Ma, X (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Key Lab Gastroenterol & Hepatol,Shanghai Canc Ins, Div Gastroenterol & Hepatol,Ren Ji Hosp,Sch Med,M, Shanghai, Peoples R China.; Gershwin, ME; Invernizzi, P (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.; Invernizzi, P (corresponding author), Univ Milano Bicocca, Int Ctr Digest Hlth, Dept Med & Surg, Milan, Italy.	megershwin@ucdavis.edu; maxiongmd@163.com; pietro.invernizzi@unimib.it	Lleo, Ana/AAA-5759-2019; Invernizzi, Pietro/AAB-8367-2022; SOBACCHI, CRISTINA/J-9345-2018	Lleo, Ana/0000-0002-0561-7902; Invernizzi, Pietro/0000-0003-3262-1998; SOBACCHI, CRISTINA/0000-0002-2684-7184; Ma, Xiong/0000-0001-9616-4672; di tommaso, luca/0000-0002-9013-4728; Roncalli, Massimo/0000-0002-7901-8910	National Natural Science Foundation of China [81170380, 81325002, 81421001, 81400608, 81200293]; Shanghai Jiaotong University School of Medicine [BXJ201321]; National Institutes of Health [DK39588]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039588] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiaotong University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by awards from the National Natural Science Foundation of China (#81170380 and #81325002 to Xiong Ma, #81421001 to Jingyuan Fang, #81400608 to Ruqi Tang and #81200293 to Qi Miao), the Doctoral Innovation Fund Projects from Shanghai Jiaotong University School of Medicine (BXJ201321 to Zhaolian Bian), and the National Institutes of Health grant (MEG), DK39588.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Akiyama T, 2012, WORLD J ORTHOP, V3, P142, DOI 10.5312/wjo.v3.i9.142; Ashcroft AJ, 2003, IMMUNITY, V19, P849, DOI 10.1016/S1074-7613(03)00326-1; Beuers U, 2015, HEPATOLOGY, V62, P1620, DOI 10.1002/hep.28140; Beuers U, 2015, CLIN REV ALLERG IMMU, V48, P127, DOI 10.1007/s12016-015-8484-9; Bianchi I, 2014, SEMIN LIVER DIS, V34, P255, DOI 10.1055/s-0034-1383725; Bowlus CL, 2014, AUTOIMMUN REV, V13, P441, DOI 10.1016/j.autrev.2014.01.041; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Chan AWH, 2014, HISTOPATHOLOGY, V65, P174, DOI 10.1111/his.12384; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Floreani A, 2015, CLIN REV ALLERG IMMU, V48, P263, DOI 10.1007/s12016-014-8456-5; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Guanabens N, 2009, J BONE MINER METAB, V27, P347, DOI 10.1007/s00774-009-0042-1; Guerrini MM, 2014, ARCH BIOCHEM BIOPHYS, V561, P118, DOI 10.1016/j.abb.2014.06.003; Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Huang WT, 2014, J AUTOIMMUN, V50, P123, DOI 10.1016/j.jaut.2014.01.034; Juran BD, 2012, HUM MOL GENET, V21, P5209, DOI 10.1093/hmg/dds359; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Kar SP, 2013, GENES IMMUN, V14, P179, DOI 10.1038/gene.2013.1; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Li YY, 2015, HEPATOLOGY, V61, P1998, DOI 10.1002/hep.27725; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lleo A, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0098-9; Lleo A, 2014, HEPATOLOGY, V60, P1314, DOI 10.1002/hep.27230; Moschen AR, 2005, GUT, V54, P479, DOI 10.1136/gut.2004.044370; Mousa HS, 2015, EXPERT OPIN PHARMACO, V16, P633, DOI 10.1517/14656566.2015.998650; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Shimoda S, 2015, HEPATOLOGY, V62, P1817, DOI 10.1002/hep.28122; Shimoda S, 2010, HEPATOLOGY, V51, P567, DOI 10.1002/hep.23318; Sirinian C, 2013, GENE, V525, P124, DOI 10.1016/j.gene.2013.04.075; Spanjol J, 2013, TRANSPL P, V45, P1766, DOI 10.1016/j.transproceed.2012.10.065; Stolina M, 2007, J IMMUNOL, V179, P7497, DOI 10.4049/jimmunol.179.11.7497; Sun Y, 2015, CLIN REV ALLERG IMMU, V48, P285, DOI 10.1007/s12016-014-8449-4; Szalay F, 2003, J HEPATOL, V38, P395, DOI 10.1016/S0168-8278(02)00435-X; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tanaka H, 2015, CLIN EXP IMMUNOL, V180, P371, DOI 10.1111/cei.12581; Tanaka H, 2014, CLIN EXP IMMUNOL, V178, P253, DOI 10.1111/cei.12415; Tsushima H, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0532-6; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Wang YH, 2015, J AUTOIMMUN, V59, P26, DOI 10.1016/j.jaut.2015.01.011; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wright HL, 2009, CURR REV MUSCULOSKE, V2, P56, DOI 10.1007/s12178-009-9046-7; Yao Y, 2014, J AUTOIMMUN, V51, P99, DOI 10.1016/j.jaut.2014.02.009; You ZR, 2012, J AUTOIMMUN, V39, P216, DOI 10.1016/j.jaut.2012.05.022; Zhang HY, 2015, DIGEST DIS, V33, P94, DOI 10.1159/000440754; Zhang J, 2014, HEPATOLOGY, V60, P1708, DOI 10.1002/hep.27313; Ziolkowska M, 2002, ARTHRITIS RHEUM-US, V46, P1744, DOI 10.1002/art.10388	56	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159612	10.1371/journal.pone.0159612	http://dx.doi.org/10.1371/journal.pone.0159612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631617	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900002
J	Moreno-Dominguez, R; Cascales-Minana, B; Ferrer, J; Diez, JB				Moreno-Dominguez, Rafael; Cascales-Minana, Borja; Ferrer, Javier; Diez, Jose B.			Acrostichum, a Pioneering Fern of Floodplain Areas from the Late Oligocene Sarinena Formation of the Iberian Peninsula	PLOS ONE			English	Article							MANGROVE FERN; CAINOZOIC FERNS; SOIL-SALINITY; EBRO BASIN; DISTURBANCES; VEGETATION; SPAIN; WATER	Acrostichum is considered today an opportunistic fern in disturbed areas, which indicates the first stages of colonisation of such zones. However, in the fossil record, Acrostichum appears related to fluvio-lacustrine environments, freshwater marshes and mangrove deposits. We report here for first time fossil evidence of Acrostichum that reveals a pioneering behaviour of this fern in the colonisation of perturbed communities in Europe, which corroborates previous assumptions about the paleobiology of Acrostichum. Plant remains were collected from the Chattian (late Oligocene) La Val fossil site (Estadilla, Huesca, northeastern Spain) belonging to the Sarinena Formation, which mainly embraces crevasse splays, levees and floodplain deposits. Evidence shows that Acrostichum grew within the levee's vegetal community or close to/on the river banks as well as on floodplain areas and closer to/on the shores of ephemeral ponds. But most importantly, the observed co-existence of Equisetum and Acrostichum remains in the same beds indicates that such strata represent short-lived inundated terrains, e.g., floodplains where the water table was temporarily stagnant. Evidence shows wetland environments dominated by pioneering taxa, implying a pioneering role for Acrostichum during the late Oligocene in the Iberian Peninsula.	[Moreno-Dominguez, Rafael; Ferrer, Javier] Univ Zaragoza, Area Paleontol, Dept Ciencias Tierra, E-50009 Zaragoza, Spain; [Cascales-Minana, Borja] Univ Liege, PPP, Dept Geol, Allee 6 Aout,B18 Sart Tilman, B-4000 Liege, Belgium; [Diez, Jose B.] Univ Vigo, Dpto Geociencias Marinas & Ordenac Terr, Campus Lagoas Marcosende, Vigo 36200, Spain	University of Zaragoza; University of Liege; Universidade de Vigo	Moreno-Dominguez, R (corresponding author), Univ Zaragoza, Area Paleontol, Dept Ciencias Tierra, E-50009 Zaragoza, Spain.; Cascales-Minana, B (corresponding author), Univ Liege, PPP, Dept Geol, Allee 6 Aout,B18 Sart Tilman, B-4000 Liege, Belgium.	noctubre7@gmail.com; bcascales@ulg.ac.be	Diez, Jose B./L-1004-2014	Diez, Jose B./0000-0001-5739-7270; MORENO-DOMINGUEZ, RAFAEL/0000-0002-3602-3410	Marie Curie COFUND Project - University of Liege [600405]; Marie Curie COFUND Postdoctoral Fellowship from the University of Liege [600405]	Marie Curie COFUND Project - University of Liege; Marie Curie COFUND Postdoctoral Fellowship from the University of Liege	This work has been funded by a Marie Curie COFUND Project - University of Liege (grant number: 600405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jose Francisco Lisa Blanco for his assistance during fieldworks. We also thank Arsenio Munoz (University of Zaragoza) for his helpful comments about the sedimentary structures. The constructive comments provided by the two anonymous referees are also acknowledged. This work has been funded by a Marie Curie COFUND Postdoctoral Fellowship from the University of Liege (BCM, grant number: 600405).	Alvarez Ramis C., 1987, B I GEOL MINER ESPAN, V98, P349; Alvarez Ramis C., 1986, B SOC HIST NATURAL B, V30, P83; alvarez-Rami C, 1982, ACTA GEOL HISP, V17, P5; Alvarez-Ramis C, 1995, C PALEONTOLOGIA, V47, P193; Arenas C., 2004, GEOLOG A ESPA A, P343; ARENES J., 1951, BOL R SOC ESPANOLA HIST NAT SEC GEOL, V49, P73; Arenes J., 1956, REV GEN BOT, V63, P347; Arnold C. A., 1963, CONTRIBUTIONS MUSEUM, V18, P205; AWASTHI N, 1996, PALEOBOTANIST, V43, P83; Bataller JR, 1950, ANALES ESC PERITOS A, V9, P3; Bauza-Rullan J, 1961, ESTUD GEOL, V17, P161; Bonde SD, 2002, REV PALAEOBOT PALYNO, V120, P285, DOI 10.1016/S0034-6667(02)00081-7; BUNT JS, 1982, AUST J BOT, V30, P401, DOI 10.1071/BT9820401; COLLENETTE I S, 1991, Fern Gazette, V14, P57; Collinson ME, 2002, REV PALAEOBOT PALYNO, V119, P51, DOI 10.1016/S0034-6667(01)00129-4; Collinson ME, 2001, BRITTONIA, V53, P173, DOI 10.1007/BF02812700; Depape G., 1931, B I CATALANA HIST NA, V31, P194; Dufour S, 2010, GEOMORPHOLOGIE, P371; Fernandez Marron M.T, 1971, THESIS U MADRID SPAI; Fliche P., 1908, BUTLLETI I CATALANA, V7, P77; Massini JLG, 2006, INT J PLANT SCI, V167, P909; Massini JLG, 2011, REV PALAEOBOT PALYNO, V164, P211, DOI 10.1016/j.revpalbo.2010.12.003; Garcia-Massini JL, 2010, PALAEONTOL ELECTRON, V13, p16A; Hamer JMM, 2007, PALAEOGEOGR PALAEOCL, V247, P220, DOI 10.1016/j.palaeo.2006.10.016; Hirst J. P. P., 1983, THESIS; Husby CE, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr022; Jarzen DM, 2009, GRANA, V48, P136, DOI 10.1080/00173130902797188; Luzon A, 2005, SEDIMENT GEOL, V177, P19, DOI 10.1016/j.sedgeo.2005.01.013; Luzon A, 1998, GEOGACETA, V24, P195; Martin-Closas C, 2004, GEOBIOS-LYON, V37, P65, DOI 10.1016/j.geobios.2003.01.006; MARTINCLOSAS C, 1995, GEOBIOS, V18, P287, DOI DOI 10.1016/S0016-6995(95)80175-8; MEDINA E, 1990, BOT GAZ, V151, P41, DOI 10.1086/337803; NAIMAN R. J., 2001, RIVER ECOLOGY MANAGE, P289, DOI DOI 10.1007/978-1-4612-1652-0_12; Nichols G.J., 2009, SEDIMENTOLOGY STRATI; Nooteboom HP, 2012, FLORA MALESIANA 2, V4, P137; Pardo G., 1989, REV SOC GEOL ESPAN, V2, P199; Sanz de Siria A., 1992, TREB MUS GEOL BARCEL, V2, P269; Sharpe JM, 2010, WETL ECOL MANAG, V18, P57, DOI 10.1007/s11273-009-9148-4; Siti Nurfazilah Abdul Rahman, 2010, [湿地科学, Wetland Science], V8, P48; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; SPICER RA, 1989, ADV BOT RES, V16, P95; Srivastava G., 2014, SPECIAL PUBLICATION, V5, P283; TAYLOR FJ, 1986, BLUMEA, V31, P271; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Ukpong, 1997, MANGROVES SALT MARSH, V1, P211, DOI [10.1023/A:1009952700317, DOI 10.1023/A:1009952700317]; Vicente-Castells JV, 1965, RECERCA FLORA EOCENI, P3; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74	47	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162334	10.1371/journal.pone.0162334	http://dx.doi.org/10.1371/journal.pone.0162334			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631099	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900039
J	Rabellino, D; Densmore, M; Frewen, PA; Theberge, J; McKinnon, MC; Lanius, RA				Rabellino, Daniela; Densmore, Maria; Frewen, Paul A.; Theberge, Jean; McKinnon, Margaret C.; Lanius, Ruth A.			Aberrant Functional Connectivity of the Amygdala Complexes in PTSD during Conscious and Subconscious Processing of Trauma-Related Stimuli	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANXIETY DISORDER; FEAR; RESPONSES; CORTEX; BRAIN; ACTIVATION; METAANALYSIS; SUBREGIONS; WOMEN	Post-traumatic stress disorder (PTSD) is characterized by altered functional connectivity of the amygdala complexes at rest. However, amygdala complex connectivity during conscious and subconscious threat processing remains to be elucidated. Here, we investigate specific connectivity of the centromedial amygdala (CMA) and basolateral amygdala (BLA) during conscious and subconscious processing of trauma-related words among individuals with PTSD (n = 26) as compared to non-trauma-exposed controls (n = 20). Psycho-physiological interaction analyses were performed using the right and left amygdala complexes as regions of interest during conscious and subconscious trauma word processing. These analyses revealed a differential, context-dependent responses by each amygdala seed during trauma processing in PTSD. Specifically, relative to controls, during subconscious processing, individuals with PTSD demonstrated increased connectivity of the CMA with the superior frontal gyrus, accompanied by a pattern of decreased connectivity between the BLA and the superior colliculus. During conscious processing, relative to controls, individuals with PTSD showed increased connectivity between the CMA and the pulvinar. These findings demonstrate alterations in amygdala subregion functional connectivity in PTSD and highlight the disruption of the innate alarm network during both conscious and subconscious trauma processing in this disorder.	[Rabellino, Daniela; Densmore, Maria; Frewen, Paul A.; Theberge, Jean; Lanius, Ruth A.] Univ Western Ontario, Dept Psychiat, London, ON, Canada; [Densmore, Maria; Theberge, Jean; Lanius, Ruth A.] Lawson Hlth Res Inst, Imaging Div, London, ON, Canada; [Frewen, Paul A.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Frewen, Paul A.; Lanius, Ruth A.] Univ Western Ontario, Dept Neurosci, London, ON, Canada; [Theberge, Jean] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [McKinnon, Margaret C.] St Josephs Healthcare, Mood Disorders Program, Hamilton, ON, Canada; [McKinnon, Margaret C.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [McKinnon, Margaret C.] Homewood Res Inst, Guelph, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University	Lanius, RA (corresponding author), Univ Western Ontario, Dept Psychiat, London, ON, Canada.; Lanius, RA (corresponding author), Lawson Hlth Res Inst, Imaging Div, London, ON, Canada.; Lanius, RA (corresponding author), Univ Western Ontario, Dept Neurosci, London, ON, Canada.	ruth.lanius@lhsc.on.ca	McKinnon, Margaret/AAT-5821-2021; Lanius, Ruth A/J-6961-2015; Theberge, Jean/A-3087-2008	McKinnon, Margaret/0000-0002-8315-7657; Lanius, Ruth A/0000-0002-3758-1393; Theberge, Jean/0000-0001-7578-4469	Canadian Institutes of Health Research [MOP97914]; MITACS; Homewood Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MITACS; Homewood Research Institute	This study was supported by the Canadian Institutes of Health Research (#MOP97914). Daniela Rabellino was supported by fellowship from MITACS and Homewood Research Institute. Canadian Institutes of Health Research: http://www.cihr-irsc.gc.ca/e/193.html. RL MITACS http://www.mitacs.ca/en. DR. Homewood Research Institute http://www.homewoodresearch.org/DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Briere J., 2002, MULTISCALE DISSOCIAT; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Bryant RA, 2008, HUM BRAIN MAPP, V29, P517, DOI 10.1002/hbm.20415; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dijksterhuis A, 2003, PSYCHOL SCI, V14, P14, DOI 10.1111/1467-9280.t01-1-01412; Duvarci S, 2014, NEURON, V82, P966, DOI 10.1016/j.neuron.2014.04.042; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Felmingham K, 2008, PSYCHOL MED, V38, P1771, DOI 10.1017/S0033291708002742; First MB, 2002, STRUCTURED CLIN INTE; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fruhholz S, 2013, CORTEX, V49, P1394, DOI 10.1016/j.cortex.2012.08.003; Gilboa A, 2004, BIOL PSYCHIAT, V55, P263, DOI 10.1016/j.biopsych.2003.08.004; Jin C, 2014, PSYCHOL MED, V44, P1927, DOI 10.1017/S003329171300250X; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kemp AH, 2009, PSYCHIAT RES-NEUROIM, V174, P158, DOI 10.1016/j.pscychresns.2009.04.012; Kozlowska K, 2015, HARVARD REV PSYCHIAT, V23, P263, DOI 10.1097/HRP.0000000000000065; Lanius UF, 2014, NEUROBIOLOGY TREATM; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Li L, 2016, EBIOMEDICINE, V4, P176, DOI 10.1016/j.ebiom.2016.01.012; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Merker B, 2007, BEHAV BRAIN SCI, V30, P63, DOI 10.1017/S0140525X07000891; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Nicholson AA, 2015, NEUROPSYCHOPHARMACOL, V40, P2317, DOI 10.1038/npp.2015.79; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Protopopescu X, 2005, BIOL PSYCHIAT, V57, P464, DOI 10.1016/j.biopsych.2004.12.026; Rabellino D, 2015, ACTA PSYCHIAT SCAND, V132, P365, DOI 10.1111/acps.12418; Rabellino D, 2016, PSYCHIAT RES-NEUROIM, V248, P142, DOI 10.1016/j.pscychresns.2015.12.005; Rabinak Christine A, 2011, Front Psychiatry, V2, P62, DOI 10.3389/fpsyt.2011.00062; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Reber TP, 2012, J NEUROSCI, V32, P6138, DOI 10.1523/JNEUROSCI.5639-11.2012; Roy AK, 2009, NEUROIMAGE, V45, P614, DOI 10.1016/j.neuroimage.2008.11.030; Sakamoto H, 2005, NEUROIMAGE, V26, P813, DOI 10.1016/j.neuroimage.2005.02.032; Sripada RK, 2012, J PSYCHIATR NEUROSCI, V37, P241, DOI 10.1503/jpn.110069; Steuwe C, 2014, SOC COGN AFFECT NEUR, V9, P88, DOI 10.1093/scan/nss105; Steuwe C, 2015, PSYCHIAT RES-NEUROIM, V232, P162, DOI 10.1016/j.pscychresns.2015.02.010; Stevens JS, 2013, J PSYCHIATR RES, V47, P1469, DOI 10.1016/j.jpsychires.2013.05.031; Williams LM, 2006, HUM BRAIN MAPP, V27, P652, DOI 10.1002/hbm.20208; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	52	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163097	10.1371/journal.pone.0163097	http://dx.doi.org/10.1371/journal.pone.0163097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631496	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900131
J	Ansari, MA; Fatima, Z; Hameed, S				Ansari, Moiz A.; Fatima, Zeeshan; Hameed, Saif			Anticandidal Effect and Mechanisms of Monoterpenoid, Perillyl Alcohol against Candida albicans	PLOS ONE			English	Article							CELL-WALL INTEGRITY; CANCER-CELLS; CALCINEURIN; VIRULENCE; STRESS; TOLERANCE; INSIGHTS; GROWTH; MITOCHONDRIAL; MORPHOGENESIS	This study explored the antifungal potential of perillyl alcohol (PA), a natural monoterpene alcohol, against most prevalent human fungal pathogen C. albicans, its clinical isolates and four non-albicans species of Candida. To resolve the potential mechanisms, we used whole genome transcriptome analyses of PA treated Candida cells to examine the affected cellular circuitry of this pathogen. The transcriptome data revealed a link between calcineurin signaling and PA as among the several categories of PA responsive genes the down regulation of calcineurin signaling gene CNB1 was noteworthy which was also confirmed by both molecular docking and susceptibility assays. We observed that PA treated Candida phenocopied compromised calcineurin pathway stress responses and turned sensitive to alkaline pH, ionic, membrane, salinity, endoplasmic reticulum and serum stresses. Indispensability of functional calcineurin was further confirmed as calcineurin mutant was hypersensitive to PA while constitutively expressed calcineurin strain remained resistant. We explored that PA leads to perturbed membrane integrity as depicted through depleted ergosterol levels and disrupted pH homeostasis. Moreover, PA caused cell wall damage which was evident from hypersensitivity against cell wall perturbing agents (congo red, cal-coflour white), SEM and enhanced rate of cell sedimentation. Furthermore, PA inhibited potential virulence traits including morphological transition, biofilm formation and displayed diminished capacity to adhere both to the polystyrene surface and buccal epithelial cells. The study also revealed that PA leads to cell cycle arrest and mitochondrial dysfunction in C. albicans. Together, the present study provides enough evidence for furtherwork on PA so that better strategies could be employed to treat Candida infections.	[Ansari, Moiz A.; Fatima, Zeeshan; Hameed, Saif] Amity Univ Haryana, Amity Inst Biotechnol, Gurgaon 122413, Manesar, India		Fatima, Z; Hameed, S (corresponding author), Amity Univ Haryana, Amity Inst Biotechnol, Gurgaon 122413, Manesar, India.	drzeeshanfatima@gmail.com; saifhameed@yahoo.co.in		ANSARI, MOIZ/0000-0002-4817-0119	Science and Engineering Research Board (SERB), New Delhi [SR/FT/LS-12/2012]	Science and Engineering Research Board (SERB), New Delhi	S.H. is thankful for the financial assistance in the form of Young Scientist award (SR/FT/LS-12/2012) from Science and Engineering Research Board (SERB), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KJ, 2003, INT J RADIAT ONCOL, V57, P813, DOI 10.1016/S0360-3016(03)00737-5; Andaluz E, 2006, MOL MICROBIOL, V59, P1452, DOI 10.1111/j.1365-2958.2005.05038.x; [Anonymous], 2008, M27A3 NAT COMM CLIN; Ansari M.A., 2013, MICROBIAL PATHOGENS, V1, P1189, DOI DOI 10.1155/2014/895193; Ansari MA, 2016, MICROB PATHOGENESIS, V98, P140, DOI 10.1016/j.micpath.2016.07.004; Bader T, 2003, INFECT IMMUN, V71, P5344, DOI 10.1128/IAI.71.9.5344-5354.2003; Bader T, 2006, INFECT IMMUN, V74, P4366, DOI 10.1128/IAI.00142-06; Belanger J T, 1998, Altern Med Rev, V3, P448; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Blankenship JR, 2005, INFECT IMMUN, V73, P5767, DOI 10.1128/IAI.73.9.5767-5774.2005; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Chen HG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123176; Chen TC, 2014, MOL CANCER THER, V13, P1181, DOI 10.1158/1535-7163.MCT-13-0882; Chen YL, 2012, G3-GENES GENOM GENET, V2, P675, DOI 10.1534/g3.112.002279; Chen YL, 2011, EUKARYOT CELL, V10, P803, DOI 10.1128/EC.00310-10; Ciudad T, 2004, MOL MICROBIOL, V53, P1177, DOI 10.1111/j.1365-2958.2004.04197.x; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; de Castro Patricia Alves, 2014, PLoS One, V9, pe103957, DOI 10.1371/journal.pone.0103957; Desai JV, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0005-2014; Gerontides AS, 1999, GENE DEV, V13, P798; Hameed Saif, 2013, Int J Microbiol, V2013, P240209, DOI 10.1155/2013/240209; Heilmann CJ, 2013, EUKARYOT CELL, V12, P254, DOI 10.1128/EC.00278-12; Islahudin F, 2013, ANTIMICROB AGENTS CH, V57, P3889, DOI 10.1128/AAC.00478-13; KAUR S, 1988, BIOCHIM BIOPHYS ACTA, V972, P277, DOI 10.1016/0167-4889(88)90202-9; Kumar A, 2014, ANTIMICROB AGENTS CH, V58, P167, DOI 10.1128/AAC.01385-13; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lopes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072203; Manzoor Nikhat, 2002, Indian Journal of Experimental Biology, V40, P785; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; Meadows SM, 2002, J GASTROINTEST CANC, V32, P125, DOI 10.1385/IJGC:32:2-3:125; Mielniczki-Pereira AA, 2011, TOXICOL LETT, V207, P104, DOI 10.1016/j.toxlet.2011.08.023; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Noble SM, 2013, CURR OPIN MICROBIOL, V16, P708, DOI 10.1016/j.mib.2013.09.006; Ofir A, 2010, EUKARYOT CELL, V9, P1311, DOI 10.1128/EC.00038-10; Pittman JK, 2004, MOL MICROBIOL, V54, P1104, DOI 10.1111/j.1365-2958.2004.04332.x; Prasad R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00202; Rizvi SMD, 2013, EXCLI J, V12, P831; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Saibabu V, 2015, ADV PHARMACOL SCI, V2015, DOI 10.1155/2015/823539; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sarkar S, 2014, CURR MOL MED, V14, P125, DOI 10.2174/1566524013666131118110827; Singh S, 2016, ARCH MICROBIOL, V198, P459, DOI 10.1007/s00203-016-1205-9; Singh Shweta, 2015, Infez Med, V23, P211; Tanwar Jyoti, 2014, Interdiscip Perspect Infect Dis, V2014, P541340, DOI 10.1155/2014/541340; Thomas E, 2013, ANTIMICROB AGENTS CH, V57, P5580, DOI 10.1128/AAC.00889-13; Tournu H, 2005, CURR DRUG TARGETS, V6, P909, DOI 10.2174/138945005774912690; Tsang PWK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050866; Yeruva L, 2010, ANTI-CANCER DRUG, V21, P1, DOI 10.1097/CAD.0b013e32832a68ad; Yu QL, 2014, FEMS YEAST RES, V14, P1037, DOI 10.1111/1567-1364.12194; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008; Zoric N, 2013, CURR DRUG TARGETS, V14, P992, DOI 10.2174/13894501113149990167	54	31	34	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162465	10.1371/journal.pone.0162465	http://dx.doi.org/10.1371/journal.pone.0162465			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627759	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600035
J	Pingel, S; Passon, SG; Pausewang, KS; Blatzheim, AK; Pizarro, C; Tuleta, I; Gliem, M; Issa, PC; Schahab, N; Nickenig, G; Skowasch, D; Schaefer, CA				Pingel, Simon; Passon, Sebastian Gorgonius; Pausewang, Kristin Solveig; Blatzheim, Anna Katharina; Pizarro, Carmen; Tuleta, Izabela; Gliem, Martin; Issa, Peter Charbel; Schahab, Nadjib; Nickenig, Georg; Skowasch, Dirk; Schaefer, Christian Alexander			Pseudoxanthoma Elasticum - Also a Lung Disease? The Respiratory Affection of Patients with Pseudoxanthoma Elasticum	PLOS ONE			English	Article							ECTOPIC MINERALIZATION; CALCIFICATION; DISORDERS	Background Pseudoxanthoma elasticum (PXE) is an autosomal-recessive mineralisation disorder caused by loss of function mutations in the ABCC6 Gen. Histological findings and data of an autopsy of a PXE-patient suggest a possible pulmonal calcification. So far, there exists no clinical data whether PXE patients actually are at high risk of developing pulmonary disorder. Methods In a cross-sectional study, 35 PXE patients and 15 healthy controls underwent a pulmonary function testing, including spirometry, body plethysmography and carbon monoxide diffusing test. Additionally, PXE patients completed a COPD-Assessment-Test (CAT). Results We observed in PXE patients normal values for predicted vital capacity (VC%; 96.0 +/- 13.0%), predicted total lung capacity (TLC%; 98.2 +/- 12.0%) and predicted forced expiration volume (FEV1%; 102.5 +/- 15.6%), whereas compared to healthy controls the PXE group showed significant diminished values for carbon monoxide diffusing capacity (DLCO, 7.2 +/- 1.4 mmol/min/kPa vs. 8.6 +/- 1.5 mmol/min/kPa; p = 0.008) and predicted carbon monoxide diffusing capacity (DLCO%; 79.7 +/- 11.5% vs. 87.2 +/- 6.6%; p = 0.008). 11/35 (31.4%) PXE patients showed pathological DLCO% values under 75% (68.5%+/- 5.4%). Conclusion PXE patients demonstrated a regular lung function testing, but nevertheless they had impaired CO diffusing parameters, which might be associated with a preclinical state of an interstitial lung disease and a risk for restrictive ventilation disorders.	[Pingel, Simon; Passon, Sebastian Gorgonius; Pausewang, Kristin Solveig; Blatzheim, Anna Katharina; Pizarro, Carmen; Tuleta, Izabela; Schahab, Nadjib; Nickenig, Georg; Skowasch, Dirk; Schaefer, Christian Alexander] Univ Bonn, Dept Internal Med 2, Bonn, North Rhine Wes, Germany; [Gliem, Martin; Issa, Peter Charbel] Univ Bonn, Dept Ophthalmol, Bonn, North Rhine Wes, Germany	University of Bonn; University of Bonn	Pingel, S (corresponding author), Univ Bonn, Dept Internal Med 2, Bonn, North Rhine Wes, Germany.	simon.pingel@ukb.uni-bonn.de	Issa, Peter Charbel/O-2580-2019; Issa, Peter Charbel/E-8935-2018	Issa, Peter Charbel/0000-0002-0351-6673; Issa, Peter Charbel/0000-0002-0351-6673				Bodolay E, 2005, RHEUMATOLOGY, V44, P656, DOI 10.1093/rheumatology/keh575; Campens L, 2013, ARTERIOSCL THROM VAS, V33, P2646, DOI 10.1161/ATVBAHA.113.301901; Finger RP, 2009, RETINA-J RET VIT DIS, V29, P1496, DOI 10.1097/IAE.0b013e3181aade47; Gliem M, 2014, AM J OPHTHALMOL, V158, P198, DOI 10.1016/j.ajo.2014.04.005; JACKSON A, 1980, HISTOPATHOLOGY, V4, P607, DOI 10.1111/j.1365-2559.1980.tb02956.x; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jansen RS, 2013, P NATL ACAD SCI USA, V110, P20206, DOI 10.1073/pnas.1319582110; Kornet L, 2004, ULTRASOUND MED BIOL, V30, P1041, DOI 10.1016/j.ultrasmedbio.2004.06.004; Leftheriotis Georges, 2013, Frontiers in Genetics, V4, P4, DOI 10.3389/fgene.2013.00004; Li QL, 2014, MATRIX BIOL, V33, P23, DOI 10.1016/j.matbio.2013.06.003; Marconi B, 2015, INTRACTABLE RARE DIS, V4, P113, DOI 10.5582/irdr.2015.01014; Miki K, 2007, MED MOL MORPHOL, V40, P172, DOI 10.1007/s00795-007-0368-5; Roach E Steve, 2015, Handb Clin Neurol, V132, P215, DOI 10.1016/B978-0-444-62702-5.00015-9; Uitto J, 2014, EXPERT OPIN ORPHAN D, V2, P567, DOI 10.1517/21678707.2014.908702; Xue P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097360; Yamamoto N, 1996, Nihon Kyobu Shikkan Gakkai Zasshi, V34, P716	16	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162337	10.1371/journal.pone.0162337	http://dx.doi.org/10.1371/journal.pone.0162337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622520	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000025
J	Cho, JS; Fang, TC; Reynolds, TL; Sofia, DJ; Hamann, S; Burkly, LC				Cho, John S.; Fang, Terry C.; Reynolds, Taylor L.; Sofia, Daniel J.; Hamann, Stefan; Burkly, Linda C.			PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; INTERFERON; EXPRESSION; THERAPY; SKIN; SCLERODERMA; ACTIVATION; RESPONSES; ASSOCIATION	Systemic sclerosis (SSc) is a chronic autoimmune disorder that can result in extensive tissue damage in the skin and, in advanced cases, internal organs. Vasculopathy, aberrant immune activation, and tissue fibrosis are three hallmarks of the disease that have been identified, with vasculopathy and aberrant immunity being amongst the earliest events. However, a mechanistic link between these processes has not been established. Here, we have identified a novel role of platelet derived growth factor-BB (PDGF-BB)/PDGFR beta activation in combination with dermal injury induced by bleomycin as a driver of early, aberrant expression of interferon stimulatory genes (ISGs) and inflammatory monocyte infiltration. Activation of PDGFR beta in combination with bleomycin-induced dermal injury resulted in increased dermal thickness, vascular density, monocyte/macrophage infiltration, and exacerbation of tissue injury. Many of these features were dependent on IFNAR-signaling, and an increase in the number of interferon-beta (IFN-beta) producing monocytes cells was found in the skin lesions. Taken together, these results identify a novel link between PDGFR beta activation, and Type I IFN-driven vascular maintenance and monocyte/macrophage cell recruitment, and provide a potential explanation linking key features of SSc that were previously thought to be unrelated.	[Cho, John S.; Fang, Terry C.; Burkly, Linda C.] Biogen, Immunol Res, Cambridge, MA 02142 USA; [Reynolds, Taylor L.; Sofia, Daniel J.; Hamann, Stefan] Biogen, Translat Sci Pathol, Cambridge, MA USA	Biogen; Biogen	Cho, JS; Burkly, LC (corresponding author), Biogen, Immunol Res, Cambridge, MA 02142 USA.	johncho@outlook.com; linda.burkly@biogen.com			Biogen	Biogen(Biogen)	This study was funded by Biogen. The funder provided support in the form of salaries for authors [JC, TF, TR, DS, SH, and LB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; [Anonymous], 2011, DIGITAL ISCHEMIC NEC, V2, P6, DOI [10.4292/wjgpt.v2.i1.6, DOI 10.4292/WJGPT.V2.I1.6]; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Barth PG, 1999, ACTA NEUROPATHOL, V98, P212, DOI 10.1007/s004010051071; Beyer C, 2010, ARTHRITIS RHEUM-US, V62, P2831, DOI 10.1002/art.27647; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Distler O, 2004, CIRC RES, V95, P109, DOI 10.1161/01.RES.0000134644.89917.96; Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939; Eloranta ML, 2010, ANN RHEUM DIS, V69, P1396, DOI 10.1136/ard.2009.121400; Fang F, 2013, J IMMUNOL, V191, P2956, DOI 10.4049/jimmunol.1300376; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; Fleming JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001452; GAY S, 1989, J INVEST DERMATOL, V92, P301, DOI 10.1111/1523-1747.ep12276895; Gordon JK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0721-3; ISHIKAWA O, 1992, J RHEUMATOL, V19, P1202; Katsumoto TR, 2011, ANNU REV PATHOL-MECH, V6, P509, DOI 10.1146/annurev-pathol-011110-130312; KLARESKOG L, 1990, ARTHRITIS RHEUM, V33, P1534, DOI 10.1002/art.1780331011; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Maurer B, 2014, ANN RHEUM DIS, V73, P1880, DOI 10.1136/annrheumdis-2013-203535; Maurer B, 2013, ANN RHEUM DIS, V72, P2039, DOI 10.1136/annrheumdis-2013-203729; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Rajkumar VS, 1999, ARTHRITIS RHEUM-US, V42, P930, DOI 10.1002/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1; Rice LM, 2015, J CLIN INVEST, V125, P2795, DOI 10.1172/JCI77958; Solans R, 2004, CLIN EXP RHEUMATOL, V22, P625; Tahara H, 2007, INTERNAL MED, V46, P473, DOI 10.2169/internalmedicine.46.6328; Trojanowska M, 2008, RHEUMATOLOGY, V47, pV2, DOI 10.1093/rheumatology/ken265; Wu MH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00266; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162758	10.1371/journal.pone.0162758	http://dx.doi.org/10.1371/journal.pone.0162758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618690	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100049
J	Desjardins, D; Liu, YY; Crosson, CE; Ablonczy, Z				Desjardins, Danielle; Liu, Yueying; Crosson, Craig E.; Ablonczy, Zsolt			Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; ENDOTHELIAL GROWTH-FACTOR; INDUCED VASCULAR LEAKAGE; IN-VIVO; 14-YEAR INCIDENCE; OCULAR DISEASE; RETINOPATHY; VEGF; HDAC6; MICROTUBULES	In diabetic individuals, macular edema is a major cause of vision loss. This condition is refractory to insulin therapy and has been attributed to metabolic memory. The retinal pigment epithelium (RPE) is central to maintaining fluid balance in the retina, and this function is compromised by the activation of advanced glycation end-product receptors (RAGE). Here we provide evidence that acute administration of the RAGE agonist, glycated-albumin (gAlb) or vascular endothelial growth factor (VEGF), increased histone deacetylase (HDAC) activity in RPE cells. The administration of the class I/II HDAC inhibitor, trichostatin-A (TSA), suppressed gAlb-induced reductions in RPE transepithelial resistance (in vitro) and fluid transport (in vivo). Systemic TSA also restored normal RPE fluid transport in rats with subchronic hyperglycemia. Both gAlb and VEGF increased HDAC activity and reduced acetyl-a-tubulin levels. Tubastatin-A, a relatively specific antagonist of HDAC6, inhibited gAlb-induced changes in RPE cell resistance. These data are consistent with the idea that RPE dysfunction following exposure to gAlb, VEGF, or hyperglycemia is associated with increased HDAC6 activity and decreased acetyl-a-tubulin. Therefore, we propose inhibiting HDAC6 in the RPE as a potential therapy for preserving normal fluid homeostasis in the hyperglycemic retina.	[Desjardins, Danielle; Liu, Yueying; Crosson, Craig E.; Ablonczy, Zsolt] Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	Medical University of South Carolina	Ablonczy, Z (corresponding author), Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA.	ablonczy@musc.edu			National Institutes of Health [EY019065, EY021368, UL1 TR000062, T32 HL7260-37, F30 EY025465]; Ola B. Williams Foundation; Research to Prevent Blindness, New York, NY; NATIONAL EYE INSTITUTE [R01EY021368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ola B. Williams Foundation; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health (nih.gov): EY019065 (ZA), EY021368 (CEC), UL1 TR000062 (DD), T32 HL7260-37 (DD), F30 EY025465 (DD); The Ola B. Williams Foundation (http://academicdepartments.musc.edu/foundation, CEC); and an unrestricted grant to the Department of Ophthalmology, Medical University of South Carolina, from Research to Prevent Blindness, New York, NY (http://www.rpbusa.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Ablonczy Z, 2014, FASEB J, V28, P2369, DOI 10.1096/fj.13-248021; Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Zapata MA, 2010, BRIT J OPHTHALMOL, V94, P1230, DOI 10.1136/bjo.2009.171702; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bhagat N, 2009, SURV OPHTHALMOL, V54, P1, DOI 10.1016/j.survophthal.2008.10.001; Bordin M, 2004, MOL CANCER RES, V2, P692; Boulton M, 1998, BRIT J OPHTHALMOL, V82, P561, DOI 10.1136/bjo.82.5.561; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chan N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120587; Chen E, 2010, CURR MED RES OPIN, V26, P1587, DOI 10.1185/03007995.2010.482503; Chen SL, 2010, AM J PHYSIOL-ENDOC M, V298, pE127, DOI 10.1152/ajpendo.00432.2009; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Dahrouj M, 2015, EXP EYE RES, V137, P50, DOI 10.1016/j.exer.2015.06.004; Dahrouj M, 2014, INVEST OPHTH VIS SCI, V55, P2269, DOI 10.1167/iovs.13-13334; Dai Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/486386; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Desjardins DM, 2016, INVEST OPHTH VIS SCI, V57, P2706, DOI 10.1167/iovs.15-18397; Edelman JL, 2005, EXP EYE RES, V80, P249, DOI 10.1016/j.exer.2004.09.013; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; FERRIS FL, 1993, JAMA-J AM MED ASSOC, V269, P1290, DOI 10.1001/jama.269.10.1290; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Glotfelty LG, 2014, AM J PHYSIOL-CELL PH, V307, pC245, DOI 10.1152/ajpcell.00336.2013; Gupta N, 2013, OPEN OPHTHALMOL J, V7, P4, DOI 10.2174/1874364101307010004; He SK, 2013, MOL VIS, V19, P665; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kakehashi A, 2008, DIABETES RES CLIN PR, V79, P438, DOI 10.1016/j.diabres.2007.10.018; Khan S, 2015, EXP MOL PATHOL, V98, P230, DOI 10.1016/j.yexmp.2015.01.003; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Ma WC, 2007, INVEST OPHTH VIS SCI, V48, P1355, DOI 10.1167/iovs.06-0738; Majumdar G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-709; Marmor MF, 1999, DOC OPHTHALMOL, V97, P239, DOI 10.1023/A:1002192829817; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; NEI N, FACTS DIAB EYE DIS 2; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Prevention CfdCa, 2014, NAT DIAB STAT REP ES; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; Romero-Aroca P, 2011, WORLD J DIABETES, V2, P98, DOI 10.4239/wjd.v2.i6.98; SCHULZE E, 1987, J CELL BIOL, V105, P2167, DOI 10.1083/jcb.105.5.2167; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; Stewart MW, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0510-4; Sugimoto M, 2013, AM J PATHOL, V183, P987, DOI 10.1016/j.ajpath.2013.05.017; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; WEBSTER DR, 1989, J CELL SCI, V92, P57; Wegener D, 2003, ANAL BIOCHEM, V321, P202, DOI 10.1016/S0003-2697(03)00426-3; Wells JA, 1996, BRIT J OPHTHALMOL, V80, P363, DOI 10.1136/bjo.80.4.363; Xie MY, 2014, MOL VIS, V20, P1411; Yokoi M, 2005, BRIT J OPHTHALMOL, V89, P673, DOI 10.1136/bjo.2004.055053; Zhong Q, 2010, J CELL BIOCHEM, V110, P1306, DOI 10.1002/jcb.22644	60	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162596	10.1371/journal.pone.0162596	http://dx.doi.org/10.1371/journal.pone.0162596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617745	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100031
J	Liberman, MC; Epstein, MJ; Cleveland, SS; Wang, HB; Maison, SF				Liberman, M. Charles; Epstein, Michael J.; Cleveland, Sandra S.; Wang, Haobing; Maison, Stephane F.			Toward a Differential Diagnosis of Hidden Hearing Loss in Humans	PLOS ONE			English	Article							AUDITORY BRAIN-STEM; COCHLEAR NERVE DEGENERATION; HAIR CELL LOSS; NOISE EXPOSURE; NEUROPATHY; TINNITUS; FIBERS; AGE; SYNAPTOPATHY; INJURY	Recent work suggests that hair cells are not the most vulnerable elements in the inner ear; rather, it is the synapses between hair cells and cochlear nerve terminals that degenerate first in the aging or noise-exposed ear. This primary neural degeneration does not affect hearing thresholds, but likely contributes to problems understanding speech in difficult listening environments, and may be important in the generation of tinnitus and/or hyperacusis. To look for signs of cochlear synaptopathy in humans, we recruited college students and divided them into low-risk and high-risk groups based on self-report of noise exposure and use of hearing protection. Cochlear function was assessed by otoacoustic emissions and click-evoked electrocochleography; hearing was assessed by behavioral audiometry and word recognition with or without noise or time compression and reverberation. Both groups had normal thresholds at standard audiometric frequencies, however, the high-risk group showed significant threshold elevation at high frequencies (10-16 kHz), consistent with early stages of noise damage. Electrocochleography showed a significant difference in the ratio between the waveform peaks generated by hair cells (Summating Potential; SP) vs. cochlear neurons (Action Potential; AP), i.e. the SP/AP ratio, consistent with selective neural loss. The high-risk group also showed significantly poorer performance on word recognition in noise or with time compression and reverberation, and reported heightened reactions to sound consistent with hyperacusis. These results suggest that the SP/AP ratio may be useful in the diagnosis of "hidden hearing loss" and that, as suggested by animal models, the noise-induced loss of cochlear nerve synapses leads to deficits in hearing abilities in difficult listening situations, despite the presence of normal thresholds at standard audiometric frequencies.	[Liberman, M. Charles; Maison, Stephane F.] Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA; [Liberman, M. Charles; Wang, Haobing; Maison, Stephane F.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Liberman, M. Charles; Maison, Stephane F.] Harvard Program Speech & Hearing Biosci & Technol, Boston, MA 02115 USA; [Epstein, Michael J.; Cleveland, Sandra S.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Commun Sci & Disorders, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Northeastern University	Maison, SF (corresponding author), Harvard Med Sch, Dept Otol & Laryngol, Boston, MA 02115 USA.; Maison, SF (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA.; Maison, SF (corresponding author), Harvard Program Speech & Hearing Biosci & Technol, Boston, MA 02115 USA.	stephane_maison@meei.harvard.edu		Maison, Stephane/0000-0003-2813-6439; Epstein, Michael/0000-0002-8290-4403	NIDCD [R01 DC00188, P30 DC 05209]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000188] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIDCD R01 DC00188 and NIDCD P30 DC 05209 (https://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas JP, 2014, NOISE HEALTH, V16, P306, DOI 10.4103/1463-1741.140511; Badri R, 2011, J ACOUST SOC AM, V129, P852, DOI 10.1121/1.3523476; Bohne BA, 2000, AM J OTOL, V21, P505; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Chambers AR, 2016, NEURON, V89, P867, DOI 10.1016/j.neuron.2015.12.041; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; Fernandez KA, 2015, J NEUROSCI, V35, P7509, DOI 10.1523/JNEUROSCI.5138-14.2015; Ferraro JA, 1997, AUDIOL NEURO-OTOL, V2, P241, DOI 10.1159/000259251; Ferraro JA, 2006, J AM ACAD AUDIOL, V17, P45, DOI 10.3766/jaaa.17.1.6; Fried M P, 1976, Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol, V82, P285; Fujioka M, 2015, TRENDS NEUROSCI, V38, P139, DOI 10.1016/j.tins.2014.12.004; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; JERGER J, 1980, ARCH OTOLARYNGOL, V106, P387; JOHNSSON LG, 1974, ANN OTO RHINOL LARYN, V83, P294, DOI 10.1177/000348947408300303; JOHNSSON LG, 1976, ANN OTO RHINOL LARYN, V85, P725, DOI 10.1177/000348947608500603; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; KIANG N. Y., 1960, ANN OTOL RHINOL AND LARYNGOL, V69, P448; Kim JS, 2005, OTOLARYNG HEAD NECK, V133, P619, DOI 10.1016/j.otohns.2005.06.012; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liberman LD, 2015, JARO-J ASSOC RES OTO, V16, P205, DOI 10.1007/s10162-015-0510-3; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lobarinas E, 2013, HEARING RES, V302, P113, DOI 10.1016/j.heares.2013.03.012; Lopez-Poveda EA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00124; MICHALEWSKI HJ, 1980, ELECTROEN CLIN NEURO, V48, P351, DOI 10.1016/0013-4694(80)90271-0; NADOL JB, 1987, ANN OTO RHINOL LARYN, V96, P449, DOI 10.1177/000348948709600420; NIKIFORIDIS GC, 1993, EAR HEARING, V14, P423, DOI 10.1097/00003446-199312000-00008; Noffsinger D, 1994, J Am Acad Audiol, V5, P231; Oates P, 1997, J ACOUST SOC AM, V102, P3597, DOI 10.1121/1.420148; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Plack CJ, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514550621; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Santarelli R, 2009, JARO-J ASSOC RES OTO, V10, P545, DOI 10.1007/s10162-009-0181-z; Schaette R, 2014, HEARING RES, V311, P63, DOI 10.1016/j.heares.2013.12.004; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; SCHMIEDT RA, 1984, J ACOUST SOC AM, V76, P1293, DOI 10.1121/1.391446; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; SCHUKNECHT H F, 1955, J Laryngol Otol, V69, P75, DOI 10.1017/S0022215100050465; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Slater J, 2015, BEHAV BRAIN RES, V291, P244, DOI 10.1016/j.bbr.2015.05.026; Sugawara M, 2005, JARO-J ASSOC RES OTO, V6, P136, DOI 10.1007/s10162-004-5050-1; Suzuki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24907; Valero MD, 2016, HEARING RES, V332, P29, DOI 10.1016/j.heares.2015.11.005; Vermiglio AJ, 2012, J AM ACAD AUDIOL, V23, P779, DOI 10.3766/jaaa.23.10.4; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Wan GQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03564; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Wilson R H, 1994, J Am Acad Audiol, V5, P269; WOELLNER R C, 1955, Trans Am Acad Ophthalmol Otolaryngol, V59, P147; Yuan YS, 2014, JARO-J ASSOC RES OTO, V15, P31, DOI 10.1007/s10162-013-0419-7	56	325	351	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162726	10.1371/journal.pone.0162726	http://dx.doi.org/10.1371/journal.pone.0162726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618300	gold, Green Published, Green Submitted			2022-12-26	WOS:000383653100045
J	Zhuo, CJ; Ma, XL; Qu, HR; Wang, LN; Jia, F; Wang, CL				Zhuo, Chuanjun; Ma, Xiaolei; Qu, Hongru; Wang, Lina; Jia, Feng; Wang, Chunli			Schizophrenia Patients Demonstrate Both Inter-Voxel Level and Intra-Voxel Level White Matter Alterations	PLOS ONE			English	Article							DIFFUSION-TENSOR; HUMAN BRAIN; DEPENDENCE; INTEGRITY	Fractional anisotropy (FA) and mean diffusivity (MD) are the most frequently used metrics to investigate white matter impairments in mental disorders. However, these two metrics are derived from intra-voxel analyses and only reflect the diffusion properties solely within the voxel unit. Local diffusion homogeneity (LDH) is a newly developed inter-voxel metric which quantifies the local coherence of water molecule diffusion in a model-free manner. In this study, 94 schizophrenia patients and 91 sex-and age-matched healthy controls underwent diffusion tensor imaging (DTI) examinations. White matter integrity was assessed by FA, MD and LDH. Group differences in these metrics were compared using tract-based spatial statistics (TBSS). Compared with healthy controls, schizophrenia patients exhibited reduced FA and increased MD in the corpus callosum, cingulum, internal capsule, fornix and widespread superficial white matter in the frontal, parietal, occipital and temporal lobes. We also found decreased LDH in the corpus callosum, cingulum, internal capsule and fornix in schizophrenia. Our findings suggest that both intra-voxel and inter-voxel diffusion metrics are able to detect impairments in the anisotropic white matter regions, and intra-voxel diffusion metrics could detect additional impairments in the widespread isotropic white matter regions in schizophrenia.	[Zhuo, Chuanjun; Wang, Lina; Jia, Feng; Wang, Chunli] Tianjin Anding Hosp, Tianjin Mental Hlth Ctr, Tianjin, Peoples R China; [Zhuo, Chuanjun] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin 300052, Peoples R China; [Zhuo, Chuanjun] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin 300052, Peoples R China; [Zhuo, Chuanjun; Ma, Xiaolei; Qu, Hongru] Tianjin Anning Hosp, Tianjin 300300, Peoples R China; [Zhuo, Chuanjun] Wenzhou Seventh peoples Hosp, Wenzhou 325000, Peoples R China	Tianjin Medical University; Tianjin Medical University	Wang, CL (corresponding author), Tianjin Anding Hosp, Tianjin Mental Hlth Ctr, Tianjin, Peoples R China.	iamdoforyou@163.com			National Basic Research Program of China (973 program) [2011CB707801]; Natural Science Foundation of China [81501451, 91332113, 81271551]; Tianjin Key Technology RD Program [14ZCZDSY00018]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Key Technology RD Program	This study was supported by grants from the National Basic Research Program of China (973 program, 2011CB707801), Natural Science Foundation of China (81501451, 91332113 and 81271551) and Tianjin Key Technology R&D Program (14ZCZDSY00018).	Abdul-Rahman MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018652; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bihel E, 2011, STROKE, V42, P1412, DOI 10.1161/STROKEAHA.110.596650; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Cui ZX, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00042; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Gong GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066366; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kunimatsu N, 2012, PSYCHIAT RES-NEUROIM, V201, P136, DOI 10.1016/j.pscychresns.2011.07.010; Kyriakopoulos M, 2008, EUR PSYCHIAT, V23, P255, DOI 10.1016/j.eurpsy.2007.12.004; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Nazeri A, 2013, NEUROPSYCHOPHARMACOL, V38, P1954, DOI 10.1038/npp.2013.93; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Rose SE, 2000, J NEUROL NEUROSUR PS, V69, P528, DOI 10.1136/jnnp.69.4.528; Rosenberger G, 2012, BRAIN IMAGING BEHAV, V6, P417, DOI 10.1007/s11682-012-9152-9; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280	21	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162656	10.1371/journal.pone.0162656	http://dx.doi.org/10.1371/journal.pone.0162656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618693	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100039
J	Gaudry, M; Bartoli, JM; Bal, L; Giorgi, R; De Masi, M; Magnan, PE; Piquet, P				Gaudry, Marine; Bartoli, Jean-Michel; Bal, Laurence; Giorgi, Roch; De Masi, Mariangela; Magnan, Pierre-Edouard; Piquet, Philippe			Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis	PLOS ONE			English	Article							SHEAR-STRESS; ANGIOPLASTY; EXPERIENCE; DISEASE; SURGERY; IMPLANTATION; DURABILITY; PATHOLOGY; OUTCOMES	Background Carotid arterystenting (CAS) has been advocated as an alternative to redo surgery for the treatment of post-carotid endarterectomy(CEA) stenosis. This study analyzed the efficacy of CAS for post-CEA restenosis, focusing on an analysis of technical and anatomical predictive factors for in-stent restenosis. Methods We performed a retrospective monocentric study. We included all patients who underwent CAS for post-CEA restenosis at our institution from July 1997 to November 2013. The primary endpoints were the technical success, the presence of in-stent restenosis > 50% or occlusion, either symptomatic or asymptomatic, during the follow-up period, and risk factors for restenosis. The secondary endpoints were early and late morbidity and mortality (TIA, stroke, myocardial infarction, or death). Results A total of 153 CAS procedures were performed for post-CEA restenosis, primarily because of asymptomatic lesions (137/153). The technical success rate was 98%. The 30-day perioperative stroke and death rate was 2.6% (two TIAs and two minor strokes), and rates of 2.2% (3/137) and 6.2% (1/16) were recorded for asymptomatic and symptomatic patients, respectively. The average follow-up time was 36 months (range, 6-171 months). In-stent restenosis or occlusion was observed in 16 patients (10.6%). Symptomatic restenosis was observed in only one patient. We found that young age (P = 0.002), stenosis > 85% (P = 0.018), and a lack of stent coverage of the common carotid artery(P = 0.006) were independent predictors of in-stent restenosis. Conclusion We identified new risk factors for in-stent restenosis that were specific to this population, and we propose a technical approach that may reduce this risk.	[Gaudry, Marine; Bal, Laurence; De Masi, Mariangela; Magnan, Pierre-Edouard; Piquet, Philippe] Hop La Timone, APHM, Dept Vasc Surg, F-13005 Marseille, France; [Bartoli, Jean-Michel] Hop La Timone, APHM, Dept Radiol, F-13005 Marseille, France; [Giorgi, Roch] Aix Marseille Univ, SESSTIM, INSERM, IRD, Marseille, France; [Giorgi, Roch] Hop La Timone, APHM, Serv Biostat & Technol Informat & Commun, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Gaudry, M (corresponding author), Hop La Timone, APHM, Dept Vasc Surg, F-13005 Marseille, France.	marine.gaudry@ap-hm.fr	GIORGI, Roch/A-6438-2009; gaudry, marine/AAF-3790-2019	GIORGI, Roch/0000-0001-6135-3078; gaudry, marine/0000-0001-9717-475X; De Masi, Mariangela/0000-0003-4779-8112				AbuRahma AF, 2002, J ENDOVASC THER, V9, P566, DOI 10.1583/1545-1550(2002)009<0566:EPCRRS>2.0.CO;2; AbuRahma AF, 2001, J VASC SURG, V34, P831, DOI 10.1067/mva.2001.118591; AbuRahma AF, 2008, J VASC SURG, V48, P589, DOI 10.1016/j.jvs.2008.04.004; AbuRahma AF, 2010, J VASC SURG, V52, P1180, DOI 10.1016/j.jvs.2010.06.074; AbuRahma AF, 2009, J VASC SURG, V50, P1031, DOI 10.1016/j.jvs.2009.06.051; Arquizan C, 2011, STROKE, V42, P1015, DOI 10.1161/STROKEAHA.110.589309; Attigah N, 2010, ANN VASC SURG, V24, P190, DOI 10.1016/j.avsg.2009.07.002; Bekelis K, 2013, BRIT J SURG, V100, P440, DOI 10.1002/bjs.9027; Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis, 1991, THE NEW ENGLAND JOUR, V325, P445, DOI 10.1056/NEJM199108153250701; Cho JS, 2004, J VASC SURG, V39, P155, DOI 10.1016/j.jvs.2003.07.003; de Borst GJ, 2007, J VASC SURG, V45, P118, DOI 10.1016/j.jvs.2006.09.013; de Borst GJ, 2008, J VASC SURG, V47, P363, DOI 10.1016/j.jvs.2007.10.002; Dorigo W, 2013, EUR J VASC ENDOVASC, V45, P437, DOI 10.1016/j.ejvs.2013.01.029; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; Fokkema M, 2015, ANN SURG, V261, P598, DOI 10.1097/SLA.0000000000000799; Giannoglou GD, 2010, EUROINTERVENTION, V6, pJ16, DOI 10.4244/EIJV6SUPJA4; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; Khan MA, 2003, AM J CARDIOL, V92, P895, DOI 10.1016/S0002-9149(03)00912-3; Koskinas KC, 2012, J AM COLL CARDIOL, V59, P1337, DOI 10.1016/j.jacc.2011.10.903; LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004; Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X; Lattimer CR, 1997, BRIT J SURG, V84, P1206; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Midy D, 2011, EUR J VASC ENDOVASC, V42, P742, DOI 10.1016/j.ejvs.2011.08.008; Mousa AY, 2015, J ENDOVASC THER, V22, P449, DOI 10.1177/1526602815581597; O'Hara PJ, 2001, J VASC SURG, V34, P5, DOI 10.1067/mva.2001.115601; RENSING BJ, 1993, CIRCULATION, V88, P975, DOI 10.1161/01.CIR.88.3.975; Setacci C, 2003, J ENDOVASC THER, V10, P1031, DOI 10.1583/1545-1550(2003)010<1031:DOIRAC>2.0.CO;2; Shankar JJS, 2012, NEURORADIOLOGY, V54, P1347, DOI 10.1007/s00234-012-1031-y; Simonetti G, 2009, RADIOL MED, V114, P95, DOI 10.1007/s11547-008-0326-x; Simonetti G, 2009, EUR RADIOL, V19, P982, DOI 10.1007/s00330-008-1207-3; Toma N, 2003, J NEUROSURG, V98, P199, DOI 10.3171/jns.2003.98.1.0199; Touze E, 2009, STROKE, V40, pE683, DOI 10.1161/STROKEAHA.109.562041; Valentine RJ, 1999, J VASC SURG, V30, P436, DOI 10.1016/S0741-5214(99)70070-4; Van Laanen J, 2008, J CARDIOVASC SURG, V49, P743; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Wasser K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022683; Willfort-Ehringer A, 2003, J ENDOVASC THER, V10, P636, DOI 10.1583/1545-1550(2003)010<0636:HOCSAP>2.0.CO;2; Zhou W, 2006, J VASC SURG, V43, P305, DOI [10.1016/j.jvs.2005.10.040, DOI 10.1016/J.JVS.2005.10.040]	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161716	10.1371/journal.pone.0161716	http://dx.doi.org/10.1371/journal.pone.0161716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611997	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900026
J	Lee, H; Kim, Y; Jeong, JH; Ryu, JH; Kim, WY				Lee, Hani; Kim, Yonghwan; Jeong, Ji Hye; Ryu, Jae-Ha; Kim, Woo-Young			ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; BRONCHIAL EPITHELIAL-CELLS; REPLICATION STRESS; IN-VIVO; S-PHASE; CARCINOGENESIS; P53; ACTIVATION; GENOTOXICITY; PREVENTION	Among the many stilbenoids found in a variety of berries, resveratrol and pterostilbene are of particular interest given their potential for use in cancer therapeutics and prevention. We purified four stilbenoids from R. undulatum and found that pterostilbene inhibits cancer cell proliferation more efficiently than rhapontigenin, piceatannol and resveratrol. To investigate the underlying mechanism of this superior action of pterostilbene on cancer cells, we utilized a reverse-phase protein array followed by bioinformatic analysis and found that the ATM/CHK pathway is modified by pterostilbene in a lung cancer cell line. Given that ATM/CHK signaling requires p53 for its biological effects, we hypothesized that p53 is required for the anticancer effect of pterostilbene. To test this hypothesis, we used two molecularly defined precancerous human bronchial epithelial cell lines, HBECR and HBECR/p53i, with normal p53 and suppressed p53 expression, respectively, to represent premalignant states of squamous lung carcinogenesis. Pterostilbene inhibited the cell cycle more efficiently in HBECR cells compared to HBECR/p53i cells, suggesting that the presence of p53 is required for the action of pterostilbene. Pterostilbene also activated ATM and CHK1/2, which are upstream of p53, in both cell lines, though pterostilbene-induced senescence was dependent on the presence of p53. Finally, pterostilbene more effectively inhibited p53-dependent cell proliferation compared to the other three stilbenoids. These results strongly support the potential chemopreventive effect of pterostilbene on p53-positive cells during early carcinogenesis.	[Lee, Hani; Jeong, Ji Hye; Ryu, Jae-Ha; Kim, Woo-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea; [Kim, Yonghwan] Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea	Sookmyung Women's University; Sookmyung Women's University	Kim, WY (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Seoul 04310, South Korea.; Kim, Y (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea.	yhkim@sookmyung.ac.kr; wykim@sookmyung.ac.kr			National Research Foundation (NRF) of Korea grant - Korea government, Bio & Medical Technology Development Program, Basic Science Research Program [NRF-2012M3A9B6055466, NRF-2015R1D1A1A01056594]; MSIP [2011-0030074]	National Research Foundation (NRF) of Korea grant - Korea government, Bio & Medical Technology Development Program, Basic Science Research Program; MSIP	This work was supported by National Research Foundation (NRF) of Korea grant funded by the Korea government, Bio & Medical Technology Development Program, Basic Science Research Program and MSIP (NRF-2012M3A9B6055466, NRF-2015R1D1A1A01056594 and 2011-0030074, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2013, NUTR CANCER, V65, P1, DOI 10.1080/01635581.2013.785012; Athar M, 2011, CURR PHARM DESIGN, V17, P631, DOI 10.2174/138161211795222595; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dong GZ, 2015, PHYTOTHER RES, V29, P1605, DOI 10.1002/ptr.5442; Dubinett SM, 2013, J CLIN ONCOL, V31, P4169, DOI 10.1200/JCO.2013.51.2400; Duthie SJ, 2007, MOL NUTR FOOD RES, V51, P665, DOI 10.1002/mnfr.200600257; Dutta C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006944; Erol A, 2011, CELL CYCLE, V10, P3239, DOI 10.4161/cc.10.19.17460; Estrela JM, 2013, CRIT REV CL LAB SCI, V50, P65, DOI 10.3109/10408363.2013.805182; Ferguson LR, 2015, SEMIN CANCER BIOL, V35, pS5, DOI 10.1016/j.semcancer.2015.03.005; Fox JT, 2012, P NATL ACAD SCI USA, V109, P5423, DOI 10.1073/pnas.1114278109; Garcia-Escudero V, 2010, MOL THER, V18, P394, DOI 10.1038/mt.2009.268; Glade MJ, 1997, NUTRITION, V13, P595, DOI 10.1016/S0899-9007(97)00127-5; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HARRIS CC, 1993, SCIENCE, V262, P1980, DOI 10.1126/science.8266092; Hecht SS, 2009, NAT REV CANCER, V9, P476, DOI 10.1038/nrc2674; Heggie SJ, 2003, J NUTR, V133, p3837S, DOI 10.1093/jn/133.11.3837S; Hong WK, 2005, LUNG CANCER-J IASLC, V49, pS50, DOI 10.1016/S0169-5002(05)80093-5; Hong WK, 2003, GYNECOL ONCOL, V88, pS56, DOI 10.1006/gyno.2002.6685; Hsiao PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105342; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Kelloff GJ, 2000, CANCER EPIDEM BIOMAR, V9, P127; Khuri FR, 2002, CANCER EPIDEM BIOMAR, V11, p1244S; Kim WY, 2009, CANCER RES, V69, P7439, DOI 10.1158/0008-5472.CAN-08-3792; Leone S, 2012, INT J CANCER, V131, pE173, DOI 10.1002/ijc.27358; Leone S, 2010, CANCER LETT, V295, P167, DOI 10.1016/j.canlet.2010.02.022; Leung HY, 2009, BRIT J NUTR, V102, P1462, DOI 10.1017/S0007114509990481; Lin VCH, 2012, J AGR FOOD CHEM, V60, P6399, DOI 10.1021/jf301499e; LIPPMAN SM, 1993, CHEST, V103, pS15, DOI 10.1378/chest.103.1_Supplement.15S; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mazouzi A, 2014, EXP CELL RES, V329, P85, DOI 10.1016/j.yexcr.2014.09.030; McCormack D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/575482; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mitrut P, 2009, ROM J MORPHOL EMBRYO, V50, P429; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Nambiar D, 2011, MUTAT RES-REV MUTAT, V728, P139, DOI 10.1016/j.mrrev.2011.07.005; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Powell SN, 2009, DNA REPAIR, V8, P1153, DOI 10.1016/j.dnarep.2009.04.011; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Riviere C, 2012, NAT PROD REP, V29, P1317, DOI 10.1039/c2np20049j; Robles AI, 2002, ONCOGENE, V21, P6898, DOI 10.1038/sj.onc.1205563; Rodin SN, 2005, SEMIN CANCER BIOL, V15, P103, DOI 10.1016/j.semcancer.2004.08.005; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soria JC, 2003, LANCET ONCOL, V4, P659, DOI 10.1016/S1470-2045(03)01244-0; Stopper H, 2005, MUTAT RES-FUND MOL M, V574, P139, DOI 10.1016/j.mrfmmm.2005.01.029; Tsao AS, 2004, CA-CANCER J CLIN, V54, P150, DOI 10.3322/canjclin.54.3.150; van Zandwijk N, 2005, EUR J CANCER, V41, P1990, DOI 10.1016/j.ejca.2005.05.011; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	28	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162335	10.1371/journal.pone.0162335	http://dx.doi.org/10.1371/journal.pone.0162335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612029	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900078
J	Xu, JM; Chen, X; Yu, SQ; Su, Y; Zhu, WY				Xu, Jumei; Chen, Xue; Yu, Shuiqing; Su, Yong; Zhu, Weiyun			Effects of Early Intervention with Sodium Butyrate on Gut Microbiota and the Expression of Inflammatory Cytokines in Neonatal Piglets	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; TUMOR-NECROSIS-FACTOR; INTESTINAL MICROBIOTA; GENE-EXPRESSION; DOWN-REGULATION; PIGS; INHIBITION; DISEASE; HEALTH; COLON	Butyrate in the gut of animals has potential properties including regulating the innate immune, modulating the lipid metabolism, and protecting gut healthy. So far, only limited information on the impact of butyrate on the neonatal is available. This study aimed to investigate effects of oral administration of sodium butyrate (SB) on gut microbiota and the expression of inflammatory cytokine in neonatal piglets. Ten litters of crossbred newborn piglets were randomly allocated to the SB and control (CO) groups, each group consisted of five litters (replicates). Piglets in the SB group were orally administrated with 7 to 13 ml sodium butyrate solution (150 mmol/l) per day from the age of 1 to 7 days, respectively; piglets in the CO group were treated with the same dose of physiological saline. On days 8 and 21 (of age), gut digesta and tissues were collected for the analysis of microbiota, butyrate concentration and gene expression of inflammatory cytokine. Results showed that there was no difference in the butyrate concentration in the gut of piglets on days 8 and 21 between two groups. Real-time PCR assay showed that SB had no effect on the numbers of total bacteria in the stomach, ileum, and colon. MiSeq sequencing of the V3-V4 region of the 16S rRNA gene revealed that SB increased the richness in the stomach and colon, and the diversity of colonic microbiota on day 8 (P < 0.05). Genera Acinetobacter, Actinobacillus, Facklamia, Globicatella, Kocuria, Rothia, unclassified Leptotrichiaceae, unclassified Neisseriaceae, and unclassified Prevotellaceae in the stomach were increased in relative abundance by SB treatment, whereas the abundances of Lactobacillus decreased on day 8 (P < 0.05). At the genus and operational taxonomic unit (OTU) levels, SB had low impact on bacterial community in the ileum and colon on days 8 and 21. SB treatment decreased the expression of IL-6, IL-8, IFN-gamma, IL-10, TGF-alpha, and histone deacetylase 1 (HDAC1) in the ileum of piglets on day 8 (P < 0.05). SB treatment down-regulated the expression of IL-8, IFN-gamma, and IL-1 beta on day 21 (P < 0.05). Correlation analysis on the combined datasets revealed some potential relationships between gut microbiota and the expression of inflammatory cytokines. The results show that early intervention with sodium butyrate can modulate the ileum inflammatory cytokine in neonatal piglets with low impact on intestinal microbial structure, which suggests oral administration of SB may have a benefit role in the health of neonatal piglets.	[Xu, Jumei; Chen, Xue; Yu, Shuiqing; Su, Yong; Zhu, Weiyun] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Su, Y (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Key Lab Gastrointestinal Nutr & Anim Hlth, Nanjing 210095, Jiangsu, Peoples R China.	yong.su@njau.edu.cn			National Natural Science Foundation of China [31572414]; National Basic Research Program of China [2012CB124705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This research has received funding from the National Natural Science Foundation of China (31572414) and National Basic Research Program of China (2012CB124705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has received funding from the National Natural Science Foundation of China (31572414) and National Basic Research Program of China (2012CB124705).	Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; BEUTLER B, 1993, CRIT CARE MED, V21, pS423; Biagi G, 2007, J ANIM SCI, V85, P1184, DOI 10.2527/jas.2006-378; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Collado MC, 2012, GUT MICROBES, V3, P352, DOI 10.4161/gmic.21215; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chinese Science and Technology Committee, 1988, REG ADM AFF EXP AN; Conroy ME, 2009, CURR OPIN ALLERGY CL, V9, P197, DOI 10.1097/ACI.0b013e32832b3f1d; Fang L, 2014, LIVEST SCI, V170, P116, DOI 10.1016/j.livsci.2014.10.004; Feng ZM, 2015, APPL PHYSIOL NUTR ME, V40, DOI 10.1139/apnm-2014-0434; FRANKLIN ST, 1991, J DAIRY SCI, V74, P2507, DOI 10.3168/jds.S0022-0302(91)78428-2; GALFI P, 1990, ACTA VET HUNG, V38, P3; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; HENDRIX WF, 1978, J ANIM SCI, V47, P1281, DOI 10.2527/jas1978.4761281x; Hou CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119505; Huang C, 2015, J NUTR, V145, P2774, DOI 10.3945/jn.115.217406; Inman CF, 2010, CLIN EXP IMMUNOL, V160, P431, DOI 10.1111/j.1365-2249.2010.04090.x; Ivarsson E, 2014, ANIMAL, V8, P1777, DOI 10.1017/S1751731114001827; Kalliomaki M., 2002, Current Drug Targets - Infectious Disorders, V2, P193; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Li GL, 2014, J NUTR, V144, P1887, DOI 10.3945/jn.114.198531; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Lin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111950; Liu LM, 2012, J EXP ZOOL PART B, V318B, P224, DOI 10.1002/jez.b.22440; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Mikkelsen LL, 2004, APPL ENVIRON MICROB, V70, P3485, DOI 10.1128/AEM.70.6.3485-3492.2004; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; Quivy V, 2004, BIOCHEM PHARMACOL, V68, P1221, DOI 10.1016/j.bcp.2004.05.039; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; RALPH P, 1992, J IMMUNOL, V148, P808; Rauch M, 2010, GUT MICROBES, V1, P335, DOI 10.4161/gmic.1.5.13169; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Saavedra JM, 2012, GASTROENTEROL CLIN N, V41, P717, DOI 10.1016/j.gtc.2012.08.001; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Sun CQ, 1998, CHEM-BIOL INTERACT, V113, P117, DOI 10.1016/S0009-2797(98)00025-8; Sun Y, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00877; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tudela CV, 2015, BRIT J NUTR, V113, P610, DOI 10.1017/S0007114514004231; Van der Meulen R, 2006, APPL ENVIRON MICROB, V72, P1006, DOI 10.1128/AEM.72.2.1006-1012.2006; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Wostmann BS., 1996, GERMFREE GNOTOBIOTIC, P101; Zhang HS, 2016, ARCH BIOCHEM BIOPHYS, V598, P50, DOI 10.1016/j.abb.2016.03.031; Zhou LP, 2016, ANAEROBE, V38, P61, DOI 10.1016/j.anaerobe.2015.12.009	59	55	65	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162461	10.1371/journal.pone.0162461	http://dx.doi.org/10.1371/journal.pone.0162461			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611998	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900104
J	Fang, D; Chen, H; Zhu, JY; Wang, W; Teng, Y; Ding, HF; Jing, Q; Su, SB; Huang, S				Fang, D.; Chen, H.; Zhu, J. Y.; Wang, W.; Teng, Y.; Ding, H-F; Jing, Q.; Su, S-B; Huang, S.			Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways	ONCOGENE			English	Article							NF-KAPPA-B; E-CADHERIN; DOWN-REGULATION; BETA-CATENIN; EMT; METASTASIS; EXPRESSION; CARCINOMA; INFLAMMATION; MIGRATION	Epithelial-mesenchymal transition (EMT) is regarded as a crucial contributing factor to cancer progression. Diverse factors have been identified as potent EMT inducers in ovarian cancer. However, molecular mechanism sustaining EMT of ovarian cancer cells remains elusive. Here we show that the presence of SOS1/EPS8/ABI1 complex is critical for sustained EMT traits of ovarian cancer cells. Consistent with the role of SOS1/EPS8/ABI1 complex as a Rac1-specific guanine nucleotide exchange factor, depleting Rac1 results in the loss of most of mesenchymal traits in mesenchymal-like ovarian cancer cells, whereas expressing constitutively active Rac1 leads to EMT in epithelial-like ovarian cancer cells. With the aid of clinically tested inhibitors targeting various EMT-associated signaling pathways, we show that only combined treatment of mitogen-activated extracellular signal-regulated kinase 1/2 (MEK1/2) and Src inhibitors can abolish constitutively active Rac1-led EMT and mesenchymal traits displayed by mesenchymal-like ovarian cancer cells. Further experiments also reveal that EMT can be induced in epithelial-like ovarian cancer cells by co-expressing constitutively active MEK1 and Src rather than either alone. As the activities of Erk and Src are higher in ovarian cancer cells with constitutively active Rac1, we conclude that Rac1 sustains ovarian cancer cell EMT through simultaneous activation of MEK1/2 and Src signaling pathways. Importantly, we demonstrate that combined use of MEK1/2 and Src inhibitors effectively suppresses development of intraperitoneal xenografts and prolongs the survival of ovarian cancer-bearing mice. This study suggests that cocktail of MEK1/2 and Src inhibitors represents an effective therapeutic strategy against ovarian cancer progression.	[Fang, D.; Wang, W.; Su, S-B; Huang, S.] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China; [Fang, D.; Su, S-B; Huang, S.] Shanghai Univ Tradit Chinese Med, E Inst Shanghai Municipal Educ Comm, Shanghai, Peoples R China; [Chen, H.] Wuhan Univ, Zhongnan Hosp, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Zhu, J. Y.; Huang, S.] Univ Florida, Coll Med, Dept Anat & Cell Biol, 2033 Mowry Rd,POB 103633, Gainesville, FL 32610 USA; [Teng, Y.] Augusta Univ, Dent Coll Georgia, Dept Oral Biol, Augusta, GA USA; [Teng, Y.; Ding, H-F] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA; [Jing, Q.] Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai Municipal Education Commission (SHMEC); Shanghai University of Traditional Chinese Medicine; Wuhan University; State University System of Florida; University of Florida; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Naval Medical University	Su, SB (corresponding author), Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China.; Huang, S (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, 2033 Mowry Rd,POB 103633, Gainesville, FL 32610 USA.	shibingsu07@163.com; shuanghuang@ufl.edu	Teng, Yong/AAK-4160-2020; Jing, Qing/F-6752-2016	Teng, Yong/0000-0002-1856-7289; Jing, Qing/0000-0001-9834-1214; Ding, Han-Fei/0000-0001-5702-3439	E-Institutes of Shanghai Municipal Education Commission [E03008]; Shanghai University of TCM [085ZY1206]; National Science Foundation of China [31229002]; NIH [CA 187152]; DoD [OC120313, W81XWH-13-1-0122]; NATIONAL CANCER INSTITUTE [R01CA187152] Funding Source: NIH RePORTER	E-Institutes of Shanghai Municipal Education Commission; Shanghai University of TCM; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by E-Institutes of Shanghai Municipal Education Commission (Project E03008), '085' First-Class Discipline Construction Innovation Science and Technology Support Project of Shanghai University of TCM (085ZY1206), National Science Foundation of China (31229002), NIH CA 187152 and DoD OC120313 (W81XWH-13-1-0122).	Ahmed N, 2010, CURR CANCER DRUG TAR, V10, P268, DOI 10.2174/156800910791190175; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chen DY, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-50; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chen HJ, 2010, CANCER RES, V70, P9979, DOI 10.1158/0008-5472.CAN-10-2394; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Cichon MA, 2014, ONCOTARGET, V5, P2827, DOI 10.18632/oncotarget.1940; Condello S, 2013, FASEB J, V27, P3100, DOI 10.1096/fj.12-222620; Davidson B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00033; Davidson B, 2015, HUM PATHOL, V46, P1, DOI 10.1016/j.humpath.2014.10.004; Gou WF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-477; Hong S, 2014, NEOPLASIA, V16, P279, DOI 10.1016/j.neo.2014.03.010; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Huang RYJ, 2012, CURR DRUG TARGETS, V13, P1649; Javle MM, 2007, ANN SURG ONCOL, V14, P3527, DOI 10.1245/s10434-007-9540-3; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Leng RB, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0329-5; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; Li Y., 2012, GENES CANC, V2, P880; Li Y, 2014, ONCOTARGET, V5, P2596, DOI 10.18632/oncotarget.1841; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; McGrail DJ, 2014, J CELL SCI, V127, P2621, DOI 10.1242/jcs.144378; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Parvani JG, 2011, J MAMMARY GLAND BIOL, V16, P127, DOI 10.1007/s10911-011-9207-3; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Prasanphanich AE, 2014, FREE RADICAL BIO MED, V76, P1, DOI 10.1016/j.freeradbiomed.2014.07.032; Radisky DC, 2007, NAT CELL BIOL, V9, P361, DOI 10.1038/ncb0407-361; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Seward SM, 2015, CANCER METAST REV, V34, P5, DOI 10.1007/s10555-014-9536-y; Takai M, 2014, J OVARIAN RES, V7, DOI [10.1186/1757-2215-7-38, 10.1186/1757-2215-7-76]; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Theriault BL, 2007, CARCINOGENESIS, V28, P1153, DOI 10.1093/carcin/bgm015; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12357; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Yamada SD, 2002, CANCER RES, V62, P6717; Yang L, 2015, ONCOTARGET, V6, P20801, DOI 10.18632/oncotarget.4600; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang WH, 2012, NAT CELL BIOL, V14, P366, DOI 10.1038/ncb2455; Yoshida S, 2009, INT J GYNECOL CANCER, V19, P992, DOI 10.1111/IGC.0b013e3181aaa93a; Zhang Z, 2014, ONCOGENE, V33, P3374, DOI 10.1038/onc.2013.337	50	63	65	0	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1546	1558		10.1038/onc.2016.323	http://dx.doi.org/10.1038/onc.2016.323			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27617576	Green Accepted			2022-12-26	WOS:000397458100009
J	Wickramaratne, S; Ji, SF; Mukherjee, S; Su, Y; Pence, MG; Lior-Hoffmann, L; Fu, I; Broyde, S; Guengerich, FP; Distefano, M; Scharer, OD; Sham, YY; Tretyakova, N				Wickramaratne, Susith; Ji, Shaofei; Mukherjee, Shivam; Su, Yan; Pence, Matthew G.; Lior-Hoffmann, Lee; Fu, Iwen; Broyde, Suse; Guengerich, F. Peter; Distefano, Mark; Scharer, Orlando D.; Sham, Yuk Yin; Tretyakova, Natalia			Bypass of DNA-Protein Cross-links Conjugated to the 7-Deazaguanine Position of DNA by Translesion Synthesis Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; gel electrophoresis; mass spectrometry (MS); molecular dynamics; DNA-protein conjugates; reductive amination; steady-state kinetics; translesion synthesis	NUCLEOTIDE EXCISION-REPAIR; ANTITUMOR NITROGEN MUSTARDS; FIBROSARCOMA HT1080 CELLS; Y-FAMILY; MAMMALIAN-CELLS; MAJOR GROOVE; REDUCTIVE AMINATION; REPLICATION; ADDUCT; KAPPA	DNA-protein cross-links (DPCs) are bulky DNA lesions that form both endogenously and following exposure to bis-electrophiles such as common antitumor agents. The structural and biological consequences of DPCs have not been fully elucidated due to the complexity of these adducts. The most common site of DPC formation in DNA following treatment with bis-electrophiles such as nitrogen mustards and cisplatin is the N7 position of guanine, but the resulting conjugates are hydrolytically labile and thus are not suitable for structural and biological studies. In this report, hydrolytically stable structural mimics of N7-guanine-conjugated DPCs were generated by reductive amination reactions between the Lys and Arg side chains of proteins/peptides and aldehyde groups linked to 7-deazaguanine residues in DNA. These model DPCs were subjected to in vitro replication in the presence of human translesion synthesis DNA polymerases. DPCs containing full-length proteins (11-28 kDa) or a 23-mer peptide blocked human polymerases and . DPC conjugates to a 10-mer peptide were bypassed with nucleotide insertion efficiency 50-100-fold lower than for native G. Both human polymerase (hPol) and hPol inserted the correct base (C) opposite the 10-mer peptide cross-link, although small amounts of T were added by hPol . Molecular dynamics simulation of an hPol ternary complex containing a template-primer DNA with dCTP opposite the 10-mer peptide DPC revealed that this bulky lesion can be accommodated in the polymerase active site by aligning with the major groove of the adducted DNA within the ternary complex of polymerase and dCTP.	[Wickramaratne, Susith; Ji, Shaofei; Tretyakova, Natalia] Univ Minnesota, Mason Canc Ctr, 2231 6th St SE,2-147 CCRB, Minneapolis, MN 55455 USA; [Wickramaratne, Susith; Ji, Shaofei; Distefano, Mark] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Sham, Yuk Yin] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Tretyakova, Natalia] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Scharer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Mukherjee, Shivam; Scharer, Orlando D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Lior-Hoffmann, Lee; Fu, Iwen; Broyde, Suse] NYU, Dept Biol, New York, NY 10003 USA; [Su, Yan; Pence, Matthew G.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; Vanderbilt University	Tretyakova, N (corresponding author), Univ Minnesota, Mason Canc Ctr, 2231 6th St SE,2-147 CCRB, Minneapolis, MN 55455 USA.; Tretyakova, N (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	trety001@umn.edu	Pence, Matthew/J-1379-2012; Ji, Shaofei/K-3555-2019; Scharer, Orlando/B-8908-2008; Pence, Matthew/C-9171-2013; Schärer, Orlando D./AAF-8613-2021; Sham, Yuk Y/A-6472-2011	Pence, Matthew/0000-0003-2271-789X; Ji, Shaofei/0000-0003-0013-0617; Scharer, Orlando/0000-0003-2425-2715; Pence, Matthew/0000-0003-2271-789X; Sham, Yuk Y/0000-0003-2601-8930	National Institutes of Health NIEHS [R01 ES023350, R01 ES010546, R01 ES025987]; National Institutes of Health [R01 CA100670, R01 CA75449]; NIGMS, National Institutes of Health [R01 GM084152]; Brainstorm Award from the University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE [R01CA165911, R01CA075449, R01CA100670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025987, R01ES023350, R01ES010546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084152] Funding Source: NIH RePORTER	National Institutes of Health NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Brainstorm Award from the University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIEHS Grants R01 ES023350 (to N. T.), R01 ES010546 (to F. P. G.), and R01 ES025987 (to S. B.); NCI, National Institutes of Health Grants R01 CA100670 (to N. T.) and R01 CA75449 (to S. B.); and NIGMS, National Institutes of Health Grant R01 GM084152 (to M. D.) and a Brainstorm Award from the University of Minnesota Masonic Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bau DT, 2002, ENVIRON HEALTH PERSP, V110, P753, DOI 10.1289/ehp.02110s5753; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Chakrabarti SK, 1999, TOXICOL APPL PHARM, V154, P245, DOI 10.1006/taap.1998.8584; Cho SH, 2013, CHEM RES TOXICOL, V26, P1005, DOI 10.1021/tx400145e; Chung JA, 2009, ANAL BIOCHEM, V386, P1, DOI 10.1016/j.ab.2008.09.007; DIZDAROGLU M, 1989, CANCER RES, V49, P3463; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Enoiu Milica, 2012, Methods Mol Biol, V920, P203, DOI 10.1007/978-1-61779-998-3_15; FEDTKE N, 1990, CARCINOGENESIS, V11, P1287, DOI 10.1093/carcin/11.8.1287; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; GAJEWSKI E, 1990, BIOCHEMISTRY-US, V29, P977, DOI 10.1021/bi00456a020; Ganguly M, 2007, NUCLEIC ACIDS RES, V35, P6181, DOI 10.1093/nar/gkm670; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Geacintov N, 2010, CHEM BIOL DNA DAMAGE; Gherezghiher TB, 2013, J PROTEOME RES, V12, P2151, DOI 10.1021/pr3011974; GILMAN A, 1946, SCIENCE, V103, P409, DOI 10.1126/science.103.2675.409; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Groehler A, 2016, CHEM RES TOXICOL, V29, P190, DOI 10.1021/acs.chemrestox.5b00430; Gueranger Q, 2011, NUCLEIC ACIDS RES, V39, P5057, DOI 10.1093/nar/gkr112; HALL AG, 1992, BLOOD REV, V6, P163, DOI 10.1016/0268-960X(92)90028-O; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kotapati S, 2012, J BIOL CHEM, V287, P38800, DOI 10.1074/jbc.M112.396788; Kowal EA, 2011, J PHYS CHEM B, V115, P13925, DOI 10.1021/jp207104w; Kumari A, 2010, J BIOL CHEM, V285, P21313, DOI 10.1074/jbc.M109.078964; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Lior-Hoffmann L, 2014, BIOCHEMISTRY-US, V53, P5683, DOI 10.1021/bi5007964; Loeber R, 2008, CHEM RES TOXICOL, V21, P787, DOI 10.1021/tx7004508; Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y; Loecken EM, 2008, CHEM RES TOXICOL, V21, P453, DOI 10.1021/tx7003618; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Maddukuri L, 2010, BIOCHEMISTRY-US, V49, P8415, DOI 10.1021/bi1009024; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Michaelson-Richie ED, 2011, J PROTEOME RES, V10, P2785, DOI 10.1021/pr200042u; Michaelson-Richie ED, 2010, J PROTEOME RES, V9, P4356, DOI 10.1021/pr1000835; Ming X. I., 2011, THESIS; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Nakano T, 2003, J BIOL CHEM, V278, P25264, DOI 10.1074/jbc.M212847200; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; OCONNOR PM, 1989, J BIOL CHEM, V264, P6391; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Rechkoblit O, 2002, J BIOL CHEM, V277, P30488, DOI 10.1074/jbc.M201167200; Roy U, 2016, DNA REPAIR, V44, P33, DOI 10.1016/j.dnarep.2016.05.004; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Singer B., 1983, MOL BIOL MUTAGENS CA; Stingele J, 2015, TRENDS BIOCHEM SCI, V40, P67, DOI 10.1016/j.tibs.2014.10.012; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Ho TV, 2011, NUCLEIC ACIDS RES, V39, P7455, DOI 10.1093/nar/gkr448; Tretyakova NY, 2015, ACCOUNTS CHEM RES, V48, P1631, DOI 10.1021/acs.accounts.5b00056; Tretyakova NY, 2013, BIOCHEMISTRY-US, V52, P3171, DOI 10.1021/bi400273m; Wang CH, 1999, J CONTROL RELEASE, V61, P21, DOI 10.1016/S0168-3659(99)00098-X; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Wickramaratne S, 2015, J BIOL CHEM, V290, P775, DOI 10.1074/jbc.M114.613638; Wickramaratne S, 2013, BIOCONJUGATE CHEM, V24, P1496, DOI 10.1021/bc400018u; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao LL, 2012, J BIOL CHEM, V287, P35516, DOI 10.1074/jbc.M112.403253; Zhitkovich A, 1998, ENVIRON HEALTH PERSP, V106, P969, DOI 10.2307/3434139	86	25	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23589	23603		10.1074/jbc.M116.745257	http://dx.doi.org/10.1074/jbc.M116.745257			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621316	Green Published, hybrid			2022-12-26	WOS:000387884400020
J	Stolwijk, JA; Zhang, XX; Gueguinou, M; Zhang, W; Matrougui, K; Renken, C; Trebak, M				Stolwijk, Judith A.; Zhang, Xuexin; Gueguinou, Maxime; Zhang, Wei; Matrougui, Khalid; Renken, Christian; Trebak, Mohamed			Calcium Signaling Is Dispensable for Receptor Regulation of Endothelial Barrier Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CA2+ CHANNELS; LIGHT-CHAIN KINASE; 2-AMINOETHYLDIPHENYL BORATE; ENTRY; CELLS; STIM1; ORAI1; THROMBIN; MYOSIN; CRAC	Endothelial barrier function is tightly regulated by plasma membrane receptors and is crucial for tissue fluid homeostasis; its dysfunction causes disease, including sepsis and inflammation. The ubiquitous activation of Ca2+ signaling upon phospholipase C-coupled receptor ligation leads quite naturally to the assumption that Ca2+ signaling is required for receptor-regulated endothelial barrier function. This widespread hypothesis draws analogy from smooth muscle and proposes the requirement of G protein-coupled receptor (GPCR)-generated Ca2+ signaling in activating the endothelial contractile apparatus and generating interendothelial gaps. Notwithstanding endothelia being non-excitable in nature, the hypothesis of Ca2+-induced endothelial contraction has been invoked to explain actions of GPCR agonists that either disrupt or stabilize endothelial barrier function. Here, we challenge this correlative hypothesis by showing a lack of causal link between GPCR-generated Ca2+ signaling and changes in human microvascular endothelial barrier function. We used three endogenous GPCR agonists: thrombin and histamine, which disrupt endothelial barrier function, and sphingosine-1-phosphate, which stabilizes barrier function. The qualitatively different effects of these three agonists on endothelial barrier function occur independently of Ca2+ entry through the ubiquitous store-operated Ca2+ entry channel Orai1, global Ca2+ entry across the plasma membrane, and Ca2+ release from internal stores. However, disruption of endothelial barrier function by thrombin and histamine requires the Ca2+ sensor stromal interacting molecule-1 (STIM1), whereas sphingosine-1-phosphate-mediated enhancement of endothelial barrier function occurs independently of STIM1. We conclude that although STIM1 is required for GPCR-mediated disruption of barrier function, a causal link between GPCR-induced cytoplasmic Ca2+ increases and acute changes in barrier function is missing. Thus, the cytosolic Ca2+ induced endothelial contraction is a cum hoc fallacy that should be abandoned.	[Stolwijk, Judith A.; Zhang, Xuexin; Gueguinou, Maxime; Zhang, Wei; Trebak, Mohamed] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA; [Matrougui, Khalid] East Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Stolwijk, Judith A.; Renken, Christian] Appl Biophys Inc, Troy, NY 12180 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Eastern Virginia Medical School	Trebak, M (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr, Hershey, PA 17033 USA.	mtrebak@hmc.psu.edu	张学新, XUEXIN ZHANG/AAD-7645-2019	张学新, XUEXIN ZHANG/0000-0001-8276-3885; Gueguinou, Maxime/0000-0002-5793-2082	American Heart Association [14GRNT18880008]; National Institutes of Health [R01HL097111, R01HL123364, R01HL095566]; Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL123364, R01HL095566] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Applied Biophysics Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Grant 14GRNT18880008, National Institutes of Health Grants R01HL097111 and R01HL123364 (to M. T.) and R01HL095566 (to K. M.), and in part by a post-doctoral fellowship from Applied Biophysics Inc. (to J. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Amado-Azevedo J, 2014, CELL TISSUE RES, V355, P557, DOI 10.1007/s00441-014-1828-6; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Borbiev T, 2001, AM J PHYSIOL-LUNG C, V280, pL983, DOI 10.1152/ajplung.2001.280.5.L983; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Fahrner M, 2013, CHANNELS, V7, P330, DOI 10.4161/chan.26742; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gonzalez-Cobos JC, 2013, CIRC RES, V112, P1013, DOI 10.1161/CIRCRESAHA.111.300220; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kassan M, 2015, PFLUG ARCH EUR J PHY, V467, P1195, DOI 10.1007/s00424-014-1556-5; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003; Law M, 2011, INT J BIOCHEM CELL B, V43, P1228, DOI 10.1016/j.biocel.2011.04.016; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; McLaughlin JN, 2005, J BIOL CHEM, V280, P25048, DOI 10.1074/jbc.M414090200; Mehta D, 2005, J BIOL CHEM, V280, P17320, DOI 10.1074/jbc.M411674200; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Moccia F, 2014, CURR MOL MED, V14, P457, DOI 10.2174/1566524013666131118113410; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Motiani RK, 2013, PFLUG ARCH EUR J PHY, V465, P1249, DOI 10.1007/s00424-013-1254-8; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Norwood N, 2000, AM J PHYSIOL-LUNG C, V279, pL815, DOI 10.1152/ajplung.2000.279.5.L815; Ohga K, 2008, INT IMMUNOPHARMACOL, V8, P1787, DOI 10.1016/j.intimp.2008.08.016; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rosado JA, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00325; Sandoval R, 2001, AM J PHYSIOL-LUNG C, V280, pL239, DOI 10.1152/ajplung.2001.280.2.L239; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Stolwijk JA, 2015, PFLUG ARCH EUR J PHY, V467, P2193, DOI 10.1007/s00424-014-1674-0; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; Takezawa R, 2006, MOL PHARMACOL, V69, P1413, DOI 10.1124/mol.105.021154; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2012, J PHYSIOL-LONDON, V590, P4201, DOI 10.1113/jphysiol.2012.233353; Trebak M, 2009, CIRC RES, V104, pE56, DOI 10.1161/CIRCRESAHA.109.196105; Amerongen GPV, 2008, AM J PHYSIOL-CELL PH, V294, pC1234, DOI 10.1152/ajpcell.00551.2007; Wang Z, 2010, J BIOL CHEM, V285, P21303, DOI 10.1074/jbc.M110.120790; Yuan D, 2014, AM J PHYSIOL-HEART C, V307, pH44, DOI 10.1152/ajpheart.00929.2013; Yuan SY, 2002, CIRC RES, V90, P1214, DOI 10.1161/01.RES.0000020402.73609.F1; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492; Zhou XP, 2011, AM J PHYSIOL-HEART C, V301, pH1788, DOI 10.1152/ajpheart.00599.2011; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH2869, DOI 10.1152/ajpheart.01080.2004; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	62	34	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22894	22912		10.1074/jbc.M116.756114	http://dx.doi.org/10.1074/jbc.M116.756114			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624938	Green Published, hybrid			2022-12-26	WOS:000387224800004
J	Kinoshita, T; Mitamura, Y; Mori, T; Akaiwa, K; Semba, K; Egawa, M; Mori, J; Sonoda, S; Sakamoto, T				Kinoshita, Takamasa; Mitamura, Yoshinori; Mori, Terumi; Akaiwa, Kei; Semba, Kentaro; Egawa, Mariko; Mori, Junya; Sonoda, Shozo; Sakamoto, Taiji			Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INDOCYANINE GREEN ANGIOGRAPHY; KOYANAGI-HARADA DISEASE; STROMAL AREAS; VISUAL-ACUITY; BINARIZATION; VERTEPORFIN; IMAGES; THICKNESS; ASSOCIATION	Purpose To determine the structural changes in the choroid after half-dose photodynamic therapy (hPDT) in eyes with chronic central serous chorioretinopathy (CSC). Methods This was a retrospective interventional study of 29 eyes of 29 patients who underwent hPDT for chronic CSC with serous retinal detachment (SRD) and were followed for >= 3 months. Enhanced depth imaging optical coherence tomographic (EDI-OCT) images of the subfoveal choroid were converted to binary images. The central choroidal thickness (CCT), the cross sectional subfoveal choroidal area, the hyporeflective and hyperreflective areas of the inner, outer, and whole choroid were determined at the baseline, and at 1, 3, and 12 months after the hPDT. Results The SRDs were resolved in 26 (89.7%) eyes at 3 months after the hPDT. The mean CCT (P = 0.001), the total choroidal area (P = 0.001), and the hypo-reflective area (P = 0.003) of the whole choroid were significantly decreased from the baseline at 3 months. The hyperreflective area of whole choroid was not significantly changed during the study period (P = 0.083). The hyperreflective but not the hyporeflective area of the inner choroid was significantly decreased at 3 months (P = 0.001, P = 1.000, respectively). The hyporeflective but not the hyperreflective area of the outer choroid was significantly decreased at 3 months (P = 0.001, P = 1.000, respectively). Conclusions The hyperreflective area of the inner choroid and hyporeflective area of the outer choroid were significantly decreased after hPDT for chronic CSC. Because the hyperreflective and hyporeflective area correspond to the choroidal stroma and vessels, respectively, the decreased CCT and subfoveal choroidal area after hPDT may be attributed to a decrease in the exudative changes in the inner choroidal stroma and the reduction of the dilation of the outer choroidal vessels.	[Kinoshita, Takamasa; Mitamura, Yoshinori; Mori, Terumi; Akaiwa, Kei; Semba, Kentaro; Egawa, Mariko] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan; [Kinoshita, Takamasa; Mori, Junya] Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Tokushima University; Sapporo City General Hospital; Kagoshima University	Kinoshita, T (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan.; Kinoshita, T (corresponding author), Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan.	knst129@gmail.com	Kinoshita, Takamasa/S-9174-2019	Kinoshita, Takamasa/0000-0002-0465-2140	Ministry of Education, Culture, Sports, Science and Technology, Japan [16K11288]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grant-in-aid 16K11288 (to YM) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2016, RETINA; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Chan WM, 2008, OPHTHALMOLOGY, V115, P1756, DOI 10.1016/j.ophtha.2008.04.014; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Egawa M, 2016, BRIT J OPHTHALMOL, V100, P1646, DOI 10.1136/bjophthalmol-2015-307734; Egawa M, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0127-7; Fujita K, 2015, OPHTHALMOLOGY, V122, P555, DOI 10.1016/j.ophtha.2014.09.034; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; Iida T, 1999, RETINA-J RET VIT DIS, V19, P508, DOI 10.1097/00006982-199911000-00005; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Inoue R, 2010, AM J OPHTHALMOL, V149, P441, DOI 10.1016/j.ajo.2009.10.011; Iwata A, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0014-2; Jirarattanasopa P, 2012, OPHTHALMOLOGY, V119, P1666, DOI 10.1016/j.ophtha.2012.02.021; Kawano H, 2016, GRAEF ARCH CLIN EXP, V254, P421, DOI 10.1007/s00417-016-3283-4; Kinoshita T, 2017, BRIT J OPHTHALMOL, V101, P360, DOI 10.1136/bjophthalmol-2016-308594; Lai TYY, 2006, BRIT J OPHTHALMOL, V90, P869, DOI 10.1136/bjo.2006.090282; Loo RH, 2002, RETINA-J RET VIT DIS, V22, P19, DOI 10.1097/00006982-200202000-00004; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Nakayama M, 2012, RETINA-J RET VIT DIS, V32, P2061, DOI 10.1097/IAE.0b013e318256205a; Nicolo M, 2014, AM J OPHTHALMOL, V157, P1033, DOI 10.1016/j.ajo.2014.01.022; Nicolo M, 2012, AM J OPHTHALMOL, V153, P474, DOI 10.1016/j.ajo.2011.08.015; PICCOLINO FC, 1995, EYE, V9, P324, DOI 10.1038/eye.1995.63; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Razavi S, 2014, AM J OPHTHALMOL, V157, P852, DOI 10.1016/j.ajo.2013.12.029; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Reibaldi M, 2010, AM J OPHTHALMOL, V149, P307, DOI 10.1016/j.ajo.2009.08.026; Schmidt-Erfurth U, 2002, ARCH OPHTHALMOL-CHIC, V120, P835; Smretschnig E, 2013, RETINA-J RET VIT DIS, V33, P316, DOI 10.1097/IAE.0b013e318280769c; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Spaide RF, 1996, OPHTHALMOLOGY, V103, P2070, DOI 10.1016/S0161-6420(96)30386-2; Spaide RF, 2015, AM J OPHTHALMOL, V160, P1211, DOI 10.1016/j.ajo.2015.08.018; Yang LH, 2013, INVEST OPHTH VIS SCI, V54, P4659, DOI 10.1167/iovs.12-10991; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002; YOSHIOKA H, 1982, JPN J OPHTHALMOL, V26, P397	41	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163104	10.1371/journal.pone.0163104	http://dx.doi.org/10.1371/journal.pone.0163104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636093	gold, Green Submitted, Green Published			2022-12-26	WOS:000383723700033
J	Sluka, JP; Fu, X; Swat, M; Belmonte, JM; Cosmanescu, A; Clendenon, SG; Wambaugh, JF; Glazier, JA				Sluka, James P.; Fu, Xiao; Swat, Maciej; Belmonte, Julio M.; Cosmanescu, Alin; Clendenon, Sherry G.; Wambaugh, John F.; Glazier, James A.			A Liver-Centric Multiscale Modeling Framework for Xenobiotics	PLOS ONE			English	Article							BIOLOGY MARKUP LANGUAGE; HEPATIC STELLATE CELLS; IN-VIVO EXTRAPOLATION; SYSTEMS BIOLOGY; GLUTATHIONE METABOLISM; INDUCED HEPATOTOXICITY; ACETAMINOPHEN; PARACETAMOL; SIMULATION; HUMANS	We describe a multi-scale, liver-centric in silico modeling framework for acetaminophen pharmacology and metabolism. We focus on a computational model to characterize whole body uptake and clearance, liver transport and phase I and phase II metabolism. We do this by incorporating sub-models that span three scales; Physiologically Based Pharmacokinetic (PBPK) modeling of acetaminophen uptake and distribution at the whole body level, cell and blood flow modeling at the tissue/organ level and metabolism at the sub-cellular level. We have used standard modeling modalities at each of the three scales. In particular, we have used the Systems Biology Markup Language (SBML) to create both the whole-body and sub-cellular scales. Our modeling approach allows us to run the individual sub-models separately and allows us to easily exchange models at a particular scale without the need to extensively rework the sub-models at other scales. In addition, the use of SBML greatly facilitates the inclusion of biological annotations directly in the model code. The model was calibrated using human in vivo data for acetaminophen and its sulfate and glucuronate metabolites. We then carried out extensive parameter sensitivity studies including the pairwise interaction of parameters. We also simulated population variation of exposure and sensitivity to acetaminophen. Our modeling framework can be extended to the prediction of liver toxicity following acetaminophen overdose, or used as a general purpose pharmacokinetic model for xenobiotics.	[Sluka, James P.; Fu, Xiao; Swat, Maciej; Belmonte, Julio M.; Cosmanescu, Alin; Clendenon, Sherry G.; Glazier, James A.] Indiana Univ Bloomington, Biocomplex Inst, Bloomington, IN 47405 USA; [Wambaugh, John F.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA	Indiana University System; Indiana University Bloomington; United States Environmental Protection Agency	Sluka, JP; Glazier, JA (corresponding author), Indiana Univ Bloomington, Biocomplex Inst, Bloomington, IN 47405 USA.	JSluka@Indiana.edu; JGlazier@Indiana.edu	Belmonte, Julio/J-8696-2013; Clendenon, Sherry G/F-7651-2010; Wambaugh, John/AAM-4487-2020; Belmonte, Julio M/AAB-6434-2020; Sluka, James P/AAL-9294-2021; Clendenon, Sherry/AAG-6655-2019	Belmonte, Julio/0000-0002-4315-9631; Clendenon, Sherry G/0000-0002-3353-0919; Wambaugh, John/0000-0002-4024-534X; Belmonte, Julio M/0000-0002-4315-9631; Sluka, James P/0000-0002-5901-1404; Clendenon, Sherry/0000-0002-3353-0919; Fu, Xiao/0000-0002-8611-891X; Glazier, James Alexander/0000-0003-3634-190X	US Environmental Protection Agency [R835001]; National Institute of Health, National Institute of General Medical Sciences [GM077138, GM111243]; Indiana University; Lilly Endowment; Indiana METACyt Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM111243] Funding Source: NIH RePORTER	US Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Indiana University; Lilly Endowment; Indiana METACyt Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the US Environmental Protection Agency (www3.epa.gov), grant number R835001 (JAG, JFW, JPS, AC), The National Institute of Health, National Institute of General Medical Sciences (www.nih.gov), grant numbers GM077138 (JAG, JPS, MS, JMB) and GM111243 (JAG, JPS, XF, SGC), by Indiana University (www.indiana.edu) (JAG, XF, MS, JMB, AC, SGC), the Lilly Endowment (JAG), and Indiana METACyt Initiative (JAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ME, 1997, TOXICOL APPL PHARM, V144, P135, DOI 10.1006/taap.1996.8066; BAGNALL WE, 1979, J PHARM PHARMACOL, V31, P157, DOI 10.1111/j.2042-7158.1979.tb13459.x; Ben-Shachar R, 2012, THEOR BIOL MED MODEL, V9, DOI 10.1186/1742-4682-9-55; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Critchley JAJH, 2005, J CLIN PHARM THER, V30, P179, DOI 10.1111/j.1365-2710.2004.00626.x; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Drasdo D, 2014, J HEPATOL, V61, P951, DOI 10.1016/j.jhep.2014.06.013; FAHRAEUS R, 1931, THE AMERICAN JOURNAL, V96, P562; Finney A, 2003, BIOCHEM SOC T, V31, P1472; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Geenen S, 2013, INTEGR BIOL-UK, V5, P877, DOI 10.1039/c3ib20245c; Ghallab A, 2016, J HEPATOLOG IN PRESS, P1; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Groneberg DA, 2002, TOXICOL PATHOL, V30, P394, DOI 10.1080/01926230252929972; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; GWILT JR, 1963, J PHARM PHARMACOL, V15, P440, DOI 10.1111/j.2042-7158.1963.tb12811.x; Hester SD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002155; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hunt CA, 2006, J PHARMACOKINET PHAR, V33, P737, DOI 10.1007/s10928-006-9031-3; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Jiang XL, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.55; KATZ NR, 1992, J NUTR, V122, P843, DOI 10.1093/jn/122.suppl_3.843; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Leclerc E, 2015, CELL BIOL TOXICOL, V31, P173, DOI 10.1007/s10565-015-9302-0; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Mazaleuskaya LL, 2015, PHARMACOGENET GENOM, V25, P416, DOI 10.1097/FPC.0000000000000150; Nishii K, 2016, J MECH BEHAV BIOMED, V57, P201, DOI 10.1016/j.jmbbm.2015.11.033; Ochoa JGD, 2013, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00204; Park BK, 2005, ANNU REV PHARMACOL, V45, P177, DOI 10.1146/annurev.pharmtox.45.120403.100058; Pery ARR, 2013, TOXICOL LETT, V220, P26, DOI 10.1016/j.toxlet.2013.03.032; PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS291, DOI 10.1111/j.1365-2125.1980.tb01812.x; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Nicolas R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-79; Sauro HM, 2000, 9 INT BIOTHERMOKINET, P221; Schliess F, 2014, HEPATOLOGY, V60, P2040, DOI 10.1002/hep.27136; Schwen LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133653; Schwen LO, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003499; Shiran MR, 2006, XENOBIOTICA, V36, P567, DOI 10.1080/00498250600761662; Shirinifard A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002440; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Somogyi ET, 2015, BIOINFORMATICS, V31, P3315, DOI 10.1093/bioinformatics/btv363; Stahl Simone H, 2015, Drug Discov Today Technol, V15, P9, DOI 10.1016/j.ddtec.2015.06.003; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Trettin A, 2011, J CHROMATOGR B, V879, P2274, DOI 10.1016/j.jchromb.2011.06.012; Vallabhajosyula RR, 2007, BIOINFORMATICS, V23, P1859, DOI 10.1093/bioinformatics/btm231; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; Ward B., 1999, ACUTE PAIN, V2, P139, DOI DOI 10.1016/S1366-0071(99)80006-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yan L, 2008, PHARM RES, V25, P1023, DOI 10.1007/s11095-007-9494-y; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoon M, 2014, TOXICOL IN VITRO, V28, P164, DOI 10.1016/j.tiv.2013.10.023; Zurlinden TJ, 2015, BRIT J CLIN PHARMACO, P1	63	34	34	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162428	10.1371/journal.pone.0162428	http://dx.doi.org/10.1371/journal.pone.0162428			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636091	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700006
J	Beeftink, MMA; Spiering, W; Bots, ML; Verloop, WL; De Jager, RL; Sanders, MF; Vonken, EJ; Blankestijn, PJ; Voskuil, M				Beeftink, Martine M. A.; Spiering, Wilko; Bots, Michiel L.; Verloop, Willemien L.; De Jager, Rosa L.; Sanders, Margreet F.; Vonken, Evert-jan; Blankestijn, Peter J.; Voskuil, Michiel			Renal Denervation in a Real Life Setting: A Gradual Decrease in Home Blood Pressure	PLOS ONE			English	Article							RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; EUROPEAN-SOCIETY; CONTROLLED-TRIAL; MANAGEMENT; PATIENT; SAFETY	Objectives To investigate the blood pressure dynamics after renal denervation through monthly home blood pressure measurements throughout the first 12 months. Methods A cohort of 70 patients performed highly standardized monthly home blood pressure monitoring during the first year after denervation according to the European Society of Hypertension guidelines. At baseline and 12 months follow-up, office and ambulatory blood pressure as well as routine physical and laboratory assessment was performed. Results Home blood pressure decreased with a rate of 0.53 mmHg/month (95% CI 0.20 to 0.86) systolic and 0.26 mmHg/month (95% CI 0.08 to 0.44) diastolic throughout 12 months of follow-up, while the use of antihypertensive medication remained stable (+ 0.03 daily defined doses/month, 95% CI -0.01 to 0.08). On average, a 12 month reduction of 8.1 mmHg (95% CI 4.2 to 12.0) was achieved in home systolic blood pressure, 9.3 mmHg (95% CI -14.2 to -4.4) as measured by 24-hour ambulatory blood pressure monitoring and 15.9 mmHg (95% CI -23.8 to -7.9) on office measurements. Conclusion Blood pressure reduction after renal denervation occurs as a gradual decrease that extends to at least one-year follow-up. Home monitoring seems a suitable alternative for ambulatory blood pressure monitoring after renal denervation.	[Beeftink, Martine M. A.; Verloop, Willemien L.; Voskuil, Michiel] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & PrimaryCare, Utrecht, Netherlands; [De Jager, Rosa L.; Sanders, Margreet F.; Blankestijn, Peter J.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Vonken, Evert-jan] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Voskuil, M (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	m.voskuil@umcutrecht.nl			Netherlands Organisation for Health Research and Development (ZonMw); Dutch Kidney Foundation [NCT02482103]; Medtronic	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Dutch Kidney Foundation; Medtronic(Medtronic)	RLD and MS are supported by grants from The Netherlands Organisation for Health Research and Development (ZonMw), the Dutch Kidney Foundation and an unrestricted grant from Medtronic (Sympathy trial). MMB is supported by an unrestricted grant from Medtronic (DIASTOLE trial). MLB has obtained grants from non-profit organisations such as The Netherlands Organisation for Health Research and Development (ZonMw) and the Dutch Kidney Foundation for conducting studies into renal denervation. For the remaining authors none were declared. The Dutch National Renal Denervation Registry is partly supported by a grant from the Dutch Kidney Foundation (NCT02482103).	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Ali S, 2002, J HUM HYPERTENS, V16, P359, DOI 10.1038/sj.jhh.1001384; Azizi M, 2015, LANCET, V385, P1957, DOI 10.1016/S0140-6736(14)61942-5; Bhatt DL, 2014, NEW ENGL J MED, V370, P1393, DOI 10.1056/NEJMoa1402670; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; De Jager RL, 2016, CLIN RES CARDIOL, V105, P755, DOI 10.1007/s00392-016-0984-y; Desch S, 2015, HYPERTENSION, V65, P1202, DOI 10.1161/HYPERTENSIONAHA.115.05283; Esler MD, 2014, EUR HEART J, V35, P1752, DOI 10.1093/eurheartj/ehu209; Esler MD, 2012, CIRCULATION, V126, P2976, DOI 10.1161/CIRCULATIONAHA.112.130880; Head GA, 2012, J HYPERTENS, V30, P253, DOI 10.1097/HJH.0b013e32834de621; Hering D, 2014, HYPERTENSION, V64, P118, DOI 10.1161/HYPERTENSIONAHA.113.03098; Kaiser L, 2014, EUROINTERVENTION, V10, P157, DOI 10.4244/EIJV10I1A24; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mahfoud F, 2015, EUR HEART J, V36, P2219, DOI 10.1093/eurheartj/ehv192; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; Mc Namara KP, 2014, FAM PRACT, V31, P437, DOI 10.1093/fampra/cmu026; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Parati G, 2010, J HUM HYPERTENS, V24, P779, DOI 10.1038/jhh.2010.54; Persu A, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0460-x; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pickering TG, 2010, J AM SOC HYPERTENS, V4, P56, DOI 10.1016/j.jash.2010.03.003; REEVES RA, 1995, JAMA-J AM MED ASSOC, V273, P1211, DOI 10.1001/jama.1995.03520390071036; Rosa J, 2015, HYPERTENSION, V65, P407, DOI 10.1161/HYPERTENSIONAHA.114.04019; Rumke CL, REGRESSION MEAN, V128, P158; Sadowski J, 2011, HYPERTENSION, V57, P911, DOI 10.1161/HYPERTENSIONAHA.110.163014; Sanders MF, 2016, NETH J MED, V74, P5; Tzafriri AR, 2014, J AM COLL CARDIOL, V64, P1079, DOI 10.1016/j.jacc.2014.07.937; Verberk WJ, 2007, HYPERTENSION, V50, P1019, DOI 10.1161/HYPERTENSIONAHA.107.094193; Verloop WL, 2015, EUR J PREV CARDIOL, V22, P558, DOI 10.1177/2047487314556003; Verloop WL, 2013, J HYPERTENS, V31, P1662, DOI 10.1097/HJH.0b013e328362152e; Vink EE, 2014, J HYPERTENS, V32, P2045, DOI 10.1097/HJH.0000000000000282; WHO Collaborating Centre for Drug Statistics Methodology, 2014, GUID ATC CLASS DDD A; World Health Organization, 2013, GLOBAL BRIEF HYPERTE; Worthley SG, 2013, EUR HEART J, V34, P2132, DOI 10.1093/eurheartj/eht197	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162251	10.1371/journal.pone.0162251	http://dx.doi.org/10.1371/journal.pone.0162251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631608	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900032
J	Murray, CC; Mach, ME; Martone, RG; Singh, GG; Miriam, O; Chan, KMA				Murray, Cathryn Clarke; Mach, Megan E.; Martone, Rebecca G.; Singh, Gerald G.; Miriam, O.; Chan, Kai M. A.			Supporting Risk Assessment: Accounting for Indirect Risk to Ecosystem Components	PLOS ONE			English	Article							CUMULATIVE HUMAN IMPACTS; BRITISH-COLUMBIA; MARINE SYSTEMS; KILLER WHALES; DYNAMICS; SPECIALIZATION; STRESSORS; WATERS; WEBS	The multi-scalar complexity of social-ecological systems makes it challenging to quantify impacts from human activities on ecosystems, inspiring risk-based approaches to assessments of potential effects of human activities on valued ecosystem components. Risk assessments do not commonly include the risk from indirect effects as mediated via habitat and prey. In this case study from British Columbia, Canada, we illustrate how such "indirect risks" can be incorporated into risk assessments for seventeen ecosystem components. We ask whether (i) the addition of indirect risk changes the at-risk ranking of the seventeen ecosystem components and if (ii) risk scores correlate with trophic prey and habitat linkages in the food web. Even with conservative assumptions about the transfer of impacts or risks from prey species and habitats, the addition of indirect risks in the cumulative risk score changes the ranking of priorities for management. In particular, resident orca, Steller sea lion, and Pacific herring all increase in relative risk, more closely aligning these species with their "at-risk status" designations. Risk assessments are not a replacement for impact assessments, but-by considering the potential for indirect risks as we demonstrate here-they offer a crucial complementary perspective for the management of ecosystems and the organisms within.	[Murray, Cathryn Clarke; Mach, Megan E.; Singh, Gerald G.; Chan, Kai M. A.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada; [Murray, Cathryn Clarke] North Pacific Marine Sci Org PICES, Sidney, BC, Canada; [Mach, Megan E.; Martone, Rebecca G.] Ctr Ocean Solut, Monterey, CA USA; [Miriam, O.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	University of British Columbia; Fisheries & Oceans Canada	Murray, CC (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada.; Murray, CC (corresponding author), North Pacific Marine Sci Org PICES, Sidney, BC, Canada.	cclarke@eos.ubc.ca	Chan, Kai M A/C-1682-2009	Chan, Kai M A/0000-0002-7804-3276	David and Lucille Packard Foundation [F08-00136]; Canada Research Chair program; NSERC Discovery grant [06-5566]	David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Canada Research Chair program(Canada Research Chairs); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was conducted with support from the David and Lucille Packard Foundation (Grant #F08-00136) (https://www.packard.org/), the Canada Research Chair program (http://www.chairschaires.gc.ca/home-accueil-eng.aspx), and an NSERC Discovery grant (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGPPSIGP_eng.asp) (#06-5566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SM, 2005, MAR POLLUT BULL, V51, P649, DOI 10.1016/j.marpolbul.2004.11.040; Adams SM, 1998, MULTIPLE STRESSES EC, P13; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; Barnthouse L., 1986, USERS MANUAL ECOLOGI; BRYAN GW, 1979, PHILOS T ROY SOC B, V286, P483, DOI 10.1098/rstb.1979.0042; Chapman PM, 2004, MAR POLLUT BULL, V48, P411, DOI 10.1016/j.marpolbul.2003.11.005; COSEWIC, 2003, COSEWIC ASS STAT REP; COSEWIC, 2008, COSEWIC ASS UPD STAT; COSEWIC, 2011, COSEWIC ASS STAT REP; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2013, COSEWIC ASS STAT REP; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crisp DJ., 1972, PRODUCTIVITY WORLD E, P71; Dahlstrom A, 2011, MAR POLICY, V35, P208, DOI 10.1016/j.marpol.2010.10.001; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Espinosa-Romero MJ, 2011, ECOL MODEL, V222, P1569, DOI 10.1016/j.ecolmodel.2011.02.008; Essington TE, 2015, P NATL ACAD SCI USA, V112, P6648, DOI 10.1073/pnas.1422020112; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fisheries & Oceans Canada, 2015, 2015037 DFO CAN SCI; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Gallagher AJ, 2014, BIOSCIENCE, V64, P619, DOI 10.1093/biosci/biu071; Giakoumi S, 2015, CONSERV BIOL, V29, P1228, DOI 10.1111/cobi.12468; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Heise Kathy, 2003, Aquatic Mammals, V29, P325, DOI 10.1578/01675420360736497; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Hughes BB, 2013, P NATL ACAD SCI USA, V110, P15313, DOI 10.1073/pnas.1302805110; Lucas B. G., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2667, P1; MacConnachie S., 2007, Canadian Technical Report of Fisheries and Aquatic Sciences, V2677, P1; Martone R, 2015, DFO CAN SCI ADVIS SE; Meador JP, 1995, REV ENVIRON CONTA<D>, V143, P79; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Murray CC, 2015, GLOB ECOL CONSERV, V4, P110, DOI 10.1016/j.gecco.2015.06.003; Murray CC, 2016, DFO CAN SCI ADVIS SE; Pastorok RA, 2003, HUM ECOL RISK ASSESS, V9, P939, DOI 10.1080/713610017; Preston BL, 2002, ENVIRON MANAGE, V29, P311, DOI 10.1007/s00267-001-0023-1; Rose GA, 2004, CAN J FISH AQUAT SCI, V61, P1553, DOI 10.1139/F04-173; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; Singh GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065435; Suter Glenn W. III, 2008, Integrated Environmental Assessment and Management, V4, P285, DOI 10.1897/IEAM_2007-062; Therriault TW, 2008, ICES J MAR SCI, V65, P781, DOI 10.1093/icesjms/fsn059; Trites AW, 2007, MAR MAMMAL SCI, V23, P751, DOI 10.1111/j.1748-7692.2006.00076.x; Walker C.H., 2013, PERSISTENT POLLUTANT; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449	46	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162932	10.1371/journal.pone.0162932	http://dx.doi.org/10.1371/journal.pone.0162932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632287	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900097
J	Wu, LG; Hu, ZX; Huang, YY; Yu, YT; Liang, W; Zheng, QH; Huang, XN; Huang, Y; Lu, XL; Zhao, YX				Wu, Lige; Hu, Zixi; Huang, Yingying; Yu, Yating; Liang, Wei; Zheng, Qinghui; Huang, Xianing; Huang, Yong; Lu, Xiaoling; Zhao, Yongxiang			Radiation Changes the Metabolic Profiling of Melanoma Cell Line B16	PLOS ONE			English	Article							IONIZING-RADIATION; RADIOSENSITIZATION; RADIORESISTANCE; BIOMARKER; CYCLE	Radiation therapy can be an effective way to kill cancer cells using ionizing radiation, but some tumors are resistant to radiation therapy and the underlying mechanism still remains elusive. It is therefore necessary to establish an appropriate working model to study and monitor radiation-mediated cancer therapy. In response to cellular stress, the metabolome is the integrated profiling of changes in all metabolites in cells, which can be used to investigate radiation tolerance mechanisms and identify targets for cancer radiation sensibilization. In this study, using H-1 nuclear magnetic resonance for untargeted metabolic profiling in radiation-tolerant mouse melanoma cell line B16, we comprehensively investigated changes in metabolites and metabolic network in B16 cells in response to radiation. Principal component analysis and partial least squares discriminant analysis indicated the difference in cellular metabolites between the untreated cells and X-ray radiated cells. In radiated cells, the content of alanine, glutamate, glycine and choline was increased, while the content of leucine, lactate, creatine and creatine phosphate was decreased. Enrichment analysis of metabolic pathway showed that the changes in metabolites were related to multiple metabolic pathways including the metabolism of glycine, arginine, taurine, glycolysis, and gluconeogenesis. Taken together, with cellular metabolome study followed by bioinformatic analysis to profile specific metabolic pathways in response to radiation, we deepened our understanding of radiation-resistant mechanisms and radiation sensibilization in cancer, which may further provide a theoretical and practical basis for personalized cancer therapy.	[Wu, Lige; Hu, Zixi; Huang, Yingying; Yu, Yating; Liang, Wei; Zheng, Qinghui; Huang, Xianing; Huang, Yong; Lu, Xiaoling; Zhao, Yongxiang] Guangxi Med Univ, Natl Ctr Int Res Biol Targeting Diag & Therapy, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Collaborat Innovat Ctr Targeting Tumor Diag & The, Nanning 530021, Guangxi, Peoples R China; [Lu, Xiaoling] Guangxi Med Univ, Dept Immunol, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Huang, Y; Lu, XL; Zhao, YX (corresponding author), Guangxi Med Univ, Natl Ctr Int Res Biol Targeting Diag & Therapy, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Collaborat Innovat Ctr Targeting Tumor Diag & The, Nanning 530021, Guangxi, Peoples R China.; Lu, XL (corresponding author), Guangxi Med Univ, Dept Immunol, Nanning 530021, Guangxi, Peoples R China.	yonghuang503@126.com; luwuliu@163.com; yongxiang_zhao@126.com	lu, xl/HDO-8340-2022; wu, lige/X-1422-2019	wu, lige/0000-0002-9388-6706	National Natural Scientific Foundation of China [81430055, 81372452]; Programs for Changjiang Scholars and Innovative Research Team in University [IRT_15R13]; International Cooperation Project of the Ministry of Science and Technology of China [2015DFA31320]; Project for Innovative Research Team in Guangxi Natural Science Foundation [2015GX NSFFA139001, 2015GXNSFFA139001]; Project of Science and Technology of Guangxi [14125008-2-12, 1599005-2-10]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Programs for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); International Cooperation Project of the Ministry of Science and Technology of China; Project for Innovative Research Team in Guangxi Natural Science Foundation; Project of Science and Technology of Guangxi	The present study was supported, in part, by grants from the National Natural Scientific Foundation of China (nos. 81430055 and 81372452), Programs for Changjiang Scholars and Innovative Research Team in University (No.IRT_15R13), the International Cooperation Project of the Ministry of Science and Technology of China (no. 2015DFA31320), the Project for Innovative Research Team in Guangxi Natural Science Foundation (2015GX NSFFA139001), and the Project of Science and Technology of Guangxi (nos. 14125008-2-12 and 1599005-2-10).; The authors are grateful to Dr. Donghai Lin and Dr. Caihua Huang (College of Chemistry and Chemical Engineering, Xiamen University) for instructions and assistance in data analysis. The authors also want to thank Jinping Gu (College of Chemistry and Chemical Engineering, Xiamen University) for MATLAB script writing. This work was supported, in part, by grants from the National Natural Scientific Foundation of China (Nos. 81430055, 81372452); Programs for Changjiang Scholars and Innovative Research Team in University (No.IRT_15R13); International Cooperation Project of the Ministry of Science and Technology of China (No. 2015DFA31320); Project for Innovative Research Team in Guangxi Natural Science Foundation (2015GXNSFFA139001); Project of Science and Technology of Guangxi (Nos. 14125008-2-12, 1599005-2-10).	Bartel J, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301009; BERNHARD EJ, 1995, RADIAT ENVIRON BIOPH, V34, P79, DOI 10.1007/BF01275210; BIAGLOW JE, 1983, INT J RADIAT BIOL, V44, P489, DOI 10.1080/09553008314551491; Bibault JE, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-12; Boccard J, 2013, ANAL CHIM ACTA, V769, P30, DOI 10.1016/j.aca.2013.01.022; Borek C, 2004, J NUTR, V134, p3207S, DOI 10.1093/jn/134.11.3207S; Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y; Chagoyen M, 2011, BIOINFORMATICS, V27, P730, DOI 10.1093/bioinformatics/btr001; Chen XY, 2016, BIOCHEM BIOPH RES CO, V473, P296, DOI 10.1016/j.bbrc.2016.03.099; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Diao CF, 2014, MOL BIOSYST, V10, P686, DOI 10.1039/c3mb70609e; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duarte IF, 2013, EXPERT REV MOL DIAGN, V13, P737, DOI 10.1586/14737159.2013.835570; GILLETTE EL, 1995, SEMIN VET MED SURG, V10, P129; Hong A, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/294735; Huber SM, 2015, BBA-BIOMEMBRANES, V1848, P2657, DOI 10.1016/j.bbamem.2014.11.004; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Kruger M, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9013; Li L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060839; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Matchuk O, 2013, CELL TISSUE BIOL, V7, P556; Ni XH, 2015, MOL CANCER THER, V14, P2797, DOI 10.1158/1535-7163.MCT-15-0291-T; Purnell PR, 2009, J THORAC ONCOL, V4, P448, DOI 10.1097/JTO.0b013e31819c78fb; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tan J, 2015, CELL COMMUNICAITONS, V2, P36; Tarish FL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5671; Teng Q, 2009, METABOLOMICS, V5, P199, DOI 10.1007/s11306-008-0137-z; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Werthmoller N, 2016, INT J HYPERTHER, V32, P23, DOI 10.3109/02656736.2015.1106011; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Willers H, 2013, CANCER J, V19, P200, DOI 10.1097/PPO.0b013e318292e4e3; Williams TM, 2013, TRANSL ONCOL, V6, P133, DOI 10.1593/tlo.13214; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xiao CN, 2009, ANALYST, V134, P916, DOI 10.1039/b818802e; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140	40	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162917	10.1371/journal.pone.0162917	http://dx.doi.org/10.1371/journal.pone.0162917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631970	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900094
J	Yuan, JW; Ren, JP; Wang, Y; He, X; Zhao, YW				Yuan, Jiawen; Ren, Jinpeng; Wang, Ying; He, Xiao; Zhao, Yuwu			Acteoside Binds to Caspase-3 and Exerts Neuroprotection in the Rotenone Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PRIMARY CULTURES; MOUSE MODEL; DEATH; PATHOGENESIS; NEURONS; PROTECT; INJURY; CELLS	Parkinson's disease (PD) is characterized by the progressive degeneration of the dopaminergic neurons in the substantia nigra (SN) region. Acteoside has displayed multiple biological functions. Its potential role against PD and the underlying signaling mechanisms are largely unknown. Here, we showed that oral administration of acteoside significantly attenuated parkinsonism symptoms in rotenone-induced PD rats. Further, acteoside inhibited rotenone-induced alpha-synuclein, caspase-3 upregulation and microtubule-associated protein 2 (MAP2) downregulation in PD rats. The molecular docking and molecular dynamics (MD) simulation results indicated that acteoside may directly bind to and inhibit caspase-3. Acteoside formed hydrogen bonds with at least six residues of caspase-3: ThrA177, SerA178, GlyA238, SerB339, ArgB341 and TrpB348. In addition, a pi-pi interaction was formed between acteoside and caspase-3's HisA237, which might further stabilize the complex. MD simulation results demonstrated that the binding affinity of the caspase-3-acteoside complex was higher than that of caspase-3 and its native ligand inhibitor. Together, we show that acteoside binds to caspase-3 and exerts neuroprotection in the rotenone rat model of PD.	[Yuan, Jiawen; Ren, Jinpeng; Zhao, Yuwu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China; [Wang, Ying; He, Xiao] East China Normal Univ, State Key Lab Precis Spect, Shanghai, Peoples R China; [Wang, Ying; He, Xiao] East China Normal Univ, Dept Phys, Shanghai, Peoples R China; [He, Xiao] NYU Shanghai, NYU ECNU Ctr Computat Chem, Shanghai, Peoples R China	Shanghai Jiao Tong University; East China Normal University; East China Normal University; NYU Shanghai	Zhao, YW (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurol, Shanghai, Peoples R China.	yuwu_zhao359@163.com	He, Xiao/G-3114-2016	He, Xiao/0000-0002-4199-8175	Shanghai Sixth People's Hospital [2014-015]	Shanghai Sixth People's Hospital	This study was funded by the the research fund of Shanghai Sixth People's Hospital affiliated to Shanghai Jiao Tong University (2014-015, to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Becker JW, 2004, J MED CHEM, V47, P2466, DOI 10.1021/jm0305523; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen J, 1998, J NEUROSCI, V18, P4914; Chompoopong S, 2016, NEUROMOLECULAR MED; D'Andrea MR, 2001, NEUROSCI LETT, V306, P137, DOI 10.1016/S0304-3940(01)01811-0; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gaki GS, 2014, NEUROMOL MED, V16, P217, DOI 10.1007/s12017-014-8294-x; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; He J, 2011, J ASIAN NAT PROD RES, V13, P449, DOI 10.1080/10286020.2011.568940; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Koo KA, 2006, LIFE SCI, V79, P709, DOI 10.1016/j.lfs.2006.02.019; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Li YY, 2008, EUR J PHARMACOL, V579, P134, DOI 10.1016/j.ejphar.2007.10.052; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Marchisella F, 2016, CYTOSKELETON HOBOKEN; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P119, DOI 10.1097/NEN.0b013e3182801cde; Peng XM, 2015, PHYTOTHER RES, V29, P1137, DOI 10.1002/ptr.5358; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Rodriguez-Nogales C, 2016, MATURITAS, V84, P25, DOI 10.1016/j.maturitas.2015.11.009; Shin J, 2009, J NEUROSCI, V29, P15375, DOI 10.1523/JNEUROSCI.3126-09.2009; Wang HQ, 2012, NEUROTOX RES, V21, P368, DOI 10.1007/s12640-011-9292-5; Wang HQ, 2009, BRAIN RES, V1283, P139, DOI 10.1016/j.brainres.2009.05.101; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weiser J, 1999, BIOPOLYMERS, V50, P373, DOI 10.1002/(SICI)1097-0282(19991005)50:4<373::AID-BIP3>3.0.CO;2-U; Xiong LN, 2016, J MED FOOD, V19, P54, DOI 10.1089/jmf.2015.3462	30	28	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162696	10.1371/journal.pone.0162696	http://dx.doi.org/10.1371/journal.pone.0162696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632381	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900067
J	Lee, SW; Baek, SH; Ahn, SY; Na, KY; Chae, DW; Chin, HJ; Kim, S				Lee, Sung Woo; Baek, Seon Ha; Ahn, Shin Young; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong			The Effects of Pre-Existing Hyponatremia and Subsequent-DevelopingAcute Kidney Injury on In-Hospital Mortality: A Retrospective Cohort Study	PLOS ONE			English	Article							HEART-FAILURE; PRIMARY-CARE; DIAGNOSIS; HYPERNATREMIA; OUTCOMES; CHILDREN; MILD	Background and Objectives Both hyponatremia and acute kidney injury (AKI) are common and harmful in hospitalized patients. However, their combined effects on patient mortalityhave been little studied. Methods We retrospectively enrolled 19191 adult patients who were admitted for 1 year. Pre-existing hyponatremia was defined as a serum sodium level < 135 mmol/L on the first measurement of their admission. AKI was defined as a rise in serum creatinine by >= 26.5 mu mol/L or >= 1.5 times of the baseline value of creatinine during the hospital stay. Results The prevalence of pre-existing hyponatremia was 8.2%. During a median 6.0 days of hospital stay, the incidence rates of AKI and in-hospital patient mortality were 5.1% and 0.9%, respectively. Pre-existing hyponatremia independently predicted AKI development and in-hospital mortality (adjusted hazard ratio [HR] 1.300, P = 0.004; HR 2.481, P = 0.002, respectively). Pre-existing hyponatremia and subsequent development of AKI increased in-hospital mortality by 85 times, compared to the patients with normonatremia and no AKI. In subgroup analysis, the AKI group showed higher rates of de novo hypernatremia than the non-AKI group during the admission. De novo hypernatremia, which might be associated with over-correction of hyponatremia, increased in-hospital mortality(HR 3.297, P < 0.001), and patients with AKI showed significantly higher rates of de novo hypernatremia than patients without AKI (16.2% vs. 1.4%, P < 0.001, respectively). Conclusion Pre-existing hyponatremia may be associated with the development of AKI in hospitalized patients, and both hyponatremia and hospital-acquired AKI could have a detrimental effect on short termpatient mortality, which might be related to the inappropriate correction of hyponatremia in AKI patients.	[Lee, Sung Woo; Baek, Seon Ha; Na, Ki Young; Chae, Dong-Wan] Seoul Natl Univ, Postgrad Sch, Dept Internal Med, Seoul, South Korea; [Lee, Sung Woo] Eulji Gen Hosp, Dept Internal Med, Seoul, South Korea; [Baek, Seon Ha; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun; Kim, Sejoong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Ahn, Shin Young] Korea Univ, Guro Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Eulji University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	sejoong2@snu.ac.kr	Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962	Korean Society of Nephrology [06-2014-151]; SNUBH Research Fund [02-2014-058]	Korean Society of Nephrology; SNUBH Research Fund	This study was supported by the Young Investigator Research Grant (no 06-2014-151) from the Korean Society of Nephrology (Kyowa Hakko Kirin 2014) and was supported by grant no 02-2014-058 from the SNUBH Research Fund. The sponsors of this study played no role in its design, or in the collection, analysis, or interpretation of data, or the writing of the report. Kyowa Hakko Kirin www.kyowakirin.com/kr/, SNUBH Research Fund www.snubh.org/.	Adams D, 2011, J NEPHROL, V24, P749, DOI 10.5301/JN.2011.6410; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Aronson D, 2014, EUR J HEART FAIL, V16, P49, DOI 10.1093/eurjhf/hft123; Bodonyi-Kovacs G, 2008, CLIN EXP NEPHROL, V12, P74, DOI 10.1007/s10157-007-0021-6; Braam B, 2014, NAT REV NEPHROL, V10, P48, DOI 10.1038/nrneph.2013.250; Chang TI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111373; Corona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124105; Corona G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080451; Doi K, 2012, KIDNEY INT, V82, P1114, DOI 10.1038/ki.2012.266; Durand F, 2016, AM J KIDNEY DIS, V67, P318, DOI 10.1053/j.ajkd.2015.09.013; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elmi G, 2014, EUR J INTERN MED, V25, pE45, DOI 10.1016/j.ejim.2014.03.013; Gheorghiade M, 2007, ARCH INTERN MED, V167, P1998, DOI 10.1001/archinte.167.18.1998; Grams ME, 2015, AM J KIDNEY DIS, V66, P591, DOI 10.1053/j.ajkd.2015.02.337; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Hackworth WA, 2009, LIVER INT, V29, P1071, DOI 10.1111/j.1478-3231.2009.01982.x; Hoorn EJ, 2013, AM J KIDNEY DIS, V62, P139, DOI 10.1053/j.ajkd.2012.09.019; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Kuramatsu JB, 2014, STROKE, V45, P1285, DOI 10.1161/STROKEAHA.113.004136; Lameire N, 2010, SEMIN NEPHROL, V30, P534, DOI 10.1016/j.semnephrol.2010.09.002; Lee SE, 2012, HEART, V98, P1798, DOI 10.1136/heartjnl-2012-302334; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140674; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liborio AB, 2012, BRAZ J INFECT DIS, V16, P558, DOI 10.1016/j.bjid.2012.08.015; Madsen CM, 2016, OSTEOPOROSIS INT, V27, P397, DOI 10.1007/s00198-015-3423-4; McGregor TL, 2016, AM J KIDNEY DIS, V67, P384, DOI 10.1053/j.ajkd.2015.07.019; Mehta RL, 2011, CONTRIB NEPHROL, V174, P200, DOI 10.1159/000329410; Nigwekar SU, 2013, AM J KIDNEY DIS, V62, P755, DOI 10.1053/j.ajkd.2013.02.367; Prats-Puig A, 2015, THROMB HAEMOSTASIS, V114, P727, DOI 10.1160/TH15-01-0037; RIIKONEN P, 1992, PEDIATR HEMAT ONCOL, V9, P365, DOI 10.3109/08880019209016609; ROTHMAN KJ, 1974, AM J EPIDEMIOL, V99, P385, DOI 10.1093/oxfordjournals.aje.a121626; Saepudin S, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0082-5; Shum HP, 2016, J CRIT CARE, V31, P82, DOI 10.1016/j.jcrc.2015.09.017; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162990	10.1371/journal.pone.0162990	http://dx.doi.org/10.1371/journal.pone.0162990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622451	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000072
J	Peterson, BA; Haak, DC; Nishimura, MT; Teixeira, PJPL; James, SR; Dangl, JL; Nimchuk, ZL				Peterson, Brenda A.; Haak, David C.; Nishimura, Marc T.; Teixeira, Paulo J. P. L.; James, Sean R.; Dangl, Jeffery L.; Nimchuk, Zachary L.			Genome-Wide Assessment of Efficiency and Specificity in CRISPR/Cas9 Mediated Multiple Site Targeting in Arabidopsis	PLOS ONE			English	Article							CHROMOSOMAL TRANSLOCATIONS; RNA; MUTAGENESIS; CAS9; VISUALIZATION; PEPTIDES; TALENS	Simultaneous multiplex mutation of large gene families using Cas9 has the potential to revolutionize agriculture and plant sciences. The targeting of multiple genomic sites at once raises concerns about the efficiency and specificity in targeting. The model Arabidopsis thaliana is widely used in basic plant research. Previous work has suggested that the Cas9 off-target rate in Arabidopsis is undetectable. Here we use deep sequencing on pooled plants simultaneously targeting 14 distinct genomic loci to demonstrate thatmultiplex targeting in Arabidopsis is highly specific to on-target sites with no detectable off-target events. In addition, chromosomal translocations are extremely rare. The high specificity of Cas9 in Arabidopsis makes this a reliable method for cleanmutant generation with no need to enhance specificity or adopt alternate Cas9 variants.	[Peterson, Brenda A.; James, Sean R.; Dangl, Jeffery L.; Nimchuk, Zachary L.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA; [Dangl, Jeffery L.; Nimchuk, Zachary L.] Univ North Carolina Chapel Hill, Carolina Ctr Genome Sci, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Dangl, Jeffery L.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Nishimura, Marc T.; Teixeira, Paulo J. P. L.; Dangl, Jeffery L.] Univ North Carolina Chapel Hill, Howard Hughes Med Inst, Chapel Hill, NC USA; [Peterson, Brenda A.; James, Sean R.; Nimchuk, Zachary L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Haak, David C.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Nimchuk, ZL (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA.; Nimchuk, ZL (corresponding author), Univ North Carolina Chapel Hill, Carolina Ctr Genome Sci, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA.; Nimchuk, ZL (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	zackn@email.unc.edu	Teixeira, Paulo/C-1546-2013	Teixeira, Paulo/0000-0002-0776-5044; Haak, David/0000-0002-3692-3152; Nishimura, Marc Tad/0000-0003-4666-6900	University of North Carolina at Chapel Hill; Virginia Tech; Pew Latin American Fellows Program in the Biomedical Sciences [00026198]; National Science Foundation-Division of Integrated Organismal Systems [IOS-1455607]; Howard Hughes Medical Institute - HHMI; Gordon and Betty Moore Foundation [GBMF3030]; UNC; Howard HughesMedical Institute; Gordon and BettyMoore Foundation [GBMF3030]; NSF-IOS [IOS-1455607]; HHMI; Direct For Biological Sciences [1257373, 1455607] Funding Source: National Science Foundation	University of North Carolina at Chapel Hill; Virginia Tech; Pew Latin American Fellows Program in the Biomedical Sciences; National Science Foundation-Division of Integrated Organismal Systems(National Science Foundation (NSF)); Howard Hughes Medical Institute - HHMI(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); UNC; Howard HughesMedical Institute(Howard Hughes Medical Institute); Gordon and BettyMoore Foundation(Gordon and Betty Moore Foundation); NSF-IOS(National Science Foundation (NSF)); HHMI(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by start up funds from University of North Carolina at Chapel Hill to ZLN; start up funds from Virginia Tech to ZLN and DCH; the Pew Latin American Fellows Program in the Biomedical Sciences (00026198 to PJPLT), http://www.pewtrusts.org/en/projects/pew-latin-american-fellows; National Science Foundation-Division of Integrated Organismal Systems (IOS-1455607 to ZLN), http://www.nsf.gov/div/index.jsp?div=IOS; and Howard Hughes Medical Institute, supported by the HHMI and the Gordon and Betty Moore Foundation (GBMF3030 to JLD), https://www.hhmi.org/programs/biomedical-research/investigator-program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: start-up funds from Virginia Tech (DCH and ZLN) and UNC (ZLN), the Howard HughesMedical Institute, supported by the HHMI and the Gordon and BettyMoore Foundation (GBMF3030, JLD), and The Pew Latin American Fellows Program in the Biomedical Sciences (00026198-PJPLT). Additional support was provided by the NSF-IOS (IOS-1455607) to ZLN.	Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Fernandez A, 2013, J EXP BOT, V64, P5263, DOI 10.1093/jxb/ert248; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jun J, 2010, PLANT PHYSIOL, V154, P1721, DOI 10.1104/pp.110.163683; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lozano-Juste J, 2014, TRENDS PLANT SCI, V19, P284, DOI 10.1016/j.tplants.2014.02.014; Mahfouz MM, 2014, PLANT BIOTECHNOL J, V12, P1006, DOI 10.1111/pbi.12256; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Meng L, 2012, P NATL ACAD SCI USA, V109, P1760, DOI 10.1073/pnas.1119864109; Morbitzer R, 2010, P NATL ACAD SCI USA, V107, P21617, DOI 10.1073/pnas.1013133107; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; O'Geen H, 2015, CURR OPIN CHEM BIOL, V29, P72, DOI 10.1016/j.cbpa.2015.10.001; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Torres R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4964; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	32	85	90	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162169	10.1371/journal.pone.0162169	http://dx.doi.org/10.1371/journal.pone.0162169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622539	Green Published, gold			2022-12-26	WOS:000383681000015
J	Tumbarello, DA; Andrews, MR; Brenton, JD				Tumbarello, David A.; Andrews, Melissa R.; Brenton, James D.			SPARC Regulates Transforming Growth Factor Beta Induced (TGFBI) Extracellular Matrix Deposition and Paclitaxel Response in Ovarian Cancer Cells	PLOS ONE			English	Article							EXPRESSION ANALYSIS; MESOTHELIAL CELLS; IN-VITRO; PROTEIN; ADHESION; IDENTIFICATION; BINDING; GENE; BETA-IG-H3; MICE	TGFBI has been shown to sensitize ovarian cancer cells to the cytotoxic effects of paclitaxel via an integrin receptor-mediated mechanism that modulates microtubule stability. Herein, we determine that TGFBI localizes within organized fibrillar structures in mesothelial-derived ECM. We determined that suppression of SPARC expression by shRNA decreased the deposition of TGFBI in mesothelial-derived ECM, without affecting its overall protein expression or secretion. Conversely, overexpression of SPARC increased TGFBI deposition. A SPARC-YFP fusion construct expressed by the Met5a cell line co-localized with TGFBI in the cell-derived ECM. Interestingly, in vitro produced SPARC was capable of precipitating TGFBI from cell lysates dependent on an intact SPARC carboxy-terminus with in vitro binding assays verifying a direct interaction. The last 37 amino acids of SPARC were shown to be required for the TGFBI interaction while expression of a SPARC-YFP construct lacking this region (aa 1-256) did not interact and co-localize with TGFBI in the ECM. Furthermore, ovarian cancer cells have a reduced motility and decreased response to the chemotherapeutic agent paclitaxel when plated on ECM derived from mesothelial cells lacking SPARC compared to control mesothelial-derived ECM. In conclusion, SPARC regulates the fibrillar ECM deposition of TGFBI through a novel interaction, subsequently influencing cancer cell behavior.	[Tumbarello, David A.; Brenton, James D.] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge, England; [Andrews, Melissa R.] Univ St Andrews, MBSB, Sch Med, St Andrews, Fife, Scotland; [Tumbarello, David A.] Univ Southampton, Biol Sci, Southampton, Hants, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of St Andrews; University of Southampton	Tumbarello, DA (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge, England.; Tumbarello, DA (corresponding author), Univ Southampton, Biol Sci, Southampton, Hants, England.	D.A.Tumbarello@soton.ac.uk	Brenton, James D/B-3174-2008	Brenton, James D/0000-0002-5738-6683; Tumbarello, David/0000-0002-5169-0561; Andrews, Melissa/0000-0001-5960-5619	Cancer Research UK [A15601]; University of Cambridge; Cancer Research UK [15601] Funding Source: researchfish; Healthway [22905] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Healthway	Funding for this project was provided by Cancer Research UK, grant number A15601 (which supported JDB and DAT) and the University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Beacham Dorothy A, 2007, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1009s33; Bradshaw AD, 2009, J CELL COMMUN SIGNAL; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Brown TJ, 1999, GYNECOL ONCOL, V75, P25, DOI 10.1006/gyno.1999.5552; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042413; De Cecco L, 2004, ONCOGENE, V23, P8171, DOI 10.1038/sj.onc.1207979; Denys H, 2009, CURR PHARM DESIGN, V15, P1373, DOI 10.2174/138161209787846711; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Gardi NL, 2014, CLIN CANCER RES, V20, P87, DOI 10.1158/1078-0432.CCR-13-2063; Golembieski WA, 2002, J NEURO-ONCOL, V60, P213, DOI 10.1023/A:1021167211131; Hashimoto K, 1997, BBA-MOL CELL RES, V1355, P303, DOI 10.1016/S0167-4889(96)00147-4; Huynh MH, 2004, CELL TISSUE RES, V317, P313, DOI 10.1007/s00441-004-0933-3; IruelaArispe ML, 1996, DEV DYNAM, V207, P171, DOI 10.1002/(SICI)1097-0177(199610)207:2<171::AID-AJA5>3.0.CO;2-E; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; Martinek N, 2008, J CELL SCI, V121, P1671, DOI 10.1242/jcs.021931; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Mok SC, 1996, ONCOGENE, V12, P1895; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Paley PJ, 2000, GYNECOL ONCOL, V78, P336, DOI 10.1006/gyno.2000.5894; Phelps SLB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.047; PORTER PL, 1995, J HISTOCHEM CYTOCHEM, V43, P791, DOI 10.1177/43.8.7622842; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rosenblatt S, 1997, BIOCHEM J, V324, P311, DOI 10.1042/bj3240311; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Said N, 2007, MOL CANCER RES, V5, P1015, DOI 10.1158/1541-7786.MCR-07-0001; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Stein WD, 2004, CANCER RES, V64, P2805, DOI 10.1158/0008-5472.CAN-03-3383; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; Wong FH, 2009, INT J ONCOL, V34, P117, DOI 10.3892/ijo_00000135; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Yuan C, 2004, PROTEIN EXPRES PURIF, V35, P39, DOI 10.1016/j.pep.2003.12.020; Yusuf N, 2014, GYNECOL ONCOL, V134, P356, DOI 10.1016/j.ygyno.2014.04.009; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zutter MM, 2007, ADV EXP MED BIOL, V608, P87	52	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162698	10.1371/journal.pone.0162698	http://dx.doi.org/10.1371/journal.pone.0162698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622658	gold, Green Published, Green Accepted			2022-12-26	WOS:000383681000048
J	van Adrichem, EJ; de Zande, SCV; Dekker, R; Verschuuren, EAM; Dijkstra, PU; van der Schans, CP				van Adrichem, Edwin J.; de Zande, Saskia C. van; Dekker, Rienk; Verschuuren, Erik A. M.; Dijkstra, Pieter U.; van der Schans, Cees P.			Perceived Barriers to and Facilitators of Physical Activity in Recipients of Solid Organ Transplantation, a Qualitative Study	PLOS ONE			English	Article							EXERCISE PARTICIPATION; OF-LIFE; DETERMINANTS; MOTIVATIONS; CAPACITY; PEOPLE	Background Sufficient physical activity is important for solid organ transplant recipients (heart, lung, liver, kidney). However, recipients do not meet the recommended amount or required type of physical activity. The perceived barriers to and facilitators of physical activity in this population are largely unknown. Methods Semi-structured in depth interviews were conducted with solid organ transplant recipients in order to explore experienced barriers and facilitators. Qualitative methodology with thematic line-by-line analysis was used for analysis, and derived themes were classified into personal and environmental factors. Results The most important indicated barriers were physical limitations, insufficient energy level, fear, and comorbidities. The most frequently mentioned facilitators included motivation, coping, consequences of (in) activity, routine/habit, goals/goal priority, and responsibility for the transplanted organ. Neutral factors acting as a barrier or facilitator were self-efficacy and expertise of personnel. A comparison of barriers and facilitators between transplant recipient groups yielded no overt differences. Conclusion Several personal and environmental factors were indicated that should be considered in intervention development to increase physical activity behavior in solid organ transplant recipients.	[van Adrichem, Edwin J.; de Zande, Saskia C. van; van der Schans, Cees P.] Hanze Univ Appl Sci, Res Grp Hlth Ageing Allied Hlth Care & Nursing, Groningen, Netherlands; [van Adrichem, Edwin J.; Dekker, Rienk; Dijkstra, Pieter U.; van der Schans, Cees P.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [van Adrichem, Edwin J.; Verschuuren, Erik A. M.] Univ Groningen, Univ Med Ctr Groningen, Groningen Transplant Ctr, Groningen, Netherlands; [Dekker, Rienk] Univ Groningen, Univ Med Ctr Groningen, Ctr Sports Med, Groningen, Netherlands; [Verschuuren, Erik A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands; [Dijkstra, Pieter U.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Adrichem, EJ (corresponding author), Hanze Univ Appl Sci, Res Grp Hlth Ageing Allied Hlth Care & Nursing, Groningen, Netherlands.; van Adrichem, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.; van Adrichem, EJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Transplant Ctr, Groningen, Netherlands.	e.j.van.adrichem@pl.hanze.nl	van Adrichem, Edwin J./AAS-1271-2020	van de Zande, Saskia/0000-0002-3063-0260; van der Schans, Cees P/0000-0003-4728-4082; Verschuuren, Erik/0000-0002-6807-6744				Bossola M, 2014, BLOOD PURIFICAT, V38, P24, DOI 10.1159/000363599; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Clarke AL, 2015, NEPHROL DIAL TRANSPL, V30, P1885, DOI 10.1093/ndt/gfv208; Cleary K, 2015, PHYSIOTHER THEOR PR, V31, P337, DOI 10.3109/09593985.2015.1004770; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; Delgado C, 2012, NEPHROL DIAL TRANSPL, V27, P1152, DOI 10.1093/ndt/gfr404; Didsbury M, 2013, TRANSPLANTATION, V95, P679, DOI 10.1097/TP.0b013e31827a3d3e; Dontje ML, 2014, CLIN TRANSPLANT, V28, P394, DOI 10.1111/ctr.12325; Evangelista Lorraine S, 2005, J Cardiovasc Nurs, V20, P334; Frith J, 2010, J HEPATOL, V52, P112, DOI 10.1016/j.jhep.2009.10.010; GODIN G, 1990, SPORTS MED, V10, P103, DOI 10.2165/00007256-199010020-00004; Goodman Eric D, 2004, Nephrol Nurs J, V31, P23; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Langer D, 2012, AM J TRANSPLANTATION; Langer D, 2009, J HEART LUNG TRANSPL, V28, P572, DOI 10.1016/j.healun.2009.03.007; Masala D, 2012, TRANSPL P, V44, P1346, DOI 10.1016/j.transproceed.2012.01.123; Mathur S, 2014, AM J TRANSPLANT, V14, P2235, DOI 10.1111/ajt.12874; Mitsui T, 2002, J NEUROL, V249, P1004, DOI 10.1007/s00415-002-0774-5; Kulak CAM, 2012, CURR OSTEOPOROS REP, V10, P48, DOI 10.1007/s11914-011-0083-y; Morton J. M., 1999, Journal of Heart and Lung Transplantation, V18, P52, DOI 10.1016/S1053-2498(99)80073-4; Myers Jonathan, 2003, J Cardiopulm Rehabil, V23, P100; Nielens H, 2001, NEPHROL DIAL TRANSPL, V16, P134, DOI 10.1093/ndt/16.1.134; Oman RF, 1998, AM J HEALTH PROMOT, V12, P154, DOI 10.4278/0890-1171-12.3.154; Pender N.J., 2002, HLTH PROMOTION NURSI, V4, P1; Pirenne J, 2004, AM J TRANSPLANT, V4, P554, DOI 10.1111/j.1600-6143.2004.00363.x; Pope C, 2006, QUALITATIVE RES HLTH, V3rd; Ritchie J., 2013, QUALITATIVE RES PRAC; Sanchez Zoila V, 2007, Prog Transplant, V17, P324; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Sherwood NE, 2000, ANNU REV NUTR, V20, P21, DOI 10.1146/annurev.nutr.20.1.21; Slapak Maurice, 2005, Ann Transplant, V10, P24; Thorpe O, 2012, J CARDIOPULM REHABIL, V32, P359, DOI 10.1097/HCR.0b013e318262d7df; Tierney S, 2011, INT J NURS STUD, V48, P1234, DOI 10.1016/j.ijnurstu.2011.03.003; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; van Adrichem EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142641; van Adrichem EJ, 2015, PHYS THER, V95, P720, DOI 10.2522/ptj.20140001; van den Ham ECH, 2005, AM J TRANSPLANT, V5, P1957, DOI 10.1111/j.1600-6143.2005.00944.x; van der Ploeg HP, 2004, SPORTS MED, V34, P639, DOI 10.2165/00007256-200434100-00002; Wang XN, 1999, AM J RESP CRIT CARE, V160, P57, DOI 10.1164/ajrccm.160.1.9805092; Williams TJ, 2012, COMPR PHYSIOL, V2, P1937, DOI 10.1002/cphy.c110021; Yates BC, 2003, RES NURS HEALTH, V26, P459, DOI 10.1002/nur.10108; Zelle DM, 2011, CLIN J AM SOC NEPHRO, V6, P898, DOI 10.2215/CJN.03340410	44	36	36	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162725	10.1371/journal.pone.0162725	http://dx.doi.org/10.1371/journal.pone.0162725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622291	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000051
J	Liu, XW; Sun, HY; Feike, T; Zhang, XY; Shao, LW; Chen, SY				Liu, Xiuwei; Sun, Hongyong; Feike, Til; Zhang, Xiying; Shao, Liwei; Chen, Suying			Assessing the Impact of Air Pollution on Grain Yield of Winter Wheat - A Case Study in the North China Plain	PLOS ONE			English	Article							PHOTOSYNTHETICALLY ACTIVE RADIATION; MODELING CANOPY PHOTOSYNTHESIS; ATMOSPHERIC AEROSOL; GLOBAL RADIATION; DIRECT COMPONENT; SOLAR-RADIATION; CROP PRODUCTION; USE EFFICIENCY; CLIMATE-CHANGE; REGIONAL HAZE	The major wheat production region of China the North China Plain (NCP) is seriously affected by air pollution. In this study, yield of winter wheat (Triticum aestivum L.) was analyzed with respect to the potential impact of air pollution index under conditions of optimal crop management in the NCP from 2001 to 2012. Results showed that air pollution was especially serious at the early phase of winter wheat growth significantly influencing various weather factors. However, no significant correlations were found between final grain yield and the weather factors during the early growth phase. In contrast, significant correlations were found between grain yield and total solar radiation gap, sunshine hour gap, diurnal temperature range and relative humidity during the late growing phase. To disentangle the confounding effects of various weather factors, and test the isolated effect of air pollution induced changes in incoming global solar radiation on yield under ceteris paribus conditions, crop model based scenario-analysis was conducted. The simulation results of the calibrated Agricultural Production Systems Simulator (APSIM) model indicated that a reduction in radiation by 10% might cause a yield reduction by more than 10%. Increasing incident radiation by 10% would lead to yield increases of (only) 7%, with the effects being much stronger during the late growing phase compared to the early growing phase. However, there is evidence that APSIM overestimates the effect of air pollution induced changes on radiation, as it does not consider the changes in radiative properties of solar insulation, i.e. the relative increase of diffuse over direct radiation, which may partly alleviate the negative effects of reduced total radiation by air pollution. Concluding, the present study could not detect a significantly negative effect of air pollution on wheat yields in the NCP.	[Liu, Xiuwei; Sun, Hongyong; Zhang, Xiying; Shao, Liwei; Chen, Suying] Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Peoples R China; [Liu, Xiuwei] Texas A&M AgriLife Res & Extens Ctr, Uvalde, TX USA; [Feike, Til] Inst Strategies & Technol Assessment, Fed Res Ctr Cultivated Plants, JKI, Kleinmachnow, Germany	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhang, XY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Ctr Agr Resources Res, Key Lab Agr Water Resources, Shijiazhuang, Peoples R China.	xyzhang@sjziam.ac.cn	sun, hongyong/AAF-5679-2020	Feike, Til/0000-0002-1978-9473; Sun, Hongyong/0000-0002-5132-7738	Special Fund for Agro-scientific Research in China [201203077, 201303133]; Hebei ST Project [14227007D]	Special Fund for Agro-scientific Research in China; Hebei ST Project	This study was supported by the Special Fund for Agro-scientific Research in China (201203077 and 201303133) and Hebei S&T Project (14227007D).; This study was supported by the Special Fund for Agro-scientific Research in China (201203077 and 201303133) and Hebei S&T Project (14227007D). Special appreciation is extended to Dr. Xuejun Dong for his help in improving the English writing of this paper.	Akitsu T, 2015, AGR FOREST METEOROL, V209, P59, DOI 10.1016/j.agrformet.2015.04.026; Alton PB, 2007, GLOBAL CHANGE BIOL, V13, P776, DOI 10.1111/j.1365-2486.2007.01316.x; Andreae MO, 2008, ATMOS ENVIRON, V42, P6335, DOI 10.1016/j.atmosenv.2008.01.030; Anwar MR, 2007, FIELD CROP RES, V104, P139, DOI 10.1016/j.fcr.2007.03.020; Asseng S, 2000, EUR J AGRON, V12, P37, DOI 10.1016/S1161-0301(99)00044-1; Asseng S, 2011, GLOBAL CHANGE BIOL, V17, P997, DOI 10.1111/j.1365-2486.2010.02262.x; Bodin P, 2012, GEOSCI MODEL DEV, V5, P535, DOI 10.5194/gmd-5-535-2012; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; Chameides WL, 1999, P NATL ACAD SCI USA, V96, P13626, DOI 10.1073/pnas.96.24.13626; Che HZ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022322; Chen C, 2010, CLIMATIC CHANGE, V100, P559, DOI 10.1007/s10584-009-9690-3; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Coe H, 2011, SCIENCE, V331, P1273, DOI 10.1126/science.1203019; Cogliani E, 2001, ATMOS ENVIRON, V35, P2871, DOI 10.1016/S1352-2310(01)00071-1; Gao W, 2003, AGR FOREST METEOROL, V120, P141, DOI 10.1016/j.agrformet.2003.08.026; Gu LH, 1999, J GEOPHYS RES-ATMOS, V104, P31421, DOI 10.1029/1999JD901068; Jing X, 2010, ATMOS CHEM PHYS, V10, P8205, DOI 10.5194/acp-10-8205-2010; Kolar P, 2014, THEOR APPL CLIMATOL, V117, P707, DOI 10.1007/s00704-013-1037-3; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Li WG, 2011, THEOR APPL CLIMATOL, V104, P473, DOI 10.1007/s00704-010-0360-1; Liu N, 2015, CROP PROT, V74, P150, DOI 10.1016/j.cropro.2015.05.001; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; Massie ST, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004620; MCCREE KJ, 1972, AGR METEOROL, V10, P443, DOI 10.1016/0002-1571(72)90045-3; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Moan J., 2001, RAD HOME OUTDOORS WO, P69; Moschini RC, 1999, PLANT DIS, V83, P381, DOI 10.1094/PDIS.1999.83.4.381; MOTT KA, 1991, PLANT CELL ENVIRON, V14, P509, DOI 10.1111/j.1365-3040.1991.tb01521.x; Munz S, 2014, AGR FOREST METEOROL, V195, P152, DOI 10.1016/j.agrformet.2014.05.009; Niyogi D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020915; Norris JR, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007794; Roderick ML, 1999, AGR FOREST METEOROL, V95, P169, DOI 10.1016/S0168-1923(99)00028-3; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P231, DOI 10.1016/0168-1923(86)90061-4; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P217, DOI 10.1016/0168-1923(86)90060-2; Streets DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026471; Sun H, 2013, INT J PLANT PROD, V7, P117; Sun HY, 2015, EUR J AGRON, V70, P48, DOI 10.1016/j.eja.2015.07.001; Sun HY, 2014, AGRON J, V106, P281, DOI 10.2134/agronj2013.0309; Sun YL, 2012, ATMOS ENVIRON, V51, P250, DOI 10.1016/j.atmosenv.2012.01.013; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; Wang E, 2003, SOL BETT ENV P 11 AU; Wang FX, 2014, INT J CLIMATOL, V34, P343, DOI 10.1002/joc.3690; Wang J, 2015, FIELD CROP RES, V176, P1, DOI 10.1016/j.fcr.2015.02.014; Wang YW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/5/054004; Wang YW, 2013, CLIM RES, V56, P11, DOI 10.3354/cr01139; Wang YW, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016753; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Xiao DP, 2016, FRONT EARTH SCI-PRC, V10, P444, DOI 10.1007/s11707-015-0534-3; Xiao DP, 2014, EUR J AGRON, V52, P112, DOI 10.1016/j.eja.2013.09.020; Zhang TY, 2013, INT J CLIMATOL, V33, P699, DOI 10.1002/joc.3463; Zhang XY, 2012, ATMOS CHEM PHYS, V12, P779, DOI 10.5194/acp-12-779-2012; Zhang XY, 2013, EUR J AGRON, V50, P52, DOI 10.1016/j.eja.2013.05.005; Zhang XY, 2011, AGR WATER MANAGE, V98, P1097, DOI 10.1016/j.agwat.2011.02.003; Zheng B., 2014, THE APSIM WHEAT MODU	56	7	8	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162655	10.1371/journal.pone.0162655	http://dx.doi.org/10.1371/journal.pone.0162655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612146	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900144
J	Ricci, L; Taffoni, F; Formica, D				Ricci, Luca; Taffoni, Fabrizio; Formica, Domenico			On the Orientation Error of IMU: Investigating Static and Dynamic Accuracy Targeting Human Motion	PLOS ONE			English	Article							ATTITUDE ESTIMATION; CALIBRATION; SENSORS	The accuracy in orientation tracking attainable by using inertial measurement units (IMU) when measuring human motion is still an open issue. This study presents a systematic quantification of the accuracy under static conditions and typical human dynamics, simulated by means of a robotic arm. Two sensor fusion algorithms, selected from the classes of the stochastic and complementary methods, are considered. The proposed protocol implements controlled and repeatable experimental conditions and validates accuracy for an extensive set of dynamic movements, that differ in frequency and amplitude of the movement. We found that dynamic performance of the tracking is only slightly dependent on the sensor fusion algorithm. Instead, it is dependent on the amplitude and frequency of the movement and a major contribution to the error derives from the orientation of the rotation axis w.r.t. the gravity vector. Absolute and relative errors upper bounds are found respectively in the range [0.7 degrees divided by 8.2 degrees]and [1.0 degrees divided by 10.3 degrees]. Alongside dynamic, static accuracy is thoroughly investigated, also with an emphasis on convergence behavior of the different algorithms. Reported results emphasize critical issues associated with the use of this technology and provide a baseline level of performance for the human motion related application.	[Ricci, Luca; Taffoni, Fabrizio; Formica, Domenico] Univ Campus Biomed Roma, Dept Engn, Unit Biomed Robot & Biomicrosyst, Via Alvaro del Portillo 21, I-00128 Rome, Italy	University Campus Bio-Medico - Rome Italy	Formica, D (corresponding author), Univ Campus Biomed Roma, Dept Engn, Unit Biomed Robot & Biomicrosyst, Via Alvaro del Portillo 21, I-00128 Rome, Italy.	d.formica@unicampus.it	Taffoni, Fabrizio/AAC-2572-2019; Formica, Domenico/G-9403-2011	Taffoni, Fabrizio/0000-0003-3215-1375; Formica, Domenico/0000-0003-0240-1265	Ministry of Education, University and Research under "FIRB\Futuro in Ricerca" research program (TOUM project) [RBFR086HEW]	Ministry of Education, University and Research under "FIRB\Futuro in Ricerca" research program (TOUM project)	This work was funded by the Italian Ministry of Education, University and Research under the "FIRB\Futuro in Ricerca" research program (TOUM project, no. RBFR086HEW).	Bachmann BYER, 2007, IEEE ROBOTICS AUTOMA; Barralon P, 2005, P ANN INT IEEE EMBS, P2447, DOI 10.1109/IEMBS.2005.1616963; Bergamini E, 2014, SENSORS-BASEL, V14, P18625, DOI 10.3390/s141018625; Brodie M., 2008, SPORTS TECHNOL, V1, P17, DOI [10.1080/19346182.2008.9648447, DOI 10.1080/19346182.2008.9648447, DOI 10.1002/JST.6]; Brodie MA, 2008, COMPUT METHOD BIOMEC, V11, P641, DOI 10.1080/10255840802326736; Campolo D, 2009, ADV ROBOTICS, V23, P955, DOI 10.1163/156855309X443052; Cooper G, 2009, J BIOMECH, V42, P2678, DOI 10.1016/j.jbiomech.2009.08.004; Crassidis JL, 2007, J GUID CONTROL DYNAM, V30, P12, DOI 10.2514/1.22452; Cutti AG, 2006, SIMPLE TEST ASSESS S, P5912; Cutti AG, 2010, MED BIOL ENG COMPUT, V48, P17, DOI 10.1007/s11517-009-0545-x; de Vries WHK, 2010, J BIOMECH, V43, P1983, DOI 10.1016/j.jbiomech.2010.03.007; Godfrey A, 2008, MED ENG PHYS, V30, P1364, DOI 10.1016/j.medengphy.2008.09.005; Godwin A, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000109; HORN BKP, 1987, J OPT SOC AM A, V4, P629, DOI 10.1364/JOSAA.4.000629; Lebel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118361; Lebel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079945; Luinge HJ, 2007, J BIOMECH, V40, P78, DOI 10.1016/j.jbiomech.2005.11.011; Madgwick SOH, 2011, INT C REHAB ROBOT; Mahony R, 2008, IEEE T AUTOMAT CONTR, V53, P1203, DOI 10.1109/TAC.2008.923738; Mann KA, 1989, FREQUENCY SPECTRUM A, P304; Picerno P, 2011, GAIT POSTURE, V33, P373, DOI 10.1016/j.gaitpost.2010.12.006; Ricci L, 2014, SENSORS-BASEL, V14, P1057, DOI 10.3390/s140101057; Roetenberg D., INERTIAL MAGNETIC SE; Roetenberg D, 2007, IEEE T BIO-MED ENG, V54, P883, DOI 10.1109/TBME.2006.889184; Sabatini AM, 2002, MED BIOL ENG COMPUT, V2005, P43; Sabatini AM, 2011, SENSORS-BASEL, V11, P9182, DOI 10.3390/s111009182; Tian Y, 2013, IEEE T NEUR SYS REH, V21, P254, DOI 10.1109/TNSRE.2012.2205706; WINTER DA, 1984, HUM MOVEMENT SCI, V3, P51, DOI 10.1016/0167-9457(84)90005-8	28	42	42	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161940	10.1371/journal.pone.0161940	http://dx.doi.org/10.1371/journal.pone.0161940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612100	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900040
J	Queisser, A; Hagedorn, S; Wang, H; Schaefer, T; Konantz, M; Alavi, S; Deng, M; Vogel, W; Von Mssenhausen, A; Kristiansen, G; Duensing, S; Kirfel, J; Lengerke, C; Perner, S				Queisser, A.; Hagedorn, S.; Wang, H.; Schaefer, T.; Konantz, M.; Alavi, S.; Deng, M.; Vogel, W.; Von Mssenhausen, A.; Kristiansen, G.; Duensing, S.; Kirfel, J.; Lengerke, C.; Perner, S.			Ecotropic viral integration site 1, a novel oncogene in prostate cancer	ONCOGENE			English	Article							CELL-CYCLE PROGRESSION; STEM-LIKE CELL; EVI1; EXPRESSION; OVARIAN; ERG; AMPLIFICATION; ONCOPROTEIN; INHIBITOR; ZEBRAFISH	Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer in men in the western world. Mutations in tumor suppressor genes and in oncogenes are important for PCa progression, whereas the role of stem cell proteins in prostate carcinogenesis is insufficiently examined. This study investigates the role of the transcriptional regulator Ecotropic Viral Integration site 1 (EVI1), known as an essential modulator of hematopoietic and leukemic stem cell biology, in prostate carcinogenesis. We show that in healthy prostatic tissue, EVI1 expression is confined to the prostate stem cell compartment located at the basal layer, as identified by the stem cell marker CD44. Instead, in a PCa progression cohort comprising 219 samples from patients with primary PCa, lymph node and distant metastases, EVI1 protein was heterogeneously distributed within samples and high expression is associated with tumor progression (P<0.001), suggesting EVI1 induction as a driver event. Functionally, short hairpin RNAmediated knockdown of EVI1 inhibited proliferation, cell cycle progression, migratory capacity and anchorage-independent growth of human PCa cells, while enhancing their apoptosis sensitivity. Interestingly, modulation of EVI1 expression also strongly regulated stem cell properties (including expression of the stem cell marker SOX2) and in vivo tumor initiation capacity. Further emphasizing a functional correlation between EVI1 induction and tumor progression, upregulation of EVI1 expression was noted in experimentally derived docetaxel-resistant PCa cells. Importantly, knockdown of EVI1 in these cells restored sensitivity to docetaxel, in part by downregulating anti-apoptotic BCL2. Together, these data indicate EVI1 as a novel molecular regulator of PCa progression and therapy resistance that may control prostate carcinogenesis at the stem cell level.	[Queisser, A.; Hagedorn, S.; Alavi, S.; Von Mssenhausen, A.; Perner, S.] Univ Hosp Bonn, Sect Prostate Canc Res, Bonn, Germany; [Queisser, A.; Hagedorn, S.; Alavi, S.; Von Mssenhausen, A.; Kristiansen, G.; Kirfel, J.; Perner, S.] Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Queisser, A.; Hagedorn, S.; Alavi, S.; Von Mssenhausen, A.; Kristiansen, G.; Kirfel, J.; Perner, S.] Univ Hosp Bonn, Ctr Integrated Oncol Cologne Bonn, Bonn, Germany; [Wang, H.; Schaefer, T.; Konantz, M.; Lengerke, C.] Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland; [Vogel, W.; Perner, S.] Univ Med Ctr Schleswig Holstein, Campus Luebeck & Res Ctr Borstel, Leibniz Ctr Med & Biosci, Borstel, Germany; [Duensing, S.] Heidelberg Univ, Sch Med, Dept Urol, Sect Mol Urooncol, Heidelberg, Germany; Univ Basel Hosp, Dept Biomed, Hebelstrasse 20, CH-4031 Basel, Switzerland	University of Bonn; University of Bonn; University of Bonn; University of Basel; Forschungszentrum Borstel; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; University of Basel	Lengerke, C (corresponding author), Univ Basel Hosp, Dept Biomed, Hebelstr 20, CH-4031 Basel, Switzerland.; Lengerke, C (corresponding author), Pathol Univ Hosp Luebeck, Leibniz Res Ctr Borstel, Inst Pathol, Ratzeburger Allee 160,Bldg 50, D-23538 Lubeck, Germany.	Claudia.Lengerke@unibas.ch; Sven.Perner@uksh.de	alavi, samin/Y-3285-2019; Lengerke, Claudia/AAV-8745-2021; , Anne/ABC-3403-2021	Lengerke, Claudia/0000-0001-5442-2805; , Anne/0000-0002-4727-782X; Schaefer, Thorsten/0000-0003-4867-8374; Konantz, Martina/0000-0002-4319-3119	German Research Foundation (Deutsche Forschungsgemeinschaft) [PE 1179/11-1]; Schweizer Nationalfonds [310030_149735]; Rudolf-Becker-Foundation; Wilhelm-Sander-Foundation [2011.077.2]; German Cancer Aid (Mildred-Scheel Doctoral Student Fellowship)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Schweizer Nationalfonds; Rudolf-Becker-Foundation; Wilhelm-Sander-Foundation; German Cancer Aid (Mildred-Scheel Doctoral Student Fellowship)	The study was supported by a grant from the German Research Foundation (Deutsche Forschungsgemeinschaft (PE 1179/11-1)) to SP, the Schweizer Nationalfonds to CL (310030_149735), the Rudolf-Becker-Foundation and the Wilhelm-Sander-Foundation (2011.077.2) to SP and the German Cancer Aid (Mildred-Scheel Doctoral Student Fellowship) to SH. We also acknowledge the TCGA Research Network for providing their cancer data sets.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Aytekin M, 2005, GENE, V356, P160, DOI 10.1016/j.gene.2005.04.032; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Bareiss PM, 2013, CANCER RES, V73, P5544, DOI 10.1158/0008-5472.CAN-12-4177; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Braun M, 2012, PROSTATE CANCER P D, V15, P165, DOI 10.1038/pcan.2011.67; Brooks DJ, 1996, BRIT J CANCER, V74, P1518, DOI 10.1038/bjc.1996.583; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen X, 2013, CELL CYCLE, V12, P579, DOI 10.4161/cc.23721; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Deng XY, 2013, MOL CARCINOGEN, V52, P255, DOI 10.1002/mc.21852; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goyama S, 2010, INT J HEMATOL, V91, P753, DOI 10.1007/s12185-010-0618-5; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; Han L, 2013, ACTA PHARM SIN B, V3, P65, DOI 10.1016/j.apsb.2013.02.006; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kataoka K, 2012, CANCER SCI, V103, P1371, DOI 10.1111/j.1349-7006.2012.02303.x; Kerr CL, 2014, CURR OPIN ONCOL, V26, P328, DOI 10.1097/CCO.0000000000000080; Konantz M, 2013, LEUKEMIA, V27, P56, DOI 10.1038/leu.2012.211; Konantz M, 2012, ANN NY ACAD SCI, V1266, P124, DOI 10.1111/j.1749-6632.2012.06575.x; Kregel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053701; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Kustikova OS, 2013, LEUKEMIA, V27, P1127, DOI 10.1038/leu.2012.355; Li P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-55; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; McGilvray R, 2007, FEBS J, V274, P3960, DOI 10.1111/j.1742-4658.2007.05928.x; Mosquera JM, 2007, J PATHOL, V212, P91, DOI 10.1002/path.2154; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nayak KB, 2013, INT J BIOCHEM CELL B, V45, P1568, DOI 10.1016/j.biocel.2013.04.032; Nwachukwu JC, 2009, CANCER RES, V69, P3140, DOI 10.1158/0008-5472.CAN-08-3738; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; PEDRALINOY G, 1980, NUCLEIC ACIDS RES, V8, P377, DOI 10.1093/nar/8.2.377; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Pflueger D, 2009, NEOPLASIA, V11, P804, DOI 10.1593/neo.09572; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rosa-Ribeiro R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097080; Sattler HP, 2000, PROSTATE, V45, P207, DOI 10.1002/1097-0045(20001101)45:3<207::AID-PROS2>3.0.CO;2-H; Schaefer T, 2015, ONCOTARGET, V6, P43540, DOI 10.18632/oncotarget.6183; Scheble VJ, 2010, MODERN PATHOL, V23, P1061, DOI 10.1038/modpathol.2010.87; Schroeder A, 2014, CANCER RES, V74, P1227, DOI 10.1158/0008-5472.CAN-13-0594; Sethi S, 2013, AM J TRANSL RES, V5, P200; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tanaka M, 2014, ONCOGENE, V33, P2454, DOI 10.1038/onc.2013.204; Taneja SS, 2004, J BIOL CHEM, V279, P13944, DOI 10.1074/jbc.M306576200; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tu SM, 2012, CLIN GENITOURIN CANC, V10, P69, DOI 10.1016/j.clgc.2012.01.002; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Van Leenders GJLH, 2001, BJU INT, V88, P35, DOI 10.1046/j.1464-410X.2001.00117.x; Volkert S, 2014, CANCER GENET-NY, V207, P103, DOI 10.1016/j.cancergen.2014.02.010; Wang H, 2015, JOVE-J VIS EXP, V95; Wieser R, 2007, GENE, V396, P346, DOI 10.1016/j.gene.2007.04.012; Yu ZR, 2012, INT J BIOCHEM CELL B, V44, P2144, DOI 10.1016/j.biocel.2012.08.022; Zhang BB, 2014, TUMOR BIOL, V35, P11861, DOI 10.1007/s13277-014-2417-8	68	26	26	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1573	1584		10.1038/onc.2016.325	http://dx.doi.org/10.1038/onc.2016.325			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27617580				2022-12-26	WOS:000397458100011
J	Watanabe, T; Kametani, K; Koyama, Y; Suzuki, D; Imamura, Y; Takehana, K; Hiramatsu, K				Watanabe, Takafumi; Kametani, Kiyokazu; Koyama, Yoh-ichi; Suzuki, Daisuke; Imamura, Yasutada; Takehana, Kazushige; Hiramatsu, Kohzy			Ring-Mesh Model of Proteoglycan Glycosaminoglycan Chains in Tendon based on Three-dimensional Reconstruction by Focused Ion Beam Scanning Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondroitin sulfate; collagen; decorin; dermatan sulfate; proteoglycan structure; tendon; focused ion beam scanning electron microscope; ring mesh	COLLAGEN FIBRIL MORPHOLOGY; MECHANICAL-PROPERTIES; IN-VITRO; DECORIN; ORGANIZATION; FORCE; LIGAMENT; TISSUE	Tendons are composed of collagen fibrils and proteoglycan predominantly consisting of decorin. Decorin is located on the d-band of collagen fibrils, and its glycosaminoglycan (GAG) chains have been observed between collagen fibrils with transmission electron microscopy. GAG chains have been proposed to interact with each other or with collagen fibrils, but its three-dimensional organization remains unclear. In this report, we used focused ion beam scanning electron microscopy to examine the three-dimensional organization of the GAG chain in the Achilles tendon of mature rats embedded in epoxy resin after staining with Cupromeronic blue, which specifically stains GAG chains. We used 250 serial back-scattered electron images of longitudinal sections with a 10-nm interval for reconstruction. Three-dimensional images revealed that GAG chains form a ring mesh-like structure with each ring surrounding a collagen fibril at the d-band and fusing with adjacent rings to form the planar network. This ring mesh model of GAG chains suggests that more than two GAG chains may interact with each other around collagen fibrils, which could provide new insights into the roles of GAG chains.	[Watanabe, Takafumi; Hiramatsu, Kohzy] Shinshu Univ, Fac Agr, Nagano 3994598, Japan; [Kametani, Kiyokazu] Shinshu Univ, Dept Instrumental Anal, Res Ctr Human & Environm Sci, Matsumoto, Nagano 3908621, Japan; [Koyama, Yoh-ichi] Nippi Inc, Res Inst Biomatrix, Toride, Ibaraki 3020017, Japan; [Suzuki, Daisuke] Sapporo Med Univ, Sch Med, Dept Musculoskeletal Biomech & Surg Dev, Sapporo, Hokkaido 0608556, Japan; [Imamura, Yasutada] Kogakuin Univ, Sch Adv Engn, Dept Chem & Life Sci, Hachioji, Tokyo 1920015, Japan; [Takehana, Kazushige] Rakuno Gakuen Univ, Sch Vet Med, Ebetsu, Hokkaido 0698501, Japan	Shinshu University; Shinshu University; Sapporo Medical University; Kogakuin University; Rakuno Gakuen University	Watanabe, T (corresponding author), Shinshu Univ, Fac Agr, Nagano 3994598, Japan.	yosenabe@shinshu-u.ac.jp	Imamura, Yasutada/AAI-3078-2020	Imamura, Yasutada/0000-0001-6264-1709				Ahmadzadeh H, 2013, J BIOMECH, V46, P2497, DOI 10.1016/j.jbiomech.2013.07.008; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Connizzo BK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023234; CRIBB AM, 1995, J ANAT, V187, P423; Dahl R, 2015, ACTA PHYSIOL, V213, P145, DOI 10.1111/apha.12289; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Feitosa VLC, 2006, MICRON, V37, P518, DOI 10.1016/j.micron.2006.01.010; Fessel G, 2012, J SHOULDER ELB SURG, V21, P209, DOI 10.1016/j.jse.2011.10.002; Fessel G, 2011, J THEOR BIOL, V268, P77, DOI 10.1016/j.jtbi.2010.10.007; Fessel G, 2009, MATRIX BIOL, V28, P503, DOI 10.1016/j.matbio.2009.08.002; Franchi M, 2010, J ANAT, V216, P301, DOI 10.1111/j.1469-7580.2009.01188.x; Kalson NS, 2015, ELIFE, V4, DOI 10.7554/eLife.05958; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Li Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02422; Liu XH, 2005, BIOCHEM BIOPH RES CO, V338, P1342, DOI 10.1016/j.bbrc.2005.10.096; Lujan TJ, 2007, J ORTHOP RES, V25, P894, DOI 10.1002/jor.20351; Nomura Y, 2006, CONNECT TISSUE RES, V47, P249, DOI 10.1080/03008200600846606; Ohta K, 2012, MICRON, V43, P612, DOI 10.1016/j.micron.2011.11.001; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; SCOTT JE, 1992, J ANAT, V180, P155; Vesentini S, 2005, J BIOMECH, V38, P433, DOI 10.1016/j.jbiomech.2004.04.032; Watanabe T, 2012, J ANAT, V220, P156, DOI 10.1111/j.1469-7580.2011.01456.x; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	31	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23704	23708		10.1074/jbc.M116.733857	http://dx.doi.org/10.1074/jbc.M116.733857			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27624935	Green Published, hybrid			2022-12-26	WOS:000387884400030
J	Medina, J; Nakagawa, Y; Nagasawa, M; Fernandez, A; Sakaguchi, K; Kitaguchi, T; Kojima, I				Medina, Johan; Nakagawa, Yuko; Nagasawa, Masahiro; Fernandez, Anny; Sakaguchi, Kazushige; Kitaguchi, Tetsuya; Kojima, Itaru			Positive Allosteric Modulation of the Calcium-sensing Receptor by Physiological Concentrations of Glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWEET TASTE RECEPTOR; EXTRACELLULAR CA2+-SENSING RECEPTOR; SIGNALING SYSTEMS; CELL-SURFACE; SECRETION; PROTEIN; CA2+; ANTAGONISTS	The calcium-sensing receptor (CaSR) is activated by various cations, cationic compounds, and amino acids. In the present study we investigated the effect of glucose on CaSR in HEK293 cells stably expressing human CaSR (HEK-CaSR cells). When glucose concentration in the buffer was raised from 3 to 25 mM, a rapid elevation of cytoplasmic Ca2+ concentration ([Ca2+](c)) was observed. This elevation was immediate and transient and was followed by a sustained decrease in [Ca2+](c). The effect of glucose was detected at a concentration of 4 mM and reached its maximum at 5 mM. 3-O-Methylglucose, a non-metabolizable analogue of glucose, reproduced the effect of glucose. Sucrose also induced an elevation of [Ca2+](c) in HEK-CaSR cells. Similarly, sucralose was nearly as effective as glucose in inducing elevation of [Ca2+](c). Glucose was not able to increase [Ca2+](c) in the absence of extracellular Ca2+. The effect of glucose on [Ca2+](c) was inhibited by NPS-2143, an allosteric inhibitor of CaSR. In addition, NPS-2143 also inhibited the [Ca2+](c) responses to sucralose and sucrose. Glucose as well as sucralose decreased cytoplasmic cAMP concentration in HEK-CaSR cells. The reduction of cAMP induced by glucose was blocked by pertussis toxin. Likewise, sucralose reduced [cAMP](c). Finally, glucose increased [Ca2+](c) in PT-r parathyroid cells and in Madin-Darby canine kidney cells, both of which express endogenous CaSR. These results indicate that glucose acts as a positive allosteric modulator of CaSR.	[Medina, Johan; Nakagawa, Yuko; Nagasawa, Masahiro; Fernandez, Anny; Kojima, Itaru] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan; [Sakaguchi, Kazushige] Wakayama Med Univ, Inst Adv Med, Wakayama 6418509, Japan; [Kitaguchi, Tetsuya] Waseda Biosci Res Inst Singapore, Singapore 138667, Singapore; [Kitaguchi, Tetsuya] Waseda Univ, Org Univ Res Initiat, Tokyo 1620041, Japan	Gunma University; Wakayama Medical University; Waseda University	Kojima, I (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma 3718512, Japan.	ikojima@gunma-u.ac.jp	KITAGUCHI, TETSUYA/AAR-1895-2021; Kitaguchi, Tetsuya/F-5260-2017	KITAGUCHI, TETSUYA/0000-0001-6701-1933; Kitaguchi, Tetsuya/0000-0001-6701-1933	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1990, CELL CALCIUM, V11, P333, DOI 10.1016/0143-4160(90)90035-S; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2002, EUR J CLIN NUTR, V56, P1072, DOI 10.1038/sj.ejcn.1601463; Conigrave AD, 2013, BEST PRACT RES CL EN, V27, P315, DOI 10.1016/j.beem.2013.05.010; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Jouret F, 2013, J CELL SCI, V126, P5132, DOI 10.1242/jcs.127555; Kojima I, 2015, J DIABETES INVEST, V6, P256, DOI 10.1111/jdi.12304; Malaisse WJ, 1999, ENDOCRINE, V11, P293, DOI 10.1385/ENDO:11:3:293; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; Mamillapalli R, 2010, J ENDOCRINOL, V204, P287, DOI 10.1677/JOE-09-0183; Maruyama Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034489; Nagano N, 2005, J PHARMACOL SCI, V97, P355, DOI 10.1254/jphs.FMJ04007X6; Nakagawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144053; Nakagawa Y, 2014, ENDOCR J, V61, P119, DOI 10.1507/endocrj.EJ13-0431; Nakagawa Y, 2013, ENDOCR J, V60, P1191, DOI 10.1507/endocrj.EJ13-0282; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290015; Odaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100252; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; Ohtsu Y, 2014, MOL CELL ENDOCRINOL, V394, P70, DOI 10.1016/j.mce.2014.07.004; Quinn SJ, 1998, J BIOL CHEM, V273, P19579, DOI 10.1074/jbc.273.31.19579; Rasschaert J, 1999, BIOCHEM BIOPH RES CO, V264, P615, DOI 10.1006/bbrc.1999.1577; Riccardi D, 2002, EXP PHYSIOL, V87, P403, DOI 10.1111/j.1469-445X.2002.tb00053.x; Rogachevskaja OA, 2011, BIOCHEM BIOPH RES CO, V416, P433, DOI 10.1016/j.bbrc.2011.11.095; SAKAGUCHI K, 1987, P NATL ACAD SCI USA, V84, P3269, DOI 10.1073/pnas.84.10.3269; Silve C, 2005, J BIOL CHEM, V280, P37917, DOI 10.1074/jbc.M506263200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Temussi P, 2007, ADV FOOD NUTR RES, V53, P199, DOI 10.1016/S1043-4526(07)53006-8; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501	33	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23126	23135		10.1074/jbc.M116.729863	http://dx.doi.org/10.1074/jbc.M116.729863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613866	Green Published, hybrid			2022-12-26	WOS:000387224800023
J	Mizzi, C; Dalabira, E; Kumuthini, J; Dzimiri, N; Balogh, I; Basak, N; Bohm, R; Borg, J; Borgiani, P; Bozina, N; Bruckmueller, H; Burzynska, B; Carracedo, A; Cascorbi, I; Deltas, C; Dolzan, V; Fenech, A; Grech, G; Kasiulevicius, V; Kadasi, L; Kucinskas, V; Khusnutdinova, E; Loukas, YL; Macek, M; Makukh, H; Mathijssen, R; Mitropoulos, K; Mitropoulou, C; Novelli, G; Papantoni, I; Pavlovic, S; Saglio, G; Setric, J; Stojiljkovic, M; Stubbs, AP; Squassina, A; Torres, M; Turnovec, M; van Schaik, RH; Voskarides, K; Wakil, SM; Werk, A; del Zompo, M; Zukic, B; Katsila, T; Lee, MTM; Motsinger-Rief, A; Mc Leod, HL; van der Spek, PJ; Patrinos, GP				Mizzi, Clint; Dalabira, Eleni; Kumuthini, Judit; Dzimiri, Nduna; Balogh, Istvan; Basak, Nazli; Boehm, Ruwen; Borg, Joseph; Borgiani, Paola; Bozina, Nada; Bruckmueller, Henrike; Burzynska, Beata; Carracedo, Angel; Cascorbi, Ingolf; Deltas, Constantinos; Dolzan, Vita; Fenech, Anthony; Grech, Godfrey; Kasiulevicius, Vytautas; Kadasi, L'udevit; Kucinskas, Vaidutis; Khusnutdinova, Elza; Loukas, Yiannis L.; Macek, Milan, Jr.; Makukh, Halyna; Mathijssen, Ron; Mitropoulos, Konstantinos; Mitropoulou, Christina; Novelli, Giuseppe; Papantoni, Ioanna; Pavlovic, Sonja; Saglio, Giuseppe; Setric, Jadranka; Stojiljkovic, Maja; Stubbs, Andrew P.; Squassina, Alessio; Torres, Maria; Turnovec, Marek; van Schaik, Ron H.; Voskarides, Konstantinos; Wakil, Salma M.; Werk, Anneke; del Zompo, Maria; Zukic, Branka; Katsila, Theodora; Lee, Ming Ta Michael; Motsinger-Rief, Alison; Mc Leod, Howard L.; van der Spek, Peter J.; Patrinos, George P.			A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics	PLOS ONE			English	Article							SIMVASTATIN-INDUCED MYOPATHY; GENETIC-VARIATION; POPULATION-STRUCTURE; DECISION-MAKING; UNITED-STATES; DRUG; MICROATTRIBUTION; CHALLENGES; GUIDELINE; MEDICINE	Pharmacogenomics aims to correlate inter-individual differences of drug efficacy and/or toxicity with the underlying genetic composition, particularly in genes encoding for protein factors and enzymes involved in drug metabolism and transport. In several European populations, particularly in countries with lower income, information related to the prevalence of pharmacogenomic biomarkers is incomplete or lacking. Here, we have implemented the microattribution approach to assess the pharmacogenomic biomarkers allelic spectrum in 18 European populations, mostly from developing European countries, by analyzing 1,931 pharmacogenomics biomarkers in 231 genes. Our data show significant interpopulation pharmacogenomic biomarker allele frequency differences, particularly in 7 clinically actionable pharmacogenomic biomarkers in 7 European populations, affecting drug efficacy and/ or toxicity of 51 medication treatment modalities. These data also reflect on the differences observed in the prevalence of high-risk genotypes in these populations, as far as common markers in the CYP2C9, CYP2C19, CYP3A5, VKORC1, SLCO1B1 and TPMT pharmacogenes are concerned. Also, our data demonstrate notable differences in predicted genotype-based warfarin dosing among these populations. Our findings can be exploited not only to develop guidelines for medical prioritization, but most importantly to facilitate integration of pharmacogenomics and to support pre-emptive pharmacogenomic testing. This may subsequently contribute towards significant cost-savings in the overall healthcare expenditure in the participating countries, where pharmacogenomics implementation proves to be cost-effective.	[Mizzi, Clint; Stubbs, Andrew P.; van der Spek, Peter J.; Patrinos, George P.] Erasmus Univ, Fac Med, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Mizzi, Clint] Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Msida, Malta; [Dalabira, Eleni; Papantoni, Ioanna; Katsila, Theodora; Patrinos, George P.] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece; [Kumuthini, Judit] Ctr Prote & Genom Res, Observ, Cape Town, South Africa; [Dzimiri, Nduna; Wakil, Salma M.] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia; [Balogh, Istvan] Univ Debrecen, Debrecen, Hungary; [Basak, Nazli] Bogazici Univ, Istanbul, Turkey; [Boehm, Ruwen; Bruckmueller, Henrike; Cascorbi, Ingolf; Werk, Anneke] Univ Kiel, Inst Expt & Clin Pharmacol, Kiel, Germany; [Borg, Joseph] Univ Malta, Fac Hlth Sci, Dept Appl Biomed Sci, Msida, Malta; [Borgiani, Paola; Novelli, Giuseppe] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Bozina, Nada; Setric, Jadranka] Univ Hosp Ctr, Zagreb, Croatia; [Burzynska, Beata] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Carracedo, Angel; Torres, Maria] Univ Santiago de Compostela, Santiago, Spain; [Deltas, Constantinos; Voskarides, Konstantinos] Univ Cyprus, Dept Biol Sci, Mol Med Res Ctr, Nicosia, Cyprus; [Dolzan, Vita] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Fenech, Anthony; Grech, Godfrey] Univ Malta, Fac Med, Dept Surg, Msida, Malta; [Kasiulevicius, Vytautas; Kucinskas, Vaidutis] Vilnius Univ, Fac Med, Dept Human & Med Genet, Vilnius, Lithuania; [Kadasi, L'udevit] Comenius Univ, Fac Nat Sci, Bratislava, Slovakia; [Kadasi, L'udevit] Slovak Acad Sci, Ctr Mol Med, Bratislava, Slovakia; [Khusnutdinova, Elza] Russian Acad Sci, Inst Biochem & Genet, Ufa Sci Ctr, Ufa, Russia; [Khusnutdinova, Elza] Bashkir State Univ, Dept Genet & Fundamental Med, Ufa, Russia; [Loukas, Yiannis L.] Univ Athens, Fac Pharm, Dept Pharmaceut Chem, Athens, Greece; [Macek, Milan, Jr.; Turnovec, Marek] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Macek, Milan, Jr.; Turnovec, Marek] Univ Hosp Motol, Prague, Czech Republic; [Makukh, Halyna] Ukrainian Natl Acad Med Sci, Inst Hereditary Pathol, Lvov, Ukraine; [Mathijssen, Ron; Mitropoulou, Christina; van Schaik, Ron H.] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands; [Mitropoulos, Konstantinos] Golden Helix Fdn, London, England; [Pavlovic, Sonja; Stojiljkovic, Maja; Zukic, Branka] Univ Belgrade, Inst Mol Genet & Genet Engn, Lab Mol Biomed, Belgrade, Serbia; [Saglio, Giuseppe] Univ Turin, Sch Med, Turin, Italy; [Setric, Jadranka] Univ Zagreb, Sch Med, Zagreb, Croatia; [Squassina, Alessio; del Zompo, Maria] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Lee, Ming Ta Michael] Riken Inst Phys & Chem Res, Ctr Genom Med, Lab Int Alliance, Yokohama, Kanagawa, Japan; [Motsinger-Rief, Alison] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Mc Leod, Howard L.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Dalabira, Eleni] Univ Lausanne Hosp, Lausanne, Switzerland; [Lee, Ming Ta Michael] Geisinger Genom Med Inst, Danville, PA USA	Erasmus University Rotterdam; Erasmus MC; University of Malta; University of Patras; King Faisal Specialist Hospital & Research Center; University of Debrecen; Bogazici University; University of Kiel; University of Malta; University of Rome Tor Vergata; University of Zagreb; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Universidade de Santiago de Compostela; University of Cyprus; University of Ljubljana; University of Malta; Vilnius University; Comenius University Bratislava; Slovak Academy of Sciences; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Bashkir State University; National & Kapodistrian University of Athens; Charles University Prague; Motol University Hospital; National Academy of Medical Sciences of Ukraine; Institute of Hereditary Pathology; National Academy of Sciences Ukraine; Erasmus University Rotterdam; Erasmus MC; University of Belgrade; University of Turin; University of Zagreb; University of Cagliari; RIKEN; University of North Carolina; North Carolina State University; H Lee Moffitt Cancer Center & Research Institute; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Patrinos, GP (corresponding author), Erasmus Univ, Fac Med, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands.; Patrinos, GP (corresponding author), Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece.	gpatrinos@upatras.gr	Carracedo, Angel/D-4257-2012; Mitropoulou, Christina/C-2851-2009; Majid, Salma/AAT-6166-2020; Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Burzynska, Beata/A-4691-2013; Kadasi, Ludevit/A-4677-2013; Khusnutdinova, Elza Kamilevna/A-4810-2013; Torres, Maria/R-5162-2019; KUČINSKAS, Vaidutis/A-4798-2013; McLeod, Howard/ABD-8364-2021; Balogh, Istvan/N-2990-2019; van Schaik, Ron H.N./G-6816-2013; Voskarides, Konstantinos/A-4669-2013; Grech, Godfrey/AAD-1303-2020; Majid, Salma/AAT-2616-2020; Katsila, Theodora/O-3228-2015; Cascorbi, Ingolf/AAT-1927-2021; Deltas, Constantinos/A-4936-2013; Novelli, Giuseppe/GQB-3329-2022; Bruckmüller, Henrike/B-6830-2015; Kasiulevicius, Vytautas/P-6819-2014	Carracedo, Angel/0000-0003-1085-8986; Majid, Salma/0000-0002-7883-2515; Novelli, Giuseppe/0000-0002-7781-602X; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Torres, Maria/0000-0002-2658-0133; McLeod, Howard/0000-0002-9004-9232; Balogh, Istvan/0000-0003-3397-2829; Voskarides, Konstantinos/0000-0002-3705-3451; Grech, Godfrey/0000-0003-4502-8237; Majid, Salma/0000-0002-1724-5405; Katsila, Theodora/0000-0002-6263-4231; Cascorbi, Ingolf/0000-0002-2182-9534; Deltas, Constantinos/0000-0001-5549-9169; Novelli, Giuseppe/0000-0002-7781-602X; Bruckmüller, Henrike/0000-0002-6027-253X; Burzynska, Beata/0000-0003-1595-0036; Kasiulevicius, Vytautas/0000-0001-9967-8257; Bohm, Ruwen/0000-0003-1007-3011; Kumuthini, Judit/0000-0002-8008-1917; Saglio, Giuseppe/0000-0002-1046-3514; Squassina, Alessio/0000-0001-7415-7607	European grant (RD-Connect) [FP7-305444]; Golden Helix Foundation; LITGEN project - European Social Fund under the Global Grant Measure [VP1-3.1-SMM-07-K-01-013]; National Institutes of Health Common Fund Award NHGRI Grant [U41HG006941];  [00064203];  [LN14073];  [LM2015091];  [NF-CZ11-PDP-3-003-2014];  [CZ.2.16/3.1.00/24022OPPK]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006941] Funding Source: NIH RePORTER	European grant (RD-Connect); Golden Helix Foundation; LITGEN project - European Social Fund under the Global Grant Measure; National Institutes of Health Common Fund Award NHGRI Grant; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The Euro-PGx project was partly funded by European grant (RD-Connect; FP7-305444) and the Golden Helix Foundation and encouraged by the Genomic Medicine Alliance Pharmacogenomics Working group. The Lithuanian segment of the project was supported by the LITGEN project (VP1-3.1-SMM-07-K-01-013), funded by the European Social Fund under the Global Grant Measure. The Czech segment of the project was supported by 00064203, LN14073, LM2015091, NF-CZ11-PDP-3-003-2014 and CZ.2.16/3.1.00/24022OPPK grants to MM. JK was funded by the National Institutes of Health Common Fund Award NHGRI Grant Number U41HG006941. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Euro-PGx project was partly funded by European grant (RD-Connect; FP7-305444) and the Golden Helix Foundation and encouraged by the Genomic Medicine Alliance Pharmacogenomics Working group. The Lithuanian segment of the project was supported by the LITGEN project (VP1-3.1-SMM-07-K-01-013), funded by the European Social Fund under the Global Grant Measure. The Czech segment of the project was supported by 00064203, LN14073, LM2015091, NF-CZ11-PDP-3-003-2014 and CZ.2.16/3.1.00/24022OPPK grants to MM. JK was funded by the National Institutes of Health Common Fund Award NHGRI Grant Number U41HG006941. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflict of interests.	Arnold FL, 2014, CLIN PHARMACOL THER, V95, P542, DOI 10.1038/clpt.2013.231; Bonifaz-Pena V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640; Chen JM, 2010, PHARMACOGENOMICS, V11, P1077, DOI 10.2217/PGS.10.79; Davies EC, 2010, BRIT J CLIN PHARMACO, V70, P102, DOI 10.1111/j.1365-2125.2010.03671.x; Delser PM, 2013, HUM GENET, V132, P563, DOI 10.1007/s00439-013-1268-5; Ehmann F, 2015, PHARMACOGENOMICS J, V15, P201, DOI 10.1038/tpj.2014.86; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Jackson JN, 2016, PHARMACOGEN IN PRESS; Jittikoon J, 2016, J HUM GENET, V61, P119, DOI 10.1038/jhg.2015.115; Kampourakis K, 2014, EMBO REP, V15, P472, DOI 10.1002/embr.201438641; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Limdi NA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00183; Mitropoulou C, 2014, PUBLIC HEALTH GENOM, V17, P280, DOI 10.1159/000365896; Mizzi C, 2014, PHARMACOGENOMICS, V15, P1223, DOI [10.2217/PGS.14.102, 10.2217/pgs.14.102]; Papadopoulos P, 2014, NUCLEIC ACIDS RES, V42, pD1020, DOI 10.1093/nar/gkt1125; Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144; Potamias G, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140071; Pritchard JK, 2000, GENETICS, V155, P945; Ramos E, 2014, PHARMACOGENOMICS J, V14, P217, DOI 10.1038/tpj.2013.24; Ramsey LB, 2014, CLIN PHARMACOL THER, V96, P423, DOI 10.1038/clpt.2014.125; Roewer L, 2005, HUM GENET, V116, P279, DOI 10.1007/s00439-004-1201-z; Schildcrout JS, 2012, CLIN PHARMACOL THER, V92, P235, DOI 10.1038/clpt.2012.66; Snyder SR, 2014, PUBLIC HEALTH GENOM, V17, P256, DOI 10.1159/000366177; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Squassina A, 2010, PHARMACOGENOMICS, V11, P1149, DOI [10.2217/pgs.10.97, 10.2217/PGS.10.97]; Van Driest SL, 2014, CLIN PHARMACOL THER, V95, P423, DOI 10.1038/clpt.2013.229; Weale ME, 2010, METHODS MOL BIOL, V628, P341, DOI 10.1007/978-1-60327-367-1_19; Wilke RA, 2012, CLIN PHARMACOL THER, V92, P112, DOI 10.1038/clpt.2012.57; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Zineh I, 2011, PHARMACOTHERAPY, V31, P729, DOI 10.1592/phco.31.8.729	32	72	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162866	10.1371/journal.pone.0162866	http://dx.doi.org/10.1371/journal.pone.0162866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636550	gold, Green Published, Green Submitted			2022-12-26	WOS:000383723700018
J	Zhang, XL; Shen, ZW; Zhang, GS; Shen, YY; Chen, MM; Zhao, JX; Wu, RH				Zhang, Xiaolei; Shen, Zhiwei; Zhang, Guishan; Shen, Yuanyu; Chen, Miaomiao; Zhao, Jiaxiang; Wu, Renhua			Short Exon Detection via Wavelet Transform Modulus Maxima	PLOS ONE			English	Article							PROTEIN-CODING REGIONS; LONG-RANGE CORRELATIONS; SEQUENCE-ANALYSIS; GENE PREDICTION; HUMAN GENOME; BRCA1 GENE; DNA; IDENTIFICATION; REPLICATION; PERIODICITY	The detection of short exons is a challenging open problem in the field of bioinformatics. Due to the fact that the weakness of existing model-independent methods lies in their inability to reliably detect small exons, a model-independent method based on the singularity detection with wavelet transform modulus maxima has been developed for detecting short coding sequences (exons) in eukaryotic DNA sequences. In the analysis of our method, the local maxima can capture and characterize singularities of short exons, which helps to yield significant patterns that are rarely observed with the traditional methods. In order to get some information about singularities on the differences between the exon signal and the background noise, the noise level is estimated by filtering the genomic sequence through a notch filter. Meanwhile, a fast method based on a piecewise cubic Hermite interpolating polynomial is applied to reconstruct the wavelet coefficients for improving the computational efficiency. In addition, the output measure of a paired-numerical representation calculated in both forward and reverse directions is used to incorporate a useful DNA structural property. The performances of our approach and other techniques are evaluated on two benchmark data sets. Experimental results demonstrate that the proposed method outperforms all assessed model-independent methods for detecting short exons in terms of evaluation metrics.	[Zhang, Xiaolei] Shantou Univ, Coll Med, Shantou, Peoples R China; [Shen, Zhiwei; Shen, Yuanyu; Chen, Miaomiao; Wu, Renhua] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Shantou, Peoples R China; [Zhang, Guishan] Shantou Univ, Coll Engn, Shantou, Peoples R China; [Zhao, Jiaxiang] Nankai Univ, Coll Elect Informat & Opt Engn, Tianjin, Peoples R China	Shantou University; Shantou University; Shantou University; Nankai University	Wu, RH (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Radiol, Shantou, Peoples R China.; Zhao, JX (corresponding author), Nankai Univ, Coll Elect Informat & Opt Engn, Tianjin, Peoples R China.	zhaojx@nankai.edu.cn; cjr.wurenhua@vip.163.com		Zhang, Xiaolei/0000-0002-5909-5820	National Natural Science Foundation of China [81471730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China: http://www.nsfc.gov.cn/ (Grant No. 81471730, RHW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar M, 2008, IEEE J-STSP, V2, P310, DOI 10.1109/JSTSP.2008.923854; Anastassiou D, 2000, BIOINFORMATICS, V16, P1073, DOI 10.1093/bioinformatics/16.12.1073; [Anonymous], 1995, WAVELETS STAT, DOI [DOI 10.1007/978-1-4612-2544-7_17, 10.1007/978-1-4612-2544-7_17]; Arneodo A, 1996, PHYSICA D, V96, P291, DOI 10.1016/0167-2789(96)00029-2; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; Arneodo A, 2011, PHYS REP, V498, P45, DOI 10.1016/j.physrep.2010.10.001; Audit B, 2002, J MOL BIOL, V316, P903, DOI 10.1006/jmbi.2001.5363; Audit B, 2001, PHYS REV LETT, V86, P2471, DOI 10.1103/PhysRevLett.86.2471; Audit B, 2013, NAT PROTOC, V8, P98, DOI 10.1038/nprot.2012.145; Bergen SW, 2005, 2005 IEEE PAC RIM C; Brodie EB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.248103; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burset M, 1996, GENOMICS, V34, P353, DOI 10.1006/geno.1996.0298; CHECHETKIN VR, 1995, PHYS LETT A, V199, P75, DOI 10.1016/0375-9601(95)00047-7; Ciernikova S, 2003, NEOPLASMA, V50, P403; Datta S, 2004, P IEEE 6 INT S MULT; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Fan ZC, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/4/045007; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Fowler JE, 2005, IEEE SIGNAL PROC LET, V12, P629, DOI 10.1109/LSP.2005.853048; Gao F, 2004, BIOINFORMATICS, V20, P673, DOI 10.1093/bioinformatics/btg467; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; Guigo R, 1997, GENETIC DATABASES, P53; Han Min, 2005, Journal of System Simulation, V17, P2616; Jain D., 2014, SURVEY RES PROPOSAL; Jiang R, 2008, PHYSICA A, V387, P4223, DOI 10.1016/j.physa.2008.02.076; Jiang R, 2008, INT J DATA MIN BIOIN, V2, P15, DOI 10.1504/IJDMB.2008.016754; Jleed H, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTER APPLICATIONS TECHNOLOGY (ICCAT); Kotlar D, 2003, GENOME RES, V13, P1930, DOI 10.1101/gr.1261703; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; MALLAT S, 1992, IEEE T INFORM THEORY, V38, P617, DOI 10.1109/18.119727; Marhon SA, 2016, IEEE ACM T COMPUT BI, V13, P742, DOI 10.1109/TCBB.2015.2476789; Marhon SA, 2011, J COMPUT BIOL, V18, P639, DOI 10.1089/cmb.2010.0184; Mathe C, 2002, NUCLEIC ACIDS RES, V30, P4103, DOI 10.1093/nar/gkf543; Mena-Chalco JP, 2008, IEEE ACM T COMPUT BI, V5, P198, DOI 10.1109/TCBB.2007.70259; Mikels A., 2003, CAN HMMGENE NET GENE; Nedelcu R, 2002, EUR J HUM GENET, V10, P150, DOI 10.1038/sj.ejhg.5200755; Nicolay S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.032902; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pesquet JC, 1996, IEEE T SIGNAL PROCES, V44, P1964, DOI 10.1109/78.533717; Ramachandran P, 2009, 2009 IEEE INT S CIRC; Rao N, 2004, 2004 INT C COMM CIRC; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; Saberkari Hamidreza, 2013, J Med Signals Sens, V3, P139; Saeys Y, 2007, BIOINFORMATICS, V23, P414, DOI 10.1093/bioinformatics/btl639; Saleh-Gohari N, 2012, IRAN J CANCER PREV, V5, P210; Salzberg S, 1998, J COMPUT BIOL, V5, P667, DOI 10.1089/cmb.1998.5.667; Shakya DK, 2013, IEEE ACM T COMPUT BI, V10, P1241, DOI 10.1109/TCBB.2013.76; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; TSONIS AA, 1991, J THEOR BIOL, V151, P323, DOI 10.1016/S0022-5193(05)80381-9; Vaidyanathan PP, 2004, J FRANKLIN I, V341, P111, DOI 10.1016/j.jfranklin.2003.12.001; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Wang Zhuo, 2004, Genomics Proteomics & Bioinformatics, V2, P216; Windsor AJ, 2006, CURR OPIN BIOTECH, V17, P161, DOI 10.1016/j.copbio.2006.01.007; Wu YH, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061916; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Zhang MQ, 1997, P NATL ACAD SCI USA, V94, P565, DOI 10.1073/pnas.94.2.565; Zhang WF, 2012, PATTERN RECOGN, V45, P947, DOI 10.1016/j.patcog.2011.08.016	63	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163088	10.1371/journal.pone.0163088	http://dx.doi.org/10.1371/journal.pone.0163088			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635656	gold, Green Submitted, Green Published			2022-12-26	WOS:000383723700032
J	Chuan, LM; He, P; Zhao, TK; Zheng, HG; Xu, XP				Chuan, Limin; He, Ping; Zhao, Tongke; Zheng, Huaiguo; Xu, Xinpeng			Agronomic Characteristics Related to Grain Yield and Nutrient Use Efficiency for Wheat Production in China	PLOS ONE			English	Article							REQUIREMENTS; NITROGEN; MAIZE	In order to make clear the recent status and trend of wheat (Triticum aestivum L.) production in China, datasets from multiple field experiments and published literature were collected to study the agronomic characteristics related to grain yield, fertilizer application and nutrient use efficiency from the year 2000 to 2011. The results showed that the mean grain yield of wheat in 2000-2011 was 5950 kg/ha, while the N, P2O5 and K2O application rates were 172, 102 and 91 kg/ha on average, respectively. The decrease in N and P2O5 and increase in K2O balanced the nutrient supply and was the main reason for yield increase. The partial factor productivity (PFP, kg grain yield produced per unit of N, P2O5 or K2O applied) values of N (PFP-N), P (PFP-P) and K (PFP-K) were in the ranges of 29.5 similar to 39.6, 43.4 similar to 74.9 and 44.1 similar to 76.5 kg/kg, respectively. While PFP-N showed no significant changes from 2000 to 2010, both PFP-P and PFP-K showed an increased trend over this period. The mean agronomic efficiency (AE, kg grain yield increased per unit of N, P2O5 or K2O applied) values of N (AEN), P (AEP) and K (AEK) were 9.4, 10.2 and 6.5 kg/kg, respectively. The AE values demonstrated marked inter-annual fluctuations, with the amplitude of fluctuation for AEN greater than those for AEP and AEK. The mean fertilizer recovery efficiency (RE, the fraction of nutrient uptake in aboveground plant dry matter to the nutrient of fertilizer application) values of N, P and K in the aboveground biomass were 33.1%, 24.3% and 28.4%, respectively. It was also revealed that different wheat ecological regions differ greatly in wheat productivity, fertilizer application and nutrient use efficiency. In summary, it was suggested that best nutrient management practices, i.e. fertilizer recommendation applied based on soil testing or yield response, with strategies to match the nutrient input with realistic yield and demand, or provided with the 4R's nutrient management (right time, right rate, right site and right fertilizer) should be adopted widely to improve the yield production and nutrient use efficiency.	[Chuan, Limin; Zheng, Huaiguo] Beijing Acad Agr & Forestry Sci, Inst Informat Sci & Technol Agr, Beijing, Peoples R China; [He, Ping] Chinese Acad Agr Sci, Minist Agr, Key Lab Crop Nutr & Fertilizat, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [He, Ping] Int Plant Nutr Inst China Program, Beijing, Peoples R China; [Zhao, Tongke; Xu, Xinpeng] Beijing Acad Agr & Forestry Sci, Inst Plant Nutr & Resources, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Beijing Academy of Agriculture & Forestry	He, P (corresponding author), Chinese Acad Agr Sci, Minist Agr, Key Lab Crop Nutr & Fertilizat, Inst Agr Resources & Reg Planning, Beijing, Peoples R China.; He, P (corresponding author), Int Plant Nutr Inst China Program, Beijing, Peoples R China.; Zhao, TK (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant Nutr & Resources, Beijing, Peoples R China.	phe@ipni.net; tkzhao@126.com	He, Ping/HGD-5389-2022		Innovation Program of Beijing Academy of Agricultural and Forestry Sciences [KJCX20140207, KJCX20160503]; National Basic Research Program of China [2013CB127405, 2016YFDO200103]; International Plant Nutrition Institute (IPNI)	Innovation Program of Beijing Academy of Agricultural and Forestry Sciences; National Basic Research Program of China(National Basic Research Program of China); International Plant Nutrition Institute (IPNI)	Funding for this research is provided by the Innovation Program of Beijing Academy of Agricultural and Forestry Sciences (KJCX20140207 and KJCX20160503), the National Basic Research Program of China (2013CB127405, 2016YFDO200103), and International Plant Nutrition Institute (IPNI).	Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chinese Society of Soil Science, 2000, METH SOIL PLANT AN; Chuan LM, 2013, FIELD CROP RES, V146, P96, DOI 10.1016/j.fcr.2013.02.015; Chuan LM, 2013, FIELD CROP RES, V140, P1, DOI 10.1016/j.fcr.2012.09.020; Cui Z., 2008, ACTA AGR BOREALI SIN, V23, P224; Dobermann A., 2007, FERTILIZER BEST MANA; Fixen P. E., 2009, Better Crops with Plant Food, V93, P12; Fixen PE, 2007, P S INF TECH SOIL FE, P52; [郭战玲 GUO Zhan-ling], 2009, [华北农学报, Acta Agriculturae Boreali-Sinica], V24, P185; He P, 2009, AGRON J, V101, P1489, DOI 10.2134/agronj2009.0099; Ladha JK, 2005, ADV AGRON, V87, P85, DOI 10.1016/S0065-2113(05)87003-8; LIN B, 1989, Acta Pedologica Sinica, V26, P273; Liu MQ, 2006, NUTR CYCL AGROECOSYS, V74, P245, DOI 10.1007/s10705-006-9002-5; Liu XY, 2011, AGRON J, V103, P1452, DOI 10.2134/agronj2010.0476; [何萍 He Ping], 2012, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V18, P499; Snyder C.S., 2007, NUTRIENT USE EFFICIE; Wang FH, 1995, SHANDONG AGR SCI, V1, P4; [王激清 WANG Jiqing], 2008, [资源科学, Resources Science], V30, P415; Wei ZA, 2002, CHEM FERT IND, V29, P32; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915; Zhou Yang, 2007, Acta Agronomica Sinica, V33, P1530; Zhu Z.L., 1992, SOIL NITROGEN CHINA; ZHU ZL, 1998, FERTILIZER PROBLEMS, P38	23	13	16	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162802	10.1371/journal.pone.0162802	http://dx.doi.org/10.1371/journal.pone.0162802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631468	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900081
J	Jiang, HJ; Xie, YF; Li, XC; Ge, HJ; Deng, YQ; Mu, HF; Feng, XL; Yin, L; Du, Z; Chen, F; He, NY				Jiang, Haojun; Xie, Yifan; Li, Xuchao; Ge, Huijuan; Deng, Yongqiang; Mu, Haofang; Feng, Xiaoli; Yin, Lu; Du, Zhou; Chen, Fang; He, Nongyue			Noninvasive Prenatal Paternity Testing (NIPAT) through Maternal Plasma DNA Sequencing: A Pilot Study	PLOS ONE			English	Article							PREGNANCY; ASSAY	Short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) have been already used to performnoninvasive prenatal paternity testing from maternal plasma DNA. The frequently used technologies were PCR followed by capillary electrophoresis and SNP typing array, respectively. Here, we developed a noninvasive prenatal paternity testing (NIPAT) based on SNP typing with maternal plasma DNA sequencing. We evaluated the influence factors (minor allele frequency (MAF), the number of total SNP, fetal fraction and effective sequencing depth) and designed three different selective SNP panels in order to verify the performance in clinical cases. Combining targeted deep sequencing of selective SNP and informative bioinformatics pipeline, we calculated the combined paternity index (CPI) of 17 cases to determine paternity. Sequencing-based NIPAT results fully agreed with invasive prenatal paternity test using STR multiplex system. Our study here proved that the maternal plasma DNA sequencing-based technology is feasible and accurate in determining paternity, which may provide an alternative in forensic application in the future.	[Jiang, Haojun; He, Nongyue] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China; [Xie, Yifan; Li, Xuchao; Ge, Huijuan; Mu, Haofang; Feng, Xiaoli; Chen, Fang] Univ Chinese Acad Sci, BGI Educ Ctr, Beijing 100049, Peoples R China; [Jiang, Haojun; Xie, Yifan] BGI Shenzhen, Shenzhen 518000, Peoples R China; [Deng, Yongqiang] Second Peoples Hosp Shenzhen, Dept Stomatol, Shenzhen 518000, Peoples R China; [Mu, Haofang; Feng, Xiaoli] Beijing Genom Inst, Ctr Forens Sci, Beijing 100049, Peoples R China; [Yin, Lu; Du, Zhou; Chen, Fang] Publ Secur Bur Shenzhen Municipal, Shenzhen 518000, Peoples R China; [Yin, Lu; Du, Zhou; Chen, Fang] Joint Lab Gene Associated Applicat Res Forens, Shenzhen 518000, Peoples R China; [Chen, Fang] BGI Shenzhen, Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen 518000, Peoples R China; [Chen, Fang] BGI Shenzhen, Guangdong Prov Key Lab Human Dis Genome, Shenzhen 518000, Peoples R China; [Chen, Fang] Univ Copenhagen, Fac Hlth & Med Sci, Sect Mol Dis Biol, Dept Vet Dis Biol, DK-1165 Copenhagen K, Kobenhavn, Denmark	Southeast University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Second People's Hospital of Shenzhen; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); University of Copenhagen	He, NY (corresponding author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing 210096, Jiangsu, Peoples R China.; Chen, F (corresponding author), Univ Chinese Acad Sci, BGI Educ Ctr, Beijing 100049, Peoples R China.; Chen, F (corresponding author), Publ Secur Bur Shenzhen Municipal, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), Joint Lab Gene Associated Applicat Res Forens, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), BGI Shenzhen, Shenzhen Municipal Key Lab Birth Defects Screenin, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), BGI Shenzhen, Guangdong Prov Key Lab Human Dis Genome, Shenzhen 518000, Peoples R China.; Chen, F (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Mol Dis Biol, Dept Vet Dis Biol, DK-1165 Copenhagen K, Kobenhavn, Denmark.	fangchen@genomics.cn; nyhe1958@163.com			Project The Establishment of 30 National Standards about Key Nucleic Acid Biotechnology [201510208]; Shenzhen Municipal Government of China [JCYJ20140414170821214, ZDSYS20140509153457495, CXZZ20140808170655268]; BGI-Shenzhen	Project The Establishment of 30 National Standards about Key Nucleic Acid Biotechnology; Shenzhen Municipal Government of China; BGI-Shenzhen	Project The Establishment of 30 National Standards about Key Nucleic Acid Biotechnology (201510208), Shenzhen Municipal Government of China (NO. JCYJ20140414170821214), Shenzhen Municipal Government of China (NO. ZDSYS20140509153457495) and Shenzhen Municipal Government of China (NO. CXZZ20140808170655268) supported this study. BGI-Shenzhen provided support in the form of salaries for F. Chen, H. J. Ge, and X. C. Li. The specific roles of these authors are articulated in the 'author contributions' section. The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borsting C, 2008, FORENSIC SCI INT-GEN, V2, P292, DOI 10.1016/j.fsigen.2008.03.007; Dorum G, 2014, FORENSIC SCI INT-GEN, V9, P93, DOI 10.1016/j.fsigen.2013.11.008; Guo X, 2012, NEW ENGL J MED, V366, P1743, DOI 10.1056/NEJMc1113044; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lo YM, 1997, LANCET, V350, P485, DOI DOI 10.1016/S0140-6736(97)02174-0; Ou XL, 2014, TRANSFUSION, V54, P2523, DOI 10.1111/trf.12659; Ou XL, 2013, TRANSFUSION, V53, P1856, DOI 10.1111/trf.12246; Ryan A, 2013, GENET MED, V15, P473, DOI 10.1038/gim.2012.155; Tynan JA, 2011, J MOL DIAGN, V13, P382, DOI 10.1016/j.jmoldx.2011.02.001; Wagner J, 2009, INT J LEGAL MED, V123, P75, DOI 10.1007/s00414-008-0292-9	12	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159385	10.1371/journal.pone.0159385	http://dx.doi.org/10.1371/journal.pone.0159385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631491	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900001
J	Nakamura, E; Kinoshita, H; Feng, GG; Hayashi, H; Satomoto, M; Sato, M; Fujiwara, Y				Nakamura, Emi; Kinoshita, Hiroyuki; Feng, Guo-Gang; Hayashi, Hisaki; Satomoto, Maiko; Sato, Motohiko; Fujiwara, Yoshihiro			Sevoflurane Inhalation Accelerates the Long-Term Memory Consolidation via Small GTPase Overexpression in the Hippocampus of Mice in Adolescence	PLOS ONE			English	Article							K+ CHANNEL FUNCTION; ACTIN CYTOSKELETON; NADPH OXIDASE; HIGH GLUCOSE; ISOFLURANE; IMPAIRMENT; ANESTHESIA; ADULT; NEUROGENESIS; EXPOSURE	Sevoflurane exposure impairs the long-term memory in neonates. Whether the exposure to animals in adolescence affects the memory, however, has been unclear. A small hydrolase enzyme of guanosine triphosphate (GTPase) rac1 plays a role in the F-actin dynamics related to the synaptic plasticity, as well as superoxide production via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation. The current study was designed to examine whether sevoflurane exposure to mice in early adolescence modifies the long-term learning ability concomitantly with the changes in F-actin constitution as well as superoxide production in the hippocampus according to the levels of rac1 protein expression. Four-week-old mice were subjected to the evaluation of long-term learning ability for three days. On day one, each mouse was allowed to enter a dark chamber for five min to acclimatization. On day two, the procedure was repeated with the addition of an electric shock as soon as a mouse entered the dark chamber. All mice subsequently inhaled 2 L/min air with (Sevoflurane group) and without (Control group) 2.5% sevoflurane for three hours. On day three, each mouse was placed on the platform and retention time, which is the latency to enter the dark chamber, was examined. The brain removed after the behavior test, was used for analyses of immunofluorescence, Western immunoblotting and intracellular levels of superoxide. Sevoflurane exposure significantly prolonged retention time, indicating the enhanced long-term memory. Sevoflurane inhalation augmented F-actin constitution coexisting with the rac1 protein overexpression in the hippocampus whereas it did not alter the levels of superoxide. Sevoflurane exposure to 4-week-old mice accelerates the long-term memory concomitantly with the enhanced F-actin constitution coexisting with the small GTPase rac1 overexpression in the hippocampus. These results suggest that sevoflurane inhalation may amplify long-term memory consolidation via the increased cytoskeleton constitution in the hippocampus of animals in early adolescence.	[Nakamura, Emi; Kinoshita, Hiroyuki; Fujiwara, Yoshihiro] Aichi Med Univ, Dept Anesthesiol, Sch Med, Nagakute, Aichi, Japan; [Feng, Guo-Gang] Aichi Med Univ, Dept Pharmacol, Sch Med, Nagakute, Aichi, Japan; [Hayashi, Hisaki; Sato, Motohiko] Aichi Med Univ, Dept Physiol, Sch Med, Nagakute, Aichi, Japan; [Satomoto, Maiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Anesthesiol, Bunkyo Ku, Tokyo, Japan	Aichi Medical University; Aichi Medical University; Aichi Medical University; Tokyo Medical & Dental University (TMDU)	Kinoshita, H (corresponding author), Aichi Med Univ, Dept Anesthesiol, Sch Med, Nagakute, Aichi, Japan.	hkinoshi@aichi-med-u.ac.jp	Kinoshita, Hiroyuki/AFC-8806-2022	Satomoto, Maiko/0000-0003-2768-7482	Japan Society for the Promotion of Science [KAKENHI] [15K15575]; Grants-in-Aid for Scientific Research [16K08600, 16K08508] Funding Source: KAKEN	Japan Society for the Promotion of Science [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science [KAKENHI Grant no. 15K15575]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Behr J, 2009, PROG NEUROBIOL, V89, P334, DOI 10.1016/j.pneurobio.2009.09.002; Callaway JK, 2012, ANESTHESIOLOGY, V117, P1091, DOI 10.1097/ALN.0b013e31826cb228; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Fan JH, 2012, HEPATOL RES, V42, P696, DOI 10.1111/j.1872-034X.2012.00972.x; Fidalgo AR, 2012, ACTA ANAESTH SCAND, V56, P1052, DOI 10.1111/j.1399-6576.2012.02691.x; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Franklin K., 2007, MOUSE BRAIN STEREOTA; Guo DW, 2012, APMIS, V120, P469, DOI 10.1111/j.1600-0463.2011.02855.x; Haditsch U, 2013, J NEUROSCI, V33, P12229, DOI 10.1523/JNEUROSCI.2939-12.2013; Kinoshita H, 2008, HYPERTENSION, V52, P507, DOI 10.1161/HYPERTENSIONAHA.108.118216; Kinoshita H, 2012, ANESTH ANALG, V115, P54, DOI 10.1213/ANE.0b013e318254270d; Kishida KT, 2007, ANTIOXID REDOX SIGN, V9, P233, DOI 10.1089/ars.2007.9.233; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kojima N, 2016, NEUROSCIENCE, V324, P218, DOI 10.1016/j.neuroscience.2016.03.015; Komatsu T, 2008, EXP GERONTOL, V43, P339, DOI 10.1016/j.exger.2008.01.008; Lamprecht R, 2014, PROG NEUROBIOL, V117, P1, DOI 10.1016/j.pneurobio.2014.02.001; Liao M, 2006, ANESTH ANALG, V102, P1452, DOI 10.1213/01.ane.0000204254.87933.f6; Mceown K, 2013, NEUROSCIENCE, V252, P169, DOI 10.1016/j.neuroscience.2013.08.012; Milad MR, 2009, NEUROSCIENCE, V164, P887, DOI 10.1016/j.neuroscience.2009.09.011; Saab BJ, 2010, ANESTHESIOLOGY, V113, P1061, DOI 10.1097/ALN.0b013e3181f56228; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Sun Z, 2016, BRIT J ANAESTH, V117, P80, DOI 10.1093/bja/aew064; Tejada-Simon MV, 2015, J NEUROCHEM, V133, P767, DOI 10.1111/jnc.13100; Vizcaychipi MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026394; Yasuda Y, 2016, PFLUG ARCH EUR J PHY, V468, P1555, DOI 10.1007/s00424-016-1857-y; Yin J, 2014, ANAESTHESIA, V69, P118, DOI 10.1111/anae.12504; York JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50252; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	32	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163151	10.1371/journal.pone.0163151	http://dx.doi.org/10.1371/journal.pone.0163151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632208	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900136
J	Shu, CW; Chang, HT; Wu, CS; Chen, CH; Wu, S; Chang, HW; Kuo, SY; Fu, E; Liu, PF; Hsieh, YD				Shu, Chih-Wen; Chang, Hong-Tai; Wu, Chieh-Shan; Chen, Chien-Hsun; Wu, Sam; Chang, Hsueh-Wei; Kuo, Soong-Yu; Fu, Earl; Liu, Pei-Feng; Hsieh, Yao-Dung			RelA-Mediated BECN1 Expression Is Required for Reactive Oxygen Species-Induced Autophagy in Oral Cancer Cells Exposed to Low-Power Laser Irradiation	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; IONIZING-RADIATION; NECK-CANCER; IN-VITRO; ACTIVATION; THERAPY; DEGRADATION; RESISTANCE; INHIBITION	Low-power laser irradiation (LPLI) is a non-invasive and safe method for cancer treatment that alters a variety of physiological processes in the cells. Autophagy can play either a cytoprotective role or a detrimental role in cancer cells exposed to stress. The detailed mechanisms of autophagy and its role on cytotoxicity in oral cancer cells exposed to LPLI remain unclear. In this study, we showed that LPLI at 810 nm with energy density 60 J/cm(2) increased the number of microtubule associated protein 1 light chain 3 (MAP1LC3) puncta and increased autophagic flux in oral cancer cells. Moreover, reactive oxygen species (ROS) production was induced, which increased RelA transcriptional activity and beclin 1 (BECN1) expression in oral cancer cells irradiated with LPLI. Furthermore, ROS scavenger or knockdown of RelA diminished LPLI-induced BECN1 expression and MAP1LC3-II conversion. In addition, pharmacological and genetic ablation of autophagy significantly enhanced the effects of LPLI-induced apoptosis in oral cancer cells. These results suggest that autophagy may be a resistant mechanism for LPLI-induced apoptosis in oral cancer cells.	[Shu, Chih-Wen; Liu, Pei-Feng] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Chang, Hong-Tai] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Wu, Chieh-Shan] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Chen, Chien-Hsun] Kaohsiung Vet Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Wu, Sam] Samwell Testing INC, Taipei, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Kuo, Soong-Yu] Fooyin Univ, Sch Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Fu, Earl] Natl Def Med Ctr, Sch Dent, Dept Periodontol, Taipei, Taiwan; [Fu, Earl] Triserv Gen Hosp, Taipei, Taiwan; [Liu, Pei-Feng] Fooyin Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Hsieh, Yao-Dung] Kaohsiung Vet Gen Hosp, Dept Stomatol, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Fooyin University; National Defense Medical Center; Tri-Service General Hospital; Fooyin University; Kaohsiung Veterans General Hospital	Liu, PF (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.; Liu, PF (corresponding author), Fooyin Univ, Dept Biotechnol, Kaohsiung, Taiwan.; Hsieh, YD (corresponding author), Kaohsiung Vet Gen Hosp, Dept Stomatol, Kaohsiung, Taiwan.	d908203@gmail.com; mrusmrus@gmail.com	Shu, Chih-Wen/AAE-9652-2019; Chang, Hsueh-Wei/C-9654-2009	Chang, Hsueh-Wei/0000-0003-0068-2366; Liu, Pei-Feng/0000-0002-7849-8940; Fu, Earl/0000-0003-0637-0208; Shu, Chih-Wen/0000-0002-7774-0002	National Science Council [NSC 101, 102-2311-B-075B-001]; Kaohsiung Veterans General Hospital [VGHKS99-072, VGHKS102-007]; Kaohsiung Veterans General Hospital, Pingtung Branch [P-001]; Samwell Testing INC	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital, Pingtung Branch; Samwell Testing INC	This work was supported by National Science Council (NSC 101 and 102-2311-B-075B-001 to C.W. Shu), Kaohsiung Veterans General Hospital (VGHKS99-072 to Y.D. Hsieh and VGHKS102-007 to C.W. Shu), and Kaohsiung Veterans General Hospital, Pingtung Branch (P-001 to Y.D. Hsieh). Co-author Sam Wu is employed by Samwell Testing INC. Samwell Testing INC provided support in the form of salary for author SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Ahn MY, 2013, J ORAL PATHOL MED, V42, P17, DOI 10.1111/j.1600-0714.2012.01187.x; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chu JR, 2010, CANCER LETT, V297, P207, DOI 10.1016/j.canlet.2010.05.013; Copetti T, 2009, AUTOPHAGY, V5, P858, DOI 10.4161/auto.8822; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Han MW, 2014, ANTICANCER RES, V34, P1449; Huang L, 2015, J CELL BIOCHEM, V116, P1741, DOI 10.1002/jcb.25133; Huang L, 2011, J CELL PHYSIOL, V226, P588, DOI 10.1002/jcp.22367; Jiang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133940; Kim J, 2014, J ORAL PATHOL MED, V43, P675, DOI 10.1111/jop.12195; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Ko A, 2014, CELL DEATH DIFFER, V21, P92, DOI 10.1038/cdd.2013.124; Krmpot AJ, 2010, LASER SURG MED, V42, P338, DOI 10.1002/lsm.20911; Lee YY, 2012, CANCER RES, V72, DOI [10.1158/1538-7445.AM2012-4651, 10.1158/0008-5472.CAN-12-2397]; Liang N, 2013, CELL SIGNAL, V25, P2530, DOI 10.1016/j.cellsig.2013.08.010; Liang WZ, 2015, LASER SURG MED, V47, P756, DOI 10.1002/lsm.22419; Liu PF, 2015, J INVEST DERMATOL, V135, P2714, DOI 10.1038/jid.2015.254; Liu PF, 2014, AUTOPHAGY, V10, P1454, DOI 10.4161/auto.29556; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Luo LY, 2013, CANCER LETT, V328, P114, DOI 10.1016/j.canlet.2012.08.034; Marocchio Luciana S, 2010, J Oral Sci, V52, P267; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morgan-Bathke M, 2015, J DENT RES, V94, P1035, DOI 10.1177/0022034515590796; Murayama H, 2012, LASER MED SCI, V27, P87, DOI 10.1007/s10103-011-0924-z; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Palumbo S, 2013, J CELL PHYSIOL, V228, P1, DOI 10.1002/jcp.24118; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Poillet-Perez L, 2015, REDOX BIOL, V4, P184, DOI 10.1016/j.redox.2014.12.003; Prajna NV, 2013, JAMA OPHTHALMOL, V131, P422, DOI 10.1001/jamaophthalmol.2013.1497; Ryter SW, 2014, INT J CELL BIOL, V2014; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shu CW, 2011, J BIOMOL SCREEN, V16, P174, DOI 10.1177/1087057110392996; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496; Trocoli A, 2011, AM J CANCER RES, V1, P629; Wang F, 2005, LASER SURG MED, V36, P2, DOI 10.1002/lsm.20130; Wu HJ, 2014, INT J BIOL SCI, V10, P1072, DOI 10.7150/ijbs.9719; Wu SA, 2014, ANTIOXID REDOX SIGN, V20, P733, DOI 10.1089/ars.2013.5229; Yeh CC, 2009, MOL CANCER THER, V8, P2718, DOI 10.1158/1535-7163.MCT-09-0211	45	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160586	10.1371/journal.pone.0160586	http://dx.doi.org/10.1371/journal.pone.0160586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632526	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900008
J	Abramson, CI; Dinges, CW; Wells, H				Abramson, Charles I.; Dinges, Christopher W.; Wells, Harrington			Operant Conditioning in Honey Bees (Apis mellifera L.): The Cap Pushing Response	PLOS ONE			English	Article							STING EXTENSION REFLEX; PROBOSCIS EXTENSION; DECISION-MAKING; LEARNED NONUSE; MEMORY; REPRESENTATIONS; MECHANISMS; PARADIGM; BEHAVIOR; NEURONS	The honey bee has been an important model organism for studying learning and memory. More recently, the honey bee has become a valuable model to understand perception and cognition. However, the techniques used to explore psychological phenomena in honey bees have been limited to only a few primary methodologies such as the proboscis extension reflex, sting extension reflex, and free flying target discrimination-tasks. Methods to explore operant conditioning in bees and other invertebrates are not as varied as with vertebrates. This may be due to the availability of a suitable response requirement. In this manuscript we offer a new method to explore operant conditioning in honey bees: the cap pushing response (CPR). We used the CPR to test for difference in learning curves between novel auto-shaping and more traditional explicit-shaping. The CPR protocol requires bees to exhibit a novel behavior by pushing a cap to uncover a food source. Using the CPR protocol we tested the effects of both explicit-shaping and auto-shaping techniques on operant conditioning. The goodness of fit and lack of fit of these data to the Rescorla-Wagner learning-curve model, widely used in classical conditioning studies, was tested. The model fit well to both control and explicit-shaping results, but only for a limited number of trials. Learning ceased rather than continuing to asymptotically approach the physiological most accurate possible. Rate of learning differed between shaped and control bee treatments. Learning rate was about 3 times faster for shaped bees, but for all measures of proficiency control and shaped bees reached the same level. Auto-shaped bees showed one-trial learning rather than the asymptotic approach to a maximal efficiency. However, in terms of return-time, the auto-shaped bees' learning did not carry over to the covered-well test treatments.	[Abramson, Charles I.; Dinges, Christopher W.] Oklahoma State Univ, Lab Comparat Psychol & Behav Biol, Stillwater, OK 74078 USA; [Wells, Harrington] Univ Tulsa, Dept Biol, Tulsa, OK 74104 USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Tulsa	Abramson, CI (corresponding author), Oklahoma State Univ, Lab Comparat Psychol & Behav Biol, Stillwater, OK 74078 USA.	charles.abramson@okstate.edu		, Charles/0000-0001-8961-3089	Chilean grant agency Conicyt - PAI; Pontificia Universidad Catolica de Valparaiso Chile; National Science Foundation [DBI 1560389, OISE 1545803, GRF 1144467]; Div Of Biological Infrastructure [1560389] Funding Source: National Science Foundation	Chilean grant agency Conicyt - PAI; Pontificia Universidad Catolica de Valparaiso Chile; National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by grants from the Chilean grant agency Conicyt - PAI, the Pontificia Universidad Catolica de Valparaiso Chile, and National Science Foundation grants, DBI 1560389, OISE 1545803, and GRF 1144467. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by grants from the Chilean grant agency Conicyt-PAI, the Pontificia Universidad Catolica de Valparaiso Chile, and National Science Foundation grants DBI 1560389, OISE 1545803, and GRF 1144467. We would like to thank Ms. Solange Elizabeth Huaiquil for her assistance in Chile.	Abramson C. I., 1990, INVERTEBRATE LEARNIN; Abramson C. I., 1994, PRIMER INVERTEBRATE; Abramson Charles I., 2011, P25; Abramson CI, 2010, ETHOLOGY, V116, P843, DOI 10.1111/j.1439-0310.2010.01796.x; Abramson CI, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.12201; Abramson CI, 2004, ENVIRON ENTOMOL, V33, P378, DOI 10.1603/0046-225X-33.2.378; Abramson CI, 2001, J ENTOMOL SCI, V36, P78, DOI 10.18474/0749-8004-36.1.78; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; ABRAMSON CI, 1997, RES DEV COMP PSY, P55; Agarwal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025371; Avargues-Weber A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1907; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Ballester BR, 2015, INT C VIRT REH ICVR; Barron AB, 2016, P NATL ACAD SCI USA, V113, P4900, DOI 10.1073/pnas.1520084113; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brembs B, 2003, CURR OPIN NEUROBIOL, V13, P710, DOI 10.1016/j.conb.2003.10.002; Cakmak I, 2009, ANIM BEHAV, V77, P1273, DOI 10.1016/j.anbehav.2009.01.032; Carcaud J, 2009, J EXP BIOL, V212, P620, DOI 10.1242/jeb.026641; Cordoba SA, 2011, ANN BOT-LONDON, V108, P919, DOI 10.1093/aob/mcr196; Craig DPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101262; Deisig N, 2001, LEARN MEMORY, V8, P70, DOI 10.1101/lm.8.2.70; Dennett D. C., 1987, OXFORD COMPANION MIN, P383; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; Dukas R, 2009, VIENNA SER THEOR BIO, P147; ETIENNE AS, 1984, HUM DEV, V27, P309, DOI 10.1159/000272924; Field Matt, 2008, Curr Drug Abuse Rev, V1, P263; Frings H, 1941, J EXP ZOOL, V88, P65, DOI 10.1002/jez.1400880106; Geddes LH, 2013, LEARN MEMORY, V20, P399, DOI 10.1101/lm.030825.113; Giovanetti M, 2011, B INSECTOL, V64, P77; Giray T, 2015, ANIM BEHAV, V100, P144, DOI 10.1016/j.anbehav.2014.11.018; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; Giurfa M, 2009, LEARN MEMORY, V16, P761, DOI 10.1101/lm.1603009; Gomez JC, 2005, TRENDS COGN SCI, V9, P118, DOI 10.1016/j.tics.2005.01.004; Jenkins H. M., 1979, 1 CENTURY EXPT PSYCH; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kisch J, 1999, BEHAV BRAIN RES, V99, P93, DOI 10.1016/S0166-4328(98)00076-X; Lee VL, 2011, BEYOND BEHAV; LORD C, 2001, DIVISION BEHAV SOCIA; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; NUNEZ JA, 1970, ACTA PHYSIOL LAT AM, V20, P140; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Putz G, 2004, J NEUROSCI, V24, P9745, DOI 10.1523/JNEUROSCI.3211-04.2004; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Ballester BR, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0178-x; Sall F, 1996, JMP IN SPSS; Scheiner R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.04; Schwarzel M, 2006, CELL MOL LIFE SCI, V63, P989, DOI 10.1007/s00018-006-6024-8; Seeley T., 1995, WISDOM HIVE SOCIAL P; Skinner B. F., 1953, SCI HUMAN BEHAV; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Sokolowski MBC, 2010, J NEUROSCI METH, V188, P235, DOI 10.1016/j.jneumeth.2010.02.013; Sokolowski MBC, 2010, J EXP ANAL BEHAV, V93, P81, DOI 10.1901/jeab.2010.93-81; Stepanov II, 2008, J MATH PSYCHOL, V52, P313, DOI 10.1016/j.jmp.2008.08.001; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; TAUB E, 1994, J EXP ANAL BEHAV, V61, P281, DOI 10.1901/jeab.1994.61-281; Tedjakumala SR, 2013, J EXP BIOL, V216, P2985, DOI 10.1242/jeb.086629; VARESCHI E, 1971, Z VERGL PHYSIOL, V75, P143; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Zhang SW, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00088	67	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162347	10.1371/journal.pone.0162347	http://dx.doi.org/10.1371/journal.pone.0162347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626797	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600030
J	de Cosio, FG; Jiwani, SS; Sanhueza, A; Soliz, PN; Becerra-Posada, F; Espinal, MA				de Cosio, Federico G.; Jiwani, Safia S.; Sanhueza, Antonio; Soliz, Patricia N.; Becerra-Posada, Francisco; Espinal, Marcos A.			Late Maternal Deaths and Deaths from Sequelae of Obstetric Causes in the Americas from 1999 to 2013: A Trend Analysis	PLOS ONE			English	Article								Background Data on maternal deaths occurring after the 42 days postpartum reference time is scarce; the objective of this analysis is to explore the trend and magnitude of late maternal deaths and deaths from sequelae of obstetric causes in the Americas between 1999 and 2013, and to recommend including these deaths in the monitoring of the Sustainable Development Goals (SDGs). Methods Exploratory data analysis enabled analyzing the magnitude and trend of late maternal deaths and deaths from sequelae of obstetric causes for seven countries of the Americas: Argentina, Brazil, Canada, Colombia, Cuba, Mexico and the United States. A Poisson regression model was developed to compare trends of late maternal deaths and deaths from sequelae of obstetric causes between two periods of time: 1999 to 2005 and 2006 to 2013; and to estimate the relative increase of these deaths in the two periods of time. Findings The proportion of late maternal deaths and deaths from sequelae of obstetric causes ranged between 2.40% (CI 0.85% - 5.48%) and 18.68% (CI 17.06% - 20.47%) in the seven countries. The ratio of late maternal deaths and deaths from sequelae of obstetric causes per 100,000 live births has increased by two times in the region of the Americas in the period 2006-2013 compared to the period 1999-2005. The regional relative increase of late maternal death was 2.46 (p<0.0001) times higher in the second period compared to the first. Interpretation Ascertainment of late maternal deaths and deaths from sequelae of obstetric causes has improved in the Americas since the early 2000's due to improvements in the quality of information and the obstetric transition. Late and obstetric sequelae maternal deaths should be included in the monitoring of the SDGs as well as in the revision of the International Classification of Diseases' 11th version (ICD-11).	[de Cosio, Federico G.; Jiwani, Safia S.; Sanhueza, Antonio; Soliz, Patricia N.; Becerra-Posada, Francisco; Espinal, Marcos A.] Pan Amer Hlth Org, Washington, DC 20037 USA	Pan American Health Organization	Jiwani, SS (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.	sjiwani1@jhu.edu						[Anonymous], 1997, Revista Panamericana de Salud Publica/Pan American Journal of Public Health, V1, P481; [Anonymous], REV PANAMERICANA SAL; Donoso E, 2012, REV MED CHILE, V140, P1253, DOI 10.4067/S0034-98872012001000003; Grove J, 2015, LANCET, V386, P1511, DOI 10.1016/S0140-6736(15)00517-6; Hill K, 2006, LANCET, P1311; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horon IL, 2005, AM J PUBLIC HEALTH, V95, P478, DOI 10.2105/AJPH.2004.040063; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Torres LM, 2014, SALUD PUBLICA MEXICO, V56, P333; McCaw-Binns AM, 2015, INT J GYNECOL OBSTET, V128, P62, DOI 10.1016/j.ijgo.2014.07.023; Ramos S, 2007, B WORLD HEALTH ORGAN, V85, P615, DOI 10.2471/BLT.06.032334; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sliwa K, 2016, LANCET, V387, P2072, DOI 10.1016/S0140-6736(16)30391-9; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; Szwarcwald CL, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00125313; Turner Linda A, 2002, Chronic Dis Can, V23, P22; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wilmoth JR, 2014, STAT POLITICS POLICY, V3; You D, 2015, LANCET, V386, P2256	20	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0160642	10.1371/journal.pone.0160642	http://dx.doi.org/10.1371/journal.pone.0160642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626277	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600001
J	Feng, Y; Zhou, JH; Li, ZH; Jiang, Y; Zhou, Y				Feng, Yuan; Zhou, Jihong; Li, Zhanhua; Jiang, Ying; Zhou, Ying			Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study	PLOS ONE			English	Article							IN-VITRO; PATHWAY; STRESS; IMMUNOTHERAPY; ACTIVATION; PERIFOSINE; APOPTOSIS; FUTURE	Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively targets cancer cells. The present preclinical study investigated the anti-cancer efficiency of ONC201, a first-in-class small molecule TRAIL inducer, in lung cancer cells. We showed that ONC201 was cytotoxic and anti-proliferative in both established (A549 and H460 lines) and primary human lung cancer cells. It was yet non-cytotoxic to normal lung epithelial cells. Further, ONC201 induced exogenous apoptosis activation in lung cancer cells, which was evidenced by TRAIL/death receptor-5 (DR5) induction and caspase-8 activation. The caspase-8 inhibitor or TRAIL/DR5 siRNA knockdown alleviated ONC201' s cytotoxicity against lung cancer cells. Molecularly, ONC201 in-activated Akt-S6K1 and Erk signalings in lung cancer cells, causing Foxo3a nuclear translocation. For the in vivo studies, intraperitoneal injection of ONC201 at well-tolerated doses significantly inhibited xenografted A549 tumor growth in severe combined immunodeficient (SCID) mice. Further, ONC201 administration induced TRAIL/DR5 expression, yet inactivated Akt-S6K1 and Erk in tumor tissues. These results of the study demonstrates the potent anti-lung cancer activity by ONC201.	[Feng, Yuan; Zhou, Jihong; Li, Zhanhua] Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Resp Med, Nanning, Peoples R China; [Jiang, Ying] Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Neurol, Nanning, Peoples R China; [Zhou, Ying] Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Oncol, Nanning, Peoples R China	Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine; Guangxi University of Chinese Medicine	Feng, Y (corresponding author), Guangxi Univ Tradit Chinese Med, Affiliated Ruikang Hosp, Dept Resp Med, Nanning, Peoples R China.	fengyugx360@163.com			Scientific grant of Guangxi University of Traditional Chinese Medicine [2014-081]	Scientific grant of Guangxi University of Traditional Chinese Medicine	This work was supported by the Scientific grant of Guangxi University of Traditional Chinese Medicine (2014-081, to YF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143082; Allen JE, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0346-9; Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Bagci-Onder T, 2013, ONCOGENE, V32, P2818, DOI 10.1038/onc.2012.304; Chen MB, 2015, CARCINOGENESIS, V36, P1061, DOI 10.1093/carcin/bgv094; Chen W, 2015, CA CANC J CLIN; Creelan BC, 2014, CANCER CONTROL, V21, P80, DOI 10.1177/107327481402100112; Endo Greer Yoshimi, 2016, Sci Signal, V9, pfs1, DOI 10.1126/scisignal.aad7955; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fu M, 2016, BIOCHEM BIOPHYS RES; Horn L, 2016, ONCOLOGIST, V21, P910, DOI 10.1634/theoncologist.2015-0523; Ishizawa J, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac4380; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Keith RL, 2013, NAT REV CLIN ONCOL, V10, P334, DOI 10.1038/nrclinonc.2013.64; Kline CLB, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac4374; Liang Y, 2000, CANCER RES, V60, P1009; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lv HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145195; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Prabhu VV, 2015, CANCER RES, V75, P1423, DOI 10.1158/0008-5472.CAN-13-3451; Rosell R, 2015, NAT REV CLIN ONCOL, V12, P75, DOI 10.1038/nrclinonc.2014.225; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Shen J, 2016, BIOCHEM BIOPH RES CO, V473, P1170, DOI 10.1016/j.bbrc.2016.04.035; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagner J, 2014, ONCOTARGET, V5, P12728, DOI 10.18632/oncotarget.2890; Wu W, 2006, MOL ENDOCRINOL, V20, P2304, DOI 10.1210/me.2006-0131; Yang L, 2016, AM J CLIN EXP IMMUNO, V5, P1; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zhang JL, 2015, TUMOR BIOL, V36, P5699, DOI 10.1007/s13277-015-3244-2; Zhu YR, 2014, BIOCHEM BIOPH RES CO, V451, P112, DOI 10.1016/j.bbrc.2014.07.077	32	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162133	10.1371/journal.pone.0162133	http://dx.doi.org/10.1371/journal.pone.0162133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626799	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600021
J	Han, J; Thamilarasan, SK; Natarajan, S; Park, JI; Chung, MY; Nou, IS				Han, Jeongsukhyeon; Thamilarasan, Senthil Kumar; Natarajan, Sathishkumar; Park, Jong-In; Chung, Mi-Young; Nou, Ill-Sup			De Novo Assembly and Transcriptome Analysis of Bulb Onion (Allium cepa L.) during Cold Acclimation Using Contrasting Genotypes	PLOS ONE			English	Article							RNA-SEQ DATA; MOLECULAR CHARACTERIZATION; STRESS TOLERANCE; GENE-EXPRESSION; BRASSICA-RAPA; SSR MARKERS; ARABIDOPSIS; DROUGHT; PROTEIN; RESPONSES	Bulb onion (Allium cepa) is the second most widely cultivated and consumed vegetable crop in the world. During winter, cold injury can limit the production of bulb onion. Genomic resources available for bulb onion are still very limited. To date, no studies on heritably durable cold and freezing tolerance have been carried out in bulb onion genotypes. We applied high-throughput sequencing technology to cold (2 degrees C), freezing (-5 and -15 degrees C), and control (25 degrees C)-treated samples of cold tolerant (CT) and cold susceptible (CS) genotypes of A. cepa lines. A total of 452 million paired-end reads were de novo assembled into 54,047 genes with an average length of 1,331 bp. Based on similarity searches, these genes were aligned with entries in the public non-redundant (nr) database, as well as KEGG and COG database. Differentially expressed genes (DEGs) were identified using log(10) values with the FPKM method. Among 5,167DEGs, 491 genes were differentially expressed at freezing temperature compared to the control temperature in both CT and CS libraries. The DEG results were validated with qRT-PCR. We performed GO and KEGG pathway enrichment analyses of all DEGs and iPath interactive analysis found 31 pathways including those related to metabolism of carbohydrate, nucleotide, energy, cofactors and vitamins, other amino acids and xenobiotics biodegradation. Furthermore, a large number of molecular markers were identified from the assembled genes, including simple sequence repeats (SSRs) 4,437 and SNP substitutions of transition and transversion types of CT and CS. Our study is the first to provide a transcriptome sequence resource for Allium spp. with regard to cold and freezing stress. We identified a large set of genes and determined their DEG profiles under cold and freezing conditions using two different genotypes. These data represent a valuable resource for genetic and genomic studies of Allium spp.	[Han, Jeongsukhyeon; Thamilarasan, Senthil Kumar; Natarajan, Sathishkumar; Park, Jong-In; Nou, Ill-Sup] Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea; [Chung, Mi-Young] Sunchon Natl Univ, Dept Agr Educ, Sunchon, Jeonnam, South Korea	Sunchon National University; Sunchon National University	Nou, IS (corresponding author), Sunchon Natl Univ, Dept Hort, Sunchon, Jeonnam, South Korea.	nis@sunchon.ac.kr	Thamilarasan, Senthil Kumar/AAX-5643-2021	Thamilarasan, Senthil Kumar/0000-0003-3691-5838; Natarajan, Sathishkumar/0000-0002-9001-8495	Golden Seed Project (Center for Horticultural Seed Development) [213003-04-4-SB110]; Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS)	Golden Seed Project (Center for Horticultural Seed Development); Ministry of Agriculture, Food and Rural Affairs (MAFRA); Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS)	This research was supported by Golden Seed Project (Center for Horticultural Seed Development, No. 213003-04-4-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).; This research was supported by Golden Seed Project (Center for Horticultural Seed Development, No. 213003-04-4-SB110), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA) and Korea Forest Service (KFS).	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Arasan SKT, 2013, INDIAN J EXP BIOL, V51, P522; Bahorun T, 2004, J SCI FOOD AGR, V84, P1553, DOI 10.1002/jsfa.1820; Bogdanovic J, 2008, EUR BIOPHYS J BIOPHY, V37, P1241, DOI 10.1007/s00249-008-0260-9; Brewster J. L., 2008, Onions and other vegetable alliums, P1, DOI 10.1079/9781845933999.0001; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Carvallo MA, 2011, J EXP BOT, V62, P3807, DOI 10.1093/jxb/err066; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Ciereszko I, 2001, BIOCHEM J, V354, P67, DOI 10.1042/0264-6021:3540067; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Duangjit J, 2013, THEOR APPL GENET, V126, P2093, DOI 10.1007/s00122-013-2121-x; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan Xueying, 2014, BMC Res Notes, V7, P493, DOI 10.1186/1756-0500-7-493; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Haq NU, 2013, PLANT MOL BIOL REP, V31, P1230, DOI 10.1007/s11105-013-0588-x; Harwood S, 1996, BIOTECHNOL SOFTW I J, V13, P22; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Hwang I, 2014, GENOMICS, V104, P194, DOI 10.1016/j.ygeno.2014.07.008; Jung Yujin, 2014, Plant Breeding and Biotechnology, V2, P1, DOI 10.9787/PBB.2014.2.1.001; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RF, 2009, PROG NAT SCI-MATER, V19, P667, DOI 10.1016/j.pnsc.2008.06.030; Manoharan RK, 2016, MOLECULES, V21, DOI 10.3390/molecules21020217; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; McCallum J, 2006, THEOR APPL GENET, V112, P958, DOI 10.1007/s00122-005-0199-5; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Rapacz M, 2002, PHYSIOL PLANTARUM, V115, P236, DOI 10.1034/j.1399-3054.2002.1150209.x; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Shanker AK, 2014, FUNCT INTEGR GENOMIC, V14, P11, DOI 10.1007/s10142-013-0356-x; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Slimestad R, 2007, J AGR FOOD CHEM, V55, P10067, DOI 10.1021/jf0712503; Takagi T, 2003, J BIOL CHEM, V278, P14174, DOI 10.1074/jbc.M212101200; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Thamilarasan SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-422; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thomashow MF, 2010, PLANT PHYSIOL, V154, P571, DOI 10.1104/pp.110.161794; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wallis JG, 1997, PLANT MOL BIOL, V35, P323, DOI 10.1023/A:1005886210159; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Yeh S, 2000, PLANT PHYSIOL, V124, P1251, DOI 10.1104/pp.124.3.1251; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237; Zhou MQ, 2011, CRIT REV BIOTECHNOL, V31, P186, DOI 10.3109/07388551.2010.505910	60	20	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161987	10.1371/journal.pone.0161987	http://dx.doi.org/10.1371/journal.pone.0161987			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627679	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600016
J	Mori, K; Moteki, H; Miyagawa, M; Nishio, S; Usami, S				Mori, Kentaro; Moteki, Hideaki; Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi			Social Health Insurance-Based Simultaneous Screening for 154 Mutations in 19 Deafness Genes Efficiently Identified Causative Mutations in Japanese Hearing Loss Patients	PLOS ONE			English	Article							VARIANTS	Sensorineural hearing loss is one of the most common neurosensory disorders in humans. The incidence of SNHL is estimated to be 1 in 500-1000 newborns. In more than half of these patients, the hearing loss is associated with genetic causes. In Japan, genetic testing for the patients with SNHL using the Invader assay to screen for 46 mutations in 13 deafness genes was approved by the Ministry of Health, Labour and Welfare for inclusion in social health insurance coverage in 2012. Furthermore, from August 2015, this genetic testing has been expanded to screen for 154 mutations in 19 deafness genes using targeted genomic enrichment with massively parallel DNA sequencing combined with the Invader assay and TaqMan genotyping. For this study we analyzed 717 unrelated Japanese hearing loss patients. The total allele frequency of 154 mutations in 19 deafness genes was 32.64% (468/1434) and the total numbers of cases associated with at least one mutation was 44.07% (316/717). Among these, we were able to diagnose 212 (30%) patients, indicating that the present screening could efficiently identify causative mutations in hearing loss patients. It is noteworthy that 27 patients (3.8%) had coexistent multiple mutations in different genes. Five of these 27 patients (0.7%, 5/717 overall) were diagnosed with genetic hearing loss affected by concomitant with responsible mutations in more than two different genes. For patients identified with multiple mutations in different genes, it is necessary to consider that several genes might have an impact on their phenotypes.	[Mori, Kentaro; Moteki, Hideaki; Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Otolaryngol, Matsumoto, Nagano, Japan; [Moteki, Hideaki; Miyagawa, Maiko; Nishio, Shin-ya; Usami, Shin-ichi] Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University	Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Otolaryngol, Matsumoto, Nagano, Japan.; Usami, S (corresponding author), Shinshu Univ, Sch Med, Dept Hearing Implant Sci, Matsumoto, Nagano 390, Japan.	usami@shinshu-u.ac.jp		Nishio, Shin-ya/0000-0001-6640-2297	Health, Labour and Welfare of Japan Scientific Research Grant [H25-Kankaku-Ippan-002]; Japan Agency for Medical Research and Development [15dk0310011h0003]; Ministry of Education, Science and Culture of Japan [15H02565]	Health, Labour and Welfare of Japan Scientific Research Grant; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was grant aided by a Health, Labour and Welfare of Japan Scientific Research Grant (H25-Kankaku-Ippan-002), Japan Agency for Medical Research and Development (15dk0310011h0003), and a Grant-in-Aid for Scientific Research (A) (15H02565) from the Ministry of Education, Science and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2001, AM J MED GENET, V103, P334, DOI 10.1002/1096-8628(20011101)103:4<334::AID-AJMG1574>3.0.CO;2-F; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Gazzo AM, 2016, NUCLEIC ACIDS RES, V44, pD900, DOI 10.1093/nar/gkv1068; Huang SS, 2013, MITOCHONDRION, V13, P791, DOI 10.1016/j.mito.2013.05.004; Huang SS, 2013, INT J PEDIATR OTORHI, V77, P379, DOI 10.1016/j.ijporl.2012.11.031; Lu SY, 2009, CLIN GENET, V75, P480, DOI 10.1111/j.1399-0004.2008.01138.x; Miyagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075793; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moteki H, 2015, ANN OTO RHINOL LARYN, V124, p177S, DOI 10.1177/0003489415575045; Nishio S, 2015, ANN OTO RHINOL LARYN, V124, p49S, DOI 10.1177/0003489415575059; Nishio SY, 2015, GENET TEST MOL BIOMA, V19, P209, DOI 10.1089/gtmb.2014.0252; Sakuma N, 2016, J HUM GENET, V61, P253, DOI 10.1038/jhg.2015.143; Shearer AE, 2015, OTOLARYNG HEAD NECK, V153, P175, DOI 10.1177/0194599815591156; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Usami S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031276; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yoshimura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090688	18	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162230	10.1371/journal.pone.0162230	http://dx.doi.org/10.1371/journal.pone.0162230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627659	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600025
J	Schneider, J; Valentini, A; Dejean, T; Montarsi, F; Taberlet, P; Glaizot, O; Fumagalli, L				Schneider, Judith; Valentini, Alice; Dejean, Tony; Montarsi, Fabrizio; Taberlet, Pierre; Glaizot, Olivier; Fumagalli, Luca			Detection of Invasive Mosquito Vectors Using Environmental DNA (eDNA) from Water Samples	PLOS ONE			English	Article							AEDES-ALBOPICTUS; DIPTERA-CULICIDAE; 1ST REPORT; IDENTIFICATION; FUTURE; KOREICUS; BIOLOGY; SURVEILLANCE; DEGRADATION; TEMPERATURE	Repeated introductions and spread of invasive mosquito species (IMS) have been recorded on a large scale these last decades worldwide. In this context, members of the mosquito genus Aedes can present serious risks to public health as they have or may develop vector competence for various viral diseases. While the Tiger mosquito (Aedes albopictus) is a well-known vector for e.g. dengue and chikungunya viruses, the Asian bush mosquito (Ae. j. japonicus) and Ae. koreicus have shown vector competence in the field and the laboratory for a number of viruses including dengue, West Nile fever and Japanese encephalitis. Early detection and identification is therefore crucial for successful eradication or control strategies. Traditional specific identification and monitoring of different and/or cryptic life stages of the invasive Aedes species based on morphological grounds may lead to misidentifications, and are problematic when extensive surveillance is needed. In this study, we developed, tested and applied an environmental DNA (eDNA) approach for the detection of three IMS, based on water samples collected in the field in several European countries. We compared real-time quantitative PCR (qPCR) assays specific for these three species and an eDNA metabarcoding approach with traditional sampling, and discussed the advantages and limitations of these methods. Detection probabilities for eDNA-based approaches were in most of the specific comparisons higher than for traditional survey and the results were congruent between both molecular methods, confirming the reliability and efficiency of alternative eDNA-based techniques for the early and unambiguous detection and surveillance of invasive mosquito vectors. The ease of water sampling procedures in the eDNA approach tested here allows the development of large-scale monitoring and surveillance programs of IMS, especially using citizen science projects.	[Schneider, Judith; Fumagalli, Luca] Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Biophore, CH-1015 Lausanne, Switzerland; [Valentini, Alice; Dejean, Tony] Savoie Technol, SPYGEN, F-73370 Le Bourget Du Lac, France; [Montarsi, Fabrizio] Ist Zooprofilatt Sperimentale Venezie, Viale Univ 10, I-35020 Padua, Italy; [Taberlet, Pierre] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Taberlet, Pierre] CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Glaizot, Olivier] Museum Zool, Pl Riponne 6, CH-1014 Lausanne, Switzerland; [Glaizot, Olivier] Univ Lausanne, Dept Ecol & Evolut, Biophore, CH-1015 Lausanne, Switzerland	University of Lausanne; IZS delle Venezie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Lausanne	Fumagalli, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lab Conservat Biol, Biophore, CH-1015 Lausanne, Switzerland.	luca.fumagalli@unil.ch	valentini, alice/S-2040-2019; Glaizot, Olivier/B-8627-2012; Valentini, Alice/AFS-1389-2022	Glaizot, Olivier/0000-0001-9116-3355; Valentini, Alice/0000-0001-5829-5479; Fumagalli, Luca/0000-0002-6648-2570; Schneider, Judith/0000-0003-2663-6130				Adams Rachel I, 2013, Microb Ecol, V66, P735, DOI 10.1007/s00248-013-0266-4; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckmann JF, 2012, J MED ENTOMOL, V49, P1103, DOI 10.1603/ME12049; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; De Jong L, 2009, ACTA TROP, V112, P266, DOI 10.1016/j.actatropica.2009.08.008; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; ECDC, 2016, VECTORNET A EUROPEAN; ECDC, 2012, GUIDELINES FOR THE S; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Engdahl C, 2014, MOL ECOL RESOUR, V14, P478, DOI 10.1111/1755-0998.12202; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Herder JE, 2014, CONTRACT NO REPORT 2; Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59; Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Marcantonio M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1340-9; McKee AM, 2015, BIOL CONSERV, V183, P70, DOI 10.1016/j.biocon.2014.11.031; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Montarsi F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-292; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Robson HLA, 2016, MOLECULAR ECOLOGY RE; Rogers DJ, 2014, ACTA TROP, V129, P1, DOI 10.1016/j.actatropica.2013.08.008; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142; Schaffner Francis, 2011, European Mosquito Bulletin, V29, P141; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Simberloff D, 2001, ENCYCLOPEDIA OF BIOL; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suter T, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1010-3; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Treguier A, 2014, J APPL ECOL, V51, P871, DOI 10.1111/1365-2664.12262; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020; Versteirt V, 2015, MOL ECOL RESOUR, V15, P449, DOI 10.1111/1755-0998.12318; Versteirt V, 2009, J MED ENTOMOL, V46, P1464, DOI 10.1603/033.046.0632; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; Werner D, 2016, PARASITOL RES, V115, P1331, DOI 10.1007/s00436-015-4848-6; WHO, 2013, REGIONAL FRAMEWORK F; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Williamson M., 1996, BIOL INVASIONS; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x	79	49	52	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162493	10.1371/journal.pone.0162493	http://dx.doi.org/10.1371/journal.pone.0162493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626642	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600038
J	Lin, PL; Yu, YW; Chung, RH				Lin, Peng-Lin; Yu, Ya-Wen; Chung, Ren-Hua			Pathway Analysis Incorporating Protein-Protein Interaction Networks Identified Candidate Pathways for the Seven Common Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAMMALIAN ZINC TRANSPORTER; NF-KAPPA-B; SUSCEPTIBILITY LOCI; BIOLOGICAL PATHWAYS; GENE INTERACTIONS; SET; HYPERTENSION; INFLAMMATION; EPISTASIS	Pathway analysis has become popular as a secondary analysis strategy for genome-wide association studies (GWAS). Most of the current pathway analysis methods aggregate signals from the main effects of single nucleotide polymorphisms (SNPs) in genes within a pathway without considering the effects of gene-gene interactions. However, gene-gene interactions can also have critical effects on complex diseases. Protein-protein interaction (PPI) networks have been used to define gene pairs for the gene-gene interaction tests. Incorporating the PPI information to define gene pairs for interaction tests within pathways can increase the power for pathway-based association tests. We propose a pathway association test, which aggregates the interaction signals in PPI networks within a pathway, for GWAS with case-control samples. Gene size is properly considered in the test so that genes do not contribute more to the test statistic simply due to their size. Simulation studies were performed to verify that the method is a valid test and can have more power than other pathway association tests in the presence of gene-gene interactions within a pathway under different scenarios. We applied the test to the Wellcome Trust Case Control Consortium GWAS datasets for seven common diseases. The most significant pathway is the chaperones modulate interferon signaling pathway for Crohn's disease (p-value = 0.0003). The pathway modulates interferon gamma, which induces the JAK/STAT pathway that is involved in Crohn's disease. Several other pathways that have functional implications for the seven diseases were also identified. The proposed test based on gene-gene interaction signals in PPI networks can be used as a complementary tool to the current existing pathway analysis methods focusing on main effects of genes. An efficient software implementing the method is freely available at http://puppi.sourceforge.net.	[Lin, Peng-Lin] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Yu, Ya-Wen; Chung, Ren-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan	Chung, RH (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan.	rchung@nhri.org.tw	Chung, Ren-Hua/AAB-8364-2019		National Health Research Institutes [PH-105-PP-10]; Ministry of Science and Technology [MOST 104-2221-E-400-004-MY2]; Medical Research Council [G1001799, MR/N01104X/1] Funding Source: researchfish; MRC [G1001799, MR/N01104X/1] Funding Source: UKRI	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RHC received the funding from the National Health Research Institutes (http://www.nhri.org.tw) with grant number PH-105-PP-10 and from the Ministry of Science and Technology (http://www.most.gov.tw) with grant number MOST 104-2221-E-400-004-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024220; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnaud-Dabernat S, 2007, DIABETES, V56, P96, DOI 10.2337/db05-1073; Babron MC, 2015, ANN HUM GENET, V79, P380, DOI 10.1111/ahg.12113; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cassim B, 2009, RHEUMATOLOGY, V48, P490, DOI 10.1093/rheumatology/kep016; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen F, 1999, CLIN CHEM, V45, P7; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Chung RH, 2015, GENET EPIDEMIOL, V39, P20, DOI 10.1002/gepi.21850; Chung RH, 2013, PROCEEDINGS OF THE 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P238, DOI 10.1109/CIBCB.2013.6595415; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; D'Eustachio P, 2011, METHODS MOL BIOL, V694, P49, DOI 10.1007/978-1-60761-977-2_4; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Emily M, 2009, EUR J HUM GENET, V17, P1231, DOI 10.1038/ejhg.2009.15; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Gregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Harrison C, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3805; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Jin Lv, 2014, Genomics Proteomics & Bioinformatics, V12, P210, DOI 10.1016/j.gpb.2014.10.002; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KARAISKOS C, 2011, GUT               S1, V60, DOI DOI 10.1136/GUT.2011.239301.304; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Lage K, 2014, BBA-MOL BASIS DIS, V1842, P1971, DOI 10.1016/j.bbadis.2014.05.028; Lassegue B, 2004, AM J HYPERTENS, V17, P852, DOI 10.1016/j.amjhyper.2004.02.004; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Leiserson MDM, 2013, CURR OPIN GENET DEV, V23, P602, DOI 10.1016/j.gde.2013.09.003; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu Y, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S15; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002714; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Park YS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-267; Pattin KA, 2009, EXPERT REV PROTEOMIC, V6, P647, DOI 10.1586/EPR.09.86; Penaranda C, 2012, P NATL ACAD SCI USA, V109, P12668, DOI 10.1073/pnas.1203692109; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Schoenhagen P, 2001, J AM COLL CARDIOL, V38, P297, DOI 10.1016/S0735-1097(01)01374-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Su Z, 2011, BIOINFORMATICS, V27, P2304, DOI 10.1093/bioinformatics/btr341; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Taylor KM, 2003, BIOCHEM J, V375, P51, DOI 10.1042/BJ20030478; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang YT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1620-3; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	78	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162910	10.1371/journal.pone.0162910	http://dx.doi.org/10.1371/journal.pone.0162910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622767	gold, Green Published, Green Submitted			2022-12-26	WOS:000383681000068
J	Gross, KS; Brandner, DD; Martinez, LA; Olive, MF; Meisel, RL; Mermelstein, PG				Gross, Kellie S.; Brandner, Dieter D.; Martinez, Luis A.; Olive, M. Foster; Meisel, Robert L.; Mermelstein, Paul G.			Opposite Effects of mGluR1a and mGluR5 Activation on Nucleus Accumbens Medium Spiny Neuron Dendritic Spine Density	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; FEMALE SEXUAL RECEPTIVITY; GROUP-I; INTRACELLULAR CALCIUM; DEPENDENT MECHANISM; SIGNALING PATHWAYS; PREFRONTAL CORTEX; BINDING PROTEIN; ESTRADIOL; DISTINCT	The group I metabotropic glutamate receptors (mGluR1a and mGluR5) are important modulators of neuronal structure and function. Although these receptors share common signaling pathways, they are capable of having distinct effects on cellular plasticity. We investigated the individual effects of mGluR1a or mGluR5 activation on dendritic spine density in medium spiny neurons in the nucleus accumbens (NAc), which has become relevant with the potential use of group I mGluR based therapeutics in the treatment of drug addiction. We found that systemic administration of mGluR subtype-specific positive allosteric modulators had opposite effects on dendritic spine densities. Specifically, mGluR5 positive modulation decreased dendritic spine densities in the NAc shell and core, but was without effect in the dorsal striatum, whereas increased spine densities in the NAc were observed with mGluR1a positive modulation. Additionally, direct activation of mGluR5 via CHPG administration into the NAc also decreased the density of dendritic spines. These data provide insight on the ability of group I mGluRs to induce structural plasticity in the NAc and demonstrate that the group I mGluRs are capable of producing not just distinct, but opposing, effects on dendritic spine density.	[Gross, Kellie S.; Brandner, Dieter D.; Martinez, Luis A.; Meisel, Robert L.; Mermelstein, Paul G.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Gross, Kellie S.; Meisel, Robert L.; Mermelstein, Paul G.] Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA; [Brandner, Dieter D.; Mermelstein, Paul G.] Univ Minnesota, Med Scientist Training Program, Minneapolis, MN 55455 USA; [Olive, M. Foster] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Arizona State University; Arizona State University-Tempe	Mermelstein, PG (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.; Mermelstein, PG (corresponding author), Univ Minnesota, Grad Program Neurosci, Minneapolis, MN 55455 USA.; Mermelstein, PG (corresponding author), Univ Minnesota, Med Scientist Training Program, Minneapolis, MN 55455 USA.	pmerm@umn.edu	Brandner, Dieter/AGR-7106-2022	Brandner, Dieter/0000-0001-7278-4391; Olive, Foster/0000-0002-2517-0351	National Institutes of Health [DA035008, AA013852, DA024355];  [DA007234];  [GM08244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008471, T32GM008244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035008, T32DA007234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants DA035008 to PGM and RLM, and AA013852 and DA024355 to MFO. KSG was supported by DA007234; DDB was supported by GM08244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benquet P, 2002, J NEUROSCI, V22, P9679; Besheer J, 2009, J NEUROSCI, V29, P9582, DOI 10.1523/JNEUROSCI.2366-09.2009; Bonsi P, 2008, NEUROPHARMACOLOGY, V55, P392, DOI 10.1016/j.neuropharm.2008.05.020; Boulware MI, 2005, J NEUROSCI, V25, P5066, DOI 10.1523/JNEUROSCI.1427-05.2005; Chaban V, 2011, J NEUROSCI RES, V89, P1707, DOI 10.1002/jnr.22718; Christensen A, 2011, J NEUROSCI, V31, P17583, DOI 10.1523/JNEUROSCI.3030-11.2011; Dewing P, 2007, J NEUROSCI, V27, P9294, DOI 10.1523/JNEUROSCI.0592-07.2007; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Grove-Strawser D, 2010, NEUROSCIENCE, V170, P1045, DOI 10.1016/j.neuroscience.2010.08.012; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Huang GZ, 2012, NEURON, V74, P801, DOI 10.1016/j.neuron.2012.03.035; Kuo J, 2009, ENDOCRINOLOGY, V150, P1369, DOI 10.1210/en.2008-0994; LaCrosse AL, 2015, CNS NEUROL DISORD-DR, V14, P476, DOI 10.2174/1871527314666150429112849; Loweth JA, 2014, NAT NEUROSCI, V17, P73, DOI 10.1038/nn.3590; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; McCutcheon JE, 2011, J NEUROSCI, V31, P14536, DOI 10.1523/JNEUROSCI.3625-11.2011; Mitrano DA, 2007, J COMP NEUROL, V500, P788, DOI 10.1002/cne.21214; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Olive M Foster, 2009, Curr Drug Abuse Rev, V2, P83; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peterson BM, 2015, BRAIN STRUCT FUNCT, V220, P2415, DOI 10.1007/s00429-014-0794-9; Poisik OV, 2003, J NEUROSCI, V23, P122; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Staffend NA, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00014; Thandi S, 2002, J NEUROCHEM, V83, P1139, DOI 10.1046/j.1471-4159.2002.01217.x; Tuscher JJ, 2016, J NEUROSCI, V36, P1483, DOI 10.1523/JNEUROSCI.3135-15.2016; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Valenti O, 2002, J CELL PHYSIOL, V191, P125, DOI 10.1002/jcp.10081; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Wang XS, 2013, ADDICT BIOL, V18, P40, DOI 10.1111/j.1369-1600.2011.00432.x; Wilkerson JR, 2014, CELL REP, V7, P1589, DOI 10.1016/j.celrep.2014.04.035; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210	36	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162755	10.1371/journal.pone.0162755	http://dx.doi.org/10.1371/journal.pone.0162755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618534	gold, Green Submitted, Green Published			2022-12-26	WOS:000383653100047
J	Cao, Z; Tong, XZ; Xia, WH; Chen, L; Zhang, XY; Yu, BB; Yang, Z; Tao, J				Cao, Zheng; Tong, Xinzhu; Xia, Wenhao; Chen, Long; Zhang, Xiaoyu; Yu, Bingbo; Yang, Zhen; Tao, Jun			CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; REENDOTHELIALIZATION CAPACITY; VASCULAR REPAIR; SHEAR-STRESS; IN-VITRO; ANGIOGENESIS; CXCR7; PROLIFERATION; RECEPTOR; PATHWAY	Coronary artery disease (CAD) is characterized by insufficient vasculogenic response to ischemia, which is typically accompanied by dysfunction of endothelial outgrowth cells (EOCs). CXC chemokine receptor 7 (CXCR7) is a key modulator of the neovascularization of EOCs to perfusion defect area. However, the mechanism underlying the role of EOCs in CAD-related abnormal vasculogenesis is still not clear. Here, we investigated the alteration of EOCs-related vasculogenic capacity in patients with CAD and its potential mechanism. Compared with EOCs isolated from healthy subjects, EOCs from CAD patients showed an impaired vasculogenic function in vitro. CXCR7 expression of EOCs from CAD patients was downregulated. Meanwhile, the phosphorylation of extracellular signal-regulated kinase (ERK), downstream of CXCR7 signaling, was also reduced. CXCR7 expression introduced by adenovirus increased the phosphorylation of ERK, which was parallel to improved function of EOCs. The enhanced adhesion and vasculogenesis of EOCs can be blocked by short interfering RNA (siRNA) against CXCR7 and ERK inhibitor PD098059. Therefore, our study demonstrates that the upregulation of CXCR7 signaling contributes to increased vasculogenic capacity of EOCs from CAD patients, indicating that CXCR7 signaling may be a novel therapeutic vasculogenic target for CAD.	[Cao, Zheng; Tong, Xinzhu] Hubei Univ Med, Taihe Hosp, Dept Cardiol, Shiyan, Hubei, Peoples R China; [Tong, Xinzhu; Xia, Wenhao; Chen, Long; Zhang, Xiaoyu; Yu, Bingbo; Yang, Zhen; Tao, Jun] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou, Guangdong, Peoples R China	Hubei University of Medicine; Sun Yat Sen University	Yang, Z; Tao, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hypertens & Vasc Dis, Guangzhou, Guangdong, Peoples R China.	yangzhen10710710@163.com; taojungz123@163.com			973 program [2013CB531200]; National Natural Science Foundation of China [31530023, 31370941, 81500205, 31270992]	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the grants from the 973 program (2013CB531200), National Natural Science Foundation of China (31530023 and 31370941), and National Natural Science Foundation of China (81500205 and 31270992). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barclay GR, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt114; Bertelsen LB, 2014, EXP GERONTOL, V58, P132, DOI 10.1016/j.exger.2014.07.021; Caiado F, 2011, BIOMATERIALS, V32, P7096, DOI 10.1016/j.biomaterials.2011.06.022; Chen L, 2010, CARDIOVASC RES, V88, P462, DOI 10.1093/cvr/cvq207; Chung ES, 2015, EUR HEART J, V36, P2228, DOI 10.1093/eurheartj/ehv254; Dai XZ, 2011, J CELL MOL MED, V15, P1299, DOI 10.1111/j.1582-4934.2011.01301.x; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; Gao JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16382; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kim SW, 2016, INT J CARDIOL, V203, P498, DOI 10.1016/j.ijcard.2015.10.110; Kitta Y, 2009, J AM COLL CARDIOL, V53, P323, DOI 10.1016/j.jacc.2008.08.074; Lamping K, 2007, CIRC RES, V100, P1243, DOI 10.1161/01.RES.0000268193.46418.d1; Lee SH, 2015, STEM CELLS, V33, P1490, DOI 10.1002/stem.1938; Liu CS, 2005, CIRC RES, V97, P135, DOI 10.1161/01.RES.0000174612.90094.fd; Lu AZ, 2015, CELL BIOL INT, V39, P484, DOI 10.1002/cbin.10405; Lu ZY, 2014, BIOCHEM BIOPH RES CO, V446, P25, DOI 10.1016/j.bbrc.2014.02.027; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miquerol L, 2015, CIRC RES, V116, P1765, DOI 10.1161/CIRCRESAHA.116.306476; Pelliccia F, 2010, JACC-CARDIOVASC INTE, V3, P78, DOI 10.1016/j.jcin.2009.10.020; Pizzi C, 2008, EUR HEART J, V29, P1110, DOI 10.1093/eurheartj/ehn137; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Tokgozoglu L, 2011, ATHEROSCLEROSIS, V219, P851, DOI 10.1016/j.atherosclerosis.2011.08.045; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wagner NM, 2013, ARTERIOSCL THROM VAS, V33, P1943, DOI 10.1161/ATVBAHA.113.301783; Wegiel B, 2010, CIRCULATION, V121, P537, DOI 10.1161/CIRCULATIONAHA.109.887695; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Xia WH, 2012, HYPERTENSION, V59, P1225, DOI 10.1161/HYPERTENSIONAHA.111.179820; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015; Yang Z, 2012, J MOL CELL CARDIOL, V52, P1155, DOI 10.1016/j.yjmcc.2012.01.019; Zaccone V, 2015, EUR REV MED PHARMACO, V19, P4047; Zhang XY, 2014, HYPERTENSION, V63, P383, DOI 10.1161/HYPERTENSIONAHA.113.02273; Zhang ZS, 2015, CELL BIOCHEM FUNCT, V33, P80, DOI 10.1002/cbf.3093; Zheng ST, 2011, MOL BIOL REP, V38, P865, DOI 10.1007/s11033-010-0178-z	36	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161255	10.1371/journal.pone.0161255	http://dx.doi.org/10.1371/journal.pone.0161255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612090	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900014
J	Bround, MJ; Wambolt, R; Cen, HN; Asghari, P; Albu, RF; Han, J; McAfee, D; Pourrier, M; Scott, NE; Bohunek, L; Kulpa, JE; Chen, SRW; Fedida, D; Brownsey, RW; Borchers, CH; Foster, LJ; Mayor, T; Moore, EDW; Allard, MF; Johnson, JD				Bround, Michael J.; Wambolt, Rich; Cen, Haoning; Asghari, Parisa; Albu, Razvan F.; Han, Jun; McAfee, Donald; Pourrier, Marc; Scott, Nichollas E.; Bohunek, Lubos; Kulpa, Jerzy E.; Chen, S. R. Wayne; Fedida, David; Brownsey, Roger W.; Borchers, Christoph H.; Foster, Leonard J.; Mayor, Thibault; Moore, Edwin D. W.; Allard, Michael F.; Johnson, James D.			Cardiac Ryanodine Receptor (Ryr2)-mediated Calcium Signals Specifically Promote Glucose Oxidation via Pyruvate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium intracellular release; cardiac metabolism; cardiomyocyte; heart failure; metabolomics; mitochondrial metabolism; proteomics; ryanodine receptor; transcriptomics; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); metabolism; calcium; mitochondria; intracellular calcium release	SARCOPLASMIC-RETICULUM; PRESSURE-OVERLOAD; ATP PRODUCTION; VENTRICULAR-ARRHYTHMIAS; MITOCHONDRIAL CA2+; HEART-FAILURE; METABOLISM; HYPERTROPHY; UNIPORTER; MICE	Cardiac ryanodine receptor (Ryr2) Ca2+ release channels and cellular metabolism are both disrupted in heart disease. Recently, we demonstrated that total loss of Ryr2 leads to cardiomyocyte contractile dysfunction, arrhythmia, and reduced heart rate. Acute total Ryr2 ablation also impaired metabolism, but it was not clear whether this was a cause or consequence of heart failure. Previous in vitro studies revealed that Ca2+ flux into the mitochondria helps pace oxidative metabolism, but there is limited in vivo evidence supporting this concept. Here, we studied heart-specific, inducible Ryr2 haploinsufficient (cRyr250) mice with a stable 50% reduction in Ryr2 protein. This manipulation decreased the amplitude and frequency of cytosolic and mitochondrial Ca2+ signals in isolated cardiomyocytes, without changes in cardiomyocyte contraction. Remarkably, in the context of well preserved contractile function in perfused hearts, we observed decreased glucose oxidation, but not fat oxidation, with increased glycolysis. cRyr250 hearts exhibited hyperphosphorylation and inhibition of pyruvate dehydrogenase, the key Ca2+-sensitive gatekeeper to glucose oxidation. Metabolomic, proteomic, and transcriptomic analyses revealed additional functional networks associated with altered metabolism in this model. These results demonstrate that Ryr2 controls mitochondrial Ca2+ dynamics and plays a specific, critical role in promoting glucose oxidation in cardiomyocytes. Our findings indicate that partial RYR2 loss is sufficient to cause metabolic abnormalities seen in heart disease.	[Bround, Michael J.; Wambolt, Rich; Cen, Haoning; Asghari, Parisa; McAfee, Donald; Pourrier, Marc; Fedida, David; Moore, Edwin D. W.; Allard, Michael F.; Johnson, James D.] Univ British Columbia, Cardiovasc Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Cen, Haoning; Asghari, Parisa; Moore, Edwin D. W.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Albu, Razvan F.; Scott, Nichollas E.; Kulpa, Jerzy E.; Brownsey, Roger W.; Foster, Leonard J.; Mayor, Thibault] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [McAfee, Donald; Pourrier, Marc; Fedida, David] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V6T 1Z3, Canada; [Wambolt, Rich; Bohunek, Lubos; Allard, Michael F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6Z 1Y6, Canada; [Wambolt, Rich; Bohunek, Lubos; Allard, Michael F.] St Pauls Hosp, Ctr Heart & Lung Innovat, Vancouver, BC V6T 1Z4, Canada; [Albu, Razvan F.; Scott, Nichollas E.; Foster, Leonard J.; Mayor, Thibault] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Han, Jun; Borchers, Christoph H.] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC V8Z 7X8, Canada; [Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 2T9, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of Victoria; Libin Cardiovascular Institute Of Alberta; University of Calgary	Johnson, JD (corresponding author), Univ British Columbia, Cardiovasc Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.; Johnson, JD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.; Johnson, JD (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 5358,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	james.d.johnson@ubc.ca	BORCHERS, Christoph/U-5964-2019; Cen, Haoning Howard/GSN-3597-2022	Cen, Haoning Howard/0000-0001-8045-1335; Asghari, Parisa/0000-0003-2285-3242; Scott, Nichollas/0000-0003-2556-8316; Moore, Edwin DW/0000-0001-7519-5592	University of British Columbia Start-Up Funds; Canadian Institutes of Health Research (CIHR) [MOP-77688, MOP 115158]; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research	University of British Columbia Start-Up Funds; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research	This work was supported by University of British Columbia Start-Up Funds (to J. D. J.), funding from the Canadian Institutes of Health Research (CIHR) (MOP-77688) (to L. J. F.) and (MOP 115158) (to E. D. W. M.), a scholarship from CIHR (to M. J. B.), a scholarship from the Michael Smith Foundation for Health Research (to N. E. S.), and Natural Sciences and Engineering Research Council of Canada (NSERC) and the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Albu RF, 2015, J PROTEOMICS, V118, P21, DOI 10.1016/j.jprot.2014.10.011; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Allard MF, 2007, AM J PHYSIOL-HEART C, V292, pH140, DOI 10.1152/ajpheart.00424.2006; Bidasse KR, 2001, MOL PHARMACOL, V60, P1356, DOI 10.1124/mol.60.6.1356; Bround MJ, 2013, J BIOL CHEM, V288, P18975, DOI 10.1074/jbc.M112.427062; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; de Haas HJ, 2014, CIRC RES, V114, P903, DOI 10.1161/CIRCRESAHA.113.302680; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Fernando V., 2006, CARDIOVASCULAR PROTE, DOI [10.1385/1597452149, DOI 10.1385/1597452149]; Garcia-Perez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gomez AM, 2004, CARDIOVASC RES, V64, P3, DOI 10.1016/j.cardiores.2004.07.018; Gong GH, 2014, J MOL CELL CARDIOL, V76, P235, DOI 10.1016/j.yjmcc.2014.09.012; Han J, 2013, ELECTROPHORESIS, V34, P2891, DOI 10.1002/elps.201200601; Han J, 2013, ANAL CHEM, V85, P5965, DOI 10.1021/ac400769g; Hernandez OM, 2007, AM J PHYSIOL-HEART C, V292, pH1643, DOI 10.1152/ajpheart.00931.2006; Herrer I, 2014, LAB INVEST, V94, P645, DOI 10.1038/labinvest.2014.54; Hiess F, 2015, J BIOL CHEM, V290, P20477, DOI 10.1074/jbc.M115.650531; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kandilci HB, 2011, J PHYSIOL BIOCHEM, V67, P317, DOI 10.1007/s13105-011-0077-3; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Komuro A, 2004, P NATL ACAD SCI USA, V101, P4053, DOI 10.1073/pnas.0308619101; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Lu D, 2014, INT J CARDIOL, V173, P146, DOI 10.1016/j.ijcard.2014.02.032; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; MATSUI H, 1995, AM J PHYSIOL-CELL PH, V268, pC252, DOI 10.1152/ajpcell.1995.268.1.C252; Milnes JT, 2001, J MOL CELL CARDIOL, V33, P473, DOI 10.1006/jmcc.2000.1320; Min CK, 2012, BIOCHEM J, V447, P371, DOI 10.1042/BJ20120705; Monfredi O, 2013, PHYSIOLOGY, V28, P74, DOI 10.1152/physiol.00054.2012; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Pouliquin P, 2009, PFLUG ARCH EUR J PHY, V458, P723, DOI 10.1007/s00424-009-0664-0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Scriven DRL, 2013, CARDIOVASC RES, V98, P169, DOI 10.1093/cvr/cvt025; Sheeran FL, 2010, BBA-BIOENERGETICS, V1797, P1138, DOI 10.1016/j.bbabio.2010.04.002; Song W, 2015, GENE, V569, P1, DOI 10.1016/j.gene.2015.06.029; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Williams S, 2014, AM J PHYSIOL-HEART C, V306, pH867, DOI 10.1152/ajpheart.00704.2013; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Zanivan S, 2011, METHODS MOL BIOL, V757, P435, DOI 10.1007/978-1-61779-166-6_25; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	55	17	17	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23490	23505		10.1074/jbc.M116.756973	http://dx.doi.org/10.1074/jbc.M116.756973			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621312	hybrid, Green Published			2022-12-26	WOS:000387884400012
J	Brutsch, SH; Rademacher, M; Roth, SR; Muller, K; Eder, S; Viertel, D; Franz, C; Kuhn, H; Borchert, A				Bruetsch, Simone Hanna; Rademacher, Marlena; Roth, Sophia Regina; Mueller, Karin; Eder, Susanne; Viertel, Dagmar; Franz, Christiane; Kuhn, Hartmut; Borchert, Astrid			Male Subfertility Induced by Heterozygous Expression of Catalytically Inactive Glutathione Peroxidase 4 Is Rescued in Vivo by Systemic Inactivation of the Alox15 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eicosanoid; lipoxygenase pathway; mitochondria; oxidative stress; sperm	OXIDATIVE STRESS; EMBRYONIC LETHALITY; REDOX HOMEOSTASIS; RAT TESTIS; 15-LIPOXYGENASE; LIPOXYGENASE; PHGPX; ACID; SPECIFICITY; MUTATIONS	Glutathione peroxidase 4 (GPX4) and arachidonic acid 15-lipoxygenase (ALOX15) are antagonizing enzymes in the metabolism of hydroperoxy lipids. In spermatoid cells and/or in the male reproductive system both enzymes are apparently expressed, and GPX4 serves as anti-oxidative enzyme but also as a structural protein. In this study we explored whether germ line inactivation of the Alox15 gene might rescue male subfertility induced by heterozygous expression of catalytically silent Gpx4. To address this question we employed Gpx4 knock-in mice expressing the Sec46Ala-Gpx4 mutant, in which the catalytic selenocysteine was replaced by a redox inactive alanine. Because homozygous Gpx4 knock-in mice (Sec46Ala-Gpx4(+/+)) are not viable we created heterozygous animals (Sec46Ala-Gpx4(+/-)) and crossed them with Alox15 knock-out mice (Alox15(-/-)). Male Sec46Ala-Gpx4(+/-) mice, but not their female littermates, were subfertile. Sperm extracted from the epididymal cauda showed strongly impaired motility characteristics and severe structural midpiece alterations (swollen mitochondria, intramitochondrial vacuoles, disordered mitochondrial capsule). Despite these structural alterations, they exhibited similar respiration characteristics than wild-type sperm. When Sec46Ala-Gpx4(+/-) mice were crossed with Alox15-deficient animals, the resulting males (Sec46Ala-Gpx4(+/-)+Alox15(-/-)) showed normalized fertility, and sperm motility was reimproved to wild-type levels. Taken together these data suggest that systemic inactivation of the Alox15 gene normalizes the reduced fertility of male Sec46Ala-Gpx4(+/-) mice by improving the motility of their sperm. If these data can be confirmed in humans, ALOX15 inhibitors might counteract male infertility related to GPX4 deficiency.	[Bruetsch, Simone Hanna; Rademacher, Marlena; Roth, Sophia Regina; Kuhn, Hartmut; Borchert, Astrid] Charite, Inst Biochem, Virchowweg 6,Chariteplatz 1, D-10117 Berlin, Germany; [Mueller, Karin; Eder, Susanne; Viertel, Dagmar; Franz, Christiane] Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Zoo und Wildtierforschung	Kuhn, H (corresponding author), Charite, Inst Biochem, Virchowweg 6,Chariteplatz 1, D-10117 Berlin, Germany.	hartmut.kuehn@charite.de		Borchert, Astrid/0000-0003-3551-5592	Deutsche Forschungsgemeinschaft (DFG) [GRK1673, Ku961/11-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants GRK1673 (to H. K.) and Ku961/11-1(to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bocci V, 2013, CURR MED CHEM, V20, P3397, DOI 10.2174/0929867311320270005; Borchert A, 2006, J BIOL CHEM, V281, P19655, DOI 10.1074/jbc.M601195200; Borchert A, 2010, IMMUNOL LETT, V133, P85, DOI 10.1016/j.imlet.2010.07.006; Brault C, 2016, GUT, V65, P144, DOI 10.1136/gutjnl-2014-307904; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Brutsch SH, 2015, ANTIOXID REDOX SIGN, V22, P281, DOI 10.1089/ars.2014.5967; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Canli O, 2016, BLOOD, V127, P139, DOI 10.1182/blood-2015-06-654194; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; De Marchi E, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/564961; de Oliveira MF, 2012, INT J CELL BIOL, V2012; Diaconu M, 2006, ANDROLOGIA, V38, P152, DOI 10.1111/j.1439-0272.2006.00729.x; Dreher I, 1997, J TRACE ELEM MED BIO, V11, P83, DOI 10.1016/S0946-672X(97)80031-4; Fischer KA, 2005, REPRODUCTION, V130, P213, DOI 10.1530/rep.1.00646; Flohe L, 2008, ANTIOXID REDOX SIGN, V10, P1485, DOI 10.1089/ars.2008.2059; Forman HJ, 2014, J MOL CELL CARDIOL, V73, P2, DOI 10.1016/j.yjmcc.2014.01.018; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gregus AM, 2013, FASEB J, V27, P1939, DOI 10.1096/fj.12-217414; GROSSMAN S, 1979, BIOCHIM BIOPHYS ACTA, V572, P293, DOI 10.1016/0005-2760(79)90044-4; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139; Ingold I, 2015, J BIOL CHEM, V290, P14668, DOI 10.1074/jbc.M115.656363; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Karunakaran U, 2013, DIABETES METAB J, V37, P106, DOI 10.4093/dmj.2013.37.2.106; KUHN H, 1990, EUR J BIOCHEM, V191, P221, DOI 10.1111/j.1432-1033.1990.tb19113.x; KUHN H, 1990, J BIOL CHEM, V265, P18351; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Moore K, 2010, CELL TISSUE RES, V340, P569, DOI 10.1007/s00441-010-0972-x; Olsen LF, 2013, REDOX REP, V18, P245, DOI 10.1179/1351000213Y.0000000059; Passaia G, 2015, PLANT SCI, V234, P22, DOI 10.1016/j.plantsci.2015.01.017; Pekarova M, 2015, ARCH BIOCHEM BIOPHYS, V571, P50, DOI 10.1016/j.abb.2015.02.029; Pfeifer H, 2001, FASEB J, V15, P1236, DOI 10.1096/fj.00-0655fje; REDDY GP, 1992, PROSTAG OTH LIPID M, V44, P497, DOI 10.1016/0090-6980(92)90020-T; ROVERI A, 1992, J BIOL CHEM, V267, P6142; Roveri A, 2001, BIOFACTORS, V14, P213, DOI 10.1002/biof.5520140127; Schneider M, 2010, NEOPLASIA, V12, P254, DOI 10.1593/neo.91782; Schnurr K, 1999, FASEB J, V13, P143, DOI 10.1096/fasebj.13.1.143; Schnurr K, 1996, J BIOL CHEM, V271, P4653; SCHON I, 1989, INT J BIOCHEM, V21, P7, DOI 10.1016/0020-711X(89)90021-9; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; SLOANE DL, 1991, ADV PROSTAG THROMB L, V21, P25; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Sun DX, 1996, J BIOL CHEM, V271, P24055, DOI 10.1074/jbc.271.39.24055; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Tourmente M, 2015, J BIOL CHEM, V290, P20613, DOI 10.1074/jbc.M115.664813; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; WATANABE T, 1993, BIOCHEM BIOPH RES CO, V192, P1023, DOI 10.1006/bbrc.1993.1519; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6	53	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23578	23588		10.1074/jbc.M116.738930	http://dx.doi.org/10.1074/jbc.M116.738930			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634046	Green Published, hybrid			2022-12-26	WOS:000387884400019
J	Rosenberg, MM; Redfield, AG; Roberts, MF; Hedstrom, L				Rosenberg, Masha M.; Redfield, Alfred G.; Roberts, Mary F.; Hedstrom, Lizbeth			Substrate and Cofactor Dynamics on Guanosine Monophosphate Reductase Probed by High Resolution Field Cycling P-31 NMR Relaxometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL ENZYMES; BINDING SITES; RELAXATION; PROTEINS; LIGAND	Guanosine-5'-monophosphate reductase (GMPR) catalyzes the reduction of GMP to IMP and ammonia with concomitant oxidation of NADPH. Here we investigated the structure and dynamics of enzyme-bound substrates and cofactors by measuring P-31 relaxation rates over a large magnetic field range using high resolution field cycling NMR relaxometry. Surprisingly, these experiments reveal differences in the low field relaxation profiles for the monophosphate of GMP compared with IMP in their respective NADP(+) complexes. These complexes undergo partial reactions that mimic different steps in the overall catalytic cycle. The relaxation profiles indicate that the substrate monophosphates have distinct interactions in E.IMP.NADP(+) and E.GMP.NADP(+) complexes. These findings were not anticipated by x-ray crystal structures, which show identical interactions for the monophosphates of GMP and IMP in several inert complexes. In addition, the motion of the cofactor is enhanced in the E.GMP.NADP(+) complex. Last, the motions of the substrate and cofactor are coordinately regulated; the cofactor has faster local motions than GMP in the deamination complex but is more constrained than IMP in that complex, leading to hydride transfer. These results show that field cycling can be used to investigate the dynamics of protein-bound ligands and provide new insights into how portions of the substrate remote from the site of chemical transformation promote catalysis.	[Rosenberg, Masha M.; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, MS009,415 South St, Waltham, MA 02453 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA; [Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02453 USA; [Roberts, Mary F.] Boston Coll, Dept Chem, 140 Commonwealth Ave, Chestnut Hill, MA 02467 USA	Brandeis University; Brandeis University; Brandeis University; Boston College	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol, MS009,415 South St, Waltham, MA 02453 USA.; Roberts, MF (corresponding author), Boston Coll, Dept Chem, 140 Commonwealth Ave, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu; hedstrom@brandeis.edu			National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jerome Fung and Seth Fraden for help with the DLS experiments. Molecular graphics images were produced using the UCSF Chimera package from the Computer Graphics Laboratory, University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).	Bloustine J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.087803; BURBAUM JJ, 1989, BIOCHEMISTRY-US, V28, P9293, DOI 10.1021/bi00450a009; Charlier C, 2013, J AM CHEM SOC, V135, P18665, DOI 10.1021/ja409820g; Clarkson MW, 2009, J BIOMOL NMR, V45, P217, DOI 10.1007/s10858-009-9347-6; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gradziel CS, 2014, BIOCHEMISTRY-US, V53, P462, DOI 10.1021/bi401720v; Grebenkov DS, 2009, J PHYS CHEM B, V113, P13347, DOI 10.1021/jp9048082; Hsieh CJ, 2013, PHYS CHEM CHEM PHYS, V15, P16634, DOI 10.1039/c3cp51739j; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KAYE W, 1973, APPL OPTICS, V12, P541, DOI 10.1364/AO.12.000541; Li JX, 2006, J MOL BIOL, V355, P980, DOI 10.1016/j.jmb.2005.11.047; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Patton GC, 2011, NAT CHEM BIOL, V7, P950, DOI [10.1038/NCHEMBIO.693, 10.1038/nchembio.693]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pravdivtsev AN, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897336; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P8282, DOI 10.1021/bi901190j; Redfield AG, 2012, J BIOMOL NMR, V52, P159, DOI 10.1007/s10858-011-9594-1; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Steele RM, 2016, MAGN RESON CHEM, V54, P502, DOI 10.1002/mrc.4220; Wei Y, 2015, J BIOL CHEM, V290, P1592, DOI 10.1074/jbc.M114.588590; WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006	27	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22988	22998		10.1074/jbc.M116.739516	http://dx.doi.org/10.1074/jbc.M116.739516			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613871	Green Published, hybrid			2022-12-26	WOS:000387224800012
J	Gill, C; van de Wijgert, JHHM; Blow, F; Darby, AC				Gill, Christina; van de Wijgert, Janneke H. H. M.; Blow, Frances; Darby, Alistair C.			Evaluation of Lysis Methods for the Extraction of Bacterial DNA for Analysis of the Vaginal Microbiota	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTERIOLYTIC AGENT; VAGINOSIS; WOMEN; HIV; ASSOCIATION; DIVERSITY; ALGORITHM; BIAS	Background Recent studies on the vaginal microbiota have employed molecular techniques such as 16S rRNA gene sequencing to describe the bacterial community as a whole. These techniques require the lysis of bacterial cells to release DNA before purification and PCR amplification of the 16S rRNA gene. Currently, methods for the lysis of bacterial cells are not standardised and there is potential for introducing bias into the results if some bacterial species are lysed less efficiently than others. This study aimed to compare the results of vaginal microbiota profiling using four different pretreatment methods for the lysis of bacterial samples (30 min of lysis with lysozyme, 16 hours of lysis with lysozyme, 60 min of lysis with a mixture of lysozyme, mutanolysin and lysostaphin and 30 min of lysis with lysozyme followed by bead beating) prior to chemical and enzyme-based DNA extraction with a commercial kit. Results After extraction, DNA yield did not significantly differ between methods with the exception of lysis with lysozyme combined with bead beating which produced significantly lower yields when compared to lysis with the enzyme cocktail or 30 min lysis with lysozyme only. However, this did not result in a statistically significant difference in the observed alpha diversity of samples. The beta diversity (Bray-Curtis dissimilarity) between different lysis methods was statistically significantly different, but this difference was small compared to differences between samples, and did not affect the grouping of samples with similar vaginal bacterial community structure by hierarchical clustering. Conclusions An understanding of how laboratory methods affect the results of microbiota studies is vital in order to accurately interpret the results and make valid comparisons between studies. Our results indicate that the choice of lysis method does not prevent the detection of effects relating to the type of vaginal bacterial community one of the main outcome measures of epidemiological studies. However, we recommend that the same method is used on all samples within a particular study.	[Gill, Christina; van de Wijgert, Janneke H. H. M.] Univ Liverpool, Inst Infect & Global Hlth, 8 West Derby St, Liverpool L69 7BE, Merseyside, England; [Blow, Frances; Darby, Alistair C.] Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Blow, Frances; Darby, Alistair C.] Univ Liverpool, Ctr Genom Res, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool; University of Liverpool	van de Wijgert, JHHM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, 8 West Derby St, Liverpool L69 7BE, Merseyside, England.	j.vandewijgert@liverpool.ac.uk	Darby, Alistair/I-6485-2012	Darby, Alistair/0000-0002-3786-6209; Gill, Christina/0000-0002-1714-1761; Blow, Frances/0000-0003-3064-5160; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	Institute of Infection and Global Health, University of Liverpool	Institute of Infection and Global Health, University of Liverpool	This work was funded by the Institute of Infection and Global Health, University of Liverpool. No external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; Abusleme L, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23990; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Brotman RM, 2014, J INFECT DIS, V210, P1723, DOI 10.1093/infdis/jiu330; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; Burton JP, 2003, APPL ENVIRON MICROB, V69, P97, DOI 10.1128/AEM.69.1.97-101.2003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cohn JA, 2005, JAIDS-J ACQ IMM DEF, V39, P340, DOI 10.1097/01.qai.0000146599.47925.e0; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Delmont TO, 2013, BIOESSAYS, V35, P744, DOI 10.1002/bies.201200155; Donders GGG, 2002, BJOG-INT J OBSTET GY, V109, P34, DOI 10.1016/S1470-0328(02)00432-9; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Faircloth B.C., 2014, FAIRCLOTH LAB SERAPU; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Frank DN, 2012, JAIDS-J ACQ IMM DEF, V60, P299, DOI 10.1097/QAI.0b013e31824e4bdb; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gillet E, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-10; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Hemme CL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01205; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huang YE, 2015, MICROB ECOL, V69, P407, DOI 10.1007/s00248-014-0487-1; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Jayaram A, 2014, PATHOG DIS, V72, P161, DOI 10.1111/2049-632X.12197; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Maukonen J, 2012, FEMS MICROBIOL ECOL, V79, P697, DOI 10.1111/j.1574-6941.2011.01257.x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mehta SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116894; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Oksanen J., 2019, VEGAN COMMUNITY ECOL; R Core Team, 2013, R LANG ENV STAT COMP; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROSENTHAL RS, 1982, INFECT IMMUN, V37, P826, DOI 10.1128/IAI.37.2.826-829.1982; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; van de Wijgert DHHM, 2008, JAIDS-J ACQ IMM DEF, V48, P203, DOI 10.1097/QAI.0b013e3181743936; van den Heuvel RN, 2010, ENVIRON MICROBIOL, V12, P3264, DOI 10.1111/j.1462-2920.2010.02301.x; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Watts DH, 2005, J INFECT DIS, V191, P1129, DOI 10.1086/427777; Weng SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110152; Wesolowska-Andersen A, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-19; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Willner D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034605; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	67	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163148	10.1371/journal.pone.0163148	http://dx.doi.org/10.1371/journal.pone.0163148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643503	gold, Green Submitted, Green Published			2022-12-26	WOS:000383891900033
J	Ceppi, F; Duval, M; Leclerc, JM; Laverdiere, C; Delva, YL; Cellot, S; Teira, P; Bittencourt, H				Ceppi, Francesco; Duval, Michel; Leclerc, Jean-Marie; Laverdiere, Caroline; Delva, Yves-Line; Cellot, Sonia; Teira, Pierre; Bittencourt, Henrique			Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; ONCOLOGY-GROUP; MARROW RELAPSE; REMISSION; CHEMOTHERAPY; RESISTANCE; THERAPY	Relapsed/refractory acute lymphoblastic leukemia (ALL) is a leading cause of death by cancer in children. Our institution has switched relapse treatment strategy to improve survival. We reviewed records of first relapse/refractory childhood ALL between 1996 and 2012. Based on length of first remission, relapse site and immunophenotype, patients were classified into two groups: standard-risk relapse (SRR) and high-risk relapse and refractory (HRRR). Before 2007, all patients were uniformly treated with the same induction as at presentation, followed by hematopoietic stem cell transplantation (HSCT). Since 2007, treatment was given according to risk of failure: SRR were mostly treated with chemotherapy; HRRR patients underwent HSCT after intensive chemotherapy, aiming reduction of pre-transplant disease burden. Sixty-four patients were included. Thirty (47%) were SRR and 34 (53%) HRRR, including 11 with refractory ALL. Five-years overall survival (OS) and event-free survival (EFS) were similar for SRR, but were significantly higher with new risk-based strategy for HRRR: 56% versus 17% (P = 0.03) for OS, and 56% vs 11% for EFS (P = 0.008), respectively. In multivariate analysis, treatment strategy was significantly associated with survival. In conclusion, change for a risk-based strategy in our institution increased survival of high-risk patients to levels similar of those of standard-risk patients.	[Ceppi, Francesco; Duval, Michel; Leclerc, Jean-Marie; Laverdiere, Caroline; Delva, Yves-Line; Cellot, Sonia; Teira, Pierre; Bittencourt, Henrique] Univ Montreal, CHU Ste Justine, Charles Bruneau Canc Res Ctr, Hematooncol Div,Dept Pediat, Montreal, PQ, Canada	Universite de Montreal	Bittencourt, H (corresponding author), Univ Montreal, CHU Ste Justine, Charles Bruneau Canc Res Ctr, Hematooncol Div,Dept Pediat, Montreal, PQ, Canada.	henrique.bittencourt.hsj@ssss.gouv.qc.ca		Ceppi, Francesco/0000-0002-9665-3190				Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Bhojwani D, 2013, LANCET ONCOL, V14, pE205, DOI 10.1016/S1470-2045(12)70580-6; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; Coustan-Smith E, 2004, LEUKEMIA, V18, P499, DOI 10.1038/sj.leu.2403283; Dalle JH, 2005, J PEDIAT HEMATOL ONC, V27, P73, DOI 10.1097/01.mph.0000152860.97998.32; Domenech C, 2008, EUR J CANCER, V44, P2461, DOI 10.1016/j.ejca.2008.08.007; Duval M, 2010, J CLIN ONCOL, V28, P3730, DOI 10.1200/JCO.2010.28.8852; Eapen M, 2006, BLOOD, V107, P4961, DOI 10.1182/blood-2005-12-4942; Eckert C, 2001, LANCET, V358, P1239, DOI 10.1016/S0140-6736(01)06355-3; Gaynon PS, 2006, J CLIN ONCOL, V24, P3150, DOI 10.1200/JCO.2005.04.5856; Goulden N, 2002, BEST PRACT RES CL HA, V15, P59, DOI 10.1053/beha.2002.0185; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; KLUMPER E, 1995, BLOOD, V86, P3861, DOI 10.1182/blood.V86.10.3861.bloodjournal86103861; KLUMPER E, 1995, BRIT J CANCER, V71, P1188, DOI 10.1038/bjc.1995.231; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Lee DW, 2012, CLIN CANCER RES, V18, P2780, DOI 10.1158/1078-0432.CCR-11-1920; Leung W, 2011, BRIT J HAEMATOL, V155, P14, DOI 10.1111/j.1365-2141.2011.08823.x; Lew G, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.684.684; Loh ML, 2013, BLOOD, V121, P485, DOI 10.1182/blood-2012-04-422691; Mateos MK, 2013, PEDIATR BLOOD CANCER, V60, P1520, DOI 10.1002/pbc.24559; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Parker C, 2010, LANCET, V376, P2009, DOI 10.1016/S0140-6736(10)62002-8; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Raetz EA, 2008, J CLIN ONCOL, V26, P3971, DOI 10.1200/JCO.2008.16.1414; Ruggeri A, 2012, LEUKEMIA, V26, P2455, DOI 10.1038/leu.2012.123; Schrappe M, 2012, NEW ENGL J MED, V366, P1371, DOI 10.1056/NEJMoa1110169; Silverman LB, 2010, LEUKEMIA, V24, P320, DOI 10.1038/leu.2009.253; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; van den Berg H, 2011, PEDIATR BLOOD CANCER, V57, P210, DOI 10.1002/pbc.22946; Vrooman LM, 2013, J CLIN ONCOL, V31, P1202, DOI 10.1200/JCO.2012.43.2070; Weston BW, 2013, J CLIN ONCOL, V31, pE413, DOI 10.1200/JCO.2012.47.6770	33	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160310	10.1371/journal.pone.0160310	http://dx.doi.org/10.1371/journal.pone.0160310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632202	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900006
J	Rathod, SD; De Silva, MJ; Ssebunnya, J; Breuer, E; Murhar, V; Luitel, NP; Medhin, G; Kigozi, F; Shidhaye, R; Fekadu, A; Jordans, M; Patel, V; Tomlinson, M; Lund, C				Rathod, Sujit D.; De Silva, Mary J.; Ssebunnya, Joshua; Breuer, Erica; Murhar, Vaibhav; Luitel, Nagendra P.; Medhin, Girmay; Kigozi, Fred; Shidhaye, Rahul; Fekadu, Abebaw; Jordans, Mark; Patel, Vikram; Tomlinson, Mark; Lund, Crick			Treatment Contact Coverage for Probable Depressive and Probable Alcohol Use Disorders in Four Low- and Middle-Income Country Districts: The PRIME Cross-Sectional Community Surveys	PLOS ONE			English	Article							MENTAL-DISORDERS; PSYCHOMETRIC PROPERTIES; IDENTIFICATION TEST; PREVALENCE; SEVERITY; VALIDITY; PHQ-9; CARE	Context A robust evidence base is now emerging that indicates that treatment for depression and alcohol use disorders (AUD) delivered in low and middle-income countries (LMIC) can be effective. However, the coverage of services for these conditions in most LMIC settings remains unknown. Objective To describe the methods of a repeat cross-sectional survey to determine changes in treatment contact coverage for probable depression and for probable AUD in four LMIC districts, and to present the baseline findings regarding treatment contact coverage. Methods Population-based cross-sectional surveys with structured questionnaires, which included validated screening tools to identify probable cases. We defined contact coverage as being the proportion of cases who sought professional help in the past 12 months. Setting Sodo District, Ethiopia; Sehore District, India; Chitwan District, Nepal; and Kamuli District, Uganda Participants 8036 adults residing in these districts between May 2013 and May 2014 Main Outcome Measures Treatment contact coverage was defined as having sought care from a specialist, generalist, or other health care provider for symptoms related to depression or AUD. Results The proportion of adults who screened positive for depression over the past 12 months ranged from 11.2% in Nepal to 29.7% in India and treatment contact coverage over the past 12 months ranged between 8.1% in Nepal to 23.5% in India. In Ethiopia, lifetime contact coverage for probable depression was 23.7%. The proportion of adults who screened positive for AUD over the past 12 months ranged from 1.7% in Uganda to 13.9% in Ethiopia and treatment contact coverage over the past 12 months ranged from 2.8% in India to 5.1% in Nepal. In Ethiopia, lifetime contact coverage for probable AUD was 13.1%. Conclusions Our findings are consistent with and contribute to the limited evidence base which indicates low treatment contact coverage for depression and for AUD in LMIC. The planned follow up surveys will be used to estimate the change in contact coverage coinciding with the implementation of district-level mental health care plans.	[Rathod, Sujit D.; De Silva, Mary J.; Patel, Vikram] London Sch Hyg & Trop Med, Dept Populat Hlth, Ctr Global Mental Hlth, London, England; [Ssebunnya, Joshua; Kigozi, Fred] Makerere Univ, Butabika Natl Referral & Teaching Hosp, Kampala, Uganda; [Breuer, Erica; Tomlinson, Mark; Lund, Crick] Univ Cape Town, Dept Psychiat & Mental Hlth, Alan J Flisher Ctr Publ Mental Hlth, Cape Town, South Africa; [Murhar, Vaibhav; Patel, Vikram] Sangath, Bhopal, India; [Luitel, Nagendra P.] Transcultural Psychosocial Org TPO Nepal, Kathmandu, Nepal; [Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Shidhaye, Rahul; Patel, Vikram] Publ Hlth Fdn India, Ctr Mental Hlth, New Delhi, India; [Shidhaye, Rahul] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Fekadu, Abebaw] Univ Addis Ababa, Dept Psychiat, Coll Hlth Sci, Addis Ababa, Ethiopia; [Fekadu, Abebaw] Kings Coll London, Ctr Affect Disorders, London, England; [Fekadu, Abebaw] Kings Coll London, Inst Psychiat Psychol & Neurosci, Affect Disorders Res Grp, London, England; [Jordans, Mark] HealthNet TPO Amsterdam, Dept Res & Dev, Amsterdam, Netherlands; [Jordans, Mark; Lund, Crick] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Global Mental Hlth, London, England; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, Alan J Flisher Ctr Publ Mental Hlth, Stellenbosch, South Africa	University of London; London School of Hygiene & Tropical Medicine; Makerere University; University of Cape Town; Addis Ababa University; Public Health Foundation of India; Maastricht University; Addis Ababa University; University of London; King's College London; University of London; King's College London; University of London; King's College London; Stellenbosch University	Rathod, SD (corresponding author), London Sch Hyg & Trop Med, Dept Populat Hlth, Ctr Global Mental Hlth, London, England.	sujit.rathod@lshtm.ac.uk	Shidhaye, Rahul/I-1329-2019; Rathod, Sujit D/M-9298-2014	Shidhaye, Rahul/0000-0001-9365-7164; Rathod, Sujit D/0000-0001-8783-7724; Medhin, Girmay/0000-0003-2146-4261; Breuer, Erica/0000-0003-0952-6650; Lund, Crick/0000-0002-5159-8220; Murhar, Vaibhav/0000-0002-1028-0363; Wassie, Abebaw Fekadu/0000-0003-2219-0952	UK aid from the UK Government; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017104] Funding Source: NIH RePORTER; Department for International Development (DFID) [201446] Funding Source: researchfish	UK aid from the UK Government(CGIAR); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department for International Development (DFID)	This study is an output of the PRogramme for Improving Mental health carE (PRIME). The material has been funded by UK aid from the UK Government, however the views expressed do not necessarily reflect the UK Government's official policies. The financial assistance of the South Africa National Research Foundation (NRF) towards this research is hereby acknowledged. Opinions expressed and conclusions arrived at, are those of the authors and are not necessarily to be attributed to the NRF (URL: http://r4d.dfid.gov.uk/Project/60851/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babor TF., 2001, AUDIT ALCOHOL USE DI; Baxter AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065514; Beecham J., 2001, MEASURING MENTAL HLT, P200; Benegal V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000170; Bennett LA, 1998, ALCOHOL HEALTH RES W, V22, P243; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Berner MM, 2007, J STUD ALCOHOL DRUGS, V68, P461, DOI 10.15288/jsad.2007.68.461; Bohra P, 2009, INT MIGR REV, V43, P621, DOI 10.1111/j.1747-7379.2009.00779.x; Breuer E, 2016, BRIT J PSYCHIAT, V208, pS55, DOI 10.1192/bjp.bp.114.153841; Central Bureau of Statistics, 2011, NPHC2011 GOV NEP CEN; De Silva MJ, 2016, BRIT J PSYCHIAT, V208, pS63, DOI 10.1192/bjp.bp.114.153858; De Silva MJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-267; De Silva MJ, 2014, INT J EPIDEMIOL, V43, P341, DOI 10.1093/ije/dyt191; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Desjarlais R., 1996, WORLD MENTAL HLTH PR; Evans-Lacko S, 2011, EPIDEMIOL PSYCH SCI, V20, P263, DOI 10.1017/S2045796011000308; Evans-Lacko S, 2010, CAN J PSYCHIAT, V55, P440, DOI 10.1177/070674371005500707; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Hanlon C, 2015, J AFFECT DISORDERS, V186, P32, DOI 10.1016/j.jad.2015.07.015; Hanlon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088437; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Jordans MJD, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-332; Kagee A, 2013, INT HEALTH, V5, P11, DOI 10.1093/inthealth/ihs004; Kohrt BA, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0768-y; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lauritsen JM, 2000, EPIDATA DATA ENTRY D; Lund C, 2016, BRIT J PSYCHIAT, V208, pS1, DOI 10.1192/bjp.bp.114.153668; Lund C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001359; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Nakku E, 2016, GLOB MENT HEALTH, DOI [10.1017/gmh.2026.14, DOI 10.1017/GMH.2026.14]; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sinha S., 2014, DISTRICT CENSUS H 24; StataCorp, 2013, STATA STAT SOFTW REL; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; TAYLOR SM, 1981, SCHIZOPHRENIA BULL, V7, P225, DOI 10.1093/schbul/7.2.225; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; Ustun B., 2010, MEASURING HLTH DISAB; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; World Health Organization, 1992, ICD 10 CLASSIFICATIO; World Health Organization, 1991, TRAIN MIDL MAN EPI C	46	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162038	10.1371/journal.pone.0162038	http://dx.doi.org/10.1371/journal.pone.0162038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632166	Green Accepted, Green Published, gold			2022-12-26	WOS:000383706900025
J	te Molder, M; de Hoog, MLA; Uiterwaal, CSPM; van der Ent, CK; Smit, HA; Schilder, AGM; Damoiseaux, RAMJ; Venekamp, RP				te Molder, Marthe; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; van der Ent, Cornelis K.; Smit, Henriette A.; Schilder, Anne G. M.; Damoiseaux, Roger A. M. J.; Venekamp, Roderick P.			Antibiotic Treatment for First Episode of Acute Otitis Media Is Not Associated with Future Recurrences	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONTROLLED-TRIAL; PRIMARY-CARE; CHILDREN; COHORT; THERAPY; CONSULTATIONS; MASTOIDITIS	Objective Antibiotic treatment of acute otitis media (AOM) has been suggested to increase the risk of future AOM episodes by causing unfavorable shifts in microbial flora. Because current evidence on this topic is inconclusive and long-term follow-up data are scarce, we wanted to estimate the effect of antibiotic treatment for a first AOM episode occurring during infancy on AOM recurrences and AOM-related health care utilization later in life. Methods We obtained demographic information and risk factors from data of the Wheezing Illnesses Study Leidsche Rijn, a prospective birth cohort study in which all healthy newborns born in Leidsche Rijn (between 2001 and 2012), The Netherlands, were enrolled. These data were linked to children's primary care electronic health records up to the age of four. Children with at least one family physician-diagnosed AOM episode before the age of two were included in analyses. The exposure of interest was the prescription of oral antibiotics (yes vs no) for a child's first AOM episode before the age of two years. Results 848 children were included in analyses and 512 (60%) children were prescribed antibiotics for their first AOM episode. Antibiotic treatmentwas not associated with an increased risk of total AOM recurrences (adjusted rate ratio: 0.94, 95% CI: 0.78-1.13), recurrent AOM (>= 3 episodes in 6 months or >= 4 in one year; adjusted risk ratio: 0.79, 95% CI: 0.57-1.11), or with increased AOM-related health care utilization during children's first four years of life. Conclusions Oral antibiotic treatment of a first AOM episode occurring during infancy does not affect the number of AOM recurrences and AOM-related health care utilization later in life. This information can be used when weighing the pros and cons of various AOM treatment options.	[te Molder, Marthe; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; Smit, Henriette A.; Schilder, Anne G. M.; Damoiseaux, Roger A. M. J.; Venekamp, Roderick P.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands; [Schilder, Anne G. M.; Venekamp, Roderick P.] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Utrecht, Netherlands; [Schilder, Anne G. M.] UCL, Ear Inst, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of London; University College London	de Hoog, MLA (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	M.L.A.deHoog@umcutrecht.nl		Schilder, Anne/0000-0002-5496-4580; Van der Ent, Cornelis/0000-0002-2501-4121; Damoiseaux, Roger/0000-0001-8052-0302; Venekamp, Roderick P/0000-0002-1446-9614	Netherlands Organization for Health Research and Development (ZonMw) [20010101322]; University Medical Center Utrecht; GlaxoSmithKline, The Netherlands; National Institute for Health Research (NIHR); National Institute for Health Research [NIHR-RP-011-045] Funding Source: researchfish	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); University Medical Center Utrecht; GlaxoSmithKline, The Netherlands(Netherlands GovernmentGlaxoSmithKline); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The WHISTLER-project was supported by grants from The Netherlands Organization for Health Research and Development (ZonMw; Grant No.: 20010101322), by the University Medical Center Utrecht, and by an unrestricted grant from GlaxoSmithKline, The Netherlands. The evidENT team at UCL, United Kingdom, is supported by a National Institute for Health Research (NIHR), Research Professorship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman AE, 2005, BRIT J GEN PRACT, V55, P114; American Academy of Pediatrics American Academy of Family Physicians, 2013, PEDIATRICS, V131, P964; Bakaletz LO, 2012, PAEDIATR RESPIR REV, V13, P154, DOI 10.1016/j.prrv.2012.03.001; Balcazar JL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01216; Bezakova N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2525; Brook I, 2005, J MED MICROBIOL, V54, P83, DOI 10.1099/jmm.0.45819-0; Cohen R, 1997, PEDIATR INFECT DIS J, V16, P555, DOI 10.1097/00006454-199706000-00004; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Damoiseaux RAMJ, 2006, FAM PRACT, V23, P40, DOI 10.1093/fampra/cmi083; Damoiseaux RAMJ, 2014, HUISARTS WET, V57, P648; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fortanier AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121572; Garbutt JM, 2012, JAMA-J AM MED ASSOC, V307, P685, DOI 10.1001/jama.2012.138; Ghaffar F, 2002, CLIN INFECT DIS, V34, P1301, DOI 10.1086/340054; Grossman Z, 2016, PEDIATR INFECT DIS J, V35, P162, DOI 10.1097/INF.0000000000000951; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Hoppe JE, 1999, PEDIATR INFECT DIS J, V18, P1085, DOI 10.1097/00006454-199912000-00012; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Piters WAAD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0294; Rosenfeld RM, 2003, LARYNGOSCOPE, V113, P1645, DOI 10.1097/00005537-200310000-00004; Rovers MM, 2008, FAM PRACT, V25, P233, DOI 10.1093/fampra/cmn030; Rubin DB, 2004, MULTIPLE IMPUTATION; Thompson M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7027; Thompson PL, 2009, PEDIATRICS, V123, P424, DOI 10.1542/peds.2007-3349; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; Venekamp RP, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000219.pub4, 10.1002/14651858.CD000219.pub3]; Williamson I, 2006, BRIT J GEN PRACT, V56, P170; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	29	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160560	10.1371/journal.pone.0160560	http://dx.doi.org/10.1371/journal.pone.0160560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632355	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900007
J	Morell, C; Bort, A; Vara-Ciruelos, D; Ramos-Torres, A; Altamirano-Dimas, M; Diaz-Laviada, I; Rodriguez-Henche, N				Morell, Cecilia; Bort, Alicia; Vara-Ciruelos, Diana; Ramos-Torres, Agata; Altamirano-Dimas, Manuel; Diaz-Laviada, Ines; Rodriguez-Henche, Nieves			Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells	PLOS ONE			English	Article							ANDROGEN DEPRIVATION THERAPY; MEMBRANE-PROTEINS; TUMOR-CELLS; MONITORING AUTOPHAGY; LYSOSOME BIOGENESIS; DANON-DISEASE; CYCLIC-AMP; PROGRESSION; CARCINOMA; TARGET	Neuroendocrine (NE) prostate cancer (PCa) is a highly aggressive subtype of prostate cancer associated with resistance to androgen ablation therapy. In this study, we used LNCaP prostate cancer cells cultured in a serum-free medium for 6 days as a NE model of prostate cancer. Serum deprivation increased the expression of NE markers such as neuron-specific enolase (NSE) and beta III tubulin (beta III tub) and decreased the expression of the androgen receptor protein in LNCaP cells. Using cDNA microarrays, we compared gene expression profiles of NE cells and non-differentiated LNCaP cells. We identified up-regulation of 155 genes, among them LAMP2, a lysosomal membrane protein involved in lysosomal stability and autophagy. We then confirmedup-regulation of LAMP2 in NE cells by qRT-PCR, Western blot and confocal microscopy assays, showing that mRNA up-regulation correlated with increased levels of LAMP2 protein. Subsequently, we determined autophagy activity in NE cells by assessing the protein levels of SQSTM/p62 and LC3 by Western blot and LC3 and Atg5 mRNAs content by qRT-PCR. The decreased levels of SQSTM/p62 was accompanied by an enhanced expression of LC3 and ATG5, suggesting activation of autophagy in NE cells. Blockage of autophagy with 1 mu MAKT inhibitor IV, or by silencing Beclin 1 and Atg5, prevented NE cell differentiation, as revealed by decreased levels of the NE markers. In addition, AKT inhibitor IV as well as Beclin1 and Atg5 kwockdown attenuated LAMP2 expression in NE cells. On the other hand, LAMP2 knockdown by siRNA led to a marked blockage of autophagy, prevention of NE differentiation and decrease of cell survival. Taken together, these results suggest that LAMP2 overexpression assists NE differentiation of LNCaP cells induced by serum deprivation and facilitates autophagy activity in order to attain the NE phenotype and cell survival. LAMP2 could thus be a potential biomarker and potential target for NE prostate cancer.	[Morell, Cecilia; Bort, Alicia; Ramos-Torres, Agata; Diaz-Laviada, Ines; Rodriguez-Henche, Nieves] Univ Alcala De Henares, Sch Med & Hlth Sci, Biochem & Mol Biol Unit, Dept Syst Biol, Alcala De Henares, Spain; [Vara-Ciruelos, Diana] Univ Dundee, Coll Life Sci, Cell Signalling & Immunol, Dundee, Scotland; [Altamirano-Dimas, Manuel] Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	Universidad de Alcala; University of Dundee	Rodriguez-Henche, N (corresponding author), Univ Alcala De Henares, Sch Med & Hlth Sci, Biochem & Mol Biol Unit, Dept Syst Biol, Alcala De Henares, Spain.	nieves.rhenche@uah.es	Vara-Ciruelos, Diana/K-6919-2017; Vara-Ciruelos, Diana/S-3077-2019; Rodriguez-Henche, Nieves/K-6828-2017; Bueno, Bort/AAC-1242-2019; Diaz-Laviada, Ines/I-2838-2015	Vara-Ciruelos, Diana/0000-0002-9508-2648; Vara-Ciruelos, Diana/0000-0002-9508-2648; Rodriguez-Henche, Nieves/0000-0001-9798-359X; Bueno, Bort/0000-0003-1490-5823; Diaz-Laviada, Ines/0000-0001-9704-4373; Morell Pucci, Maria Cecilia/0000-0002-9759-855X	University of Alcala [PI2005/063]; Spanish Ministry of Economy and Competitiveness [BFU2012-31444]; Junta de Comunidades Castilla-LaMancha; European Commission FEDER Funds [POII11-0159-0054]; Comunidad de Madrid [S2010-BMD2308]; Fundacion Tatiana Perez de Guzman el Bueno [Patrocinio 2013-001]	University of Alcala; Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Comunidades Castilla-LaMancha(Junta de Comunidades de Castilla-La Mancha); European Commission FEDER Funds(European Commission); Comunidad de Madrid(Comunidad de Madrid); Fundacion Tatiana Perez de Guzman el Bueno	This work was supported by the University of Alcala (Grant no PI2005/063) to ART; the Spanish Ministry of Economy and Competitiveness (Grant no BFU2012-31444); Junta de Comunidades Castilla-LaMancha and European Commission FEDER Funds (Grant no POII11-0159-0054); Comunidad de Madrid (Grant S2010-BMD2308); and the Fundacion Tatiana Perez de Guzman el Bueno (Grant no Patrocinio 2013-001) to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Lilian Puebla for English assistance and Isabel Trabado and Pilar Rubio for technical assistance. This research has been supported by the University of Alcala (Grant no PI2005/063); the Spanish Ministry of Economy and Competitiveness (Grant no BFU2012-31444); Junta de Comunidades Castilla-LaMancha and European Commission FEDER Funds (Grant no POII11-0159-0054); Comunidad de Madrid (Grant S2010-BMD2308); and the Fundacion Tatiana Perez de Guzman el Bueno (Grant no Patrocinio 2013-001). AB: is supported by grant from Fundacion Tatiana Perez de Guzman el Bueno. ART: is supported by grant from University of Alcala.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Chang PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088556; Cox ME, 1999, CANCER RES, V59, P3821; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; Cussenot O, 1996, J UROLOGY, V155, P1340, DOI 10.1016/S0022-5347(01)66261-X; Damaghi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9752; Deeble PD, 2001, MOL CELL BIOL, V21, P8471, DOI 10.1128/MCB.21.24.8471-8482.2001; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Endo Y, 2015, ACTA NEUROPATHOL, V129, P391, DOI 10.1007/s00401-015-1385-4; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Farrow JM, 2014, NAT REV UROL, V11, P508, DOI 10.1038/nrurol.2014.196; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujiwara Y, 2013, AUTOPHAGY, V9, P1167, DOI 10.4161/auto.24880; Fujiwara Y, 2013, AUTOPHAGY, V9, P403, DOI 10.4161/auto.23002; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Furuta K, 2001, AM J PATHOL, V159, P449, DOI 10.1016/S0002-9440(10)61716-6; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Gutierrez-Canas I, 2005, PROSTATE, V63, P44, DOI 10.1002/pros.20173; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Hvamstad T, 2003, EUR UROL, V44, P215, DOI 10.1016/S0302-2838(03)00257-4; Ibrahim-Hashim A, 2012, J UROLOGY, V188, P624, DOI 10.1016/j.juro.2012.03.113; Isshiki S, 2002, J UROLOGY, V167, P512, DOI 10.1016/S0022-5347(01)69075-X; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kannan K, 1996, CELL IMMUNOL, V171, P10, DOI 10.1006/cimm.1996.0167; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Lapuk AV, 2012, J PATHOL, V227, P286, DOI 10.1002/path.4047; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Matsuda-Lennikov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079795; Morell C, 2016, PROSTATE CANCER P D, V19, P248, DOI 10.1038/pcan.2016.19; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Noguchi M, 2014, BBA-REV CANCER, V1846, P342, DOI 10.1016/j.bbcan.2014.07.013; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Rick FG, 2015, UROL ONCOL-SEMIN ORI, V33, P270, DOI 10.1016/j.urolonc.2014.11.006; Saad F, 2015, UROLOGY, V86, P852, DOI 10.1016/j.urology.2015.07.034; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Saha T, 2012, AUTOPHAGY, V8, P1643, DOI 10.4161/auto.21654; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Sauer CG, 2006, PROSTATE, V66, P227, DOI 10.1002/pros.20338; Shafi AA, 2013, PHARMACOL THERAPEUT, V140, P223, DOI 10.1016/j.pharmthera.2013.07.003; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2009, AM J TRANSL RES, V1, P148; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Terry S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00060; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; Wyatt AW, 2015, EMBO MOL MED, V7, P878, DOI 10.15252/emmm.201303701; Xie SZ, 2004, PROSTATE, V60, P61, DOI 10.1002/pros.20048; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhu YZ, 2014, PROSTATE, V74, P1086, DOI 10.1002/pros.22819	62	28	31	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162977	10.1371/journal.pone.0162977	http://dx.doi.org/10.1371/journal.pone.0162977			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627761	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600071
J	Savige, J; Storey, H; Cheong, HI; Kang, HG; Park, E; Hilbert, P; Persikov, A; Torres-Fernandez, C; Ars, E; Torra, R; Hertz, JM; Thomassen, M; Shagam, L; Wang, DM; Wang, YY; Flinter, F; Nagel, M				Savige, Judith; Storey, Helen; Cheong, Hae Il; Kang, Hee Gyung; Park, Eujin; Hilbert, Pascale; Persikov, Anton; Torres-Fernandez, Carmen; Ars, Elisabet; Torra, Roser; Hertz, Jens Michael; Thomassen, Mads; Shagam, Lev; Wang, Dongmao; Wang, Yanyan; Flinter, Frances; Nagel, Mato			X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations	PLOS ONE			English	Article							BASEMENT-MEMBRANE NEPHROPATHY; COL4A5 COLLAGEN GENE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BENIGN FAMILIAL HEMATURIA; IV COLLAGEN; COL4A3/COL4A4 MUTATIONS; NATURAL-HISTORY; RENAL-FAILURE; PCR; IDENTIFICATION	Alport syndrome results from mutations in the COL4A5 (X-linked) or COL4A3/COL4A4 (recessive) genes. This study examined 754 previously-unpublished variants in these genes from individuals referred for genetic testing in 12 accredited diagnostic laboratories worldwide, in addition to all published COL4A5, COL4A3 and COL4A4 variants in the LOVD databases. It also determined genotype-phenotype correlations for variants where clinical data were available. Individuals were referred for genetic testing where Alport syndrome was suspected clinically or on biopsy (renal failure, hearing loss, retinopathy, lamellated glomerular basement membrane), variant pathogenicity was assessed using currently-accepted criteria, and variants were examined for gene location, and age at renal failure onset. Results were compared using Fisher's exact test (DNA Stata). Altogether 754 new DNA variants were identified, an increase of 25%, predominantly in people of European background. Of the 1168 COL4A5 variants, 504 (43%) were missense mutations, 273 (23%) splicing variants, 73 (6%) nonsense mutations, 169 (14%) short deletions and 76 (7%) complex or large deletions. Only 135 of the 432 Gly residues in the collagenous sequence were substituted (31%), which means that fewer than 10% of all possible variants have been identified. Both missense and nonsense mutations in COL4A5 were not randomly distributed but more common at the 70 CpG sequences (p<10(-41) and p<0.001 respectively). Gly>Ala substitutions were underrepresented in all three genes (p<0.0001) probably because of an association with a milder phenotype. The average age at end-stage renal failure was the same for all mutations in COL4A5 (24.4 +/- 7.8 years), COL4A3 (23.3 +/- 9.3) and COL4A4 (25.4 +/- 10.3) (COL4A5 and COL4A3, p = 0.45; COL4A5 and COL4A4, p = 0.55; COL4A3 and COL4A4, p = 0.41). For COL4A5, renal failure occurred sooner with non-missense than missense variants (p<0.01). For the COL4A3 and COL4A4 genes, age at renal failure occurred sooner with two non-missense variants (p = 0.08, and p = 0.01 respectively). Thus DNA variant characteristics that predict age at renal failure appeared to be the same for all three Alport genes. Founder mutations (with the pathogenic variant in at least 5 apparently-unrelated individuals) were not necessarily associated with a milder phenotype. This study illustrates the benefits when routine diagnostic laboratories share and analyse their data.	[Savige, Judith; Wang, Dongmao; Wang, Yanyan] Univ Melbourne, Melbourne Hlth & Northern Hlth, Melbourne, Vic, Australia; [Storey, Helen] Guys & St Thomas Hosp, Mol Genet Lab, London, England; [Cheong, Hae Il; Kang, Hee Gyung; Park, Eujin] Seoul Natl Univ Hosp, Res Coordinat Ctr Rare Dis, Seoul, South Korea; [Hilbert, Pascale] Inst Pathol & Genet, Dept Mol Biol, Gosselles, Belgium; [Persikov, Anton] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Torres-Fernandez, Carmen] Mol Genet Ctr GENETAQ, Malaga, Spain; [Ars, Elisabet; Torra, Roser] Univ Autonoma Barcelona, Fundacio Puigvert, REDINREN, Mol Biol Lab, Barcelona, Spain; [Ars, Elisabet; Torra, Roser] Univ Autonoma Barcelona, Fundacio Puigvert, REDINREN, Dept Nephrol, Barcelona, Spain; [Hertz, Jens Michael; Thomassen, Mads] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Shagam, Lev] Pirogov Russian Med Univ, Inst Pediat, Moscow, Russia; [Flinter, Frances] Guys & St Thomas Hosp, Dept Genet, London, England; [Nagel, Mato] Ctr Nephrol & Metab Med, D-02943 Weisswasser, Germany	University of Melbourne; Guy's & St Thomas' NHS Foundation Trust; Seoul National University (SNU); Seoul National University Hospital; Princeton University; Autonomous University of Barcelona; Fundacio Puigvert; Autonomous University of Barcelona; Fundacio Puigvert; University of Southern Denmark; Odense University Hospital; Pirogov Russian National Research Medical University; Guy's & St Thomas' NHS Foundation Trust	Savige, J (corresponding author), Univ Melbourne, Melbourne Hlth & Northern Hlth, Melbourne, Vic, Australia.	jasavige@unimelb.edu.au	Ars, Elisabet/AAM-8454-2021; Park, Eujin/AAZ-5931-2020; Hertz, Jens Michael/H-6269-2014; Torra, Roser/A-9983-2008	Ars, Elisabet/0000-0002-4118-4358; Park, Eujin/0000-0002-4413-468X; Hertz, Jens Michael/0000-0003-0087-4739; Storey, Helen/0000-0002-2214-6444; Torra, Roser/0000-0001-8714-2332	US Alport Foundation; Australian Alport Foundation; Korean government through the Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea [HI12C0014]	US Alport Foundation; Australian Alport Foundation; Korean government through the Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea	JS received seed funding to establish the Alport mutation databases from the US Alport Foundation and the Australian Alport Foundation ($USD 10,000 and $AUD 20,000 respectively). HIC, HGK and EP received funding from the Korean government through the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea ($USD142,000) (HI12C0014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrondel C, 2004, KIDNEY INT, V65, P2030, DOI 10.1111/j.1523-1755.2004.00622.x; Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248; Barker DF, 1996, AM J HUM GENET, V58, P1157; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Barker DF, 2001, AM J MED GENET, V98, P148, DOI 10.1002/1096-8628(20010115)98:2<148::AID-AJMG1024>3.0.CO;2-W; Barker DF, 1997, HUM GENET, V99, P681, DOI 10.1007/s004390050429; Buzza M, 2001, KIDNEY INT, V60, P480, DOI 10.1046/j.1523-1755.2001.060002480.x; Chatterjee R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076360; Crockett DK, 2010, HUM MUTAT, V31, pE1652, DOI 10.1002/humu.21312; Dagher Hayat, 2002, Hum Mutat, V20, P321, DOI 10.1002/humu.9065; den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262; Des Parkin J, 2011, HUM MUTAT, V32, P127, DOI 10.1002/humu.21401; FEINGOLD J, 1985, KIDNEY INT, V27, P672, DOI 10.1038/ki.1985.63; Gross O, 2002, NEPHROL DIAL TRANSPL, V17, P1218, DOI 10.1093/ndt/17.7.1218; Grunfeld J P, 1997, Rev Prat, V47, P1566; GUO CY, 1995, J CLIN INVEST, V95, P1832, DOI 10.1172/JCI117862; Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Jais JP, 2003, J AM SOC NEPHROL, V14, P2603, DOI 10.1097/01.ASN.0000090034.71205.74; KNEBELMANN B, 1992, AM J HUM GENET, V51, P135; Knebelmann B, 1996, AM J HUM GENET, V59, P1221; Lemmink HH, 1997, HUM MUTAT, V9, P477; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; Longo I, 2002, KIDNEY INT, V61, P1947, DOI 10.1046/j.1523-1755.2002.00379.x; Malone AF, 2014, KIDNEY INT, V86, P1253, DOI 10.1038/ki.2014.305; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Martin P, 1998, J AM SOC NEPHROL, V9, P2291; Mencarelli MA, 2015, J MED GENET, V52, P163, DOI 10.1136/jmedgenet-2014-102822; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Mohammad M, 2014, PEDIATR NEPHROL, V29, P481, DOI 10.1007/s00467-013-2682-6; Ozen S, 2001, PEDIATR NEPHROL, V16, P874, DOI 10.1007/s004670100673; Pierides A, 2013, HIPPOKRATIA, V17, P207; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Plant KE, 1999, HUM MUTAT, V13, P124, DOI 10.1002/(SICI)1098-1004(1999)13:2<124::AID-HUMU4>3.0.CO;2-Z; Renieri A, 1996, AM J HUM GENET, V58, P1192; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Savige J, 2003, KIDNEY INT, V64, P1169, DOI 10.1046/j.1523-1755.2003.00234.x; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Storey H, 2013, J AM SOC NEPHROL, V24, P1945, DOI 10.1681/ASN.2012100985; Tan R, 2010, CLIN J AM SOC NEPHRO, V5, P34, DOI 10.2215/CJN.01030209; van der Loop FTL, 2000, KIDNEY INT, V58, P1870, DOI 10.1046/j.1523-1755.2000.00358.x; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Wang YY, 2004, KIDNEY INT, V65, P786, DOI 10.1111/j.1523-1755.2004.00453.x; Webb BD, 2014, CLIN GENET, V86, P155, DOI 10.1111/cge.12247; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; ZHOU J, 1993, KIDNEY INT, V43, P722, DOI 10.1038/ki.1993.103	48	47	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161802	10.1371/journal.pone.0161802	http://dx.doi.org/10.1371/journal.pone.0161802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627812	Green Published, gold			2022-12-26	WOS:000383680600009
J	Shokoohi, M; Karamouzian, M; Mirzazadeh, A; Haghdoost, A; Rafierad, AA; Sedaghat, A; Sharifi, H				Shokoohi, Mostafa; Karamouzian, Mohammad; Mirzazadeh, Ali; Haghdoost, AliAkbar; Rafierad, Ali-Ahmad; Sedaghat, Abbas; Sharifi, Hamid			HIV Knowledge, Attitudes, and Practices of Young People in Iran: Findings of a National Population-Based Survey in 2013	PLOS ONE			English	Article							HEALTH; STIGMA; AFRICA	Introduction The evidence is mixed on the HIV knowledge, attitude, and practices of youth in Iran. The aim of the current study was to assess knowledge, attitudes, and practices of Iranian youth towards HIV through a national survey. Materials and Methods Through a cross-sectional study with multistage cluster sampling, we administered a pilot-tested standard questionnaire to assess the levels of HIV knowledge, attitudes and practices of individuals aged 15-29 years old. Participants were recruited from 13 provinces in Iran and consisted of 2456 men and 2412 women. Results Only 37.3% of the participants had a high knowledge score. Most participants knew the main routes of HIV transmission; however, misconceptions existed about the transmission of HIV through mosquito bites across all age groups (31.7% correct response). Positive levels of attitude wereobserved among 20.7% of the participants. Most participants believed that people living with HIV (PLHIV) should be supported (88.3%) while only 46.3% were ready to share a table with them. Among those aged 19-29 years old, the main source of HIV information was mass media (69.1%), only 13.1% had ever tested for HIV, around 20.8% had ever had extramarital sex (31.7% male vs. 9.6% female), 1.8% ever injected drugs (2.9% male vs. and 0.7% female). Among sexually active subjects in this age group, only 21.8% (26.1% male vs. 7.1% female) were consistent condom users. Conclusions The findings showed that Iranian youth and young adults have relatively insufficient overall knowledge and negative attitudes about HIV and PLHIV. Novel strategies involving schools and youth's networks could be employed to deliver a culturally sensitive sexual health program.	[Shokoohi, Mostafa; Karamouzian, Mohammad; Mirzazadeh, Ali; Rafierad, Ali-Ahmad; Sharifi, Hamid] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran; [Shokoohi, Mostafa; Karamouzian, Mohammad; Mirzazadeh, Ali; Rafierad, Ali-Ahmad; Sharifi, Hamid] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Shokoohi, Mostafa] Univ Western Ontario, Schulich Sch Med & Dent, Epidemiol & Biostat, London, ON, Canada; [Karamouzian, Mohammad] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada; [Mirzazadeh, Ali] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Haghdoost, AliAkbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Modeling Hlth Res Ctr, Kerman, Iran; [Sedaghat, Abbas] Minist Hlth & Med Educ, CDC, Tehran, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Western University (University of Western Ontario); University of British Columbia; University of California System; University of California San Francisco; Kerman University of Medical Sciences; Ministry of Health & Medical Education (MOHME)	Karamouzian, M (corresponding author), Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran.; Karamouzian, M (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran.; Karamouzian, M (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada.	Karamouzian.m@ubc.alumni.ca	Haghdoost, Ali Akbar/C-2823-2009; Karamouzian, Mohammad/C-9277-2018; Sharifi, Hamid/B-5493-2019; Mirzazadeh, Ali/AAJ-5907-2021	Haghdoost, Ali Akbar/0000-0003-4628-4849; Karamouzian, Mohammad/0000-0002-5631-4469; Sharifi, Hamid/0000-0002-9008-7618; Mirzazadeh, Ali/0000-0002-0478-3220; Shokoohi, Mostafa/0000-0002-3810-752X	Ministry of Health of Iran	Ministry of Health of Iran	The survey was financially supported by the Ministry of Health of Iran in 2013. However, the authors received no funding for this specific paper.	Askarian M, 2004, J HOSP INFECT, V58, P292, DOI 10.1016/j.jhin.2004.07.004; Askarian M, 2009, ARCH IRAN MED, V12, P48; Behjati Ardekani M, 2005, IRAN J PEDIATR, V15, P321; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Farahani Farideh Khalaj Abadi, 2012, J Reprod Infertil, V13, P101; Ganczak M, 2007, J ADOLESCENT HEALTH, V40, pCOVER1, DOI 10.1016/j.jadohealth.2007.01.011; Gao XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044881; Ghabili Kamyar, 2008, AIDS Res Ther, V5, P15, DOI 10.1186/1742-6405-5-15; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Haghdoost A. A., 2011, Iranian Journal of Epidemiology, V6, P8; Haghdoost AA, 2013, IRAN RED CRESCENT ME, V15, P500, DOI 10.5812/ircmj.7673; Haroun D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149920; Hedayati-Moghaddam M. R., 2008, Eastern Mediterranean Health Journal, V14, P1321; Kakoko DC, 2006, AIDS CARE, V18, P554, DOI 10.1080/09540120500259779; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Karamouzian M, 2014, J ADOLESCENT HEALTH, V55, P149, DOI 10.1016/j.jadohealth.2014.04.009; Khajehkazemi R, 2013, SEX TRANSM INFECT, V89, P29, DOI 10.1136/sextrans-2013-051204; Martin RJ, 2016, SUBST ABUS, V37, P488, DOI 10.1080/08897077.2016.1142922; Mazloumi MS, 2006, ZAHEDAN J RES MED SC, V8, P53; Montazeri A, 2005, PATIENT EDUC COUNS, V57, P199, DOI 10.1016/j.pec.2004.05.014; Mosavi SA, 2014, J ADOLESCENT HEALTH, V55, P107, DOI 10.1016/j.jadohealth.2013.11.029; Nasirian M, 2016, INT J HEALTH POLICY, V5, P5, DOI 10.15171/ijhpm.2015.146; Nasirian M, 2012, J RES HEALTH SCI, V12, P81; National AIDS Committee Secretariat Ministry of Health and Medical Education, 2015, ISL REP IR AIDS PROG; O'Byrne P, 2014, NURS INQ, V21, P20, DOI 10.1111/nin.12014; ROSS CE, 1994, J HEALTH SOC BEHAV, V35, P161, DOI 10.2307/2137363; Roudsari H. R. Sadeghipour, 2006, Eastern Mediterranean Health Journal, V12, P862; Shoveller J, 2009, SEX TRANSM INFECT, V85, P397, DOI 10.1136/sti.2008.035568; Statistical Center of Iran, 2011, SEL FIND 2011 NAT PO; Taheri JB, 2009, J DENT SCH, V26, P303; Taj SS, 2005, ANN MILITARY HLTH SC, V3, P565; Tavoosi A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-17; Tehrani F. Ramezani, 2008, Eastern Mediterranean Health Journal, V14, P142; Terry Paul E, 2005, Int Q Community Health Educ, V24, P29, DOI 10.2190/F5VV-JPNE-71AT-8FUH; Tulloch HE, 2012, J IMMIGR MINOR HEALT, V14, P132, DOI 10.1007/s10903-011-9480-7; UNAIDS, 2015, ALL ENDADOLESCENTAID; UNAIDS, 2014, THE GAP REP; USAID, 2012, DEM HLTH SURV TOOLK; Wood K, 2002, PROMOTING YOUNG PEOP	40	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161849	10.1371/journal.pone.0161849	http://dx.doi.org/10.1371/journal.pone.0161849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626638	gold, Green Published, Green Submitted			2022-12-26	WOS:000383680600011
J	Tian, W; Yuan, JF; Yang, D; Zhang, LJ				Tian, Wei; Yuan, Jiangfan; Yang, Dong; Zhang, Lanjing			Descriptive Analysis on the Impacts of Universal Zero-Markup Drug Policy on a Chinese Urban Tertiary Hospital	PLOS ONE			English	Article							PRESCRIBING ERRORS; MEDICINES; PROVINCE; IMPLEMENTATION; INPATIENTS; WORKLOAD	Background Universal Zero-Markup Drug Policy (UZMDP) mandates no price mark-ups on any drug dispensed by a healthcare institution, and covers the medicines not included in the China's National Essential Medicine System. Five tertiaryhospitals in Beijing, China implemented UZMDP in 2012. Its impacts on these hospitals are unknown. We described the effects of UZMDP on a participating hospital, Jishuitan Hospital, Beijing, China (JST). Methods This retrospective longitudinal study examined the hospital-level data of JST and city-level data of tertiaryhospitals of Beijing, China (BJT) 2009-2015. Rank-sum tests and join-point regression analyses were used to assess absolute changes and differences in trends, respectively. Results In absolute terms, after the UZDMP implementation, there were increased annual patient-visits and decreased ratios of medicine-to-healthcare-charges(RMOH) in JST outpatient and inpatient services; however, in outpatient service, physician work-days decreased and physician- workload and inflation-adjusted per-visit healthcare charges increased, while the inpatient physician work-days increased and inpatient mortality-ratereduced. Interestingly, the decreasing trend in inpatient mortality-ratewas neutralized after UZDMP implementation. Compared with BJT and under influence of UZDMP, JST outpatient and inpatient services both had increasing trends in annual patient-visits (annual percentage changes[APC] = 8.1% and 6.5%, respectively) and decreasing trends in RMOH (APC = -4.3% and -5.4%,respectively), while JST outpatient services had increasing trend in inflation-adjusted per-visit healthcare charges (APC = 3.4%) and JST inpatient service had decreasing trend in inflation-adjusted per-visit medicine-charges (APC = -5.2%). Conclusion Implementation of UZMDP seems to increase annual patient- visits, reduce RMOH and have different impacts on outpatient and inpatient services in a Chinese urban tertiary hospital.	[Tian, Wei] Jishuitan Hosp, Dept Spine Surg, Beijing, Peoples R China; [Yuan, Jiangfan] Jishuitan Hosp, Off Patient Phys Relationship, Beijing, Peoples R China; [Yang, Dong] Jishuitan Hosp, Off Performance Management, Beijing, Peoples R China; [Zhang, Lanjing] Univ Med Ctr Princeton, Dept Pathol, Plainsboro, NJ 08536 USA; [Zhang, Lanjing] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Zhang, Lanjing] Rutgers State Univ, RobertWood Johnson Med Sch, Dept Pathol, New Brunswick, NJ 08854 USA; [Zhang, Lanjing] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zhang, LJ (corresponding author), Univ Med Ctr Princeton, Dept Pathol, Plainsboro, NJ 08536 USA.; Zhang, LJ (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.; Zhang, LJ (corresponding author), Rutgers State Univ, RobertWood Johnson Med Sch, Dept Pathol, New Brunswick, NJ 08854 USA.; Zhang, LJ (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ 08854 USA.	ljzhang@hotmail.com	Zhang, Lanjing/GZB-0260-2022; Zhang, Lanjing/AGY-7838-2022	Zhang, Lanjing/0000-0001-5436-887X				BIHM, 2013, BRIEFINGS ON THE HEA; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Elliott DJ, 2014, JAMA INTERN MED, V174, P786, DOI 10.1001/jamainternmed.2014.300; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Gong YH, 2016, HEALTH POLICY PLANN, V31, P21, DOI 10.1093/heapol/czv008; Gong YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103242, 10.1371/journal.pone.0095597]; Kee F, 1999, BRIT MED J, V318, P1381, DOI 10.1136/bmj.318.7195.1381; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Ma XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140568; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Michtalik HJ, 2013, JAMA INTERN MED, V173, P375, DOI 10.1001/jamainternmed.2013.1864; NBSC, 2015, ANN STAT STAT CHIN; Pannick S, 2015, JAMA INTERN MED, V175, P1288, DOI 10.1001/jamainternmed.2015.2421; Ross S, 2013, BMJ QUAL SAF, V22, P97, DOI 10.1136/bmjqs-2012-001175; Song Yan, 2014, J Pharm Policy Pract, V7, P12, DOI 10.1186/2052-3211-7-12; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Wang J, 2013, CHINA PHARM, V23, P2982, DOI DOI 10.6039/J.ISSN.1001-0408.2012.32.03; Wang JY, 2015, INDIAN J PHARMACOL, V47, P535, DOI 10.4103/0253-7613.165192; Xu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138948; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yi HM, 2015, HEALTH AFFAIR, V34, P1391, DOI 10.1377/hlthaff.2014.1114; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang X, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006471; Zhou ZL, 2015, J ASIAN PUBLIC POLIC, V8, P102, DOI 10.1080/17516234.2015.1005561; Zhou ZL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121630	28	13	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162795	10.1371/journal.pone.0162795	http://dx.doi.org/10.1371/journal.pone.0162795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627811	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600054
J	Didiano, TJ; Johnson, MTJ; Duval, TP				Didiano, Teresa J.; Johnson, Marc T. J.; Duval, Tim P.			Disentangling the Effects of Precipitation Amount and Frequency on the Performance of 14 Grassland Species	PLOS ONE			English	Article							EXTREME PRECIPITATION; GAS-EXCHANGE; ROOT DISTRIBUTIONS; RAINFALL REGIMES; CLIMATE EXTREMES; ECOSYSTEM; DROUGHT; RESPONSES; EVENTS; PRODUCTIVITY	Climate change is causing shifts in the amount and frequency of precipitation in many regions, which is expected to have implications for plant performance. Most research has examined the impacts of the amount of precipitation on plants rather than the effects of both the amount and frequency of precipitation. To understand how climate-driven changes in precipitation can affect grassland plants, we asked: (i) How does the amount and frequency of precipitation affect plant performance? (ii) Do plant functional groups vary in their response to variable precipitation? To answer these questions we grew 14 monocot and eudicot grassland species and conducted a factorial manipulation of the amount (70 vs 90mm/month) and frequency (every 3, 15, or 30 days) of precipitation under rainout shelters. Our results show that both the amount and frequency of precipitation impact plant performance, with larger effects on eudicots than monocots. Above-and below-ground biomass were affected by the amount of precipitation and/or the interaction between the amount and frequency of precipitation. Above-ground biomass increased by 21-30% when the amount of precipitation was increased. When event frequency was decreased from 3 to 15 or 30 days, below-ground biomass generally decreased by 18-34% in the 70 mm treatment, but increased by 33-40% in the 90 mm treatment. Changes in stomatal conductance were largely driven by changes in event frequency. Our results show that it is important to consider changes in both the amount and frequency of precipitation when predicting how plant communities will respond to variable precipitation.	[Didiano, Teresa J.; Duval, Tim P.] Univ Toronto Mississauga, Dept Geog, Mississauga, ON, Canada; [Johnson, Marc T. J.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga	Didiano, TJ (corresponding author), Univ Toronto Mississauga, Dept Geog, Mississauga, ON, Canada.	teresa.didiano@gmail.com		Duval, Tim/0000-0002-7494-2709	Natural Sciences and Engineering Research Council Canadian Graduate Scholarship; Ontario Graduate Scholarship; University of Toronto Mississauga Department of Geography Graduate Expansion Fund; Natural Sciences and Engineering Research Council; NSERC CGS-M; OGS; University of Toronto Mississauga Dept. of Geography Graduate Expansion Fund; NSERC	Natural Sciences and Engineering Research Council Canadian Graduate Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); University of Toronto Mississauga Department of Geography Graduate Expansion Fund; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS-M(Natural Sciences and Engineering Research Council of Canada (NSERC)); OGS(Ontario Graduate Scholarship); University of Toronto Mississauga Dept. of Geography Graduate Expansion Fund; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	TJD: Natural Sciences and Engineering Research Council Canadian Graduate Scholarship, Ontario Graduate Scholarship, and University of Toronto Mississauga Department of Geography Graduate Expansion Fund, MTJJ: Natural Sciences and Engineering Research Council Discovery grants, and TPD: Natural Sciences and Engineering Research Council Discovery grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S. Ariano, M. Harris, S. Homewood, A. Maglalang, M. Malone, D. Radu, C. Soden, P. Vora, H. Wilson, V. Yip, and S. Zamora for assistance in setting up and maintaining the field experiment. Technical assistance was provided by P. Rudz. T.J.D was supported by an NSERC CGS-M, OGS, and University of Toronto Mississauga Dept. of Geography Graduate Expansion Fund. The project was supported by NSERC Discovery grants to M.T.J.J. and T.P.D.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Campos GEP, 2013, NATURE, V494, P349, DOI 10.1038/nature11836; Cao ZH, 2009, J APPL METEOROL CLIM, V48, P1955, DOI 10.1175/2009JAMC2055.1; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; D'Odorico P, 2010, BIOSCIENCE, V60, P898, DOI 10.1525/bio.2010.60.11.6; Diffenbaugh NS, 2013, SCIENCE, V341, P486, DOI 10.1126/science.1237123; Dijkstra FA, 2012, OECOLOGIA, V170, P799, DOI 10.1007/s00442-012-2336-6; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Edenhofer O., 2014, CONTRIBUTION WORKING; Evans SE, 2013, ECOSYSTEMS, V16, P20, DOI 10.1007/s10021-012-9593-4; Evans SE, 2011, J ECOL, V99, P1500, DOI 10.1111/j.1365-2745.2011.01864.x; Fay PA, 2002, INT J PLANT SCI, V163, P549, DOI 10.1086/339718; Fay PA, 2008, GLOBAL CHANGE BIOL, V14, P1600, DOI 10.1111/j.1365-2486.2008.01605.x; Fry EL, 2014, PLANT SOIL, V381, P351, DOI 10.1007/s11104-014-2137-2; Halekoh U, 2014, J STAT SOFTW, V59, P1; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Heisler-White JL, 2009, GLOBAL CHANGE BIOL, V15, P2894, DOI 10.1111/j.1365-2486.2009.01961.x; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; KNAPP AK, 1993, ECOLOGY, V74, P113, DOI 10.2307/1939506; KNAPP AK, 1984, OECOLOGIA, V65, P35, DOI 10.1007/BF00384460; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knapp AK, 2015, OECOLOGIA, V177, P949, DOI 10.1007/s00442-015-3233-6; Kuznetsova A., 2014, LMERTEST TESTS LINEA; Nippert JB, 2007, OIKOS, V116, P1017, DOI [10.1111/j.2007.0030-1299.15630.x, 10.1111/j.0030-1299.2007.15630.x]; PEARCY RW, 1984, PLANT CELL ENVIRON, V7, P1, DOI 10.1111/j.1365-3040.1984.tb01194.x; R Core Team, 2014, R A LANGUAGE AND ENV; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Robinson TMP, 2013, OIKOS, V122, P727, DOI 10.1111/j.1600-0706.2012.20655.x; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; SALA OE, 1992, ECOLOGY, V73, P1175, DOI 10.2307/1940667; SALA OE, 1982, OECOLOGIA, V53, P301, DOI 10.1007/BF00389004; Schneider AC, 2014, INT J PLANT SCI, V175, P702, DOI 10.1086/676304; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Shi Z, 2014, BIOGEOSCIENCES, V11, P621, DOI 10.5194/bg-11-621-2014; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Sun GW, 1997, J VEG SCI, V8, P587, DOI 10.2307/3237211; Thomey ML, 2011, GLOBAL CHANGE BIOL, V17, P1505, DOI 10.1111/j.1365-2486.2010.02363.x; TURNER CL, 1995, INT J PLANT SCI, V156, P216, DOI 10.1086/297243; Weaver JE, 1954, NORTHAMERICAN PRAIRI; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Westra S, 2014, REV GEOPHYS, V52, P522, DOI 10.1002/2014RG000464; Wilcox KR, 2015, GLOBAL CHANGE BIOL, V21, P335, DOI 10.1111/gcb.12673; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3; Zeppel MJB, 2014, BIOGEOSCIENCES, V11, P3083, DOI 10.5194/bg-11-3083-2014; Zhang YG, 2013, J GEOPHYS RES-BIOGEO, V118, P148, DOI 10.1029/2012JG002136	52	25	26	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162310	10.1371/journal.pone.0162310	http://dx.doi.org/10.1371/journal.pone.0162310			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622497	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000023
J	Iyoda, T; Nagamine, Y; Nakane, Y; Tokita, Y; Akari, S; Otsuka, K; Fujita, M; Itagaki, K; Takizawa, Y; Orita, H; Owaki, T; Taira, J; Hayashi, R; Kodama, H; Fukai, F				Iyoda, Takuya; Nagamine, Yumi; Nakane, Yoshitomi; Tokita, Yuya; Akari, Shougo; Otsuka, Kazuki; Fujita, Motomichi; Itagaki, Keisuke; Takizawa, You-ichi; Orita, Hiroaki; Owaki, Toshiyuki; Taira, Jyunichi; Hayashi, Ryo; Kodama, Hiroaki; Fukai, Fumio			Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim	PLOS ONE			English	Article							BREAST-CANCER CELLS; FUNCTIONAL-ROLE; FIBRONECTIN; RESISTANCE; COMBINATION; INTEGRIN; ADHESION; EXPRESSION; OVEREXPRESSION; DOXORUBICIN	The acquisition of drug resistance mediated by the interaction of tumor cells with the extracellular matrix (ECM), commonly referred to as cell adhesion-mediated drug resistance (CAM-DR), has been observed not only in hematopoietic tumor cells but also in solid tumor cells. We have previously demonstrated that a 22-mer peptide derived from fibronectin, FNIII14, can inhibit cell adhesion through the inactivation of beta 1 integrin; when coadministered with cytarabine, FNIII14 completely eradicates acute myelogenous leukemia by suppressing CAM-DR. In this study, we show that our FNIII14 peptide also enhances chemotherapy efficacy in solid tumors. Coadministration of FNIII14 synergistically enhances the cytotoxicity of doxorubicin and aclarubicin in mammary tumor and melanoma cells, respectively. The solid tumor cell chemosensitization induced by FNIII14 is dependent upon the upregulation and activation of the pro-apoptotic protein, Bim. Furthermore, the metastasis of tumor cells derived from ventrally transplanted mammary tumor grafts is suppressed by the coadministration of FNIII14 and doxorubicin. These results suggest that the coadministration of our FNIII14 peptide with chemotherapy could achieve efficient solid tumor eradication by increasing chemosensitivity and decreasing metastasis. The major causes of tumor recurrence are the existence of chemotherapy-resistant primary tumor cells and the establishment of secondary metastatic lesions. As such, coadministering FNIII14 with anti-cancer drugs could provide a promising new approach to improve the prognosis of patients with solid tumors.	[Iyoda, Takuya; Nagamine, Yumi; Nakane, Yoshitomi; Tokita, Yuya; Akari, Shougo; Otsuka, Kazuki; Fujita, Motomichi; Itagaki, Keisuke; Takizawa, You-ichi; Orita, Hiroaki; Owaki, Toshiyuki; Fukai, Fumio] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Noda, Chiba, Japan; [Iyoda, Takuya; Fukai, Fumio] Tokyo Univ Sci, Res Inst Sci & Technol, Translat Res Ctr, Noda, Chiba, Japan; [Taira, Jyunichi; Hayashi, Ryo; Kodama, Hiroaki] Saga Univ, Dept Biochem, Fac Sci & Engn, Saga, Saga, Japan	Tokyo University of Science; Tokyo University of Science; Saga University	Fukai, F (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Noda, Chiba, Japan.; Fukai, F (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Translat Res Ctr, Noda, Chiba, Japan.	fukai@rs.noda.tus.ac.jp		Taira, Junichi/0000-0002-8438-865X	Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency [5010010052A]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency, JST [5010010052A]	Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency; Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency, JST	This work was supported by Adaptable and Seamless Technology Transfer Program through Target-driven R&D from Japan Science and Technology Agency (Grant#5010010052A/www.jst.go.jp/tt/EN/univ-ip/a-step.html).; This research was supported in part by the Adaptable and Seamless Technology Transfer Program through Target-driven R&D (#5010010052A) from Japan Science and Technology Agency, JST.	Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Buchheit CL, 2015, CELL DEATH DIFFER, V22, P1275, DOI 10.1038/cdd.2014.209; Canpinar H, 2008, TURK J MED SCI, V38, P97; DREWINKO B, 1976, CANCER TREAT REP, V60, P1619; Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416; Fukai F, 2000, CELL MOL BIOL, V46, P145; Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Fukazawa H, 2004, MOL CANCER THER, V3, P1281; Garcia R, 2006, CELL CYCLE, V5, P2820, DOI 10.4161/cc.5.23.3535; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; HAMADA H, 1988, J BIOL CHEM, V263, P1454; Kamiya S, BIOCHEMISTRY, V41, P3270; Kato R, 2002, CLIN CANCER RES, V8, P2455; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Li HY, 2013, CANCER BIOTHER RADIO, V28, P115, DOI 10.1089/cbr.2012.1268; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Marchesin V, 2015, J CELL BIOL, V211, P339, DOI 10.1083/jcb.201506002; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Morozevich GE, 2006, BIOCHEMISTRY-MOSCOW+, V71, P489, DOI 10.1134/S000629790605004X; NAITO M, 1988, J BIOL CHEM, V263, P11887; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Nakagawa Y, 2014, INT J ONCOL, V44, P1376, DOI 10.3892/ijo.2014.2265; Nam JM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3454; Nista A, 1997, INT J CANCER, V72, P133, DOI 10.1002/(SICI)1097-0215(19970703)72:1<133::AID-IJC19>3.0.CO;2-K; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park HK, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-431; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Sanchez-Ruderisch H, 2011, CELL DEATH DIFFER, V18, P806, DOI 10.1038/cdd.2010.148; Savry A, 2013, NEOPLASIA, V15, P49, DOI 10.1593/neo.121074; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Yan HJ, 2012, DIGEST DIS SCI, V57, P3160, DOI 10.1007/s10620-012-2400-4; Yang MC, 2015, CELL CYCLE, V22	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162525	10.1371/journal.pone.0162525	http://dx.doi.org/10.1371/journal.pone.0162525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622612	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000036
J	Macia, E; Gueye, L; Duboz, P				Macia, Enguerran; Gueye, Lamine; Duboz, Priscilla			Hypertension and Obesity in Dakar, Senegal	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TO-HEIGHT RATIO; CARDIOVASCULAR-DISEASE; ARTERIAL-HYPERTENSION; WAIST CIRCUMFERENCE; OLDER-ADULTS; PREVALENCE; HEALTH; RISK; AWARENESS	Background Cardiovascular disease is a major public health problem in many sub-Saharan African countries, but data on the main cardiovascular risk factors-hypertension and obesity-are almost nonexistent in Senegal. The aims of this study were therefore (i) to report the prevalence, awareness, treatment and control of hypertension among adults in Dakar, (ii) to assess the prevalence of general and central obesity, and (iii) to analyze the association between hypertension and general and central obesity. Methods A cross-sectional survey was carried out in 2015 on a representative sample of 1000 dwellers of the Senegalese capital aged 20-90. Results The overall prevalence of hypertensionwas 24.7%. Among hypertensive respondents, 28.4% were aware of their condition; 16.0% were on antihypertensive medication; 4.9% had controlled blood pressure. The frequency of doctor visits was a significant predictor of awareness (OR = 2.16; p<0.05) and treatment (OR = 2.57; p<0.05) of hypertension. The prevalence of underweight, overweight and general obesity were 12.6%, 19.2% and 9.7% respectively. The prevalence of central obesity was 26% by WC and 39.8% by WHtR. General obesity and central obesity by WHtR significantly predicted HTN among men and women, but not central obesity by WC. Conclusions This study has demonstrated a high prevalence of hypertension in Dakar and a high prevalence of obesity among women-particularlyamong older women. The awareness, treatment, and effective control of hypertension are unacceptably low. The blood pressure of women with general obesity, and men with central obesity, in the community should be monitored regularly to limit the burden of cardiovascular disease in Senegal.	[Macia, Enguerran; Gueye, Lamine] Univ Bamako, UMI Environm 3189, Fac Med Pharm & Odontostomatol,CNRS, Sante,Soc,Univ Cheikh Anta Diop,CNRST Burkina Fas, Dakar, Senegal; [Duboz, Priscilla] Aix Marseille Univ, UMR Anthropol Droit Eth & Sante 7268, CNRS, EFS,Sect Nord,Fac Med, CS 80011, Marseille 15, France	University Cheikh Anta Diop Dakar; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Macia, E (corresponding author), Univ Bamako, UMI Environm 3189, Fac Med Pharm & Odontostomatol,CNRS, Sante,Soc,Univ Cheikh Anta Diop,CNRST Burkina Fas, Dakar, Senegal.	enguerranmacia@gmail.com			National Center for Scientific Research, France (PEPS "Ecological Health")	National Center for Scientific Research, France (PEPS "Ecological Health")	The authors received funding for this research from the National Center for Scientific Research, France (PEPS "Ecological Health"; http://www.cnrs.fr/inee/outils/PEPS2014.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-801; Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Adeloye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104300; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Asmar R, 2010, BLOOD PRESS MONIT, V15, P49, DOI 10.1097/MBP.0b013e3283354b11; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Brundtland GH, 2002, WORLD HLTH REPORT 20; Campbell NRC, 2015, CARDIOVASC J AFR, V26, P152; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cohen E., 2012, THESIS; Commodore-Mensah Y, 2014, J HYPERTENS, V32, P464, DOI 10.1097/HJH.0000000000000061; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Desabie J., 1963, REVUE DE STATISTIQUE, V11, P5; Duboz P, 2015, MED SANTE TROP, V25, P165, DOI 10.1684/mst.2015.0450; Duboz P, 2014, J HUM HYPERTENS, V28, P489, DOI 10.1038/jhh.2013.142; ELBAGIR M, 1990, J HUM HYPERTENS, V4, P621; Foulds HJA, 2012, J HYPERTENS, V30, P359, DOI 10.1097/HJH.0b013e32834f0b86; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Golaz V, 2012, POPULATION SOC, P491; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kwan GF, 2015, CIRCULATION, V132, P1217, DOI 10.1161/CIRCULATIONAHA.115.019226; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Macia E, 2015, Bull Soc Pathol Exot, V108, P49, DOI 10.1007/s13149-014-0369-2; Macia E, 2010, OBES REV, V11, P691, DOI 10.1111/j.1467-789X.2010.00749.x; Macia E, 2015, SANTE SOC AFRIQUE OU, P241; Macia E, 2015, AGEING SOC, V35, P405, DOI 10.1017/S0144686X13000792; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Marie A., 1997, AFRIQUE INDIVIDUS, P53; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Nwankwo T, 2013, NCHS DATA BRIEF, V133, P1; Ogah OS, 2013, HEART, V99, P1390, DOI 10.1136/heartjnl-2012-303227; Organization WH, 2016, GLOBAL STATUS REPORT; Peltzer K, 2013, CARDIOVASC J AFR, V24, P66, DOI 10.5830/CVJA-2013-002; POPKIN BM, 1993, POPUL DEV REV, V19, P138, DOI 10.2307/2938388; Quasem I, 2001, B WORLD HEALTH ORGAN, V79, P490; Reddy KS, 1998, CIRCULATION, V97, P596; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Seck SM, 2015, MED SANTE TROP, V25, P160, DOI 10.1684/mst.2015.0452; Steyn NP, 2014, ANN NY ACAD SCI, V1311, P88, DOI 10.1111/nyas.12433; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Unwin N, 2001, HEALTH POLICY PLANN, V16, P351, DOI 10.1093/heapol/16.4.351; WANG SA, 2014, PLOS BIOL, V12, DOI DOI 10.1371/JOURNAL.PONE.0114424; Ware LJ, 2014, NUTR METAB CARDIOVAS, V24, P900, DOI 10.1016/j.numecd.2014.02.005; Ware LJ, 2016, J CLIN HYPERTENS, V18, P396, DOI 10.1111/jch.12768; WHO, 2003, DIET NUTR PREVENTION, V916; WHO Regional Office for Africa, 2006, HLTH PEOPL AFR REG H; World Health Organization, 2000, WHO TECHN REP SER, V894; Wyatt SB, 2008, HYPERTENSION, V51, P650, DOI 10.1161/HYPERTENSIONAHA.107.100081; Yu Y, 2012, OBESITY, V20, P904, DOI 10.1038/oby.2011.307; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	59	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161544	10.1371/journal.pone.0161544	http://dx.doi.org/10.1371/journal.pone.0161544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622534	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000006
J	Wang, L; Zhang, Y; Wang, ZW; Gong, N; Kweon, TD; Vo, B; Wang, CR; Zhang, XL; Chung, JY; Alachkar, A; Liang, XM; Luo, DZ; Civelli, O				Wang, Lien; Zhang, Yan; Wang, Zhiwei; Gong, Nian; Kweon, Tae Dong; Vo, Benjamin; Wang, Chaoran; Zhang, Xiuli; Chung, Jae Yoon; Alachkar, Amal; Liang, Xinmiao; Luo, David Z.; Civelli, Olivier			The Antinociceptive Properties of the Corydalis yanhusuo Extract	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DOPAMINE D2 RECEPTORS; NEUROPATHIC PAIN; FORMALIN TEST; ISOQUINOLINE ALKALOIDS; NUCLEUS-ACCUMBENS; SCIATIC-NERVE; RATS; MICE; STIMULATION	Corydalis yanhusuo. W.T. extracts (YHS) are widely used for the treatment of pain and inflammation. There are a few studies that assessed the effects of YHS in pain assays; however, none of these studies has systematically compared its activities in the different pain animal modes namely: acute, inflammatory and chronic pain. Furthermore, little is known about the mechanism of YHS activity in these assays. The aim of this study was to systematically evaluate the antinociceptive properties of YHS by testing it in four standardized pain assays and to investigate its mechanism. YHS antinociceptive properties were analyzed in the tail flick, the formalin paw licking, the von Frey filament and the hot box assays after spinal nerve ligation, which monitors acute nociceptive, persistent inflammatory and chronic neuropathic pain, respectively. YHS pharmacological profile was determined by screening it against a battery of G-protein coupled receptors and its mechanism of action was studied using knock-out mice. Our study shows that YHS, at a non-sedative dose, increases the tail flick latency in the tail flick assay without resulting in development of tolerance. YHS also decreases paw licking time in the formalin assay. Further, YHS increases paw withdraw threshold and latency in the von Frey filament and the hot box assays, respectively. In vitro, YHS exhibits prominent dopamine receptor antagonistic properties. In dopamine D2 receptor knockout mice, its antinociceptive effects are attenuated in acute and neuropathic pain but not inflammatory pain assays. Our results therefore indicate that YHS effectively attenuates acute, inflammatory and neuropathic pain, without causing tolerance. The effects on acute and neuropathic pain, but not inflammatory pain, are at least partially mediated through dopamine D2 receptor antagonism. Since YHS is a dietary supplement commercially available in the United States, our data suggest that it might be a candidate for alternative pain treatment.	[Wang, Lien; Zhang, Yan; Wang, Zhiwei; Chung, Jae Yoon; Alachkar, Amal; Civelli, Olivier] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Gong, Nian; Kweon, Tae Dong; Vo, Benjamin; Luo, David Z.] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA; [Wang, Chaoran; Zhang, Xiuli; Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Liaoning, Peoples R China; [Civelli, Olivier] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Civelli, Olivier] Univ Calif Irvine, Dev & Cell Biol, Irvine, CA 92617 USA; [Zhang, Yan] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Chung, Jae Yoon] Wonkwang Univ, Dept Anesthesiol & Pain Med, Sanbon Hosp, Gunpo, Gyeonggi, South Korea	University of California System; University of California Irvine; University of California System; University of California Irvine; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of California System; University of California Irvine; University of California System; University of California Irvine; Shanghai Jiao Tong University; Wonkwang University	Civelli, O (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.; Civelli, O (corresponding author), Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA.; Civelli, O (corresponding author), Univ Calif Irvine, Dev & Cell Biol, Irvine, CA 92617 USA.	ocivelli@uci.edu	Civelli, Olivier/A-8392-2012		National Institutes of Health grant [DA024746]; Center for Autism Research and Translation (CART); William & Nancy Thompson Family Foundation; Key Program of National Natural Science Foundation of China [21135005, 81402806]; Major Project of National High Technology Research and Development Program of China [2012AA020203]	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Autism Research and Translation (CART); William & Nancy Thompson Family Foundation; Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Institutes of Health grant DA024746 and Eric L. and Lila D. Nelson Chair in Neuropharmacology awared to OC. This work is also supported by the Center for Autism Research and Translation (CART), which is supported by the William & Nancy Thompson Family Foundation. The recipient is OC. This work was also supported by the Key Program of National Natural Science Foundation of China 21135005 awarded to XL and 81402806 awarded to YZ and the Major Project of National High Technology Research and Development Program of China 2012AA020203 awarded to XL.	Almanza A, 2015, PHARMACOL BIOCHEM BE, V137, P119, DOI 10.1016/j.pbb.2015.08.013; Ansah OB, 2007, EXP NEUROL, V205, P536, DOI 10.1016/j.expneurol.2007.03.010; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BARASI S, 1985, EUR J PHARMACOL, V117, P287, DOI 10.1016/0014-2999(85)90001-9; Cherny N, 2001, J CLIN ONCOL, V19, P2542, DOI 10.1200/JCO.2001.19.9.2542; Chinese Pharmacopoeia Commission, 2015, PHARM PEOPL REP CHIN; Choi JG, 2012, KOREAN J PHYSIOL PHA, V16, P387, DOI 10.4196/kjpp.2012.16.6.387; Cobacho N, 2014, BRAIN RES BULL, V106, P62, DOI 10.1016/j.brainresbull.2014.06.003; Crofford LJ, 2010, NAT REV RHEUMATOL, V6, P191, DOI 10.1038/nrrheum.2010.24; Dang YH, 2011, EUR J PHARMACOL, V657, P97, DOI 10.1016/j.ejphar.2011.01.064; Ding B, 2007, J PHARMACEUT BIOMED, V45, P219, DOI 10.1016/j.jpba.2007.06.009; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; Gao X, 2001, EUR J PHARMACOL, V418, P73, DOI 10.1016/S0014-2999(01)00930-X; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hu JY, 1999, ACTA PHARMACOL SIN, V20, P715; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Kim HJ, 2015, J MED FOOD, V18, P909, DOI 10.1089/jmf.2014.3346; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kim SO, 2013, J MED FOOD, V16, P511, DOI 10.1089/jmf.2012.2648; Kupeli E, 2002, LIFE SCI, V72, P645, DOI 10.1016/S0024-3205(02)02200-2; LIU QS, 1992, LIFE SCI, V51, P1485; Liu XH, 2010, ARCH PHARM RES, V33, P981, DOI 10.1007/s12272-010-0702-7; Lu Ziming, 2012, Zhongguo Zhong Yao Za Zhi, V37, P235; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma ZZ, 2008, MOLECULES, V13, P2303, DOI 10.3390/molecules13092303; MAGNUSSON O, 1986, NEUROPHARMACOLOGY, V25, P187, DOI 10.1016/0028-3908(86)90040-7; Mansikka H, 2005, BRAIN RES, V1052, P82, DOI 10.1016/j.brainres.2005.06.021; Moradi M, 2015, BEHAV BRAIN RES, V292, P508, DOI 10.1016/j.bbr.2015.07.007; Moulin DE, 2014, PAIN RES MANAG, V19, P328; Nagasaki H, 2009, EUR J PHARMACOL, V602, P194, DOI 10.1016/j.ejphar.2008.10.068; Nishiyama Y, 2010, J NAT MED-TOKYO, V64, P9, DOI 10.1007/s11418-009-0356-2; Pasquinucci L, 2012, LIFE SCI, V90, P66, DOI 10.1016/j.lfs.2011.10.024; Qiu ZhiChun, 2009, Progress in Modern Biomedicine, V9, P4518; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Stein C, 2003, NAT MED, V9, P1003, DOI 10.1038/nm908; Taylor BK, 2003, BRAIN RES, V987, P135, DOI 10.1016/S0006-8993(03)03318-3; Viisanen H, 2012, BRAIN RES BULL, V89, P133, DOI 10.1016/j.brainresbull.2012.08.002; Wang C, 2010, ANAL BIOANAL CHEM, V396, P1731, DOI 10.1007/s00216-009-3409-1; Weizman T, 2003, EUR J PHARMACOL, V478, P155, DOI 10.1016/j.ejphar.2003.08.049; Wood Patrick B, 2008, Expert Rev Neurother, V8, P781, DOI 10.1586/14737175.8.5.781; Wu HW, 2014, MOLECULES, V19, P11487, DOI 10.3390/molecules190811487; [张先洪 ZHANG Xian-hong], 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P449; Zhang Y, 2014, CURR BIOL, V24, P117, DOI 10.1016/j.cub.2013.11.039; Zhang Y, 2012, NEUROCHEM RES, V37, P410, DOI 10.1007/s11064-011-0627-7	47	34	37	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162875	10.1371/journal.pone.0162875	http://dx.doi.org/10.1371/journal.pone.0162875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622550	Green Published, gold			2022-12-26	WOS:000383681000065
J	Lee, K; Goh, GYS; Wong, MA; Klassen, TL; Taubert, S				Lee, Kayoung; Goh, Grace Ying Shyen; Wong, Marcus Andrew; Klassen, Tara Leah; Taubert, Stefan			Gain-of-Function Alleles in Caenorhabditis elegans Nuclear Hormone Receptor nhr-49 Are Functionally Distinct	PLOS ONE			English	Article							C. ELEGANS; MEDIATOR SUBUNIT; BILE-ACID; LIGAND; POLYKETIDES; HNF4-ALPHA; METABOLISM; LONGEVITY; COMPLEX; BINDING	Nuclear hormone receptors (NHRs) are transcription factors that regulate numerous physiological and developmental processes and represent important drug targets. NHR-49, an ortholog of Hepatocyte Nuclear Factor 4 (HNF4), has emerged as a key regulator of lipid metabolism and life span in the nematode worm Caenorhabditis elegans. However, many aspects of NHR-49 function remain poorly understood, including whether and how it regulates individual sets of target genes and whether its activity is modulated by a ligand. A recent study identified three gain-of-function (gof) missen semutations in nhr-49 (nhr-49(et7), nhr-49 (et8), and nhr-49(et13), respectively). These substitutions all affect the ligand-binding domain (LBD), which is critical for ligand binding and protein interactions. Thus, these alleles provide an opportunity to test how three specific residues contribute to NHR-49 dependent gene regulation. We used computational and molecular methods to delineate how the semutations alter NHR-49 activity. We find that despite originating from a screen favoring the activation of specific NHR-49 targets, all three gof alleles cause broad upregulation of NHR-49 regulated genes. Interestingly, nhr-49(et7) and nhr-49(et8) exclusively affect nhr-49 dependent activation, whereas the nhr-49(et13) surprisingly affects both nhr-49 mediated activation and repression, implicating the affected residue as dually important. We also observed phenotypic non-equivalence of these alleles, as they unexpectedly caused a long, short, and normal life span, respectively. Mechanistically, the gof substitutions altered neither protein interactions with the repressive partner NHR-66 and the coactivator MDT-15 nor the subcellular localization or expression of NHR-49. However, in silico structural modeling revealed that NHR-49 likely interacts with small molecule ligands and that the missensemutations might alter ligand binding, providing a possible explanation for increased NHR-49 activity. In sum, our findings indicate that the three nhr-49 gof alleles are non-equivalent, and highlight the conserved V411 residue affected by et13 as critical for gene activation and repression alike.	[Lee, Kayoung; Taubert, Stefan] Univ British Columbia, Grad Program Med Genet, Vancouver, BC, Canada; [Lee, Kayoung; Goh, Grace Ying Shyen; Wong, Marcus Andrew; Taubert, Stefan] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [Lee, Kayoung; Goh, Grace Ying Shyen; Wong, Marcus Andrew; Taubert, Stefan] Univ British Columbia, Child & Family Res Inst, Vancouver, BC, Canada; [Goh, Grace Ying Shyen; Taubert, Stefan] Univ British Columbia, Grad Program Cell & Dev Biol, Vancouver, BC, Canada; [Klassen, Tara Leah] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Taubert, Stefan] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Taubert, S (corresponding author), Univ British Columbia, Grad Program Med Genet, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Child & Family Res Inst, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Grad Program Cell & Dev Biol, Vancouver, BC, Canada.; Taubert, S (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	taubert@cmmt.ubc.ca	Taubert, Stefan/A-8104-2015	Taubert, Stefan/0000-0002-2432-7257	Canadian Institute of Health Research (CIHR) [MOP-93713]; Natural Sciences and Engineering Council of Canada (NSERC) [RGPIN 386398-13]; Centre of Molecular Medicine and Therapeutics (CMMT); Canadian Foundation for Innovation (CFI); British Columbia Knowledge Development Fund (BCKDF) [CFI32952]; NSERC Alexander Graham Bell Canada Graduate Scholarships-Master's (CGS M) scholarship; Child and Family Research Institute (CFRI); CFRI summer studentship; Canada Research Chair; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre of Molecular Medicine and Therapeutics (CMMT); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); British Columbia Knowledge Development Fund (BCKDF); NSERC Alexander Graham Bell Canada Graduate Scholarships-Master's (CGS M) scholarship; Child and Family Research Institute (CFRI); CFRI summer studentship; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Canadian Institute of Health Research (CIHR; http://www.cihr-irsc.gc.ca/e/193.html; funding # MOP-93713 to ST), the Natural Sciences and Engineering Council of Canada (NSERC; http://www.nserc-crsng.gc.ca; funding # RGPIN 386398-13 to ST), the Centre of Molecular Medicine and Therapeutics (CMMT; http://www.cmmt.ubc.ca), and the Canadian Foundation for Innovation (CFI) and the British Columbia Knowledge Development Fund (BCKDF; computational modeling infrastructure to TLK, CFI32952). KL was supported by an NSERC Alexander Graham Bell Canada Graduate Scholarships-Master's (CGS M) scholarship, GYSG by a Child and Family Research Institute (CFRI; http://www.cfri.ca) graduate scholarship, MW by a CFRI summer studentship, and ST by a Canada Research Chair (http://www.chairschaires.gc.ca/home-accueil-eng.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all Taubert lab members for critical discussions, and Shirley Chen for help with experiments. We also thank Dr. Marc Pilon (University of Goteborg, Sweden) for the strains QC120, QC121, and QC126 and Dr. Arjumand Ghazi (University of Pittsburgh, PA, USA) for the pnhr-49::nhr-49::gfp plasmid. Some strains were provided by the CGC, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Antebi Adam, 2015, WormBook, P1, DOI 10.1895/wormbook.1.64.2; Arda HE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.23; Bourguet W, 2000, TRENDS PHARMACOL SCI, V21, P381, DOI 10.1016/S0165-6147(00)01548-0; Brelivet Y, 2004, EMBO REP, V5, P423, DOI 10.1038/sj.embor.7400119; BRENNER S, 1974, GENETICS, V77, P71; Chamoli M, 2014, AGING CELL; Chianese G, 2016, J ORG CHEM, V81, P5135, DOI 10.1021/acs.joc.6b00695; Chiang JYL, 2009, EXPERT OPIN DRUG MET, V5, P137, DOI [10.1517/17425250802707342 , 10.1517/17425250802707342]; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Festa C, 2013, MAR DRUGS, V11, P2314, DOI 10.3390/md11072314; Folick A, 2015, SCIENCE, V347, P83, DOI 10.1126/science.1258857; Goh GYS, 2014, AGING CELL, V13, P70, DOI 10.1111/acel.12154; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Heestand BN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003651; Hou NS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00143; Kaestner KH, 2010, HEPATOLOGY, V51, P376, DOI 10.1002/hep.23487; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lee D, 2005, J ANTIBIOT, V58, P615, DOI 10.1038/ja.2005.84; Liang B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009869; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Magner DB, 2013, CELL METAB, V18, P212, DOI 10.1016/j.cmet.2013.07.007; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mikolas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058462; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Noble T, 2013, CELL METAB, V18, P672, DOI 10.1016/j.cmet.2013.09.007; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Park D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002519; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Piskacek M, 2015, MOL BIOSYST, V11, P844, DOI 10.1039/c4mb00672k; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Ratnappan R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004829; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Ridderstrale M, 2009, MOL CELL ENDOCRINOL, V297, P10, DOI 10.1016/j.mce.2008.10.002; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Svensson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021343; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Taubert S, 2011, MOL CELL ENDOCRINOL, V334, P49, DOI 10.1016/j.mce.2010.04.021; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Van Gilst MR, 2005, P NATL ACAD SCI USA, P102; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xu WJ, 2015, J MOL GRAPH MODEL, V57, P76, DOI 10.1016/j.jmgm.2015.01.009; Yamagata K, 2014, VITAM HORM, V95, P407, DOI 10.1016/B978-0-12-800174-5.00016-8; Yamamoto KR, 1998, COLD SPRING HARB SYM, V63, P587, DOI 10.1101/sqb.1998.63.587; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	53	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162708	10.1371/journal.pone.0162708	http://dx.doi.org/10.1371/journal.pone.0162708			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618178	gold, Green Published, Green Submitted			2022-12-26	WOS:000383653100044
J	Rishi, P; Raka, N; Rishi, E				Rishi, Pukhraj; Raka, Neha; Rishi, Ekta			Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naive Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective, Interventional Case-Series	PLOS ONE			English	Article							ARTERY-OCCLUSION; OPTIC NEUROPATHY; INJECTION; MEMBRANE	Background To study potential ischemic effects of intravitreal Bevacizumab (IVB) on unaffected retina in treatment-naive eyes with macular edema secondary to branch retinal vein occlusion (BRVO) and contralateral eyes secondary to systemic absorption. Methods and Findings Prospective, interventional series included 27 treatment-naive eyes with BRVO and macular edema. Exclusion criteria: Eyes with diabetic retinopathy, glaucoma, vasculitides, papilledema or systemic neurologic condition. Subjects underwent complete ophthalmological examination including fluoroscein angiography (FA), optical coherence tomography (OCT) and multifocal electroretinogram (mf-ERG). All subjects received single 1.25 mg/0.05ml IVB injection. Two observers measured all parameters; inter-observer agreements were expressed as kappa values. Paired t-test was used to compare values at baseline and follow-up. The statistical analysis was done using SPSS for Windows, Version 14.0. (Chicago, SPSS Inc.) Presenting mean CFT (central foveal thickness) was 499.5(+/-229.7) mu m, mean BCVA (best corrected visual acuity) was 0.64(+/-0.41) logMAR. At last follow-up, mean CFT was 267.9(+/-159.3) mu m (P<0.001), 95% CI [127.18, 422.32]; mean BCVA was 0.28(+/-0.24) logMAR. Respectively, mean N1 and P1 amplitudes of mfERG in 'unaffected quadrant' at presentation were -6.10(+/-4.00) nV/deg(2) and 17.17(+/-11.54) nV/deg(2); and -5.33(+/-1.30) nV/deg(2) and 15.29(+/-4.69) nV/deg(2) at final follow-up (P = 0.631 and 0.197, respectively), (95% CIs [-0.93, 1.42] and [-4.22, 1.08] respectively). In fundus quadrant of fellow eyes corresponding to unaffected quadrant in treated eyes, mean N1 and P1 amplitudes at presentation were -5.39(+/-1.56) nV/deg(2) and 15.89(+/-3.89) nV/deg(2); and -5.39(+/-1.90) nV/deg(2) and 15.9(+/-5.52) nV/deg(2) (P = 0.380 and 0.208), (95% CIs [-0.57, 1.28] and [-4.1, 1.1]) at last follow-up, respectively. Limitations: This study analysed the effects with a single injection of bevacizumab. However, whether ischemic adverse effects will emerge with repeated IVB injections as a consequence of cumulative dosing needs further investigation. The setting of our study being a tertiarycare centre, the numbers of fresh BRVO cases without prior intervention were limited. Thus, the limitations of our study include a small sample size with a small follow-up period. No major ocular/systemic adverse event was observed in the study period. Conclusion No evidence of progressive ischaemia attributable to single bevacizumab treatment was observed in this study. However, a larger prospective study involving subjects with cumulative dosing of bevacizumab and a longer follow-up could provide a better understanding of the potential ischaemic effects of bevacizumab or other anti-VEGF agents.	[Rishi, Pukhraj; Raka, Neha; Rishi, Ekta] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India		Rishi, P (corresponding author), Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India.	docrishi@yahoo.co.in	Rishi, Pukhraj/AAZ-5296-2020					Ameri H, 2007, INVEST OPHTH VIS SCI, V48, P5708, DOI 10.1167/iovs.07-0731; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campbell RJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4203; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chen E, 2009, OPHTHAL SURG LAS IM, V40, P68, DOI 10.3928/15428877-20090101-04; Chu YK, 2013, RETINA-J RET VIT DIS, V33, P2110, DOI 10.1097/IAE.0b013e3182899205; D'Amore PA, 2007, AM J PATHOL, V171, P14, DOI 10.2353/ajpath.2007.070385; Ganssauge M, 2009, GRAEF ARCH CLIN EXP, V247, P1707, DOI 10.1007/s00417-009-1184-5; Goel Neha, 2011, International Ophthalmology, V31, P39, DOI 10.1007/s10792-010-9390-z; Hasegawa S, 2001, INVEST OPHTH VIS SCI, V42, P298; Hosseini H, 2009, J NEURO-OPHTHALMOL, V29, P160, DOI 10.1097/WNO.0b013e3181a58fd1; Hvarfner C, 2006, RETINA-J RET VIT DIS, V26, P292, DOI 10.1097/00006982-200603000-00007; Ikeda F, 2010, JPN J OPHTHALMOL, V54, P423, DOI 10.1007/s10384-010-0841-x; Ikeda Jun, 2004, Nippon Ganka Gakkai Zasshi, V108, P84; Isola V, 2013, CLIN OPHTHALMOL, V7, P455, DOI 10.2147/OPTH.S30156; Kim KS, 2008, ACTA OPHTHALMOL, V86, DOI 10.1111/j.1755-3768.2008.01175.x; Mathew R, 2010, CLIN OPHTHALMOL, V4, P1159, DOI 10.2147/OPTH.S13592; Ohshima A, 2001, JPN J OPHTHALMOL, V45, P516, DOI 10.1016/S0021-5155(01)00374-4; Pai SA, 2007, AM J OPHTHALMOL, V143, P601, DOI 10.1016/j.ajo.2006.12.037; PARODI MB, 1995, INT OPHTHALMOL, V19, P25, DOI 10.1007/BF00156415; Pece A, 2011, BRIT J OPHTHALMOL, V95, P56, DOI 10.1136/bjo.2009.174060; Pieramici Dante J, 2008, Ophthalmology, V115, pe47, DOI 10.1016/j.ophtha.2008.06.021; Rabena MD, 2007, RETINA-J RET VIT DIS, V27, P419, DOI 10.1097/IAE.0b013e318030e77e; Rouvas AA, 2008, GRAEFES ARCH CLIN EX, V247, P1707; Saxena Sandeep, 1997, Indian Journal of Ophthalmology, V45, P125; Wildberger H, 2002, KLIN MONATSBL AUGENH, V219, P254, DOI 10.1055/s-2002-30653; Yokoyama K, 2008, ACTA OPHTHALMOL, V86, P927, DOI 10.1111/j.1755-3768.2008.01187.x; 1991, OPHTHALMOLOGY S, V98, P807	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162533	10.1371/journal.pone.0162533	http://dx.doi.org/10.1371/journal.pone.0162533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618696	gold, Green Submitted, Green Published			2022-12-26	WOS:000383653100029
J	Younes, F; Halawi, G; Jabbour, H; El Osta, N; Karam, L; Hajj, A; Khabbaz, LR				Younes, Farah; Halawi, Ghinwa; Jabbour, Hicham; El Osta, Nada; Karam, Latife; Hajj, Aline; Khabbaz, Lydia Rabbaa			Internet Addiction and Relationships with Insomnia, Anxiety, Depression, Stress and Self-Esteemin University Students: A Cross-Sectional Designed Study	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; KOREAN ADOLESCENTS; SUICIDAL IDEATION; COLLEGE-STUDENTS; SEVERITY INDEX; SCALES DASS; DSM-V; SYMPTOMS; HEALTH; PERSONALITY	Background and Aims Internet addiction (IA) could be a major concern in university medical students aiming to develop into health professionals. The implications of this addiction as well as its association with sleep, mood disorders and self-esteem can hinder their studies, impact their long-termcareer goals and have wide and detrimental consequences for society as a whole. The objectives of this study were to: 1) Assess potential IA in university medical students, as well as factors associated with it; 2) Assess the relationships between potential IA, insomnia, depression, anxiety, stress and self-esteem. Methods Our study was a cross-sectional questionnaire-based survey conducted among 600 students of three faculties: medicine, dentistry and pharmacy at Saint-Joseph University. Four validated and reliable questionnaires were used: the Young Internet Addiction Test, the Insomnia Severity Index, the Depression Anxiety Stress Scales (DASS 21), and the Rosenberg Self Esteem Scale (RSES). Results The average YIAT score was 30 +/- 18.474; Potential IA prevalence rate was 16.8% (95% confidence interval: 13.81-19.79%) and it was significantly different between males and females (p-value = 0.003), with a higher prevalence in males (23.6% versus 13.9%). Significant correlations were found between potential IA and insomnia, stress, anxiety, depression and self-esteem (p-value < 0.001); ISI and DASS sub-scores were higher and self-esteem lower in students with potential IA. Conclusions Identifying students with potential IA is important because this addiction often coexists with other psychological problems. Therefore, interventions should include not only IA management but also associated psychosocial stressors such as insomnia, anxiety, depression, stress, and self-esteem.	[Younes, Farah; Halawi, Ghinwa; Karam, Latife; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Hotel Dieu France Hosp, Dept Anesthesia & Crit Care, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Fac Med, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Dept Publ Hlth, Fac Med, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Dept Prosthodont, Fac Med Dent, Beirut, Lebanon; [El Osta, Nada] Univ Auvergne, Clermont Univ, CROC EA4847, Ctr Rech Odontol Clin, BP 10448, F-63000 Clermont Ferrand, France; [Karam, Latife] St Joseph Univ Beirut, Hotel Dieu France Hosp, Dept Pharm, Beirut, Lebanon; [Younes, Farah; Karam, Latife; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Med, Beirut, Lebanon	Universite Clermont Auvergne (UCA)	Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon.; Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Med, Beirut, Lebanon.	lydia.khabbaz@usj.edu.lb	EL OSTA, Nada/GRS-4789-2022					Alpaslan AH, 2015, PSYCHIAT RES, V226, P224, DOI 10.1016/j.psychres.2014.12.052; An J, 2014, J ADDICT MED, V8, P282, DOI 10.1097/ADM.0000000000000026; [Anonymous], 2016, SOCIAL NETWORKING RE; Bernardi S, 2009, COMPR PSYCHIAT, V50, P510, DOI 10.1016/j.comppsych.2008.11.011; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Bremer J, 2005, CHILD ADOL PSYCH CL, V14, P405, DOI 10.1016/j.chc.2005.02.003; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Carli V, 2013, PSYCHOPATHOLOGY, V46, P1, DOI 10.1159/000337971; Cho YW, 2014, J CLIN NEUROL, V10, P210, DOI 10.3988/jcn.2014.10.3.210; Choueiry N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149643; Christakis DA, 2009, ARCH PEDIAT ADOL MED, V163, P959, DOI 10.1001/archpediatrics.2009.162; Creemers DHM, 2012, J BEHAV THER EXP PSY, V43, P638, DOI 10.1016/j.jbtep.2011.09.006; Dalbudak E, 2014, PSYCHIAT RES, V219, P577, DOI 10.1016/j.psychres.2014.02.032; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Durkee T, 2012, ADDICTION, V107, P2210, DOI 10.1111/j.1360-0443.2012.03946.x; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Fernandez-Villa T, 2015, ADICCIONES, V27, P265; Fischer A, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.365; Floros G, 2014, CYBERPSYCH BEH SOC N, V17, P672, DOI 10.1089/cyber.2014.0182; Floros G, 2014, ADDICT BEHAV, V39, P1839, DOI 10.1016/j.addbeh.2014.07.031; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Garaigordobil M, 2008, PSICOTHEMA, V20, P114; Gellis LA, 2014, BEHAV THER, V45, P806, DOI 10.1016/j.beth.2014.05.002; Holden C, 2010, SCIENCE, V327, P935, DOI 10.1126/science.327.5968.935; Internet World Stats, 2016, INT US WORLD DISTR W; Khazaal Y, 2008, CYBERPSYCHOL BEHAV, V11, P703, DOI 10.1089/cpb.2007.0249; Kim EJ, 2008, EUR PSYCHIAT, V23, P212, DOI 10.1016/j.eurpsy.2007.10.010; Kim JH, 2010, J ADOLESCENCE, V33, P215, DOI 10.1016/j.adolescence.2009.03.012; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Kraut R, 1998, AM PSYCHOL, V53, P1017, DOI 10.1037/0003-066X.53.9.1017; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lee HW, 2012, CYBERPSYCH BEH SOC N, V15, P373, DOI 10.1089/cyber.2012.0063; Lin IH, 2014, COMPR PSYCHIAT, V55, P504, DOI 10.1016/j.comppsych.2013.11.012; Liu TC, 2011, J CLIN PSYCHIAT, V72, P836, DOI 10.4088/JCP.10m06057; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Moksnes UK, 2012, SCAND J PSYCHOL, V53, P483, DOI 10.1111/sjop.12021; Naseri L, 2015, IRAN J PSYCHIATRY BE, V9, DOI 10.17795/ijpbs-421; Ni XL, 2009, CYBERPSYCHOL BEHAV, V12, P327, DOI 10.1089/cpb.2008.0321; Ortega-Montiel J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2112-8; Park SK, 2008, ADOLESCENCE, V43, P895; Pies Ronald, 2009, Psychiatry (Edgmont), V6, P31; Pujazon-Zazik M, 2010, AM J MENS HEALTH, V4, P77, DOI 10.1177/1557988309360819; ROSENBERG M, 1962, J PSYCHIAT RES, V1, P135, DOI 10.1016/0022-3956(62)90004-3; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Siomos KE, 2008, CYBERPSYCHOL BEHAV, V11, P653, DOI 10.1089/cpb.2008.0088; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Tavernier R, 2014, CHRONOBIOL INT, V31, P232, DOI 10.3109/07420528.2013.843541; Taylor R, 2005, CLIN J PAIN, V21, P91, DOI 10.1097/00002508-200501000-00011; Thomas SJ, 2014, BEHAV SLEEP MED, V12, P169, DOI 10.1080/15402002.2013.778202; Tsai CC, 2003, CYBERPSYCHOL BEHAV, V6, P649, DOI 10.1089/109493103322725432; van den Eijnden RJJM, 2010, J ABNORM CHILD PSYCH, V38, P77, DOI 10.1007/s10802-009-9347-8; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; White K, 2015, AM J MED SCI, V350, P290, DOI 10.1097/MAJ.0000000000000554; Widyanto L, 2011, CYBERPSYCH BEH SOC N, V14, P141, DOI 10.1089/cyber.2010.0151; Wildt BTT, 2007, PSYCHIAT PRAX, V34, pS318, DOI 10.1055/s-2007-970973; Young K, 1999, Cyberpsychol Behav, V2, P475, DOI 10.1089/cpb.1999.2.475; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K. S, 1998, CAUGHT NET RECOGNIZE; Young KS, 2004, CYBERPSYCHOL BEHAV, V7, P105, DOI 10.1089/109493104322820174; Young KS, 1996, PSYCHOL REP, V79, P899, DOI 10.2466/pr0.1996.79.3.899	62	167	168	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161126	10.1371/journal.pone.0161126	http://dx.doi.org/10.1371/journal.pone.0161126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618306	gold, Green Submitted, Green Published			2022-12-26	WOS:000383653100005
J	Liu, T; Xiong, J; Yi, S; Zhang, H; Zhou, S; Gu, L; Zhou, M				Liu, T.; Xiong, J.; Yi, S.; Zhang, H.; Zhou, S.; Gu, L.; Zhou, M.			FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2	ONCOGENE			English	Article							UBIQUITIN-PROTEIN LIGASE; P53 TUMOR-SUPPRESSOR; FK506-BINDING PROTEINS; PROLYL ISOMERASE; DEGRADATION; PROMOTES; TRANSACTIVATION; STABILIZATION; IMMUNOPHILIN; EXPRESSION	The FK506-binding protein 12 (FKBP12) is a cytoplasmic protein and has been reported to possess multiple functions in signaling transduction based on its interaction with different cellular targets. Here, we report that FKBP12 interacts with oncoprotein MDM2 and induces MDM2 degradation. We demonstrate that FKBP12 degrades MDM2 through binding to MDM2 protein, disrupting MDM2/MDM4 interaction and inducing MDM2 self-ubiquitination. The FKBP12-mediated MDM2 degradation was significantly enhanced when the transfected MDM2 was localized in the cytoplasm. The endogenous MDM2, when it was induced by p53 subjecting to DNA-damaging stimuli such as treatment with doxorubicin, was also significantly inhibited by FKBP12. This is due to translocation of p53-induced MDM2 from the nucleus to the cytoplasm, which facilitates interaction with cytoplasmic FKBP12. Furthermore, the enhanced level of MDM2 following p53 activation in nutlin-3 treated cells was also inhibited by FKBP12. The FKBP12-mediated downregulation of MDM2 in response to doxorubicin or nutlin-3 results in continuing and constitutive activation of p53, inhibition of XIAP and sensitization of cancer cells to apoptosis. These results identify a novel function for FKBP12 in downregulating MDM2, which directly enhances sensitivity of cancer cells to chemotherapy and nutlin-3 treatment.	[Liu, T.; Yi, S.; Zhang, H.; Gu, L.; Zhou, M.] Emory Univ, Sch Med, Dept Pediat, Div Hematol Oncol,Aflac Canc Ctr & Blood Disorder, 1760 Haygood Dr, Atlanta, GA 30322 USA; [Xiong, J.; Zhou, S.] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Inst Pathol, Wuhan, Peoples R China	Emory University; Huazhong University of Science & Technology	Gu, L; Zhou, M (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Hematol Oncol,Aflac Canc Ctr & Blood Disorder, 1760 Haygood Dr, Atlanta, GA 30322 USA.	lbgu@emory.edu; mzhou@emory.edu			R01 grants [CA180519, CA123490, CA143107]; Hyundai Hope on Wheels [79387GA]; CURE; National Natural Science Foundation of China [81472488]; NATIONAL CANCER INSTITUTE [R01CA123490, R01CA143107, R01CA180519] Funding Source: NIH RePORTER	R01 grants; Hyundai Hope on Wheels; CURE; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01 grants (CA180519, CA123490 and CA143107) to MZ; the Scholar award (79387GA) from Hyundai Hope on Wheels to MZ; research grants from CURE to MZ and LG; and a National Natural Science Foundation of China grant (No. 81472488) to SZ.	BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; BUESORAMOS CE, 1993, BLOOD, V82, P2617; Cheng QA, 2011, CELL CYCLE, V10, P1162, DOI 10.4161/cc.10.7.15249; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Gudavicius G, 2014, RNA, V20, P1014, DOI 10.1261/rna.042648.113; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; JUVEN T, 1993, ONCOGENE, V8, P3411; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Linares LK, 2003, FEBS LETT, V554, P73, DOI 10.1016/S0014-5793(03)01108-6; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu T, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0334-0; Mathea S, 2011, BIOCHEMISTRY-US, V50, P10844, DOI 10.1021/bi2013855; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meek DW, 2003, MOL CANCER RES, V1, P1017; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Ochocka AM, 2009, FEBS LETT, V583, P621, DOI 10.1016/j.febslet.2009.01.009; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Schreiber KH, 2015, AGING CELL, V14, P265, DOI 10.1111/acel.12313; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Somarelli JA, 2008, PROTEINS, V72, P197, DOI 10.1002/prot.21908; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	36	18	18	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1678	1686		10.1038/onc.2016.331	http://dx.doi.org/10.1038/onc.2016.331			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27617579	Green Published, hybrid			2022-12-26	WOS:000397460600007
J	Yu, RR; Liu, WM; Li, DQ; Zhao, XM; Ding, GW; Zhang, M; Ma, E; Zhu, K; Li, S; Moussian, B; Zhang, JZ				Yu, Rongrong; Liu, Weimin; Li, Daqi; Zhao, Xiaoming; Ding, Guowei; Zhang, Min; Ma, Enbo; Zhu, KunYan; Li, Sheng; Moussian, Bernard; Zhang, Jianzhen			Helicoidal Organization of Chitin in the Cuticle of the Migratory Locust Requires the Function of the Chitin Deacetylase2 Enzyme (LmCDA2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERITROPHIC MATRIX; DROSOPHILA-MELANOGASTER; PROTEINS; EXPRESSION; BINDING	In the three-dimensional extracellular matrix of the insect cuticle, horizontally aligned microfibrils composed of the polysaccharide chitin and associated proteins are stacked either parallel to each other or helicoidally. The underlying molecular mechanisms that implement differential chitin organization are largely unknown. To learn more about cuticle organization, we sought to study the role of chitin deacetylases (CDA) in this process. In the body cuticle of nymphs of the migratory locust Locusta migratoria, helicoidal chitin organization is changed to an organization with unidirectional microfibril orientation when LmCDA2 expression is knocked down by RNA interference. In addition, the buCDA2-deficient cuticle is less compact suggesting that LmCDA2 is needed for chitin packaging. Animals with reduced LmCDA2 activity die at molting, underlining that correct chitin organization is essential for survival. Interestingly, we find that LmCDA2 localizes only to the initially produced chitin microfibrils that constitute the apical site of the chitin stack. Based on our data, we hypothesize that LmCDA2-mediated chitin deacetylation at the beginning of chitin production is a decisive reaction that triggers helicoidal arrangement of subsequently assembled chitin-protein microfibrils.	[Yu, Rongrong; Liu, Weimin; Li, Daqi; Zhao, Xiaoming; Ding, Guowei; Zhang, Min; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China; [Yu, Rongrong; Liu, Weimin; Li, Daqi; Zhao, Xiaoming; Ding, Guowei; Zhang, Min; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China; [Zhu, KunYan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA; [Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, ThelKey Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Moussian, Bernard] Tech Univ Dresden, Chair Appl Zool, Inst Zool, D-01217 Dresden, Germany	Shanxi University; Shanxi University; Kansas State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Technische Universitat Dresden	Zhang, JZ (corresponding author), Shanxi Univ, Res Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China.; Zhang, JZ (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China.; Moussian, B (corresponding author), Univ Nice, Inst Biol Valrose, Nice, France.	bernard.moussian@tu-dresden.de; zjz@sxu.edu.cn	zhao, xiaoming/GNM-5551-2022	Zhao, Xiaoming/0000-0003-2237-3417; Zhu, Kun Yan/0000-0001-9372-8030	National Natural Science Foundation of China [31272380, 31672364]; National Basic Research Program of China [2012CB114102]; Natural Science Foundation of Shanxi Province, China [2015011070]; Shanxi Scholarship Council of China [2015-007]; German Science Foundation (DFG) [MO1714/7-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Shanxi Province, China(Natural Science Foundation of Shanxi Province); Shanxi Scholarship Council of China; German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by National Natural Science Foundation of China Grants 31272380 and 31672364, National Basic Research Program of China Grant 2012CB114102, Natural Science Foundation of Shanxi Province, China, Grant 2015011070, and Shanxi Scholarship Council of China Grant 2015-007. The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by German Science Foundation (DFG) Grant MO1714/7-1. To whom correspondence may be addressed: Institute of Biology Valrose, University of Nice, Nice, France. E-mail: bernard.moussian@tu-dresden.de.	Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; BOULIGAND Y, 1965, CR HEBD ACAD SCI, V261, P4864; Campbell PM, 2008, INSECT BIOCHEM MOLEC, V38, P950, DOI 10.1016/j.ibmb.2008.07.009; Chen Yong-Lin, 2000, Entomological Knowledge, V37, P50; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Gangishetti U, 2012, INSECT MOL BIOL, V21, P283, DOI 10.1111/j.1365-2583.2012.01134.x; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; Guo YQ, 2012, INSECT SCI, V19, P75, DOI 10.1111/j.1744-7917.2011.01450.x; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Liu WM, 2009, J INVERTEBR PATHOL, V101, P96, DOI 10.1016/j.jip.2009.03.002; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Moussian B, 2010, INSECT BIOCHEM MOLEC, V40, P363, DOI 10.1016/j.ibmb.2010.03.003; NEVILLE A C, 1969, Tissue and Cell, V1, P183, DOI 10.1016/S0040-8166(69)80011-X; NEVILLE A C, 1969, Tissue and Cell, V1, P689, DOI 10.1016/S0040-8166(69)80041-8; Neville A. C., 1975, BIOL ARTHROPOD CUTIC, P71; NEVILLE AC, 1965, Q J MICROSC SCI, V106, P315; NEVILLE AC, 1965, Q J MICROSC SCI, V106, P269; Noh MY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004963; Noh MY, 2014, INSECT BIOCHEM MOLEC, V53, P22, DOI 10.1016/j.ibmb.2014.07.005; Quan GX, 2013, INSECT BIOCHEM MOLEC, V43, P683, DOI 10.1016/j.ibmb.2013.04.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toprak U, 2008, INSECT MOL BIOL, V17, P573, DOI 10.1111/j.1365-2583.2008.00829.x; Toprak U, 2010, INSECT MOL BIOL, V19, P163, DOI 10.1111/j.1365-2583.2009.00966.x; Toprak U, 2014, INSECT BIOCHEM MOLEC, V54, P89, DOI 10.1016/j.ibmb.2014.09.002; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wang YW, 2014, APIDOLOGIE, V45, P733, DOI 10.1007/s13592-014-0292-3; Yang M.L., 2009, Archives of Insect Biochemistry and Physiology, V71, P3, DOI 10.1002/arch.20254; Zhang JZ, 2006, INSECT BIOCHEM MOLEC, V36, P712, DOI 10.1016/j.ibmb.2006.06.002; Zhang JZ, 2010, INSECT BIOCHEM MOLEC, V40, P824, DOI 10.1016/j.ibmb.2010.08.001; Zhong XW, 2014, INT J MOL SCI, V15, P1946, DOI 10.3390/ijms15021946; Zhu Q, 2008, INSECT BIOCHEM MOLEC, V38, P467, DOI 10.1016/j.ibmb.2007.06.011	36	51	63	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24352	24363		10.1074/jbc.M116.720581	http://dx.doi.org/10.1074/jbc.M116.720581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27637332	Green Published, hybrid			2022-12-26	WOS:000388875500003
J	Sehanobish, E; Williamson, HR; Davidson, VL				Sehanobish, Esha; Williamson, Heather R.; Davidson, Victor L.			Roles of Conserved Residues of the Glycine Oxidase GoxA in Controlling Activity, Cooperativity, Subunit Composition, and Cysteine Tryptophylquinone Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-EPSILON-OXIDASE; MARINOMONAS-MEDITERRANEA; METHYLAMINE DEHYDROGENASE; AMINE DEHYDROGENASE; STEADY-STATE; LODA; QUINOPROTEINS; COFACTORS; GENES	GoxA is a glycine oxidase that possesses a cysteine tryptophylquinone (CTQ) cofactor that is formed by posttranslational modifications that are catalyzed by a modifying enzyme GoxB. It is the second known tryptophylquinone enzyme to function as an oxidase, the other being the lysine epsilon-oxidase, LodA. All other enzymes containing CTQ or tryptophan tryptophylquinone (TTQ) cofactors are dehydrogenases. Kinetic analysis of GoxA revealed allosteric cooperativity for its glycine substrate, but not O-2. This is the first CTQ-or TTQ-dependent enzyme to exhibit cooperativity. Here, we show that cooperativity and homodimer stabilization are strongly dependent on the presence of Phe-237. Conversion of this residue, which is a Tyr in LodA, to Tyr or Ala eliminates the cooperativity and destabilizes the dimer. These mutations also significantly affect the k(cat) and K-m values for the substrates. On the basis of structural and modeling studies, a mechanism by which Phe-237 exerts this influence is presented. Two active site residues, Asp-547 and His-466, were also examined and shown by site-directed mutagenesis to be critical for CTQbiogenesis. This result is compared with the results of similar studies of mutagenesis of structurally conserved residues of other tryptophylquinone enzymes. These results provide insight into the roles of specific active-site residues in catalysis and CTQ biogenesis, as well as describing an interesting mechanism by which a single residue can dictate whether or not an enzyme exhibits cooperative allosteric behavior toward a substrate.	[Sehanobish, Esha; Williamson, Heather R.; Davidson, Victor L.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Davidson, VL (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	victor.davidson@ucf.edu		Williamson, Heather/0000-0002-2413-659X	Burnett School of Biomedical Sciences; NIGMS, National Institutes of Health [R37GM41574]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041574] Funding Source: NIH RePORTER	Burnett School of Biomedical Sciences; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by internal funds from the Burnett School of Biomedical Sciences and in part by the NIGMS, National Institutes of Health Grant R37GM41574 (to V. L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Campillo-Brocal JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1455-y; Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511; Campillo-Brocal JC, 2013, MICROBIOLOGYOPEN, V2, P684, DOI 10.1002/mbo3.107; Datta S, 2001, P NATL ACAD SCI USA, V98, P14268, DOI 10.1073/pnas.241429098; Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t; Davidson VL, 2011, MOL BIOSYST, V7, P29, DOI 10.1039/c005311b; Chacon-Verdu MD, 2015, BBA-PROTEINS PROTEOM, V1854, P1123, DOI 10.1016/j.bbapap.2014.12.018; Chacon-Verdu MD, 2014, APPL MICROBIOL BIOT, V98, P2981, DOI 10.1007/s00253-013-5168-3; Gomez D, 2006, BBA-PROTEINS PROTEOM, V1764, P1577, DOI 10.1016/j.bbapap.2006.08.014; Gomez D, 2010, MOL MICROBIOL, V75, P462, DOI 10.1111/j.1365-2958.2009.07000.x; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Hossain GS, 2014, APPL MICROBIOL BIOT, V98, P1507, DOI 10.1007/s00253-013-5444-2; Jones LH, 2005, J BIOL CHEM, V280, P17392, DOI 10.1074/jbc.M500943200; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; Mai-Prochnow A, 2008, J BACTERIOL, V190, P5493, DOI 10.1128/JB.00549-08; Okazaki S, 2013, J BIOCHEM, V154, P233, DOI 10.1093/jb/mvt070; PAZ MA, 1991, J BIOL CHEM, V266, P689; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Roujeinikova A, 2006, J BIOL CHEM, V281, P40264, DOI 10.1074/jbc.M605559200; Sehanobish E, 2016, BIOCHEMISTRY-US, V55, P2305, DOI 10.1021/acs.biochem.6b00274; Sehanobish E, 2015, ARCH BIOCHEM BIOPHYS, V579, P26, DOI 10.1016/j.abb.2015.05.013; Sehanobish E, 2014, FEBS LETT, V588, P752, DOI 10.1016/j.febslet.2014.01.021; WALSH K, 1984, J BIOL CHEM, V259, P9646	24	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23199	23207		10.1074/jbc.M116.741835	http://dx.doi.org/10.1074/jbc.M116.741835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637328	Green Published, hybrid			2022-12-26	WOS:000387224800029
J	Choo, JM; Cheung, JK; Wisniewski, JA; Steer, DL; Bulach, DM; Hiscox, TJ; Chakravorty, A; Smith, AI; Gell, DA; Rood, JI; Awad, MM				Choo, Jocelyn M.; Cheung, Jackie K.; Wisniewski, Jessica A.; Steer, David L.; Bulach, Dieter M.; Hiscox, Thomas J.; Chakravorty, Anjana; Smith, A. Ian; Gell, David A.; Rood, Julian I.; Awad, Milena M.			The NEAT Domain-Containing Proteins of Clostridium perfringens Bind Heme	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; DETERMINANT ISD PROTEINS; GRAM-POSITIVE BACTERIA; MEDIATED GAS-GANGRENE; GROUP-A STREPTOCOCCUS; STAPHYLOCOCCUS-AUREUS; LISTERIA-MONOCYTOGENES; BACILLUS-ANTHRACIS; IRON ACQUISITION; HEMOGLOBIN RECEPTOR	The ability of a pathogenic bacterium to scavenge iron from its host is important for its growth and survival during an infection. Our studies on C. perfringens gas gangrene strain JIR325, a derivative of strain 13, showed that it is capable of utilizing both human hemoglobin and ferric chloride, but not human holo-transferrin, as an iron source for in vitro growth. Analysis of the C. perfringens strain 13 genome sequence identified a putative heme acquisition system encoded by an iron-regulated surface gene region that we have named the Cht (Clostridium perfringens heme transport) locus. This locus comprises eight genes that are co-transcribed and includes genes that encode NEAT domain-containing proteins (ChtD and ChtE) and a putative sortase (Srt). The ChtD, ChtE and Srt proteins were shown to be expressed in JIR325 cells grown under iron-limited conditions and were localized to the cell envelope. Moreover, the NEAT proteins, ChtD and ChtE, were found to bind heme. Both chtDE and srt mutants were constructed, but these mutants were not defective in hemoglobin or ferric chloride utilization. They were, however, attenuated for virulence when tested in a mouse myonecrosis model, although the virulence phenotype could not be restored via complementation and, as is common with such systems, secondary mutations were identified in these strains. In summary, this study provides evidence for the functional redundancies that occur in the heme transport pathways of this life threatening pathogen.	[Choo, Jocelyn M.; Cheung, Jackie K.; Wisniewski, Jessica A.; Hiscox, Thomas J.; Chakravorty, Anjana; Rood, Julian I.; Awad, Milena M.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Choo, Jocelyn M.; Cheung, Jackie K.; Wisniewski, Jessica A.; Hiscox, Thomas J.; Chakravorty, Anjana; Rood, Julian I.; Awad, Milena M.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Steer, David L.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Bulach, Dieter M.; Smith, A. Ian] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia; [Gell, David A.] Univ Tasmania, Sch Med, Hobart, Tas 7000, Australia	Monash University; Monash University; Monash University; Monash University; University of Tasmania	Awad, MM (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Awad, MM (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	milena.awad@monash.edu	Bulach, Dieter M/D-5793-2011; Rood, Julian I/A-4858-2008	Bulach, Dieter M/0000-0001-9823-6078; Rood, Julian I/0000-0003-2126-7209; Awad, Milena/0000-0002-9275-3979; Hiscox, Thomas/0000-0003-2182-2874	Australian National Health and Medical Research Council [GNT1005991]; Monash Graduate Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Graduate Scholarship(Monash University)	This work was supported by the Australian National Health and Medical Research Council (Project Grant GNT1005991) (https://www.nhmrc.gov.au/). Jocelyn M. Choo was the recipient of a Monash Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.We acknowledge the Australian National Health and Medical Research Council for supporting this work (Project Grant GNT1005991). Jocelyn M. Choo was the recipient of a Monash Graduate Scholarship.	Ahn SH, 2005, INFECT IMMUN, V73, P722, DOI 10.1128/IAI.73.2.722-729.2005; Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Andrade MA, 2002, GENOME BIOL, V3; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Awad MM, 2016, ANAEROBE, V41, P10, DOI 10.1016/j.anaerobe.2016.05.005; AWAD MM, 1995, MOL MICROBIOL, V15, P191, DOI 10.1111/j.1365-2958.1995.tb02234.x; Awad MM, 2001, INFECT IMMUN, V69, P7904, DOI 10.1128/IAI.69.12.7904-7910.2001; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brown JS, 2002, INFECT IMMUN, V70, P4389, DOI 10.1128/IAI.70.8.4389-4398.2002; Cabrera G, 2001, APPL ENVIRON MICROB, V67, P1001, DOI 10.1128/AEM.67.2.1001-1003.2001; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dumas Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1055; Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190; Eichenbaum Z, 1996, INFECT IMMUN, V64, P5428, DOI 10.1128/IAI.64.12.5428-5429.1996; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Fisher M, 2008, INFECT IMMUN, V76, P5006, DOI 10.1128/IAI.00300-08; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hassan S, 2010, J MICROBIOL, V48, P96, DOI 10.1007/s12275-009-0384-3; HEBBEL RP, 1988, AM J HEMATOL, V29, P222, DOI 10.1002/ajh.2830290409; Honsa ES, 2013, J BIOL CHEM, V288, P8479, DOI 10.1074/jbc.M112.430009; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Hughes ML, 2007, J BACTERIOL, V189, P7531, DOI 10.1128/JB.00767-07; Hurd AF, 2012, FEMS MICROBIOL LETT, V329, P93, DOI 10.1111/j.1574-6968.2012.02502.x; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Jin B, 2006, MOL MICROBIOL, V59, P1185, DOI 10.1111/j.1365-2958.2005.05015.x; Jonsson IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014209; Kennedy CL, 2009, MICROBES INFECT, V11, P413, DOI 10.1016/j.micinf.2009.01.002; Kim H, 2012, BIOCHEM BIOPH RES CO, V423, P733, DOI 10.1016/j.bbrc.2012.06.027; Kirillina O, 2006, INFECT IMMUN, V74, P6171, DOI 10.1128/IAI.00874-06; Kok M, 2003, MICROBIOL-SGM, V149, P2645, DOI 10.1099/mic.0.26406-0; LABRUDE P, 1984, CRYOBIOLOGY, V21, P33, DOI 10.1016/0011-2240(84)90020-8; LEE BC, 1992, J GEN MICROBIOL, V138, P2647, DOI 10.1099/00221287-138-12-2647; Lei BF, 2002, INFECT IMMUN, V70, P4494, DOI 10.1128/IAI.70.8.4494-4500.2002; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Merkley ED, 2012, J PROTEOME RES, V11, P6147, DOI 10.1021/pr3007914; Miller CE, 2009, MICROBIOL-SGM, V155, P3157, DOI 10.1099/mic.0.032425-0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morelle G, 1989, FOCUS, V11, P7; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Naikare H, 2006, INFECT IMMUN, V74, P5433, DOI 10.1128/IAI.00052-06; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pishchany G, 2013, JOVE-J VIS EXP, DOI 10.3791/50072; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; Ran YC, 2013, BIOCHEMISTRY-US, V52, P6537, DOI 10.1021/bi400965u; RODKEY FL, 1974, CLIN CHEM, V20, P83; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; ROOD JI, 1983, CAN J MICROBIOL, V29, P1241, DOI 10.1139/m83-193; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; SCOTT PT, 1989, GENE, V82, P327, DOI 10.1016/0378-1119(89)90059-0; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Suryadinata R, 2015, ACTA CRYSTALLOGR D, V71, P1505, DOI 10.1107/S1399004715009219; TAI SS, 1993, INFECT IMMUN, V61, P5401, DOI 10.1128/IAI.61.12.5401-5405.1993; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Velayudhan J, 2000, MOL MICROBIOL, V37, P274, DOI 10.1046/j.1365-2958.2000.01987.x; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wright JA, 2012, FEMS MICROBIOL LETT, V329, P177, DOI 10.1111/j.1574-6968.2012.02519.x; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	91	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162981	10.1371/journal.pone.0162981	http://dx.doi.org/10.1371/journal.pone.0162981			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637108	gold, Green Published			2022-12-26	WOS:000383723700022
J	Chanthavilay, P; Reinharz, D; Mayxay, M; Phongsavan, K; Marsden, DE; Moore, L; White, LJ				Chanthavilay, Phetsavanh; Reinharz, Daniel; Mayxay, Mayfong; Phongsavan, Keokedthong; Marsden, Donald E.; Moore, Lynne; White, Lisa J.			Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR	PLOS ONE			English	Article							COST-EFFECTIVENESS; VISUAL INSPECTION; ACETIC-ACID; NATURAL-HISTORY; DNA TEST; ACCURACY; TECHNOLOGIES; MANAGEMENT; DIAGNOSIS; CYTOLOGY	Background Several approaches to reduce the incidence of invasive cervical cancers exist. The approach adopted should take into account contextual factors that influence the cost-effectiveness of the available options. Objective To determine the cost-effectiveness of screening strategies combined with a vaccination program for 10-year old girls for cervical cancer prevention in Vientiane, Lao PDR. Methods A population-based dynamic compartment model was constructed. The interventions consisted of a 10-year old girl vaccination program only, or this program combined with screening strategies, i.e., visual inspection with acetic acid (VIA), cytology-based screening, rapid human papillomavirus (HPV) DNA testing, or combined VIA and cytology testing. Simulations were run over 100 years. In base-case scenario analyses, we assumed a 70% vaccination coverage with lifelong protection and a 50% screening coverage. The outcome of interest was the incremental cost per Disability-Adjusted Life Year (DALY) averted. Results In base-case scenarios, compared to the next best strategy, the model predicted that VIA screening of women aged 30-65 years old every three years, combined with vaccination, was the most attractive option, costing 2 544 international dollars (I$) per DALY averted. Meanwhile, rapid HPV DNA testing was predicted to be more attractive than cytology-based screening or its combination with VIA. Among cytology-based screening options, combined VIA with conventional cytology testing was predicted to be the most attractive option. Multi-way sensitivity analyses did not change the results. Compared to rapid HPV DNA testing, VIA had a probability of cost-effectiveness of 73%. Compared to the vaccination only option, the probability that a program consisting of screening women every five years would be cost-effective was around 60% and 80% if the willingness-to-pay threshold is fixed at one and three GDP per capita, respectively. Conclusions A VIA screening program in addition to a girl vaccination program was predicted to be the most attractive option in the health care context of Lao PDR. When compared with other screening methods, VIA was the primary recommended method for combination with vaccination in Lao PDR.	[Chanthavilay, Phetsavanh; Mayxay, Mayfong] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Chanthavilay, Phetsavanh; Reinharz, Daniel; Moore, Lynne] Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Reinharz, Daniel] Inst Francophonie Med Trop, Viangchan, Laos; [Mayxay, Mayfong] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos; [Mayxay, Mayfong; Marsden, Donald E.] Univ Oxford, Ctr Trop Med & Global Hlth, Churchill Hosp, Oxford, England; [Phongsavan, Keokedthong] Setthathirath Hosp, Gynecol Oncol Unit, Viangchan, Laos; [White, Lisa J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Fac Trop Med, Bangkok, Thailand; [White, Lisa J.] Univ Oxford, Nuffield Dept Med, Oxford, England	Laval University; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Chanthavilay, P (corresponding author), Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos.; Chanthavilay, P (corresponding author), Univ Laval, Fac Med, Dept Social & Prevent Med, Quebec City, PQ, Canada.	phetsavanh456@gmail.com		White, Lisa/0000-0002-6523-185X	Agence Universitaire de la Francophonie; Wellcome-Trust Major Oversees Programme in SE Asia [077166/Z/05/Z]; Global Health Research Capacity Strengthening Programme	Agence Universitaire de la Francophonie; Wellcome-Trust Major Oversees Programme in SE Asia; Global Health Research Capacity Strengthening Programme	Funding for PC was approved by the Agence Universitaire de la Francophonie, Global Health Research Capacity Strengthening Programme [http://www.pifrsm-ghrcaps.org/home.html]. Funding for LJW was provided by the Wellcome-Trust Major Oversees Programme in SE Asia (grant number 077166/Z/05/Z) [http://www.wellcome.ac.uk/Funding/Biomedical-science/Funded-projects/Major-initiatives/Major-Overseas-Programmes/index.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T., 2003, MAKING CHOICES HLTH; American College of Obstetricians and Gynecologists (ACOG), 2012, OBSTET GYNECOL, V120, P1222, DOI DOI 10.1097/AOG.0B013E318277C92A; [Anonymous], 1986, BMJ-BRIT MED J, V293, P659; [Anonymous], LIF TABL WHO MEM STA; [Anonymous], 2013, WORLD POP PROSP 2012; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Bank World, GDP PER CAP PPP CURR; Bosch FX, 2011, EXPERT OPIN PHARMACO, V12, P2189, DOI 10.1517/14656566.2011.596527; Briggs AH, 2012, MED DECIS MAKING, V32, P722, DOI 10.1177/0272989X12458348; Bruni L, 2019, ICO IARC INFORM CTR; Chanthavilay Phetsavanh, 2015, Asian Pac J Cancer Prev, V16, P5889; Chen CX, 2012, INT J GYNECOL CANCER, V22, P908, DOI 10.1097/IGC.0b013e318256e5e4; Gage JC, 2012, INT J CANCER, V131, P2903, DOI 10.1002/ijc.27563; Goldhaber-Fiebert Jeremy D, 2006, Cost Eff Resour Alloc, V4, P13, DOI 10.1186/1478-7547-4-13; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Gravitt PE, 2008, VACCINE, V26, pK42, DOI 10.1016/j.vaccine.2008.05.002; Guerrero AM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2046-1; Insinga RP, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-119; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; JONES HW, 1995, BAILLIERE CLIN OB GY, V9, P221, DOI 10.1016/S0950-3552(05)80367-0; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Levin CE, 2010, INT J CANCER, V127, P1404, DOI 10.1002/ijc.25150; Macey RI., 2010, BERKELEY MADONNA VER; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Praditsitthikorn N, 2011, PHARMACOECONOMICS, V29, P781, DOI 10.2165/11586560-000000000-00000; Qiao L, 2015, J OBSTET GYNAECOLOGY; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sankaranarayanan R, 2003, INT J CANCER, V106, P404, DOI 10.1002/ijc.11245; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Sauvaget C, 2013, INT J GYNECOL OBSTET, V120, P218, DOI 10.1016/j.ijgo.2012.10.014; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Sharma M, 2012, BJOG-INT J OBSTET GY, V119, P166, DOI 10.1111/j.1471-0528.2011.02974.x; Shelbaya SG, 2009, GLOBAL GUIDANCE CERV, P11; Sherris J, 2009, INT PERSPECT SEX R H, V35, P147, DOI [10.1363/3514709, 10.1363/ifpp.35.147.09]; Shi JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-123; Sritipsukho Paskorn, 2010, J Med Assoc Thai, V93 Suppl 7, pS254; Steele H, MACROECONOMICS HLTH; Suprasert P, 2009, ASIAN PAC J CANCER P, V10, P587; Wang KL, 2010, J PSYCHOSOM OBST GYN, V31, P16, DOI 10.3109/01674820903564440; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; WHO, 2014, COMPR CERV CANC CONT; WHO, 2013, WHO GUID SCREEN TREA; WHO, 2012, HEALTH SERVICE DELIV; World Bank, PPP CONV FACT GDP LC; [No title captured]	50	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162915	10.1371/journal.pone.0162915	http://dx.doi.org/10.1371/journal.pone.0162915			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631732	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900093
J	Elchaninov, A; Fatkhudinov, T; Usman, N; Kananykhina, E; Arutyunyan, I; Makarov, A; Bolshakova, G; Goldshtein, D; Sukhikh, G				Elchaninov, Andrey; Fatkhudinov, Timur; Usman, Natalia; Kananykhina, Evgeniya; Arutyunyan, Irina; Makarov, Andrey; Bolshakova, Galina; Goldshtein, Dmitry; Sukhikh, Gennady			Molecular Survey of Cell Source Usage during Subtotal Hepatectomy-Induced Liver Regeneration in Rats	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; GENE-EXPRESSION; WEAK INDUCER; INJURY; APOPTOSIS; RECEPTOR; INTACT; EXTENT	Proliferation of hepatocytes is known to be the main process in the hepatectomy-induced liver regrowth; however, in cases of extensive loss it may be insufficient for complete recovery unless supported by some additional sources e.g. mobilization of undifferentiated progenitors. The study was conducted on rat model of 80% subtotal hepatectomy; the objective was to evaluate contributions of hepatocytes and resident progenitor cells to the hepatic tissue recovery via monitoring specific mRNA and/or protein expression levels for a panel of genes implicated in growth, cell differentiation, angiogenesis, and inflammation. Some of the genes showed distinctive temporal expression patterns, which were loosely associated with two waves of hepatocyte proliferation observed at 2 and 7 days after the surgery. Focusing on genes implicated in regulation of the progenitor cell activity, we came across slight increases in expression levels for Sox9 and two genes encoding tumor necrosis factor-like cytokine TWEAK (Tnfsf12) and its receptor Fn14 (Tnfrsf12a). At the same time, no increase in numbers of cytokeratin 19-positive (CK19(+)) cells was observed in periportal areas, and no CK19+ cells were found in hepatic plates. Since CK19 is thought to be a specific marker of both cholangiocytes and the hepatic progenitor cells, the data indicate a lack of activation of the resident progenitor cells during recovery of hepatic tissue after 80% subtotal hepatectomy. Thus, proliferation of hepatocytes invariably makes the major contribution to the hepatic tissue recovery, although in the cases of subtotal loss this contribution is distinctively modulated. In particular, induction of Sox9 and TWEAK/Fn14 regulatory pathways, conventionally attributed to progenitor cell activation, may incidentally stimulate mitotic activity of hepatocytes.	[Elchaninov, Andrey; Fatkhudinov, Timur; Usman, Natalia; Kananykhina, Evgeniya; Arutyunyan, Irina; Makarov, Andrey; Sukhikh, Gennady] Minist Healthcare Russian Federat, Res Ctr Obstet Gynecol & Perinatol, 4 Oparina St, Moscow 117997, Russia; [Elchaninov, Andrey; Fatkhudinov, Timur; Usman, Natalia; Kananykhina, Evgeniya; Arutyunyan, Irina; Makarov, Andrey; Bolshakova, Galina] Sci Res Inst Human Morphol, 3 Tsurupa St, Moscow 117418, Russia; [Elchaninov, Andrey; Usman, Natalia; Makarov, Andrey] Pirogov Russian Natl Res Med Univ, Minist Healthcare Russian Federat, 1 Ostrovitianov St, Moscow 117997, Russia; [Goldshtein, Dmitry] Med Genet Res Ctr, 1 Moskvorechie St, Moscow 115478, Russia	Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Pirogov Russian National Research Medical University; Research Centre for Medical Genetics	Fatkhudinov, T (corresponding author), Minist Healthcare Russian Federat, Res Ctr Obstet Gynecol & Perinatol, 4 Oparina St, Moscow 117997, Russia.; Fatkhudinov, T (corresponding author), Sci Res Inst Human Morphol, 3 Tsurupa St, Moscow 117418, Russia.	fatkhudinov@gmail.com	Makarov, Andrey V/A-4130-2014; Arutyunyan, Irina V/A-5939-2014; Fatkhudinov, Timur Kh/A-5871-2014; Bolshakova, Galina B/A-5771-2014; Kananykhina, Evgeniya Y/A-8228-2014; Goldshtein, Dmitry/AAK-8313-2021; Elchaninov, Andrey V./B-5320-2013	Makarov, Andrey V/0000-0003-2133-2293; Arutyunyan, Irina V/0000-0002-4344-8943; Fatkhudinov, Timur Kh/0000-0002-6498-5764; Bolshakova, Galina B/0000-0002-9669-0821; Kananykhina, Evgeniya Y/0000-0002-9779-2918; Elchaninov, Andrey V./0000-0002-2392-4439; Suhih, Gennadii Tihonovic/0000-0002-7712-1260	Russian Foundation for Basic Research [14-04-01224]; Russian Presidential Grant for Young Scientists [14.120.14.6239]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Presidential Grant for Young Scientists	This work was supported by Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng; Agreement 14-04-01224 of 26 December 2013, TF) and the Russian Presidential Grant for Young Scientists (https://grants.extech.ru/;. 14.120.14.6239 of 3 February 2014, AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026; Chen YM, 2014, LIVER INT, V34, P976, DOI 10.1111/liv.12496; Coudriet GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015384; Dalgetty DM, 2009, AM J PHYSIOL-GASTR L, V297, pG241, DOI 10.1152/ajpgi.00138.2009; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Eshkenazy Rony, 2014, Hepatobiliary Surg Nutr, V3, P303, DOI 10.3978/j.issn.2304-3881.2014.09.08; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Karaca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083987; KONO S, 1992, BIOCHEM BIOPH RES CO, V186, P991, DOI 10.1016/0006-291X(92)90844-B; Li JN, 2009, AM J PATHOL, V175, P947, DOI 10.2353/ajpath.2009.090043; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Masson S, 1999, LIVER, V19, P312, DOI 10.1111/j.1478-3231.1999.tb00055.x; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 2014, EXPERT REV GASTROENT, V8, P897, DOI 10.1586/17474124.2014.934358; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2005, J BIOL CHEM, V280, P2562, DOI 10.1074/jbc.M412372200; Ninomiya M, 2010, AM J TRANSPLANT, V10, P1580, DOI 10.1111/j.1600-6143.2010.03150.x; Panis Y, 1998, J SURG RES, V79, P103, DOI 10.1006/jsre.1998.5400; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rai RM, 1998, P NATL ACAD SCI USA, V95, P13829, DOI 10.1073/pnas.95.23.13829; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Scotte M, 1997, CYTOKINE, V9, P859, DOI 10.1006/cyto.1997.0273; Sowa JP, 2008, WORLD J GASTROENTERO, V14, P7093, DOI 10.3748/wjg.14.7093; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WEINBREN K, 1965, BRIT J EXP PATHOL, V46, P413; YANAGITA K, 1992, BIOCHEM BIOPH RES CO, V182, P802, DOI 10.1016/0006-291X(92)91803-X; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001; Zou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030675	38	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162613	10.1371/journal.pone.0162613	http://dx.doi.org/10.1371/journal.pone.0162613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631110	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900059
J	Ko, CC; Tai, MH; Li, CF; Chen, TY; Chen, JH; Shu, G; Kuo, YT; Lee, YC				Ko, Ching Chung; Tai, Ming Hong; Li, Chien Feng; Chen, Tai Yuan; Chen, Jeon Hor; Shu, Ginger; Kuo, Yu Ting; Lee, Yu Chang			Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging	PLOS ONE			English	Article							SOLITARY METASTATIC LESIONS; NERVOUS-SYSTEM LYMPHOMA; PRIMARY CNS LYMPHOMA; BRAIN-TUMORS; PERITUMORAL EDEMA; COEFFICIENT; PERFUSION; GLIOMA	The differentiation between glioblastomamultiforme (GBM) and primary cerebral lymphoma (PCL) is importantbecause the treatments are substantially different. The purpose of this article is to describe the MR imaging characteristics of GBM and PCL with emphasis on the quantitative ADC analysis in the tumor necrosis, the most strongly-enhanced tumor area, and the peritumoral edema. This retrospective cohort study collected 104 GBM (WHO grade IV) patients and 22 immune-competent PCL (diffuse large B cell lymphoma) patients. All these patients had pretreatment brain MR DWI and ADC imaging. Analysis of conventional-MR imaging and quantitative ADC measurement including the tumor necrosis (ADCn), the most strongly-enhanced tumor area (ADCt), and the peritumoral edema (ADCe) were done. ROC analysis with optimal cut-off values and area-under-the ROC curve (AUC) was performed. For conventional MR imaging, there are statistical differences in tumor size, tumor location, tumor margin, and the presence of tumor necrosis between GBM and PCL. Quantitative ADC analysis shows that GBM tended to have significantly (P<0.05) higher ADC in the most strongly-enhanced area (ADCt) and lower ADC in the peritumoral edema (ADCe) as compared with PCL. Excellent AUC (0.94) with optimal sensitivity of 90% and specificity of 86% for differentiating between GBM and PCL was obtained by combination of ADC in the tumor necrosis (ADCn), the most strongly-enhanced tumor area (ADCt), and the peritumoral edema (ADCe). Besides, there are positive ADC gradients in the peritumoral edema in a subset of GBMs but not in the PCLs. Quantitative ADC analysis in these three areas can thus be implemented to improve diagnostic accuracy for these two brain tumor types. The histological correlation of the ADC difference deserves further investigation.	[Ko, Ching Chung; Chen, Tai Yuan; Shu, Ginger; Kuo, Yu Ting] Chi Mei Med Ctr, Dept Med Imaging, Tainan, Taiwan; [Ko, Ching Chung; Tai, Ming Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Li, Chien Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan; [Chen, Tai Yuan] Chang Jung Christian Univ, Grad Inst Med Sci, Tainan, Taiwan; [Chen, Jeon Hor; Lee, Yu Chang] I Shou Univ, E DA Hosp, Dept Radiol, Kaohsiung, Taiwan	Chi Mei Hospital; National Sun Yat Sen University; Chi Mei Hospital; Chang Jung Christian University; E-Da Hospital; I Shou University	Lee, YC (corresponding author), I Shou Univ, E DA Hosp, Dept Radiol, Kaohsiung, Taiwan.	drtimlee@ms54.hinet.net		Li, Chien-Feng/0000-0002-9527-7576				Ahn SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112948; Batra A, 2004, Australas Radiol, V48, P388, DOI 10.1111/j.0004-8461.2004.01324.x; Brat DJ, 2004, CANCER RES, V64, P920, DOI 10.1158/0008-5472.CAN-03-2073; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chiang IC, 2004, NEURORADIOLOGY, V46, P619, DOI 10.1007/s00234-004-1246-7; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Giese A, 2001, J CANCER RES CLIN, V127, P217, DOI 10.1007/s004320000188; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Haldorsen IS, 2011, AM J NEURORADIOL, V32, P984, DOI 10.3174/ajnr.A2171; Horger M, 2009, AM J ROENTGENOL, V193, P1384, DOI 10.2214/AJR.09.2486; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Koeller KK, 1997, RADIOGRAPHICS, V17, P1497, DOI 10.1148/radiographics.17.6.9397461; Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee EJ, 2011, AM J ROENTGENOL, V196, P71, DOI 10.2214/AJR.10.4752; Lemercier P, 2014, AM J ROENTGENOL, V203, P163, DOI 10.2214/AJR.13.11186; Makino K, 2011, ANN NUCL MED, V25, P432, DOI 10.1007/s12149-011-0483-1; Matsushima N, 2012, ANN NUCL MED, V26, P262, DOI 10.1007/s12149-012-0570-y; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; Peters S, 2012, ROFO-FORTSCHR RONTG, V184, P713, DOI 10.1055/s-0032-1312862; Rollin N, 2006, NEURORADIOLOGY, V48, P150, DOI 10.1007/s00234-005-0030-7; Schlegel Uwe, 2009, Ther Adv Neurol Disord, V2, P93, DOI 10.1177/1756285608101222; Server A, 2009, ACTA RADIOL, V50, P682, DOI 10.1080/02841850902933123; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Toh CH, 2006, J NEUROSURG, V105, P132, DOI 10.3171/jns.2006.105.1.132; Yamasaki F, 2005, RADIOLOGY, V235, P985, DOI 10.1148/radiol.2353031338; Yamashita K, 2013, NEURORADIOLOGY, V55, P135, DOI 10.1007/s00234-012-1089-6	32	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162565	10.1371/journal.pone.0162565	http://dx.doi.org/10.1371/journal.pone.0162565			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631626	gold, Green Submitted, Green Published			2022-12-26	WOS:000383706900052
J	Rodriguez-Cuenca, S; Whyte, L; Hagen, R; Vidal-Puig, A; Fuller, M				Rodriguez-Cuenca, Sergio; Whyte, Lauren; Hagen, Rachel; Vidal-Puig, Antonio; Fuller, Maria			Stearoyl-CoA Desaturase 1 Is a Key Determinant of Membrane Lipid Composition in 3T3-L1 Adipocytes	PLOS ONE			English	Article							GAUCHER-DISEASE; PROTECTS MICE; SCD1; CHOLESTEROL; OBESITY; TRIACYLGLYCEROL; PURIFICATION; INHIBITION; FLUIDITY; POTENT	Stearoyl-CoA desaturase 1 (SCD1) is a lipogenic enzyme important for the regulation of membrane lipid homeostasis; dysregulation likely contributes to obesity associated metabolic disturbances. SCD1 catalyses the Delta 9 desaturation of 12-19 carbon saturated fatty acids to monounsaturated fatty acids. To understand its influence in cellular lipid composition we investigated the effect of genetic ablation of SCD1 in 3T3-L1 adipocytes on membrane microdomain lipid composition at the species-specific level. Using liquid chromatography/electrospray ionisation-tandem mass spectrometry, we quantified 70 species of ceramide, mono-, di- and trihexosylceramide, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, bis(monoacylglycero) phosphate, phosphatidylinositol and cholesterol in 3T3-L1 adipocytes in which a 90% reduction in scd1 mRNA expression was achieved with siRNA. Cholesterol content was unchanged although decreases in other lipids resulted in cholesterol accounting for a higher proportion of lipid in the membranes. This was associated with decreased membrane lateral diffusion. An increased ratio of 24: 0 to 24: 1 in ceramide, mono-and dihexosylceramide, and sphingomyelin likely also contributed to this decrease in lateral diffusion. Of particular interest, we observed a decrease in phospholipids containing arachidonic acid. Given the high degree of structural flexibility of this acyl chain this will influence membrane lateral diffusion, and is likely responsible for the transcriptional activation of Lands' cycle enzymes lpcat3 and mboat7. Of relevance these profound changes in the lipidome were not accompanied by dramatic changes in gene expression in mature differentiated adipocytes, suggesting that adaptive homeostatic mechanisms to ensure partial maintenance of the biophysical properties of membranes likely occur at a post-transcriptional level.	[Rodriguez-Cuenca, Sergio; Hagen, Rachel; Vidal-Puig, Antonio] Univ Cambridge, Metab Res Labs, Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Cambridge, England; [Whyte, Lauren; Fuller, Maria] SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Hinxton, England; [Fuller, Maria] Univ Adelaide, North Terrace, Adelaide, SA 5000, Australia	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; SA Pathology; Wellcome Trust Sanger Institute; University of Adelaide	Fuller, M (corresponding author), SA Pathol, Genet & Mol Pathol, Adelaide, SA, Australia.; Fuller, M (corresponding author), Univ Adelaide, North Terrace, Adelaide, SA 5000, Australia.	maria.fuller@adelaide.edu.au		Vidal-Puig, Antonio/0000-0003-4220-9577	Biotechnology and Biological Sciences Research Council [BB/H002731/1] Funding Source: Medline; British Heart Foundation [PG/12/53/29714, RG/12/13/29853] Funding Source: Medline; Medical Research Council [MC_UU_12012/2, G0400192, G0802051] Funding Source: Medline; Medical Research Council [MC_UU_12012/5/B] Funding Source: researchfish; BBSRC [BB/H002731/1] Funding Source: UKRI; MRC [G0802051, G0400192, MC_UU_12012/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calder P. C., 2006, Scandinavian Journal of Food & Nutrition, V50, P54, DOI [10.1080/17482970601066389, 10.1080/17482970600786821]; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Collins JM, 2010, J BIOL CHEM, V285, P6044, DOI 10.1074/jbc.M109.053280; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; FEWSTER ME, 1975, J NEUROCHEM, V25, P207, DOI 10.1111/j.1471-4159.1975.tb06954.x; Hattersley KJ, 2013, BIOCHEM BIOPH RES CO, V442, P62, DOI 10.1016/j.bbrc.2013.11.009; Hein LK, 2013, J LIPID RES, V54, P1691, DOI 10.1194/jlr.M038232; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hyun CK, 2010, BIOCHEM BIOPH RES CO, V399, P480, DOI 10.1016/j.bbrc.2010.07.072; Kabayama K, 2005, GLYCOBIOLOGY, V15, P21, DOI 10.1093/glycob/cwh135; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; LISANTI MP, 1995, METHOD ENZYMOL, V250, P655; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUDA M, 1987, J IMMUNOL METHODS, V96, P225, DOI 10.1016/0022-1759(87)90318-8; Mobius W, 2003, TRAFFIC, V4, P222; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ortinau LC, 2013, OBESITY, V21, P344, DOI 10.1002/oby.20040; Ralston JC, 2014, INT J OBESITY, V38, P1449, DOI 10.1038/ijo.2014.35; Ralston JC, 2015, PROSTAG LEUKOTR ESS, V98, P29, DOI 10.1016/j.plefa.2015.04.008; Rioux V, 2013, J LIPID RES, V54, P3438, DOI 10.1194/jlr.M042572; Rogowski MP, 2013, J LIPID RES, V54, P2636, DOI 10.1194/jlr.M035865; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Wassall SR, 2009, BBA-BIOMEMBRANES, V1788, P24, DOI 10.1016/j.bbamem.2008.10.011; Yang SM, 2014, BIOORG MED CHEM LETT, V24, P1437, DOI 10.1016/j.bmcl.2013.12.075; Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255; Zhang ZH, 2013, J MED CHEM, V56, P568, DOI 10.1021/jm301661h	35	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162047	10.1371/journal.pone.0162047	http://dx.doi.org/10.1371/journal.pone.0162047			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632198	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900026
J	Wesener, T; Conrad, C				Wesener, Thomas; Conrad, Cathrin			Local Hotspots of Endemism or Artifacts of Incorrect Taxonomy? The Status of Microendemic Pill Millipede Species of the Genus Glomeris in Northern Italy (Diplopoda, Glomerida)	PLOS ONE			English	Article							INTEGRATIVE REDESCRIPTION; MITOCHONDRIAL-DNA; PHYLOGENY; KOCH; ARTHROPODA; SEQUENCES; IDENTITY; VERHOEFF; ALLOZYME	Local endemic species with their unique evolutionary history always stirred the interest of scientists. One such area especially rich in endemics is northern Italy. In case of pill millipedes of the genus Glomeris Latreille, 1803, only a single species is found in northern Europe, while 22 country-endemics alone are known from Italy. Many of these endemics, however, have not been studied in several decades; therefore we aimed to determine whether this diversity is the result of overlooked synonymies or natural processes. A focus was placed on the local endemics that are in some aspects morphologically similar to the widespread and variable G. klugii Brandt, 1833. The local endemics Glomeris larii Verhoeff, 1921, G. primordialis Verhoeff, 1930, G. oblongoguttata Verhoeff, 1894, G. oropensis Verhoeff, 1936, G. transalpina Koch, 1836, G. romana Verhoeff, 1900, G. ligurica Latzel, 1884 and G. apuana Verhoeff, 1911 were included in a molecular analysis incorporating ribosomal nuclear (28S) and mitochondrial (COI) genes. Individuals were sequenced and compared to 31 specimens from 18 localities of G. klugii. The final dataset included 657 base pairs for 56 terminals in the COI, and 14 terminals with 1068 base pairs in the combined 28S and COI analysis. Our analysis shows intraspecific distances of up to 5% in the COI gene in G. klugii that are not strictly correlated to geography or color pattern. G. larii is discovered to be genetically and morphologically identical to G. klugii and is synonymised with the latter. Interspecific distances in our dataset vary between 6.7 to 15.9%, with the lowest (6.7-9.0%) between G. primordialis and G. klugii. Our analysis confirmsthe species status of the local endemics G. primordialis, G. oblongoguttata, G. oropensis, G. transalpina, G. ligurica and G. apuana. We also confirm the synonymy of G. undulata Koch, 1844 under G. klugii. G. genuensis Latzel, 1886 is indistinguishable from G. ligurica.	[Wesener, Thomas; Conrad, Cathrin] Leibniz Inst Anim Biodivers, Sect Myriapoda, Ctr Taxon & Evolutionary Res, Zool Res Museum A Koenig, Bonn, Germany		Wesener, T (corresponding author), Leibniz Inst Anim Biodivers, Sect Myriapoda, Ctr Taxon & Evolutionary Res, Zool Res Museum A Koenig, Bonn, Germany.	t.wesener@zfmk.de						Ahrens D, 2013, MOL PHYLOGENET EVOL, V69, P83, DOI 10.1016/j.ympev.2013.05.016; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez N, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-21; Attems C., 1927, ABHANDLUNGEN SENCKEN, V39, P233; Blanke A, 2014, ARTHROPOD STRUCT DEV, V43, P63, DOI 10.1016/j.asd.2013.10.003; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Daavalos LM, 2014, J MAMMAL, V95, P781, DOI 10.1644/14-MAMM-A-107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foddai D., 1995, CHECKLIST SPECIE FAU, V32/33, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Golovatch SI, 2009, ZOOKEYS, P47, DOI 10.3897/zookeys.12.179; Golovatch SI, 2003, ARTHROPODA SEL, V11, P255; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoess R, 2001, ZOOL ANZ, V240, P15, DOI 10.1078/0044-5231-00003; Hoess R, 1997, ENTOMOL SCAND, P133; Hoess R, 1999, REV SUISSE ZOOL, V106, P643, DOI 10.5962/bhl.part.80100; Hoess R, 1999, REV SUISSE ZOOL, V106, P1013, DOI 10.5962/bhl.part.80113; Hoess R., 2000, JB NATURHISTORISCHEN, V13, P3; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Kime R. Desmond, 2000, Fragmenta Faunistica (Warsaw), V43, P281; Kime RD, 2011, ATLAS EUROPEAN MILLI, V1; Latzel R, 1886, B SOC ENTOMOL ITAL, V18, P308; Latzel R, 1884, MYRIOPODEN OSTERREIC, V2; Mauries Jean-Paul, 2005, Arthropoda Selecta, V14, P241; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Oeyen JP, 2015, ZOOKEYS, P49, DOI 10.3897/zookeys.510.8675; Pitz KM, 2010, CLADISTICS, V26, P497, DOI 10.1111/j.1096-0031.2009.00303.x; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Schubart O., 1934, TAUSENDFUSSLER ODER, P28; Shelley Rowland M., 2011, Insecta Mundi, V0158, P1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Strasser K., 1984, SOC VENEZIANA SCI NA, V9, P193; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VERHOEFF K. W., 1921, Archiv fuer Naturgeschichte Berlin, V87, P1; Verhoeff K. W., 1937, Zoologische Jahrbuecher Jena Systematik, V70, P87; VERHOEFF KARL W., 1930, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V59, P387; VERHOEFF KARL W., 1936, ZOOL JAHRB ABT SYST OKOL U GEOGR TIERE, V68, P353; Verhoeff Karl W., 1911, Jahresheft des Vereins fuer Naturkunde Stuttgart, V67; Wesener T, 2016, ZOOKEYS, P21, DOI 10.3897/zookeys.564.7535; Wesener T, 2015, ZOOTAXA, V4039, P391, DOI 10.11646/zootaxa.4039.2.11; Wesener T, 2015, ZOOTAXA, V3999, P571, DOI 10.11646/zootaxa.3999.4.7; Wesener T, 2015, ZOOKEYS, P15, DOI 10.3897/zookeys.510.8852; Wesener Thomas, 2012, Zootaxa, V3258, P58; Wesener Thomas, 2010, Zootaxa, V2725, P28; Wilbrandt J, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e5176	50	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162284	10.1371/journal.pone.0162284	http://dx.doi.org/10.1371/journal.pone.0162284			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632210	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900036
J	Andritschke, D; Dilling, S; Emmenlauer, M; Welz, T; Schmich, F; Misselwitz, B; Ramo, P; Rottner, K; Kerkhoff, E; Wada, T; Penninger, JM; Beerenwinkel, N; Horvath, P; Dehio, C; Hardt, WD				Andritschke, Daniel; Dilling, Sabrina; Emmenlauer, Mario; Welz, Tobias; Schmich, Fabian; Misselwitz, Benjamin; Ramo, Pauli; Rottner, Klemens; Kerkhoff, Eugen; Wada, Teiji; Penninger, Josef M.; Beerenwinkel, Niko; Horvath, Peter; Dehio, Christoph; Hardt, Wolf-Dietrich			A Genome-Wide siRNA Screen Implicates Spire1/2 in SipA-Driven Salmonella Typhimurium Host Cell Invasion	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION; EFFECTOR PROTEINS; DEPENDENT MECHANISM; EMBRYO FIBROBLASTS; ACTIN NUCLEATORS; RHO GTPASES; RNAI SCREEN; SOPE; MEMBRANE	Salmonella Typhimurium (S. Tm) is a leading cause of diarrhea. The disease is triggered by pathogen invasion into the gut epithelium. Invasion is attributed to the SPI-1 type 3 secretion system (T1). T1 injects effector proteins into epithelial cells and thereby elicits rearrangements of the host cellular actin cytoskeleton and pathogen invasion. The T1 effector proteins SopE, SopB, SopE2 and SipA are contributing to this. However, the host cell factors contributing to invasion are still not completely understood. To address this question comprehensively, we used Hela tissue culture cells, a genome-wide siRNA library, a modified gentamicin protection assay and S. Tm-SipA, a sopBsopE2sopE mutant which strongly relies on the T1 effector protein SipA to invade host cells. We found that S. TmSipA invasion does not elicit membrane ruffles, nor promote the entry of non-invasive bacteria "in trans". However, SipA-mediated infection involved the SPIRE family of actin nucleators, besides well-established host cell factors (WRC, ARP2/3, RhoGTPases, COPI). Stage-specific follow-up assays and knockout fibroblasts indicated that SPIRE1 and SPIRE2 are involved in different steps of the S. Tm infection process. Whereas SPIRE1 interferes with bacterial binding, SPIRE2 influences intracellular replication of S. Tm. Hence, these two proteins might fulfill non-redundant functions in the pathogen-host interaction. The lack of co-localization hints to a short, direct interaction between S. Tm and SPIRE proteins or to an indirect effect.	[Andritschke, Daniel; Dilling, Sabrina; Misselwitz, Benjamin; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Emmenlauer, Mario; Ramo, Pauli; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Welz, Tobias; Kerkhoff, Eugen] Univ Regensburg, Dept Neurol, DE-93040 Regensburg, Germany; [Schmich, Fabian; Beerenwinkel, Niko] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Schmich, Fabian; Beerenwinkel, Niko] SIB, CH-4058 Basel, Switzerland; [Misselwitz, Benjamin] Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Rottner, Klemens] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res, Dept Cell Biol, D-38124 Braunschweig, Germany; [Wada, Teiji] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Horvath, Peter] ETH, Light Microscopy Ctr, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; University of Regensburg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; University of Zurich; University Zurich Hospital; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Hardt, WD (corresponding author), ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Penninger, Josef M/I-6860-2013; Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016; Misselwitz, Benjamin/L-7193-2016; Rottner, Klemens/AAE-5030-2020	Penninger, Josef M/0000-0002-8194-3777; Dehio, Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052; Misselwitz, Benjamin/0000-0002-8719-5175; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Rottner, Klemens/0000-0003-4244-4198	SystemsX.ch; Swiss Initiative in Systems Biology [51RT-0_126008, 51RTP0_151029]; Swiss National Science Foundation [310030_153074/1]; SyBIT, the IT project of SystemsX	SystemsX.ch; Swiss Initiative in Systems Biology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SyBIT, the IT project of SystemsX	This project was funded in part by SystemsX.ch, the Swiss Initiative in Systems Biology, RTD grants 51RT-0_126008 (InfectX) and 51RTP0_151029 (TargetInfectX), evaluated by the Swiss National Science Foundation and Swiss National Science Foundation grant 310030_153074/1 to WDH. Further support was received from SyBIT, the IT project of SystemsX.	Agbor TA, 2011, CELL MICROBIOL, V13, P1858, DOI 10.1111/j.1462-5822.2011.01701.x; Bakshi CS, 2000, J BACTERIOL, V182, P2341, DOI 10.1128/JB.182.8.2341-2344.2000; Bauch A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-468; Birmingham CL, 2005, INFECT IMMUN, V73, P1204, DOI 10.1128/IAI.73.2.1204-1208.2005; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cossart P, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016972; COWIE A, 1986, MOL CELL BIOL, V6, P4344, DOI 10.1128/MCB.6.12.4344; Davidson AC, 2015, MBIO, V6, DOI 10.1128/mBio.02253-14; Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Franceschini A, 2014, P NATL ACAD SCI USA, V111, P4548, DOI 10.1073/pnas.1402353111; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; GONG S, 1990, VIROLOGY, V178, P81, DOI 10.1016/0042-6822(90)90381-Z; Hanisch J, 2011, CELL HOST MICROBE, V9, P273, DOI 10.1016/j.chom.2011.03.009; Hanisch J, 2010, CELL MICROBIOL, V12, P84, DOI 10.1111/j.1462-5822.2009.01380.x; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hayward RD, 2002, TRENDS CELL BIOL, V12, P15, DOI 10.1016/S0962-8924(01)02183-3; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Humphreys D, 2013, P NATL ACAD SCI USA, V110, P16880, DOI 10.1073/pnas.1311680110; Humphreys D, 2012, CELL HOST MICROBE, V11, P129, DOI 10.1016/j.chom.2012.01.006; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kerkhoff E, 2001, CURR BIOL, V11, P1963, DOI 10.1016/S0960-9822(01)00602-9; Kerkhoff E, 2011, EUR J CELL BIOL, V90, P922, DOI 10.1016/j.ejcb.2010.10.011; Kreibich S, 2015, CELL HOST MICROBE, V18, P527, DOI 10.1016/j.chom.2015.10.015; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kuhbacher A, 2015, MBIO, V6, DOI 10.1128/mBio.00598-15; Lagal V, 2014, J CELL SCI, V127, P328, DOI 10.1242/jcs.130161; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Meier R, 2014, GENOME WIDE SIRNA SC, P809; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; Misselwitz B, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.7; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pleiser S, 2014, EUR J CELL BIOL, V93, P225, DOI 10.1016/j.ejcb.2013.11.001; Pleiser S, 2010, GENE EXPR PATTERNS, V10, P345, DOI 10.1016/j.gep.2010.08.001; Prager R, 2000, INT J MED MICROBIOL, V290, P605; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Ramo P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1162; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002; Santos AJM, 2013, J CELL SCI, V126, P2990, DOI 10.1242/jcs.115253; Schlumberger MC, 2007, MOL MICROBIOL, V65, P741, DOI 10.1111/j.1365-2958.2007.05823.x; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Schmich F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0783-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; TAKEUCHI A, 1967, AM J PATHOL, V50, P109; Tittel J, 2015, J BIOL CHEM, V290, P6428, DOI 10.1074/jbc.M114.602672; Truong D, 2013, CELL MICROBIOL, V15, P2051, DOI 10.1111/cmi.12173; Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x; Vonaesch P, 2014, CELL MICROBIOL, V16, P1723, DOI 10.1111/cmi.12333; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991	87	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161965	10.1371/journal.pone.0161965	http://dx.doi.org/10.1371/journal.pone.0161965			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627128	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000383680600014
J	Hull, V; Zhang, JD; Huang, JY; Zhou, SQ; Vina, A; Shortridge, A; Li, RG; Liu, DA; Xu, WH; Ouyang, ZY; Zhang, HM; Liu, JG				Hull, Vanessa; Zhang, Jindong; Huang, Jinyan; Zhou, Shiqiang; Vina, Andres; Shortridge, Ashton; Li, Rengui; Liu, Dian; Xu, Weihua; Ouyang, Zhiyun; Zhang, Hemin; Liu, Jianguo			Habitat Use and Selection by Giant Pandas	PLOS ONE			English	Article							WILDLIFE HABITAT; SPACE-USE; NATURE-RESERVE; DYNAMICS; RANGE; CHINA; TRACKING; IMPACTS; MODELS	Animals make choices about where to spend their time in complex and dynamic landscapes, choices that reveal information about their biology that in turn can be used to guide their conservation. Using GPS collars, we conducted a novel individual-based analysis of habitat use and selection by the elusive and endangered giant pandas (Ailuropoda melanoleuca). We constructed spatial autoregressive resource utilization functions (RUF) to model the relationship between the pandas' utilization distributions and various habitat characteristics over a continuous space across seasons. Results reveal several new insights, including use of a broader range of habitat characteristics than previously understood for the species, particularly steep slopes and non-forest areas. We also used compositional analysis to analyze habitat selection (use with respect to availability of habitat types) at two selection levels. Pandas selected against low terrain position and against the highest clumped forest at the at-home range level, but no significant factors were identified at the within-home range level. Our results have implications for modeling and managing the habitat of this endangered species by illustrating how individual pandas relate to habitat and make choices that differ from assumptions made in broad scale models. Our study also highlights the value of using a spatial autoregressive RUF approach on animal species for which a complete picture of individual-level habitat use and selection across space is otherwise lacking.	[Hull, Vanessa; Zhang, Jindong; Vina, Andres; Liu, Jianguo] Michigan State Univ, Ctr Syst Integrat & Sustainabil, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Zhang, Jindong] China West Normal Univ, Key Lab Southwest China Wildlife Resources Conser, Minist Educ, Nanchong, Peoples R China; [Huang, Jinyan; Zhou, Shiqiang; Li, Rengui; Liu, Dian; Zhang, Hemin] CCRCGP, Wolong Nat Reserve, Chengdu, Sichuan, Peoples R China; [Shortridge, Ashton] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA; [Xu, Weihua; Ouyang, Zhiyun] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Michigan State University; China West Normal University; Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Hull, V (corresponding author), Michigan State Univ, Ctr Syst Integrat & Sustainabil, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	hullvane@msu.edu	Liu, Jianguo/G-5211-2015; Shiqiang, Zhou/G-1331-2019	Liu, Jianguo/0000-0001-6344-0087; Shiqiang, Zhou/0000-0002-5537-3205; Vina, Andres/0000-0001-6240-6610	National Science Foundation (NSF); National Aeronautics and Space Administration (NASA); Michigan AgBioResearch; Michigan State University Distinguished Fellowship Program; William W. and Evelyn M. Taylor International Engagement Program; National Natural Science Foundation of China [40901289, 41571517]; State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences [SKLURE2008-1]; Giant Panda International Collaboration Fund [SD0631, SD1113]; Direct For Biological Sciences [1340812] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Michigan AgBioResearch; Michigan State University Distinguished Fellowship Program; William W. and Evelyn M. Taylor International Engagement Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences; Giant Panda International Collaboration Fund; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We gratefully acknowledge the following funding sources: National Science Foundation (NSF), the National Aeronautics and Space Administration (NASA), Michigan AgBioResearch, the Michigan State University Distinguished Fellowship Program, the William W. and Evelyn M. Taylor International Engagement Program, the National Natural Science Foundation of China (40901289, 41571517), the State Key Laboratory of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences (SKLURE2008-1), and the Giant Panda International Collaboration Fund (Grant SD0631; SD1113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; An L, 2006, BIODIVERS CONSERV, V15, P2343, DOI 10.1007/s10531-004-1064-6; An L, 2014, ANN ASSOC AM GEOGR, V104, P723, DOI 10.1080/00045608.2014.910085; Bailey T, 1995, INTERACTIVE SPATIAL; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Bearer S, 2008, BIOL CONSERV, V141, P385, DOI 10.1016/j.biocon.2007.10.009; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Bradbury M, 2014, POPUL ENVIRON, V36, P73, DOI 10.1007/s11111-014-0203-6; Calenge C, 2011, ANALYSIS OF HABITAT; Chen XD, 2010, CONSERV BIOL, V24, P1469, DOI 10.1111/j.1523-1739.2010.01551.x; Chen XD, 2009, BIOL CONSERV, V142, P1740, DOI 10.1016/j.biocon.2009.03.012; Connor T, 2016, INTEGR ZOOL, V11, P295, DOI 10.1111/1749-4877.12197; Cumming GS, 2012, DIVERS DISTRIB, V18, P1057, DOI 10.1111/j.1472-4642.2012.00908.x; Durnin ME, 2004, J WILDLIFE MANAGE, V68, P987, DOI 10.2193/0022-541X(2004)068[0987:EOROGP]2.0.CO;2; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hu Jinchu, 2004, P137; Huang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1268-z; Hull V, 2015, J MAMMAL, V96, P230, DOI 10.1093/jmammal/gyu031; Hull V, 2014, URSUS, V25, P148, DOI 10.2192/URSUS-D-13-00011.1; Hull V, 2014, J NAT CONSERV, V22, P256, DOI 10.1016/j.jnc.2014.02.003; Hull V, 2011, BIOL CONSERV, V144, P3028, DOI 10.1016/j.biocon.2011.09.007; Jenness J., 2012, LAND FACET CORRIDOR; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kramer-Schadt S, 2004, J APPL ECOL, V41, P711, DOI 10.1111/j.0021-8901.2004.00933.x; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Linderman MA, 2006, ECOL APPL, V16, P452, DOI 10.1890/1051-0761(2006)016[0452:IEONAH]2.0.CO;2; Liu J., 2016, PANDAS AND PEOPLE CO; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1023/A:1022101026466; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Liu JG, 2015, SCIENCE, V348, P642, DOI 10.1126/science.348.6235.642-a; Liu JG, 2010, CRIT REV ENV SCI TEC, V40, P823, DOI 10.1080/10643389.2010.502645; Liu XH, 2005, J WILDLIFE MANAGE, V69, P1623, DOI 10.2193/0022-541X(2005)69[1623:GPHSIF]2.0.CO;2; Liu XH, 2011, ECOL MODEL, V222, P645, DOI 10.1016/j.ecolmodel.2010.10.012; Manly B.F., 2002, RESOURCE SELECTION B; Marzluff JM, 2004, ECOLOGY, V85, P1411, DOI 10.1890/03-0114; McGarigal K., 2015, FRAGSTATS HELP PIEEJ; Miller CS, 2010, INTEGR ZOOL, V5, P378, DOI 10.1111/j.1749-4877.2010.00216.x; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Morrison ML., 2006, WILDLIFE HABITAT REL; Nie YG, 2012, ANIM BEHAV, V84, P39, DOI 10.1016/j.anbehav.2012.03.026; Pan W., 2001, CHANCE LASTING SURVI; R Development Core Team, 2005, R LANG ENV STAT COMP; Ran Jiang-Hong, 2003, Acta Ecologica Sinica, V23, P2253; Ran Jianghong, 2004, Acta Theriologica Sinica, V24, P277; REID DG, 1991, J APPL ECOL, V28, P228, DOI 10.2307/2404127; Rogerson P., 2001, STATISTICAL METHODS; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Schaller GB, 1985, THE GIANT PANDAS OF; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; State Forestry Administration of China, 2015, THE FOURTH NATIONAL; Swaisgood RR, 2010, BIOL LETTERS, V6, P143, DOI 10.1098/rsbl.2009.0786; TAYLOR AH, 1993, AM J BOT, V80, P375, DOI 10.2307/2445383; Taylor AH, 2004, FOREST ECOL MANAG, V200, P347, DOI 10.1016/j.foreco.2004.07.007; Tuanmu MN, 2011, J BIOGEOGR, V38, P1510, DOI 10.1111/j.1365-2699.2011.02479.x; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; Vina A, 2008, REMOTE SENS ENVIRON, V112, P2160, DOI 10.1016/j.rse.2007.09.012; Vina A, 2011, AMBIO, V40, P274, DOI 10.1007/s13280-010-0098-0; Vina A, 2010, BIOL CONSERV, V143, P1960, DOI 10.1016/j.biocon.2010.04.046; Wang Xuezhi, 2008, Acta Ecologica Sinica, V28, P821; Witt CM, 2015, SCIENCE, V347, pS50; Xu WH, 2006, DIVERS DISTRIB, V12, P610, DOI 10.1111/j.1366-9516.2006.00236.x; Yang W, 2015, ASCE-ASME J RISK U B, V1, DOI 10.1115/1.4029751; Yu E, 2007, P NATL ACAD SCI USA, V104, P20629, DOI 10.1073/pnas.0707267104; Zhang ZJ, 2014, INTEGR ZOOL, V9, P46, DOI 10.1111/1749-4877.12030	68	29	38	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162266	10.1371/journal.pone.0162266	http://dx.doi.org/10.1371/journal.pone.0162266			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627805	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600027
J	Khalil, MA; Hrabeta, J; Groh, T; Prochazka, P; Doktorova, H; Eckschlager, T				Khalil, Mohamed Ashraf; Hrabeta, Jan; Groh, Tomas; Prochazka, Pavel; Doktorova, Helena; Eckschlager, Tomas			Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; HISTONE DEACETYLASE; COLON-CANCER; MARKER CD133; INITIATING CELLS; PROSTATE-CANCER; EXPRESSION; TUMORS; PATHWAY; CHEMORESISTANCE	Valproic acid (VPA) is a well-known antiepileptic drug that exhibits antitumor activities through its action as a histone deacetylase inhibitor. CD133 is considered to be a cancer stem cell marker in several tumors including neuroblastoma. CD133 transcription is strictly regulated by epigenetic modifications. We evaluated the epigenetic effects of treatment with 1mM VPA and its influence on the expression of CD133 in four human neuroblastoma cell lines. Chemoresistance and cell cycle of CD133+ and CD133- populations were examined by flow cytometry. We performed bisulfite conversion followed by methylation-sensitive high resolution melting analysis to assess the methylation status of CD133 promoters P1 and P3. Our results revealed that VPA induced CD133 expression that was associated with increased acetylation of histones H3 and H4. On treatment with VPA and cytostatics, CD133+ cells were mainly detected in the S and G2/M phases of the cell cycle and they showed less activated caspase-3 compared to CD133-cells. UKF-NB-3 neuroblastoma cells which express CD133 displayed higher colony and neurosphere formation capacities when treated with VPA, unlike IMR-32 which lacks for CD133 protein. Induction of CD133 in UKF-NB-3 was associated with increased expression of phosphorylated Akt and pluripotency transcription factors Nanog, Oct-4 and Sox2. VPA did not induce CD133 expression in cell lines with methylated P1 and P3 promoters, where the CD133 protein was not detected. Applying the demethylating agent 5-aza-2'-deoxycytidine to the cell lines with methylated promoters resulted in CD133 re-expression that was associated with a drop in P1 and P3 methylation level. In conclusion, CD133 expression in neuroblastoma can be regulated by histone acetylation and/or methylation of its CpG promoters. VPA can induce CD133+ cells which display high proliferation potential and low sensitivity to cytostatics in neuroblastoma. These results give new insight into the possible limitations to use VPA in cancer therapy.	[Khalil, Mohamed Ashraf; Hrabeta, Jan; Doktorova, Helena; Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic; [Khalil, Mohamed Ashraf; Hrabeta, Jan; Doktorova, Helena; Eckschlager, Tomas] Univ Hosp Motol, Prague, Czech Republic; [Groh, Tomas] Fac Sci, Dept Biochem, Prague, Czech Republic; [Prochazka, Pavel] Acad Sci, Inst Expt Med, Prague, Czech Republic; [Prochazka, Pavel] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Eckschlager, T (corresponding author), Charles Univ Prague, Fac Med 2, Dept Pediat Hematol & Oncol, Prague, Czech Republic.; Eckschlager, T (corresponding author), Univ Hosp Motol, Prague, Czech Republic.	tomas.eckschlager@lfmotol.cuni.cz		Abdel-Rahman, Mohamed Ashraf khalil/0000-0003-4280-0607; Doktorova, Helena/0000-0002-5748-8807	Grant Agency of Czech Republic [P301/12/1734]; project Grant Agency Charles University in Prague [620612, 635712/2012]; Ministry of Health of the Czech Republic [00064203]; Charles University in Prague, project GA UK grant [620612, 635712/2012];  [GA CR P301/12/1734]	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); project Grant Agency Charles University in Prague; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Charles University in Prague, project GA UK grant; 	This work was funded by Grant Agency of Czech Republic (www.gacr.cz) P301/12/1734, project Grant Agency Charles University in Prague (www.cuni.cz/UK-33.html) grants No 620612 and 635712/2012, and the Ministry of Health of the Czech Republic (www.mzcr.cz) for conceptual development of research organization 00064203 (University Hospital Motol, Prague, Czech Republic).; This work was supported by grant GA CR P301/12/1734 and by Charles University in Prague, project GA UK grant No 620612 and 635712/2012. Support also came from the Ministry of Health of the Czech Republic for conceptual development of research organization 00064203 (University Hospital Motol, Prague, Czech Republic).	Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Barrantes-Freer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130519; Boudadi E, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-11; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Burba I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022158; Chatpun S, 2011, J TRAUMA, V70, P787, DOI 10.1155/2010/479364; Chen CL, 2006, J PHARMACOL EXP THER, V319, P533, DOI 10.1124/jpet.106.106658; CINATL J, 1990, Journal of Cancer Research and Clinical Oncology, V116, P9; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; Ellis L, 2013, ONCOTARGET, V4, P2225, DOI 10.18632/oncotarget.1314; Feng JM, 2012, CANCER BIOL THER, V13, P1396, DOI 10.4161/cbt.22000; Feng JT, 2015, CELL ADHES MIGR, V9, P495, DOI 10.1080/19336918.2015.1112486; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Groh T, 2015, INT J ONCOL, V47, P343, DOI 10.3892/ijo.2015.2996; Groh T, 2012, NEUROENDOCRINOL LETT, V33, P16; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hammerle B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076761; Han L, 2013, ACTA PHARM SIN B, V3, P65, DOI 10.1016/j.apsb.2013.02.006; Higuchi A, 2015, LAB INVEST, V95, P26, DOI 10.1038/labinvest.2014.132; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Hrebackova J, 2010, CURR DRUG TARGETS, V11, P361, DOI 10.2174/138945010790711923; Irollo E, 2013, AM J TRANSL RES, V5, P563; Kamijo T, 2012, PEDIATR RES, V71, P511, DOI 10.1038/pr.2011.54; Kaneko Y, 2015, CANCER SCI, V106, P840, DOI 10.1111/cas.12677; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Khalil MA, 2012, NEOPLASMA, V59, P737, DOI 10.4149/neo_2012_093; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Koyama-Nasu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053710; Kretsovali A, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/184154; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee HZ, 2015, CLIN CANCER RES, V21, P2666, DOI 10.1158/1078-0432.CCR-14-3119; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Donovan N, 2003, CLIN CANCER RES, V9, P738; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Pezzolo A, 2011, CELL RES, V21, P1470, DOI 10.1038/cr.2011.38; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Poljakova J, 2014, ONCOL REP, V31, P1928, DOI 10.3892/or.2014.2999; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Ross RA, 2003, CANCER LETT, V197, P35, DOI 10.1016/S0304-3835(03)00079-X; Sartelet H, 2012, HISTOPATHOLOGY, V60, P1144, DOI 10.1111/j.1365-2559.2012.04191.x; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shi GL, 2011, J CELL PHYSIOL, V226, P3190, DOI 10.1002/jcp.22679; Shin JH, 2013, J NEURO-ONCOL, V115, P333, DOI 10.1007/s11060-013-1234-z; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tong QS, 2008, WORLD J PEDIATR, V4, P58, DOI 10.1007/s12519-008-0012-z; Vangipuram SD, 2010, PEDIATR BLOOD CANCER, V54, P361, DOI 10.1002/pbc.22351; de Tudela MVP, 2010, J NEUROCHEM, V113, P819, DOI 10.1111/j.1471-4159.2010.06648.x; Wakao Shohei, 2012, Cells, V1, P1045, DOI 10.3390/cells1041045; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wheler JJ, 2014, CANCER CHEMOTH PHARM, V73, P495, DOI 10.1007/s00280-014-2384-1; Wu CP, 2014, HEAD NECK-J SCI SPEC, V36, P1279, DOI 10.1002/hed.23447; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	66	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162916	10.1371/journal.pone.0162916	http://dx.doi.org/10.1371/journal.pone.0162916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627801	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600063
J	Gao, CH; Wang, JZ; Li, C; Zhang, W; Liu, GX				Gao, Chunhai; Wang, Jinzhu; Li, Chong; Zhang, Wei; Liu, Guoxia			A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population	PLOS ONE			English	Article							DNA-REPAIR GENES; LUNG-CANCER RISK; ENVIRONMENT INTERACTION; NER PATHWAY; SUSCEPTIBILITY; DAMAGE; XRCC1	Single nucleotide polymorphisms of XPA gene have been studied in several cancers such as rs10817938, rs2808668. However, the role of XPA polymorphisms in patients with oral squamous cell carcinoma (OSCC) remains unclear. Thus, we analyzed the association of XPA polymorphisms with OSCC risk, clinicopathological characteristics and prognosis in the present study. TaqMan genotyping was used to evaluate the frequency of rs10817938, rs2808668 polymorphisms in OSCC patients. The prognostic significance of these polymorphisms was evaluated using Kaplan-Meier curves, Log-Rank analyses, and the Cox proportional hazard model. Luciferase reporterassay, RT-PCR and western blot were used to determine whether rs10817938 could influence transcription activity and XPA expression. The results showed that individuals carrying TC and CC genotypes had significantly greater risk of developing OSCC (OR = 1.42, 95% CI 1.04-1.93; OR = 2.75, 95% CI 1.32-5.71, respectively) when compared with wild-type TT genotype at rs10817938. OSCC patients with C allele at rs10817938 were more susceptible to lymph metastases, poor pathological differentiation and late TNM stage (OR = 1.67, 95% CI 1.17-2.37; OR = 1.64, 95% CI 1.182.28; OR = 1.54, 95% CI 1.11-2.14; respectively). A significant gene-environment interaction between smoking and CC genotype at rs10817938 was observed (COR = 3.60, 95% CI 1.20-10.9) and data also showed that OSCC patients with CC genotype and C allele had worse survival (p<0.001 for both). The T to C substitution at rs10817938 significantly decreased transcription activity of XPA gene, XPA mRNA and protein were also decreased in individuals with C allele at rs10817938. In addition, no significant association of rs2808668 polymorphism with OSCC risk, prognosis could be observed. In conclusion, the present study showed that XPA rs10817938 polymorphism is a functional SNP in vitro and in vivo and a biomarker for poor prognosis in OSCC patients.	[Gao, Chunhai; Wang, Jinzhu] Linyi Peoples Hosp, Dept Clin Lab, Linyi, Shandong, Peoples R China; [Li, Chong; Liu, Guoxia] Jinan Stomatol Hosp, Jinan, Shandong, Peoples R China; [Zhang, Wei] Linyi Peoples Hosp, Dept Rehabil, Linyi, Shandong, Peoples R China		Liu, GX (corresponding author), Jinan Stomatol Hosp, Jinan, Shandong, Peoples R China.	runninglgx@163.com						ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; Butkiewicz D, 2001, CARCINOGENESIS, V22, P593, DOI 10.1093/carcin/22.4.593; Camenisch U, 2008, ADV EXP MED BIOL, V637, P28; Cancela MD, 2010, HEAD NECK-J SCI SPEC, V32, P357, DOI 10.1002/hed.21193; Ding DP, 2012, INT J CANCER, V131, P488, DOI 10.1002/ijc.26391; Duell EJ, 2000, CARCINOGENESIS, V21, P965, DOI 10.1093/carcin/21.5.965; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Guo W, 2008, J CANCER RES CLIN, V134, P263, DOI 10.1007/s00432-007-0283-0; Han W, 2012, CANCER-AM CANCER SOC, V118, P594, DOI 10.1002/cncr.26220; He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hua RX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087057; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Larsen LK, 2002, BIOCHEM J, V366, P767, DOI 10.1042/BJ20011821; Liu J, 2016, ONCOTARGET; Liu J, 2012, MOL BIOL REP, V39, P6791, DOI 10.1007/s11033-012-1504-4; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lou YQ, 2014, TUMOR BIOL, V35, P6607, DOI 10.1007/s13277-014-1824-1; Markopoulos AK, 2012, OPEN DENT J, V6, P126, DOI 10.2174/1874210601206010126; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Mei CR, 2014, THORAC CANCER, V5, P232, DOI 10.1111/1759-7714.12073; Miyashita H, 2001, ONCOL REP, V8, P1133; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Palli D, 2004, EUR J CANCER, V40, P2474, DOI 10.1016/j.ejca.2004.07.012; Rafiq R, 2016, TUMOUR BIOL; Ruiz-Cosano J, 2013, J BUON, V18, P486; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038606; Spitz MR, 2001, CANCER RES, V61, P1354; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; Sun YN, 2015, INT J CLIN EXP PATHO, V8, P11615; Thoma BS, 2003, MOL CARCINOGEN, V38, P1, DOI 10.1002/mc.10143; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang BC., 2016, ONCOTARGET; Wang Y, 2007, CLIN CANCER RES, V13, P3753, DOI 10.1158/1078-0432.CCR-06-1911; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu XF, 2003, CARCINOGENESIS, V24, P505, DOI 10.1093/carcin/24.3.505; Zhao FL, 2015, INT J CLIN EXP PATHO, V8, P11579; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036293	40	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0160801	10.1371/journal.pone.0160801	http://dx.doi.org/10.1371/journal.pone.0160801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622501	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000003
J	Best, J; Verhulst, S; Syn, WK; Lagaisse, K; van Hul, N; Heindryckx, F; Sowa, JP; Peeters, L; Van Vlierberghe, H; Leclercq, IA; Canbay, A; Dolle, L; van Grunsven, LA				Best, Jan; Verhulst, Stefaan; Syn, Wing-Kin; Lagaisse, Kimberly; van Hul, Noemi; Heindryckx, Femke; Sowa, Jan-Peter; Peeters, Liesbeth; Van Vlierberghe, Hans; Leclercq, Isabelle A.; Canbay, Ali; Dolle, Laurent; van Grunsven, Leo A.			Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; LIVER PROGENITOR CELLS; MURINE MODEL; INJURY; PROLIFERATION; CHOLANGIOCYTES; LIPOSOMES; APOPTOSIS; CIRRHOSIS; LIGATION	Chronic cholangiopathies, such as primary and secondary sclerosing cholangitis, are progressive disease entities, associated with periportal accumulation of inflammatory cells, encompassing monocytes and macrophages, peribiliary extracellular matrix (ECM) deposition and ductular reaction (DR). This study aimed to elucidate the relevance of macrophages in the progression of chronic cholangiopathies through macrophage depletion in a 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) mouse model. One group of mice received a single i.p. injection of Clodronate encapsulated liposomes (CLOLipo) at day 7 of a 14 day DDC treatment, while control animals were co-treated with PBSLipo instead. Mice were sacrificed after 7 or respectively 14 days of treatment for immunohistochemical assessment of macrophage recruitment (F4/80), ECM deposition (Sirius Red, Laminin) and DR (CK19). Macrophage depletion during a 14 day DDC treatment resulted in a significant inhibition of ECM deposition. Porto-lobular migration patterns of laminin-rich ECM and ductular structures were significantly attenuated and a progression of DR was effectively inhibited by macrophage depletion. CLOLipo co-treatment resulted in a confined DR to portal regions without amorphous cell clusters. This study suggests that therapeutic options selectively directed towards macrophages might represent a feasible treatment for chronic cholestatic liver diseases.	[Best, Jan; Verhulst, Stefaan; Lagaisse, Kimberly; Peeters, Liesbeth; Dolle, Laurent; van Grunsven, Leo A.] Vrije Univ Brussel, Dept Basic Biomed Sci, Liver Cell Biol Lab, Brussels, Belgium; [Best, Jan; Sowa, Jan-Peter; Canbay, Ali] Univ Duisburg Essen, Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Syn, Wing-Kin] Inst Hepatol, Fdn Liver Res, London, England; [Syn, Wing-Kin] Med Univ South Carolina, Div Gastroenterol & Hepatol, Charleston, SC USA; [van Hul, Noemi; Leclercq, Isabelle A.] UCL, IREC, Lab Hepatogastroenterol, Brussels, Belgium; [Heindryckx, Femke; Van Vlierberghe, Hans] Univ Ghent, Dept Gastroenterol & Hepatol, Ghent, Belgium; [Syn, Wing-Kin] Ralph H Johnson Veteran Affairs Med Ctr, Gastroenterol Sect, Charleston, SC USA	Vrije Universiteit Brussel; University of Duisburg Essen; University of London; University College London; Medical University of South Carolina; Universite Catholique Louvain; Ghent University	van Grunsven, LA (corresponding author), Vrije Univ Brussel, Dept Basic Biomed Sci, Liver Cell Biol Lab, Brussels, Belgium.	lvgrunsv@vub.ac.be	Van Hul, Noemi/AAB-7985-2020; Verhulst, Stefaan/AAH-7603-2020; Sowa, Jan-Peter/AAQ-6318-2020; van Grunsven, Leo/E-5839-2010; Verhulst, Stefaan/ABD-2923-2020; Canbay, Ali/AAL-9620-2020; Best, Jan/AAG-2350-2020; Syn, Wing-Kin/AAB-8406-2020	Verhulst, Stefaan/0000-0001-6566-6071; van Grunsven, Leo/0000-0002-0990-7034; Best, Jan/0000-0003-2074-0930; Heindryckx, Femke/0000-0002-1987-7676; Van Hul, Noemi/0000-0003-1410-8808; Canbay, Ali/0000-0001-6069-7899	Brustem: Impulse program (Brussels Government) [2011-IP-LS-104-Brustem]; Flemish Government Agency for Innovation by Science and Technology [IWT/SB/121548]; Interuniversity Attraction Poles (IAP)-phase VII (Federal Science Policy-BELSPO) [P7/47]; Research Foundation Flanders (FWO) [G.0333.13N]; Foundation for Liver Research, UK; Deutsche Forschungsgemeinschaft (DFG) [267/4-1, 267/6-1, 267/8-1]; Wilhelm Laupitz Foundation; NICHD;  [FWO G.0348.13N]	Brustem: Impulse program (Brussels Government); Flemish Government Agency for Innovation by Science and Technology; Interuniversity Attraction Poles (IAP)-phase VII (Federal Science Policy-BELSPO); Research Foundation Flanders (FWO)(FWO); Foundation for Liver Research, UK; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); 	This work was supported by the following sources of funding. JB: Brustem: Impulse program 2011-IP-LS-104-Brustem (Brussels Government); SV: Flemish Government Agency for Innovation by Science and Technology, IWT/SB/121548; LD, LvG, NvH, KL & IAL: Interuniversity Attraction Poles (IAP)-phase VII-contract P7/47 (Federal Science Policy-BELSPO), and Brustem: Impulse program 2011-IP-LS-104-Brustem (Brussels Government). HVV, LvG & LD: Research Foundation Flanders (FWO, grant: G.0333.13N); LvG & LD: (FWO G.0348.13N); WKS: Foundation for Liver Research, UK; AC: Deutsche Forschungsgemeinschaft (DFG, grants 267/4-1; 267/6-1 and 267/8-1) and the Wilhelm Laupitz Foundation.; We thank Danielle Blyweert, Tom Schouteet, Bill Roskams, Nathalie Eysackers, Jie Mei, Christophe Empsen, Jan Martin Schlattjan and Svenja Sydor for their excellent technical assistance and we express our sincerest thanks to Jean-Marc Lazou and Kris Deromfor their administrative assistance. The TROMA-III antibody developed by Rolf Kemler was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA52242.	Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767; Alpini G, 2002, HEPATOLOGY, V35, P1256, DOI 10.1053/jhep.2002.33541; Alvaro D, 2000, J HEPATOL, V33, P333, DOI 10.1016/S0168-8278(00)80377-3; Alvaro D, 2007, GASTROENTEROLOGY, V132, P415, DOI 10.1053/j.gastro.2006.07.023; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Bird TG, 2013, P NATL ACAD SCI USA, V110, P6542, DOI 10.1073/pnas.1302168110; Bogert PT, 2007, CURR OPIN GASTROEN, V23, P299, DOI 10.1097/MOG.0b013e3280b079fb; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brown AC, 2017, FOOD CHEM TOXICOL, V107, P472, DOI 10.1016/j.fct.2016.07.001; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Chang ML, 2005, WORLD J GASTROENTERO, V11, P4167; Desmet VJ, 2009, HEPATOLOGY, V50, P333, DOI 10.1002/hep.23152; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Hirschfield GM, 2013, CLIN LIVER DIS, V17, P147, DOI 10.1016/j.cld.2012.12.002; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Lazaridis KN, 2008, J GASTROINTEST SURG, V12, P417, DOI 10.1007/s11605-007-0344-3; Lazaridis KN, 2015, MAYO CLIN PROC, V90, P791, DOI 10.1016/j.mayocp.2015.03.017; LeSage G, 1996, GASTROENTEROLOGY, V111, P1633, DOI 10.1016/S0016-5085(96)70027-6; Lorenzini S, 2010, GUT, V59, P645, DOI 10.1136/gut.2009.182345; Mendes F, 2010, NAT REV GASTRO HEPAT, V7, P611, DOI 10.1038/nrgastro.2010.155; Mousa HS, 2016, AUTOIMMUN REV, V15, P870, DOI 10.1016/j.autrev.2016.07.003; Nayagam JS, 2016, WORLD J HEPATOL, V8, P265, DOI 10.4254/wjh.v8.i5.265; POPPER HANS, 1957, JOUR MT SINAI HOSP, V24, P551; Priester Sally, 2010, World J Gastrointest Pathophysiol, V1, P30, DOI 10.4291/wjgp.v1.i2.30; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Scheuer PJ, 1998, MAYO CLIN PROC, V73, P179; Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022; Svegliati-Baroni G, 2008, LIVER INT, V28, P1052, DOI 10.1111/j.1478-3231.2008.01825.x; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Van Hul N, 2011, AM J PATHOL, V179, P1839, DOI 10.1016/j.ajpath.2011.06.042; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wagner M., 2016, F1000RESEARCH, V5	36	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162286	10.1371/journal.pone.0162286	http://dx.doi.org/10.1371/journal.pone.0162286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618307	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100015
J	Nikkhoo, N; Cumby, N; Gulak, PG; Maxwell, KL				Nikkhoo, Nasim; Cumby, Nichole; Gulak, P. Glenn; Maxwell, Karen L.			Rapid Bacterial Detection via an All-Electronic CMOS Biosensor	PLOS ONE			English	Article							ION-SELECTIVE ELECTRODES; LABEL-FREE DETECTION; COLI O157/H7; STATE; VIRULENCE	The timely and accurate diagnosis of infectious diseases is one of the greatest challenges currently facing modern medicine. The development of innovative techniques for the rapid and accurate identification of bacterial pathogens in point-of-care facilities using low-cost, portable instruments is essential. We have developed a novel all-electronic biosensor that is able to identify bacteria in less than ten minutes. This technology exploits bacteriocins, protein toxins naturally produced by bacteria, as the selective biological detection element. The bacteriocins are integrated with an array of potassium-selective sensors in Complementary Metal Oxide Semiconductor technology to provide an inexpensive bacterial biosensor. An electronic platform connects the CMOS sensor to a computer for processing and real-time visualization. We have used this technology to successfully identify both Gram-positive and Gram-negative bacteria commonly found in human infections.	[Nikkhoo, Nasim; Gulak, P. Glenn] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Cumby, Nichole; Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Cumby, Nichole] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Gulak, PG (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada.; Maxwell, KL (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.	gulak@eecg.toronto.edu; karen.maxwell@utoronto.ca		Maxwell, Karen/0000-0002-0211-5480	Canadian Institutes of Health Research (CIHR) [MOP-62796, XNE86943]; NSERC [RGPIN -36580-09]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Canadian Institutes of Health Research (CIHR) operating grant to KLM (MOP-62796), a CIHR Emerging Team Grant to KLM and PGG (XNE86943) and an NSERC grant to PGG (RGPIN -36580-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2014, CLIN MICROBIOL REV, V27, P631, DOI 10.1128/CMR.00120-13; Baffone W, 2003, INT J FOOD MICROBIOL, V89, P31, DOI 10.1016/S0168-1605(03)00102-8; Bakker E, 2002, ANAL CHEM, V74, p420A, DOI 10.1021/ac022086f; Bausells J, 1999, SENSORS ACTUATORS B, V57; BENEDETTI H, 1991, J MOL BIOL, V217, P429, DOI 10.1016/0022-2836(91)90747-T; Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5; BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688; BOURDINEAUD JP, 1990, P NATL ACAD SCI USA, V87, P1037, DOI 10.1073/pnas.87.3.1037; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; CDC, 2013, ANTIBIOTIC RESISTANC; Chan KY, 2013, BIOSENS BIOELECTRON, V41, P532, DOI 10.1016/j.bios.2012.09.016; Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855; de la Rica R, 2009, ANAL CHEM, V81, P3830, DOI 10.1021/ac9001854; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gasparyan VK, 2013, ANAL CHIM ACTA, V766, P83, DOI 10.1016/j.aca.2012.12.015; Glynn Barry, 2006, V345, P97; Hu JB, 2016, TRAC-TREND ANAL CHEM, V76, P102, DOI 10.1016/j.trac.2015.11.004; Joung CK, 2013, BIOSENS BIOELECTRON, V44, P210, DOI 10.1016/j.bios.2013.01.024; Lai CZ, 2009, J SOLID STATE ELECTR, V13, P123, DOI 10.1007/s10008-008-0579-2; Ligler FS, 2007, ANAL SCI, V23, P5, DOI 10.2116/analsci.23.5; Maalouf R, 2007, ANAL CHEM, V79, P4879, DOI 10.1021/ac070085n; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Michalska AJ, 2004, ANAL CHEM, V76, P2031, DOI 10.1021/ac0353132; MOSS SD, 1975, ANAL CHEM, V47, P2238, DOI 10.1021/ac60363a005; Mouffouk F, 2011, BIOSENS BIOELECTRON, V26, P3517, DOI 10.1016/j.bios.2011.01.037; Narsaiah K, 2012, J FOOD SCI TECH MYS, V49, P383, DOI 10.1007/s13197-011-0437-6; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Ohk SH, 2013, FOOD MICROBIOL, V33, P166, DOI 10.1016/j.fm.2012.09.013; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; OLIVER JD, 1995, APPL ENVIRON MICROB, V61, P2620, DOI 10.1128/AEM.61.7.2620-2623.1995; Pitt TL, METHODS MOL BIOL, P5; PRESSLER U, 1986, J BIOL CHEM, V261, P2654; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Summers WC, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P5; Tripathi SM, 2012, BIOSENS BIOELECTRON, V35, P308, DOI 10.1016/j.bios.2012.03.006; WENDT L, 1970, J BACTERIOL, V104, P1236, DOI 10.1128/JB.104.3.1236-1241.1970; World Health Organization, 2004, WORLD HLTH REP 2004; Zourob Mohammed, 2008, P139, DOI 10.1007/978-0-387-75113-9_8	38	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162438	10.1371/journal.pone.0162438	http://dx.doi.org/10.1371/journal.pone.0162438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618185	gold, Green Published, Green Submitted			2022-12-26	WOS:000383653100024
J	Sharma, P; Dahiya, S; Balaji, V; Kanga, A; Panda, P; Das, R; Dhanraju, A; Mendiratta, DK; Sood, S; Das, BK; Kapil, A				Sharma, Priyanka; Dahiya, Sushila; Balaji, Veeraraghavan; Kanga, Anil; Panda, Preetilata; Das, Rashna; Dhanraju, Anbumani; Mendiratta, Deepak Kumar; Sood, Seema; Das, Bimal Kumar; Kapil, Arti			Typhoidal Salmonellae: Use of Multi-Locus Sequence Typing to Determine Population Structure	PLOS ONE			English	Article							HAEMOPHILUS-INFLUENZAE; TYPHI; STRAINS; RESISTANCE; DIVERSITY; SEROTYPES; NUMBER; FEVER; INDIA	Enteric fever is an invasive infection predominantly caused by Salmonella enterica serovars Typhi and Paratyphi A. The pathogens have evolved from other nontyphoidal salmonellaeto become invasive and host restricted. Emergence of antimicrobial resistance in typhoidal salmonellae in some countries is a major therapeutic concern as the travelers returning from endemic countries carry resistant strains to non endemic areas. In order to understand the epidemiology and to design disease control strategies molecular typing of the pathogen is very important. We performed Multilocus Sequence Typing (MLST) of 251 S. Typhi and 18 S. Paratyphi strains isolated from enteric fever patients from seven centers across India during 2010-2013 to determine the population structure and prevalence of MLST sequence types in India. MLST analysis revealed the presence of five sequence types (STs) of typhoidal salmonellae in India namely ST1, ST2 and ST3 for S. Typhi and ST85 and ST129 for S. Paratyphi A. S. Typhi strains showed monophyletic lineage and clustered in to 3 Sequence Types-ST1, ST2 and ST3 and S. Paratyphi A isolates segregated in two sequence types ST85 and ST129 respectively. No association was found between antimicrobial susceptibility and sequence types. This study found ST1 as the most prevalent sequence type of S. Typhi in India followed by ST2, which is in concordance with previous studies and MLST database. In addition a rare sequence type ST3 has been found which is reported for the first time from the Indian subcontinent. Amongst S. Paratyphi A, the most common sequence type is ST129 as also reported from other parts of world. This distribution and prevalence suggest the common spread of the sequence types across the globe and these findings can help in understanding the disease distribution.	[Sharma, Priyanka; Dahiya, Sushila; Sood, Seema; Das, Bimal Kumar; Kapil, Arti] All India Inst Med Sci, New Delhi, India; [Balaji, Veeraraghavan] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Kanga, Anil] Indira Gandhi Med Coll, Shimla, India; [Panda, Preetilata] Maharaja Krishna Chandra Gajapati Med Coll, Brahmapur, Orissa, India; [Das, Rashna] North Eastern Indira Gandhi Reg Inst Hlth & Med S, Shillong, Meghalaya, India; [Dhanraju, Anbumani] Sri Ramachandra Med Coll & Res Inst, Madras, Tamil Nadu, India; [Mendiratta, Deepak Kumar] Mahatma Gandhi Inst Med Sci, Wardha, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Christian Medical College & Hospital (CMCH) Vellore; Indira Gandhi Medical College & Hospital Shimla; North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS); Sri Ramachandra Institute of Higher Education & Research; Mahatma Gandhi Institute of Medical Sciences, Sevagram	Kapil, A (corresponding author), All India Inst Med Sci, New Delhi, India.	akapilmicro@gmail.com	Dahiya, Sushila/GOG-9170-2022	Veeraraghavan, Balaji/0000-0002-8662-4257; Sharma, priyanka/0000-0002-8853-1126	ICMR (Indian Council of Medical Research), India [5/3/3/13/2008-ECD I]	ICMR (Indian Council of Medical Research), India(Indian Council of Medical Research (ICMR))	The study was funded by ICMR (Indian Council of Medical Research), India, Grant No: 5/3/3/13/2008-ECD I, URL:http://www.icmr.nic.in/.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Capoor Malini R., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P1170; Clinical and Laboratory Standards Institute, 2015, M10025 CLSI S; Collee JG, 1996, MACKIE MCCARTNEY PRA; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Dahiya S, 2013, INDIAN J MED RES, V137, P957; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gokul BN, 2010, EMERG INFECT DIS, V16, P1170, DOI 10.3201/eid1607.091643; Grimont PA, 2007, ANTIGENIC FORMULAE S, V9th; Kadhiravan T, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-37; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kwong JC, 2015, PATHOLOGY, V47, P199, DOI 10.1097/PAT.0000000000000235; Martinez-Gamboa A, 2015, INT MICROBIOL, V18, P99, DOI 10.2436/20.1501.01.239; Mohanty S, 2006, EPIDEMIOL INFECT, V134, P961, DOI 10.1017/S0950268805005844; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nusch-Inderbinen M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0948-2; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Renuka K, 2004, MICROB DRUG RESIST, V10, P146, DOI 10.1089/1076629041310028; Sabat AJ, 2013, EUROSURVEILLANCE, V24, P18; Saikia KK, 2011, INDIAN J MED MICROBI, V29, P158, DOI 10.4103/0255-0857.81800; Saikia KK, 2012, INDIAN J MED RES, V136, P855; Sankar S, 2013, MOL DIAGN THER, V17, P257, DOI 10.1007/s40291-013-0034-7; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Zhang HF, 2011, CROAT MED J, V52, P688, DOI 10.3325/cmj.2011.52.688	32	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162530	10.1371/journal.pone.0162530	http://dx.doi.org/10.1371/journal.pone.0162530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618626	Green Submitted, Green Published, gold			2022-12-26	WOS:000383653100028
J	Song, QJ; Weng, XG; Cai, DJ; Zhang, W; Wang, JF				Song, Quan-Jiang; Weng, Xiao-Gang; Cai, Dong-Jie; Zhang, Wang; Wang, Jiu-Feng			Forsythoside A Inhibits BVDV Replication via TRAF2-Dependent CD28-4-1BB Signaling in Bovine PBMCs	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; T-CELL FUNCTION; CYTOKINE RESPONSES; FAMILY-MEMBERS; TNFR FAMILY; 4-1BB; COSTIMULATION; ACTIVATION; INFECTION; CALVES	Bovine viral diarrhea virus (BVDV), the causative agent of bovine viral diarrhea/mucosal disease (BVD/MD), is an important pathogen of cattle and other wild animals throughout the world. BVDV infection typically leads to an impaired immune response in cattle. In the present study, we investigated the effect of Forsythoside A (FTA) on BVDV infection of bovine peripheral blood mononuclear cells (PBMCs). We found that Forsythoside A could not only promote proliferation of PBMCs and T cells activation but also inhibit the replication of BVDV as well as apoptosis induced by BVDV. FTA treatment could counteract the BVDV-induced overproduction of IFN-gamma to maintain the immune homeostasis in bovine PBMCs. At same time, FTA can enhance the secretion of IL-2. What's more, BVDV promotes the expression of CD28, 4-1BB and TRAF-2, which can be modulated by FTA. Our data suggest that FTA protects PBMCs from BVDV infection possibly via TRAF2-dependent CD28-4-1BB signaling, which may activate PBMCs in response to BVDV infection. Therefore, this aids in the development of an effective adjuvant for vaccines against BVDV and other specific FTA-based therapies for preventing BVDV infection.	[Song, Quan-Jiang; Cai, Dong-Jie; Zhang, Wang; Wang, Jiu-Feng] China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China; [Weng, Xiao-Gang] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China	China Agricultural University; Northeast Agricultural University - China	Wang, JF (corresponding author), China Agr Univ, Dept Vet Clin Sci, Coll Vet Med, Beijing, Peoples R China.	jiufeng_wang@hotmail.com						Aschermann S, 2010, CLIN EXP IMMUNOL, V160, P161, DOI 10.1111/j.1365-2249.2009.04081.x; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Beyersdorf N, 2015, IMMUNOTARGETS THER, V4, P111, DOI 10.2147/ITT.S61647; Biburger M, 2014, ADV IMMUNOL, V124, P67, DOI 10.1016/B978-0-12-800147-9.00003-0; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Brodersen BW, 1999, VIRAL IMMUNOL, V12, P323, DOI 10.1089/vim.1999.12.323; Cao JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077922; Chase CCL, 2013, BIOLOGICALS, V41, P52, DOI 10.1016/j.biologicals.2012.09.009; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng L, 2015, INT IMMUNOPHARMACOL, V28, P494, DOI 10.1016/j.intimp.2015.07.011; Cho HC, 2015, GUT LIVER; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Dawicki W, 2004, J IMMUNOL, V173, P5944, DOI 10.4049/jimmunol.173.10.5944; Degen Winfried G J, 2003, Expert Rev Vaccines, V2, P327, DOI 10.1586/14760584.2.2.327; Dumitriu IE, 2012, CIRC RES, V110, P857, DOI 10.1161/CIRCRESAHA.111.261933; Gardner D, 2014, AM J TRANSPLANT, V14, P1985, DOI 10.1111/ajt.12834; Glew EJ, 2003, J GEN VIROL, V84, P1771, DOI 10.1099/vir.0.18964-0; Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031; Hirao LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024250; Hou L, 1998, VIRAL IMMUNOL, V11, P233, DOI 10.1089/vim.1998.11.233; HOUE H, 1995, VET CLIN N AM-FOOD A, V11, P521, DOI 10.1016/S0749-0720(15)30465-5; Huang CK, 2014, NEUROCHEM RES, V40, P1; Jegaskanda S, 2014, J IMMUNOL, V193, P469, DOI 10.4049/jimmunol.1400432; Karcher EL, 2008, VET IMMUNOL IMMUNOP, V124, P50, DOI 10.1016/j.vetimm.2008.01.006; Ko HC, 2005, J ETHNOPHARMACOL, V102, P418, DOI 10.1016/j.jep.2005.06.029; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Li HW, 2011, PHYTOTHER RES, V25, P338, DOI 10.1002/ptr.3260; Lim HS, 2015, J IMMUNOL, V195, P5432, DOI 10.4049/jimmunol.1500707; Lin FC, 2014, CYTOKINE GROWTH F R, V25, P369, DOI 10.1016/j.cytogfr.2014.07.015; Lin GHY, 2009, J IMMUNOL, V182, P934, DOI 10.4049/jimmunol.182.2.934; Martinez-Forero I, 2013, J IMMUNOL, V190, P6694, DOI 10.4049/jimmunol.1203010; Mbanwi AN, 2014, SEMIN IMMUNOL, V26, P210, DOI 10.1016/j.smim.2014.05.001; McPherson AJ, 2012, J BIOL CHEM, V287, P23010, DOI 10.1074/jbc.M112.350538; Nobuhiro N, 2009, PLOS PATHOG, V5, P15332; Oh HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126765; Palomares RA, 2014, VET RES COMMUN, V38, P329, DOI 10.1007/s11259-014-9613-2; Pedrera M, 2009, J COMP PATHOL, V141, P52, DOI 10.1016/j.jcpa.2009.03.004; Polak MP, 2000, COMP IMMUNOL MICROB, V23, P141, DOI 10.1016/S0147-9571(99)00060-0; POTGIETER LND, 1995, VET CLIN N AM-FOOD A, V11, P501, DOI 10.1016/S0749-0720(15)30464-3; Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006; Rhodes SG, 1999, J GEN VIROL, V80, P1673, DOI 10.1099/0022-1317-80-7-1673; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Ridpath JF, 2006, VIRUS RES, V118, P62, DOI 10.1016/j.virusres.2005.11.014; Ridpath JF, 2013, BIOLOGICALS, V41, P14, DOI 10.1016/j.biologicals.2012.07.003; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Sercan O, 2010, J IMMUNOL, V184, P2855, DOI 10.4049/jimmunol.0902708; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Turin L, 2012, J VET MED SCI, V74, P1397, DOI 10.1292/jvms.12-0011; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wang C, 2012, J EXP MED, V209, P77, DOI 10.1084/jem.20110675; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Wang XF, 2013, J VIRAL HEPATITIS, V20, P27, DOI 10.1111/jvh.12061; Whitmire JK, 2007, J IMMUNOL, V179, P1190, DOI 10.4049/jimmunol.179.2.1190; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Zhang FJ, 2014, J ANIM SCI, V92, P3026, DOI 10.2527/jas.2013-6932; Zhang G, 1996, J GEN VIROL, V77, P1677, DOI 10.1099/0022-1317-77-8-1677; Zhuge ZY, 2010, PLOS ONE, V7, P1	64	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162791	10.1371/journal.pone.0162791	http://dx.doi.org/10.1371/journal.pone.0162791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617959	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100053
J	Huang, ZR; Tsai, CL; Huang, YY; Shiue, CY; Tzen, KY; Yen, RF; Hsin, LW				Huang, Zih-Rou; Tsai, Chia-Ling; Huang, Ya-Yao; Shiue, Chyng-Yann; Tzen, Kai-Yuan; Yen, Ruoh-Fang; Hsin, Ling-Wei			A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2	PLOS ONE			English	Article							BETA-CELL MASS; ALPHA-DIHYDROTETRABENAZINE; PARKINSONS-DISEASE; 2 ISOFORMS; RAT-BRAIN; BINDING; VMAT2; PET; RADIOLIGAND; C-11-(+)-ALPHA-DIHYDROTETRABENAZINE	In the early 1990s, 9-(+)-C-11-dihydrotetrabenazine (9-(+)-C-11-DTBZ) was shown to be a useful positron emission tomography (PET) imaging agent for various neurodegenerative disorders. Here, we described the radiosynthesis and evaluation of the 9-(+)-C-11-DTBZ analog, 10-(+)-C-11-DTBZ, as a vesicular monoamine transporter2 (VMAT2) imaging agent and compare it with 9-(+)-C-11-DTBZ. 10-(+)-C-11-DTBZ was obtained by C-11-MeI methylation with its 10 hydroxy precursor in the presence of 5 M NaOH. It had a slightly better average radiochemical yield of 35.3 +/- 3.6% (decay-corrected to end of synthesis (EOS)) than did 9-(+)-C-11-DTBZ (30.5 +/- 2.3%). MicroPET studies showed that 10-(+)-C-11-DTBZ had a striatum-to-cerebellum ratio of 3.74 +/- 0.21 at 40 min post-injection, while the ratio of 9-(+)-C-11-DTBZ was 2.50 +/- 0.33. This indicated that 10-(+)-C-11-DTBZ has a higher specific uptake in VMAT2-rich brain regions, and 10-(+)-C-11-DTBZ may be a potential VMAT2 radioligand. Our experiment is the first study of 10-(+)-C-11-DTBZ to include dynamic brain distribution in rat brains.	[Huang, Zih-Rou; Hsin, Ling-Wei] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Tsai, Chia-Ling; Huang, Ya-Yao; Shiue, Chyng-Yann; Tzen, Kai-Yuan; Yen, Ruoh-Fang] Natl Taiwan Univ Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan; [Shiue, Chyng-Yann; Yen, Ruoh-Fang; Hsin, Ling-Wei] Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan; [Shiue, Chyng-Yann] Triserv Gen Hosp, Dept Nucl Med, PET Ctr, Taipei, Taiwan; [Hsin, Ling-Wei] Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Tri-Service General Hospital; National Taiwan University	Hsin, LW (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Mol Imaging Ctr, Taipei, Taiwan.; Hsin, LW (corresponding author), Natl Taiwan Univ, Ctr Innovat Therapeut Discovery, Taipei, Taiwan.	lwhsin@ntu.edu.tw	Huang, Ya-Yao/AAR-9221-2020	Huang, Ya-Yao/0000-0002-3460-7922; YEN, RUOH-FANG/0000-0003-1648-6482; TZEN, KAI-YUAN/0000-0002-5657-8579	 [NSC98-2320-B-002-028-MY3]		Support was provided by NSC98-2320-B-002-028-MY3.	Anlauf M, 2003, J HISTOCHEM CYTOCHEM, V51, P1027, DOI 10.1177/002215540305100806; Blesa J, 2010, NEUROBIOL DIS, V38, P456, DOI 10.1016/j.nbd.2010.03.006; Bohnen NI, 2006, J CEREBR BLOOD F MET, V26, P1198, DOI 10.1038/sj.jcbfm.9600276; Boileau I, 2010, SYNAPSE, V64, P417, DOI 10.1002/syn.20743; Chang CC, 2015, EUR J NEUROL, V22, P845, DOI 10.1111/ene.12672; Chen JJ, 2012, CLIN THER, V34, P1487, DOI 10.1016/j.clinthera.2012.06.010; Collantes M, 2008, REV ESP MED NUCL, V27, P103; DASILVA JN, 1993, APPL RADIAT ISOTOPES, V44, P1487, DOI 10.1016/0969-8043(93)90103-H; Deng AF, 2014, AAPS J, V16, P592, DOI 10.1208/s12248-014-9584-9; Erickson JD, 1996, P NATL ACAD SCI USA, V93, P5166, DOI 10.1073/pnas.93.10.5166; Freyberg Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10652; Goswami R, 2006, NUCL MED BIOL, V33, P685, DOI 10.1016/j.nucmedbio.2006.05.006; Harris PE, 2008, J MOL MED, V86, P5, DOI 10.1007/s00109-007-0242-x; KILBOURN M, 1995, EUR J PHARMACOL, V278, P249, DOI 10.1016/0014-2999(95)00162-E; Kilbourn MR, 2010, NUCL MED BIOL, V37, P869, DOI 10.1016/j.nucmedbio.2010.06.001; Kilbourn MR, 2010, NUCL MED BIOL, V37, P3, DOI 10.1016/j.nucmedbio.2009.08.013; Kilbourn MR, 2004, NUCL MED BIOL, V31, P591, DOI 10.1016/j.nucmedbio.2004.02.003; Koeppe RA, 2005, J NUCL MED, V46, P936; Koeppe RA, 1999, J CEREBR BLOOD F MET, V19, P1376, DOI 10.1097/00004647-199912000-00011; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; Kumar A, 2014, BIOORG MED CHEM LETT, V24, P5663, DOI 10.1016/j.bmcl.2014.10.070; Li XM, 2014, ARCH PHARM, V347, P313, DOI 10.1002/ardp.201300307; Penthala NR, 2013, BIOORG MED CHEM LETT, V23, P3342, DOI 10.1016/j.bmcl.2013.03.092; Piel M, 2014, J MED CHEM, V57, P9232, DOI 10.1021/jm5001858; Quincoces G, 2008, REV ESP MED NUCL, V27, P13; Simpson NR, 2006, NUCL MED BIOL, V33, P855, DOI 10.1016/j.nucmedbio.2006.07.002; Singhal T, 2011, MOL IMAGING BIOL, V13, P973, DOI 10.1007/s11307-010-0406-x; Souza F, 2006, J CLIN INVEST, V116, P1506, DOI 10.1172/JCI27645; Tong JC, 2008, SYNAPSE, V62, P873, DOI 10.1002/syn.20573; Zhu L, 2009, BIOORG MED CHEM LETT, V19, P5026, DOI 10.1016/j.bmcl.2009.07.048	30	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161295	10.1371/journal.pone.0161295	http://dx.doi.org/10.1371/journal.pone.0161295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612194	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900015
J	Jang, MK; Lee, S; Jung, MH				Jang, Min-Kyung; Lee, Sunwoo; Jung, Myeong Ho			RNA-Seq Analysis Reveals a Negative Role of KLF16 in Adipogenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ADIPOCYTE DIFFERENTIATION; GAMMA EXPRESSION; FAMILY	In this study, we performed high throughput RNA sequencing at the preadipocyte (D0) and differentiated adipocyte (D7) stages of primary brown preadipocyte differentiation in order to characterize the transcriptional events regulating differentiation and function. Compared to the preadipocyte stage (D0), 6,668 genes were identified as differentially expressed genes (DEGs) with a fold change of >= 2.0 at the differentiated adipocyte stage (D7). Several adipogenic genes including peroxisome proliferator-activated receptor-gamma (PPAR.) and CCAAT/enhancer-binding protein-alpha (C/EBP alpha), and Kruppel-like factor (KLF) family genes were differentially expressed at D0 and D7. Since KLF16 gene expression was downregulated at day 7 and its adipogenic function has not been characterized, we investigated its role in adipogenesis. Knockdown of KLF16 stimulated the differentiation of both brown and 3T3-L1 preadipocytes, and led to increased PPAR. expression. However, overexpression of KLF16 had opposite effects. Furthermore, KLF16 downregulated PPAR. expression in brown adipocytes and inhibited its promoter activity. These results indicate that KLF16 inhibits adipogenesis through downregulation of PPAR. expression.	[Jang, Min-Kyung; Jung, Myeong Ho] Pusan Natl Univ, Sch Korean Med, Div Longev & Biofunct Med, Yangsan, Gyeongnam, South Korea; [Lee, Sunwoo] GenomicWorks, Daejeon, South Korea	Pusan National University	Jung, MH (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Longev & Biofunct Med, Yangsan, Gyeongnam, South Korea.	jung0603@pusan.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C1310]; GenomicWorks	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; GenomicWorks	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1310). GenomicWorks provided support in the form of salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Brey CW, 2009, INT J BIOL SCI, V5, P622; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Jang MK, 2014, BIOCHEM BIOPH RES CO, V454, P58, DOI 10.1016/j.bbrc.2014.10.028; Kimura H, 2014, GENE, V534, P169, DOI 10.1016/j.gene.2013.10.065; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Yao YX, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003295; Zhang ZW, 2013, ACTA BIOCH BIOPH SIN, V45, P280, DOI 10.1093/abbs/gmt010	17	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162238	10.1371/journal.pone.0162238	http://dx.doi.org/10.1371/journal.pone.0162238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611969	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900065
J	Yanaihara, N; Noguchi, Y; Saito, M; Takenaka, M; Takakura, S; Yamada, K; Okamoto, A				Yanaihara, Nozomu; Noguchi, Yukiko; Saito, Misato; Takenaka, Masataka; Takakura, Satoshi; Yamada, Kyosuke; Okamoto, Aikou			MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; CANCER-CELLS; AMPLIFICATION; ONCOMIRS; NETWORK; DEFINES; PLAYERS; FAMILY	Previous studies have identified microRNA (miRNA) involvement in human cancers. This study aimed to elucidate potential clinical and biological associations of ovarian cancer-related miRNA gene expression profiles in high-grade serous carcinoma (HGSC) and ovarian clear cell carcinoma (OCCC). Accordingly, we investigated 27 patients with ovarian cancer (12 HGSC and 15 OCCC cases) using quantitative real-time reverse transcription polymerase chain reaction to determine the cancer-related miRNA expressions. Gene Cluster 3.0 was used for hierarchical clustering analysis, and differentially expressed miRNAs between HGSC and OCCC were identified by the class comparison analysis using BRB-Array Tools. An unsupervised hierarchical clustering analysis identified two distinct miRNA expression clusters, with histological subtype-related significant differences in the associations between clusters and clinicopathological features. A comparison of miRNA expression in HGSCs and OCCCs identified five miRNAs (miR-132, miR-9, miR-126, miR-34a, and miR-21), with OCCCs demonstrating a statistically higher expression. Further investigation of the biological significance of miR-9 overexpression in OCCC revealed that miR-9 inhibition reduced the cell invasion ability and upregulated E-cadherin expression. Using a luciferase reporter assay, we further demonstrated the direct binding of miR-9 to E-cadherin. Global cancer-related miRNA expression analysis identified statistically unique profiles that could discriminate ovarian cancer histotypes. In OCCC, miR-9 overexpression may affect pathogenesis by targeting E-cadherin, thereby inducing an epithelial-mesenchymal transition. Therefore, miR-9 may be a promising therapeutic target strategy for OCCC.	[Yanaihara, Nozomu; Noguchi, Yukiko; Saito, Misato; Takenaka, Masataka; Yamada, Kyosuke; Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Takakura, Satoshi] Dokkyo Med Univ, Koshigaya Hosp, Dept Obstet & Gynecol, Saitama, Japan	Jikei University; Dokkyo Medical University	Yanaihara, N (corresponding author), Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan.	yanazou@jikei.ac.jp			Japan Society for the Promotion of Science KAKENHI [25462615, 25462616, JP16K11159]; Jikei University Research Fund for Graduate Students	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Jikei University Research Fund for Graduate Students	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25462615(NY), 25462616(ST), and JP16K11159 (NY) (https://www.jsps.go.jp/j-grantsinaid/) and The Jikei University Research Fund for Graduate Students (YN)(http://j-net.jikei.ac.jp/similar to daigakuin/H24jyoseikinsaitaku.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calura E, 2013, CLIN CANCER RES, V19, P4114, DOI 10.1158/1078-0432.CCR-13-0360; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Chen X, 2015, SCI REP-UK, V5, DOI [10.1038/srep15744, 10.1038/srep17031]; Dalmay T, 2006, ONCOGENE, V25; Davidson B, 2014, GYNECOL ONCOL, V133, P640, DOI 10.1016/j.ygyno.2014.03.575; Elgaaen BV, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-80; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hirata Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-799; Ho CM, 2010, INT J GYNECOL CANCER, V20, P1490, DOI 10.1111/IGC.0b013e3181e68a4d; Huang HN, 2014, HUM PATHOL, V45, P2318, DOI 10.1016/j.humpath.2014.07.020; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jang SG, 2014, INT J GYNECOL CANCER, V24, P1558, DOI 10.1097/IGC.0000000000000267; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lu MH, 2012, CLIN CANCER RES, V18, P6416, DOI 10.1158/1078-0432.CCR-12-0832; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Okamoto A, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5507; Okamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116977; Parikh A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3977; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reshmi G, 2008, FEBS LETT, V582, P4113, DOI 10.1016/j.febslet.2008.11.011; Rotkrua P, 2011, INT J CANCER, V129, P2611, DOI 10.1002/ijc.25923; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Song Y, 2014, ONCOTARGET, V5, P11669, DOI 10.18632/oncotarget.2581; Sun CY, 2013, JNCI-J NATL CANCER I, V105, P1750, DOI 10.1093/jnci/djt302; Sun Y, 2015, J PATHOL, V235, P25, DOI 10.1002/path.4443; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yanaihara N, 2016, MOL CARCINOGEN, V55, P832, DOI 10.1002/mc.22325; Yanaihara N, 2013, CLIN CHEM, V59, P1811, DOI 10.1373/clinchem.2012.198176; Yanaihara N, 2012, INT J ONCOL, V41, P1094, DOI 10.3892/ijo.2012.1533; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020	40	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162584	10.1371/journal.pone.0162584	http://dx.doi.org/10.1371/journal.pone.0162584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612152	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900130
J	Yang, F; Ma, HW; Belcher, J; Butler, MR; Redmond, TM; Boye, SL; Hauswirth, WW; Ding, XQ				Yang, Fan; Ma, Hongwei; Belcher, Joshua; Butler, Michael R.; Redmond, T. Michael; Boye, Sanford L.; Hauswirth, William W.; Ding, Xi-Qin			Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration	FASEB JOURNAL			English	Article						thyroid hormone; photoreceptor; cone degeneration; iopanoic acid	THYROID-HORMONE RECEPTOR; ENDOPLASMIC-RETICULUM STRESS; CONE CELL-DEATH; TYPE-3 DEIODINASE; GENE DELIVERY; MOUSE MODEL; PHOTORECEPTOR DEGENERATION; EXPRESSION; RPE65; MICE	Recent studies have implicated thyroid hormone (TH) signaling in cone photoreceptor viability. Using mouse models of retinal degeneration, we found that antithyroid treatment preserves cones. This work investigates the significance of targeting intracellular TH components locally in the retina. The cellular TH level is mainly regulated by deiodinase iodothyronine (DIO)-2 and -3. DIO2 converts thyroxine (T4) to triiodothyronine (T3), which binds to the TH receptor, whereas DIO3 degrades T3 and T4. We examined cone survival after overexpression of DIO3 and inhibition of DIO2 and demonstrated the benefits of these manipulations. Subretinal delivery of AAV5-IRBP/GNAT2-DIO3, which directs expression of human DIO3 specifically in cones, increased cone density by 30-40% in a Rpe65(-/-) mouse model of Lebers congenital amaurosis (LCA) and in a Cpfl1 mouse with Pde6c defect model of achromatopsia, compared with their respective untreated controls. Intravitreal and topical delivery of the DIO2 inhibitor iopanoic acid also significantly improved cone survival in the LCA model mice. Moreover, the expression levels of DIO2 and Slc16a2 were significantly higher in the diseased retinas, suggesting locally elevated TH signaling. We show that targeting DIOs protects cones, and intracellular inhibition of TH components locally in the retina may represent a novel strategy for retinal degeneration management.	[Yang, Fan; Ma, Hongwei; Belcher, Joshua; Butler, Michael R.; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Butler, Michael R.] NEI, Lab Retinal Cell & Mol Biol, Bethesda, MD 20892 USA; [Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA; [Hauswirth, William W.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Yang, Fan/I-5735-2019	hauswirth, william/0000-0002-3244-4947; Redmond, T. Michael/0000-0002-1813-5291	NIH NEI [P30EY021725, P30EY021721, T32EY023202, R01EY019490, R21EY024583]; Research to Prevent Blindness; Foundation Fighting Blindness; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [T32EY023202, P30EY021721, R01EY019490, P30EY021725, R21EY024583] Funding Source: NIH RePORTER	NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Anand Swaroop [U.S. National Institutes of Health (NIH) National Eye Institute (NEI)] for the Nrl<SUP>-/-</SUP> mouse line; Dr. P. Reed Larsen (Brigham and Women's Hospital Boston, MA, USA) for human DIO3 cDNA; Bruce Baretz (Lipoid LLC, Newark, NJ, USA) for phospholipon 90G; Dr. Cheryl Craft (The University of Southern California, Los Angeles, CA, USA) for anti-M-opsin and anti-cone arrestin antibodies; Dr. Muna Naash (University of Houston, Houston, TX, USA) for anti-S-opsin antibody; Dr. Robert Molday (University of British Columbia, Vancouver, BC, Canada) for mouse anti-rhodopsin antibody 1D4; and Imaging Core Facility of the Department of Cell Biology at the University of Oklahoma Health Sciences Center for technical assistance. This work was supported by NIH NEI Grants P30EY021725, P30EY021721, T32EY023202, R01EY019490, and R21EY024583; an unrestricted grant to the Department of Ophthalmology, University of Florida, from Research to Prevent Blindness; the Foundation Fighting Blindness; and the Knights Templar Eye Foundation. The authors declare no conflicts of interest.	Bernal J, 2013, BBA-GEN SUBJECTS, V1830, P3893, DOI 10.1016/j.bbagen.2012.04.014; Bhumika S, 2015, MOL CELL NEUROSCI, V68, P92, DOI 10.1016/j.mcn.2015.04.002; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bianco AC, 2011, ENDOCRINOLOGY, V152, P3306, DOI 10.1210/en.2011-1104; Bouzaffour M, 2010, GEN COMP ENDOCR, V168, P88, DOI 10.1016/j.ygcen.2010.04.006; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Chaker L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0329-0; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Curcio C, 2001, J BIOL CHEM, V276, P30183, DOI 10.1074/jbc.C100325200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Deeb SS, 2010, OPHTHAL PHYSL OPT, V30, P446, DOI 10.1111/j.1475-1313.2010.00735.x; Dentice M, 2014, CELL METAB, V20, P1038, DOI 10.1016/j.cmet.2014.10.009; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Dyka FM, 2014, ADV EXP MED BIOL, V801, P695, DOI 10.1007/978-1-4614-3209-8_87; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Huang SA, 2008, NAT CLIN PRACT ENDOC, V4, P148, DOI 10.1038/ncpendmet0727; Jo SR, 2012, J NEUROSCI, V32, P8491, DOI 10.1523/JNEUROSCI.6514-11.2012; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Kuiper GGJM, 2003, ENDOCRINOLOGY, V144, P2505, DOI 10.1210/en.2003-0084; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Meulenbelt I, 2008, HUM MOL GENET, V17, P1867, DOI 10.1093/hmg/ddn082; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Olivares EL, 2007, ENDOCRINOLOGY, V148, P4786, DOI 10.1210/en.2007-0043; PASCUAL A, 1987, ENDOCRINOLOGY, V120, P1089, DOI 10.1210/endo-120-3-1089; Peeters RP, 2013, ENDOCRINOLOGY, V154, P550, DOI 10.1210/en.2012-1738; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rowe-Rendleman CL, 2014, INVEST OPHTH VIS SCI, V55, P2714, DOI 10.1167/iovs.13-13707; Safer JD, 2009, THYROID, V19, P181, DOI 10.1089/thy.2008.0227; Sagar GDV, 2008, MOL ENDOCRINOL, V22, P1382, DOI 10.1210/me.2007-0490; SALVATORE D, 1995, J CLIN INVEST, V96, P2421, DOI 10.1172/JCI118299; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Schaeferhoff K, 2010, CELL MOL LIFE SCI, V67, P3173, DOI 10.1007/s00018-010-0376-9; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Tsai TI, 2009, DOC OPHTHALMOL, V119, P199, DOI 10.1007/s10633-009-9191-8; Ueta CB, 2011, ENDOCRINOLOGY, V152, P3571, DOI 10.1210/en.2011-1066; Wassen FWJS, 2002, ENDOCRINOLOGY, V143, P2812, DOI 10.1210/en.143.7.2812; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Xu Jia-peng, 2011, COLLECTED ESSAYS FIN, V3, P3, DOI DOI 10.3791/3612; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yamaguchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2088; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; YOSHIZUMI MO, 1988, RETINA-J RET VIT DIS, V8, P210, DOI 10.1097/00006982-198808030-00012	67	13	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4313	4325		10.1096/fj.201600715R	http://dx.doi.org/10.1096/fj.201600715R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27623928	Green Published			2022-12-26	WOS:000388201500035
J	De La Fuente, S; Fernandez-Sanz, C; Vail, C; Agra, EJ; Holmstrom, K; Sun, JH; Mishra, J; Williams, D; Finkel, T; Murphy, E; Joseph, SK; Sheu, SS; Csordas, G				De La Fuente, Sergio; Fernandez-Sanz, Celia; Vail, Caitlin; Agra, Elorm J.; Holmstrom, Kira; Sun, Junhui; Mishra, Jyotsna; Williams, Dewight; Finkel, Toren; Murphy, Elizabeth; Joseph, Suresh K.; Sheu, Shey-Shing; Csordas, Gyoergy			Strategic Positioning and Biased Activity of the Mitochondrial Calcium Uniporter in Cardiac Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CA2+ UPTAKE; MICU1; MCU; STRESS; COMMUNICATION; HOMEOSTASIS; GATEKEEPER; TRANSPORT; RESPONSES	Control of myocardial energetics by Ca2+ signal propagation to the mitochondrial matrix includes local Ca2+ delivery from sarcoplasmic reticulum (SR) ryanodine receptors (RyR2) to the inner mitochondrial membrane (IMM) Ca2+ uniporter (mtCU). mtCU activity in cardiac mitochondria is relatively low, whereas the IMM surface is large, due to extensive cristae folding. Hence, stochastically distributed mtCU may not suffice to support local Ca2+ transfer. We hypothesized that mtCU concentrated at mitochondria-SR associations would promote the effective Ca2+ transfer. mtCU distribution was determined by tracking MCU and EMRE, the proteins essential for channel formation. Both proteins were enriched in the IMM-outer mitochondrial membrane (OMM) contact point submitochondrial fraction and, as super-resolution microscopy revealed, located more to the mitochondrial periphery (inner boundary membrane) than inside the cristae, indicating high accessibility to cytosol-derived Ca2+ inputs. Furthermore, MCU immunofluorescence distribution was biased toward the mitochondria-SR interface (RyR2), and this bias was promoted by Ca2+ signaling activity in intact cardiomyocytes. The SR fraction of heart homogenate contains mitochondria with extensive SR associations, and these mitochondria are highly enriched in EMRE. Size exclusion chromatography suggested for EMRE- and MCU-containing complexes a wide size range and also revealed MCU-containing complexes devoid of EMRE (thus disabled) in the mitochondrial but not the SR fraction. Functional measurements suggested more effective mtCU-mediated Ca2+ uptake activity by the mitochondria of the SR than of the mitochondrial fraction. Thus, mtCU "hot spots" can be formed at the cardiac muscle mitochondria-SR associations via localization and assembly bias, serving local Ca2+ signaling and the excitation-energetics coupling.	[De La Fuente, Sergio; Vail, Caitlin; Agra, Elorm J.; Joseph, Suresh K.; Csordas, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Mitochondrial Imaging Res & Diagnost, 527J Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA; [Holmstrom, Kira; Finkel, Toren] NHLBI, Ctr Mol Med, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Sun, Junhui; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, Lab Cardiac Physiol, NIH, Bethesda, MD 20892 USA; [Mishra, Jyotsna; Sheu, Shey-Shing] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Williams, Dewight] Univ Penn, Penn EM Resource Lab, Philadelphia, PA 19104 USA	Jefferson University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Jefferson University; University of Pennsylvania	Csordas, G (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr Mitochondrial Imaging Res & Diagnost, 527J Jefferson Alumni Hall,1020 Locust St, Philadelphia, PA 19107 USA.	Gyorgy.Csordas@jefferson.edu	Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601; Fernandez-Sanz, Celia/0000-0002-3437-7792; Holmstrom, Kira/0000-0001-6434-7909; De la Fuente, Sergio/0000-0001-7823-063X; , Sergio/0000-0002-8021-2390; Mishra, Jyotsna/0000-0002-7798-4891; Csordas, Gyorgy/0000-0003-3156-1460; Fernandez Sanz, Celia/0000-0002-0809-0675	NHLBI, National Institutes of Health [RO1 HL122124]; American Heart Association Postdoctoral Fellowship [16POST27770032]; National Institutes of Health [RO1 DK103558]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122124, ZIGHL006020, ZIAHL002066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103558] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Postdoctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NHLBI, National Institutes of Health, Grant RO1 HL122124 (to G. C. and S. S. S.), by American Heart Association Postdoctoral Fellowship 16POST27770032 (to S. F.), and National Institutes of Health Grant RO1 DK103558 (to S. K. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony AN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10955; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Boyman L, 2014, BIOPHYS J, V107, P1289, DOI 10.1016/j.bpj.2014.07.045; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; Chen Y, 2012, CIRC RES, V111, P863, DOI 10.1161/CIRCRESAHA.112.266585; Cosson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046293; Csordas G, 2001, TRENDS CARDIOVAS MED, V11, P269, DOI 10.1016/S1050-1738(01)00123-2; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Despa S, 2014, CIRC RES, V115, P339, DOI 10.1161/CIRCRESAHA.115.303582; Fernandez-Sanz C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.526; Fieni F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2325; Filadi R, 2015, P NATL ACAD SCI USA, V112, pE2174, DOI 10.1073/pnas.1504880112; Franzini-Armstrong C, 2007, PHYSIOLOGY, V22, P261, DOI 10.1152/physiol.00017.2007; Fulop L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025199; Garcia-Perez C, 2008, J BIOL CHEM, V283, P32771, DOI 10.1074/jbc.M803385200; Garcia-Perez C, 2011, AM J PHYSIOL-HEART C, V301, pH1907, DOI 10.1152/ajpheart.00397.2011; Holmstrom KM, 2015, J MOL CELL CARDIOL, V85, P178, DOI 10.1016/j.yjmcc.2015.05.022; Huang XH, 2013, P NATL ACAD SCI USA, V110, P2846, DOI 10.1073/pnas.1300741110; Kamer KJ, 2015, NAT REV MOL CELL BIO, V16, P545, DOI 10.1038/nrm4039; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kovacs-Bogdan E, 2014, P NATL ACAD SCI USA, V111, P8985, DOI 10.1073/pnas.1400514111; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011; Lu XY, 2013, CIRC RES, V112, P424, DOI 10.1161/CIRCRESAHA.111.300501; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mammucari C, 2016, BBA-MOL CELL RES, V1863, P2457, DOI 10.1016/j.bbamcr.2016.03.006; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oxenoid K, 2016, NATURE, V533, P269, DOI 10.1038/nature17656; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Parfenov AS, 2006, BIOPHYS J, V90, P1107, DOI 10.1529/biophysj.105.071787; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Tsai MF, 2016, ELIFE, V5, DOI 10.7554/eLife.15545; Vais H, 2016, CELL REP, V14, P403, DOI 10.1016/j.celrep.2015.12.054; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yamamoto T, 2016, BBA-BIOENERGETICS, V1857, P831, DOI 10.1016/j.bbabio.2016.03.019	47	40	40	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23343	23362		10.1074/jbc.M116.755496	http://dx.doi.org/10.1074/jbc.M116.755496			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637331	hybrid, Green Published			2022-12-26	WOS:000387224800041
J	Koch, S; de Wit, JG; Vos, I; Birkner, JP; Gordiichuk, P; Herrmann, A; van Oijen, AM; Driessen, AJM				Koch, Sabrina; de Wit, Janny G.; Vos, Iuliia; Birkner, Jan Peter; Gordiichuk, Pavlo; Herrmann, Andreas; van Oijen, Antoine M.; Driessen, Arnold J. M.			Lipids Activate SecA for High Affinity Binding to the SecYEG Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; lipid bilayer; membrane biophysics; membrane function; membrane protein; protein-lipid interaction; scaffold protein; SecA; SecYEG; nanodiscs	COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; PROTEIN-TRANSLOCATION; IN-VIVO; NANOLIPOPROTEIN PARTICLES; PREPROTEIN TRANSLOCASE; PHOSPHOLIPID-BILAYER; ACIDIC PHOSPHOLIPIDS; DEPENDENT MANNER; ATPASE	Protein translocation across the bacterial cytoplasmic membrane is an essential process catalyzed predominantly by the Sec translocase. This system consists of the membrane-embedded protein-conducting channel SecYEG, the motor ATPase SecA, and the heterotrimeric SecDFyajC membrane protein complex. Previous studies suggest that anionic lipids are essential for SecA activity and that the N terminus of SecA is capable of penetrating the lipid bilayer. The role of lipid binding, however, has remained elusive. By employing differently sized nanodiscs reconstituted with single SecYEG complexes and comprising varying amounts of lipids, we establish that SecA gains access to the SecYEG complex via a lipid-bound intermediate state, whereas acidic phospholipids allosterically activate SecA for ATP-dependent protein translocation.	[Koch, Sabrina; de Wit, Janny G.; Vos, Iuliia; Driessen, Arnold J. M.] Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Koch, Sabrina; de Wit, Janny G.; Vos, Iuliia; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Birkner, Jan Peter; van Oijen, Antoine M.] Univ Groningen, Single Mol Biophys, Zernike Inst Adv Mat, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Gordiichuk, Pavlo; Herrmann, Andreas] Univ Groningen, Zernike Inst Adv Mat, Polymer Chem & Bioengn, NL-9747 AG Groningen, Netherlands; [van Oijen, Antoine M.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Gordiichuk, Pavlo] Northwestern Univ, Dept Chem, Evanston, IL USA	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Wollongong; Northwestern University	Driessen, AJM (corresponding author), Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.; Driessen, AJM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Birkner, Jan Peter/E-8316-2014; Driessen, Arnold J.M./D-1876-2012; Institute, Zernike/W-7033-2019; van Oijen, Antoine/I-3167-2014; Herrmann, Andreas/F-3189-2016	van Oijen, Antoine/0000-0002-1794-5161; Herrmann, Andreas/0000-0002-8886-0894; Gordiichuk, Pavlo/0000-0003-4152-7186; Driessen, Arnold J.M./0000-0001-9258-9104; Birkner, Jan Peter/0000-0002-5536-2274	Stichting voor Fundamenteel Onderzoek der Materie (FOM)	Stichting voor Fundamenteel Onderzoek der Materie (FOM)(FOM (The Netherlands))	This work was supported by the Stichting voor Fundamenteel Onderzoek der Materie (FOM). The authors declare that they have no conflicts of interest with the contents of this article.	Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Bello OD, 2016, LANGMUIR, V32, P3015, DOI 10.1021/acs.langmuir.6b00245; Blanchette CD, 2008, J LIPID RES, V49, P1420, DOI 10.1194/jlr.M700586-JLR200; Blanchette CD, 2009, BBA-BIOMEMBRANES, V1788, P724, DOI 10.1016/j.bbamem.2008.11.019; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; CUNNINGHAM K, 1989, EMBO J, V8, P955, DOI 10.1002/j.1460-2075.1989.tb03457.x; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Dickey A, 2008, BIOPHYS J, V95, P2636, DOI 10.1529/biophysj.107.128074; Dong J, 2001, BIOCHEMISTRY-US, V40, P2826, DOI 10.1021/bi002417n; Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Floyd JH, 2014, BIOCHEM BIOPH RES CO, V453, P138, DOI 10.1016/j.bbrc.2014.09.080; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; Gari RRS, 2013, J BIOL CHEM, V288, P16848, DOI 10.1074/jbc.M113.471870; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Kedrov A, 2013, J MOL BIOL, V425, P4112, DOI 10.1016/j.jmb.2013.07.042; Kedrov A, 2011, EMBO J, V30, P4387, DOI 10.1038/emboj.2011.314; KELLER RCA, 1995, FEBS LETT, V358, P251, DOI 10.1016/0014-5793(94)01439-8; KLOSE M, 1993, J BIOL CHEM, V268, P4504; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Prabudiansyah I, 2015, BBA-BIOMEMBRANES, V1848, P2050, DOI 10.1016/j.bbamem.2015.06.024; Prabudiansyah I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128788; Ramadurai S, 2010, BIOPHYS J, V99, P1482, DOI 10.1016/j.bpj.2010.06.036; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tafvizi A, 2011, CHEMPHYSCHEM, V12, P1481, DOI 10.1002/cphc.201100112; Taufik I, 2013, J MOL BIOL, V425, P4145, DOI 10.1016/j.jmb.2013.08.012; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	44	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22534	22543		10.1074/jbc.M116.743831	http://dx.doi.org/10.1074/jbc.M116.743831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27613865	Green Published, hybrid			2022-12-26	WOS:000386760600015
J	Fu, T; Sharmab, A; Xie, F; Liu, YL; Li, K; Wan, WW; Baylin, SB; Wolfgang, CL; Ahuja, N				Fu, Tao; Sharmab, Anup; Xie, Fei; Liu, Yanliang; Li, Kai; Wan, Weiwei; Baylin, Stephen B.; Wolfgang, Christopher L.; Ahuja, Nita			Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE MGMT; SMALL-BOWEL ADENOCARCINOMA; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; COLORECTAL-CANCER; K-RAS; LUNG-CANCER; GENE; HYPERMETHYLATION; GLIOBLASTOMA	Background O-6-methylguanine-DNA methyltransferase (MGMT) methylation status has not been extensively investigated in duodenal adenocarcinoma (DA). The aim of this study was to evaluate the MGMT methylation status and examine its possible prognostic value in patients with stage III DA. Methods Demographics, tumor characteristics and survival were available for 64 patients with stage III DA. MGMT methylation was detected by using MethyLight. A Cox proportional hazard model was built to predict survival, adjusted for clinicopathological characteristics and tumor molecular features, including the CpG island methylator phenotype (CIMP), microsatellite instability (MSI), and KRAS mutations. Results MGMT methylation was detected in 17 of 64 (26.6%) patients, and was not correlated with sex, age, tumor differentiation, CIMP, MSI, or KRAS mutations. MGMT methylation was the only one factor associated with both overall survival (OS) and disease-free survival (DFS) on both univariate and multivariate analyses. In patients treated with surgery alone, MGMT-methylated group had worse OS and DFS when compared with MGMT-unmethylated group. However, in patients treated with chemotherapy/radiotherapy, outcomes became comparable between the two groups. Conclusions Our results demonstrate MGMT methylation is a reliable and independent prognostic factor in DAs. Methylation of MGMT is associated with poor prognosis in patients with stage III DAs.	[Fu, Tao; Xie, Fei; Liu, Yanliang; Li, Kai; Wan, Weiwei] Wuhan Univ, Renmin Hosp, Dept Gastrointestinal Surg 2, Key Lab Hubei Prov Digest Syst Dis, Wuhan, Peoples R China; [Sharmab, Anup; Wolfgang, Christopher L.; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Baylin, Stephen B.; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Wuhan University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fu, T (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastrointestinal Surg 2, Key Lab Hubei Prov Digest Syst Dis, Wuhan, Peoples R China.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.; Ahuja, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA.	futao1975@tom.com; nahuja1@jhmi.edu	Wolfgang, Christopher/HGD-0863-2022	Fu, Tao/0000-0003-4713-7269	National Institutes of Health [CA140599, CA127141]; National Natural Science Foundation of China [81000898, 81472289]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by National Institutes of Health grants CA140599 and CA127141, National Natural Science Foundation of China grants 81000898 and 81472289, and sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China.	ALWMARK A, 1980, ANN SURG, V191, P13, DOI 10.1097/00000658-198001000-00003; Baumann S, 2006, INT J CANCER, V119, P264, DOI 10.1002/ijc.21848; Bilimoria KY, 2009, ANN SURG, V249, P63, DOI 10.1097/SLA.0b013e31818e4641; Brabender J, 2003, CLIN CANCER RES, V9, P223; Cecchini S, 2012, J GASTROINTEST SURG, V16, P113, DOI 10.1007/s11605-011-1704-6; Chalmers AJ, 2009, INT J RADIAT ONCOL, V75, P1511, DOI 10.1016/j.ijrobp.2009.07.1703; Christmann M, 2011, BBA-REV CANCER, V1816, P179, DOI 10.1016/j.bbcan.2011.06.002; Cloyd JM, 2014, ANN SURG ONCOL, DOI [10.1245/1208250, DOI 10.1245/1208250]; Dietmaier W, 1997, CANCER RES, V57, P4749; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2000, CANCER RES, V60, P2368; Fu T, 2013, INT J CANCER, V132, P2502, DOI 10.1002/ijc.27910; Fu T, 2012, CLIN CANCER RES, V18, P4743, DOI 10.1158/1078-0432.CCR-12-0707; Fumagalli C, 2014, CLIN BREAST CANCER, V14, P285, DOI 10.1016/j.clbc.2014.02.010; Hawkins NJ, 2009, MODERN PATHOL, V22, P1588, DOI 10.1038/modpathol.2009.130; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hibi K, 2009, ANTICANCER RES, V29, P5053; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Jesien-Lewandowicz E, 2009, CANCER GENET CYTOGEN, V188, P77, DOI 10.1016/j.cancergencyto.2008.09.015; Kelsey CR, 2007, INT J RADIAT ONCOL, V69, P1436, DOI 10.1016/j.ijrobp.2007.05.006; Kim JI, 2009, HUM PATHOL, V40, P934, DOI 10.1016/j.humpath.2009.01.005; Kim SG, 2003, GASTROENTEROLOGY, V124, P1300, DOI 10.1016/S0016-5085(03)00278-6; Kohonen-Corish MRJ, 2005, J CLIN ONCOL, V23, P2318, DOI 10.1200/JCO.2005.00.109; Laforest A, 2014, EUR J CANCER, V50, P1740, DOI 10.1016/j.ejca.2014.04.007; Liu Y, 2006, NEOPLASIA, V8, P46, DOI 10.1593/neo.05586; Murakami J, 2007, ONCOL REP, V17, P1461; Nagasaka T, 2003, CLIN CANCER RES, V9, P5306; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Nagy E, 2014, BRIT J CANCER, V110, P2874, DOI 10.1038/bjc.2014.263; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Overman MJ, 2010, BRIT J CANCER, V102, P144, DOI 10.1038/sj.bjc.6605449; Overman MJ, 2012, ANN SURG ONCOL, V19, P1439, DOI 10.1245/s10434-011-2173-6; Overman MJ, 2010, CANCER-AM CANCER SOC, V116, P5374, DOI 10.1002/cncr.25324; Poultsides GA, 2012, ANN SURG ONCOL, V19, P1928, DOI 10.1245/s10434-011-2168-3; Raghav K, 2013, NAT REV CLIN ONCOL, V10, P534, DOI 10.1038/nrclinonc.2013.132; Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240; Shima K, 2011, CANCER CAUSE CONTROL, V22, P301, DOI 10.1007/s10552-010-9698-z; Singhal N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005202.pub2; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Swartz MJ, 2007, ARCH SURG-CHICAGO, V142, P285, DOI 10.1001/archsurg.142.3.285; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Wu Ming, 2004, Gastric Cancer, V7, P246, DOI 10.1007/s10120-004-0300-9; Yachida S, 2009, AM J SURG PATHOL, V33, P1823, DOI 10.1097/PAS.0b013e3181b6da19; Yan L, 2005, ONCOGENE, V24, P2175, DOI 10.1038/sj.onc.1208250; Zhang Y, 2014, CELL DEATH DIFFER, V21, P720, DOI 10.1038/cdd.2013.196; Zhao JJ, 2014, TUMOUR BIOL J INT SO, DOI [10.1007/s13277-014-2276-3, DOI 10.1007/S13277-014-2276-3.IJC.23398]	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162929	10.1371/journal.pone.0162929	http://dx.doi.org/10.1371/journal.pone.0162929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643594	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900025
J	Dietrich, JF; Huber, S; Klein, E; Willmes, K; Pixner, S; Moeller, K				Dietrich, Julia Felicitas; Huber, Stefan; Klein, Elise; Willmes, Klaus; Pixner, Silvia; Moeller, Korbinian			A Systematic Investigation of Accuracy and Response Time Based Measures Used to Index ANS Acuity	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; NUMERICAL MAGNITUDE REPRESENTATIONS; INDIVIDUAL-DIFFERENCES; ACHIEVEMENT EVIDENCE; MATH ACHIEVEMENT; INTUITIVE SENSE; NEURAL BASIS; RELIABILITY; CHILDREN; MODEL	The approximate number system (ANS) was proposed to be a building block for later mathematical abilities. Several measures have been used interchangeably to assess ANS acuity. Some of these measures were based on accuracy data, whereas others relied on response time (RT) data or combined accuracy and RT data. Previous studies challenged the view that all these measures can be used interchangeably, because low correlations between some of the measures had been observed. These low correlations might be due to poor reliability of some of the measures, since the majority of these measures are mathematically related. Here we systematically investigated the relationship between common ANS measures while avoiding the potential confound of poor reliability. Our first experiment revealed high correlations between all accuracy based measures supporting the assumption that all of them can be used interchangeably. In contrast, not all RT based measures were highly correlated. Additionally, our results revealed a speed-accuracy trade-off. Thus, accuracy and RT based measures provided conflicting conclusions regarding ANS acuity. Therefore, we investigated in two further experiments which type of measure (accuracy or RT) is more informative about the underlying ANS acuity, depending on participants' preferences for accuracy or speed. To this end, we manipulated participants' preferences for accuracy or speed both explicitly using different task instructions and implicitly varying presentation duration. Accuracy based measures were more informative about the underlying ANS acuity than RT based measures. Moreover, the influence of the underlying representations on accuracy data was more pronounced when participants preferred accuracy over speed after the accuracy instruction as well as for long or unlimited presentation durations. Implications regarding the diffusion model as a theoretical framework of dot comparison as well as regarding the relationship between ANS acuity and math performance are discussed.	[Dietrich, Julia Felicitas; Huber, Stefan; Klein, Elise; Moeller, Korbinian] Leibniz Inst Fuer Wissensmedien, Tubingen, Germany; [Dietrich, Julia Felicitas; Moeller, Korbinian] Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany; [Willmes, Klaus] Rhein Westfal TH Aachen, Univ Hosp, Dept Neurol, Sect Neuropsychol, Aachen, Germany; [Pixner, Silvia] UMIT Hlth & Life Sci Univ, Inst Appl Psychol, Hall In Tirol, Austria; [Moeller, Korbinian] Eberhard Karls Univ Tubingen, LEAD Grad Sch, Tubingen, Germany	Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen	Dietrich, JF (corresponding author), Leibniz Inst Fuer Wissensmedien, Tubingen, Germany.; Dietrich, JF (corresponding author), Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany.	julia.dietrich@iwm-tuebingen.de	Moeller, Korbinian/AAC-6387-2020; Willmes, Klaus F/A-1268-2014	Willmes, Klaus F/0000-0002-9012-0553; Pixner, Silvia/0000-0001-5605-8576	German Research Foundation (DFG) [MO 2525/2-1]; Leibniz-Competition Fund [SAW-2014-IWM-4]; Ministery Science, Research and Arts Baden-Wuerttemberg; European Social Fonds (ESF)	German Research Foundation (DFG)(German Research Foundation (DFG)); Leibniz-Competition Fund; Ministery Science, Research and Arts Baden-Wuerttemberg; European Social Fonds (ESF)	Julia Dietrich was supported by the German Research Foundation (DFG) providing funding to Korbinian Moeller and Elise Klein (MO 2525/2-1) (http://www.dfg.de/). Stefan Huber was supported by the Leibniz-Competition Fund providing funding to Elise Klein (SAW-2014-IWM-4) (http://www.leibniz-gemeinschaft.de/ueber-uns/leibniz-wettbewerb/). Elise Klein was supported by the Margarete von-Wrangell Fellowship of the Ministery Science, Research and Arts Baden-Wuerttemberg and the European Social Fonds (ESF) (http://margarete-von-wrangell.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-26; Anobile G, 2013, J EXP CHILD PSYCHOL, V116, P380, DOI 10.1016/j.jecp.2013.06.006; Baguley T, 2012, SERIOUS STATS GUIDE; Bartelet D, 2014, J EXP CHILD PSYCHOL, V117, P12, DOI 10.1016/j.jecp.2013.08.010; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Barton K., 2016, MUMIN MULTIMODEL INF; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonny JW, 2013, J EXP CHILD PSYCHOL, V114, P375, DOI 10.1016/j.jecp.2012.09.015; Brankaer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093565; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Clayton S, 2015, ZDM-MATH EDUC, V47, P759, DOI 10.1007/s11858-014-0655-2; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 2011, NUMBER SENSE MIND CR; DEHAENE S, 2007, ATTENTION PERFORMANC; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; DeWind NK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00310; DeWind NK, 2015, COGNITION, V142, P247, DOI 10.1016/j.cognition.2015.05.016; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; Dietrich JF, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00295; Fazio LK, 2014, J EXP CHILD PSYCHOL, V123, P53, DOI 10.1016/j.jecp.2014.01.013; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2013, CHILD DEV PERSPECT, V7, P74, DOI 10.1111/cdep.12019; Ferreira Fernanda de Oliveira, 2012, Psychol. Neurosci., V5, P037, DOI 10.3922/j.psns.2012.1.06; FITTS PM, 1966, J EXP PSYCHOL, V71, P849, DOI 10.1037/h0023232; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Gandini D, 2008, ACTA PSYCHOL, V129, P175, DOI 10.1016/j.actpsy.2008.05.009; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gilmore C, 2014, LEARN INDIVID DIFFER, V29, P50, DOI 10.1016/j.lindif.2013.10.004; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Goodwin LD, 2006, J EXP EDUC, V74, P251, DOI 10.3200/jexe.74.3.249-266; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gullick MM, 2011, LEARN INDIVID DIFFER, V21, P644, DOI 10.1016/j.lindif.2010.10.003; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Harrell Jr FE, 2015, HMISC HARRELL MISCEL; Heitz RP, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00150; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Huber S, 2014, PSYCHOL RES-PSYCH FO, V78, P539, DOI 10.1007/s00426-013-0504-x; Huber S., 2013, P 12 INT C COGN MOD, P185; Inglis M, 2014, ACTA PSYCHOL, V145, P147, DOI 10.1016/j.actpsy.2013.11.009; Inglis M, 2013, COGNITION, V129, P63, DOI 10.1016/j.cognition.2013.06.003; KOPRIVA RJ, 1991, EDUC PSYCHOL MEAS, V51, P585, DOI 10.1177/0013164491513006; Krinzinger H, 2011, DEV NEUROPSYCHOL, V36, P721, DOI 10.1080/87565641.2010.549882; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2012, ACTA PSYCHOL, V141, P373, DOI 10.1016/j.actpsy.2012.09.009; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Libertus ME, 2009, CURR DIR PSYCHOL SCI, V18, P346, DOI 10.1111/j.1467-8721.2009.01665.x; Lindskog M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00510; Linsen S, 2014, ACTA PSYCHOL, V145, P75, DOI 10.1016/j.actpsy.2013.10.008; Lonnemann J, 2011, J NEUROLINGUIST, V24, P583, DOI 10.1016/j.jneuroling.2011.02.004; Lyons IM, 2015, J EXP PSYCHOL GEN, V144, P1021, DOI 10.1037/xge0000094; Lyons IM, 2015, HUM BRAIN MAPP, V36, P475, DOI 10.1002/hbm.22641; Macizo P, 2013, PSYCHOL RES-PSYCH FO, V77, P651, DOI 10.1007/s00426-012-0456-6; Macizo P, 2011, ACTA PSYCHOL, V136, P112, DOI 10.1016/j.actpsy.2010.10.008; Maloney EA, 2010, ACTA PSYCHOL, V134, P154, DOI 10.1016/j.actpsy.2010.01.006; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Moeller K, 2011, RES DEV DISABIL, V32, P1837, DOI 10.1016/j.ridd.2011.03.012; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Murphy K. R., 1988, PSYCHOL TESTING PRIN; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2003, NEURON, V37, P149, DOI 10.1016/S0896-6273(02)01144-3; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nieder A, 2015, OXFORD HDB NUMERICAL, P456; Nieder A, 2007, J NEUROSCI, V27, P5986, DOI 10.1523/JNEUROSCI.1056-07.2007; Nieder A, 2013, J COMP PHYSIOL A, V199, P1, DOI 10.1007/s00359-012-0763-9; Nieder A, 2011, ATTENTION PERFORM, P103, DOI 10.1016/B978-0-12-385948-8.00008-6; Nieder A, 2012, P NATL ACAD SCI USA, V109, P11860, DOI 10.1073/pnas.1204580109; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Park J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01955; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; POLTROCK SE, 1989, J MATH PSYCHOL, V33, P131, DOI 10.1016/0022-2496(89)90027-8; Price GR, 2012, ACTA PSYCHOL, V140, P50, DOI 10.1016/j.actpsy.2012.02.008; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ratclifff R, 2015, COGNITION, V137, P115, DOI 10.1016/j.cognition.2014.12.004; SANTEE JL, 1982, J EXP PSYCHOL HUMAN, V8, P489, DOI 10.1037/0096-1523.8.4.489; Sasanguie D, 2012, MIND BRAIN EDUC, V6, P119, DOI 10.1111/j.1751-228X.2012.01147.x; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; Sasanguie D, 2011, ACTA PSYCHOL, V136, P73, DOI 10.1016/j.actpsy.2010.10.004; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simon TJ, 2008, NEUROPSYCHOLOGIA, V46, P82, DOI 10.1016/j.neuropsychologia.2007.08.016; Singmann H., 2015, AFEX ANAL FACTORIAL; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Stoianov I, 2012, NAT NEUROSCI, V15, P194, DOI 10.1038/nn.2996; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Townsend J., 1978, COGNITIVE THEORY; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Voss A, 2013, EXP PSYCHOL, V60, P385, DOI 10.1027/1618-3169/a000218; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Willse JT, 2014, CTT CLASSICAL TEST T	113	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163076	10.1371/journal.pone.0163076	http://dx.doi.org/10.1371/journal.pone.0163076			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5YN	27637109	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700031
J	Garganese, F; Schena, L; Siciliano, I; Prigigallo, MI; Spadaro, D; De Grassi, A; Ippolito, A; Sanzani, SM				Garganese, Francesca; Schena, Leonardo; Siciliano, Ilenia; Prigigallo, Maria Isabella; Spadaro, Davide; De Grassi, Anna; Ippolito, Antonio; Sanzani, Simona Marianna			Characterization of Citrus-Associated Alternaria Species in Mediterranean Areas	PLOS ONE			English	Article							HOST-SELECTIVE TOXINS; BROWN SPOT; TANGERINE PATHOTYPE; BIOSYNTHESIS; IDENTIFICATION; PATHOGENICITY; METABOLITES; MYCOTOXINS; DISEASES; TOMATO	Alternaria brown spot is one of the most important diseases of tangerines and their hybrids worldwide. Recently, outbreaks in Mediterranean areas related to susceptible cultivars, refocused attention on the disease. Twenty representatives were selected from a collection of 180 isolates of Alternaria spp. from citrus leaves and fruit. They were characterized along with reference strains of Alternaria spp. Micro-and macroscopic characteristics separated most Alternaria isolates into six morphotypes referable to A. alternata (5) and A. arborescens (1). Phylogenetic analyses, based on endopolygalacturonase (endopg) and internal transcribed spacer (ITS), confirmedthis finding. Moreover, a five-gene phylogeny including two anonymous genomics regions (OPA 1-3 and OPA 2-1), and the beta-tubulin gene (beta-tub), produced a further clustering of A. alternata into three clades. This analysis suggested the existence of intra-species molecular variability. Investigated isolates showed different levels of virulence on leaves and fruit. In particular, the pathogenicity on fruit seemed to be correlated with the tissue of isolation and the clade. The toxigenic behavior of Alternaria isolates was also investigated, with tenuazonic acid (TeA) being the most abundant mycotoxin (0.2-20 mg/L). Isolates also synthesized the mycotoxins alternariol(AOH), its derivate alternariol monomethyl ether (AME), and altenuene (ALT), although to a lesser extent. AME production significantly varied among the six morphotypes. The expression of pksJ/pksH, biosynthetic genes of AOH/AME, was not correlated with actual toxin production, but it was significantly different between the two genotypes and among the four clades. Finally, ten isolates proved to express the biosynthetic genes of ACTT1 phytotoxin, and thus to be included in the Alternaria pathotype tangerine. A significant correlation between pathogenicity on leaves and ACTT1 gene expression was recorded. The latter was significantly dependent on geographical origin. The widespread occurrence of Alternaria spp. on citrus fruit and their ability to producemycotoxins might represent a serious concern for producers and consumers.	[Garganese, Francesca; Ippolito, Antonio; Sanzani, Simona Marianna] Univ Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy; [Schena, Leonardo; Prigigallo, Maria Isabella] Univ Mediterranea, Dipartimento Agr, Reggio Di Calabria, Italy; [Siciliano, Ilenia; Spadaro, Davide] Univ Torino, Ctr Competenza Innovaz Campo Agroambientle, AGROINNOVA, Grugliasco, TO, Italy; [Spadaro, Davide] Univ Torino, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, TO, Italy; [De Grassi, Anna] Univ Aldo Moro, Dipartimentodi Biosci Biotecnol & Biofarmaceut, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita Mediterranea di Reggio Calabria; University of Turin; University of Turin; Universita degli Studi di Bari Aldo Moro	Sanzani, SM (corresponding author), Univ Aldo Moro, Dipartimento Sci Suolo Pianta & Alimenti, Bari, Italy.	simonamarianna.sanzani@uniba.it	Prigigallo, Maria Isabella/A-1935-2019; Spadaro, Davide/F-1994-2011; SANZANI, Simona Marianna/AAE-2175-2022; Sanzani, Simona Marianna/B-9233-2019; Schena, Leonardo/A-7492-2018; Garganese, Francesca/AAC-2152-2020; De Grassi, Anna/AAE-6036-2020	Prigigallo, Maria Isabella/0000-0002-6913-5232; Spadaro, Davide/0000-0001-5207-9345; SANZANI, Simona Marianna/0000-0002-1631-638X; Schena, Leonardo/0000-0002-9737-2593; Garganese, Francesca/0000-0002-7386-8543; De Grassi, Anna/0000-0001-7273-4263; Siciliano, Ilenia/0000-0002-9258-0107	grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee" PON Ricerca e competitivita [PON03PE_00090_03]	grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee" PON Ricerca e competitivita	This work was partially funded by grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee" PON Ricerca e competitivita 2007-2013 (PON03PE_00090_03).; This work was partially funded by grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee"-PON Ricerca e competitivita 2007-2013 (PON03PE_00090_03). We thank Dr. Sylvia Stastny for her critical English revision.	Ajiro N, 2010, PHYTOPATHOLOGY, V100, P120, DOI 10.1094/PHYTO-100-2-0120; Akimitsu KA, 2003, MOL PLANT PATHOL, V4, P435, DOI 10.1046/j.1364-3703.2003.00189.X; Akimitsu K, 2014, J GEN PLANT PATHOL, V80, P109, DOI 10.1007/s10327-013-0498-7; Andersen B, 2008, MYCOL RES, V112, P241, DOI 10.1016/j.mycres.2007.09.004; Andersen B, 2006, INT J FOOD MICROBIOL, V111, P105, DOI 10.1016/j.ijfoodmicro.2006.04.021; Andersen B, 2015, INT J FOOD MICROBIOL, V196, P1, DOI 10.1016/j.ijfoodmicro.2014.11.029; Asam S, 2013, EUR FOOD RES TECHNOL, V236, P491, DOI 10.1007/s00217-012-1901-x; Bella P., 2001, Journal of Plant Pathology, V83, P231; Brun S, 2013, FUNGAL BIOL-UK, V117, P32, DOI 10.1016/j.funbio.2012.11.003; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; EFSA, 2011, EFSA J, V2011, P97; Elena K, 2006, EUR J PLANT PATHOL, V115, P259, DOI 10.1007/s10658-006-9005-8; Fleck SC, 2012, TOXICOL LETT, V214, P27, DOI 10.1016/j.toxlet.2012.08.003; GATENBEC.S, 1965, ACTA CHEM SCAND, V19, P65, DOI 10.3891/acta.chem.scand.19-0065; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Graf E, 2012, INT J FOOD MICROBIOL, V157, P353, DOI 10.1016/j.ijfoodmicro.2012.06.004; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Howlett BJ, 2006, CURR OPIN PLANT BIOL, V9, P371, DOI 10.1016/j.pbi.2006.05.004; Huang F, 2015, FUNGAL BIOL-UK, V119, P320, DOI 10.1016/j.funbio.2014.09.006; Isshiki A, 1997, PHYSIOL MOL PLANT P, V51, P155, DOI 10.1006/pmpp.1997.0106; KOHMOTO K, 1993, PHYTOPATHOLOGY, V83, P495, DOI 10.1094/Phyto-83-495; Logrieco A, 2003, EUR J PLANT PATHOL, V109, P645, DOI 10.1023/A:1026033021542; Logrieco A, 2009, WORLD MYCOTOXIN J, V2, P129, DOI 10.3920/WMJ2009.1145; Markham JE, 2001, MOL PLANT PATHOL, V2, P229, DOI 10.1046/j.1464-6722.2001.00066.x; Masunaka A, 2000, PHYTOPATHOLOGY, V90, P762, DOI 10.1094/PHYTO.2000.90.7.762; Ntasiou P, 2015, INT J FOOD MICROBIOL, V197, P22, DOI 10.1016/j.ijfoodmicro.2014.12.008; Peever TL, 2002, PHYTOPATHOLOGY, V92, P794, DOI 10.1094/PHYTO.2002.92.7.794; Peever TL, 2005, PHYTOPATHOLOGY, V95, P512, DOI 10.1094/PHYTO-95-0512; Peever TL, 2004, MYCOLOGIA, V96, P119, DOI 10.2307/3761993; Perrone G, 2013, FOOD ADDIT CONTAM A, V30, P1339, DOI 10.1080/19440049.2013.796594; Prelle A, 2013, FOOD CHEM, V140, P161, DOI 10.1016/j.foodchem.2012.12.065; Pruss S, 2014, APPL ENVIRON MICROB, V80, P2582, DOI 10.1128/AEM.00327-14; Pryor BM, 2002, PHYTOPATHOLOGY, V92, P406, DOI 10.1094/PHYTO.2002.92.4.406; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Saha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040564; Sanzani SM, 2012, INT J FOOD MICROBIOL, V153, P323, DOI 10.1016/j.ijfoodmicro.2011.11.021; Sanzani SM, 2012, POSTHARVEST BIOL TEC, V68, P64, DOI 10.1016/j.postharvbio.2012.02.003; Schwarz C, 2012, ARCH TOXICOL, V86, P1911, DOI 10.1007/s00204-012-0958-4; Scott P. M., 2004, Mycotoxins in food: detection and control, P406, DOI 10.1533/9781855739086.3.406; Siciliano I, 2015, TOXINS, V7, P743, DOI 10.3390/toxins7030743; Stewart JE, 2014, BMC EVOLUTIONARY BIO, V14, P1; THOMAS R, 1961, BIOCHEM J, V80, P234, DOI 10.1042/bj0800234; Timmer Lavern W., 2003, Phytopathologia Mediterranea, V42, P99; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Van de Perre E, 2014, FOOD CONTROL, V37, P165, DOI 10.1016/j.foodcont.2013.09.034; Vicent A., 2000, Plant Disease, V84, P1044, DOI 10.1094/PDIS.2000.84.9.1044B; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Woudenberg JHC, 2015, STUD MYCOL, P1, DOI 10.1016/j.simyco.2015.07.001	48	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163255	10.1371/journal.pone.0163255	http://dx.doi.org/10.1371/journal.pone.0163255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636202	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700043
J	Coombe, L; Warren, RL; Jackman, SD; Yang, C; Vandervalk, BP; Moore, RA; Pleasance, S; Coope, RJ; Bohlmann, J; Holt, RA; Jones, SJM; Birol, I				Coombe, Lauren; Warren, Rene L.; Jackman, Shaun D.; Yang, Chen; Vandervalk, Benjamin P.; Moore, Richard A.; Pleasance, Stephen; Coope, Robin J.; Bohlmann, Joerg; Holt, Robert A.; Jones, Steven J. M.; Birol, Inanc			Assembly of the Complete Sitka Spruce Chloroplast Genome Using 10X Genomics' GemCode Sequencing Data	PLOS ONE			English	Article							DRAFT GENOMES; LONG READS; TOOL; ALIGNMENT; DNA; ANNOTATION; GENERATION; NUMBER; PLANTS	The linked read sequencing library preparation platformby 10X Genomics produces barcoded sequencing libraries, which are subsequently sequenced using the Illumina short read sequencing technology. In this new approach, long fragments of DNA are partitioned into separate micro-reactions, where the same index sequence is incorporated into each of the sequencing fragment inserts derived from a given long fragment. In this study, we exploited this property by using reads from index sequences associated with a large number of reads, to assemble the chloroplast genome of the Sitka spruce tree (Picea sitchensis). Here we report on the first Sitka spruce chloroplast genome assembled exclusively from P. sitchensis genomic libraries prepared using the 10X Genomics protocol. We show that the resulting 124,049 base pair long genome shares high sequence similarity with the related white spruce and Norway spruce chloroplast genomes, but diverges substantially from a previously published P. sitchensis-P. thunbergii chimeric genome. The use of reads from high-frequency indices enabled separation of the nuclear genome reads from that of the chloroplast, which resulted in the simplification of the de Bruijn graphs used at the various stages of assembly.	[Coombe, Lauren; Warren, Rene L.; Jackman, Shaun D.; Yang, Chen; Vandervalk, Benjamin P.; Moore, Richard A.; Pleasance, Stephen; Coope, Robin J.; Holt, Robert A.; Jones, Steven J. M.; Birol, Inanc] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia	Warren, RL; Birol, I (corresponding author), British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	rwarren@bcgsc.ca; ibirol@bcgsc.ca	Jones, Steven J/C-3621-2009; Birol, Inanc/G-5440-2011; Holt, Robert A/C-3303-2009; Warren, Rene/R-7681-2016; Jackman, Shaun/G-9622-2013	Jones, Steven J/0000-0003-3394-2208; Birol, Inanc/0000-0003-0950-7839; Holt, Robert A/0000-0002-7259-1247; Coombe, Lauren/0000-0002-7518-2326; Vandervalk, Ben/0000-0002-3082-3476; Warren, Rene/0000-0002-9890-2293; Jackman, Shaun/0000-0002-9275-5966	BC Cancer Foundation; Genome BC; Genome Canada [212SEQ]	BC Cancer Foundation; Genome BC; Genome Canada(Genome Canada)	This study was supported by the BC Cancer Foundation, Genome BC and Genome Canada under grant award 212SEQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; De La Torre AR, 2014, PLANT PHYSIOL, V166, P1724, DOI 10.1104/pp.114.248708; Eisenstein M, 2015, NAT BIOTECHNOL, V33, P433, DOI 10.1038/nbt0515-433; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hall DE, 2011, PLANT J, V65, P936, DOI 10.1111/j.1365-313X.2010.04478.x; Hamilton JA, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0817-y; HILDEBRAND M, 1988, P NATL ACAD SCI USA, V85, P372, DOI 10.1073/pnas.85.2.372; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jackman SD, 2016, GENOME BIOL EVOL, V8, P29, DOI 10.1093/gbe/evv244; Kubinova Z, 2014, J EXP BOT, V65, P609, DOI 10.1093/jxb/ert407; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Li H., 2013, ARXIV13033997 Q BIO; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SAVARD L, 1994, P NATL ACAD SCI USA, V91, P5163, DOI 10.1073/pnas.91.11.5163; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Vandervalk BP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S3-S1; Vieira Ldo N, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084792, DOI 10.1371/JOURNAL.PONE.0084792]; Vieira LD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084792, 10.1371/journal.pone.0090618]; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Warren RL, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0076-3; Warren RL, 2015, PLANT J, V83, P189, DOI 10.1111/tpj.12886; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163059	10.1371/journal.pone.0163059	http://dx.doi.org/10.1371/journal.pone.0163059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632164	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900125
J	Dasgupta, SK; Le, A; Da, Q; Cruz, M; Rumbaut, RE; Thiagarajan, P				Dasgupta, Swapan K.; Anhquyen Le; Da, Qi; Cruz, Miguel; Rumbaut, Rolando E.; Thiagarajan, Perumal			Wdr1-Dependent Actin Reorganization in Platelet Activation	PLOS ONE			English	Article							TALIN HEAD DOMAIN; INTEGRIN ACTIVATION; INTERACTING PROTEIN-1; FILAMENT DYNAMICS; VINCULIN-BINDING; STRUCTURAL BASIS; IIB-IIIA; COFILIN; FIBRINOGEN; ADHESION	In resting platelets, the integrin alpha IIb beta 3 is present in a low-affinity "bent" state. During platelet aggregation, intracytoplasmic signals induce conformational changes (inside-out signaling) that result in a "swung-out" conformation competent to bind ligands such as fibrinogen. The cytoskeleton plays an essential role in alpha IIb beta 3 activation. We investigated the role of the actin interacting protein Wdr1 in alpha IIb beta 3 activation. Wdr1-hypomorphic mice had a prolonged bleeding time (> 10 minutes) compared to that of wild-type mice (2.1 +/- 0.7 minutes). Their platelets had impaired aggregation to collagen and thrombin. In a FeCl3 induced carotid artery thrombosis model, vessel occlusion in Wdr1-hypomorphic mice was prolonged significantly compared to wild-type mice (9.0 +/- 10.5 minutes versus 5.8 +/- 12.6 minutes (p = 0.041). Activation-induced binding of JON/A (a conformation-specific antibody to activated alpha IIb beta 3) was significantly less in Wdr1-hypomorphic platelets at various concentrations of collagen, indicating impaired inside-out activation of alpha IIb beta 3, despite a normal calcium response. Actin turnover, assessed by measuring F-actin and G-actin ratios during collagen- and thrombin-induced platelet aggregation, was highly impaired in Wdr1-hypomorphic platelets. Furthermore, talin failed to redistribute and translocate to the cytoskeleton following activation in Wdr1-hypomorphic platelets. These studies show that Wdr1 is essential for talin-induced activation of alpha IIb beta 3 during platelet activation.	[Dasgupta, Swapan K.; Anhquyen Le; Thiagarajan, Perumal] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Da, Qi; Cruz, Miguel; Rumbaut, Rolando E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Dasgupta, Swapan K.; Anhquyen Le; Da, Qi; Cruz, Miguel; Rumbaut, Rolando E.; Thiagarajan, Perumal] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Dasgupta, SK (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Dasgupta, SK (corresponding author), Michael E DeBakey VA Med Ctr, CTRID, Houston, TX 77030 USA.	swapand@bcm.edu		Thiagarajan, Perumal/0000-0003-2186-7036; Rumbaut, Rolando/0000-0002-8486-1013	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; National Institutes of Health [HL 116524]; American Heart Association; Gulf Cost Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116524] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002551] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Gulf Cost Blood Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by grants from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (to PT and RR), grants from National Institutes of Health (HL 116524 to RR and PT), a grant from the American Heart Association (to SKD) and a grant from Gulf Cost Blood Center.	Bennett JS, 1999, J BIOL CHEM, V274, P25301, DOI 10.1074/jbc.274.36.25301; BERTAGNOLLI ME, 1993, J CELL SCI, V106, P1189; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Ciobanasu C, 2015, NAT PROTOC, V10, P75, DOI 10.1038/nprot.2014.200; Ciobanasu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4095; Coller BS, 2015, J THROMB HAEMOST, V13, pS17, DOI 10.1111/jth.12915; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Dasgupta SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084649; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Fox JEB, 2001, THROMB HAEMOSTASIS, V86, P198; FOX JEB, 1993, J BIOL CHEM, V268, P25973; Ginsberg MH, 2014, BMB REP, V47, P655, DOI 10.5483/BMBRep.2014.47.12.241; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Hartwig JH, 1996, J BIOL CHEM, V271, P32986, DOI 10.1074/jbc.271.51.32986; Hemmings L, 1996, J CELL SCI, V109, P2715; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Kasirer-Friede A, 2014, BLOOD, V123, P3156, DOI 10.1182/blood-2013-08-520627; Kile BT, 2007, BLOOD, V110, P2371, DOI 10.1182/blood-2006-10-055087; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; LEFEBVRE P, 1993, EUR J CELL BIOL, V62, P194; Luxenburg C, 2015, NAT CELL BIOL, V17, P592, DOI 10.1038/ncb3146; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Morowski M, 2013, BLOOD, V121, P4938, DOI 10.1182/blood-2012-10-461459; MUGURUMA M, 1990, BIOCHEM BIOPH RES CO, V171, P1217, DOI 10.1016/0006-291X(90)90815-5; O'Neill EE, 2002, PROTEOMICS, V2, P288, DOI 10.1002/1615-9861(200203)2:3<288::AID-PROT288>3.0.CO;2-0; Okada K, 1999, J CELL SCI, V112, P1553; Okreglak V, 2010, J CELL BIOL, V188, P769, DOI 10.1083/jcb.200909176; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Rodal AA, 1999, J CELL BIOL, V145, P1251, DOI 10.1083/jcb.145.6.1251; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Song XQ, 2012, CELL RES, V22, P1533, DOI 10.1038/cr.2012.97; Srinivasan S, 2015, J BIOL CHEM, V290, P25129, DOI 10.1074/jbc.M115.650978; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xue B, 2013, EUR J CELL BIOL, V92, P316, DOI 10.1016/j.ejcb.2013.10.012	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162897	10.1371/journal.pone.0162897	http://dx.doi.org/10.1371/journal.pone.0162897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627652	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600061
J	O'Rourke, M; Cullen, CL; Auderset, L; Pitman, KA; Achatz, D; Gasperini, R; Young, KM				O'Rourke, Megan; Cullen, Carlie L.; Auderset, Loic; Pitman, Kimberley A.; Achatz, Daniela; Gasperini, Robert; Young, Kaylene M.			Evaluating Tissue-Specific Recombination in a Pdgfr alpha-CreER(T2) Transgenic Mouse Line	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PERIPHERAL NERVOUS-SYSTEM; HEMATOPOIETIC STEM-CELLS; ALPHA-POSITIVE CELLS; PDGF-A; BONE-MARROW; OLIGODENDROCYTE LINEAGE; CNS DEMYELINATION; PROGENITOR CELLS; BETA-RECEPTORS	In the central nervous system (CNS) platelet derived growth factor receptor alpha (PDGFR alpha) is expressed exclusively by oligodendrocyte progenitor cells (OPCs), making the Pdgfr alpha promoter an ideal tool for directing transgene expression in this cell type. Two Pdgfr alpha-CreER(T2) mouse lines have been generated for this purpose which, when crossed with cre-sensitive reporter mice, allow the temporally restricted labelling of OPCs for line-age- tracing studies. These mice have also been used to achieve the deletion of CNS-specific genes from OPCs. However the ability of Pdgfr alpha-CreER(T2) mice to induce cre-mediated recombination in PDGFR alpha(+) cell populations located outside of the CNS has not been examined. Herein we quantify the proportion of PDGFR alpha(+) cells that become YFP-labelled following Tamoxifen administration to adult Pdgfr alpha-CreER(T2):: Rosa26-YFP transgenic mice. We report that the vast majority (>90%) of PDGFR alpha(+) OPCs in the CNS, and a significant proportion of PDGFR alpha(+) stromal cells within the bone marrow (similar to 38%) undergo recombination and become YFP-labelled. However, only a small proportion of the PDGFR alpha(+) cell populations found in the sciatic nerve, adrenal gland, pituitary gland, heart, gastrocnemius muscle, kidney, lung, liver or intestine become YFP-labelled. These data suggest that Pdgfr alpha-CreER(T2) transgenic mice can be used to achieve robust recombination in OPCs, while having a minimal effect on most PDGFR alpha(+) cell populations outside of the CNS.	[O'Rourke, Megan; Cullen, Carlie L.; Auderset, Loic; Pitman, Kimberley A.; Achatz, Daniela; Gasperini, Robert; Young, Kaylene M.] Univ Tasmania, Menzies Inst Med Res, Liverpool St, Hobart, Tas 7000, Australia; [Gasperini, Robert] Univ Tasmania, Sch Med, Liverpool St, Hobart, Tas 7000, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania	Young, KM (corresponding author), Univ Tasmania, Menzies Inst Med Res, Liverpool St, Hobart, Tas 7000, Australia.	kaylene.young@utas.edu.au	Pitman, Kimberley/O-4843-2017; Cullen, Carlie/J-7706-2014	Pitman, Kimberley/0000-0003-3198-9336; Cullen, Carlie/0000-0001-6929-6258; Young, Kaylene/0000-0002-1686-3463	National Health and Medical Research Council [1045240, 1066025]; Multiple Sclerosis Research Australia [15-054]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Multiple Sclerosis Research Australia	We thank our colleagues at the University of Tasmania for their constructive feedback and suggestions for improvement. This research was supported by the National Health and Medical Research Council (grant numbers 1045240 and 1066025) and Multiple Sclerosis Research Australia (15-054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our colleagues at the University of Tasmania for their constructive feedback and suggestions for improvement. This research was supported by the National Health and Medical Research Council (grant numbers 1045240 and 1066025) and Multiple Sclerosis Research Australia (15-054).	Anthony BA, 2014, TRENDS IMMUNOL, V35, P32, DOI 10.1016/j.it.2013.10.002; Auderset L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155878; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; BOWENPOPE DF, 1982, J BIOL CHEM, V257, P5161; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Chang M, 2008, PEDIATR RES, V64, P240, DOI 10.1203/PDR.0b013e318180e47a; Chen LL, 2012, AM J RESP CELL MOL, V47, P517, DOI 10.1165/rcmb.2012-0030OC; Chong JJH, 2013, STEM CELLS DEV, V22, P1932, DOI 10.1089/scd.2012.0542; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Contreras O, 2016, CELL TISSUE RES, V364, P647, DOI 10.1007/s00441-015-2343-0; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; ECCLESTON PA, 1993, DEV BIOL, V155, P459, DOI 10.1006/dbio.1993.1044; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; GLENN K, 1982, J BIOL CHEM, V257, P5172; Gnessi L, 2000, J CELL BIOL, V149, P1019, DOI 10.1083/jcb.149.5.1019; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; Hayes BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092925; HERMANSON M, 1992, CANCER RES, V52, P3213; Hermanson M, 1996, CANCER RES, V56, P164; Horikawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17948; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kurahashi M, 2014, AM J PHYSIOL-CELL PH, V307, pC561, DOI 10.1152/ajpcell.00080.2014; Kurahashi M, 2013, AM J PHYSIOL-GASTR L, V304, pG823, DOI 10.1152/ajpgi.00001.2013; Kurahashi M, 2011, J PHYSIOL-LONDON, V589, P697, DOI 10.1113/jphysiol.2010.201129; Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nakamura M, 1997, ANN SURG, V226, P35, DOI 10.1097/00000658-199707000-00005; Noseda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7930; Ntokou A, 2015, AM J PHYSIOL-LUNG C, V309, pL942, DOI 10.1152/ajplung.00272.2014; Oishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056641; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Parretta E, 2008, J IMMUNOL, V180, P7230, DOI 10.4049/jimmunol.180.11.7230; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Seyed-Razavi Y, 2013, AM J PHYSIOL-LUNG C, V305, pL635, DOI 10.1152/ajplung.00092.2013; Soriano P, 1997, DEVELOPMENT, V124, P2691; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162858	10.1371/journal.pone.0162858	http://dx.doi.org/10.1371/journal.pone.0162858			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626928	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600058
J	Li, ZY; Zeng, JW; Jin, W; Long, W; Lan, WZ; Yang, X				Li, Zhouyue; Zeng, Junwen; Jin, Wei; Long, Wen; Lan, Weizhong; Yang, Xiao			Time-Course of Changes in Choroidal Thickness after Complete Mydriasis Induced by Compound Tropicamide in Children	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CENTRAL SEROUS CHORIORETINOPATHY; AXIAL LENGTH; FORM DEPRIVATION; HEALTHY-SUBJECTS; MYOPIC DEFOCUS; YOUNG-ADULTS; HUMAN EYES; ACCOMMODATION; FLUCTUATIONS	Purpose The aim of this study was to investigate the time-course of changes in choroidal thickness (ChT) following complete mydriasis induced by compound tropicamide. Methods ChT was measured by OCT with the enhanced-depth imaging technique (Spectralis HRA+ OCT, Heidelberg Engineering, Germany) at nine locations of the fundus: subfoveal ChT (SFChT) and ChT at 1 mm and 3 mm from the fovea in four quadrants. Mydriasis was induced with compound tropicamide (0.5% tropicamide plus 0.5% phenylephrine hydrochloride, three doses at 5-minute intervals). Measurements were conducted prior to the instillation and at 0, 30, and 60 min following complete mydriasis. Results at different time-points were compared using repeated-measures ANOVA to investigate the time-course of the changes. Results Thirty-nine subjects (mean age 11.9 +/- 2 years; 16 males and 23 females) were enrolled in the study. Compound tropicamide resulted in a statistically significant decrease in SFChT at 0, 30, and 60 min after complete mydriasis, as compared to baseline (-5 +/- 4 mu m, -12 +/- 4 mu m, and -13 +/- 4 mu m, respectively; all P<0.0001). No significant changes were detected in the parafoveal choroid except at 1 mm temporal (T-1mm) and nasal (N-1mm) to the fovea at 30 and 60 min (T-1mm: -6 +/- 4 mu m and -7 +/- 5 mu mat 30 and 60 min; N-1mm: -6 +/- 4 mu m and -7 +/- 5 mu m at 30 and 60 min, respectively; all P< 0.0001). Repeated-measures ANOVA showed a significant interaction between the time after complete mydriasis and the effect of the mydriasis agent. Conclusions Complete mydriasis induced by compound tropicamide led to choroidal thinning, and the magnitude varied over time.	[Li, Zhouyue; Zeng, Junwen; Jin, Wei; Long, Wen; Lan, Weizhong; Yang, Xiao] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Lan, Weizhong] Aier Eye Hosp Grp, Optometry & Visual Sci Inst, Changsha, Hunan, Peoples R China	Sun Yat Sen University	Lan, WZ; Yang, X (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; Lan, WZ (corresponding author), Aier Eye Hosp Grp, Optometry & Visual Sci Inst, Changsha, Hunan, Peoples R China.	13725458845@139.com; yangxiao3366@gmail.com		Lan, Weizhong/0000-0002-3829-7415	National Natural Science Foundation of China, China [81170871]; Science and Technology Program of Guangdong Province, China [2013B020400003]; Science and Technology Program of Guangzhou, China [15570001, 11BPP2Xaa2060017]	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong Province, China; Science and Technology Program of Guangzhou, China	This work was supported by grants from National Natural Science Foundation of China, China (grant no.: 81170871), Science and Technology Program of Guangdong Province, China (2013B020400003) and Science and Technology Program of Guangzhou, China (15570001), and Science and Technology Program of Guangzhou, China (11BPP2Xaa2060017).	Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Brown JS, 2009, INVEST OPHTH VIS SCI, V50, P5, DOI 10.1167/iovs.08-1779; Chakraborty R, 2013, OPTOMETRY VISION SCI, V90, P1187, DOI 10.1097/OPX.0000000000000035; Chakraborty R, 2012, EXP EYE RES, V103, P47, DOI 10.1016/j.exer.2012.08.002; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Cheung SW, 2009, CLIN EXP OPTOM, V92, P476, DOI 10.1111/j.1444-0938.2009.00419.x; Chia A, 2014, AM J OPHTHALMOL, V157, P451, DOI 10.1016/j.ajo.2013.09.020; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Drexler W, 1998, INVEST OPHTH VIS SCI, V39, P2140; Drexler W, 1997, VISION RES, V37, P2789, DOI 10.1016/S0042-6989(97)00066-7; Fitzgerald MEC, 2002, EXP EYE RES, V74, P561, DOI 10.1006/exer.2002.1142; Gardner DJ, 2015, OPTOMETRY VISION SCI, V92, P579, DOI 10.1097/OPX.0000000000000573; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Gupta B, 2011, OPHTHALMOLOGICA, V225, P207, DOI 10.1159/000324050; Harb E, 2015, AM J OPHTHALMOL, V160, P62, DOI 10.1016/j.ajo.2015.04.018; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kara N, 2014, J OCUL PHARMACOL TH, V30, P366, DOI 10.1089/jop.2013.0093; Khambhiphant B, 2015, INT OPHTHALMOL, V35, P853, DOI 10.1007/s10792-015-0063-9; Kim M, 2012, OPTOMETRY VISION SCI, V89, P1150, DOI 10.1097/OPX.0b013e318264f657; Lin T, 1996, CURR EYE RES, V15, P453, DOI 10.3109/02713689609000756; Mallen EAH, 2006, INVEST OPHTH VIS SCI, V47, P1251, DOI 10.1167/iovs.05-1086; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Nickla DL, 2012, EXP EYE RES, V102, P93, DOI 10.1016/j.exer.2012.07.002; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Portney L.G., 2008, FDN CLIN RES APPL PR, DOI [10.1016/j.ophtha.2008.10.020, DOI 10.1016/J.OPHTHA.2008.10.020]; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P3103, DOI 10.1167/iovs.15-16446; Read SA, 2010, INVEST OPHTH VIS SCI, V51, P6262, DOI 10.1167/iovs.10-5457; Sander BP, 2014, EXP EYE RES, V128, P181, DOI 10.1016/j.exer.2014.10.003; Sander Beata P., 2016, ARVO; Sizmaz S, 2013, BRIT J OPHTHALMOL, V97, P601, DOI 10.1136/bjophthalmol-2012-302393; Stone RA, 2004, INVEST OPHTH VIS SCI, V45, P63, DOI 10.1167/iovs.03-0294; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Tong L, 2009, OPHTHALMOLOGY, V116, P572, DOI 10.1016/j.ophtha.2008.10.020; Vural AD, 2014, RETINA-J RET VIT DIS, V34, P1223, DOI 10.1097/IAE.0000000000000043; Yuvaci I, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/981274	39	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162468	10.1371/journal.pone.0162468	http://dx.doi.org/10.1371/journal.pone.0162468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622495	gold, Green Published, Green Submitted			2022-12-26	WOS:000383681000033
J	Rydberg, DM; Holm, L; Engqvist, I; Fryckstedt, J; Lindh, JD; Stiller, CO; Asker-Hagelberg, C				Rydberg, Diana M.; Holm, Lennart; Engqvist, Ida; Fryckstedt, Jessica; Lindh, Jonatan D.; Stiller, Carl-Olav; Asker-Hagelberg, Charlotte			Adverse Drug Reactions in a Tertiary Care Emergency MedicineWard - Prevalence, Preventability and Reporting	PLOS ONE			English	Article							REACTION-RELATED ADMISSIONS; HOSPITAL ADMISSIONS; RISK-FACTORS; FREQUENCY; EVENTS; METAANALYSIS; DEFINITIONS; COST	Purpose To identify the prevalence and preventability of adverse drug reactions (ADRs) in an emergency ward setting in a tertiaryhospital in Sweden and to what extent the detected ADRs were reported to the Medical Product Agency (MPA). Methods In this prospective cross sectional observational study, 706 patients admitted to one of the Emergency Wards, at the Karolinska University Hospital in Solna, Stockholm during September 2008 - September 2009, were included. The electronic patient records were reviewed for patients' demographic parameters, prevalence of possible ADRs and assessment of their preventability. In addition, the extent of formal and required ADR reporting to national registers was studied. Results Approximately 40 percent of the patient population had at least one possible ADR (n = 284). In themultivariable regression model, age and number of drugs were significantly associated with risk of presenting with an ADR (p<0.01 and p<0.001, respectively). Sex was not identified as a significant predictor of ADRs (p = 0.27). The most common ADRs were cardiovascular, followed by electrolyte disturbances, and hemorrhage. In 18 percent of the patient population ADRs were the reason for admission or had contributed to admission and 24% of these ADRs were assessed as preventable. The under-reporting of ADRs to the MPA was 99%. Conclusions ADRs are common in Emergency Medicine in tertiarycare in Sweden, but under-reporting of ADRs is substantial. The most frequent ADRs are caused by cardiovascular drugs, and significantly associated with age and number of drugs. However, only a minority of the detected serious ADRs contributing to admission could have been avoided by increased risk awareness.	[Rydberg, Diana M.; Stiller, Carl-Olav; Asker-Hagelberg, Charlotte] Karolinska Inst, Dept Med Solna, Clin Pharmacol, Stockholm, Sweden; [Rydberg, Diana M.; Stiller, Carl-Olav] Karolinska Univ, Hosp Solna, Clin Pharmacol Drug Safety & Evaluat Sect, Stockholm, Sweden; [Holm, Lennart; Asker-Hagelberg, Charlotte] Med Prod Agcy, Uppsala, Sweden; [Engqvist, Ida; Fryckstedt, Jessica] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Emergency Med,Dept Med, Stockholm, Sweden; [Lindh, Jonatan D.] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Lindh, Jonatan D.] Karolinska Univ, Huddinge Hosp, Dept Clin Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Medical Products Agency; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Rydberg, DM (corresponding author), Karolinska Inst, Dept Med Solna, Clin Pharmacol, Stockholm, Sweden.; Rydberg, DM (corresponding author), Karolinska Univ, Hosp Solna, Clin Pharmacol Drug Safety & Evaluat Sect, Stockholm, Sweden.	diana.rydberg@ki.se		Fryckstedt, Jessica/0000-0003-4944-8909	Health Care Division of Stockholm County Council; Swedish foundation of Clinical Pharmacology and Pharmacotherapy	Health Care Division of Stockholm County Council(Stockholm County Council); Swedish foundation of Clinical Pharmacology and Pharmacotherapy	The study was funded by a public funder, the Health Care Division of Stockholm County Council. DR was partly funded by a grant offered by the Swedish foundation of Clinical Pharmacology and Pharmacotherapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern F, 2014, EMERG MED J, V31, P24, DOI 10.1136/emermed-2012-201945; Alexopoulou A, 2008, EUR J INTERN MED, V19, P505, DOI 10.1016/j.ejim.2007.06.030; Backstrom M, 2004, PHARMACOEPIDEM DR S, V13, P483, DOI 10.1002/pds.962; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Beijer HJM, 2002, PHARM WORLD SCI, V24, P46, DOI 10.1023/A:1015570104121; Benard-Laribiere A, 2015, FUND CLIN PHARMACOL, V29, P106, DOI 10.1111/fcp.12088; Brvar Miran, 2009, BMC Clin Pharmacol, V9, P8, DOI 10.1186/1472-6904-9-8; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Ekman E, 2009, EUR J CLIN PHARMACOL, V65, P43, DOI 10.1007/s00228-008-0564-9; Eudra Vigilance Expert Working Group (EV-EWG), 2015, IMPORTANTMEDICAL EV; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Fryckstedt Jessica, 2008, Lakartidningen, V105, P894; Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; HALLAS J, 1990, J INTERN MED, V228, P83, DOI 10.1111/j.1365-2796.1990.tb00199.x; Hellden A, 2009, DRUG AGING, V26, P595, DOI 10.2165/11315790-000000000-00000; Hopf Y, 2008, PHARM WORLD SCI, V30, P854, DOI 10.1007/s11096-008-9240-5; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Kanjanarat P, 2003, AM J HEALTH-SYST PH, V60, P1750, DOI 10.1093/ajhp/60.17.1750; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Kongkaew C, 2013, PHARMACOTHERAPY, V33, P827, DOI 10.1002/phar.1287; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; Lagnaoui R, 2000, EUR J CLIN PHARMACOL, V56, P181, DOI 10.1007/s002280050738; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Leendertse AJ, 2010, DRUG SAFETY, V33, P233, DOI 10.2165/11319030-000000000-00000; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lovborg H, 2012, EUR J CLIN PHARMACOL, V68, P1183, DOI 10.1007/s00228-012-1237-2; Mjorndal T, 2002, PHARMACOEPIDEM DR S, V11, P65, DOI 10.1002/pds.667; Moore N, 1998, BRIT J CLIN PHARMACO, V45, P301, DOI 10.1046/j.1365-2125.1998.00667.x; Muehlberger N, 1997, PHARMACOEPIDEM DR S, V6, pS71, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S71::AID-PDS282>3.3.CO;2-9; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Nebeker JR, 2004, ANN INTERN MED, V140, P795, DOI 10.7326/0003-4819-140-10-200405180-00009; Olivier P, 2002, DRUG SAFETY, V25, P1035, DOI 10.2165/00002018-200225140-00005; Onder G, 2002, J AM GERIATR SOC, V50, P1962, DOI 10.1046/j.1532-5415.2002.50607.x; Paul Esbjorn, 2008, Lakartidningen, V105, P2338; Pedros C, 2014, EUR J CLIN PHARMACOL, V70, P361, DOI 10.1007/s00228-013-1630-5; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Ruiter R, 2012, DRUG AGING, V29, P225, DOI 10.2165/11599430-000000000-00000; SBU, 2009, 193 SBU; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A; Wiffen P, 2002, BANDOLIER EXTRA  JUN, DOI [10.1111/j.1365-2125.2006.02698.x, DOI 10.1111/J.1365-2125.2006.02698.X]; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	42	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162948	10.1371/journal.pone.0162948	http://dx.doi.org/10.1371/journal.pone.0162948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622270	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000071
J	Zhang, Z; Li, M; Chen, FX; Li, LX; Liu, J; Li, Z; Ji, R; Zuo, XL; Li, YQ				Zhang, Zhen; Li, Ming; Chen, Feixue; Li, Lixiang; Liu, Jun; Li, Zhen; Ji, Rui; Zuo, Xiuli; Li, Yanqing			Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo	PLOS ONE			English	Article							STROMAL CELLS; BONE-MARROW; THERAPY; DELIVERY; CANCER; GROWTH; METASTASIS; ANTIBODIES; MIGRATION; APOPTOSIS	Introduction Mesenchymal stem cells (MSCs) can serve as vehicles for therapeutic genes. However, little is known about MSC behavior in vivo. Here, we demonstrated that probe-based confocal laser endomicroscopy (pCLE) can be used to track MSCs in vivo and individually monitor tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) gene expression within carcinomas. Methods Isolated BALB/c nu/nu mice MSCs (MSCs) were characterized and engineered to co-express the TRAIL and enhanced green fluorescent protein (EGFP) genes. The number of MSCs co-expressing EGFP and TRAIL (TRAIL-MSCs) at tumor sites was quantified with pCLE in vivo, while their presence was confirmedusing immunofluorescence (IF) and quantitative polymerase chain reaction (qPCR). The therapeutic effects of TRAIL-MSCs were evaluated by measuring the volumes and weights of subcutaneous HT29-derived xenograft tumors. Results Intravital imaging of the subcutaneous xenograft tumors revealed that BALB/c mice treated with TRAIL-MSCs exhibited specific cellular signals, whereas no specific signals were observed in the control mice. The findings from the pCLE images were consistent with the IF and qPCR results. Conclusion The pCLE results indicated that endomicroscopy could effectively quantify injected MSCs that homed to subcutaneous xenograft tumor sites in vivo and correlated well with the therapeutic effects of the TRAIL gene. By applying pCLE for the in vivo monitoring of cellular trafficking, stem cell-based anticancer gene therapeutic approaches might be feasible and attractive options for individualized clinical treatments.	[Zhang, Zhen; Li, Ming; Chen, Feixue; Liu, Jun; Li, Zhen; Ji, Rui; Zuo, Xiuli; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Peoples R China; [Zhang, Zhen; Li, Lixiang] Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Jinan, Peoples R China	Shandong University; Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Peoples R China.	liyanqing@sdu.edu.cn	Li, Zhen/AFK-5293-2022; Li, Zhen/HHM-3328-2022; Li, Zhen/AAH-2515-2022	Li, Zhen/0000-0002-9783-169X; 	National Natural Science Foundation of China [81330012, 81300284]; Shandong Province Science and Technology Committee [2013GSF11833]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Science and Technology Committee	This study was funded by the National Natural Science Foundation of China (grant numbers 81330012 and 81300284) and the Shandong Province Science and Technology Committee (grant number 2013GSF11833). They are 81300284 to R.J, 81330012 and 2013GSF11833 to Y.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Science Foundation of China (grant numbers 81330012 and 81300284) and the Shandong Province Science and Technology Committee (grant number 2013GSF11833).	Altmeyer A, 2011, IN VIVO, V25, P1; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Atreya R, 2014, NAT MED, V20, P313, DOI 10.1038/nm.3462; Barczewska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074658; Belmar-Lopez C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-139; Belyanskaya LL, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-66; Bipat S, 2012, NETH J MED, V70, P26; Choi SA, 2011, NEURO-ONCOLOGY, V13, P61, DOI 10.1093/neuonc/noq147; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duiker EW, 2006, EUR J CANCER, V42, P2233, DOI 10.1016/j.ejca.2006.03.018; Dwyer RM, 2010, HUM GENE THER, V21, P1506, DOI 10.1089/hum.2010.135; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; Goetz M, 2013, ENDOSCOPY, V45, P469, DOI 10.1055/s-0032-1326361; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; Grisendi G, 2010, CANCER RES, V70, P3718, DOI 10.1158/0008-5472.CAN-09-1865; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Jarrett Monica, 2003, J Spec Pediatr Nurs, V8, P81, DOI 10.1111/j.1088-145X.2003.00081.x; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Ju SH, 2007, RADIOLOGY, V245, P206, DOI 10.1148/radiol.2443061290; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Khalil PN, 2007, GASTROENTEROLOGY, V132, P944, DOI 10.1053/j.gastro.2006.12.029; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, P1975, DOI DOI 10.1093/JNCI/DJV048; Lee K, 2001, MOL THER, V3, P857, DOI 10.1006/mthe.2001.0327; Li M, 2015, INFLAMM BOWEL DIS, V21, P2068, DOI 10.1097/MIB.0000000000000458; Loebinger MR, 2009, CANCER RES, V69, P4134, DOI 10.1158/0008-5472.CAN-08-4698; Millard SM, 2013, BIOESSAYS, V35, P173, DOI 10.1002/bies.201200087; Morgan B, 2011, NAT REV CLIN ONCOL, V8, P517, DOI 10.1038/nrclinonc.2011.62; Mouiseddine M, 2007, BRIT J RADIOL, V80, pS49, DOI 10.1259/bjr/25927054; Mueller LP, 2011, CANCER GENE THER, V18, P229, DOI 10.1038/cgt.2010.68; Oh Y, 2015, J CONTROL RELEASE, V220, P671, DOI 10.1016/j.jconrel.2015.09.014; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Roorda BD, 2009, CRIT REV ONCOL HEMAT, V69, P187, DOI 10.1016/j.critrevonc.2008.06.004; Ruan J, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-309; Ruan J, 2011, INT J NANOMED, V6, P425, DOI 10.2147/IJN.S16498; Sathornsumetee S, 2006, ANTI-CANCER DRUG, V17, P1003, DOI 10.1097/01.cad.0000231473.00030.1f; Shah K, 2005, ANN NEUROL, V57, P34, DOI 10.1002/ana.20306; Shah K, 2008, J NEUROSCI, V28, P4406, DOI 10.1523/JNEUROSCI.0296-08.2008; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Stoff-Khalili MA, 2007, BREAST CANCER RES TR, V105, P157, DOI 10.1007/s10549-006-9449-8; Tummala S, 2016, DRUG DELIV, V23, P1773, DOI 10.3109/10717544.2015.1084400; Wang Z, 2009, NANOSCALE RES LETT, V4, P593, DOI 10.1007/s11671-009-9292-z; Zhou B, 2010, MAGN RESON IMAGING, V28, P394, DOI 10.1016/j.mri.2009.12.005	50	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162700	10.1371/journal.pone.0162700	http://dx.doi.org/10.1371/journal.pone.0162700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617958	gold, Green Submitted, Green Published			2022-12-26	WOS:000383653100043
J	Fleckenstein, J; Jelden, M; Kremp, S; Jagoda, P; Stroeder, J; Khreish, F; Ezziddin, S; Buecker, A; Rube, C; Schneider, GK				Fleckenstein, Jochen; Jelden, Michael; Kremp, Stephanie; Jagoda, Philippe; Stroeder, Jonas; Khreish, Fadi; Ezziddin, Samer; Buecker, Arno; Ruebe, Christian; Schneider, Guenther K.			The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; LOCALLY ADVANCED NSCLC; PET; DELINEATION; DISEASE; SCANS	Objective The study was designed to evaluate diffusion-weighted magnetic resonance imaging (DWI) vs. PET-CT of the thorax in the determination of gross tumor volume (GTV) in radiotherapy planning of non-small-cell lung cancer (NSCLC). Materials and Methods Eligible patients with NSCLC who were supposed to receive definitive radio(chemo) therapy were prospectively recruited. For MRI, a respiratory gated T2-weighted sequence in axial orientation and non-gatedDWI (b = 0, 800, 1,400 and apparent diffusion coefficient map [ADC]) were acquired on a 1.5 Tesla scanner. Primary tumors were delineated on FDGPET/CT (stGTV) and DWI images (dwGTV). The definition of stGTV was based on the CT and visually adapted to the FDG-PET component if indicated (e.g., in atelectasis). For DWI, dwGTV was visually determined and adjusted for anatomical plausibility on T2w sequences. Beside a statistical comparison of stGTV and dwGTB, spatial agreementwas determined with the "Hausdorff-Distance" (HD) and the "Dice Similarity Coefficient" (DSC). Results Fifteen patients (one patient with two synchronous NSCLC) were evaluated. For 16 primary tumors with UICC stages I (n = 4), II (n = 3), IIIA (n = 2) and IIIB (n = 7) mean values for dwGTV were significantly larger than those of stGTV (76.6 +/- 84.5 ml vs. 66.6 +/- 75.2 ml, p<0.01). The correlation of stGTV and dwGTV was highly significant (r = 0.995, p<0.001). Yet, some considerable volume deviations between these two methods were observed (median 27.5%, range 0.4-52.1%). An acceptable agreement between dwGTV and stGTV regarding the spatial extent of primary tumors was found (average HD: 2.25 +/- 0.7 mm; DC 0.68 +/- 0.09). Conclusion The overall level of agreement between PET-CT and MRI based GTV definition is acceptable. Tumor volumes may differ considerably in single cases. DWI-derived GTVs are significantly, yet modestly, larger than their PET-CT based counterparts. Prospective studies to assess the safety and efficacy of DWI-based radiotherapy planning in NSCLC are warranted.	[Fleckenstein, Jochen; Jelden, Michael; Kremp, Stephanie; Ruebe, Christian] Univ Saarland, Med Ctr, Dept Radiotherapy & Radiat Oncol, Homburg, Germany; [Jagoda, Philippe; Stroeder, Jonas; Schneider, Guenther K.] Univ Saarland, Med Ctr, Dept Diagnost & Intervent Radiol, Homburg, Germany; [Khreish, Fadi; Ezziddin, Samer; Buecker, Arno] Univ Saarland, Med Ctr, Dept Nucl Med, Homburg, Germany	Saarland University; Saarland University; Saarland University	Fleckenstein, J (corresponding author), Univ Saarland, Med Ctr, Dept Radiotherapy & Radiat Oncol, Homburg, Germany.	jochen.fleckenstein@uks.eu	Ezziddin, Samer/E-8406-2014	Ezziddin, Samer/0000-0003-4110-3375; Stroeder, Jonas/0000-0001-8498-6134				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bradley J, 2004, INT J RADIAT ONCOL, V59, P78, DOI 10.1016/j.ijrobp.2003.10.044; Chen W, 2010, MAGN RESON IMAGING, V28, P613, DOI 10.1016/j.mri.2010.02.009; De Ruysscher D, 2012, LUNG CANCER, V75, P141, DOI 10.1016/j.lungcan.2011.07.018; De Ruysscher D, 2010, J CLIN ONCOL, V28, P5301, DOI 10.1200/JCO.2010.30.3271; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Everitt S, 2010, CANCER-AM CANCER SOC, V116, P5030, DOI 10.1002/cncr.25392; Fleckenstein J, 2016, STRAHLENTHER ONKOL, V192, P75, DOI 10.1007/s00066-015-0900-9; Fleckenstein J, 2011, INT J RADIAT ONCOL, V81, pE283, DOI 10.1016/j.ijrobp.2011.01.020; HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850, DOI 10.1109/34.232073; Konert T, 2015, RADIOTHER ONCOL, V116, P27, DOI 10.1016/j.radonc.2015.03.014; Liao ZXX, 2010, INT J RADIAT ONCOL, V76, P775, DOI 10.1016/j.ijrobp.2009.02.032; McCloskey P, 2013, EUR J CANCER, V49, P1555, DOI 10.1016/j.ejca.2012.12.023; Ohba Y, 2009, J THORAC CARDIOV SUR, V138, P439, DOI 10.1016/j.jtcvs.2008.12.026; Ohno Y, 2011, RADIOLOGY, V261, P605, DOI 10.1148/radiol.11110281; Palma D, 2012, INT J RADIAT ONCOL, V82, P1149, DOI 10.1016/j.ijrobp.2011.03.005; Schaefer A, 2013, EUR J NUCL MED MOL I, V40, P1233, DOI 10.1007/s00259-013-2407-x; Sommer G, 2012, EUR RADIOL, V22, P2859, DOI 10.1007/s00330-012-2542-y; Ung YC, 2011, J THORAC ONCOL, V6, P86, DOI 10.1097/JTO.0b013e3181fc7687; Wu LM, 2012, J SURG RES, V178, P304, DOI 10.1016/j.jss.2012.03.074; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	21	13	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162816	10.1371/journal.pone.0162816	http://dx.doi.org/10.1371/journal.pone.0162816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612171	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900170
J	Lei, Y; Hu, TT; Song, XF; Nie, H; Chen, M; Chen, WX; Zhou, Z; Zhang, DZ; Hu, HD; Hu, P; Ren, H				Lei, Yu; Hu, Tingting; Song, Xiaofei; Nie, Hong; Chen, Min; Chen, Weixian; Zhou, Zhi; Zhang, Dazhi; Hu, Huaidong; Hu, Peng; Ren, Hong			Production of Autoantibodies in Chronic Hepatitis B Virus Infection Is Associated with the Augmented Function of Blood CXCR5(+)CD4(+) T Cells	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; IL-21; DIFFERENTIATION; SEROCONVERSION; PATHOGENESIS; EXPRESSION; EXPANSION; HBV	T follicular helper cells (Tfh) provide help to B cells to support their activation, expansion and differentiation. However, the role of Tfh cells in chronic HBV infection is poorly defined. The aim of this research was to examine the function of Tfh cells and whether they are involved in HBV related disease. Blood CXCR5(+)CD4(+) T cells and B cells in 85 patients with chronic HBV infection (HBV patients) and health controls (HC) were examined by flow cytometry. The molecule expression in blood CXCR5(+)CD4(+) T cells was detected by realtime PCR. Blood CXCR5(+)CD4(+) T cells and B cells were co-cultured and the production of Ig and cytokines was detected by ELISA. Autoantibodies were detected by indirect immunofluorescence and immunospot assay. We found that blood CXCR5(+)CD4(+) T cells in patients with chronic HBV infection (HBV patients) expressed higher level of activation related molecules and cytokines than that from health controls (HC). In HBV patients, the frequency of blood CXCR5(+)CD4(+) T cells was significantly correlated with serum ALT and AST. We also found that blood CXCR5(+)CD4(+) T cells from HBV patients could induce B cells to secret higher level of immunoglobulin than that from HC. Several autoantibodies, including ANA, ss-A, ss-B, Scl-70, Jo-1, ect, were indeed positive in 65% HBV patients. Among HBV patients, expression of function related molecules was significantly higher in blood CXCR5(+)CD4(+) T cells from patients with autoantibodies than that without autoantibodies. Our research indicated that blood CXCR5(+)CD4(+) T cells from HBV patients were over activated and show augmented capacity to help B cells for antibody secreting, which might correlated with liver inflammation and the production of autoantibodies in extrahepatic manifestations.	[Lei, Yu; Hu, Tingting; Song, Xiaofei; Chen, Min; Zhou, Zhi; Zhang, Dazhi; Hu, Huaidong; Hu, Peng; Ren, Hong] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis,Minist Educ, Inst Viral Hepatitis,Key Lab Mol Biol Infect Dis, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China; [Nie, Hong; Chen, Weixian] Chongqing Med Univ, Affiliated Hosp 2, Dept Lab Med, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University	Hu, P; Ren, H (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis,Minist Educ, Inst Viral Hepatitis,Key Lab Mol Biol Infect Dis, 74 Lin Jiang Rd, Chongqing 400010, Peoples R China.	hp_cq@163.com; renhong0531@vip.sina.com			National Natural Science Foundation of China [30930082, 31000397, 81171561]; National Science and Technology Major Project of China [2008ZX10002-006, 2012ZX1002007001, 2012ZX09303001-001]; Key Project of Chongqing Science and Technology Commission [cstc2012gg-yyjsB10007]; Chongqing Post-doctor grant [XM20120016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Key Project of Chongqing Science and Technology Commission; Chongqing Post-doctor grant	This work was supported by the National Natural Science Foundation of China http://www.nsfc.gov.cn/, [grant numbers 30930082 to HongRen, 31000397 to Yu Lei, 81171561 to Peng Hu], the National Science and Technology Major Project of China http://www.nmp.gov.cn [grant numbers 2008ZX10002-006, 2012ZX1002007001, 2012ZX09303001-001 to Hong Ren], the Key Project of Chongqing Science and Technology Commission http://www.cqwsjsw.gov.cn/ [grant number cstc2012gg-yyjsB10007 to Hong Ren], Chongqing Post-doctor grant http://www.cqhrss.gov.cn/ [grant number XM20120016 to Yu Lei].	Amarapurkar Deepak N, 2002, Ann Hepatol, V1, P192; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Cacoub P, 2005, J HEPATOL, V43, P764, DOI 10.1016/j.jhep.2005.05.029; Cacoub P, 2009, RHEUM DIS CLIN N AM, V35, P125, DOI 10.1016/j.rdc.2009.03.006; Chen M, 2008, J INFECT DIS, V198, P1643, DOI 10.1086/593065; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021698; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Han Steven-Huy B, 2004, Clin Liver Dis, V8, P403, DOI 10.1016/j.cld.2004.02.003; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hu TT, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-54; Kakimi K, 2001, J IMMUNOL, V167, P6701, DOI 10.4049/jimmunol.167.12.6701; Li YY, 2013, HEPATOLOGY, V58, P1277, DOI 10.1002/hep.26489; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma SW, 2012, J HEPATOL, V56, P775, DOI 10.1016/j.jhep.2011.10.020; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oliviero B, 2011, J HEPATOL, V55, P53, DOI 10.1016/j.jhep.2010.10.016; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Wang J, 2013, CLIN EXP IMMUNOL, V174, P212, DOI 10.1111/cei.12162; Wang LF, 2015, HEPATOLOGY, V61, P627, DOI 10.1002/hep.27306; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	33	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162241	10.1371/journal.pone.0162241	http://dx.doi.org/10.1371/journal.pone.0162241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612199	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900067
J	Li, G; Li, M; Hu, J; Lei, R; Xiong, H; Ji, H; Yin, H; Wei, Q; Hu, G				Li, G.; Li, M.; Hu, J.; Lei, R.; Xiong, H.; Ji, H.; Yin, H.; Wei, Q.; Hu, G.			The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis	ONCOGENE			English	Article							TARGETING HEXOKINASE 2; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; MIR-182 EXPRESSION; UP-REGULATION; FATTY-ACID; CANCER; CELL; KINASE; MICRORNA	Reprogrammed metabolism is one of the hallmarks of cancer. The dysregulation of glycolysis in cancer has been heavily studied. However, it remains largely unclear how other metabolic processes are regulated in cancer cells. Here we show that microRNA-182 (miR-182) suppresses pyruvate dehydrogenase (PDH) kinase 4 (PDK4) and promotes lung tumorigenesis. miR-182 is dysregulated and inversely correlated with PDK4 in human lung adenocarcinomas. The miR-182-PDK4 axis regulates lung cancer cell growth by modulating the activity of PDH, the gatekeeping enzyme of pyruvate flux into acetyl-CoA, and subsequently de novo lipogenesis of cancer cells. Suppression of lipogenesis by silencing ATP citrate lyase (ACLY) and fatty acid synthase (FASN) or by chemical inhibitors diminishes the effects of miR-182-PDK4 in tumor growth. Alteration of de novo lipogenesis also affects reactive oxygen species (ROS) production and the downstream JNK signaling pathway. Hence, our work suggests that the miR-182-PDK4 axis is a crucial regulator of cancer cell metabolism and a potential target for antitumor therapy.	[Li, G.; Hu, J.; Lei, R.; Hu, G.] Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Li, G.; Hu, J.; Lei, R.; Hu, G.] Shanghai Jiao Tong Univ, Sch Med, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Li, G.; Hu, J.; Lei, R.; Hu, G.] Univ Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Li, M.; Yin, H.] Chinese Acad Sci, Key Lab Food Safety Res, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Xiong, H.] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China; [Ji, H.] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Wei, Q.] Tongji Univ, Sch Med, Dept Pathol, Shanghai Peoples Hosp 10, 301 Yanchang Rd, Shanghai 200072, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Hu, G (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Hu, G (corresponding author), Shanghai Jiao Tong Univ, Sch Med, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Hu, G (corresponding author), Univ Chinese Acad Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Wei, Q (corresponding author), Tongji Univ, Sch Med, Dept Pathol, Shanghai Peoples Hosp 10, 301 Yanchang Rd, Shanghai 200072, Peoples R China.	weiqing1971@aliyun.com; ghhu@sibs.ac.cn		Hu, Guohong/0000-0002-2980-5166; Li, Gang/0000-0001-9761-1323; yin, hui yong/0000-0001-7049-1560	Ministry of Science and Technology of China [2011CB510105, 2012ZX09506-001-005, 2013CB910904]; National Natural Science Foundation of China [81430070, 81222032, 31371409]; Chinese Academy of Sciences [XDA01040402]; Science and Technology Commission of Shanghai Municipality [14431900800]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	We thank Dr Weihong Sun at the Tissue Bank of the Institute of Health Sciences for technical support. The study was funded by grants from the Ministry of Science and Technology of China (2011CB510105, 2012ZX09506-001-005 and 2013CB910904), National Natural Science Foundation of China (81430070, 81222032 and 31371409), Chinese Academy of Sciences (XDA01040402) and Science and Technology Commission of Shanghai Municipality (14431900800).	Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen B, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-228; Chiang CH, 2013, BBA-GEN SUBJECTS, V1830, P3067, DOI 10.1016/j.bbagen.2013.01.009; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Fang ZY, 2012, CELL RES, V22, P565, DOI 10.1038/cr.2011.149; Fei X, 2012, FEBS LETT, V586, P392, DOI 10.1016/j.febslet.2012.01.006; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Guo WJ, 2015, HEPATOLOGY, V62, P1132, DOI 10.1002/hep.27929; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Horie T, 2009, BIOCHEM BIOPH RES CO, V389, P315, DOI 10.1016/j.bbrc.2009.08.136; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim HR, 2013, BIOCHEM BIOPH RES CO, V437, P225, DOI 10.1016/j.bbrc.2013.06.043; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; LABER B, 1987, BIOCHEM J, V248, P351, DOI 10.1042/bj2480351; Landi MT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001651; Lei R, 2014, ONCOGENE, V33, P1287, DOI 10.1038/onc.2013.65; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liu AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086872; Liu H, 2013, INT J COLORECTAL DIS, V28, P697, DOI 10.1007/s00384-013-1674-0; Ma XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6212; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; OOKHTENS M, 1984, AM J PHYSIOL, V247, pR146, DOI 10.1152/ajpregu.1984.247.1.R146; Park YY, 2013, HEPATOLOGY, V58, P182, DOI 10.1002/hep.26310; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Qin J, 2014, GENE, V538, P342, DOI 10.1016/j.gene.2013.12.043; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; SABINE JR, 1967, CANCER RES, V27, P793; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Singh Pankaj K, 2011, Mol Cell Pharmacol, V3, P125; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Sun JB, 2015, INT J CLIN EXP PATHO, V8, P4755; Sun WY, 2015, CANCER RES, V75, P4923, DOI 10.1158/0008-5472.CAN-15-1023; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tan XG, 2011, CLIN CANCER RES, V17, P6802, DOI 10.1158/1078-0432.CCR-11-0419; Wang J, 2015, ONCOTARGET, V6, P19456, DOI 10.18632/oncotarget.3318; Wang PY, 2013, ONCOL LETT, V6, P1681, DOI 10.3892/ol.2013.1593; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wei Q, 2015, THORAC CANCER, V6, P2, DOI 10.1111/1759-7714.12164; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang WB, 2014, ONCOTARGET, V5, P740, DOI 10.18632/oncotarget.1608; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhu HL, 2014, BIOCHEM BIOPH RES CO, V450, P857, DOI 10.1016/j.bbrc.2014.06.073	57	47	48	4	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 16	2017	36	7					989	998		10.1038/onc.2016.265	http://dx.doi.org/10.1038/onc.2016.265			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8JG	27641336				2022-12-26	WOS:000394169100011
J	Haque, MM; Ray, SS; Stuehr, DJ				Haque, Mohammad Mahfuzul; Ray, Sougata Sinha; Stuehr, Dennis J.			Phosphorylation Controls Endothelial Nitric-oxide Synthase by Regulating Its Conformational Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFLAVIN ELECTRON-TRANSFER; HUMAN CYTOCHROME-P450 REDUCTASE; NO SYNTHASE; FMN DOMAIN; METHIONINE SYNTHASE; CALMODULIN-BINDING; DIFLAVIN REDUCTASE; 2-DOMAIN CONSTRUCT; ENZYME ACTIVATION; CATALYTIC CYCLE	The activity of endothelial NO synthase (eNOS) is triggered by calmodulin (CaM) binding and is often further regulated by phosphorylation at several positions in the enzyme. Phosphorylation at Ser(1179) occurs in response to diverse physiologic stimuli and increases the NO synthesis and cytochrome c reductase activities of eNOS, thereby enhancing its participation in biological signal cascades. Despite its importance, the mechanism by which Ser(1179) phosphorylation increases eNOS activity is not understood. To address this, we used stopped-flow spectroscopy and computer modeling approaches to determine how the phosphomimetic mutation (S1179D) may impact electron flux through eNOS and the conformational behaviors of its reductase domain, both in the absence and presence of bound CaM. We found that S1179D substitution in CaM-free eNOS had multiple effects; it increased the rate of flavin reduction, altered the conformational equilibrium of the reductase domain, and increased the rate of its conformational transitions. We found these changes were equivalent in degree to those caused by CaM binding to wild-type eNOS, and the S1179D substitution together with CaM binding caused even greater changes in these parameters. The modeling indicated that the changes caused by the S1179D substitution, despite being restricted to the reductase domain, are sufficient to explain the stimulation of both the cytochrome c reductase and NO synthase activities of eNOS. This helps clarify how Ser(1179) phosphorylation regulates eNOS and provides a foundation to compare its regulation by other phosphorylation events.	[Haque, Mohammad Mahfuzul; Ray, Sougata Sinha; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Haque, MM; Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	haquem@ccf.org; stuehrd@ccf.org		HAQUE, MOHAMMAD/0000-0003-0852-6368	National Institutes of Health [GM051491, HL076491]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM051491 and HL076491 (to D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arnett DC, 2015, FEBS LETT, V589, P1173, DOI 10.1016/j.febslet.2015.03.035; Campbell MG, 2014, P NATL ACAD SCI USA, V111, pE3614, DOI 10.1073/pnas.1413763111; Chen PF, 2003, J BIOL CHEM, V278, P52392, DOI 10.1074/jbc.M305469200; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Feng CJ, 2006, BIOCHEMISTRY-US, V45, P6354, DOI 10.1021/bi060223n; Feng CJ, 2006, J AM CHEM SOC, V128, P3808, DOI 10.1021/ja0578606; Finn RD, 2003, EUR J BIOCHEM, V270, P1164, DOI 10.1046/j.1432-1033.2003.03474.x; Frances O, 2015, BIOPHYS J, V108, P1527, DOI 10.1016/j.bpj.2015.01.032; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh DK, 2012, FEBS J, V279, P1306, DOI 10.1111/j.1742-4658.2012.08525.x; Guan ZW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.000810; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Hannibal L, 2015, BIOCHEM J, V467, P153, DOI 10.1042/BJ20141319; Haque MM, 2014, FEBS J, V281, P5325, DOI 10.1111/febs.13073; Haque MM, 2011, FEBS J, V278, P4055, DOI 10.1111/j.1742-4658.2011.08310.x; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Haque MM, 2013, BIOCHEM J, V450, P607, DOI 10.1042/BJ20121488; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; He YF, 2015, P NATL ACAD SCI USA, V112, P11835, DOI 10.1073/pnas.1508829112; Hedison TM, 2015, FEBS J, V282, P4357, DOI 10.1111/febs.13501; Huang WC, 2013, STRUCTURE, V21, P1581, DOI 10.1016/j.str.2013.06.022; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; KLATT P, 1992, J BIOL CHEM, V267, P11374; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Leferink NGH, 2015, FEBS J, V282, P3016, DOI 10.1111/febs.13171; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Pudney CR, 2012, FEBS J, V279, P1534, DOI 10.1111/j.1742-4658.2011.08442.x; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Salerno JC, 2013, FEBS LETT, V587, P44, DOI 10.1016/j.febslet.2012.10.039; Sheng YH, 2015, J INORG BIOCHEM, V153, P186, DOI 10.1016/j.jinorgbio.2015.08.006; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tejero J, 2010, J BIOL CHEM, V285, P27232, DOI 10.1074/jbc.M110.138842; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Volkmann N, 2014, J STRUCT BIOL, V188, P46, DOI 10.1016/j.jsb.2014.08.006; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang ZQ, 2016, J INORG BIOCHEM, V158, P122, DOI 10.1016/j.jinorgbio.2016.03.002; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Yokom AL, 2014, J BIOL CHEM, V289, P16855, DOI 10.1074/jbc.M114.564005	57	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23047	23057		10.1074/jbc.M116.737361	http://dx.doi.org/10.1074/jbc.M116.737361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613870	Green Published, hybrid			2022-12-26	WOS:000387224800017
J	Piepenbrink, KH; Lillehoj, E; Harding, CM; Labonte, JW; Zuo, XT; Rapp, CA; Munson, RS; Goldblum, SE; Feldman, MF; Gray, JJ; Sundberg, EJ				Piepenbrink, Kurt H.; Lillehoj, Erik; Harding, Christian M.; Labonte, Jason W.; Zuo, Xiaotong; Rapp, Chelsea A.; Munson, Robert S., Jr.; Goldblum, Simeon E.; Feldman, Mario F.; Gray, Jeffrey J.; Sundberg, Eric J.			Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN-GLYCOSYLATION; PSEUDOMONAS-AERUGINOSA; VIBRIO-CHOLERAE; BAUMANNII EVOLUTION; ANTIGENIC VARIATION; ESCHERICHIA-COLI; X-RAY; MOTILITY; IDENTIFICATION; PHENIX	Acinetobacter baumannii is a Gram-negative coccobacillus found primarily in hospital settings that has recently emerged as a source of hospital-acquired infections. A. baumannii expresses a variety of virulence factors, including type IV pili, bacterial extracellular appendages often essential for attachment to host cells. Here, we report the high resolution structures of the major pilin subunit, PilA, from three Acinetobacter strains, demonstrating that A. baumannii subsets produce morphologically distinct type IV pilin glycoproteins. We examine the consequences of this heterogeneity for protein folding and assembly as well as host-cell adhesion by Acinetobacter. Comparisons of genomic and structural data with pilin proteins from other species of soil gammaproteobacteria suggest that these structural differences stem from evolutionary pressure that has resulted in three distinct classes of type IVa pilins, each found in multiple species.	[Piepenbrink, Kurt H.; Rapp, Chelsea A.; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Goldblum, Simeon E.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Lillehoj, Erik] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Labonte, Jason W.; Zuo, Xiaotong; Gray, Jeffrey J.] Johns Hopkins Univ, Whiting Sch Engn, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Munson, Robert S., Jr.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Microbial Pathogenesis,Res Inst, Columbus, OH 43205 USA; [Munson, Robert S., Jr.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA; [Harding, Christian M.; Feldman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Johns Hopkins University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Washington University (WUSTL)	Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.; Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.; Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	esundberg@ihv.umaryland.edu	Gray, Jeffrey J./B-5682-2008	Gray, Jeffrey J./0000-0001-6380-2324; Piepenbrink, Kurt/0000-0002-2527-0301; Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074; Sundberg, Eric/0000-0003-0478-3033	National Institutes of Health [R01 AI114902]; National Institutes of Health Training Grant [T32 AI095190]; National Institutes of Health Fellowship [F32 AI110045, F32 CA189246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114902, T32AI095190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01 AI114902 (to E. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Training Grant T32 AI095190 and National Institutes of Health Fellowship F32 AI110045.r Supported by National Institutes of Health Fellowship F32 CA189246.	Aagesen AM, 2012, MICROB ECOL, V64, P509, DOI 10.1007/s00248-012-0021-2; Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allison TM, 2015, MICROBIOL-SGM, V161, P1780, DOI 10.1099/mic.0.000128; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Audette GF, 2004, BIOCHEMISTRY-US, V43, P11427, DOI 10.1021/bi048957s; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhardwaj V, 2014, VACCINE, V32, P6979, DOI 10.1016/j.vaccine.2014.10.031; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Blank TE, 2000, INFECT IMMUN, V68, P7028, DOI 10.1128/IAI.68.12.7028-7038.2000; Borbulevych OY, 2011, J IMMUNOL, V186, P2950, DOI 10.4049/jimmunol.1003150; Cagatay TI, 2008, VET MICROBIOL, V126, P160, DOI 10.1016/j.vetmic.2007.06.007; Carruthers Michael D, 2013, Genome Announc, V1, DOI 10.1128/genomeA.00906-13; Cehovin A, 2010, VACCINE, V28, P4817, DOI 10.1016/j.vaccine.2010.04.065; Chabane YN, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-62; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Clemmer KM, 2011, MICROBIOL-SGM, V157, P2534, DOI 10.1099/mic.0.049791-0; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Criss AK, 2005, MOL MICROBIOL, V58, P510, DOI 10.1111/j.1365-2958.2005.04838.x; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Doi Y, 2015, SEMIN RESP CRIT CARE, V36, P85, DOI 10.1055/s-0034-1398388; Drew K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067051; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falagas ME, 2006, J HOSP INFECT, V64, P7, DOI 10.1016/j.jhin.2006.04.015; Gault J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005162; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Hu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070329; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Iwashkiw JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002758; Jacobs AC, 2014, MBIO, V5, DOI 10.1128/mBio.01076-14; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Jones CL, 2015, CLIN INFECT DIS, V61, P145, DOI 10.1093/cid/civ225; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Korpi Fatemeh, 2015, J Microbiol Biotechnol, DOI 10.4014/jmb.1507.07044; Lassak K, 2012, RES MICROBIOL, V163, P630, DOI 10.1016/j.resmic.2012.10.024; Lees-Miller RG, 2013, MOL MICROBIOL, V89, P816, DOI 10.1111/mmi.12300; Lillehoj EP, 2015, J BIOL CHEM, V290, P18316, DOI 10.1074/jbc.M115.657114; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Maldarelli GA, 2014, PATHOG DIS, V71, P302, DOI 10.1111/2049-632X.12137; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Oh MH, 2015, J MICROBIOL BIOTECHN, V25, P1390, DOI 10.4014/jmb.1504.04069; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piepenbrink KH, 2015, STRUCTURE, V23, P385, DOI 10.1016/j.str.2014.11.018; Piepenbrink KH, 2014, J BIOL CHEM, V289, P4334, DOI 10.1074/jbc.M113.534404; Scott NE, 2014, MOL CELL PROTEOMICS, V13, P2354, DOI 10.1074/mcp.M114.038315; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Smedley JG, 2005, INFECT IMMUN, V73, P7922, DOI 10.1128/IAI.73.12.7922-7931.2005; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Takahashi H, 2012, INFECT IMMUN, V80, P4154, DOI 10.1128/IAI.00423-12; Tan RM, 2015, INFECT IMMUN, V83, P1339, DOI 10.1128/IAI.02874-14; Tan RM, 2014, J INNATE IMMUN, V6, P227, DOI 10.1159/000354304; TANIGUCHI T, 1995, INFECT IMMUN, V63, P724, DOI 10.1128/IAI.63.2.724-728.1995; Toma C, 2002, FEMS IMMUNOL MED MIC, V33, P35, DOI 10.1111/j.1574-695X.2002.tb00569.x; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wilharm G, 2013, J BACTERIOL, V195, P4146, DOI 10.1128/JB.00754-13	75	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22924	22935		10.1074/jbc.M116.751099	http://dx.doi.org/10.1074/jbc.M116.751099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27634041	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000387224800006
J	Myat, MM; Patel, U				Myat, Monn Monn; Patel, Unisha			Receptor-Type Guanylyl Cyclase at 76C (Gyc76C) Regulates De Novo Lumen Formation during Drosophila Tracheal Development	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; TUBE FUSION; GTPASE; CGMP; PROTEIN; ACTIN; MIGRATION; SIZE; RHO	Lumen formation and maintenance are important for the development and function of essential organs such as the lung, kidney and vasculature. In the Drosophila embryonic trachea, lumena form de novo to connect the different tracheal branches into an interconnected network of tubes. Here, we identify a novel role for the receptor type guanylyl cyclase at 76C (Gyc76C) in de novo lumen formation in the Drosophila trachea. We show that in embryos mutant for gyc76C or its downsteam effector protein kinase G (PKG) 1, tracheal lumena are disconnected. Dorsal trunk (DT) cells of gyc76C mutant embryos migrate to contact each other and complete the initial steps of lumen formation, such as the accumulation of E-cadherin (E-cad) and formation of an actin track at the site of lumen formation. However, the actin track and E-cad contact site of gyc76C mutant embryos did not mature to become a new lumen and DT lumena did not fuse. We also observed failure of the luminal protein Vermiform to be secreted into the site of new lumen formation in gyc76C mutant trachea. These DT lumen formation defects were accompanied by altered localization of the Arf-like 3 GTPase (Arl3), a known regulator of vesicle-vesicle and vesicle-membrane fusion. In addition to the DT lumen defect, lumena of gyc76C mutant terminal cells were shorter compared to wild-type cells. These studies show that Gyc76C and downstream PKG-dependent signaling regulate de novo lumen formation in the tracheal DT and terminal cells, most likely by affecting Arl3-mediated luminal secretion.	[Myat, Monn Monn; Patel, Unisha] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Myat, Monn Monn] City Univ New York, Medgar Evers College, Dept Biol, Brooklyn, NY USA	Cornell University; City University of New York (CUNY) System	Myat, MM (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA.; Myat, MM (corresponding author), City Univ New York, Medgar Evers College, Dept Biol, Brooklyn, NY USA.	mmyat@mec.cuny.edu			NIH [GM082996]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grant GM082996 to M.M.M. There was no additional external funding received for this study.	Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Baer MM, 2009, CURR TOP DEV BIOL, V89, P137, DOI 10.1016/S0070-2153(09)89006-6; Caviglia S, 2014, SEMIN CELL DEV BIOL, V31, P82, DOI 10.1016/j.semcdb.2014.03.018; Chak K, 2014, DEVELOPMENT, V141, P136, DOI 10.1242/dev.095968; Davies SA, 2006, CELL SIGNAL, V18, P409, DOI 10.1016/j.cellsig.2005.08.011; Eguchi K, 2012, NEURON, V74, P517, DOI 10.1016/j.neuron.2012.03.028; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; GIGLIOTTI S, 1993, DEV BIOL, V159, P450, DOI 10.1006/dbio.1993.1255; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049; Jones TA, 2014, DEV BIOL, V390, P41, DOI 10.1016/j.ydbio.2014.02.021; Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012; KALDERON D, 1989, J BIOL CHEM, V264, P10738; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Liao WT, 2015, J MOL MED, V93, P523, DOI 10.1007/s00109-014-1236-0; Lucas KA, 2000, PHARMACOL REV, V52, P375; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Morton DB, 2004, MOL NEUROBIOL, V29, P97, DOI 10.1385/MN:29:2:097; Myat MM, 2005, DEV BIOL, V281, P38, DOI 10.1016/j.ydbio.2005.02.005; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Overend G, 2012, PEPTIDES, V34, P209, DOI 10.1016/j.peptides.2011.08.019; Patel U, 2013, BIOL OPEN, V000, P1; Patel U, 2012, BIOL OPEN, V1, P507, DOI 10.1242/bio.2012943; Peng QL, 2016, J NEUROSCI, V36, P4635, DOI 10.1523/JNEUROSCI.3726-15.2016; Petrov AM, 2008, J NEUROSCI, V28, P13216, DOI 10.1523/JNEUROSCI.2947-08.2008; Pirraglia C, 2013, DEV BIOL, V377, P21, DOI 10.1016/j.ydbio.2013.02.020; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Schleede J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005576; Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016; Sigurbjornsdottir S, 2014, NAT REV MOL CELL BIO, V15, P665, DOI 10.1038/nrm3871; Vermehren-Schmaedick A, 2010, GENETICS, V186, P183, DOI 10.1534/genetics.110.118166; Xu N, 2011, DEVELOPMENT, V138, P5415, DOI 10.1242/dev.069831	33	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0161865	10.1371/journal.pone.0161865	http://dx.doi.org/10.1371/journal.pone.0161865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642749	Green Published, gold			2022-12-26	WOS:000383891900005
J	Dorado, EJ; Okoth, SA; Montenegro, LM; Diaz, G; Barnwell, JW; Udhayakumar, V; Solano, CM				Jimena Dorado, Erika; Okoth, Sheila Akinyi; Madeline Montenegro, Lidia; Diaz, Gustavo; Barnwell, John W.; Udhayakumar, Venkatachalam; Murillo Solano, Claribel			Genetic Characterisation of Plasmodium falciparum Isolates with Deletion of the pfhrp2 and/or pfhrp3 Genes in Colombia: The Amazon Region, a Challenge for Malaria Diagnosis and Control	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN-2; MICROSATELLITE MARKERS; SEQUENCE VARIATION; TESTS; PARASITES; PERFORMANCE	Most Plasmodium falciparum-detecting rapid diagnostic tests (RDTs) target histidine-rich protein 2 (PfHRP2). However, P. falciparum isolates with deletion of the pfhrp2 gene and its homolog gene, pfhrp3, have been detected. We carried out an extensive investigation on 365 P. falciparum dried blood samples collected from seven P. falciparum endemic sites in Colombia between 2003 and 2012 to genetically characterise and geographically map pfhrp2-and/or pfhrp3-negative P. falciparum parasites in the country. We found a high proportion of pfhrp2-negative parasites only in Amazonas (15/39; 38.5%), and these parasites were also pfhrp3-negative. These parasites were collected between 2008 and 2009 in Amazonas, while pfhrp3-negative parasites (157/365, 43%) were found in all the sites and from each of the sample collection years evaluated (2003 to 2012). We also found that all pfhrp2-and/or pfhrp3-negative parasites were also negative for one or both flanking genes. Six sub-population clusters were established with 93.3% (14/15) of the pfhrp2-negative parasites grouped in the same cluster and sharing the same haplotype. This haplotype corresponded with the genetic lineage B-V1, a multidrug resistant strain that caused two outbreaks reported in Peru between 2010 and 2013. We found this B-V1 lineage in the Colombian Amazon as early as 2006. Two new clonal lineages were identified in these parasites from Colombia: the genetic lineages E-V1 and F. PfHRP2 sequence analysis revealed high genetic diversity at the amino acid level, with 17 unique sequences identified among 53 PfHRP2 sequences analysed. The use of PfHRP2-based RDTs is not recommended in Amazonas because of the high proportion of parasites with pfhrp2 deletion (38.5%), and implementation of new strategies for malaria diagnosis and control in Amazonas must be prioritised. Moreover, studies to monitor and genetically characterise pfhrp2-negative P. falciparum parasites in the Americas are warranted, given the extensive human migration occurring in the region.	[Jimena Dorado, Erika; Madeline Montenegro, Lidia; Diaz, Gustavo; Murillo Solano, Claribel] Ctr Int Entrenamiento & Invest Med CIDEIM, Malaria Res Grp, Cali, Valle, Colombia; [Okoth, Sheila Akinyi; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA; [Okoth, Sheila Akinyi] Atlanta Res & Educ Fdn, Decatur, GA USA	Centers for Disease Control & Prevention - USA	Dorado, EJ; Solano, CM (corresponding author), Ctr Int Entrenamiento & Invest Med CIDEIM, Malaria Res Grp, Cali, Valle, Colombia.	erika.dorado@gmail.com; claribel.murillo@gmail.com		DIAZ, GUSTAVO/0000-0002-9313-1936	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia, COLCIENCIAS [222951928929]; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER	Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia, COLCIENCIAS; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by Departamento Administrativo de Ciencia, Tecnologia e Innovacion de la Republica de Colombia, COLCIENCIAS (www.colciencias.gov.co), Grant 222951928929. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the patients who participated at each site studied. We thank the microscopists, the healthcare workers from the ColombianMalaria Project supported by The Global Fund Project, the Colombian National Institute of Health (INS), Hospital Divino Nino-Tumaco, Instituto Departamental de Salud de Narino-IDSN, Laboratorio de Salud Publica del Amazonas, Hospital San Sebastian de Uraba-Necocli, Hospital Nuestra Senora del Carmen-El Bagre, Laboratorio de Salud Publica del Choco-DASALUD and other institutions from our previous studies for their support in the collection of the samples. We thank Olga L. Murillo and Nancy E. Molina for their assistance in establishing the study sites in Antioquia, Choco, Cauca and Valle. We thank Alvaro M. Lasso, AngelicaMera, Katherine Navarro, Jonathan A. Mora, Paula Castaneda, Javier Martinez, Samanda Aponte, Catalina Alvarez, Cesar Restrepo andMelissa Rios for their assistance with the sample collection in Narino, Choco, Guaviare and Amazonas. We also thank Dragan Ljolje and LindsayMorton for their support in sample handling at the CDC in Atlanta, USA.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2015, B EP I NAC SAL; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022593; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Baldeviano GC, 2015, EMERG INFECT DIS, V21, P797, DOI 10.3201/eid2105.141427; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P399, DOI 10.1111/1469-0691.12151; Mariette N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-219; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; Solano CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131576; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Okoth SA, 2016, AM J TROP MED HYG, V94, P128, DOI 10.4269/ajtmh.15-0442; Okoth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126805; Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343; Pava Z, 2010, AM J TROP MED HYG, V83, P834, DOI 10.4269/ajtmh.2010.10-0075; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Pritchard JK, 2000, GENETICS, V155, P945; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Silbergeld Ellen K., 2002, Rev. Soc. Bras. Med. Trop., V35, P421, DOI 10.1590/S0037-86822002000500001; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Trouvay M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074269; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WHO, 2015, WORLD MAL REP 2015; WHO-WPRO website, MAL RAP DIAGN TESTS; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	39	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163137	10.1371/journal.pone.0163137	http://dx.doi.org/10.1371/journal.pone.0163137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636709	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700037
J	Liu, LN; Wang, YJ; Li, Y; Lin, Y; Hou, Y; Zhang, Y; Wei, SG; Zhao, P; Zhao, P; He, HW				Liu, Lina; Wang, Yejing; Li, Yu; Lin, Ying; Hou, Yong; Zhang, Yan; Wei, Shuguang; Zhao, Peng; Zhao, Ping; He, Huawei			LBD1 of Vitellogenin Receptor Specifically Binds to the Female-Specific Storage Protein SP1 via LBR1 and LBR3	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; RNA INTERFERENCE ANALYSIS; LARVAL SERUM-PROTEIN; CYSTEINE-RICH REPEAT; BOMBYX-MORI; FAT-BODY; LIGAND-BINDING; MEDIATED ENDOCYTOSIS; MOLECULAR-CLONING; FAMILIAL HYPERCHOLESTEROLEMIA	Storage proteins are the major protein synthesized in the fat body, released into hemolymph and re-sequestered into the fat body before pupation in most insect species. Storage proteins are important amino acid and nutrition resources during the non-feeding pupal period and play essential roles for the metamorphosis and oogenesis of insects. The sequestration of storage protein is a selective, specific receptor-mediated process. However, to date, the potential receptor mediating the sequestration of storage protein has not been determined in Bombyx mori. In this study, we expressed and purified the first ligand binding domain of Bombyx mori vitellogenin receptor (BmVgR), LBD1, and found LBD1 could bind with an unknown protein from the hemolymph of the ultimate silkworm larval instar via pull-down assay. This unknown protein was subsequently identified to be the female-specific storage protein SP1 by mass spectrometry. Furthermore, far western blotting assay, immunoprecipitation and isothermal titration calorimetry analysis demonstrated LBD1 specifically bound with the female-specific SP1, rather than another unisex storage protein SP2. The specific binding of LBD1 with SP1 was dependent on the presence of Ca2+ as it was essential for the proper conformation of LBD1. Deletion mutagenesis and ITC analysis revealed the first and third ligand binding repeats LBR1 and LBR3 were indispensable for the binding of LBD1 with SP1, and LBR2 and LBR4 also had a certain contribution to the specific binding. Our results implied BmVgR may mediate the sequestration of SP1 from hemolymph into the fat body during the larval-pupal transformation of Bombyx mori.	[Liu, Lina; Wang, Yejing; Li, Yu; Lin, Ying; Hou, Yong; Zhang, Yan; Wei, Shuguang; Zhao, Peng; Zhao, Ping; He, Huawei] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Wang, Yejing; He, Huawei] Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Coll Biotechnol, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Wang, YJ; He, HW (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.; Wang, YJ; He, HW (corresponding author), Southwest Univ, Chongqing Engn & Technol Res Ctr Novel Silk Mat, Coll Biotechnol, Chongqing 400715, Peoples R China.	yjwang@swu.edu.cn; hehuawei@swu.edu.cn		Liu, Lina/0000-0002-1035-9821	National Basic Research Program of China [2012CB114602]; State Key Program of National Natural Science of China [31530071]; National Natural Science Foundation of China [31572465, 31402139]; Chongqing Research Program of Basic Research and Frontier Technology [cstc2015jcyjA00040, cstc2015jcyjBX0035]; Fundamental Research Funds for the Central Universities [XDJK2013A019, XDJK2016E02 0]; Graduate Research and Innovation Project of Chongqing [CYS16074]; Open Project Program of Chongqing Engineering and Technology Research Center for Novel Silk Materials [silkgczx2016003]; Start-up Grant from Southwest University [SWU112111]	National Basic Research Program of China(National Basic Research Program of China); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Research Program of Basic Research and Frontier Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Graduate Research and Innovation Project of Chongqing; Open Project Program of Chongqing Engineering and Technology Research Center for Novel Silk Materials; Start-up Grant from Southwest University	This work was supported by National Basic Research Program of China (2012CB114602), State Key Program of National Natural Science of China (31530071), National Natural Science Foundation of China (31572465, 31402139), Chongqing Research Program of Basic Research and Frontier Technology (cstc2015jcyjA00040, cstc2015jcyjBX0035), Fundamental Research Funds for the Central Universities (XDJK2013A019, XDJK2016E02 0), Graduate Research and Innovation Project of Chongqing (CYS16074), Open Project Program of Chongqing Engineering and Technology Research Center for Novel Silk Materials (silkgczx2016003) and Start-up Grant from Southwest University (SWU112111).	Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; ANDREASEN PA, 1994, FEBS LETT, V338, P239, DOI 10.1016/0014-5793(94)80276-9; Bajari TM, 1998, BIOL CHEM, V379, P1053, DOI 10.1515/bchm.1998.379.8-9.1053; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Burmester T, 1998, J MOL EVOL, V47, P93, DOI 10.1007/PL00006366; BURMESTER T, 1992, INSECT BIOCHEM MOLEC, V22, P211, DOI 10.1016/0965-1748(92)90057-L; Burmester T, 1997, EUR J BIOCHEM, V247, P695, DOI 10.1111/j.1432-1033.1997.00695.x; Burmester T, 1997, EUR J BIOCHEM, V244, P713, DOI 10.1111/j.1432-1033.1997.00713.x; Burmester T, 1999, EUR J BIOCHEM, V262, P49, DOI 10.1046/j.1432-1327.1999.00315.x; Chandrasekar R, 2008, ARCH INSECT BIOCHEM, V69, P70, DOI 10.1002/arch.20266; Chen JQ, 2015, PROTEIN J, V34, P256, DOI 10.1007/s10930-015-9619-9; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Duan J, 2009, NUCLEIC ACIDS RES; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; FUJII T, 1989, J BIOL CHEM, V264, P11020; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; JONES G, 1990, J BIOL CHEM, V265, P8596; Kirankumar N, 1997, INSECT BIOCHEM MOLEC, V27, P671, DOI 10.1016/S0965-1748(97)00047-7; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Lin WJ, 2015, ARCH INSECT BIOCHEM, V90, P169, DOI 10.1002/arch.21252; Lin Y, 2013, J BIOL CHEM, V288, P13345, DOI 10.1074/jbc.M113.462556; Liu LN, 2016, INT J BIOL MACROMOL, V86, P701, DOI 10.1016/j.ijbiomac.2016.02.016; Lu K, 2015, J INSECT PHYSIOL, V73, P20, DOI 10.1016/j.jinsphys.2015.01.007; Mikhailenko I, 1999, J CELL SCI, V112, P3269; MINE E, 1983, DEV BIOL, V97, P329, DOI 10.1016/0012-1606(83)90090-8; MOESTRUP SK, 1994, BBA-REV BIOMEMBRANES, V1197, P197, DOI 10.1016/0304-4157(94)90005-1; OGAWA K, 1981, APPL ENTOMOL ZOOL, V16, P288, DOI 10.1303/aez.16.288; PAN ML, 1992, ARCH INSECT BIOCHEM, V19, P203, DOI 10.1002/arch.940190306; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; SAKURAI H, 1988, J BIOL CHEM, V263, P7876; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Savonen R, 1999, J BIOL CHEM, V274, P25877, DOI 10.1074/jbc.274.36.25877; Schneider WJ, 1996, INT REV CYTOL, V166, P103, DOI 10.1016/S0074-7696(08)62507-3; Shu YH, 2011, INSECT MOL BIOL, V20, P61, DOI 10.1111/j.1365-2583.2010.01054.x; STRICKLAND DK, 1995, FASEB J, V9, P890, DOI 10.1096/fasebj.9.10.7615159; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; TOJO S, 1980, INSECT BIOCHEM, V10, P289, DOI 10.1016/0020-1790(80)90024-4; Tufail M, 2005, INSECT MOL BIOL, V14, P389, DOI 10.1111/j.1365-2583.2005.00570.x; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Tufail M, 2007, INSECT BIOCHEM MOLEC, V37, P235, DOI 10.1016/j.ibmb.2006.11.007; WANG ZX, 1994, CELL TISSUE RES, V278, P107, DOI 10.1007/s004410050197; Wheeler DE, 2000, J INSECT PHYSIOL, V46, P951, DOI 10.1016/S0022-1910(99)00202-4; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; WILLOTT E, 1989, J BIOL CHEM, V264, P19052; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	58	4	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162317	10.1371/journal.pone.0162317	http://dx.doi.org/10.1371/journal.pone.0162317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637099	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700004
J	Noronha, V; Ramaswamy, A; Patil, VM; Joshi, A; Chougule, A; Kane, S; Kumar, R; Sahu, A; Doshi, V; Nayak, L; Mahajan, A; Janu, A; Prabhash, K				Noronha, Vanita; Ramaswamy, Anant; Patil, Vijay M.; Joshi, Amit; Chougule, Anuradha; Kane, Subhadha; Kumar, Rajiv; Sahu, Arvind; Doshi, Vipul; Nayak, Lingaraj; Mahajan, Abhishek; Janu, Amit; Prabhash, Kumar			ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country	PLOS ONE			English	Article							1ST-LINE CRIZOTINIB; GENE; CHEMOTHERAPY; SURVIVAL; REARRANGEMENTS; MUTATIONS	Objectives To evaluate the performance and treatment profile of advanced EML4-ALK positive Non-small cell lung cancer (NSCLC) patients in a developing country with potentially restricted access to Crizotinib. Materials and Methods A retrospective analysis of advanced ALK positive NSCLC patients who were treated from June 2012 to September 2015 was conducted. The primary goal was to evaluate outcomes of advanced ALK positive NSCLC in our practice and examine the logistic constraints in procuring Crizotinib. Results 94 patients were available for analysis. 21 (22.3%) patients were started on Crizotinib upfront, 60 (63.8%) on chemotherapy, 10 (10.6%) on Tyrosine kinase inhibitors (in view of poor PS) and 3 (3.2%) patients were offered best supportive care. Reasons for not starting Crizotinib upfront included symptomatic patients needing early initiation of therapy (23.3%), ALK not tested upfront (23.3%) and financial constraints (21.9%). 69 patients (73.4%) received Crizotinib at some stage during treatment. Dose interruptions (> 1 week) with Crizotinib were seen in 20 patients (29%), with drug toxicity being the commonest reason (85%). Median Progression free survival (PFS) on first line therapy for the entire cohort was 10 months, with a significant difference between patients receiving Crizotinib and those who did not ever receive Crizotinib (10 months vs. 2 months, p = 0.028). Median Overall Survival (OS) was not reached for the entire cohort, with 1 year survival being 81.2%. Patients with an ECOG Performance Status (PS) of > 2 had a significantly reduced PFS compared to patients with PS < = 2 (1.5 months vs. 11 months, p < 0.001). 47 patients with financial constraints (68.1%) received Crizotinib completely free via various extramural support schemes. Conclusion A majority of our ALK positive NSCLC patients were exposed to Crizotinib through the help of various support mechanisms and these patients had similar outcomes to that reported from previously published literature.	[Noronha, Vanita; Ramaswamy, Anant; Patil, Vijay M.; Joshi, Amit; Chougule, Anuradha; Sahu, Arvind; Doshi, Vipul; Nayak, Lingaraj; Prabhash, Kumar] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India; [Kane, Subhadha; Kumar, Rajiv] Tata Mem Hosp, Dept Pathol, Bombay, Maharashtra, India; [Mahajan, Abhishek; Janu, Amit] Tata Mem Hosp, Dept Radiol, Bombay, Maharashtra, India	Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital; Tata Memorial Centre (TMC); Tata Memorial Hospital	Prabhash, K (corresponding author), Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India.	kprabhash1@gmail.com	Nayak, Lingaraj/Q-5997-2019; Mahajan, Abhishek/AAO-1329-2021	Nayak, Lingaraj/0000-0001-9520-795X; Mahajan, Abhishek/0000-0001-6606-6537				Ahn HK, 2013, J THORAC ONCOL, V8, P250, DOI 10.1097/JTO.0b013e3182746772; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Cui SH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0626-7; Djalalov S, 2014, J CLIN ONCOL, V32, P1012, DOI 10.1200/JCO.2013.53.1186; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lilenbaum RC, 2004, ONCOLOGY-NY, V18, P1321; Mano H, 2008, CANCER SCI, V99, P2349, DOI 10.1111/j.1349-7006.2008.00972.x; Park S, 2015, CLIN LUNG CANCER, V16, pE83, DOI 10.1016/j.cllc.2015.01.003; Shaw AT, 2013, ANN ONCOL, V24, P59, DOI 10.1093/annonc/mds242; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Shaw AT, 2011, CLIN CANCER RES, V17, P2081, DOI 10.1158/1078-0432.CCR-10-1591; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; STANLEY KE, 1980, J NATL CANCER I, V65, P25; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tamai K, 2013, RESPIR INVESTIG, V51, P46, DOI 10.1016/j.resinv.2012.12.001; Teixido C, 2014, TRANSL LUNG CANCER R, V3, P70, DOI 10.3978/j.issn.2218-6751.2014.02.02; Wang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101551; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9	24	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0160752	10.1371/journal.pone.0160752	http://dx.doi.org/10.1371/journal.pone.0160752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637025	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700003
J	Zhou, ZM; Hu, Z; Li, M; Zhu, FX; Zhang, H; Nie, J; Ai, J				Zhou, Zhanmei; Hu, Zheng; Li, Mei; Zhu, Fengxin; Zhang, Hao; Nie, Jing; Ai, Jun			QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of beta-Catenin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; UNILATERAL URETERAL OBSTRUCTION; P38 MAP KINASE; TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; EPITHELIAL-CELLS; UNITED-STATES; NEPHROPATHY; SMAD3	Chronic kidney disease (CKD) is becoming a worldwide problem. However, current treatment options are limited. In the current study we showed that QiShenYiQi (QSYQ), a water-ethanol extract from several Chinese medicines, is a potent inhibitor of renal interstitial fibrosis. QSYQ inhibited transforming growth factor-beta 1 (TGF-beta 1)-responsive alpha-smoothmuscle actin (alpha-SMA), collagen I, and fibronectin up-regulation in obstructive nephropathy and cultured cells. Administration of QSYQ also inhibited the established renal interstitial fibrosis in obstructive nephropathy. Interestingly, QSYQ selectively inhibited TGF-beta 1-induced beta-catenin up-regulation and downstream gene transcription. Taken together, our study suggests that QSYQ selectively inhibits TGF-beta 1-induced beta-catenin up-regulation and might have significant therapeutic potential for the treatment of renal fibrosis.	[Zhou, Zhanmei; Hu, Zheng; Li, Mei; Zhu, Fengxin; Nie, Jing; Ai, Jun] Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Zhang, Hao] Tasly R&D Inst, Tianjin, Peoples R China	Southern Medical University - China	Ai, J (corresponding author), Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol,State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	aij1980@163.com			Nanfang Hospital Fundation, Southern Medical University [2012C08]; Tasly RD Institute; Nanfang Hospital Foundation of Southern Medical University [2012C08]	Nanfang Hospital Fundation, Southern Medical University; Tasly RD Institute; Nanfang Hospital Foundation of Southern Medical University	This work was supported by the Nanfang Hospital Fundation, Southern Medical University (2012C08) to Dr. Ai. Tasly R&D Institute provided support in the form of salaries for author HZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by the Nanfang Hospital Foundation of Southern Medical University (2012C08) to Dr. Ai.	Ai J, 2015, J AM SOC NEPHROL, V26, P1827, DOI 10.1681/ASN.2014040363; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Cassidy Hilary, 2012, J Signal Transduct, V2012, P463617, DOI 10.1155/2012/463617; Chevalier RL, 1999, PEDIATR NEPHROL, V13, P612, DOI 10.1007/s004670050756; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Ely JJ, 2010, COMPARATIVE MED, V60, P154; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hong Chengtao, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1018; Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513; Ina K, 2011, HISTOL HISTOPATHOL, V26, P855, DOI 10.14670/HH-26.855; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Komesli S, 1998, EUR J BIOCHEM, V254, P505, DOI 10.1046/j.1432-1327.1998.2540505.x; Langham RG, 2006, DIABETES CARE, V29, P2670, DOI 10.2337/dc06-0911; Li YC, 2012, CLIN HEMORHEOL MICRO, V51, P177, DOI 10.3233/CH-2011-1523; Lin SQ, 2013, INT J CARDIOL, V168, P967, DOI 10.1016/j.ijcard.2012.10.042; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lv SC, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/415068; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Moll S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056575; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Ning XH, 2013, INT IMMUNOPHARMACOL, V15, P406, DOI 10.1016/j.intimp.2012.12.019; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Shang HC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/738391; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Suwanabol PA, 2012, AM J PHYSIOL-HEART C, V302, pH2211, DOI 10.1152/ajpheart.00966.2011; Thornhill Barbara A, 2012, Methods Mol Biol, V886, P381, DOI 10.1007/978-1-61779-851-1_33; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; VIEDT C, 1995, KIDNEY INT, V48, P1810, DOI 10.1038/ki.1995.479; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zeisberg M, 2005, METH MOLEC MED, V117, P261; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	44	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162873	10.1371/journal.pone.0162873	http://dx.doi.org/10.1371/journal.pone.0162873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636716	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700019
J	Buijze, GA; Sierevelt, IN; van der Heijden, BCJM; Dijkgraaf, MG; Frings-Dresen, MHW				Buijze, Geert A.; Sierevelt, Inger N.; van der Heijden, Bas C. J. M.; Dijkgraaf, Marcel G.; Frings-Dresen, Monique H. W.			The Effect of Cold Showering on Health and Work: A Randomized Controlled Trial	PLOS ONE			English	Article							WHOLE-BODY CRYOTHERAPY; INNATE IMMUNE-RESPONSE; NERVOUS-SYSTEM; INITIAL RESPONSES; WATER IMMERSION; EXPOSURE; HUMANS; SF-36; INFECTION; RECOVERY	Purpose The aim of this study was to determine the cumulative effect of a routine (hot-to-) cold shower on sickness, quality of life and work productivity. Methods Between January and March 2015, 3018 participants between 18 and 65 years without severe comorbidity and no routine experience of cold showering were randomized (1: 1: 1: 1) to a (hot-to-) cold shower for 30, 60, 90 seconds or a control group during 30 consecutive days followed by 60 days of showering cold at their own discretion for the intervention groups. The primary outcome was illness days and related sickness absence from work. Secondary outcomes were quality of life, work productivity, anxiety, thermal sensation and adverse reactions. Results 79% of participants in the interventions groups completed the 30 consecutive days protocol. A negative binomial regression model showed a 29% reduction in sickness absence for (hot-to-) cold shower regimen compared to the control group (incident rate ratio: 0.71, P = 0.003). For illness days there was no significant group effect. No related serious advents events were reported. Conclusion A routine (hot-to-) cold shower resulted in a statistical reduction of self-reported sickness absence but not illness days in adults without severe comorbidity.	[Buijze, Geert A.] Acad Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands; [Sierevelt, Inger N.] Med Ctr Slotervaart, Dept Orthopaed Surg, Amsterdam, Netherlands; [van der Heijden, Bas C. J. M.] Achmea, Risk Management, Zeist, Netherlands; [Dijkgraaf, Marcel G.] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Frings-Dresen, Monique H. W.] Acad Med Ctr, Inst Occupat Hlth, Dept Coronel, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Slotervaart Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Buijze, GA (corresponding author), Acad Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands.	g.a.buijze@amc.nl						Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; [Anonymous], 2004, GEDRAG ORGAN, DOI DOI 10.5117/2004.017.002.002; Banerjee SK, 1999, J PARASITOL, V85, P442, DOI 10.2307/3285776; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Bleakley CM, 2014, OPEN ACCESS J SPORTS, V5, P25, DOI 10.2147/OAJSM.S41655; Brenner IKM, 1999, J APPL PHYSIOL, V87, P699, DOI 10.1152/jappl.1999.87.2.699; Castellani JW, 2002, MED SCI SPORT EXER, V34, P2013, DOI 10.1097/00005768-200212000-00023; Centraal Bureau voor de Statistiek (CBS), 2016, NATIONAL STATISTICS; Claridge RT, 1843, HYDROPATHY OR THE CO; Cold Showers, THE DEFINITIVE GUIDE; Costello JT, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD010789; Crowe MJ, 2007, INT J SPORTS MED, V28, P994, DOI 10.1055/s-2007-965118; de Beurs E, 2006, MAANDBLAD GEESTELIJK, P120; Demerouti E, 2001, SCAND J WORK ENV HEA, V27, P279, DOI 10.5271/sjweh.615; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Eglin CM, 2005, EUR J APPL PHYSIOL, V93, P624, DOI 10.1007/s00421-004-1239-6; Evans JDR, 2013, COMPANION ARCHAEOLOG; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Gagnon DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110774; Hendriksen IJM, 2010, PREV MED, V51, P132, DOI 10.1016/j.ypmed.2010.05.007; Huffman GR, 2008, J BONE JOINT SURG AM, V90A, P471, DOI 10.2106/JBJS.G.00325; Jansky L, 1996, EUR J APPL PHYSIOL O, V72, P445, DOI 10.1007/BF00242274; Jastrzabek R, 2013, RHEUMATOL INT, V33, P2053, DOI 10.1007/s00296-013-2692-5; Juliff LE, 2014, J STRENGTH COND RES, V28, P2353, DOI 10.1519/JSC.0000000000000417; Kaptchuk TJ, 2015, NEW ENGL J MED, V373, P8, DOI 10.1056/NEJMp1504023; Kox M, 2014, P NATL ACAD SCI USA, V111, P7379, DOI 10.1073/pnas.1322174111; Kox M, 2012, PSYCHOSOM MED, V74, P489, DOI 10.1097/PSY.0b013e3182583c6d; Lee HK, 2014, KOREAN J FAM MED, V35, P119, DOI 10.4082/kjfm.2014.35.3.119; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Nieman DC, 2011, BRIT J SPORT MED, V45, P987, DOI 10.1136/bjsm.2010.077875; Shephard RJ, 1998, CAN J PHYSIOL PHARM, V76, P828, DOI 10.1139/cjpp-76-9-828; Sramek P, 2000, EUR J APPL PHYSIOL, V81, P436, DOI 10.1007/s004210050065; Teirlinck AC, 2015, REPORT OF THE NATION, P1; Tiessen-Raaphorst A, 2015, REPORT OF THE NETHER, P1; Tipton MJ, 1998, J PHYSIOL-LONDON, V512, P621, DOI 10.1111/j.1469-7793.1998.621be.x; van Middendorp H, 2016, CLIN RHEUMATOL, V35, P1081, DOI 10.1007/s10067-015-3009-8; VASWANI KK, 1988, PHARMACOL BIOCHEM BE, V29, P163, DOI 10.1016/0091-3057(88)90290-0; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	8	10	9	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161749	10.1371/journal.pone.0161749	http://dx.doi.org/10.1371/journal.pone.0161749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631616	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900022
J	Liu, JC; Hsu, YP; Wu, SY				Liu, Ju-Chi; Hsu, Yi-Ping; Wu, Szu-Yuan			Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONVERTING ENZYME-INHIBITORS; COA REDUCTASE INHIBITORS; RENAL-DISEASE; TASK-FORCE; CARDIOVASCULAR-DISEASE; PERITONEAL-DIALYSIS; AMERICAN-COLLEGE; HEART-FAILURE; PROGRESSION	Background Taiwan has the highest renal disease incidence and prevalence in the world. We evaluated the association of statin and renin-angiotensin system inhibitor (RASI) use with dialysis risk in hypertensive patients. Methods Of 248,797 patients who received a hypertension diagnosis in Taiwan during 2001-2012, our cohort contained 110,829 hypertensive patients: 44,764 who used RASIs alone; 7,606 who used statins alone; 27,836 who used both RASIs and statins; and 33,716 who used neither RASIs or statins. We adjusted for the following factors to reduce selection bias by using propensity scores (PSs): age; sex; comorbidities; urbanization level; monthly income; and use of nonstatin lipid-lowering drugs, metformin, aspirin, antihypertensives, diuretics, and beta and calcium channel blockers. The statin and RASI use index dates were considered the hypertension confirmation dates. To examine the dose-response relationship, we categorized only statin or RASI use into four groups in each cohort: < 28 (nonusers), 28-90, 91-365, and > 365 cumulative defined daily doses (cDDDs). Results In the main model, PS-adjusted hazard ratios (aHRs; 95% confidence intervals [CIs]) for dialysis risk were 0.57 (0.50-0.65), 0.72 (0.53-0.98), and 0.47 (0.41-0.54) in the only RASI, only statin, and RASI + statin users, respectively. RASIs dose-dependently reduced dialysis risk in most subgroups and in the main model. RASI use significantly reduced dialysis risk in most subgroups, regardless of comorbidities or other drug use (P < 0.001). Statins at > 365 cDDDs protected hypertensive patients against dialysis risk in the main model (aHR = 0.62, 95% CI: 0.54-0.71), regardless of whether a high cDDD of RASIs, metformin, or aspirin was used. Conclusion Statins and RASIs independently have a significant dose-dependent protective effect against dialysis risk in hypertensive patients. The combination of statins and RASIs can additively protect hypertensive patients against dialysis risk.	[Liu, Ju-Chi; Hsu, Yi-Ping] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiovasc Med, New Taipei, Taiwan; [Wu, Szu-Yuan] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan; [Wu, Szu-Yuan] Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Liu, Ju-Chi; Wu, Szu-Yuan] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Wu, Szu-Yuan] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan	Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Hungkuang University	Wu, SY (corresponding author), Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan.; Wu, SY (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Radiat Oncol, Taipei, Taiwan.; Wu, SY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.; Wu, SY (corresponding author), Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan.	szuyuanwu5399@gmail.com		Wu, Szu-Yuan/0000-0001-5637-558X	Wan Fang Hospital	Wan Fang Hospital	This work was supported by Wan Fang Hospital.	Atthobari J, 2006, NEPHROL DIAL TRANSPL, V21, P3106, DOI 10.1093/ndt/gfl244; Bakris GL, 2009, KIDNEY INT, V75, P449, DOI 10.1038/ki.2008.694; Bianchi S, 2003, AM J KIDNEY DIS, V41, P565, DOI 10.1053/ajkd.2003.50140; Blacher J, 2002, CURR OPIN NEPHROL HY, V11, P629, DOI 10.1097/00041552-200211000-00010; Campese VM, 2007, CLIN J AM SOC NEPHRO, V2, P1100, DOI 10.2215/CJN.04060907; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Catapano F, 2008, AM J KIDNEY DIS, V52, P475, DOI 10.1053/j.ajkd.2008.03.008; Chang YK, 2012, MEDICINE, V91, P144, DOI 10.1097/MD.0b013e318256538e; Chawla V, 2010, CLIN J AM SOC NEPHRO, V5, P1582, DOI 10.2215/CJN.01450210; CHEN JH, 2016, MEDICINE, V95, DOI DOI 10.1097/MD; Chen JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002845; Chiang CE, 2015, J CHIN MED ASSOC, V78, P1, DOI 10.1016/j.jcma.2014.11.005; Cordell HJ, 2004, AM J HUM GENET, V74, P1294, DOI 10.1086/421476; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; DIAMOND JR, 1987, KIDNEY INT, V32, P671, DOI 10.1038/ki.1987.259; Douglas K, 2006, ANN INTERN MED, V145, P117, DOI 10.7326/0003-4819-145-2-200607180-00009; Fink HA, 2012, ANN INTERN MED, V156, P570, DOI [10.7326/0003-4819-156-8-201204170-00008, 10.7326/0003-4819-156-8-201204170-00004]; Fried LF, 2008, KIDNEY INT, V74, P571, DOI 10.1038/ki.2008.231; Grone EF, 2008, NAT CLIN PRACT NEPHR, V4, P424, DOI 10.1038/ncpneph0863; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Jayatilake N, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-180; Kao TW, 2013, PERITON DIALYSIS INT, V33, P671, DOI 10.3747/pdi.2012.00081; KEANE WF, 1994, KIDNEY INT, V46, P910, DOI 10.1038/ki.1994.349; Kent DM, 2007, J AM SOC NEPHROL, V18, P1959, DOI 10.1681/ASN.2006101081; KIM SY, 1995, KIDNEY INT, V48, P363, DOI 10.1038/ki.1995.304; Konstadinidou I, 2003, TRANSPLANT P, V35, P1364, DOI 10.1016/S0041-1345(03)00376-2; Landray MJ, 2001, AM J KIDNEY DIS, V38, P537, DOI 10.1053/ajkd.2001.26850; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, NEPHROL DIAL TRANSPL, V14, P828, DOI 10.1093/ndt/14.4.828; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Michel O, 1997, KIDNEY INT, V52, P1532, DOI 10.1038/ki.1997.483; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007784; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Ozsoy RC, 2007, NEPHROL DIAL TRANSPL, V22, P1578, DOI 10.1093/ndt/gfl790; Parfrey PS, 1999, J AM SOC NEPHROL, V10, P1606; PARRA G, 1988, CLIN NEPHROL, V29, P58; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; RODRIGUEZITURBE B, 1990, KIDNEY INT, V38, P512, DOI 10.1038/ki.1990.233; RUBIN R, 1994, HYPERTENSION, V23, P92, DOI 10.1161/01.HYP.23.1.92; Ruggenenti P, 2010, CLIN J AM SOC NEPHRO, V5, P1928, DOI 10.2215/CJN.03380410; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Sarafidis PA, 2009, ANN INTERN MED, V150, P731, DOI 10.7326/0003-4819-150-10-200905190-00014; Schaeffner ES, 2003, J AM SOC NEPHROLOGY, V14, P2084; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shao JYH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001801; Shepherd J, 2007, CLIN J AM SOC NEPHRO, V2, P1131, DOI 10.2215/CJN.04371206; Singh S, 2014, HEPATOLOGY, V59, P735, DOI [10.1002/hep.26575, 10.1002/hep.26614]; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Tonelli M, 2003, ANN INTERN MED, V138, P98, DOI 10.7326/0003-4819-138-2-200301210-00010; Weiner DE, 2004, J GEN INTERN MED, V19, P1045, DOI 10.1111/j.1525-1497.2004.40049.x; Whaley-Connell AT, 2008, AM J KIDNEY DIS, V51, pS13, DOI 10.1053/j.ajkd.2007.12.016; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P04; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	60	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162588	10.1371/journal.pone.0162588	http://dx.doi.org/10.1371/journal.pone.0162588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632175	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900055
J	Aghakhanyan, G; Bonanni, P; Randazzo, G; Nappi, S; Tessarotto, F; De Martin, L; Frijia, F; De Marchi, D; De Masi, F; Kuppers, B; Lombardo, F; Caramella, D; Montanaro, D				Aghakhanyan, Gayane; Bonanni, Paolo; Randazzo, Giovanna; Nappi, Sara; Tessarotto, Federica; De Martin, Lara; Frijia, Francesca; De Marchi, Daniele; De Masi, Francesco; Kuppers, Beate; Lombardo, Francesco; Caramella, Davide; Montanaro, Domenico			From Cortical and Subcortical Grey Matter Abnormalities to Neurobehavioral Phenotype of Angelman Syndrome: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; BASAL GANGLIA; MOUSE MODEL; DEFICITS; BRAIN; ORIENTATION; INVOLVEMENT; EXPRESSION; CIRCUITS; EPILEPSY	Angelman syndrome (AS) is a rare neurogenetic disorder due to loss of expression of maternal ubiquitin-protein ligase E3A (UBE3A) gene. It is characterized by severe developmental delay, speech impairment, movement or balance disorder and typical behavioral uniqueness. Affected individuals show normal magnetic resonance imaging (MRI) findings, although mild dysmyelination may be observed. In this study, we adopted a quantitative MRI analysis with voxel-based morphometry(FSL-VBM) method to investigate disease-related changes in the cortical/subcortical grey matter (GM) structures. Since 2006 to 2013 twenty-six AS patients were assessed by our multidisciplinary team. From those, sixteen AS children with confirmed maternal 15q11-q13 deletions (mean age 7.7 +/- 3.6 years) and twenty-one age-matched controls were recruited. The developmental delay and motor dysfunction were assessed using Bayley III and Gross Motor Function Measure (GMFM). Principal component analysis (PCA) was applied to the clinical and neuropsychological datasets. High-resolution T1-weighted images were acquired and FSL-VBM approach was applied to investigate differences in the local GM volume and to correlate clinical and neuropsychological changes in the regional distribution of GM. We found bilateral GM volume loss in AS compared to control children in the striatum, limbic structures, insular and orbito-frontal cortices. Voxel-wise correlation analysis with the principal components of the PCA output revealed a strong relationship with GM volume in the superior parietal lobule and precuneus on the left hemisphere. The anatomical distribution of cortical/subcortical GM changes plausibly related to several clinical features of the disease and may provide an importantmorphological underpinning for clinical and neurobehavioral symptoms in children with AS.	[Aghakhanyan, Gayane; Frijia, Francesca; De Marchi, Daniele; Lombardo, Francesco; Montanaro, Domenico] Fdn CNR Reg Toscana G Monasterio, Unit Neuroradiol, Pisa, Italy; [Bonanni, Paolo; Randazzo, Giovanna; Nappi, Sara; Tessarotto, Federica; De Martin, Lara] E Medea Sci Inst, Epilepsy & Clin Neurophysiol Unit, Conegliano, TV, Italy; [De Masi, Francesco; Kuppers, Beate] Univ Hosp Pisa, Div Anesthesiol & Intens Care, Pisa, Italy; [Caramella, Davide] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Diagnost & Intervent Radiol, Pisa, Italy	IRCCS Eugenio Medea; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Pisa	Montanaro, D (corresponding author), Fdn CNR Reg Toscana G Monasterio, Unit Neuroradiol, Pisa, Italy.	domont@ftgm.it	Montanaro, Domenico/AAB-9718-2022; Montanaro, Domenico/K-5938-2016; Caramella, Davide/AAI-6802-2020; Aghakhanyan, Gayane/AAC-7691-2022; bonanni, paolo/T-7360-2017	Montanaro, Domenico/0000-0002-9895-7016; Caramella, Davide/0000-0002-9951-2916; Aghakhanyan, Gayane/0000-0001-5152-497X; bonanni, paolo/0000-0002-9448-9059; Frijia, Francesca/0000-0003-3802-326X	Italian Ministry of Health; Organization of Angelman Syndrome	Italian Ministry of Health(Ministry of Health, Italy); Organization of Angelman Syndrome	This research was partially supported by the Italian Ministry of Health granted to PB (RC 2015) and the Organization of Angelman Syndrome, (Organizzazione Sindrome di Angelman - http://www.sindromediangelman.org).	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersen W H, 2001, Logoped Phoniatr Vocol, V26, P2, DOI 10.1080/140154301300109044; Andersson J.L.R., 2007, TR07JA1 FMRIB; Barkovich AJ, 1997, EPILEPSIA, V38, P1255; Bayley N., 2019, BAYLEY SCALES INFANT; Biraben A, 2004, NEUROLOGY, V63, P73, DOI 10.1212/01.WNL.0000132840.40838.13; Bouilleret V, 2005, J NUCL MED, V46, P540; Bruinsma CF, 2015, J CLIN INVEST, V125, P4305, DOI 10.1172/JCI83541; Castro-Gago M, 2010, EUR J PAEDIATR NEURO, V14, P292, DOI 10.1016/j.ejpn.2009.07.007; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Cummings Jeffrey L., 2008, CONCISE GUIDE NEUROP; Dan B, 2004, ANN NY ACAD SCI, V1030, P599, DOI 10.1196/annals.1329.070; Dan B, 2001, CLIN NEUROPHYSIOL, V112, P1618, DOI 10.1016/S1388-2457(01)00618-6; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Gentile JK, 2010, J DEV BEHAV PEDIATR, V31, P592, DOI 10.1097/DBP.0b013e3181ee408e; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2002, NEUROIMAGE; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guerrini R, 1996, ANN NEUROL, V40, P39, DOI 10.1002/ana.410400109; Guerrini Renzo, 2003, Paediatr Drugs, V5, P647, DOI 10.2165/00148581-200305100-00001; Gustin RM, 2010, NEUROBIOL DIS, V39, P283, DOI 10.1016/j.nbd.2010.04.012; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harbord M, 2001, J CLIN NEUROSCI, V8, P421, DOI 10.1054/jocn.2000.0753; Hart H, 2008, DEV MED CHILD NEUROL, V50, P564, DOI 10.1111/j.1469-8749.2008.03035.x; Harting I, 2009, EUR J PAEDIATR NEURO, V13, P271, DOI 10.1016/j.ejpn.2008.04.005; Hayrapetyan V, 2014, EUR J NEUROSCI, V39, P1018, DOI 10.1111/ejn.12442; Jackowski AP, 2012, REV BRAS PSIQUIATR, V34, P207, DOI 10.1590/S1516-44462012000200014; Jana NR, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/710943; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; Judson MC, 2014, J COMP NEUROL, V522, P1874, DOI 10.1002/cne.23507; Kara S, 2010, AM J NEURORADIOL, V31, P1602, DOI 10.3174/ajnr.A2133; Karnath HO, 1997, PHILOS T ROY SOC B, V352, P1411, DOI 10.1098/rstb.1997.0127; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lichtenberger EO, 2005, MENT RETARD DEV D R, V11, P197, DOI 10.1002/mrdd.20076; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Mulherkar SA, 2010, NEUROBIOL DIS, V40, P586, DOI 10.1016/j.nbd.2010.08.002; Peters SU, 2011, DEV MED CHILD NEUROL, V53, P361, DOI 10.1111/j.1469-8749.2010.03838.x; Riday TT, 2012, J CLIN INVEST, V122, P4544, DOI 10.1172/JCI61888; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Sahoo T, 2006, J MED GENET, V43, P512, DOI 10.1136/jmg.2005.036913; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Thompson RJ, 2003, J AUTISM DEV DISORD, V33, P171, DOI 10.1023/A:1022991410822; Tiwari VN, 2012, NEUROIMAGE, V59, P349, DOI 10.1016/j.neuroimage.2011.07.067; Wild B, 2003, BRAIN, V126, P2121, DOI 10.1093/brain/awg226; Williams CA, 2005, AM J MED GENET, V2006, P413; Williams CA, 2010, AM J MED GENET C, V154C, P432, DOI 10.1002/ajmg.c.30278; Wilson BJ, 2011, PEDIATR NEUROL, V44, P350, DOI 10.1016/j.pediatrneurol.2010.12.002; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147	57	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162817	10.1371/journal.pone.0162817	http://dx.doi.org/10.1371/journal.pone.0162817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626634	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600056
J	Ding, YY; Wang, ZH; Zhang, X; Teng, Z; Gao, CX; Qian, BH; Wang, LL; Feng, JJ; Wang, JH; Zhao, CY; Guo, CJ; Pan, W				Ding, Yingying; Wang, Zhihong; Zhang, Xi; Teng, Zheng; Gao, Caixia; Qian, Baohua; Wang, Lili; Feng, Jiaojiao; Wang, Jinhong; Zhao, Chunyan; Guo, Cunjiu; Pan, Wei			Different Antibody Response against the Coxsackievirus A16 VP1 Capsid Protein: Specific or Non-Specific	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ENTEROVIRUS 71; MOUTH-DISEASE; MONOCLONAL-ANTIBODY; VIRUS; HAND; FOOT; EPIDEMIC; EPITOPE; IDENTIFICATION	Coxsackievirus A16 (CA16) is one of the major causative agents of hand, foot, and mouth disease worldwide. The non-neutralizing antibody response that targets CA16 VP1 remains poorly elucidated. In the present study, antibody responses against CA16 VP1 in Shanghai blood donors and Shanxi individuals were analyzed by ELISA and inhibitory ELISA using five CA16 VP1 antigens: VP1(1-297), VP1(41-297), VP1(1-60), VP1(45-58) and VP1(61-297). The correlation coefficients for most of the reactions against each of the five antigens and the inhibition of the anti-CA16 VP1 antibody response produced by the various antigens were higher in Shanghai blood donors compared to those in Shanxi individuals. VP1(1-297) and VP1(41-297) strongly inhibited the anti-CA16 VP1 response in serum samples from both populations, while VP1(45-58) and VP1(61-297) intermediately and weakly inhibited the anti-CA16 VP1 response, respectively, in only Shanghai group. A specific type of inhibition (anti-CA16 VP1 was completely inhibited by both VP1(1-60) and VP1(41-297)) characterized by high neutralizing antibody titers was identified and accounted for 71.4% of the strongly reactive samples from the Shanghai group. These results indicate that the Shanghai blood donors exhibited a consistent and specific antibody response, while the Shanxi individuals showed an inconsistent and non-specific antibody response. These findings may improve the understanding of host humoral immunity against CA16 and help to identify an effective approach for seroepide-miological surveillance and specific diagnosis of CA16 infection based on normal and competitive ELISA.	[Ding, Yingying; Gao, Caixia; Wang, Lili; Feng, Jiaojiao; Wang, Jinhong; Zhao, Chunyan; Pan, Wei] Second Mil Med Univ, Sch Basic Med, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China; [Wang, Zhihong; Guo, Cunjiu] Shanxi Med Coll, Affiliated Hosp 2, Dept Clin Lab, Taiyuan, Peoples R China; [Zhang, Xi; Teng, Zheng] Shanghai Municipal Ctr Dis Control & Prevent, Dept Infect Dis Control & Prevent, Shanghai, Peoples R China; [Qian, Baohua] Second Mil Med Univ, Dept Blood Transfus, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Shanxi Medical University; Shanghai Center for Disease Control & Prevention; Naval Medical University	Pan, W (corresponding author), Second Mil Med Univ, Sch Basic Med, Dept Med Microbiol & Parasitol, Shanghai, Peoples R China.	pwpanwei@126.com	wang, lili/HDL-7210-2022; ding, yy/HHS-9589-2022		National Natural Science Foundation of China [30872405, 30972632]; Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases [2009ZX10004-105]; Chinese National Key Special Project for Major New Drug Discovery [2011ZX09506-001]; National 863 Project [2014AA021403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases; Chinese National Key Special Project for Major New Drug Discovery; National 863 Project(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/), grant number: No. 30872405 and 30972632 to WP; Chinese National Key Special Project for the Prevention and Control of Major Infectious Diseases (http://www.nmp.gov.cn/), grant number: 2009ZX10004-105 to WP; Chinese National Key Special Project for Major New Drug Discovery (http://www.nmp.gov.cn/), grant number: 2011ZX09506-001 to WP and the National 863 Project (http://program.most.gov.cn/), grant number: 2014AA021403 to WP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; BLOMBERG J, 1974, LANCET, V2, P112; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Cao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018477; Chau BNT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021116, 10.1371/journal.pone.0025969]; Cifuente JO, 2013, J VIROL, V87, P7637, DOI 10.1128/JVI.03519-12; daSilva EE, 1996, EMERG INFECT DIS, V2, P231, DOI 10.3201/eid0203.960312; Ding YY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10636; Gao CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21979; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hirota J, 2012, CLIN VACCINE IMMUNOL, V19, P277, DOI 10.1128/CVI.05382-11; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08904; Jiang LP, 2015, VACCINE, V33, P6596, DOI 10.1016/j.vaccine.2015.10.104; Jiang SHH, 2008, DNA CELL BIOL, V27, P423, DOI 10.1089/dna.2007.0708; Ke YY, 2006, J COMPUT CHEM, V27, P1556, DOI 10.1002/jcc.20460; Kiener TK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002895; Kirk K, 2012, VACCINE, V30, P7105, DOI 10.1016/j.vaccine.2012.09.030; Li C, 2007, CURR MED CHEM, V14, P847, DOI 10.2174/092986707780363032; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Plevka P, 2012, ACTA CRYSTALLOGR D, V68, P1217, DOI 10.1107/S0907444912025772; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; SAMUDA GM, 1987, PEDIATR INFECT DIS J, V6, P206, DOI 10.1097/00006454-198702000-00013; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sharma N, 2013, CLIN VACCINE IMMUNOL, V20, P9, DOI 10.1128/CVI.00516-12; Shi JP, 2013, VACCINE, V31, P2130, DOI 10.1016/j.vaccine.2013.02.051; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Whitton JL, 2005, NAT REV MICROBIOL, V3, P765, DOI 10.1038/nrmicro1284; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu LF, 2014, THERANOSTICS, V4, P498, DOI 10.7150/thno.7457; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yang H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-137; Zhang PP, 2013, GENE, V524, P347, DOI 10.1016/j.gene.2013.03.126; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206	42	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162820	10.1371/journal.pone.0162820	http://dx.doi.org/10.1371/journal.pone.0162820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622652	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000059
J	Hoenen, C; Gustin, A; Birck, C; Kirchmeyer, M; Beaume, N; Felten, P; Grandbarbe, L; Heuschling, P; Heurtaux, T				Hoenen, Claire; Gustin, Audrey; Birck, Cindy; Kirchmeyer, Melanie; Beaume, Nicolas; Felten, Paul; Grandbarbe, Luc; Heuschling, Paul; Heurtaux, Tony			Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant	PLOS ONE			English	Article							NF-KAPPA-B; FAMILIAL PARKINSONS-DISEASE; NORMAL MOUSE-BRAIN; NEURODEGENERATIVE DISEASES; SIGNALING PATHWAYS; ACTIVATES MICROGLIA; THERAPEUTIC TARGET; OXIDATIVE STRESS; THP-1 CELLS; MUTATION	Parkinson's disease (PD) is histologically described by the deposition of alpha-synuclein, whose accumulation in Lewy bodies causes dopaminergic neuronal death. Although most of PD cases are sporadic, point mutations of the gene encoding the alpha-synuclein protein cause inherited forms of PD. There are currently six known point mutations that result in familial PD. Oxidative stress and neuroinflammation have also been described as early events associated with dopaminergic neuronal degeneration in PD. Though it is known that microglia are activated by wild-type alpha-synuclein, little is known about its mutated forms and the signaling cascades responsible for this microglial activation. The present study was designed to investigate consequences of wild-type and mutant alpha-synuclein (A53T, A30P and E46K) exposure on microglial reactivity. Interestingly, we described that alpha-synuclein-induced microglial reactivity appeared to be peptide-dependent. Indeed, the A53T protein activated more strongly microglia than the wild-type alpha-synuclein and othermutants. This A53T-induced microglial reactivity mechanism was found to depend on phosphorylation mechanisms mediated by MAPKs and on successive NFkB/AP-1/Nrf2 pathways activation. These results suggest that the microgliosis intensity during PD might depend on the type of alpha-synuclein protein implicated. Indeed, mutated forms are more potent microglial stimulators than wild-type alpha-synuclein. Based on these data, anti-inflammatory and antioxidant therapeutic strategies may be valid in order to reduce microgliosis but also to subsequently slow down PD progression, especially in familial cases.	[Hoenen, Claire; Gustin, Audrey; Birck, Cindy; Kirchmeyer, Melanie; Beaume, Nicolas; Felten, Paul; Grandbarbe, Luc; Heuschling, Paul; Heurtaux, Tony] Univ Luxembourg, Fac Sci Technol & Commun, Life Sci Res Unit, Neurobiol Lab, 7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg	University of Luxembourg	Heurtaux, T (corresponding author), Univ Luxembourg, Fac Sci Technol & Commun, Life Sci Res Unit, Neurobiol Lab, 7 Ave Hauts Fourneaux, L-4362 Esch Sur Alzette, Luxembourg.	tony.heurtaux@uni.lu		HEURTAUX, Tony/0000-0002-1709-5312; Birck, Cindy/0000-0002-0763-7544	National Research Fund of Luxembourg; University of Luxembourg	National Research Fund of Luxembourg(Luxembourg National Research Fund); University of Luxembourg	This work was financed through grants from the National Research Fund of Luxembourg and the University of Luxembourg.	Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Ahmad R, 2014, CELL PHYSIOL BIOCHEM, V34, P929, DOI 10.1159/000366310; Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; Aravalli RN, 2008, J NEUROIMMUNE PHARM, V3, P5, DOI 10.1007/s11481-007-9097-8; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Barrett PJ, 2015, BRAIN RES, V1628, P247, DOI 10.1016/j.brainres.2015.06.002; Beraud D, 2013, J NEUROIMMUNE PHARM, V8, P94, DOI 10.1007/s11481-012-9401-0; Bliederhaeuser C, 2016, ACTA NEUROPATHOL, V131, P379, DOI 10.1007/s00401-015-1504-2; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Campa VM, 2005, INFLAMM RES, V54, P328, DOI 10.1007/s00011-005-1359-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; de Medeiros MC, 2014, J APPL ORAL SCI, V22, P185, DOI 10.1590/1678-775720130593; DebRoy A, 2014, J BIOL CHEM, V289, P24188, DOI 10.1074/jbc.M114.570051; Delgado M, 2008, GLIA, V56, P1091, DOI 10.1002/glia.20681; Durrenberger PF, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/214714; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Galimberti D, 2006, ARCH NEUROL-CHICAGO, V63, P538, DOI 10.1001/archneur.63.4.538; Ghosh D, 2014, BIOCHEMISTRY-US, V53, P6419, DOI 10.1021/bi5010365; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Heurtaux T, 2010, J NEUROCHEM, V114, P576, DOI 10.1111/j.1471-4159.2010.06783.x; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Johnson DA, 2015, FREE RADICAL BIO MED, V88, P253, DOI 10.1016/j.freeradbiomed.2015.07.147; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kim MO, 2002, J NEUROCHEM, V81, P1361, DOI 10.1046/j.1471-4159.2002.00949.x; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Korlipara LVP, 2002, INT REV NEUROBIOL, V53, P283; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee JK, 2009, J NEUROIMMUNE PHARM, V4, P419, DOI 10.1007/s11481-009-9176-0; Lee SB, 2009, BIOCHEM BIOPH RES CO, V381, P39, DOI 10.1016/j.bbrc.2009.02.002; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Losciuto S, 2012, J NEUROSCI METH, V207, P59, DOI 10.1016/j.jneumeth.2012.03.010; Lundblad M, 2012, P NATL ACAD SCI USA, V109, P3213, DOI 10.1073/pnas.1200575109; Mahul-Mellier AL, 2015, CELL DEATH DIFFER, V22, P2107, DOI 10.1038/cdd.2015.79; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martin FL, 2004, PROTEIN PEPTIDE LETT, V11, P229, DOI 10.2174/0929866043407138; McGeer PL, 2001, ADV NEUROL, V86, P83; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Ozansoy M, 2013, MOL NEUROBIOL, V47, P460, DOI 10.1007/s12035-012-8369-3; Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373; Pfeiffer RF, 2016, PARKINSONISM RELAT D, V22, pS119, DOI 10.1016/j.parkreldis.2015.09.004; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pradhan S, 2013, EXP NEUROL, V241, P148, DOI 10.1016/j.expneurol.2012.12.008; Reish HEA, 2015, J PARKINSON DIS, V5, P1, DOI 10.3233/JPD-140491; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Rojanathammanee L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-44; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Sahay S, 2015, J BIOL CHEM, V290, P7804, DOI 10.1074/jbc.M114.598607; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Stckl MT, 2013, MOL NEUROBIOL, V47, P613, DOI 10.1007/s12035-012-8331-4; Stefanis L, 2012, CSH PERSPECT BIOL, V4; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Tichauer J, 2007, NEUROIMMUNOMODULAT, V14, P168, DOI 10.1159/000110642; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; Totterdell S, 2005, NEUROSCIENCE, V135, P907, DOI 10.1016/j.neuroscience.2005.06.047; Totterdell S, 2004, BRAIN RES, V1004, P61, DOI 10.1016/j.brainres.2003.10.072; Vivekanantham S, 2015, INT J NEUROSCI, V125, P717, DOI 10.3109/00207454.2014.982795; Wang QQ, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0042-0; Wilkaniec A, 2013, NEUROCHEM INT, V62, P776, DOI 10.1016/j.neuint.2013.02.004; Wilkinson K, 2012, INT J ALZHEIMERS DIS, V2012, DOI [DOI 10.1155/2012/489456, 10.1155/2012/489456]; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	85	86	88	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162717	10.1371/journal.pone.0162717	http://dx.doi.org/10.1371/journal.pone.0162717			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622765	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000050
J	Yom-Din, S; Hollander-Cohen, L; Aizen, J; Boehm, B; Shpilman, M; Golan, M; Hurvitz, A; Degani, G; Levavi-Sivan, B				Yom-Din, Svetlana; Hollander-Cohen, Lian; Aizen, Joseph; Boehm, Benjamin; Shpilman, Michal; Golan, Matan; Hurvitz, Avshalom; Degani, Gad; Levavi-Sivan, Berta			Gonadotropins in the Russian Sturgeon: Their Role in Steroid Secretion and the Effect of Hormonal Treatment on Their Secretion	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; HUMAN CHORIONIC-GONADOTROPIN; LINKED-IMMUNOSORBENT-ASSAY; TROUT ONCORHYNCHUS-MYKISS; PITUITARY-GONADAL AXIS; RAINBOW-TROUT; LUTEINIZING-HORMONE; REPRODUCTIVE-CYCLE; ALPHA-SUBUNIT; ACIPENSER-GUELDENSTAEDTII	In the reproduction process of male and female fish, pituitary derived gonadotropins (GTHs) play a key role. To be able to specifically investigate certain functions of Luteinizing (LH) and Follicle stimulating hormone (FSH) in Russian sturgeon (Acipenser gueldenstaedtii; st), we produced recombinant variants of the hormones using the yeast Pichia pastoris as a protein production system. We accomplished to create in vitro biologically active heterodimeric glycoproteins consisting of two associated alpha- and beta-subunits in sufficient quantities. Three dimensional modelling of both GTHs was conducted in order to study the differences between the two GTHs. Antibodies were produced against the unique beta-subunit of each of the GTHs, in order to be used for immunohistochemical analysis and to develop an ELISA for blood and pituitary hormone quantification. This detection technique revealed the specific localization of the LH and FSH cells in the sturgeon pituitary and pointed out that both cell types are present in substantially higher numbers in mature males and females, compared to immature fish. With the newly attained option to prevent cross-contamination when investigating on the effects of GTH administration, we compared the steroidogeneic response (estradiol and 11-Keto testosterone (11-KT) in female and males, respectively) of recombinant stLH, stFSH, and carp pituitary extract in male and female sturgeon gonads at different developmental stages. Finally, we injected commercially available gonadotropin releasing hormones analog (GnRH) to mature females, and found a moderate effect on the development of ovarian follicles. Application of only testosterone (T) resulted in a significant increase in circulating levels of 11-KT whereas the combination of GnRH + T did not affect steroid levels at all. The response pattern for estradiol demonstrated a similar situation. FSH levels showed significant increases when GnRH + T was administered, while no changes were present in LH levels.	[Yom-Din, Svetlana; Hollander-Cohen, Lian; Aizen, Joseph; Boehm, Benjamin; Shpilman, Michal; Golan, Matan; Levavi-Sivan, Berta] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-76100 Rehovot, Israel; [Hurvitz, Avshalom; Degani, Gad] MIGAL Galilee Technol Ctr, POB 831, IL-10200 Kiryat Shmona, Israel	Hebrew University of Jerusalem	Levavi-Sivan, B (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, IL-76100 Rehovot, Israel.	berta.sivan@mail.huji.ac.il	Aizen, Joseph/Y-1122-2019	Aizen, Joseph/0000-0002-2018-7322; Golan, Matan/0000-0003-4861-5912; Yom, Sue/0000-0002-0779-7476; Levavi-Sivan, Berta/0000-0002-0183-9524	European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Grant [642893 - IMPRESS]; Binational Agricultural Research and Development Fund [BARD IS-420209]	European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie Grant; Binational Agricultural Research and Development Fund	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement no 642893 - IMPRESS and from the Binational Agricultural Research and Development Fund (BARD IS-420209).	Aizen J, 2007, GEN COMP ENDOCR, V153, P323, DOI 10.1016/j.ygcen.2007.04.004; Aizen J, 2007, BIOL REPROD, V76, P692, DOI 10.1095/biolreprod.106.055822; Aizen J, 2012, GEN COMP ENDOCR, V178, P28, DOI 10.1016/j.ygcen.2012.04.002; Alavi SMH, 2012, FISH PHYSIOL BIOCHEM, V38, P1655, DOI 10.1007/s10695-012-9662-9; Barannikova IA, 2004, J FISH BIOL, V64, P1330, DOI 10.1111/j.0022-1112.2004.00395.x; Birstein VJ, 1997, ENVIRON BIOL FISH, V48, P427, DOI 10.1023/A:1007382724251; Bobe J, 2004, BIOL REPROD, V71, P73, DOI 10.1095/biolreprod.103.025205; Cao H, 2009, MOL CELL ENDOCRINOL, V303, P34, DOI 10.1016/j.mce.2009.01.015; Chauvigne F, 2016, COMP BIOCHEM PHYS A, V191, P35, DOI 10.1016/j.cbpa.2015.09.015; Chauvigne F, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100784; CHEN F, 1992, MOL ENDOCRINOL, V6, P914, DOI 10.1210/me.6.6.914; CRIM LW, 1979, GEN COMP ENDOCR, V37, P192, DOI 10.1016/0016-6480(79)90107-2; Crossin GT, 2010, J FISH BIOL, V76, P112, DOI 10.1111/j.1095-8649.2009.02479.x; CUISSET B, 1995, FISH PHYSIOL BIOCHEM, V14, P313, DOI 10.1007/BF00004069; CUISSET B, 1994, COMP BIOCHEM PHYS C, V108, P229, DOI 10.1016/1367-8280(94)90035-3; Doroshov SI, 1997, ENVIRON BIOL FISH, V48, P265, DOI 10.1023/A:1007336802423; Erbel PJA, 1999, EUR J BIOCHEM, V260, P490, DOI 10.1046/j.1432-1327.1999.00188.x; Erbel PJA, 2000, BIOCHEMISTRY-US, V39, P6012, DOI 10.1021/bi992786n; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Fares F, 2006, BBA-GEN SUBJECTS, V1760, P560, DOI 10.1016/j.bbagen.2005.12.022; Fox KM, 2001, MOL ENDOCRINOL, V15, P378, DOI 10.1210/me.15.3.378; GIELEN JT, 1984, GEN COMP ENDOCR, V56, P457, DOI 10.1016/0016-6480(84)90088-1; GIELEN JT, 1983, CELL TISSUE RES, V233, P377, DOI 10.1007/BF00238304; Golan M, 2015, ENDOCRINOLOGY, V156, P4163, DOI 10.1210/en.2015-1150; Golan M, 2013, GEN COMP ENDOCR, V192, P126, DOI 10.1016/j.ygcen.2013.04.032; Guzman JM, 2015, GEN COMP EN IN PRESS; Holland JW, 2002, J ENDOCRINOL, V175, P261, DOI 10.1677/joe.0.1750261; Holland LZ, 2000, DEV BIOL, V226, P18, DOI 10.1006/dbio.2000.9810; Holland MCH, 2002, GEN COMP ENDOCR, V129, P178, DOI 10.1016/S0016-6480(02)00532-4; Holmes RL., 1974, PITUITARY GLAND COMP; HUANG JN, 1993, J BIOL CHEM, V268, P9311; Hurvitz A, 2005, GEN COMP ENDOCR, V140, P61, DOI 10.1016/j.ygcen.2004.09.019; Hurvitz A, 2007, AQUACULTURE, V270, P158, DOI 10.1016/j.aquaculture.2007.05.020; Hurvitz A, 2008, CYBIUM, V32, P283; Jarvis P.L., 2004, STURGEONS PADDLEFISH; Kamei H, 2003, GEN COMP ENDOCR, V134, P244, DOI 10.1016/S0016-6480(03)00259-4; Kasuto H, 2005, GEN COMP ENDOCR, V140, P222, DOI 10.1016/j.ygcen.2004.10.016; KAWAUCHI H, 1989, FISH PHYSIOL BIOCHEM, V7, P29, DOI 10.1007/BF00004687; Ko H, 2007, J MOL ENDOCRINOL, V38, P99, DOI 10.1677/jme.1.02163; Kobayashi M, 2010, GEN COMP ENDOCR, V167, P379, DOI 10.1016/j.ygcen.2010.01.003; Levavi-Sivan B, 2004, BIOL REPROD, V70, P1545, DOI 10.1095/biolreprod.103.021998; Levavi-Sivan B, 2004, AQUACULTURE, V229, P419, DOI 10.1016/S0044-8486(03)00349-1; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Levavi-Sivan B, 2006, BIOL REPROD, V75, P642, DOI 10.1095/biolreprod.106.051540; Levavi-Sivan B, 2008, CYBIUM, V32, P17; LEVAVIZERMONSKY B, 1986, GEN COMP ENDOCR, V62, P89, DOI 10.1016/0016-6480(86)90097-3; Lo A, 1998, GEN COMP ENDOCR, V111, P334, DOI 10.1006/gcen.1998.7117; Lokman PM, 2002, GEN COMP ENDOCR, V129, P1, DOI 10.1016/S0016-6480(02)00562-2; Mateos J, 2002, COMP BIOCHEM PHYS B, V132, P75, DOI 10.1016/S1096-4959(01)00535-8; Meiri I, 2000, FUNCTIONAL EXPRESSIO, P488; Moberg GP, 1995, AQUACULTURE, V135, P27, DOI 10.1016/0044-8486(95)01004-1; Moles G, 2012, GEN COMP ENDOCR, V176, P70, DOI 10.1016/j.ygcen.2011.12.029; Moles G, 2011, BIOL REPROD, V84, P1171, DOI 10.1095/biolreprod.110.086470; Mylonas CC, 2001, REV FISH BIOL FISHER, V10, P463; Pavlick RJ, 1997, GEN COMP ENDOCR, V105, P218, DOI 10.1006/gcen.1996.6823; PELISSERO C, 1988, FISH PHYSIOL BIOCHEM, V5, P109, DOI 10.1007/BF01875699; Planas JV, 2000, BIOL REPROD, V62, P1262, DOI 10.1095/biolreprod62.5.1262; Prat F, 1996, BIOL REPROD, V54, P1375, DOI 10.1095/biolreprod54.6.1375; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Shimizu A, 2012, GEN COMP ENDOCR, V178, P463, DOI 10.1016/j.ygcen.2012.07.003; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Sower SA, 2015, ENDOCRINOLOGY, V156, P3026, DOI 10.1210/en.2014-1797; SUZUKI K, 1988, GEN COMP ENDOCR, V71, P459, DOI 10.1016/0016-6480(88)90275-4; SWANSON P, 1989, FISH PHYSIOL BIOCHEM, V7, P169, DOI 10.1007/BF00004704; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Zenkevics H, 2000, ACTA BIOCHIM POL, V47, P815, DOI 10.18388/abp.2000_3999; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zmora N, 2007, J ENDOCRINOL, V194, P407, DOI 10.1677/JOE-07-0171	69	24	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162344	10.1371/journal.pone.0162344	http://dx.doi.org/10.1371/journal.pone.0162344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622546	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000026
J	Nunes-de-Almeida, CHL; Assis, CL; Feio, RN; Toledo, LF				Nunes-de-Almeida, Carlos H. L.; Assis, Clodoaldo L.; Feio, Renato N.; Toledo, Luis Felipe			Redescription of the Advertisement Call of Five Species of Thoropa (Anura, Cycloramphidae), Including Recordings of Rare and Endangered Species	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; AMPHIBIA; FROGS; LEPTODACTYLIDAE; EVOLUTION; HYLIDAE; SIGNALS	Frogs of the genus Thoropa comprise six endemic Brazilian species on the Eastern side of the country. Little is known about their natural history, especially about their acoustic communication. Therefore, aiming to provide an overview of their vocalizations, we analyzed and redescribed male advertisement calls of three living and two possibly extinct species. The smaller species, T. petropolitana and T. lutzi, produce simple calls (one single note) with a higher frequency range than the remaining larger ones. On the other hand, the larger species present complex calls, with more than one note: T. megatympanum calls have three notes, T. taophora calls have four notes, and T. miliaris calls varies from three to six notes. Population snout-vent length negatively correlated with peak of dominant frequency as expected. However, highlighted differences between two populations of T. lutzi, which could indicate need of further taxonomic evaluation of those lineages. Peculiar morphology, such as the absence of vocal sacs and slits, may have contributed to their call variation and highly banded frequency structure. If the observed population differences reflect species-level differences, T. lutzi may be classified as a critically endangered species, as T. petropolitana. Furthermore, we provided a suggestion to an unusual behavior in frogs: calling with the mouth open in the smaller species of the genus.	[Nunes-de-Almeida, Carlos H. L.; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, LaHNAB, Campinas, SP, Brazil; [Assis, Clodoaldo L.; Feio, Renato N.] Univ Fed Vicosa, Dept Biol Anim, Museu Zool Joao Moojen, Vicosa, MG, Brazil; [Nunes-de-Almeida, Carlos H. L.] Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade Estadual de Campinas	Nunes-de-Almeida, CHL (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, LaHNAB, Campinas, SP, Brazil.; Nunes-de-Almeida, CHL (corresponding author), Univ Estadual Campinas, Inst Biol, Programa Posgrad Biol Anim, Campinas, SP, Brazil.	nunesdealmeida.carlos@gmail.com	Feio, Renato/AAD-8127-2020; de Almeida, Carlos Henrique Luz Nunes/D-6903-2014; Toledo, Luís Felipe/I-4017-2012; Assis, Clodoaldo/AAC-2477-2020	Feio, Renato/0000-0002-3607-2896; de Almeida, Carlos Henrique Luz Nunes/0000-0001-7898-7819; Toledo, Luís Felipe/0000-0002-4929-9598; Assis, Clodoaldo/0000-0001-5009-2706	Sao Paulo Research Foundation (FAPESP) [2014/23388-7, 2013/09964-2]; National Council for Scientific and Technological Development (CNPq) [405285/2013-2, 302589/2013-9, 306732/2015-7]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by: Sao Paulo Research Foundation (FAPESP) #2014/23388-7 Luis Felipe Toledo; National Council for Scientific and Technological Development (CNPq) #405285/2013-2 Luis Felipe Toledo; National Council for Scientific and Technological Development (CNPq) #302589/2013-9 Luis Felipe Toledop; National Council for Scientific and Technological Development (CNPq) #306732/2015-7 Renato Neves Feio; Coordination for the Improvement of Higher Education Personnel (CAPES)-Mr. Carlos Henrique Luz Nunes-de-Almeida; and Sao Paulo Research Foundation (FAPESP) #2013/09964-2 Mr. Carlos Henrique Luz Nunes-de-Almeida.	ABE AS, 1991, ZOOL ANZ, V227, P313; AMIET J-L, 1989, Alytes (Paris), V8, P99; BOKERMANN WERNER C. A., 1965, AN ACAD BRASIL CIENC, V37, P525; CARAMASCHI U, 1984, Revista Brasileira de Zoologia, V2, P139; Caramaschi U, 2000, FAUNA AMEACADA EXTIN; Cochran D. M., 1938, Proceedings of the Biological Society of Washington, V51, P41; COCROFT RB, 1988, P BIOL SOC WASH, V101, P209; De Andrade FS, 2013, ZOOTAXA, V3608, P389, DOI 10.11646/zootaxa.3608.5.7; De Carvalho TR, 2013, ZOOTAXA, V3701, P207, DOI 10.11646/zootaxa.3701.2.5; de Miranda-Ribeiro A., 1923, REV MUS PAUL, V13, P825; de Toledo Luis Felipe, 2009, South American Journal of Herpetology, V4, P25, DOI 10.2994/057.004.0104; DOE-Diario Oficial do Estado do Rio Grande do Sul, 2014, TAX FAUN SILV EST RI, V173; DOSP-Diario Oficial do Estado de Sao Paulo, 2014, LIST OF ESP FAUN AM, V1,124, P25; DOU-Diario Oficial da Uniao, 2014, LIST NAC OF ESP FAUN, P121; Erdtmann L, 2009, ETHOLOGY, V115, P801, DOI 10.1111/j.1439-0310.2009.01673.x; Feio RN, 2002, THESIS; Forti LR, 2016, PEERJ, V4, DOI 10.7717/peerj.2014; Forti Lucas R., 2012, Herpetology Notes, V5, P187; Frost DR, AMPHIBIAN SPECIES WO; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Giaretta Ariovaldo Antonio, 2004, Biota Neotrop., V4, P1, DOI 10.1590/S1676-06032004000200008; Goicoechea N, 2010, ZOOL SCR, V39, P141, DOI 10.1111/j.1463-6409.2009.00413.x; Grenat PR, 2013, AMPHIBIA-REPTILIA, V34, P471, DOI 10.1163/15685381-00002902; Gridi-Papp M, 2008, J ACOUST SOC AM, V123, P2895, DOI 10.1121/1.2897001; HADDAD C.F.B., 2013, GUIA ANFIBIOS MATA A; Heyer W.R., 1988, P245; HEYER W R, 1990, Arquivos de Zoologia (Sao Paulo), V31, P231; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Izecksohn E, 2001, ANFIBIOS MUNICIPIO R; Kaefer IL, 2012, BEHAVIOUR, V149, P15, DOI 10.1163/156853912X623757; Magalhaes FD, 2014, HERPETOLOGICA, V70, P77; Muralidhar P, 2014, MOL ECOL, V23, P453, DOI 10.1111/mec.12592; Nali RC, 2014, SALAMANDRA, V50, P181; Neves Feio Renato, 2006, Arquivos do Museu Nacional Rio de Janeiro, V64, P41; Nunes-De-Almeida CHL, 2012, ZOOTAXA, P43; Orrico VGD, 2014, ZOOTAXA, V3881, P341, DOI 10.11646/zootaxa.3881.4.3; Passamani M, 2007, ESPECIES FAUNA AMEAC; Pauly GB, 2006, PHYSIOL BIOCHEM ZOOL, V79, P708, DOI 10.1086/504613; PELOSO PL, 2014, B AM MUS NAT HIST, V386, P1, DOI DOI 10.1206/834.1; Preininger D, 2016, HERPETOL J, V26, P187; Robillard T, 2006, CLADISTICS, V22, P533, DOI 10.1111/j.1096-0031.2006.00118.x; Rodel MO, 2004, TROP ZOOL, V17, P201; Rodel MO, 2002, SALAMANDRA, V38, P213; SAZIMA I, 1971, Ciencia e Cultura (Sao Paulo), V23, P647; Smith MJ, 2003, COPEIA, P750, DOI 10.1643/HA02-133.1; Spix J.B., 1824, MAXIMILIANI HUBSCHMA, P1; Toledo Luis F., 2015, Acta Ethologica, V18, P87; Toledo LF, 2007, ZOOTAXA, P57, DOI 10.11646/zootaxa.1658.1.4; Wandolleck B, 1907, ZOOLOGISCHEN ANTHOPO, V11, P1; Wells DK, 2010, ECOLOGY BEHAV AMPHIB; Wollenberg KC, 2007, MOL PHYLOGENET EVOL, V45, P14, DOI 10.1016/j.ympev.2007.06.024; Wycherley J, 2002, BIOL J LINN SOC, V77, P355, DOI 10.1046/j.1095-8312.2002.00104.x	52	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162617	10.1371/journal.pone.0162617	http://dx.doi.org/10.1371/journal.pone.0162617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617833	Green Submitted, Green Published, gold			2022-12-26	WOS:000383653100032
J	Piskacek, M; Havelka, M; Rezacova, M; Knight, A				Piskacek, Martin; Havelka, Marek; Rezacova, Martina; Knight, Andrea			The 9aaTAD Transactivation Domains: From Gal4 to p53	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION DOMAINS; CREB-BINDING PROTEIN; KIX DOMAIN; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; IN-VITRO; COACTIVATOR; YEAST; CBP; MEDIATOR	The family of the Nine amino acid Transactivation Domain, 9aaTAD family, comprises currently over 40 members. The 9aaTAD domains are universally recognized by the transcriptional machinery from yeast to man. We had identified the 9aaTAD domains in the p53, Msn2, Pdr1 and B42 activators by our prediction algorithm. In this study, their competence to activate transcription as small peptides was proven. Not surprisingly, we elicited immense 9aaTAD divergence in hundreds of identified orthologs and numerous examples of the 9aaTAD species' convergence. We found unforeseen similarity of the mammalian p53 with yeast Gal4 9aaTAD domains. Furthermore, we identified artificial 9aaTAD domains generated accidentally by others. From an evolutionary perspective, the observed easiness to generate 9aaTAD transactivation domains indicates the natural advantage for spontaneous generation of transcription factors from DNA binding precursors.	[Piskacek, Martin; Havelka, Marek; Rezacova, Martina] Masaryk Univ Brno, Dept Pathol Physiol, Lab Canc Biol & Genet, Fac Med, Kamenice 5, Brno 62500, Czech Republic; [Knight, Andrea] Masaryk Univ Brno, Dept Pathol Physiol, Gamma Delta Cell Lab T, Fac Med, Kamenice 5, Brno 62500, Czech Republic	Masaryk University Brno; Masaryk University Brno	Piskacek, M (corresponding author), Masaryk Univ Brno, Dept Pathol Physiol, Lab Canc Biol & Genet, Fac Med, Kamenice 5, Brno 62500, Czech Republic.	Piskacek@med.muni.cz	Piskacek, Martin/I-4280-2016	Piskacek, Martin/0000-0002-6283-1542; Knight, Andrea/0000-0001-7291-7975	Ministry of Health of the Czech Republic [NT14310, 15-32935A]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by Ministry of Health of the Czech Republic NT14310 (M.P.) and 15-32935A (A.K.).	Aguilar X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098575; Arai M, 2010, FEBS LETT, V584, P4500, DOI 10.1016/j.febslet.2010.10.024; Bates CA, 2011, BIOPOLYMERS, V95, P17, DOI 10.1002/bip.21548; Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; Brzovic PS, 2011, MOL CELL, V44, P942, DOI 10.1016/j.molcel.2011.11.008; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Cook PR, 2011, J MOL BIOL, V409, P384, DOI 10.1016/j.jmb.2011.04.003; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; FASSLER JS, 1989, MOL CELL BIOL, V9, P5602, DOI 10.1128/MCB.9.12.5602; Feng HQ, 2009, STRUCTURE, V17, P202, DOI 10.1016/j.str.2008.12.009; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Frangioni JV, 2000, NAT BIOTECHNOL, V18, P1080, DOI 10.1038/80280; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Han Y, 2000, J BIOL CHEM, V275, P14979, DOI 10.1074/jbc.275.20.14979; Hong JY, 2011, PHYTOCHEMISTRY, V72, P27, DOI 10.1016/j.phytochem.2010.10.005; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Jackson BM, 1996, MOL CELL BIOL, V16, P5557; Jedidi I, 2010, J BIOL CHEM, V285, P2438, DOI 10.1074/jbc.M109.071589; Jenkins LMM, 2009, BIOCHEMISTRY-US, V48, P1244, DOI 10.1021/bi801716h; Jeong CJ, 2001, BIOCHEMISTRY-US, V40, P9421, DOI 10.1021/bi010011k; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; Klein J, 2003, J BIOL CHEM, V278, P6779, DOI 10.1074/jbc.M212514200; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lallet S, 2006, MOL MICROBIOL, V62, P438, DOI 10.1111/j.1365-2958.2006.05363.x; Langlois C, 2012, J AM CHEM SOC, V134, P1715, DOI 10.1021/ja208999e; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lindert U, 2009, MOL CELL BIOL, V29, P6283, DOI 10.1128/MCB.00847-09; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Lou S, 2012, J VIROL, V86, P10748, DOI 10.1128/JVI.01007-12; Lu XY, 2000, P NATL ACAD SCI USA, V97, P1988, DOI 10.1073/pnas.040573197; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Majmudar CY, 2009, ANGEW CHEM INT EDIT, V48, P7021, DOI 10.1002/anie.200902669; Matsushita A, 2013, PLANT J, V73, P302, DOI 10.1111/tpj.12035; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Piskacek M., 2009, NATURE PRECEDINGS, DOI [10.1038/npre.2009.3984.1, DOI 10.1038/NPRE.2009.3984.1]; Piskacek M, 2009, NATURE PRECEDINGS, DOI [10.1038/npre.2009.3939.1, DOI 10.1038/NPRE.2009.3939.1]; Piskacek M., 2009, NAT PRECED, DOI [10.1038/npre.2009.3488.2, DOI 10.1038/NPRE.2009.3488.2]; Piskacek M, 2015, MOL BIOSYST, V11, P844, DOI 10.1039/c4mb00672k; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Pomerantz WC, 2012, ACS CHEM BIOL, V7, P1345, DOI 10.1021/cb3002733; Ptashne M, 2014, J BIOL CHEM, V289, P5417, DOI 10.1074/jbc.X114.547323; Qiu YJ, 2015, PLANT CELL, V27, P1409, DOI 10.1105/tpc.114.136093; RUDEN DM, 1991, NATURE, V350, P250, DOI 10.1038/350250a0; Sadeh A, 2012, J CELL SCI, V125, P3333, DOI 10.1242/jcs.096446; SAKURAI H, 1993, P NATL ACAD SCI USA, V90, P8382, DOI 10.1073/pnas.90.18.8382; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Shekhawat UKS, 2011, MOL BIOL REP, V38, P4023, DOI 10.1007/s11033-010-0521-4; Suzuki Y, 1992, Mol Cell Biol, V12, P4806; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Wang NK, 2014, P NATL ACAD SCI USA, V111, P12061, DOI 10.1073/pnas.1406033111; Wojciak JM, 2009, EMBO J, V28, P948, DOI 10.1038/emboj.2009.30; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	64	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162842	10.1371/journal.pone.0162842	http://dx.doi.org/10.1371/journal.pone.0162842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618436	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100056
J	Kim, B; Rhee, K				Kim, Byunghyuk; Rhee, Kunsoo			BOULE, a Deleted in Azoospermia Homolog, Is Recruited to Stress Granules in the Mouse Male Germ Cells	PLOS ONE			English	Article							HUMAN Y-CHROMOSOME; HEAT-STRESS; GENE FAMILY; IN-VIVO; DAZ; PROTEIN; EXPRESSION; RNA; SPERMATOGENESIS; TRANSLATION	High temperature adversely affects normal development of male germcells in mammals. Acute heat stress induces the formation of stress granules (SGs) in a set of male germ cells, and the SGs have been proposed to protect those cells from heat-induced apoptosis. DAZL, one of DAZ (Deleted in Azoospermia) family proteins, was shown to be an essential component of SGs, which is required for SG formation in the mouse testis. In the present study, we asked whether BOULE, the founding member of DAZ family proteins, is a component of the SGs. We show that BOULE is recruited to the SGs upon heat stress, and that these SGs are developmental stage-specific. These results suggest that DAZ family proteins may have conserved roles in the SGs of male germcells.	[Kim, Byunghyuk; Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Kim, Byunghyuk] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Seoul National University (SNU); Yeshiva University; Albert Einstein College of Medicine	Rhee, K (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	rheek@snu.ac.kr			Marine Biotechnology Program [PJT200620]	Marine Biotechnology Program	This study was supported by grants from the Marine Biotechnology Program (PJT200620). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; Haag ES, 2001, P NATL ACAD SCI USA, V98, P6983, DOI 10.1073/pnas.141237898; Harlow E, 1999, USING ANTIBODIES A L; Houston DW, 2000, DEVELOPMENT, V127, P447; Huang WJ, 2008, HUM REPROD, V23, P1280, DOI 10.1093/humrep/den099; Karashima T, 2000, DEVELOPMENT, V127, P1069; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim B, 2014, REPROD FERT DEVELOP, V26, P307, DOI 10.1071/RD12290; Kim B, 2013, CELL MOL LIFE SCI, V70, P2623, DOI 10.1007/s00018-012-1165-4; Kim B, 2012, DEVELOPMENT, V139, P568, DOI 10.1242/dev.075846; Kim B, 2009, HUM REPROD, V24, P1507, DOI 10.1093/humrep/dep032; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Lee KH, 2006, EMBO J, V25, P4263, DOI 10.1038/sj.emboj.7601304; Maines JZ, 1999, NAT CELL BIOL, V1, P171, DOI 10.1038/11091; Menke DB, 1997, AM J HUM GENET, V60, P237; Ollinger R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000199; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Sekine K, 2015, DEV BIOL, V399, P154, DOI 10.1016/j.ydbio.2014.12.027; Setchell B. P., 2006, Animal Reproduction, V3, P81; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Tanaka SS, 2000, GENE DEV, V14, P841; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Vogt PH, 2003, APMIS, V111, P115, DOI 10.1034/j.1600-0463.2003.11101161.x; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zeng M, 2009, MOL BIOL REP, V36, P2399, DOI 10.1007/s11033-009-9470-1	39	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163015	10.1371/journal.pone.0163015	http://dx.doi.org/10.1371/journal.pone.0163015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632217	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900116
J	van der Zwaard, S; Jaspers, RT; Blokland, IJ; Achterberg, C; Visser, JM; den Uil, AR; Hofmijster, MJ; Levels, K; Noordhof, DA; de Haan, A; de Koning, JJ; van der Laarse, WJ; de Ruiter, CJ				van der Zwaard, Stephan; Jaspers, Richard T.; Blokland, Ilse J.; Achterberg, Chantal; Visser, Jurrian M.; den Uil, Anne R.; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Haan, Arnold; de Koning, Jos J.; van der Laarse, Willem J.; de Ruiter, Cornelis J.			Oxygenation Threshold Derived from Near-Infrared Spectroscopy: Reliability and Its Relationship with the First Ventilatory Threshold	PLOS ONE			English	Article							RAMP INCREMENTAL EXERCISE; ALVEOLAR GAS-EXCHANGE; MUSCLE BLOOD-FLOW; SKELETAL-MUSCLE; DYNAMIC HETEROGENEITY; VASTUS-LATERALIS; CYCLE EXERCISE; HEALTHY-ADULTS; DEOXYGENATION; NIRS	Background Near-infrared spectroscopy (NIRS) measurements of oxygenation reflect O-2 delivery and utilization in exercising muscle and may improve detection of a critical exercise threshold. Purpose First, to detect an oxygenation breakpoint (Delta[O(2)HbMb-HHbMb]-BP) and compare this breakpoint to ventilatory thresholds during a maximal incremental test across sexes and training status. Second, to assess reproducibility of NIRS signals and exercise thresholds and investigate confounding effects of adipose tissue thickness on NIRS measurements. Methods Forty subjects (10 trained male cyclists, 10 trained female cyclists, 11 endurance trained males and 9 recreationally trained males) performed maximal incremental cycling exercise to determine Delta[O(2)HbMb-HHbMb]-BP and ventilatory thresholds (VT1 and VT2). Muscle haemoglobin and myoglobin O-2 oxygenation ([HHbMb], [O(2)HbMb], SmO2) was determined in m. vastus lateralis. Delta[O(2)HbMb-HHbMb]-BP was determined by double linear regression. Trained cyclists performed the maximal incremental test twice to assess reproducibility. Adipose tissue thickness (ATT) was determined by skinfold measurements. Results Delta[O(2)HbMb-HHbMb]-BP was not different from VT1, but only moderately related (r = 0.58-0.63, p<0.001). VT1 was different across sexes and training status, whereas Delta[O(2)HbMb-HHbMb]-BP differed only across sexes. Reproducibility was high for SmO2 (ICC = 0.69-0.97), Delta[O(2)HbMb-HHbMb]-BP (ICC = 0.80-0.88) and ventilatory thresholds (ICC = 0.96-0.99). SmO2 at peak exercise and at occlusion were strongly related to adipose tissue thickness (r(2) = 0.81, p<0.001; r(2) = 0.79, p<0.001).Moreover, ATT was related to asymmetric changes in Delta[HHbMb] and Delta[O(2)HbMb] during incremental exercise (r = -0.64, p<0.001) and during occlusion (r = -0.50, p<0.05). Conclusion Although the oxygenation threshold is reproducible and potentially a suitable exercise threshold, VT1 discriminates better across sexes and training status during maximal step-wise incremental exercise. Continuous-wave NIRS measurements are reproducible, but strongly affected by adipose tissue thickness.	[van der Zwaard, Stephan; Jaspers, Richard T.; Blokland, Ilse J.; Achterberg, Chantal; Visser, Jurrian M.; den Uil, Anne R.; Hofmijster, Mathijs J.; Levels, Koen; Noordhof, Dionne A.; de Haan, Arnold; de Koning, Jos J.; de Ruiter, Cornelis J.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands; [van der Laarse, Willem J.] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Amsterdam, Netherlands; [Hofmijster, Mathijs J.] Amsterdam Univ Appl Sci, Fac Sports & Nutr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Zwaard, S (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Dept Human Movement Sci, Amsterdam, Netherlands.	s.vander.zwaard@vu.nl	Noordhof, Dionne/AFR-6657-2022; van der Zwaard, Stephan/J-9622-2019	van der Zwaard, Stephan/0000-0002-8296-828X; van der Laarse, Willem J/0000-0002-8391-0354; Jaspers, Richard/0000-0002-6951-0952; de Koning, Jos J/0000-0002-5596-0282	Technologiestichting STW (NL) [12891]; Technologiestichting STW, the Netherlands	Technologiestichting STW (NL); Technologiestichting STW, the Netherlands	This work was supported by Technologiestichting STW (NL). Award number: 12891. Recipient: JJdK. URL: http://stw.nl/nl/projecten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors' work was supported by a research grant from Technologiestichting STW, the Netherlands.	Amann M, 2004, MED SCI SPORT EXER, V36, P1716, DOI 10.1249/01.MSS.0000142305.18543.34; Austin KG, 2005, RES Q EXERCISE SPORT, V76, P440; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bellotti C, 2013, MED SCI SPORT EXER, V45, P1208, DOI 10.1249/MSS.0b013e3182828ab2; Bhambhani YN, 2004, CAN J APPL PHYSIOL, V29, P504, DOI 10.1139/h04-033; Boone J, 2015, APPL PHYSIOL NUTR ME, DOI [10.1139/apnm-2015-02610b013e3182828ab2, DOI 10.1139/APNM-2015-02610B013E3182828AB2]; Boone J, 2015, EUR J APPL PHYSIOL, V115, P57, DOI 10.1007/s00421-014-2991-x; Celie B, 2012, EUR J APPL PHYSIOL, V112, P2369, DOI 10.1007/s00421-011-2183-x; Chin LMK, 2011, J APPL PHYSIOL, V111, P1259, DOI 10.1152/japplphysiol.01216.2010; Davis ML, 2013, RESP PHYSIOL NEUROBI, V186, P180, DOI 10.1016/j.resp.2013.01.012; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; De Ruiter CJ, 2007, MED SCI SPORT EXER, V39, P443, DOI 10.1249/mss.0b013e31802dd3cc; de Ruiter CJ, 2005, J APPL PHYSIOL, V99, P579, DOI 10.1152/japplphysiol.01420.2004; de Ruiter CJ, 2012, MED SCI SPORT EXER, V44, P1366, DOI 10.1249/MSS.0b013e318249d701; Evans JD., 1996, STRAIGHTFORWARD STAT; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Ferreira LF, 2007, J APPL PHYSIOL, V102, P358, DOI 10.1152/japplphysiol.00920.2005; Fontana FY, 2015, J SCI MED SPORT, V18, P590, DOI 10.1016/j.jsams.2014.07.016; Goodwin ML, 2012, J APPL PHYSIOL, V112, P9, DOI 10.1152/japplphysiol.01480.2010; Grassi B, 1999, J APPL PHYSIOL, V87, P348, DOI 10.1152/jappl.1999.87.1.348; Hopker JG, 2007, APPL PHYSIOL NUTR ME, V32, P1036, DOI 10.1139/H07-070; Keir DA, 2015, MED SCI SPORT EXER, V47, P1932, DOI 10.1249/MSS.0000000000000613; Koga S, 2014, MED SCI SPORT EXER, V46, P860, DOI 10.1249/MSS.0000000000000178; Koga S, 2011, AM J PHYSIOL-REG I, V301, pR534, DOI 10.1152/ajpregu.00101.2011; MANCINI DM, 1994, J APPL PHYSIOL, V77, P2740, DOI 10.1152/jappl.1994.77.6.2740; McArdle WD, 2010, EXERCISE PHYSL NUTR, V7th; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; McDonough P, 2005, J PHYSIOL-LONDON, V563, P903, DOI 10.1113/jphysiol.2004.079533; MITCHELL JH, 1992, MED SCI SPORT EXER, V24, pS258; Miura T, 1998, JPN CIRC J, V62, P649, DOI 10.1253/jcj.62.649; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Murias JM, 2013, RESP PHYSIOL NEUROBI, V189, P530, DOI 10.1016/j.resp.2013.08.011; Murias JM, 2013, AM J PHYSIOL-REG I, V304, pR720, DOI 10.1152/ajpregu.00016.2013; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Osawa T, 2011, MED SCI SPORT EXER, V43, P1406, DOI 10.1249/MSS.0b013e3182100261; Peltonen JE, 2013, RESP PHYSIOL NEUROBI, V188, P102, DOI 10.1016/j.resp.2013.05.014; Racinais S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00142; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; Rissanen APE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00265; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Southern WM, 2014, APPL PHYSIOL NUTR ME, V39, P521, DOI 10.1139/apnm-2013-0347; Spencer MD, 2012, EUR J APPL PHYSIOL, V112, P3349, DOI 10.1007/s00421-012-2323-y; STRINGER W, 1994, J APPL PHYSIOL, V76, P1462, DOI 10.1152/jappl.1994.76.4.1462; Tew GA, 2010, EUR J APPL PHYSIOL, V110, P1083, DOI 10.1007/s00421-010-1596-2; Thiel C, 2011, INT J SPORTS MED, V32, P277, DOI 10.1055/s-0030-1269922; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; Wang BD, 2012, J SPORT SCI MED, V11, P606; Wang BD, 2012, EUR J APPL PHYSIOL, V112, P567, DOI 10.1007/s00421-011-2007-z; Wang LX, 2006, APPL PHYSIOL NUTR ME, V31, P612, DOI 10.1139/H06-069; WASSERMAN K, 1994, AM J PHYSIOL, V266, pE519, DOI 10.1152/ajpendo.1994.266.4.E519; WASSERMAN K, 1987, CIRCULATION, V76, P29	52	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162914	10.1371/journal.pone.0162914	http://dx.doi.org/10.1371/journal.pone.0162914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631607	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900092
J	Wang, L; Zhao, MC; Shi, ZR; Feng, ZS; Guo, WW; Yang, S; Liu, LP; Li, GX				Wang, Le; Zhao, Mengchuan; Shi, Zhongren; Feng, Zhishan; Guo, Weiwei; Yang, Shuo; Liu, Lanping; Li, Guixia			A GeXP-Based Assay for Simultaneous Detection of Multiple Viruses in Hospitalized Children with Community Acquired Pneumonia	PLOS ONE			English	Article							TRANSCRIPTION-PCR ASSAY; RESPIRATORY VIRUSES; EPIDEMIOLOGY	The GeXP-based assay has recently been developed for simultaneous detection of multiple pathogens. So far, the application of the GeXP assay to test larger clinical samples has hardly been reported. Community-acquired pneumonia (CAP) is the leading cause of death in children worldwide and a substantial proportion of childhood CAP is caused by viruses. Rapid and accurate diagnosis of virus infection is important for the clinical management of CAP. In this study, we explored the GeXP assay for simultaneous detection of 20 types/subtypes of viruses in hospitalized children with CAP. A total of 1699 nasopharyngeal swabs were prospectively collected and viral nucleic acid was extracted and assayed. Using viral genomic DNA or RNA as template, we showed that at the concentration of 10(4) copies of DNA or RNA of each virus/mu l, all 20 target viruses were simultaneously identified by the GeXP assay. Fifteen control microorganisms, in contrast, failed to be amplified by the assay. About 65% of cases tested in this study had viral infection, with patients aged <3 years having a 70% positive rate, significantly higher than that in patients aged > 3 years (40%). The most frequently detected virus was RSV followed by PIV3, HRV, ADV and HBoV. Seasonal distribution analysis revealed that RSV was the most predominant in autumn and winter, while in spring and summer PIV3 and RSV were the most frequently identified with similar positive percentages. One hundred twenty randomly-chosen samples tested by the GeXP assay were re-evaluated by mono-RT-PCR, the results showed 97.5% diagnosis agreement between these 2 methods. Our findings suggest that the GeXP assay could be a valuable diagnostic tool for virus infection in pediatric patients with CAP.	[Wang, Le; Shi, Zhongren; Feng, Zhishan; Guo, Weiwei; Yang, Shuo; Liu, Lanping; Li, Guixia] Childrens Hosp Hebei Prov, Pediat Res Inst, Shijiazhuang 050031, Peoples R China; [Zhao, Mengchuan] Hebei Med Univ, Grad Sch, Shijiazhuang 050000, Peoples R China; [Li, Guixia] Childrens Hosp Hebei Prov, Dept Lab Med, Shijiazhuang 050031, Peoples R China	Hebei Medical University	Liu, LP; Li, GX (corresponding author), Childrens Hosp Hebei Prov, Pediat Res Inst, Shijiazhuang 050031, Peoples R China.; Li, GX (corresponding author), Childrens Hosp Hebei Prov, Dept Lab Med, Shijiazhuang 050031, Peoples R China.	LLp19620901@163.com; hbetlgx@126.com			Science and Technology Support Program of Hebei Province, China [15277705D]	Science and Technology Support Program of Hebei Province, China	Support for this study was provided by the Science and Technology Support Program of Hebei Province, China. Grant Number: 15277705D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cantais A, 2014, J CLIN VIROL, V60, P402, DOI 10.1016/j.jcv.2014.05.006; Chen KP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1422-1; Coiras MT, 2004, J MED VIROL, V72, P484, DOI 10.1002/jmv.20008; He Li-xian, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P649; Hu XM, 2012, J CLIN MICROBIOL, V50, P288, DOI 10.1128/JCM.05828-11; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Rhedin S, 2015, THORAX, V70, P847, DOI 10.1136/thoraxjnl-2015-206933; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Wolf DG, 2010, J PEDIATR-US, V156, P115, DOI 10.1016/j.jpeds.2009.07.014; Zhang YF, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0590-6	19	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162411	10.1371/journal.pone.0162411	http://dx.doi.org/10.1371/journal.pone.0162411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627439	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600033
J	Creanga, AA; Odhiambo, GA; Odera, B; Odhiambo, FO; Desai, M; Goodwin, M; Laserson, K; Goldberg, H				Creanga, Andreea A.; Odhiambo, George Awino; Odera, Benjamin; Odhiambo, Frank O.; Desai, Meghna; Goodwin, Mary; Laserson, Kayla; Goldberg, Howard			Pregnant Women's Intentions and Subsequent Behaviors Regarding Maternal and Neonatal Service Utilization: Results from a Cohort Study in Nyanza Province, Kenya	PLOS ONE			English	Article							FACILITY-BASED DELIVERY; OF-THE-LITERATURE; PLANNED BEHAVIOR; DEVELOPING-COUNTRIES; HOME DELIVERY; CARE; BARRIERS; HEALTH; METAANALYSIS; CHILDBIRTH	Higher use of maternal and neonatal health (MNH) services may reduce maternal and neonatal mortality in Kenya. This study aims to: 1) prospectively explore women's intentions to use MNH services (antenatal care, delivery in a facility, postnatal care, neonatal care) at < 20 and 30-35 weeks' gestation and their actual use of these services; 2) identify predictors of intention-behavior discordance among women with positive service use intentions; 3) examine associations between place of delivery, women's reasons for choosing it, and birthing experiences. We used data from a 2012-2013 population-based cohort of pregnant women in the Demographic Surveillance Site in Nyanza province, Kenya. Of 1,056 women completing the study (89.1% response rate), 948 had live-births and 22 stillbirths, and they represent our analytic sample. Logistic regression analysis identified predictors of intention-behavior discordance regarding delivery in a facility and use of postnatal and neonatal care. At < 20 and 30-35 weeks' gestation, most women intended to seek MNH services (>= 93.9% and >= 87.5%, respectively, for all services assessed). Actual service use was high for antenatal (98.1%) and neonatal (88.5%) care, but lower for delivery in a facility (76.9%) and postnatal care (51.8%). Woman's age > 35 and high-school education were significant predictors of intention-behavior discordance regarding delivery in a facility; several delivery-related factors were significantly associated with intention-behavior discordance regarding use of postnatal and neonatal care. Delivery facilities were chosen based on proximity to women's residence, affordability, and service quality; among women who delivered outside a health facility, 16.3% could not afford going to a facility. Good/very good birth experiences were reported by 93.6% of women who delivered in a facility and 32.6% of women who did not. We found higher MNH service utilization than previously documented in Nyanza province. Further increasing the number of facility deliveries and use of postnatal care may improve MNH in Kenya.	[Creanga, Andreea A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Creanga, Andreea A.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA; [Odhiambo, George Awino; Odera, Benjamin; Odhiambo, Frank O.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Desai, Meghna; Laserson, Kayla] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Goodwin, Mary; Goldberg, Howard] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Laserson, Kayla] Ctr Dis Control & Prevent, Div Global Hlth Protect, Ctr Global Hlth, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Creanga, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Creanga, AA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA.	acreanga@jhu.edu			US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the US Centers for Disease Control and Prevention; authors have received no funding to prepare the manuscript.	Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2012, KENYA COUNTRY STAT; Audo M O, 2005, East Afr Med J, V82, P547; Bell J, 2003, BIRTH-ISS PERINAT C, V30, P227, DOI 10.1046/j.1523-536X.2003.00252.x; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Conner M, 1998, J APPL SOC PSYCHOL, V28, P1429, DOI 10.1111/j.1559-1816.1998.tb01685.x; Conner M., 1996, PREDICTING HLTH BEHA; de Bernis L, 2003, BRIT MED BULL, V67, P39, DOI 10.1093/bmb/ldg017; Doctor HV, 2012, REPROD HEALTH MATTER, V20, P104, DOI 10.1016/S0968-8080(12)39615-8; Dogba M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-7; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Iyengar SD, 2008, J PERINATOL, V28, pS23, DOI 10.1038/jp.2008.174; Izugbara CO, 2009, PUBLIC HEALTH REP, V124, P585, DOI 10.1177/003335490912400416; Kenya National Bureau of Statistics Nairobi Kenya and MEASURE DHS ICF Macro Calverton Maryland USA, 2009, NAIR KEN MEASURE DHS; Loundon I, 1992, DEATH CHILD BIRTH IN; Magoma M, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-13; Mrisho M, 2007, TROP MED INT HEALTH, V12, P862, DOI 10.1111/j.1365-3156.2007.01855.x; Mwangome FK, 2012, RURAL REMOTE HEALTH, V12; Nair M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004749; Ono M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-214; Ouma PO, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-1; Oyerinde K, 2012, J COMMUN MED HLTH ED, V2, P1, DOI DOI 10.4172/2161-0711.1000149; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Pembe Andrea B, 2008, Afr J Reprod Health, V12, P120; RANDALL DM, 1994, BRIT J SOC PSYCHOL, V33, P405, DOI 10.1111/j.2044-8309.1994.tb01037.x; Seljeskog Line, 2006, Afr J Reprod Health, V10, P66; Sheeran P, 1998, BRIT J SOC PSYCHOL, V37, P231, DOI 10.1111/j.2044-8309.1998.tb01167.x; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Sorensen BL, 2011, AFR J REPROD HEALTH, V15, P2; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; WHO UNICEF, 2013, TRENDS MAT MORT 1990; World Bank, 2014, KEN COUNTR EST	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162017	10.1371/journal.pone.0162017	http://dx.doi.org/10.1371/journal.pone.0162017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622496	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000013
J	Konduru, K; Shurtleff, AC; Bradfute, SB; Nakamura, S; Bavari, S; Kaplan, G				Konduru, Krishnamurthy; Shurtleff, Amy C.; Bradfute, Steven B.; Nakamura, Siham; Bavari, Sina; Kaplan, Gerardo			Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge	PLOS ONE			English	Article							RESPIRATORY-TRACT IMMUNIZATION; NONHUMAN-PRIMATES; VIRUS GLYCOPROTEIN; HEMORRHAGIC-FEVER; PARTICLES PROTECT; VACCINE; ANTIBODY; REPLICATION; RESPONSES; IMMUNITY	Ebola virus (EBOV), a member of the Filoviridae that can cause severe hemorrhagic fever in humans and nonhuman primates, poses a significant threat to the public health. Currently, there are no licensed vaccines or therapeutics to prevent and treat EBOV infection. Several vaccines based on the EBOV glycoprotein (GP) are under development, including vectored, virus-like particles, and protein-based subunit vaccines. We previously demonstrated that a subunit vaccine containing the extracellular domain of the Ebola ebolavirus (EBOV) GP fused to the Fc fragment of human IgG1 (EBOVgp-Fc) protected mice against EBOV lethal challenge. Here, we show that the EBOVgp-Fc vaccine formulated with QS-21, alum, or polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose (poly-ICLC) adjuvants induced strong humoral immune responses in guinea pigs. The vaccinated animals developed anti-GP total antibody titers of approximately 10(5)-10(6) and neutralizing antibody titers of approximately 103 as assessed by a BSL-2 neutralization assay based on vesicular stomatitis virus (VSV) pseudotypes. The poly-ICLC formulated EBOVgp-Fc vaccine protected all the guinea pigs against EBOV lethal challenge performed under BSL-4 conditions whereas the same vaccine formulated with QS-21 or alum only induced partial protection. Vaccination with a mucin-deleted EBOVgp-Fc construct formulated with QS-21 adjuvant did not have a significant effect in anti-GP antibody levels and protection against EBOV lethal challenge compared to the full-length GP construct. The bulk of the humoral response induced by the EBOVgp-Fc vaccine was directed against epitopes outside the EBOV mucin region. Our findings indicate that different adjuvants can eliciting varying levels of protection against lethal EBOV challenge in guinea pigs vaccinated with EBOVgp-Fc, and suggest that levels of total anti-GP antibodies elicit by protein-based GP subunit vaccines do not correlate with protection. Our data further support the development of Fc fusions of GP as a candidate vaccine for human use.	[Konduru, Krishnamurthy; Nakamura, Siham; Kaplan, Gerardo] Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Shurtleff, Amy C.; Bradfute, Steven B.; Bavari, Sina] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Bradfute, Steven B.] Univ New Mexico, Albuquerque, NM 87131 USA	US Food & Drug Administration (FDA); University of New Mexico	Konduru, K (corresponding author), Food & Drug Adm, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	krishnamurthy.konduru@fda.hhs.gov	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635; kaplan, gerardo/0000-0003-3303-7259	CBER/FDA from National Institutes of Allergy and Infectious Disease (NIH) [IAA Y1-AI-0664-01]; Defense Threat Reduction Agency (DTRA) [IAA 11005IA-3333-Basic]; FDA; USAMRIID; FDA-U.S. Department of Energy	CBER/FDA from National Institutes of Allergy and Infectious Disease (NIH); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); FDA(United States Department of Health & Human Services); USAMRIID; FDA-U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by Interagency Agreements (IAAs) with CBER/FDA (GK) from the National Institutes of Allergy and Infectious Disease (NIH IAA Y1-AI-0664-01) and the Defense Threat Reduction Agency (DTRA IAA 11005IA-3333-Basic) and intramural funds from FDA (GK) and USAMRIID (SB). SN was supported by an appointment to a Research Participation Program administered by the Oak Ridge Institute for Science and Education through a FDA-U.S. Department of Energy interagency agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Barrette RW, 2011, INFECT GENET EVOL, V11, P1514, DOI 10.1016/j.meegid.2011.06.017; Bradfute SB, 2011, VIRUSES-BASEL, V3, P982, DOI 10.3390/v3070982; Bradfute SB, 2011, HUM VACCINES, V7, P701, DOI 10.4161/hv.7.6.15398; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Bukreyev A, 2007, J VIROL, V81, P6379, DOI 10.1128/JVI.00105-07; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Cenciarelli Orlando, 2015, Int J Microbiol, V2015, P769121, DOI 10.1155/2015/769121; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Connolly BM, 1999, J INFECT DIS, V179, pS203, DOI 10.1086/514305; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; De Santis O, 2016, LANCET INFECT DIS, V16, P311, DOI 10.1016/S1473-3099(15)00486-7; DiNapoli JM, 2010, VACCINE, V29, P17, DOI 10.1016/j.vaccine.2010.10.024; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Feldmann H, 2001, J GEN VIROL, V82, P2839, DOI 10.1099/0022-1317-82-12-2839; Feldmann H, 2007, PLOS PATHOG, V3, P54, DOI 10.1371/journal.ppat.0030002; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Guyre PM, 1997, CANCER IMMUNOL IMMUN, V45, P146, DOI 10.1007/s002620050418; Halfmann P, 2009, J VIROL, V83, P3810, DOI 10.1128/JVI.00074-09; Hartman AL, 2010, CLIN LAB MED, V30, P161, DOI 10.1016/j.cll.2009.12.001; Heeney JL, 2015, NATURE, V527, P453, DOI 10.1038/527453a; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Konduru K, 2011, VACCINE, V29, P2968, DOI 10.1016/j.vaccine.2011.01.113; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Marzi A, 2013, P NATL ACAD SCI USA, V110, P1893, DOI 10.1073/pnas.1209591110; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Olson Sarah H, 2012, Emerg Health Threats J, V5, DOI 10.3402/ehtj.v5i0.9134; Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P529, DOI 10.1111/j.1365-3024.2009.01101.x; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005547; Ragupathi G, 2011, EXPERT REV VACCINES, V10, P463, DOI [10.1586/erv.11.18, 10.1586/ERV.11.18]; Sanchez A, 2004, J VIROL, V78, P10370, DOI 10.1128/JVI.78.19.10370-10377.2004; Schmidt SR, 2009, IDRUGS, V12, P284; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Shurtleff AC, 2011, EXPERT OPIN DRUG DIS, V6, P233, DOI 10.1517/17460441.2011.554815; Spengler JR, 2016, EMERG INFECT DIS, V22, P956, DOI [10.32032/eid2206.160021, 10.3201/eid2206.160021]; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Sullivan NJ, 2006, PLOS MED, V3, P865, DOI 10.1371/journal.pmed.0030177; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Volchkov VE, 2005, ADV VIRUS RES, V64, P359, DOI 10.1016/S0065-3527(05)64011-0; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2004, VACCINE, V22, P3495, DOI 10.1016/j.vaccine.2004.01.063; Warfield KL, 2003, P NATL ACAD SCI USA, V100, P15889, DOI 10.1073/pnas.2237038100; Wong G, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004582; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083	64	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162446	10.1371/journal.pone.0162446	http://dx.doi.org/10.1371/journal.pone.0162446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622456	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000032
J	Paramelle, D; Peng, T; Free, P; Fernig, DG; Lim, S; Tomczak, N				Paramelle, David; Peng, Tao; Free, Paul; Fernig, David G.; Lim, Sierin; Tomczak, Nikodem			Specific Internalisation of Gold Nanoparticles into Engineered Porous Protein Cages via Affinity Binding	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; VIRUS-BASED NANOPARTICLES; DRUG-DELIVERY; FERRITIN; ENCAPSULATION; APOFERRITIN; FABRICATION; SCAFFOLD; DESIGN; CORES	Porous protein cages are supramolecular protein self-assemblies presenting pores that allow the access of surrounding molecules and ions into their core in order to store and transport them in biological environments. Protein cages' pores are attractive channels for the internalisation of inorganic nanoparticles and an alternative for the preparation of hybrid bioinspired nanoparticles. However, strategies based on nanoparticle transport through the pores are largely unexplored, due to the difficulty of tailoring nanoparticles that have diameters commensurate with the pores size and simultaneously displaying specific affinity to the cages' core and low non-specific binding to the cages' outer surface. We evaluated the specific internalisation of single small gold nanoparticles, 3.9 nm in diameter, into porous protein cages via affinity binding. The E2 protein cage derived from the Geobacillus stearothermophilus presents 12 pores, 6 nm in diameter, and an empty core of 13 nm in diameter. We engineered the E2 protein by site-directed mutagenesis with oligohistidine sequences exposing them into the cage's core. Dynamic light scattering and electron microscopy analysis show that the structures of E2 protein cages mutated with bis-or penta-histidine sequences are well conserved. The surface of the gold nanoparticles was passivated with a self-assembled monolayer made of a mixture of short peptidols and thiolated alkane ethylene glycol ligands. Such monolayers are found to provide thin coatings preventing non-specific binding to proteins. Further functionalisation of the peptide coated gold nanoparticles with Ni2+ nitrilotriacetic moieties enabled the specific binding to oligohistidine tagged cages. The internalisation via affinity binding was evaluated by electron microscopy analysis. From the various mutations tested, only the penta-histidine mutated E2 protein cage showed repeatable and stable internalisation. The present work overcomes the limitations of currently available approaches and provides a new route to design tailored and well-controlled hybrid nanoparticles.	[Paramelle, David; Free, Paul; Tomczak, Nikodem] ASTAR, Inst Mat Res & Engn, Singapore, Singapore; [Peng, Tao; Lim, Sierin] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore, Singapore; [Fernig, David G.] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England; [Lim, Sierin] Nanyang Technol Univ, NTU Northwestern Inst Nanomed, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Liverpool; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Paramelle, D; Tomczak, N (corresponding author), ASTAR, Inst Mat Res & Engn, Singapore, Singapore.; Lim, S (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore, Singapore.; Lim, S (corresponding author), Nanyang Technol Univ, NTU Northwestern Inst Nanomed, Singapore, Singapore.	paramelled@imre.a-star.edu.sg; SLim@ntu.edu.sg; tomczakn@imre.a-star.edu.sg	Lim, Sierin/G-6109-2010; Free, Paul/AAW-7885-2021; Fernig, David G/A-3590-2008; Paramelle, David/B-8026-2008	Lim, Sierin/0000-0001-7455-6771; Free, Paul/0000-0002-6231-6989; Fernig, David G/0000-0003-4875-4293; Paramelle, David/0000-0002-5388-9339	Agency for Science, Technology and Research (A*STAR); Institute of Materials Research and Engineering (IMRE) [IMRE/11-1C0215-OOE]; North West Cancer Research; Cancer and Polio Research Fund; Ministry of Education Academic Research Fund Tier 1 [RG33/07]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Institute of Materials Research and Engineering (IMRE); North West Cancer Research; Cancer and Polio Research Fund; Ministry of Education Academic Research Fund Tier 1	DP, PF and NT are grateful for financial support by the Agency for Science, Technology and Research (A*STAR), and the Institute of Materials Research and Engineering (IMRE) (Grant number IMRE/11-1C0215-OOE). DGF was funded by the North West Cancer Research, and the Cancer and Polio Research Fund. TP and SL were funded by the Ministry of Education Academic Research Fund Tier 1 (RG33/07).	Algar WR, 2011, BIOCONJUGATE CHEM, V22, P825, DOI 10.1021/bc200065z; Aniagyei SE, 2008, J MATER CHEM, V18, P3763, DOI 10.1039/b805874c; Blum AS, 2006, NANOTECHNOLOGY, V17, P5073, DOI 10.1088/0957-4484/17/20/006; Bronstein LM, 2011, SMALL, V7, P1609, DOI 10.1002/smll.201001992; Chen WH, 2012, BIOMATERIALS, V33, P7895, DOI 10.1016/j.biomaterials.2012.07.016; Chen XY, 2012, AUST J CHEM, V65, P266, DOI 10.1071/CH11432; Dai Q, 2014, ANGEW CHEM INT EDIT, V53, P5093, DOI 10.1002/anie.201309464; Dalmau M, 2008, BIOTECHNOL BIOENG, V101, P654, DOI 10.1002/bit.21988; Daniel MC, 2010, ACS NANO, V4, P3853, DOI 10.1021/nn1005073; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Duchesne L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001361; Duchesne L, 2008, LANGMUIR, V24, P13572, DOI 10.1021/la802876u; Estrada LPH, 2015, BIOMATER SCI-UK, V3, P787, DOI 10.1039/c5bm00052a; Fan RL, 2010, SMALL, V6, P1483, DOI 10.1002/smll.201000457; Free P, 2012, AUST J CHEM, V65, P275, DOI 10.1071/CH11429; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; Jolley C, 2011, NANOSCALE, V3, P1004, DOI 10.1039/c0nr00378f; Jolley CC, 2010, CHEM MATER, V22, P4612, DOI 10.1021/cm100657w; Jutz G, 2015, CHEM REV, V115, P1653, DOI 10.1021/cr400011b; Kale A, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/4/045603; Kasyutich O, 2010, J AM CHEM SOC, V132, P3621, DOI 10.1021/ja910918b; Keyes JD, 2011, J NANOPART RES, V13, P2563, DOI 10.1007/s11051-010-0149-2; Knecht S, 2009, J MOL RECOGNIT, V22, P270, DOI 10.1002/jmr.941; Lee LA, 2009, NANO RES, V2, P349, DOI 10.1007/s12274-009-9033-8; Li F, 2014, SMALL, V10, P230, DOI 10.1002/smll.201301393; Li K, 2012, NANOSCALE, V4, P188, DOI 10.1039/c1nr11132a; Li T, 2012, J MATER CHEM, V22, P14458, DOI 10.1039/c2jm30633f; Lim S, 2013, IFMBE P, P321; Ma YJ, 2012, ADV DRUG DELIVER REV, V64, P811, DOI 10.1016/j.addr.2012.01.005; Octeau V, 2009, ACS NANO, V3, P345, DOI 10.1021/nn800771m; Okuda M, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/41/415601; Paramelle D, 2015, ADV HEALTHC MATER, V4, P911, DOI 10.1002/adhm.201400730; Peng T, 2014, SMALL, V10, P3131, DOI 10.1002/smll.201303516; Peng T, 2011, BIOMACROMOLECULES, V12, P3131, DOI 10.1021/bm2005438; Pieters BJGE, 2016, CHEM SOC REV, V45, P24, DOI 10.1039/c5cs00157a; Pokorski JK, 2011, MOL PHARMACEUT, V8, P29, DOI 10.1021/mp100225y; Qiu HJ, 2013, ACS APPL MATER INTER, V5, P782, DOI 10.1021/am3022366; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Ren DM, 2012, ADV FUNCT MATER, V22, P3170, DOI 10.1002/adfm.201200052; Ren DM, 2011, SMALL, V7, P1051, DOI 10.1002/smll.201002242; San BH, 2012, J MATER CHEM, V22, P1774, DOI 10.1039/c1jm14581a; Swift J, 2009, LANGMUIR, V25, P5219, DOI 10.1021/la8040743; van Rijn P, 2011, J MATER CHEM, V21, P16735, DOI 10.1039/c1jm11433f; Vieweger M, 2011, ACS NANO, V5, P7324, DOI 10.1021/nn202184x; Xie H, 2009, SMALL, V5, P1036, DOI 10.1002/smll.200801106; Zhen ZP, 2013, ACS NANO, V7, P4830, DOI 10.1021/nn305791q	48	2	2	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162848	10.1371/journal.pone.0162848	http://dx.doi.org/10.1371/journal.pone.0162848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622533	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000064
J	Rosato, M; Kovarik, A; Garilleti, R; Rossello, JA				Rosato, Marcela; Kovarik, Ales; Garilleti, Ricardo; Rossello, Josep A.			Conserved Organisation of 45S rDNA Sites and rDNA Gene Copy Number among Major Clades of Early Land Plants	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; GENOME SIZE; X-CHROMOSOME; EVOLUTION; DIVERSITY; REPEAT; LOCUS; UNIT; 5S; RECOMBINATION	Genes encoding ribosomal RNA (rDNA) are universal key constituents of eukaryotic genomes, and the nuclear genome harbours hundreds to several thousand copies of each species. Knowledge about the number of rDNA loci and gene copy number provides information for comparative studies of organismal and molecular evolution at various phylogenetic levels. With the exception of seed plants, the range of 45S rDNA locus (encoding 18S, 5.8S and 26S rRNA) and gene copy number variation within key evolutionary plant groups is largely unknown. This is especially true for the three earliest land plant lineages Marchantiophyta (liverworts), Bryophyta (mosses), and Anthocerotophyta (hornworts). In this work, we report the extent of rDNA variation in early land plants, assessing the number of 45S rDNA loci and gene copy number in 106 species and 25 species, respectively, of mosses, liverworts and hornworts. Unexpectedly, the results show a narrow range of ribosomal locus variation (one or two 45S rDNA loci) and gene copies not present in vascular plant lineages, where a wide spectrum is recorded. Mutation analysis of whole genomic reads showed higher (3-fold) intragenomic heterogeneity of Marchantia polymorpha (Marchantiophyta) rDNA compared to Physcomitrella patens (Bryophyta) and two angiosperms(Arabidopsis thaliana and Nicotiana tomentosifomis) suggesting the presence of rDNA pseudogenes in its genome. No association between phylogenetic position, taxonomic adscription and the number of rDNA loci and gene copy number was found. Our results suggest a likely evolutionary rDNA stasis during land colonisation and diversification across 480 myr of bryophyte evolution. We hypothesise that strong selection forces may be acting against ribosomal gene locus amplification. Despite showing a predominant haploid phase and infrequent meiosis, overall rDNA homogeneity is not severely compromised in bryophytes.	[Rosato, Marcela; Rossello, Josep A.] Univ Valencia, ICBiBE Unidad Asociada CSIC, Jardin Bot, C Quart 80, E-46008 Valencia, Spain; [Kovarik, Ales] Acad Sci Czech Republ, Inst Biophys, CZ-61265 Brno, Czech Republic; [Garilleti, Ricardo] Univ Valencia, Fac Farm, Dept Bot, E-46100 Burjassot, Spain; [Rossello, Josep A.] Carl Faust Fdn, Marimurtra Bot Garden, POB 112, E-17300 Blanes, Catalonia, Spain	University of Valencia; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Valencia	Rossello, JA (corresponding author), Univ Valencia, ICBiBE Unidad Asociada CSIC, Jardin Bot, C Quart 80, E-46008 Valencia, Spain.; Rossello, JA (corresponding author), Carl Faust Fdn, Marimurtra Bot Garden, POB 112, E-17300 Blanes, Catalonia, Spain.	rossello@uv.es	Garilleti, Ricardo/A-2862-2014; Kovarik, Ales/H-1952-2014	Garilleti, Ricardo/0000-0002-5977-2908; Kovarik, Ales/0000-0003-2896-0698	Spanish Ministry of Science and Innovation [CGL2010-22347-C02-01, CGL2010-15693/BOS]; Catalan Government [2009SGR608]; Czech Scientific Foundation [P501/12/G090]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government; Czech Scientific Foundation(Grant Agency of the Czech Republic)	This work was supported by funds from the Spanish Ministry of Science and Innovation (Projects CGL2010-22347-C02-01 and CGL2010-15693/BOS), the Catalan Government (Consolidated Research Group 2009SGR608) and the Czech Scientific Foundation (P501/12/G090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainard JD, 2013, GENOME, V56, P431, DOI 10.1139/gen-2013-0041; Bainard JD, 2013, MOL PHYLOGENET EVOL, V68, P619, DOI 10.1016/j.ympev.2013.04.008; Bennett MD, 2012, PLANT DNA C VALUES D; Berrie GK, 1958, T BRIT BRYOL SOC, V3, P422, DOI [10.1179/006813858804829451, DOI 10.1179/006813858804829451]; Berrie GK, 1958, T BRIT BRYOL SOC, V3, P427, DOI [DOI 10.1179/006813858804829334, 10.1179/006813858804829334]; Caperta AD, 2002, J CELL SCI, V115, P2839; Capesius I, 1997, PLANT MOL BIOL, V33, P559, DOI 10.1023/A:1005740031313; Clark J, 2016, NEW PHYTOL, V210, P1072, DOI 10.1111/nph.13833; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; Datson PM, 2006, CHROMOSOME RES, V14, P845, DOI 10.1007/s10577-006-1092-z; DUBCOVSKY J, 1995, GENETICS, V140, P1367; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Fojtova M, 2015, PLANT MOL BIOL, V87, P591, DOI 10.1007/s11103-015-0299-9; Fritsch R, 1982, REGNUM VEG, V108, P1; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fujisawa M, 2003, CHROMOSOME RES, V11, P695, DOI 10.1023/A:1025941206391; Garcia S, 2012, CHROMOSOMA, V121, P389, DOI 10.1007/s00412-012-0368-7; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Hein N, 2012, SENESCENCE, P171; Hilger HH, 2013, BRYOPHYTE PHYLOGENY; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; INGLE J, 1975, PLANT PHYSIOL, V55, P496, DOI 10.1104/pp.55.3.496; Jovet-Ast S, 1969, REVUE BRYOL LICHEN, V36, P673; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Kovarik A, 2012, BOT J LINN SOC, V170, P459, DOI 10.1111/j.1095-8339.2012.01280.x; Kugita M, 2003, NUCLEIC ACIDS RES, V31, P716, DOI 10.1093/nar/gkg155; Leary DJ, 2001, FEBS LETT, V509, P145, DOI 10.1016/S0014-5793(01)03143-X; LEE M, 1988, ANNU REV PLANT PHYS, V39, P413, DOI 10.1146/annurev.arplant.39.1.413; Lim KY, 2000, CHROMOSOMA, V109, P161; Liu Y, 2013, MOL PHYLOGENET EVOL, V66, P1089, DOI 10.1016/j.ympev.2012.12.006; Marcon AB, 2005, ANN BOT-LONDON, V95, P271, DOI 10.1093/aob/mci022; Matyasek R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-722; MCADAM SV, 1982, J BRYOL, V12, P233, DOI 10.1179/jbr.1982.12.2.233; MCADAM SV, 1981, J BRYOL, V11, P591, DOI 10.1179/jbr.1981.11.4.591; Milyutina IA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1485, DOI 10.1134/S0006297915110103; Murray B.G., 2013, PLANT GENOME DIVERSI, P231, DOI DOI 10.1007/978-3-7091-1160-4_; Nakayama S, 2001, CHROMOSOME RES, V9, P469, DOI 10.1023/A:1011676328165; NEWTON ME, 1988, J BRYOL, V15, P303, DOI 10.1179/jbr.1988.15.2.303; NEWTON ME, 1971, T BRIT BRYOL SOC, V6, P244, DOI 10.1179/006813871804146364; NEWTON ME, 1986, J BRYOL, V14, P43, DOI 10.1179/jbr.1986.14.1.43; NEWTON ME, 1975, J BRYOL, V8, P365, DOI 10.1179/jbr.1975.8.3.365; Newton ME, 1983, NEW MANUAL BRYOLOGY, V1, P117; Newton ME, 1984, EXPT BIOL BRYOPHYTES, P65; Nieto Feliner G., 2012, PLANT GENOME DIVERSI, VVol. 1, P171, DOI [10.1007/978-3-7091-1130-7_12, DOI 10.1007/978-3-7091-1130-7_12]; Orzechowska M, 2010, J BRYOL, V32, P113, DOI 10.1179/037366810X12578498136075; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; PRUITT RE, 1986, J MOL BIOL, V187, P169, DOI 10.1016/0022-2836(86)90226-3; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Ramsay HP, 1983, NEW MANUAL BRYOLOGY, V1, P151; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Raskina O, 2004, P NATL ACAD SCI USA, V101, P14818, DOI 10.1073/pnas.0405817101; RENZAGLIA KS, 1995, AM J BOT, V82, P18, DOI 10.2307/2445781; Rosato M, 2008, ANN BOT-LONDON, V102, P15, DOI 10.1093/aob/mcn055; Rosato M, 2009, FOLIA GEOBOT, V44, P423, DOI 10.1007/s12224-009-9048-7; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schwarzacher T., 2000, PRACTICAL SITU HYBRI; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; Smith AJE., 1978, ADV BOT RES, V6, P195; Sone T, 1999, PLANT MOL BIOL, V41, P679, DOI 10.1023/A:1006398419556; SRIVASTAVA AK, 1991, BIOCHIMIE, V73, P631, DOI 10.1016/0300-9084(91)90042-Y; Temsch EM, 2010, PRESLIA, V82, P63; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Voglmayr H, 2000, ANN BOT-LONDON, V85, P531, DOI 10.1006/anbo.1999.1103; Wang W, 2015, CHROMOSOMA, DOI [10.1007/s00412-015-0556-3, DOI 10.1007/S00412-015-0556]; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Wicke S, 2011, MOL PHYLOGENET EVOL, V61, P321, DOI 10.1016/j.ympev.2011.06.023; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Zhong XB, 1996, PLANT MOL BIOL REP, V14, P232, DOI 10.1007/BF02671658	77	27	27	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162544	10.1371/journal.pone.0162544	http://dx.doi.org/10.1371/journal.pone.0162544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622766	gold, Green Published, Green Submitted			2022-12-26	WOS:000383681000039
J	Tourki, B; Mateo, P; Morand, J; Elayeb, M; Godin-Ribuot, D; Marrakchi, N; Belaidi, E; Messadi, E				Tourki, Bochra; Mateo, Philippe; Morand, Jessica; Elayeb, Mohamed; Godin-Ribuot, Diane; Marrakchi, Naziha; Belaidi, Elise; Messadi, Erij			Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion	PLOS ONE			English	Article							EXPERIMENTAL HEART-FAILURE; LIMITS INFARCT SIZE; GUANYLYL CYCLASE-A; ISOLATED RAT-HEART; PROTEIN-KINASE-C; NITRIC-OXIDE; PLATELET-AGGREGATION; CARDIOMYOCYTE DEATH; KAPPA-B; RECEPTOR	Cardiac ischemia is one of the leading causes of death worldwide. It is now well established that natriuretic peptides can attenuate the development of irreversible ischemic injury during myocardial infarction. Lebetin 2 (L2) is a new discovered peptide isolated from Macrovipera lebetina venom with structural similarity to B-type natriuretic peptide (BNP). Our objectives were to define the acute cardioprotective actions of L2 in isolated Langendorff-perfused rat hearts after regional or global ischemia-reperfusion (IR). We studied infarct size, left ventricular contractile recovery, survival protein kinases and mitochondrial permeability transition pore (mPTP) opening in injured myocardium. L2 dosage was determined by preliminary experiments at its ability to induce cyclic guanosine monophosphate (cGMP) release without changing hemodynamic effects in normoxic hearts. L2 was found to be as effective as BNP in reducing infarct size after the induction of either regional or global IR. Both peptides equally improved contractile recovery after regional IR, but only L2 increased coronary flow and reduced severe contractile dysfunction after global ischemia. Cardioprotection afforded by L2 was abolished after isatin or 5-hydroxydecanote pretreatment suggesting the involvement of natriuretic peptide receptors and mitochondrial K-ATP (mitoK(ATP)) channels in the L2-induced effects. L2 also increased survival protein expression in the reperfused myocardium as evidenced by phosphorylation of signaling pathways PKC epsilon/ERK/GSK3 beta and PI3K/Akt/eNOS. IR induced mitochondrial pore opening, but this effect was markedly prevented by L2 treatment. These data show that L2 has strong cardioprotective effect in acute ischemia through stimulation of natriuretic peptide receptors. These beneficial effects are mediated, at least in part, by mitoK(ATP) channel opening and downstream activated survival kinases, thus delaying mPTP opening and improving IR-induced mitochondrial dysfunction.	[Tourki, Bochra; Elayeb, Mohamed; Marrakchi, Naziha; Messadi, Erij] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Venins & Biomol Therapeut LR11 IPT08, Tunis, Tunisia; [Tourki, Bochra; Elayeb, Mohamed; Marrakchi, Naziha; Messadi, Erij] Univ Tunis El Manar, Inst Pasteur Tunis, Plateformede Physiol & Physiopathol Cardiovasc P2, Tunis, Tunisia; [Tourki, Bochra] Univ Carthage Tunis, Bizerte, Tunisia; [Mateo, Philippe] Univ Paris 11, Fac Pharm, UMR S 1180, Lab Signalisat & Physiopathol Cardiovasc, Paris, France; [Morand, Jessica; Godin-Ribuot, Diane; Belaidi, Elise] Univ Grenoble Alpes, Fac Pharm, Inserm U1042, Lab Hypoxie & Physiopathol Cardiaque, Grenoble, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Messadi, E (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Venins & Biomol Therapeut LR11 IPT08, Tunis, Tunisia.; Messadi, E (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Plateformede Physiol & Physiopathol Cardiovasc P2, Tunis, Tunisia.	erij.messadi@pasteur.rns.tn	Belaidi, Elise/AAC-9050-2019; Godin-Ribuot, Diane/B-6945-2014	Belaidi, Elise/0000-0003-4589-1612; Godin-Ribuot, Diane/0000-0001-7589-932X	Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Tunis; Ministere de l'Enseignement Superieur et de la Recherche de Tunisie; Pasteur Institutes Network; INSERM	Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Tunis; Ministere de l'Enseignement Superieur et de la Recherche de Tunisie; Pasteur Institutes Network; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the Reseau International des Instituts Pasteur (RIIP), the Institut Pasteur de Tunis, INSERM and the Ministere de l'Enseignement Superieur et de la Recherche de Tunisie. B. Tourki was supported by a grant-in-aid from the Pasteur Institutes Network.	Abdallah Y, 2005, CARDIOVASC RES, V66, P123, DOI 10.1016/j.cardiores.2005.01.007; Argaud L, 2004, CARDIOVASC RES, V61, P115, DOI 10.1016/j.cardiores.2003.11.003; Barbouche R, 1998, TOXICON, V36, P1939, DOI 10.1016/S0041-0101(98)00118-4; Barbouche R, 1996, FEBS LETT, V392, P6, DOI 10.1016/0014-5793(96)00774-0; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bibli SI, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/986813; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breivik L, 2015, PEPTIDES, V66, P43, DOI 10.1016/j.peptides.2015.01.011; Burley DS, 2007, BRIT J PHARMACOL, V152, P855, DOI 10.1038/sj.bjp.0707409; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Burley DS, 2007, HEART FAIL REV, V12, P279, DOI 10.1007/s10741-007-9029-y; Burley DS, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0402-4; Chandrakala AN, 2012, AM J PHYSIOL-CELL PH, V302, pC165, DOI 10.1152/ajpcell.00116.2011; Chen HH, 2000, J AM COLL CARDIOL, V36, P1706, DOI 10.1016/S0735-1097(00)00911-6; Chen HH, 2002, J AM COLL CARDIOL, V40, P1186, DOI 10.1016/S0735-1097(02)02127-7; Chen HT, 2008, ACTA PHARMACOL SIN, V29, P931, DOI 10.1111/j.1745-7254.2008.00824.x; Costello-Boerrigter LC, 2010, CIRC-HEART FAIL, V3, P412, DOI 10.1161/CIRCHEARTFAILURE.109.916114; D'Souza SP, 2003, AM J PHYSIOL-HEART C, V284, pH1592, DOI 10.1152/ajpheart.00902.2002; D'Souza SP, 2003, HEART, V89, P707, DOI 10.1136/heart.89.7.707; El Andalousi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076183; Evangelista JSAM, 2008, TOXICON, V52, P737, DOI 10.1016/j.toxicon.2008.08.014; Gomez L, 2006, AM J TRANSPLANT, V6, P487, DOI 10.1111/j.1600-6143.2005.01219.x; Gomez L, 2005, AM J PHYSIOL-HEART C, V289, pH2153, DOI 10.1152/ajpheart.00165.2005; Ha KC, 2006, REGUL PEPTIDES, V133, P13, DOI 10.1016/j.regpep.2005.09.015; Hausenloy DJ, 2012, BRIT J PHARMACOL, V165, P1235, DOI 10.1111/j.1476-5381.2011.01700.x; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; HELLER R, 1995, AGENT ACTION SUPPL, V45, P177; Huang YY, 2016, ANN BIOMED ENG, V44, P432, DOI 10.1007/s10439-015-1389-1; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Inserte J, 2000, CARDIOVASC RES, V45, P351, DOI 10.1016/S0008-6363(99)00371-5; Inserte J, 2011, J MOL CELL CARDIOL, V50, P903, DOI 10.1016/j.yjmcc.2011.02.013; Izumi T, 2001, J CLIN INVEST, V108, P203, DOI 10.1172/JCI12088; Johns DG, 2007, BIOCHEM BIOPH RES CO, V358, P145, DOI 10.1016/j.bbrc.2007.04.079; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kawakami R, 2004, CIRCULATION, V110, P3306, DOI 10.1161/01.CIR.0000147829.78357.C5; Kiemer AK, 2002, BIOCHEM BIOPH RES CO, V295, P1068, DOI 10.1016/S0006-291X(02)00807-0; Kim SY, 2011, CARDIOVASC RES, V92, P307, DOI 10.1093/cvr/cvr219; Laude K, 2002, CARDIOVASC RES, V55, P466, DOI 10.1016/S0008-6363(02)00277-8; Lochner A, 2009, CARDIOVASC J AFR, V20, P43; Luo ZY, 1997, ANN THORAC SURG, V64, P993, DOI 10.1016/S0003-4975(97)00715-7; Lyu T, 2014, INT HEART J, V55, P8, DOI 10.1536/ihj.13-109; Manivasagam S, 2016, MOL CELL ENDOCRINOL, V433, P117, DOI 10.1016/j.mce.2016.06.010; Prendes MGM, 2014, J PHYSIOL BIOCHEM, V70, P791, DOI 10.1007/s13105-014-0347-y; Marrakchi N, 2001, HAEMOSTASIS, V31, P207; Medvedev A, 2005, BRAIN RES, V1042, P119, DOI 10.1016/j.brainres.2005.02.051; Messadi E, 2014, J CARDIOVASC PHARM, V63, P274, DOI 10.1097/FJC.0000000000000045; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Nakanishi M, 2005, HYPERTENSION, V46, P441, DOI 10.1161/01.HYP.0000173420.31354.ef; Pagel-Langenickel I, 2007, J MOL MED, V85, P797, DOI 10.1007/s00109-007-0183-4; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Pasdois P, 2007, J MOL CELL CARDIOL, V42, P631, DOI 10.1016/j.yjmcc.2006.12.014; Ren B, 2010, TRANSPL P, V42, P4496, DOI 10.1016/j.transproceed.2010.09.163; Ren BH, 2007, CLIN CHIM ACTA, V377, P83, DOI 10.1016/j.cca.2006.08.027; Rose RA, 2010, CURR OPIN INVEST DR, V11, P349; Sangawa K, 2004, ANN THORAC SURG, V77, P233, DOI 10.1016/S0003-4975(03)01493-0; SCHWEITZ H, 1992, J BIOL CHEM, V267, P13928; Shi SJ, 2003, AM J PHYSIOL-RENAL, V285, pF694, DOI 10.1152/ajprenal.00097.2003; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; St Pierre L, 2006, BIOCHIMIE, V88, P1923, DOI 10.1016/j.biochi.2006.06.014; SUGA SI, 1992, ENDOCRINOLOGY, V130, P229, DOI 10.1210/en.130.1.229; Sun YG, 2009, BIOL PHARM BULL, V32, P1545, DOI 10.1248/bpb.32.1545; Taimor G, 2000, CARDIOVASC RES, V45, P588, DOI 10.1016/S0008-6363(99)00272-2; Takahashi N, 2003, HYPERTENS RES, V26, P847, DOI 10.1291/hypres.26.847; Talha S, 2013, J APPL PHYSIOL, V114, P172, DOI 10.1152/japplphysiol.00239.2012; Tong HY, 2000, CIRC RES, V87, P309, DOI 10.1161/01.RES.87.4.309; Verdouw PD, 1998, CARDIOVASC RES, V39, P121, DOI 10.1016/S0008-6363(98)00069-8; Verma S, 2002, CIRCULATION, V105, P2332, DOI 10.1161/01.CIR.0000016602.96363.36; Vink S, 2012, TOXICON, V59, P434, DOI 10.1016/j.toxicon.2010.12.001; Wu B, 2009, TOHOKU J EXP MED, V219, P107, DOI 10.1620/tjem.219.107; Yang XM, 2006, BASIC RES CARDIOL, V101, P311, DOI 10.1007/s00395-006-0587-2; YOSHIMURA M, 1991, CIRCULATION, V84, P1581, DOI 10.1161/01.CIR.84.4.1581; Zhang Y, 2004, J CARDIOVASC PHARM, V43, P227, DOI 10.1097/00005344-200402000-00010	73	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162632	10.1371/journal.pone.0162632	http://dx.doi.org/10.1371/journal.pone.0162632			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618302	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100035
J	Cassimere, EK; Mauvais, C; Denicourt, C				Cassimere, Erica K.; Mauvais, Claire; Denicourt, Catherine			p27(Kip1) Is Required to Mediate a G1 Cell Cycle Arrest Downstream of ATM following Genotoxic Stress	PLOS ONE			English	Article							KINASE INHIBITOR P27(KIP1); DNA-DAMAGE; DEPENDENT KINASES; MICE LACKING; PROTEIN; DEGRADATION; PROTEOLYSIS; GROWTH; P27; IDENTIFICATION	The DNA damage response (DDR) is a coordinated signaling network that ensures the maintenance of genome stability under DNA damaging stress. In response to DNA lesions, activation of the DDR leads to the establishment of cell cycle checkpoints that delay cell-cycle progression and allow repair of the defects. The tumor suppressor p27(Kip1) is a cyclinCDK inhibitor that plays an important role in regulating quiescence in a variety of tissues. Several studies have suggested that p27(Kip1) also plays a role in the maintenance of genomic integrity. Here we demonstrate that p27(Kip1) is essential for the establishment of a G1 checkpoint arrest after DNA damage. We also uncovered that ATM phosphorylates p27(Kip1) on a previously uncharacterized residue (Ser-140), which leads to its stabilization after induction of DNA double-strand breaks. Inhibition of this stabilization by replacing endogenous p27(Kip1) with a Ser-140 phospho-mutant (S140A) significantly sensitized cells to IR treatments. Our findings reveal a novel role for p27(Kip1) in the DNA damage response pathway and suggest that part of its tumor suppressing functions relies in its ability to mediate a G1 arrest after the induction of DNA double strand breaks.	[Cassimere, Erica K.; Mauvais, Claire; Denicourt, Catherine] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Cassimere, Erica K.] Texas Southern Univ, Dept Biol, Houston, TX 77004 USA	University of Texas System; University of Texas Health Science Center Houston; Texas Southern University	Denicourt, C (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	Catherine.Denicourt@uth.tmc.edu		Denicourt, Catherine/0000-0001-8721-0163	Suzan G. Komen postdoctoral fellowship; University of Texas Health Science Center at Houston McGovern Medical School institutional funds	Suzan G. Komen postdoctoral fellowship; University of Texas Health Science Center at Houston McGovern Medical School institutional funds	This work was supported by a Suzan G. Komen postdoctoral fellowship to E.C. and by The University of Texas Health Science Center at Houston McGovern Medical School institutional funds to C.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Cuadrado M, 2009, CANCER RES, V69, P8726, DOI 10.1158/0008-5472.CAN-09-0729; Deckbar D, 2010, CANCER RES, V70, P4412, DOI 10.1158/0008-5472.CAN-09-3198; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Eymin B, 1999, ONCOGENE, V18, P4839, DOI 10.1038/sj.onc.1202860; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; HARPER JW, 1993, CELL, V75, P805; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Loubat A, 1999, ONCOGENE, V18, P3324, DOI 10.1038/sj.onc.1202668; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Munshi A, 2005, METH MOLEC MED, V110, P21; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Payne SR, 2008, MOL CELL BIOL, V28, P258, DOI 10.1128/MCB.01536-07; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Santra MK, 2009, NATURE, V459, P722, DOI 10.1038/nature08011; See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; StCroix B, 1996, NAT MED, V2, P1204; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162806	10.1371/journal.pone.0162806	http://dx.doi.org/10.1371/journal.pone.0162806			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611996	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900169
J	Thi, HTH; Choi, SW; Kim, YM; Kim, HY; Hong, S				Huyen Trang Ha Thi; Choi, Seo-Won; Kim, Young-Mi; Kim, Hye-Youn; Hong, Suntaek			Protein Tyrosine Phosphatase N2 Is a Positive Regulator of Lipopolysaccharide Signaling in Raw264.7 Cell through Derepression of Src Tyrosine Kinase	PLOS ONE			English	Article							NF-KAPPA-B; FAMILY KINASES; INFLAMMATION; ACTIVATION; DEPHOSPHORYLATION; MACROPHAGES; INHIBITION; EXPRESSION; ALPHA; MICE	T cell protein tyrosine phosphatase N2 (PTPN2) is a phosphotyrosine-specific nonreceptor phosphatase and is ubiquitously expressed in tissues. Although PTPN2 functions as an important regulator in different signaling pathways, it is still unclear what is specific target protein of PTPN2 and how is regulated in lipopolysaccharide (LPS)-induced inflammatory signaling pathway. Here, we found that PTPN2 deficiency downregulated the expression of LPS-mediated pro-inflammtorycytokine genes. Conversely, overexpression of PTPN2 in Raw264.7 cells enhanced the expression and secretion of those cytokines. The activation of MAPK and NF-kappa B signaling pathways by LPS was reduced in PTPN2-knockdowned cells and ectopic expression of PTPN2 reversed these effects. Furthermore, we found that PTNP2 directly interacted with Src and removed the inhibitory Tyr527 phosphorylation of Src to enhance the activatory phosphorylation of Tyr416 residue. These results suggested that PTPN2 is a positive regulator of LPS-induced inflammatory response by enhancing the activity of Src through targeting the inhibitory phosphor-tyrosine527 of Src.	[Huyen Trang Ha Thi; Choi, Seo-Won; Kim, Young-Mi; Kim, Hye-Youn; Hong, Suntaek] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Canc Cell Biol Lab, Inchon, South Korea	Gachon University	Hong, S (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Canc Cell Biol Lab, Inchon, South Korea.	sthong@gachon.ac.kr	Kim, Hye Youn/K-3590-2016		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A1A2004620]; Gil Medical Center, Gachon University [FRD2014-9]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Gil Medical Center, Gachon University	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education (2012R1A1A2004620) and by Gil Medical Center, Gachon University (FRD2014-9).	Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Choi YH, 2014, DRUG DES DEV THER, V8, P1941, DOI 10.2147/DDDT.S71957; Curnow SJ, 2004, J IMMUNOL, V173, P5290, DOI 10.4049/jimmunol.173.8.5290; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; Fang HQ, 2004, J IMMUNOL, V173, P360, DOI 10.4049/jimmunol.173.1.360; Frazier WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050071; Han ZN, 1998, AUTOIMMUNITY, V28, P197, DOI 10.3109/08916939808995367; Ibarra-Sanchez MD, 2000, SEMIN IMMUNOL, V12, P379, DOI 10.1006/smim.2000.0220; Ibarra-Sanchez MD, 2001, ONCOGENE, V20, P4728, DOI 10.1038/sj.onc.1204648; Lee HS, 2007, J IMMUNOL, V179, P7001, DOI 10.4049/jimmunol.179.10.7001; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Moron B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073703; Ren JL, 2009, CELL SIGNAL, V21, P378, DOI 10.1016/j.cellsig.2008.10.011; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Scharl M, 2010, INFLAMM BOWEL DIS, V16, P2055, DOI 10.1002/ibd.21325; Shrivastava P, 2004, BLOOD, V103, P1425, DOI 10.1182/blood-2003-03-0716; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Xu YH, 2008, CELL RES, V18, P1220, DOI 10.1038/cr.2008.310; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162724	10.1371/journal.pone.0162724	http://dx.doi.org/10.1371/journal.pone.0162724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611995	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900156
J	Boko, PM; Ibikounle, M; Onzo-Aboki, A; Tougoue, JJ; Sissinto, Y; Batcho, W; Kinde-Gazard, D; Kabore, A				Boko, Pelagie M.; Ibikounle, Moudachirou; Onzo-Aboki, Ablawa; Tougoue, Jean-Jacques; Sissinto, Yollande; Batcho, Wilfrid; Kinde-Gazard, Dorothe; Kabore, Achille			Schistosomiasis and Soil Transmitted Helminths Distribution in Benin: A Baseline Prevalence Survey in 30 Districts	PLOS ONE			English	Article							INFECTION; EPIDEMIOLOGY	In 2013, Benin developed strategies to control neglected tropical diseases and one of the first step was the disease mapping of the entire country in order to identify endemic districts of schistosomiasis and soil transmitted helminths (STH). This study was carried out in 30 of the 77 districts of Benin. Of these 30 districts 22 were previously treated for Lymphatic Filariasis (LF) using the Ivermectin and Albendazole combination. In each district, five schools were selected and 50 children aged 8 to 14 years were sampled in each school, making a total of 250 children sampled in the district. The schools were selected mainly according to their proximity to lakes or any bodies of water that were likely to have been used by the children. Samples of faeces and urine were collected from each pupil. Urinary schistosomiasis was identified using the urine filtration technique while STH and intestinal schistosomiasis were identified through the Kato Katz method. Overall a total of 7500 pupils were surveyed across 150 schools with a gender ratio of 1:1. Hookworm was identified in all 30 districts with a prevalence ranging from 1.2% (95% CI: 0.0-2.5) to 60% (95% CI: 53.9-66.1). Ascaris lumbricoides was detected in 19 districts with a prevalence rate between 1% (95% CI: 0.0-2.2) and 39% (95% CI: 32.9-45.0). In addition to these common STH, Trichuris trichiura, Enterobius vermicularis and Strongyloides stercoralis were found at low prevalence. Only 16 districts were endemic to Schistosoma mansoni, while 29 districts were endemic to S. haematobium. The S. haematobium prevalence ranged from 0.8% (95% CI: 0.0-1.9) to 56% (95% CI: 50.2-62.5) while the prevalence of S. mansoni varied from 0.4% (95% CI: 0.0-1.2) to 46% (95% CI: 39.8-52.2). The 22 districts, where LF was successfully eliminated, still require mass drug administration (MDA) of albendazole indicating that school-based MDA would be needed even after LF elimination in districts co-endemic to LF and STH in Benin.	[Boko, Pelagie M.; Batcho, Wilfrid] Minist Hlth Benin, Natl Control Program Communicable Dis, 01BP882, Cotonou, Benin; [Ibikounle, Moudachirou; Onzo-Aboki, Ablawa] Univ Abomey Calavi, Fac Sci & Tech, 01BP526, Cotonou, Benin; [Tougoue, Jean-Jacques; Kabore, Achille] Res Triangle Inst, Washington, DC USA; [Tougoue, Jean-Jacques; Kabore, Achille] 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA; [Sissinto, Yollande; Kinde-Gazard, Dorothe] Univ Abomey Calavi, Fac Hlth Sci, 01BP 526, Cotonou, Benin	University of Abomey Calavi; Research Triangle Institute; University of Abomey Calavi	Boko, PM (corresponding author), Minist Hlth Benin, Natl Control Program Communicable Dis, 01BP882, Cotonou, Benin.	pelagieboko@gmail.com		IBIKOUNLE, Moudachirou/0000-0002-3640-0175; Moudachirou, IBIKOUNLE/0000-0002-3517-1729	United States Agency for International Development (USAID); USAID through the ENVISION project [AID-OAA-A-11-00048]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID through the ENVISION project	This study was made possible with funding from the United States Agency for International Development (USAID). USAID support for NTD control in Benin led by RTI International under Cooperative Agreement No AID-OAA-A-11-00048 through the ENVISION project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alelign Tilahun, 2015, J Parasitol Res, V2015, P641602, DOI 10.1155/2015/641602; Awasthi S, 2003, BMJ-BRIT MED J, V327, P431, DOI 10.1136/bmj.327.7412.431; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; CHIPPAUX JP, 1990, B SOC PATHOL EXOT, V83, P498; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Garba A, 1999, SANTE MONTROUGE FR, V10, P323; Hotez P.J., 2006, HELMINTH INFECT SOIL; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Ibikounle M, 2014, Bull Soc Pathol Exot, V107, P171, DOI 10.1007/s13149-014-0344-y; INSAE & ICF, 2013, ENQ DEM SANT BEN 201; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Katz N, 1972, SIMPLE DEVICE QUANTI; Kheir MM, 1999, AM J TROP MED HYG, V60, P307, DOI 10.4269/ajtmh.1999.60.307; Mone H, 2012, SCI WORLD J, DOI 10.1100/2012/793420; Mone H, 2010, ADV PARASIT, V71, P33, DOI 10.1016/S0065-308X(10)71001-0; NOKES C, 1991, T ROY SOC TROP MED H, V85, P272, DOI 10.1016/0035-9203(91)90052-Z; NOKES C, 1994, PARASITOL TODAY, V10, P14, DOI 10.1016/0169-4758(94)90348-4; Panesar A, 2015, SANITATION ACTIVITIE; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Sady H, 2015, PARASITE VECTOR, V8, P1, DOI DOI 10.1186/s13071-014-0608-1; Salawu A. S., 2014, Journal of Public Health and Epidemiology, V6, P417; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Tomas J, 2012, EPITOOLS EPIDEMIOLOG; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2015, SCHIST; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization, 2001, SCHIST SOIL TRANSM H; World Health Organization, 2002, WHO TECHN REP SER; World Health Organization, 2015, PREV CHEM HUM HELM C	33	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162798	10.1371/journal.pone.0162798	http://dx.doi.org/10.1371/journal.pone.0162798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643795	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900018
J	Eschbaumer, M; Stenfeldt, C; Smoliga, GR; Pacheco, JM; Rodriguez, LL; Li, RW; Zhu, J; Arzt, J				Eschbaumer, Michael; Stenfeldt, Carolina; Smoliga, George R.; Pacheco, Juan M.; Rodriguez, Luis L.; Li, Robert W.; Zhu, James; Arzt, Jonathan			Transcriptomic Analysis of Persistent Infection with Foot-and-Mouth Disease Virus in Cattle Suggests Impairment of Apoptosis and Cell-Mediated Immunity in the Nasopharynx	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC VIRAL-INFECTION; ESOPHAGEAL-PHARYNGEAL FLUID; CDNA MICROARRAY DATA; NF-KAPPA-B; CARRIER STATE; SECRETORY IGA; TR1 CELLS; IN-VITRO; PATHOGENESIS	In order to investigate the mechanisms of persistent foot-and-mouth disease virus (FMDV) infection in cattle, transcriptome alterations associated with the FMDV carrier state were characterized using a bovine whole-transcriptome microarray. Eighteen cattle (8 vaccinated with a recombinantFMDV A vaccine, 10 non-vaccinated) were challenged with FMDV A(24) Cruzeiro, and the gene expression profiles of nasopharyngeal tissues collected between 21 and 35 days after challenge were compared between 11 persistently infected carriers and 7 non-carriers. Carriers and non-carrierswere further compared to 2 naive animals that had been neither vaccinated nor challenged. At a controlled false-discovery rate of 10% and a minimum difference in expression of 50%, 648 genes were differentially expressed between FMDV carriers and non-carriers, and most (467) had higher expression in carriers. Among these, genes associated with cellular proliferation and the immune response-such as chemokines, cytokines and genes regulating T and B cells-were significantly overrepresented. Differential gene expression was significantly correlated between non-vaccinated and vaccinated animals (biological correlation +0.97), indicating a similar transcriptome profile across these groups. Genes related to prostaglandin E-2 production and the induction of regulatory T cells were over-expressed in carriers. In contrast, tissues from non-carrier animals expressed higher levels of complement regulators and pro-apoptotic genes that could promote virus clearance. Based on these findings, we propose a working hypothesis for FMDV persistence in nasopharyngeal tissues of cattle, in which the virus may be maintained by an impairment of apoptosis and the local suppression of cell-mediated antiviral immunity by inducible regulatory T cells.	[Eschbaumer, Michael; Stenfeldt, Carolina; Smoliga, George R.; Pacheco, Juan M.; Rodriguez, Luis L.; Zhu, James; Arzt, Jonathan] ARS, PIADC, FADRU, USDA, Greenport, NY 11944 USA; [Eschbaumer, Michael; Stenfeldt, Carolina] PIADC Res Participat Program, Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Li, Robert W.] ARS, AGIL, USDA, Beltsville, MD USA; [Eschbaumer, Michael] Friedrich Loeffler Inst, Inst Diagnost Virol, Sudufer 10, D-17493 Greifswald, Germany	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Department of Agriculture (USDA); Friedrich Loeffler Institute	Zhu, J; Arzt, J (corresponding author), ARS, PIADC, FADRU, USDA, Greenport, NY 11944 USA.	james.zhu@ars.usda.gov; jonathan.arzt@ars.usda.gov	Ibrahim, Essam Hassan/G-1960-2018; Stenfeldt, Carolina/AAG-7940-2021	Ibrahim, Essam Hassan/0000-0003-0130-2257; Pacheco, Juan/0000-0001-5477-0201; Eschbaumer, Michael/0000-0002-1104-0695; Arzt, Jonathan/0000-0002-7517-7893; Stenfeldt, Carolina/0000-0002-2074-3886	CRIS project (USDA, Agricultural Research Service) [1940-32000-057-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQPM-13-X-00131]; PIADC Research Participation Program fellowships	CRIS project (USDA, Agricultural Research Service); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); PIADC Research Participation Program fellowships	This work was funded in part by CRIS project 1940-32000-057-00D (USDA, Agricultural Research Service), as well as through an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQPM-13-X-00131. ME and CS were recipients of PIADC Research Participation Program fellowships, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement with the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki Y, 2004, J IMMUNOL, V173, P4352, DOI 10.4049/jimmunol.173.7.4352; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bell MP, 2007, J IMMUNOL, V179, P1893, DOI 10.4049/jimmunol.179.3.1893; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BETZ M, 1991, J IMMUNOL, V146, P108; Brake DA, 2012, DEV BIOLOGICALS, V134, P123; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; BURROWS R, 1981, J COMP PATHOL, V91, P599, DOI 10.1016/0021-9975(81)90089-X; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Cecere TE, 2012, VIRUSES-BASEL, V4, P833, DOI 10.3390/v4050833; Chen JH, 2015, NAT MED, V21, P327, DOI 10.1038/nm.3831; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Crawford RR, 2015, J BIOL CHEM, V290, P15878, DOI 10.1074/jbc.M114.635144; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eisen HN, 2014, CANCER IMMUNOL RES, V2, P381, DOI 10.1158/2326-6066.CIR-14-0029; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Gharibi T, 2016, IMMUNOBIOLOGY, V221, P357, DOI 10.1016/j.imbio.2015.09.021; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Grubman MJ, 2010, FUTURE VIROL, V5, P51, DOI 10.2217/FVL.09.68; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P59; Ilott MC, 1997, EPIDEMIOL INFECT, V118, P181, DOI 10.1017/S0950268896007376; Juleff ND, 2012, VET IMMUNOL IMMUNOP, V148, P145, DOI 10.1016/j.vetimm.2011.05.013; Juleff N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003434; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kochel TJ, 2015, PROSTAG OTH LIPID M, V116, P99, DOI 10.1016/j.prostaglandins.2014.11.003; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; Koyama AH, 2000, MICROBES INFECT, V2, P1111, DOI 10.1016/S1286-4579(00)01265-X; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; Maree F, 2016, J VIROL, V90, P5132, DOI 10.1128/JVI.00166-16; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; McFadden C, 2007, J IMMUNOL, V179, P6439, DOI 10.4049/jimmunol.179.10.6439; McGuire HM, 2015, J IMMUNOL, V195, P5123, DOI 10.4049/jimmunol.1501463; Gonzalez SM, 2016, VIRAL IMMUNOL, V29, P2, DOI 10.1089/vim.2015.0066; Mohan MS, 2008, VET IMMUNOL IMMUNOP, V125, P337, DOI 10.1016/j.vetimm.2008.05.031; Moonen P, 2004, VET MICROBIOL, V103, P151, DOI 10.1016/j.vetmic.2004.07.005; Murphy MLP, 1999, VIRUS RES, V62, P67, DOI 10.1016/S0168-1702(99)00050-7; Ng CT, 2014, CURR TOP MICROBIOL, V380, P129, DOI 10.1007/978-3-662-43492-5_6; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Odorizzi PM, 2012, J IMMUNOL, V188, P2957, DOI 10.4049/jimmunol.1100038; OIE, 2012, MANUAL DIAGNOSTIC TE, P163; Olson BM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00315; Oosting M, 2014, P NATL ACAD SCI USA, V111, pE4478, DOI 10.1073/pnas.1410293111; Otani K, 2014, J PATHOL, V234, P302, DOI 10.1002/path.4391; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pandya M, 2015, IMMUNOGENETICS, V67, P691, DOI 10.1007/s00251-015-0877-7; Parida S, 2006, VACCINE, V24, P1107, DOI 10.1016/j.vaccine.2005.09.006; Pellerin L, 2014, IMMUNOL RES, V58, P358, DOI 10.1007/s12026-014-8512-5; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; R Core Team, 2013, R LANG ENV STAT COMP; Rabizadeh E, 2015, THROMB RES, V136, P118, DOI 10.1016/j.thromres.2014.11.023; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Richter K, 2009, J BIOL CHEM, V284, P30652, DOI 10.1074/jbc.M109.014506; Rieder E, 2005, J VIROL, V79, P12989, DOI 10.1128/JVI.79.20.12989-12998.2005; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2014, CURR TOP MICROBIOL, V380, P39, DOI 10.1007/978-3-662-43492-5_3; Rossi D, 2003, HAEMATOLOGICA, V88, P212; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; SALT JS, 1993, BRIT VET J, V149, P207, DOI 10.1016/S0007-1935(05)80168-X; Schutta C, 2016, VACCINE, V34, P3214, DOI 10.1016/j.vaccine.2015.12.018; Shannon W, 2003, PHARMACOGENOMICS, V4, P41, DOI 10.1517/phgs.4.1.41.22581; Shen L, 2015, CLIN SCI, V128, P665, DOI 10.1042/CS20140586; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Simmons MJ, 2008, ONCOGENE, V27, P1421, DOI 10.1038/sj.onc.1210771; Smyth G, 2015, LIMMA LINEAR MODELS; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Stack G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004641; Stenfeldt C, 2016, TRANSBOUND EMERG DIS, V63, P152, DOI 10.1111/tbed.12235; Stenfeldt C, 2012, J COMP PATHOL, V146, P243, DOI 10.1016/j.jcpa.2011.06.005; Stenfeldt C, 2016, J VIROL IN PRESS; Stenfeldt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143666; Stenfeldt C, 2012, VET MICROBIOL, V154, P230, DOI 10.1016/j.vetmic.2011.07.007; SUTMOLLER P, 1965, VET REC, V77, P968, DOI 10.1136/vr.77.33.968; Svitek N, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-50; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Theron AJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/608930; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Tumis ME, 2016, IMMUNITY, V44, P316, DOI 10.1016/j.immuni.2016.01.013; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang YH, 2003, INST MATH S, V40, P403; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Zeng HY, 2015, CELL MOL IMMUNOL, V12, P566, DOI 10.1038/cmi.2015.44; Zeng LL, 2012, J BIOL CHEM, V287, P29125, DOI 10.1074/jbc.M112.362038; Zhang Z, 2006, J COMP PATHOL, V134, P56, DOI 10.1016/j.jcpa.2005.06.011; Zhang ZD, 2004, J GEN VIROL, V85, P415, DOI 10.1099/vir.0.19538-0; Zhang ZD, 2003, J VIROL METHODS, V111, P95, DOI 10.1016/S0166-0934(03)00165-4; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431; Zhang ZD, 2015, VET RES, V46, DOI 10.1186/s13567-015-0276-y; Zhu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064119	121	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162750	10.1371/journal.pone.0162750	http://dx.doi.org/10.1371/journal.pone.0162750			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643611	Green Submitted, gold, Green Published			2022-12-26	WOS:000383891900016
J	Avva, SVSP; Hart, CM				Avva, S. V. Satya Prakash; Hart, Craig M.			Characterization of the Drosophila BEAF-32A and BEAF-32B Insulator Proteins	PLOS ONE			English	Article							CHROMATIN-BOUNDARY-ELEMENT; CHROMOSOMAL DOMAINS; IN-VIVO; GENE; TRANSCRIPTION; MELANOGASTER; EXPRESSION; IDENTIFICATION; BINDING; GENOME	Data implicate the Drosophila 32 kDa Boundary Element-Associated Factors BEAF-32A and BEAF-32B in both chromatin domain insulator element function and promoter function. They might also function as an epigenetic memory by remaining bound to mitotic chromosomes. Both proteins are made from the same gene. They differ in their N-terminal 80 amino acids, which contain single DNA-binding BED fingers. The remaining 200 amino acids are identical in the two proteins. The structure and function of the middle region of 120 amino acids is unknown, while the C-terminal region of 80 amino acids has a putative leucine zipper and a BESS domain and mediates BEAF-BEAF interactions. Here we report a further characterization of BEAF. We show that the BESS domain alone is sufficient to mediate BEAF-BEAF interactions, although the presence of the putative leucine zipper on at least one protein strengthens the interactions. BEAF-32B is sufficient to rescue a null BEAF mutation in flies. Using mutant BEAF-32B rescue transgenes, we show that the middle region and the BESS domain are essential. In contrast, the last 40 amino acids of the middle region, which is poorly conserved among Drosophila species, is dispensable. Deleting the putative leucine zipper results in a hypomorphicmutant BEAF-32B protein. Finally, we document the dynamics of BEAF-32A-EGFP and BEAF-32B-mRFP during mitosis in embryos. A subpopulation of both proteins appears to remain on mitotic chromosomes and also on the mitotic spindle, while much of the fluorescence is dispersed during mitosis. Differences in the dynamics of the two proteins are observed in syncytial embryos, and both proteins show differences between syncytial and later embryos. This characterization of BEAF lays a foundation for future studies into molecular mechanisms of BEAF function.	[Avva, S. V. Satya Prakash; Hart, Craig M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Hart, CM (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	chart4@lsu.edu	Hart, Craig/B-4832-2016	Hart, Craig/0000-0002-9870-991X	NSF grant from Division of Molecular and Cellular Biosciences [1244100]; Louisiana Board of Regents PFund grant [LEQSF-EPS(2012)-PFUND-274]; Div Of Molecular and Cellular Bioscience [1244100] Funding Source: National Science Foundation	NSF grant from Division of Molecular and Cellular Biosciences; Louisiana Board of Regents PFund grant; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grant 1244100 from the Division of Molecular and Cellular Biosciences (http://www.nsf.gov) and Louisiana Board of Regents PFund grant LEQSF-EPS(2012)-PFUND-274 (http://www.regents.la.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Bhaskar V, 2002, GENE, V299, P173, DOI 10.1016/S0378-1119(02)01058-2; Buchenau P, 1997, J CELL BIOL, V137, P291, DOI 10.1083/jcb.137.2.291; BUCHENAU P, 1993, J CELL SCI, V106, P189; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cuvier O, 1998, MOL CELL BIOL, V18, P7478, DOI 10.1128/MCB.18.12.7478; Cuvier O, 2002, CHROMOSOMA, V110, P519, DOI 10.1007/s00412-001-0181-1; Delattre M, 2002, INT J DEV BIOL, V46, P167; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Follmer NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003135; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Gilbert MK, 2006, GENETICS, V173, P1365, DOI 10.1534/genetics.106.056002; Hart CM, 1997, MOL CELL BIOL, V17, P999, DOI 10.1128/MCB.17.2.999; Hart CM, 1999, CHROMOSOMA, V108, P375, DOI 10.1007/s004120050389; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Lam KC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002736; Maeda RK, 2007, CURR OPIN GENET DEV, V17, P394, DOI 10.1016/j.gde.2007.08.002; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pathak RU, 2007, MOL CELL BIOL, V27, P4796, DOI 10.1128/MCB.00305-07; Prioleau MN, 1999, EMBO J, V18, P4035, DOI 10.1093/emboj/18.14.4035; Rath U, 2004, J CELL BIOCHEM, V93, P1033, DOI 10.1002/jcb.20243; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Roy S, 2007, GENETICS, V176, P801, DOI 10.1534/genetics.106.068056; Roy S, 2007, MOL GENET GENOMICS, V277, P273, DOI 10.1007/s00438-006-0187-8; Sarge KD, 2005, TRENDS BIOCHEM SCI, V30, P605, DOI 10.1016/j.tibs.2005.09.004; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Scott KS, 1995, EMBO J, V14, P6258, DOI 10.1002/j.1460-2075.1995.tb00316.x; Segil N, 1996, GENE DEV, V10, P2389, DOI 10.1101/gad.10.19.2389; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vogelmann J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004544; Yang JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2469; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X	48	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162906	10.1371/journal.pone.0162906	http://dx.doi.org/10.1371/journal.pone.0162906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622635	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000067
J	Paula, DP; Linard, B; Crampton-Platt, A; Srivathsan, A; Timmermans, MJTN; Sujii, ER; Pires, CSS; Souza, LM; Andow, DA; Vogler, AP				Paula, Debora P.; Linard, Benjamin; Crampton-Platt, Alex; Srivathsan, Amrita; Timmermans, Martijn J. T. N.; Sujii, Edison R.; Pires, Carmen S. S.; Souza, Lucas M.; Andow, David A.; Vogler, Alfried P.			Uncovering Trophic Interactions in Arthropod Predators through DNA Shotgun-Sequencing of Gut Contents	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PREY DNA; MITOCHONDRIAL GENOMES; PCR PRIMERS; BIODIVERSITY; ECOLOGY; ENHANCE; SAMPLES; BIAS	Characterizing trophic networks is fundamental to many questions in ecology, but this typically requires painstaking efforts, especially to identify the diet of small generalist predators. Several attempts have been devoted to develop suitable molecular tools to determine predatory trophic interactions through gut content analysis, and the challenge has been to achieve simultaneously high taxonomic breadth and resolution. General and practical methods are still needed, preferably independent of PCR amplification of barcodes, to recover a broader range of interactions. Here we applied shotgun-sequencing of the DNA from arthropod predator gut contents, extracted from four common coccinellid and dermapteran predators co-occurring in an agroecosystem in Brazil. By matching unassembled reads against six DNA reference databases obtained from public databases and newly assembled mitogenomes, and filtering for high overlap length and identity, we identified prey and other foreign DNA in the predator guts. Good taxonomic breadth and resolution was achieved (93% of prey identified to species or genus), but with low recovery of matching reads. Two to nine trophic interactions were found for these predators, some of which were only inferred by the presence of parasitoids and components of the microbiome known to be associated with aphid prey. Intraguild predation was also found, including among closely related ladybird species. Uncertainty arises from the lack of comprehensive reference databases and reliance on low numbers of matching reads accentuating the risk of false positives. We discuss caveats and some future prospects that could improve the use of direct DNA shotgun-sequencing to characterize arthropod trophic networks.	[Paula, Debora P.; Sujii, Edison R.; Pires, Carmen S. S.; Souza, Lucas M.] Embrapa Genet Resources & Biotechnol, Parque Estacao Biol, Brasilia, DF, Brazil; [Paula, Debora P.; Linard, Benjamin; Crampton-Platt, Alex; Srivathsan, Amrita; Timmermans, Martijn J. T. N.; Vogler, Alfried P.] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London, England; [Crampton-Platt, Alex] UCL, Dept Genet Evolut & Environm, Fac Life Sci, Gower St, London, England; [Srivathsan, Amrita] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Srivathsan, Amrita; Timmermans, Martijn J. T. N.; Vogler, Alfried P.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England; [Timmermans, Martijn J. T. N.] Middlesex Univ, Dept Nat Sci, Hendon Campus, London, England; [Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Natural History Museum London; University of London; University College London; National University of Singapore; Imperial College London; Middlesex University; University of Minnesota System; University of Minnesota Twin Cities	Paula, DP (corresponding author), Embrapa Genet Resources & Biotechnol, Parque Estacao Biol, Brasilia, DF, Brazil.; Paula, DP (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London, England.	debora.pires@embrapa.br	Sujii, Edison Ryoiti/H-7715-2015; de Souza, Lucas Machado/J-8621-2012	Sujii, Edison Ryoiti/0000-0002-0702-0181; Linard, Benjamin/0000-0002-5555-898X; Crampton-Platt, Alex/0000-0002-8096-615X; Machado de Souza, Lucas/0000-0001-8589-9534	NERC (GB) [NE/M021955]; EMBRAPA; Natural History Museum; Biodiversity Initiative	NERC (GB)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Natural History Museum; Biodiversity Initiative	This work was supported by NERC (GB), NE/M021955 to Alfried Volgler; EMBRAPA, No grant number, to Debora Pires Paula; and the Natural History Museum, Biodiversity Initiative to Alfried Vogler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andujar C, 2015, MOL ECOL, V24, P3603, DOI 10.1111/mec.13195; Brooke M. M., 1946, JOUR NATION MALARIA SOC, V5, P45; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Clare EL, 2014, MOL ECOL, V23, P3633, DOI 10.1111/mec.12519; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; Crampton-Platt A, 2015, MOL BIOL EVOL, V32, P2302, DOI 10.1093/molbev/msv111; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Dixon A.F.G., 2000, INSECT PREDATOR PREY; Elton C., 1927, ANIMAL ECOLOGY; Evans EW, 2011, BIOCONTROL, V56, P597, DOI 10.1007/s10526-011-9374-6; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Geoghegan IE, 1998, EUR J ENTOMOL, V95, P571; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Lo N, 2006, BIOL TERMITES MODERN, P27; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mollot G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093740; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Murray DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124671; Paula DP, 2015, MOL ECOL RESOUR, V15, P880, DOI 10.1111/1755-0998.12364; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Prinja S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043093, 10.1371/journal.pone.0030362]; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rosenheim JA, 1999, ECOL APPL, V9, P409, DOI 10.1890/1051-0761(1999)009[0409:IOGPOA]2.0.CO;2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Sicsu PR, 2013, THESIS; Srivathsan A, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0150-4; Srivathsan A, 2015, MOL ECOL RESOUR, V15, P250, DOI 10.1111/1755-0998.12302; Sunderland K.D., 2005, P299, DOI 10.1007/1-4020-2625-0_6; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tang M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku917; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vestheim H, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-12; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Zaidi RH, 1999, MOL ECOL, V8, P2081, DOI 10.1046/j.1365-294x.1999.00823.x; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4	57	39	42	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161841	10.1371/journal.pone.0161841	http://dx.doi.org/10.1371/journal.pone.0161841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622637	gold, Green Published, Green Accepted			2022-12-26	WOS:000383681000008
J	Rauzi, F; Kirkby, NS; Edin, ML; Whiteford, J; Zeldin, DC; Mitchell, JA; Warner, TD				Rauzi, Francesca; Kirkby, Nicholas S.; Edin, Matthew L.; Whiteford, James; Zeldin, Darryl C.; Mitchell, Jane A.; Warner, Timothy D.			Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1	FASEB JOURNAL			English	Article						angiogenesis; eicosanoids; endothelium; prostaglandins	ANGIOGENESIS; ACID; AGGREGOMETRY; METABOLITES; MECHANISM	Regular consumption of low-dose aspirin reduces the occurrence of colorectal, esophageal, stomach, and gastrointestinal cancers. The underlying mechanism is unknown but may be linked to inhibition of angiogenesis. Because the effective doses of aspirin are consistent with the inhibition of cyclooxygenase-1 in platelets, we used liquid chromatography with tandem mass spectrometry analyses and immunoassays of human platelet releasates coupled with angiogenesis assays to search for the mediators of these effects. Blood or platelet-rich plasma from healthy volunteers stimulated with platelet activators produced a broad range of eicosanoids. Notably, preincubation of platelets with aspirin, but not with a P2Y12 receptor antagonist, caused a marked reduction in the production of 11-hydroxyeicosatetraenoic acid (HETE) and 15(S)-HETE, in addition to prostanoids such as thromboxane A(2). Releasates from activated platelets caused cell migration and tube formation in cultured human endothelial cells and stimulated the sprouting of rat aortic rings in culture. These proangiogenic effects were absent when platelets were treated with aspirin but returned by coincubation with exogenous 15(S)-HETE. These results reveal 15(S)-HETE as a major platelet cyclooxygenase-1 product with strong proangiogenic effects. Thus, 15(S)-HETE represents a potential target for the development of novel antiangiogenic therapeutics, and blockade of its production may provide a mechanism for the anticancer effects of aspirin.	[Rauzi, Francesca; Kirkby, Nicholas S.; Whiteford, James; Warner, Timothy D.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Kirkby, Nicholas S.; Mitchell, Jane A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of London; Queen Mary University London; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Warner, TD (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	t.d.warner@qmul.ac.uk	Edin, Matthew/AAI-1934-2019; Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Whiteford, James/0000-0002-8967-7389; Edin, Matthew/0000-0002-7042-500X; Kirkby, Nicholas/0000-0003-3509-8549	Wellcome Trust [085255/Z/08/Z]; British Heart Foundation [FS/10/033/28271]; William Harvey Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [Z01-025034]; British Heart Foundation [FS/16/1/31699, FS/10/33/28271] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025043] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); William Harvey Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Wellcome Trust (Grant 085255/Z/08/Z), the British Heart Foundation (Grant FS/10/033/28271), the William Harvey Research Foundation, and the Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grant Z01-025034).	Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111; Armstrong PCJ, 2008, J THROMB HAEMOST, V6, P1933, DOI 10.1111/j.1538-7836.2008.03133.x; Armstrong PCJ, 2009, THROMB HAEMOSTASIS, V102, P772, DOI 10.1160/TH09-04-0215; Brooke MA, 2014, GUT, V63, P96, DOI 10.1136/gutjnl-2012-303581; Chan MV, 2011, PLATELETS, V22, P485, DOI 10.3109/09537104.2011.592958; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; Etulain J, 2013, BRIT J PHARMACOL, V170, P255, DOI 10.1111/bph.12250; GOETZL EJ, 1980, J IMMUNOL, V125, P1789; Harrison P, 2009, SEMIN THROMB HEMOST, V35, P150, DOI 10.1055/s-0029-1220323; Kirkby NS, 2015, FASEB J, V29, P4568, DOI 10.1096/fj.15-275065; Kirkby NS, 2013, P NATL ACAD SCI USA, V110, P15782, DOI 10.1073/pnas.1218880110; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; Langley RE, 2014, CURR OPIN ONCOL, V26, P441, DOI 10.1097/CCO.0000000000000098; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; O'Donnell VB, 2014, CIRC RES, V114, P1185, DOI 10.1161/CIRCRESAHA.114.301597; Rothwell PM, 2013, ANN INTERN MED, V159, P148, DOI 10.7326/0003-4819-159-2-201307160-00013; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Soumya SJ, 2012, INFLAMM RES, V61, P707, DOI 10.1007/s00011-012-0463-5; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Warner TD, 2011, BRIT J CLIN PHARMACO, V72, P619, DOI 10.1111/j.1365-2125.2011.03943.x; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633	26	33	35	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4256	4266		10.1096/fj.201600530R	http://dx.doi.org/10.1096/fj.201600530R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27633788	Green Published, hybrid			2022-12-26	WOS:000388201500030
J	Piccolo, LR; Merz, EC; He, XF; Sowell, ER; Noble, KG				Piccolo, Luciane R.; Merz, Emily C.; He, Xiaofu; Sowell, Elizabeth R.; Noble, Kimberly G.		Pediat Imaging Neurocognition	Age-Related Differences in Cortical Thickness Vary by Socioeconomic Status	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; GENETIC INFLUENCES; PREFRONTAL CORTEX; BRAIN-DEVELOPMENT; SEX-DIFFERENCES; SURFACE-AREA; TRAJECTORIES; CHILDREN; ADOLESCENCE; PLASTICITY	Recent findings indicate robust associations between socioeconomic status (SES) and brain structure in children, raising questions about the ways in which SES may modify structural brain development. In general, cortical thickness and surface area develop in nonlinear patterns across childhood and adolescence, with developmental patterns varying to some degree by cortical region. Here, we examined whether age-related nonlinear changes in cortical thickness and surface area varied by SES, as indexed by family income and parental education. We hypothesized that SES disparities in age-related change may be particularly evident for language-and literacy-supportingcortical regions. Participants were 1148 typically-developing individuals between 3 and 20 years of age. Results indicated that SES factors moderate patterns of age-associated change in cortical thickness but not surface area. Specifically, at lower levels of SES, associations between age and cortical thickness were curvilinear, with relatively steep age-related decreases in cortical thickness earlier in childhood, and subsequent leveling off during adolescence. In contrast, at high levels of SES, associations between age and cortical thickness were linear, with consistent reductions across the age range studied. Notably, this interaction was prominent in the left fusi-form gyrus, a region that is critical for reading development. In a similar pattern, SES factors significantly moderated linear age-related change in left superior temporal gyrus, such that higher SES was linked with steeper age-related decreases in cortical thickness in this region. These findings suggest that SES may moderate patterns of age-related cortical thinning, especially in language-and literacy-supportingcortical regions.	[Piccolo, Luciane R.; Noble, Kimberly G.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Merz, Emily C.] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; [He, Xiaofu] Columbia Univ, Dept Psychiat, New York State Psychiat Inst, New York, NY USA; [Sowell, Elizabeth R.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA	Columbia University; Columbia University Teachers College; Columbia University; Columbia University; New York State Psychiatry Institute; Children's Hospital Los Angeles	Noble, KG (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	kgn2106@tc.columbia.edu		Noble, Kimberly/0000-0003-1496-5113	Pediatric Imaging, Neurocognition, and Genetics Study (PING) (National Institutes of Health Grant) [RC2DA029475]; National Institute on Drug Abuse; Annie E. Casey Foundation; Teachers College, Columbia University; National Institute of Mental Health (NIMH) [T32MH13043]; Brazilian National Council for the Improvement of Higher Education (CAPES); Eunice Kennedy Shriver National Institute of Child Health & Human Development; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013043] Funding Source: NIH RePORTER	Pediatric Imaging, Neurocognition, and Genetics Study (PING) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Annie E. Casey Foundation; Teachers College, Columbia University; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brazilian National Council for the Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data collection and sharing for this project was funded by the Pediatric Imaging, Neurocognition, and Genetics Study (PING) (National Institutes of Health Grant RC2DA029475). PING is funded by the National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health & Human Development. PING data are disseminated by the PING Coordinating Center at the Center Human Development, University of California, San Diego. This work was also made possible by funding from the Annie E. Casey Foundation; Teachers College, Columbia University; a National Institute of Mental Health (NIMH) training grant (T32MH13043); and the Brazilian National Council for the Improvement of Higher Education (CAPES).	Aiken L. S., 1991, MULTIPLE REGRESSION; Akshoomoff N, 2014, NEUROPSYCHOLOGY, V28, P1, DOI 10.1037/neu0000001; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Avants BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138217; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; Balsamo LM, 2006, NEUROIMAGE, V31, P1306, DOI 10.1016/j.neuroimage.2006.01.027; Bartsch H, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00025; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brito Natalie H, 2014, Front Neurosci, V8, P276, DOI 10.3389/fnins.2014.00276; Brooks-Gunn J, 2005, FUTURE CHILD, V15, P139, DOI 10.1353/foc.2005.0001; Brown TT, 2012, NEUROPSYCHOL REV, V22, P313, DOI 10.1007/s11065-012-9214-1; Brown TT, 2012, CURR BIOL, V22, P1693, DOI 10.1016/j.cub.2012.07.002; Burgaleta M, 2014, NEUROIMAGE, V84, P810, DOI 10.1016/j.neuroimage.2013.09.038; Callaghan BL, 2016, CURR OPIN BEHAV SCI, V7, P76, DOI 10.1016/j.cobeha.2015.11.018; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cohen J.E., 1988, STAT POWER ANAL BEHA; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dong WK, 2004, MENT RETARD DEV D R, V10, P85, DOI 10.1002/mrdd.20016; Duncan GJ, 2012, WIRES COGN SCI, V3, P377, DOI 10.1002/wcs.1176; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; Fjell AM, 2012, P NATL ACAD SCI USA, V109, P19620, DOI 10.1073/pnas.1208243109; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Hansen J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080954, 10.1371/journal.pone.0081648]; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Hart B., 1995, MEANINGFUL DIFFERENC; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jernigan TL, 2016, NEUROIMAGE, V124, P1149, DOI 10.1016/j.neuroimage.2015.04.057; Johnson SB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3075; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Lawson GM, 2013, DEVELOPMENTAL SCI, V16, P641, DOI 10.1111/desc.12096; Lebel C, 2012, J NEUROSCI, V32, P15243, DOI 10.1523/JNEUROSCI.1161-12.2012; Mackey AP, 2015, PSYCHOL SCI, V26, P925, DOI 10.1177/0956797615572233; Mangina CA, 2006, INT J PSYCHOPHYSIOL, V60, P203, DOI 10.1016/j.ijpsycho.2005.11.004; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Mutlu AK, 2013, NEUROIMAGE, V82, P200, DOI 10.1016/j.neuroimage.2013.05.076; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2005, FUTURE CHILD, V15, P71, DOI 10.1353/foc.2005.0006; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Raizada RDS, 2008, NEUROIMAGE, V40, P1392, DOI 10.1016/j.neuroimage.2008.01.021; Raizada Rajeev D S, 2010, Front Hum Neurosci, V4, P3, DOI 10.3389/neuro.09.003.2010; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shaw P, 2013, BIOL PSYCHIAT, V74, P599, DOI 10.1016/j.biopsych.2013.04.007; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Tamnes CK, 2013, J COGNITIVE NEUROSCI, V25, P1611, DOI 10.1162/jocn_a_00434; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Tottenham N, 2015, SOC NEUROSCI-UK, V10, P489, DOI 10.1080/17470919.2015.1087424; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25; Vijayakumar N, 2014, SOC COGN AFFECT NEUR, V9, P1845, DOI 10.1093/scan/nst183; Wang JJ, 2015, HUM BRAIN MAPP, V36, P1908, DOI 10.1002/hbm.22745; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Yang JY, 2016, COGN AFFECT BEHAV NE, V16, P51, DOI 10.3758/s13415-015-0371-6; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhou DM, 2015, NEUROIMAGE, V104, P138, DOI 10.1016/j.neuroimage.2014.10.005	79	87	88	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162511	10.1371/journal.pone.0162511	http://dx.doi.org/10.1371/journal.pone.0162511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27644039	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900012
J	Park, HS; Rinehart, M; Walzer, KA; Chi, JTA; Wax, A				Park, Han Sang; Rinehart, MatthewT.; Walzer, Katelyn A.; Chi, Jen-Tsan Ashley; Wax, Adam			Automated Detection of P. falciparum Using Machine Learning Algorithms with Quantitative Phase Images of Unstained Cells	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-FALCIPARUM; MALARIA; SENSITIVITY; MICROSCOPY	Malaria detection through microscopic examination of stained blood smears is a diagnostic challenge that heavily relies on the expertise of trained microscopists. This paper presents an automated analysis method for detection and staging of red blood cells infected by the malaria parasite Plasmodium falciparum at trophozoite or schizont stage. Unlike previous efforts in this area, this study uses quantitative phase images of unstained cells. Erythrocytes are automatically segmented using thresholds of optical phase and refocused to enable quantitative comparison of phase images. Refocused images are analyzed to extract 23 morphological descriptors based on the phase information. While all individual descriptors are highly statistically different between infected and uninfected cells, each descriptor does not enable separation of populations at a level satisfactory for clinical utility. To improve the diagnostic capacity, we applied various machine learning techniques, including linear discriminant classification (LDC), logistic regression (LR), and k-nearest neighbor classification (NNC), to formulate algorithms that combine all of the calculated physical parameters to distinguish cells more effectively. Results show that LDC provides the highest accuracy of up to 99.7% in detecting schizont stage infected cells compared to uninfected RBCs. NNC showed slightly better accuracy (99.5%) than either LDC (99.0%) or LR (99.1%) for discriminating late trophozoites from uninfected RBCs. However, for early trophozoites, LDC produced the best accuracy of 98%. Discrimination of infection stage was less accurate, producing high specificity (99.8%) but only 45.0%-66.8% sensitivity with early trophozoites most often mistaken for late trophozoite or schizont stage and late trophozoite and schizont stage most often confused for each other. Overall, this methodology points to a significant clinical potential of using quantitative phase imaging to detect and stage malaria infection without staining or expert analysis.	[Park, Han Sang; Rinehart, MatthewT.; Wax, Adam] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Walzer, Katelyn A.; Chi, Jen-Tsan Ashley] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA; [Walzer, Katelyn A.; Chi, Jen-Tsan Ashley] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA	Duke University; Duke University; Duke University	Park, HS (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	hp36@duke.edu		Chi, Jen-Tsan/0000-0003-3433-903X	National Science Foundation, Division of Industrial Innovation and Partnership [NSF IIP-1346349]; National Institutes of Health (NIH) [R01-CA167421]; World Anti-Doping Agent; Burroughs Wellcome Fund; NSF GRFP; NATIONAL CANCER INSTITUTE [R01CA167421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754] Funding Source: NIH RePORTER	National Science Foundation, Division of Industrial Innovation and Partnership; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Anti-Doping Agent; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by National Science Foundation, Division of Industrial Innovation and Partnership (NSF IIP-1346349, http://www.nsf.gov/, AW) and National Institutes of Health (NIH R01-CA167421, www.nih.gov/, AW) grants. JAC acknowledges financial support from the World Anti-Doping Agent (https://www.wada-ama.org/) and Burroughs Wellcome Fund (www.bwfund.org/). KAW is supported by the NSF GRFP (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2012, IEEE PHOTONICS J, V4, P1456, DOI 10.1109/JPHOT.2012.2210199; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Das DK, 2013, MICRON, V45, P97, DOI 10.1016/j.micron.2012.11.002; Di Ruberto C, 2002, IMAGE VISION COMPUT, V20, P133, DOI 10.1016/S0262-8856(01)00092-0; Diez-Silva M, 2010, MRS BULL, V35, P382, DOI 10.1557/mrs2010.571; Eldridge WJ, 2016, OPT LETT, V41, P352, DOI 10.1364/OL.41.000352; GEARY TG, 1989, AM J TROP MED HYG, V40, P240, DOI 10.4269/ajtmh.1989.40.240; Grobusch MP, 2003, CYTOM PART B-CLIN CY, V55B, P46, DOI 10.1002/cyto.b.10039; Hanscheid T, 2000, PARASITOL TODAY, V16, P549, DOI 10.1016/S0169-4758(00)01742-7; Iqbal J, 2003, MED PRIN PRACT, V12, P156, DOI 10.1159/000070751; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Kilian AHD, 2000, TROP MED INT HEALTH, V5, P3, DOI 10.1046/j.1365-3156.2000.00509.x; Liebling M, 2004, J OPT SOC AM A, V21, P367, DOI 10.1364/JOSAA.21.000367; Manser M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-428; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Organization WH, 2006, GUID TREATM MAL; Rinehart M, 2012, BIOMED OPT EXPRESS, V3, P958, DOI 10.1364/BOE.3.000958; Rinehart MT, 2015, BIOMED OPT EXPRESS, V6, P2067, DOI 10.1364/BOE.6.002067; Saliba K, 2013, MALARIA, P17, DOI DOI 10.1007/978-1-62703-026-7; Sangokoya C, 2010, METHODS MOL BIOL, V667, P193, DOI 10.1007/978-1-60761-811-9_13; Shaked NT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3556717; Shaked NT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290242; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; Stauffer WM, 2009, CLIN INFECT DIS, V49, P908, DOI 10.1086/605436; Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003; Yoo M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.128005	29	74	76	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163045	10.1371/journal.pone.0163045	http://dx.doi.org/10.1371/journal.pone.0163045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636719	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700028
J	Plaisance, V; Brajkovic, S; Tenenbaum, M; Favre, D; Ezanno, H; Bonnefond, A; Bonner, C; Gmyr, V; Kerr-Conte, J; Gauthier, BR; Widmann, C; Waeber, G; Pattou, F; Froguel, P; Abderrahmani, A				Plaisance, Valerie; Brajkovic, Saska; Tenenbaum, Mathie; Favre, Dimitri; Ezanno, Helene; Bonnefond, Amelie; Bonner, Caroline; Gmyr, Valery; Kerr-Conte, Julie; Gauthier, Benoit R.; Widmann, Christian; Waeber, Gerard; Pattou, Francois; Froguel, Philippe; Abderrahmani, Amar			Endoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; DIABETES-MELLITUS; DENSITY-LIPOPROTEINS; ER STRESS; MACROPHAGES; APOPTOSIS; ANTIOXIDANTS; METABOLISM; ACTIVATION; EXPRESSION	Elevated plasma concentration of the pro-atherogenic oxidized low density lipoprotein cholesterol (LDL) triggers adverse effects in pancreatic beta-cells and is associated with type 2 diabetes. Here, we investigated whether the endoplasmic reticulum (ER) stress is a key player coupling oxidative stress to beta-cell dysfunction and death elicited by human oxidized LDL. We found that human oxidized LDL activates ER stress as evidenced by the activation of the inositol requiring 1a, and the elevated expression of both DDIT3 (also called CHOP) and DNAJC3 (also called P58IPK) ER stress markers in isolated human islets and the mouse insulin secreting MIN6 cells. Silencing of Chop and inhibition of ER stress markers by the chemical chaperone phenyl butyric acid (PBA) prevented cell death caused by oxidized LDL. Finally, we found that oxidative stress accounts for activation of ER stress markers induced by oxidized LDL. Induction of Chop/ CHOP and p58IPK/P58IPK by oxidized LDL was mimicked by hydrogen peroxide and was blocked by co-treatment with the N-acetylcystein antioxidant. As a conclusion, the harmful effects of oxidized LDL in beta-cells requires ER stress activation in a manner that involves oxidative stress. This mechanism may account for impaired beta-cell function in diabetes and can be reversed by antioxidant treatment.	[Plaisance, Valerie; Brajkovic, Saska; Tenenbaum, Mathie; Favre, Dimitri; Ezanno, Helene; Bonnefond, Amelie; Froguel, Philippe; Abderrahmani, Amar] Univ Lille, CNRS, Inst Pasteur Lille, UMR 8199 EGID, Lille, France; [Brajkovic, Saska; Favre, Dimitri; Waeber, Gerard] Univ Lausanne, Ctr Hosp Univ Vaudois, Serv Internal Med, Lausanne, Switzerland; [Bonner, Caroline; Gmyr, Valery; Kerr-Conte, Julie; Pattou, Francois] Univ Lille, INSERM, CHU Lille, U1190 EGID, Lille, France; [Gauthier, Benoit R.] Andalusian Ctr Mol Biol & Regenerat Med, Dept Stem Cells, Seville, Spain; [Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Bonnefond, Amelie; Froguel, Philippe; Abderrahmani, Amar] Imperial Coll London, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Lausanne; Imperial College London	Abderrahmani, A (corresponding author), Univ Lille, CNRS, Inst Pasteur Lille, UMR 8199 EGID, Lille, France.; Abderrahmani, A (corresponding author), Imperial Coll London, Dept Genom Common Dis, London, England.	amar.abderrahmani@univ-lille2.fr	Bonnefond, Amélie/O-2784-2017; Gauthier, Benoit R/C-3138-2017; Abderrahmani, Amar/O-3124-2017; Pattou, Francois/O-6151-2017; FROGUEL, Philippe/O-6799-2017; Bonner, Caroline/A-9819-2015; Widmann, Christian/N-9851-2013	Bonnefond, Amélie/0000-0001-9976-3005; Gauthier, Benoit R/0000-0001-8146-7486; Abderrahmani, Amar/0000-0003-0752-0343; Pattou, Francois/0000-0001-8388-3766; FROGUEL, Philippe/0000-0003-2972-0784; Bonner, Caroline/0000-0002-4430-8280; Waeber, Gerard/0000-0003-4193-788X; Widmann, Christian/0000-0002-6881-0363	"European Genomic Institute for Diabetes" (E.G.I.D.) [ANR-10-LABX-46]; European Commission; Regional Council Nord Pas de Calais; European Regional Development Fund	"European Genomic Institute for Diabetes" (E.G.I.D.); European Commission(European CommissionEuropean Commission Joint Research Centre); Regional Council Nord Pas de Calais(Region Hauts-de-France); European Regional Development Fund(European Commission)	This work was supported by the "European Genomic Institute for Diabetes" (E.G.I.D., ANR-10-LABX-46), European Commission, the Regional Council Nord Pas de Calais and the European Regional Development Fund.; This work was supported by the "European Genomic Institute for Diabetes" (E.G.I.D., ANR-10-LABX-46), European Commission, the Regional Council Nord Pas de Calais and the European Regional Development Fund. We are grateful to Denis Fahmi, Mr. Gilles Dubuis, Mr Guy Niederhauser, Mr Raphael Boutry and Ms Laure Rolland for technical assistance.	Abderrahmani A, 2007, DIABETOLOGIA, V50, P1304, DOI 10.1007/s00125-007-0642-z; Akerfeldt MC, 2008, DIABETES, V57, P3034, DOI 10.2337/db07-1802; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; BELLOMO G, 1995, DIABETES, V44, P60, DOI 10.2337/diabetes.44.1.60; Brajkovic S, 2012, ADIPOCYTE, V1, P157, DOI 10.4161/adip.20000; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; Hamer M, 2007, J HYPERTENS, V25, P2361, DOI 10.1097/HJH.0b013e3282efc214; Holvoet P, 2004, DIABETES, V53, P1068, DOI 10.2337/diabetes.53.4.1068; Jessup W, 2000, CURR OPIN LIPIDOL, V11, P473, DOI 10.1097/00041433-200010000-00005; Li E, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0077-2; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Maedler K, 2004, HORM RES, V62, P67, DOI 10.1159/000080503; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Nakhjavani M, 2010, LIPIDS, V45, P321, DOI 10.1007/s11745-010-3401-8; Nakka VP, 2016, MOL NEUROBIOL, V53, P532, DOI 10.1007/s12035-014-9029-6; Nicholson AC, 2004, VASC PHARMACOL, V41, P139, DOI 10.1016/j.vph.2004.08.003; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Noushmehr H, 2005, DIABETES, V54, P472, DOI 10.2337/diabetes.54.2.472; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okajima F, 2005, BBA-MOL CELL BIOL L, V1687, P173, DOI 10.1016/j.bbalip.2004.11.018; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Petremand J, 2008, CURR OPIN LIPIDOL, V19, P95, DOI 10.1097/MOL.0b013e3282f41982; Petremand J, 2012, DIABETES, V61, P1100, DOI 10.2337/db11-1221; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Preston AM, 2009, DIABETOLOGIA, V52, P2369, DOI 10.1007/s00125-009-1506-5; Rohrer L, 2004, CURR OPIN LIPIDOL, V15, P269, DOI 10.1097/00041433-200406000-00006; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vantyghem MC, 2009, DIABETES CARE, V32, P1473, DOI 10.2337/dc08-1685; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799	39	59	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163046	10.1371/journal.pone.0163046	http://dx.doi.org/10.1371/journal.pone.0163046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636901	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700029
J	Cuppen, BVJ; Fu, JZ; van Wietmarschen, HA; Harms, AC; Koval, S; Marijnissen, ACA; Peeters, JJW; Bijlsma, JJ; Tekstra, J; van Laar, JM; Hankemeier, T; Lafeber, FPJG; van der Greef, J				Cuppen, Bart V. J.; Fu, Junzeng; van Wietmarschen, Herman A.; Harms, Amy C.; Koval, Slavik; Marijnissen, Anne C. A.; Peeters, Judith J. W.; Bijlsma, JohannesW. J.; Tekstra, Janneke; van Laar, Jacob M.; Hankemeier, Thomas; Lafeber, Floris P. J. G.; van der Greef, Jan		Soc Rheumatology Res Utrecht Inves	Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-alpha Inhibitors in Rheumatoid Arthritis	PLOS ONE			English	Article							VALIDATION; DISEASES; CYTOKINES; THERAPY; PROTEIN; MODELS	In clinical practice, approximately one-third of patients with rheumatoid arthritis(RA) respond insufficiently to TNF-alpha inhibitors (TNFis). The aim of the study was to explore the use of a metabolomics to identify predictors for the outcome of TNFi therapy, and study the metabolomic fingerprint in active RA irrespective of patients' response. In the metabolomic profiling, lipids, oxylipins, and amines were measured in serum samples of RA patients from the observational BiOCURA cohort, before start of biological treatment. Multivariable logistic regression models were established to identify predictors for good-and non-response in patients receiving TNFi (n = 124). The added value of metabolites over prediction using clinical parameters only was determined by comparing the area under receiver operating characteristic curve (AUC-ROC), sensitivity, specificity, positive-and negative predictive value and by the net reclassification index (NRI). The models were further validated by 10-fold cross validation and tested on the complete TNFi treatment cohort including moderate responders. Additionally, metabolites were identified that cross-sectionally associated with the RA disease activity score based on a 28-joint count (DAS28), erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP). Out of 139 metabolites, the best-performing predictors were sn1-LPC(18:3-omega 3/omega 6), sn1-LPC(15: 0), ethanolamine, and lysine. The model that combined the selected metabolites with clinical parameters showed a significant larger AUC-ROC than that of the model containing only clinical parameters (p = 0.01). The combined model was able to discriminate good-and non-responders with good accuracy and to reclassify non-responders with an improvement of 30% (total NRI = 0.23) and showed a prediction error of 0.27. For the complete TNFi cohort, the NRI was 0.22. In addition, 88 metaboliteswere associated with DAS28, ESR or CRP (p<0.05). Our study established an accurate prediction model for response to TNFi therapy, containing metabolites and clinical parameters. Associations between metabolites and disease activity may help elucidate additional pathologic mechanisms behind RA.	[Cuppen, Bart V. J.; Marijnissen, Anne C. A.; Bijlsma, JohannesW. J.; Tekstra, Janneke; van Laar, Jacob M.; Lafeber, Floris P. J. G.] Univ Med Ctr Utrecht, Rheumatol & Clin Immunol, Utrecht, Netherlands; [Fu, Junzeng; Harms, Amy C.; Koval, Slavik; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Fu, Junzeng; van Wietmarschen, Herman A.; van der Greef, Jan] Sinodutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [van Wietmarschen, Herman A.; van der Greef, Jan] TNO, Netherlands Org Appl Sci Res Microbiol & Syst Bio, Zeist, Netherlands; [Harms, Amy C.; Koval, Slavik; Hankemeier, Thomas; van der Greef, Jan] Netherlands Metabol Ctr, Leiden, Netherlands; [Peeters, Judith J. W.] St Jansdal Hosp, Harderwijk, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Fu, JZ (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands.; Fu, JZ (corresponding author), Sinodutch Ctr Prevent & Personalized Med, Zeist, Netherlands.	j.fu@lacdr.leidenuniv.nl	Hankemeier, Thomas/V-5407-2019	Hankemeier, Thomas/0000-0001-7871-2073	ZonMw: The Netherlands Association for Health Research and Development [152001008]; Pfizer; BMS; UCB; Roche; Schering-Plough; ReumaFonds [LLP-9] Funding Source: researchfish	ZonMw: The Netherlands Association for Health Research and Development; Pfizer(Pfizer); BMS(Bristol-Myers Squibb); UCB(UCB Pharma SA); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); ReumaFonds	This research was supported by ZonMw: The Netherlands Association for Health Research and Development (project no. 152001008), the Foundation Friends of the UMC Utrecht based on a private gift, and unrestricted grants from Pfizer, BMS, UCB, Roche, and Schering-Plough. None of the funders were involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; AUSTGEN TR, 1992, J TRAUMA, V32, P600, DOI 10.1097/00005373-199205000-00011; Behrens F, 2013, ARTHRIT CARE RES, V65, P1608, DOI 10.1002/acr.22037; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Cuppen BVJ, 2016, RHEUMATOLOGY, V55, P826, DOI 10.1093/rheumatology/kev421; Draisma HHM, 2010, ANAL CHEM, V82, P1039, DOI 10.1021/ac902346a; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; FISCHER JE, 1991, AM J SURG, V161, P266, DOI 10.1016/0002-9610(91)91143-7; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; GINSBURG I, 1989, INFLAMMATION, V13, P163, DOI 10.1007/BF00924787; Guma M, 2016, NAT REV RHEUMATOL, V12, P269, DOI 10.1038/nrrheum.2016.1; Heemskerk MM, 2014, J LIPID RES, V55, P2532, DOI 10.1194/jlr.M051938; Heimerl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111348; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Huang YH, 1999, CLIN EXP IMMUNOL, V116, P326; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Madsen OR, 2016, CLIN RHEUMATOL, V35, P2403, DOI 10.1007/s10067-016-3322-x; Marcinkiewicz J, 2014, AMINO ACIDS, V46, P7, DOI 10.1007/s00726-012-1361-4; Martins FM, 2015, RHEUMATOLOGY, V54, P286, DOI 10.1093/rheumatology/keu313; Hung ND, 2012, INFLAMM RES, V61, P473, DOI 10.1007/s00011-012-0434-x; Nicastro H, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/136937; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Ouyang X, 2011, LUPUS, V20, P1411, DOI 10.1177/0961203311418707; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Priori R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138537; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; Sugiura T, 2016, ATHEROSCLEROSIS, V246, P157, DOI 10.1016/j.atherosclerosis.2016.01.015; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; WOLFE A M, 1968, Bulletin on the Rheumatic Diseases, V19, P524; Ye XQ, 2008, HUM REPROD UPDATE, V14, P519, DOI 10.1093/humupd/dmn023; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zabek A, 2016, J PHARMACEUT BIOMED, V117, P544, DOI 10.1016/j.jpba.2015.10.007	49	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163087	10.1371/journal.pone.0163087	http://dx.doi.org/10.1371/journal.pone.0163087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631111	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900129
J	Xie, YP; Meng, Y; Sun, H; Nie, ZL				Xie, Yan-Ping; Meng, Ying; Sun, Hang; Nie, Ze-Long			Molecular Phylogeny of Gueldenstaedtia and Tibetia (Fabaceae) and Their Biogeographic Differentiation within Eastern Asia	PLOS ONE			English	Article							HENGDUAN MOUNTAINS; TRIBE HEDYSAREAE; LEGUMINOSAE; DIVERSIFICATION; PAPILIONOIDEAE; RATES; EVOLUTIONARY; INFERENCE; EMPHASIS; REVISION	Tibetia and Gueldenstaedtia are two morphologically similar and small genera in Fabaceae, with distributions largely corresponding to the Sino-Himalayan and Sino-Japanese subkingdoms in eastern Asia, respectively. These two genera have confusing relationships based on morphology; therefore, we aimed to provide a clear understanding of their phylogenetic and biogeographic evolution within eastern Asia. In our investigations we included 88 samples representing five Gueldenstaedtia species, five Tibetia species, and outgroup species were sequenced using five markers (nuclear: ITS; chloroplast: matK, trnL-F, psbA-trnH and rbcL). Our phylogenetic results support (1) the monophyly of Tibetia and of Gueldenstaedtia, respectively; and (2) that Tibetia and Gueldenstaedtia are sister genera. Additionally, our data identified that Tibetia species hadmuch higher sequence variation than Gueldenstaedtia species. Our results suggest that the two genera were separated from each other about 17.23 million years ago, which is congruent with the Himalayan orogeny and the uplift of the Tibetan Plateau in the mid Miocene. The divergence of Tibetia and Gueldenstaedtia is strongly supported by the separation of the Sino-Himalayan and Sino-Japanese region within eastern Asia. In addition, the habitat heterogeneitymay accelerate the molecular divergence of Tibetia in the Sino-Himalayan region.	[Xie, Yan-Ping; Sun, Hang] Chinese Acad Sci, Key Lab Biodivers & Biogeog East Asia, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Xie, Yan-Ping] Univ Chinese Acad Sci, Beijing, Peoples R China; [Meng, Ying; Nie, Ze-Long] Jishou Univ, Key Lab Plant Resources Conservat & Utilizat, Coll Biol & Environm Sci, Jishou, Hunan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jishou University	Nie, ZL (corresponding author), Jishou Univ, Key Lab Plant Resources Conservat & Utilizat, Coll Biol & Environm Sci, Jishou, Hunan, Peoples R China.	zelongnie@163.com			Natural Sciences Foundation of China [NSFC 31570211]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Sciences Foundation of China (NSFC 31570211) to Ze-Long Nie.	Ahangarian S., 2007, Iranian Journal of Botany, V13, P64; ALI S. I., 1962, Candollea, V18, P137; Bao BJ, 2010, FLORA CHINA, V10, P506; Bruneau A, 2008, BOTANY, V86, P697, DOI 10.1139/B08-058; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Cui HP, 1998, FL REIP POP SIN, V42, P146; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duan L, 2015, TAXON, V64, P49, DOI 10.12705/641.26; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher FE, 1823, MEM SOC NAT MOSCON, V6, P170; GRIERSON AJC, 1987, FLORA BHUTAN; Gu Zhi-Jian, 1993, Acta Botanica Yunnanica, V15, P377; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; HERENDEEN PS, 1990, SYST BOT, V15, P526, DOI 10.2307/2419152; Herendeen PS, 1992, FOSSIL RECORD; Herendeen PS, 2001, P BOT, P12; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Karamian, 2003, THAISZIA J BOT, V13, P67; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li J., 1995, UPLIFT QINGHAI XIZAN; LI P, 1989, Acta Botanica Yunnanica, V11, P285; Li PC, 1985, FLORA OF XIZANGICA, V2, P793; Li XW, 1993, ACTA BOT YUNNANICA, V3, P217; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu JQ, 2002, MOL PHYLOGENET EVOL, V23, P307, DOI 10.1016/S1055-7903(02)00039-8; Liu YS, 2000, EVOLUTION LATE CRETA; Mabberley DJ, 1997, PLANT BOOK; Mao Kang-Shan, 2005, Acta Botanica Yunnanica, V27, P620; MATTEN LC, 1977, REV PALAEOBOT PALYNO, V24, P195, DOI 10.1016/0034-6667(77)90047-1; Nie ZL, 2006, MOL PHYLOGENET EVOL, V40, P155, DOI 10.1016/j.ympev.2006.03.012; Nie ZL, 2002, J PLANT RES, V115, P17, DOI 10.1007/s102650200003; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; PAGE VM, 1993, IAWA J, V14, P299, DOI 10.1163/22941932-90001333; Polhill R. M., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)]., P1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2009, TRACER VERSION 1 5; Sanderson MJ, 1996, AM J BOT, V83, P1488, DOI 10.2307/2446103; Scherson RA, 2008, AM J BOT, V95, P1030, DOI 10.3732/ajb.0800017; Shi Y., 1999, ACTA GEOGR SIN CHIN, V54, P20; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P273; Swofford DL, 2003, PAUP 4 OB 10 PHYLOGE; Thompson J.D., 2002, CURRENT PROTOCOLS BI; TSUI HP, 1979, B BOT LAB N E FOREST, V5, P31; Wang YJ, 2004, ACTA PHYTOTAXON SIN, V42, P481; Wheeler E.A., 2001, P DENVER MUS SCI IND, V4, P197; WHEELER EA, 1992, REV PALAEOBOT PALYNO, V74, P267, DOI 10.1016/0034-6667(92)90011-5; Wojciechowski M.F., 2000, ADV LEGUME SYST, V9, P277; Wojciechowski MF, 2005, BRITTONIA, V57, P382, DOI 10.1663/0007-196X(2005)057[0382:AFAMPP]2.0.CO;2; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Wu, 1988, J JPN BOT, V63, P297; WU C-Y, 1979, Acta Botanica Yunnanica, V1, P1; Wu ZY., 1998, P 1 INT S FLOR CHAR, P3; Xie Yan-Ping, 2012, Plant Diversity and Resources, V34, P326, DOI 10.3724/SP.J.1143.2012.12006; YAKOVLEV G P, 1980, Botanicheskii Zhurnal (St. Petersburg), V65, P104; [杨德奎 Yang Dekui], 2002, [广西植物, Guihaia], V22, P349; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhou Z, 2013, MOL PHYLOGENET EVOL, V68, P482, DOI 10.1016/j.ympev.2013.04.027; Zhu XiangYun, 2005, Nordic Journal of Botany, V23, P373; Zhu XY, 2005, BOT J LINN SOC, V148, P475, DOI 10.1111/j.1095-8339.2005.00414.x; Zhu XY, 2004, ANN BOT FENN, V41, P283	70	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162982	10.1371/journal.pone.0162982	http://dx.doi.org/10.1371/journal.pone.0162982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632535	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900107
J	Hall, TG; Yu, Y; Eathiraj, S; Wang, YX; Savage, RE; Lapierre, JM; Schwartz, B; Abbadessa, G				Hall, Terence G.; Yu, Yi; Eathiraj, Sudharshan; Wang, Yunxia; Savage, Ronald E.; Lapierre, Jean-Marc; Schwartz, Brian; Abbadessa, Giovanni			Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; 8P11 MYELOPROLIFERATIVE SYNDROME; TIGHT-BINDING INHIBITORS; CANCER-CELL-LINES; SOLID TUMORS; TYROSINE KINASE; GENE FUSIONS; INTRAHEPATIC CHOLANGIOCARCINOMA; THERAPEUTIC TARGETS; SELECTIVE INHIBITOR	Dysregulation of Fibroblast Growth Factor Receptor (FGFR) signaling through amplifications, mutations, and gene fusions has been implicated in a broad array of cancers (e.g. liver, gastric, ovarian, endometrial, and bladder). ARQ 087 is a novel, ATP competitive, small molecule, multi-kinase inhibitor with potent in vitro and in vivo activity against FGFR addicted cell lines and tumors. Biochemically, ARQ 087 exhibited IC50 values of 1.8 nM for FGFR2, and 4.5 nM for FGFR1 and 3. In cells, inhibition of FGFR2 auto-phosphorylation and other proteins downstream in the FGFR pathway (FRS2 alpha, AKT, ERK) was evident by the response to ARQ 087 treatment. Cell proliferation studies demonstrated ARQ 087 has anti-proliferative activity in cell lines driven by FGFR dysregulation, including amplifications, fusions, and mutations. Cell cycle studies in cell lines with high levels of FGFR2 protein showed a positive relationship between ARQ 087 induced G1 cell cycle arrest and subsequent induction of apoptosis. In addition, ARQ 087 was effective at inhibiting tumor growth in vivo in FGFR2 altered, SNU-16 and NCI-H716, xenograft tumor models with gene amplifications and fusions. ARQ 087 is currently being studied in a phase 1/2 clinical trial that includes a sub cohort for intrahepatic cholangiocarcinoma patients with confirmed FGFR2 gene fusions (NCT01752920).	[Hall, Terence G.; Yu, Yi; Eathiraj, Sudharshan; Wang, Yunxia; Savage, Ronald E.; Lapierre, Jean-Marc; Schwartz, Brian; Abbadessa, Giovanni] ArQule Inc, Burlington, MA 01803 USA		Hall, TG (corresponding author), ArQule Inc, Burlington, MA 01803 USA.	thall@arqule.com		Schwartz, Brian/0000-0003-2632-6351	ArQule, Inc.	ArQule, Inc.	Funding for this work was provided by ArQule, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Syed M., 2010, US Patent Application, Patent No. [12/649,573, 12649573]; Arai Y, 2014, HEPATOLOGY, V59, P1427, DOI 10.1002/hep.26890; ARMSTRONG E, 1992, CANCER RES, V52, P2004; Bai AL, 2010, CANCER RES, V70, P7630, DOI 10.1158/0008-5472.CAN-10-1489; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Borad MJ, 2015, CURR OPIN GASTROEN, V31, P264, DOI 10.1097/MOG.0000000000000171; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Capelletti M, 2014, CLIN CANCER RES, V20, P6551, DOI 10.1158/1078-0432.CCR-14-1337; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chase A, 2007, BLOOD, V110, P3729, DOI 10.1182/blood-2007-02-074286; Chase A, 2013, HAEMATOL-HEMATOL J, V98, P103, DOI 10.3324/haematol.2012.066407; Churi CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115383; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Eathiraj S, 2011, J BIOL CHEM, V286, P20677, DOI 10.1074/jbc.M110.213736; Finch PW, 2006, JNCI-J NATL CANCER I, V98, P812, DOI 10.1093/jnci/djj228; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Graham RP, 2014, HUM PATHOL, V45, P1630, DOI 10.1016/j.humpath.2014.03.014; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Katoh Y, 2009, INT J MOL MED, V23, P307, DOI 10.3892/ijmm_00000132; Kelleher FC, 2013, CARCINOGENESIS, V34, P2198, DOI 10.1093/carcin/bgt254; Kim ST, 2014, MOL CANCER THER, V13, P2527, DOI 10.1158/1535-7163.MCT-14-0255; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Konecny GE, 2015, LANCET ONCOL, V16, P686, DOI 10.1016/S1470-2045(15)70159-2; Kumar BVSS, 2013, CURR PHARM DESIGN, V19, P687, DOI 10.2174/138161213804581963; Lemieux S, 2013, ANTI-CANCER AGENT ME, V13, P748, DOI 10.2174/18715206113139990080; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Lewin J, 2015, J CLIN ONCOL, V33, P3372, DOI 10.1200/JCO.2015.62.7380; Liang G, 2013, CYTOKINE GROWTH F R, V24, P467, DOI 10.1016/j.cytogfr.2013.05.002; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mathur A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098515; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Nakamura H, 2015, NAT GENET, V47, P1003, DOI 10.1038/ng.3375; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248; Papadopoulos KP, 2015, J CLIN ONCOL S, V33, P2545; Parker BC, 2014, J PATHOL, V232, P4, DOI 10.1002/path.4297; Parker BC, 2013, CHIN J CANCER, V32, P594, DOI 10.5732/cjc.013.10178; Rizvi S, 2014, SEMIN LIVER DIS, V34, P456, DOI 10.1055/s-0034-1394144; Ross JS, 2014, ONCOLOGIST, V19, P235, DOI 10.1634/theoncologist.2013-0352; Sia D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7087; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Tabernero J, 2015, J CLIN ONCOL, V33, P3401, DOI 10.1200/JCO.2014.60.7341; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Zaid TM, 2013, CLIN CANCER RES, V19, P809, DOI 10.1158/1078-0432.CCR-12-2736; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729	57	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162594	10.1371/journal.pone.0162594	http://dx.doi.org/10.1371/journal.pone.0162594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627808	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600045
J	Madsen, JS; Riber, L; Kot, W; Basfeld, A; Burmolle, M; Hansen, LH; Sorensen, SJ				Madsen, Jonas Stenlokke; Riber, Leise; Kot, Witold; Basfeld, Alrun; Burmolle, Mette; Hansen, Lars Hestbjerg; Sorensen, Soren Johannes			Type 3 Fimbriae Encoded on Plasmids Are Expressed from a Unique Promoter without Affecting Host Motility, Facilitating an Exceptional Phenotype That Enhances Conjugal Plasmid Transfer	PLOS ONE			English	Article							CYCLIC DI-GMP; BIOFILM FORMATION; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; GENE-EXPRESSION; H-NS; MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; NUCLEOTIDE-SEQUENCE; PSEUDOMONAS	Horizontal gene transfer (HGT), the transmission of genetic material to a recipient that is not the progeny of the donor, is fundamental in bacterial evolution. HGT is often mediated by mobile genetic elements such as conjugative plasmids, which may be in conflict with the chromosomal elements of the genome because they are independent replicons that may petition their own evolutionary strategy. Here we study differences between type 3 fimbriae encoded on wild type plasmids and in chromosomes. Using known and newly characterized plasmids we show that the expression of type 3 fimbriae encoded on plasmids is systematically different, as MrkH, a c-di-GMP dependent transcriptional activator is not needed for strong expression of the fimbriae. MrkH is required for expression of type 3 fimbriae of the Klebsiella pneumoniae chromosome, where from the fimbriae operon (mrkABCDF) of plasmids is believed to have originated. We find that mrkABCDFs of plasmids are highly expressed via a unique promoter that differs from the original Klebsiella promoter resulting in fundamental behavioral consequences. Plasmid associated mrkABCDFs did not influence the swimming behavior of the host, that hereby acquired an exceptional phenotype being able to both actively swim (planktonic behavior) and express biofilm associated fimbriae (sessile behavior). We show that this exceptional phenotype enhances the conjugal transfer of the plasmid.	[Madsen, Jonas Stenlokke; Riber, Leise; Kot, Witold; Basfeld, Alrun; Burmolle, Mette; Hansen, Lars Hestbjerg; Sorensen, Soren Johannes] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Kot, Witold; Hansen, Lars Hestbjerg] Aarhus Univ, Dept Environm Sci, Aarhus, Denmark; [Basfeld, Alrun] Max Planck Inst Biochem, Max Planck Res Grp Chromosome Org & Dynam, Martinsried, Germany	University of Copenhagen; Aarhus University; Max Planck Society	Hansen, LH (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.; Hansen, LH (corresponding author), Aarhus Univ, Dept Environm Sci, Aarhus, Denmark.	lhha@envs.au.dk	Kot, Witold/M-2170-2014; Sørensen, Søren J/J-5015-2014; Kot, Witold/N-3747-2017; Sørensen, Søren Johannes/N-2120-2019; Burmølle, Mette/L-8002-2014	Kot, Witold/0000-0002-0188-4587; Sørensen, Søren J/0000-0001-6227-9906; Kot, Witold/0000-0002-0188-4587; Sørensen, Søren Johannes/0000-0001-6227-9906; Burmølle, Mette/0000-0003-1870-632X; Madsen, Jonas Stenlokke/0000-0003-4830-1796; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Riber, Leise/0000-0003-4793-6095	Danish Council for Independent Research grant [11106571]; Danish Innovation Consortium grant; Lundbeck Foundation grant [R93-A8499]; Villum Fonden [00010098] Funding Source: researchfish	Danish Council for Independent Research grant; Danish Innovation Consortium grant; Lundbeck Foundation grant; Villum Fonden(Villum Fonden)	This work was supported by The Danish Council for Independent Research grant 11106571, Danish Innovation Consortium grant 11804520 and Lundbeck Foundation grant R93-A8499. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Aarestrup FM, 1998, APMIS, V106, P745, DOI 10.1111/j.1699-0463.1998.tb00222.x; ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banos RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000513; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burmolle M, 2008, MICROBIOL-SGM, V154, P187, DOI 10.1099/mic.0.2007/010454-0; Burmolle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041259; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; DUGUID JP, 1959, J GEN MICROBIOL, V21, P271, DOI 10.1099/00221287-21-1-271; FLETCHER M, 1977, CAN J MICROBIOL, V23, P1, DOI 10.1139/m77-001; Garcia J, 2005, BIOCHEM J, V388, P755, DOI 10.1042/BJ20050002; GERLACH GF, 1988, J BACTERIOL, V170, P3547, DOI 10.1128/jb.170.8.3547-3553.1988; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Guyer MS, 1981, IDENTIFICATION OF A; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hansen LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019912; Hansen LH, 1997, GENE, V186, P167, DOI 10.1016/S0378-1119(96)00688-9; Hansen LH, 1998, CURR MICROBIOL, V36, P341, DOI 10.1007/s002849900320; Huang YJ, 2006, BIOCHEM BIOPH RES CO, V350, P537, DOI 10.1016/j.bbrc.2006.09.070; Huang YJ, 2009, RES MICROBIOL, V160, P71, DOI 10.1016/j.resmic.2008.10.009; Johnson JG, 2011, J BACTERIOL, V193, P3453, DOI 10.1128/JB.00286-11; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; KORHONEN TK, 1983, J BACTERIOL, V155, P860, DOI 10.1128/JB.155.2.860-865.1983; Kurihara S, 2011, J BIOL CHEM, V286, P10185, DOI 10.1074/jbc.M110.176032; Landini P, 2002, J BACTERIOL, V184, P1522, DOI 10.1128/JB.184.6.1522-1529.2002; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Lesic B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-20; LEVINS RICHARD, 1968; Madsen JS, 2015, APPL ENVIRON MICROB, V81, P8414, DOI 10.1128/AEM.02628-15; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Miller JH., 1972, EXPERIMENTS IN MOLEC; Norman A, 2008, PLASMID, V60, P59, DOI 10.1016/j.plasmid.2008.03.003; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Papagiannitsis CC, 2013, J ANTIMICROB CHEMOTH, V68, P2259, DOI 10.1093/jac/dkt196; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Ren DW, 2014, MICROB ECOL, V68, P146, DOI 10.1007/s00248-013-0315-z; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J., 1989, MOLECULAR CLONING A; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; van Ditmarsch D, 2013, CELL REP, V4, P697, DOI 10.1016/j.celrep.2013.07.026; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079038; Zienkiewicz M, 2007, ANTIMICROB AGENTS CH, V51, P1164, DOI 10.1128/AAC.00772-06	63	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162390	10.1371/journal.pone.0162390	http://dx.doi.org/10.1371/journal.pone.0162390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627107	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600032
J	Pils, S; Promberger, R; Springer, S; Joura, E; Ott, J				Pils, Sophie; Promberger, Regina; Springer, Stephanie; Joura, Elmar; Ott, Johannes			Decreased Ovarian Reserve Predicts Inexplicability of Recurrent Miscarriage? A Retrospective Analysis	PLOS ONE			English	Article							OOCYTE QUALITY; HORMONE; COUPLES; LEVEL	Objective To evaluate anti-Mullerian hormone, basal follicle stimulating hormone, luteinizing hormone, estradiol, and female age in women with recurrent miscarriage and to compare women with explained and idiopathic recurrent miscarriage. Design Retrospective cohort study. Setting University hospital, tertiary care center. Patients Women with recurrent miscarriage (78 explained, 66 idiopathic). Intervention(s) None. Main Outcome Measures(s) Anti-Mullerian hormone, basal follicle stimulating hormone, luteinizing hormone, estradiol, and age. Results Anti-Mullerian hormone and estradiol were significantly lower in women with idiopathic recurrent miscarriage (median 1.2 ng/ml, IQR 0.6-2.1, and median 36.5 pg/ml, IQR 25.8-47.3, respectively) than in women with explained recurrent miscarriage (median 2.0 ng/ml, IQR 1.1-2.7, and median 42.5 pg/ml, IQR 32.8-59.8, respectively; p<0.05). Optimized cutoff values for the prediction of idiopathic recurrent miscarriage were <39.5 pg/ml for estradiol (sensitivity: 63.3%, 95% CI: 50.9-75.1; specificity: 56.4%, 95% CI: 44.7-67.6) and <1.90 ng/ml for anti-Mullerian hormone (sensitivity: 72.7%, 95% CI: 60.4-83.0; specificity: 52.6%, 95% CI: 40.9-64.0). Conclusion Idiopathic recurrent miscarriage was associated with lower basal estradiol and anti-Mullerian hormone levels compared to explained recurrent miscarriage.	[Pils, Sophie; Springer, Stephanie; Joura, Elmar; Ott, Johannes] Med Univ Vienna, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria; [Promberger, Regina] St John God Hosp Eisenstadt, Dept Obstet & Gynecol, Burgenland, Austria	Medical University of Vienna	Ott, J (corresponding author), Med Univ Vienna, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria.	johannes.ott@meduniwien.ac.at	Ott, Johannes/AAD-1700-2019	Ott, Johannes/0000-0002-2761-5262				Amanvermez R, 2016, INT J FERTIL STERIL, V9, P411; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; [Anonymous], 2002, INT J GYNECOL OBSTET, V78, P179; [Anonymous], 2015, Obstet Gynecol, V125, P268, DOI 10.1097/01.AOG.0000459864.68372.ec; Atasever M, 2016, FERTIL STER IN PRESS; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; Ebner T, 2006, HUM REPROD, V21, P2022, DOI 10.1093/humrep/del127; Guerif F, 2009, ANN ENDOCRINOL-PARIS, V70, P230, DOI 10.1016/j.ando.2009.03.007; Jeve Yadava B, 2014, J Hum Reprod Sci, V7, P159, DOI 10.4103/0974-1208.142475; Ljunger E, 2005, ACTA OBSTET GYN SCAN, V84, P1103, DOI 10.1111/j.0001-6349.2005.00882.x; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Robberecht C, 2012, PRENATAL DIAG, V32, P933, DOI 10.1002/pd.3936; Saravelos SH, 2014, OBSTET GYN CLIN N AM, V41, P157, DOI 10.1016/j.ogc.2013.10.008; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Tarlatzis BC, 2008, HUM REPROD, V23, P462, DOI 10.1093/humrep/dem426; Tempfer CB, 2006, FERTIL STERIL, V86, P145, DOI 10.1016/j.fertnstert.2005.12.035; TONER JP, 1991, FERTIL STERIL, V55, P784; Van den Berg MMJ, 2014, OBSTET GYN CLIN N AM, V41, P145, DOI 10.1016/j.ogc.2013.10.010	19	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161606	10.1371/journal.pone.0161606	http://dx.doi.org/10.1371/journal.pone.0161606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627119	gold, Green Submitted, Green Published			2022-12-26	WOS:000383680600005
J	Lopes, CS; Daifalla, N; Das, B; da Silva, VD; Campos-Neto, A				Lopes, Carolina S.; Daifalla, Nada; Das, Bikul; da Silva, Valdo Dias; Campos-Neto, Antonio			CD271+Mesenchymal Stem Cells as a Possible Infectious Niche for Leishmania infantum	PLOS ONE			English	Article							BONE-MARROW; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; LATENT LEISHMANIASIS; SURFACE-MARKERS; STROMAL CELLS; HOST-CELL; DONOVANI; CD271	Visceral leishmaniasis (VL) is a serious and fatal disease. Therapeutic drugs are toxic and non-sterilizing. The etiological agents Leishmania infantum and Leishmania donovani cause active and asymptomatic diseases. Effective drugs to treat VL exist but unfortunately, post-treatment relapses are common. Little is known why drugs are non-sterilizing or how these intracellular pathogens can escape treatment. Here, using a murine model of VL we found that CD271+/Sca1+ bone marrow mesenchymal stem cells (BM-MSCs) are readily infected in vitro and in vivo by L. infantum. Because BM-MSCs express potent drug efflux pumps, e.g., ABCG2 it is possible that this unique intracellular infectious niche could allow L. infantum to escape anti-parasite drugs.	[Lopes, Carolina S.; Daifalla, Nada; Das, Bikul; Campos-Neto, Antonio] Forsyth Inst, Cambridge, MA USA; [Lopes, Carolina S.; da Silva, Valdo Dias] Triangulo Mineiro Fed Univ, Inst Biol & Nat Sci, Dept Biochem Pharmacol Physiol & Mol Biol, Uberaba, MG, Brazil	Harvard University; Forsyth Institute; Universidade Federal do Triangulo Mineiro	Campos-Neto, A (corresponding author), Forsyth Inst, Cambridge, MA USA.	acampos@forsyth.org	Das, Bikul/ABF-9292-2020; Daifalla, Nada/E-6005-2017	Daifalla, Nada/0000-0001-7895-9586	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), a Brazilian Government for Education and Scientific Research - Fellowship	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), a Brazilian Government for Education and Scientific Research - Fellowship	This work was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), a Brazilian Government for Education and Scientific Research - Fellowship awarded to CSL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Allahverdiyev AM, 2011, AM J TROP MED HYG, V85, P535, DOI 10.4269/ajtmh.2011.11-0037; Alvarez-Viejo M, 2015, WORLD J STEM CELLS, V7, P470, DOI 10.4252/wjsc.v7.i2.470; Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Beamer G, 2014, AM J PATHOL, V184, P3170, DOI 10.1016/j.ajpath.2014.08.024; Bogdan C, 2000, J EXP MED, V191, P2121, DOI 10.1084/jem.191.12.2121; Campos-Neto A, 2003, INFECT IMMUN, V71, P5065, DOI 10.1128/IAI.71.9.5065-5076.2003; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Das B, 2008, NEOPLASIA, V10, P1105, DOI 10.1593/neo.08466; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Gallacher L, 2000, BLOOD, V95, P2813, DOI 10.1182/blood.V95.9.2813.009k20_2813_2820; Gangneux JP, 2005, J EUKARYOT MICROBIOL, V52, P489, DOI 10.1111/j.1550-7408.2005.00055.x; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Hasker E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002053; Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kuci S, 2010, HAEMATOL-HEMATOL J, V95, P651, DOI 10.3324/haematol.2009.015065; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Watson JT, 2013, CELLS TISSUES ORGANS, V197, P496, DOI 10.1159/000348794	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162927	10.1371/journal.pone.0162927	http://dx.doi.org/10.1371/journal.pone.0162927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622907	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000069
J	Selasi, GN; Nicholas, A; Jeon, H; Na, SH; Il Kwon, H; Kim, YJ; Heo, ST; Oh, MH; Lee, JC				Selasi, Gati Noble; Nicholas, Asiimwe; Jeon, Hyejin; Na, Seok Hyeon; Il Kwon, Hyo; Kim, Yoo Jeong; Heo, Sang Taek; Oh, Man Hwan; Lee, Je Chul			Differences in Biofilm Mass, Expression of Biofilm-Associated Genes, and Resistance to Desiccation between Epidemic and Sporadic Clones of Carbapenem-Resistant Acinetobacter baumannii Sequence Type 191	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANCE; ABIOTIC SURFACES; EUKARYOTIC CELLS; DRY SURFACES; STRAINS; ATTACHMENT; PATHOGEN; IMIPENEM; SURVIVAL	Understanding the biology behind the epidemicity and persistence of Acinetobacter baumannii in the hospital environment is critical to control outbreaks of infection. This study investigated the contributing factors to the epidemicity of carbapenem-resistant A. baumannii (CRAB) sequence type (ST) 191 by comparing the differences in biofilm formation, expression of biofilm-associated genes, and resistance to desiccation between major epidemic (n = 16), minor epidemic (n = 12), and sporadic (n = 12) clones. Biofilm mass was significantly greater in the major epidemic than the minor epidemic and sporadic clones. Major and minor epidemic clones expressed biofilm-associated genes, abaI, bap, pgaABCD, and csuA/BABCDE, higher than the sporadic clones in sessile conditions. The csuC, csuD, and csuE genes were more highly expressed in the major epidemic than minor epidemic clones. Interestingly, minor epidemic clones expressed more biofilm-associated genes than the major epidemic clone under planktonic conditions. Major epidemic clones were more resistant to desiccation than minor epidemic and sporadic clones on day 21. In conclusion, the epidemic CRAB ST191 clones exhibit a higher capacity to form biofilms, express the biofilm-associated genes under sessile conditions, and resist desiccation than sporadic clones. These phenotypic and genotypic characteristics of CRAB ST191 may account for the epidemicity of specific CRAB ST191 clones in the hospital.	[Selasi, Gati Noble; Nicholas, Asiimwe; Jeon, Hyejin; Na, Seok Hyeon; Il Kwon, Hyo; Kim, Yoo Jeong; Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Daegu, South Korea; [Heo, Sang Taek] Jeju Natl Univ, Dept Internal Med, Sch Med, Jeju, South Korea; [Oh, Man Hwan] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea	Kyungpook National University; Jeju National University; Dankook University	Lee, JC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Daegu, South Korea.	leejc@knu.ac.kr		Na, Seok Hyeon/0000-0002-8550-9150; Heo, Sang Taek/0000-0001-8947-5069; Gati, Noble Selasi/0000-0002-4229-2908; Asiimwe, Nicholas/0000-0003-0484-4481	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C0257]	Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI14C0257).	Alvarez-Fraga L, 2016, VIRULENCE, V7, P443, DOI 10.1080/21505594.2016.1145335; Cevahir N, 2008, J MICROBIOL IMMUNOL, V41, P513; Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; De Gregorio E, 2015, NEW MICROBIOL, V38, P251; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5; Giannouli M, 2013, BMC INFECT DIS, V13, DOI [10.1186/1471-2334-13-470, 10.1186/1471-2334-13-282]; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; Huttner A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-31; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Kuo HY, 2012, INT J ANTIMICROB AG, V39, P33, DOI 10.1016/j.ijantimicag.2011.08.016; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Luo TL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00182; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Marti Sara, 2011, BMC Res Notes, V4, P5, DOI 10.1186/1756-0500-4-5; Martins N, 2015, ANTIMICROB AGENTS CH, V59, P698, DOI 10.1128/AAC.02415-14; McQueary CN, 2011, J MICROBIOL, V49, P243, DOI 10.1007/s12275-011-0343-7; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Ralston A., 2008, NATURE ED, V1, P216; Rao RS, 2008, INDIAN J MED MICROBI, V26, P333; Richmond GE, 2016, MBIO, V7, DOI 10.1128/mBio.00430-16; Rumbo-Feal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072968; Samuelsen O, 2011, CLIN MICROBIOL INFEC, V17, P1811, DOI 10.1111/j.1469-0691.2011.03532.x; Selasi GN, 2015, INFECT GENET EVOL, V36, P1, DOI 10.1016/j.meegid.2015.09.001; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Wroblewska MM, 2008, FEMS IMMUNOL MED MIC, V53, P140, DOI 10.1111/j.1574-695X.2008.00403.x	33	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162576	10.1371/journal.pone.0162576	http://dx.doi.org/10.1371/journal.pone.0162576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622249	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000041
J	Demir, O; Ieong, PU; Amaro, RE				Demir, Oe; Ieong, P. U.; Amaro, R. E.			Full-length p53 tetramer bound to DNA and its quaternary dynamics	ONCOGENE			English	Article							TUMOR-SUPPRESSOR P53; C-TERMINAL DOMAIN; MOLECULAR-DYNAMICS; MUTANT P53; BINDING DOMAIN; ELECTRON-MICROSCOPY; PROTEIN; REACTIVATION; RESTORATION; ELEMENTS	P53 is a major tumor suppressor that is mutated and inactivated in similar to 50% of all human cancers. Thus, reactivation of mutant p53 using small molecules has been a long sought-after anticancer therapeutic strategy. Full structural characterization of the full-length oligomeric p53 is challenging because of its complex architecture and multiple highly flexible regions. To explore p53 structural dynamics, here we developed a series of atomistic integrative models with available crystal structures of the full-length p53 (fl-p53) tetramer bound to three different DNA sequences: a p21 response element, a puma response element and a nonspecific DNA sequence. Explicitly solvated, all-atom molecular dynamics simulations of the three complexes (totaling nearly 1 mu s of aggregate simulation time) yield final structures consistent with electron microscopy maps and, for the first time, show the direct interactions of the p53 C-terminal with DNA. Through a collective principal component analysis, we identify sequence-dependent differential quaternary binding modes of the p53 tetramer interfacing with DNA. Additionally, L1 loop dynamics of fl-p53 in the presence of DNA is revealed, and druggable pockets of p53 are identified via solvent mapping to aid future drug discovery studies.	[Demir, Oe; Ieong, P. U.; Amaro, R. E.] Univ Calif San Diego, Dept Chem & Biochem, 3234 Urey Hall,9500 Gilman Dr,MC 0332, La Jolla, CA 92103 USA; [Ieong, P. U.; Amaro, R. E.] Univ Calif San Diego, Natl Biomed Computat Resource, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Amaro, RE (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 3234 Urey Hall,9500 Gilman Dr,MC 0332, La Jolla, CA 92103 USA.	ramaro@ucsd.edu		Demir, Ozlem/0000-0002-3317-4731	University of California Cancer Research Coordinating Committee award and NIH Innovator award [DP2-007237]; National Biomedical Computation Resource [NIH P41, GM103426]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103426] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007237] Funding Source: NIH RePORTER	University of California Cancer Research Coordinating Committee award and NIH Innovator award; National Biomedical Computation Resource; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Mikel Valle for kindly providing the three-dimensional cryo-EM maps in 2011 Melero et al. article, and Steffen Lindert, Rob Swift, Clarisse Ricci, Lane Votapka, Jacob Durrant and Elizabeth Villa for helpful discussions. This work was supported by the University of California Cancer Research Coordinating Committee award and NIH Innovator award DP2-007237. Computing time on Stampede and Comet supercomputers was provided through the NSF XSEDE supercomputer resources grant RAC CHE060073N (to REA). Additional support from the National Biomedical Computation Resource NIH P41 GM103426 is acknowledged.	Ahn J, 2001, NAT STRUCT BIOL, V8, P730, DOI 10.1038/nsb0901-730; Altintas I, 2004, 16TH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, PROCEEDINGS, P423; [Anonymous], 2015, MAESTR VERS 10 4; Arlt C, 2015, PROTEOMICS, V15, P2746, DOI 10.1002/pmic.201400549; BALAGURUMOORTHY P, 1995, P NATL ACAD SCI USA, V92, P8591, DOI 10.1073/pnas.92.19.8591; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Case D., 2015, AMBER, V14; D'Abramo M, 2016, ONCOGENE, V35, P3272, DOI 10.1038/onc.2015.388; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Durrant JD, 2014, J CHEM THEORY COMPUT, V10, P5047, DOI 10.1021/ct500381c; Emamzadah S, 2014, J MOL BIOL, V426, P936, DOI 10.1016/j.jmb.2013.12.020; Emamzadah S, 2011, MOL CANCER RES, V9, P1493, DOI 10.1158/1541-7786.MCR-11-0351; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Friedler A, 2005, STRUCTURE, V13, P629, DOI 10.1016/j.str.2005.01.020; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hupp TR, 1999, CELL MOL LIFE SCI, V55, P88, DOI 10.1007/s000180050272; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Janert P.K., 2010, GNUPLOT ACTION UNDER; Joerger AC, 2015, STRUCTURE, V23, P2246, DOI 10.1016/j.str.2015.10.016; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Leith JS, 2012, P NATL ACAD SCI USA, V109, P16552, DOI 10.1073/pnas.1120452109; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Lim KW, 2009, J AM CHEM SOC, V131, P4301, DOI 10.1021/ja807503g; Liu XR, 2013, NUCLEIC ACIDS RES, V41, P6034, DOI 10.1093/nar/gkt305; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; Lukman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080221; Ma BY, 2007, NUCLEIC ACIDS RES, V35, P2986, DOI 10.1093/nar/gkm192; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; McKinney K, 2004, MOL CELL, V16, P413, DOI 10.1016/j.molcel.2004.09.032; Melero R, 2011, P NATL ACAD SCI USA, V108, P557, DOI [10.1073/pnas.1015520107, 10.1073/pnas.101S520107]; Molecular Operating Environment (MOE), 2016, H3A 2R7; Nagaich AK, 1999, P NATL ACAD SCI USA, V96, P1875, DOI 10.1073/pnas.96.5.1875; Natan E, 2011, J MOL BIOL, V409, P358, DOI 10.1016/j.jmb.2011.03.047; Ngan CH, 2012, NUCLEIC ACIDS RES, V40, pW271, DOI 10.1093/nar/gks441; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petty TJ, 2011, EMBO J, V30, P2167, DOI 10.1038/emboj.2011.127; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; R-Core-Team, 2015, LANG ENV STAT COMP; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Votapka LW, 2013, COMMUN COMPUT PHYS, V13, P256, DOI 10.4208/cicp.170711.111111s; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wassman CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2361; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Weinberg RL, 2004, J MOL BIOL, V341, P1145, DOI 10.1016/j.jmb.2004.06.071; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiman KG, 2007, ADV CANCER RES, V97, P321, DOI 10.1016/S0065-230X(06)97014-6; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042	63	21	23	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1451	1460		10.1038/onc.2016.321	http://dx.doi.org/10.1038/onc.2016.321			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27641333	Green Accepted			2022-12-26	WOS:000395862500013
J	Donners, MMPC; Bai, LL; Lutgens, SPM; Wijnands, E; Johnson, J; Schurgers, LJ; Liu, CL; Daemen, MJAP; Cleutjens, KBJM; Shi, GP; Biessen, EAL; Heeneman, S				Donners, Marjo M. P. C.; Bai, Lili; Lutgens, Suzanne P. M.; Wijnands, Erwin; Johnson, Jason; Schurgers, Leon J.; Liu, Cong-Lin; Daemen, Mat J. A. P.; Cleutjens, Kitty B. J. M.; Shi, Guo-Ping; Biessen, Erik A. L.; Heeneman, Sylvia			Cathepsin K Deficiency Prevents the Aggravated Vascular Remodeling Response to Flow Cessation in ApoE(-/-) Mice	PLOS ONE			English	Article							ALTERNATIVE MACROPHAGE ACTIVATION; CAROTID-ARTERY; NEOINTIMA; GROWTH; ATHEROGENESIS; INFLAMMATION; EXPRESSION; INJURY	Cathepsin K (catK) is a potent lysosomal cysteine protease involved in extracellular matrix (ECM) degradation and inflammatory remodeling responses. Here we have investigated the contribution of catK deficiency on carotid arterial remodeling in response to flow cessation in apoE(-/-) and wild type (wt) background. Ligation-induced hyperplasia is considerably aggravated in apoE(-/-) versus wt mice. CatK protein expression was significantly increased in neointimal lesions of apoE(-/-) compared with wt mice, suggesting a role for catK in intimal hyperplasia under hyperlipidemic conditions. Surprisingly, CatK deficiency completely blunted the augmented hyperplastic response to flow cessation in apoE(-/-), whereas vascular remodeling in wt mice was unaffected. As catK deficiency did neither alter lesion collagen content and elastic laminae fragmentation in vivo, we focused on effects of catK on (systemic) inflammatory responses. CatK deficiency significantly reduced circulating CD3 T-cell numbers, but increased the regulatory T cell subset in apoE(-/-) but not wt mice. Moreover, catK deficiency changed CD11b+Ly6G-Ly6C (high) monocyte distribution in apoE(-/-) but not wt mice and tended to favour macrophage M2a polarization. In conclusion, catK deficiency almost completely blunted the increased vascular remodeling response of apoE(-)/(-) mice to flow cessation, possibly by correcting hyperlipidemia-associated pro-inflammatory effects on the peripheral immune response.	[Donners, Marjo M. P. C.; Bai, Lili; Lutgens, Suzanne P. M.; Wijnands, Erwin; Daemen, Mat J. A. P.; Cleutjens, Kitty B. J. M.; Biessen, Erik A. L.; Heeneman, Sylvia] Maastricht Univ, Med Ctr, Expt Vasc Pathol Grp, Dept Pathol,Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Schurgers, Leon J.] Maastricht Univ, Med Ctr, Dept Biochem, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Daemen, Mat J. A. P.] Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Johnson, Jason] Univ Bristol, Bristol Royal Infirm, Bristol Heart Inst, Marlbrough St, Bristol BS2 8HW, Avon, England; [Liu, Cong-Lin; Shi, Guo-Ping] Brigham & Womens Hosp, Cardiovasc Med, NRB 742,77 Ave Louis Pasteur, Boston, MA 02115 USA	Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Bristol Royal Infirmary; University of Bristol; Harvard University; Brigham & Women's Hospital	Heeneman, S (corresponding author), Maastricht Univ, Med Ctr, Expt Vasc Pathol Grp, Dept Pathol,Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands.	S.heeneman@maastrichtuniversity.nl	Johnson, Jason/AAC-3124-2019; Schurgers, Leon/AAT-7100-2021	Johnson, Jason/0000-0003-0630-9183; Daemen, Mat/0000-0003-1076-199X; Schurgers, Leon/0000-0001-7867-6957; Biessen, Erik/0000-0002-6454-8548	Netherlands Heart Foundation [2012T079, 2003T201]	Netherlands Heart Foundation(Netherlands Heart Foundation)	M.M.P.C. Donners and E.A.L. Biessen are supported by the Netherlands Heart Foundation (grant nrs. 2012T079 and 2003T201, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Bossard MJ, 1996, J BIOL CHEM, V271, P12517, DOI 10.1074/jbc.271.21.12517; Chazov EI, 2007, CAN J PHYSIOL PHARM, V85, P332, DOI 10.1139/Y07-008; Cheng XW, 2004, AM J PATHOL, V164, P243, DOI 10.1016/S0002-9440(10)63114-8; CLOWES AW, 1983, LAB INVEST, V49, P327; Eschert H, 2009, ATHEROSCLEROSIS, V204, P96, DOI 10.1016/j.atherosclerosis.2008.08.025; FERNS GAA, 1992, P NATL ACAD SCI USA, V89, P11312, DOI 10.1073/pnas.89.23.11312; Fortuna-Costa A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00138; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Ivan E, 2002, CIRCULATION, V105, P2686, DOI 10.1161/01.CIR.0000016825.17448.11; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Kukhtina N B, 2009, Neurosci Behav Physiol, V39, P153, DOI 10.1007/s11055-009-9112-z; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lessner SM, 2004, ARTERIOSCL THROM VAS, V24, P2123, DOI 10.1161/01.ATV.0000141840.27300.fd; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; Lutgens E, 2001, ARTERIOSCL THROM VAS, V21, P1359, DOI 10.1161/hq0801.093669; Lutgens SPM, 2006, J PATHOL, V210, P334, DOI 10.1002/path.2054; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; MEHRA M, 1995, THE JOURNAL OF HEART, V14, pS207; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ostriker A, 2014, ARTERIOSCL THROM VAS, V34, P877, DOI 10.1161/ATVBAHA.114.303214; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Zouggari Y, 2009, CIRCULATION, V120, P1415, DOI 10.1161/CIRCULATIONAHA.109.875583	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162595	10.1371/journal.pone.0162595	http://dx.doi.org/10.1371/journal.pone.0162595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636705	gold, Green Published, Green Submitted			2022-12-26	WOS:000383723700010
J	Granic, A; Davies, K; Jagger, C; Kirkwood, TBL; Syddall, HE; Sayer, AA				Granic, Antoneta; Davies, Karen; Jagger, Carol; Kirkwood, Thomas B. L.; Syddall, Holly E.; Sayer, Avan A.			Grip Strength Decline and Its Determinants in the Very Old: Longitudinal Findings from the Newcastle 85+Study	PLOS ONE			English	Article							HANDGRIP STRENGTH; PHYSICAL-ACTIVITY; SEX-DIFFERENCES; MUSCLE MASS; HEALTH; MEN; ASSOCIATION; PERFORMANCE; MORTALITY; AGE	Background Weak grip strength (GS) is a key component of sarcopenia and frailty and a powerful predictor of mortality, morbidity and disability. Despite increasing interest in understanding GS across the lifespan, little is known about GS decline in the very old (aged >= 85). We examined trajectories of GS in very old adults and identified the determinants. Methods GS (kg) was measured four times over 5 years in 319 men and 526 women participating in the Newcastle 85+ Study. A weak GS sub-cohort was identified as having strength of <= 27 kg (men), and <= 16 kg (women) at baseline and follow-up. Mixed models were used to establish trajectories of GS and associated factors in all participants, men and women, and in those with weak GS. Results Men's mean grip strength was 24.42 (SD = 6.77) kg, and women's 13.23 (4.42) kg (p<0.001) at baseline, with mean absolute change of -5.27 (4.90) kg and -3.14 (3.41), respectively (p<0.001) by 5-year follow-up. In the time-only mixed model, men experienced linear annual decline in GS of -1.13 (0.8) kg (beta (SE), p<0.001), whilst women's decline although slower, accelerated by -0.06 (0.02) kg (p = 0.01) over time. In the saturated model, higher baseline physical activity, height, fat-free mass, better self-rated health, and not having arthritis in hand(s) were associated with stronger GS initially in both sexes. Annual GS decline in men and participants with weak GS who were highly physically active was slower by 0.95 and 0.52 kg, respectively compared with inactive counterparts. Conclusion Grip strength decline in the very old followed linear (men) and curvilinear (women) trends. High levels of physical activity were protective of GS loss in men (but not in women) and in those with weak GS. Thus maintaining muscle strength in later life is important to reduce the morbidity and mortality in the very old.	[Granic, Antoneta; Davies, Karen; Sayer, Avan A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Granic, Antoneta; Davies, Karen; Sayer, Avan A.] Newcastle Univ, Ctr Ageing & Chron Dis, NIHR Newcastle Biomed Res, Newcastle Upon Tyne, Tyne & Wear, England; [Granic, Antoneta; Davies, Karen; Sayer, Avan A.] Newcastle Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Granic, Antoneta; Davies, Karen; Jagger, Carol; Kirkwood, Thomas B. L.; Sayer, Avan A.] Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Jagger, Carol] Newcastle Univ Baddiley Clark, Inst Hlth & Soc, Richardson Rd, Newcastle Upon Tyne, Tyne & Wear, England; [Kirkwood, Thomas B. L.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Syddall, Holly E.; Sayer, Avan A.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Sayer, Avan A.] Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res & Care, Southampton, Hants, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Southampton; University of Southampton	Sayer, AA (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Newcastle Univ, Ctr Ageing & Chron Dis, NIHR Newcastle Biomed Res, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Newcastle Tyne NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Newcastle Univ, Inst Ageing, Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.; Sayer, AA (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.; Sayer, AA (corresponding author), Univ Southampton, NIHR Collaborat Leadership Appl Hlth Res & Care, Southampton, Hants, England.	avan.sayer@newcastle.ac.uk		Jagger, Carol/0000-0002-6377-9926; Aihie Sayer, Avan/0000-0003-1283-6457; Granic, Antoneta/0000-0001-9247-899X	National Institute for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Disease based at Newcastle Hospitals Foundation Trust; Newcastle University; Medical Research Council; Biotechnology and Biological Sciences Research Council; Dunhill Medical Trust; British Heart Foundation; Unilever Corporate Research; North of England Commissioning Support Unit; National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust; MRC [G0500997, MC_UU_12011/2, MC_UP_A620_1015, MR/J50001X/1] Funding Source: UKRI; Medical Research Council [G0500997, U1475000002, MC_UP_A620_1015, MR/J50001X/1, MC_UU_12011/2] Funding Source: researchfish	National Institute for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Disease based at Newcastle Hospitals Foundation Trust; Newcastle University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dunhill Medical Trust(Dunhill Medical Trust); British Heart Foundation(British Heart Foundation); Unilever Corporate Research(Unilever); North of England Commissioning Support Unit; National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study has been funded by the National Institute for Health Research Newcastle Biomedical Research Centre in Ageing and Chronic Disease based at Newcastle Hospitals Foundation Trust and Newcastle University (AG). The Newcastle 85+ Study has been funded by the Medical Research Council, Biotechnology and Biological Sciences Research Council and the Dunhill Medical Trust. Parts of the work have also been funded by the British Heart Foundation, Unilever Corporate Research, Newcastle University and the North of England Commissioning Support Unit (formerly NHS North of Tyne). The research was also supported by the National Institute for Health Research Newcastle Biomedical Research Centre, based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the authors and not necessarily those of the National Health Service, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000192; Botoseneanu A, 2015, J AGING HEALTH, V27, P1123, DOI 10.1177/0898264315577587; Cawthon PM, 2013, GERONTOLOGIST, V53, P594, DOI 10.1093/gerona/glu023; Cevenini E, 2014, AGE, V36, P949, DOI 10.1007/s11357-013-9604-1; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; Cheung CL, 2013, AGE, V35, P929, DOI 10.1007/s11357-012-9385-y; Clouston SAP, 2013, EPIDEMIOL REV, V35, P33, DOI 10.1093/epirev/mxs004; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; COOPER R, 2011, PLOS ONE, V0006; Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013; Davies K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108370; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Gomez-Cabello A, 2014, MATURITAS, V78, P106, DOI 10.1016/j.maturitas.2014.03.007; Haidar SG, 2004, J HAND SURG-BRIT EUR, V29B, P82, DOI 10.1016/j.jhsb.2003.09.012; Hardy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056483; Hicks GE, 2012, J GERONTOL A-BIOL, V67, P66, DOI 10.1093/gerona/glr055; Innerd P, 2015, AGE AGEING, V44, P691, DOI 10.1093/ageing/afv062; Ishizaki T, 2011, J EPIDEMIOL, V21, P176, DOI 10.2188/jea.JE20100138; Keevil VL, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-93; Kerr A, 2006, AGE AGEING, V35, P82, DOI 10.1093/ageing/afj010; Kingston A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088016; Legrand D, 2013, ARCH GERONTOL GERIAT, V57, P345, DOI 10.1016/j.archger.2013.06.003; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; Nahhas RW, 2010, AM J HUM BIOL, V22, P648, DOI 10.1002/ajhb.21057; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Oksuzyan A, 2010, J AGING HEALTH, V22, P589, DOI 10.1177/0898264310366752; Proctor DN, 2006, AGING CLIN EXP RES, V18, P517; Quinones AR, 2011, J GERONTOL B-PSYCHOL, V66, P739, DOI 10.1093/geronb/gbr106; Rantanen Taina, 2002, Aging Clin Exp Res, V14, P10; Roberts HC, 2014, AGE AGEING, V43, P241, DOI 10.1093/ageing/aft118; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Sayer AA, 2006, AGE AGEING, V35, P409, DOI 10.1093/ageing/afl024; Sayer AA, 2015, LANCET, V386, P226, DOI 10.1016/S0140-6736(14)62349-7; Seino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099487; Siervo M, 2015, ARCH GERONTOL GERIAT, V60, P227, DOI 10.1016/j.archger.2014.09.004; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spruit MA, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.013; Stenholm S, 2012, J GERONTOL A-BIOL, V67, P1068, DOI 10.1093/gerona/gls064; Sternang O, 2015, AGE AGEING, V44, P269, DOI 10.1093/ageing/afu170; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Taekema DG, 2010, AGE AGEING, V39, P331, DOI 10.1093/ageing/afq022; Visser M, 2000, J AM GERIATR SOC, V48, P381, DOI 10.1111/j.1532-5415.2000.tb04694.x; Xue QL, 2011, ARCH INTERN MED, V171, P1119, DOI 10.1001/archinternmed.2011.252	49	31	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163183	10.1371/journal.pone.0163183	http://dx.doi.org/10.1371/journal.pone.0163183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637107	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700040
J	Jimenez-Fernandez, A; Lopez-Sanchez, A; Jimenez-Diaz, L; Navarrete, B; Calero, P; Platero, AI; Govantes, F				Jimenez-Fernandez, Alicia; Lopez-Sanchez, Aroa; Jimenez-Diaz, Lorena; Navarrete, Blanca; Calero, Patricia; Isabel Platero, Ana; Govantes, Fernando			Complex Interplay between FleQ, Cyclic Diguanylate and Multiple sigma Factors Coordinately Regulates Flagellar Motility and Biofilm Development in Pseudomonas putida	PLOS ONE			English	Article							C-DI-GMP; STARVATION-INDUCED DISPERSION; BINDING PROTEIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATOR; CELLULOSE SYNTHESIS; ESCHERICHIA-COLI; AERUGINOSA; DNA; ADHESION	Most bacteria alternate between a free living planktonic lifestyle and the formation of structured surface-associated communities named biofilms. The transition between these two lifestyles requires a precise and timely regulation of the factors involved in each of the stages that has been likened to a developmental process. Here we characterize the involvement of the transcriptional regulator FleQ and the second messenger cyclic diguanylate in the coordinate regulation of multiple functions related to motility and surface colonization in Pseudomonas putida. Disruption of fleQ caused strong defects in flagellar motility, biofilm formation and surface attachment, and the ability of this mutation to suppress multiple biofilm-related phenotypes associated to cyclic diguanylate overproduction suggests that FleQ mediates cyclic diguanylate signaling critical to biofilm growth. We have constructed a library containing 94 promoters potentially involved in motility and biofilm development fused to gfp and lacZ, screened this library for FleQ and cyclic diguanylate regulation, and assessed the involvement of alternative sigma factors sigma(N) and FliA in the transcription of FleQ-regulated promoters. Our results suggest a dual mode of action for FleQ. Low cyclic diguanylate levels favor FleQ interaction with sigma(N)-dependent promoters to activate the flagellar cascade, encompassing the flagellar cluster and additional genes involved in cyclic diguanylate metabolism, signal transduction and gene regulation. On the other hand, characterization of the FleQ-regulated sigma(N)- and FliA-independent PlapA and PbcsD promoters revealed two disparate regulatory mechanisms leading to a similar outcome: the synthesis of biofilm matrix components in response to increased cyclic diguanylate levels.	[Govantes, Fernando] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol & Desarrollo, Junta Andalucia, Seville, Spain; Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Carretera Utrera,Km 1, Seville 41013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Universidad Pablo de Olavide	Govantes, F (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol & Desarrollo, Junta Andalucia, Seville, Spain.	fgovrom@upo.es	Govantes, Fernando/E-4790-2017; Sánchez, Aroa López/F-3465-2016; Jiménez-Fernández, Alicia/AAD-7751-2021; Platero, Ana Isabel/P-8266-2018	Govantes, Fernando/0000-0002-4866-6798; Sánchez, Aroa López/0000-0001-9022-3811; Jimenez-Fernandez, Alicia/0000-0002-5696-7865; Platero, Ana Isabel/0000-0002-4461-910X; Navarrete, Blanca/0000-0002-5122-1562	Ministerio de Ciencia e Innovacion, Spain; European Regional Development fund [BIO2010-17853, BIO2013-420173-P]; Ministerio de Economia y Competitividad, Spain; Consejo Superior de Investigaciones Cientificas, Spain	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development fund(European Commission); Ministerio de Economia y Competitividad, Spain(Spanish Government); Consejo Superior de Investigaciones Cientificas, Spain	This work was supported by Ministerio de Ciencia e Innovacion, Spain (http://www.idi.mineco.gob.es/) and European Regional Development fund (http://ec.europa.eu/regional_policy/en/funding/erdf/), Grant BIO2010-17853, awarded to FG; Ministerio de Economia y Competitividad, Spain (http://www.idi.mineco.gob.es/) and European Regional Development fund (http://ec.europa.eu/regional_policy/en/funding/erdf/), Grant BIO2013-420173-P, awarded to FG; and Consejo Superior de Investigaciones Cientificas, Spain (http://www.csic.es/), JAE-Predoc 2010 scholarship, awarded to AJ-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2010, J BACTERIOL, V192, P446, DOI 10.1128/JB.00610-09; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Reyes-Darias JA, 2015, MOL MICROBIOL, V97, P488, DOI 10.1111/mmi.13045; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Baraquet C, 2016, J BACTERIOL, V198, P178, DOI 10.1128/JB.00539-15; Baraquet C, 2013, P NATL ACAD SCI USA, V110, P18478, DOI 10.1073/pnas.1318972110; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Brouwer RWW, 2008, BRIEF BIOINFORM, V9, P367, DOI 10.1093/bib/bbn019; Camesano TA, 2002, BIOMACROMOLECULES, V3, P661, DOI 10.1021/bm015648y; Casaz P, 2001, MICROBIOL-UK, V147, P355, DOI 10.1099/00221287-147-2-355; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chang WS, 2003, J BACTERIOL, V185, P6199, DOI 10.1128/JB.185.20.6199-6204.2003; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Garcia-Gonzalez V, 2005, J BACTERIOL, V187, P155, DOI 10.1128/JB.187.1.155-167.2005; Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x; Gjermansen M, 2006, FEMS MICROBIOL LETT, V265, P215, DOI 10.1111/j.1574-6968.2006.00493.x; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Govantes F, 1996, J BACTERIOL, V178, P6817, DOI 10.1128/jb.178.23.6817-6823.1996; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jimenez-Fernandez A, 2015, ENV MICROBIOL REP, V7, P78, DOI 10.1111/1758-2229.12153; Joly N, 2012, BBA-MOL CELL RES, V1823, P108, DOI 10.1016/j.bbamcr.2011.08.012; Rodriguez-Herva JJ, 2010, ENV MICROBIOL REP, V2, P373, DOI 10.1111/j.1758-2229.2009.00084.x; Jyot J, 2002, J BACTERIOL, V184, P5251, DOI 10.1128/JB.184.19.5251-5260.2002; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klausen M, 2006, FEMS MICROBIOL LETT, V261, P1, DOI 10.1111/j.1574-6968.2006.00280.x; KOHLER T, 1989, J BACTERIOL, V171, P4326; Llamas MA, 2000, J BACTERIOL, V182, P4764, DOI 10.1128/JB.182.17.4764-4772.2000; Lopez-Sanchez A, 2013, ENV MICROBIOL REP, V5, P679, DOI 10.1111/1758-2229.12067; LOPEZSANCHEZ A, 2016, FEMS MICROBIOL LETT, V363, DOI DOI 10.1093/IEM&LEDNW127; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Martinez-Gil M, 2014, J BACTERIOL, V196, P1484, DOI 10.1128/JB.01287-13; Martinez-Gil M, 2010, MOL MICROBIOL, V77, P549, DOI 10.1111/j.1365-2958.2010.07249.x; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x; Matsuyama BY, 2016, P NATL ACAD SCI USA, V113, pE209, DOI 10.1073/pnas.1523148113; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Nilsson M, 2011, ENVIRON MICROBIOL, V13, P1357, DOI 10.1111/j.1462-2920.2011.02447.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; PARKINSON JS, 1976, J BACTERIOL, V126, P758, DOI 10.1128/JB.126.2.758-770.1976; Porrua O, 2009, MOL MICROBIOL, V73, P419, DOI 10.1111/j.1365-2958.2009.06779.x; Robleto EA, 2003, J BACTERIOL, V185, P453, DOI 10.1128/JB.185.2.453-460.2003; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Romling U, 2012, ENVIRON MICROBIOL, V14, P1817, DOI 10.1111/j.1462-2920.2011.02617.x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Turnbull GA, 2001, FEMS MICROBIOL ECOL, V35, P57, DOI 10.1111/j.1574-6941.2001.tb00788.x; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Xiao YJ, 2016, ENV MICROBIOL REP, V8, P659, DOI 10.1111/1758-2229.12419; YANG CH, 1994, APPL ENVIRON MICROB, V60, P473, DOI 10.1128/AEM.60.2.473-481.1994; Yousef-Coronado F, 2008, FEMS MICROBIOL LETT, V288, P118, DOI 10.1111/j.1574-6968.2008.01339.x; Yuste L, 2006, ENVIRON MICROBIOL, V8, P165, DOI 10.1111/j.1462-2920.2005.00890.x	85	32	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163142	10.1371/journal.pone.0163142	http://dx.doi.org/10.1371/journal.pone.0163142			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636892	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700038
J	Hung, TH; Lay, CJ; Tseng, CW; Tsai, CC; Tsai, CC				Hung, Tsung-Hsing; Lay, Chorng-Jang; Tseng, Chih-Wei; Tsai, Chih-Chun; Tsai, Chen-Chi			The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Followup Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SPONTANEOUS BACTERIAL PERITONITIS; HEPATORENAL-SYNDROME; HOSPITAL MORTALITY; FAILURE; DIAGNOSIS; NORADRENALINE; TERLIPRESSIN; DIALYSIS; CRITERIA	Renal function impairment (RFI) contributes to poor prognosis in cirrhotic patients. However, there have been no studies that seek to identify the effect of different types of RFI on the mortality of cirrhotic patients. We used the National Health Insurance Database, derived from the Taiwan National Health Insurance Program, to identify 44365 cirrhotic patients between January 1, 2007 and December 31, 2007. RFI was identified in 2832 cirrhotic patients, including 1075 with acute renal failure (ARF) (169 with hepatorenal syndrome, HRS; 906 with non-hepatorenal syndrome, NHRS), 705 with chronic kidney disease (CKD), and 1052 with end stage renal disease (ESRD). After Cox proportional hazard regression analysis adjusted by gender, age, and comorbid disorders, the 30-day, 30 to 90-day, 90-day to 1-year, and 1 to 3-year mortality hazard ratios (HR) compared to the non-RFI group were: (ARF) 5.19 (4.70-5.74), 3.23 (2.76-3.77), 1.51 (1.26-1.81), and 1.35 (1.13-1.61), respectively; (CKD) 2.70 (2.30-3.18), 2.03 (1.66-2.49), 1.60 (1.34-1.90), and 1.26 (1.06-1.49), respectively; and (ESRD) 1.42 (1.17-1.72), 1.62 (1.35-1.94), 1.90 (1.68-2.15), and 1.67 (1.48-1.89), respectively. Compared to NHRS, the 30-day, 30 to 90-day, 90-day to 1-year, and 1 to 3-year mortalityHRs of HRS were 1.03 (0.80-1.32), 2.13 (1.46-3.11), 1.58 (0.90-2.75), and 2.51 (1.41-4.48), respectively, in cirrhotic patients with ARF. These results indicate the effects of CKD and ESRD on the mortality of cirrhotic patients are distributed equally in every survival stage, whereas the effect of ARF appears only in the early stage. Compared to NHRS, HRS contributes to a higher mortality risk at the late survival stage.	[Hung, Tsung-Hsing; Tseng, Chih-Wei] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Gastroenterol, Dept Med, Chiayi, Taiwan; [Hung, Tsung-Hsing; Lay, Chorng-Jang; Tseng, Chih-Wei; Tsai, Chen-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lay, Chorng-Jang; Tsai, Chen-Chi] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Infect Dis, Dept Med, Chiayi, Taiwan; [Tsai, Chih-Chun] Tamkang Univ, Dept Math, Tamsui, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tamkang University	Tsai, CC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Tsai, CC (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Infect Dis, Dept Med, Chiayi, Taiwan.	antibody_1@msn.com	Tseng, Chih-Wei/AAP-8291-2020	Tseng, Chih-Wei/0000-0002-6951-4646				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Angeli P, 2015, GUT, V64, P1616, DOI 10.1136/gutjnl-2014-307526; Angeli P, 2015, GUT, V64, P531, DOI 10.1136/gutjnl-2014-308874; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Cholongitas E, 2009, EUR J GASTROEN HEPAT, V21, P744, DOI 10.1097/MEG.0b013e328308bb9c; de Carvalho GC, 2012, ANN HEPATOL, V11, P90; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Ghosh S, 2013, LIVER INT, V33, P1187, DOI 10.1111/liv.12179; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gluud LL, 2010, HEPATOLOGY, V51, P576, DOI 10.1002/hep.23286; Hartleb M, 2012, WORLD J GASTROENTERO, V18, P3035, DOI 10.3748/wjg.v18.i24.3035; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; HSU HC, 1983, CANCER-AM CANCER SOC, V52, P1825, DOI 10.1002/1097-0142(19831115)52:10<1825::AID-CNCR2820521011>3.0.CO;2-M; Hung TH, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000079; Hung TH, 2012, CLIN GASTROENTEROL H, V10, P677, DOI 10.1016/j.cgh.2012.02.026; Karvellas CJ, 2015, CRIT CARE CLIN, V31, P737, DOI 10.1016/j.ccc.2015.06.009; KELLER F, 1995, RENAL FAILURE, V17, P135, DOI 10.3109/08860229509026250; Maiwall R, 2015, HEPATOL INT, V9, P627, DOI 10.1007/s12072-015-9653-x; Martin-Llahi M, 2011, GASTROENTEROLOGY, V140, P488, DOI 10.1053/j.gastro.2010.07.043; Nadkarni GN, 2016, HEPATOL INT, V10, P525, DOI 10.1007/s12072-016-9706-9; Nassar AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107466; Piano S, 2013, J HEPATOL, V59, P482, DOI 10.1016/j.jhep.2013.03.039; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Singh V, 2012, J HEPATOL, V56, P1293, DOI 10.1016/j.jhep.2012.01.012; Thuluvath PJ, 2001, AM J GASTROENTEROL, V96, P1232, DOI 10.1111/j.1572-0241.2001.03708.x	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162987	10.1371/journal.pone.0162987	http://dx.doi.org/10.1371/journal.pone.0162987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631098	gold, Green Submitted, Green Published			2022-12-26	WOS:000383706900109
J	Kuprian, E; Tuong, TD; Pfaller, K; Wagner, J; Livingston, DP; Neuner, G				Kuprian, Edith; Tuong, Tan D.; Pfaller, Kristian; Wagner, Johanna; Livingston, David P., III; Neuner, Gilbert			Persistent Supercooling of Reproductive Shoots Is Enabled by Structural Ice Barriers Being Active Despite an Intact Xylem Connection	PLOS ONE			English	Article							FROST-RESISTANCE; FLOWER BUDS; CELL-WALL; COLD-ACCLIMATION; THERMAL-ANALYSIS; FREEZING AVOIDANCE; PLANTS; WINTER; PROPAGATION; NUCLEATION	Extracellular ice nucleation usually occurs at mild subzero temperatures in most plants. For persistent supercooling of certain plant parts ice barriers are necessary to prevent the entry of ice from already frozen tissues. The reproductive shoot of Calluna vulgaris is able to supercool down to below -22 degrees C throughout all developmental stages (shoot elongation, flowering, fruiting) despite an established xylem conductivity. After localization of the persistent ice barrier between the reproductive and vegetative shoot at the base of the pedicel by infrared differential thermal analysis, the currently unknown structural features of the ice barrier tissue were anatomically analyzed on cross and longitudinal sections. The ice barrier tissue was recognized as a 250 mu m long constriction zone at the base of the pedicel that lacked pith tissue and intercellular spaces. Most cell walls in this region were thickened and contained hydrophobic substances (lignin, suberin, and cutin). A few cell walls had what appeared to be thicker cellulose inclusions. In the ice barrier tissue, the area of the xylem was as much as 5.7 times smaller than in vegetative shoots and consisted of tracheids only. The mean number of conducting units in the xylem per cross section was reduced to 3.5% of that in vegetative shoots. Diameter of conducting units and tracheid length were 70% and 60% (respectively) of that in vegetative shoots. From vegetative shoots water transport into the ice barrier must pass pit membranes that are likely impermeable to ice. Pit apertures were about 1.9 mu m x 0.7 mu m, which was significantly smaller than in the vegetative shoot. The peculiar anatomical features of the xylem at the base of the pedicel suggest that the diameter of pores in pit membranes could be the critical constriction for ice propagation into the persistently supercooled reproductive shoots of C. vulgaris.	[Kuprian, Edith; Wagner, Johanna; Neuner, Gilbert] Univ Innsbruck, Inst Bot, Innsbruck, Austria; [Tuong, Tan D.; Livingston, David P., III] USDA ARS, Raleigh, NC 27695 USA; [Tuong, Tan D.; Livingston, David P., III] North Carolina State Univ, Raleigh, NC 27695 USA; [Pfaller, Kristian] Med Univ Innsbruck, Div Histol & Embryol, Innsbruck, Austria	University of Innsbruck; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Medical University of Innsbruck	Kuprian, E (corresponding author), Univ Innsbruck, Inst Bot, Innsbruck, Austria.	Edith.Kuprian@uibk.ac.at	Neuner, Gilbert/J-9909-2017	Neuner, Gilbert/0000-0003-2415-6125	Austrian Science Fund [23681 - B16]; Austrian Science Fund (FWF) [P 23681] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grant number: 23681 - B16 from the Austrian Science Fund: https://www.fwf.ac.at/.	Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; ASHWORTH EN, 1992, PLANT CELL ENVIRON, V15, P607, DOI 10.1111/j.1365-3040.1992.tb01495.x; ASHWORTH EN, 1984, PLANT PHYSIOL, V76, P201, DOI 10.1104/pp.76.1.201; ASHWORTH EN, 1984, PLANT PHYSIOL, V74, P862, DOI 10.1104/pp.74.4.862; ASHWORTH EN, 1985, PLANT PHYSIOL, V79, P1033, DOI 10.1104/pp.79.4.1033; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; Carlquist S, 2002, AM J BOT, V89, P185, DOI 10.3732/ajb.89.2.185; Carter J, 2001, HORTSCIENCE, V36, P1027, DOI 10.21273/HORTSCI.36.6.1027; CHALKERSCOTT L, 1992, ANN BOT-LONDON, V70, P409, DOI 10.1093/oxfordjournals.aob.a088496; Fuller M, 2003, ANN APPL BIOL, V143, P93, DOI 10.1111/j.1744-7348.2003.tb00273.x; GEORGE MF, 1977, PLANT PHYSIOL, V59, P326, DOI 10.1104/pp.59.2.326; GEORGE MF, 1982, CRYOBIOLOGY, V19, P628, DOI 10.1016/0011-2240(82)90192-4; GIMINGHAM CH, 1960, J ECOL, V48, P455, DOI 10.2307/2257528; Greguss P., 1959, HOLZANATOMIE EUROPAI; Hacker J, 2007, TREE PHYSIOL, V27, P1661, DOI 10.1093/treephys/27.12.1661; Hacker J, 2011, PLANT SCI, V180, P149, DOI 10.1016/j.plantsci.2010.07.013; Hacker J, 2008, ARCT ANTARCT ALP RES, V40, P660, DOI 10.1657/1523-0430(07-077)[HACKER]2.0.CO;2; ISHIKAWA M, 1981, PLANT CELL PHYSIOL, V22, P953; ISHIKAWA M, 1985, PLANT CELL ENVIRON, V8, P333, DOI 10.1111/j.1365-3040.1985.tb01407.x; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Jones KS, 2000, CAN J BOT, V78, P3, DOI 10.1139/cjb-78-1-3; Julian C, 2007, J APPL BOT FOOD QUAL, V81, P21; Korner C., 2003, ALPINE PLANT LIFE, P344, DOI [10.1007/978-3-642-18970-8, DOI 10.1007/978-3-642-18970-8]; Kubacka-Zebalska M, 1999, PLANT SCI, V148, P59, DOI 10.1016/S0168-9452(99)00122-3; Kuprian E, 2014, ENVIRON EXP BOT, V106, P4, DOI 10.1016/j.envexpbot.2014.01.011; Ladinig U, 2013, OECOLOGIA, V171, P743, DOI 10.1007/s00442-012-2581-8; Landolt E, 1992, UNSERE ALPENFLORA; Livingston DP, 2009, CROP SCI, V49, P1837, DOI 10.2135/cropsci2009.02.0077; Neuner G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00654; Neuner G, 2014, METHODS MOL BIOL, V1166, P91, DOI 10.1007/978-1-4939-0844-8_9; Neuner G, 2013, PHYSIOL PLANTARUM, V147, P88, DOI 10.1111/j.1399-3054.2012.01616.x; Neuner G, 2012, PLANTS IN ALPINE REGIONS: CELL PHYSIOLOGY OF ADAPTION AND SURVIVAL STRATEGIES, P163, DOI 10.1007/978-3-7091-0136-0_12; Pearce RS, 2001, ANN BOT-LONDON, V87, P417, DOI 10.1006/anbo.2000.1352; Pramsohler M, 2013, TREE PHYSIOL, V33, P807, DOI 10.1093/treephys/tpt057; QUAMME HA, 1978, J AM SOC HORTIC SCI, V103, P57; QUAMME HA, 1995, J AM SOC HORTIC SCI, V120, P814, DOI 10.21273/JASHS.120.5.814; Rajashekar CB, 1996, PLANT PHYSIOL, V111, P605, DOI 10.1104/pp.111.2.605; Sakai A., 1987, Frost survival of plants. Responses and adaptation to freezing stress.; Schulte PJ, 2003, J EXP BOT, V54, P1597, DOI 10.1093/jxb/erg169; Schweingruber FH, 2013, ATLAS STEM ANATOMY H, VII, DOI [10.1007/978-3-642-20435-7, DOI 10.1007/978-3-642-20435-7]; Sitte P, 2002, STRASBURGER LEHRBUCH; Solecka D, 2008, ANN BOT-LONDON, V101, P521, DOI 10.1093/aob/mcm329; Stefanowska M, 1999, ANN BOT-LONDON, V84, P313, DOI 10.1006/anbo.1999.0924; STONE W, 1993, ANN BOT-LONDON, V72, P613, DOI 10.1006/anbo.1993.1152; Taschler D, 2004, PLANT CELL ENVIRON, V27, P737, DOI 10.1111/j.1365-3040.2004.01176.x; Tyree M. T., 2002, SPR S WOOD; Vandvik V, 2005, J APPL ECOL, V42, P139, DOI 10.1111/j.1365-2664.2005.00982.x; WEISER RL, 1990, PLANT PHYSIOL, V93, P1021, DOI 10.1104/pp.93.3.1021; WISNIEWSKI M, 1995, TREES-STRUCT FUNCT, V9, P253, DOI 10.1007/BF00202015; Wisniewski M, 1997, PLANT PHYSIOL, V113, P327, DOI 10.1104/pp.113.2.327; Wisniewski ME, 2009, PLANT COLD HARDINESS: FROM THE LABORATORY TO THE FIELD, P1, DOI 10.1079/9781845935139.0001; Wisniewski M, 2015, JOVE-J VIS EXP, DOI 10.3791/52703; Wisniewski M, 2014, ENVIRON EXP BOT, V99, P133, DOI 10.1016/j.envexpbot.2013.11.011; Workmaster BAA, 1999, J AM SOC HORTIC SCI, V124, P619, DOI 10.21273/JASHS.124.6.619	54	28	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163160	10.1371/journal.pone.0163160	http://dx.doi.org/10.1371/journal.pone.0163160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632365	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900137
J	Lin, CT; Lin, TH; Wu, CC; Wan, L; Huang, CF; Peng, HL				Lin, Ching-Ting; Lin, Tien-Huang; Wu, Chien-Chen; Wan, Lei; Huang, Chun-Fa; Peng, Hwei-Ling			CRP-Cyclic AMP Regulates the Expression of Type 3 Fimbriae via Cyclic di-GMP in Klebsiella pneumoniae	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; RECEPTOR PROTEIN; CATABOLITE REPRESSION; GENE-EXPRESSION; ANTIBIOTIC-RESISTANCE; SERRATIA-MARCESCENS; CPDA GENE; TRANSCRIPTION; BINDING	Klebsiella pneumoniae is the predominant pathogen isolated from liver abscesses of diabetic patients in Asian countries. However, the effects of elevated blood glucose levels on the virulence of this pathogen remain largely unknown. Type 3 fimbriae, encoded by the mrkABCDF genes, are important virulence factors in K. pneumoniae pathogenesis. In this study, the effects of exogenous glucose and the intracellular cyclic AMP (cAMP) signaling pathway on type 3 fimbriae expression regulation were investigated. The production of MrkA, the major subunit of type 3 fimbriae, was increased in glucose-rich medium, whereas cAMP supplementation reversed the effect. MrkA production was markedly increased by cyaA or crp deletion, but slightly decreased by cpdA deletion. In addition, the mRNA levels of mrkABCDF genes and the activity of P-mrkA were increased in Delta crp strain, as well as the mRNA levels of mrkHIJ genes that encode cyclic di-GMP (c-di-GMP)-related regulatory proteins that influence type 3 fimbriae expression. Moreover, the activities of P-mrkHI and P-mrkJ were decreased in Delta lacZ Delta crp strain. These results indicate that CRP-cAMP down-regulates mrkABCDF and mrkHIJ at the transcriptional level. Further deletion of mrkH or mrkI in Delta crp strain diminished the production of MrkA, indicating that MrkH and MrkI are required for the CRP regulation of type 3 fimbriae expression. Furthermore, the high activity of P-mrkHI in the Delta lacZ Delta crp strain was diminished in Delta lacZ Delta crp Delta mrkHI, but increased in the Delta lacZ Delta crp Delta mrkJ strain. Deletion of crp increased the intracellular c-di-GMP concentration and reduced the phosphodiesterase activity. Moreover, we found that the mRNA levels of multiple genes related to c-di-GMP metabolism were altered in Delta crp strain. These indicate that CRP regulates type 3 fimbriae expression indirectly via the c-di-GMP signaling pathway. In conclusion, we found evidence of a coordinated regulation of type 3 fimbriae expression by the CRP-cAMP and c-di-GMP signaling pathways in K. pneumoniae.	[Lin, Ching-Ting; Wan, Lei; Huang, Chun-Fa] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Lin, Tien-Huang] Taichung Tzu Chi Hosp, Div Urol, Buddhist Tzu Chi Med Fdn, Taichung, Taiwan; [Lin, Tien-Huang] Tzu Chi Univ, Sch Post Baccalaureate Chinese Med, Hualien, Taiwan; [Wu, Chien-Chen; Peng, Hwei-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan	China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Tzu Chi University; National Yang Ming Chiao Tung University	Lin, CT (corresponding author), China Med Univ, Sch Chinese Med, Taichung, Taiwan.; Peng, HL (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.	gingting@mail.cmu.edu.tw; hlpeng@cc.nctu.edu.tw			Ministry of Science and Technology [MOST 104-2320-B-039-037-]; Taichung Tzuchi Hospital; Buddhist Tzu Chi Medical Foundation [TTCRD103-10]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taichung Tzuchi Hospital; Buddhist Tzu Chi Medical Foundation	The work is supported by the grant from Ministry of Science and Technology (MOST 104-2320-B-039-037-) and Taichung Tzuchi Hospital, The Buddhist Tzu Chi Medical Foundation (TTCRD103-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Di Martino P, 2003, RES MICROBIOL, V154, P9, DOI 10.1016/S0923-2508(02)00004-9; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; EBRIGHT RH, 1993, MOL MICROBIOL, V8, P797, DOI 10.1111/j.1365-2958.1993.tb01626.x; EISENSTEIN BI, 1981, J BACTERIOL, V145, P620, DOI 10.1128/JB.145.1.620-623.1981; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Fong JCN, 2008, J BACTERIOL, V190, P6646, DOI 10.1128/JB.00466-08; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P309; Goncalves MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099995; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HORNICK DB, 1992, INFECT IMMUN, V60, P1577, DOI 10.1128/IAI.60.4.1577-1588.1992; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066740; Imamura R, 1996, J BIOL CHEM, V271, P25423, DOI 10.1074/jbc.271.41.25423; ISHIZUKA H, 1993, MOL MICROBIOL, V10, P341, DOI 10.1111/j.1365-2958.1993.tb01960.x; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Kalivoda EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071267; Kim HS, 2009, J BACTERIOL, V191, P922, DOI 10.1128/JB.01350-08; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Lavender H, 2005, INT J MED MICROBIOL, V295, P153, DOI 10.1016/j.ijmm.2005.04.001; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lim B, 2007, J BACTERIOL, V189, P717, DOI 10.1128/JB.00834-06; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054430; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Lin TH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/621701; Livrelli V, 1996, J CLIN MICROBIOL, V34, P1963, DOI 10.1128/JCM.34.8.1963-1969.1996; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Morgan R, 2006, J BACTERIOL, V188, P7335, DOI 10.1128/JB.00599-06; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; Murphy CN, 2012, FUTURE MICROBIOL, V7, P991, DOI [10.2217/fmb.12.74, 10.2217/FMB.12.74]; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; PETERKOFSKY A, 1971, P NATL ACAD SCI USA, V68, P2794, DOI 10.1073/pnas.68.11.2794; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; SAIER MH, 1978, J BACTERIOL, V134, P356, DOI 10.1128/JB.134.1.356-358.1978; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Sebghati TA, 1999, INFECT IMMUN, V67, P1672; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Spurbeck RR, 2013, J BACTERIOL, V195, P3156, DOI 10.1128/JB.02254-12; Stella NA, 2014, ARCH MICROBIOL, V196, P323, DOI 10.1007/s00203-014-0970-6; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tan JWH, 2015, J BACTERIOL, V197, P1659, DOI 10.1128/JB.02615-14; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; Vuotto C, 2014, PATHOGENS, V3, P743, DOI 10.3390/pathogens3030743; Wang Q, 2016, CANCER BIOMARK, V16, P1, DOI 10.3233/CBM-150535; Wang ZC, 2013, MICROBIOL-SGM, V159, P1402, DOI 10.1099/mic.0.067793-0; Weyand NJ, 2001, MOL MICROBIOL, V39, P1504, DOI 10.1046/j.1365-2958.2001.02338.x; White-Ziegler CA, 2000, J BACTERIOL, V182, P6391, DOI 10.1128/JB.182.22.6391-6400.2000; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2012, MICROBIOL-SGM, V158, P1045, DOI 10.1099/mic.0.053801-0; Wu JH, 2005, EXP BIOL MED, V230, P757, DOI 10.1177/153537020523001009; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079038; Yang YS, 2009, J CLIN MICROBIOL, V47, P3336, DOI 10.1128/JCM.00918-09; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	73	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162884	10.1371/journal.pone.0162884	http://dx.doi.org/10.1371/journal.pone.0162884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631471	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900091
J	Popova, TG; Teunis, A; Espina, V; Liotta, LA; Popov, SG				Popova, Taissia G.; Teunis, Allison; Espina, Virginia; Liotta, Lance A.; Popov, Serguei G.			Chemokine-Releasing Microparticles Improve Bacterial Clearance and Survival of Anthrax Spore-Challenged Mice	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; BACILLUS-ANTHRACIS; LISTERIA-MONOCYTOGENES; LEUKOCYTE RECRUITMENT; MURINE MODEL; RESISTANCE; NANOPARTICLES; INTERLEUKIN-8; RESPONSES; CHEMOTAXIS	In this study the hydrogel microparticles (MPs) were used to enhance migration of neutrophils in order to improve outcome of anthrax infection in a mouse model. Two MP formulations were tested. In the first one the polyacrylamide gel MPs were chemically coupled with Cibacron Blue (CB) affinity bait. In the second one the bait molecules within the MPs were additionally loaded with neutrophil-attracting chemokines (CKs), human CXCL8 and mouse CCL3. A non-covalent interaction of the bait with the CKs provided their gradual release after administration of the MPs to the host. Mice were challenged into footpads with Bacillus anthracis Sterne spores and given a dose of MPs a few hours before and/or after the spores. Pre-treatment with a single dose of CK-releasing MPs without any additional intervention was able to induce influx of neutrophils to the site of spore inoculation and regional lymph nodes correlating with reduced bacterial burden and decreased inflammatory response in footpads. On average, in two independent experiments, up to 53% of mice survived over 13 days. All control spore-challenged but MP-untreated mice died. The CB-coupled particles were also found to improve survival likely due to the capacity to stimulate release of endogenous CKs, but were less potent at decreasing the inflammatory host response than the CK-releasing MPs. The CK post-treatment did not improve survival compared to the untreated mice which died within 4 to 6 days with a strong inflammation of footpads, indicating quick dissemination of spores though the lymphatics after challenge. This is the first report on the enhanced innate host resistance to anthrax in response to CKs delivered and/or endogenously induced by the MPs.	[Popova, Taissia G.; Espina, Virginia; Liotta, Lance A.] George Mason Univ, Sch Syst Biol, Dept Mol Microbiol, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA; [Teunis, Allison; Popov, Serguei G.] George Mason Univ, Sch Syst Biol, Dept Mol Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA	George Mason University; George Mason University	Popov, SG (corresponding author), George Mason Univ, Sch Syst Biol, Dept Mol Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA.	spopov@gmu.edu		Espina, Virginia/0000-0001-5080-5972	National Institutes of Health, USA [1R21AI117425-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117425] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grant 1R21AI117425-01 from the National Institutes of Health, USA (SP VE and LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Barakat LA, 2002, JAMA-J AM MED ASSOC, V287, P863, DOI 10.1001/jama.287.7.863; Bonecchi R, 1999, J IMMUNOL, V162, P474; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Nguyen C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-2; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; Cote CK, 2008, MICROBES INFECT, V10, P613, DOI 10.1016/j.micinf.2008.02.006; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Gao D, 2008, NANO LETT, V8, P3320, DOI 10.1021/nl8017274; Garraud K, 2012, INFECT IMMUN, V80, P131, DOI 10.1128/IAI.05988-11; Garvy BA, 1996, INFLAMMATION, V20, P499, DOI 10.1007/BF01487042; Goncalves DM, 2011, THESCIENTIFICWORLDJO, V11, P1877, DOI 10.1100/2011/768350; GRAHAM GJ, 1994, J BIOL CHEM, V269, P4974; Guichard A, 2012, MICROBES INFECT, V14, P97, DOI 10.1016/j.micinf.2011.08.016; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jeyaseelan S, 2006, J IMMUNOL, V177, P538, DOI 10.4049/jimmunol.177.1.538; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Klemola K., 2007, AUTEX RES J, V7, P224; Kobayashi SD, 2009, WIRES SYST BIOL MED, V1, P309, DOI 10.1002/wsbm.32; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kress H, 2009, NAT METHODS, V6, P905, DOI 10.1038/nmeth.1400; Kumamoto T, 2002, NAT BIOTECHNOL, V20, P64, DOI 10.1038/nbt0102-64; Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1; Lisanby MW, 2008, J IMMUNOL, V181, P4989, DOI 10.4049/jimmunol.181.7.4989; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Marshall AJ, 1998, INFECT IMMUN, V66, P1325, DOI 10.1128/IAI.66.4.1325-1333.1998; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mejia JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013546; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Paccani SR, 2007, CELL MICROBIOL, V9, P924, DOI 10.1111/j.1462-5822.2006.00840.x; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Popova TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129860; Popova TG, 2015, NANOMATERIALS-BASEL, V5, P298, DOI 10.3390/nano5010298; Popova TG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110873; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Raymond B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000359; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Romani L, 1997, J IMMUNOL, V158, P5349; Romani L, 1997, J IMMUNOL, V158, P2356; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Singer M, 2004, J IMMUNOL, V173, P4197, DOI 10.4049/jimmunol.173.6.4197; STANDIFORD TJ, 1995, J IMMUNOL, V155, P1515; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; van de Weert M, 2000, PHARM RES-DORDR, V17, P1159, DOI 10.1023/A:1026498209874; van Sorge NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002964; WELKOS SL, 1989, MICROB PATHOGENESIS, V7, P15, DOI 10.1016/0882-4010(89)90108-3; Wenger Y, 2011, TOXICOL APPL PHARM, V251, P181, DOI 10.1016/j.taap.2010.11.017; Yang Q, 2013, INFECT IMMUN, V81, P1751, DOI 10.1128/IAI.01409-12; Zeilhofer HU, 2000, CURR OPIN HEMATOL, V7, P178, DOI 10.1097/00062752-200005000-00009; Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003	58	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163163	10.1371/journal.pone.0163163	http://dx.doi.org/10.1371/journal.pone.0163163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632537	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900138
J	Prost, S; Kishen, REB; Kluth, DC; Bellamy, COC				Prost, Sandrine; Kishen, Ria E. B.; Kluth, David C.; Bellamy, Christopher O. C.			Choice of Illumination System & Fluorophore for Multiplex Immunofluorescenceon FFPE Tissue Sections	PLOS ONE			English	Article							QUANTUM DOTS; CELLS; IMMUNOHISTOCHEMISTRY; AUTOFLUORESCENCE	The recent availability of novel dyes and alternative light sources to facilitate complex tissue immunofluorescence studies such as multiplex labelling has not been matched by reports critically evaluating the considerations and relative benefits of these new tools, particularly in combination. Product information is often limited to wavelengths used for older fluorophores (FITC, TRITC & corresponding Alexa dyes family). Consequently, novel agents such as Quantum dots are not widely appreciated or used, despite highly favourable properties including extremely bright emission, stability and potentially reduced tissue autofluorescence at the excitation wavelength. Using spectral analysis, we report here a detailed critical appraisal and comparative evaluation of different light sources and fluorophores in multiplex immunofluorescence of clinical biopsy sections. The comparison includes mercury light, metal halide and 3 different LED-based systems, using 7 Qdots (525, 565, 585, 605, 625, 705), Cy3 and Cy5. We discuss the considerations relevant to achieving the best combination of light source and fluorophore for accurate multiplex fluorescence quantitation. We highlight practical limitations and confounders to quantitation with filter-based approaches.	[Prost, Sandrine; Kishen, Ria E. B.] Univ Edinburgh, Dept Pathol, Deanery Mol Genet & Publ Hlth Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Kluth, David C.] Univ Edinburgh, Edinburgh Med Sch, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Univ Edinburgh, Royal Infirm Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Prost, S (corresponding author), Univ Edinburgh, Dept Pathol, Deanery Mol Genet & Publ Hlth Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.	s.prost@ed.ac.uk		prost, sandrine/0000-0002-0140-7115	CSO (Chief Scientist Office Scotland) [ETM/189]; University of Edinburgh Development Trust [GR01858]; Chief Scientist Office [ETM/189] Funding Source: researchfish	CSO (Chief Scientist Office Scotland); University of Edinburgh Development Trust; Chief Scientist Office	The work was supported by a project grant from the CSO (Chief Scientist Office Scotland) ETM/189 to David Kluth, Christopher Bellamy & Sandrine Prost; a Moray Endowment Fund award to Sandrine Prost (University of Edinburgh), and an Innovation grant (GR01858) from the University of Edinburgh Development Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, US MAN NUANC 3 0 2; [Anonymous], 2010, MOL PROB HDB; Aswani KJ T., 2012, MICROSCOPY TODAY, V20, P18; Beacher J., 2008, BIOPHOTONICS INT, V15, P34; Biolegend, FLUOR SPECTR AN 2016; Brown CM, 2007, J CELL SCI, V120, P3488, DOI 10.1242/jcs.022079; Croce AC, 2014, EUR J HISTOCHEM, V58, P320, DOI 10.4081/ejh.2014.2461; Diebele I, 2012, BIOMED OPT EXPRESS, V3, P467, DOI 10.1364/BOE.3.000467; Evans EW, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0037; Goldman ER, 2005, METH MOL B, V303, P19; Hoffman G., 2008, SHORT COURSE; Hoffman GE, 2008, CURRENT PROTOCOLS NE, DOI [10.1364/BOE.3.000467, DOI 10.1364/BOE.3.000467]; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; Levenson RM, 2006, CYTOM PART A, V69A, P592, DOI 10.1002/cyto.a.20292; Lumencor, SOL LIGHT ENG SOL ST; Ma B, 2006, ACTA HISTOCHEM, V108, P243, DOI 10.1016/j.acthis.2006.02.002; Mansfield JR, 2001, CURRENT PROTOCOLS MO; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Osman TA, 2013, EUR J HISTOCHEM, V57, P143, DOI 10.4081/ejh.2013.e22; Pautke C, 2007, J ANAT, V210, P117, DOI 10.1111/j.1469-7580.2006.00660.x; Pinaud F, 2006, BIOMATERIALS, V27, P1679, DOI 10.1016/j.biomaterials.2005.11.018; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Schieker M, 2007, J ANAT, V210, P592, DOI 10.1111/j.1469-7580.2007.00716.x; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Taylor CR, 2006, HISTOPATHOLOGY, V49, P411, DOI 10.1111/j.1365-2559.2006.02513.x; ThermoFisher, 2016, FLURO SPETRAVIEWER 2; Tholouli E, 2008, J PATHOL, V216, P275, DOI 10.1002/path.2421; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Viegas MS, 2007, EUR J HISTOCHEM, V51, P59; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Zeiss, FILT ASS 2016; Zeiss, 2016, FUND LIGHT EM DIOD	34	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162419	10.1371/journal.pone.0162419	http://dx.doi.org/10.1371/journal.pone.0162419			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632367	Green Submitted, gold, Green Published			2022-12-26	WOS:000383706900046
J	Salmiheimo, A; Mustonen, H; Stenman, UH; Puolakkainen, P; Kemppainen, E; Seppanen, H; Haglund, C				Salmiheimo, Aino; Mustonen, Harri; Stenman, Ulf-Hakan; Puolakkainen, Pauli; Kemppainen, Esko; Seppanen, Hanna; Haglund, Caj			Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEUTROPHIL-LYMPHOCYTE RATIO; PROGNOSTIC SCORE; CANCER; MECHANISMS; RESECTION; COLON	Background Estimation of the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) currently relies on tumour-related factors such as resection margins and on lymph-node ratio (LNR) both inconveniently available only postoperatively. Our aim was to assess the accuracy of preoperative laboratory data in predicting PDAC prognosis. Methods Collection of laboratory and clinical data was retrospective from 265 consecutive patients undergoing surgery for PDAC at Helsinki University Hospital. Cancer-specific survival assessment utilized Kaplan-Meier analysis, and independent associations between factors were by the Cox regression model. Results During follow-up, 76% of the patients died of PDAC, with a median survival time of 19.6 months. In univariate analysis, CRP, albumin, CEA, and CA19-9 were significantly associated with postoperative cancer-specific survival. In multivariate analysis, taking into account age, gender, LNR, resection margins, tumour status, and adjuvant chemotherapy, the preoperative biomarkers independently associated with adverse prognosis were hypoalbuminemia (< 36 g/L, hazard ratio (HR) 1.56, 95% confidence interval (CI) 1.10-2.19, p = 0.011), elevated CRP (> 5 mg/L, HR 1.44, 95% CI 1.03-2.02, p = 0.036), CEA (> 5 mu g/L, HR 1.60, 95% CI 1.07-2.53, p = 0.047), and CA19-9 (>= 555 kU/L, HR 1.91, 95% CI 1.18-3.08, p = 0.008). Conclusion For patients with resectable PDAC, preoperative CRP, along with albumin and tumour markers, is useful for predicting prognosis.	[Salmiheimo, Aino; Mustonen, Harri; Puolakkainen, Pauli; Kemppainen, Esko; Seppanen, Hanna; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Salmiheimo, Aino; Mustonen, Harri; Stenman, Ulf-Hakan; Puolakkainen, Pauli; Kemppainen, Esko; Seppanen, Hanna; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Stenman, Ulf-Hakan] Univ Helsinki, Dept Clin Chem, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Res Programs Unit, Translat Canc Biol Program, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Salmiheimo, A (corresponding author), Univ Helsinki, Dept Surg, Helsinki, Finland.	aino.koski@helsinki.fi	Haglund, Caj/N-1240-2019; Seppänen, Hanna/AER-1337-2022	Stenman, Ulf-Hakan/0000-0002-2695-3454; Mustonen, Harri Kalevi/0000-0001-5632-6796	Finnish Cancer Society; Medicinska understodsforeningen Liv och Halsa; Mary and Georg C Ehrnrooth -foundation	Finnish Cancer Society; Medicinska understodsforeningen Liv och Halsa; Mary and Georg C Ehrnrooth -foundation	This work was supported by the Finnish Cancer Society (www.cancersociety.fi) to CH, Medicinska understodsforeningen Liv och Halsa (http://www.livochhalsa.fi/) to CH and Mary and Georg C Ehrnrooth -foundation (http://www.marygeorg.fi/) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2012, BMC MED, V10, DOI [10.1186/1741-7015-10-51, 10.1371/journal.pmed.1001216]; Atsumi T, 2014, CANCER RES, V74, P8, DOI 10.1158/0008-5472.CAN-13-2322; Benassai G, 2015, INT J SURG, V21, pS1, DOI 10.1016/j.ijsu.2015.06.050; Bockhorn M, 2014, SURGERY, V155, P977, DOI 10.1016/j.surg.2014.02.001; Boeck S, 2006, ONCOLOGY-BASEL, V70, P255, DOI 10.1159/000094888; Bower JE, 2013, BRAIN BEHAV IMMUN, V30, pS48, DOI 10.1016/j.bbi.2012.06.011; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Doumatey AP, 2014, CLIN BIOCHEM, V47, P315, DOI 10.1016/j.clinbiochem.2013.12.014; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Garcea G, 2008, J PANCREAS, V9, P99; Gebhardt C, 2000, LANGENBECK ARCH SURG, V385, P14, DOI 10.1007/s004230050004; Haas M, 2013, J CANCER RES CLIN, V139, P681, DOI 10.1007/s00432-012-1371-3; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Humphris JL, 2012, ANN ONCOL, V23, P1713, DOI 10.1093/annonc/mdr561; Kersten C, 2013, ACTA ONCOL, V52, P1691, DOI 10.3109/0284186X.2013.835494; La Torre M, 2012, ANN SURG ONCOL, V19, P2917, DOI 10.1245/s10434-012-2348-9; Laird BJ, 2013, ONCOLOGIST, V18, P1050, DOI 10.1634/theoncologist.2013-0120; Liu L, 2015, INT J CANCER, V136, P2216, DOI 10.1002/ijc.29242; LUNDIN J, 1994, BRIT J CANCER, V69, P515, DOI 10.1038/bjc.1994.93; MAGNANI JL, 1983, CANCER RES, V43, P5489; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Riediger H, 2009, J GASTROINTEST SURG, V13, P1337, DOI 10.1007/s11605-009-0919-2; Ruiz-Tovar J, 2010, REV ESP ENFERM DIG, V102, P631; Saito K, 2013, INT J UROL, V20, P161, DOI 10.1111/j.1442-2042.2012.03121.x; Sanjay P, 2012, J PANCREAS, V13, P199; Seppanen H, 2017, SCAND J SURG, V106, P54, DOI 10.1177/1457496916645963; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stevens L, 2015, HPB, V17, P285, DOI 10.1111/hpb.12355; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Szkandera J, 2014, BRIT J CANCER, V110, P183, DOI 10.1038/bjc.2013.701	36	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163064	10.1371/journal.pone.0163064	http://dx.doi.org/10.1371/journal.pone.0163064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632196	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900126
J	Wang, Q; Liu, L; Li, H; Tao, P; Qi, YN; Li, JY				Wang, Qiong; Liu, Li; Li, Hui; Tao, Ping; Qi, Yana; Li, Jiayuan			Effects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility	PLOS ONE			English	Article							GROWTH-FACTOR-I; IGF BINDING PROTEIN-3; CIRCULATING LEVELS; SERUM-LEVELS; POSTMENOPAUSAL WOMEN; OVARIAN-CANCER; FACTOR (IGF)-I; CHINESE WOMEN; RISK; ASSOCIATION	Background Polymorphisms of IGF-1 and IGFBP-3 and environmental factors may work together to influence insulin-like growth factor (IGF) levels and thus breast cancer (BC) risk. However, very few studies have investigated high-order interactions among these variables. Methods A total of 277 newly diagnosed BC cases and 277 controls were recruited between October 2010 and July 2012. We collected each participant's demographic characteristics, dietary intake, and blood sample. IGF-1 rs1520220 and IGFBP-3 rs2854744 were then genotyped. A multi-analytic strategy combining unconditional logistic regression (ULR), generalized multifactor dimensionality reduction (GMDR), and classification and regression tree (CART) approaches was applied to systematically identify the interactions of the two single nucleotide polymorphisms (SNPs), body mass index (BMI), and daily intake of soy isoflavone (DISI) on BC susceptibility. Results In GMDR analyses, high-order interactions among BMI, DISI, and SNP rs2854744 were identified among overall and postmenopausal women. We also found significant dosage effects on BC risk with an increasing number of exposure factors, namely carrying the rs2854744 AA genotype, DISI < 9.85 mg/day, and BMI >= 24 kg/m(2) (P (trend)<0.05). Similarly, in CART analyses, compared with individuals having BMI<24kg/m(2), DISI<9.85 mg/day, and the rs2854744 CC+CA genotype, BC risk increased significantly for those carrying the rs2854744 AA genotype, with BMI<24 kg/m(2) and DISI<9.85 mg/day (OR = 1.95, 95% CI: 1.03-3.69), and also for those with BMI >= 24kg/m(2) and DISI<9.85 mg/day (OR = 2.13, 95% CI: 1.00-4.51). Similar interaction effects were observed among postmenopausal women. Conclusions This study suggests high-order interactions of the IGFBP-3 rs2854744 AA genotype, BMI >= 24kg/m(2), and DISI<9.85 mg/day on increased BC risk, particularly among postmenopausal women.	[Wang, Qiong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Guangzhou, Guangdong, Peoples R China; [Wang, Qiong; Li, Hui; Li, Jiayuan] Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Liu, Li] Chengdu Womens & Childrens Cent Hosp, Comprehens Guidance Ctr Womens Hlth, Chengdu, Sichuan, Peoples R China; [Tao, Ping] Second Peoples Hosp Sichuan Prov, Dept Breast Surg, Chengdu, Sichuan, Peoples R China; [Qi, Yana] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China	Sun Yat Sen University; Sichuan University; Sichuan University	Li, JY (corresponding author), Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.	lijiayuan@scu.edu.cn	li, jia/GVT-7587-2022		Medical Scientific Research Foundation of Guangdong Province [A2015443]; National Natural Science Foundation of China [81602819, 81302500]; Medical Scientific Research Foundation of Sichuan Province [120520]	Medical Scientific Research Foundation of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Sichuan Province	Interpretation of data and manuscript writing was supported by: (1) Medical Scientific Research Foundation of Guangdong Province (funding number: A2015443). The first author QW received this funding. The URLs of funder's website is http://www.gdwst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; (2) National Natural Science Foundation of China (funding number: 81602819). The first author QW received this funding. The URLs of funder's website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; (3) National Natural Science Foundation of China (funding number: 81302500). The corresponding author JL received this funding. The URLs of funder's website is http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; (4) Medical Scientific Research Foundation of Sichuan Province (funding number: 120520). The co-first author LL received this funding. The URLs of funder's website is http://www.scwst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Andrew AS, 2008, HUM HERED, V65, P105, DOI 10.1159/000108942; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Canzian F, 2006, BRIT J CANCER, V94, P299, DOI 10.1038/sj.bjc.6602936; Chen WF, 2004, J CLIN ENDOCR METAB, V89, P2351, DOI 10.1210/jc.2003-032065; Crowe FL, 2011, ANN HUM BIOL, V38, P194, DOI 10.3109/03014460.2010.507221; Deal C, 2001, J CLIN ENDOCR METAB, V86, P1274, DOI 10.1210/jc.86.3.1274; Dong JY, 2011, BREAST CANCER RES TR, V125, P315, DOI 10.1007/s10549-010-1270-8; Ferlay J., 2008, GLOBOCAN 2008 V1 2 C; Ferlay J, 2002, GLOBOCAN 2002 V2 0 C; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Fletcher O, 2005, CANCER EPIDEM BIOMAR, V14, P2; Fowke JH, 2010, ENDOCR-RELAT CANCER, V17, P51, DOI 10.1677/ERC-09-0023; Gann PH, 2005, INT J CANCER, V116, P297, DOI 10.1002/ijc.21042; Garcia-Magarinos M, 2009, ANN HUM GENET, V73, P360, DOI 10.1111/j.1469-1809.2009.00511.x; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hakkak R, 2011, ONCOL LETT, V2, P29, DOI 10.3892/ol.2010.202; Hu XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067275; Jernstrom H, 2001, MOL GENET METAB, V72, P144, DOI 10.1006/mgme.2000.3130; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; Lagiou P, 2009, BRIT J CANCER, V100, P1794, DOI 10.1038/sj.bjc.6605074; Linos E, 2008, JNCI-J NATL CANCER I, V100, P1352, DOI 10.1093/jnci/djn305; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Liu XO, 2014, ASIAN PAC J CANCER P, V15, P1291, DOI 10.7314/APJCP.2014.15.3.1291; Lu LG, 2013, CARCINOGENESIS, V34, P2024, DOI 10.1093/carcin/bgt168; Lu LG, 2012, CARCINOGENESIS, V33, P2119, DOI 10.1093/carcin/bgs243; NCBI, 2015, DAT SINGL NUCL POL S; Patel AV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002578; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qian BY, 2011, BREAST CANCER RES TR, V130, P217, DOI 10.1007/s10549-011-1552-9; Qiu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036497; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rinaldi S, 2006, ENDOCR-RELAT CANCER, V13, P593, DOI 10.1677/erc.1.01150; Sarkissyan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103534; Schernhammer ES, 2003, INT J CANCER, V107, P60, DOI 10.1002/ijc.11358; Tao Ping, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P164; Wang J, 2016, CANCER EPIDEMIOL, V42, P1, DOI 10.1016/j.canep.2016.02.010; Wang Q, 2014, NANOTOXICOLOGY, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0108934; Wang Q, 2011, DNA CELL BIOL, V30, P585, DOI 10.1089/dna.2010.1195; Wang Qiong, 2010, Chin J Cancer, V29, P683; Wangen KE, 2000, J CLIN ENDOCR METAB, V85, P3043, DOI 10.1210/jc.85.9.3043; Wu YP, 2003, CANCER RES, V63, P4384; Yu H, 2002, CANCER EPIDEM BIOMAR, V11, P705; Zhai RH, 2010, J CLIN ONCOL, V28, P2445, DOI 10.1200/JCO.2009.26.2790	48	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162970	10.1371/journal.pone.0162970	http://dx.doi.org/10.1371/journal.pone.0162970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631779	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900103
J	Choi, YB; Yi, ES; Kang, JM; Lee, JW; Yoo, KH; Kim, YJ; Sung, KW; Koo, HH				Choi, Young Bae; Yi, Eun Sang; Kang, Ji-Man; Lee, Ji Won; Yoo, Keon Hee; Kim, Yae-Jean; Sung, Ki Woong; Koo, Hong Hoe			Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High- Risk or Recurrent Solid Tumors	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; ZOSTER-VIRUS INFECTION; CLOSTRIDIUM-DIFFICILE; FUNGAL-INFECTIONS; CANCER; RESCUE; RECIPIENTS; TRIAL; NEUROBLASTOMA; EPIDEMIOLOGY	We retrospectively analyzed infectious complications during tandem high-dose chemotherapy and autologous stem cell transplantation (HDCT/auto-SCT) in children and adolescents with high-risk or recurrent solid tumors. A total of 324 patients underwent their first HDCT/auto- SCT between October 2004 and September 2014, and 283 of them proceeded to their second HDCT/auto-SCT (a total of 607 HDCT/auto-SCTs). During the early transplant period of 607 HDCT/auto-SCTs (from the beginning of HDCT to day 30 post-transplant), bacteremia, urinary tract infection (UTI), respiratory virus infection, and varicella zoster virus (VZV) reactivation occurred in 7.1%, 2.3%, 13.0%, and 2.5% of HDCT/auto-SCTs, respectively. The early transplant period of the second HDCT/auto-SCT had infectious complications similar to the first HDCT/auto-SCT. During the late transplant period of HDCT/auto-SCT (from day 31 to 1 year post-transplant), bacteremia, UTI, and VZV reactivation occurred in 7.5%, 2.5%, and 3.9% of patients, respectively. Most infectious complications in the late transplant period occurred during the first 6 months post-transplant. There were no invasive fungal infections during the study period. Six patients died from infectious complications (4 from bacterial sepsis and 2 from respiratory virus infection). Our study suggests that infectious complications are similar following second and first HDCT/auto-SCT in children.	[Choi, Young Bae] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea; [Yi, Eun Sang; Kang, Ji-Man; Lee, Ji Won; Yoo, Keon Hee; Kim, Yae-Jean; Sung, Ki Woong; Koo, Hong Hoe] Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea; [Yi, Eun Sang; Kang, Ji-Man; Lee, Ji Won; Yoo, Keon Hee; Kim, Yae-Jean; Sung, Ki Woong; Koo, Hong Hoe] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Sung, KW (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pediat, Seoul, South Korea.; Sung, KW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea.	kwsped@skku.edu		Yi, Eun Sang/0000-0001-8214-2106	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI13C1521]; Astellas Pharma Korea, Inc.	Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Astellas Pharma Korea, Inc.	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (No. HI13C1521) and by Astellas Pharma Korea, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso CD, 2013, BIOL BLOOD MARROW TR, V19, P1502, DOI 10.1016/j.bbmt.2013.07.022; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Auner HW, 2002, ANN HEMATOL, V81, P374, DOI 10.1007/s00277-002-0484-1; Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Barton TD, 2001, CLIN INFECT DIS, V32, P391, DOI 10.1086/318491; Berman JN, 2006, BONE MARROW TRANSPL, V37, P73, DOI 10.1038/sj.bmt.1705191; Bilgrami S, 1999, BONE MARROW TRANSPL, V23, P469, DOI 10.1038/sj.bmt.1701594; Burke MJ, 2007, PEDIATR BLOOD CANCER, V49, P196, DOI 10.1002/pbc.21182; Costa PD, 2014, BRAZ J INFECT DIS, V18, P591, DOI 10.1016/j.bjid.2014.05.012; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; GOODMAN JL, 1992, NEW ENGL J MED, V326, P845, DOI 10.1056/NEJM199203263261301; KESSINGER A, 1991, BLOOD, V77, P211; KLUMPP TR, 1995, J CLIN ONCOL, V13, P1323, DOI 10.1200/JCO.1995.13.6.1323; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Lee SH, 2008, BONE MARROW TRANSPL, V42, P385, DOI 10.1038/bmt.2008.181; Leung TF, 2000, BONE MARROW TRANSPL, V25, P167, DOI 10.1038/sj.bmt.1702119; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Pinana JL, 2014, ANN HEMATOL, V93, P299, DOI 10.1007/s00277-013-1872-4; Mossad SB, 1996, BONE MARROW TRANSPL, V18, P265; Oliveira AL, 2007, BONE MARROW TRANSPL, V39, P775, DOI 10.1038/sj.bmt.1705677; Science M, 2014, PEDIATR BLOOD CANCER, V61, P393, DOI 10.1002/pbc.24847; Son MH, 2013, J KOREAN MED SCI, V28, P220, DOI 10.3346/jkms.2013.28.2.220; Srinivasan A, 2014, TRANSPL INFECT DIS, V16, P90, DOI 10.1111/tid.12165; Stram DO, 1996, J CLIN ONCOL, V14, P2417, DOI 10.1200/JCO.1996.14.9.2417; Styczynski J, 2009, BONE MARROW TRANSPL, V43, P757, DOI 10.1038/bmt.2008.386; Sung KW, 2013, BONE MARROW TRANSPL, V48, P68, DOI 10.1038/bmt.2012.86; Sung KW, 2012, J NEURO-ONCOL, V107, P335, DOI 10.1007/s11060-011-0745-8; Weaver CH, 1997, BONE MARROW TRANSPL, V19, P671, DOI 10.1038/sj.bmt.1700713; WIMPERIS JZ, 1991, BONE MARROW TRANSPL, V8, P363	29	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162178	10.1371/journal.pone.0162178	http://dx.doi.org/10.1371/journal.pone.0162178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627440	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600024
J	Noh, JY; Park, JK; Lee, DH; Yuk, SS; Kwon, JH; Lee, SW; Lee, JB; Park, SY; Choi, IS; Song, CS				Noh, Jin-Yong; Park, Jae-Keun; Lee, Dong-Hun; Yuk, Seong-Su; Kwon, Jung-Hoon; Lee, Sang-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon			Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals ( DIVA)	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; AVIAN INFLUENZA-VIRUS; GP5 PROTEIN; IMMUNOGENICITY; ANTIBODIES; BIRDS; SERA; H7	Highly pathogenic avian influenza (HPAI) and Newcastle disease (ND) are considered as the most devastating poultry infections, owing to their worldwide distribution and economical threat. Vaccines have been widely used to control these diseases in the poultry industry in endemic countries. However, vaccination policy without differentiating infected animals from vaccinated animals (DIVA) makes the virus surveillance difficult. In this study, we developed a bivalent virus-like particle (VLP) vaccine that is composed of the hemagglutinin (HA) and matrix 1 (M1) proteins of the H5N1 HPAI virus (HPAIV) and a chimeric protein containing the ectodomain of the ND virus (NDV) fusion (F) protein fused with the cytoplasmic and transmembrane domains of the HPAIV HA protein. A single immunization of chickens with the chimeric VLP vaccine induced high levels of hemagglutination inhibition (HI) antibody titers against H5N1 HPAI virus and anti-NDV antibody detected in ELISA and protected chickens against subsequent lethal HPAIV and NDV infections. Furthermore, we could easily perform DIVA test using the commercial NP-cELISA tests against HPAIV and HI assay against NDV. These results strongly suggest that utilization of chimeric VLP vaccine in poultry species would be a promising strategy for the better control of HPAI and ND simultaneously.	[Noh, Jin-Yong; Park, Jae-Keun; Lee, Dong-Hun; Yuk, Seong-Su; Kwon, Jung-Hoon; Lee, Sang-Won; Lee, Joong-Bok; Park, Seung-Yong; Choi, In-Soo; Song, Chang-Seon] Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea; [Park, Jae-Keun] NIAID, Viral Pathogenesis & Evolut Sect, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lee, Dong-Hun] USDA ARS, Southeast Poultry Res Lab, Athens, GA 30613 USA	Konkuk University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Agriculture (USDA)	Song, CS (corresponding author), Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul, South Korea.	songcs@konkuk.ac.kr	노, 진용/ABC-9303-2020; Youk, Sungsu/AAC-2316-2019	노, 진용/0000-0003-4824-2335; Youk, Sungsu/0000-0002-3106-3712; Park, Jaekeun/0000-0002-4506-8127	Animal Disease Management Technology Development Program, Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea [313013-3]	Animal Disease Management Technology Development Program, Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	This research was supported by the Animal Disease Management Technology Development Program (Grant No. 313013-3), Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; BEACH JR, 1948, J AM VET MED ASSOC, V112, P85; Brown C, 1999, VET PATHOL, V36, P125, DOI 10.1354/vp.36-2-125; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Deo VK, 2015, MOL PHARMACEUT, V12, P839, DOI 10.1021/mp500860x; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Kalthoff D, 2010, J VIROL, V84, P12002, DOI 10.1128/JVI.00940-10; Kim SH, 2014, VACCINE, V32, P4428, DOI 10.1016/j.vaccine.2014.06.061; Lee DH, 2015, J VIROL, V89, P6521, DOI 10.1128/JVI.00728-15; Lee DH, 2014, CLIN EXP VACCINE RES, V3, P133, DOI 10.7774/cevr.2014.3.2.133; Lee DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058186; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Liu QF, 2015, J VIROL, V89, P7401, DOI 10.1128/JVI.00031-15; Lv LS, 2014, J VET SCI, V15, P209, DOI 10.4142/jvs.2014.15.2.209; McLaws M, 2015, EPIDEMIOL INFECT, V143, P1632, DOI 10.1017/S0950268814002623; Park JK, 2014, CLIN VACCINE IMMUNOL, V21, P360, DOI 10.1128/CVI.00636-13; Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]; Senne DA, 2004, DEV BIOLOGICALS, V119, P165; Shafer AL, 1998, AVIAN DIS, V42, P28, DOI 10.2307/1592573; Shen HF, 2013, VIRUS RES, V178, P430, DOI 10.1016/j.virusres.2013.09.009; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; Suarez DL, 2012, AVIAN DIS, V56, P836, DOI 10.1637/10207-041512-Review.1; Suarez DL, 2005, BIOLOGICALS, V33, P221, DOI 10.1016/j.biologicals.2005.08.003; Swayne DE, 2009, COMP IMMUNOL MICROB, V32, P351, DOI 10.1016/j.cimid.2008.01.006; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; TOYODA T, 1988, J VIROL, V62, P4427, DOI 10.1128/JVI.62.11.4427-4430.1988; Tretyakova I, 2013, VIROLOGY, V442, P67, DOI 10.1016/j.virol.2013.03.027; Wang W, 2012, VACCINE, V30, P7072, DOI 10.1016/j.vaccine.2012.09.048; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; WHO, 2015, CUM NUMB CONF HUM CA; Xue CY, 2014, ARCH VIROL, V159, P3043, DOI 10.1007/s00705-014-2178-0	35	13	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162946	10.1371/journal.pone.0162946	http://dx.doi.org/10.1371/journal.pone.0162946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626934	gold, Green Published			2022-12-26	WOS:000383680600067
J	Toh, YF; Yew, SM; Chan, CL; Na, SL; Lee, KW; Hoh, CC; Yee, WY; Ng, KP; Kuan, CS				Toh, Yue Fen; Yew, Su Mei; Chan, Chai Ling; Na, Shiang Ling; Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan; Ng, Kee Peng; Kuan, Chee Sian			Genome Anatomy of Pyrenochaeta unguis-hominis UM 256, a Multidrug Resistant Strain Isolated from Skin Scraping	PLOS ONE			English	Article							CANDIDA-ALBICANS; TRANSPOSABLE ELEMENTS; FILAMENTOUS FUNGI; RIBOSOMAL DNA; PROTEIN; IDENTIFICATION; ANNOTATION; SEQUENCE; GENES; VISUALIZATION	Pyrenochaeta unguis-hominis is a rare human pathogen that causes infection in human skin and nail. P. unguis-hominis has received little attention, and thus, the basic biology and pathogenicity of this fungus is not fully understood. In this study, we performed in-depth analysis of the P. unguis-hominis UM 256 genome that was isolated from the skin scraping of a dermatitis patient. The isolate was identified to species level using a comprehensive multilocus phylogenetic analysis of the genus Pyrenochaeta. The assembled UM 256 genome has a size of 35.5 Mb and encodes 12,545 putative genes, and 0.34% of the assembled genome is predicted transposable elements. Its genomic features propose that the fungus is a heterothallic fungus that encodes a wide array of plant cell wall degrading enzymes, peptidases, and secondary metabolite biosynthetic enzymes. Antifungal drug resistance genes including MDR, CDR, and ERG11/CYP51 were identified in P. unguis-hominis UM 256, which may confer resistance to this fungus. The genome analysis of P. unguis-hominis provides an insight into molecular and genetic basis of the fungal lifestyles, understanding the unrevealed biology of antifungal resistance in this fungus.	[Toh, Yue Fen; Yew, Su Mei; Chan, Chai Ling; Na, Shiang Ling; Ng, Kee Peng; Kuan, Chee Sian] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Lee, Kok Wei; Hoh, Chee-Choong; Yee, Wai-Yan] Codon Genom SB, Seri Kembangan, Selangor Darul, Malaysia	Universiti Malaya	Kuan, CS (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	cs_sam85@yahoo.com.my			University of Malaya; High Impact Research MoE Grant from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/MED/31]; Codon Genomics SB	University of Malaya(Universiti Malaya); High Impact Research MoE Grant from the Ministry of Education Malaysia; Codon Genomics SB	This project was funded by University of Malaya research grants. This study was supported by High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/MED/31 (Account no. H-20001-00-E000070) from the Ministry of Education Malaysia. Codon Genomics SB provided support in the form of salaries for authors KWL, CCH and WYY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amselem J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1347-1; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Aragona M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-313; Bagut ET, 2012, VET MICROBIOL, V160, P413, DOI 10.1016/j.vetmic.2012.06.011; Baldo A, 2012, MYCOSES, V55, P218, DOI 10.1111/j.1439-0507.2011.02081.x; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; Biely P, 2012, BIOTECHNOL ADV, V30, P1575, DOI 10.1016/j.biotechadv.2012.04.010; Blackman LM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-785; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Burmester A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r7; Busk PK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1601-6; Castanera R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006108; Chan CL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2200-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00197; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; DABOUSSI MJ, 1994, GENETICA, V93, P49, DOI 10.1007/BF01435239; de Gruyter J, 2013, STUD MYCOL, P1, DOI 10.3114/sim0004; de Gruyter J, 2010, MYCOLOGIA, V102, P1066, DOI 10.3852/09-240; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Dickman MB, 1999, FUNGAL GENET BIOL, V26, P99, DOI 10.1006/fgbi.1999.1118; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; ENGLISH MP, 1980, BRIT J DERMATOL, V103, P91, DOI 10.1111/j.1365-2133.1980.tb15843.x; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Gao L, 2007, MYCOL RES, V111, P87, DOI 10.1016/j.mycres.2006.07.019; Gostincar C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-549; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Infantino A, 2014, PLANT PATHOL; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jousson O, 2004, GENE, V339, P79, DOI 10.1016/j.gene.2004.06.024; Kempken F, 1998, BIOESSAYS, V20, P652, DOI 10.1002/(SICI)1521-1878(199808)20:8&lt;652::AID-BIES8&gt;3.0.CO;2-K; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Khan Z, 2011, J MED MICROBIOL, V60, P842, DOI 10.1099/jmm.0.029520-0; KIMURA N, 1993, J BACTERIOL, V175, P4427, DOI 10.1128/JB.175.14.4427-4435.1993; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Kuan CS, 2015, DNA RES, V22, P219, DOI 10.1093/dnares/dsv007; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; KUNERT J, 1972, EXPERIENTIA, V28, P1025, DOI 10.1007/BF01918649; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leach MD, 2012, EUKARYOT CELL, V11, P98, DOI 10.1128/EC.05238-11; Lechenne B, 2007, MICROBIOL-SGM, V153, P905, DOI 10.1099/mic.0.2006/003335-0; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Levic J, 2012, ROM AGRIC RES, V29, P339; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Monod M, 2005, MICROBIOL-SGM, V151, P145, DOI 10.1099/mic.0.27484-0; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Monod M, 2008, MYCOPATHOLOGIA, V166, P285, DOI 10.1007/s11046-008-9105-4; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Oh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042868; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Park YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093560; Perea S, 2002, CLIN INFECT DIS, V35, P1073, DOI 10.1086/344058; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PUNITHALINGAM E, 1975, T BRIT MYCOL SOC, V64, P539, DOI 10.1016/S0007-1536(75)80163-X; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Santana MF., 2015, SCI J GENETICS GEN T, V1, P12, DOI [10.17352/sjggt.000003, DOI 10.17352/SJGGT.000003]; Saupe SJ, 2000, CURR OPIN MICROBIOL, V3, P608, DOI 10.1016/S1369-5274(00)00148-X; Schrettl M, 2007, DISTINCT ROLES INTRA; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Verkley GJM, 2010, REV IBEROAM MICOL, V27, P22, DOI 10.1016/j.riam.2009.09.001; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Walker LA, 2010, FUNGAL GENET BIOL, V47, P117, DOI 10.1016/j.fgb.2009.09.003; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yew SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104352; Yew SM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00158-13; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Ying Y, 2013, MICROB DRUG RESIST, V19, P266, DOI 10.1089/mdr.2012.0204; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07; Zhao ZT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-6	87	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162095	10.1371/journal.pone.0162095	http://dx.doi.org/10.1371/journal.pone.0162095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626635	gold, Green Published, Green Submitted			2022-12-26	WOS:000383680600020
J	Alcaino, J; Bravo, N; Cordova, P; Marcoleta, AE; Contreras, G; Barahona, S; Sepulveda, D; Fernandez-Lobato, M; Baeza, M; Cifuentes, V				Alcaino, Jennifer; Bravo, Natalia; Cordova, Pamela; Marcoleta, Andres E.; Contreras, Gabriela; Barahona, Salvador; Sepulveda, Dionisia; Fernandez-Lobato, Maria; Baeza, Marcelo; Cifuentes, Victor			The Involvement of Mig1 from Xanthophyllomyces dendrorhous in Catabolic Repression: An Active Mechanism Contributing to the Regulation of Carotenoid Production	PLOS ONE			English	Article							ASTAXANTHIN BIOSYNTHESIS PATHWAY; YEAST SACCHAROMYCES-CEREVISIAE; PHAFFIA-RHODOZYMA; GLUCOSE REPRESSION; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL REGULATION; ASPERGILLUS-NIDULANS; SYNTHASE GENE; BETA-CAROTENE	The red yeast X. dendrorhous is one of the few natural sources of astaxanthin, a carotenoid used in aquaculture for salmonid fish pigmentation and in the cosmetic and pharmaceutical industries for its antioxidant properties. Genetic control of carotenogenesis is well characterized in this yeast; however, little is known about the regulation of the carotenogenesis process. Several lines of evidence have suggested that carotenogenesis is regulated by catabolic repression, and the aim of this work was to identify and functionally characterize the X. dendrorhous MIG1 gene encoding the catabolic repressor Mig1, which mediates transcriptional glucose-dependent repression in other yeasts and fungi. The identified gene encodes a protein of 863 amino acids that demonstrates the characteristic conserved features of Mig1 proteins, and binds in vitro to DNA fragments containing Mig1 boxes. Gene functionality was demonstrated by heterologous complementation in a S. cerevisiae mig1(-) strain; several aspects of catabolic repression were restored by the X. dendrorhous MIG1 gene. Additionally, a X. dendrorhous mig1-mutant was constructed and demonstrated a higher carotenoid content than the wild-type strain. Most important, the mig1(-) mutation alleviated the glucose-mediated repression of carotenogenesis in X. dendrorhous: the addition of glucose to mig1(-) and wild-type cultures promoted the growth of both strains, but carotenoid synthesis was observed only in the mutant strain. Transcriptomic and RT-qPCR analyses revealed that several genes were differentially expressed between X. dendrorhous mig1(-) and the wild-type strain when cultured with glucose as the sole carbon source. The results obtained in this study demonstrate that catabolic repression in X. dendrorhous is an active process in which the identified MIG1 gene product plays a central role in the regulation of several biological processes, including carotenogenesis.	[Alcaino, Jennifer; Bravo, Natalia; Cordova, Pamela; Contreras, Gabriela; Barahona, Salvador; Sepulveda, Dionisia; Baeza, Marcelo; Cifuentes, Victor] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Lab Genet, Santiago, Chile; [Marcoleta, Andres E.] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Fernandez-Lobato, Maria] Univ Autonoma Madrid, CSIC, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Madrid, Cantoblanco, Spain	Universidad de Chile; Universidad de Chile; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Cifuentes, V (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Lab Genet, Santiago, Chile.	vcifuentes@uchile.cl	Lobato, Maria Fernandez/F-1338-2016; /C-6686-2008; Alcaino, Jennifer/H-4576-2012	Lobato, Maria Fernandez/0000-0003-0778-7443; Alcaino, Jennifer/0000-0001-8984-0943; Contreras, Gabriela/0000-0002-5637-3004; Marcoleta Caldera, Andres Esteban/0000-0003-2950-7510	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1140504]; Mejoramiento de la Calidad y la Equidad en la Educacion Superior (MECESUP) [2-UCH0604]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [21110252]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Mejoramiento de la Calidad y la Equidad en la Educacion Superior (MECESUP); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Funding was provided by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1140504 (http://www.conicyt.cl/fondecyt/); Mejoramiento de la Calidad y la Equidad en la Educacion Superior (MECESUP) 2-UCH0604 (http://www.mecesup.cl/) NB; and Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) 21110252 (http://www.conicyt.cl/becas-conicyt/) PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuatzi D, 2004, J BIOL CHEM, V279, P14440, DOI 10.1074/jbc.M313431200; Alcaino J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096626; Alcaino J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-169; Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; Alvarez V, 2006, FUNGAL GENET BIOL, V43, P261, DOI 10.1016/j.fgb.2005.12.004; AN GH, 1989, APPL ENVIRON MICROB, V55, P116, DOI 10.1128/AEM.55.1.116-124.1989; ANDREWES AG, 1976, PHYTOCHEMISTRY, V15, P1009, DOI 10.1016/S0031-9422(00)84391-5; Baeza M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1493-5; Bourgarel D, 1999, MOL MICROBIOL, V31, P1205, DOI 10.1046/j.1365-2958.1999.01263.x; Cifuentes V, 1997, ANTON LEEUW INT J G, V72, P111, DOI 10.1023/A:1000200119447; Conlan RS, 1999, J BIOL CHEM, V274, P205, DOI 10.1074/jbc.274.1.205; Contreras G, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-84; CUBERO B, 1994, EMBO J, V13, P407, DOI 10.1002/j.1460-2075.1994.tb06275.x; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fell JW, 1999, J IND MICROBIOL BIOT, V23, P677, DOI 10.1038/sj.jim.2900681; Fuentealba M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152403; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Goldstein A, 1975, Methods Enzymol, V42, P504; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; Hermosilla G, 2003, ANTON LEEUW INT J G, V84, P279, DOI 10.1023/A:1026090008405; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Kajiwara S, 1997, BIOCHEM J, V324, P421, DOI 10.1042/bj3240421; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Karunanithi S, 2012, GENETICS, V192, P869, DOI 10.1534/genetics.112.142661; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Klein CJL, 1998, MICROBIOL-SGM, V144, P13, DOI 10.1099/00221287-144-1-13; Klein CJL, 1999, J BIOTECHNOL, V68, P197, DOI 10.1016/S0168-1656(98)00205-3; Leiva K, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0428-2; Linde D, 2009, APPL ENVIRON MICROB, V75, P1065, DOI 10.1128/AEM.02061-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodato P, 2003, APPL ENVIRON MICROB, V69, P4676, DOI 10.1128/AEM.69.8.4676-4682.2003; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Marcoleta A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-190; Mercadante A. Z, 2004, CAROTENOIDS HDB; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Miller MW, 1976, INT J SYST BACTERIOL, V26, P6; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Niklitschek M, 2012, MICROBIAL CAROTENOID, P219; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Ojima K, 2006, MOL GENET GENOMICS, V275, P148, DOI 10.1007/s00438-005-0072-x; Ostling J, 1996, MOL CELL BIOL, V16, P753; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, MOL CELL BIOL, V16, P6419; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Torres P, 1998, J AGR FOOD CHEM, V46, P354, DOI 10.1021/jf970570r; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; TRUMBLY RJ, 1992, MOL MICROBIOL, V6, P15, DOI 10.1111/j.1365-2958.1992.tb00832.x; VALLIER LG, 1994, GENETICS, V137, P49; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; Verdoes JC, 1999, BIOTECHNOL BIOENG, V63, P750, DOI 10.1002/(SICI)1097-0290(19990620)63:6<750::AID-BIT13>3.0.CO;2-7; Wery J, 1996, YEAST, V12, P641; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Wozniak A, 2011, FEMS YEAST RES, V11, P252, DOI 10.1111/j.1567-1364.2010.00711.x; Zimmermann FK, 1997, BIOCH GENETICS BIOTE	64	18	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162838	10.1371/journal.pone.0162838	http://dx.doi.org/10.1371/journal.pone.0162838			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622474	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000063
J	Yang, QH; Liao, JY; Huang, J; Li, YP; Huang, SG; Zhou, HT; Xie, Y; Pan, J; Li, YH; Wang, JH; Wang, J				Yang, Qinghua; Liao, Jianyi; Huang, Jie; Li, Yi Ping; Huang, Shungen; Zhou, Huiting; Xie, Yi; Pan, Jian; Li, Yanhong; Wang, Jiang Huai; Wang, Jian			Cardiopulmonary Bypass Down-Regulates NOD Signaling and Inflammatory Response in Children with Congenital Heart Disease	PLOS ONE			English	Article							MURAMYL DIPEPTIDE; INFECTION; RIP2	In the present study, we aimed to examine the impact of cardiopulmonary bypass (CPB) on expression and function of NOD1 and NOD2 in children with congenital heart disease (CHD), in an attempt to clarify whether NOD1 and NOD2 signaling is involved in the modulation of host innate immunity against postoperative infection in pediatric CHD patients. Peripheral blood samples were collected from pediatric CHD patients at five different time points: before CPB, immediately after CPB, and 1, 3, and 7 days after CPB. Real-time PCR, Western blot, and ELISA were performed to measure the expression of NOD1 and NOD2, their downstream signaling pathways, and inflammatory cytokines at various time points. Proinflammatorycytokine IL-6 and TNF-alpha levels in response to stimulation with either the NOD1 agonist Tri-DAP or the NOD2 agonist MDP were significantly reduced after CPB compared with those before CPB, which is consistent with a suppressed inflammatory response postoperatively. The expression of phosphorylated RIP2 and activation of the downstream signaling pathways NF-kB p65 and MAPK p38 upon Tri-DAP or MDP stimulation in PBMCs were substantially inhibited after CPB. The mRNA level of NOD1 and protein levels of NOD1 and NOD2 were also markedly decreased after CPB. Our results demonstrated that NOD-mediated signaling pathways were substantially inhibited after CPB, which correlates with the suppressed inflammatory response and may account, at least in part, for the increased risk of postoperative infection in pediatric CHD patients.	[Yang, Qinghua; Liao, Jianyi; Huang, Shungen; Wang, Jian] Soochow Univ, Childrens Hosp, Dept Pediat Surg, Suzhou, Peoples R China; [Huang, Jie] Soochow Univ, Childrens Hosp, Dept Pediat Cardiol, Suzhou, Peoples R China; [Li, Yi Ping; Zhou, Huiting; Xie, Yi; Pan, Jian; Li, Yanhong] Soochow Univ, Childrens Hosp, Pediat Res Inst, Suzhou, Peoples R China; [Wang, Jiang Huai] Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland	Soochow University - China; Soochow University - China; Soochow University - China; University College Cork	Wang, J (corresponding author), Soochow Univ, Childrens Hosp, Dept Pediat Surg, Suzhou, Peoples R China.; Wang, JH (corresponding author), Cork Univ Hosp, Univ Coll Cork, Acad Dept Surg, Cork, Ireland.	jh.wang@ucc.ie; wj196312@gmail.com			National Natural Science Foundation of China [81272143, 81420108022]; National Natural Science Foundation of Jiangsu Province [BK2011310]; Jiangsu Innovation Team [LJ201141]; Jiang Su Province Program of innovative and Entrepreneurial Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Innovation Team; Jiang Su Province Program of innovative and Entrepreneurial Talents	This work was supported by the National Natural Science Foundation of China (Grants 81272143 and 81420108022), the National Natural Science Foundation of Jiangsu Province (Grant BK2011310), Jiangsu Innovation Team (Grant LJ201141), and Jiang Su Province Program of innovative and Entrepreneurial Talents (2011-2014).	Bist P, 2014, INFECT IMMUN, V82, P1112, DOI 10.1128/IAI.01459-13; Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Li YP, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2013.10.008; Maharana J, 2015, MOL BIOSYST, V11, P2324, DOI 10.1039/c5mb00212e; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Moreno L, 2013, BRIT J PHARMACOL, V170, P475, DOI 10.1111/bph.12300; O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Sirard JC, 2007, PLOS PATHOG, V3, P1829, DOI 10.1371/journal.ppat.0030152; Takeuchi D, 2015, CIRC J, V79, P1828, DOI 10.1253/circj.CJ-15-0042; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vijarnsorn Chodchanok, 2012, Journal of the Medical Association of Thailand, V95, P761	16	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162179	10.1371/journal.pone.0162179	http://dx.doi.org/10.1371/journal.pone.0162179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622570	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000017
J	Pakanen, VM; Orell, M; Vatka, E; Rytkonen, S; Broggi, J				Pakanen, Veli-Matti; Orell, Markku; Vatka, Emma; Rytkonen, Seppo; Broggi, Juli			Different Ultimate Factors Define Timing of Breeding in Two Related Species	PLOS ONE			English	Article							TIT PARUS-MONTANUS; CLIMATE-CHANGE; GREAT TITS; POPULATION FLUCTUATIONS; TROPHIC INTERACTIONS; FOOD AVAILABILITY; SOCIAL-DOMINANCE; NORTHERN FINLAND; CLUTCH-SIZE; MARSH TIT	Correct reproductive timing is crucial for fitness. Breeding phenology even in similar species can differ due to different selective pressures on the timing of reproduction. These selection pressures define species' responses to warming springs. The temporal match-mismatch hypothesis suggests that timing of breeding in animals is selected to match with food availability (synchrony). Alternatively, time-dependent breeding success (the date hypothesis) can result from other seasonally deteriorating ecological conditions such as intra-or interspecific competition or predation. We studied the effects of two ultimate factors on the timing of breeding, synchrony and other time-dependent factors (time-dependence), in sympatric populations of two related forest-dwelling passerine species, the great tit (Parus major) and the willow tit (Poecile montanus) by modelling recruitment with long-termcapture-recapture data. We hypothesized that these two factors have different relevance for fitness in these species. We found that local recruitment in both species showed quadratic relationships with both time-dependence and synchrony. However, the importance of these factors was markedly different between the studied species. Caterpillar food played a predominant role in predicting the timing of breeding of the great tit. In contrast, for the willow tit time-dependence modelled as timing in relation to conspecifics was more important for local recruitment than synchrony. High caterpillar biomass experienced during the pre- and post-fledging periods increased local recruitment of both species. These contrasting results confirm that these species experience different selective pressures upon the timing of breeding, and hence responses to climate change may differ. Detailed information about life-history strategies is required to understand the effects of climate change, even in closely related taxa. The temporal match-mismatch hypothesis should be extended to consider subsequent critical periods when food needs to be abundantly available.	[Pakanen, Veli-Matti; Orell, Markku; Vatka, Emma; Rytkonen, Seppo] Univ Oulu, Dept Ecol, POB 3000, FIN-90014 Oulu, Finland; [Broggi, Juli] UO CISC, Res Unit Biodivers, UMIB, PA, Ed Invest 5a C Gonzalo Gutierrez Quiros S-N, Mieres 33600, Spain; [Broggi, Juli] Lund Univ, Sect Evolutionary Ecol, Dept Biol, S-22362 Lund, Sweden	University of Oulu; Lund University	Pakanen, VM (corresponding author), Univ Oulu, Dept Ecol, POB 3000, FIN-90014 Oulu, Finland.	veli-matti.pakanen@oulu.fi	Broggi, Juli/AAB-1796-2020; Pakanen, Veli-Matti/L-8134-2015	Pakanen, Veli-Matti/0000-0003-4838-9927; Broggi, Juli/0000-0002-1706-4014	Academy of Finland, Research Council for Biosciences and Environment [128193, 258638, 278759]; Thule Institute of the University of Oulu; Foundations' Professor Pool	Academy of Finland, Research Council for Biosciences and Environment(Academy of Finland); Thule Institute of the University of Oulu; Foundations' Professor Pool	The Academy of Finland, Research Council for Biosciences and Environment (to MO, project numbers 128193 and 258638; to VMP, project number 278759) http://www.aka.fi/en/, Thule Institute of the University of Oulu (to MO) http://www.oulu.fi/thuleinstitute/, and Foundations' Professor Pool (to MO) http://www.professoripooli.fi/index_en.php?cat=1&lang=3.	Ahola MP, 2009, J ANIM ECOL, V78, P1298, DOI 10.1111/j.1365-2656.2009.01596.x; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dias PC, 1996, IBIS, V138, P644, DOI 10.1111/j.1474-919X.1996.tb04766.x; DRENT RH, 1980, ARDEA, V68, P225; Drent RH, 2006, ARDEA, V94, P305; DUNN E K, 1976, British Birds, V69, P45; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Eeva T, 2012, J ORNITHOL, V153, P653, DOI 10.1007/s10336-011-0783-1; Eeva T, 2000, CAN J ZOOL, V78, P67, DOI 10.1139/cjz-78-1-67; EKMAN J, 1989, WILSON BULL, V101, P263; Garcia-Navas V, 2011, OECOLOGIA, V165, P639, DOI 10.1007/s00442-010-1858-z; GARNETT MC, 1981, IBIS, V123, P31, DOI 10.1111/j.1474-919X.1981.tb00170.x; Goodenough AE, 2011, BIRD STUDY, V58, P221, DOI 10.1080/00063657.2010.548006; Goodenough AE, 2010, CLIMATIC CHANGE, V102, P687, DOI 10.1007/s10584-010-9932-4; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Harrap S, 1996, TITS NUTHACHES TREEC; Johansson J, 2014, J ANIM ECOL, V83, P440, DOI 10.1111/1365-2656.12151; KOIVULA K, 1993, BEHAV ECOL SOCIOBIOL, V33, P283, DOI 10.1007/BF02027126; Koivula K, 1996, IBIS, V138, P624, DOI 10.1111/j.1474-919X.1996.tb04763.x; Lambrechts MM, 2000, ECOGRAPHY, V23, P525, DOI 10.1034/j.1600-0587.2000.230502.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LENS L, 1993, BEHAV ECOL SOCIOBIOL, V33, P79; Lof ME, 2012, P ROY SOC B-BIOL SCI, V279, P3161, DOI 10.1098/rspb.2012.0431; MINOT EO, 1981, J ANIM ECOL, V50, P375, DOI 10.2307/4061; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; NILSSON JA, 1989, J ANIM ECOL, V58, P619, DOI 10.2307/4852; NILSSON JA, 1988, J ANIM ECOL, V57, P917, DOI 10.2307/5101; ORELL M, 1989, IBIS, V131, P112, DOI 10.1111/j.1474-919X.1989.tb02750.x; ORELL M, 1983, ANN ZOOL FENN, V20, P99; ORELL M, 1983, HOLARCTIC ECOL, V6, P413; ORELL M, 1983, ARDEA, V71, P183; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; Post E, 2001, P ROY SOC B-BIOL SCI, V268, P15, DOI 10.1098/rspb.2000.1324; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Reed TE, 2013, SCIENCE, V340, P488, DOI 10.1126/science.1232870; Rytkonen S, 1996, J AVIAN BIOL, V27, P21, DOI 10.2307/3676957; Rytkonen S, 2003, J AVIAN BIOL, V34, P288, DOI 10.1034/j.1600-048X.2003.03041.x; Stevenson IR, 2000, NATURE, V406, P366, DOI 10.1038/35019151; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; VANBALEN JH, 1973, ARDEA, V61, P1; Vatka E, 2016, GLOBAL CHANGE BIOL, V22, P1585, DOI 10.1111/gcb.13144; Vatka E, 2014, OECOLOGIA, V176, P595, DOI 10.1007/s00442-014-3022-7; Vatka E, 2011, GLOBAL CHANGE BIOL, V17, P3002, DOI 10.1111/j.1365-2486.2011.02430.x; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2012, J ORNITHOL, V153, pS75, DOI 10.1007/s10336-011-0770-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Wesolowski T, 1998, ARDEA, V86, P89; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; ZANDT HS, 1994, OECOLOGIA, V97, P399, DOI 10.1007/BF00317331	55	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162643	10.1371/journal.pone.0162643	http://dx.doi.org/10.1371/journal.pone.0162643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611971	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900143
J	Rucker, V; Keil, U; Fitzgerald, AP; Malzahn, U; Prugger, C; Ertl, G; Heuschmann, PU; Neuhauser, H				Ruecker, Viktoria; Keil, Ulrich; Fitzgerald, Anthony P.; Malzahn, Uwe; Prugger, Christof; Ertl, Georg; Heuschmann, Peter U.; Neuhauser, Hannelore			Predicting 10-Year Risk of Fatal Cardiovascular Disease in Germany: An Update Based on the SCORE-Deutschland Risk Charts	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MONICA AUGSBURG; POPULATION; PREVALENCE; VALIDATION; MORTALITY; ABSOLUTE; TOOL	Estimation of absolute risk of cardiovascular disease (CVD), preferably with population-specific risk charts, has become a cornerstone of CVD primary prevention. Regular recalibration of risk charts may be necessary due to decreasing CVD rates and CVD risk factor levels. The SCORE risk charts for fatal CVD risk assessment were first calibrated for Germany with 1998 risk factor level data and 1999 mortality statistics. We present an update of these risk charts based on the SCORE methodology including estimates of relative risks from SCORE, risk factor levels from the German Health Interview and Examination Survey for Adults 2008-11 (DEGS1) and official mortality statistics from 2012. Competing risks methods were applied and estimates were independently validated. Updated risk charts were calculated based on cholesterol, smoking, systolic blood pressure risk factor levels, sex and 5-year age-groups. The absolute 10-year risk estimates of fatal CVD were lower according to the updated risk charts compared to the first calibration for Germany. In a nationwide sample of 3062 adults aged 40-65 years free of major CVD from DEGS1, the mean 10-year risk of fatal CVD estimated by the updated charts was lower by 29% and the estimated proportion of high risk people (10-year risk > = 5%) by 50% compared to the older risk charts. This recalibration shows a need for regular updates of risk charts according to changes in mortality and risk factor levels in order to sustain the identification of people with a high CVD risk.	[Ruecker, Viktoria; Malzahn, Uwe; Heuschmann, Peter U.] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany; [Keil, Ulrich] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Fitzgerald, Anthony P.] Univ Coll Cork, Dept Epidemiol & Publ Hlth, Dept Stat, Cork, Ireland; [Malzahn, Uwe; Heuschmann, Peter U.] Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany; [Prugger, Christof] Charite, Inst Publ Hlth, Berlin, Germany; [Ertl, Georg] Univ Hosp Wurzburg, Dept Med 1, Wurzburg, Germany; [Ertl, Georg; Heuschmann, Peter U.] Univ Wurzburg, Comprehens Heart Failure Ctr Wurzburg, Wurzburg, Germany; [Neuhauser, Hannelore] Robert Koch Inst Berlin, Dept Epidemiol & Hlth Monitoring, Berlin, Germany; [Neuhauser, Hannelore] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany	University of Wurzburg; University of Munster; University College Cork; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; University of Wurzburg; Robert Koch Institute; German Centre for Cardiovascular Research	Neuhauser, H (corresponding author), Robert Koch Inst Berlin, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.; Neuhauser, H (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	neuhauserh@rki.de	Fitzgerald, Tony/AAB-5331-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Prugger, Christof/0000-0003-1845-0950; Neuhauser, Hannelore K./0000-0002-6605-6221; Fitzgerald, Tony/0000-0001-6437-5686	German Centre of Cardiovascular Research, DZHK [MDC2014Z3]; Federal Ministry of Education and Research (BMBF); BMBF (German Ministry of Education and Research); German Cardiac Society	German Centre of Cardiovascular Research, DZHK; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Cardiac Society	The work of VR has been supported by the German Centre of Cardiovascular Research, DZHK, grant MDC2014Z3 (http://dzhk.de/en/). The DZHK is funded by the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research). We thank the German Cardiac Society for their general support and Dr. Beyersmann, Ulm, for statistical comments.	[Anonymous], 1999, GESUNDHEITSWESEN, V61, P121; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2016, EUR J PREV CARDIOL, V23, P1093, DOI 10.1177/2047487315588390; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; De Backer G, 2003, ATHEROSCLEROSIS, V171, P145, DOI 10.1016/j.atherosclerosis.2003.10.001; Diener A, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-13; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Germano G, 2012, EUR HEART J, V33, P137; Gohlke H, 2007, EUR J CARDIOV PREV R, V14, P141, DOI 10.1097/01.hjr.0000244581.30421.69; Hense H.-W., 2005, DTSCH ARZTEBL, V102, P1808; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; Jackson R, 2000, BMJ-BRIT MED J, V320, P659, DOI 10.1136/bmj.320.7236.659; Jdanov DA, 2014, EUR J EPIDEMIOL, V29, P621, DOI 10.1007/s10654-014-9947-7; Keil U, 1998, EUR HEART J, V19, P1197, DOI 10.1053/euhj.1998.1089; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Marques-Vidal P, 2008, EUR J CARDIOV PREV R, V15, P402, DOI 10.1097/HJR.0b013e3282fb040f; Menotti A, 2000, EUR HEART J, V21, P365, DOI 10.1053/euhj.1999.1864; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66; Neuhauser HK, 2015, J HUM HYPERTENS, V29, P247, DOI 10.1038/jhh.2014.82; Panagiotakos Demosthenes B, 2007, Hellenic J Cardiol, V48, P55; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Thamm M, 1999, Gesundheitswesen, V61 Spec No, pS90; Thomsen TF, 2002, INT J EPIDEMIOL, V31, P817, DOI 10.1093/ije/31.4.817; Townsend N, 2015, EUR HEART J, V36, P2696, DOI 10.1093/eurheartj/ehv428; Truthmann J, 2015, P 10 M GERM EP SOC; van Dis I, 2010, EUR J CARDIOV PREV R, V17, P244, DOI 10.1097/HJR.0b013e328337cca2	29	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162188	10.1371/journal.pone.0162188	http://dx.doi.org/10.1371/journal.pone.0162188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612145	Green Published, gold			2022-12-26	WOS:000383255900053
J	Roy, P; Mukherjee, T; Chatterjee, B; Vijayaragavan, B; Banoth, B; Basak, S				Roy, P.; Mukherjee, T.; Chatterjee, B.; Vijayaragavan, B.; Banoth, B.; Basak, S.			Non-canonical NF kappa B mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB: p50 NF kappa B pathway	ONCOGENE			English	Article							TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTORS; INDUCED APOPTOSIS; ACTIVATION; ALPHA; CELLS; TARGET; ABNORMALITIES; INFLAMMATION; THALIDOMIDE	Environmental drug resistance constitutes a serious impediment for therapeutic intervention in multiple myeloma. Tumorpromoting cytokines, such as tumor necrosis factor (TNF), induce nuclear factor-kappa B (NF kappa B)-driven expression of pro-survival factors, which confer resistance in myeloma cells to apoptotic insults from TNF-related apoptosis-inducing ligand (TRAIL) and other chemotherapeutic drugs. It is thought that RelA: p50 dimer, activated from I.Ba-inhibited complex in response to TNF-induced canonical NF kappa B signal, mediates the pro-survival NF kappa B function in cancerous cells. Myeloma cells additionally acquire gain-offunction mutations in the non-canonical N kappa B module, which induces partial proteolysis of p100 into p52 to promote RelB: p52/NF kappa B activation from p100-inhibited complex during immune cell differentiation. However, role of non-canonical NF kappa B signaling in the drug resistance in multiple myeloma remains unclear. Here we report that myeloma-associated non-canonical aberrations reinforce pro-survival TNF signaling in producing a protracted TRAIL-refractory state. These mutations did not act through a typical p52 NF kappa B complex, but completely degraded p100 to reposition RelB under I kappa Ba control, whose degradation during TNF signaling induced an early RelB: p50 containing NF kappa B activity. More so, autoregulatory RelB synthesis prolonged this TNF-induced RelB: p50 activity in myeloma cells harboring non-canonical mutations. Intriguingly, TNF-activated RelB: p50 dimer was both necessary and sufficient, and RelA was not required, for NF kappa B-dependent pro-survival gene expressions and suppression of apoptosis. Indeed, high RelB mRNA expressions in myeloma patients correlated with the augmented level of pro-survival factors and resistance to therapeutic intervention. In sum, we provide evidence that cancer-associated mutations perpetuate TNF-induced pro-survival NF kappa B activity through autoregulatory RelB control and thereby exacerbate environmental drug resistance in multiple myeloma.	[Roy, P.; Mukherjee, T.; Chatterjee, B.; Vijayaragavan, B.; Banoth, B.; Basak, S.] Natl Inst Immunol, Syst Immunol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India; [Chatterjee, B.] IIT Delhi, Kusuma Sch Biol Sci, Hauz Khas, New Delhi, India; [Vijayaragavan, B.] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Weizmann Institute of Science	Basak, S (corresponding author), Natl Inst Immunol, Syst Immunol Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	sobasak@nii.ac.in	Banoth, Balaji/ABF-7350-2020	Banoth, Balaji/0000-0002-7467-2198; MUKHERJEE, TAPAS/0000-0002-9433-3716; Chatterjee, Budhaditya/0000-0003-2260-8642; Basak, Soumen/0000-0002-3586-1279	SERB; Department of Science and Technology, Govt. of India [EMR/2015/000658]; Wellcome Trust DBT India Alliance [500094/Z/09/Z]; CSIR; UGC	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Wellcome Trust DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance); CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India)	We sincerely thank Ranjan Sen, NIH, and Anna George, NII, for critical reading and constructive suggestions. We also thank Michael Kuehl, NCI, for providing us HMCLs and Dr Shao Cong Sun, University of Texas for p100<INF>S866A, S870A</INF> construct. We thank V Kumar, MVR Prasad, J Sanghani and S Goel for technical assistance. Multiple myeloma-related research was funded by SERB, Department of Science and Technology, Govt. of India (EMR/2015/000658). Research in PI's laboratory is funded by an intermediate fellowship (500094/Z/09/Z) to SB from Wellcome Trust DBT India Alliance and NII-Core. PR and BB thank CSIR, and BC and TM thank UGC for research fellowships.	Almaden JV, 2014, CELL REP, V9, P2098, DOI 10.1016/j.celrep.2014.11.024; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Annunziata CM, 2010, CANCER-AM CANCER SOC, V116, P3276, DOI 10.1002/cncr.25190; Authier H, 2014, P NATL ACAD SCI USA, V111, P14794, DOI 10.1073/pnas.1410124111; Banoth B, 2015, ELIFE, V4, DOI 10.7554/eLife.05648; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Cormier F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059127; Dai Y, 2004, BLOOD, V103, P2761, DOI 10.1182/blood-2003-09-3037; Demchenko YN, 2014, ONCOTARGET, V5, P4554, DOI 10.18632/oncotarget.2128; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Geng CY, 2014, AM J HEMATOL, V89, P1037, DOI 10.1002/ajh.23822; Hengeveld PJ, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.3; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Jourdan M, 1999, EUR CYTOKINE NETW, V10, P65; Jurisic V, 2002, MED ONCOL, V19, P133, DOI 10.1385/MO:19:3:133; Kawano Y, 2015, IMMUNOL REV, V263, P160, DOI 10.1111/imr.12233; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Koslowski M, 2011, ONCOGENE, V30, P876, DOI 10.1038/onc.2010.481; Latif T, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-27; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Lincz LF, 2001, LEUKEMIA, V15, P1650, DOI 10.1038/sj.leu.2402251; MIGLIAZZA A, 1994, BLOOD, V84, P3850, DOI 10.1182/blood.V84.11.3850.bloodjournal84113850; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades N, 2002, BLOOD, V99, P4079, DOI 10.1182/blood.V99.11.4079; Mitsiades N, 2002, BLOOD, V99, P2162, DOI 10.1182/blood.V99.6.2162; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Rauert H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.78; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Vallabhapurapu SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9428; Wang XS, 2015, LEUKEMIA LYMPHOMA, V56, P1335, DOI 10.3109/10428194.2014.956313; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037; Zong WX, 1998, CELL DEATH DIFFER, V5, P963, DOI 10.1038/sj.cdd.4400441	52	22	22	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1417	1429		10.1038/onc.2016.309	http://dx.doi.org/10.1038/onc.2016.309			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27641334	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000395862500010
J	Tian, JJ; Yang, GX; Chen, HY; Hsu, DK; Tomilov, A; Olson, KA; Dehnad, A; Fish, SR; Cortopassi, G; Zhao, B; Liu, FT; Gershwin, ME; Torok, NJ; Jiang, JX				Tian, Jijing; Yang, Guoxiang; Chen, Huan-Yuan; Hsu, Daniel K.; Tomilov, Alexey; Olson, Kristin A.; Dehnad, Ali; Fish, Sarah R.; Cortopassi, Gino; Zhao, Bin; Liu, Fu-Tong; Gershwin, M. Eric; Torok, Natalie J.; Jiang, Joy X.			Galectin-3 regulates inflammasome activation in cholestatic liver injury	FASEB JOURNAL			English	Article						primary biliary cholangitis; NLRP3; galectin-3; IL-17	PRIMARY BILIARY-CIRRHOSIS; GROWTH-FACTOR-BETA; DEOXYCHOLIC-ACID DCA; IGE-BINDING PROTEIN; T-CELLS; URSODEOXYCHOLIC ACID; ANTIMITOCHONDRIAL ANTIBODIES; KAPPA-B; EXPRESSION; RECEPTOR	Macrophage activation is an important feature of primary biliary cholangitis (PBC) pathogenesis and other cholestatic liver diseases. Galectin-3 (Gal3), a pleiotropic lectin, is produced by monocytic cells and macrophages. However, its role in PBC has not been addressed. We hypothesized that Gal3 is a key to induce NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome in macrophages and in turn to propagate proinflammatory IL-17 signaling. In liver tissues from patients with PBC and dnTGF-beta RII mice, a model of autoimmune cholangitis, the expression of Gal3, NLRP3, and the adaptor protein adaptor apoptosis-associated speck-like protein was induced, with the down stream activation of caspase-1 and IL-1 beta. In wild-type hepatic macrophages, deoxycholic acid induced the association of Gal3 and NLRP3 with direct activation of the inflammasome, resulting in an increase in IL-1b. Downstream retinoid-related orphan receptor C mRNA, IL-17A, and IL-17F were induced. In Gal3(-/-) macrophages, no inflammasome activation was detected. To confirm the key role of Gal3 in the pathogenesis of cholestatic liver injury, we generated dnTGF-bRII/galectin-3(-/-) (dn/Gal3(-/-)) mice, which showed impaired inflammasome activation along with significantly improved inflammation and fibrosis. Taken together, our data point to a novel role of Gal3 as an initiator of inflammatory signaling in autoimmune cholangitis, mediating the activation of NLRP3 inflammasome and inducing IL-17 proinflammatory cascades. These studies provide a rationale to target Gal3 in autoimmune cholangitis and potentially other cholestatic diseases.	[Tian, Jijing; Dehnad, Ali; Fish, Sarah R.; Jiang, Joy X.] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA; [Yang, Guoxiang; Gershwin, M. Eric] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Rheumatol Allergy & Clin Immunol, Sacramento, CA 95817 USA; [Chen, Huan-Yuan; Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Med Ctr, Dept Dermatol, Sacramento, CA 95817 USA; [Olson, Kristin A.] Univ Calif Davis, Med Ctr, Dept Pathol, Sacramento, CA 95817 USA; [Tomilov, Alexey; Cortopassi, Gino] Univ Calif Davis, Dept Mol Biosci, Sacramento, CA 95817 USA; [Tian, Jijing] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Chen, Huan-Yuan; Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Torok, Natalie J.] Vet Adm Northern Calif Med Ctr, Mather, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Chinese Academy of Sciences; Academia Sinica - Taiwan	Jiang, JX (corresponding author), UC Davis Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, PSSB, 4150,5 St,Suite 3500, Sacramento, CA 95817 USA.	joyjiang@ucdavis.edu	Liu, FU-TONG/A-5749-2019	Liu, FU-TONG/0000-0002-3354-1001	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK090121, DK106467, DK083283, DK39588, DK090019]; U.S. Veterans Administration [BX002418]; National Natural Science Foundation of China [NNSFC21525730]; NIH National Institute on Aging [AG025532]; Taiwan Ministry of Science and Technology [MOST104-2321-B-001-036]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK106467, R37DK039588, R01DK090019, R01DK083283, R01DK039588, K01DK090121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002418] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Veterans Administration(US Department of Veterans Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Taiwan Ministry of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK090121 and DK106467 (to J.X.J.), DK083283 (to N.J.T.), DK39588 and DK090019 (to M.E.G.); U.S. Veterans Administration Grant BX002418 (to N.J.T.); National Natural Science Foundation of China Grant NNSFC21525730 (to B.Z.); and NIH National Institute on Aging Grant AG025532 (to G.C.); and Taiwan Ministry of Science and Technology Grant MOST104-2321-B-001-036 (to H.-Y.C.). The authors declare no conflicts of interest.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Chang CH, 2014, CLIN EXP IMMUNOL, V177, P373, DOI 10.1111/cei.12298; Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106; Chuang YH, 2008, HEPATOLOGY, V47, P571, DOI 10.1002/hep.22052; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Eisa NH, 2015, J ONCOL PHARM PRACT, V21, P323, DOI 10.1177/1078155214532698; Ferreira DMS, 2014, MOL CELL BIOL, V34, P1100, DOI 10.1128/MCB.00420-13; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; GELLER DA, 1995, J IMMUNOL, V155, P4890; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; He XS, 2006, CELL IMMUNOL, V239, P1, DOI 10.1016/j.cellimm.2006.04.006; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; HSU DK, 1992, J BIOL CHEM, V267, P14167; Hsu DK, 1996, AM J PATHOL, V148, P1661; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.3.CO;2-S; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Jenkins GJS, 2004, CARCINOGENESIS, V25, P317, DOI 10.1093/carcin/bgh032; Jiang JX, 2012, AM J PHYSIOL-GASTR L, V302, pG439, DOI 10.1152/ajpgi.00257.2011; Kawata K, 2013, HEPATOLOGY, V58, P1094, DOI 10.1002/hep.26418; Kim K, 2003, BBA-MOL CELL RES, V1641, P13, DOI 10.1016/S0167-4889(03)00045-4; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Leicester KL, 2006, LIVER INT, V26, P559, DOI 10.1111/j.1478-3231.2006.01255.x; LIU FT, 1990, CRIT REV IMMUNOL, V10, P289; Liu L, 2004, BIOCHEM J, V380, P31, DOI 10.1042/BJ20031300; Ljubuncic P, 1996, GUT, V39, P475, DOI 10.1136/gut.39.3.475; Lleo A, 2010, HEPATOLOGY, V52, P987, DOI 10.1002/hep.23783; Looby E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-190; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; Meng F., 2012, GASTROENTEROLOGY, V143; Nomoto K, 2012, SCI WORLD J, P1, DOI 10.1100/2012/959824; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Sanz-Cameno P, 2002, J HEPATOL, V37, P723, DOI 10.1016/S0168-8278(02)00266-0; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083481; Tsai HF, 2016, J MOL MED, V94, P545, DOI 10.1007/s00109-015-1368-x; Wang JJ, 2014, SEMIN LIVER DIS, V34, P285, DOI 10.1055/s-0034-1383728; Wijesundera KK, 2014, EXP MOL PATHOL, V96, P382, DOI 10.1016/j.yexmp.2014.04.003; Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Yang CY, 2014, HEPATOLOGY, V59, P1944, DOI 10.1002/hep.26979; Zhang WC, 2010, HEPATOLOGY, V52, P215, DOI 10.1002/hep.23664; Zhu P, 2011, HUM GENE THER, V22, P853, DOI 10.1089/hum.2010.145	52	35	35	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4202	4213		10.1096/fj.201600392RR	http://dx.doi.org/10.1096/fj.201600392RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27630169	Green Published			2022-12-26	WOS:000388201500026
J	Ricq, EL; Hooker, JM; Haggarty, SJ				Ricq, Emily L.; Hooker, Jacob M.; Haggarty, Stephen J.			Activity-dependent Regulation of Histone Lysine Demethylase KDM1 A by a Putative Thiol/Disulfide Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE-OXIDASE-A; STRUCTURAL BASIS; MOLECULAR-MECHANISMS; DNA OXIDATION; LSD1; INACTIVATION; INHIBITION; ASSAY; TRANSCRIPTION; METHYLATION	Lysine demethylation of proteins such as histones is catalyzed by several classes of enzymes, including the FAD-dependent amine oxidases KDM1A/B. The KDM1 family is homologous to the mitochondrial monoamine oxidases MAO-A/B and produces hydrogen peroxide in the nucleus as a byproduct of demethylation. Here, we show KDM1A is highly thiol-reactive in vitro and in cellular models. Enzyme activity is potently and reversibly inhibited by the drug disulfiram and by hydrogen peroxide. Hydrogen peroxide produced by KDM1A catalysis reduces thiol labeling and inactivates demethylase activity over time. MALDI-TOF mass spectrometry indicates that hydrogen peroxide blocks labeling of cysteine 600, which we propose forms an intramolecular disulfide with cysteine 618 to negatively regulate the catalytic activity of KDM1A. This activity dependent regulation is unique among histone-modifying enzymes but consistent with redox sensitivity of epigenetic regulators.	[Ricq, Emily L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Ricq, Emily L.; Hooker, Jacob M.] Harvard Med Sch, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Ricq, Emily L.; Haggarty, Stephen J.] Harvard Med Sch, Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Human Genet Res,Dept Neurol, Boston, MA 02114 USA; [Ricq, Emily L.; Haggarty, Stephen J.] Harvard Med Sch, Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Human Genet Res,Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Haggarty, SJ (corresponding author), Massachusetts Gen Hosp, Chem Neurobiol Lab, Ctr Human Genet Res, 185 Cambridge St, Boston, MA 02114 USA.	shaggarty@mgh.harvard.edu	Haggarty, Stephen J/M-9495-2016; Hooker, Jacob M/P-5716-2018	Haggarty, Stephen J/0000-0002-7872-168X; Hooker, Jacob M/0000-0002-9394-7708	National Institute of Mental Health [R01MH095088]; National Institutes of Health [2T90DA022759-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095088] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by National Institute of Mental Health Grant R01MH095088. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Training Grant 2T90DA022759-06.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Baldwin AD, 2011, BIOCONJUGATE CHEM, V22, P1946, DOI 10.1021/bc200148v; Burg JM, 2015, BIOPOLYMERS, V104, P213, DOI 10.1002/bip.22643; Chuang JY, 2011, FREE RADICAL BIO MED, V51, P2309, DOI 10.1016/j.freeradbiomed.2011.10.001; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dahlin JL, 2015, J MED CHEM, V58, P2091, DOI 10.1021/jm5019093; Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194; De Colibus L, 2005, P NATL ACAD SCI USA, V102, P12684, DOI 10.1073/pnas.0505975102; Doyle K, 2010, J BIOL CHEM, V285, P17417, DOI 10.1074/jbc.M109.089250; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Gaweska H, 2009, BIOCHEMISTRY-US, V48, P5440, DOI 10.1021/bi900499w; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Hayward D, 2016, METHOD ENZYMOL, V573, P261, DOI 10.1016/bs.mie.2016.01.020; Hubalek F, 2003, J BIOL CHEM, V278, P28612, DOI 10.1074/jbc.M303712200; Kakizawa T, 2016, BIOORG MED CHEM LETT, V26, P1193, DOI 10.1016/j.bmcl.2016.01.036; Karytinos A, 2009, J BIOL CHEM, V284, P17775, DOI 10.1074/jbc.M109.003087; Laitaoja M, 2016, PROTEIN SCI, V25, P572, DOI 10.1002/pro.2849; Li JF, 2013, ANTIOXID REDOX SIGN, V18, P2429, DOI 10.1089/ars.2012.5107; Lu YH, 2014, CELL REP, V8, P500, DOI 10.1016/j.celrep.2014.06.035; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; Luka Z, 2011, BIOCHEMISTRY-US, V50, P4750, DOI 10.1021/bi200247b; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Neelamegam R, 2012, ACS CHEM NEUROSCI, V3, P120, DOI 10.1021/cn200104y; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Sablin SO, 1998, J BIOL CHEM, V273, P14074, DOI 10.1074/jbc.273.23.14074; Sekirnik R, 2009, CHEM COMMUN, P6376, DOI 10.1039/b916357c; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; SILVERMAN RB, 1986, BIOCHEM BIOPH RES CO, V135, P154, DOI 10.1016/0006-291X(86)90955-1; TAMAI K, 1990, BIOCHEM BIOPH RES CO, V167, P331, DOI 10.1016/0006-291X(90)91769-O; Vintem APB, 2005, BIOORGAN MED CHEM, V13, P3487, DOI 10.1016/j.bmc.2005.02.061; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Wigle TJ, 2015, J BIOMOL SCREEN, V20, P810, DOI 10.1177/1087057115575689; Wouters MA, 2010, ANTIOXID REDOX SIGN, V12, P53, DOI [10.1089/ars.2009.2510, 10.1089/ARS.2009.2510]; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Yang S, 2015, PROSTATE, V75, P936, DOI 10.1002/pros.22977; Zhang Q, 2013, CELL RES, V23, P225, DOI 10.1038/cr.2012.177	42	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2016	291	47					24756	24767		10.1074/jbc.M116.734426	http://dx.doi.org/10.1074/jbc.M116.734426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ED5EX	27634040	Green Published, hybrid			2022-12-26	WOS:000388875500033
J	Nair, B; Wong-Riley, MTT				Nair, Bindu; Wong-Riley, Margaret T. T.			Transcriptional Regulation of Brain-derived Neurotrophic Factor Coding Exon IX: ROLE OF NUCLEAR RESPIRATORY FACTOR 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain-derived neurotrophic factor (BDNF); chromatin immunoprecipitation (ChiP); short hairpin RNA (shRNA); transcription factor; transcription regulation	NUCLEAR RESPIRATORY FACTOR-2; CYTOCHROME-C-OXIDASE; CONTROLLING MITOCHONDRIAL BIOGENESIS; RECEPTOR SUBUNIT GENES; RAT BDNF-GENE; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; ENERGY-METABOLISM; CORTICAL-NEURONS; BIPOLAR DISORDER	Brain-derived neurotrophic factor (BDNF) is an active neurotrophin abundantly expressed throughout the nervous system. It plays an important role in synaptic transmission, plasticity, neuronal proliferation, differentiation, survival, and death. The Bdnf gene in rodents has eight non-coding exons and only a single coding exon (IX). Despite its recognized regulation by neuronal activity, relatively little is known about its transcriptional regulation, and even less about the transcription factor candidates that may play such a role. The goal of the present study was to probe for such a candidate that may regulate exon IX in the rat Bdnf gene. Our in silico analysis revealed tandem binding sites for nuclear respiratory factor 2 (NRF-2) on the promoter of exon IX. NRF-2 is of special significance because it co-regulates the expressions of mediators of energy metabolism (cytochrome c oxidase) and mediators of neuronal activity (glutamatergic receptors). To test our hypothesis that NRF-2 also regulates the Bdnf gene, we performed electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP), promoter cloning, and site-directed mutagenesis, real-time quantitative PCR (RT-qPCR), and Western blotting analysis. Results indicate that NRF-2 functionally regulates exon IX of the rat Bdnf gene. The binding sites of NRF-2 are conserved between rats and mice. Overexpressing NRF-2 up-regulated the expression of Bdnf exon IX, whereas knocking down NRF-2 down-regulated such expression. These findings are consistent with our hypothesis that NRF-2, in addition to regulating the coupling between neuronal activity and energy metabolism, also regulates the expression of BDNF, which is intimately associated with energy-demanding neuronal activity.	[Nair, Bindu; Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Wong-Riley, MTT (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mwr@mcw.edu	Wong-Riley, Margaret/AGM-6202-2022		National Institutes of Health [R01 EY018441]; NATIONAL EYE INSTITUTE [R01EY018441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY018441. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Naoki, 2014, World J Biol Chem, V5, P409, DOI 10.4331/wjbc.v5.i4.409; Agrawal R, 2014, BBA-MOL BASIS DIS, V1842, P535, DOI 10.1016/j.bbadis.2013.12.004; Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BISHOP JF, 1994, MOL BRAIN RES, V26, P225, DOI 10.1016/0169-328X(94)90094-9; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Burkhalter J, 2003, J NEUROSCI, V23, P8212; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Castren E, 2004, MOL NEUROBIOL, V29, P289, DOI 10.1385/MN:29:3:289; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; Conner JM, 1997, J NEUROSCI, V17, P2295; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; Dhar SS, 2009, J NEUROSCI, V29, P483, DOI 10.1523/JNEUROSCI.3704-08.2009; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Jiang XY, 2008, J NEUROSCI, V28, P1118, DOI 10.1523/JNEUROSCI.2262-07.2008; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; KatohSemba R, 1997, J NEUROCHEM, V69, P34; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Lahiri DK, 2000, BRAIN RES PROTOC, V5, P257, DOI 10.1016/S1385-299X(00)00021-0; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; Liang HL, 2010, J NEUROSCI RES, V88, P640, DOI 10.1002/jnr.22222; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Markham A, 2004, EUR J NEUROSCI, V20, P1189, DOI 10.1111/j.1460-9568.2004.03578.x; Markham A, 2014, BRIT J PHARMACOL, V171, P2206, DOI 10.1111/bph.12531; Martin Jean-Luc, 2011, Commun Integr Biol, V4, P14, DOI 10.4161/cib.4.1.13761; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McCarthy Deirdre M., 2012, Yale Journal of Biology and Medicine, V85, P437; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nair B, 2016, BBA-MOL CELL RES, V1863, P1, DOI 10.1016/j.bbamcr.2015.10.005; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Palomino A, 2006, SCHIZOPHR RES, V86, P321, DOI 10.1016/j.schres.2006.05.028; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Priya A, 2014, BBA-MOL CELL RES, V1843, P3018, DOI 10.1016/j.bbamcr.2014.09.006; Priya A, 2013, BBA-MOL CELL RES, V1833, P48, DOI 10.1016/j.bbamcr.2012.10.014; Pruunsild P, 2011, J NEUROSCI, V31, P3295, DOI 10.1523/JNEUROSCI.4540-10.2011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Takei N, 1997, J NEUROCHEM, V68, P370; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang CY, 1999, J NEUROCYTOL, V28, P525, DOI 10.1023/A:1007053204929; Zheng Fei, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P188; Zheng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028441	68	13	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22583	22593		10.1074/jbc.M116.742304	http://dx.doi.org/10.1074/jbc.M116.742304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27624937	hybrid, Green Published			2022-12-26	WOS:000386760600019
J	Kim, KM; Moon, YJ; Park, SH; Park, HJ; Il Wang, S; Park, HS; Lee, H; Kwon, KS; Moon, WS; Lee, DG; Kim, JR; Jang, KY				Kim, Kyoung Min; Moon, Young Jae; Park, See-Hyoung; Park, Hye Jeong; Il Wang, Sung; Park, Ho Sung; Lee, Ho; Kwon, Keun Sang; Moon, Woo Sung; Lee, Dong Geun; Kim, Jung Ryul; Jang, Kyu Yun			Individual and Combined Expression of DNA Damage Response Molecules PARP1, gamma H2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients	PLOS ONE			English	Article							RIBOSE POLYMERASE INHIBITION; BREAST-CANCER; OVARIAN-CARCINOMA; GENE-EXPRESSION; POOR-PROGNOSIS; CELLS; RESISTANCE; H2AX	DNA damage response (DDR) molecules are protective against genotoxic stresses. DDR molecules are also involved in the survival of cancer cells in patients undergoing anti-cancer therapies. Therefore, DDR molecules are potential markers of cancer progression in addition to being potential therapeutic targets. In this study, we evaluated the immunohistochemical expression of PARP1, gamma H2AX, BRCA1, and BRCA2 and their prognostic significance in 112 cases of soft tissue sarcoma (STS). The expression of PARP1, gamma H2AX, BRCA1, and BRCA2 were significantly associated with each other and were associated with higher tumor stage and presence of distant metastasis. The expression of PARP1,gamma H2AX, and BRCA2 were significantly associated with shorter disease-specific survival (DSS) and event-free survival (EFS) by univariate analysis. BRCA1 expression was associated with shorter DSS. Multivariate analysis revealed the expression of PARP1 and gamma H2AX to be independent indicators of poor prognosis of DSS and EFS. BRCA2 expression was an independent indicator of poor prognosis of DSS. In addition, the combined expressional patterns of PARP1, gamma H2AX, BRCA1, and BRCA2 (CSddrm) were independent prognostic predictors of DSS (P < 0.001) and EFS (P = 0.016). The ten-year DSS rate of the CSddrm-low, CSddrm-intermediate, and CSddrm-high subgroups were 81%, 26%, and 0%, respectively. In conclusion, this study demonstrates that the individual and combined expression patterns of the DDR molecules PARP1, gamma H2AX, BRCA1, and BRCA2 could be predictive of the prognosis of STS patients and suggests that controlling the activity of these DDR molecules could be employed in new therapeutic stratagems for the treatment of STS.	[Kim, Kyoung Min; Park, Hye Jeong; Park, Ho Sung; Moon, Woo Sung; Lee, Dong Geun; Jang, Kyu Yun] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Pathol,Sch Med,Biomed Res Inst, Jeonju, South Korea; [Kim, Kyoung Min; Moon, Young Jae; Park, Hye Jeong; Il Wang, Sung; Park, Ho Sung; Moon, Woo Sung; Lee, Dong Geun; Kim, Jung Ryul; Jang, Kyu Yun] Res Inst Endocrine Sci, Jeonju, South Korea; [Moon, Young Jae; Il Wang, Sung; Kim, Jung Ryul] Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Orthoped Surg,Sch Med,Biomed Res Inst, Jeonju, South Korea; [Park, See-Hyoung] Hongik Univ, Dept Bio & Chem Engn, Sejong, South Korea; [Lee, Ho] Chonbuk Natl Univ, Sch Med, Dept Forens Med, Jeonju, South Korea; [Kwon, Keun Sang] Chonbuk Natl Univ, Sch Med, Dept Prevent Med, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Hongik University; Jeonbuk National University; Jeonbuk National University	Jang, KY (corresponding author), Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Pathol,Sch Med,Biomed Res Inst, Jeonju, South Korea.; Kim, JR (corresponding author), Chonbuk Natl Univ, Chonbuk Natl Univ Hosp, Res Inst Clin Med, Dept Orthoped Surg,Sch Med,Biomed Res Inst, Jeonju, South Korea.	jrkeem@jbnu.ac.kr; kyjang@chonbuk.ac.kr			National Research Foundation of Korea (NRF) - Korea government [NRF-2014R1A2A1A11052707]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (NRF-2014R1A2A1A11052707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Brunner AH, 2011, GYNECOL ONCOL, V121, P206, DOI 10.1016/j.ygyno.2010.11.037; Carey LA, 2011, NEW ENGL J MED, V364, P277, DOI 10.1056/NEJMe1012546; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Cho DH, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0129-3; Choy E, 2013, CANCER RES, V73, pLB; Coindre JM, 1998, VERHANDLUNGEN DER DEUTSCHEN GESELLSCHAFT FUR PATHOLOGIE 82. TAGUNG, P59; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Edge SB, 2010, AJCC CANC STAGING HD, P1073, DOI [10.1634/theoncologist.2013-0163, DOI 10.1634/THEONCOLOGIST.2013-0163]; Engert F, 2015, MOL CANCER THER, V14, P2818, DOI 10.1158/1535-7163.MCT-15-0587; Fam HK, 2013, MOL CANCER RES, V11, P1179, DOI 10.1158/1541-7786.MCR-12-0575; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Galia A, 2012, EUR J HISTOCHEM, V56, P45, DOI 10.4081/ejh.2012.e9; Gan A, 2013, HUM PATHOL, V44, P1638, DOI 10.1016/j.humpath.2013.01.015; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia-Parra J, 2014, EUR J CANCER, V50, P2725, DOI 10.1016/j.ejca.2014.07.004; Garg K, 2013, AM J SURG PATHOL, V37, P138, DOI 10.1097/PAS.0b013e31826cabbd; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Gill SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140988; Kang MJ, 2013, TRANSL ONCOL, V6, P282, DOI 10.1593/tlo.13256; Kim JE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074458, 10.1371/journal.pone.0069961, 10.1371/journal.pone.0051986, 10.1371/journal.pone.0060505]; Kim JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082870; Kivlin CM, 2016, CANCER BIOL THER, V17, P129, DOI 10.1080/15384047.2015.1108486; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Li ZH, 2016, CANCER BIOMARK, V16, P633, DOI 10.3233/CBM-160605; Matthaios D, 2012, ONCOTARGETS THER, V5, P309, DOI 10.2147/OTT.S36995; Mylona E, 2014, PATHOL RES PRACT, V210, P533, DOI 10.1016/j.prp.2014.05.009; Nagelkerke A, 2011, RADIOTHER ONCOL, V101, P39, DOI 10.1016/j.radonc.2011.07.009; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; Park SH, 2015, ONCOTARGET, V6, P44819, DOI 10.18632/oncotarget.6264; Park SH, 2015, TRANSL ONCOL, V8, P239, DOI 10.1016/j.tranon.2015.04.004; PRASAD SC, 1990, CANCER RES, V50, P38; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rojo F, 2012, ANN ONCOL, V23, P1156, DOI 10.1093/annonc/mdr361; Santarpia L, 2013, ONCOLOGIST, V18, P1063, DOI 10.1634/theoncologist.2013-0163; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Staibano S, 2005, HUM PATHOL, V36, P724, DOI 10.1016/j.humpath.2005.04.017; Stewart BW, 2014, WORLD CANC REPORT 20, P211, DOI [10.1016/j.ygyno.2010.11.037, DOI 10.1016/J.YGYNO.2010.11.037]; Stewart E, 2014, CELL REP, V9, P829, DOI 10.1016/j.celrep.2014.09.028; Tutt A, 2009, J CLIN ONCOL, V27; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vormoor B, 2014, CURR OPIN ONCOL, V26, P428, DOI 10.1097/CCO.0000000000000091; Wiedemeyer WR, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00034; Xing D, 2009, CANCER RES, V69, P8231, DOI 10.1158/0008-5472.CAN-09-2543; Yan J, 2014, EXP CELL RES, V328, P132, DOI 10.1016/j.yexcr.2014.08.016; Zhou F, 2011, J HUAZHONG U SCI-MED, V31, P154, DOI 10.1007/s11596-011-0242-5	54	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163193	10.1371/journal.pone.0163193	http://dx.doi.org/10.1371/journal.pone.0163193			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643881	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900037
J	Musa, HI; Hassan, L; Shamsuddin, ZH; Panchadcharam, C; Zakaria, Z; Aziz, SA				Musa, Hassan Ismail; Hassan, Latiffah; Shamsuddin, Zulkifli Hj.; Panchadcharam, Chandrawathani; Zakaria, Zunita; Aziz, Saleha Abdul			Physicochemical Properties Influencing Presence of Burkholderia pseudomallei in Soil from Small Ruminant Farms in Peninsular Malaysia	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; ENVIRONMENTAL-FACTORS; ORGANIC-MATTER; MELIOIDOSIS; SURVIVAL; WATER; IRON; GROWTH; MICROBIOLOGY; ACQUISITION	Soil is considered to be a major reservoir of Burkholderia pseudomallei in the environment. This paper investigates soil physicochemical properties that may influence presence of B. pseudomallei in soil samples from small ruminant farms in Peninsular Malaysia. Soil samples were collected from the farms and cultured for B. pseudomallei. The texture, organic matter and water contents, pH, elemental contents, cation exchange capacities, carbon, sulfur and nitrogen contents were determined. Analysis of soil samples that were positive and negative for B. pseudomallei using multivariable logistic regression found that the odds of bacterial isolation from soil was significantly higher for samples with higher contents of iron (OR = 1.01, 95% CI = 1.00-1.02, p = 0.03), water (OR = 1.28, 95% CI = 1.05-1.55, p = 0.01) and clay (OR = 1.54, 95% CI = 1.15-2.06, p = 0.004) compared to the odds of isolation in samples with lower contents of the above variables. These three factors may have favored the survival of B. pseudomallei because iron regulates expression of respiratory enzymes, while water is essential for soil ecology and agent's biological processes and clay retains water and nutrients.	[Musa, Hassan Ismail; Hassan, Latiffah; Zakaria, Zunita; Aziz, Saleha Abdul] Univ Putra Malaysia, Fac Vet Med, Serdang, Selangor, Malaysia; [Shamsuddin, Zulkifli Hj.] Univ Putra Malaysia, Dept Land Management, Fac Agr, Serdang, Selangor, Malaysia; [Panchadcharam, Chandrawathani] Vet Res Inst, Ipoh, Perak, Malaysia; [Musa, Hassan Ismail] Univ Maiduguri, Dept Vet Publ Hlth & Prevent Med, Fac Vet Med, Maiduguri, Borno State, Nigeria	Universiti Putra Malaysia; Universiti Putra Malaysia; Institute Penyelidikan Haiwan	Hassan, L (corresponding author), Univ Putra Malaysia, Fac Vet Med, Serdang, Selangor, Malaysia.	latiffah@upm.edu.my	Zakaria, Zunita/AAF-5110-2020		Universiti Putra Malaysia research grant [GP-IBT/2013/9419100]	Universiti Putra Malaysia research grant	This study was supported by Universiti Putra Malaysia research grant GP-IBT/2013/9419100. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAM D, 1961, CAN J MICROBIOL, V7, P741, DOI 10.1139/m61-088; Alef K, 1995, METHODS APPL SOIL MI; Amornrit W, 2012, ASIAN BIOMED, V6, P465, DOI 10.5372/1905-7415.0603.078; Baker AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138953; Brook MD, 1997, J APPL MICROBIOL, V82, P589, DOI 10.1111/j.1365-2672.1997.tb02867.x; Chantratita N, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000182; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chen YS, 2003, FOLIA MICROBIOL, V48, P253, DOI 10.1007/BF02930965; Cho MH, 2012, J MICROBIOL, V50, P1029, DOI 10.1007/s12275-012-2267-2; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; DEJSIRILERT S, 1991, JPN J MED SCI BIOL, V44, P63, DOI 10.7883/yoken1952.44.63; Deni SM, 2008, THEOR APPL CLIMATOL, V94, P163, DOI 10.1007/s00704-007-0355-8; Draper ADK, 2010, APPL ENVIRON MICROB, V76, P5305, DOI 10.1128/AEM.00287-10; ENGLAND LS, 1993, SOIL BIOL BIOCHEM, V25, P525, DOI 10.1016/0038-0717(93)90189-I; Hicks CL, 2000, AUST VET J, V78, P193, DOI 10.1111/j.1751-0813.2000.tb10593.x; Inglis TJJ, 2006, APPL ENVIRON MICROB, V72, P6865, DOI 10.1128/AEM.01036-06; Inglis TJJ, 2001, REV MED MICROBIOL, V12, P13; JUMA NG, 1993, GEODERMA, V57, P3, DOI 10.1016/0016-7061(93)90145-B; Kaestli M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000364; Kaestli M, 2007, APPL ENVIRON MICROB, V73, P6891, DOI 10.1128/AEM.01038-07; Kaestli M, 2012, ENVIRON MICROBIOL, V14, P2058, DOI 10.1111/j.1462-2920.2011.02671.x; Kamjumphol W, 2013, SE ASIAN J TROP MED, V44, P72; Kanai K, 1994, MELIOIDOSIS PREVAILI, P26; Lehtola MJ, 2004, WATER RES, V38, P3769, DOI 10.1016/j.watres.2004.06.024; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002105; Limmathurotsakul D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002072; Limmathurotsakul D, 2012, APPL ENVIRON MICROB, V78, P876, DOI 10.1128/AEM.07039-11; Lunsdorf H, 2000, ENVIRON MICROBIOL, V2, P161; MARSHALL KC, 1975, ANNU REV PHYTOPATHOL, V13, P357, DOI 10.1146/annurev.py.13.090175.002041; MILLER WP, 1987, COMMUN SOIL SCI PLAN, V18, P1, DOI 10.1080/00103628709367799; Musa HI, 2015, J APPL MICROBIOL, V119, P331, DOI 10.1111/jam.12830; Musa HI, 2012, MALAYS J VET RES, V3, P41; Palasatien Supapong, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS5, DOI 10.1016/S0035-9203(08)70003-8; Paul EA, 2006, SOIL MICROBIOLOGY EC, P30; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Perkin-Elmer, 1964, AN METH AT ABS SPECT; Praveen S., 2009, ANAL MICRONUTRIENTS; Pumpuang A, 2011, T ROY SOC TROP MED H, V105, P598, DOI 10.1016/j.trstmh.2011.06.004; Ranjard L, 2001, RES MICROBIOL, V152, P707, DOI 10.1016/S0923-2508(01)01251-7; Rattanavong S, 2011, APPL ENVIRON MICROB, V77, P532, DOI 10.1128/AEM.01822-10; Robert M., 1992, SOIL BIOCH, P307; Salehi MH, 2011, PEDOSPHERE, V21, P473, DOI 10.1016/S1002-0160(11)60149-5; Schulte EE, 1999, SOIL AND APPLIED COP; Schulte EE, 2004, SOIL AND APPLIED IRO, P2; Schwertmann U, 1993, SOIL SCI SOC AM J, V31, P51, DOI DOI 10.2136/SSSASPECPUB31.C4; SMITH MD, 1995, T ROY SOC TROP MED H, V89, P488, DOI 10.1016/0035-9203(95)90078-0; STRAUSS JM, 1969, AM J TROP MED HYG, V18, P698, DOI 10.4269/ajtmh.1969.18.698; SUPUTTAMONGKOL Y, 1994, INT J EPIDEMIOL, V23, P1082, DOI 10.1093/ije/23.5.1082; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; THOMAS AD, 1981, AUST VET J, V57, P535, DOI 10.1111/j.1751-0813.1981.tb05804.x; THOMAS AD, 1979, AM J EPIDEMIOL, V110, P515, DOI 10.1093/oxfordjournals.aje.a112832; Tong SD, 1996, MICROBIOL IMMUNOL, V40, P451, DOI 10.1111/j.1348-0421.1996.tb01092.x; Tuanyok A, 2005, FEMS MICROBIOL LETT, V252, P327, DOI 10.1016/j.femsle.2005.09.043; van der Kooij D, 2005, WATER RES, V39, P2789, DOI 10.1016/j.watres.2005.04.075; Vidyalakshmi K, 2012, INT J INFECT DIS, V16, pE491, DOI 10.1016/j.ijid.2012.02.012; Wang-Ngarm S, 2014, AM J TROP MED HYG, V90, P480, DOI 10.4269/ajtmh.13-0446; Weightman B. B. A, 2011, DRAGONS TIGERS GEOGR; WUTHIEKANUN V, 1995, T ROY SOC TROP MED H, V89, P41, DOI 10.1016/0035-9203(95)90651-7; Yip TW, 2015, EMERG INFECT DIS, V21, P1038, DOI 10.3201/eid2106.141908	62	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162348	10.1371/journal.pone.0162348	http://dx.doi.org/10.1371/journal.pone.0162348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635652	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700005
J	Boon, PJ; Belopolsky, AV; Theeuwes, J				Boon, Paul J.; Belopolsky, Artem V.; Theeuwes, Jan			The Role of the Oculomotor System in Updating Visual-Spatial Working Memory across Saccades	PLOS ONE			English	Article							FRONTAL EYE FIELD; MONKEY SUPERIOR COLLICULUS; TRANSSACCADIC INTEGRATION; COROLLARY DISCHARGE; SPACE CONSTANCY; PARIETAL CORTEX; MOVEMENTS; PERCEPTION; ATTENTION; DISPLACEMENT	Visual-spatial working memory (VSWM) helps us to maintain and manipulate visual information in the absence of sensory input. It has been proposed that VSWM is an emergent property of the oculomotor system. In the present study we investigated the role of the oculomotor system in updating of spatial working memory representations across saccades. Participants had to maintain a location in memory while making a saccade to a different location. During the saccade the target was displaced, which went unnoticed by the participants. After executing the saccade, participants had to indicate the memorized location. If memory updating fully relies on cancellation driven by extraretinal oculomotor signals, the displacement should have no effect on the perceived location of the memorized stimulus. However, if postsaccadic retinal information about the location of the saccade target is used, the perceived location will be shifted according to the target displacement. As it has been suggested that maintenance of accurate spatial representations across saccades is especially important for action control, we used different ways of reporting the location held in memory; a match-to-sample task, a mouse click or by making another saccade. The results showed a small systematic target displacement bias in all response modalities. Parametric manipulation of the distance between the to-be-memorized stimulus and saccade target revealed that target displacement bias increased over time and changed its spatial profile from being initially centered on locations around the saccade target to becoming spatially global. Taken together results suggest that we neither rely exclusively on extraretinal nor on retinal information in updating working memory representations across saccades. The relative contribution of retinal signals is not fixed but depends on both the time available to integrate these signals as well as the distance between the saccade target and the remembered location.	[Boon, Paul J.; Belopolsky, Artem V.; Theeuwes, Jan] Vrije Univ, Dept Expt & Appl Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Boon, PJ (corresponding author), Vrije Univ, Dept Expt & Appl Psychol, Amsterdam, Netherlands.	p.j.boon@vu.nl	Theeuwes, Jan/ABF-3771-2020	Belopolsky, Artem/0000-0003-3606-2134; Theeuwes, Jan/0000-0002-5849-7721	Open Area Research Grant from the Netherlands Organization for Scientific Research [ORA 464-15-193]; ERC [ERC-2012-AdG - 323413]	Open Area Research Grant from the Netherlands Organization for Scientific Research; ERC(European Research Council (ERC)European Commission)	This research was supported by an Open Area Research Grant from the Netherlands Organization for Scientific Research to Artem Belopolsky [ORA 464-15-193] and an ERC advanced grant [ERC-2012-AdG - 323413 Jan Theeuwes]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball K, 2013, COGNITION, V129, P439, DOI 10.1016/j.cognition.2013.08.006; Bays PM, 2007, NEUROREPORT, V18, P1207, DOI 10.1097/WNR.0b013e328244e6c3; Belopolsky AV, 2015, PERCEPTION, V44, P920, DOI 10.1177/0301006615596866; Belopolsky AV, 2013, J NEUROPHYSIOL, V110, P2370, DOI 10.1152/jn.00293.2013; Belopolsky AV, 2011, NEUROPSYCHOLOGIA, V49, P1605, DOI 10.1016/j.neuropsychologia.2010.12.045; Boon PJ, 2014, VISION RES, V94, P51, DOI 10.1016/j.visres.2013.11.002; Bray LCJ, 2016, J NEUROPHYSIOL, V115, P1132, DOI 10.1152/jn.00657.2015; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; CARLSONRADVANSKY LA, 1995, J EXP PSYCHOL LEARN, V21, P1441, DOI 10.1037/0278-7393.21.6.1441; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Collins T, 2009, J VISION, V9, DOI 10.1167/9.5.29; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Currie CB, 2000, PERCEPT PSYCHOPHYS, V62, P673, DOI 10.3758/BF03206914; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; Deubel H, 2004, VIS COGN, V11, P173, DOI 10.1080/13506280344000284; Deubel H, 1998, VISION RES, V38, P3147, DOI 10.1016/S0042-6989(98)00048-0; Deubel H, 2002, PROGR BRAIN RES, P140; Deubel H, 2010, VISION RES, V50, P249, DOI 10.1016/j.visres.2009.09.020; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dunn CA, 2010, J NEUROPHYSIOL, V104, P1267, DOI 10.1152/jn.00675.2009; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Germeys F, 2004, VIS COGN, V11, P203, DOI 10.1080/13506280344000301; Hamker FH, 2004, VISION RES, V44, P501, DOI 10.1016/j.visres.2003.09.033; Hollingworth A, 2008, J EXP PSYCHOL GEN, V137, P163, DOI 10.1037/0096-3445.137.1.163; Irwin DE, 1998, VIS COGN, V5, P127, DOI 10.1080/713756783; Irwin DE, 2002, PERCEPT PSYCHOPHYS, V64, P882, DOI 10.3758/BF03196793; Jerde TA, 2012, J NEUROSCI, V32, P17382, DOI 10.1523/JNEUROSCI.3810-12.2012; Jonikaitis D, 2014, J NEUROSCI, V34, P6687, DOI 10.1523/JNEUROSCI.4453-13.2014; Jonikaitis D, 2013, J NEUROPHYSIOL, V109, P1425, DOI 10.1152/jn.00656.2012; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; LI WX, 1990, PERCEPT PSYCHOPHYS, V48, P453, DOI 10.3758/BF03211589; McConkie GW, 1996, J EXP PSYCHOL HUMAN, V22, P563, DOI 10.1037/0096-1523.22.3.563; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Niemeier M, 2003, NATURE, V422, P76, DOI 10.1038/nature01439; Ostendorf F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116810; Parks NA, 2008, PSYCHOPHYSIOLOGY, V45, P776, DOI 10.1111/j.1469-8986.2008.00669.x; Pearson DG, 2014, COGNITION, V132, P416, DOI 10.1016/j.cognition.2014.05.006; Poletti M, 2013, J NEUROSCI, V33, P14259, DOI 10.1523/JNEUROSCI.0523-13.2013; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Rolfs M, 2011, NAT NEUROSCI, V14, P252, DOI 10.1038/nn.2711; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Sprague TC, 2014, CURR BIOL, V24, P2174, DOI 10.1016/j.cub.2014.07.066; Szinte M, 2015, J NEUROPHYSIOL, V113, P2220, DOI 10.1152/jn.00966.2014; Theeuwes J, 2005, PSYCHOL SCI, V16, P196, DOI 10.1111/j.0956-7976.2005.00803.x; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Ziesche A, 2011, J NEUROSCI, V31, P17392, DOI 10.1523/JNEUROSCI.3407-11.2011	54	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161829	10.1371/journal.pone.0161829	http://dx.doi.org/10.1371/journal.pone.0161829			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27631767	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900023
J	Budzinska, MA; Tu, T; d'Avigdor, WMH; McCaughan, GW; Luciani, F; Shackel, NA				Budzinska, Magdalena A.; Tu, Thomas; d'Avigdor, William M. H.; McCaughan, Geoffrey W.; Luciani, Fabio; Shackel, Nicholas A.			Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SOMATIC MUTATIONS; CANCER; P53; AFLATOXINS; PATHWAYS	In hepatocellular carcinoma (HCC), somatic genome-wide DNA mutations are numerous, universal and heterogeneous. Some of these somatic mutations are drivers of the malignant process but the vast majority are passenger mutations. These passenger mutations can be deleterious to individual protein function but are tolerated by the cell or are offset by a survival advantage conferred by driver mutations. It is unknown if these somatic deleterious passenger mutations (DPMs) develop in the precancerous state of cirrhosis or if it is confined to HCC. Therefore, we studied four whole-exome sequencing datasets, including patients with non-cirrhotic liver (n = 12), cirrhosis without HCC (n = 6) and paired HCC with surrounding non-HCC liver (n = 74 paired samples), to identify DPMs. After filtering out putative germline mutations, we identified 187+/-22 DPMs per non-diseased tissue. DPMs number was associated with liver disease progressing to HCC, independent of the number of exonic mutations. Tumours contained significantly more DPMs compared to paired non-tumour tissue (258-293 per HCC exome). Cirrhosis-and HCC-associated DPMs do not occur predominantly in specific genes, chromosomes or biological pathways and the effect on tumour biology is presently unknown. Importantly, for the first time we have shown a significant increase in DPMs with HCC.	[Budzinska, Magdalena A.; Tu, Thomas; d'Avigdor, William M. H.; McCaughan, Geoffrey W.; Shackel, Nicholas A.] Univ Sydney, Centenary Inst, Sydney, NSW, Australia; [Budzinska, Magdalena A.; Tu, Thomas; d'Avigdor, William M. H.; McCaughan, Geoffrey W.; Shackel, Nicholas A.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Budzinska, Magdalena A.; Luciani, Fabio] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [McCaughan, Geoffrey W.; Shackel, Nicholas A.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of New South Wales Sydney; University of Sydney	Shackel, NA (corresponding author), Univ Sydney, Centenary Inst, Sydney, NSW, Australia.; Shackel, NA (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.; Shackel, NA (corresponding author), Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia.	n.shackel@centenary.usyd.edu.au	Tu, Thomas/H-2894-2019; Budzinska, Magdalena/X-5364-2019	Tu, Thomas/0000-0002-0482-4387; Budzinska, Magdalena/0000-0002-3624-431X; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636	Sydney Foundation for Medical Research [53030]	Sydney Foundation for Medical Research	This project, T.T. and M.A.B. were funded by Sydney Foundation for Medical Research (Grant number 53030) NAS, http://nfmri.org.au/about-us/.	1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Azechi H, 2001, ONCOLOGY-BASEL, V60, P346, DOI 10.1159/000058531; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Dan LUO, 1998, WORLD J GASTROENTERO, V4, P97; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Ito T, 2004, J GASTROENTEROL, V39, P355, DOI 10.1007/s00535-003-1302-9; Iwamoto KS, 1998, J NATL CANCER I, V90, P1167, DOI 10.1093/jnci/90.15.1167; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jhunjhunwala S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0436-9; Jiang SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040363; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Kumar R, 2008, QJM-INT J MED, V101, P479, DOI 10.1093/qjmed/hcn033; Lim KC, 2012, BRIT J SURG, V99, P1622, DOI 10.1002/bjs.8915; Mason WS, 2010, J VIROL, V84, P8308, DOI 10.1128/JVI.00833-10; McFarland CD, 2013, P NATL ACAD SCI USA, V110, P2910, DOI 10.1073/pnas.1213968110; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Morris-Stiff G, 2009, SURG ONCOL, V18, P298, DOI 10.1016/j.suronc.2008.08.003; Nault JC, 2014, HEPATOLOGY; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Omer RE, 2004, NUTR CANCER, V48, P15, DOI 10.1207/s15327914nc4801_3; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Peng L, 2015, HEPATOLOGY, V61, P1251, DOI 10.1002/hep.27608; Schoniger-Hekele M, 2000, EUR J GASTROEN HEPAT, V12, P941, DOI 10.1097/00042737-200012080-00015; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Su H, 2008, MUTAT RES-FUND MOL M, V641, P27, DOI 10.1016/j.mrfmmm.2008.02.005; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Tu T, 2015, J VIRAL HEPATITIS, V22, P737, DOI 10.1111/jvh.12380; Tu T, 2015, LIVER INT, V35, P1786, DOI 10.1111/liv.12773; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wong PY, 2011, J IMMIGR MINOR HEALT, V13, P842, DOI 10.1007/s10903-010-9395-8; Woo HG, 2011, MOL CARCINOGEN, V50, P235, DOI 10.1002/mc.20691; YEH FS, 1989, CANCER RES, V49, P2506	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162586	10.1371/journal.pone.0162586	http://dx.doi.org/10.1371/journal.pone.0162586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631787	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900053
J	Harter, M; Dirmaier, J; Dwinger, S; Kriston, L; Herbarth, L; Siegmund-Schultze, E; Bermejo, I; Matschinger, H; Heider, D; Konig, HH				Haerter, Martin; Dirmaier, Joerg; Dwinger, Sarah; Kriston, Levente; Herbarth, Lutz; Siegmund-Schultze, Elisabeth; Bermejo, Isaac; Matschinger, Herbert; Heider, Dirk; Koenig, Hans-Helmut			Effectiveness of Telephone-Based Health Coaching for Patients with Chronic Conditions: A Randomised Controlled Trial	PLOS ONE			English	Article							CARE; DISEASE; DISABILITY; SERVICES; PEOPLE; COSTS	Background Chronic diseases, like diabetes mellitus, heart disease and cancer are leading causes of death and disability. These conditions are at least partially preventable or modifiable, e.g. by enhancing patients' self-management. We aimed to examine the effectiveness of telephone-based health coaching (TBHC) in chronically ill patients. Methods and Findings This prospective, pragmatic randomized controlled trial compares an intervention group (IG) of participants in TBHC to a control group (CG) without TBHC. Endpoints were assessed two years after enrolment. Three different groups of insurees with 1) multiple conditions (chronic campaign), 2) heart failure (heart failure campaign), or 3) chronic mental illness conditions (mental health campaign) were targeted. The telephone coaching included evidence-based information and was based on the concepts of motivational interviewing, shared decision-making, and collaborative goal setting. Patients received an average of 12.9 calls. Primary outcome was time from enrolment until hospital readmission within a two-year follow-up period. Secondary outcomes comprised the probability of hospital readmission, number of daily defined medication doses (DDD), frequency and duration of inability to work, and mortality within two years. All outcomes were collected from routine data provided by the statutory health insurance. As informed consent was obtained after randomization, propensity score matching (PSM) was used to minimize selection bias introduced by decliners. For the analysis of hospital readmission and mortality, we calculated Kaplan-Meier curves and estimated hazard ratios (HR). Probability of hospital readmission and probability of death were analysed by calculating odds ratios (OR). Quantity of health service use and inability to work were analysed by linear random effects regression models. PSM resulted in patient samples of 5,309 (IG: 2,713; CG: 2,596) in the chronic campaign, of 660 (IG: 338; CG: 322) in the heart failure campaign, and of 239 (IG: 101; KG: 138) in the mental health campaign. In none of the three campaigns, there were significant differences between IG and CG in time until hospital readmission. In the chronic campaign, the probability of hospital readmission was higher in the IG than in the CG (OR = 1.13; p = 0.045); no significant differences could be found for the other two campaigns. In the heart failure campaign, the IG showed a significantly reduced number of hospital admissions (-0.41; p = 0.012), although the corresponding reduction in the number of hospital days was not significant. In the chronic campaign, the IG showed significantly increased number of DDDs. Most striking, there were significant differences in mortality between IG and CG in the chronic campaign (OR = 0.64; p = 0.005) as well as in the heart failure campaign (OR = 0.44; p = 0.001). Conclusions While TBHC seems to reduce hospitalization only in specific patient groups, it may reduce mortality in patients with chronic somatic conditions. Further research should examine intervention effects in various subgroups of patients, for example for different diagnostic groups within the chronic campaign, or duration of coaching.	[Haerter, Martin; Dirmaier, Joerg; Dwinger, Sarah; Kriston, Levente] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Herbarth, Lutz; Siegmund-Schultze, Elisabeth] Kaufmann Krankenkasse KKH, Hannover, Germany; [Bermejo, Isaac] Univ Med Ctr Freiburg, Freiburg, Germany; [Matschinger, Herbert; Heider, Dirk; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Harter, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	m.haerter@uke.de	König, Hans-Helmut/P-1211-2018; Kriston, Levente/D-1713-2013	König, Hans-Helmut/0000-0001-5711-6862; Kriston, Levente/0000-0003-0748-264X; Harter, Martin/0000-0001-7443-9890; Dwinger, Sarah/0000-0003-4868-5662; Matschinger, Herbert/0000-0001-7146-6770; Dirmaier, Joerg/0000-0002-5729-7357	Kaufmannische Krankenkasse Hannover (KKH)	Kaufmannische Krankenkasse Hannover (KKH)	The study is funded by Kaufmannische Krankenkasse Hannover (KKH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema GE, 2007, HEALTH SERV RES, V42, P1632, DOI 10.1111/j.1475-6773.2006.00668.x; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Bloom DE, 2011, GLOBAL EC BURDEN NON; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Dennis SM, 2013, AUST HEALTH REV, V37, P381, DOI 10.1071/AH13005; DeVol R, 2007, UNHEALTHY AM EC BURD; Dwinger S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-337; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Harter M, 2013, HEALTH EDUC J, V72, P622, DOI 10.1177/0017896912453990; Hoffmann F, 2007, BUNDESGESUNDHEITSBLA, V50, P1418, DOI 10.1007/s00103-007-0369-5; Hutchison AJ, 2011, J TELEMED TELECARE, V17, P451, DOI 10.1258/jtt.2011.110513; Inglis SC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub3; Jia HM, 2013, VALUE HEALTH, V16, P140, DOI 10.1016/j.jval.2012.08.2208; Jonk Y, 2015, MED CARE, V53, P133, DOI 10.1097/MLR.0000000000000287; Kim SE, 2013, HEALTH SERV RES, V48, P1730, DOI 10.1111/1475-6773.12060; Lin WC, 2012, MED CARE, V50, P91, DOI 10.1097/MLR.0b013e31822dcedf; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Richards T., 2012, BMJ, V344; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Schubert I, 2010, GESUNDHEITSWESEN, V72, P316, DOI 10.1055/s-0030-1249688; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Steventon A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4585; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Veroff D, 2013, HEALTH AFFAIR, V32, P285, DOI 10.1377/hlthaff.2011.0941; Wennberg DE, 2010, NEW ENGL J MED, V363, P1245, DOI 10.1056/NEJMsa0902321; ZELEN M, 1979, NEW ENGL J MED, V300, P1242, DOI 10.1056/NEJM197905313002203	31	31	32	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161269	10.1371/journal.pone.0161269	http://dx.doi.org/10.1371/journal.pone.0161269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632360	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900017
J	Raudales, JLM; Yoshimura, A; Ziauddin, SM; Kaneko, T; Ozaki, Y; Ukai, T; Miyazaki, T; Latz, E; Hara, Y				Raudales, Jorge Luis Montenegro; Yoshimura, Atsutoshi; Ziauddin, S. M.; Kaneko, Takashi; Ozaki, Yukio; Ukai, Takashi; Miyazaki, Toshihiro; Latz, Eicke; Hara, Yoshitaka			Dental Calculus Stimulates Interleukin-1 beta Secretion by Activating NLRP3 Inflammasome in Human and Mouse Phagocytes	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; BONE-RESORPTION INVITRO; NALP3 INFLAMMASOME; PERIODONTAL-DISEASES; SUBGINGIVAL CALCULUS; ELECTRON-MICROSCOPY; CELLS; EXPRESSION; IL-1-BETA; CRYSTALS	Dental calculus is a mineralized deposit associated with periodontitis. The bacterial components contained in dental calculus can be recognized by host immune sensors, such as Toll-like receptors (TLRs), and induce transcription of proinflammatory cytokines, such as IL-1 beta. Studies have shown that cellular uptake of crystalline particles may trigger NLRP3 inflammasome activation, leading to the cleavage of the IL-1 beta precursor to its mature form. Phagocytosis of dental calculus in the periodontal pocket may therefore lead to the secretion of IL-1 beta, promoting inflammatory responses in periodontal tissues. However, the capacity of dental calculus to induce IL-1 beta secretion in human phagocytes has not been explored. To study this, we stimulated human polymorphonuclear leukocytes (PMNs) and peripheral blood mononuclear cells (PBMCs) with dental calculus collected from periodontitis patients, and measured IL-1 beta secretion by ELISA. We found that calculus induced IL-1 beta secretion in both human PMNs and PBMCs. Calculus also induced IL-1 beta in macrophages from wildtype mice, but not in macrophages from NLRP3- and ASC-deficient mice, indicating the involvement of NLRP3 and ASC. IL-1 beta induction was inhibited by polymyxin B, suggesting that LPS is one of the components of calculus that induces pro-IL-1 beta transcription. To analyze the effect of the inorganic structure, we baked calculus at 250 degrees C for 1 h. This baked calculus failed to induce pro-IL-1 beta transcription. However, it did induce IL-1 beta secretion in lipid A-primed cells, indicating that the crystalline structure of calculus induces inflammasome activation. Furthermore, hydroxyapatite crystals, a component of dental calculus, induced IL-1 beta in mouse macrophages, and baked calculus induced IL-1 beta in lipid A-primed human PMNs and PBMCs. These results indicate that dental calculus stimulates IL-1 beta secretion via NLRP3 inflammasome in human and mouse phagocytes, and that the crystalline structure has a partial role in the activation of NLRP3 inflammasome.	[Raudales, Jorge Luis Montenegro; Yoshimura, Atsutoshi; Ziauddin, S. M.; Ozaki, Yukio; Ukai, Takashi; Hara, Yoshitaka] Nagasaki Univ, Grad Sch Biomed Sci, Dept Periodontol, Nagasaki, Japan; [Kaneko, Takashi] Fukuoka Dent Coll, Ctr Oral Dis, Fukuoka, Japan; [Miyazaki, Toshihiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Nagasaki, Japan; [Latz, Eicke] Univ Bonn, Univ Hosp, Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Dept Infect Dis & Immunol, Worcester, MA USA; [Latz, Eicke] German Ctr Neurodegenerat Dis, Bonn, Germany; [Latz, Eicke] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Trondheim, Norway	Nagasaki University; Fukuoka Dental College (FDC); Nagasaki University; University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Norwegian University of Science & Technology (NTNU)	Yoshimura, A (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Periodontol, Nagasaki, Japan.	ayoshi@nagasaki-u.ac.jp	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; MONTENEGRO CAMACHO, LUIS ARTURO/0000-0002-5224-4854; Kaneko, Takashi/0000-0001-9276-5550	Japan Society for the Promotion of Science, Tokyo, Japan [24593126]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (C) 24593126 from the Japan Society for the Promotion of Science, Tokyo, Japan (https://www.jsps.go.jp/j-grantsinaid/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2005, J BIOMED MATER RES A, V75A, P623, DOI 10.1002/jbm.a.30484; Assuma R, 1998, J IMMUNOL, V160, P403; Bostanci N, 2009, CLIN EXP IMMUNOL, V157, P415, DOI 10.1111/j.1365-2249.2009.03972.x; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Delaleu N, 2004, PERIODONTOL 2000, V35, P42, DOI 10.1111/j.0906-6713.2004.003569.x; Delben JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155427; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; FUJIKAWA K, 1988, J PERIODONTOL, V59, P170, DOI 10.1902/jop.1988.59.3.170; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; GOWEN M, 1986, J IMMUNOL, V136, P2478; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Horvath GL, 2011, IMMUNOL REV, V243, P119, DOI 10.1111/j.1600-065X.2011.01050.x; Huang X, 2015, J PERIODONTOL, V86, P327, DOI 10.1902/jop.2014.140403; Jepsen S, 2011, PERIODONTOL 2000, V55, P167, DOI 10.1111/j.1600-0757.2010.00382.x; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Jun HK, 2012, IMMUNITY, V36, P755, DOI 10.1016/j.immuni.2012.05.002; Kakei M, 2009, J ELECTRON MICROSC, V58, P393, DOI 10.1093/jmicro/dfp034; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; LUSTMANN J, 1976, CALC TISS RES, V21, P47, DOI 10.1007/BF02547382; Madouri F, 2015, J MOL CELL BIOL, V7, P351, DOI 10.1093/jmcb/mjv012; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; MANDEL ID, 1986, J CLIN PERIODONTOL, V13, P249, DOI 10.1111/j.1600-051X.1986.tb02219.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Nair P N, 1999, Aust Endod J, V25, P19; Oh H, 2015, J ORAL SCI, V57, P67, DOI 10.2334/josnusd.57.67; Ono M, 2011, IN VIVO, V25, P763; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938; Roberts-Harry EA, 2000, J DENT, V28, P93, DOI 10.1016/S0300-5712(99)00056-1; Rutter JL, 1997, J CELL BIOCHEM, V66, P322, DOI 10.1002/(SICI)1097-4644(19970901)66:3<322::AID-JCB5>3.3.CO;2-D; Ryu OH, 2007, J PERIODONTOL, V78, P1627, DOI 10.1902/jop.2007.070066; Song M, 2011, J ENDODONT, V37, P1516, DOI 10.1016/j.joen.2011.06.032; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vanaja SK, 2014, P NATL ACAD SCI USA, V111, P7765, DOI 10.1073/pnas.1400075111; WELCH H, 1945, J AM PHARM ASSOC SCI, V34, P114, DOI 10.1002/jps.3030340404; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhang K, 2010, J ENDODONT, V36, P105, DOI 10.1016/j.joen.2009.10.020; Zhang K, 2010, DENT MATER, V26, P514, DOI 10.1016/j.dental.2010.01.009; Zhu HH, 2015, INT J CLIN EXP PATHO, V8, P2214	53	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162865	10.1371/journal.pone.0162865	http://dx.doi.org/10.1371/journal.pone.0162865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632566	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900088
J	Tan, WC; Isa, NAM				Tan, Weng Chun; Isa, Nor Ashidi Mat			Automated Sperm Head Detection Using Intersecting Cortical Model Optimised by Particle Swarm Optimization	PLOS ONE			English	Article							SEGMENTATION; ALGORITHM; MOTILITY	In human spermmotility analysis, sperm segmentation plays an important role to determine the location of multiple sperms. To ensure an improved segmentation result, the Laplacian of Gaussian filter is implemented as a kernel in a pre-processing step before applying the image segmentation process to automatically segment and detect human spermatozoa. This study proposes an intersecting cortical model (ICM), which was derived from several visual cortex models, to segment the spermhead region. However, the proposed method suffered from parameter selection; thus, the ICM network is optimised using particle swarm optimization where feature mutual information is introduced as the new fitness function. The final results showed that the proposed method is more accurate and robust than four state-of-the-artsegmentation methods. The proposed method resulted in rates of 98.14%, 98.82%, 86.46% and 99.81% in accuracy, sensitivity, specificity and precision, respectively, after testing with 1200 sperms. The proposed algorithm is expected to be implemented in analysing spermmotility because of the robustness and capability of this algorithm.	[Tan, Weng Chun; Isa, Nor Ashidi Mat] Univ Sains Malaysia, Imaging & Intelligent Syst Res Team ISRT, Sch Elect & Elect Engn, Nibong Tebal, Penang, Malaysia	Universiti Sains Malaysia	Isa, NAM (corresponding author), Univ Sains Malaysia, Imaging & Intelligent Syst Res Team ISRT, Sch Elect & Elect Engn, Nibong Tebal, Penang, Malaysia.	ashidi@usm.my	Tan, Jason/AAS-6418-2021; Isa, Nor Ashidi Mat/I-7826-2017	Isa, Nor Ashidi Mat/0000-0002-2675-4914	Ministry of Higher Education (MOHE), Malaysia; Universiti Sains Malaysia (USM) through the Research University Grants (RU) entitled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Universiti Sains Malaysia (USM) through the Research University Grants (RU) titled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Ministry of Higher Education (MOHE)	Ministry of Higher Education (MOHE), Malaysia; Universiti Sains Malaysia (USM) through the Research University Grants (RU) entitled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Universiti Sains Malaysia (USM) through the Research University Grants (RU) titled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns"; Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR))	This study is supported by the Universiti Sains Malaysia (USM) through the Research University Grants (RU) entitled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns". The fund is received by Nor Ashidi Mat Isa. The study was also partially supported by the Ministry of Higher Education (MOHE), Malaysia under MyPhD Scholarship [https://biasiswa.mohe.gov.my/MyBrain15/v2/index_myphd.php]. The fund is received by Tan Weng Chun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the Universiti Sains Malaysia (USM) through the Research University Grants (RU) titled "Development of an Intelligent Auto-Immune Diseases Diagnostic System by Classification of Hep-2 Immunofluorescence Patterns," and by the Ministry of Higher Education (MOHE) under the MyPhD Scholarship. Credits are given to Associate Professor Dr Mahaneem Mohamed and Nur Syuhada Mohd Nafis for their assistance on taking the sperm videos.	Abbiramy V.S, 2010, INT J COMPUT APPL, V3; Balafar MA, 2008, 4 INT C INT COMP ICI, P177; Bijar A., 2012, J BIOMED SCI ENG, V5, P384, DOI [10.4236/jbise.2012.57049, DOI 10.4236/JBISE.2012.57049]; Bogovic JA, 2013, COMPUT VIS IMAGE UND, V117, P145, DOI 10.1016/j.cviu.2012.10.006; Carrillo H, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P1152; Chang V, 2014, COMPUT METH PROG BIO, V117, P225, DOI 10.1016/j.cmpb.2014.06.018; Chen Y, 2011, IEEE T NEURAL NETWOR, V22, P880, DOI 10.1109/TNN.2011.2128880; Chou N, 2011, IEEE T IMAGE PROCESS, V20, P2554, DOI 10.1109/TIP.2011.2126587; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; Deng X, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/9/090601; Djerou L, 2012, J APPL COMPUT SCI MA, V13, P24; Ekblad U, 2004, NUCL INSTRUM METH A, V525, P392, DOI 10.1016/j.nima.2004.03.102; Ekblad U, 2004, SIGNAL PROCESS, V84, P1131, DOI 10.1016/j.sigpro.2004.03.012; Ellis AL, 2014, COMPUT VIS IMAGE UND, V122, P47, DOI 10.1016/j.cviu.2014.01.009; Filippone M, 2008, PATTERN RECOGN, V41, P176, DOI 10.1016/j.patcog.2007.05.018; Gao C, 2013, NEUROCOMPUTING, V119, P332, DOI 10.1016/j.neucom.2013.03.025; Ghamisi P, 2012, EXPERT SYST APPL, V39, P12407, DOI 10.1016/j.eswa.2012.04.078; Hage I, 2013, COMPUT MED IMAGING G; Hage IS, 2013, COMPUT MED IMAG GRAP, V37, P466, DOI 10.1016/j.compmedimag.2013.08.003; Hammouche K, 2008, COMPUT VIS IMAGE UND, V109, P163, DOI 10.1016/j.cviu.2007.09.001; Ma YD, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P743; Mortimer ST, 1997, HUM REPROD UPDATE, V3, P403, DOI 10.1093/humupd/3.5.403; Murugavel M, 2009, NEUROIMAGE, V45, P845, DOI 10.1016/j.neuroimage.2008.12.021; Niu JQ, 2009, 2009 3RD INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING, VOLS 1-11, P185; Park KS, 1997, ANN BIOMED ENG, V25, P294, DOI 10.1007/BF02648044; PAVLIDIS T, 1990, IEEE T PATTERN ANAL, V12, P225, DOI 10.1109/34.49050; Ranamuka NG, 2013, IET IMAGE PROCESS, V7, P121, DOI 10.1049/iet-ipr.2012.0134; Wang H, 2014, ALGORITHMS, V7, P405, DOI 10.3390/a7030405; Wilson-Leedy JG, 2007, THERIOGENOLOGY, V67, P661, DOI 10.1016/j.theriogenology.2006.10.003; Wong WK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124720; Xu GZ, 2008, INT J COGN INFORM NA, V2, P43, DOI 10.4018/jcini.2008070104; Xu Xinzheng, 2011, Journal of Computers, V6, P1546, DOI 10.4304/jcp.6.8.1546-1553; Xuan Z, 2010, 2010 INT C 11 14 JUL, Vl5, p[2448, 11]; Yan PK, 2013, COMPUT VIS IMAGE UND, V117, P1017, DOI 10.1016/j.cviu.2013.03.006; Yonekawa M, 2009, LECT NOTES COMPUT SC, V5768, P834, DOI 10.1007/978-3-642-04274-4_86; Zheng Li Xuan, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P2444, DOI 10.1109/ICMLC.2010.5580766; Zheng RL, 1997, FREE RADICAL BIO MED, V22, P581, DOI 10.1016/S0891-5849(96)00272-9; Zhou DG, 2016, PATTERN ANAL APPL, V19, P939, DOI 10.1007/s10044-015-0462-6	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162985	10.1371/journal.pone.0162985	http://dx.doi.org/10.1371/journal.pone.0162985			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632581	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900108
J	Vitali, F; Cohen, LD; Demartini, A; Amato, A; Eterno, V; Zambelli, A; Bellazzi, R				Vitali, Francesca; Cohen, Laurie D.; Demartini, Andrea; Amato, Angela; Eterno, Vincenzo; Zambelli, Alberto; Bellazzi, Riccardo			A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer	PLOS ONE			English	Article							IMATINIB MESYLATE; PHARMACOLOGY; IDENTIFICATION; DISCOVERY; PARADIGM; EFFICACY; DISEASE; SAFETY; HUBS	The integration of data and knowledge from heterogeneous sources can be a key success factor in drug design, drug repurposing and multi-target therapies. In this context, biological networks provide a useful instrument to highlight the relationships and to model the phenomena underlying therapeutic action in cancer. In our work, we applied network-based modeling within a novel bioinformatics pipeline to identify promising multi-target drugs. Given a certain tumor type/ subtype, we derive a disease-specific Protein-Protein Interaction (PPI) network by combining different data-bases and knowledge repositories. Next, the application of suitable graph-based algorithms allows selecting a set of potentially interesting combinations of drug targets. A list of drug candidates is then extracted by applying a recent data fusion approach based on matrix tri-factorization. Available knowledge about selected drugs mechanisms of action is finally exploited to identify the most promising candidates for planning in vitro studies. We applied this approach to the case of Triple Negative Breast Cancer (TNBC), a subtype of breast cancer whose biology is poorly understood and that lacks of specific molecular targets. Our "in-silico" findings have been confirmed by a number of in vitro experiments, whose results demonstrated the ability of the method to select candidates for drug repurposing.	[Vitali, Francesca; Cohen, Laurie D.; Demartini, Andrea; Bellazzi, Riccardo] Univ Pavia, Dipartimento Ingn Ind & Informaz, Pavia, Italy; [Amato, Angela; Eterno, Vincenzo; Zambelli, Alberto; Bellazzi, Riccardo] IRCCS Fdn S Maugeri, Pavia, Italy; [Zambelli, Alberto] ASST Papa Giovanni XXIII, Oncol Med, Bergamo, Italy	University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; ASST Papa Giovanni XXIII	Vitali, F (corresponding author), Univ Pavia, Dipartimento Ingn Ind & Informaz, Pavia, Italy.	francesca.vitali03@universitadipavia.it	Bellazzi, Riccardo/J-6432-2018; Amato, Angela/T-1221-2019; Zambelli, Alberto/HGB-1572-2022	Bellazzi, Riccardo/0000-0002-6974-9808; Zambelli, Alberto/0000-0002-1374-1831; Vitali, Francesca/0000-0003-2916-6402; Amato, Angela/0000-0002-1932-1299	Regione Lombardia through the project "Metodologie e tecnologie bioinformatiche per l'integrazione di informazioni cliniche e conscenze biologiche a supporto della ricerca translazionalein oncologia (Onco-i2b2)" [A1.2010.0103195]; Associazione Italiana per la Ricerca sul Cancro AIRC [10016]	Regione Lombardia through the project "Metodologie e tecnologie bioinformatiche per l'integrazione di informazioni cliniche e conscenze biologiche a supporto della ricerca translazionalein oncologia (Onco-i2b2)"; Associazione Italiana per la Ricerca sul Cancro AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Regione Lombardia through the project "Metodologie e tecnologie bioinformatiche per l'integrazione di informazioni cliniche e conscenze biologiche a supporto della ricerca translazionalein oncologia (Onco-i2b2)"- A1.2010.0103195-http://www.regione.lombardia.it/. The in vitro experiments were conducted through the support of Associazione Italiana per la Ricerca sul Cancro AIRC 5x1000 Program (2010-2015) Grant (10016-http://www.airc.it/aiutare-la-ricerca/5-per-mille.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Amato A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-119; Billur Engin H, NETWORK BASED STRATE; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen HL, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/130620; Cogle CR, 2015, ONCOLOGIST, V20, P1404, DOI 10.1634/theoncologist.2015-0165; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Emig D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060618; Fearnley LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041977; Fumia HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069008; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Huang L, 2014, BIOINFORMATICS, V30, P228, DOI 10.1093/bioinformatics/btu278; Jimeno-Yepes AJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-171; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kibble M, 2015, NAT PROD REP, V32, P1249, DOI 10.1039/c5np00005j; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Krumsiek J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-233; Kuhn M, 2016, NUCLEIC ACIDS RES, V44, pD1075, DOI 10.1093/nar/gkv1075; Kuhn M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.10; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lin DD, 2013, BMC BIOINFORMATICS, V14, DOI [10.1186/1471-2105-14-245, 10.1186/1471-2105-14-S16-S3]; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Maass N, 2014, ONCOLOGY-BASEL, V87, P300, DOI 10.1159/000365553; Machado D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-45; McArthur GA, 2006, CURR OPIN ONCOL, V18, P341, DOI 10.1097/01.cco.0000228739.62756.df; McGarry K, 2015, IDENTIFYING CANDIDAT; Merijn van Erp LS., VARIANTS BORDA COUNT; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Raju R, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0490-y; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Schriml LM, 2015, MAMM GENOME, V26, P584, DOI 10.1007/s00335-015-9576-9; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Steggles LJ, 2006, LECT NOTES COMPUT SC, V4210, P127; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang J, 2014, CURR PHARM DESIGN, V20, P23, DOI 10.2174/13816128113199990470; Terfve C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-133; TYAGI AK, 1983, TRENDS PHARMACOL SCI, V4, P299, DOI 10.1016/0165-6147(83)90412-1; Vallabhajosyula RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005344; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Vitali F, 2013, J BIOMED INFORM, V46, P876, DOI 10.1016/j.jbi.2013.06.015; Wang F., 2008, P SIAM INT C DAT MIN, P1, DOI DOI 10.1137/1.9781611972788.1; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Woochang Hwang YCAZMR, BRIDGING CENTRALITY; Wright CJM, 2013, DRUGS, V73, P1245, DOI 10.1007/s40265-013-0096-1; Wu ZK, 2013, MOL BIOSYST, V9, P1268, DOI 10.1039/c3mb25382a; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zitnik M, 2015, IEEE T PATTERN ANAL, V37, P41, DOI 10.1109/TPAMI.2014.2343973; Zou D, 2015, GENOM PROTEOM BIOINF, V13, P55, DOI 10.1016/j.gpb.2015.01.006	58	31	31	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162407	10.1371/journal.pone.0162407	http://dx.doi.org/10.1371/journal.pone.0162407			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632168	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900045
J	Xu, DW; Zhao, W; Zhu, XH; Fan, JB; Cui, SY; Sun, YY; Chen, X; Liu, W; Cui, ZM				Xu, Dawei; Zhao, Wei; Zhu, Xinhui; Fan, Jianbo; Cui, Shengyu; Sun, Yuyu; Chen, Xiang; Liu, Wei; Cui, Zhi-ming			OSU53 Rescues Human OB-6 Osteoblastic Cells from Dexamethasone through Activating AMPK Signaling	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED-APOPTOSIS; PROTEIN-KINASE; CULTURED OSTEOBLASTS; IN-VITRO; STRESS; ENERGY; OSTEONECROSIS; HOMEOSTASIS; METABOLISM; MECHANISMS	Excessive dexamethasone (Dex) application causes osteoblast cell death, which could lead to osteoporosis or osteonecrosis. AMP-activated protein kinase (AMPK) activation is shown to protect osteoblasts/osteoblastic cells from Dex. In this report, we tested the potential effect of OSU53, a novel AMPK activator, in Dex-treated osteoblastic cells. We show that OSU53 activated AMPK signaling in human OB-6 osteoblastic cells. Further, Dex-induced osteoblastic OB-6 cell death and apoptosis were largely attenuated with pre-treatment with OSU53. OSU53 was more efficient than other known AMPK activators (A769662 and Compound 13) in protecting OB-6 cells against Dex. AMPK activation is required for OSU53-induced actions in OB-6 cells. AMPK alpha shRNA knockdown or dominant- negative mutation (dn-AMPK alpha T172A) almost completely blocked OSU53-induced AMPK activation and OB-6 cell protection against Dex. Further studies showed that OSU53 increased NADPH (nicotinamide adenine dinucleotide phosphate) activity and alleviated Dex-induced oxidative stress in OB-6 cells. Such effects by OSU53 were again almost abolished with AMPK alpha shRNA or dn-AMPK alpha in OB-6 cells. Together, these results demonstrate that OSU53 protects osteoblastic cells from Dex possibly via activating AMPK-dependent signaling.	[Xu, Dawei; Zhao, Wei; Zhu, Xinhui; Fan, Jianbo; Cui, Shengyu; Sun, Yuyu; Chen, Xiang; Liu, Wei; Cui, Zhi-ming] Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China	Nantong University	Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Orthopaed, Nantong 226001, Peoples R China.	zhimingcuiorth@163.com			National Natural Scientific Foundation of China [81300955]; Projects of Nantong [MS22015047]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Nantong	This work was supported by the National Natural Scientific Foundation of China (No. 81300955, to ZC) and Projects of Nantong (MS22015047, to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2011, J BIOL CHEM, V286, P44326, DOI 10.1074/jbc.M111.283481; Balteau M., 2014, AM J PHYSL HEART CIR; den Uyl D, 2011, CURR RHEUMATOL REP, V13, P233, DOI 10.1007/s11926-011-0173-y; Ding HY, 2015, BIOCHEM BIOPH RES CO, V460, P157, DOI 10.1016/j.bbrc.2015.02.161; Fan JB, 2015, MOL CELL BIOCHEM, V398, P105, DOI 10.1007/s11010-014-2210-4; Fan JB, 2014, BIOCHEM BIOPH RES CO, V447, P425, DOI 10.1016/j.bbrc.2014.04.002; Gohel A, 1999, ENDOCRINOLOGY, V140, P5339, DOI 10.1210/en.140.11.5339; Guh JH, 2010, J MED CHEM, V53, P2552, DOI 10.1021/jm901773d; Guo SG, 2016, BIOCHEM BIOPH RES CO, V469, P281, DOI 10.1016/j.bbrc.2015.11.104; Guo SH, 2015, CHIN AUTOM CONGR, P1, DOI 10.1109/CAC.2015.7382459; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hu X, 2015, TUMOUR BIOL; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kerachian MA, 2009, J STEROID BIOCHEM, V114, P121, DOI 10.1016/j.jsbmb.2009.02.007; Kim IY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00175; Lu PH, 2016, ONCOTARGET; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Sato AY, 2015, BONE, V73, P60, DOI 10.1016/j.bone.2014.12.012; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; She C, 2014, CELL SIGNAL, V26, P1, DOI 10.1016/j.cellsig.2013.08.046; Souttou B, 2001, J CELL PHYSIOL, V187, P59, DOI 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F; Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Yun SI, 2009, J BONE MINER METAB, V27, P140, DOI 10.1007/s00774-008-0019-5; Zhang K, 2016, BIOCHEM BIOPH RES CO, V469, P753, DOI [10.1016/j.bbrc.2015.12.014, DOI 10.1016/J.BBRC.2015.12.014]; Zhen YF, 2014, J CELL PHYSIOL, V229, P1475, DOI 10.1002/jcp.24589; Zheng KL, 2016, BIOCHEM BIOPH RES CO, V469, P753, DOI 10.1016/j.bbrc.2015.12.014; Zhu YL, 2014, INT J MOL SCI, V15, P11190, DOI 10.3390/ijms150611190	33	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162694	10.1371/journal.pone.0162694	http://dx.doi.org/10.1371/journal.pone.0162694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632213	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900066
J	Han, WJ; Coutinho, E; Ruan, HB; Li, HF; Schuller, B; Yu, XJ; Zhu, X				Han, Wenjing; Coutinho, Eduardo; Ruan, Huabin; Li, Haifeng; Schuller, Bjoern; Yu, Xiaojie; Zhu, Xuan			Semi-Supervised Active Learning for Sound Classification in Hybrid Learning Environments	PLOS ONE			English	Article								Coping with scarcity of labeled data is a common problem in sound classification tasks. Approaches for classifying sounds are commonly based on supervised learning algorithms, which require labeled data which is often scarce and leads to models that do not generalize well. In this paper, we make an efficient combination of confidence-based Active Learning and Self-Training with the aim of minimizing the need for human annotation for sound classification model training. The proposed method pre-processes the instances that are ready for labeling by calculating their classifier confidence scores, and then delivers the candidates with lower scores to human annotators, and those with high scores are automatically labeled by the machine. We demonstrate the feasibility and efficacy of this method in two practical scenarios: pool-based and stream-based processing. Extensive experimental results indicate that our approach requires significantly less labeled instances to reach the same performance in both scenarios compared to Passive Learning, Active Learning and Self-Training. A reduction of 52.2% in human labeled instances is achieved in both of the pool-based and stream-based scenarios on a sound classification task considering 16,930 sound instances.	[Han, Wenjing; Yu, Xiaojie; Zhu, Xuan] Samsung R&D Inst China Beijing SRC B, Language Comp Lab, Beijing, Peoples R China; [Coutinho, Eduardo] Univ Liverpool, Dept Mus, Liverpool, Merseyside, England; [Coutinho, Eduardo; Schuller, Bjoern] Imperial Coll London, Dept Comp, London, England; [Ruan, Huabin] Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China; [Li, Haifeng; Schuller, Bjoern] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin, Peoples R China; [Schuller, Bjoern] Univ Passau, Complex Syst Engn, Passau, Germany	University of Liverpool; Imperial College London; Tsinghua University; Harbin Institute of Technology; University of Passau	Ruan, HB (corresponding author), Tsinghua Univ, Dept Comp Sci & Technol, Beijing, Peoples R China.	ruanhuabin@mail.tsinghua.edu.cn	Coutinho, Eduardo/K-1391-2019; yu, xiaojie/GSI-9676-2022	Coutinho, Eduardo/0000-0001-5234-1497; Schuller, Bjorn/0000-0002-6478-8699	National Natural Science Foundation of China [61171186, 61271345]; Fundamental Research Funds for the Central Universities [HIT.NSRIF.2012047]; European Research Council [338164]; European Union's Horizon research and innovation program [645378]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); European Research Council(European Research Council (ERC)European Commission); European Union's Horizon research and innovation program	This work was supported by National Natural Science Foundation of China, No. 61171186, 61271345, www.nsfc.gov.cn, HL; Fundamental Research Funds for the Central Universities, HIT.NSRIF.2012047, www.moe.gov.cn, HL; European Research Council, No. 338164, http://erc.europa.eu/, BS; and European Union's Horizon 2020 research and innovation program, 645378, EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IEEE INT C AC SPEECH; Beygelzimer A, 2008, P INT C MACH LEARN, P49; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Bujrbidge R, 2007, LECT NOTES COMPUT SC, V4881, P209; Chapelle O., 2006, SEMISUPERVISED LEARN; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; COHN D, 1994, MACH LEARN, V15, P201, DOI 10.1007/BF00993277; Cui XD, 2012, IEEE T AUDIO SPEECH, V20, P1923, DOI 10.1109/TASL.2012.2191955; de Sa Virginia R., 1994, NEURIPS, P112; Duan SF, 2014, ARTIF INTELL REV, V42, P637, DOI 10.1007/s10462-012-9362-y; DUDA RO, 2001, PATTERN CLASSIFICATI; Eyben F., 2010, ACM MULTIMEDIA MM, P1459, DOI DOI 10.1145/1873951.1874246; Ferguson BG, 2006, DEF SEC S ORL FLOR U; Fleury A, 2008, IEEE ENG MED BIO, P4644, DOI 10.1109/IEMBS.2008.4650248; Foggia P, 2015, PATTERN RECOGN LETT, V65, P22, DOI 10.1016/j.patrec.2015.06.026; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Tran HD, 2011, INT CONF ACOUST SPEE, P2272; Phan H, 2015, EUR SIGNAL PR CONF, P2546, DOI 10.1109/EUSIPCO.2015.7362844; Jiaxing Ye, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P5944, DOI 10.1109/ICASSP.2014.6854744; Jin F, 2014, NEUROCOMPUTING, V123, P362, DOI 10.1016/j.neucom.2013.07.033; Lewis D. D., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P3; Li MK, 2006, IEEE T PATTERN ANAL, V28, P1251, DOI 10.1109/TPAMI.2006.156; Litvak D, 2008, IEEE ENG MED BIO, P4632, DOI 10.1109/IEMBS.2008.4650245; McCallum Andrew, 1998, ICML, DOI DOI 10.1023/A:1007692713085; Muslea I., 2002, INT C MACH LEARN, VVolume 2, P435; Phuong NC, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTING, MANAGEMENT AND TELECOMMUNICATIONS (COMMANTEL), P330, DOI 10.1109/ComManTel.2013.6482415; Nowak R., 2009, ADV NEURAL INFORM PR, P1366; Peng YT, 2009, IEEE INT CON MULTI, P1218, DOI 10.1109/ICME.2009.5202720; Piczak KJ, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1015, DOI 10.1145/2733373.2806390; Platt JC, 2000, ADV NEUR IN, P61; Riccardi G, 2005, IEEE T SPEECH AUDI P, V13, P504, DOI 10.1109/TSA.2005.848882; Roma G, 2012, P INT C MULT RETR, P1; Roy Nicholas, 2001, P 18 INT C MACH LEAR, P441; Schuller B, 2012, P INT AUD VIS EM CHA; Settles B., 2010, TECHNICAL REPORT, DOI DOI 10.1016/J.MATLET.2010.11.072; Seung H. S., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P287, DOI 10.1145/130385.130417; Tomanek K., 2009, P JOINT C 47 ANN M A, P1039; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Tur G, 2005, SPEECH COMMUN, V45, P171, DOI 10.1016/j.specom.2004.08.002; Valenzise G, 2007, 2007 IEEE CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P21, DOI 10.1109/AVSS.2007.4425280; Wang JC, 2014, IEEE T AUTOM SCI ENG, V11, P607, DOI 10.1109/TASE.2013.2285131; Wang M, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1899412.1899414; Yarowsky D, 1995, P ACL, P189, DOI [10.3115/981658.981684, DOI 10.3115/981658.981684]; Zhang Z, 2012, P INTERSPEECH; Zhang Z, 2012, P 37 IEEE INT C AC S, P25; Zhou ZH, 2004, LECT NOTES COMPUT SC, V3201, P525; Zhu X., 2003, P INT C MACH LEARN I, V3; Zhu X., 2006, COMPUT SCI, V2, P4	48	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162075	10.1371/journal.pone.0162075	http://dx.doi.org/10.1371/journal.pone.0162075			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627768	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600017
J	Lee, PY; Lin, SI; Liao, YT; Lin, RM; Hsu, CC; Huang, KY; Chen, YT; Tsai, YJ				Lee, Pei-Yun; Lin, Sang-I; Liao, Yu-Ting; Lin, Ruey-Mo; Hsu, Che-Chia; Huang, Kuo-Yuan; Chen, Yi-Ting; Tsai, Yi-Ju			Postural Responses to a Suddenly Released Pulling Force in Older Adults with Chronic Low Back Pain: An Experimental Study	PLOS ONE			English	Article							OSWESTRY-DISABILITY-INDEX; CHINESE VERSION; PHYSICAL-ACTIVITY; ELDERLY PERSONS; BALANCE; STABILITY; TRUNK; PREVALENCE; STRATEGY; PERTURBATIONS	Chronic low back pain (CLBP), one of the most common musculoskeletal conditions in older adults, might affect balance and functional independence. The purpose of this study was to investigate the postural responses to a suddenly released pulling force in older adults with and without CLBP. Thirty community-dwelling older adults with CLBP and 26 voluntary controls without CLBP were enrolled. Participants were required to stand on a force platform while, with one hand, they pulled a string that was fastened at the other end to a 2-kg or to a 4-kg force in the opposite direction at a random order. The number of times the participants lost their balance and motions of center of pressure (COP) when the string was suddenly released were recorded. The results demonstrated that although the loss of balance rates for each pulling force condition did not differ between groups, older adults with CLBP had poorer postural responses: delayed reaction, larger displacement, higher velocity, longer path length, and greater COP sway area compared to the older controls. Furthermore, both groups showed larger postural responses in the 4-kg pulling force condition. Although aging is generally believed to be associated with declining balance and postural control, these findings highlight the effect of CLBP on reactive balance when responding to an externally generated force in an older population. This study also suggests that, for older adults with CLBP, in addition to treating them for pain and disability, reactive balance evaluation and training, such as reaction and movement strategy training should be included in their interventions. Clinicians and older patients with CLBP need to be made aware of the significance of impaired reactive balance and the increased risk of falls when encountering unexpected perturbations.	[Lee, Pei-Yun; Lin, Sang-I; Liao, Yu-Ting; Chen, Yi-Ting; Tsai, Yi-Ju] Natl Cheng Kung Univ, Dept Phys Therapy, Coll Med, Tainan, Taiwan; [Lin, Ruey-Mo] China Med Univ, Tainan Municipal An Nan Hosp, Dept Orthoped, Tainan, Taiwan; [Hsu, Che-Chia; Huang, Kuo-Yuan] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan, Taiwan	National Cheng Kung University; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital	Tsai, YJ (corresponding author), Natl Cheng Kung Univ, Dept Phys Therapy, Coll Med, Tainan, Taiwan.	yijutsai@mail.ncku.edu.tw	Chen, Yi/HIR-2608-2022; Tsai, Yi-Ju/C-3324-2009	Tsai, Yi-Ju/0000-0003-4082-2634	Ministry of Science and Technology of Taiwan [NSC 101-2314-B-006-008, NSC 102-2314-B-006-003-MY3]; Taiwan National Science Council; National Cheng Kung University Hospital	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This study was supported by research grants from the Ministry of Science and Technology of Taiwan (NSC 101-2314-B-006-008 and NSC 102-2314-B-006-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the research grants from the Taiwan National Science Council and National Cheng Kung University Hospital. We thank Pei-Ying Hsieh for her help collecting data.	Brauer SG, 2000, J GERONTOL A-BIOL, V55, pM469, DOI 10.1093/gerona/55.8.M469; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; BYL NN, 1991, SPINE, V16, P325, DOI 10.1097/00007632-199103000-00012; Carty CP, 2015, AGE AGEING, V44, P109, DOI 10.1093/ageing/afu054; Cohen J, 1977, F TESTS MEANS ANAL V, P273; Cooper NA, 2016, EUR SPINE J, V25, P1258, DOI 10.1007/s00586-015-4027-6; da Cunha-Filho Inacio Teixeira, 2010, Physiotherapy Theory and Practice, V26, P49, DOI 10.3109/09593980802602844; de Freitas PB, 2010, J ELECTROMYOGR KINES, V20, P693, DOI 10.1016/j.jelekin.2009.11.009; Dionne CE, 2006, AGE AGEING, V35, P229, DOI 10.1093/ageing/afj055; Fairbank J C, 1980, Physiotherapy, V66, P271; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Hamaoui A, 2004, NEUROSCI LETT, V357, P135, DOI 10.1016/j.neulet.2003.12.047; Henry SM, 2006, CLIN BIOMECH, V21, P881, DOI 10.1016/j.clinbiomech.2006.04.016; Hislop H.J., 2007, DANIELS WORTHINGHAMS; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Kamaz M, 2007, DIAGN INTERV RADIOL, V13, P144; Kaya BK, 1998, J GERONTOL A-BIOL, V53, pM126, DOI 10.1093/gerona/53A.2.M126; Kim HJ, 2011, SPINE, V36, pE588, DOI 10.1097/BRS.0b013e3181f92d8e; Kim S, 2012, J BIOMECH, V45, P1379, DOI 10.1016/j.jbiomech.2012.03.001; Klass M, 2008, J APPL PHYSIOL, V104, P739, DOI 10.1152/japplphysiol.00550.2007; Kuo YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128318; Lee CE, 2007, SPINE, V32, P1329, DOI 10.1097/BRS.0b013e318059af3b; Lee HJ, 2006, ARCH PHYS MED REHAB, V87, P569, DOI 10.1016/j.apmr.2005.11.033; LEE JH, 1995, SPINE, V20, P1994, DOI 10.1097/00007632-199509150-00006; Lin SI, 2002, J MOTOR BEHAV, V34, P37, DOI 10.1080/00222890209601929; Lue YJ, 2008, SPINE, V33, P2354, DOI 10.1097/BRS.0b013e31818018d8; Macfarlane DJ, 2007, J SCI MED SPORT, V10, P45, DOI 10.1016/j.jsams.2006.05.003; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Mazaheri M, 2013, GAIT POSTURE, V37, P12, DOI 10.1016/j.gaitpost.2012.06.013; Mazzocchio R, 2001, BMC Musculoskelet Disord, V2, P4, DOI 10.1186/1471-2474-2-4; Melton BL, 2016, SPINE, DOI 10.1097/brs.0000000000001563; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Mok NW, 2013, EXP BRAIN RES, V231, P305, DOI 10.1007/s00221-013-3692-0; Mok NW, 2011, SPINE, V36, pE45, DOI 10.1097/BRS.0b013e3181dfce83; Mok NW, 2004, SPINE, V29, pE107, DOI 10.1097/01.BRS.0000115134.97854.C9; Muraki S, 2011, ARTHRIT CARE RES, V63, P1425, DOI 10.1002/acr.20562; O'Sullivan PB, 2003, SPINE, V28, P1074, DOI 10.1097/00007632-200305150-00022; Parthan Anju, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P359, DOI 10.1586/14737167.6.3.359; Pei LB, 2010, J INT MED RES, V38, P1985, DOI 10.1177/147323001003800612; Pinto RZ, 2014, EUR J PAIN, V18, P1190, DOI 10.1002/j.1532-2149.2014.00468.x; Radebold A, 2000, SPINE, V25, P947, DOI 10.1097/00007632-200004150-00009; Ringheim I, 2015, GAIT POSTURE, V42, P584, DOI 10.1016/j.gaitpost.2015.09.008; Rottermund J, 2015, MED PR, V66, P771, DOI 10.13075/mp.5893.00121; Scheele J, 2012, EUR J PHYS REHAB MED, V48, P379; Shahvarpour A, 2014, J ELECTROMYOGR KINES, V24, P394, DOI 10.1016/j.jelekin.2014.03.007; Shumway-Cook A., 2007, MOTOR CONTROL TRANSL; Simmonds MJ, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/214980; Tang PF, 1998, J GERONTOL A-BIOL, V53, pM471, DOI 10.1093/gerona/53A.6.M471; Tucker K, 2009, J NEUROSCI, V29, P10820, DOI 10.1523/JNEUROSCI.5211-08.2009; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Vuillerme N, 2009, GAIT POSTURE, V30, P122, DOI 10.1016/j.gaitpost.2009.03.004; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Welch TDJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096440; Wertli MM, 2014, SPINE J, V14, P2658, DOI 10.1016/j.spinee.2014.02.033; Wertli MM, 2014, SPINE J, V14, P2639, DOI 10.1016/j.spinee.2014.03.003; Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005; Yarjanian JA, 2013, PM&R, V5, P39, DOI 10.1016/j.pmrj.2012.08.017; 1999, LANCET, V354, P581, DOI DOI 10.1016/S0140-6736(99)01312-4	62	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162187	10.1371/journal.pone.0162187	http://dx.doi.org/10.1371/journal.pone.0162187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622646	gold, Green Submitted, Green Published			2022-12-26	WOS:000383681000018
J	Peeters, ETHM; Neefjes, REM; van Zuidam, BG				Peeters, Edwin T. H. M.; Neefjes, Rozemarijn E. M.; van Zuidam, Bastiaan G.			Competition between Free-Floating Plants Is Strongly Driven by Previously Experienced Phosphorus Concentrations in the Water Column	PLOS ONE			English	Article							SUBMERGED MACROPHYTES; AQUATIC PLANTS; DIFFERENTIAL RESPONSES; AZOLLA; TEMPERATURE; GROWTH; DEFICIENCY; DITCHES; ALGAE	Nutrients can determine the outcome of the competition between different floating plant species. The response of floating plants to current phosphorus levels may be affected by previously experienced phosphorus concentrations because some species have the ability to store excess phosphorus for later use. This might have an impact on their competition. Here, we investigate the effect of previous and actual phosphorus concentrations on the growth rate of free-floating plant species (Azolla filiculoides, Lemna minor/gibba and Ricciocarpus natans) and the effect of phosphorus history on the competition between L. minor/gibba and A. filiculoides and between L. minor/gibba and R. natans. As expected, plant growth was lower when previously kept at low instead of high phosphorus concentrations. Growth of L. minor/gibba and A. filiculoides with a phosphorus rich history was comparable for low and high actual phosphorus concentrations, however, internal phosphorus concentrations were significantly lower with low actual phosphorus concentration. This indicates that both species perform luxury phosphorus uptake. Furthermore, internal P concentration in Azolla and Lemna increased within two weeks after a period of P deficit without a strong increase in growth. A. filiculoides in a mixture with L. minor/gibba grew faster than its monoculture. Morphological differences may explain why A. filiculoides outcompeted L. minor/gibba and these differences may be induced by phosphorus concentrations in the past. Growth of L. minor/gibba was only reduced by the presence of A. filiculoides with a high phosphorus history. Growth of L. minor/gibba and R. natans in mixtures was positively affected only when they had a high phosphorus history themselves and their competitor a low phosphorus history. These observations clearly indicate that phosphorus history of competing plants is important for understanding the outcome of the competition. Therefore, actual and previously experienced phosphorus concentrations should be taken into account in future studies dealing with competition between plants.	[Peeters, Edwin T. H. M.; Neefjes, Rozemarijn E. M.; van Zuidam, Bastiaan G.] Wageningen Univ, Aquat Ecol andWater Qual Management Grp, Wageningen, Netherlands; [Neefjes, Rozemarijn E. M.] RIWA Rhine Water Works, Nieuwegein, Netherlands; [van Zuidam, Bastiaan G.] Water Board Rijn & IJssel, Doetinchem, Netherlands	Wageningen University & Research	Peeters, ETHM (corresponding author), Wageningen Univ, Aquat Ecol andWater Qual Management Grp, Wageningen, Netherlands.	edwin.peeters@wur.nl		Peeters, Edwin T.H.M./0000-0003-2541-1829				[Anonymous], 1986, FAMILY LEMNACEAE A M; Cheng WG, 2010, HYDROBIOLOGIA, V656, P5, DOI 10.1007/s10750-010-0441-2; Costa ML, 2010, P 14 RAMIRAN INT C L; Dickinson MB, 1998, AM MIDL NAT, V140, P55, DOI 10.1674/0003-0031(1998)140[0055:CASFFA]2.0.CO;2; Forchhammer NC, 1999, FRESHWATER BIOL, V41, P183, DOI 10.1046/j.1365-2427.1999.00390.x; Garbey C, 2004, FRESHWATER BIOL, V49, P346, DOI 10.1111/j.1365-2427.2004.01188.x; Gibson CE, 2001, CHEMOSPHERE, V42, P215, DOI 10.1016/S0045-6535(00)00128-4; GOPAL B, 1993, BOT REV, V59, P155, DOI 10.1007/BF02856599; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Hill MP, 1999, HYDROBIOLOGIA, V415, P203, DOI 10.1023/A:1003869230591; Hussner A, 2012, WEED RES, V52, P297, DOI 10.1111/j.1365-3180.2012.00926.x; Hutchinson G. E, 1975, TREATISE LIMNOLOGY; Janes RA, 1996, HYDROBIOLOGIA, V340, P23, DOI 10.1007/BF00012729; Klein J. C., 2008, THESIS; KUSHARI DP, 1991, SOIL SCI PLANT NUTR, V37, P271, DOI 10.1080/00380768.1991.10415037; KUSHARI DP, 1992, SOIL SCI PLANT NUTR, V38, P65, DOI 10.1080/00380768.1992.10416953; LUMPKIN TA, 1980, ECON BOT, V34, P111, DOI 10.1007/BF02858627; Lurling M, 2006, ANN LIMNOL-INT J LIM, V42, P65, DOI 10.1051/limn/2006010; MCILRAITH AL, 1989, CAN J BOT, V67, P2904, DOI 10.1139/b89-373; Milne J, 2007, FUND APPL LIMNOL, V169, P169, DOI 10.1127/1863-9135/2007/0169-0169; Netten JJC, 2011, FRESHWATER BIOL, V56, P1761, DOI 10.1111/j.1365-2427.2011.02611.x; Netten JJC, 2010, FUND APPL LIMNOL, V177, P125, DOI 10.1127/1863-9135/2010/0177-0125; Njambuya J, 2011, AQUAT BOT, V94, P158, DOI 10.1016/j.aquabot.2011.02.001; NNI, 1997, 13395 NNI NENENISO; NNI, 1986, 6663 NNI NEN; NNI, 1990, 6646 NNI NEN; NOVOZAMSKY I, 1984, NETH J AGR SCI, V32, P322; NOVOZAMSKY I, 1983, COMMUN SOIL SCI PLAN, V14, P239, DOI 10.1080/00103628309367359; Peeters ETHM, 2013, J APPL ECOL, V50, P585, DOI 10.1111/1365-2664.12066; Pot R, 2003, VELDGIDS WATER OEVER; Rejmankova E., 1975, AQUAT BOT, V1, P423, DOI [10.1016/0304-3770(75)90042-X, DOI 10.1016/0304-3770(75)90042-X]; Roijackers R, 2004, ARCH HYDROBIOL, V160, P401, DOI 10.1127/0003-9136/2004/0160-0401; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SUBUDHI BPR, 1981, SOIL SCI PLANT NUTR, V27, P237, DOI 10.1080/00380768.1981.10431275; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; TUNG HF, 1983, NEW PHYTOL, V93, P423, DOI 10.1111/j.1469-8137.1983.tb03442.x; van der Heide T, 2006, AQUAT BOT, V84, P171, DOI 10.1016/j.aquabot.2005.09.004; Verdonschot RCM, 2014, LIMNOLOGY, V15, P225, DOI 10.1007/s10201-013-0416-x; Wu ZH, 2007, AQUAT BOT, V86, P316, DOI 10.1016/j.aquabot.2006.11.008	39	11	11	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162780	10.1371/journal.pone.0162780	http://dx.doi.org/10.1371/journal.pone.0162780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622519	gold, Green Published, Green Submitted			2022-12-26	WOS:000383681000055
J	Sun, X; Li, YQ; Zheng, MZ; Zuo, WS; Zheng, WZ				Sun, Xu; Li, Yongqing; Zheng, Meizhu; Zuo, Wenshu; Zheng, Wenzhu			MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1	PLOS ONE			English	Article							CASPASE-9 ACTIVATION; SUPPRESSION; CHEMORESISTANCE; BIOGENESIS; EXPRESSION; RESISTANCE; MIGRATION; THERAPY; PROTEIN; ROS	Drug resistance remains a significant challenge in the treatment of triple-negative breast cancer (TNBC). Recent studies have demonstrated that this drug resistance is associated with a group of cells known as cancer stem cells (CSCs), which are believed to determine the sensitivity of tumor cells to cancer treatment. MicroRNAs (miRNAs) are small, non-coding RNAs that play significant roles in normal and cancer cells. MiR-223 reportedly acts as a tumor suppressor in a range of cancers. However, the role of miR-223 in TNBC, especially in triple-negative breast cancer stem cells (TNBCSCs), remains unknown. Here, we found that miR-223 expression was down-regulated in CD44(+)CD24(-/low) TNBCSCs compared with non-CSCs. Furthermore, we found that miR-223 overexpression resensitized TNBCSCs to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. The HAX-1 gene, which is located in the mitochondria and functions as an anti-apoptotic protein, was found to be directly regulated by miR-223 in MDA-MB-231 cells. We demonstrated that miR-223 overexpression promoted TRAIL-induced apoptosis through the mitochondria/ROS pathway. In conclusion, our results suggest that miR-223 increases the sensitivity of TNBCSCs to TRAIL-induced apoptosis by targeting HAX-1. Our findings have improved our understanding of the role of miR-223 in TNBC and may contribute to TNBC treatment.	[Sun, Xu] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Dept Gastrointestinal Surg, Jinan 250117, Peoples R China; [Li, Yongqing; Zheng, Meizhu; Zuo, Wenshu] Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Breast Canc Ctr, Jinan 250117, Peoples R China; [Zheng, Wenzhu] Jinan Lixia Dist Peoples Hosp, Emergency Med, Jinan 250000, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Jinan	Zheng, MZ (corresponding author), Shandong Univ, Shandong Canc Hosp, Shandong Acad Med Sci, Breast Canc Ctr, Jinan 250117, Peoples R China.	jnmeizhuzheng@126.com			Key research and development program of Shandong Province [2015GSF118132]	Key research and development program of Shandong Province	This study is supported by the Key research and development program of Shandong Province (grant no: 2015GSF118132) received by Meizhu Zheng. URL: http://www.sdstc.gov.cn/gggs/1000008680.htm.	Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; Arnedos M, 2012, THER ADV MED ONCOL, V4, P195, DOI 10.1177/1758834012444711; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bimonte S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1065230; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; den Hollander P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00250; Duan WJ, 2010, J PHARMACOL SCI, V113, P48, DOI 10.1254/jphs.09315FP; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gucalp Ayca, 2011, Chemother Res Pract, V2011, P696208, DOI 10.1155/2011/696208; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; He HF, 2016, TUMOR BIOL, V37, P1599, DOI 10.1007/s13277-015-3844-x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kurozumi A, 2016, CANCER SCI, V107, P84, DOI 10.1111/cas.12842; Laussmann MA, 2012, J BIOL CHEM, V287, P14402, DOI 10.1074/jbc.M111.304378; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Piggott L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2945; Pinto CA, 2013, CANCER LETT, V341, P56, DOI 10.1016/j.canlet.2013.06.003; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Shaw J, 2006, CIRC RES, V99, P336, DOI 10.1161/01.RES.0000239408.03169.94; Sheng CY, 2015, INT J CLIN EXP MED, V8, P20904; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Tang YL, 2015, INT J CLIN EXP PATHO, V8, P11224; Trebinska A, 2014, FEBS LETT, V588, P2921, DOI 10.1016/j.febslet.2014.05.042; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Xie XH, 2015, TUMOR BIOL, V36, P7185, DOI 10.1007/s13277-015-3438-7; Yan JL, 2015, ONCOL REP, V34, P2776, DOI 10.3892/or.2015.4202; Ye ZQ, 2016, TUMOR BIOL, V37, P4509, DOI 10.1007/s13277-015-4267-4; Yousefi M, 2014, ARCH IRAN MED, V17, P366, DOI 0141705/AIM.0011; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zheng YB, 2016, ONCOL REP, V35, P683, DOI 10.3892/or.2015.4417; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	38	60	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162754	10.1371/journal.pone.0162754	http://dx.doi.org/10.1371/journal.pone.0162754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618431	gold, Green Submitted, Green Published			2022-12-26	WOS:000383653100046
J	Gunness, P; Michiels, J; Vanhaecke, L; De Smet, S; Kravchuk, O; Van de Meene, A; Gidley, MJ				Gunness, Purnima; Michiels, Joris; Vanhaecke, Lynn; De Smet, Stefaan; Kravchuk, Olena; Van de Meene, Allison; Gidley, Michael J.			Reduction in circulating bile acid and restricted diffusion across the intestinal epithelium are associated with a decrease in blood cholesterol in the presence of oat beta-glucan	FASEB JOURNAL			English	Article						Ussing chamber; microscopy; nonstarch polysaccharides; deoxycholic acid; soluble dietary fiber	DIETARY FIBER; EXCRETION; MODEL; PIG; TRIGLYCERIDES; PERMEABILITY; ARABINOXYLAN; MODULATION; MECHANISMS; DIGESTION	Although oat (1,3: 1,4)-beta-glucan (BG) has been shown to decrease blood cholesterol in intervention trials, the detailed mechanism is not yet defined, but restricted reabsorption of bile acids (BAs) has been hypothesized. Using pigs as a model for humans we demonstrated that, compared to the control, BG added to the diet for 26 d caused decreases of 24% in blood total BAs (TBAs), 34% in total cholesterol (TC), and 57% in LDL cholesterol (LDL-C) (P < 0.01); decreases of 20% TBA in the midjejunumand terminal ileum(P < 0.01); increases of 80% in cecal total neutral sterols (TNSs) including cholesterol (P < 0.01); a 50% reduction in BA active transport across ex vivo ileum after 40 min (P < 0.001); and 32% decrease in jejunal microvillus heights with apparent increased goblet cell activity. The results suggest that BG not only physically hinders the active reabsorption of BAs and uptake of cholesterol, but also changes the BAs profile with lower circulating levels without excess excretion in the feces, thus resulting in reduced blood TC and LDL-C. Fermentation of sterols reaching the colon enhanced production of therapeutic ursodeoxycholic acid, suppressed toxic lithocholic acid, and decreased the possibility of cholesterol absorption by transforming the latter into coprostanol, a nonabsorbable NS.	[Gunness, Purnima; Gidley, Michael J.] Univ Queensland, Australian Res Council, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Hartley Teakle Bldg 83, Brisbane, Qld 4072, Australia; [Michiels, Joris] Univ Ghent, Dept Appl Biosci, Fac Biosci Engn, Ghent, Belgium; [Vanhaecke, Lynn] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Melle, Belgium; [De Smet, Stefaan] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Merelbeke, Belgium; [Kravchuk, Olena] Univ Adelaide, Sch Agr Food & Wine, Biometry Hub, Glen Osmond, SA, Australia; [Van de Meene, Allison] Univ Melbourne, Australian Res Council, Ctr Excellence Plant Cell Walls, Sch Biosci Bot, Parkville, Vic, Australia	University of Queensland; Ghent University; Ghent University; Ghent University; University of Adelaide; University of Melbourne	Gunness, P (corresponding author), Univ Queensland, Australian Res Council, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Hartley Teakle Bldg 83, Brisbane, Qld 4072, Australia.	nimagunness@uq.edu.au	Gidley, Mike/AAT-9543-2021; Gunness, Purnima/A-7915-2011; DeSmet, Stefaan/N-7576-2017; Vanhaecke, Lynn/N-1061-2017	DeSmet, Stefaan/0000-0003-1422-805X; Vanhaecke, Lynn/0000-0003-0400-2188; Kravchuk, Olena/0000-0001-5291-3600	Australian Research Council [CE110001007]	Australian Research Council(Australian Research Council)	The authors thank the staff of the Departments of Applied Biosciences and Animal Production (Faculty of Bioscience Engineering, Ghent University), for setting up of the animal facilities and pens and their help with experiments. This study was supported by Australian Research Council Grant CE110001007 to the Centre of Excellence in Plant Cell Walls.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Brown L, 1999, AM J CLIN NUTR, V69, P30; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Davis HR, 2011, CURR OPIN LIPIDOL, V22, P467, DOI 10.1097/MOL.0b013e32834c7c28; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; Dillard A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-89; Ellegard L, 2007, EUR J CLIN NUTR, V61, P938, DOI 10.1038/sj.ejcn.1602607; Gerard P, 2007, APPL ENVIRON MICROB, V73, P5742, DOI 10.1128/AEM.02806-06; Gerard P, 2014, PATHOGENS, V3, P14, DOI 10.3390/pathogens3010014; Gunness P, 2016, MOL NUTR FOOD RES, V60, P642, DOI 10.1002/mnfr.201500686; Gunness P, 2010, FOOD FUNCT, V1, P149, DOI 10.1039/c0fo00080a; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hofmann AF, 2004, DRUG METAB REV, V36, P703, DOI 10.1081/DMR-200033475; Jenkins DJA, 2002, AM J CLIN NUTR, V75, P834, DOI 10.1093/ajcn/75.5.834; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; LIA A, 1995, AM J CLIN NUTR, V62, P1245, DOI 10.1093/ajcn/62.6.1245; Mackie A, 2016, J FUNCT FOODS, V26, P418, DOI 10.1016/j.jff.2016.08.018; Marlett JA, 2002, J NUTR, V132, P2638, DOI 10.1093/jn/132.9.2638; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; MCCARTHY JF, 1974, CAN J ANIM SCI, V54, P107, DOI 10.4141/cjas74-016; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H; Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Tanghe S, 2013, J ANIM SCI, V91, P3253, DOI 10.2527/jas.2012-5874; Tsang HG, 2016, CELL BIOCHEM FUNCT, V34, P113, DOI 10.1002/cbf.3173; van der Gronde T, 2016, FOOD CHEM, V199, P746, DOI 10.1016/j.foodchem.2015.12.050; VSN International Ltd, 2015, GENSTAT WINDOWS, V15; Wolever TMS, 2010, AM J CLIN NUTR, V92, P723, DOI 10.3945/ajcn.2010.29174; Zhang DG, 2015, NUTRITION, V31, P1141, DOI 10.1016/j.nut.2015.03.006; ZHANG JX, 1993, BRIT J NUTR, V70, P525, DOI 10.1079/BJN19930146	31	49	52	1	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4227	4238		10.1096/fj.201600465R	http://dx.doi.org/10.1096/fj.201600465R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27630168	hybrid			2022-12-26	WOS:000388201500028
J	Maganti, AV; Tersey, SA; Syed, F; Nelson, JB; Colvin, SC; Maier, B; Mirmira, RG				Maganti, Aarthi V.; Tersey, Sarah A.; Syed, Farooq; Nelson, Jennifer B.; Colvin, Stephanie C.; Maier, Bernhard; Mirmira, Raghavendra G.			Peroxisome Proliferator-activated Receptor- Activation Augments the -Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and Cell Death in Non-obese Diabetic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmunity; beta cell (B-cell); diabetes; endoplasmic reticulum stress (ER stress); insulin; peroxisome proliferator-activated receptor (PPAR); unfolded protein response (UPR)	ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELL; PPAR-GAMMA; NOD MOUSE; INSULIN-SECRETION; OXIDATIVE STRESS; ER-STRESS; T-CELLS; IN-VIVO; PIOGLITAZONE	Type 1 diabetes is an autoimmune disorder that is characterized by a failure of the unfolded protein response in islet cells with subsequent endoplasmic reticulum stress and cellular death. Thiazolidinediones are insulin sensitizers that activate the nuclear receptor PPAR- and have been shown to partially ameliorate autoimmune type 1 diabetes in humans and non-obese diabetic (NOD) mice. We hypothesized that thiazolidinediones reduce cell stress and death independently of insulin sensitivity. To test this hypothesis, female NOD mice were administered pioglitazone during the pre-diabetic phase and assessed for insulin sensitivity and cell function relative to controls. Pioglitazone-treated mice showed identical weight gain, body fat distribution, and insulin sensitivity compared with controls. However, treated mice showed significantly improved glucose tolerance with enhanced serum insulin levels, reduced cell death, and increased cell mass. The effect of pioglitazone was independent of actions on T cells, as pancreatic lymph node T cell populations were unaltered and T cell proliferation was unaffected by pioglitazone. Isolated islets of treated mice showed a more robust unfolded protein response, with increases in Bip and ATF4 and reductions in spliced Xbp1 mRNA. The effect of pioglitazone appears to be a direct action on cells, as islets from mice treated with pioglitazone showed reductions in PPAR- (Ser-273) phosphorylation. Our results demonstrate that PPAR- activation directly improves cell function and survival in NOD mice by enhancing the unfolded protein response and suggest that blockade of PPAR- (Ser-273) phosphorylation may prevent type 1 diabetes.	[Maganti, Aarthi V.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Maganti, Aarthi V.; Tersey, Sarah A.; Colvin, Stephanie C.; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Tersey, Sarah A.; Syed, Farooq; Nelson, Jennifer B.; Colvin, Stephanie C.; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Biosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Mirmira, RG (corresponding author), 635 Barnhill Dr,MS2031B, Indianapolis, IN 46202 USA.	rmirmira@iu.edu	Vijaykumar, Aarthi Maganti/AAC-6844-2019; Mirmira, Raghavendra G/AAD-7592-2020; Syed, Farooq/AAK-6781-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Syed, Farooq/0000-0002-0284-0631; Tersey, Sarah/0000-0003-0667-2361	National Institutes of Health [P30 DK097512]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104166, R01DK105588, F32DK094489, R01DK060581, P30DK097512] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. Stull and K. Benninger of the Center for Diabetes and Metabolic Diseases Islet and Physiology Core laboratory for expert assistance in the isolation of islets and in the metabolic characterization of mice. This work utilized core services supported by National Institutes of Health Grant P30 DK097512 to the Indiana University School of Medicine.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Beales PE, 1998, EUR J PHARMACOL, V357, P221, DOI 10.1016/S0014-2999(98)00574-3; Beales PE, 2002, DIABETES-METAB RES, V18, P114, DOI 10.1002/dmrr.262; Bhat R, 2007, DIABETES RES CLIN PR, V78, P349, DOI 10.1016/j.diabres.2007.04.012; Cabrera SM, 2013, CLIN EXP IMMUNOL, V172, P375, DOI 10.1111/cei.12068; Carrington EM, 2011, EUR J IMMUNOL, V41, P2238, DOI 10.1002/eji.201141476; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi SS, 2016, DIABETES, V65, P829, DOI 10.2337/db15-1382; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Colvin SC, 2013, J BIOL CHEM, V288, P36226, DOI 10.1074/jbc.M113.473942; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Fisher MM, 2013, ENDOCRINOLOGY, V154, P3476, DOI 10.1210/en.2013-1223; Fusakio ME, 2016, MOL BIOL CELL, V27, P1536, DOI 10.1091/mbc.E16-01-0039; Gastaldelli A, 2007, AM J PHYSIOL-ENDOC M, V292, pE871, DOI 10.1152/ajpendo.00551.2006; Gupta D, 2010, DIABETES OBES METAB, V12, P1036, DOI 10.1111/j.1463-1326.2010.01299.x; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021; Iwasaki N, 2015, J CELL BIOCHEM, V116, P1300, DOI 10.1002/jcb.25085; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Jorns A, 2014, DIABETOLOGIA, V57, P512, DOI 10.1007/s00125-013-3125-4; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kawano Y, 2009, INTERNAL MED, V48, P1037, DOI 10.2169/internalmedicine.48.1990; Klotz L, 2009, J IMMUNOL, V183, P129, DOI 10.4049/jimmunol.0804260; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Krokowski D, 2013, J BIOL CHEM, V288, P17202, DOI 10.1074/jbc.M113.466920; Lamontagne J, 2013, DIABETES, V62, P2122, DOI 10.2337/db12-0428; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; LEITER EH, 1987, AM J PATHOL, V128, P380; Lipson KL, 2006, CURR MOL MED, V6, P71, DOI 10.2174/156652406775574613; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Maganti A, 2014, ISLETS, V6, DOI 10.4161/isl.28778; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Marre ML, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00067; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; McGinty JW, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0657-7; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Nishio N, 2015, SCI REP-UK, V5, DOI 10.1038/srep13519; O'Sullivan-Murphy B, 2012, DIABETES, V61, P780, DOI 10.2337/db12-0091; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tersey SA, 2014, MOL CELL BIOL, V34, P3735, DOI 10.1128/MCB.00157-14; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Watkins RA, 2016, TRANSL RES, V168, P96, DOI 10.1016/j.trsl.2015.08.010; Watkins RA, 2014, TRANSL RES, V164, P110, DOI 10.1016/j.trsl.2014.02.004; Zdravkovic V, 2006, J PEDIATR-US, V149, P845, DOI 10.1016/j.jpeds.2006.08.049	63	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22524	22533		10.1074/jbc.M116.741694	http://dx.doi.org/10.1074/jbc.M116.741694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27613867	Green Published, hybrid			2022-12-26	WOS:000386760600014
J	Arroyo-Lopez, FN; Medina, E; Ruiz-Bellido, MA; Romero-Gil, V; Montes-Borrego, M; Landa, BB				Noe Arroyo-Lopez, Francisco; Medina, Eduardo; Angel Ruiz-Bellido, Miguel; Romero-Gil, Veronica; Montes-Borrego, Miguel; Landa, Blanca B.			Enhancement of the Knowledge on Fungal Communities in Directly Brined Alorena de Malaga Green Olive Fermentations by Metabarcoding Analysis	PLOS ONE			English	Article							TABLE OLIVES; MICROBIAL COMMUNITIES; DIVERSITY; IDENTIFICATION; DYNAMICS; YEASTS; BACTERIAL; SPOILAGE; STORAGE	Nowadays, our knowledge of the fungal biodiversity in fermented vegetables is limited although these microorganisms could have a great influence on the quality and safety of this kind of food. This work uses a metagenetic approach to obtain basic knowledge of the fungal community ecology during the course of fermentation of natural Alorena de Malaga table olives, from reception of raw material to edible fruits. For this purpose, samples of brines and fruits were collected from two industries in Guadalhorce Valley (Malaga, Spain) at different moments of fermentation (0, 7, 30 and 120 days). The physicochemical and microbial counts performed during fermentation showed the typical evolution of this type of processes, mainly dominated by yeasts in apparent absence of Enterobacteriaceae and Lactobacillaceae. High-throughput barcoded pyrosequencing analysis of ITS1-5.8S-ITS2 region showed a low biodiversity of the fungal community, with the presence at 97% identity of 29 different fungal genera included in 105 operational taxonomic units (OTUs). The most important genera in the raw material at the moment of reception in the industry were Penicillium, Cladosporium, Malassezia, and Candida, whilst after 4 months of fermentation in brines Zygotorulaspora and Pichia were predominant, whereas in fruits were Candida, Penicillium, Debaryomyces and Saccharomyces. The fungal genera Penicillium, Pichia, and Zygotorulaspora were shared among the three types of substrates during all the course of fermentation, representing the core fungal population for this table olive specialty. A phylogenetic analysis of the ITS sequences allowed a more accurate assignment of diverse OTUs to Pichia manshurica, Candida parapsilosis/C. tropicalis, Candida diddensiae, and Citeromyces nyonensis clades. This study highlights the existence of a complex fungal consortium in olive fermentations including phytopathogenic, saprofitic, spoilage and fermentative genera. Insights into the ecology, identification and quantification of fungi species in olive fermentation will facilitate the design of new strategies to improve the quality and safety of this fermented vegetable.	[Noe Arroyo-Lopez, Francisco; Medina, Eduardo; Romero-Gil, Veronica] Univ Campus Pablo Olavide, IG CSIC, Dept Food Biotechnol, Bldg 46,Ctra,Utrera,Km 1, Seville 41013, Spain; [Angel Ruiz-Bellido, Miguel; Romero-Gil, Veronica] Regulatory Council PDO Alorena Malaga Table Olive, C Dehesa 80, Malaga 29560, Spain; [Montes-Borrego, Miguel; Landa, Blanca B.] Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Ave Menendez Pidal S-N Campus Alameda Obispo, Cordoba 14004, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Landa, BB (corresponding author), Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Ave Menendez Pidal S-N Campus Alameda Obispo, Cordoba 14004, Spain.	blanca.landa@csic.es	Gil, Verónica Romero/AAA-1604-2020; Landa, Blanca B/K-9629-2014; Arroyo-Lopez, Francisco Noe/I-8266-2012; Eduardo, Medina/D-3296-2014	Gil, Verónica Romero/0000-0002-9644-1745; Landa, Blanca B/0000-0002-9511-3731; Arroyo-Lopez, Francisco Noe/0000-0001-6308-7746; Eduardo, Medina/0000-0002-9978-4524	Junta de Andalucia Government through the PrediAlo project [AGR-7755]; FEDER European funds	Junta de Andalucia Government through the PrediAlo project(Junta de Andalucia); FEDER European funds(European Commission)	The research leading to these results has received funding from Junta de Andalucia Government through the PrediAlo project (AGR-7755: www.predialo.science.com.es) and FEDER European funds. FNAL wishes to express thanks to the Spanish government for his Ramon y Cajal postdoctoral research contract, while VRG would like to thank ceiA3, Spanish Government, Bank of Santander, IG-CSIC and 'Alorena de Malaga' Olive Manufacturing Association for her pre-doctoral fellowship.; The research leading to these results has received funding from Junta de Andalucia Government through the PrediAlo project (AGR-7755: www.predialo.science.com.es) and FEDER European funds. FNAL wishes to express thanks to the Spanish government for his RyC postdoctoral research contract while VRG would like to thank ceiA3, Spanish Government, Bank of Santander, IG-CSIC and 'Alorena de Malaga' Olive Manufacturing Association for her predoctoral fellowship.	Abdelfattah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131069; Abriouel H, 2011, INT J FOOD MICROBIOL, V144, P487, DOI 10.1016/j.ijfoodmicro.2010.11.006; Arroyo-Lopez FN, 2006, FOOD MICROBIOL, V23, P791, DOI 10.1016/j.fm.2006.02.008; Arroyo-Lopez FN, 2012, INT J FOOD MICROBIOL, V160, P42, DOI 10.1016/j.ijfoodmicro.2012.08.003; Baffi MA, 2012, NEW BIOTECHNOL, V29, P451, DOI 10.1016/j.nbt.2011.05.004; Bautista-Gallego J, 2011, INT J FOOD MICROBIOL, V147, P89, DOI 10.1016/j.ijfoodmicro.2011.03.013; Bevilacqua A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00194; Bokulich NA, 2014, APPL ENVIRON MICROB, V80, P5522, DOI 10.1128/AEM.00663-14; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen P, 2016, GENOM DATA, V7, P134, DOI 10.1016/j.gdata.2015.12.028; Cocolin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069074; De Angelis M, 2015, FOOD MICROBIOL, V52, P18, DOI 10.1016/j.fm.2015.06.002; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garrido-Fernandez A., 1997, TABLE OLIVES PRODUCT; Gholami M, 2012, PLANT BIOTECHNOL J, V10, P635, DOI 10.1111/j.1467-7652.2012.00696.x; Gonzalez Cancho F., 1995, GRASAS ACEITES, V16, P230; Heperkan D, 2006, ADV EXP MED BIOL, V571, P203, DOI 10.1007/0-387-28391-9_13; Hurtado A, 2012, FOOD MICROBIOL, V31, P1, DOI 10.1016/j.fm.2012.01.006; Illeghems K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038040; IOC, 2015, WORLD TABL OL FIG; Jeong SH, 2013, INT J FOOD MICROBIOL, V160, P252, DOI 10.1016/j.ijfoodmicro.2012.10.015; Kergourlay G, 2015, INT J FOOD MICROBIOL, V213, P31, DOI 10.1016/j.ijfoodmicro.2015.09.010; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Liu WJ, 2015, ANN MICROBIOL, V65, P1741, DOI 10.1007/s13213-014-1013-x; Lopez-Lopez A., 2006, PRODUCCION ELABORACI; Lucena-Padros H, 2014, FOOD MICROBIOL, V42, P154, DOI 10.1016/j.fm.2014.03.020; Marsh AJ, 2014, FOOD MICROBIOL, V38, P171, DOI 10.1016/j.fm.2013.09.003; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; Mateus T, 2016, INT J FOOD MICROBIOL, V218, P57, DOI 10.1016/j.ijfoodmicro.2015.11.008; Medina E, 2016, J FOOD SCI, V81, pM121, DOI 10.1111/1750-3841.13158; MRAK EM, 1956, FOOD TECHNOL-CHICAGO, V10, P416; Nisiotou AA, 2010, J APPL MICROBIOL, V108, P396, DOI 10.1111/j.1365-2672.2009.04424.x; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pereira EL, 2015, FOOD MICROBIOL, V46, P582, DOI 10.1016/j.fm.2014.10.003; Prigigallo MI, 2016, PHYTOPATHOLOGY, V106, P305, DOI 10.1094/PHYTO-07-15-0167-R; Rodriguez-Gomez F, 2015, LWT-FOOD SCI TECHNOL, V63, P367, DOI 10.1016/j.lwt.2015.03.095; Romero-Gil V, 2016, LWT-FOOD SCI TECHNOL, V70, P252, DOI 10.1016/j.lwt.2016.02.058; Roussos S, 2006, MOL NUTR FOOD RES, V50, P500, DOI 10.1002/mnfr.200600005; RUIZBARBA JL, 1993, J APPL BACTERIOL, V74, P15, DOI 10.1111/j.1365-2672.1993.tb02990.x; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Silva T, 2011, LWT-FOOD SCI TECHNOL, V44, P1349, DOI 10.1016/j.lwt.2011.01.029; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tofalo R, 2013, INT J FOOD MICROBIOL, V161, P203, DOI 10.1016/j.ijfoodmicro.2012.12.011; del Arbol JT, 2016, INT J FOOD MICROBIOL, V216, P1, DOI 10.1016/j.ijfoodmicro.2015.09.001; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041	47	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163135	10.1371/journal.pone.0163135	http://dx.doi.org/10.1371/journal.pone.0163135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636546	Green Published, gold			2022-12-26	WOS:000383723700036
J	Bevilacqua, A; Costabile, A; Bergillos-Meca, T; Gonzalez, I; Landriscina, L; Ciuffreda, E; D'Agnello, P; Corbo, MR; Sinigaglia, M; Lamacchia, C				Bevilacqua, Antonio; Costabile, Adele; Bergillos-Meca, Triana; Gonzalez, Isidro; Landriscina, Loretta; Ciuffreda, Emanuela; D'Agnello, Paola; Corbo, Maria Rosaria; Sinigaglia, Milena; Lamacchia, Carmela			Impact of Gluten-Friendly Bread on the Metabolism and Function of In Vitro Gut Microbiota in Healthy Human and Coeliac Subjects	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; DUODENAL MICROBIOTA; OLIGONUCLEOTIDE PROBES; SITU HYBRIDIZATION; DISEASE PATIENTS; CHILDREN; BIFIDOBACTERIUM; FERMENTATION; VIABILITY; MODEL	The main aim of this paper was to assess the in vitro response of healthy and coeliac human faecal microbiota to gluten-friendly bread (GFB). Thus, GFB and control bread (CB) were fermented with faecal microbiota in pH-controlled batch cultures. The effects on the major groups of microbiota were monitored over 48 h incubations by fluorescence in situ hybridisation. Short-chain fatty acids (SCFAs) were measured by high-performance liquid chromatography (HPLC). Furthermore, the death kinetics of Lactobacillus acidophilus, Bifidobacterium animalis subsp. lactis, Staphylococcus aureus, and Salmonella Typhimurium in a saline solution supplemented with GFB or CB were also assessed. The experiments in saline solution pinpointed that GFB prolonged the survival of L. acidophilus and exerted an antibacterial effect towards S. aureus and S. Typhimurium. Moreover, GFB modulated the intestinal microbiota in vitro, promoting changes in lactobacilli and bifidobacteria members in coeliac subjects. A final multivariate approach combining both viable counts and metabolites suggested that GFB could beneficially modulate the coeliac gut microbiome; however, human studies are needed to prove its efficacy.	[Bevilacqua, Antonio; Landriscina, Loretta; Ciuffreda, Emanuela; D'Agnello, Paola; Corbo, Maria Rosaria; Sinigaglia, Milena; Lamacchia, Carmela] Univ Foggia, Dept Sci Agr Food & Environm, Via Foggia, Foggia, Italy; [Costabile, Adele; Bergillos-Meca, Triana; Gonzalez, Isidro] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Costabile, Adele] Univ Roehampton, Hlth Sci Res Ctr, Dept Life Sci, Whitelands Coll, London, England	University of Foggia; University of Reading; Roehampton University	Lamacchia, C (corresponding author), Univ Foggia, Dept Sci Agr Food & Environm, Via Foggia, Foggia, Italy.	carmela.lamacchia@unifg.it		Costabile, Adele/0000-0003-3185-030X; Bevilacqua, Antonio/0000-0002-2118-9186	Casillo Group	Casillo Group	Casillo Group supported the research, but the funder had no role in any aspect of the research (design, data collection and analysis, decision to publish, preparation of the manuscript).	Altieri C, 2008, FOOD MICROBIOL, V25, P729, DOI 10.1016/j.fm.2008.03.005; Altieri C, 2013, ANAEROBE, V23, P23, DOI 10.1016/j.anaerobe.2013.07.008; Altieri C, 2011, J FOOD SCI, V76, pM336, DOI 10.1111/j.1750-3841.2011.02269.x; Bevilacqua A, 2008, J FOOD PROTECT, V71, P1366, DOI 10.4315/0362-028X-71.7.1366; Chapot-Chartier MP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S9; Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366; Collado Maria Carmen, 2007, Curr Issues Intest Microbiol, V8, P9; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Costabile A, 2014, PLOS ONE, V30, P9; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Galipeau HJ, 2014, GUT MICROBES, V5, P594, DOI 10.4161/19490976.2014.969635; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Harmsen HJM, 1999, MICROB ECOL HEALTH D, V11, P3, DOI DOI 10.1080/089106099435862; Kang Jo-Eun, 2015, Prev Nutr Food Sci, V20, P78, DOI 10.3746/pnf.2015.20.1.78; Krishnan S, 2015, CURR OPIN BIOTECH, V36, P137, DOI 10.1016/j.copbio.2015.08.015; Lamacchia C, 2015, BIOVARIACONGRESS EUR; Lamacchia C., 2015, Italian Patent, Patent No. 0001414717; Lamacchia C, 2015, Patent Cooperation Treaty, Patent No. [PCT/IB 2013/000797, 2013000797]; Lamacchia C, 2016, FOOD CHEM, V197, P634, DOI 10.1016/j.foodchem.2015.11.016; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Maccaferri S, 2012, MOL NUTR FOOD RES, V56, P1342, DOI 10.1002/mnfr.201200046; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; Malanovic N, 2016, BBA-BIOMEMBRANES, V1858, P936, DOI 10.1016/j.bbamem.2015.11.004; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; New Gluten World, Italian priority patent, Patent No. 102015000084813; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oda H, 2013, APPL ENVIRON MICROB, V79, P1843, DOI 10.1128/AEM.03343-12; Rizzello CG, 2007, APPL ENVIRON MICROB, V73, P4499, DOI 10.1128/AEM.00260-07; Rosero JA, 2016, INT J SYST EVOL MICR, V66, P768, DOI 10.1099/ijsem.0.000788; Rossi M, 2010, J LEUKOCYTE BIOL, V87, P749, DOI 10.1189/jlb.1209784; Sanchez E, 2013, APPL ENVIRON MICROB, V79, P5472, DOI 10.1128/AEM.00869-13; Sanz Y, 2007, FEMS IMMUNOL MED MIC, V51, P562, DOI 10.1111/j.1574-695X.2007.00337.x; Schippa S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-175; Sugahara H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13548; Tejero-Sarinena S, 2012, ANAEROBE, V18, P530, DOI 10.1016/j.anaerobe.2012.08.004; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Wacklin P, 2014, AM J GASTROENTEROL, V109, P1933, DOI 10.1038/ajg.2014.355; Wacklin P, 2013, INFLAMM BOWEL DIS, V19, P934, DOI 10.1097/MIB.0b013e31828029a9; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	49	16	16	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162770	10.1371/journal.pone.0162770	http://dx.doi.org/10.1371/journal.pone.0162770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632361	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000383706900077
J	Gieraltowski, L; Higa, J; Peralta, V; Green, A; Schwensohn, C; Rosen, H; Libby, T; Kissler, B; Marsden-Haug, N; Booth, H; Kimura, A; Grass, J; Bicknese, A; Tolar, B; Defibaugh-Chavez, S; Williams, I; Wise, M				Gieraltowski, Laura; Higa, Jeffrey; Peralta, Vi; Green, Alice; Schwensohn, Colin; Rosen, Hilary; Libby, Tanya; Kissler, Bonnie; Marsden-Haug, Nicola; Booth, Hillary; Kimura, Akiko; Grass, Julian; Bicknese, Amelia; Tolar, Beth; Defibaugh-Chavez, Stephanie; Williams, Ian; Wise, Matthew		Salmonella Heidelberg Invest Team	National Outbreak of Multidrug Resistant Salmonella Heidelberg Infections Linked to a Single Poultry Company	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; UNITED-STATES; FOOD ANIMALS; SEROTYPE	Importance This large outbreak of foodborne salmonellosis demonstrated the complexity of investigating outbreaks linked to poultry products. The outbreak also highlighted the importance of efforts to strengthen food safety policies related to Salmonella in chicken parts and has implications for future changes within the poultry industry. Objective To investigate a large multistate outbreak of multidrug resistant Salmonella Heidelberg infections. Design Epidemiologic and laboratory investigations of patients infected with the outbreak strains of Salmonella Heidelberg and traceback of possible food exposures. Setting United States. Outbreak period was March 1, 2013 through July 11, 2014 Patients A case was defined as illness in a person infected with a laboratory-confirmed Salmonella Heidelberg with 1 of 7 outbreak pulsed-field gel electrophoresis (PFGE) XbaI patterns with illness onset from March 1, 2013 through July 11, 2014. A total of 634 case-patients were identified through passive surveillance; 200/528 (38%) were hospitalized, none died. Results Interviews were conducted with 435 case-patients: 371 (85%) reported eating any chicken in the 7 days before becoming ill. Of 273 case-patients interviewed with a focused questionnaire, 201 (74%) reported eating chicken prepared at home. Among case-patients with available brand information, 152 (87%) of 175 patients reported consuming Company A brand chicken. Antimicrobial susceptibility testing was completed on 69 clinical isolates collected from case-patients; 67% were drug resistant, including 24 isolates (35%) that were multidrug resistant. The source of Company A brand chicken consumed by case-patients was traced back to 3 California production establishments from which 6 of 7 outbreak strains were isolated. Conclusions Epidemiologic, laboratory, traceback, and environmental investigations conducted by local, state, and federal public health and regulatory officials indicated that consumption of Company A chicken was the cause of this outbreak. The outbreak involved multiple PFGE patterns, a variety of chicken products, and 3 production establishments, suggesting a reservoir for contamination upstream from the production establishments. Sources of bacteria and genes responsible for resistance, such as farms providing birds for slaughter or environmental reservoir on farms that raise chickens, might explain how multiple PFGE patterns were linked to chicken from 3 separate production establishments and many different poultry products.	[Gieraltowski, Laura; Schwensohn, Colin; Grass, Julian; Bicknese, Amelia; Tolar, Beth; Williams, Ian; Wise, Matthew] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA; [Higa, Jeffrey; Peralta, Vi; Rosen, Hilary; Kimura, Akiko] Calif Dept Publ Hlth, Gardena, CA USA; [Higa, Jeffrey; Peralta, Vi; Rosen, Hilary; Kimura, Akiko] Calif Dept Publ Hlth, Richmond, CA USA; [Higa, Jeffrey; Peralta, Vi; Rosen, Hilary; Kimura, Akiko] Calif Dept Publ Hlth, Sacramento, CA USA; [Libby, Tanya] Calif Emerging Infect Program, Oakland, CA USA; [Marsden-Haug, Nicola] Washington State Dept Hlth, Olympia, WA USA; [Booth, Hillary] Oregon Publ Hlth Div, Portland, OR USA; [Green, Alice; Kissler, Bonnie; Defibaugh-Chavez, Stephanie] US Food Safety & Inspect Serv, Off Publ Hlth Sci, USDA, Washington, DC 20250 USA	Centers for Disease Control & Prevention - USA; California Department of Public Health; California Department of Public Health; California Department of Public Health; California Emerging Infections Program; United States Department of Agriculture (USDA)	Gieraltowski, L (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA.	LGieraltowski@cdc.gov	Brown, Allison Cory/ABB-3230-2021	Brown, Allison Cory/0000-0003-0011-0309; Libby, Tanya/0000-0002-8569-9206; Bhatnagar, Amelia/0000-0003-3859-0328; /0000-0003-2270-5573				BARNHART HM, 1993, AVIAN DIS, V37, P977, DOI 10.2307/1591902; CDC, MULT OUTBR HUM SALM; CDC, 2013, NAT ANT RES MON SYST; CDC, 2014, FOODB DIS ACT SURV N; Folster JP, 2012, FOODBORNE PATHOG DIS, V9, P638, DOI 10.1089/fpd.2012.1130; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Lynne AM, 2009, FOODBORNE PATHOG DIS, V6, P207, DOI 10.1089/fpd.2008.0172; National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), 2013, NAT ANT ERS MON SYST; Naugle AL, 2005, J FOOD PROTECT, V68, P462, DOI 10.4315/0362-028X-68.3.462; Routh JA, 2015, EPIDEMIOL INFECT, V143, P3227, DOI 10.1017/S0950268815000497; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; U.S. Centers for Disease Control and Prevention, 2007, FOODB DIS ACT SURV N; United States Department of Agriculture, 2012, NAT MICR BAS DAT COL; US Food and Drug Administration, 2015, NAT ANT RES MON SYST; Varma JK, 2005, J INFECT DIS, V191, P554, DOI 10.1086/427263; Zhao S, 2008, APPL ENVIRON MICROB, V74, P6656, DOI 10.1128/AEM.01249-08	17	64	64	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162369	10.1371/journal.pone.0162369	http://dx.doi.org/10.1371/journal.pone.0162369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631492	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900041
J	Kuo, SM				Kuo, Shiu-Ming			Gender Difference in Bacteria Endotoxin-Induced Inflammatory and Anorexic Responses	PLOS ONE			English	Article							INDUCED SICKNESS BEHAVIOR; TUMOR-NECROSIS-FACTOR; IMMUNE-RESPONSE; FOOD-INTAKE; LIPOPOLYSACCHARIDE; MICE; BRAIN; INTERLEUKIN-10; DISEASE; LIVER	Inflammation-related anorexic response has been observed in systemic diseases as well as in localized infection and is an important issue in patient care. We tested the hypothesis that upon the same endotoxin exposure, males have more severe inflammatory responses and thus suffer from more negative effect on appetite. Ten-week old male and female mice were compared in their plasma levels of pro-inflammatory cytokines after a body weight-based i.p. injection of bacterial endotoxin lipopolysaccharide. Male mice consistently showed significantly higher levels of IL6 and TNF alpha than female mice. The difference was observed starting at 3 hours after the systemic endotoxin exposure. It was independent of the level of endotoxin dosage and of the genotype of the anti-inflammatory cytokine, IL10. Interestingly, endotoxin-injected male mice also had significantly higher plasma IL10 levels compared to the female mice. Pre-puberty young mice showed no gender differences in the plasma levels of IL6, TNFa and IL10. Their cytokine levels were mostly between that of the adult males and females. Consistent with the higher inflammatory response in malemice, the endotoxin exposure also led to significantly more appetite loss in male mice at a range of doses in two strains of mice. Saline injection in the absence of endotoxin affected neither the cytokine levels nor the appetite. Although a direct mechanistic link between inflammation parameters and appetite was not addressed here, the results support that male gender could be a risk factor for higher pro-inflammatory cytokines and anorexic response after the endotoxin exposure.	[Kuo, Shiu-Ming] SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kuo, SM (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Buffalo, NY 14260 USA.	smkuo@buffalo.edu			University at Buffalo Gender Institute	University at Buffalo Gender Institute	This study was supported partly by a University at Buffalo Gender Institute Research Award. Beside University at Buffalo Gender Institute, there was no additional external funding received for this study.	Biesmans S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/716920; Bluthe RM, 1999, PSYCHONEUROENDOCRINO, V24, P301, DOI 10.1016/S0306-4530(98)00077-8; Burton MD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-54; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Chaskiel L, 2016, NEUROPHARMACOLOGY, V107, P146, DOI 10.1016/j.neuropharm.2016.03.030; Coyle SM, 2006, SHOCK, V26, P538, DOI 10.1097/01.shk.0000232589.39001.4d; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; DISANTO E, 1995, NEUROIMMUNOMODULAT, V2, P149, DOI 10.1159/000096885; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Geary N, 2004, PHYSIOL BEHAV, V82, P251, DOI 10.1016/j.physbeh.2004.03.034; Hill NE, 2015, CRIT CARE MED, V43, pE84, DOI 10.1097/CCM.0000000000000854; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Konsman JP, 2001, NUTRITION, V17, P664, DOI 10.1016/S0899-9007(01)00602-5; Kuo SM, 2005, J NUTR, V135, P2411, DOI 10.1093/jn/135.10.2411; Kuo SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060270; Kuo SM, 2004, J NUTR, V134, P2216; Lasselin J, 2016, CURR OPIN PHARMACOL, V29, P34, DOI 10.1016/j.coph.2016.05.003; Leon LR, 1999, AM J PHYSIOL-REG I, V276, pR81, DOI 10.1152/ajpregu.1999.276.1.R81; Masso-Welch PA, 2012, IMMUNOL INVEST, V41, P521, DOI 10.3109/08820139.2012.684193; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Moxley G, 2004, J RHEUMATOL, V31, P686; Nasir N, 2015, PAK J MED SCI, V31, P1201, DOI 10.12669/pjms.315.6925; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Peluso I, 2016, HUM IMMUNOL, V77, P47, DOI 10.1016/j.humimm.2015.10.008; Razmara A, 2005, AM J PHYSIOL-HEART C, V289, pH1843, DOI 10.1152/ajpheart.00465.2005; Roberts BJ, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-25; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; Ruud J, 2013, FASEB J, V27, P1973, DOI 10.1096/fj.12-225433; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Speyer CL, 2005, AM J PHYSIOL-CELL PH, V288, pC881, DOI 10.1152/ajpcell.00467.2004; Temple SEL, 2008, CELL IMMUNOL, V251, P69, DOI 10.1016/j.cellimm.2008.04.013; Trentzsch H, 2003, CRIT CARE MED, V31, P232, DOI 10.1097/00003246-200301000-00036; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vollmer-Conna U, 2008, CLIN INFECT DIS, V47, P1418, DOI 10.1086/592967; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wegner A, 2015, PAIN, V156, P1954, DOI 10.1097/j.pain.0000000000000256	37	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162971	10.1371/journal.pone.0162971	http://dx.doi.org/10.1371/journal.pone.0162971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631979	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900104
J	Raja, WK; Mungenast, AE; Lin, YT; Ko, T; Abdurrob, F; Seo, J; Tsai, LH				Raja, Waseem K.; Mungenast, Alison E.; Lin, Yuan-Ta; Ko, Tak; Abdurrob, Fatema; Seo, Jinsoo; Tsai, Li-Huei			Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; NEURODEGENERATIVE DISORDERS; HYPOTHETICAL MODEL; CEREBRAL ORGANOIDS; DYNAMIC BIOMARKERS; MISSENSE MUTATION; AMYLOID PROTEIN; CULTURE-SYSTEM; DOWN-SYNDROME; MOUSE MODEL	The dismal success rate of clinical trials for Alzheimer's disease (AD) motivates us to develop model systems of AD pathology that have higher predictive validity. The advent of induced pluripotent stem cells (iPSCs) allows us to model pathology and study disease mechanisms directly in human neural cells from healthy individual as well as AD patients. However, two-dimensional culture systems do not recapitulate the complexity of neural tissue, and phenotypes such as extracellular protein aggregation are difficult to observe. We report brain organoids that use pluripotent stem cells derived from AD patients and recapitulate AD-like pathologies such as amyloid aggregation, hyperphosphorylated tau protein, and endosome abnormalities. These pathologies are observed in an age-dependent manner in organoids derived from multiple familial AD (fAD) patients harboring amyloid precursor protein (APP) duplication or presenilin1 (PSEN1) mutation, compared to controls. The incidence of AD pathology was consistent amongst several fAD lines, which carried different mutations. Although these are complex assemblies of neural tissue, they are also highly amenable to experimental manipulation. We find that treatment of patient-derived organoids with beta- and gamma-secretase inhibitors significantly reduces amyloid and tau pathology. Moreover, these results show the potential of this model system to greatly increase the translatability of pre-clinical drug discovery in AD.	[Raja, Waseem K.; Mungenast, Alison E.; Lin, Yuan-Ta; Abdurrob, Fatema; Seo, Jinsoo; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Ko, Tak] MIT, Induced Pluripotent Stem Cell Core Facil, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Northwell Health	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Seo, Jinsoo/AAD-4950-2019	Seo, Jinsoo/0000-0001-6432-6964; Mungenast, Alison/0000-0003-1020-0471	National Institutes of Health [RF1AG042978, RF1AG048029, R01NS051874]; JPB foundation; Picower Institute Innovation Fund; Robert A. and Renee E. Belfer Family Foundation; Belfer Neurodegeneration Consortium; NATIONAL INSTITUTE ON AGING [RF1AG048029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB foundation; Picower Institute Innovation Fund; Robert A. and Renee E. Belfer Family Foundation; Belfer Neurodegeneration Consortium; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (https://www.nih.gov/), Grant numbers: RF1AG042978, RF1AG048029, and R01NS051874 to LHT; Jeffry M. Picower and Barbara Picower (JPB foundation) (http://www.jpbfoundation.org/), Picower Institute Innovation Fund to LHT; and the Robert A. and Renee E. Belfer Family Foundation and Belfer Neurodegeneration Consortium to LHT. The funder provided support in the form of salaries for authors WKR, AM, YL, FA, and JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P356, DOI 10.1007/BF02866241; Association A., 2013, ALZHEIMERS DEMENT, V8, P131, DOI DOI 10.1016/J.JALZ.2012.02.001; Bai B, 2013, P NATL ACAD SCI USA, V110, P16562, DOI 10.1073/pnas.1310249110; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Cataldo A, 2001, ANN NEUROL, V50, P661, DOI 10.1002/ana.1254.abs; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Cucullo L, 2002, BRAIN RES, V951, P243, DOI 10.1016/S0006-8993(02)03167-0; D'Avanzo C, 2015, BIOESSAYS, V37, P1139, DOI 10.1002/bies.201500063; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Feany MB, 1996, ANN NEUROL, V40, P139, DOI 10.1002/ana.410400204; Fjell AM, 2012, MOL NEUROBIOL, V45, P153, DOI 10.1007/s12035-011-8228-7; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goate A, 2006, J ALZHEIMERS DIS, V9, P341; GOLDGABER D, 1987, J NEURAL TRANSM, P23; Graeber MB, 1997, NEUROGENETICS, V1, P73, DOI 10.1007/s100480050011; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hossini AM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1262-5; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; IOVINO M, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV222; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Janke D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057227; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Koch P, 2012, AM J PATHOL, V180, P2404, DOI 10.1016/j.ajpath.2012.02.012; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee VMY GoedertM, 2001, NEURODEGENERATIVE TA, DOI [10.1146/annurev.neuro.24.1.1121, DOI 10.1146/ANNUREV.NEURO.24.1.1121]; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Mahmoudi S, 2012, CURR OPIN CELL BIOL, V24, P744, DOI 10.1016/j.ceb.2012.10.004; Matsusaki M, 2014, ADV DRUG DELIVER REV, V74, P95, DOI 10.1016/j.addr.2014.01.003; Merkle FT, 2013, CELL STEM CELL, V12, P656, DOI 10.1016/j.stem.2013.05.016; Miller J, 2014, AGING-US, V6, P246, DOI 10.18632/aging.100653; Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064; Murray ME, 2011, LANCET NEUROL, V10, P785, DOI 10.1016/S1474-4422(11)70156-9; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; ROBAKIS NK, 1987, LANCET, V1, P384; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sasai Y, 2013, CELL STEM CELL, V12, P520, DOI 10.1016/j.stem.2013.04.009; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Vardarajan BN, 2015, ANN NEUROL, V77, P215, DOI 10.1002/ana.24305; WISNIEWSKI HM, 1989, ACTA NEUROPATHOL, V78, P22, DOI 10.1007/BF00687398; Wren MC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0042-7; Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Young JE, 2015, CELL STEM CELL, V16, P373, DOI 10.1016/j.stem.2015.02.004; Zhang DW, 2014, BIOMATERIALS, V35, P1420, DOI 10.1016/j.biomaterials.2013.11.028; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	91	266	270	8	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161969	10.1371/journal.pone.0161969	http://dx.doi.org/10.1371/journal.pone.0161969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622770	gold, Green Published, Green Submitted			2022-12-26	WOS:000383681000010
J	Ropars, J; Lempereur, M; Vuillerot, C; Tiffreau, V; Peudenier, S; Cuisset, JM; Pereon, Y; Leboeuf, F; Delporte, L; Delpierre, Y; Gross, R; Brochard, S				Ropars, Juliette; Lempereur, Mathieu; Vuillerot, Carole; Tiffreau, Vincent; Peudenier, Sylviane; Cuisset, Jean-Marie; Pereon, Yann; Leboeuf, Fabien; Delporte, Ludovic; Delpierre, Yannick; Gross, Raphael; Brochard, Sylvain			Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SPASTIC CEREBRAL-PALSY; WALKING; SPEED; DEVIATION; PROFILES; INDEX	The aim of this prospective study was to investigate changes in muscle activity during gait in children with Duchennemuscular Dystrophy (DMD). Dynamic surface electromyography recordings (EMGs) of 16 children with DMD and pathological gait were compared with those of 15 control children. The activity of the rectus femoris (RF), vastus lateralis (VL), medial hamstrings (HS), tibialis anterior (TA) and gastrocnemius soleus (GAS) muscles was recorded and analysed quantitatively and qualitatively. The overall muscle activity in the children with DMD was significantly different from that of the control group. Percentage activation amplitudes of RF, HS and TA were greater throughout the gait cycle in the children with DMD and the timing of GAS activity differed from the control children. Significantly greater muscle coactivation was found in the children with DMD. There were no significant differences between sides. Since the motor command is normal in DMD, the hyper-activity and co-contractions likely compensate for gait instability and muscle weakness, however may have negative consequences on the muscles and may increase the energy cost of gait. Simple rehabilitative strategies such as targeted physical therapies may improve stability and thus the pattern of muscle activity.	[Ropars, Juliette; Peudenier, Sylviane] CHRU Brest, Serv Pediat, Brest, France; [Ropars, Juliette; Lempereur, Mathieu; Brochard, Sylvain] INSERM, U1101, Lab Traitement Informat Med, Brest, France; [Lempereur, Mathieu; Brochard, Sylvain] CHRU Brest, Serv Med Phys & Readaptat, Brest, France; [Vuillerot, Carole] Serv Cent Reeduc Pediat, Escale, Lyon, France; [Vuillerot, Carole] CNRS, UMR5558, Pierre Benite, France; [Tiffreau, Vincent] CHRU Lille, Serv Med Phys & Readaptat, Lille, France; [Cuisset, Jean-Marie; Gross, Raphael] CHRU Lille, Serv Neurol Pediat, Lille, France; [Pereon, Yann] CHU Nantes, Ctr Reference Malad Neuromusculaires Nantes Anger, Nantes, France; [Pereon, Yann] Atlantic Gene Therapy Inst, Nantes, France; [Leboeuf, Fabien] CHU Nantes, Pole Med Phys & Readaptat, Nantes, France; [Delporte, Ludovic] Hosp Civils Lyon, Plateforme Mouvement & Handicap, Bron, France; [Delpierre, Yannick] Ctr Arche, Serv Reeduc Neurol Pediat, Le Mans, France	CHU Brest; Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; CHU Lyon	Ropars, J (corresponding author), CHRU Brest, Serv Pediat, Brest, France.; Ropars, J (corresponding author), INSERM, U1101, Lab Traitement Informat Med, Brest, France.	juliette.ropars@chu-brest.fr	Brochard, Sylvain/AAI-7291-2021; Mathieu, Lempereur/G-5470-2012	Brochard, Sylvain/0000-0002-4950-1696; Mathieu, Lempereur/0000-0002-6717-7033; Delpierre, Yannick/0000-0002-4505-7014				Baker R, 2012, GAIT POSTURE, V35, P612, DOI 10.1016/j.gaitpost.2011.12.008; Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Bervet K, 2013, J ELECTROMYOGR KINES, V23, P930, DOI 10.1016/j.jelekin.2013.02.006; Boccardi S, 1997, J PHYS REHABILITATIO, V33, P13; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chang WN, 2007, J ELECTROMYOGR KINES, V17, P437, DOI 10.1016/j.jelekin.2006.02.003; Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274; D'Angelo MG, 2009, GAIT POSTURE, V29, P36, DOI 10.1016/j.gaitpost.2008.06.002; Damiano DL, 2000, ARCH PHYS MED REHAB, V81, P895, DOI 10.1053/apmr.2000.5579; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; DE LUCA CJ, 1988, ELECTROEN CLIN NEURO, V69, P568, DOI 10.1016/0013-4694(88)90169-1; Doglio L, 2011, EUR J PHYS REHAB MED, V47, P587; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Ganea R, 2012, J CHILD NEUROL, V27, P30, DOI 10.1177/0883073811413581; Gaudreault N, 2005, CRIT REV PHYS REHAB, V17, P231; Gaudreault N, 2010, GAIT POSTURE, V32, P342, DOI 10.1016/j.gaitpost.2010.06.003; Gianola S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065414; Gross R, 2013, CLIN BIOMECH, V28, P312, DOI 10.1016/j.clinbiomech.2013.01.002; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Khodadadeh S, 1990, Proc Inst Mech Eng H, V204, P241, DOI 10.1243/PIME_PROC_1990_204_262_02; KHODADADEH S, 1986, LANCET, V2, P544, DOI 10.1016/S0140-6736(86)90114-5; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; MCDONALD CM, 1995, AM J PHYS MED REHAB, V74, pS70, DOI 10.1097/00002060-199509001-00003; Patte K., 2000, Annales de Readaptation et de Medecine Physique, V43, P57, DOI 10.1016/S0168-6054(00)88728-0; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; Shiavi R, 1998, MED BIOL ENG COMPUT, V36, P171, DOI 10.1007/BF02510739; SUTHERLAND DH, 1981, DEV MED CHILD NEUROL, V23, P3; Thomas SS, 2010, J CHILD NEUROL, V25, P1103, DOI 10.1177/0883073810371002; Unnithan V B, 1996, Electromyogr Clin Neurophysiol, V36, P487; VIGNOS PJ, 1963, JAMA-J AM MED ASSOC, V184, P89, DOI 10.1001/jama.1963.03700150043007	35	21	23	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161938	10.1371/journal.pone.0161938	http://dx.doi.org/10.1371/journal.pone.0161938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622734	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000009
J	Poher, AL; Arsenijevic, D; Asrih, M; Dulloo, AG; Jornayvaz, FR; Rohner-Jeanrenaud, F; Veyrat-Durebex, C				Poher, Anne-Laure; Arsenijevic, Denis; Asrih, Mohamed; Dulloo, Abdul G.; Jornayvaz, Francois R.; Rohner-Jeanrenaud, Francoise; Veyrat-Durebex, Christelle			Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet	PLOS ONE			English	Article							IMPROVES INSULIN SENSITIVITY; BROWN ADIPOSE-TISSUE; ARCUATE NUCLEUS; FOOD-INTAKE; GENE-EXPRESSION; NEURONS; MICE; HYPOTHALAMUS; PHENOTYPE; ADULTHOOD	Physiological processes at adulthood, such as energy metabolism and insulin sensitivity may originate before or weeks after birth. These underlie the concept of fetal and/or neonatal programming of adult diseases, which is particularly relevant in the case of obesity and type 2 diabetes. The aim of this study was to determine the impact of a perinatal high fat diet on energy metabolism and on leptin as well as insulin sensitivity, early in life and at adulthood in two strains of rats presenting different susceptibilities to diet-induced obesity. The impact of a perinatal high fat diet on glucose tolerance and diet-induced obesity was also assessed. The development of glucose intolerance and of increased fat mass was confirmed in the obesity-prone Wistar rat, even after 28 days of age. By contrast, in obesity-resistant Lou/C rats, an improved early leptin signaling may be responsible for the lack of deleterious effect of the perinatal high fat diet on glucose tolerance and increased adiposity in response to high fat diet at adulthood. Altogether, this study shows that, even if during the perinatal period adaptation to the environment appears to be genetically determined, adaptive mechanisms to nutritional challenges occurring at adulthood can still be observed in rodents.	[Poher, Anne-Laure; Rohner-Jeanrenaud, Francoise; Veyrat-Durebex, Christelle] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland; [Poher, Anne-Laure; Rohner-Jeanrenaud, Francoise] Univ Geneva, Dept Med Specialties, Lab Metab, Fac Med, Geneva, Switzerland; [Arsenijevic, Denis; Dulloo, Abdul G.] Univ Fribourg, Dept Med Physiol, Fribourg, Switzerland; [Asrih, Mohamed; Jornayvaz, Francois R.] Univ Lausanne Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland	University of Geneva; University of Geneva; University of Fribourg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Veyrat-Durebex, C (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.	christelle.veyrat-durebex@unige.ch	Jornayvaz, François/AAL-2134-2020; Arsenijevic, Denis/O-8315-2016	Arsenijevic, Denis/0000-0001-5741-9652; DULLOO, Abdul/0000-0003-3877-6149; Veyrat-Durebex, Christelle/0000-0001-5301-6493; Poher, Anne-Laure/0000-0002-6657-4336; Jornayvaz, Francois/0000-0001-9425-3137	Societe Francophone du Diabete	Societe Francophone du Diabete	The work was supported by Societe Francophone du Diabete.	Aalinkeel R, 2001, AM J PHYSIOL-ENDOC M, V281, pE640, DOI 10.1152/ajpendo.2001.281.3.E640; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Martinez JA, 2012, P NUTR SOC, V71, P276, DOI 10.1017/S0029665112000055; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P3, DOI 10.1113/jphysiol.2004.079756; Attig L, 2008, INT J OBESITY, V32, P1153, DOI 10.1038/ijo.2008.39; Baquero AF, 2014, J NEUROSCI, V34, P9982, DOI 10.1523/JNEUROSCI.0933-14.2014; Bazin H., 1990, THE LOUVAIN LOU RATS, P43; Beall MH, 2004, CLIN OBSTET GYNECOL, V47, P957, DOI 10.1097/01.grf.0000135668.61661.9c; Benoit C, 2013, J ENDOCRINOL, V218, P35, DOI 10.1530/JOE-12-0561; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P3099, DOI 10.1210/en.2013-1191; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Commins SP, 2000, J BIOL CHEM, V275, P33059, DOI 10.1074/jbc.M006328200; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Coupe Berengere, 2013, Front Endocrinol (Lausanne), V4, P38, DOI 10.3389/fendo.2013.00038; D'Asti E, 2010, ENDOCRINOLOGY, V151, P1685, DOI 10.1210/en.2009-1092; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Delahaye F, 2010, AM J PHYSIOL-REG I, V299, pR101, DOI 10.1152/ajpregu.00604.2009; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Enriori PJ, 2011, J NEUROSCI, V31, P12189, DOI 10.1523/JNEUROSCI.2336-11.2011; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; Grove KL, 2005, PHYSIOL BEHAV, V86, P646, DOI 10.1016/j.physbeh.2005.08.063; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; LINN TC, 1981, ARCH BIOCHEM BIOPHYS, V209, P613, DOI 10.1016/0003-9861(81)90320-9; Marcelino H, 2013, DIABETES, V62, P362, DOI 10.2337/db12-0255; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Parente LB, 2008, CLIN NUTR, V27, P623, DOI 10.1016/j.clnu.2008.05.005; Pedrazzi P, 1998, PEPTIDES, V19, P157, DOI 10.1016/S0196-9781(97)00258-1; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Poher AL, 2015, DIABETES, V64, P3700, DOI 10.2337/db15-0210; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Srinivasan M, 2006, AM J PHYSIOL-ENDOC M, V291, pE792, DOI 10.1152/ajpendo.00078.2006; Taleux N, 2008, INT J OBESITY, V32, P639, DOI 10.1038/sj.ijo.0803759; Ueno N, 1998, MECH AGEING DEV, V100, P67, DOI 10.1016/S0047-6374(97)00123-1; Veyrat-Durebex C, 1998, MECH AGEING DEV, V103, P223, DOI 10.1016/S0047-6374(98)00013-X; Veyrat-Durebex C, 1997, PHYSIOL BEHAV, V62, P1273, DOI 10.1016/S0031-9384(97)00304-1; Veyrat-Durebex C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073452; Veyrat-Durebex C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1146, DOI 10.1152/ajpendo.00575.2010; Veyrat-Durebex C, 2009, AM J PHYSIOL-ENDOC M, V296, pE1120, DOI 10.1152/ajpendo.90592.2008; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392	51	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162517	10.1371/journal.pone.0162517	http://dx.doi.org/10.1371/journal.pone.0162517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618559	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100027
J	Liu, Y; Gibson, GR; Walton, GE				Liu, Yue; Gibson, Glenn R.; Walton, Gemma E.			An In Vitro Approach to Study Effects of Prebiotics and Probiotics on the Faecal Microbiota and Selected Immune Parameters Relevant to the Elderly	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; LACTOBACILLUS-ACIDOPHILUS NCFM; HUMAN INTESTINAL MICROBIOTA; MIXTURE B-GOS; GUT MICROBIOTA; HUMAN FECES; BIFIDOBACTERIUM-LACTIS; BACTERIAL-POPULATIONS; SITU HYBRIDIZATION; AGE	The aging process leads to alterations of gut microbiota and modifications to the immune response, such changes may be associated with increased disease risk. Prebiotics and probiotics can modulate microbiome changes induced by aging; however, their effects have not been directly compared. The aim of this study was to use anaerobic batch culture fermenters to assess the impact of various fermentable carbohydrates and microorganisms on the gut microbiota and selected immune markers. Elderly volunteers were used as donors for these experiments to enable relevance to an aging population. The impact of fermentation supernatants on immune markers relevant to the elderly were assessed in vitro. Levels of IL-1 beta, IL-6, IL-8, IL-10 and TNF-alpha in peripheral blood mononuclear cell culture supernatants were measured using flow cytometry. Trans-galactooligosaccharides (B-GOS) and inulin both stimulated bifidobacteria compared to other treatments (p < 0.05). Fermentation supernatants taken from faecal batch cultures supplemented with B-GOS, inulin, B. bifidum, L. acidophilus and Ba. coagulans inhibited LPS induced TNF-alpha (p < 0.05). IL-10 production, induced by LPS, was enhanced by fermentation supernatants from faecal batch cultures supplemented with B-GOS, inulin, B. bifidum, L. acidophilus, Ba. coagulans and Bac. thetaiotaomicron (p < 0.05). To conclude, prebiotics and probiotics could lead to potentially beneficial effects to host health by targeting specific bacterial groups, increasing saccharolytic fermentation and decreasing inflammation associated with aging. Compared to probiotics, prebiotics led to greater microbiota modulation at the genus level within the fermenters.	[Liu, Yue; Gibson, Glenn R.; Walton, Gemma E.] Univ Reading, Dept Food & Nutr Sci, POB 226, Reading, Berks, England	University of Reading	Walton, GE (corresponding author), Univ Reading, Dept Food & Nutr Sci, POB 226, Reading, Berks, England.	g.e.walton@reading.ac.uk						Agrawal A, 2008, J CLIN IMMUNOL, V28, P14, DOI 10.1007/s10875-007-9127-6; Arunachalam K, 2000, EUR J CLIN NUTR, V54, P263, DOI 10.1038/sj.ejcn.1600938; Bartosch S, 2005, CLIN INFECT DIS, V40, P28, DOI 10.1086/426027; Bjorklund M, 2012, AGE, V34, P987, DOI 10.1007/s11357-011-9294-5; BROKLEHU.JC, 1972, P ROY SOC MED, V65, P66, DOI 10.1177/003591577206500126; Bruunsgaard H, 2001, EXP GERONTOL, V37, P127, DOI 10.1016/S0531-5565(01)00162-0; Butcher SK, 2001, J LEUKOCYTE BIOL, V70, P881; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; CASTELL D O, 1988, Practical Gastroenterology, V12, P37; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costabile A, 2010, BRIT J NUTR, V104, P1007, DOI 10.1017/S0007114510001571; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; FAO/WHO, 2001, HEALTH AND NUTRITION; FAO/WHO, GUID EV PROB FOOD 20; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Gavini Francoise, 2001, Microbial Ecology in Health and Disease, V13, P40, DOI 10.1080/089106001750071690; Gibson G. R., 2010, Food Science and Technology Bulletin: Functional Foods, V7, P1; GOODWIN JS, 1995, NUTR REV, V53, pS41; Guigoz Y, 2002, NUTR RES, V22, P13, DOI 10.1016/S0271-5317(01)00354-2; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Harmsen HJM, 2000, APPL ENVIRON MICROB, V66, P4523, DOI 10.1128/AEM.66.10.4523-4527.2000; Honda H., 2011, International Journal of Probiotics and Prebiotics, V6, P65; Honda H, 2011, ANAEROBE, V17, P36, DOI 10.1016/j.anaerobe.2010.12.006; Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Imaoka A, 2008, WORLD J GASTROENTERO, V14, P2511, DOI 10.3748/wjg.14.2511; Jensen GS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-15; Kleessen B, 1997, AM J CLIN NUTR, V65, P1397, DOI 10.1093/ajcn/65.5.1397; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Langkamp-Henken B, 2004, J AM GERIATR SOC, V52, P3, DOI 10.1111/j.1532-5415.2004.52003.x; Langkamp-Henken B, 2006, J AM GERIATR SOC, V54, P1861, DOI 10.1111/j.1532-5415.2006.00982.x; Liu TF, 2012, INFLAMMATION, V35, P1676, DOI 10.1007/s10753-012-9484-z; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; McCartney AL, 1996, APPL ENVIRON MICROB, V62, P4608, DOI 10.1128/AEM.62.12.4608-4613.1996; Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Newton J P, 1993, Gerodontology, V10, P16, DOI 10.1111/j.1741-2358.1993.tb00074.x; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Ogue-Bon E, 2010, FEMS MICROBIOL ECOL, V73, P587, DOI 10.1111/j.1574-6941.2010.00915.x; Ouwehand AC, 2008, FEMS IMMUNOL MED MIC, V53, P18, DOI 10.1111/j.1574-695X.2008.00392.x; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Peterson CT, 2015, CLIN EXP IMMUNOL, V179, P363, DOI 10.1111/cei.12474; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Saemann MD, 2000, FASEB J, V14, P2380; Schiffrin EJ, 2010, MUTAT RES-FUND MOL M, V690, P50, DOI 10.1016/j.mrfmmm.2009.07.011; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x; Tonna I, 2005, POSTGRAD MED J, V81, P367, DOI 10.1136/pgmj.2004.028480; Tzortzis G, 2005, J NUTR, V135, P1726, DOI 10.1093/jn/135.7.1726; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; Vendrig JC, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-147; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vulevic J, 2008, AM J CLIN NUTR, V88, P1438, DOI 10.3945/ajcn.2008.26242; Vulevic J, 2015, BRIT J NUTR, V114, P586, DOI 10.1017/S0007114515001889; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Walton GE, 2012, BRIT J NUTR, V107, P1466, DOI 10.1017/S0007114511004697; WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x; WHO, FACTS AG 2014; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Yagamata A, 1965, JAP J GASTROENTEROL, V62, P229	72	39	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162604	10.1371/journal.pone.0162604	http://dx.doi.org/10.1371/journal.pone.0162604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612304	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000383255900132
J	Liu, S; Tackmann, NR; Yang, J; Zhang, Y				Liu, S.; Tackmann, N. R.; Yang, J.; Zhang, Y.			Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis	ONCOGENE			English	Article							MULTIPLE INTESTINAL NEOPLASIA; MYC-INDUCED LYMPHOMAGENESIS; B-CELL LINE; C-MYC; RIBOSOME BIOGENESIS; IN-VIVO; P53; CANCER; IDENTIFICATION; GENES	Inactivation of the adenomatous polyposis coli (APC) tumor suppressor is frequently found in colorectal cancer. Loss of APC function results in deregulation of the Wnt/beta-catenin signaling pathway causing overexpression of the c-MYC oncogene. In lymphoma, both p19ARF and ribosomal proteins RPL11 and RPL5 respond to c-MYC activation to induce p53. Their role in c-MYCdriven colorectal carcinogenesis is unclear, as p19ARF deletion does not accelerate APC loss-triggered intestinal tumorigenesis. To determine the contribution of the ribosomal protein (RP)-murine double minute 2 (MDM2)-p53 pathway to APC loss-induced tumorigenesis, we crossed mice bearing MDM2(C305F) mutation, which disrupts RPL11-and RPL5-MDM2 binding, with Apc(min/+) mice, which are prone to intestinal tumor formation. Interestingly, loss of RP-MDM2 binding significantly accelerated colorectal tumor formation while having no discernable effect on small intestinal tumor formation. Mechanistically, APC loss leads to overexpression of c-MYC, RPL11 and RPL5 in mouse colonic tumor cells irrespective of MDM2(C305F) mutation. However, notable p53 stabilization and activation were observed only in Apc(min/+); Mdm2(+/+) but not Apc(min/+); Mdm2(C305F/C305F) colon tumors. These data establish that the RP-MDM2-p53 pathway, in contrast to the p19ARF-MDM2-p53 pathway, is a critical mediator of colorectal tumorigenesis following APC loss.	[Liu, S.; Tackmann, N. R.; Yang, J.; Zhang, Y.] Univ N Carolina, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27514 USA; [Liu, S.; Tackmann, N. R.; Yang, J.; Zhang, Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27514 USA; [Tackmann, N. R.; Zhang, Y.] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Yang, J.; Zhang, Y.] Xuzhou Med Coll, Inst Canc, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xuzhou Medical University	Zhang, Y (corresponding author), Univ N Carolina, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27514 USA.; Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27514 USA.	ypzhang@med.unc.edu			National Institutes of Health [CA127770, CA 100302, CA167637]; Natural Science Foundation of China (NSFC); National Institute of General Medical Sciences [5T32 GM007092]; NATIONAL CANCER INSTITUTE [R01CA100302, R01CA167637, R01CA155235, R01CA127770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institutes of Health (CA127770, CA 100302 and CA167637) and Natural Science Foundation of China (NSFC) to YZ, and the National Institute of General Medical Sciences (5T32 GM007092) to NRT.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Chen DL, 2013, MOL CELL, V51, P46, DOI 10.1016/j.molcel.2013.05.006; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Elyada E, 2011, NATURE, V470, P409, DOI 10.1038/nature09673; Feng Y, 2013, AM J PATHOL, V183, P493, DOI 10.1016/j.ajpath.2013.04.013; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gibson SL, 2005, CANCER BIOL THER, V4, P1389, DOI 10.4161/cbt.4.12.2303; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hill RM, 2015, CANCER CELL, V27, P72, DOI 10.1016/j.ccell.2014.11.002; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026057; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim TH, 2014, ONCOTARGET, V5, P860, DOI 10.18632/oncotarget.1784; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Littlewood TD, 2012, CELL, V151, P11, DOI 10.1016/j.cell.2012.09.006; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Meng X, 2015, ONCOGENE, V34, P5709, DOI 10.1038/onc.2015.39; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1992, J CELL BIOL, V116, P1517, DOI 10.1083/jcb.116.6.1517; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Oliner JD, 1993, ONCOPROTEIN MDM2 CON, P53; Sabo A, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014191; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Toshiyuki M, 1995, CELL, V80, P293, DOI DOI 10.1016/0092-8674(95)90412-3; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	52	22	22	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1374	1383		10.1038/onc.2016.301	http://dx.doi.org/10.1038/onc.2016.301			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27617574	Green Submitted, Green Accepted			2022-12-26	WOS:000395862500006
J	Guo, Y; Tang, CY; Man, XF; Tang, HN; Tang, J; Wang, F; Zhou, CL; Tan, SW; Feng, YZ; Zhou, HD				Guo, Yue; Tang, Chen-Yi; Man, Xiao-Fei; Tang, Hao-Neng; Tang, Jun; Wang, Fang; Zhou, Ci-La; Tan, Shu-Wen; Feng, Yun-Zhi; Zhou, Hou-De			Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen I alpha 2 expression via miR-342	FASEB JOURNAL			English	Article						insulin receptor substrate; bone formation; collagen 1 alpha 2; miR-342	OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; ANABOLIC FUNCTION; MINERAL DENSITY; DOWN-REGULATION; ADIPOSE-TISSUE; MARROW; GROWTH; ROLES; CELLS	Insulin promotes bone formation via a well-studied canonical signaling pathway. An adapter in this pathway, insulin-receptor substrate (IRS)-1, has been implicated in the diabetic osteopathy provoked by impaired insulin signaling. To further investigate IRS-1's role in the bone metabolism, we generated Irs-1-deficient Irs-1(smla/smla) mice. These null mice developed a spontaneous mutation that led to an increase in trabecular thickness (Tb.Th) in 12-mo-old, but not in 2-mo-old mice. Analyses of the bone marrow stromal cells (BMSCs) from these mice revealed their differential expression of osteogenesis-related genes and miRNAs. The expression of miR-342, predicted and then proven to target the gene encoding collagen type I alpha 2 (COL1A2), was reduced in BMSCs derived from Irs-1-null mice. COL1A2expressionwas then shown to be age dependent in osteoblasts and BMSCs derived from Irs-1(smla/smla) mice. After the induction of osteogenesis in BMSCs, miR-342 expression correlated inversely with that of Col1a2. Further, Col1a2-specific small interfering RNA (siRNA) reduced alkaline phosphatase (ALP) activity and inhibited BMSC differentiation into osteocyte-like cells, both in wild-type (WT) and Irs-1(smla/smla) mice. Conversely, in Irs-1(smla/smla) osteocytes overexpressing COL1A2, ALP-positive staining was stronger than in WT osteocytes. In summary, we uncovered a temporal regulation of BMSC differentiation/bone formation, controlled via Irs-1/miR-342 mediated regulation of Col1a2 expression.	[Guo, Yue; Tang, Chen-Yi; Man, Xiao-Fei; Tang, Hao-Neng; Tang, Jun; Wang, Fang; Zhou, Ci-La; Tan, Shu-Wen; Zhou, Hou-De] Cent S Univ, Natl Clin Res Ctr Metab Dis, Dept Endocrinol & Metab, Xiangya Hosp 2, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China; [Feng, Yun-Zhi] Cent S Univ, Dept Stomatol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, HD (corresponding author), Cent S Univ, Natl Clin Res Ctr Metab Dis, Dept Endocrinol & Metab, Xiangya Hosp 2, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	houdezhou@csu.edu.cn		Zhou, Hou-De/0000-0001-9131-4141; Tang, Jun/0000-0002-6908-1027	National Natural Scientific Foundation of China [81370975, 81070278]; Science and Technology Department of Hunan Province [2015JC3012, 100JJ1007]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province	This work was supported by National Natural Scientific Foundation of China Grants 81370975 and 81070278, and Science and Technology Department of Hunan Province Grants 2015JC3012 and 100JJ1007. The authors declare no conflicts of interest.	Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Bu YH, 2009, J ENDOCRINOL INVEST, V32, P682, DOI [10.1007/BF03345741, 10.3275/6328]; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; de Paula FJA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129764; Dhaliwal R, 2014, OSTEOPOROSIS INT, V25, P1969, DOI 10.1007/s00198-014-2704-7; Egusa H, 2007, TISSUE ENG, V13, P2589, DOI 10.1089/ten.2007.0080; Ell Brian, 2014, Bonekey Rep, V3, P549, DOI 10.1038/bonekey.2014.44; Fowlkes JL, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.S1-003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hernandez JL, 2011, MATURITAS, V68, P217, DOI 10.1016/j.maturitas.2010.12.010; Hoshi K, 2004, J BONE MINER RES, V19, P214, DOI 10.1359/JBMR.0301221; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kalajzic I, 2002, ENDOCRINOLOGY, V143, P1594, DOI 10.1210/en.143.5.1594; Kitamura M, 2016, J BONE MINER RES, V31, P806, DOI 10.1002/jbmr.2738; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Li EQ, 2014, MOL CELL BIOCHEM, V390, P69, DOI 10.1007/s11010-013-1957-3; Lian J B, 1995, Iowa Orthop J, V15, P118; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Ma H, 2015, EXP CLIN ENDOCR DIAB, V123, P126, DOI 10.1055/s-0034-1390422; Mathen PG, 2015, J CLIN DIAGN RES, V9, pOC8, DOI 10.7860/JCDR/2015/14390.6450; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Ornstrup MJ, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0792; Papaioannou G, 2014, CELL MOL LIFE SCI, V71, P4747, DOI 10.1007/s00018-014-1700-6; Pramojanee SN, 2014, ENDOCR RES, V39, P144, DOI 10.3109/07435800.2013.879168; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schultz HS, 2015, J IMMUNOL, V194, P3169, DOI 10.4049/jimmunol.1402800; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shimoaka T, 2004, J BIOL CHEM, V279, P15314, DOI 10.1074/jbc.M312525200; Shu A, 2012, OSTEOPOROSIS INT, V23, P635, DOI 10.1007/s00198-011-1595-0; Sun QL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.26; Szulc P, 2010, J BONE MINER RES, V25, P1446, DOI 10.1002/jbmr.13; Thrailkill K, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/703589; Titorencu I, 2014, CELL TISSUE RES, V355, P23, DOI 10.1007/s00441-013-1750-3; Wang Su-Fang, 2012, Enzyme Res, V2012, P192867, DOI 10.1155/2012/192867; Wang T, 2015, J BONE MINER RES, V30, P1572, DOI 10.1002/jbmr.2510; Yamaguchi M, 2005, ENDOCRINOLOGY, V146, P2620, DOI 10.1210/en.2004-1511; Zappitelli T, 2015, MOL BIOL CELL, V26, P832, DOI 10.1091/mbc.E14-06-1136; Zhang H, 2007, J CELL BIOCHEM, V102, P1011, DOI 10.1002/jcb.21337	41	20	20	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4214	4226		10.1096/fj.201600445RR	http://dx.doi.org/10.1096/fj.201600445RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27623927	Green Published, hybrid			2022-12-26	WOS:000388201500027
J	Dandekar, A; Qiu, YN; Kim, H; Wang, JM; Hou, X; Zhang, XB; Zheng, Z; Mendez, R; Yu, FS; Kumar, A; Fang, DY; Sun, F; Zhang, KZ				Dandekar, Aditya; Qiu, Yining; Kim, Hyunbae; Wang, Jiemei; Hou, Xia; Zhang, Xuebao; Zheng, Ze; Mendez, Roberto; Yu, Fu-Shin; Kumar, Ashok; Fang, Deyu; Sun, Fei; Zhang, Kezhong			Toll-like Receptor (TLR) Signaling Interacts with CREBH to Modulate High-density Lipoprotein (HDL) in Response to Bacterial Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; FATTY-ACID OXIDATION; TRANSCRIPTION FACTOR; SEVERE SEPSIS; A-IV; TRAF6; ACTIVATION; STRESS; ACETYLATION; METABOLISM	Bacterial endotoxin can induce inflammatory and metabolic changes in the host. In this study, we revealed a molecular mechanism by which a stress-inducible, liver-enriched transcription factor, cAMP-responsive element-binding protein hepatic-specific (CREBH), modulates lipid profiles to protect the liver from injuries upon the bacterial endotoxin lipopolysaccharide (LPS). LPS challenge can activate CREBH in mouse liver tissues in a toll-like receptor (TLR)/MyD88-dependent manner. Upon LPS challenge, CREBH interacts with TNF receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase that functions as a key mediator of TLR signaling, and this interaction relies on MyD88. Further analysis demonstrated that TRAF6 mediates K63-linked ubiquitination of CREBH to facilitate CREBH cleavage and activation. CREBH directly activates expression of the gene encoding Apolipoprotein A4 (ApoA4) under LPS challenge, leading to modulation of high-density lipoprotein (HDL) in animals. CREBH deficiency led to reduced production of circulating HDL and increased liver damage upon high-dose LPS challenge. Therefore, TLR/MyD88-dependent, TRAF6-facilitated CREBH activation represents a mammalian hepatic defense response to bacterial endotoxin by modulating HDL.	[Qiu, Yining; Kim, Hyunbae; Wang, Jiemei; Zhang, Xuebao; Zheng, Ze; Mendez, Roberto; Zhang, Kezhong] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Dandekar, Aditya; Zhang, Kezhong] Wayne State Univ, Sch Med, Dept Immunol & Microbiol, Detroit, MI 48201 USA; [Hou, Xia; Sun, Fei] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Yu, Fu-Shin; Kumar, Ashok] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Fang, Deyu] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Northwestern University; Feinberg School of Medicine	Zhang, KZ (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, 3202 Scott Hall,540 East Canfield, Detroit, MI 48201 USA.	kzhang@med.wayne.edu	Dandekar, Aditya/L-9510-2019; Hou, Xia/AAD-2235-2020; Wang, Jie-Mei/N-9528-2019	Dandekar, Aditya/0000-0002-3803-4930; Wang, Jie-Mei/0000-0002-8723-4410; Hou, Xia/0000-0002-6733-086X; Zhang, Kezhong/0000-0002-6062-235X; Zheng, Ze/0000-0002-4453-224X	National Institutes of Health (NIH) [DK090313, ES017829, AR066634]; American Heart Association [09GRNT2280479]; NATIONAL EYE INSTITUTE [R01EY017960, R01EY010869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK090313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017829] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health (NIH) Grants DK090313 and ES017829 (to K. Z.), AR066634 (to K. Z. and D. F.), and American Heart Association Grant 09GRNT2280479 (to K. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Feingold KR, 2011, J LIPID RES, V52, P1, DOI 10.1194/jlr.E012138; GHISELLI G, 1989, BIOCHIM BIOPHYS ACTA, V1006, P26, DOI 10.1016/0005-2760(89)90319-6; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kapatos G, 2007, J NEUROCHEM, V101, P1119, DOI 10.1111/j.1471-4159.2007.04486.x; Khovidhunkit W, 2004, ATHEROSCLEROSIS, V176, P37, DOI 10.1016/j.atherosclerosis.2004.04.018; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Machida K, 2009, P NATL ACAD SCI USA, V106, P1548, DOI 10.1073/pnas.0807390106; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Nemzek JA, 2008, COMPARATIVE MED, V58, P120; Qiu Q, 2013, EMBO J, V32, P2477, DOI 10.1038/emboj.2013.183; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; van Leeuwen HJ, 2001, NETH J MED, V59, P102, DOI 10.1016/S0300-2977(01)00144-9; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zheng Z, 2016, DIABETES, V65, P3369, DOI 10.2337/db16-0298	31	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23149	23158		10.1074/jbc.M116.755728	http://dx.doi.org/10.1074/jbc.M116.755728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27637329	hybrid, Green Published			2022-12-26	WOS:000387224800025
J	Bourrelle-Langlois, M; Morrow, G; Finet, S; Tanguay, RM				Bourrelle-Langlois, Maxime; Morrow, Genevieve; Finet, Stephanie; Tanguay, Robert M.			In Vitro Structural and Functional Characterization of the Small Heat Shock Proteins (sHSP) of the Cyanophage S-ShM2 and Its Host, Synechococcus sp. WH7803	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; ESCHERICHIA-COLI GROES; CHAPERONE ACTIVITY; PCC 6803; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; PHOTOSYNTHESIS GENES; SUBUNIT EXCHANGE; MARINE VIRUSES; STABILITY	We previously reported the in silico characterization of Synechococcus sp. phage 18 kDa small heat shock protein (HspSP-ShM2). This small heat shock protein (sHSP) contains a highly conserved core alpha crystalline domain of 92 amino acids and relatively short Nand C-terminal arms, the later containing the classical C-terminal anchoring module motif (L-X-I/L/V). Here we establish the oligomeric profile of HspSP-ShM2 and its structural dynamics under in vitro experimental conditions using size exclusion chromatography (SEC/FPLC), gradient native gels electrophoresis and dynamic light scattering (DLS). Under native conditions, HspSP-ShM2 displays the ability to form large oligomers and shows a polydisperse profile. At higher temperatures, it shows extensive structural dynamics and undergoes conformational changes through an increased of subunit rearrangement and formation of sub-oligomeric species. We also demonstrate its capacity to prevent the aggregation of citrate synthase, malate dehydrogenase and luciferase under heat shock conditions through the formation of stable and soluble hetero-oligomeric complexes (sHSP: substrate). In contrast, the host cyanobacteria Synechococcus sp. WH7803 15 kDa sHSP (HspS-WH7803) aggregates when in the same conditions as HspSP-ShM2. However, its solubility can be maintained in the presence of non-ionic detergent Triton (TM) X-100 and forms an oligomeric structure estimated to be between dimer and tetramer but exhibits no apparent inducible structural dynamics neither chaperon-like activity in all the assays and molar ratios tested. SEC/FPLC and thermal aggregation prevention assays results indicate no formation of hetero-oligomeric complex or functional interactions between both sHSPs. Taken together these in vitro results portray the phage HspSP-ShM2 as a classical sHSP and suggest that it may be functional at the in vivo level while behaving differently than its host amphitropic sHSP.	[Bourrelle-Langlois, Maxime; Morrow, Genevieve; Tanguay, Robert M.] Fac Med, IBIS, Lab Biol Cellulaire & Mol, Quebec City, PQ, Canada; [Bourrelle-Langlois, Maxime; Morrow, Genevieve; Tanguay, Robert M.] Fac Med, PROTEO, Dept Biol Mol Biochim Med, Quebec City, PQ, Canada; [Finet, Stephanie] Univ Paris 06, Sorbonne Univ, CNRS, IRD MNHN,IMPMC UMR7590, Paris, France	Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Tanguay, RM (corresponding author), Fac Med, IBIS, Lab Biol Cellulaire & Mol, Quebec City, PQ, Canada.; Tanguay, RM (corresponding author), Fac Med, PROTEO, Dept Biol Mol Biochim Med, Quebec City, PQ, Canada.	Robert.tanguay@fmed.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [3526-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from Natural Sciences and Engineering Research Council of Canada to RMT (grant number: 3526-2011 and URL: http://www.nserc-crsng.gc.ca/index_eng.asp) and studentships from PROTEO (URL: http://www.proteo.ca/index.html) and Universite Laval Medicine Faculty (URL: http://www.fmed.ulaval.ca/accueil/) to MBL.	Ang D, 2001, J BIOL CHEM, V276, P8720, DOI 10.1074/jbc.M008477200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Balogi Z, 2005, ARCH BIOCHEM BIOPHYS, V436, P346, DOI 10.1016/j.abb.2005.02.018; Balogi Z, 2008, J BIOL CHEM, V283, P22983, DOI 10.1074/jbc.M710400200; Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2013, J MOL BIOL, V425, P1683, DOI 10.1016/j.jmb.2013.02.011; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Benesch JLP, 2010, CHEM BIOL, V17, P1008, DOI 10.1016/j.chembiol.2010.06.016; Bepperling A, 2012, P NATL ACAD SCI USA, V109, P20407, DOI 10.1073/pnas.1209565109; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bova MP, 2002, J BIOL CHEM, V277, P38468, DOI 10.1074/jbc.M205594200; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151; Delbecq SP, 2013, FEBS LETT, V587, P1073, DOI 10.1016/j.febslet.2013.01.021; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Fernando P, 2000, CELL STRESS CHAPERON, V5, P148, DOI 10.1379/1466-1268(2000)005<0148:FCOXSH>2.0.CO;2; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Fu XM, 2014, ACTA BIOCH BIOPH SIN, V46, P347, DOI 10.1093/abbs/gmt152; Fu XM, 2013, J BIOL CHEM, V288, P31646, DOI 10.1074/jbc.M113.501817; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hertveldt K, 2005, J MOL BIOL, V354, P536, DOI 10.1016/j.jmb.2005.08.075; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Kurochkina LP, 2012, J VIROL, V86, P10103, DOI 10.1128/JVI.00940-12; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee S, 2000, CURR MICROBIOL, V40, P283, DOI 10.1007/s002849910056; Lee SY, 1998, CURR MICROBIOL, V37, P403, DOI 10.1007/s002849900400; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Maaroufi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081207; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Michiel M, 2010, EXP EYE RES, V90, P688, DOI 10.1016/j.exer.2010.02.007; Michiel M, 2009, BIOCHEMISTRY-US, V48, P442, DOI 10.1021/bi8014967; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Nakamoto H, 2000, FEBS LETT, V483, P169, DOI 10.1016/S0014-5793(00)02097-4; Nitta K, 2005, FEBS LETT, V579, P1235, DOI 10.1016/j.febslet.2004.12.095; Semenyuk PI, 2015, BIOCHEMISTRY-MOSCOW+, V80, P172, DOI 10.1134/S0006297915020042; Semenyuk PI, 2016, BIOCHEM J, V473, P2383, DOI 10.1042/BCJ20160367; Skouri-Panet F, 2012, BIOCHIMIE, V94, P975, DOI 10.1016/j.biochi.2011.12.018; Stengel F, 2012, CHEM BIOL, V19, P599, DOI 10.1016/j.chembiol.2012.04.007; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; Stromer T, 2003, J BIOL CHEM, V278, P18015, DOI 10.1074/jbc.M301640200; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Torok Z, 2001, P NATL ACAD SCI USA, V98, P3098, DOI 10.1073/pnas.051619498; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; White HE, 2006, STRUCTURE, V14, P1197, DOI 10.1016/j.str.2006.05.021; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; Zhang H, 2005, BIOCHEM BIOPH RES CO, V330, P1055, DOI 10.1016/j.bbrc.2005.03.092	71	5	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162233	10.1371/journal.pone.0162233	http://dx.doi.org/10.1371/journal.pone.0162233			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643500	gold, Green Published, Green Submitted			2022-12-26	WOS:000383891900006
J	Gavazzi, F; Braglia, L; Mastromauro, F; Giani, S; Morello, L; Breviario, D				Gavazzi, Floriana; Braglia, Luca; Mastromauro, Francesco; Giani, Silvia; Morello, Laura; Breviario, Diego			The Tubulin-Based-Polymorphism Method Provides a Simple and Effective Alternative to the Genomic Profiling of Grape	PLOS ONE			English	Article							GENETIC DIVERSITY; MICROSATELLITE MARKERS; PHYLOGENETIC ANALYSIS; AUTHENTICITY MARKERS; MOLECULAR MARKERS; VITIS VITACEAE; SSR MARKERS; IDENTIFICATION; CULTIVARS; L.	The TBP (Tubulin-Based-Polymorphism) method, based on a nuclear ILP (Intron-Length-Polymorphism) molecular marker, has been used for genotyping 37 accessions of the genus Vitis inclusive of different species, rootstocks, wild and cultivated subspecies. A distinct DNA barcode made up by a different number of amplicons, was attributed to each of the different accessions. TBP data were compared with those obtained, with the use of an internationally validated set of six SSR markers. Genetic relationships among the different accessions, dendrogram distributions, correlation values and polymorphic index values (PICs) were definitively comparable when not in favor of TBP. Such an experimental consistency is based upon a genomic organization of the multiple members of the beta-tubulin gene family, the targets of TBP-mediated amplification, that is conserved in Vitis as in any other plant species. The TBP amplicons can actually be used as a useful source of sequence polymorphisms for generating primer pairs capable of identifying specific cultivars in a simple assay. An example for the identification of the 'Sangiovese' cv. is reported. More generally, these data are discussed in terms of the actual advantages that the introduction of the TBP method in the field of grape characterization and genotyping can provide.	[Gavazzi, Floriana; Braglia, Luca; Mastromauro, Francesco; Giani, Silvia; Morello, Laura; Breviario, Diego] CNR, Inst Agr Biol & Biotechnol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR)	Breviario, D (corresponding author), CNR, Inst Agr Biol & Biotechnol, Milan, Italy.	breviario@ibba.cnr.it	Gavazzi, Floriana/AAC-4544-2022; Braglia, Luca/G-4122-2018; Breviario, Diego/AAX-6378-2020; MORELLO, LAURAEMMAMARIA/AAX-4620-2020; Gianì, Silvia/AAV-3716-2020; Braglia, Luca/AAA-4803-2019; Morello, Laura/ABF-9139-2022	Braglia, Luca/0000-0001-6772-5362; Breviario, Diego/0000-0002-3062-7598; Braglia, Luca/0000-0001-6772-5362; Morello, Laura/0000-0002-8854-1770; GIANI, SILVIA/0000-0001-8740-1787	project2 "Risorse biologiche e tecnologie innovative per lo sviluppo sostenibile del sistema agroalimentare"; Accordo quadro Regione Lombardia-Consiglio Nazionale delle Ricerche 583; intramural funds (IBBA-CNR)	project2 "Risorse biologiche e tecnologie innovative per lo sviluppo sostenibile del sistema agroalimentare"; Accordo quadro Regione Lombardia-Consiglio Nazionale delle Ricerche 583; intramural funds (IBBA-CNR)	This work was supported by both project2 "Risorse biologiche e tecnologie innovative per lo sviluppo sostenibile del sistema agroalimentare", Accordo quadro Regione Lombardia-Consiglio Nazionale delle Ricerche 583 and intramural funds (IBBA-CNR) available from residuals.	Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; Alba V, 2015, MOL BIOTECHNOL, V57, P709, DOI 10.1007/s12033-015-9862-5; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; [Anonymous], 2009, VITIS; Bardini M, 2004, GENOME, V47, P281, DOI [10.1139/g03-132, 10.1139/G03-132]; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bowers JE, 1999, AM J ENOL VITICULT, V50, P243; Bowers JE, 1996, GENOME, V39, P628, DOI 10.1139/g96-080; Braglia L., 2010, Diversity, V2, P572; Braglia L, 2014, MOL BREEDING, V33, P209, DOI 10.1007/s11032-013-9945-6; Bureau SM, 2000, J AGR FOOD CHEM, V48, P1290, DOI 10.1021/jf990507x; Cantos E, 2002, J AGR FOOD CHEM, V50, P5691, DOI 10.1021/jf0204102; Casazza AP, 2012, J CEREAL SCI, V56, P733, DOI 10.1016/j.jcs.2012.08.015; Chabreyrie D, 2008, J AGR FOOD CHEM, V56, P6785, DOI 10.1021/jf800117k; Chitwood DH, 2014, PLANT PHYSIOL, V164, P259, DOI 10.1104/pp.113.229708; Cipriani G, 2010, THEOR APPL GENET, V121, P1569, DOI 10.1007/s00122-010-1411-9; Cipriani G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-127; Costa JH, 2009, PHYSIOL PLANTARUM, V137, P553, DOI 10.1111/j.1399-3054.2009.01267.x; Cunha J, 2009, GENET RESOUR CROP EV, V56, P975, DOI 10.1007/s10722-009-9416-4; Dhanorkar VM, 2005, VITIS, V44, P127; Di Vecchi Staraz M, 2007, J AM SOC HORTIC SCI, V132, P514; Losada ED, 2010, VITIS, V49, P55; Dodig D, 2010, CROP PASTURE SCI, V61, P812, DOI 10.1071/CP10001; Fan L, 2013, PLANT MOL BIOL REP, V31, P1271, DOI 10.1007/s11105-013-0586-z; Gavazzi F, 2012, ELECTROPHORESIS, V33, P2840, DOI 10.1002/elps.201200144; Ghan R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2115-y; HANSEN JM, 1978, BER DEUT BOT GES, V91, P39; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang Ke, 2011, BMC Res Notes, V4, P52, DOI 10.1186/1756-0500-4-52; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Liu XQ, 2016, MOL PHYLOGENET EVOL, V95, P217, DOI 10.1016/j.ympev.2015.10.013; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Lopez M, 2009, AM J ENOL VITICULT, V60, P215; MANTEL N, 1967, CANCER RES, V27, P209; McGovern PE, 2003, ANCIENT WINE SEARCH; Merdinoglu D, 2005, MOL BREEDING, V15, P349, DOI 10.1007/s11032-004-7651-0; Mwamahonje A, 2015, AM J RES COMMUN, V3, P10; Nasi A, 2008, FOOD CHEM, V110, P762, DOI 10.1016/j.foodchem.2008.03.001; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Peros JP, 2011, J BIOGEOGR, V38, P471, DOI 10.1111/j.1365-2699.2010.02410.x; Ponzoni E, 2013, ANAL BIOANAL CHEM, V405, P9849, DOI 10.1007/s00216-013-7434-8; Popluechai S, 2009, NATURE PRECEEDING; Ren H, 2011, TAXON, V60, P629, DOI 10.1002/tax.603001; Riviere C, 2012, NAT PROD REP, V29, P1317, DOI 10.1039/c2np20049j; Rohlf FJ, 1998, NTSYSPC NUMERICAL TA; Sefc KM, 1999, GENOME, V42, P367, DOI 10.1139/gen-42-3-367; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Tamborra P, 2010, ANAL CHIM ACTA, V660, P221, DOI 10.1016/j.aca.2009.11.014; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; THOMAS MR, 1993, THEOR APPL GENET, V86, P985, DOI 10.1007/BF00211051; Trondle D, 2010, AM J BOT, V97, P1168, DOI 10.3732/ajb.0900218; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; VERSINI G, 1991, VITIS, V30, P143; Versini G, 2003, ENOLOGIE 2003, P166; Villano C, 2014, MOL BIOTECHNOL, V56, P1011, DOI 10.1007/s12033-014-9780-y; von Baer D, 2008, ANAL CHIM ACTA, V621, P52, DOI 10.1016/j.aca.2007.11.034; Wang XS, 2005, DNA RES, V12, P417, DOI 10.1093/dnares/dsi019; Wen J., 2007, FAMILIES GENERA VASC, P466, DOI [10.1007/978-3-540-32219-1_54, DOI 10.1007/978-3-540-32219-1_54]; Zecca G, 2010, PLANT BIOLOGY, V12, P558, DOI 10.1111/j.1438-8677.2009.00226.x; Zecca G, 2012, MOL PHYLOGENET EVOL, V62, P736, DOI 10.1016/j.ympev.2011.11.015; Zhang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144701	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163335	10.1371/journal.pone.0163335	http://dx.doi.org/10.1371/journal.pone.0163335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643687	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900044
J	Menard, L; Trudeau-Fisette, P; Cote, D; Turgeon, C				Menard, Lucie; Trudeau-Fisette, Pamela; Cote, Dominique; Turgeon, Christine			Speaking Clearly for the Blind: Acoustic and Articulatory Correlates of Speaking Conditions in Sighted and Congenitally Blind Speakers	PLOS ONE			English	Article							HARD-OF-HEARING; CONVERSATIONAL SPEECH; FRENCH VOWELS; PERCEPTION; INTELLIGIBILITY; ADULTS; LISTENERS; DISCRIMINATION; IDENTIFICATION; CONTRAST	Compared to conversational speech, clear speech is produced with longer vowel duration, greater intensity, increased contrasts between vowel categories, and decreased dispersion within vowel categories. Those acoustic correlates are produced by larger movements of the orofacial articulators, including visible (lips) and invisible (tongue) articulators. Thus, clear speech provides the listener with audible and visual cues that are used to increase the overall intelligibility of speech produced by the speaker. It is unclear how those cues are produced by visually impaired speakers who never had access to vision. In this paper, we investigate the acoustic and articulatory correlates of vowels in clear versus conversational speech, and in sighted and congenitally blind speakers. Participants were recorded using electroarticulography while producing multiple repetitions of the ten Quebec French oral vowels in carrier sentences in both speaking conditions. Articulatory variables (lip, jaw, and tongue positions) as well as acoustic variables (contrasts between vowels, within-vowel dispersion, pitch, duration, and intensity) were measured. Lip movements were larger when going from conversational to clear speech in sighted speakers only. On the other hand, tongue movements were affected to a larger extent in blind speakers compared to their sighted peers. These findings confirm that vision plays an important role in the maintenance of speech intelligibility.	[Menard, Lucie; Trudeau-Fisette, Pamela; Cote, Dominique; Turgeon, Christine] Univ Quebec Montreal, Ctr Res Brain Language & Mus, Lab Phonet, Montreal, PQ, Canada	University of Quebec; University of Quebec Montreal	Menard, L (corresponding author), Univ Quebec Montreal, Ctr Res Brain Language & Mus, Lab Phonet, Montreal, PQ, Canada.	menard.lucie@uqam.ca			Social Sciences and Humanities Research Council of Canada [411779]; Natural Sciences and Engineering Research Council of Canada [279863]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by the Social Sciences and Humanities Research Council of Canada (grant number 411779) and the Natural Sciences and Engineering Research Council of Canada (grant number 279863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the Social Sciences and Humanities Research Council of Canada (Insight Grant) and a grant from the Natural Sciences and Engineering Research Council of Canada (Discovery Grant). Thanks to Marlene Busko for copyediting the paper and to Joseph Perkell for insightful comments and suggestions.	Barbier G., 2015, INTERSPEECH 2015; Bradlow AR, 2003, J SPEECH LANG HEAR R, V46, P80, DOI 10.1044/1092-4388(2003/007); Carstens Medizinelektronik, 2006, AG500 MAN; Chen Francine Robina, 1980, THESIS; Dietrich S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-74; Ferguson SH, 2002, J ACOUST SOC AM, V112, P259, DOI 10.1121/1.1482078; Ferland-Longpre V., 2013, LORS JOURN SCI CTR R; Gagne JP, 2002, SPEECH COMMUN, V37, P213, DOI 10.1016/S0167-6393(01)00012-7; Goldreich D, 2003, J NEUROSCI, V23, P3439; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Hay JF, 2006, J ACOUST SOC AM, V119, P3022, DOI 10.1121/1.2184226; Helfer KS, 1997, J AM ACAD AUDIOL, V9, P234; Hugdahl K, 2004, COGNITIVE BRAIN RES, V19, P28, DOI 10.1016/j.cogbrainres.2003.10.015; Krause J. C., 1995, J ACOUST SOC AM, V98, P2982; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; LINDBLOM B, 1990, NATO ADV SCI I D-BEH, V55, P403; Liu S, 2004, J ACOUST SOC AM, V116, P2374, DOI 10.1121/1.1787528; LUCAS SA, 1984, INT J REHABIL RES, V7, P74, DOI 10.1097/00004356-198403000-00016; Menard L, 2007, J ACOUST SOC AM, V121, P3790, DOI 10.1121/1.2710963; Menard L, 2014, J SPEECH LANG HEAR R, V57, P793, DOI 10.1044/2014_JSLHR-S-12-0395; Menard L, 2013, J ACOUST SOC AM, V134, P2975, DOI 10.1121/1.4818740; Menard L, 2009, J ACOUST SOC AM, V126, P1406, DOI 10.1121/1.3158930; Moon S-J, 1991, ACOUSTIC PERCEPTUAL, P153; MOON SJ, 1994, J ACOUST SOC AM, V96, P40, DOI 10.1121/1.410492; Ozdemir RA, 2013, GAIT POSTURE, V38, P603, DOI 10.1016/j.gaitpost.2013.02.003; PAYTON KL, 1994, J ACOUST SOC AM, V95, P1581, DOI 10.1121/1.408545; Perkell JS, 2000, J PHONETICS, V28, P233, DOI 10.1006/jpho.2000.0116; Perkell JS, 2002, J ACOUST SOC AM, V112, P1627, DOI 10.1121/1.1506369; PICHENY MA, 1985, J SPEECH HEAR RES, V28, P96, DOI 10.1044/jshr.2801.96; PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; PICKETT JM, 1956, J ACOUST SOC AM, V28, P902, DOI 10.1121/1.1908510; Schum D J, 1996, J Am Acad Audiol, V7, P212; SCHWARTZ JL, 1993, J PHONETICS, V21, P411, DOI 10.1016/S0095-4470(19)30228-1; Smiljanic R, 2005, J ACOUST SOC AM, V118, P1677, DOI 10.1121/1.2000788; Tasko SM, 2004, J SPEECH HEAR RES, V53, P84; Torre P, 2009, J COMMUN DISORD, V42, P324, DOI 10.1016/j.jcomdis.2009.03.001; Uchanski RM, 1996, J SPEECH HEAR RES, V39, P494, DOI 10.1044/jshr.3903.494; Uchanski RM, 2005, BLACKW HBK LINGUIST, P207, DOI 10.1002/9780470757024.ch9; Vick JC, 2001, J SPEECH LANG HEAR R, V44, P1257, DOI 10.1044/1092-4388(2001/098); Westbury J. R., 1994, XRAY MICROBEAM SPEEC	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0160088	10.1371/journal.pone.0160088	http://dx.doi.org/10.1371/journal.pone.0160088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27643997	gold, Green Submitted, Green Published			2022-12-26	WOS:000383891900002
J	Goel, P; Bhuria, M; Kaushal, M; Singh, AK				Goel, Parul; Bhuria, Monika; Kaushal, Mamta; Singh, Anil Kumar			Carbon: Nitrogen Interaction Regulates Expression of Genes Involved in N-Uptake and Assimilation in Brassica juncea L.	PLOS ONE			English	Article							AFFINITY NITRATE TRANSPORTER; LATERAL ROOT INITIATION; ARABIDOPSIS-THALIANA; GLUTAMINE-SYNTHETASE; MICROARRAY ANALYSIS; NUTRIENT RESPONSE; ION TRANSPORTERS; GENOMIC ANALYSIS; ELEVATED CO2; C-STATUS	In plants, several cellular and metabolic pathways interact with each other to regulate processes that are vital for their growth and development. Carbon (C) and Nitrogen (N) are two main nutrients for plants and coordination of C and N pathways is an important factor for maintaining plant growth and development. In the present work, influence of nitrogen and sucrose (C source) on growth parameters and expression of genes involved in nitrogen transport and assimilatory pathways was studied in B. juncea seedlings. For this, B. juncea seedlings were treated with four combinations of C and N source viz., N source alone (-Suc +N), C source alone (+Suc-N), with N and C source (+Suc+N) or without N and C source (-Suc-N). Cotyledon size and shoot length were found to be increased in seedlings, when nitrogen alone was present in the medium. Distinct expression pattern of genes in both, root and shoot tissues was observed in response to exogenously supplied N and C. The presence or depletion of nitrogen alone in the medium leads to severe up-or down-regulation of key genes involved in N-uptake and transport (BjNRT1.1, BjNRT1.8) in root tissue and genes involved in nitrate reduction (BjNR1 and BjNR2) in shoot tissue. Moreover, expression of several genes, like BjAMT1.2, BjAMT2 and BjPK in root and two genes BjAMT2 and BjGS1.1 in shoot were found to be regulated only when C source was present in the medium. Majority of genes were found to respond in root and shoot tissues, when both C and N source were present in the medium, thus reflecting their importance as a signal in regulating expression of genes involved in N-uptake and assimilation. The present work provides insight into the regulation of genes of N-uptake and assimilatory pathway in B. juncea by interaction of both carbon and nitrogen.	[Goel, Parul; Bhuria, Monika; Kaushal, Mamta; Singh, Anil Kumar] Inst Himalayan Bioresource Technol, CSIR, Palampur 176061, Himachal Prades, India; [Goel, Parul; Bhuria, Monika; Singh, Anil Kumar] Acad Sci & Innovat Res, New Delhi, India; [Singh, Anil Kumar] ICAR Indian Inst Agr Biotechnol, IINRG, PDU Campus, Namkum 834010, Ranchi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Academy of Scientific & Innovative Research (AcSIR); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Agricultural Biotechnology; ICAR - Indian Institute of Natural Resins & Gums	Singh, AK (corresponding author), Inst Himalayan Bioresource Technol, CSIR, Palampur 176061, Himachal Prades, India.; Singh, AK (corresponding author), Acad Sci & Innovat Res, New Delhi, India.; Singh, AK (corresponding author), ICAR Indian Inst Agr Biotechnol, IINRG, PDU Campus, Namkum 834010, Ranchi, India.	anils13@gmail.com		Bhuria, Monika/0000-0003-4254-6805; Singh, Anil/0000-0002-3569-5207	Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Authors thank Director CSIR-Institute of Himalayan Bioresource Technology, Palampur for constant support and encouragement. Authors thank Prof. Deepak Pental, Department of Genetics, Delhi University South Campus, New Delhi, India for providing seeds of B. juncea cv. Varuna. PG and MB acknowledge Council of Scientific and Industrial Research, New Delhi for providing Junior and Senior Research Fellowship. This manuscript represents CSIR-IHBT communication number 4055A.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Ahmad T, 2007, PAK J BOT, V39, P1269; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bi YM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-281; Bloom AJ, 2002, J PLANT GROWTH REGUL, V21, P416, DOI 10.1007/s00344-003-0009-8; Camanes G, 2007, J EXP BOT, V58, P2811, DOI 10.1093/jxb/erm135; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; CHENG CL, 1992, P NATL ACAD SCI USA, V89, P1861, DOI 10.1073/pnas.89.5.1861; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; de Jong F, 2014, PLANT PHYSIOL, V164, P308, DOI 10.1104/pp.113.230599; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Foyer CH, 2011, J EXP BOT, V62, P1467, DOI 10.1093/jxb/erq453; Freixes S, 2002, PLANT CELL ENVIRON, V25, P1357, DOI 10.1046/j.1365-3040.2002.00912.x; Gao P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001387; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Girin T, 2007, PLANT CELL ENVIRON, V30, P1366, DOI 10.1111/j.1365-3040.2007.01712.x; Goel P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143645; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Jorgensen I, 1916, NEW PHYTOL, V15, P176; Kang JM, 2003, P NATL ACAD SCI USA, V100, P6872, DOI 10.1073/pnas.1030961100; Krapp A, 2011, PLANT PHYSIOL, V157, P1255, DOI 10.1104/pp.111.179838; Kusano M, 2011, J EXP BOT, V62, P1439, DOI 10.1093/jxb/erq417; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Lejay L, 1999, PLANT J, V18, P509, DOI 10.1046/j.1365-313X.1999.00480.x; Lejay L, 2003, PLANT CELL, V15, P2218, DOI 10.1105/tpc.013516; Lejay L, 2008, PLANT PHYSIOL, V146, P2036, DOI 10.1104/pp.107.114710; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloret F, 1999, FUNCT ECOL, V13, P210, DOI 10.1046/j.1365-2435.1999.00309.x; Lopes MS, 2008, PHYSIOL PLANTARUM, V134, P134, DOI 10.1111/j.1399-3054.2008.01114.x; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; MANCINELLI AL, 1988, PLANT PHYSIOL, V86, P652, DOI 10.1104/pp.86.3.652; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Matt P, 2002, PLANT J, V30, P663, DOI 10.1046/j.1365-313X.2002.01323.x; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Miller AJ, 2008, J EXP BOT, V59, P111, DOI 10.1093/jxb/erm208; Mokhele B, 2012, CAN J PLANT SCI, V92, P399, DOI [10.4141/CJPS2011-135, 10.4141/cjps2011-135]; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Ourry A, 2001, PLANT NITROGEN, P255; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Patterson K, 2010, PLANT CELL ENVIRON, V33, P1486, DOI 10.1111/j.1365-3040.2010.02158.x; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; RAAB TK, 1994, PLANT PHYSIOL, V105, P1159, DOI 10.1104/pp.105.4.1159; Rabha BK, 1998, PHOTOSYNTHETICA, V35, P597, DOI 10.1023/A:1006991210089; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; Rawat SR, 1999, PLANT J, V19, P143, DOI 10.1046/j.1365-313X.1999.00505.x; Roycewicz P, 2012, PHILOS T R SOC B, V367, P1489, DOI 10.1098/rstb.2011.0230; Scheible WR, 1997, PLANT J, V11, P671, DOI 10.1046/j.1365-313X.1997.11040671.x; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Sehtiya HL, 2000, PLANT SOIL, V227, P185, DOI 10.1023/A:1026503700825; Seth CS, 2014, J PLANT RES, V127, P793, DOI 10.1007/s10265-014-0664-9; Shangguan ZP, 2004, BOT BULL ACAD SINICA, V45, P49; Signora L, 2001, PLANT J, V28, P655, DOI 10.1046/j.1365-313x.2001.01185.x; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Stitt M, 2002, J EXP BOT, V53, P959, DOI 10.1093/jexbot/53.370.959; Sun WF, 2013, J PLANT GROWTH REGUL, V32, P575, DOI 10.1007/s00344-013-9324-x; Thompson MR., 1987, CELL TISSUE CULTURE, P89, DOI [DOI 10.1007/978-94-017-0994-1_6, 10.1007/978-94-017-0994-1_6]; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Uprety DC, 2000, J AGRON CROP SCI, V184, P271, DOI 10.1046/j.1439-037x.2000.00392.x; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wind J, 2010, PHYTOCHEMISTRY, V71, P1610, DOI 10.1016/j.phytochem.2010.07.007; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540; Zhou SY, 2009, Z NATURFORSCH C, V64, P697; Zhu GH, 2006, J INTEGR PLANT BIOL, V48, P1177, DOI 10.1111/j.1744-7909.2006.00332.x	77	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163061	10.1371/journal.pone.0163061	http://dx.doi.org/10.1371/journal.pone.0163061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637072	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700030
J	Inic-Kanada, A; Stojanovic, M; Marinkovic, E; Becker, E; Stein, E; Lukic, I; Djokic, R; Schuerer, N; Hegemann, JH; Barisani-Asenbauer, T				Inic-Kanada, Aleksandra; Stojanovic, Marijana; Marinkovic, Emilija; Becker, Elisabeth; Stein, Elisabeth; Lukic, Ivana; Djokic, Radmila; Schuerer, Nadine; Hegemann, Johannes H.; Barisani-Asenbauer, Talin			A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C	PLOS ONE			English	Article							REGULATORY T-CELLS; TRACHOMATIS INFECTION; PROTECTIVE IMMUNITY; GENITAL-TRACT; VACCINE; ADHESION; DELIVERY; FAMILY; IGG	Recent advances in the development of chlamydia vaccines, using live-attenuated or ultraviolet light-inactivated chlamydia, are paving the way for new possibilities to oppose the societal challenges posed by chlamydia-related diseases, such as blinding trachoma. An effective subunit vaccine would mitigate the risks associated with the use of a whole-cell vaccine. Our rationale for the design of an efficient subunit vaccine against Chlamydia trachomatis (Ct) is based on the membrane proteins involved in the initial Ct-host cell contact and on the route of immunization that mimics the natural infection process (i.e., via the ocular mucosa). The first aim of our study was to characterize the specific conjunctival and vaginal immune responses following eye drop immunization in BALB/c mice, using the N-terminal portion of the Ct serovar E polymorphic membrane protein C (N-PmpC) as the subunit vaccine antigen. Second, we aimed to examine the adjuvant properties of the probiotic Lactobacillus rhamnosus (LB) when formulated with N-PmpC. N-PmpC applied alone stimulated the production of N-PmpC-and Ct serovar B-specific antibodies in serum, tears and vaginal washes, whereas the combination with LB significantly enhanced these responses. The N-PmpC/LB combination initiated a T cell response characterized by an elevated percentage of CD25+ T cells and CD8+ effector T cells, enhanced CD4+ T-helper 1 skewing, and increased regulatory T cell responses. Together, these results show that eye drop vaccination with combined use of N-PmpC and a live probiotic LB stimulates specific cellular and humoral immune responses, not only locally in the conjunctiva but also in the vaginal mucosa, which could be a promising approach in Ct vaccine development.	[Inic-Kanada, Aleksandra; Stein, Elisabeth; Schuerer, Nadine; Barisani-Asenbauer, Talin] Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Stojanovic, Marijana; Marinkovic, Emilija; Lukic, Ivana; Djokic, Radmila] Inst Virol Vaccines & Sera TORLAK, Dept Res & Dev, Belgrade, Serbia; [Becker, Elisabeth; Hegemann, Johannes H.] Heinrich Heine Univ Dusseldorf, Inst Funkt Genomforsch Mikroorganismen, Univ Str 1,Gebaude 25-02-U1, D-40225 Dusseldorf, Germany	Medical University of Vienna; Heinrich Heine University Dusseldorf	Barisani-Asenbauer, T (corresponding author), Med Univ Vienna, OCUVAC Ctr Ocular Inflammat & Infect, Laura Bassi Ctr Expertise, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	talin.barisani@meduniwien.ac.at		Stojanovic, Marijana/0000-0002-8204-4183; Stein, Elisabeth/0000-0002-1240-506X; Barisani-Asenbauer, Talin/0000-0002-8661-9183; Lukic, Ivana/0000-0002-6330-471X; Schuerer, Nadine/0000-0002-5894-2784; Inic-Kanada, Aleksandra/0000-0001-7854-3812	"Laura Bassi Centers of Expertise" program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project) [822768]; Ministry of Education, Science, and Technological Development of the Republic of Serbia [172049]	"Laura Bassi Centers of Expertise" program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project); Ministry of Education, Science, and Technological Development of the Republic of Serbia	This research was funded by the "Laura Bassi Centers of Expertise" program of the Austrian Federal Ministry of Economy through the Austrian Research Promotion Agency (FFG project number 822768) (https://www.ffg.at/en), and by the Ministry of Education, Science, and Technological Development of the Republic of Serbia (grant number 172049) (http://www.mpn.gov.rs/).	BAILEY RL, 1993, EPIDEMIOL INFECT, V111, P315, DOI 10.1017/S0950268800057022; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Boje S, 2015, IMMUNOL CELL BIOL; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Brunham RC, 2013, VACCINE, V31, P1892, DOI 10.1016/j.vaccine.2013.01.024; Cochrane M, 2010, FUTURE MICROBIOL, V5, P1833, DOI [10.2217/fmb.10.148, 10.2217/FMB.10.148]; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Dasgupta G, 2011, INVEST OPHTH VIS SCI, V52, P3321, DOI 10.1167/iovs.10-6522; GILL HS, 2001, THE BRITISH JOURNAL, V86, P285; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Gray RT, 2009, J INFECT DIS, V199, P1680, DOI 10.1086/598983; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Inic-Kanada A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144380; Iovieno A, 2008, GRAEF ARCH CLIN EXP, V246, P435, DOI 10.1007/s00417-007-0682-6; Johansson M, 1997, INFECT IMMUN, V65, P1032, DOI 10.1128/IAI.65.3.1032-1044.1997; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Licciardi PV, 2011, DISCOV MED, V12, P525; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Nesburn AB, 2005, VACCINE, V23, P873, DOI 10.1016/j.vaccine.2004.08.019; Norman J, 2002, BEST PRACT RES CL OB, V16, P775, DOI 10.1053/beog.2002.0325; Perry LL, 1999, J IMMUNOL, V162, P3541; Rockey DD, 2000, INFECT IMMUN, V68, P5473, DOI 10.1128/IAI.68.10.5473-5479.2000; Rosenthal K L, 1997, Semin Immunol, V9, P303; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; SCHACHTER J, 1980, ANNU REV MICROBIOL, V34, P285, DOI 10.1146/annurev.mi.34.100180.001441; SCHACHTER J, 1985, REV INFECT DIS, V7, P713; Schautteet Katelijn, 2011, Infect Dis Obstet Gynecol, V2011, P963513, DOI 10.1155/2011/963513; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wizel B, 2008, MICROBES INFECT, V10, P1420, DOI 10.1016/j.micinf.2008.08.006	38	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0157875	10.1371/journal.pone.0157875	http://dx.doi.org/10.1371/journal.pone.0157875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636704	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700001
J	Morel, M; Vanderstraete, M; Cailliau, K; Hahnel, S; Grevelding, CG; Dissous, C				Morel, Marion; Vanderstraete, Mathieu; Cailliau, Katia; Hahnel, Steffen; Grevelding, Christoph G.; Dissous, Colette			SmShb, the SH2-Containing Adaptor Protein B of Schistosoma mansoni Regulates Venus Kinase Receptor Signaling Pathways	PLOS ONE			English	Article							TYROSINE KINASE; GROWTH-FACTOR; SHB; DOMAIN; PRAZIQUANTEL; DIFFERENTIATION; REPRODUCTION; REQUIRES; INSULIN; FAMILY	Venus kinase receptors (VKRs) are invertebrate receptor tyrosine kinases (RTKs) formed by an extracellular Venus Fly Trap (VFT) ligand binding domain associated via a transmembrane domain with an intracellular tyrosine kinase (TK) domain. Schistosoma mansoni VKRs, SmVKR1 and SmVKR2, are both implicated in reproductive activities of the parasite. In this work, we show that the SH2 domain-containing protein SmShb is a partner of the phosphorylated formof SmVKR1. Expression of these proteins in Xenopus oocytes allowed us to demonstrate that the SH2 domain of SmShb interacts with the phosphotyrosine residue (pY979) located in the juxtamembrane region of SmVKR1. This interaction leads to phosphorylation of SmShb on tyrosines and promotes SmVKR1 signaling towards the JNK pathway. SmShb transcripts are expressed in all parasite stages and they were found in ovary and testes of adult worms, suggesting a possible colocalization of SmShb and SmVKR1 proteins. Silencing of SmShb in adult S. mansoni resulted in an accumulation of mature spermin testes, indicating a possible role of SmShb in gametogenesis.	[Morel, Marion; Vanderstraete, Mathieu; Dissous, Colette] Univ Lille, CHU Lille, INSERM,U1019,UMR 8204,CIIL, CNRS,Inst Pasteur Lille,Ctr Infect & Immun Lille, Lille, France; [Cailliau, Katia] Univ Lille, CNRS, UMR 8576, UGSF, Lille, France; [Hahnel, Steffen; Grevelding, Christoph G.] Justus Liebig Univ, Inst Parasitol, BFS, Giessen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Justus Liebig University Giessen	Dissous, C (corresponding author), Univ Lille, CHU Lille, INSERM,U1019,UMR 8204,CIIL, CNRS,Inst Pasteur Lille,Ctr Infect & Immun Lille, Lille, France.	colette.dissous@pasteur-lille.fr	Morel, Marion/X-4104-2019	Cailliau, Katia/0000-0001-7993-8437; Morel, Marion/0000-0002-1439-5360; cailliau, katia/0000-0003-1772-1034	CNRS; INSERM; Universita Lille Nord de France; Ministere de l'Education Nationale et de la Recherche; Fondation pour La Recherche Medicale, France (FRM) [FDT20150532257]; Deutsche Forschungsgemeinschaft [GR1549/7-2]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universita Lille Nord de France; Ministere de l'Education Nationale et de la Recherche; Fondation pour La Recherche Medicale, France (FRM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by CNRS, INSERM and Universita Lille Nord de France. M.M. fellowships were from the Ministere de l'Education Nationale et de la Recherche and from the Fondation pour La Recherche Medicale, France (FRM No FDT20150532257). This work was supported by the Deutsche Forschungsgemeinschaft, grant GR1549/7-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; Akerblom B, 2009, J ENDOCRINOL, V203, P271, DOI 10.1677/JOE-09-0198; Anneren C, 2003, CURR MOL MED, V3, P313, DOI 10.2174/1566524033479744; Beckmann S, 2010, PARASITOLOGY, V137, P497, DOI 10.1017/S0031182010000053; Calounova G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011155; Cross MJ, 2002, MOL BIOL CELL, V13, P2881, DOI 10.1091/mbc.E02-02-0103; Dissous C, 2007, BIOESSAYS, V29, P1281, DOI 10.1002/bies.20662; Dissous C, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00118; Dissous C, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00072; Doenhoff Michael J, 2006, Expert Rev Anti Infect Ther, V4, P199, DOI 10.1586/14787210.4.2.199; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Funa NS, 2008, DIFFERENTIATION, V76, P443, DOI 10.1111/j.1432-0436.2007.00249.x; Gelmedin V, 2015, FUTURE MED CHEM, V7, P737, DOI [10.4155/FMC.15.31, 10.4155/fmc.15.31]; Gouignard N, 2012, EXP PARASITOL, V132, P32, DOI 10.1016/j.exppara.2011.05.007; Gustafsson K, 2014, IMMUNOLOGY, V143, P33, DOI 10.1111/imm.12286; Gustafsson K, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-3; Hagerkvist R, 2007, EXP CELL RES, V313, P284, DOI 10.1016/j.yexcr.2006.10.011; Hahnel S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00170; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; KARLSSON T, 1995, ONCOGENE, V10, P1475; Krautz-Peterson G, 2010, PARASITOLOGY, V137, P485, DOI 10.1017/S0031182009991168; Kriz V, 2006, J BIOL CHEM, V281, P34484, DOI 10.1074/jbc.M604084200; Lindholm CK, 2000, BIOCHEM BIOPH RES CO, V278, P537, DOI 10.1006/bbrc.2000.3847; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LG, 2000, EXP CELL RES, V259, P370, DOI 10.1006/excr.2000.4984; Machado-Silva JR, 1998, MEM I OSWALDO CRUZ, V93, P303, DOI 10.1590/S0074-02761998000700060; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Morel M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00238; Neves R, 2005, PARASITOL RES, V95, P43, DOI 10.1007/s00436-004-1241-2; Oda T, 1997, ONCOGENE, V15, P1255, DOI 10.1038/sj.onc.1201299; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pica-Mattoccia L, 2009, ACTA TROP, V111, P82, DOI 10.1016/j.actatropica.2009.01.012; Quack T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006998; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vanderstraete M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004138; Vanderstraete M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-361; Vanderstraete M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002226; Vicogne J, 2004, J BIOL CHEM, V279, P37407, DOI 10.1074/jbc.M313738200; Vicogne J, 2003, MOL BIOCHEM PARASIT, V126, P51, DOI 10.1016/S0166-6851(02)00249-9; Vogel KJ, 2015, P NATL ACAD SCI USA, V112, P5057, DOI 10.1073/pnas.1501814112; WELSH M, 1994, ONCOGENE, V9, P19; Welsh M, 1998, ONCOGENE, V16, P891, DOI 10.1038/sj.onc.1201607; Welsh M, 2016, J MOL ENDOCRINOL, V56, pR21, DOI 10.1530/JME-15-0228	45	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163283	10.1371/journal.pone.0163283	http://dx.doi.org/10.1371/journal.pone.0163283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636711	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700046
J	Aoki, H; Ogino, H; Tomita, H; Hara, A; Kunisada, T				Aoki, Hitomi; Ogino, Hajime; Tomita, Hiroyuki; Hara, Akira; Kunisada, Takahiro			Disruption of Rest Leads to the Early Onset of Cataracts with the Aberrant Terminal Differentiation of Lens Fiber Cells	PLOS ONE			English	Article							MELANOCYTE STEM-CELLS; CONGENITAL CATARACTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; TARGET GENES; MOLECULAR-GENETICS; DOWN-SYNDROME; IN-VIVO; REPRESSOR; NEUROGENESIS	REST (RE1-silencing transcription factor, also called Nrsf) is involved in the maintenance of the undifferentiated state of neuronal stem/progenitor cells in vitro by preventing precocious expression of neuronal genes. REST expression was then decreased in developing neurons to down-regulate neuronal genes which allow their maturation. However, the function of REST during neurogenesis in vivo remains to be elucidated because of the early embryonic lethal phenotype of conventional Rest knockout mice. In order to investigate the role of REST in ocular tissues, we generated and examined the mice evoking genetic ablation to Rest specifically to neural tissues including ocular tissue. We used a Sox1-Cre allele to excise the floxed Rest gene in the early neural tissues including the lens and retinal primordia. The resulting Rest conditional knockout (CKO) and co cntrol mice were used in comparative morphological, histological, and gene expression analyses. Rest CKO mice had an abnormal lens morphology after birth. The proliferation of lens epithelial cells was likely to be slightly reduced, and vacuoles formed without a visible increase in apoptotic cells. Although the aberrant expression of late onset cataract marker proteins was not detected, the expression of Notch signaling-related genes including a previously identified REST-target gene was up-regulated around birth, and this was followed by the down-regulated expression of lens fiber regulators such as c-Maf and Prox1. Rest CKO induces a unique cataract phenotype just after birth. Augmented Notch signaling and the down-regulated expression of lens fiber regulator genes may be responsible for this phenotype. Our results highlight the significance of REST function in lens fiber formation, which is necessary for maintaining an intact lens structure.	[Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Dept Tissue & Organ Dev, Grad Sch Med, Gifu, Japan; [Ogino, Hajime] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Japan; [Tomita, Hiroyuki; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan	Gifu University; Gifu University	Kunisada, T (corresponding author), Gifu Univ, Dept Tissue & Organ Dev, Grad Sch Med, Gifu, Japan.	tkunisad@gifu-u.ac.jp	Ogino, Hajime/G-5279-2019; Tomita, Hiroyuki/L-5571-2019	Ogino, Hajime/0000-0003-2707-2330; Tomita, Hiroyuki/0000-0002-3291-0274	Japan Science and Technology Agency; JSPS	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by a grant from the Japan Science and Technology Agency and by Grants-in-Aid for Scientific Research by the JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2005, FEBS LETT, V579, P6199, DOI 10.1016/j.febslet.2005.09.093; Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Aoki H, 2014, GENES CELLS, V19, P723, DOI 10.1111/gtc.12172; Aoki H, 2013, J INVEST DERMATOL, V133, P2143, DOI 10.1038/jid.2013.155; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Aoki H, 2011, J INVEST DERMATOL, V131, P1906, DOI 10.1038/jid.2011.148; Audette DS, 2016, DEVELOPMENT, V143, P318, DOI 10.1242/dev.127860; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Berry V, 2011, MOL VIS, V17, P1249; Bitel CL, 2010, MOL VIS, V16, P2301; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Deng H, 2014, EUR J MED GENET, V57, P113, DOI 10.1016/j.ejmg.2013.12.006; Duncan MK, 2002, MECH DEVELOP, V112, P195, DOI 10.1016/S0925-4773(01)00645-1; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Frederikse PH, 2012, DEV BIOL, V368, P255, DOI 10.1016/j.ydbio.2012.05.022; Gillespie RL, 2015, INVEST OPHTH VIS SCI, V56, P883, DOI 10.1167/iovs.14-15861; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kawauchi S, 1999, J BIOL CHEM, V274, P19254, DOI 10.1074/jbc.274.27.19254; Kohyama J, 2010, J CELL BIOL, V189, P159, DOI 10.1083/jcb.200908048; Kok FO, 2012, DEVELOPMENT, V139, P3838, DOI 10.1242/dev.080994; Korsakova N V, 2008, Neurosci Behav Physiol, V38, P887, DOI 10.1007/s11055-008-9066-6; Le TT, 2012, DEV DYNAM, V241, P493, DOI 10.1002/dvdy.23739; Lepagnol-Bestel AM, 2009, HUM MOL GENET, V18, P1405, DOI 10.1093/hmg/ddp047; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Merath K, 2013, INVEST OPHTH VIS SCI, V54, P6646, DOI 10.1167/iovs.13-12283; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Ogino H, 2000, DEV GROWTH DIFFER, V42, P437; Ogino H, 1998, SCIENCE, V280, P115, DOI 10.1126/science.280.5360.115; Ogino H, 2008, DEVELOPMENT, V135, P249, DOI 10.1242/dev.009548; Ogino H, 2012, DEV BIOL, V363, P333, DOI 10.1016/j.ydbio.2012.01.006; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Riesenberg AN, 2009, J NEUROSCI, V29, P12865, DOI 10.1523/JNEUROSCI.3382-09.2009; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Takeuchi T, 2009, GENES CELLS, V14, P941, DOI 10.1111/j.1365-2443.2009.01321.x; Uusitalo M, 1997, GRAEF ARCH CLIN EXP, V235, P506, DOI 10.1007/BF00947008; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	52	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163042	10.1371/journal.pone.0163042	http://dx.doi.org/10.1371/journal.pone.0163042			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631609	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900122
J	de Munck, E; Palomo, V; Munoz-Saez, E; Perez, DI; Gomez-Miguel, B; Solas, MT; Gil, C; Martinez, A; Arahuetes, RM				de Munck, Estefania; Palomo, Valle; Munoz-Saez, Emma; Perez, Daniel I.; Gomez-Miguel, Begona; Teresa Solas, M.; Gil, Carmen; Martinez, Ana; Arahuetes, Rosa M.			Small GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating Autophagy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SYNTHASE KINASE 3; METHYLAMINO-L-ALANINE; ALZHEIMERS-DISEASE; SPINAL-CORD; NEURODEGENERATIVE DISEASES; BMAA NEUROTOXICITY; TRANSGENIC MICE; PROTEIN-KINASE; MOUSE MODEL	Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron degenerative disease that has no effective treatment up to date. Drug discovery tasks have been hampered due to the lack of knowledge in its molecular etiology together with the limited animal models for research. Recently, a motor neuron disease animal model has been developed using beta-N-methylamino-L-alanine (L-BMAA), a neurotoxic amino acid related to the appearing of ALS. In the present work, the neuroprotective role of VP2.51, a small heterocyclic GSK-3 inhibitor, is analysed in this novel murine model together with the analysis of autophagy. VP2.51 daily administration for two weeks, starting the first day after L-BMAA treatment, leads to total recovery of neurological symptoms and prevents the activation of autophagic processes in rats. These results show that the L-BMAAmurine model can be used to test the efficacy of new drugs. In addition, the results confirm the therapeutic potential of GSK-3 inhibitors, and specially VP2.51, for the disease-modifying future treatment of motor neuron disorders like ALS.	[de Munck, Estefania; Arahuetes, Rosa M.] Univ Complutense Madrid, Dept Biol Anim 2, Ciudad Univ, Madrid, Spain; [Palomo, Valle; Perez, Daniel I.; Gil, Carmen; Martinez, Ana] CSIC, Ctr Invest Biol, Ramiro de Maetzu 9, Madrid, Spain; [Munoz-Saez, Emma; Gomez-Miguel, Begona] Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Ciudad Univ, Madrid, Spain; [Teresa Solas, M.] Univ Complutense Madrid, Dept Biol Celular, Ciudad Univ, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Complutense University of Madrid	Arahuetes, RM (corresponding author), Univ Complutense Madrid, Dept Biol Anim 2, Ciudad Univ, Madrid, Spain.; Martinez, A (corresponding author), CSIC, Ctr Invest Biol, Ramiro de Maetzu 9, Madrid, Spain.	ana.martinez@csic.es; rportero@bio.ucm.es	Martinez, Ana/L-6414-2014; Gil, Carmen/J-8932-2014; Muñoz-Sáez, Emma EMS/F-4937-2016; del Valle Palomo Ruiz, María/N-2932-2016; de Munck Garcia, Estefania/C-8910-2015; Perez, Daniel I./L-6245-2014	Martinez, Ana/0000-0002-2707-8110; Gil, Carmen/0000-0002-3882-6081; Muñoz-Sáez, Emma EMS/0000-0003-3654-0343; del Valle Palomo Ruiz, María/0000-0002-1473-4086; de Munck Garcia, Estefania/0000-0001-6073-5242; Perez, Daniel I./0000-0003-1774-4471	MINECO [SAF2012-37979-C03-01]; FUNDELA (Spanish Amyotrophic Lateral Sclerosis Foundation); Association Francaise contre les Myopathies [AFM-16169]	MINECO(Spanish Government); FUNDELA (Spanish Amyotrophic Lateral Sclerosis Foundation); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The authors wish to express their gratitude for the expert technical assistance provided by the Animal Facilities of the Biological Science School of Complutense University of Madrid. This work was supported by MINECO (grant no. SAF2012-37979-C03-01), FUNDELA (Spanish Amyotrophic Lateral Sclerosis Foundation) and Association Francaise contre les Myopathies (AFM-16169).	Agostini M, 2011, BIOCHEM BIOPH RES CO, V414, P451, DOI 10.1016/j.bbrc.2011.09.081; Ahn SW, 2014, J NEUROL SCI, V340, P112, DOI 10.1016/j.jns.2014.03.008; Ahn SW, 2012, J NEUROL SCI, V320, P1, DOI 10.1016/j.jns.2012.05.038; ALLEY MC, 1988, CANCER RES, V48, P589; [Anonymous], 2013, ADV BIOSCI BIOTECHNO, DOI DOI 10.4236/ABB.2013.45083; Baki A, 2007, ASSAY DRUG DEV TECHN, V5, P75, DOI 10.1089/adt.2006.029; Banack SA, 2010, TOXINS, V2, P2837, DOI 10.3390/toxins2122837; Beurel E, 2013, J IMMUNOL, V190, P5000, DOI 10.4049/jimmunol.1203057; Bucchia M, 2015, CLIN THER, V37, P668, DOI 10.1016/j.clinthera.2014.12.020; Chen S, 2012, BRAIN PATHOL, V22, P110, DOI 10.1111/j.1750-3639.2011.00546.x; Crippa V, 2010, AUTOPHAGY, V6, P958, DOI 10.4161/auto.6.7.13042; de Munck E, 2015, ENVIRON TOXICOL PHAR, V39, P1232, DOI 10.1016/j.etap.2015.04.022; de Munck E, 2013, ENVIRON TOXICOL PHAR, V36, P243, DOI 10.1016/j.etap.2013.04.007; Di L, 2003, EUR J MED CHEM, V38, P223, DOI 10.1016/S0223-5234(03)00012-6; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Emde A, 2015, EMBO J, V34, P2633, DOI 10.15252/embj.201490493; Ferrucci M, 2011, ARCH ITAL BIOL, V149, P121, DOI 10.4449/aib.v149i1.1258; Gladman M, 2014, AMYOTROPH LAT SCL FR, V15, P426, DOI 10.3109/21678421.2014.932382; Hellwig C T, 2011, Curr Mol Med, V11, P31; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA110, DOI 10.1289/ehp.120-a110; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Jennum P, 2013, J NEUROL, V260, P785, DOI 10.1007/s00415-012-6706-0; Karamyan VT, 2008, LIFE SCI, V82, P233, DOI 10.1016/j.lfs.2007.11.020; King MK, 2014, PHARMACOL THERAPEUT, V141, P1, DOI 10.1016/j.pharmthera.2013.07.010; Kiriyama Y, 2015, INT J MOL SCI, V16, P26797, DOI 10.3390/ijms161125990; Koh SH, 2007, EXP NEUROL, V205, P336, DOI 10.1016/j.expneurol.2007.03.004; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Martinez A, 2013, CURR TOP MED CHEM, V13, P1808, DOI 10.2174/15680266113139990138; Morales-Garcia JA, 2012, ACS CHEM NEUROSCI, V3, P963, DOI 10.1021/cn300110c; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; Moujalled D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067433; Munoz-Saez E, 2015, NEUROTOXICOLOGY, V48, P192, DOI 10.1016/j.neuro.2015.04.001; Nassif M, 2011, AUTOPHAGY, V7, P450, DOI 10.4161/auto.7.4.14700; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; Paez-Colasante X, 2015, NAT REV NEUROL, V11, P266, DOI 10.1038/nrneurol.2015.57; Palomo V, 2011, CURR MED CHEM, V18, P3028, DOI 10.2174/092986711796391697; Palomo V, 2012, J MED CHEM, V55, P1645, DOI 10.1021/jm201463v; Palomo V, 2011, J MED CHEM, V54, P8461, DOI 10.1021/jm200996g; Perez DI, 2011, J MED CHEM, V54, P4042, DOI 10.1021/jm1016279; Rosenfeld J, 2015, NEUROTHERAPEUTICS, V12, P317, DOI 10.1007/s13311-014-0332-8; Salado IG, 2014, J MED CHEM, V57, P2755, DOI 10.1021/jm500065f; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Scotter EL, 2015, NEUROTHERAPEUTICS, V12, P352, DOI 10.1007/s13311-015-0338-x; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Tasker RA, 2010, EPMA J, V1, P217, DOI 10.1007/s13167-010-0019-0; Yang WC, 2008, BRAIN RES, V1196, P131, DOI 10.1016/j.brainres.2007.12.031; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Zhang X, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/765143	52	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162723	10.1371/journal.pone.0162723	http://dx.doi.org/10.1371/journal.pone.0162723			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631495	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000383706900071
J	Eastwood, SV; Mathur, R; Atkinson, M; Brophy, S; Sudlow, C; Flaig, R; de Lusignan, S; Allen, N; Chaturvedi, N				Eastwood, Sophie V.; Mathur, Rohini; Atkinson, Mark; Brophy, Sinead; Sudlow, Cathie; Flaig, Robin; de Lusignan, Simon; Allen, Naomi; Chaturvedi, Nishi			Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank	PLOS ONE			English	Article							PRIMARY-CARE; SELF-REPORTS; MISCLASSIFICATION; MISDIAGNOSIS; VALIDITY	Objectives UK Biobank is a UK-wide cohort of 502,655 people aged 40-69, recruited from National Health Service registrants between 2006-10, with healthcare data linkage. Type 2 diabetes is a key exposure and outcome. We developed algorithms to define prevalent and incident diabetes for UK Biobank. The algorithms will be implemented by UK Biobank and their results made available to researchers on request. Methods We used UK Biobank self-reported medical history and medication to assign prevalent diabetes and type, and tested this against linked primary and secondary care data in Welsh UK Biobank participants. Additionally, we derived and tested algorithms for incident diabetes using linked primary and secondary care data in the English Clinical Practice Research Datalink, and ran these on secondary care data in UK Biobank. Results and Significance For prevalent diabetes, 0.001% and 0.002% of people classified as "diabetes unlikely" in UK Biobank had evidence of diabetes in their primary or secondary care record respectively. Of those classified as "probable" type 2 diabetes, 75% and 96% had specific type 2 diabetes codes in their primary and secondary care records. For incidence, 95% of people with the type 2 diabetes-specific C10F Read code in primary care had corroborative evidence of diabetes from medications, blood testing or diabetes specific process of care codes. Only 41% of people identified with type 2 diabetes in primary care had secondary care evidence of type 2 diabetes. In contrast, of incident cases using ICD-10 type 2 diabetes specific codes in secondary care, 77% had corroborative evidence of diabetes in primary care. We suggest our definition of prevalent diabetes from UK Biobank baseline data has external validity, and recommend that specific primary care Read codes should be used for incident diabetes to ensure precision. Secondary care data should be used for incident diabetes with caution, as around half of all cases are missed, and a quarter have no corroborative evidence of diabetes in primary care.	[Eastwood, Sophie V.; Chaturvedi, Nishi] UCL, Inst Cardiovasc Sci, London, England; [Mathur, Rohini] London Sch Hyg & Trop Med, Dept Noncommunicable Dis, London, England; [Atkinson, Mark; Brophy, Sinead] Swansea Univ, CIPHER Ctr Improvement Populat Hlth E Records Res, Coll Med, Swansea, W Glam, Wales; [Sudlow, Cathie; Flaig, Robin] Univ Edinburgh, CCBS, Edinburgh, Midlothian, Scotland; [de Lusignan, Simon] Univ Surrey, Dept Clin & Expt Med, Guildford, England; [Allen, Naomi] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Sudlow, Cathie; Flaig, Robin; Allen, Naomi] United Kingdom Biobank, Stockport, Lancs, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Swansea University; University of Edinburgh; University of Surrey; University of Oxford	Eastwood, SV (corresponding author), UCL, Inst Cardiovasc Sci, London, England.	sophie.eastwood@ucl.ac.uk	de Lusignan, Smion/S-7838-2019; Atkinson, Mark D/K-1813-2013	de Lusignan, Smion/0000-0002-8553-2641; Atkinson, Mark D/0000-0003-4237-3588; Chaturvedi, Nishi/0000-0002-6211-2775; Brophy, Sinead/0000-0001-7417-2858; Eastwood, Sophie/0000-0002-1883-8771; Sudlow, Cathie/0000-0002-7725-7520	UK Biobank; MRC [MC_U137686860, MR/K006525/1, MR/K023233/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1, MC_U137686860, MC_qA137853, MR/K023233/1] Funding Source: researchfish	UK Biobank; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from UK Biobank. Funders inputted into discussion around the design of the work, and contributed to manuscript writing. They did not however have any role in data analysis.	Bergmann MM, 2004, EUR J EPIDEMIOL, V19, P411, DOI 10.1023/B:EJEP.0000027350.85974.47; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; de Lusignan S, 2012, DIABETIC MED, V29, P181, DOI 10.1111/j.1464-5491.2011.03419.x; de Lusignan S, 2010, DIABETIC MED, V27, P203, DOI 10.1111/j.1464-5491.2009.02917.x; Goto A, 2013, J EPIDEMIOL, V23, P295, DOI 10.2188/jea.JE20120221; Jackson JM, 2014, MENOPAUSE, V21, P861, DOI [10.1097/GME.0000000000000189, 10.1097/gme.0000000000000189]; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Sigfrid LA, 2006, J PUBLIC HEALTH-UK, V28, P221, DOI 10.1093/pubmed/fdl028; Sluijs I, 2010, NETH J MED, V68, P333; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779	11	102	102	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162388	10.1371/journal.pone.0162388	http://dx.doi.org/10.1371/journal.pone.0162388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631769	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000383706900043
J	Koo, M; Chen, JC; Hwang, JH				Koo, Malcolm; Chen, Jin-Cherng; Hwang, Juen-Haur			Risk of Peripheral Artery Occlusive Disease in Patients with Vertigo, Tinnitus, or Sudden Deafness: A Secondary Case-Control Analysis of a Nationwide, Population-Based Health Claims Database	PLOS ONE			English	Article							DYSFUNCTION	Background Cochleovestibular symptoms, such as vertigo, tinnitus, and sudden deafness, are common manifestations of microvascular diseases. However, it is unclear whether these symptoms occurred preceding the diagnosis of peripheral arteryocclusive disease (PAOD). Therefore, the aim of this case-control study was to investigate the risk of PAOD among patients with vertigo, tinnitus, and sudden deafness using a nationwide, population-based health claim database in Taiwan. Methods We identified 5,340 adult patients with PAOD diagnosed between January 1, 2006 and December 31, 2010 and 16,020 controls, frequency matched on age interval, sex, and year of index date, from the Taiwan National Health Insurance Research Database. Risks of PAOD in patients with vertigo, tinnitus, or sudden deafness were separately evaluated with multivariate logistic regression analyses. Results Of the 5,340 patients with PAOD, 12.7%, 6.7%, and 0.3% were diagnosed with vertigo, tinnitus, and sudden deafness, respectively. In the controls, 10.6%, 6.1%, and 0.3% were diagnosed with vertigo (P < 0.001), tinnitus (P = 0.161), and sudden deafness (P = 0.774), respectively. Results from the multivariate logistic regression analyses showed that the risk of PAOD was significantly increased in patients with vertigo (adjusted odds ratio = 1.12, P = 0.027) but not in those with tinnitus or sudden deafness. Conclusions A modest increase in the risk of PAOD was observed among Taiwanese patients with vertigo, after adjustment for comorbidities.	[Koo, Malcolm] Dalin Tzu Chi Hosp, Dept Med Res, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chen, Jin-Cherng] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Chiayi, Taiwan; [Chen, Jin-Cherng; Hwang, Juen-Haur] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Sleep Ctr, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Hwang, JH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hwang, JH (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan.; Hwang, JH (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Sleep Ctr, Chiayi, Taiwan.	g120796@tzuchi.com.tw	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Berard AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0037882; Criqui MH, 2005, CIRCULATION, V112, P2703, DOI 10.1161/CIRCULATIONAHA.105.546507; GRAD A, 1989, ARCH NEUROL-CHICAGO, V46, P281, DOI 10.1001/archneur.1989.00520390047014; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Hirsch AT, 2012, CIRCULATION, V125, P1449, DOI 10.1161/CIR.0b013e31824c39ba; Horikawa C, 2013, J CLIN ENDOCR METAB, V98, P51, DOI 10.1210/jc.2012-2119; Kakarlapudi V, 2003, OTOL NEUROTOL, V24, P382, DOI 10.1097/00129492-200305000-00006; Kim JS, 2009, SEMIN NEUROL, V29, P534, DOI 10.1055/s-0029-1241037; Kuwabara M, 2015, PULSE, V3, P242, DOI 10.1159/000443769; Lai YT, 2011, OTOLARYNG HEAD NECK, V145, P110, DOI 10.1177/0194599811400007; Linden E, 2008, CLIN J AM SOC NEPHRO, V3, P691, DOI 10.2215/CJN.04291007; MacLean A, 2010, SOC SCI MED, V70, P597, DOI 10.1016/j.socscimed.2009.10.042; Moubayed SP, 2009, LARYNGOSCOPE, V119, P2071, DOI 10.1002/lary.20597; National Health Insurance Administration Ministry of Health and Welfare Taiwan, 2013, NATIONAL HEALTH INSU; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Ouriel K, 2001, LANCET, V358, P1257, DOI 10.1016/S0140-6736(01)06351-6; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Sen S, 2009, STROKE, V40, P3472, DOI 10.1161/STROKEAHA.109.559278; Welsh LW, 2000, ANN OTO RHINOL LARYN, V109, P239, DOI 10.1177/000348940010900301; Wong TY, 2008, AM J EPIDEMIOL, V167, P51, DOI 10.1093/aje/kwm256	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162629	10.1371/journal.pone.0162629	http://dx.doi.org/10.1371/journal.pone.0162629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631630	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900062
J	Weng, YJ; Husebekk, A; Skogen, B; Kjaer, M; Lin, LT; Burnouf, T				Weng, Ying-Jan; Husebekk, Anne; Skogen, Bjorn; Kjaer, Mette; Lin, Liang-Tzung; Burnouf, Thierry			Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia	PLOS ONE			English	Article							HEPATITIS-C VIRUS; CAPRYLIC-ACID; HUMAN PLASMA; INTRACRANIAL HEMORRHAGE; VIRAL SAFETY; PRODUCTS; NANOFILTRATION; INACTIVATION; IGG; CHROMATOGRAPHY	Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a severe disease that is caused by maternal alloantibodies generated during pregnancy or at delivery as a result of incompatibility between maternal and fetal human platelet antigens (HPAs) inherited from the father. Antibody-mediated immune suppression using anti-HPA-1a immunoglobulins is thought to be able to prevent FNAIT caused by HPA-1a. A fractionation process to prepare anti-HPA-1a immunoglobulin (Ig) G (IgG) from human plasma was therefore developed. Anti-HPA-1a plasma was obtained from volunteer mothers who underwent alloimmunization against HPA-1a during a previous pregnancy. Plasma was cryoprecipitated and the supernatant treated with caprylic acid and solvent/detergent (S/D), purified by chromatography, nanofiltered, concentrated, and sterile-filtered. The anti-HPA-1a immunoglobulin fraction was characterized for purity and safety. PAK12 and quantitative monoclonal antibody immobilization of platelet antigen (MAIPA) assays were used to detect anti-HPA-1a IgG. Hepatitis C virus (HCV) removal during nanofiltration was assessed by spiking experiments, using cell culture-derived reporter HCV and luciferase analysis. The caprylic acid treatment precipitated non-Ig proteins yielding a 90% pure Ig supernatant. S-HyperCel chromatography of the S/D-treated supernatant followed by HyperCel STAR AX provided high IgG recovery (>80%) and purity (>99.5%), and efficient IgA and IgM removal. Concentrations of complement factors C3 and C4 were < 0.5 and < 0.4 mg/dL, respectively. The final IgG could be nanofiltered on Planova 20N under conditions removing more than 3 log HCV infectivity to baseline mock infection level, and concentrated to ca. 30 g/L. Proteolytic activity and thrombin generation were low in the final fraction. The Pak12 and MAIPA assays showed good recovery of anti-HPA-1a throughout the process. Clinical-grade HPA-1a IgG can be prepared using a process compliant with current quality requirements opening perspectives for the prevention of FNAIT.	[Weng, Ying-Jan; Burnouf, Thierry] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Husebekk, Anne; Skogen, Bjorn] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Skogen, Bjorn; Kjaer, Mette] Univ Hosp North Norway, Dept Lab Med, Tromso, Norway; [Kjaer, Mette] Finnmark Hosp Trust, Hammerfest, Norway; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Liang-Tzung] Taipei Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, Taipei, Taiwan	Taipei Medical University; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; Taipei Medical University; Taipei Medical University	Burnouf, T (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	thburnouf@gmail.com	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243; Lin, Liang-Tzung/0000-0001-7374-7234	National Science Council of Taiwan [NSC 102-2320-B-038-041-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from National Science Council of Taiwan (NSC 102-2320-B-038-041-MY3). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abdulla I, 2014, J IMMUNOL METHODS, V402, P15, DOI 10.1016/j.jim.2013.11.001; [Anonymous], 2015, HUMAN ANTI D IMMUNOG, P2657; Arnold D M, 2012, J Thromb Haemost, V10, P695, DOI 10.1111/j.1538-7836.2012.04664.x; Bertrand G, 2014, TRANSFUSION; Burnouf T, 2005, CURR NANOSCI, V1, P189, DOI 10.2174/157341305774642894; Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x; Burnouf T, 2000, BLOOD REV, V14, P94, DOI 10.1054/blre.2000.0129; Burnouf T, 2007, TRANSFUS MED REV, V21, P101, DOI 10.1016/j.tmrv.2006.11.001; Busse JB, 2008, BLOOD REV, V22, P33, DOI 10.1016/j.blre.2007.09.002; Caballero S, 2014, BIOLOGICALS, V42, P79, DOI 10.1016/j.biologicals.2013.10.003; Caballero S, 2010, BIOLOGICALS, V38, P486, DOI 10.1016/j.biologicals.2010.02.008; Chilcott J, 2003, REV CLIN EFFECTIVENE; Chou ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117800; Daniel GW, 2012, TRANSFUSION, V52, P2113, DOI 10.1111/j.1537-2995.2012.03589.x; Dichtelmuller HO, 2009, TRANSFUSION, V49, P1931, DOI 10.1111/j.1537-2995.2009.02222.x; Dichtelmuller H, 2002, BIOLOGICALS, V30, P135, DOI 10.1006/biol.2002.0332; El-Ekiaby M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003501; Germishuizen WA, 2014, BIOLOGICALS, V42, P260, DOI 10.1016/j.biologicals.2014.04.002; Horowitz B, 2004, WHO TECH REP SER, V924, P1; Husebekk A, 2011, ISBT SCI SERIES, V6, P261; Kamphuis MM, 2010, BJOG-INT J OBSTET GY, V117, P1335, DOI 10.1111/j.1471-0528.2010.02657.x; Kanhai HHH, 2006, FETAL DIAGN THER, V21, P55, DOI 10.1159/000089048; KIEFEL V, 1987, BLOOD, V70, P1722; KIEFEL V, 1992, TRANSFUSION MED, V2, P181, DOI 10.1111/j.1365-3148.1992.tb00153.x; Killie MK, 2008, HAEMATOLOGICA, V93, P870, DOI 10.3324/haematol.12515; Killie MK, 2010, TRANSFUS APHER SCI, V43, P149, DOI 10.1016/j.transci.2010.07.001; Kjeldsen-Kragh J, 2007, BLOOD, V110, P833, DOI 10.1182/blood-2006-08-040121; Kjeldsen-Kragh J, 2012, CURR OPIN HEMATOL, V19, P469, DOI 10.1097/MOH.0b013e328358f86c; Koenderman AHL, 2012, BIOLOGICALS, V40, P473, DOI 10.1016/j.biologicals.2012.07.010; Korneyeva M, 2002, BIOLOGICALS, V30, P153, DOI 10.1006/biol.2002.0334; Kumpel BM, 2001, TRENDS IMMUNOL, V22, P26, DOI 10.1016/S1471-4906(00)01801-9; Lebing W, 2003, VOX SANG, V84, P193, DOI 10.1046/j.1423-0410.2003.00285.x; Lin LT, 2015, J HEPATOL, V62, P541, DOI 10.1016/j.jhep.2014.10.040; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; MORAIS V, 2014, IMMUNOGLOBULIN PURIF, P137, DOI DOI 10.1007/978-1-52703-977-2_13; Ni HY, 2006, BLOOD, V107, P2976, DOI 10.1182/blood-2005-06-2562; Parkkinen J, 2006, VOX SANG, V90, P97, DOI 10.1111/j.1423-0410.2005.00731.x; Radosevich M, 2010, VOX SANG, V98, P12, DOI 10.1111/j.1423-0410.2009.01226.x; Roemisch JR, 2011, IDENTIFICATION ACTIV; ROJAS G, 1994, TOXICON, V32, P351, DOI 10.1016/0041-0101(94)90087-6; Spencer JA, 2001, AUST NZ J OBSTET GYN, V41, P45, DOI 10.1111/j.1479-828X.2001.tb01293.x; Thorpe SJ, 2003, VOX SANG, V85, P313, DOI 10.1111/j.0042-9007.2003.00367.x; Tiblad E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070984; Tiller H, 2012, TRANSFUSION, V52, P1446, DOI 10.1111/j.1537-2995.2011.03480.x; Turner ML, 2005, TRANSFUSION, V45, P1945, DOI 10.1111/j.1537-2995.2005.00645.x; van den Akker ESA, 2008, BEST PRACT RES CL OB, V22, P3, DOI 10.1016/j.bpobgyn.2007.08.001; Vargas M, 2015, VOX SANG, V108, P169, DOI 10.1111/vox.12209; WHO, 2015, ANN 1 19 WHO MOD LIS; Williamson LM, 1998, BLOOD, V92, P2280, DOI 10.1182/blood.V92.7.2280.2280_2280_2287; World Health Organization, 2010, WHO GUIDELINES PRODU; Wu YW, 2014, TRANSFUSION, V54, P169, DOI 10.1111/trf.12243; Yougbare I, 2015, J CLIN INVEST, V125, P1545, DOI 10.1172/JCI77820; Zdravic D, 2016, SEMIN FETAL NEONAT M, V21, P19, DOI 10.1016/j.siny.2015.12.004	53	5	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162973	10.1371/journal.pone.0162973	http://dx.doi.org/10.1371/journal.pone.0162973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627660	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600070
J	Pedral-Sampaio, G; Alves, JS; Schriefer, A; Magalhaes, A; Meyer, R; Glesby, MJ; Carvalho, EM; Carvalho, LP				Pedral-Sampaio, Geraldo; Alves, Jesse S.; Schriefer, Albert; Magalhaes, Andrea; Meyer, Roberto; Glesby, Marshall J.; Carvalho, Edgar M.; Carvalho, Lucas P.			Detection of IgG Anti-Leishmania Antigen by Flow Cytometry as a Diagnostic Test for Cutaneous Leishmaniasis	PLOS ONE			English	Article							AMERICAN TEGUMENTARY LEISHMANIASIS; BRAZILIENSIS IMMUNOGLOBULIN-G; VIANNIA BRAZILIENSIS; VISCERAL LEISHMANIASIS; IMMUNE-RESPONSE; MUCOCUTANEOUS LEISHMANIASIS; MUCOSAL LEISHMANIASIS; TRYPANOSOMA-CRUZI; PCR ASSAY; INFECTION	Diagnosis of cutaneous leishmaniasis (CL) relies on clinical presentation, parasite isolation, histopathologic evaluation and positive Montenegro skin test. However, the low amounts of parasites in the lesion of these individuals make parasite isolation and histopatologic diagnosis unreliable, often leading to false-negative results. Also, 15% of people living in endemic areas have sub-clinical infection characterized by positive Montenegro skin test, which may contribute to misdiagnosis. Although the main Leishmania killing mechanism is through cell-mediated immune response, antibodies against Leishmania antigens are found in infected individuals. Here our goal was to develop a new serological technique using polystyrene microspheres sensitized with soluble Leishmania antigens as a tool for the detection of IgG in serum from CL patients by flow cytometry. To validate the assay we carried out a comparative test (ELISA) commonly used as a diagnostic test for parasitic diseases. To determine cross-reactivity we used serum from patients with Chagas disease, caused by a trypanosome that has several proteins with high homology to those of the Leishmania genus. We observed that the flow cytometry technique was more sensitive than the ELISA, but, less specific. Our results show that the flow cytometry serologic test can be used to confirm CL cases in L. braziliensis transmission areas, however, presence of Chagas disease has to be ruled out in these individuals.	[Pedral-Sampaio, Geraldo; Meyer, Roberto] Univ Fed Bahia, Inst Ciencias Saude, Lab Imunol, Salvador, BA, Brazil; [Alves, Jesse S.; Schriefer, Albert; Magalhaes, Andrea; Carvalho, Edgar M.; Carvalho, Lucas P.] Univ Fed Bahia, Complexo Hosp Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Glesby, Marshall J.] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA; [Schriefer, Albert; Carvalho, Edgar M.; Carvalho, Lucas P.] INCT DT, Salvador, BA, Brazil; [Carvalho, Edgar M.; Carvalho, Lucas P.] FIOCRUZ BA, Lab Avancado Saude Publ, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Cornell University; Fundacao Oswaldo Cruz	Carvalho, LP (corresponding author), Univ Fed Bahia, Complexo Hosp Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.; Carvalho, LP (corresponding author), INCT DT, Salvador, BA, Brazil.; Carvalho, LP (corresponding author), FIOCRUZ BA, Lab Avancado Saude Publ, Salvador, BA, Brazil.	carvalholp76@gmail.com	Carvalho, Lucas/AAP-1844-2020; Schriefer, Albert/AAP-2765-2020	Schriefer, Albert/0000-0002-5496-6789	Japan Society for the Promotion of Science, Tokyo, Japan [24593126, 16K11836]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (C) 24593126 and 16K11836 from the Japan Society for the Promotion of Science, Tokyo, Japan (https://www.jsps.go.jp/j-grantsinaid/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pereira VRA, 2012, DIAGN MICR INFEC DIS, V74, P292, DOI 10.1016/j.diagmicrobio.2012.06.025; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; BADARO R, 1983, AM J TROP MED HYG, V32, P480, DOI 10.4269/ajtmh.1983.32.480; BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72; BITTENCOURT AL, 1991, MEM I OSWALDO CRUZ, V86, P51, DOI 10.1590/S0074-02761991000100009; Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344; Carvalho LP, 2007, PARASITE IMMUNOL, V29, P251, DOI 10.1111/j.1365-3024.2007.00940.x; Cavalcanti MD, 2013, MOL CELL PROBE, V27, P122, DOI 10.1016/j.mcp.2013.01.003; Chiaramonte MG, 1999, ACTA TROP, V72, P295, DOI 10.1016/S0001-706X(99)00005-4; de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5; de Oliveira AP, 2013, J IMMUNOL METHODS, V387, P245, DOI 10.1016/j.jim.2012.11.002; GUTIERREZ Y, 1991, AM J TROP MED HYG, V45, P281, DOI 10.4269/ajtmh.1991.45.281; MALCHIODI EL, 1994, CLIN EXP IMMUNOL, V97, P417, DOI 10.1111/j.1365-2249.1994.tb06104.x; MARTINS-FILHO OA, 1995, CLIN DIAGN LAB IMMUN, V2, P569, DOI 10.1128/CDLI.2.5.569-573.1995; Morgado FN, 2008, BRIT J DERMATOL, V158, P50, DOI 10.1111/j.1365-2133.2007.08255.x; ONEIL CE, 1993, AM J TROP MED HYG, V49, P181, DOI 10.4269/ajtmh.1993.49.181; PAPPAS MG, 1983, AM J TROP MED HYG, V32, P1260, DOI 10.4269/ajtmh.1983.32.1260; Passos S, 2005, CLIN DIAGN LAB IMMUN, V12, P1164, DOI 10.1128/CDLI.12.10.1164-1167.2005; Pissinate JF, 2008, J IMMUNOL METHODS, V336, P193, DOI 10.1016/j.jim.2008.04.018; REED SG, 1987, J IMMUNOL, V138, P1596; Rocha RDR, 2006, TROP MED INT HEALTH, V11, P156, DOI 10.1111/j.1365-3156.2005.01552.x; Rocha Roberta Dias Rodrigues, 2002, Rev. Soc. Bras. Med. Trop., V35, P551, DOI 10.1590/S0037-86822002000600002; Rodriguez V, 1996, PARASITE IMMUNOL, V18, P341, DOI 10.1046/j.1365-3024.1996.d01-113.x; Romero GAS, 2005, ACTA TROP, V93, P49, DOI 10.1016/j.actatropica.2004.09.005; Schnorr D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001947; Silvestre R, 2009, AM J TROP MED HYG, V81, P202, DOI 10.4269/ajtmh.2009.81.202; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Souza AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066110; Szargiki R, 2009, BRAZ J INFECT DIS, V13, P47, DOI 10.1590/S1413-86702009000100011; Tsukayama P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001956; Vidigal CD, 2008, ACTA TROP, V107, P208, DOI 10.1016/j.actatropica.2008.04.026; Weigle KA, 2002, J CLIN MICROBIOL, V40, P601, DOI 10.1128/JCM.40.2.601-606.2002; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11	33	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162793	10.1371/journal.pone.0162793	http://dx.doi.org/10.1371/journal.pone.0162793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622535	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000056
J	Lopez, J; Fernandez, SN; Gonazlez, R; Solana, MJ; Urbano, J; Lopez-Herce, J				Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus			Different Respiratory Rates during Resuscitation in a Pediatric Animal Model of Asphyxial Cardiac Arrest	PLOS ONE			English	Article							PLUS CHEST COMPRESSIONS; ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; COUNCIL GUIDELINES; TREATMENT RECOMMENDATIONS; INTERNATIONAL CONSENSUS; SPONTANEOUS CIRCULATION; CHILDREN; EPIDEMIOLOGY; VENTILATION	Aims Actual resuscitation guidelines recommend 10 respirations per minute (rpm) for advanced pediatric life support. This respiratory rate (RR) is much lower than what is physiological for children. The aim of this study is to compare changes in ventilation, oxygenation, haemodynamics and return of spontaneous circulation (ROSC) rates with three RR. Methods An experimental model of asphyxial cardiac arrest (CA) in 46 piglets (around 9.5 kg) was performed. Resuscitation with three different RR (10, 20 and 30 rpm) was carried out. Haemodynamics and gasometrical data were obtained at 3, 9, 18 and 24 minutes after beginning of resuscitation. Measurements were compared between the three groups. Results No statistical differences were found in ROSC rate between the three RR (37.5%, 46.6% and 60% in the 10, 20 and 30 rpm group respectively P = 0.51). 20 and 30 rpm groups had lower PaCO2 values than 10 rpm group at 3 minutes (58 and 55 mmHg vs 75 mmHg P = 0.08). 30 rpm group had higher PaO2 (61 mmHg) at 3 minutes than 20 and 10 rpm groups (53 and 45 mmHg P = 0.05). No significant differences were found in haemodynamics or tissue perfusion between hyperventilated (PaCO2 <30 mmHg), normoventilated (30-50 mmHg) and hypoventilated (>50 mmHg) animals. PaO2 was significantly higher in hyperventilated (PaO2 153 mmHg) than in normoventilated (79 mmHg) and hypoventilated (47 mmHg) piglets (P<0.001). Conclusions Our study confirms the hypothesis that higher RR achieves better oxygenation and ventilation without affecting haemodynamics. A higher RR is associated but not significantly with better ROSC rates.	[Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Gregorio Maranon Gen Univ Hosp, Pediat Intens Care Unit, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Univ Complutense Madrid, Sch Med, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Gregorio Maranon Hlth Res Inst, Madrid, Spain; [Lopez, Jorge; Fernandez, Sarah N.; Gonazlez, Rafael; Solana, Maria J.; Urbano, Javier; Lopez-Herce, Jesus] Carlos III Hlth Inst, Mother Child Hlth & Dev Network RedSAMID, Bilbao, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid	Lopez, J; Lopez-Herce, J (corresponding author), Gregorio Maranon Gen Univ Hosp, Pediat Intens Care Unit, Madrid, Spain.; Lopez, J; Lopez-Herce, J (corresponding author), Univ Complutense Madrid, Sch Med, Madrid, Spain.; Lopez, J; Lopez-Herce, J (corresponding author), Gregorio Maranon Hlth Res Inst, Madrid, Spain.; Lopez, J; Lopez-Herce, J (corresponding author), Carlos III Hlth Inst, Mother Child Hlth & Dev Network RedSAMID, Bilbao, Spain.	dr_pyta@yahoo.es; pielvi@hotmail.com	Fernandez Lafever, Sarah Nicole/AAE-4978-2022; Cortes, Rafael Gonzalez/ABB-4855-2020; Lopez-Herce, Jesus/A-1602-2019; Lopez, Jorge/AAD-4109-2022	Fernandez Lafever, Sarah Nicole/0000-0003-4859-5966; Cortes, Rafael Gonzalez/0000-0002-3259-7898; Lopez-Herce, Jesus/0000-0001-6105-9178; Lopez, Jorge/0000-0002-9942-6399; Urbano, Javier/0000-0002-3511-2905; SOLANA, MARIA JOSE/0000-0001-6083-2528	Carlos III Health Institute [PI12/01307]; Mother-Child Health and Development Network (Red SAMID) - RETICS - PN I+D+I (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF) [RD12/0026]	Carlos III Health Institute(Instituto de Salud Carlos III); Mother-Child Health and Development Network (Red SAMID) - RETICS - PN I+D+I (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission)	This work was supported by Carlos III Health Institute (PI12/01307): JL SNF RG MJS JU JL-H, URL: http://www.isciii.es/; Mother-Child Health and Development Network (Red SAMID) - RETICS funded by the PN I+D+I 2008-2011 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF), ref. RD12/0026: JL SNF RG MJS JU JL-H, URL: http://www.redsamid.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; Aufderheide TP, 2006, CURR OPIN CRIT CARE, V12, P207, DOI 10.1097/01.ccx.0000224863.55711.56; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Biarent D, 2010, RESUSCITATION, V81, P1364, DOI 10.1016/j.resuscitation.2010.08.012; Botran M, 2011, INTENS CARE MED, V37, P1873, DOI 10.1007/s00134-011-2338-6; del Castillo J, 2012, RESUSCITATION, V83, P1456, DOI 10.1016/j.resuscitation.2012.07.019; Gazmuri RJ, 2007, CIRCULATION, V116, P2501, DOI 10.1161/CIRCULATIONAHA.107.186228; Gonzalez R, 2014, PEDIATR CRIT CARE ME, V15, pE280, DOI 10.1097/PCC.0000000000000127; Herlitz J, 2005, RESUSCITATION, V64, P37, DOI 10.1016/j.resuscitation.2004.06.019; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; Kjaergaard J, 2015, RESUSCITATION, V96, P310, DOI 10.1016/j.resuscitation.2015.06.021; KUISMA M, 1995, RESUSCITATION, V30, P141, DOI 10.1016/0300-9572(95)00888-Z; Lopez-Herce J, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0607-9; Lopez-Herce J, 2013, INTENS CARE MED, V39, P309, DOI 10.1007/s00134-012-2709-7; Lopez-Herce J, 2011, RESUSCITATION, V82, P755, DOI 10.1016/j.resuscitation.2011.02.013; Lopez-Herce J, 2011, INTENS CARE MED, V37, P147, DOI 10.1007/s00134-010-2006-2; Lopez-Herce J, 2010, LANCET, V375, P1321, DOI 10.1016/S0140-6736(10)60316-9; Maconochie IK, 2015, RESUSCITATION, V95, pE147, DOI 10.1016/j.resuscitation.2015.07.044; Maconochie IK, 2015, RESUSCITATION, V95, P223, DOI 10.1016/j.resuscitation.2015.07.028; Iglesias JM, 2010, INTENS CARE MED, V36, P712, DOI 10.1007/s00134-010-1777-9; O'Leary F, 2015, ARCH DIS CHILD, V100, P733, DOI 10.1136/archdischild-2014-307401; O'Neill JF, 2007, RESUSCITATION, V73, P82, DOI 10.1016/j.resuscitation.2006.09.012; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Rajan S, 2015, RESUSCITATION, V88, P12, DOI 10.1016/j.resuscitation.2014.11.025; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; Roberts BW, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-9; Sirbaugh PE, 1999, ANN EMERG MED, V33, P174, DOI 10.1016/S0196-0644(99)70391-4; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Sutton RM, 2015, RESUSCITATION, V93, P150, DOI 10.1016/j.resuscitation.2015.04.010; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299; Yannopoulos D, 2010, CRIT CARE MED, V38, P254, DOI 10.1097/CCM.0b013e3181b42f6c; Young KD, 1999, ANN EMERG MED, V33, P195, DOI 10.1016/S0196-0644(99)70394-X; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162185	10.1371/journal.pone.0162185	http://dx.doi.org/10.1371/journal.pone.0162185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618183	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100014
J	Wu, DC; Guo, M; Philips, MA; Qu, LZ; Jiang, LY; Li, J; Chen, XJ; Chen, ZC; Chen, L; Chen, YH				Wu, Daichao; Guo, Ming; Philips, Michael A.; Qu, Lingzhi; Jiang, Longying; Li, Jun; Chen, Xiaojuan; Chen, Zhuchu; Chen, Lin; Chen, Yongheng			Crystal Structure of the FGFR4/LY2874455 Complex Reveals Insights into the Pan-FGFR Selectivity of LY2874455	PLOS ONE			English	Article							FACTOR RECEPTOR 4; HUMAN BREAST; GROWTH; INHIBITOR; POTENT; MUTATIONS; XENOGRAFT; AZD4547; BINDING; FAMILY	Aberrant FGFR4 signaling has been documented abundantly in various human cancers. The majority of FGFR inhibitors display significantly reduced potency toward FGFR4 compared to FGFR1-3. However, LY2874455 has similar inhibition potency for FGFR1-4 with IC50 less than 6.4 nM. To date, there is no published crystal structure of LY2874455 in complex with any kinase. To better understand the pan-FGFR selectivity of LY2874455, we have determined the crystal structure of the FGFR4 kinase domain bound to LY2874455 at a resolution of 2.35 angstrom. LY2874455, a type I inhibitor for FGFR4, binds to the ATP-binding pocket of FGFR4 in a DFG-in active conformation with three hydrogen bonds and a number of van der Waals contacts. After alignment of the kinase domain sequence of 4 FGFRs, and superposition of the ATP-binding pocket of 4 FGFRs, our structural analyses reveal that the interactions of LY2874455 to FGFR4 are largely conserved in 4 FGFRs, explaining at least partly, the broad inhibitory activity of LY2874455 toward 4 FGFRs. Consequently, our studies reveal new insights into the pan-FGFR selectivity of LY2874455 and provide a structural basis for developing novel FGFR inhibitors that target FGFR1-4 broadly.	[Wu, Daichao; Guo, Ming; Qu, Lingzhi; Jiang, Longying; Li, Jun; Chen, Xiaojuan; Chen, Zhuchu; Chen, Lin; Chen, Yongheng] Cent S Univ, Struct Biol Lab, Key Lab Canc Prote, Chinese Minist Hlth,XiangYa Hosp, Changsha 410008, Hunan, Peoples R China; [Philips, Michael A.; Chen, Lin; Chen, Yongheng] Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol, Los Angeles, CA 90089 USA; [Chen, Yongheng] Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China	Central South University; University of Southern California	Chen, L; Chen, YH (corresponding author), Cent S Univ, Struct Biol Lab, Key Lab Canc Prote, Chinese Minist Hlth,XiangYa Hosp, Changsha 410008, Hunan, Peoples R China.; Chen, L; Chen, YH (corresponding author), Univ Southern Calif, Dept Biol Sci, Mol & Computat Biol, Los Angeles, CA 90089 USA.; Chen, YH (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.	linchen@usc.edu; yonghenc@163.com			National Natural Science Foundation of China [81372904, 81570537, 81272971]; Science and Technology Department of Hunan Province [2015SK2037]; Hunan 555 project; "Shenghua Scholar" project of Central South University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064642] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province; Hunan 555 project; "Shenghua Scholar" project of Central South University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National Natural Science Foundation of China (Y.C., project numbers 81372904 and 81570537, Z.C. project number 81272971). This project was supported by the Science and Technology Department of Hunan Province (2015SK2037), Hunan 555 project (Y.C.), and "Shenghua Scholar" project of Central South University (Y.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Chen YH, 2015, NUCLEIC ACIDS RES, V43, P1268, DOI 10.1093/nar/gku1373; Desai A, 2016, J THORAC ONCOL, V11, P9, DOI 10.1016/j.jtho.2015.08.003; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Duan YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106225; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Gowardhan B, 2005, BRIT J CANCER, V92, P320, DOI 10.1038/sj.bjc.6602274; Guagnano V, 2011, J MED CHEM, V54, P7066, DOI 10.1021/jm2006222; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Ho HK, 2014, DRUG DISCOV TODAY, V19, P51, DOI 10.1016/j.drudis.2013.07.021; Huang ZF, 2015, ACS CHEM BIOL, V10, P299, DOI 10.1021/cb500674s; JAAKKOLA S, 1993, INT J CANCER, V54, P378, DOI 10.1002/ijc.2910540305; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Lesca E, 2014, J MOL BIOL, V426, P3744, DOI 10.1016/j.jmb.2014.09.004; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Lu CM, 2015, CELLS TISSUES ORGANS, V201, P26, DOI 10.1159/000441349; Motoda N, 2011, INT J ONCOL, V38, P133, DOI 10.3892/ijo_00000832; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248; Penault Llorca F, INT J CANC; Repana Dimitra, 2015, Diseases, V3, P294, DOI 10.3390/diseases3040294; Roidl A, 2010, ONCOGENE, V29, P1543, DOI 10.1038/onc.2009.432; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Tan L, 2014, P NATL ACAD SCI USA, V111, pE4869, DOI 10.1073/pnas.1403438111; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Treiber DK, 2013, CHEM BIOL, V20, P745, DOI 10.1016/j.chembiol.2013.06.001; Tucker JA, 2014, STRUCTURE, V22, P1764, DOI 10.1016/j.str.2014.09.019; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Wu DC, 2014, PROCESS BIOCHEM, V49, P402, DOI 10.1016/j.procbio.2014.01.005; Yamada SM, 2002, NEUROL RES, V24, P244, DOI 10.1179/016164102101199864; Zhao GS, 2011, MOL CANCER THER, V10, P2200, DOI 10.1158/1535-7163.MCT-11-0306	32	25	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162491	10.1371/journal.pone.0162491	http://dx.doi.org/10.1371/journal.pone.0162491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618313	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100025
J	Acharya, KP; Paudel, PK; Neupane, PR; Kohl, M				Acharya, Krishna Prasad; Paudel, Prakash Kumar; Neupane, Prem Raj; Koehl, Michael			Human-Wildlife Conflicts in Nepal: Patterns of Human Fatalities and Injuries Caused by Large Mammals	PLOS ONE			English	Article							HUMAN-ELEPHANT CONFLICT; RHINOCEROS RHINOCEROS-UNICORNIS; CHITWAN NATIONAL-PARK; PANTHERA-TIGRIS; PREY SELECTION; TIGER RESERVE; DRY SEASON; CONSERVATION; COEXISTENCE; LIVESTOCK	Injury and death from wildlife attacks often result in people feeling violent resentment and hostility against the wildlife involved and, therefore, may undermine public support for conservation. Although Nepal, with rich biodiversity, is doing well in its conservation efforts, human-wildlife conflicts have been a major challenge in recent years. The lack of detailed information on the spatial and temporal patterns of human-wildlife conflicts at the national level impedes the development of effective conflict mitigation plans. We examined patterns of human injury and death caused by large mammals using data from attack events and their spatiotemporal dimensions collected from a national survey of data available in Nepal over five years (2010-2014). Data were analyzed using logistic regression and chi-square or Fisher's exact tests. The results show that Asiatic elephants and common leopards are most commonly involved in attacks on people in terms of attack frequency and fatalities. Although one-horned rhinoceros and bears had a higher frequency of attacks than Bengal tigers, tigers caused more fatalities than each of these two species. Attacks by elephants peaked in winter and most frequently occurred outside protected areas in human settlements. Leopard attacks occurred almost entirely outside protected areas, and a significantly greater number of attacks occurred in human settlements. Attacks by one-horned rhinoceros and tigers were higher in the winter, mainly in forests inside protected areas; similarly, attacks by bears occurred mostly within protected areas. We found that human settlements are increasingly becoming conflict hotspots, with burgeoning incidents involving elephants and leopards. We conclude that species-specific conservation strategies are urgently needed, particularly for leopards and elephants. The implications of our findings for minimizing conflicts and conserving these imperiled species are discussed.	[Acharya, Krishna Prasad] Govt Nepal, Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal; [Paudel, Prakash Kumar] Nepal Acad Sci & Technol, POB 3323, Khumaltar, Lalitpur, Nepal; [Acharya, Krishna Prasad; Neupane, Prem Raj; Koehl, Michael] Univ Hamburg, World Forestry, Leuschnerstr 91, D-21031 Hamburg, Germany; [Neupane, Prem Raj] Friends Nat, Kathmandu, Nepal	Nepal Academy of Science & Technology (NAST); University of Hamburg	Acharya, KP (corresponding author), Govt Nepal, Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal.; Acharya, KP (corresponding author), Univ Hamburg, World Forestry, Leuschnerstr 91, D-21031 Hamburg, Germany.	kpacharya1@hotmail.com	Puadel, Prakash K/J-5094-2014	Puadel, Prakash K/0000-0001-5583-7615				Acharya K, 2016, AN ASSESSMENT OF ZER; Acharya KP, 2002, INT FOREST REV, V4, P149, DOI 10.1505/IFOR.4.2.149.17447; Andheria AP, 2007, J ZOOL, V273, P169, DOI 10.1111/j.1469-7998.2007.00310.x; Archie EA, 2012, MOL ECOL, V21, P765, DOI 10.1111/j.1365-294X.2011.05237.x; Aryal A, 2016, ETHOL ECOL EVOL, V28, P117, DOI 10.1080/03949370.2014.1002115; Bagchi S, 2003, J ZOOL, V260, P285, DOI 10.1017/S0952836903003765; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Choudhury Anwaruddin, 2004, Human Dimensions of Wildlife, V9, P261, DOI 10.1080/10871200490505693; Constant NL, 2015, BIODIVERS CONSERV, V24, P2967, DOI 10.1007/s10531-015-0989-2; DHM, 2015, ANNUAL WEATHER SUMMA; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Distefano E., 2015, HUMAN WILDLIFE CONFL; Dowie M., 2011, CONSERVATION REFUGEE; Dunham KM, 2010, ORYX, V44, P185, DOI 10.1017/S003060530999086X; Dutta AK, 1991, THE GREAT INDIAN ONE; FAO, 1999, COUNTRY REPORT; GoN/ MoFSC, 2007, THE ELEPHANT CONSERV; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Heinen JT, 2015, CONSERV SCI, V3; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Jnawali Sit, 1989, PARK PEOPLE CONFLICT; Jnawali SR, 2011, THE STATUS OF NEPALS; Kabir M, 2014, EUR J WILDLIFE RES, V60, P291, DOI 10.1007/s10344-013-0782-z; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; LAURIE A, 1982, J ZOOL, V196, P307; Madhusudan MD, 2003, ENVIRON MANAGE, V31, P466, DOI 10.1007/s00267-002-2790-8; Mikkola K., 2002, COMMUNITY FORESTRYS; MOFSC, 2015, STRATEGY AND ACTION; Murphy ST, 2013, ORYX, V47, P361, DOI 10.1017/S003060531200124X; Nyhus PJ, 2004, ORYX, V38, P68, DOI 10.1017/S0030605304000110; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Pandey P, 2016, EUR J WILDLIFE RES, V62, P103, DOI 10.1007/s10344-015-0978-5; Pant G, 2016, ORYX, V50, P724, DOI 10.1017/S0030605315000381; Parker GE, 2006, ORYX, V40, P343, DOI 10.1017/S0030605306000822; Paudel PK, 2015, GEOFORUM, V64, P192, DOI 10.1016/j.geoforum.2015.06.021; Paudel PK, 2015, APPL GEOGR, V56, P127, DOI 10.1016/j.apgeog.2014.11.018; Paudel Prakash Kumar, 2012, P1; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; Primack RB, 2013, CONSERVATION BIOL; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Sangay T, 2008, BIOL CONSERV, V141, P1272, DOI 10.1016/j.biocon.2008.02.027; Santiapillai C, 1990, THE ASIAN ELEPHANT A; Sillero-Zubiri C., 2007, KEY TOPICS CONSERVAT, P266; Stattersfield A., 1998, ENDEMIC BIRD AREAS O; Steinheim G, 2005, J ZOOL, V265, P377, DOI 10.1017/S0952836905006448; Stoen OG, 1996, MAMMALIA, V60, P363; Subedi N, 2013, ORYX, V47, P352, DOI 10.1017/S0030605313000562; Sukumar R, 1992, THE ASIAN ELEPHANT E; Sukumar R., 2003, THE LIVING ELEPHANTS, V85, P581, DOI [10.1644/1545-1542(2004)0852.0.CO;2, DOI 10.1644/1545-1542(2004)0852.0.CO;2]; Thapa K., 2015, ETHOL ECOL EVOL, P1; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2014, SCIENCE, V344, P475, DOI 10.1126/science.1252690; White PCL, 2010, WILDLIFE RES, V37, P623, DOI 10.1071/WR10191; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Wilson S, 2015, ORYX, V49, P140, DOI 10.1017/S0030605313000513; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P388; Zhang L, 2003, BIOL CONSERV, V112, P453, DOI 10.1016/S0006-3207(02)00335-X	63	88	95	2	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161717	10.1371/journal.pone.0161717	http://dx.doi.org/10.1371/journal.pone.0161717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612174	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900027
J	Pankhurst, MW; Clark, CA; Zarek, J; Laskin, CA; McLennan, IS				Pankhurst, Michael W.; Clark, Christine A.; Zarek, Judith; Laskin, Carl A.; McLennan, Ian S.			Changes in Circulating ProAMH and Total AMH during Healthy Pregnancy and Post-Partum: A Longitudinal Study	PLOS ONE			English	Article							ANTI-MULLERIAN-HORMONE; INHIBITING SUBSTANCE; ANTIMULLERIAN HORMONE; MLLERIAN HORMONE; VOLUME EXPANSION; HUMAN BLOOD; VITAMIN-D; SERUM; ESTRADIOL; PRECURSOR	Circulating Anti-Mullerian hormone (AMH) is derived from the gonads, and is a mixture of the prohormone(proAMH), which does not bind to AMH receptors, and receptor-competent AMH. The functions of a hormone are partially defined by the factors that control its levels. Ovarian reserve accounts for 55 similar to 75% of the woman-to-woman variation in AMH level, leaving over 25% of the biological variation to be explained. Pregnancy has been reported to decrease circulating AMH levels, but the observations are inconsistent, with the effect of pregnancy on the bioactivity of AMH being unknown. We have therefore undertaken a longitudinal study of circulating proAMH and total AMH during pregnancy. Serum samples were drawn at 6-8 gestational time-points (first trimester to post-partum) from 25 healthy women with prior uneventful pregnancies. The total AMH and proAMH levels were measured at each time-point using ELISA. The level of circulating total AMH progressively decreased during pregnancy, in all women (p<0.001). On average, the percentage decline between the first trimester and 36-39 weeks' gestation was 61.5%, with a standard deviation of 13.0% (range 30.4-81.2%). The percentage decline in total AMH levels associated with maternal age (R = -0.53, p = 0.024), but not with the women's first trimester AMH level. The postpartum total AMH levels showed no consistent relationship to the woman's first trimester values (range 31-273%). This raises the possibility that a fundamental determinant of circulating AMH levels is reset during pregnancy. The ratio of proAMH to total AMH levels exhibited little or no variation during pregnancy, indicating that the control of the cleavage/activation of AMH is distinct from the mechanisms that control the total level of AMH.	[Pankhurst, Michael W.; McLennan, Ian S.] Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand; [Clark, Christine A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Clark, Christine A.; Zarek, Judith; Laskin, Carl A.] LifeQuest Ctr Reprod Med, Toronto, ON, Canada; [Zarek, Judith] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON, Canada	University of Otago; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McLennan, IS (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.	ian.mclennan@otago.ac.nz	Pankhurst, Michael/F-2585-2017	Pankhurst, Michael/0000-0002-0976-5742	Health Research Council New Zealand [14-441]	Health Research Council New Zealand(Health Research Council of New Zealand)	This study was funded by the Health Research Council New Zealand (www.hrc.govt.nz/, 14-441 to ISM, MWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani A, 2005, CLIN ENDOCRINOL, V63, P267, DOI 10.1111/j.1365-2265.2005.02336.x; Bentzen JG, 2013, J CLIN ENDOCR METAB, V98, P1602, DOI 10.1210/jc.2012-1829; DEKEL N, 1977, INT J FERTIL, V22, P24; Dennis NA, 2012, J CLIN ENDOCR METAB, V97, P2450, DOI 10.1210/jc.2012-1213; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; di Clemente N, 2010, MOL ENDOCRINOL, V24, P2193, DOI 10.1210/me.2010-0273; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P1720, DOI 10.1158/1055-9965.EPI-07-0311; Gerli S, 2015, ENDOCRINE, V50, P250, DOI 10.1007/s12020-014-0515-4; GOVAN ADT, 1968, J ENDOCRINOL, V40, P421, DOI 10.1677/joe.0.0400421; GOVAN ADT, 1970, J ENDOCRINOL, V48, P235, DOI 10.1677/joe.0.0480235; Griesinger G, 2012, J CLIN ENDOCR METAB, V97, P2160, DOI 10.1210/jc.2012-1070; Grynberg M, 2012, J CLIN ENDOCR METAB, V97, pE1649, DOI 10.1210/jc.2011-3133; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; Irani M, 2014, FERTIL STERIL, V102, P460, DOI 10.1016/j.fertnstert.2014.04.046; Jeppesen JV, 2013, MOL HUM REPROD, V19, P519, DOI 10.1093/molehr/gat024; Kissell KA, 2014, HUM REPROD, V29, P1764, DOI 10.1093/humrep/deu142; Koninger A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-60; Kumar A, 2010, J IMMUNOL METHODS, V362, P51, DOI 10.1016/j.jim.2010.08.011; La Marca A, 2005, HUM REPROD, V20, P1569, DOI 10.1093/humrep/deh819; La Marca A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/959487; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; Lockshin MD, 2012, ARTHRITIS RHEUM-US, V64, P2311, DOI 10.1002/art.34402; Lockwood GM, 1998, HUM REPROD UPDATE, V4, P284, DOI 10.1093/humupd/4.3.284; Lutterodt M, 2009, REPROD BIOMED ONLINE, V18, P694, DOI 10.1016/S1472-6483(10)60016-8; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McLennan IS, 2015, J ENDOCRINOL, V226, pR45, DOI 10.1530/JOE-15-0206; McNeilly AS, 1997, J MAMMARY GLAND BIOL, V2, P291, DOI 10.1023/A:1026340606252; Namkung J, 2012, J CLIN ENDOCR METAB, V97, P3224, DOI 10.1210/jc.2012-1538; Nelson SM, 2010, FERTIL STERIL, V93, P1356, DOI 10.1016/j.fertnstert.2009.07.1676; Novembri R, 2015, PLACENTA, V36, P731, DOI 10.1016/j.placenta.2015.04.009; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; Pankhurst MW, 2016, FERTIL STERIL, V106, P1238, DOI 10.1016/j.fertnstert.2016.06.010; Pankhurst MW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12783; Pankhurst MW, 2016, ENDOCRINOLOGY, V157, P1622, DOI 10.1210/en.2015-1834; Pankhurst MW, 2016, MOL CELL ENDOCRINOL, V419, P165, DOI 10.1016/j.mce.2015.10.013; Pankhurst MW, 2014, FERTIL STERIL, V101, P846, DOI 10.1016/j.fertnstert.2013.12.009; Pankhurst MW, 2013, AM J PHYSIOL-ENDOC M, V305, pE1241, DOI 10.1152/ajpendo.00395.2013; Pfennig F, 2015, GEN COMP ENDOCR, V223, P87, DOI 10.1016/j.ygcen.2015.09.025; PIVARNIK JM, 1994, OBSTET GYNECOL, V83, P265; Segev DL, 2000, J BIOL CHEM, V275, P28371, DOI 10.1074/jbc.M004554200; SHORT RV, 1993, ANN MED, V25, P175, DOI 10.3109/07853899309164164; Smith R, 2009, J CLIN ENDOCR METAB, V94, P2066, DOI 10.1210/jc.2008-2257; STARUP J, 1974, ACTA OBSTET GYN SCAN, V53, P211, DOI 10.3109/00016347409162159; Vanky E, 2012, FERTIL STERIL, V97, P509, DOI 10.1016/j.fertnstert.2011.11.021; Wang J, 2009, FERTIL STERIL, V91, P1195, DOI 10.1016/j.fertnstert.2008.01.028; Wang PY, 2005, P NATL ACAD SCI USA, V102, P16421, DOI 10.1073/pnas.0508304102; Whittaker PG, 1996, OBSTET GYNECOL, V88, P33, DOI 10.1016/0029-7844(96)00095-6	54	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162509	10.1371/journal.pone.0162509	http://dx.doi.org/10.1371/journal.pone.0162509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612037	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900118
J	Liu, CC; Cai, DL; Sun, F; Wu, ZH; Yue, B; Zhao, SL; Wu, XS; Zhang, M; Zhu, XW; Peng, ZH; Yan, DW				Liu, C-C; Cai, D-L; Sun, F.; Wu, Z-H; Yue, B.; Zhao, S-L; Wu, X-S; Zhang, M.; Zhu, X-W; Peng, Z-H; Yan, D-W			FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of beta-catenin transcriptional activity	ONCOGENE			English	Article							COLORECTAL-CANCER; KINDLIN-1; WNT; EXPRESSION; INHIBITION; CARCINOMA; ADHESION; COMPLEX; PROLIFERATION; KERATINOCYTES	We previously demonstrated that fermitin family member 1 (FERMT1) was significantly overexpressed in colon cancer (CC) and associated with poor metastasis-free survival. This study aimed to investigate the precise role of FERMT1 in CC metastasis and the mechanism by which FERMT1 is involved in the epithelial-mesenchymal transition (EMT). Correlations between FERMT1 and EMT markers (E-cadherin, Slug, N-cadherin and beta-catenin) were examined via immunohistochemistry in a cohort of CC tissues and adjacent normal colon mucosae. A series of in vitro and in vivo assays were performed to elucidate the function of FERMT1 in CC metastasis and underlying mechanisms. The upregulated expression of FERMT1 in CC tissues correlated positively with that of Slug, N-cadherin and beta-catenin, but correlated inversely with E-cadherin expression. Altered FERMT1 expression led to marked changes in the proliferation, migration, invasion and EMT markers of CC cells both in vitro and in vivo. Investigations of underlying mechanisms found that FERMT1 interacted directly with beta-catenin and activated the Wnt/beta-catenin signaling pathway by decreasing the phosphorylation level of beta-catenin, enhancing beta-catenin nuclear translocation and increasing the transcriptional activity of beta-catenin/TCF/LEF. Activation of the Wnt/beta-catenin pathway by CHIR99021 reversed the effect of FERMT1 knockdown, whereas inhibition of the Wnt/beta-catenin pathway by XAV939 impaired the effect of FERMT1 overexpression on EMT and cell motility. In conclusion, findings of this study suggest that FERMT1 activates the beta-catenin transcriptional activity to promote EMT in CC metastasis.	[Liu, C-C; Yue, B.; Zhao, S-L; Zhu, X-W; Peng, Z-H; Yan, D-W] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Gen Surg, Sch Med, 85 Wujin Rd, Shanghai 200080, Peoples R China; [Cai, D-L] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Drug Allocat Ctr, Sch Med, Shanghai, Peoples R China; [Sun, F.; Wu, X-S] Kunming Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 2, Kunming, Peoples R China; [Wu, Z-H] Qingdao Univ, Dept Hapatobiliary Surg, Affiliated Hosp, Qingdao, Peoples R China; [Zhang, M.] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Pathol, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Kunming Medical University; Qingdao University; Shanghai Jiao Tong University	Yan, DW (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Gen Surg, Sch Med, 85 Wujin Rd, Shanghai 200080, Peoples R China.	yandw70@163.com			National Natural Science Foundation of China [81172328]; Medical Guidance Project of Shanghai Science and Technology Commission [114119a4600, 124119a1700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Guidance Project of Shanghai Science and Technology Commission	This work was supported by National Natural Science Foundation of China (no. 81172328) and Medical Guidance Project of Shanghai Science and Technology Commission (114119a4600) (124119a1700). We thank Jiachen Nan for her generous help.	Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Fagotto F, 2013, EMBO REP, V14, P422, DOI 10.1038/embor.2013.45; Fan JW, 2011, CLIN CANCER RES, V17, P2908, DOI 10.1158/1078-0432.CCR-10-2552; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Has C, 2008, BRIT J DERMATOL, V159, P1192, DOI 10.1111/j.1365-2133.2008.08760.x; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kern J S, 2007, J Pathol, V213, P462, DOI 10.1002/path.2253; Kiriyama K, 2013, ANTICANCER RES, V33, P167; Lai-Cheong JE, 2009, AM J PATHOL, V175, P1431, DOI 10.2353/ajpath.2009.081154; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Ma HX, 2015, TUMOR BIOL, V36, P4235, DOI 10.1007/s13277-015-3060-8; Mahawithitwong P, 2013, INT J ONCOL, V42, P1360, DOI 10.3892/ijo.2013.1838; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Rognoni E, 2014, NAT MED, V20, P350, DOI 10.1038/nm.3490; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Sin S, 2011, J NATL CANCER I, V103, P1323, DOI 10.1093/jnci/djr290; Sleeman JP, 2011, CELL, V145, DOI 10.1016/j.cell.2011.03.029; Thaker PH, 2004, CLIN CANCER RES, V10, P5145, DOI 10.1158/1078-0432.CCR-03-0589; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Weng WH, 2015, INT J CANCER, V136, P493, DOI 10.1002/ijc.28722; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yan DW, 2010, BRIT J CANCER, V103, P961, DOI 10.1038/sj.bjc.6605870; Yu HY, 2014, CLIN CANCER RES, V20, P3434, DOI 10.1158/1078-0432.CCR-13-2952	43	70	71	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 30	2017	36	13					1779	1792		10.1038/onc.2016.339	http://dx.doi.org/10.1038/onc.2016.339			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EQ5NF	27641329				2022-12-26	WOS:000398128900004
J	Pan, JY; Yuan, SJ; Yu, T; Su, CL; Liu, XL; He, J; Li, H				Pan, Jing-Ying; Yuan, Shijin; Yu, Tao; Su, Cong-Lin; Liu, Xiao-Long; He, Jun; Li, He			Regulation of L-type Ca2+ Channel Activity and Insulin Secretion by Huntingtin-associated Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; GATED CALCIUM-CHANNELS; INTRACELLULAR TRAFFICKING; MUTANT HUNTINGTIN; MOLECULAR-MECHANISMS; VESICULAR TRANSPORT; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; EXOCYTOSIS; DISEASE	Huntingtin-associated protein 1 (Hap1) was originally identified as a protein that binds to the Huntington disease protein, huntingtin. Growing evidence has shown that Hap1 participates in intracellular trafficking via its association with various microtubule-dependent transporters and organelles. Recent studies also revealed that Hap1 is involved in exocytosis such as insulin release from pancreatic beta-cells. However, the mechanism underlying the action of Hap1 on insulin release remains to be investigated. We found that Hap1 knock-out mice had a lower plasma basal insulin level than control mice. Using cultured pancreatic beta-cell lines, INS-1 cells, we confirmed that decreasing Hap1 reduces the number of secreted vesicles and inhibits vesicle exocytosis. Electrophysiology and imaging of intracellular Ca2+ measurements demonstrated that Hap1 depletion significantly reduces the influx of Ca2+ mediated by L-type Ca2+ channels (Cav). This decrease is not due to reduced expression of Cav1.2 channel mRNA but results from the decreased distribution of Cav1.2 on the plasma membrane of INS-1 cells. Fluorescence recovery after photobleaching showed a defective movement of Cav1.2 in Hap1 silencing INS-1 cells. Our findings suggest that Hap1 is important for insulin secretion of pancreatic beta-cells via regulating the intracellular trafficking and plasma membrane localization of Cav1.2, providing new insight into the mechanisms that regulate insulin release from pancreatic beta-cells.	[Pan, Jing-Ying; Yuan, Shijin; Su, Cong-Lin; Liu, Xiao-Long; He, Jun; Li, He] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Histol & Embryol, Wuhan 430030, Peoples R China; [Pan, Jing-Ying; Yuan, Shijin; Su, Cong-Lin; Liu, Xiao-Long; He, Jun; Li, He] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430030, Peoples R China; [Yu, Tao] Wuhan Childrens Hosp, Clin Lab, Wuhan 430016, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	He, J; Li, H (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Histol & Embryol, Wuhan 430030, Peoples R China.; He, J; Li, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430030, Peoples R China.	junhe@mails.tjmu.edu.cn; heli@mails.tjmu.edu.cn			National Natural Science Foundation of China [30871311, 31171155, 31371217]; Research Fund for the Doctoral Program of Higher Education of China [20070487184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China Grants 30871311, 31171155, and 31371217 and Research Fund for the Doctoral Program of Higher Education of China Grant 20070487184. The authors declare that they have no conflicts of interest with the contents of this article.	AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Bito M, 2013, BIOL PHARM BULL, V36, P31, DOI 10.1248/bpb.b12-00425; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Burcelin R, 2008, DIABETES METAB, V34, pS49, DOI 10.1016/S1262-3636(08)73395-0; Cape A, 2012, CELL MOL LIFE SCI, V69, P1305, DOI 10.1007/s00018-011-0692-8; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Dragatsis I, 2000, NEUROSCI LETT, V282, P37, DOI 10.1016/S0304-3940(00)00872-7; FARRER LA, 1985, CLIN GENET, V27, P62; Gandini MA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187757; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; IWASHIMA Y, 1993, DIABETES, V42, P948, DOI 10.2337/diabetes.42.7.948; KEOGH HJ, 1976, J NEUROL NEUROSUR PS, V39, P244, DOI 10.1136/jnnp.39.3.244; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; LAVIN PJM, 1981, J NEUROL NEUROSUR PS, V44, P414, DOI 10.1136/jnnp.44.5.414; Li SH, 2003, J NEUROSCI, V23, P6956; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li XJ, 2005, TRENDS PHARMACOL SCI, V26, P1, DOI 10.1016/j.tips.2004.11.001; Liao M, 2005, J HISTOCHEM CYTOCHEM, V53, P1517, DOI 10.1369/jhc.5A6662.2005; Liao M, 2010, J HISTOCHEM CYTOCHEM, V58, P255, DOI 10.1369/jhc.2009.954479; MacDonald PE, 2006, PLOS BIOL, V4, P167, DOI 10.1371/journal.pbio.0040049; Martin EJ, 1999, J COMP NEUROL, V403, P421; Mayer BJ, 2001, J CELL SCI, V114, P1253; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; PODOLSKY S, 1977, GERONTOLOGY, V23, P55, DOI 10.1159/000212174; PODOLSKY S, 1972, LANCET, V1, P1356; Roe MW, 1996, AM J PHYSIOL-ENDOC M, V270, pE133, DOI 10.1152/ajpendo.1996.270.1.E133; Rong J, 2007, J NEUROSCI RES, V85, P3025, DOI 10.1002/jnr.21326; Rong JA, 2007, J BIOL CHEM, V282, P4748, DOI 10.1074/jbc.M609057200; Rong J, 2006, J NEUROSCI, V26, P6019, DOI 10.1523/JNEUROSCI.1251-06.2006; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Satin LS, 2000, ENDOCRINE, V13, P251, DOI 10.1385/ENDO:13:3:251; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; SCHWEIZER FE, 1995, NEURON, V14, P689, DOI 10.1016/0896-6273(95)90213-9; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; Sheng G, 2008, J CLIN INVEST, V118, P2785, DOI 10.1172/JCI35339; Sheng GQ, 2006, NAT MED, V12, P526, DOI 10.1038/nm1382; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Smith R, 2009, HUM MOL GENET, V18, P3942, DOI 10.1093/hmg/ddp336; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Tang TS, 2004, EUR J NEUROSCI, V20, P1779, DOI 10.1111/j.1460-9568.2004.03633.x; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Tian G, 2012, J BIOL CHEM, V287, P9862, DOI 10.1074/jbc.M111.292854; Wang S, 2006, BIOCHEM SOC T, V34, P687, DOI 10.1042/BST0340687; Wang Z, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165631; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Yamada Y, 2001, DIABETES-METAB RES, V17, P213, DOI 10.1002/dmrr.193; YAMADA Y, 1995, GENOMICS, V27, P312, DOI 10.1006/geno.1995.1048; Yang G, 2015, CELL MOL LIFE SCI, V72, P1197, DOI 10.1007/s00018-014-1737-6; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004; Ye CF, 2009, BIOSCI BIOTECH BIOCH, V73, P1787, DOI 10.1271/bbb.90147; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2	64	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26352	26363		10.1074/jbc.M116.727990	http://dx.doi.org/10.1074/jbc.M116.727990			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27624941	Green Published, hybrid			2022-12-26	WOS:000391568200010
J	Ueda, Y; Frindte, K; Knief, C; Ashrafuzzaman, M; Frei, M				Ueda, Yoshiaki; Frindte, Katharina; Knief, Claudia; Ashrafuzzaman, Md; Frei, Michael			Effects of Elevated Tropospheric Ozone Concentration on the Bacterial Community in the Phyllosphere and Rhizoplane of Rice	PLOS ONE			English	Article							GROUND-LEVEL OZONE; MICROBIAL COMMUNITIES; RHIZOSPHERE MICROBIOME; ARABIDOPSIS-THALIANA; ATMOSPHERIC CO2; AIR-QUALITY; CELL-DEATH; PLANTS; CARBON; SOIL	Microbes constitute a vital part of the plant holobiont. They establish plant-microbe or microbe-microbe associations, forming a unique microbiota with each plant species and under different environmental conditions. These microbial communities have to adapt to diverse environmental conditions, such as geographical location, climate conditions and soil types, and are subjected to changes in their surrounding environment. Elevated ozone concentration is one of the most important aspects of global change, but its effect on microbial communities living on plant surfaces has barely been investigated. In the current study, we aimed at elucidating the potential effect of elevated ozone concentrations on the phyllosphere (aerial part of the plant) and rhizoplane (surface of the root) microbiota by adopting next-generation 16S rRNA amplicon sequencing. A standard japonica rice cultivar Nipponbare and an ozone-tolerant breeding line L81 (Nipponbare background) were pre-grown in a greenhouse for 10 weeks and then exposed to ozone at 85 ppb for 7 h daily for 30 days in open top chambers. Microbial cells were collected from the phyllosphere and rhizoplane separately. The treatment or different genotypes did not affect various diversity indices. On the other hand, the relative abundance of some bacterial taxa were significantly affected in the rhizoplane community of ozone-treated plants. A significant effect of ozone was detected by homogeneity of molecular variance analysis in the phyllosphere, meaning that the community from ozone-treated phyllosphere samples was more variable than those from control plants. In addition, a weak treatment effect was observed by clustering samples based on the Yue and Clayton and weighted UniFrac distance matrices among samples. We therefore conclude that the elevated ozone concentrations affected the bacterial community structure of the phyllosphere and the rhizosplane as a whole, even though this effect was rather weak and did not lead to changes of the function of the communities.	[Ueda, Yoshiaki; Ashrafuzzaman, Md; Frei, Michael] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Nu, Bonn, Germany; [Frindte, Katharina; Knief, Claudia] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Mol Biol, Bonn, Germany; [Ueda, Yoshiaki] Univ Tokyo, Biotechnol Res Ctr, Plant Biotechnol Lab, Tokyo, Japan	University of Bonn; University of Bonn; University of Tokyo	Frei, M (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES Plant Nu, Bonn, Germany.	mfrei@uni-bonn.de	, Ashrafuzzaman/P-6485-2016; Ashrafuzzaman/O-7750-2014; Frei, Michael/K-5511-2013; Knief, Claudia/H-1221-2013	, Ashrafuzzaman/0000-0001-8564-7943; Ashrafuzzaman/0000-0001-8454-3173; Frei, Michael/0000-0002-2474-6558; Knief, Claudia/0000-0001-9939-6241; Frindte, Katharina/0000-0002-6801-5853; Ueda, Yoshiaki/0000-0002-4304-368X	Deutsche Forschungsgemeinschaft [FR2952-1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was financially supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/; Project ID FR2952-1/1).	Ai C, 2015, SOIL BIOL BIOCHEM, V80, P70, DOI 10.1016/j.soilbio.2014.09.028; Ainsworth EA, 2012, ANNU REV PLANT BIOL, V63, P637, DOI 10.1146/annurev-arplant-042110-103829; Akimoto H, 2003, SCIENCE, V302, P1716, DOI 10.1126/science.1092666; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; Andersen CP, 1995, NEW PHYTOL, V131, P471, DOI 10.1111/j.1469-8137.1995.tb03084.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLASCHKE H, 1990, ENVIRON POLLUT, V68, P409, DOI 10.1016/0269-7491(90)90041-A; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Brandt BW, 2012, NUCLEIC ACIDS RES, V40, pW82, DOI 10.1093/nar/gks418; Bringel F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00486; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen CP, 2011, PLANT CELL ENVIRON, V34, P1141, DOI 10.1111/j.1365-3040.2011.02312.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; DYAS A, 1983, J CLIN PATHOL, V36, P1102, DOI 10.1136/jcp.36.10.1102; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Elford WJ, 1942, J HYG-CAMBRIDGE, V42, P240, DOI 10.1017/S0022172400035464; ERNST D, 1992, PLANT MOL BIOL, V20, P673, DOI 10.1007/BF00046452; Fares S, 2008, PLANT BIOLOGY, V10, P44, DOI 10.1055/s-2007-965257; Feng YZ, 2015, ENVIRON POLLUT, V197, P195, DOI 10.1016/j.envpol.2014.11.032; Feng YZ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03193; Feng ZZ, 2014, ENVIRON POLLUT, V193, P296, DOI 10.1016/j.envpol.2014.06.004; Franks PJ, 2013, NEW PHYTOL, V197, P1077, DOI 10.1111/nph.12104; Frei M, 2008, J EXP BOT, V59, P3741, DOI 10.1093/jxb/ern222; Frei M, 2015, ENVIRON POLLUT, V197, P144, DOI 10.1016/j.envpol.2014.12.011; Frei M, 2010, J EXP BOT, V61, P1405, DOI 10.1093/jxb/erq007; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gutjahr C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00204; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; Holler S, 2014, PLANTA, V239, P367, DOI 10.1007/s00425-013-1978-x; Im WT, 2010, INT J SYST EVOL MICR, V60, P1565, DOI 10.1099/ijs.0.014514-0; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Innerebner G, 2011, APPL ENVIRON MICROB, V77, P3202, DOI 10.1128/AEM.00133-11; Jing LQ, 2016, ENVIRON POLLUT, V210, P397, DOI 10.1016/j.envpol.2016.01.023; Junker RR, 2013, J CHEM ECOL, V39, P810, DOI 10.1007/s10886-013-0325-9; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; Katanic M, 2014, EUR J FOREST RES, V133, P735, DOI 10.1007/s10342-013-0751-9; Kerner R, 2014, J PROTEOMICS, V109, P417, DOI 10.1016/j.jprot.2014.05.021; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LAISK A, 1989, PLANT PHYSIOL, V90, P1163, DOI 10.1104/pp.90.3.1163; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lei H, 2013, ATMOS ENVIRON, V68, P315, DOI 10.1016/j.atmosenv.2012.12.002; Lelieveld J, 2000, J GEOPHYS RES-ATMOS, V105, P3531, DOI 10.1029/1999JD901011; Loya WM, 2003, NATURE, V425, P705, DOI 10.1038/nature02047; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Maignien L, 2014, MBIO, V5, DOI 10.1128/mBio.00682-13; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mills G, 2007, ATMOS ENVIRON, V41, P2630, DOI 10.1016/j.atmosenv.2006.11.016; Niswati A, 2005, SOIL SCI PLANT NUTR, V51, P565, DOI 10.1111/j.1747-0765.2005.tb00065.x; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Quain MD, 2015, PHYTOCHEMISTRY, V112, P179, DOI 10.1016/j.phytochem.2014.12.027; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rai R, 2015, ECOTOX ENVIRON SAFE, V112, P29, DOI 10.1016/j.ecoenv.2014.10.031; Ren GD, 2014, APPL MICROBIOL BIOT, V98, P9459, DOI 10.1007/s00253-014-5915-0; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sugano S, 2010, PLANT MOL BIOL, V74, P549, DOI 10.1007/s11103-010-9695-3; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; TURNER NC, 1974, NATURE, V250, P486, DOI 10.1038/250486a0; Ueda Y, 2015, PLANT PHYSIOL, V169, P873, DOI 10.1104/pp.15.00956; Vainonen JP, 2015, PLANT CELL ENVIRON, V38, P240, DOI 10.1111/pce.12273; van Dam NM, 2016, TRENDS PLANT SCI, V21, P256, DOI 10.1016/j.tplants.2016.01.008; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wang SG, 2011, J ENVIRON SCI-CHINA, V23, P968, DOI 10.1016/S1001-0742(10)60503-7; Wang XK, 2007, ENVIRON POLLUT, V147, P394, DOI 10.1016/j.envpol.2006.05.006; Wang XN, 2015, ENVIRON POLLUT, V197, P116, DOI 10.1016/j.envpol.2014.11.031; Wang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01748; Wang YX, 2014, ENVIRON EXP BOT, V104, P26, DOI 10.1016/j.envexpbot.2014.03.005; Yamaji K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008663; Yoshida S, 2009, PHYSIOL PLANTARUM, V136, P284, DOI 10.1111/j.1399-3054.2009.01220.x; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zhang JW, 2016, ENVIRON POLLUT, V213, P127, DOI 10.1016/j.envpol.2016.01.062	90	21	21	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163178	10.1371/journal.pone.0163178	http://dx.doi.org/10.1371/journal.pone.0163178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643794	gold, Green Submitted, Green Published			2022-12-26	WOS:000383891900036
J	Bazelet, CS; Thompson, AC; Naskrecki, P				Bazelet, Corinna S.; Thompson, Aileen C.; Naskrecki, Piotr			Testing the Efficacy of Global Biodiversity Hotspots for Insect Conservation: The Case of South African Katydids	PLOS ONE			English	Article							CAPE FLORISTIC REGION; SPECIES RICHNESS; LEAFHOPPERS HOMOPTERA; DIVERSITY; ENDEMISM; RESTIONACEAE; DRAGONFLIES; PATTERNS	The use of endemism and vascular plants only for biodiversity hotspot delineation has long been contested. Few studies have focused on the efficacy of global biodiversity hotspots for the conservation of insects, an important, abundant, and often ignored component of biodiversity. We aimed to test five alternative diversity measures for hotspot delineation and examine the efficacy of biodiversity hotspots for conserving a non-typical target organism, South African katydids. Using a 1 degrees fishnet grid, we delineated katydid hotspots in two ways: (1) count-based: grid cells in the top 10% of total, endemic, threatened and/or sensitive species richness; vs. (2) score-based: grid cells with a mean value in the top 10% on a scoring system which scored each species on the basis of its IUCN Red List threat status, distribution, mobility and trophic level. We then compared katydid hotspots with each other and with recognized biodiversity hotspots. Grid cells within biodiversity hotspots had significantly higher count-based and score-based diversity than non-hotspot grid cells. There was a significant association between the three types of hotspots. Of the count-based measures, endemic species richness was the best surrogate for the others. However, the score-based measure out-performedall count-based diversity measures. Species richness was the least successful surrogate of all. The strong performance of the score-based method for hotspot prediction emphasizes the importance of including species' natural history information for conservation decision-making, and is easily adaptable to other organisms. Furthermore, these results add empirical support for the efficacy of biodiversity hotspots in conserving non-target organisms.	[Bazelet, Corinna S.; Thompson, Aileen C.] Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa; [Naskrecki, Piotr] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Stellenbosch University; Harvard University	Bazelet, CS (corresponding author), Univ Stellenbosch, Dept Conservat Ecol & Entomol, Private Bag X1, ZA-7602 Matieland, South Africa.	cbazelet@sun.ac.za	van der Mescht, Aileen/AAY-3475-2021		South Africa's National Research Foundation (NRF)	South Africa's National Research Foundation (NRF)(National Research Foundation - South Africa)	CSB was funded through South Africa's National Research Foundation (NRF) Innovation Postdoctoral Fellowship. The authors received no specific funding for this work.	[Anonymous], 2015, ARCGIS 9 2; BJORNSTAD ON, 2013, NCF SPATIAL NONPARAM; Braschler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031463; Burnham K. P., 2002, MODEL SELECTION AND; Cadotte MW, 2010, DIVERS DISTRIB, V16, P376, DOI 10.1111/j.1472-4642.2010.00650.x; COLWELL R. K., 2013, ESTIMATES STATISTICA; Cottrell C.B., 1985, Transvaal Museum Monograph, P115; DAVIES DM, 1988, J ENTOMOL SOC S AFR, V51, P31; DAVIES DM, 1988, J ENTOMOL SOC S AFR, V51, P65; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Eades DC, 2015, ORTHOPTERASPECIES FI; Giliomee JH, 2003, AFR J ECOL, V41, P237, DOI 10.1046/j.1365-2028.2003.00442.x; Grant PBC, 2007, BIODIVERS CONSERV, V16, P787, DOI 10.1007/s10531-005-6201-3; Huang JH, 2012, DIVERS DISTRIB, V18, P673, DOI 10.1111/j.1472-4642.2011.00845.x; International Union for Conservation of Nature, 2012, IUCN RED LIST CATEGO; International Union for Conservation of Nature, 2014, THE IUCN RED LIST OF; Jennings MD, 2008, BIODIVERS CONSERV, V17, P833, DOI 10.1007/s10531-008-9322-7; Kaltenbach A.P., 1990, P280; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; Kleynhans E, 2009, BIOL LETTERS, V5, P93, DOI 10.1098/rsbl.2008.0545; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Magoba RN, 2010, J INSECT CONSERV, V14, P627, DOI 10.1007/s10841-010-9291-5; Mucina L, 2006, THE VEGETATION OF SO; Mugleston JD, 2013, MOL PHYLOGENET EVOL, V69, P1120, DOI 10.1016/j.ympev.2013.07.014; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Naskrecki P., 2008, MANTIS A MANAGER OF; Naskrecki PA, 1993, J AFRICAN ZOOLOGY, V108, P279; Naskrecki P, 2012, ZOOTAXA, P47, DOI 10.11646/zootaxa.3218.1.5; Naskrecki P, 2009, ZOOTAXA, P46, DOI 10.11646/zootaxa.2056.1.2; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pohlert T., 2015, PMCMR CALCULATE PAIR; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Price BW, 2007, MOL ECOL, V16, P2574, DOI 10.1111/j.1365-294X.2007.03328.x; Proches S, 2007, S AFR J SCI, V103, P258; Proches S, 2006, GLOBAL ECOL BIOGEOGR, V15, P445, DOI 10.1111/j.1566-822x.2006.00239.x; Proches S, 2009, MOL PHYLOGENET EVOL, V51, P94, DOI 10.1016/j.ympev.2008.05.040; Quantum GIS Development Team, 2015, QUANTUM GIS GEOGRAPH; R Development Core Team, 2015, R A LANGUAGE AND ENV; Simaika JP, 2009, BIODIVERS CONSERV, V18, P1171, DOI 10.1007/s10531-008-9484-3; Simaika JP, 2009, BIOL CONSERV, V142, P638, DOI 10.1016/j.biocon.2008.11.012; Slatyer C, 2007, J BIOGEOGR, V34, P583, DOI 10.1111/j.1365-2699.2006.01647.x; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Wright MG, 1998, OECOLOGIA, V115, P427, DOI 10.1007/s004420050537	47	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160630	10.1371/journal.pone.0160630	http://dx.doi.org/10.1371/journal.pone.0160630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631131	Green Published, gold			2022-12-26	WOS:000383706900009
J	El Atat, O; Antonios, D; Hilal, G; Hokayem, N; Abou-Ghoch, J; Hashim, H; Serhal, R; Hebbo, C; Moussa, M; Alaaeddine, N				El Atat, Oula; Antonios, Diane; Hilal, George; Hokayem, Nabil; Abou-Ghoch, Joelle; Hashim, Hussein; Serhal, Rim; Hebbo, Clara; Moussa, Mayssam; Alaaeddine, Nada			An Evaluation of the Stemness, Paracrine, and Tumorigenic Characteristics of Highly Expanded, Minimally Passaged Adipose-Derived Stem Cells	PLOS ONE			English	Article							THERAPY POSITION STATEMENT; MESENCHYMAL STROMAL CELLS; GROWTH-PROMOTING ACTIVITY; TISSUE INHIBITOR; BONE-MARROW; TELOMERASE ACTIVITY; REGENERATIVE MEDICINE; INTERNATIONAL-SOCIETY; SIGNALING PATHWAY; LIFE-SPAN	The use of adipose-derived stem cells (ADSC) in regenerative medicine is rising due to their plasticity, capacity of differentiation and paracrine and trophic effects. Despite the large number of cells obtained from adipose tissue, it is usually not enough for therapeutic purposes for many diseases or cosmetic procedures. Thus, there is the need for culturing and expanding cells in-vitro for several weeks remain. Our aim is to investigate if long-term proliferation with minimal passaging will affect the stemness, paracrine secretions and carcinogenesis markers of ADSC. The immunophenotypic propertiesand aldehyde dehydrogenase (ALDH) activity of the initial stromal vascular fraction (SVF) and serially passaged ADSC were observed by flow cytometry. In parallel, the telomerase activity and the relative expression of oncogenes and tumor suppressor genes were assessed by q-PCR. We also assessed the cytokine secretion profile of passaged ADSC by an ELISA. The expanded ADSC retain their morphological and phenotypical characteristics. These cells maintained in culture for up to 12 weeks until P4, possessed stable telomerase and ALDH activity, without having a TP53mutation. Furthermore, the relative expression levels of TP53, RB, and MDM2 were not affected while the relative expression of c-Myc decreased significantly. Finally, the levels of the secretions of PGE2, STC1, and TIMP2 were not affected but the levels of IL-6, VEGF, and TIMP 1 significantly decreased at P2. Our results suggest that the expansion of passaged ADSC does not affect the differentiation capacity of stem cells and does not confer a cancerous state or capacity in vitro to the cells.	[El Atat, Oula; Serhal, Rim; Hebbo, Clara; Moussa, Mayssam; Alaaeddine, Nada] St Joseph Univ, Regenerat Med & Inflammat Lab, Fac Med, Beirut, Lebanon; [Antonios, Diane] St Joseph Univ, Toxicol Lab, Fac Pharm, Beirut, Lebanon; [Hilal, George] St Joseph Univ, Canc & Metab Lab, Fac Med, Beirut, Lebanon; [Hokayem, Nabil] Hotel Dieu France, Dept Plast & Reconstruct Surg, Beirut, Lebanon; [Hokayem, Nabil] St Joseph Univ, Fac Med, Beirut, Lebanon; [Abou-Ghoch, Joelle] St Joseph Univ, Med Genet Unit, Fac Med, Beirut, Lebanon; [Hashim, Hussein] Fuad Khoury Hosp, Dept Plast & Reconstruct Surg, Beirut, Lebanon		Alaaeddine, N (corresponding author), St Joseph Univ, Regenerat Med & Inflammat Lab, Fac Med, Beirut, Lebanon.	nada.aladdin@usj.edu.lb	atat, oula el/AAH-7689-2019; Antonios, Diane/ABG-5120-2020	atat, oula el/0000-0003-1341-0204; antonios, diane/0000-0003-2740-1640	Research Council of Saint-Joseph University	Research Council of Saint-Joseph University	This work was supported in whole by the Research Council of Saint-Joseph University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTAUX B, 1991, J INVEST DERMATOL, V97, P679, DOI 10.1111/1523-1747.ep12483956; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Bouchard C, 1998, TRENDS CELL BIOL, V8, P202, DOI 10.1016/S0962-8924(98)01251-3; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caterson Edward J., 2008, Birth Defects Research, V84, P322, DOI 10.1002/bdrc.20139; Chatterjee D, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0063-9; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dennis J E, 1992, Cell Transplant, V1, P23; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elenitoba-Johnson KSJ, 2001, AM J PATHOL, V159, P405, DOI 10.1016/S0002-9440(10)61710-5; Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808; Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gao Q, 2012, MOL BIOL REP, V39, P5791, DOI 10.1007/s11033-011-1371-4; Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ihn H, 2002, J IMMUNOL, V168, P1895, DOI 10.4049/jimmunol.168.4.1895; Ivanova-Todorova E, 2009, IMMUNOL LETT, V126, P37, DOI 10.1016/j.imlet.2009.07.010; Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904; Jean E, 2011, J CELL MOL MED, V15, P119, DOI 10.1111/j.1582-4934.2009.00942.x; Jeon BG, 2011, CELL TISSUE RES, V345, P149, DOI 10.1007/s00441-011-1191-9; Kang SK, 2004, STEM CELLS, V22, P1356, DOI 10.1634/stemcells.2004-0023; Kaplanski G, 2003, TRENDS IMMUNOL, V24, P25, DOI 10.1016/S1471-4906(02)00013-3; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Kota DJ, 2013, DIABETES, V62, P2048, DOI 10.2337/db12-0931; Lambert E, 2003, BIOCHEM J, V372, P767, DOI 10.1042/BJ20030187; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li H, 2010, TOHOKU J EXP MED, V222, P131, DOI 10.1620/tjem.222.131; Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091; Liu XW, 2003, J BIOL CHEM, V278, P40364, DOI 10.1074/jbc.M302999200; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Manferdini C, 2013, ARTHRITIS RHEUM-US, V65, P1271, DOI 10.1002/art.37908; Melief SM, 2013, HAEMATOLOGICA, V98, pE121, DOI 10.3324/haematol.2013.093864; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakanishi C, 2011, CIRC J, V75, P2260, DOI 10.1253/circj.CJ-11-0246; Nava MB, 2015, PLAST RECONSTR SURG, V135, p114E, DOI 10.1097/PRS.0000000000001008; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Oh JY, 2014, STEM CELLS, V32, P1553, DOI 10.1002/stem.1608; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Parsch D, 2004, J MOL MED-JMM, V82, P49, DOI 10.1007/s00109-003-0506-z; Paula ACC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0030-4; Qi Y, 2014, J INVEST DERMATOL, V134, P526, DOI 10.1038/jid.2013.328; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Rodriguez R, 2013, STEM CELLS, V31, P2061, DOI 10.1002/stem.1472; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Rubio R, 2013, ONCOGENE, V32, P4970, DOI 10.1038/onc.2012.507; Rubio R, 2014, STEM CELLS, V32, P1136, DOI 10.1002/stem.1647; Schneider-Stock R, 2003, PATHOL RES PRACT, V199, P445, DOI 10.1078/0344-0338-00444; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028; Sterodimas A, 2009, ANN PLAS SURG, V62, P97, DOI 10.1097/SAP.0b013e3181788ec9; STETLERSTEVENSON WG, 1992, FEBS LETT, V296, P231, DOI 10.1016/0014-5793(92)80386-U; Tang LN, 2012, CELL REPROGRAM, V14, P342, DOI 10.1089/cell.2011.0098; Ueda M, 1997, CANCER RES, V57, P370; Yanez R, 2010, EXP CELL RES, V316, P3109, DOI 10.1016/j.yexcr.2010.08.008; Zaman WSWK, 2014, J TISSUE ENG REGEN M, V8, P67, DOI 10.1002/term.1501; Zeng X, 2007, NEUROSCIENCE, V145, P1348, DOI 10.1016/j.neuroscience.2006.09.017; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	76	12	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162332	10.1371/journal.pone.0162332	http://dx.doi.org/10.1371/journal.pone.0162332			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632538	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900038
J	Oliveira, ERA; Goncalves, AJS; Costa, SM; Azevedo, AS; Mantuano-Barradas, M; Nogueira, ACMA; Alves, AMB				Oliveira, Edson R. A.; Goncalves, Antonio J. S.; Costa, Simone M.; Azevedo, Adriana S.; Mantuano-Barradas, Marcio; Nogueira, Ana Cristina M. A.; Alves, Ada M. B.			Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; BALB/C MICE; VIRUS-INFECTION; NS1 GENE; CD4(+); PROTECTION; RESPONSES; DISEASE; TRAFFICKING; ANESTHETICS	Dengue disease has emerged as a major public health issue across tropical and subtropical countries. Infections caused by dengue virus (DENV) can evolve to life-threatening forms, resulting in about 20,000 deaths every year worldwide. Several animal models have been described concerning pre-clinical stages in vaccine development against dengue, each of them presenting limitations and advantages. Among these models, a traditional approach is the inoculation of a mouse-brain adapted DENV variant in immunocompetent animals by the intracerebral (i.c.) route. Despite the historical usage and relevance of this model for vaccine testing, little is known about the mechanisms by which the protection is developed upon vaccination. To cover this topic, a DNA vaccine based on the DENV non-structural protein 1 (pcTPANS1) was considered and investigations were focused on the induced T cell-mediated immunity against i.c.-DENV infection. Immunophenotyping assays by flow cytometry revealed that immunization with pcTPANS1 promotes a sustained T cell activation in spleen of i.c.-infected mice. Moreover, we found that the downregulation of CD45RB on T cells, as an indicator of cell activation, correlated with absence of morbidity upon virus challenge. Adoptive transfer procedures supported by CFSE-labeled cell tracking showed that NS1-specific T cells induced by vaccination, proliferate and migrate to peripheral organs of infected mice, such as the liver. Additionally, in late stages of infection (from the 7th day onwards), vaccinated mice also presented reduced levels of circulating IFN-gamma and IL-12p70 in comparison to non-vaccinated animals. In conclusion, this work presented new aspects about the T cell-mediated immunity concerning DNA vaccination with pcTPANS1 and the i.c. infection model. These insights can be explored in further studies of anti-dengue vaccine efficacy.	[Oliveira, Edson R. A.; Goncalves, Antonio J. S.; Costa, Simone M.; Azevedo, Adriana S.; Mantuano-Barradas, Marcio; Nogueira, Ana Cristina M. A.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil; [Nogueira, Ana Cristina M. A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Nogueira, ACMA; Alves, AMB (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil.; Nogueira, ACMA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Clin Immunol Lab, Rio De Janeiro, Brazil.	ana.martins@ioc.fiocruz.br; ada@ioc.fiocruz.br	Nogueira, Ana Cristina M A/C-2200-2013	Oliveira, Edson RA/0000-0002-8606-7454; Souza Azevedo, Adriana/0000-0001-7401-5107	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [44371/2014-0]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E26/110.271/2014]; Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) [573547/2008-4]; Programa de Desenvolvimento Tecnologico e Inovacao em Saude da Fundacao Oswaldo Cruz (PDTIS-FIOCRUZ) [RVR11]	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Programa de Desenvolvimento Tecnologico e Inovacao em Saude da Fundacao Oswaldo Cruz (PDTIS-FIOCRUZ)	This work was supported by the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) (grant number: 44371/2014-0) - http://www.cnpq.br/, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (grant number: E26/110.271/2014) - http://www.faperj.br/, Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV) (grant number: 573547/2008-4) - http://www.cpqrr.fiocruz.br/inctv/, Programa de Desenvolvimento Tecnologico e Inovacao em Saude da Fundacao Oswaldo Cruz (PDTIS-FIOCRUZ) (grant number: RVR11) - http://www.castelo.fiocruz.br/vpplr/pdtis.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528; Bentivoglio M, 2014, TRENDS NEUROSCI, V37, P325, DOI 10.1016/j.tins.2014.03.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Buitrago S, 2008, J AM ASSOC LAB ANIM, V47, P11; Camirand G, 2014, J CLIN INVEST, V124, P4603, DOI 10.1172/JCI74087; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15; de Matos AM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003520; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Goncalves AJS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004277; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Gurunathan S, 2000, CURR OPIN IMMUNOL, V12, P442, DOI 10.1016/S0952-7915(00)00118-7; Hawk TA, 2005, FORMULARY LAB ANIMAL; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Krummey SM, 2016, J IMMUNOL, V196, P2838, DOI 10.4049/jimmunol.1500639; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Malavige GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050387; Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Remakus S, 2013, ADV EXP MED BIOL, V785, P77, DOI 10.1007/978-1-4614-6217-0_9; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; SABIN AB, 1945, SCIENCE, V101, P640, DOI 10.1126/science.101.2634.640; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Sreekanth GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149486; Sung JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046292; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; World Health Organization, 2009, DENGUE GUIDELINES DI; Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P499, DOI 10.1111/j.1440-1681.2007.04601.x; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709	51	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163240	10.1371/journal.pone.0163240	http://dx.doi.org/10.1371/journal.pone.0163240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631083	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900139
J	Dey, P; Panga, V; Raghunathan, S				Dey, Poulami; Panga, Venugopal; Raghunathan, Srivatsan			A Cytokine Signalling Network for the Regulation of Inducible Nitric Oxide Synthase Expression in Rheumatoid Arthritis	PLOS ONE			English	Article							NF-KAPPA-B; IFN-GAMMA; GENE-EXPRESSION; UP-REGULATION; TGF-BETA; MACROPHAGE ACTIVATION; JAK/STAT PATHWAY; SYNOVIAL-FLUID; NO SYNTHASE; PROTEIN	In rheumatoid arthritis (RA), nitric oxide (NO) is implicated in inflammation, angiogenesis and tissue destruction. The enzyme inducible nitric oxide synthase (iNOS) is responsible for the localised over-production of NO in the synovial joints affected by RA. The pro-and anti-inflammatory cytokines stimulate the synovial macrophages and the fibroblast-like synoviocytes to express iNOS. Therefore, the cytokine signalling network underlying the regulation of iNOS is essential to understand the pathophysiology of the disease. By using information from the literature, we have constructed, for the first time, the cytokine signalling network involved in the regulation of iNOS expression. Using the differential expression patterns obtained by re-analysing the microarray data on the RA synovium and the synovial macrophages available in the Gene Expression Omnibus (GEO) database, we aimed to establish the role played by the network genes towards iNOS regulation in the RA synovium. Our analysis reveals that the network genes belonging to interferon (IFN) and interleukin-10 (IL-10) pathways are always up-regulated in the RA synovium whereas the genes which are part of the anti-inflammatory transforming growth factor-beta (TGF-beta) signalling pathway are mostly down-regulated. We observed a consistent up-regulation of the transcription factor signal transducers and activators of transcription 1 (STAT1) in the RA synovium and the macrophages. Interestingly, we found a consistent up-regulation of the iNOS interacting protein ras-related C3 botulinum toxin substrate 2 (RAC2) in the RA synovium as well as the macrophages. Importantly, we have constructed a model to explain the impact of IFN and IL-10 pathways on Rac2-iNOS interaction leading to over-production of NO and thereby causing chronic inflammation in the RA synovium. The interplay between STAT1 and RAC2 in the regulation of NO could have implications for the identification of therapeutic targets for RA.	[Dey, Poulami; Panga, Venugopal; Raghunathan, Srivatsan] IBAB, Biotech Pk,Elect City Phase 1, Bengaluru 560100, Karnataka, India; [Dey, Poulami; Panga, Venugopal] Manipal Univ, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Raghunathan, S (corresponding author), IBAB, Biotech Pk,Elect City Phase 1, Bengaluru 560100, Karnataka, India.	srivatsan@ibab.ac.in		panga, venugopal/0000-0002-9262-3277	Indian Council of Medical Research (ICMR), India [3/1/3JRF-2013/HRD-106(20835)]; Council of Scientific and Industrial Research (CSIR), INDIA [09/1086(0001)/2012-EMR-1]; Department of Biotechnology, Government of India [BTPR12422/MED/31/287/2014]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), INDIA(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The authors received their salaries from the following funding agencies: Poulami Dey from Indian Council of Medical Research (ICMR), India, Grant No. 3/1/3JRF-2013/HRD-106(20835). Venugopal Panga from Council of Scientific and Industrial Research (CSIR), INDIA, Grant No. 09/1086(0001)/2012-EMR-1. Srivatsan Raghunathan from Department of Biotechnology, Government of India, Grant No. BTPR12422/MED/31/287/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2008, OSTEOARTHR CARTILAGE, V16, pS15, DOI 10.1016/S1063-4584(08)60008-4; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Avramescu Carmen, 2005, Rom J Morphol Embryol, V46, P87; Berg DT, 2007, J BIOL CHEM, V282, P36837, DOI 10.1074/jbc.M706909200; Borderie D, 2002, NITRIC OXIDE-BIOL CH, V6, P271, DOI 10.1006/niox.2001.0418; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Burke SJ, 2013, MOL ENDOCRINOL, V27, P1724, DOI 10.1210/me.2013-1159; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chan ED, 1999, J IMMUNOL, V162, P415; CHEN E, 1993, ARTHRITIS RHEUM, V36, P901, DOI 10.1002/art.1780360706; CHESROWN SE, 1994, BIOCHEM BIOPH RES CO, V200, P126, DOI 10.1006/bbrc.1994.1424; Coccia EM, 2000, INT IMMUNOL, V12, P977, DOI 10.1093/intimm/12.7.977; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; FARRELL AJ, 1992, ANN RHEUM DIS, V51, P1219, DOI 10.1136/ard.51.11.1219; Fearon U, 1999, ANN NY ACAD SCI, V878, P619, DOI 10.1111/j.1749-6632.1999.tb07743.x; Gao QY, 2016, INT J MOL MED, V37, P347, DOI 10.3892/ijmm.2015.2433; Grabowski PS, 1996, BRIT J RHEUMATOL, V35, P207; Grabowski PS, 1997, BRIT J RHEUMATOL, V36, P651; Guo Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146640; Habelhah Hasem, 2010, Genes Cancer, V1, P735; Hiroi M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/369693; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huber R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2485; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Ivashkiv LB, 2003, ARTHRITIS RHEUM, V48, P2092, DOI 10.1002/art.11095; Jyoti A, 2014, ANTIOXID REDOX SIGN, V20, P417, DOI 10.1089/ars.2012.4970; Kaur J, 2014, IJRCI, V2, pOA2; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Kuncewicz T, 2001, AM J PHYSIOL-RENAL, V281, pF326, DOI 10.1152/ajprenal.2001.281.2.F326; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee S, 2005, CANC RES, V65; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Luu K, 2014, IMMUNOL CELL BIOL, P1; Mao RF, 2011, CELL SIGNAL, V23, P222, DOI 10.1016/j.cellsig.2010.09.006; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nagy G, 2007, IMMUNOL LETT, V111, P1, DOI 10.1016/j.imlet.2007.04.013; Nguyen H, 2003, J INTERF CYTOK RES, V23, P183, DOI 10.1089/107999003765027384; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Paramalingam SS, 2007, ANN ACAD MED SINGAP, V36, P96; Park KS, 2009, J MOL BIOL, V390, P595, DOI 10.1016/j.jmb.2009.05.036; Pohlers D, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2217; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292; Srirangan S, 2010, THER ADV MUSCULOSKEL, V2, P247, DOI 10.1177/1759720X10378372; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Ueki Y, 1996, J RHEUMATOL, V23, P230; Ungethuem U, 2010, PHYSIOL GENOMICS, V42A, P267, DOI 10.1152/physiolgenomics.00004.2010; Walker JG, 2005, J RHEUMATOL, V32, P1650; Werner F, 2000, J BIOL CHEM, V275, P36653, DOI 10.1074/jbc.M004536200; Woetzel D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4526; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhu XJ, 1997, MOL CELL BIOL, V17, P6618, DOI 10.1128/MCB.17.11.6618	71	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161306	10.1371/journal.pone.0161306	http://dx.doi.org/10.1371/journal.pone.0161306			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626941	gold, Green Submitted, Green Published			2022-12-26	WOS:000383680600004
J	Ge, Y; Bruno, M; Haykal-Coates, N; Wallace, K; Andrews, D; Swank, A; Winnik, W; Ross, JA				Ge, Yue; Bruno, Maribel; Haykal-Coates, Najwa; Wallace, Kathleen; Andrews, Debora; Swank, Adam; Winnik, Witold; Ross, Jeffrey A.			Proteomic Assessment of Biochemical Pathways That Are Critical to Nickel-Induced Toxicity Responses in Human Epithelial Cells	PLOS ONE			English	Article							14-3-3 PROTEINS; EXPRESSION; HYPOXIA; HIF-1-ALPHA; BINDING; MARKERS; NI(II); A2	Understanding the mechanisms underlying toxicity initiated by nickel, a ubiquitous environmental contaminant and known human carcinogen is necessary for proper assessment of its risks to human and environment. Among a variety of toxic mechanisms, disruption of protein responses and protein response-based biochemical pathways represents a key mechanism through which nickel induces cytotoxicity and carcinogenesis. To identify protein responses and biochemical pathways that are critical to nickel-induced toxicity responses, we measured cytotoxicity and changes in expression and phosphorylation status of 14 critical biochemical pathway regulators in human BEAS-2B cells exposed to four concentrations of nickel using an integrated proteomic approach. A subset of the pathway regulators, including interleukin-6, and JNK, were found to be linearly correlated with cell viability, and may function as molecular determinants of cytotoxic responses of BEAS-2B cells to nickel exposures. In addition, 128 differentially expressed proteins were identified by two dimensional electrophoresis (2-DE) and mass spectrometry. Principal component analysis, hierarchical cluster analyses, and ingenuity signaling pathway analysis (IPA) identified putative nickel toxicity pathways. Some of the proteins and pathways identified have not previously been linked to nickel toxicity. Based on the consistent results obtained from both ELISA and 2-DE proteomic analysis, we propose a core signaling pathway regulating cytotoxic responses of human BEAS-2B cells to nickel exposures, which integrates a small set of proteins involved in glycolysis and gluconeogenesis pathways, apoptosis, protein degradation, and stress responses including inflammation and oxidative stress.	[Ge, Yue; Bruno, Maribel; Haykal-Coates, Najwa; Wallace, Kathleen; Andrews, Debora; Swank, Adam; Winnik, Witold; Ross, Jeffrey A.] US EPA, Natl Hlth & Environm Effects Res Lab, Durham, NC USA	United States Environmental Protection Agency	Ge, Y (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Durham, NC USA.	Ge.Yue@epa.gov	Ross, Jeffrey/E-4782-2010	Ross, Jeffrey/0000-0002-7002-4548	US Environmental Protection Agency; Pathfinder Innovation Project (PIP) from Office of Research and Development (ORD), US Environmental Protection Agency	US Environmental Protection Agency(United States Environmental Protection Agency); Pathfinder Innovation Project (PIP) from Office of Research and Development (ORD), US Environmental Protection Agency	The research was funded by Pathfinder Innovation Project from US Environmental Protection Agency.; This research was supported by the Pathfinder Innovation Project (PIP) from Office of Research and Development (ORD), US Environmental Protection Agency. The authors also would like to thank Drs. Sheau-Fung Thai, Aimen Farraj, and Charlene McQueen for their very helpful comments on this manuscript, and Alan Tennant for his assistance on the apoptosis imaging. The information in this document has been funded wholly by the US Environmental Protection Agency. It has been subjected to review by the National Health and Environmental Effects Research Laboratory and approved for publication. Approval does not signify that the contents reflect the views of the Agency nor doesmention of trade names or commercial products constitute endorsement or recommendation for use.	Ambler DR, 2012, SYST BIOL REPROD MED, V58, P324, DOI 10.3109/19396368.2012.713439; Andrew AS, 2001, AM J PHYSIOL-LUNG C, V281, pL607, DOI 10.1152/ajplung.2001.281.3.L607; BERNAL SD, 1985, CRC CR REV ONCOL-HEM, V3, P191, DOI 10.1016/S1040-8428(85)80026-3; Branescu C, 2013, CHIRURGIA-BUCHAREST, V108, P206; Brant KA, 2009, TOXICOL SCI, V107, P227, DOI 10.1093/toxsci/kfn208; Carpenter RL, 2013, CURR CANCER DRUG TAR, V13, P252; Chen L, 2009, ENVIRON HEALTH PERSP, V117, P1124, DOI 10.1289/ehp.0800157; Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Ding J, 2009, CANCER EPIDEM BIOMAR, V18, P1720, DOI 10.1158/1055-9965.EPI-09-0115; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741; GUENICHE A, 1994, ARCH DERMATOL RES, V286, P466, DOI 10.1007/BF00371573; Harris GK, 2001, MUTAT RES, V533, P2183; HARTWIG A, 1994, TOXICOL LETT, V72, P353, DOI 10.1016/0378-4274(94)90048-5; Jung H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.558; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kasprzak KS, 2003, MUTAT RES-FUND MOL M, V533, P67, DOI 10.1016/j.mrfmmm.2003.08.021; Kim HL, 2012, ONCOL REP, V28, P1959, DOI 10.3892/or.2012.2057; Kim SU, 2014, STEM CELLS, V32, P998, DOI 10.1002/stem.1593; Kirkaldy AA, 2003, CLIN EXP IMMUNOL, V134, P447, DOI 10.1111/j.1365-2249.2003.02306.x; Krueger I, 1999, CARCINOGENESIS, V20, P1177, DOI 10.1093/carcin/20.7.1177; Leikauf GD, 2002, CHEST, V121, p70S, DOI 10.1378/chest.121.3_suppl.70S; LEONARD A, 1981, MUTAT RES, V87, P1, DOI 10.1016/0165-1110(81)90002-6; Li JX, 2004, CANCER RES, V64, P94, DOI 10.1158/0008-5472.CAN-03-0737; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Park JH, 2006, RESPIROLOGY, V11, P269, DOI 10.1111/j.1440-1843.2006.00849.x; Reinstein E, 2004, ISR MED ASSOC J, V6, P420; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Tessier DM, 2006, TOXICOL LETT, V167, P114, DOI 10.1016/j.toxlet.2006.08.015; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Wawryk-Gawda E, 2014, PROTOPLASMA, V251, P525, DOI 10.1007/s00709-013-0548-1; Wesselkamper SC, 2006, AM J RESP CELL MOL, V34, P73, DOI 10.1165/rcmb.2005-0248OC; Wezynfeld NE, 2014, CHEM RES TOXICOL, V27, P1996, DOI 10.1021/tx500337w; Wong VC, 2013, TOXICOL APPL PHARM, V269, P233, DOI 10.1016/j.taap.2013.03.023; Xu XH, 2015, ONCOL REP, V33, P2121, DOI 10.3892/or.2015.3837	40	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162522	10.1371/journal.pone.0162522	http://dx.doi.org/10.1371/journal.pone.0162522			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626938	gold, Green Published, Green Submitted			2022-12-26	WOS:000383680600040
J	Shim, E; Kim, D; Woo, H; Cho, Y				Shim, Eunyoung; Kim, Dohyeong; Woo, Hyekyung; Cho, Youngtae			Designing a Sustainable Noise Mapping System Based on Citizen Scientists Smartphone Sensor Data	PLOS ONE			English	Article							INTERPOLATION; HEALTH	In this study, we attempted to assess the feasibility of collecting population health data via mobile devices. Specifically, we constructed noise maps based on sound information monitored by individuals' smartphones. We designed a sustainable way of creating noise maps that can overcome the shortcomings of existing station-based noise-monitoring systems. Three hundred and nine Seoul residents aged 20-49 years who used Android-based smartphones were recruited, and the subjects installed a special application that we developed for this study. This application collected information on sound and geographical location every 10 min for 7 days. Using GIS, we were able to construct various types of noise maps of Seoul (e.g., daytime/nighttime and weekdays/weekends) using the information on sound and geographical location obtained via the users' smartphones. Despite the public health importance of noise management, a number of countries and cities lack a sustainable system to monitor noise. This pilot study showed the possibility of using the smartphones of citizen scientists as an economical and sustainable way of monitoring noise, particularly in an urban context in developing countries.	[Shim, Eunyoung; Woo, Hyekyung; Cho, Youngtae] Seoul Natl Univ, Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [Shim, Eunyoung; Woo, Hyekyung; Cho, Youngtae] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Kim, Dohyeong] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX USA; [Shim, Eunyoung] Samsung Fire & Marine Insurance, Dept New Business, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Texas System; University of Texas Dallas	Cho, Y (corresponding author), Seoul Natl Univ, Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea.; Cho, Y (corresponding author), Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea.	youngtae@snu.ac.kr	Woo, hyekyung/AFJ-9969-2022		Seoul National University [900-20130074]; Seoul National University Brain Fusion Research Grant	Seoul National University; Seoul National University Brain Fusion Research Grant	This work was funded by Seoul National University #900-20130074 (Youngtae Cho).; This study was supported by the Seoul National University Brain Fusion Research Grant.	Babak O, 2009, STOCH ENV RES RISK A, V23, P543, DOI 10.1007/s00477-008-0226-6; Boulos MNK, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-67; Brush A, 2013, P SIGCHI C HUM FACT; Chatzimilioudis G, 2012, IEEE INTERNET COMPUT, V16, P36, DOI 10.1109/MIC.2012.70; Council NR, 2012, URB MET FOR MON M US; D'Hondt E, 2013, PERVASIVE MOB COMPUT, V9, P681, DOI 10.1016/j.pmcj.2012.09.002; Faggiani A, 2012, MOD OPT MOB AD HOC W; Guo B., 2014, PERV COMP COMM WORKS; Hurtley C., 2009, NIGHT NOISE GUIDELIN; Kanjo E, 2010, MOBILE NETW APPL, V15, P562, DOI 10.1007/s11036-009-0217-y; Kardous CA, 2014, J ACOUST SOC AM, V135, pEL186, DOI 10.1121/1.4865269; Kim S., 2011, P SIGCHI C HUM FACT; Lian KY, 2013, SENSORS-BASEL, V13, P17379, DOI 10.3390/s131217379; Lu GY, 2008, COMPUT GEOSCI-UK, V34, P1044, DOI 10.1016/j.cageo.2007.07.010; Ma HR, 2013, J KOREAN SOC SAFETY, V28, P24; Maisonneuve Nicolas, 2009, P 10 ANN INT C DIG G; Oke AO., 2013, ACTA GEOGRAPHICA DEB, V7, P48; Organization WH, BURD DIS ENV NOISE20; Ramos Y., 2015, J EXPOSURE SCI ENV E; Rana R., 2010, P 9 ACM IEEE INT C I; Rana R, 2015, PERVASIVE MOB COMPUT, V17, P1, DOI 10.1016/j.pmcj.2014.02.001; Spitzhirn M., 2016, ADV ERGONOMIC DESIGN, P281; Stevens M., 2010, WORKSH UBIQ CROWD; Yanosk JD, 2008, ATMOS ENVIRON, V42, P4047, DOI 10.1016/j.atmosenv.2008.01.044	24	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161835	10.1371/journal.pone.0161835	http://dx.doi.org/10.1371/journal.pone.0161835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626273	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600010
J	Crespo-Lopez, ME; Costa-Malaquias, A; Oliveira, EHC; Miranda, MS; Arrifano, GPF; Souza-Monteiro, JR; Sagica, FES; Fontes, EA; Maia, CSF; Macchi, BM; do Nascimento, JLM				Crespo-Lopez, Maria Elena; Costa-Malaquias, Allan; Oliveira, Edivaldo H. C.; Miranda, Moyses S.; Arrifano, Gabriela P. F.; Souza-Monteiro, Jose R.; Sagica, Fernanda Espirito-Santo; Fontes-Junior, Eneas A.; Maia, Cristiane S. F.; Macchi, Barbarella M.; do Nascimento, Jose Luiz M.			Is Low Non-Lethal Concentration of Methylmercury Really Safe? A Report on Genotoxicity with Delayed Cell Proliferation	PLOS ONE			English	Article							TAPAJOS RIVER-BASIN; LOW-LEVEL; DNA-DAMAGE; INDUCED NEUROTOXICITY; MOLECULAR-MECHANISMS; MERCURY POLLUTION; OXIDATIVE STRESS; BRAZILIAN AMAZON; EXPOSURE; APOPTOSIS	Human exposure to relatively low levels of methylmercury is worrying, especially in terms of its genotoxicity. It is currently unknown as to whether exposure to low levels of mercury (below established limits) is safe. Genotoxicity was already shown in lymphocytes, but studies with cells of the CNS (as the main target organ) are scarce. Moreover, disturbances in the cell cycle and cellular proliferation have previously been observed in neuronal cells, but no data are presently available for glial cells. Interestingly, cells of glial origin accumulate higher concentrations of methylmercury than those of neuronal origin. Thus, the aim of this work was to analyze the possible genotoxicity and alterations in the cell cycle and cell proliferation of a glioma cell line (C6) exposed to a low, non-lethal and non-apoptotic methylmercury concentration. Biochemical (mitochondrial activity) and morphological (integrity of the membrane) assessments confirmed the absence of cell death after exposure to 3 mu M methylmercury for 24 hours. Even without promoting cell death, this treatment significantly increased genotoxicity markers (DNA fragmentation, micronuclei, nucleoplasmic bridges and nuclear buds). Changes in the cell cycle profile (increased mitotic index and cell populations in the S and G2/M phases) were observed, suggesting arrest of the cycle. This delay in the cycle was followed, 24 hours after methylmercury withdrawal, by a decrease number of viable cells, reduced cellular confluence and increased doubling time of the culture. Our work demonstrates that exposure to a low sublethal concentration of MeHg considered relatively safe according to current limits promotes genotoxicity and disturbances in the proliferation of cells of glial origin with sustained consequences after methylmercury withdrawal. This fact becomes especially important, since this cellular type accumulates more methylmercury than neurons and displays a vital role protecting the CNS, especially in chronic intoxication with this heavy metal.	[Crespo-Lopez, Maria Elena; Costa-Malaquias, Allan; Arrifano, Gabriela P. F.; Souza-Monteiro, Jose R.] Fed Univ Para, Inst Ciencias Biol, Lab Farmacol Mol, BR-66075110 Belem, Para, Brazil; [Oliveira, Edivaldo H. C.; Sagica, Fernanda Espirito-Santo] Inst Evandro Chagas, Dept Meio Ambiente, Lab Cultura Tecidos & Citogenet, BR-67030000 Ananindeua, Para, Brazil; [Miranda, Moyses S.] Fed Univ Para, Inst Ciencias Biol, Lab Fertilizacao In Vitro, BR-66075110 Belem, Para, Brazil; [Fontes-Junior, Eneas A.; Maia, Cristiane S. F.] Fed Univ Para, Inst Ciencias Saude, Lab Farmacol Inflamacao & Comportamento, BR-66075110 Belem, Para, Brazil; [Macchi, Barbarella M.; do Nascimento, Jose Luiz M.] Fed Univ Para, Inst Ciencias Saude, Lab Neuroquim Mol & Celular, BR-66075110 Belem, Para, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Crespo-Lopez, ME (corresponding author), Fed Univ Para, Inst Ciencias Biol, Lab Farmacol Mol, BR-66075110 Belem, Para, Brazil.	maria.elena.crespo.lopez@gmail.com	de Oliveira, Edivaldo H. C./C-3368-2013; DE PAULA FONSECA ARRIFANO, GABRIELA/E-3451-2014; Miranda, Moysés dos Santos/X-1691-2019; Macchi, Barbarella/ACM-9455-2022; Crespo-Lopez, Maria Elena/X-7912-2018; Maia, Cristiane/E-7217-2016; Fontes-Júnior, Enéas Andrade/ABF-8064-2020; Fontes-Júnior, Enéas Andrade/R-6372-2018	de Oliveira, Edivaldo H. C./0000-0001-6315-3352; DE PAULA FONSECA ARRIFANO, GABRIELA/0000-0003-2817-3539; Miranda, Moysés dos Santos/0000-0001-7771-8174; Crespo-Lopez, Maria Elena/0000-0002-1335-6853; Maia, Cristiane/0000-0003-4493-7375; Fontes-Júnior, Enéas Andrade/0000-0002-6186-9581; Sagica, Fernanda/0000-0002-0578-2692; Macchi, Barbarella/0000-0002-8667-1942; do Nascimento, jose/0000-0003-3647-9124	Conselho Nacional de Ciencia e Tecnologia em Pesquisa (CNPq, Brazil) [467143/2014-5, 447568/ 2014-0]; Instituto Evandro Chagas (IEC, Brazil); CNPq; Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)	Conselho Nacional de Ciencia e Tecnologia em Pesquisa (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Instituto Evandro Chagas (IEC, Brazil); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA, Brazil)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Ciencia e Tecnologia em Pesquisa (CNPq, Brazil; grants 467143/2014-5 and 447568/ 2014-0) and Instituto Evandro Chagas (IEC, Brazil). J.L.M. do Nascimento, E.H.C. Oliveira and M.E. Crespo-Lopez thank CNPq for their CNPq fellowships. Also, A. Costa-Malaquias, J. R. Souza-Monteiro and G.P.F. Arrifano thank Fundacao de Amparo a Pesquisa do Estado do Para (FAPESPA, Brazil) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) for their PhD fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger N, 2005, NEUROTOXICOLOGY, V26, P149, DOI 10.1016/j.neuro.2004.12.005; Belletti S, 2002, J NEUROSCI RES, V70, P703, DOI 10.1002/jnr.10419; Nevado JJB, 2010, ENVIRON INT, V36, P593, DOI 10.1016/j.envint.2010.03.011; Nevado JJB, 2009, MICROCHEM J, V93, P12, DOI 10.1016/j.microc.2009.03.008; Bose R, 2012, TOXICOL SCI, V130, P383, DOI 10.1093/toxsci/kfs257; BURBACHER TM, 1990, NEUROTOXICOL TERATOL, V12, P191, DOI 10.1016/0892-0362(90)90091-P; Burke K, 2006, NEUROTOXICOLOGY, V27, P970, DOI 10.1016/j.neuro.2006.09.001; Carta P, 2003, NEUROTOXICOLOGY, V24, P617, DOI 10.1016/S0161-813X(03)00080-9; Ceccatelli S, 2013, J INTERN MED, V273, P490, DOI 10.1111/joim.12045; Ceccatelli S, 2010, CHEM-BIOL INTERACT, V188, P301, DOI 10.1016/j.cbi.2010.04.007; Costa-Malaquias A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110815; Crespo-Lopez ME, 2007, ENVIRON INT, V33, P141, DOI 10.1016/j.envint.2006.08.005; Crespo-Lopez ME, 2011, ENVIRON INT, V37, P136, DOI 10.1016/j.envint.2010.08.009; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; Crespo-Lopez ME, 2005, REV NEUROLOGIA, V40, P441, DOI 10.33588/rn.4007.2004499; Dare E, 2001, FREE RADICAL BIO MED, V30, P1347, DOI 10.1016/S0891-5849(01)00526-3; Das S, 2011, CHEM-BIOL INTERACT, V193, P129, DOI 10.1016/j.cbi.2011.06.002; Falnoga I, 2000, ENVIRON RES, V84, P211, DOI 10.1006/enrs.2000.4116; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Harada M, 2001, ENVIRON INT, V27, P285, DOI 10.1016/S0160-4120(01)00059-9; Hong Ji-Young, 2014, J Cancer Prev, V19, P273, DOI 10.15430/JCP.2014.19.4.273; Huyck RW, 2015, NEUROTOXICOL TERATOL, V47, P102, DOI 10.1016/j.ntt.2014.11.010; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Magos L, 1987, TOXICITY METHYL MERC, P24; Mendoza MAC, 2002, TOXICOL APPL PHARM, V178, P117, DOI 10.1006/taap.2001.9267; Miura K, 1999, TOXICOL APPL PHARM, V160, P279, DOI 10.1006/taap.1999.8781; Morris MC, 2016, JAMA-J AM MED ASSOC, V315, P489, DOI 10.1001/jama.2015.19451; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundy WR, 2010, TOXICOLOGY, V270, P121, DOI 10.1016/j.tox.2010.02.004; Pieper I, 2014, METALLOMICS, V6, P662, DOI 10.1039/c3mt00337j; Pinheiro MCN, 2007, ENVIRON INT, V33, P56, DOI 10.1016/j.envint.2006.06.024; PONCE RA, 1994, TOXICOL APPL PHARM, V127, P83, DOI 10.1006/taap.1994.1142; Martin-Doimeadios RC, 2014, ENVIRON SCI POLLUT R, V21, P7466, DOI 10.1007/s11356-014-2680-7; Safeliu C, 2001, NEUROTOXICOLOGY, V22, P317, DOI 10.1016/S0161-813X(01)00015-8; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sokolowski K, 2013, DEV NEUROBIOL, V73, P936, DOI 10.1002/dneu.22119; Strober W., 2001, CURRENT PROTOCOLS IM; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Takahashi A, 2004, INT J RADIAT ONCOL, V60, P591, DOI 10.1016/j.ijrobp.2004.05.062; Thomas P, 2003, MUTAGENESIS, V18, P187, DOI 10.1093/mutage/18.2.187; USEPA, 1997, MERC STUD REP C HLTH, VV; WHO, 1990, INT PROGR CHEM SAF, P101; Xu MY, 2010, BRAIN RES, V1359, P272, DOI 10.1016/j.brainres.2010.08.069; Zhang P, 2009, FREE RADICAL RES, V43, P224, DOI 10.1080/10715760802677348	44	32	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162822	10.1371/journal.pone.0162822	http://dx.doi.org/10.1371/journal.pone.0162822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622704	gold, Green Published, Green Submitted			2022-12-26	WOS:000383681000060
J	Vafai, SB; Mevers, E; Higgins, KW; Fomina, Y; Zhang, JM; Mandinova, A; Newman, D; Shaw, SY; Clardy, J; Mootha, VK				Vafai, Scott B.; Mevers, Emily; Higgins, Kathleen W.; Fomina, Yevgenia; Zhang, Jianming; Mandinova, Anna; Newman, David; Shaw, Stanley Y.; Clardy, Jon; Mootha, Vamsi K.			Natural Product Screening Reveals Naphthoquinone Complex I Bypass Factors	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; APOPTOSIS; DISEASE; PINK1; CELLS; DEFICIENCY; IDEBENONE; OXIDATION; NDUFA9	Deficiency of mitochondrial complex I is encountered in both rare and common diseases, but we have limited therapeutic options to treat this lesion to the oxidative phosphorylation system (OXPHOS). Idebenone and menadione are redox-active molecules capable of rescuing OXPHOS activity by engaging complex I-independent pathways of entry, often referred to as "complex I bypass." In the present study, we created a cellular model of complex I deficiency by using CRISPR genome editing to knock out Ndufa9 in mousemyoblasts, and utilized this cell line to develop a high-throughput screening platform for novel complex I bypass factors. We screened a library of similar to 40,000 natural product extracts and performed bioassay-guided fractionation on a subset of the top scoring hits. We isolated four plant-derived 1,4-naphthoquinone complex I bypass factors with structural similarity to menadione: chimaphilin and 3-chloro-chimaphilin from Chimaphila umbellata and dehydro-alpha-lapachone and dehydroiso-alpha-lapachone from Stereospermum euphoroides. We also tested a small number of structurally related naphthoquinones from commercial sources and identified two additional compounds with complex I bypass activity: 2-methoxy-1,4-naphthoquinone and 2-methoxy-3-methyl-1,4,-naphthoquinone. The six novel complex I bypass factors reported here expand this class of molecules and will be useful as tool compounds for investigating complex I disease biology.	[Vafai, Scott B.; Higgins, Kathleen W.; Fomina, Yevgenia; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Vafai, Scott B.; Higgins, Kathleen W.; Fomina, Yevgenia; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Vafai, Scott B.; Higgins, Kathleen W.; Fomina, Yevgenia; Mootha, Vamsi K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mevers, Emily; Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Zhang, Jianming; Mandinova, Anna] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Newman, David] NCI, Nat Prod Branch, Frederick, MD 21701 USA; [Shaw, Stanley Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Vafai, SB; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.; Vafai, SB; Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Vafai, SB; Mootha, VK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Mootha, VK (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	svafai@broadinstitute.org; vamsi@hms.harvard.edu		Zhang, Jianming/0000-0001-6326-3906; Higgins, Kathleen/0000-0002-3551-9502	NIH [R01GM099683]; KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources); KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [KL2 TR001100]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources); KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health)	This work was supported by a T-R01 grant R01GM099683 from NIH to VKM. VKM is an investigator of the Howard Hughes Medical Institute. SBV was supported by a KL2/Catalyst Medical Research Investigator Training award (an appointed KL2 award) from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award KL2 TR001100). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	[Anonymous], 2015, EMA4800392015 EUR ME; ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615; ARNASON T, 1981, CAN J BOT, V59, P2189, DOI 10.1139/b81-287; CONOVER TE, 1963, BIOCHIM BIOPHYS ACTA, V67, P268; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529; Erb M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036153; Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267; Garkavtsev I, 2011, P NATL ACAD SCI USA, V108, P11596, DOI 10.1073/pnas.1104225108; Giorgio V, 2012, BBA-BIOENERGETICS, V1817, P363, DOI 10.1016/j.bbabio.2011.10.012; Gueyen N, 2015, REDOX BIOL, V4, P289, DOI 10.1016/j.redox.2015.01.009; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Ishigooka M., 1995, International Urology and Nephrology, V27, P61; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; La Morgia C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00141; Ma WD, 2014, FOOD CHEM TOXICOL, V70, P1, DOI 10.1016/j.fct.2014.04.014; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Ong JYH, 2015, LIFE SCI, V135, P158, DOI 10.1016/j.lfs.2015.03.019; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Raja S., 2014, International Journal of Phytomedicine, V6, P464; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013	28	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162686	10.1371/journal.pone.0162686	http://dx.doi.org/10.1371/journal.pone.0162686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622560	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000046
J	DiStefano, PV; Smrcka, AV; Glading, AJ				DiStefano, Peter V.; Smrcka, Alan V.; Glading, Angela J.			Phospholipase C epsilon Modulates Rap1 Activity and the Endothelial Barrier	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; CELL-CELL JUNCTIONS; VASCULAR-PERMEABILITY; CARDIAC-HYPERTROPHY; SIGNALING NETWORKS; FOCAL ADHESIONS; STRESS FIBERS; RHO KINASE; RAS; BETA	The phosphoinositide-specific phospholipase C, PLC epsilon, is a unique signaling protein with known roles in regulating cardiac myocyte growth, astrocyte inflammatory signaling, and tumor formation. PLC epsilon is also expressed in endothelial cells, however its role in endothelial regulation is not fully established. We show that endothelial cells of multiple origins, including human pulmonary artery (HPAEC), human umbilical vein (HUVEC), and immortalized brain microvascular (hCMEC/D3) endothelial cells, express PLC epsilon. Knockdown of PLC epsilon in arterial endothelial monolayers decreased the effectiveness of the endothelial barrier. Concomitantly, RhoA activity and stress fiber formation were increased. PLC epsilon-deficient arterial endothelial cells also exhibited decreased Rap1-GTP levels, which could be restored by activation of the Rap1 GEF, Epac, to rescue the increase in monolayer leak. Reintroduction of PLC epsilon rescued monolayer leak with both the CDC25 GEF domain and the lipase domain of PLC epsilon required to fully activate Rap1 and to rescue endothelial barrier function. Finally, we demonstrate that the barrier promoting effects PLC epsilon are dependent on Rap1 signaling through the Rap1 effector, KRIT1, which we have previously shown is vital for maintaining endothelial barrier stability. Thus we have described a novel role for PLC epsilon PIP2 hydrolytic and Rap GEF activities in arterial endothelial cells, where PLC epsilon-dependent activation of Rap1/KRIT1 signaling promotes endothelial barrier stability.	[DiStefano, Peter V.; Smrcka, Alan V.; Glading, Angela J.] Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA	University of Rochester	Glading, AJ (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	angela_glading@urmc.rochester.edu	Glading, Angela/AAI-3455-2020	Glading, Angela/0000-0002-1830-6601	National Institutes of Health [HL117885-01]; American Heart Association predoctoral fellowship [14PRE2038009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant HL117885-01 to A.J. Glading and American Heart Association predoctoral fellowship 14PRE2038009 to P.V. DiStefano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beziau DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123769; Bijli KM, 2016, AM J PHYSIOL-LUNG C, V311, pL517, DOI 10.1152/ajplung.00069.2016; Bogatcheva NV, 2003, AM J PHYSIOL-LUNG C, V285, pL415, DOI 10.1152/ajplung.00364.2001; Bokhari SM, 2006, J INVEST DERMATOL, V126, P460, DOI 10.1038/sj.jid.5700071; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Chrzanowska-Wodnicka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145689; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Corr M, 2012, ARTERIOSCL THROM VAS, V32, P2702, DOI 10.1161/ATVBAHA.112.300115; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; DiStefano PV, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582304; Dusaban SS, 2015, J BIOL CHEM, V290, P26776, DOI 10.1074/jbc.M115.676098; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Dzhura I, 2010, J PHYSIOL-LONDON, V588, P4871, DOI 10.1113/jphysiol.2010.198424; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Hoeppner LH, 2012, BLOOD, V120, P2167, DOI 10.1182/blood-2012-03-417824; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Lo Vasco VR, 2011, J CLIN PATHOL, V64, P911, DOI 10.1136/jclinpath-2011-200096; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Meliton A, 2015, AM J RESP CELL MOL, V53, P834, DOI 10.1165/rcmb.2014-0376OC; Mleynek TM, 2014, HUM MOL GENET, V23, P6223, DOI 10.1093/hmg/ddu342; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Pannekoek WJ, 2011, CELL SIGNAL, V23, P2056, DOI 10.1016/j.cellsig.2011.07.022; Pappa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1036-1; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Post A, 2015, MOL CELL BIOL, V35, P2495, DOI 10.1128/MCB.01453-14; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sahoo T, 2001, GENOMICS, V71, P123, DOI 10.1006/geno.2000.6426; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Sumagin R, 2008, AM J PHYSIOL-HEART C, V295, pH969, DOI 10.1152/ajpheart.00400.2008; Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; Vliem MJ, 2008, CHEMBIOCHEM, V9, P2052, DOI 10.1002/cbic.200800216; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162338	10.1371/journal.pone.0162338	http://dx.doi.org/10.1371/journal.pone.0162338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612188	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900079
J	Klein, G; Stupak, A; Biernacka, D; Wojtkiewicz, P; Lindner, B; Raina, S				Klein, Gracjana; Stupak, Anna; Biernacka, Daria; Wojtkiewicz, Pawel; Lindner, Buko; Raina, Satish			Multiple Transcriptional Factors Regulate Transcription of the rpoE Gene in Escherichia coli under Different Growth Conditions and When the Lipopolysaccharide Biosynthesis Is Defective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK SIGMA-FACTOR; ENVELOPE-STRESS; OUTER-MEMBRANE; RESPONSE REGULATOR; RNA-POLYMERASE; FUNCTIONAL-CHARACTERIZATION; 2-COMPONENT SYSTEM; STRUCTURAL BASIS; SOLUBLE-RNA; PROTEIN	The RpoE sigma factor is essential for the viability of Escherichia coli. RpoE regulates extracytoplasmic functions including lipopolysaccharide (LPS) translocation and some of its non-stoichiometric modifications. Transcription of the rpoE gene is positively autoregulated by E sigma(E) and by unknown mechanisms that control the expression of its distally located promoter(s). Mapping of 5' ends of rpoE mRNA identified five new transcriptional initiation sites (P1 to P5) located distal to E sigma(E)-regulated promoter. These promoters are activated in response to unique signals. Of these P2, P3, and P4 defined major promoters, recognized by RpoN, RpoD, and RpoS sigma factors, respectively. Isolation of trans-acting factors, in vitro transcriptional and gel retardation assays revealed that the RpoN-recognized P2 promoter is positively regulated by a QseE/F two-component system and NtrC activator, whereas the RpoD-regulated P3 promoter is positively regulated by a Rcs system in response to defects in LPS core biosynthesis, overproduction of certain lipoproteins, and the global regulator CRP. Strains synthesizing Kdo2-LA LPS caused up to 7-fold increase in the rpoEP3 activity, which was abrogated in Delta (waaC rcsB). Overexpression of a novel 73-nucleotide sRNA rirA (RfaH interacting RNA) generated by the processing of 5'UTR of the waaQ mRNA induces the rpoEP3 promoter activity concomitant with a decrease in LPS content and defects in the O-antigen incorporation. In the presence of RNA polymerase, RirA binds LPS regulator RfaH known to prevent premature transcriptional termination of waaQ and rfb operons. RirA in excess could titrate out RfaH causing LPS defects and the activation of rpoE transcription.	[Klein, Gracjana; Stupak, Anna; Biernacka, Daria; Wojtkiewicz, Pawel; Raina, Satish] Gdansk Univ Technol, Unit Bacterial Genet, Narutowicza 11-12, PL-80233 Gdansk, Poland; [Lindner, Buko] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Pk Allee 22, D-23845 Borstel, Germany	Fahrenheit Universities; Gdansk University of Technology; Forschungszentrum Borstel	Raina, S (corresponding author), Gdansk Univ Technol, Unit Bacterial Genet, Narutowicza 11-12, PL-80233 Gdansk, Poland.	satish.raina@pg.gda.pl	Raina, Satish/AAU-9550-2021; Biernacka, Daria/X-2755-2019	Raina, Satish/0000-0003-3175-4932; Stupak, Anna/0000-0003-4731-8879; Klein, Gracjana/0000-0001-8695-8065	National Science Grants [2011/03/B/NZ1/02825, 2013/11/B/NZ2/02641]	National Science Grants	This work was supported by National Science Grants 2011/03/B/NZ1/02825 and 2013/11/B/NZ2/02641 (to S. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Burmann BM, 2012, CELL, V150, P291, DOI 10.1016/j.cell.2012.05.042; Coornaert A, 2010, MOL MICROBIOL, V76, P467, DOI 10.1111/j.1365-2958.2010.07115.x; CREEGER ES, 1984, J BIOL CHEM, V259, P3064; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gerken H, 2009, MOL MICROBIOL, V72, P1408, DOI 10.1111/j.1365-2958.2009.06728.x; Gronow S, 2010, EUR J CELL BIOL, V89, P3, DOI 10.1016/j.ejcb.2009.10.002; Guckes KR, 2013, P NATL ACAD SCI USA, V110, P16592, DOI 10.1073/pnas.1315320110; Guo MS, 2014, GENE DEV, V28, P1620, DOI 10.1101/gad.243485.114; Janaszak A, 2009, FEMS MICROBIOL LETT, V291, P65, DOI 10.1111/j.1574-6968.2008.01436.x; Johansen J, 2006, J MOL BIOL, V364, P1, DOI 10.1016/j.jmb.2006.09.004; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klein G, 2003, MOL MICROBIOL, V48, P269, DOI 10.1046/j.1365-2958.2003.03449.x; Klein G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/153561; Klein G, 2013, J BIOL CHEM, V288, P8111, DOI 10.1074/jbc.M112.445981; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Lima S, 2013, SCIENCE, V340, P837, DOI 10.1126/science.1235358; Madhugiri R, 2010, MOL GENET GENOMICS, V284, P307, DOI 10.1007/s00438-010-0568-x; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Marolda CL, 1998, J BACTERIOL, V180, P3070, DOI 10.1128/JB.180.12.3070-3079.1998; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x; Miyadai H, 2004, J BIOL CHEM, V279, P39807, DOI 10.1074/jbc.M406390200; Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Noor R, 2009, GENES CELLS, V14, P885, DOI 10.1111/j.1365-2443.2009.01318.x; PARKER CT, 1992, J BACTERIOL, V174, P2525, DOI 10.1128/jb.174.8.2525-2538.1992; Pesavento C, 2012, NUCLEIC ACIDS RES, V40, P4783, DOI 10.1093/nar/gks055; Pratt LA, 1996, P NATL ACAD SCI USA, V93, P2488, DOI 10.1073/pnas.93.6.2488; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; RAINA S, 1991, NUCLEIC ACIDS RES, V19, P3811, DOI 10.1093/nar/19.14.3811; Reading NC, 2010, MICROBIOL-SGM, V156, P1167, DOI 10.1099/mic.0.033027-0; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Reichenbach B, 2009, MOL MICROBIOL, V74, P1054, DOI 10.1111/j.1365-2958.2009.06918.x; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Santos JM, 2006, MOL MICROBIOL, V60, P177, DOI 10.1111/j.1365-2958.2006.05078.x; Sikdar R, 2013, J BACTERIOL, V195, P12, DOI 10.1128/JB.00762-12; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Syed A, 1997, MOL MICROBIOL, V23, P987, DOI 10.1046/j.1365-2958.1997.2851651.x; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tao K, 2012, J BACTERIOL, V194, P3643, DOI 10.1128/JB.00553-12; TAYLOR WE, 1984, CELL, V38, P371, DOI 10.1016/0092-8674(84)90492-6; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Xiao JF, 2012, LETT APPL MICROBIOL, V55, P91, DOI 10.1111/j.1472-765X.2012.03260.x; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yethon JA, 2000, J BACTERIOL, V182, P5620, DOI 10.1128/JB.182.19.5620-5623.2000; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	63	31	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22999	23019		10.1074/jbc.M116.748954	http://dx.doi.org/10.1074/jbc.M116.748954			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27629414	Green Published, hybrid			2022-12-26	WOS:000387224800013
J	Feijen, EAM; Font-Gonzalez, A; van Dalen, EC; van der Pal, HJH; Reulen, RC; Winter, DL; Kuehni, CE; Haupt, R; Alessi, D; Byrne, J; Bardi, E; Jakab, Z; Grabow, D; Garwicz, S; Jankovic, M; Levitt, GA; Skinner, R; Zaletel, LZ; Hjorth, L; Tissing, WJE; de Vathaire, F; Hawkins, MM; Kremer, LCM				Feijen, Elizabeth A. M.; Font-Gonzalez, Anna; van Dalen, Elvira C.; van der Pal, Helena J. H.; Reulen, Raoul C.; Winter, David L.; Kuehni, Claudia E.; Haupt, Riccardo; Alessi, Daniela; Byrne, Julianne; Bardi, Edit; Jakab, Zsuzsanna; Grabow, Desiree; Garwicz, Stanislaw; Jankovic, Momcilo; Levitt, Gill A.; Skinner, Roderick; Zaletel, Lorna Zadravec; Hjorth, Lars; Tissing, Wim J. E.; de Vathaire, Florent; Hawkins, Mike M.; Kremer, Leontien C. M.		PanCareSurFup Consortium	Late Cardiac Events after Childhood Cancer: Methodological Aspects of the Pan-European Study PanCareSurFup	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; LONG-TERM; ADULT SURVIVORS; RISK-FACTORS; DOXORUBICIN THERAPY; HEALTH OUTCOMES; CARDIOTOXICITY; MORTALITY	Background and Aim Childhood cancer survivors are at high risk of long-term adverse effects of cancer and its treatment, including cardiac events. The pan-European PanCareSurFup study determined the incidence and risk factors for cardiac events among childhood cancer survivors. The aim of this article is to describe the methodology of the cardiac cohort and nested case-control study within PanCareSurFup. Methods Eight data providers in Europe participating in PanCareSurFup identified and validated symptomatic cardiac events in their cohorts of childhood cancer survivors. Data on symptomatic heart failure, ischemia, pericarditis, valvular disease and arrhythmia were collected and graded according to the Criteria for Adverse Events. Detailed treatment data, data on potential confounders, lifestyle related risk factors and general health problems were collected. Results The PanCareSurFup cardiac cohort consisted of 59,915 5-year childhood cancer survivors with malignancies diagnosed between 1940 and 2009 and classified according to the International Classification of Childhood Cancer 3. Different strategies were used to identify cardiac events such as record linkage to population/hospital or regional based databases, and patient-and general practitioner-based questionnaires. Conclusion The cardiac study of the European collaborative research project PanCareSurFup will provide the largest cohort of 5-year childhood cancer survivors with systematically ascertained and validated data on symptomatic cardiac events. The result of this study can provide information to minimize the burden of cardiac events in childhood cancer survivors by tailoring the follow-up of childhood cancer survivors at high risk of cardiac adverse events, transferring this knowledge into evidence-based clinical practice guidelines and providing a platform for future research studies in childhood cancer patients.	[Feijen, Elizabeth A. M.; Font-Gonzalez, Anna; van Dalen, Elvira C.; van der Pal, Helena J. H.; Kremer, Leontien C. M.] Acad Med Ctr Amsterdam, Emma Childrens Hosp, Dept Pediat Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van der Pal, Helena J. H.; Reulen, Raoul C.; Winter, David L.] Acad Med Ctr Amsterdam, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Hawkins, Mike M.] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England; [Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Finkenhubelweg 11, CH-3012 Bern, Switzerland; [Haupt, Riccardo] Gaslini Children Hosp, Epidemiol & Biostat Sect, Via Gerolamo Gaslini,5, I-16148 Genoa, Italy; [Alessi, Daniela] Univ Turin, Citta Salute & Sci Hosp, Canc Epidemiol Unit, Childhood Canc Registry Piedmont, Via Santena 7, I-10126 Turin, Italy; [Alessi, Daniela] Ctr Canc Prevent CPO, Via Santena 7, I-10126 Turin, Italy; [Byrne, Julianne] Boyne Res Inst, Tiernan House, Fair Green, Drogheda, Ireland; [Bardi, Edit] Semmelweis Univ, Dept Pediat 2, Ulloi Ut 26, H-1085 Budapest, Hungary; [Jakab, Zsuzsanna] Markusovszky Hosp, Dept Pediat Oncol, Markusovszky Lajos U 5, H-9700 Szombathely, Hungary; [Grabow, Desiree] Univ Med Ctr, Inst Med Biostat Epidemiol & Informat, GCCR, Mainz, Germany; [Garwicz, Stanislaw; Hjorth, Lars] Skane Univ Lund, Dept Pediat, Getingevagen 4, S-22241 Lund, Sweden; [Jankovic, Momcilo] San Gerardo Hosp, Pediat Hematol Unit, Via Primo Maggio,22, I-38089 Monza, Italy; [Levitt, Gill A.] Great North Childrens Hosp, Dept Paediat & Adolescent Haematol & Oncol, Newcastle, England; [Levitt, Gill A.; Skinner, Roderick] Great North Childrens Hosp, Childrens BMT Unit, Newcastle, England; [Skinner, Roderick] Newcastle Univ, Dept Paediat & Adolescent Haematol & Oncol, Newcastle, England; [Skinner, Roderick] Newcastle Univ, Great North Childrens Hosp, Newcastle, England; [Skinner, Roderick] Newcastle Univ, Northern Inst Canc Res, Newcastle, England; [Zaletel, Lorna Zadravec] Inst Oncol, Div Radiotherapy, Zaloska Cesta 2, SL-1000 Ljubljana, Slovenia; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Oncol, Groningen, Netherlands; [de Vathaire, Florent] INSERM, Gustave Roussy, Radiat Epidemiol Grp, UMR1018, Villejuif, France	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; University of Bern; University of Genoa; IRCCS Istituto Giannina Gaslini; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Semmelweis University; Johannes Gutenberg University of Mainz; San Gerardo Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Institute of Oncology - Slovenia; University of Groningen; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Feijen, EAM (corresponding author), Acad Med Ctr Amsterdam, Emma Childrens Hosp, Dept Pediat Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.a.feijen@amc.uva.nl	Haupt, Riccardo/AAA-7437-2020; de Vathaire, Florent/L-2983-2016; Reulen, Raoul/AAO-1033-2020	Haupt, Riccardo/0000-0003-0571-8460; Reulen, Raoul/0000-0002-7328-0467; Kremer, Leontien/0000-0001-7422-3248; kremer, leontien/0000-0002-7619-7845; Zadravec Zaletel, Lorna/0000-0002-4423-0276; de Vathaire, Florent/0000-0002-8374-9281	PanCareSurFup, EU [257505]; Swiss Cancer League [KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011, KLS-3412-02-2014]	PanCareSurFup, EU; Swiss Cancer League	This study was supported by PanCareSurFup, EU-Grant agreement number 257505, https://ec.europa.eu/research/fp7/, no role. The Swiss Childhood Cancer Survivor Study was funded by the Swiss Cancer League (KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011, KLS-3412-02-2014), http://www.uicc.org/, no role.	Armenian SH, 2015, LANCET ONCOL, V16, pE123, DOI 10.1016/S1470-2045(14)70409-7; Armstrong GT, 2013, J CLIN ONCOL, V31, P3673, DOI 10.1200/JCO.2013.49.3205; Badouna ANI, 2012, PHYS MED BIOL, V57, P473, DOI 10.1088/0031-9155/57/2/473; Behar C, 1996, MED PEDIATR ONCOL, V26, P173, DOI 10.1002/(SICI)1096-911X(199603)26:3<173::AID-MPO5>3.0.CO;2-H; Blanco JG, 2008, CANCER-AM CANCER SOC, V112, P2789, DOI 10.1002/cncr.23534; Feijen EAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100432; Garwicz S, 2012, INT J CANCER, V131, P1659, DOI 10.1002/ijc.27393; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Geskus RB, 2011, BIOMETRICS, V67, P39, DOI 10.1111/j.1541-0420.2010.01420.x; GOLDBERG MA, 1986, BLOOD, V68, P1114; GOTTDIENER JS, 1981, ARCH INTERN MED, V141, P758, DOI 10.1001/archinte.141.6.758; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P53, DOI 10.1002/pbc.24679; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; Gudmundsdottir T, 2015, INT J CANCER, V137, P1176, DOI 10.1002/ijc.29468; Hoff DD, 1977, AM J MED, V62, P200; Hudson MM, 2007, J CLIN ONCOL, V25, P3635, DOI 10.1200/JCO.2006.09.7451; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Hummel YM, 2015, ACTA ONCOL, V54, P515, DOI 10.3109/0284186X.2014.969845; Kero AE, 2014, INT J CANCER, V134, P664, DOI 10.1002/ijc.28385; Kleinbaum DG, 2010, LOGISTIC REGRESSION, DOI DOI 10.1136/bmjopen-2015-008188; Kremer LCM, 2013, PEDIATR BLOOD CANCER, V60, P543, DOI 10.1002/pbc.24445; Landy DC, 2013, PEDIATR CARDIOL, V34, P826, DOI 10.1007/s00246-012-0539-6; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Mulrooney DA, 2014, CANCER-AM CANCER SOC, V120, P3536, DOI 10.1002/cncr.28925; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; NCI, 2010, COMMONTERMINOLOGY CR; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Robison LL, 2014, NAT REV CANCER, V14, P61, DOI 10.1038/nrc3634; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Tassinari D, 1997, ANN ONCOL, V8, P1263, DOI 10.1023/A:1008231521553; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; van Dalen EC, 2004, EUR J CANCER, V40, P643, DOI 10.1016/j.ejca.2003.12.006; van der Pal HJ, 2015, INT J RADIAT ONCOL, V91, P213, DOI 10.1016/j.ijrobp.2014.09.010; van der Pal HJ, 2012, J CLIN ONCOL, V30, P1429, DOI 10.1200/JCO.2010.33.4730; Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Winther JF, 2015, ACTA ONCOL, V54, P655, DOI 10.3109/0284186X.2015.1008648	40	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162778	10.1371/journal.pone.0162778	http://dx.doi.org/10.1371/journal.pone.0162778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643694	Green Submitted, gold, Green Published			2022-12-26	WOS:000383891900017
J	Liu, XX; Zheng, W; Sivasankar, MP				Liu, Xinxin; Zheng, Wei; Sivasankar, M. Preeti			Acute Acrolein Exposure Induces Impairment of Vocal Fold Epithelial Barrier Function	PLOS ONE			English	Article							CIGARETTE-SMOKE; ION-TRANSPORT; EXPRESSION; DECREASES; MEMBRANE; CLAUDINS; OCCLUDIN; DEFENSE; PROTEIN; MUCOSA	Acrolein is a ubiquitous pollutant abundant in cigarette smoke, mobile exhaust, and industrial waste. There is limited literature on the effects of acrolein on vocal fold tissue, although there are clinical reports of voice changes after pollutant exposures. Vocal folds are responsible for voice production. The overall objective of this study was to investigate the effects of acrolein exposure on viable, excised vocal fold epithelial tissue and to characterize the mechanism underlying acrolein toxicity. Vocal fold epithelia were studied because they form the outermost layer of the vocal folds and are a primary recipient of inhaled pollutants. Porcine vocal fold epithelia were exposed to 0, 50, 100, 500, 900 or 1300 mu M of acrolein for 3 hours; the metabolic activity, epithelial resistance, epithelial permeability, tight junction protein (occludin and claudin 3) expression, cell membrane integrity and lipid peroxidation were investigated. The data demonstrated that acrolein exposure at 500 mu M significantly reduced vocal fold epithelial metabolic activity by 27.2% (p <= 0.001). Incubation with 100 mu M acrolein caused a marked increase in epithelial permeability by 130.5% (p<0.05) and a reduction in transepithelial electrical resistance (TEER) by 180.0% (p<0.001). While the expression of tight junctional protein did not change in acrolein-treated samples, the cell membrane integrity was significantly damaged with a 45.6% increase of lipid peroxidation as compared to controls (p<0.05). Taken together, these data provide evidence that acute acrolein exposure impairs vocal fold epithelial barrier integrity. Lipid peroxidation-induced cell membrane damage may play an important role in reducing the barrier function of the epithelium.	[Liu, Xinxin; Zheng, Wei] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Sivasankar, M. Preeti] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Sivasankar, M. Preeti] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sivasankar, MP (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Sivasankar, MP (corresponding author), Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA.	msivasan@purdue.edu			National Institutes of Health/National Institute on Deafness and other Communication Disorders [R01DC011759]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011759] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC011759 (National Institutes of Health/National Institute on Deafness and other Communication Disorders), https://www.nidcd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JD, 1993, FREE RADICAL BIO MED, V15, P187, DOI 10.1016/0891-5849(93)90058-3; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P1510, DOI 10.1016/j.freeradbiomed.2008.08.025; AYER HE, 1982, AM J PUBLIC HEALTH, V72, P1283, DOI 10.2105/AJPH.72.11.1283; Baum M, 2010, TOXICOL LETT, V196, pS44, DOI 10.1016/j.toxlet.2010.03.182; Branski RC, 2011, LARYNGOSCOPE, V121, P601, DOI 10.1002/lary.21388; BURNS AR, 1989, J APPL PHYSIOL, V66, P2109, DOI 10.1152/jappl.1989.66.5.2109; CDC, 1992, OCC SAF HLTH GUID AC; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Dorman DC, 2008, INHAL TOXICOL, V20, P205, DOI 10.1080/08958370701864151 ; Durkes A, 2014, ANN OTO RHINOL LARYN, V123, P71, DOI 10.1177/0003489414521143; ELMOFTY SK, 1975, AM J PATHOL, V79, P579; Erickson E, 2010, LARYNGOSCOPE, V120, P1569, DOI 10.1002/lary.20983; Erickson-DiRenzo E, 2015, LARYNGOSCOPE, V125, pE180, DOI 10.1002/lary.25100; Erickson-Levendoski E, 2012, OTOLARYNG HEAD NECK, V146, P272, DOI 10.1177/0194599811428273; Faroon O, 2008, TOXICOL IND HEALTH, V24, P543, DOI 10.1177/0748233708098124; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; GAAFAR HA, 1981, J LARYNGOL OTOL, V95, P721, DOI 10.1017/S0022215100091349; Gonzalez J, 2004, MED SCI MONITOR, V10, pCR649; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Higo R, 2003, J NEUROL NEUROSUR PS, V74, P982, DOI 10.1136/jnnp.74.7.982; Horton ND, 1999, J BIOL CHEM, V274, P9200, DOI 10.1074/jbc.274.14.9200; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Isik ACU, 2004, J OTOLARYNGOL, V33, P382; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Jang AS, 2011, AM J RESP CELL MOL, V44, P483, DOI 10.1165/rcmb.2009-0391OC; Kasahara DI, 2008, J IMMUNOL, V181, P736, DOI 10.4049/jimmunol.181.1.736; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Lambert C, 2005, J ALLERGY CLIN IMMUN, V116, P916, DOI 10.1016/j.jaci.2005.05.046; LEONARD R, 1995, J VOICE, V9, P443, DOI 10.1016/S0892-1997(05)80208-5; Levendoski EE, 2014, J SPEECH LANG HEAR R, V57, P1679, DOI 10.1044/2014_JSLHR-S-13-0283; Levendoski EE, 2014, J MEMBRANE BIOL, V247, P441, DOI 10.1007/s00232-014-9651-2; Leydon C, 2009, J VOICE, V23, P658, DOI 10.1016/j.jvoice.2008.03.010; Li Hongyu, 2004, J Cyst Fibros, V3 Suppl 2, P123, DOI 10.1016/j.jcf.2004.05.026; Liu XY, 2010, TOXICOL MECH METHOD, V20, P36, DOI 10.3109/15376510903530845; Mizuta M, 2012, ANN OTO RHINOL LARYN, V121, P804, DOI 10.1177/000348941212101206; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; NISHIKAWA H, 1987, ANALYST, V112, P859, DOI 10.1039/an9871200859; Pang XB, 2011, SCI TOTAL ENVIRON, V409, P5000, DOI 10.1016/j.scitotenv.2011.07.065; Phillips JE, 1999, BIOPHYS J, V76, P869, DOI 10.1016/S0006-3495(99)77250-4; Piade JJ, 2013, FOOD CHEM TOXICOL, V55, P329, DOI 10.1016/j.fct.2013.01.016; ROMETHADDAD S, 1993, TOXICOL IN VITRO, V7, P373, DOI 10.1016/0887-2333(93)90030-9; Sivasankar M, 2007, J SPEECH LANG HEAR R, V50, P886, DOI 10.1044/1092-4388(2007/063); Spiess PC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-107; STAHLMANN R, 1985, ARCH TOXICOL, V57, P163, DOI 10.1007/BF00290881; Sun Y, 2014, TOXICOL LETT, V229, P384, DOI 10.1016/j.toxlet.2014.06.021; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Xu XB, 2014, AURIS NASUS LARYNX, V41, P539, DOI 10.1016/j.anl.2014.05.011; Zhang QR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034017	51	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163237	10.1371/journal.pone.0163237	http://dx.doi.org/10.1371/journal.pone.0163237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643990	gold, Green Submitted, Green Published			2022-12-26	WOS:000383891900038
J	Bonmati-Carrion, MA; Hild, K; Isherwood, C; Sweeney, SJ; Revell, VL; Skene, DJ; Rol, MA; Madrid, JA				Angeles Bonmati-Carrion, Maria; Hild, Konstanze; Isherwood, Cheryl; Sweeney, Stephen J.; Revell, Victoria L.; Skene, Debra J.; Angeles Rol, Maria; Antonio Madrid, Juan			Relationship between Human Pupillary Light Reflex and Circadian System Status	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; MELATONIN SUPPRESSION; ACTION SPECTRUM; MOTOR-ACTIVITY; SLEEP-APNEA; MELANOPSIN; SENSITIVITY; WAVELENGTH; RESPONSES; RHYTHM	Intrinsically photosensitive retinal ganglion cells (ipRGCs), whose photopigment melanopsin has a peak of sensitivity in the short wavelength range of the spectrum, constitute a common light input pathway to the olivary pretectal nucleus (OPN), the pupillary light reflex (PLR) regulatory centre, and to the suprachiasmatic nuclei (SCN), the major pacemaker of the circadian system. Thus, evaluating PLR under short wavelength light (lambda(max) <= 500 nm) and creating an integrated PLR parameter, as a possible tool to indirectly assess the status of the circadian system, becomes of interest. Nine monochromatic, photon-matched light stimuli (300 s), in 10 nm increments from lambda(max) 420 to 500 nm were administered to 15 healthy young participants (8 females), analyzing: i) the PLR; ii) wrist temperature (WT) and motor activity rhythms (WA), iii) light exposure (L) pattern and iv) diurnal preference (Horne (TM) stberg), sleep quality (Pittsburgh) and daytime sleepiness (Epworth). Linear correlations between the different PLR parameters and circadian status index obtained from WT, WA and L recordings and scores from questionnaires were calculated. In summary, we found markers of robust circadian rhythms, namely high stability, reduced fragmentation, high amplitude, phase advance and low internal desynchronization, were correlated with a reduced PLR to 460-490 nm wavelengths. Integrated circadian (CSI) and PLR (cp-PLR) parameters are proposed, that also showed an inverse correlation. These results demonstrate, for the first time, the existence of a close relationship between the circadian system robustness and the pupillary reflex response, two non-visual functions primarily under mela-nopsin- ipRGC input.	[Angeles Bonmati-Carrion, Maria; Angeles Rol, Maria; Antonio Madrid, Juan] Univ Murcia, Chronobiol Lab, Dept Physiol, Fac Biol,IMIB Arrixaca, E-30100 Murcia, Spain; [Hild, Konstanze; Sweeney, Stephen J.] Univ Surrey, Adv Technol Inst, Guildford GU2 7XH, Surrey, England; [Hild, Konstanze; Sweeney, Stephen J.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Isherwood, Cheryl; Revell, Victoria L.; Skene, Debra J.] Univ Surrey, Fac Hlth & Med Sci, Chronobiol, Guildford GU2 7XH, Surrey, England	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; University of Surrey; University of Surrey; University of Surrey	Rol, MA (corresponding author), Univ Murcia, Chronobiol Lab, Dept Physiol, Fac Biol,IMIB Arrixaca, E-30100 Murcia, Spain.	angerol@um.es	ROL, ANGELES/ABH-6431-2020; Sweeney, Stephen/P-9879-2019; ROL, ANGELES/C-6718-2009	ROL, ANGELES/0000-0002-9343-3918; Sweeney, Stephen/0000-0001-8561-6071; ROL, ANGELES/0000-0002-9343-3918; Bonmati-Carrion, Maria-Angeles/0000-0002-9050-6448; Skene, Debra/0000-0001-8202-6180; Madrid, Juan Antonio/0000-0002-9286-1371	Instituto de Salud Carlos III; Spanish Ministry of Science and Innovation; Ministry of Economy and Competitiveness through the Spanish Network for Light Pollution Studies [AYA2015-71542-REDT]; EPSRC MILES grant [EP/1000992/1]; EPSRC Leadership Fellowship [EP/H005587/1]; FEDER; Seneca Foundation [19410/PI/14, AP2009-1051]; Engineering and Physical Sciences Research Council [EP/I000992/1] Funding Source: researchfish; EPSRC [EP/I000992/1] Funding Source: UKRI	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitiveness through the Spanish Network for Light Pollution Studies; EPSRC MILES grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC Leadership Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FEDER(European Commission); Seneca Foundation(Fundacion Seneca); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors wish to thank the Instituto de Salud Carlos III, the Spanish Ministry of Science and Innovation and the Ministry of Economy and Competitiveness for their financial support through the Spanish Network for Light Pollution Studies (AYA2015-71542-REDT), the Ageing and Frailty Cooperative Research Network, RD12/0043/0011, SAF2013-49132-C2-1-R, the latter including FEDER cofunding granted to Juan Antonio Madrid, and Seneca Foundation 19410/PI/14 to Maria Angeles Rol. Research fellowship granted to MA Bonmati (AP2009-1051). The work was parted funded by an EPSRC MILES grant [EP/1000992/1]. S. J. Sweeney gratefully acknowledges EPSRC Leadership Fellowship funding under project EP/H005587/1. D. J. Skene is a Royal Society Wolfson Research Merit Award holder.; The authors wish to thank the Instituto de Salud Carlos III, the Ministry of Science and Innovation and the Ministry of Economy and Competitiveness for their financial support through the Spanish Network for Light Pollution Studies (AYA2015-71542-REDT), the Ageing and Frailty Cooperative Research Network, RD12/0043/0011, SAF2013-49132-C2-1-R, the latter including FEDER cofounding, granted to Juan Antonio Madrid, and Seneca Foundation 19410/PI/14 to Maria Angeles Rol. Research fellowship granted to MA Bonmati-Carrion (AP2009-1051). The work was partly funded by an EPSRC MILES grant [EP/1000992/1]. S. J. Sweeney gratefully acknowledges EPSRC Leadership Fellowship funding under project EP/H005587/1. D. J. Skene is a Royal Society Wolfson Research Merit Award holder. We also want to thank Benita Middleton for her assistance with administration of the pupil dilator.	Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Bonmati-Carrion MA, 2014, INT J MOL SCI, V15, P23448, DOI 10.3390/ijms151223448; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; Bonmati-Carrion MA, 2015, CHRONOBIOL INT, V32, P701, DOI 10.3109/07420528.2015.1016613; Bonmati-Carrion MA, 2014, CHRONOBIOL INT, V31, P37, DOI 10.3109/07420528.2013.820740; BOUMA H, 1962, NATURE, V193, P690, DOI 10.1038/193690a0; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Feigl B, 2014, OPTOMETRY VISION SCI, V91, P894, DOI 10.1097/OPX.0000000000000284; Figueiro Mariana G, 2005, J Circadian Rhythms, V3, P14, DOI 10.1186/1740-3391-3-14; Fonken LK, 2012, J BIOL RHYTHM, V27, P319, DOI 10.1177/0748730412448324; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; Kawasaki A, 2007, J NEURO-OPHTHALMOL, V27, P195, DOI 10.1097/WNO.0b013e31814b1df9; Koenig D, 2011, J VISION, V11, DOI 10.1167/11.1.21; Krauchi K, 2000, AM J PHYSIOL-REG I, V278, pR741, DOI 10.1152/ajpregu.2000.278.3.R741; Lockley SW, 2003, J CLIN ENDOCR METAB, V88, P4502, DOI 10.1210/jc.2003-030570; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Martinez-Nicolas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061142; McDougal DH, 2010, VISION RES, V50, P72, DOI 10.1016/j.visres.2009.10.012; MICIELI G, 1995, ACTA NEUROL SCAND, V91, P382, DOI 10.1111/j.1600-0404.1995.tb07025.x; Monaco A, 2014, CRANIO, V32, P139, DOI 10.1179/0886963413Z.00000000022; Munch M, 2012, INVEST OPHTH VIS SCI, V53, P4546, DOI 10.1167/iovs.12-9494; Mure LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005991; Ortiz-Tudela E, 2014, PHYSIOL BEHAV, V126, P30, DOI 10.1016/j.physbeh.2013.12.009; Ortiz-Tudela E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000996; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Revell VL, 2010, CHRONOBIOL INT, V27, P1762, DOI 10.3109/07420528.2010.516048; Roecklein K, 2013, PSYCHIAT RES, V210, P150, DOI 10.1016/j.psychres.2013.05.023; Sarabia JA, 2008, PHYSIOL BEHAV, V95, P570, DOI 10.1016/j.physbeh.2008.08.005; STOCKMAN A, 1999, COLOR VISION GENES P, P53; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Tsujimura S, 2010, P ROY SOC B-BIOL SCI, V277, P2485, DOI 10.1098/rspb.2010.0330; Van Cauter E, 2005, MEDSCAPE NEUROL, V7; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; Vartanian GV, 2015, J BIOL RHYTHM, V30, P351, DOI 10.1177/0748730415585413; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860; Zornoza-Moreno M, 2011, CHRONOBIOL INT, V28, P330, DOI 10.3109/07420528.2011.565895	53	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162476	10.1371/journal.pone.0162476	http://dx.doi.org/10.1371/journal.pone.0162476			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636197	Green Published, gold			2022-12-26	WOS:000383723700007
J	Bamberger, S; Vinson, CM; Mohamed, D; Viala, J; Carel, JC; Hugot, JP; Simon, D				Bamberger, Sarah; Vinson, Christine Martinez; Mohamed, Damir; Viala, Jerome; Carel, Jean-Claude; Hugot, Jean-Pierre; Simon, Dominique			Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor a Antibodies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LINEAR GROWTH; INFLIXIMAB THERAPY; FACTOR-ALPHA; CHILDREN; HORMONE; ADALIMUMAB; FAILURE; COLITIS	Inflammation contributes to growth failure associated with inflammatory bowel diseases. Anti-TNF alpha therapy induces sustained remission and short-term improvements in height velocity and/or height standard deviation score (H-SDS) patients with Crohn's disease. The purpose of this study was to evaluate growth and adult height in patients with Crohn's disease taking maintenance infliximab or adalimumab therapy. This university-hospital based retrospective study included 61 patients, with a median follow-up of 2.6 years (2.0; 3.3). 38 patients (62%) reached their adult height. H-SDS was collected at diagnosis and together with disease activity markers (Harvey-Bradshaw Index, albumin, and C-reactive protein) at treatment initiation (baseline), and follow-up completion. Wilcoxon's signed-rank test was chosen for comparisons. Median H-SDS decreased from diagnosis to baseline (-0.08 [-0.73; +0.77] to -0.94 [-1.44; +0.11], p<0.0001) and then increased to follow-up completion (-0.63 [-1.08; 0.49], p = 0.003 versus baseline), concomitantly with an improvement in disease activity. Median adult H-SDS was within the normal range (-0.72 [-1.25; +0.42]) but did not differ from baseline H-SDS and was significantly lower than the target H-SDS (-0.09 [-0.67; +0.42], p = 0.01). Only 2 (6%) males had adult heights significantly below their target heights (10.5 and -13.5 cm [-1.75 and -2.25 SD]). In conclusion, anti-tumor necrosis factor a (TNF) therapy prevented loss of height without fully restoring the genetic growth potential in this group of patients with CD. Earlier treatment initiation might improve growth outcomes in these patients.	[Bamberger, Sarah; Vinson, Christine Martinez; Viala, Jerome; Hugot, Jean-Pierre] Hop Robert Debre, AP HP, Serv Gastroenterol Pediat, Paris, France; [Mohamed, Damir] Hop Robert Debre, AP HP, Unite Epidemiol Clin, Paris, France; [Mohamed, Damir] INSERM, Ctr Invest Clin, Epidemiol Clin Unite 1426, Paris, France; [Carel, Jean-Claude; Simon, Dominique] Hop Robert Debre, AP HP, Serv Endocrinol Diabetol Pediat, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France; [Carel, Jean-Claude] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Carel, Jean-Claude; Simon, Dominique] DHU Protect, INSERM, Unite 1141, Paris, France; [Hugot, Jean-Pierre] INSERM, Ctr Rech Inflammat, Unite 1149, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Simon, D (corresponding author), Hop Robert Debre, AP HP, Serv Endocrinol Diabetol Pediat, Ctr Reference Malad Endocriniennes Rares Croissan, Paris, France.; Simon, D (corresponding author), DHU Protect, INSERM, Unite 1141, Paris, France.	dominique.simon@aphp.fr	Carel, Jean-Claude/AAZ-7691-2020	Carel, Jean-Claude/0000-0002-0424-6767; Hugot, Jean-Pierre/0000-0002-8446-6056				Alemzadeh N, 2002, GUT, V51, P26, DOI 10.1136/gut.51.1.26; Assa A, 2013, J CROHNS COLITIS, V7, P369, DOI 10.1016/j.crohns.2012.03.006; Ballinger AB, 2000, GUT, V46, P694, DOI 10.1136/gut.46.5.695; Borrelli O, 2004, DIGEST LIVER DIS, V36, P342, DOI 10.1016/j.dld.2003.12.014; Calenda KA, 2005, INFLAMM BOWEL DIS, V11, P435, DOI 10.1097/01.MIB.0000159321.58773.a6; Church PC, 2014, INFLAMM BOWEL DIS, V20, P1177, DOI 10.1097/MIB.0000000000000083; Crombe V, 2011, INFLAMM BOWEL DIS, V17, P2144, DOI 10.1002/ibd.21615; DeBoer MD, 2010, J GASTROENTEROL, V45, P277, DOI 10.1007/s00535-009-0192-x; DeBoer M, 2012, J GASTROENTEROL, V47, P647, DOI 10.1007/s00535-012-0542-y; Fuentes D, 2003, ALIMENT PHARM THER, V17, P913, DOI 10.1046/j.1365-2036.2003.01540.x; Gentilucci UV, 2005, ALIMENT PHARM THER, V21, P1063, DOI 10.1111/j.1365-2036.2005.02449.x; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; HARVEY RF, 1980, LANCET, V1, P514; Hyams J, 2011, CURR MED RES OPIN, V27, P651, DOI 10.1185/03007995.2010.547575; Hyams JS, 2012, GASTROENTEROLOGY, V143, P365, DOI 10.1053/j.gastro.2012.04.046; Levine A, 2011, INFLAMM BOWEL DIS, V17, P1314, DOI 10.1002/ibd.21493; LIPSON AB, 1990, EUR J PEDIATR, V149, P687, DOI 10.1007/BF01959522; Lonnkvist MH, 2011, SCAND J GASTROENTERO, V46, P420, DOI 10.3109/00365521.2010.539253; Luo ZC, 1998, PEDIATR RES, V44, P563, DOI 10.1203/00006450-199810000-00016; MacRae VE, 2006, INT J MOL MED, V18, P1011; Malik S, 2012, J CROHNS COLITIS, V6, P337, DOI 10.1016/j.crohns.2011.09.004; MARKOWITZ J, 1993, J PEDIATR GASTR NUTR, V16, P373, DOI 10.1097/00005176-199305000-00005; Martensson K, 2004, J BONE MINER RES, V19, P1805, DOI 10.1359/JBMR.040805; Mason A, 2011, HORM RES PAEDIAT, V75, P8, DOI 10.1159/000315902; Mauras N, 2002, METABOLISM, V51, P127, DOI 10.1053/meta.2002.28972; Rolland-Cachera MF, 1991, AM J CLIN NUTR, V45, P13; Ruemmele FM, 2014, J CROHNS COLITIS, V8, P1179, DOI 10.1016/j.crohns.2014.04.005; SANDERSON IR, 1987, ARCH DIS CHILD, V62, P123, DOI 10.1136/adc.62.2.123; Sawczenko A, 2006, PEDIATRICS, V118, P124, DOI 10.1542/peds.2005-2931; Sempe M, 1979, AUXOLOGIE METHODE ET; Thayu M, 2010, GASTROENTEROLOGY, V139, P430, DOI 10.1053/j.gastro.2010.04.044; Travis SPL, 2006, GUT, V55, DOI 10.1136/gut.2005.081950b; Walters TD, 2007, INFLAMM BOWEL DIS, V13, P424, DOI 10.1002/ibd.20069; Walters TD, 2014, GASTROENTEROLOGY, V146, P383, DOI 10.1053/j.gastro.2013.10.027; Wong SC, 2010, CLIN ENDOCRINOL, V73, P220, DOI 10.1111/j.1365-2265.2010.03799.x	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163126	10.1371/journal.pone.0163126	http://dx.doi.org/10.1371/journal.pone.0163126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636201	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700034
J	Gupta, A; Herman, Y; Ayers, C; Beg, MS; Lakoski, SG; Abdullah, SM; Johnson, DH; Neeland, IJ				Gupta, Arjun; Herman, Yehuda; Ayers, Colby; Beg, Muhammad S.; Lakoski, Susan G.; Abdullah, Shuaib M.; Johnson, David H.; Neeland, Ian J.			Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; PROSTATE-CANCER; COLORECTAL-CANCER; BREAST-CANCER; LUNG-CANCER; ADIPONECTIN; METAANALYSIS; ADIPOKINES; RECEPTOR	Purpose Leptin dysregulation has been postulated to affect cancer risk through its effects on obesity and inflammation. Epidemiological data evaluating this relationship are conflicting and studies in non-white cohorts is lacking. Therefore, we examined the association of leptin with the risk of incident cancer in the multiethnic Dallas Heart Study (DHS). Methods Participants enrolled in the DHS without prevalent cancer and with baseline leptin measurements were included. Incident cancer cases were identified through a systematic linkage of the DHS and the Texas Cancer Registry. Leptin was evaluated both as a continuous variable and in sex-specific quartiles. Multivariable Cox proportional hazards modeling was performed to examine the association between leptin levels with incident cancer after adjusting for age, sex, race, smoking status, alcohol use, family history of malignancy, body mass index (BMI), diabetes mellitus and C-reactive protein. Results Among 2,919 participants (median age 44 years; 54% women; 70% nonwhite; median BMI 29.4 kg/m(2)), 190 (6.5%) developed cancer after median follow-up of 12 years. Median leptin levels were 12.9 (interquartile range [IQR] 5.8-29.5) ng/ml in the incident cancer group vs. 12.3 (IQR 5.4-26.4) ng/ml those without an incident cancer (p = 0.34). Leptin was not associated with cancer incidence in multivariable analysis (unit standard deviation increase in log-transformed leptin, hazard ratio 0.95; 95% confidence interval, 0.77-1.16; p = 0.60). No association was observed in analyses stratified by sex, race/ethnicity, diabetes, or obesity status. Conclusions In this study of a predominantly minority population, no association between premorbid leptin levels and cancer incidence was demonstrated. Despite preclinical rationale and positive findings in other studies, this association may not replicate across all racial/ethnic populations.	[Gupta, Arjun; Johnson, David H.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Herman, Yehuda] Collin Coll, Preston Rd, Frisco, TX USA; [Ayers, Colby] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Beg, Muhammad S.] Univ Texas Southwestern Med Ctr Dallas, Div Oncol, Dallas, TX 75390 USA; [Lakoski, Susan G.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent & Cardiol, Houston, TX 77030 USA; [Abdullah, Shuaib M.; Neeland, Ian J.] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Neeland, IJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA.	ian.neeland@utsouthwestern.edu	Johnson, David/AHI-8369-2022	Gilchrist, Susan C./0000-0001-9624-0292; Gupta, Arjun/0000-0003-0875-4731	National Institute of Diabetes and Digestive and Kidney Diseases [1K23DK106520]; National Institutes of Health [UL1DE019584, PL1DK081182]; National Center for Advancing Translational Sciences [UL1TR001105]; Dedman Family Scholar in Clinical Care at UT Southwestern Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Dedman Family Scholar in Clinical Care at UT Southwestern Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grant 1K23DK106520 from the National Institute of Diabetes and Digestive and Kidney Diseases to Dr. Neeland, by grants UL1DE019584 and PL1DK081182 from the National Institutes of Health, and by grant number UL1TR001105 from the National Center for Advancing Translational Sciences. Dr. Neeland is supported as a Dedman Family Scholar in Clinical Care at UT Southwestern Medical Center.	Abdullah SM, 2007, ATHEROSCLEROSIS, V195, P404, DOI 10.1016/j.atherosclerosis.2006.10.022; Aleksandrova K, 2012, CANCER RES, V72, P5328, DOI 10.1158/0008-5472.CAN-12-0465; Aparicio T, 2005, GUT, V54, P1136, DOI 10.1136/gut.2004.060533; Baillargeon J, 2006, CANCER EPIDEM BIOMAR, V15, P1331, DOI 10.1158/1055-9965.EPI-06-0082; Beg MS, 2015, J NATL COMPR CANC NE, V13, P873, DOI 10.6004/jnccn.2015.0104; Bologna M, 2013, ONCOLOGY HEMATOLOGY, V9, P10; Chandra A, 2014, J AM COLL CARDIOL, V64, P997, DOI 10.1016/j.jacc.2014.05.057; Chen CL, 2014, CANCER EPIDEM BIOMAR, V23, P1659, DOI 10.1158/1055-9965.EPI-14-0161; Engineer Diana R, 2012, Int J Pept, V2012, P287457, DOI 10.1155/2012/287457; Frederich R, 2002, J LAB CLIN MED, V139, P72, DOI 10.1067/mlc.2002.121014; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Gong TT, 2015, INT J CANCER, V137, P1967, DOI 10.1002/ijc.29561; Harris HR, 2011, CANCER PREV RES, V4, P1449, DOI 10.1158/1940-6207.CAPR-11-0125; Hsing AW, 2001, JNCI-J NATL CANCER I, V93, P783, DOI 10.1093/jnci/93.10.783; Joshi RK, 2014, ASIAN PAC J CANCER P, V15, P397, DOI 10.7314/APJCP.2014.15.1.397; Kerem M, 2008, WORLD J GASTROENTERO, V14, P3633, DOI 10.3748/wjg.14.3633; Lai GY, 2014, CANCER CAUSE CONTROL, V25, P625, DOI 10.1007/s10552-014-0369-3; Li HJ, 2010, CLIN CHEM, V56, P34, DOI 10.1373/clinchem.2009.133272; Liu PC, 2014, J BUON, V19, P855; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Niu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067349; Ollberding NJ, 2013, CANCER PREV RES, V6, P188, DOI 10.1158/1940-6207.CAPR-12-0374; Petridou E, 2002, ANN NUTR METAB, V46, P147, DOI 10.1159/000063081; Petridou E, 2000, CANCER CAUSE CONTROL, V11, P383, DOI 10.1023/A:1008903727238; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Snoussi K, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-38; Song CH, 2014, CLIN BIOCHEM, V47, P230, DOI 10.1016/j.clinbiochem.2013.12.003; Song MY, 2013, CANCER PREV RES, V6, P875, DOI 10.1158/1940-6207.CAPR-13-0169; Unsal M, 2014, TUMOR BIOL, V35, P10231, DOI 10.1007/s13277-014-2293-2; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wannamethee SG, 2007, ATHEROSCLEROSIS, V191, P418, DOI 10.1016/j.atherosclerosis.2006.04.012; Wu MH, 2009, BRIT J CANCER, V100, P578, DOI 10.1038/sj.bjc.6604913; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104630; Wulaningsih W, 2016, CANCER MED-US, V5, P120, DOI 10.1002/cam4.570; Yeung CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078594	35	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162845	10.1371/journal.pone.0162845	http://dx.doi.org/10.1371/journal.pone.0162845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636369	Green Submitted, Green Published, gold			2022-12-26	WOS:000383723700017
J	Pan, FD; Shi, L; Zhang, L; Lu, QY; Xue, S				Pan, Fada; Shi, Liang; Zhang, Li; Lu, Qingyun; Xue, Song			Different Stages, Different Signals: The Modulating Effect of Cognitive Conflict on Subsequent Processing	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX	The present study used event-related potentials (ERPs) to investigate the function of signals induced by cognitive conflict during the detection stage and the resolution stage of perceptual processing. The study used a combination of the Stroop task and an affective priming task to examine the conflict priming effect when the stimulus onset asynchrony (SOA) was 200 ms or 800 ms. Behavioral results showed that the RTs were shorter for positive targets following congruent primes relative to incongruent primes, and for negative targets following incongruent primes relative to congruent primes when the SOA was 200 ms. ERP results showed that the N2 amplitudes (200-300 ms) for incongruent stimuli were significantly larger than for congruent stimuli in the Stroop task, which indicated a significant conflict effect. Moreover, the N400 amplitudes (500-700 ms) for positive targets after congruent primes were significantly lower than those after incongruent primes when the SOA was 200 ms, which showed a significant negative priming effect. While the SOA was 800 ms, behavioral results showed that the RTs were shorter for positive targets following incongruent primes relative to congruent primes. ERP results showed that the N2 amplitudes (200-300 ms) for incongruent stimuli were significantly larger than for congruent stimuli in the Stroop task, which indicated a significant conflict effect. The N400 amplitudes (11001300 ms) for the negative targets after congruent primes were significantly lower than those after incongruent primes when the SOA was 800 ms, which showed a significant positive priming effect. The results demonstrated that the functions of signals induced by cognitive conflict were reversed in two different cognitive processing stages.	[Pan, Fada; Shi, Liang; Zhang, Li] Nantong Univ, Sch Educ Sci, Nantong, Peoples R China; [Lu, Qingyun] Nantong Univ, Sch Publ Hlth, Nantong, Peoples R China; [Xue, Song] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Xue, Song] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China	Nantong University; Nantong University; Beijing Normal University; Beijing Normal University	Pan, FD (corresponding author), Nantong Univ, Sch Educ Sci, Nantong, Peoples R China.; Xue, S (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Xue, S (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.	psyc_lee2015@126.com; xues@mail.bnu.edu.cn			Humanities and Social Sciences Foundation of the Chinese Ministry of Education [12YJC190026]; Social Sciences Foundation of Jiangsu Province, China [14SHC006]; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China [C-a/2013/01/003]; National Natural Science Foundation of China [81502827]	Humanities and Social Sciences Foundation of the Chinese Ministry of Education; Social Sciences Foundation of Jiangsu Province, China; Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Humanities and Social Sciences Foundation of the Chinese Ministry of Education, grant number: 12YJC190026, http://www.sinoss.net/#, to FDP; this funder had roles in study design and decision to publish. The Social Sciences Foundation of Jiangsu Province, China, also supported this work: grant number: 14SHC006, http://jspopss.jschina.com.cn, to FDP; this funder had roles in data collection, analysis and decision to publish. This work was also supported by the Program for Twelfth Five-Year Plan of Educational Science of Jiangsu Province, China, grant number: C-a/2013/01/003, http://www.jssghb.cn/, to FDP; this funder had a role in decision to publish; and the National Natural Science Foundation of China, grant number: 81502827, http://www.nsfc.gov.cn/, to QYL; this funder had a role in preparation of the manuscript.	Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braem S, 2012, COGNITION, V125, P324, DOI 10.1016/j.cognition.2012.07.015; Brouillet T, 2011, EMOTION, V11, P1202, DOI 10.1037/a0024742; Brown CM, 2000, BRAIN LANG, V72, P158, DOI 10.1006/brln.1999.2284; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Dreisbach G, 2012, BRAIN COGNITION, V78, P94, DOI 10.1016/j.bandc.2011.12.003; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fritz J, 2015, EXP PSYCHOL, V62, P30, DOI 10.1027/1618-3169/a000271; Fritz J, 2013, COGN AFFECT BEHAV NE, V13, P311, DOI 10.3758/s13415-012-0147-1; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Guo TM, 2003, PSYCHOL SCI SHANGHAI, V26, P750; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Molapour T., 2011, LANG ACQUIS, P1; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Schouppe N, 2015, COGN AFFECT BEHAV NE, V15, P251, DOI 10.3758/s13415-014-0318-3; Schouppe N, 2014, ACTA PSYCHOL, V146, P63, DOI 10.1016/j.actpsy.2013.11.010; Schouppe N, 2012, Q J EXP PSYCHOL, V65, P1052, DOI 10.1080/17470218.2012.685080; Silvetti M, 2010, FRONT HUM NEUROSCI, V5, P75; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; van Bochove ME, 2013, COGN AFFECT BEHAV NE, V13, P346, DOI 10.3758/s13415-012-0138-2; van Steenbergen H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00215; van Steenbergen H, 2012, BIOL PSYCHOL, V90, P234, DOI 10.1016/j.biopsycho.2012.03.018; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007; [王一牛 WANG Yi-Niu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P608; Zhang Q, 2006, BRAIN RES BULL, V71, P316, DOI 10.1016/j.brainresbull.2006.09.023	30	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163263	10.1371/journal.pone.0163263	http://dx.doi.org/10.1371/journal.pone.0163263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5YN	27636368	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700044
J	Komiyama, EY; Lepesqueur, LSS; Yassuda, CG; Samaranayake, LP; Parahitiyawa, NB; Balducci, I; Koga-Ito, CY				Komiyama, Edson Yukio; Souto Lepesqueur, Laura Soares; Yassuda, Cinthia Gomes; Samaranayake, Lakshman P.; Parahitiyawa, Nipuna B.; Balducci, Ivan; Koga-Ito, Cristiane Yumi			Enterococcus Species in the Oral Cavity: Prevalence, Virulence Factors and Antimicrobial Susceptibility	PLOS ONE			English	Article							ENDODONTIC ENTEROCOCCUS; ANTIBIOTIC-RESISTANCE; IN-VITRO; FAECALIS; IDENTIFICATION; CULTURE; ENDOCARDITIS; PHENOTYPE; INFECTION; BACTERIAL	Enterococci are considered as transient constituent components of the oral microbiome that may cause a variety of oral and systemic infections. As there is sparse data on the oral enterococcal prevalence, we evaluated the Enterococcus spp. and their virulence attributes including antimicrobial resistance in a healthy Brazilian cohort. A total of 240 individuals in different age groups were studied (children 4-11 yrs, adolescents 12-17 yrs, young adults 18-29 yrs, adults 30-59 yrs, elderly over 60 yrs). Oral rinses were collected and isolates were identified by API 20 Strep and confirmed by 16S rDNA sequencing. E. faecalis isolates, in particular, were evaluated for virulence attributes such as their biofilm formation potential, and susceptibility to antimicrobials and an antiseptic, chlorhexidine gluconate. A total of 40 individuals (16.6%) and 10% children, 4% adolescents, 14% young adults, 30% adults, and 25% elderly carried oral enterococci. The oral enterococcal burden in adolescents was significantly lower than in the adults (p = 0.000) and elderly (p = 0.004). The proportion of carriers was higher among females (p = 0.001). E. faecalis was the most frequent isolate in all the age groups (p = 0.000), followed by E. durans and E. faecium. Whilst all the clinical isolates were able to form biofilms, only a proportion of them were able to produce lipase (92%), hemolysin (38%), and gelatinase (39%). Of all the isolates 53.8% were resistant to tetracycline, 12.3% to amoxicillin, 16.0% to ampicillin, 20.8% to chloramphenicol and 43.4% to erythromycin. None of the isolates were resistant to vancomycin. Our data suggest that in this Brazilian cohort the oral cavity may act as a significant reservoir of rather virulent and antibiotic resistant enterococci, with an increasing degree of carriage in the adults and elderly. Hence clinicians should be cognizant of this silent reservoir of virulent enterococci that may pose a particular threat of nosocomial infection.	[Komiyama, Edson Yukio; Souto Lepesqueur, Laura Soares; Yassuda, Cinthia Gomes; Koga-Ito, Cristiane Yumi] Univ Estadual Paulista UNESP, Dept Oral Biosci & Diag, Oral Biopathol Grad Program, Inst Sci & Technol, Sao Paulo, Brazil; [Samaranayake, Lakshman P.] Univ Queensland, UQ Oral Hlth Ctr, Sch Dent, Brisbane, Qld, Australia; [Parahitiyawa, Nipuna B.] Univ Hong Kong, Dept Oral Biosci, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Balducci, Ivan] Univ Estadual Paulista UNESP, Dept Social Dent, Inst Sci & Technol, Sao Paulo, Brazil; [Koga-Ito, Cristiane Yumi] Univ Estadual Paulista UNESP, Dept Environm Engn, Inst Sci & Technol, Sao Paulo, Brazil	Universidade Estadual Paulista; University of Queensland; University of Hong Kong; Universidade Estadual Paulista; Universidade Estadual Paulista	Koga-Ito, CY (corresponding author), Univ Estadual Paulista UNESP, Dept Oral Biosci & Diag, Oral Biopathol Grad Program, Inst Sci & Technol, Sao Paulo, Brazil.; Koga-Ito, CY (corresponding author), Univ Estadual Paulista UNESP, Dept Environm Engn, Inst Sci & Technol, Sao Paulo, Brazil.	cristiane@ict.unesp.br	Koga-Ito, Cristiane/ABC-6537-2020; Koga-Ito, Cristiane Y/D-7999-2012	Koga-Ito, Cristiane Y/0000-0002-2416-2173; Soares Souto Lepesqueur, Laura/0000-0001-8584-885X	Sao Paulo Research Foundation [06/50503-5, 07/54438-6, 09/50497-3, 07/ 5443-0, 09/50498-0]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (www.fapesp.br/en), 06/50503-5 (CYKI), 07/54438-6, 09/50497-3 (LSSL), and 07/ 5443-0, 09/50498-0 (CGY); and Coordination for the Improvement of Higher Education Personnel (CAPES), http://www.iie.org/Programs/CAPES#.V1vVBLsrLIU, EYK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Ahmad A, 2009, J ENDODONT, V35, P986, DOI 10.1016/j.joen.2009.04.013; Anderson AC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01534; Andre P, 2005, FEMS MICROBIOL LETT, V245, P123, DOI 10.1016/j.femsle.2005.02.036; Appelbe OK, 2007, ORAL MICROBIOL IMMUN, V22, P169, DOI 10.1111/j.1399-302X.2007.00340.x; Araya M, 2005, ARCH LATINOAM NUTR, V55, P161; Butler Karina M, 2006, Semin Pediatr Infect Dis, V17, P128, DOI 10.1053/j.spid.2006.06.006; Chai Wen L, 2007, J Oral Sci, V49, P161, DOI 10.2334/josnusd.49.161; Chirouze C, 2013, CLIN MICROBIOL INFEC, V19, P1140, DOI 10.1111/1469-0691.12166; Chomicz Lidia, 2004, Wiad Parazytol, V50, P177; Chowdhury SA, 2014, J CLIN MICROBIOL, V52, P549, DOI 10.1128/JCM.02763-13; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Colodner R, 2006, EUR J CLIN MICROBIOL, V25, P238, DOI 10.1007/s10096-006-0132-0; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Dahlen G, 1993, Adv Dent Res, V7, P163; Duggan JM, 2007, J ENDODONT, V33, P815, DOI 10.1016/j.joen.2007.02.016; Elsner HA, 2000, EUR J CLIN MICROBIOL, V19, P39, DOI 10.1007/s100960050007; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foschi F, 2005, ORAL MICROBIOL IMMUN, V20, P289, DOI 10.1111/j.1399-302X.2005.00227.x; Franzetti L, 2004, CURR MICROBIOL, V49, P255, DOI 10.1007/s00284-004-4242-6; Garcia-Garrote F, 2000, J CLIN MICROBIOL, V38, P2108; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Kirschner C, 2001, J CLIN MICROBIOL, V39, P1763, DOI 10.1128/JCM.39.5.1763-1770.2001; Kouidhi B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-155; Lavigne JP, 2005, PATHOL BIOL, V53, P539, DOI 10.1016/j.patbio.2005.06.005; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P1; Mihaila-Amrouche L, 2004, INDIAN J MED RES, V119, P80; Miranda JM, 2005, LETT APPL MICROBIOL, V41, P153, DOI 10.1111/j.1472-765X.2005.01728.x; Mittal S, 2016, J PATHOG, V2016, DOI 10.1155/2016/8262561; Rams TE, 2013, J PERIODONTOL, V84, P1026, DOI 10.1902/jop.2012.120050; Ran S, 2015, INT ENDOD J, V48, P362, DOI 10.1111/iej.12322; Razavi A, 2007, ORAL MICROBIOL IMMUN, V22, P248, DOI 10.1111/j.1399-302X.2006.00349.x; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI 10.1586/ERI.10.106; Salah Randa, 2008, BMC Oral Health, V8, P17, DOI 10.1186/1472-6831-8-17; Samaranayake LP, 1998, J ORAL PATHOL, V15, P286; Sedgley C, 2006, J ENDODONT, V32, P104, DOI 10.1016/j.joen.2005.10.022; Sedgley CM, 2005, ARCH ORAL BIOL, V50, P575, DOI 10.1016/j.archoralbio.2004.10.017; Sedgley CM, 2005, ORAL MICROBIOL IMMUN, V20, P10, DOI 10.1111/j.1399-302X.2004.00180.x; Sedgley CM, 2004, ORAL MICROBIOL IMMUN, V19, P95, DOI 10.1111/j.0902-0055.2004.00122.x; Sena NT, 2006, INT ENDOD J, V39, P878, DOI 10.1111/j.1365-2591.2006.01161.x; Silva J, 2005, REV MED CHILE, V133, P1201; Sun J, 2012, EUR J CLIN MICROBIOL, V31, P267, DOI 10.1007/s10096-011-1305-z; Vidana R, 2016, INT ENDOD J, V49, P343, DOI 10.1111/iej.12464; Winston LG, 2004, DIAGN MICR INFEC DIS, V48, P287, DOI 10.1016/j.diagmicrobio.2003.10.008; Zehnder M, 2009, INT ENDOD J, V42, P277, DOI 10.1111/j.1365-2591.2008.01537.x; Zoletti GO, 2006, J ENDODONT, V32, P722, DOI 10.1016/j.joen.2006.02.001	46	75	79	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163001	10.1371/journal.pone.0163001	http://dx.doi.org/10.1371/journal.pone.0163001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631785	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900113
J	Krishnan, P; Ghosh, S; Wang, B; Heyns, M; Graham, K; Mackey, JR; Kovalchuk, O; Damaraju, S				Krishnan, Preethi; Ghosh, Sunita; Wang, Bo; Heyns, Mieke; Graham, Kathryn; Mackey, John R.; Kovalchuk, Olga; Damaraju, Sambasivarao			Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis	PLOS ONE			English	Article							SMALL NONCODING RNA; LUNG-CANCER; MICRORNA SIGNATURE; MICROARRAY DATA; GASTRIC-CANCER; MESSENGER-RNA; C-ELEGANS; SNORNA; EXPRESSION; GENE	One of the most abundant, yet least explored, classes of RNA is the small nucleolar RNAs (snoRNAs), which are well known for their involvement in post-transcriptional modifications of other RNAs. Although snoRNAs were only considered to perform housekeeping functions for a long time, recent studies have highlighted their importance as regulators of gene expression and as diagnostic/prognostic markers. However, the prognostic potential of these RNAs has not been interrogated for breast cancer (BC). The objective of the current study was to identify snoRNAs as prognostic markers for BC. Small RNA sequencing (Illumina Genome Analyzer IIx) was performed for 104 BC cases and 11 normal breast tissues. Partek Genomics Suite was used for analyzing the sequencing files. Two independent and proven approaches were used to identify prognostic markers: case-control (CC) and case-only (CO). For both approaches, snoRNAs significant in the permutation test, following univariate Cox proportional hazards regression model were used for constructing risk scores. Risk scores were subsequently adjusted for potential confounders in a multivariate Cox model. For both approaches, thirteen snoRNAs were associated with overall survival and/or recurrence free survival. Patients belonging to the high-risk group were associated with poor outcomes, and the risk score was significant after adjusting for confounders. Validation of representative snoRNAs (SNORD46 and SNORD89) using qRT-PCR confirmedthe observations from sequencing experiments. We also observed 64 snoRNAs harboring piwi-interacting RNAs and/or microRNAs that were predicted to target genes (mRNAs) involved in tumorigenesis. Our results demonstrate the potential of snoRNAs to serve (i) as novel prognostic markers for BC and (ii) as indirect regulators of gene expression.	[Krishnan, Preethi; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Ghosh, Sunita; Graham, Kathryn; Mackey, John R.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Ghosh, Sunita; Graham, Kathryn; Mackey, John R.; Damaraju, Sambasivarao] Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada; [Wang, Bo; Heyns, Mieke; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB, Canada	University of Alberta; University of Alberta; Alberta Health Services (AHS); University of Alberta; University of Lethbridge	Damaraju, S (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.; Damaraju, S (corresponding author), Alberta Hlth Serv, Cross Canc Inst, Edmonton, AB, Canada.	sdamaraj@ualberta.ca	Heyns, Mieke/ABB-6676-2021; Krishnan, Preethi/AAY-2604-2020		Canadian Breast Cancer Foundation-Prairies/NWT Chapter	Canadian Breast Cancer Foundation-Prairies/NWT Chapter	This work was supported by the Canadian Breast Cancer Foundation-Prairies/NWT Chapter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0463-6; Bertoli G, 2015, THERANOSTICS, V5, P1122, DOI 10.7150/thno.11543; Bogdanova N, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-12; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dobbin KK, 2008, CLIN CANCER RES, V14, P108, DOI 10.1158/1078-0432.CCR-07-0443; Dobbin KK, 2007, BIOSTATISTICS, V8, P101, DOI 10.1093/biostatistics/kxj036; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gao L, 2015, INT J CANCER, V136, pE623, DOI 10.1002/ijc.29169; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Germain DR, 2011, BREAST CANCER RES TR, V127, P53, DOI 10.1007/s10549-010-0943-7; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Hashim A, 2014, ONCOTARGET, V5, P9901, DOI 10.18632/oncotarget.2476; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Krishnan P, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9272; Krishnan P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1899-0; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Liu N, 2014, INT J CANCER, V134, P1359, DOI 10.1002/ijc.28468; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martens-Uzunova ES, 2015, ONCOTARGET, V6, P17430, DOI 10.18632/oncotarget.4172; Martens-Uzunova ES, 2013, CANCER LETT, V340, P201, DOI 10.1016/j.canlet.2012.11.058; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okugawa Y, 2015, GUT; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Ravo M, 2015, ONCOTARGET, V6, P4677, DOI 10.18632/oncotarget.2911; Ribelles N, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3559; Ronchetti D, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-27; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Su H, 2014, ONCOGENE, V33, P1348, DOI 10.1038/onc.2013.89; Su YY, 2012, INT IMMUNOPHARMACOL, V13, P468, DOI 10.1016/j.intimp.2012.05.016; Venkataraman S, 2013, J BIOL CHEM, V288, P1918, DOI 10.1074/jbc.M112.396762; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu G, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-216; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhong FD, 2015, NUCLEIC ACIDS RES, V43, P10474, DOI 10.1093/nar/gkv954	52	40	42	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162622	10.1371/journal.pone.0162622	http://dx.doi.org/10.1371/journal.pone.0162622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631501	Green Published, gold			2022-12-26	WOS:000383706900061
J	Kunkanjanawan, T; Carter, RL; Prucha, MS; Yang, JJ; Parnpai, R; Chan, AWS				Kunkanjanawan, Tanut; Carter, Richard L.; Prucha, Melinda S.; Yang, Jinjing; Parnpai, Rangsun; Chan, Anthony W. S.			miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells	PLOS ONE			English	Article							MUTANT HUNTINGTIN; ALZHEIMERS-DISEASE; NONCODING RNAS; CAG REPEATS; EXPRESSION; MODEL; DYSREGULATION; APOPTOSIS; MOUSE; GENE	Huntington's disease (HD) is an inherited neurodegenerative disorder caused by the expansion of polyglutamine (polyQ) tract that leads to motor, cognitive and psychiatric impairment. Currently there is no cure for HD. A transgenic HD nonhuman primate (HD-NHP) model was developed with progressive development of clinical and pathological features similar to human HD, which suggested the potential preclinical application of the HD-NHP model. Elevated expression of miR-196a was observed in both HD-NHP and human HD brains. Cytotoxicity and apoptosis were ameliorated by the overexpression of miR-196a in HD-NHP neural progenitor cells (HD-NPCs) and differentiated neural cells (HD-NCs). The expression of apoptosis related gene was also down regulated. Mitochondrial morphology and activity were improved as indicated by mitotracker staining and the upregulation of CBP and PGC-1a in HD-NPCs overexpressing miR-196a. Here we demonstrated the amelioration of HD cellular phenotypes in HD-NPCs and HD-NCs overexpressing miR-196a. Our results also suggested the regulatory role of miR-196a in HD pathogenesis that may hold the key for understanding molecular regulation in HD and developing novel therapeutics.	[Kunkanjanawan, Tanut; Carter, Richard L.; Prucha, Melinda S.; Yang, Jinjing; Chan, Anthony W. S.] Yerkes Natl Primate Res Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA; [Kunkanjanawan, Tanut; Carter, Richard L.; Prucha, Melinda S.; Yang, Jinjing; Chan, Anthony W. S.] Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA; [Kunkanjanawan, Tanut; Parnpai, Rangsun] Suranaree Univ Technol, Sch Biotechnol, Embryo Technol & Stem Cell Res Ctr, Nakhon Ratchasima 30000, Thailand	Emory University; Suranaree University of Technology	Chan, AWS (corresponding author), Yerkes Natl Primate Res Ctr, 954 Gatewood Rd NE, Atlanta, GA 30329 USA.; Chan, AWS (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	awchan@emory.edu			ORIP/NIH [OD010930]; NINDS/NIH [NS084163]; Royal Golden Jubilee PhD program of Thailand Research Fund; Office of Research and Infrastructure Program (ORIP)/OD [P51OD11132]; NINDS [NS084163]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084163] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, R24OD010930] Funding Source: NIH RePORTER	ORIP/NIH; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Royal Golden Jubilee PhD program of Thailand Research Fund(Thailand Research Fund (TRF)); Office of Research and Infrastructure Program (ORIP)/OD; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by ORIP/NIH: OD010930 and NINDS/NIH: NS084163. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All experimental procedures described in this study were approved by Emory Environmental Health and Biosafety committee. Study using human tissue complied with NIH guidelines. Human brain tissues were provided by Emory Alzheimer's disease Research Center and the Emory Neuroscience NINDS Core Facilities (ENNCF). Transgenic HD monkey brain tissues and NPCs were provided by the Transgenic Huntington's disease monkey resource (THDMR) sponsored by the ORIP/NIH (OD010930). We thank Dr. Oskar Laur of the Emory Custom Cloning Core Facility and Ms. Leslee Sinclair for her assistance in proofing and editing. Tanut Kunkanjanawan and Rangsan Pranpai are supported by the Royal Golden Jubilee PhD program of Thailand Research Fund. YNPRC is supported by the Office of Research and Infrastructure Program (ORIP)/OD P51OD11132. This study is supported in part by grant awarded by the NINDS (NS084163) and the ORIP/NIH (OD010930; Transgenic Huntington's Disease Monkey Resource) to AWSC.	Acuna AI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3917; Asli NS, 2010, DEV BIOL, V344, P857, DOI 10.1016/j.ydbio.2010.06.003; Bagashev A, 2014, APOPTOSIS, V19, P1202, DOI 10.1007/s10495-014-1003-2; Batchelor RH, 2004, ANAL BIOCHEM, V329, P35, DOI 10.1016/j.ab.2004.02.007; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Berrios GE, 2001, PSYCHIAT RES, V102, P217, DOI 10.1016/S0165-1781(01)00257-8; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Carter RL, 2014, STEM CELL REP, V3, P585, DOI 10.1016/j.stemcr.2014.07.011; Chan AWS, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-36; Chan Anthony W. S., 2012, Frontiers in Genetics, V3, P82, DOI 10.3389/fgene.2012.00082; Chan AWS, 2010, CELL REPROGRAM, V12, P509, DOI 10.1089/cell.2010.0019; Chan AWS, 2015, PLOS ONE IN PRESS; Chan AWS, 2014, TRANSGENIC ANIMAL TE; Chang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046492; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Chen S, 2012, NEUROCHEM RES, V37, P2805, DOI 10.1007/s11064-012-0874-2; Chen Y, 2014, DRUG DISCOVERY TODAY; Cheng PH, 2013, AM J HUM GENET, V93, P306, DOI 10.1016/j.ajhg.2013.05.025; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Choi YS, 2009, NEUROBIOL DIS, V36, P259, DOI 10.1016/j.nbd.2009.07.014; Eckmann J, 2014, MOL NEUROBIOL, P1; Fu MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137637; Galkina EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095556; Gambazzi L, 2010, J PHARMACOL EXP THER, V335, P13, DOI 10.1124/jpet.110.167551; Giampa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064037; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Her L-S, 2014, BRAIN PATHOLOGY; Hoss AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004188; HUET O, 1992, CYTOMETRY, V13, P532, DOI 10.1002/cyto.990130513; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Jin YNN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057932; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kocerha J, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-46; Kocerha J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-88; Kocerha J, 2009, NEUROMOL MED, V11, P162, DOI 10.1007/s12017-009-8066-1; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Li Y, 2014, MOL BIOSYST, V10, P1757, DOI 10.1039/c4mb00066h; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Martin E, 2011, HUM MOL GENET, V20, P2422, DOI 10.1093/hmg/ddr148; Mastrokolias A, 2015, EUR J HUM GENET; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; Moran S, 2015, THERIOGENOLOGY; Muller S, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-17; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Putkhao K, 2013, STEM CELLS DEV, V22, P1198, DOI 10.1089/scd.2012.0469; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; Severino P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-533; Snider BJ, 2003, NEUROSCIENCE, V120, P617, DOI 10.1016/S0306-4522(03)00382-8; Soldati C, 2013, J NEUROCHEM, V124, P418, DOI 10.1111/jnc.12090; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Toulmond S, 2004, BRIT J PHARMACOL, V141, P689, DOI 10.1038/sj.bjp.0705662; Tsai M-M, 2014, CANC LETT; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Vis JC, 2005, ACTA NEUROPATHOL, V109, P321, DOI 10.1007/s00401-004-0957-5; Wade BE, 2014, J NEUROSCI, V34, P8411, DOI 10.1523/JNEUROSCI.0775-14.2014; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Yoon G, 2006, NEUROLOGY, V67, P1265, DOI 10.1212/01.wnl.0000238390.86304.4e; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zhu DW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-301; Zizak VS, 2005, COGN BEHAV NEUROL, V18, P198, DOI 10.1097/01.wnn.0000192134.53616.39	73	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162788	10.1371/journal.pone.0162788	http://dx.doi.org/10.1371/journal.pone.0162788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631085	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900079
J	Markus, B; Grote, K; Worsch, M; Parviz, B; Boening, A; Schieffer, B; Parahuleva, MS				Markus, Birgit; Grote, Karsten; Worsch, Michael; Parviz, Behnoush; Boening, Andreas; Schieffer, Bernhard; Parahuleva, Mariana S.			Differential Expression of MicroRNAs in Endarterectomy Specimens Taken from Patients with Asymptomatic and Symptomatic Carotid Plaques	PLOS ONE			English	Article							ACTIVATING PROTEASE FSAP; ATHEROSCLEROTIC PLAQUES; ISCHEMIC-STROKE; SIGNATURE; HUMANS; INSTABILITY; DISEASE; LESIONS; CELLS	Objective Stroke and transient ischemic attacks are considered as clinical manifestations of atherosclerotic disease due to on-going vascular inflammation and finally atherothrombosis of the carotid arteries. MicroRNAs (miRNA/miR) are known to be involved in vascular inflammation and plaque destabilization. The aim of this study was to analyze the expression profile of selected miRNAs in endarterectomy specimen from carotid arteries that were taken from patients with asymptomatic and symptomatic atherosclerotic plaques. Methods and Results 11 miRNAs were selected and their expression was analyzed using real-time RT-PCR. Therefore, samples were divided into three different groups. On the one hand we investigated the expression patterns from patients in asymptomatic (n = 14) and symptomatic (n = 10) plaques; on the other hand we took samples from normal configurated internalmammary arteries (n = 15). Out of these 11 targets we identified some miRNAs, which were up- or down-regulated in either one of the two groups. Interestingly, the expression of two miRNAs was significantly different between asymptomatic and symptomatic samples, namely miR-21 (P<0.01) and miR-143 (P<0.05). Conclusion In the present study, we identified miRNA subtypes which showed different expression in endarterectomy specimen from patients with asymptomatic and symptomatic plaques, suggesting that these miRNAs correlated with advanced vascular inflammation and plaque stability. They may represent new therapeutic targets for vascular proliferative diseases such as atherosclerosis.	[Markus, Birgit; Grote, Karsten; Schieffer, Bernhard; Parahuleva, Mariana S.] Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol, Marburg, Germany; [Worsch, Michael; Parviz, Behnoush; Parahuleva, Mariana S.] Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol 1, Giessen, Germany; [Boening, Andreas] Univ Hosp Giessen & Marburg, Dept Cardiovasc Surg, Giessen, Germany	University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg	Parahuleva, MS (corresponding author), Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol, Marburg, Germany.; Parahuleva, MS (corresponding author), Univ Hosp Giessen & Marburg, Internal Med Cardiol & Angiol 1, Giessen, Germany.	parahule@med.uni-marburg.de	Parahuleva, Mariana/AAN-8686-2021	Grote, Karsten/0000-0001-7914-3159				Andreou L, 2015, TRENDS MOL MED, V21, P307, DOI 10.1016/j.molmed.2015.02.003; Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Cipollone F, 2011, STROKE, V42, P2556, DOI 10.1161/STROKEAHA.110.597575; Fan XS, 2014, EXP MOL PATHOL, V96, P242, DOI 10.1016/j.yexmp.2014.02.009; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Gui T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/693083; Hartmann P, 2015, CELL MOL LIFE SCI, V72, P3253, DOI 10.1007/s00018-015-1925-z; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Jansen F, 2015, J CELL MOL MED, V19, P2202, DOI 10.1111/jcmm.12607; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Li SH, 2015, CURR NEUROVASC RES, V12, P214, DOI 10.2174/1567202612666150605121709; Maitrias P, 2015, J VASC SURG, V62, P1245, DOI 10.1016/j.jvs.2015.06.136; Nazari-Jahantigh M, 2015, J MOL CELL CARDIOL, V89, P35, DOI 10.1016/j.yjmcc.2014.10.021; Parahuleva MS, 2008, ATHEROSCLEROSIS, V196, P164, DOI 10.1016/j.atherosclerosis.2007.03.042; Parahuleva MS, 2012, CIRC J, V76, P2653, DOI 10.1253/circj.CJ-11-1502; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rink C, 2011, PHYSIOL GENOMICS, V43, P521, DOI 10.1152/physiolgenomics.00158.2010; Santovito D, 2013, EXPERT OPIN THER TAR, V17, P217, DOI 10.1517/14728222.2013.745512; Soeki T, 2015, CIRC J, V79, P413, DOI 10.1253/circj.CJ-14-0958; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Swirski FK, 2012, CELL METAB, V15, P135, DOI 10.1016/j.cmet.2012.01.012; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Thim T, 2008, J INTERN MED, V263, P506, DOI 10.1111/j.1365-2796.2008.01947.x; Togliatto G, 2011, DIABETOLOGIA, V54, P1930, DOI 10.1007/s00125-011-2125-5	28	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161632	10.1371/journal.pone.0161632	http://dx.doi.org/10.1371/journal.pone.0161632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631489	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900021
J	Hoang, TN; Van, TN; Gammeltoft, T; Meyrowitsch, DW; Thuy, HNT; Rasch, V				Thanh Nguyen Hoang; Toan Ngo Van; Gammeltoft, Tine; Meyrowitsch, Dan W.; Hanh Nguyen Thi Thuy; Rasch, Vibeke			Association between Intimate Partner Violence during Pregnancy and Adverse Pregnancy Outcomes in Vietnam: A Prospective Cohort Study	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; LAST MENSTRUAL PERIOD; DOMESTIC VIOLENCE; PRETERM BIRTH; NEONATAL OUTCOMES; MATERNAL EXPOSURE; HEALTH; WOMEN; RISK; PREVALENCE	Background Violence against pregnant women is an increasing public health concern particularly in low- and middle-income countries. The purpose of this study was to measure the association between intimate partner violence (IPV) during pregnancy and the risk of adverse birth outcomes. Methods Prospective cohort study of 1276 pregnant women in Dong Anh district, Vietnam. Women with gestational age less than 24 weeks were enrolled and interviewed. Repeated interviews were performed at 30-34 weeks gestation to assess experience of IPV during pregnancy and again 48 hours post-delivery to assess the birth outcome including birth weight and gestational age at delivery. Results There was a statistically significant association between exposure to physical violence during pregnancy and preterm birth (PTB) or low birth weight (LBW). After adjustment for age, education, occupation, body mass index (BMI), haemoglobin level, previous adverse pregnancy outcomes, the pregnant women who were exposed to physical violence during pregnancy were five times more likely to have PTB (AOR = 5.5; 95% CI: 2.1-14.1) and were nearly six times more likely to give birth to a child of LBW (AOR = 5.7; 95% CI: 2.2-14.9) as compared to those who were not exposed to physical violence. Conclusion Exposure to IPV during pregnancy increases the risk of PTB and LBW. Case-finding for violence in relation to antenatal care may help protect pregnant women and improve pregnancy outcomes.	[Thanh Nguyen Hoang; Toan Ngo Van; Hanh Nguyen Thi Thuy] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Gammeltoft, Tine] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark; [Meyrowitsch, Dan W.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Rasch, Vibeke] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Hanoi Medical University; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Hoang, TN (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.	nguyenhoangthanh@hmu.edu.vn	Rasch, Vibeke/G-9393-2019	Rasch, Vibeke/0000-0001-6557-0985; Gammeltoft, Tine Mette/0000-0002-6723-2370	Danish International Development Agency; larger research project The Impact of Violence on Reproductive Health in Tanzania and Vietnam (PAVE)	Danish International Development Agency; larger research project The Impact of Violence on Reproductive Health in Tanzania and Vietnam (PAVE)	This work was supported by the Danish International Development Agency. The funder had no role in study design, data collection and analysis, manuscript preparation.; This research was conducted under the auspices of the larger research project The Impact of Violence on Reproductive Health in Tanzania and Vietnam (PAVE). We are extremely grateful to the pregnant women who took part in this study, the research assistants, the hospital staff at Dong Anh Hospital and Bac Thang Long Hospital and, the population centre and community health centre in Dong Anh district.	Abadi MNL, 2013, J NERV MENT DIS, V201, P602, DOI 10.1097/NMD.0b013e3182982b1d; Abdollahi F, 2015, J FAM COMMUNITY MED, V22, P13, DOI 10.4103/2230-8229.149577; Alhusen JL, 2015, J WOMENS HEALTH, V24, P100, DOI 10.1089/jwh.2014.4872; Alhusen JL, 2013, J PEDIATR-US, V163, P471, DOI 10.1016/j.jpeds.2013.01.036; Nunes MAA, 2011, EUR J PUBLIC HEALTH, V21, P92, DOI 10.1093/eurpub/ckp241; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Campbell J, 2004, VIOLENCE AGAINST WOM, V10, P770, DOI 10.1177/1077801204265551; Chai J, 2016, B WORLD HEALTH ORGAN, V94, P331, DOI 10.2471/BLT.15.152462; Chan KL, 2011, J INTERPERS VIOLENCE, V26, P1478, DOI 10.1177/0886260510369134; Devries KM, 2010, REPROD HEALTH MATTER, V18, P158, DOI 10.1016/S0968-8080(10)36533-5; El-Mohandes AAE, 2011, MATERN CHILD HLTH J, V15, P19, DOI [10.1007/s10995-009-0557-z, 10.1007/s10995-011-0843-4, 10.1007/s10995-011-0856-z]; Audi CAF, 2008, J PEDIAT-BRAZIL, V84, P60, DOI 10.2223/JPED.1744; Garcia-Moreno C, 2005, MULTICOUNTRY STUDY W, V1ra; Garcia-Moreno C, 2013, PREVALENCE HLTH EFFE; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Han A, 2014, INT J GYNECOL OBSTET, V124, P6, DOI 10.1016/j.ijgo.2013.06.037; Henrica AFMJ, 2010, RESULTS NATL STUDY D; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Ibrahim Zm Fau-Sayed Ahmed WA, 2015, INTIMATE PARTNER VIO; James L, 2013, VIOLENCE VICTIMS, V28, P359, DOI 10.1891/0886-6708.VV-D-12-00034; Kaye DK, 2006, TROP MED INT HEALTH, V11, P1576, DOI 10.1111/j.1365-3156.2006.01711.x; Leone JM, 2010, J WOMENS HEALTH, V19, P1501, DOI 10.1089/jwh.2009.1716; Ministry of Health General Statistics Office, 2011, MULT IND CLUST SURV; Niemi M, 2013, TROP MED INT HEALTH, V18, P687, DOI 10.1111/tmi.12101; Saito A, 2013, HEALTH CARE WOMEN IN, V34, P757, DOI 10.1080/07399332.2013.794459; Sanchez SE, 2013, MATERN CHILD HLTH J, V17, P485, DOI 10.1007/s10995-012-1012-0; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Shah PS, 2010, J WOMENS HEALTH, V19, P2017, DOI 10.1089/jwh.2010.2051; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Tessa W, 2004, LOW BIRTHW COUNTR RE; Waller DK, 2000, PAEDIATR PERINAT EP, V14, P263, DOI 10.1046/j.1365-3016.2000.00275.x; Zhang Y, 2013, ASIA-PAC PSYCHIAT, V5, P2, DOI 10.1111/appy.12021	33	32	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162844	10.1371/journal.pone.0162844	http://dx.doi.org/10.1371/journal.pone.0162844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631968	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900084
J	Ayala, AJ; Dimitrov, KM; Becker, CR; Goraichuk, IV; Arns, CW; Bolotin, VI; Ferreira, HL; Gerilovych, AP; Goujgoulova, GV; Martini, MC; Muzyka, DV; Orsi, MA; Scagion, GP; Silva, RK; Solodiankin, OS; Stegniy, BT; Miller, PJ; Afonso, CL				Ayala, Andrea J.; Dimitrov, Kiril M.; Becker, Cassidy R.; Goraichuk, Iryna V.; Arns, Clarice W.; Bolotin, Vitaly I.; Ferreira, Helena L.; Gerilovych, Anton P.; Goujgoulova, Gabriela V.; Martini, Matheus C.; Muzyka, Denys V.; Orsi, Maria A.; Scagion, Guilherme P.; Silva, Renata K.; Solodiankin, Olexii S.; Stegniy, Boris T.; Miller, Patti J.; Afonso, Claudio L.			Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; AVIAN INFLUENZA-VIRUSES; MOLECULAR EPIDEMIOLOGY; DOMESTIC-ANIMALS; RECENT OUTBREAKS; POULTRY; STRAIN; TRANSMISSION; GENOTYPES; CHICKENS	Our study demonstrates the repeated isolation of vaccine-derived Newcastle disease viruses from different species of wild birds across four continents from 1997 through 2014. The data indicate that at least 17 species from ten avian orders occupying different habitats excrete vaccine-derived Newcastle disease viruses. The most frequently reported isolates were detected among individuals in the order Columbiformes (n = 23), followed in frequency by the order Anseriformes (n = 13). Samples were isolated from both free-ranging (n = 47) and wild birds kept in captivity (n = 7). The number of recovered vaccine-derived viruses corresponded with the most widely utilized vaccines, LaSota (n = 28) and Hitchner B1 (n = 19). Other detected vaccine-derived viruses resembled the PHY-LMV2 and V4 vaccines, with five and two cases, respectively. These results and the ubiquitous and synanthropic nature of wild pigeons highlight their potential role as indicator species for the presence of Newcastle disease virus of low virulence in the environment. The reverse spillover of live agents from domestic animals to wildlife as a result of the expansion of livestock industries employing massive amounts of live virus vaccines represent an underappreciated and poorly studied effect of human activity on wildlife.	[Ayala, Andrea J.] Univ Georgia, Coll Vet Med, Athens, GA USA; [Ayala, Andrea J.; Dimitrov, Kiril M.; Goraichuk, Iryna V.; Miller, Patti J.; Afonso, Claudio L.] ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA; [Dimitrov, Kiril M.; Goujgoulova, Gabriela V.] Natl Diagnost Res Vet Med Inst, Sofia, Bulgaria; [Becker, Cassidy R.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Goraichuk, Iryna V.; Bolotin, Vitaly I.; Gerilovych, Anton P.; Muzyka, Denys V.; Solodiankin, Olexii S.; Stegniy, Boris T.] Natl Sci Ctr, Inst Expt & Clin Vet Med, Kharkiv, Ukraine; [Arns, Clarice W.; Scagion, Guilherme P.] Univ Estadual Campinas, UNICAMP, Inst Biol, Lab Anim Virol, Campinas, SP, Brazil; [Ferreira, Helena L.] Univ Sao Paulo, Coll Anim Sci & Food Engn, Dept Vet Med, Sao Paulo, Brazil; [Ferreira, Helena L.] Univ Sao Paulo, Grad Program Expt Epidemiol Zoonosis, Sao Paulo, Brazil; [Ferreira, Helena L.; Silva, Renata K.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Postgrad Program Expt Epidemiol Zoonoses, Sao Paulo, Brazil; [Orsi, Maria A.] Natl Agr Lab Sao Paulo, Campinas, SP, Brazil	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); National Veterinary Medical Institute - Bulgaria; University System of Georgia; University of Georgia; National Academy of Agrarian Sciences of Ukraine; National Scientific Center "Institute of Experimental & Clinical Veterinary Medicine"; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Afonso, CL (corresponding author), ARS, Exot & Emerging Avian Viral Dis Res Unit, Southeast Poultry Res Lab, US Natl Poultry Res Ctr,USDA, Athens, GA 30602 USA.	Claudio.Afonso@ars.usda.gov	Gerilovych, Anton/N-5608-2019; Денис, Muzyka Denys Музыка/AAP-5876-2020; Dimitrov, Kiril M./I-4280-2019; Stegniy, Borys/AAD-2967-2020; Lage Ferreira, Helena/A-2046-2010; Goraichuk, Iryna/AAC-5395-2019; Martini, Matheus C/E-9416-2015; Miller, Patti/T-3933-2019; Bolotin, Vitaliy/AAA-4161-2021; Arns, Clarice/F-2762-2015	Dimitrov, Kiril M./0000-0002-5525-4492; Stegniy, Borys/0000-0003-1787-5789; Lage Ferreira, Helena/0000-0002-3261-3712; Goraichuk, Iryna/0000-0002-5841-5765; Martini, Matheus C/0000-0003-0135-4364; Bolotin, Vitaliy/0000-0001-9875-6639; Orsi, Maria Angela/0000-0002-6114-197X; Muzyka, Denys/0000-0003-1598-6338; Gerilovych, Anton/0000-0002-3280-4172; Solodiankin, Oleksii/0000-0002-8698-0390; Arns, Clarice/0000-0002-7308-460X	DTRA BAA project [FRCALL 12-6-3412-0005]; FAPESP [2013/02059-2, 2015/11510-5]; American Ornithologists' Union; Oconee Audubon Society; Odum School of Ecology; USDA, ARS [CRIS 6040-32000-064]	DTRA BAA project; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); American Ornithologists' Union; Oconee Audubon Society; Odum School of Ecology; USDA, ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by USDA, ARS, CRIS 6040-32000-064, DTRA BAA project FRCALL 12-6-3412-0005, FAPESP 2013/02059-2, FAPESP 2015/11510-5, the American Ornithologists' Union, the Oconee Audubon Society, and the Odum School of Ecology.	Aldous EW, 2004, AVIAN PATHOL, V33, P258, DOI 10.1080/0307945042000195768; Alexander D. J., 1998, LAB MANUAL ISOLATION, V4, P156; Alexander DJ, 2006, AVIAN PATHOL, V35, P99, DOI 10.1080/03079450600597444; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2015, EPIDEMIOLOGY PREVENT; Ayala AJ, 2013, THESIS; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; Brown C, 1999, VET PATHOL, V36, P125, DOI 10.1354/vp.36-2-125; Cardenas-Garcia S, 2015, BIOLOGICALS, V43, P136, DOI 10.1016/j.biologicals.2014.11.003; Caron A, 2014, PREV VET MED, V117, P590, DOI 10.1016/j.prevetmed.2014.09.014; Cherkasova EA, 2005, J VIROL, V79, P1062, DOI 10.1128/JVI.79.2.1062-1070.2005; Chong YL, 2013, INFECT GENET EVOL, V17, P260, DOI 10.1016/j.meegid.2013.04.025; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Clifford DL, 2009, BIOL CONSERV, V142, P2559, DOI 10.1016/j.biocon.2009.06.001; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; Coppo MJC, 2013, AVIAN PATHOL, V42, P195, DOI 10.1080/03079457.2013.800634; Czegledi A, 2002, EPIDEMIOL INFECT, V129, P679, DOI 10.1017/S0950268802007732; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Deem SL, 2012, ANIM CONSERV, V15, P73, DOI 10.1111/j.1469-1795.2011.00489.x; DeSante DF, 2015, 127 I BIRD POP; Devlin JM, 2016, CURR OPIN VIROL, V19, P23, DOI 10.1016/j.coviro.2016.06.007; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dimitrov KM, 2016, J CLIN MICROBIOL, V54, P1228, DOI 10.1128/JCM.03044-15; Etikan I., 2016, AMERICAL J THEORETIC, V5, P1, DOI [DOI 10.11648/J.ATAS.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Friend M, 2001, AUK, V118, P290, DOI 10.1642/0004-8038(2001)118[0290:DEIBCF]2.0.CO;2; Garcia SC, 2013, APPL ENVIRON MICROB, V79, P4985, DOI 10.1128/AEM.00993-13; Gilchrist P, 2005, WORLD POULTRY SCI J, V61, P198, DOI 10.1079/WPS200451; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; GOLDHAFT TM, 1980, AVIAN DIS, V24, P297, DOI 10.2307/1589696; Guan Y, 2004, LANCET, V363, P99, DOI 10.1016/S0140-6736(03)15259-2; Herczeg J, 2001, AVIAN PATHOL, V30, P163, DOI 10.1080/03079450120044000; HITCHNER SB, 1975, AVIAN DIS, V19, P215, DOI 10.2307/1588975; Hull J, 2006, CONDOR, V108, P435, DOI 10.1650/0010-5422(2006)108[435:VOWNVA]2.0.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kaleta E. F., 1988, Newcastle disease., P197; Kasambe R., 2014, MISTNET, V15, P10; Kim BY, 2012, INFECT GENET EVOL, V12, P478, DOI 10.1016/j.meegid.2011.12.004; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kuiken T, 1998, CAN VET J, V39, P299; LaRussa P, 1997, J INFECT DIS, V176, P1072, DOI 10.1086/516514; Lebarbenchon C, 2013, INFLUENZA OTHER RESP, V7, P1237, DOI 10.1111/irv.12070; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; LEFEBVRE L, 1985, AUK, V102, P886; Magnus M., 2008, ESSENTIALS INFECT DI; Manning L., 2004, British Food Journal, V106, P819, DOI 10.1108/00070700410561414; Marangon S, 2007, REV SCI TECH OIE, V26, P265, DOI 10.20506/rst.26.1.1742; da Silva TAM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0837-y; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; MCCANDLISH IAP, 1992, VET REC, V130, P27, DOI 10.1136/vr.130.2.27; Menendez KR, 2014, AVIAN PATHOL, V43, P108, DOI 10.1080/03079457.2014.886004; Miller M, 2013, COMP IMMUNOL MICROB, V36, P263, DOI 10.1016/j.cimid.2012.07.005; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00235; Miller PJ, 2015, INFECT GENET EVOL, V29, P216, DOI 10.1016/j.meegid.2014.10.032; Miller PJ, 2013, DEV COMP IMMUNOL, V41, P505, DOI 10.1016/j.dci.2013.06.007; Miller PJ, 2010, J VIROL, V84, P11496, DOI 10.1128/JVI.00822-10; Miller PJ, 2013, DIS OFPOULTRY, V13th, P89, DOI DOI 10.1002/9781119421481.CH3; Miller RS, 2013, PREV VET MED, V110, P119, DOI 10.1016/j.prevetmed.2012.11.021; Morton DB, 2007, REV SCI TECH OIE, V26, P157, DOI 10.20506/rst.26.1.1735; Muller H, 2012, AVIAN PATHOL, V41, P133, DOI 10.1080/03079457.2012.661403; Nusser SM, 2008, J WILDLIFE MANAGE, V72, P52, DOI 10.2193/2007-317; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; OIE, 2014, NEW DIS MAN DIAGN 2, V1; Ollinger M., 2000, FoodReview, V23, P2; Palmer MV, 2007, CURR TOP MICROBIOL, V315, P195; Palya V, 2012, AVIAN DIS, V56, P282, DOI 10.1637/9935-091511-Reg.1; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Pedersen JC, 2004, J CLIN MICROBIOL, V42, P2329, DOI 10.1128/JCM.42.5.2329-2334.2004; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Prosperi M, 2013, MOL EPIDEMIOLOGY COM; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Pyle P, 1997, IDENTIFICATION GUIDE; Qin ZM, 2008, J CLIN MICROBIOL, V46, P601, DOI 10.1128/JCM.01356-07; Ranstam J, 2009, OSTEOARTHR CARTILAGE, V17, P1416, DOI 10.1016/j.joca.2009.04.007; Read AF, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002198; Saif YM, 2002, AVIAN DIS, V46, P505, DOI 10.1637/0005-2086(2002)046[0505:IMITSF]2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samour J, 2014, J AVIAN MED SURG, V28, P1, DOI 10.1647/2011-041; SAS Institute Inc, 1999, MULTTEST P CAR, P2311; Seewagen CL, 2008, J FIELD ORNITHOL, V79, P80, DOI 10.1111/j.1557-9263.2007.00132.x; Senne DA, 2004, DEV BIOLOGICALS, V119, P165; Sepkowitz KA, 2003, NEW ENGL J MED, V348, P439, DOI 10.1056/NEJMra022500; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Siembieda J. L., 2011, Animal Health Research Reviews, V12, P95, DOI 10.1017/S1466252311000041; SMYTH GK, 1989, J ROY STAT SOC B MET, V51, P47; Snoeck CJ, 2013, APPL ENVIRON MICROB, V79, P639, DOI 10.1128/AEM.02437-12; Sol D, 2000, ECOGRAPHY, V23, P307, DOI 10.1034/j.1600-0587.2000.d01-1639.x; Sol D, 2003, OECOLOGIA, V135, P542, DOI 10.1007/s00442-003-1223-6; Sol D, 1998, CONDOR, V100, P298, DOI 10.2307/1370270; Sol D, 2008, BIOL J LINN SOC, V93, P657, DOI 10.1111/j.1095-8312.2008.00957.x; Soos C, 2008, AUK, V125, P445, DOI 10.1525/auk.2008.06235; Swayne DE, 2014, ECOHEALTH, V11, P94, DOI 10.1007/s10393-013-0861-3; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomazelli LM, 2010, VET MICROBIOL, V146, P155, DOI 10.1016/j.vetmic.2010.05.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; United States Department of Agriculture, 2009, DEC FIND NO SIGN IMP; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x; VANECK JHH, 1991, AVIAN PATHOL, V20, P497, DOI 10.1080/03079459108418787; Vargha A, 1998, J EDUC BEHAV STAT, V23, P170, DOI 10.3102/10769986023002170; WESTBURY HA, 1984, AUST VET J, V61, P5, DOI 10.1111/j.1751-0813.1984.tb07120.x; Woodford MH, 2009, TROP ANIM HEALTH PRO, V41, P1023, DOI 10.1007/s11250-008-9269-4; Yuan XY, 2013, VIRUS GENES, V46, P377, DOI 10.1007/s11262-012-0863-1; Zanetti F, 2005, AVIAN DIS, V49, P546, DOI 10.1637/7381-051605R.1; Zhu W, 2010, VIRUS GENES, V40, P231, DOI 10.1007/s11262-009-0436-0	113	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162484	10.1371/journal.pone.0162484	http://dx.doi.org/10.1371/journal.pone.0162484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626272	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600037
J	Braselmann, E; Chaney, JL; Champion, MM; Clark, PL				Braselmann, Esther; Chaney, Julie L.; Champion, Matthew M.; Clark, Patricia L.			DegP Chaperone Suppresses Toxic Inner Membrane Translocation Intermediates	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; BACTERIAL OUTER-MEMBRANE; AUTOTRANSPORTER VIRULENCE PROTEINS; ENVELOPE STRESS-RESPONSE; ESCHERICHIA-COLI; CELL-ENVELOPE; EXTRACYTOPLASMIC STRESS; PROTEOLYTIC ACTIVITY; PASSENGER PROTEINS; FOLDING MECHANISM	The periplasm of Gram-negative bacteria includes a variety of molecular chaperones that shepherd the folding and targeting of secreted proteins. A central player of this quality control network is DegP, a protease also suggested to have a chaperone function. We seren-dipitously discovered that production of the Bordetella pertussis autotransporter virulence protein pertactin is lethal in Escherichia coli Delta degP strains. We investigated specific contributions of DegP to secretion of pertactin as a model system to test the functions of DegP in vivo. The DegP chaperone activity was sufficient to restore growth during pertactin production. This chaperone dependency could be relieved by changing the pertactin signal sequence: an E. coli signal sequence leading to co-translational inner membrane (IM) translocation was sufficient to suppress lethality in the absence of DegP, whereas an E. coli post-translational signal sequence was sufficient to recapitulate the lethal phenotype. These results identify a novel connection between the DegP chaperone and the mechanism used to translocate a protein across the IM. Lethality coincided with loss of periplasmic proteins, soluble sigma(E), and proteins regulated by this essential stress response. These results suggest post-translational IM translocation can lead to the formation of toxic periplasmic folding intermediates, which DegP can suppress.	[Braselmann, Esther; Chaney, Julie L.; Champion, Matthew M.; Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Clark, Patricia L.] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Braselmann, Esther] Univ Colorado Boulder, Dept Chem & Biochem, Boulder, CO 80309 USA; [Braselmann, Esther] Univ Colorado Boulder, BioFrontiers Inst, Boulder, CO 80309 USA; [Chaney, Julie L.] Siemens Healthineers, 3400 Middlebury St, Elkhart, IN 46516 USA	University of Notre Dame; University of Notre Dame; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Siemens AG	Braselmann, E (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Braselmann, E (corresponding author), Univ Colorado Boulder, Dept Chem & Biochem, Boulder, CO 80309 USA.; Braselmann, E (corresponding author), Univ Colorado Boulder, BioFrontiers Inst, Boulder, CO 80309 USA.	esther.braselmann@colorado.edu		Clark, Patricia/0000-0001-5462-8248; Champion, Matthew M./0000-0001-5927-5277	National Institutes of Health (US) [R01 GM097573]; Notre Dame CBBI Graduate Fellowship (National Institutes of Health grant) [T32 GM075762]; Henry Luce Foundation	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame CBBI Graduate Fellowship (National Institutes of Health grant); Henry Luce Foundation	This project was supported by the National Institutes of Health (US) grant R01 GM097573 to PLC. EB was supported by a Notre Dame CBBI Graduate Fellowship (National Institutes of Health grant T32 GM075762). JLC was supported by a Clare Boothe Luce Graduate Fellowship from the Henry Luce Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Barnard TJ, 2012, J MOL BIOL, V415, P128, DOI 10.1016/j.jmb.2011.10.049; Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x; Baud C, 2011, MOL MICROBIOL, V80, P1625, DOI 10.1111/j.1365-2958.2011.07672.x; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Braselmann E, 2012, J PHYS CHEM LETT, V3, P1063, DOI 10.1021/jz201654k; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; CastilloKeller M, 2003, J BACTERIOL, V185, P148, DOI 10.1128/JB.185.1.148-154.2003; Celik N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043245; Champion MM, 2014, J PROTEOME RES, V13, P5151, DOI 10.1021/pr500484w; Champion MM, 2003, MOL MICROBIOL, V47, P383, DOI 10.1046/j.1365-2958.2003.03294.x; Chatzi KE, 2013, BIOCHEM J, V449, P25, DOI 10.1042/BJ20121227; Chevalier N, 2004, J MOL MICROB BIOTECH, V8, P7, DOI 10.1159/000082076; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dautin N, 2007, EMBO J, V26, P1942, DOI 10.1038/sj.emboj.7601638; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Desvaux M, 2007, MICROBIOL-SGM, V153, P59, DOI 10.1099/mic.0.29091-0; Desvaux M, 2006, FEMS MICROBIOL LETT, V264, P22, DOI 10.1111/j.1574-6968.2006.00425.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Drobnak I, 2015, J BIOL CHEM, V290, P10104, DOI 10.1074/jbc.M114.629170; Dutta PR, 2003, J BIOL CHEM, V278, P39912, DOI 10.1074/jbc.M303595200; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ge X, 2014, FEBS J, V281, P1226, DOI 10.1111/febs.12701; Goemans C, 2014, BBA-MOL CELL RES, V1843, P1517, DOI 10.1016/j.bbamcr.2013.10.014; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Huber D, 2008, STRUCTURE, V16, P989, DOI 10.1016/j.str.2008.06.004; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Jong WSP, 2008, BIOCHEM BIOPH RES CO, V368, P522, DOI 10.1016/j.bbrc.2008.01.122; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Jong WSP, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-85; Jong WSP, 2010, J BIOL CHEM, V285, P39682, DOI 10.1074/jbc.M110.167650; Jose J, 1996, GENE, V178, P107, DOI 10.1016/0378-1119(96)00343-5; Jose J, 2012, J BIOTECHNOL, V161, P92, DOI 10.1016/j.jbiotec.2012.04.001; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Leyton DL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5239; Leyton DL, 2012, NAT REV MICROBIOL, V10, P213, DOI 10.1038/nrmicro2733; Leyton DL, 2011, J BIOL CHEM, V286, P42283, DOI 10.1074/jbc.M111.306118; Mansell TJ, 2010, PROTEIN SCI, V19, P1079, DOI 10.1002/pro.388; Marrichi M, 2008, J BIOL CHEM, V283, P35223, DOI 10.1074/jbc.M802660200; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Mutalik VK, 2009, J BACTERIOL, V191, P7279, DOI 10.1128/JB.01047-09; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Norell D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6396; Penas AD, 1997, J BACTERIOL, V179, P6862; Peterson JH, 2010, P NATL ACAD SCI USA, V107, P17739, DOI 10.1073/pnas.1009491107; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Purdy GE, 2002, INFECT IMMUN, V70, P6355, DOI 10.1128/IAI.70.11.6355-6364.2002; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Renn JP, 2012, CHEM BIOL, V19, P287, DOI 10.1016/j.chembiol.2011.11.009; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Ruiz-Perez F, 2009, J BACTERIOL, V191, P6571, DOI 10.1128/JB.00754-09; Sander IM, 2014, J AM CHEM SOC, V136, P858, DOI 10.1021/ja411302m; Sauri A, 2012, J MOL BIOL, V416, P335, DOI 10.1016/j.jmb.2011.12.047; Sauri A, 2011, J MOL BIOL, V412, P553, DOI 10.1016/j.jmb.2011.07.035; Sawa J, 2010, CURR OPIN STRUC BIOL, V20, P253, DOI 10.1016/j.sbi.2010.01.014; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Sklar JG, 2007, DEFINING ROLES PERIP, P2473; Soprova Z, 2010, J BIOL CHEM, V285, P38224, DOI 10.1074/jbc.M110.180505; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Teh MY, 2012, MICROBIOL-SGM, V158, P2835, DOI 10.1099/mic.0.062471-0; Tozakidis IEP, 2015, NEW BIOTECHNOL, V32, P644, DOI 10.1016/j.nbt.2014.12.008; Vogt SL, 2012, FEMS MICROBIOL LETT, V326, P2, DOI 10.1111/j.1574-6968.2011.02406.x; Weski J, 2012, J BACTERIOL, V194, P3225, DOI 10.1128/JB.00221-12; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	93	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162922	10.1371/journal.pone.0162922	http://dx.doi.org/10.1371/journal.pone.0162922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626276	gold, Green Published, Green Submitted			2022-12-26	WOS:000383680600064
J	Lojo, N; Rasic, Z; Sever, AZ; Kolenc, D; Vukusic, D; Drmic, D; Zoricic, I; Sever, M; Seiwerth, S; Sikiric, P				Lojo, Nermin; Rasic, Zarko; Sever, Anita Zenko; Kolenc, Danijela; Vukusic, Darko; Drmic, Domagoj; Zoricic, Ivan; Sever, Marko; Seiwerth, Sven; Sikiric, Predrag			Effects of Diclofenac, L-NAME, L-Arginine, and Pentadecapeptide BPC 157 on Gastrointestinal, Liver, and Brain Lesions, Failed Anastomosis, and Intestinal Adaptation Deterioration in 24 Hour-Short-Bowel Rats	PLOS ONE			English	Article							NITRIC-OXIDE; NO-SYSTEM; BPC-157; THERAPY; MICE; RANITIDINE; ENCEPHALOPATHY; COUNTERACTION; ATTENUATION; INHIBITION	Stable gastric pentadecapeptide BPC 157 was previously used to ameliorate wound healing following major surgery and counteract diclofenac toxicity. To resolve the increasing early risks following major massive small bowel resectioning surgery, diclofenac combined with nitric oxide (NO) system blockade was used, suggesting therapy with BPC 157 and the nitric oxide synthase (NOS substrate) L-arginine, is efficacious. Immediately after anastomosis creation, short-bowel rats were untreated or administered intraperitoneal diclofenac (12 mg/kg), BPC 157 (10 mu g/kg or 10 ng/kg), L-NG-nitroarginine methyl ester (L-NAME, 5 mg/kg), L-arginine (100 mg/kg) alone or combined, and assessed 24 h later. Short-bowel rats exhibited poor anastomosis healing, failed intestine adaptation, and gastrointestinal, liver, and brain lesions, which worsened with diclofenac. This was gradually ameliorated by immediate therapy with BPC 157 and L-arginine. Contrastingly, NOS-blocker L-NAME induced further aggravation and lesions gradually worsened. Specifically, rats with surgery alone exhibited mild stomach/duodenum lesions, considerable liver lesions, and severe cerebral/hippocampal lesions while those also administered diclofenac showed widespread severe lesions in the gastrointestinal tract, liver, cerebellar nuclear/Purkinje cells, and cerebrum/hippocampus. Rats subjected to surgery, diclofenac, and L-NAME exhibited the mentioned lesions, worsening anastomosis, and macro/microscopical necrosis. Thus, rats subjected to surgery alone showed evidence of deterioration. Furtheremore, rats subjected to surgery and administered diclofenac showed worse symptoms, than the rats subjected to surgery alone did. Rats subjected to surgery combined with diclofenac and L-NAME showed the worst deterioration. Rats subjected to surgery exhibited habitual adaptation of the remaining small intestine, which was markedly reversed in rats subjected to surgery and diclofenac, and those with surgery, diclofenac, and L-NAME. BPC 157 completely ameliorated symptoms in massive intestinal resection-, massive intestinal resection plus diclofenac-, and massive intestinal resection plus diclofenac plus L-NAME-treated short bowel rats that presented with cyclooxygenase (COX)-NO-system inhibition. L-arginine ameliorated only L-NAME-induced aggravation of symptoms in rats subjected to massive intestinal resection and administered diclofenac plus L-NAME.	[Lojo, Nermin; Rasic, Zarko; Vukusic, Darko; Drmic, Domagoj; Zoricic, Ivan; Sever, Marko; Sikiric, Predrag] Univ Zagreb, Sch Med, Dept Pharmacol, POB 916,Salata 11, Zagreb 10000, Croatia; [Sever, Anita Zenko; Kolenc, Danijela; Seiwerth, Sven] Univ Zagreb, Sch Med, Dept Pathol, Salata 9, Zagreb 10000, Croatia	University of Zagreb; University of Zagreb	Sikiric, P (corresponding author), Univ Zagreb, Sch Med, Dept Pharmacol, POB 916,Salata 11, Zagreb 10000, Croatia.	sikiric@mef.hr			Ministry of Science, Education and Sports, Republic of Croatia [108-1083570-3635, 108-1080321-0389]	Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	Ministry of Science, Education and Sports, Republic of Croatia [grants' numbers 108-1083570-3635, 108-1080321-0389]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Ministry of Science, Education, and Sports of the Republic of Croatia (grant numbers: 108-1083570-3635 and 108-1080321-0389).	Balenovic D, 2009, REGUL PEPTIDES, V156, P83, DOI 10.1016/j.regpep.2009.05.008; Baric M, 2016, LIFE SCI, V148, P63, DOI 10.1016/j.lfs.2016.02.029; Barisic I, 2013, REGUL PEPTIDES, V181, P50, DOI 10.1016/j.regpep.2012.12.007; Bilic I, 2001, LIFE SCI, V68, P1905, DOI 10.1016/S0024-3205(00)01025-0; Bilic M, 2005, BURNS, V31, P310, DOI 10.1016/j.burns.2004.10.013; Cesarec V, 2013, EUR J PHARMACOL, V701, P203, DOI 10.1016/j.ejphar.2012.11.055; Chang C.H., 2011, J APPL PHYSIOL, V110, P774; Chang CH, 2014, MOLECULES, V19, P19066, DOI 10.3390/molecules191119066; Grgic T, 2016, EUR J PHARMACOL, V780, P1, DOI 10.1016/j.ejphar.2016.02.038; Hrelec M, 2009, J PHYSIOL PHARMACOL, V60, P161; Huang TL, 2015, DRUG DES DEV THER, V9, P2485, DOI 10.2147/DDDT.S82030; Ilic S, 2010, J PHYSIOL PHARMACOL, V61, P241; Ilic S, 2009, J PHYSIOL PHARMACOL, V60, P107; Ilic S, 2011, EUR J PHARMACOL, V667, P322, DOI 10.1016/j.ejphar.2011.05.038; Ilic S, 2011, LIFE SCI, V88, P535, DOI 10.1016/j.lfs.2011.01.015; Klein M, 2012, EUR SURG RES, V48, P73, DOI 10.1159/000336208; Klicek R, 2013, J PHYSIOL PHARMACOL, V64, P597; Klicek R, 2008, J PHARMACOL SCI, V108, P7, DOI 10.1254/jphs.FP0072161; Mikus D, 2001, BURNS, V27, P817, DOI 10.1016/S0305-4179(01)00055-9; Murase T, 2003, AM J PHYSIOL-REG I, V284, pR354, DOI 10.1152/ajpregu.00065.2002; Prkacin I, 2001, J PHYSIOL-PARIS, V95, P315, DOI 10.1016/S0928-4257(01)00044-4; SALVEMINI D, 1995, J CLIN INVEST, V96, P301, DOI 10.1172/JCI118035; Seiwerth S, 2014, CURR PHARM DESIGN, V20, P1121, DOI 10.2174/13816128113199990421; Sever M, 2009, DIGEST DIS SCI, V54, P2070, DOI 10.1007/s10620-008-0598-y; Sikiric P, 2003, BURNS, V29, P323, DOI 10.1016/S0305-4179(03)00004-4; Sikiric P, 2012, CURR MED CHEM, V19, P126, DOI 10.2174/092986712803414015; Sikiric P, 2001, J PHYSIOL-PARIS, V95, P261, DOI 10.1016/S0928-4257(01)00036-5; SIKIRIC P, 1993, LIFE SCI, V53, pPL291, DOI 10.1016/0024-3205(93)90589-U; Sikiric P, 1997, J PHYSIOL-PARIS, V91, P113, DOI 10.1016/S0928-4257(97)89474-0; Sikiric P, 1997, EUR J PHARMACOL, V332, P23, DOI 10.1016/S0014-2999(97)01033-9; Sikiric P, 2014, CURR PHARM DESIGN, V20, P1126, DOI 10.2174/13816128113190990411; Sikiric P, 2013, CURR PHARM DESIGN, V19, P76; Sikiric P, 2011, CURR PHARM DESIGN, V17, P1612, DOI 10.2174/138161211796196954; Sikiric P, 2010, CURR PHARM DESIGN, V16, P1224, DOI 10.2174/138161210790945977; Stupnisek M, 2012, THROMB RES, V129, P652, DOI 10.1016/j.thromres.2011.07.035; Tkalcevic VI, 2007, EUR J PHARMACOL, V570, P212, DOI 10.1016/j.ejphar.2007.05.072; Trettin A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/212576; Tudor M, 2010, REGUL PEPTIDES, V160, P26, DOI 10.1016/j.regpep.2009.11.012; Vuksic T, 2007, SURG TODAY, V37, P768, DOI 10.1007/s00595-006-3498-9	39	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162590	10.1371/journal.pone.0162590	http://dx.doi.org/10.1371/journal.pone.0162590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627764	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600044
J	Greene, M; Lai, YJ; Pajcini, K; Bailis, W; Pear, WS; Lancaster, E				Greene, Maxwell; Lai, Yongjie; Pajcini, Kostandin; Bailis, Will; Pear, Warren S.; Lancaster, Eric			Delta/Notch-Like EGF-Related Receptor (DNER) Is Not a Notch Ligand	PLOS ONE			English	Article							PARANEOPLASTIC CEREBELLAR DEGENERATION; INTRACELLULAR DOMAIN; TRANSACTIVATION; DIFFERENTIATION; ACTIVATION; MYOGENESIS; PATHWAY; MYOD; TR	Delta/Notch-like EGF-related receptor (DNER) has been reported to act as a Notch ligand, despite lacking a Delta/Serrate/Lag (DSL) binding domain common to all other known ligands. The established Notch ligand Delta-like 1 (DLL1), but not DNER, activated Notch1 in a luciferase assay, prevented the differentiation of myoblasts through Notch signaling, and bound Notch-fc in a cell-based assay. DNER is not a Notch ligand and its true function remains unknown.	[Greene, Maxwell; Lai, Yongjie; Lancaster, Eric] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pajcini, Kostandin; Bailis, Will; Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Pajcini, Kostandin] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Bailis, Will] Yale Sch Med, Dept Immunobiol, New Haven, CT USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University	Lancaster, E (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA.	eric.lancaster@uphs.upenn.edu			National Institutes of Health; National Institute of Neurologic Diseases and Stroke [R25 NS065745, K08 NS075142]; Dana Foundation Neuroimmunology award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS075142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurologic Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dana Foundation Neuroimmunology award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MG is supported by National Institutes of Health, National Institute of Neurologic Diseases and Stroke, grant R25 NS065745, http://www.ninds.nih.gov/. EL is supported by National Institutes of Health, National Institute of Neurologic Diseases and Stroke, grant K08 NS075142, http://www.ninds.nih. gov/, and a Dana Foundation Neuroimmunology award, http://www.dana.org/.	Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; de Graaff E, 2012, ANN NEUROL, V71, P815, DOI 10.1002/ana.23550; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Eiraku M, 2002, J BIOL CHEM, V277, P25400, DOI 10.1074/jbc.M110793200; Greene M, 2014, JAMA NEUROL, V71, P1003, DOI 10.1001/jamaneurol.2014.999; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Shawber C, 1996, DEVELOPMENT, V122, P3765; Tohgo A, 2006, MOL CELL NEUROSCI, V31, P326, DOI 10.1016/j.mcn.2005.10.003	16	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161157	10.1371/journal.pone.0161157	http://dx.doi.org/10.1371/journal.pone.0161157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622512	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000004
J	Jamal, S; Arora, S; Scaria, V				Jamal, Salma; Arora, Sonam; Scaria, Vinod			Computational Analysis and Predictive Cheminformatics Modeling of Small Molecule Inhibitors of Epigenetic Modifiers	PLOS ONE			English	Article							METHYLATION; PATTERNS; GENOME; NOISE; G9A	Background The dynamic and differential regulation and expression of genes is majorly governed by the complex interactions of a subset of biomolecules in the cell operating at multiple levels starting from genome organisation to protein post-translational regulation. The regulatory layer contributed by the epigenetic layer has been one of the favourite areas of interest recently. This layer of regulation as we know today largely comprises of DNA modifications, histone modifications and noncoding RNA regulation and the interplay between each of these major components. Epigenetic regulation has been recently shown to be central to development of a number of disease processes. The availability of datasets of high-throughput screens for molecules for biological properties offer a new opportunity to develop computational methodologies which would enable in-silico screening of large molecular libraries. Methods In the present study, we have used data from high throughput screens for the inhibitors of epigenetic modifiers. Computational predictive models were constructed based on the molecular descriptors. Machine learning algorithms for supervised training, Naive Bayes and Random Forest, were used to generate predictive models for the small molecule inhibitors of histone methyl-transferases and demethylases. Random forest, with the accuracy of 80%, was identified as the most accurate classifier. Further we complemented the study with substructure search approach filtering out the probable pharmacophores from the active molecules leading to drug molecules. Results We show that effective use of appropriate computational algorithms could be used to learn molecular and structural correlates of biological activities of small molecules. The computational models developed could be potentially used to screen and identify potential new biological activities of molecules from large molecular libraries and prioritise them for in-depth biological assays. To the best of our knowledge, this is the first and most comprehensive computational analysis towards understanding activities of small molecules inhibitors of epigenetic modifiers.	[Jamal, Salma] CSIR Open Source Drug Discovery Unit CSIR OSDD, Delhi, India; [Arora, Sonam] Delhi Technol Univ, Delhi, India; [Scaria, Vinod] CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; Delhi Technological University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Scaria, V (corresponding author), CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vinods@igib.in	Scaria, Vinod/AAS-3151-2021; Arora, Sonam/AAY-4466-2021	Scaria, Vinod/0000-0001-7644-7181	CSIR-OSDD; Council of Scientific and Industrial Research (CSIR), India [BSC0122]; National Knowledge Network (NKN); CDAC-Garuda	CSIR-OSDD; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); National Knowledge Network (NKN); CDAC-Garuda	SJ acknowledges a Project Fellowship from CSIR-OSDD. This work was funded by the Council of Scientific and Industrial Research (CSIR), India through Grant BSC0122 (CARDIOMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Chetana Sachidanandan and Dr. Shantanu Sengupta for reviewing the manuscript. The authors are also thankful for discussions with members of the Open Source Drug Discovery (OSDD) Programme. SJ acknowledges a Project Fellowship from CSIR-OSDD. The authors acknowledge the support from National Knowledge Network (NKN) and CDAC-Garuda for computing. The authors acknowledge technical help and support from the CDAC-Garuda team, especially Ms. Janaki Chintalapati, Ms. Mangala N and Dr. Subrata Chattopadhyay.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bouckaert RR, 2010, J MACH LEARN RES, V11, P2533; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Budapest H, CHEMAXON JCSEARCH VE; Budapest H, 2008, CHEMAXON LIB MCS VER; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chen B, 2012, J CHEM INF MODEL, V52, P792, DOI 10.1021/ci200615h; Cigliano RA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-57; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Ekins Sean, 2013, Methods Mol Biol, V993, P245, DOI 10.1007/978-1-62703-342-8_16; Falk H, 2011, J BIOMOL SCREEN, V16, P1196, DOI 10.1177/1087057111421631; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839; Huang SY, 2010, INT J MOL SCI, V11, P3016, DOI 10.3390/ijms11083016; Jamal S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-55; Jamal S, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-16; Johnson M. A., 1990, CONCEPTS APPL MOL SI; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kumar N, 2006, DRUG DISCOV TODAY, V11, P806, DOI 10.1016/j.drudis.2006.07.010; Leong HS, 2013, CANCER RES, V73, P1591, DOI 10.1158/0008-5472.CAN-12-3019; Liu KJ, 2005, J CHEM INF MODEL, V45, P515, DOI 10.1021/ci049847v; Lv SL, 2012, OMICS, V16, P552, DOI 10.1089/omi.2012.0005; Miller-Jensen K, 2011, TRENDS BIOTECHNOL, V29, P517, DOI 10.1016/j.tibtech.2011.05.004; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Mund C, 2010, BIOESSAYS, V32, P949, DOI 10.1002/bies.201000061; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ozboyaci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014765; Periwal Vinita, 2012, BMC Pharmacology, V12, P1, DOI 10.1186/1471-2210-12-1; Periwal Vinita, 2011, BMC Res Notes, V4, P504, DOI 10.1186/1756-0500-4-504; Piekarz RL, 2009, CLIN CANCER RES, V15, P3918, DOI 10.1158/1078-0432.CCR-08-2788; Quinn Amy M, 2011, Curr Chem Genomics, V5, P95, DOI 10.2174/1875397301005010095; Rabinowitz JR, 2008, ENVIRON HEALTH PERSP, V116, P573, DOI 10.1289/ehp.11077; Sati S, 2012, NUCLEIC ACIDS RES, V40, P10018, DOI 10.1093/nar/gks776; Sean E, 2006, WILEY SERIES DRUG DI; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Shu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027346; Svetnik V, 2005, J CHEM INF MODEL, V45, P786, DOI 10.1021/ci0500379; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Unoki M, 2011, RECENT PAT ANTI-CANC, V6, P116, DOI 10.2174/157489211793980024; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Vermeulen M, 2010, EPIGENOMICS-UK, V2, P395, DOI 10.2217/EPI.10.11; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wang XQD, 2011, CURR GENOMICS, V12, P307, DOI 10.2174/138920211796429772; Xu J, 2002, MOLECULES, V7, P566, DOI 10.3390/70800566	49	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0083032	10.1371/journal.pone.0083032	http://dx.doi.org/10.1371/journal.pone.0083032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622288	Green Submitted, gold, Green Published			2022-12-26	WOS:000383681000001
J	Bisetegn, TA; Mihretie, G; Muche, T				Bisetegn, Telake Azale; Mihretie, Getnet; Muche, Tefera			Prevalence and Predictors of Depression among Pregnant Women in Debretabor Town, Northwest Ethiopia	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; RIO-DE-JANEIRO; RISK-FACTORS; ANTENATAL DEPRESSION; ADDIS-ABABA; OUTCOMES; HEALTH; BRAZIL; PERSISTENCE; ANXIETY	Background Depression during pregnancy is a major health problem because it is prevalent and chronic, and its impact on birth outcome and child health is serious. Several psychosocial and obstetric factors have been identified as predictors. Evidence on the prevalence and predictors of antenatal depression is very limited in Ethiopia. This study aims to determine prevalence and associated factors with antenatal depression. Methods Community based cross-sectional study was conducted among 527 pregnant women recruited in a cluster sampling method. Data were collected by face-to-face interviews on socio-demographic, obstetric, and psychosocial characteristics. Depression symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS). The List of Threatening Experiences questionnaire (LTE-Q) and the Oslo Social Support Scale (OSS3) were used to assess stressful events and social support, respectively. Data were entered into Epi-info and analyzed using SPSS-20. Descriptive and logistic regression analyses were carried out. Results The prevalence of antenatal depression was found to be 11.8%. Having debt (OR = 2.79, 95% CI = 1.33, 5.85), unplanned pregnancy (OR = 2.39, 95% CI = (1.20, 4.76), history of stillbirth (OR = 3.97, 95% CI = (1.67,9.41), history of abortion (OR = 2.57, 95% CI = 1.005, 6.61), being in the third trimester of pregnancy (OR = 1.70, 95% CI = 1.07,2.72), presence of a complication in the current pregnancy (OR = 3.29, 95% CI = 1.66,6.53), and previous history of depression (OR = 3.48, 95% CI = 1.71,7.06) were factors significantly associated with antenatal depression. Conclusion The prevalence of antenatal depression was high, especially in the third trimester. Poverty, unmet reproductive health needs, and obstetric complications are the main determinants of antenatal depression. For early detection and appropriate intervention, screening for depression during the routine antenatal care should be promoted.	[Bisetegn, Telake Azale] Univ Gondar, Coll Med & Hlth Sci, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia; [Mihretie, Getnet] Univ Gondar, Coll Med & Hlth Sci, Dept Psychiat, Gondar, Ethiopia; [Muche, Tefera] Amanuel Mental Specialized Hosp, Addis Ababa, Ethiopia	University of Gondar; University of Gondar	Bisetegn, TA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia.	telakea@yahoo.com			University of Gondar; Amanuel mental specialized hospital	University of Gondar; Amanuel mental specialized hospital	Our special appreciation goes to University of Gondar and Amanuel mental specialized hospital for providing support for this research project. We would like to express our thanks to the women who participated in the study for generously giving their time and energy to complete interviews.	Adewuya AO, 2007, DEPRESS ANXIETY, V24, P15, DOI 10.1002/da.20221; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; [Anonymous], 2006, PLOS MED, V3, pe252; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bennett HA, 2004, CLIN DRUG INVEST, V24, P157, DOI 10.2165/00044011-200424030-00004; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Boen H, 2012, BMC GERIATR, V12; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; DDHO, 2012, DEB DISTR HLTH OFF A; Dibaba Y, 2014, PLOS ONE; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Faisal-Cury A., 2016, PSYCHOL HEALTH MED, P1; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Fernandes M., 2014, CHILD CARE HLTH DEV; Fisher J, 2013, J AFFECT DISORDERS, V146, P213, DOI 10.1016/j.jad.2012.09.007; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gausia K, 2009, ARCH WOMEN MENT HLTH, V12, P351, DOI 10.1007/s00737-009-0080-7; Gentile S, 2015, NEUROSCIENCE; Hanlon C, 2010, BRIT J PSYCHIAT, V197, P468, DOI 10.1192/bjp.bp.109.076497; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Jenkins R, 2010, INT J ENV RES PUB HE, V7, P2543, DOI 10.3390/ijerph7062543; Lovisi GM, 2005, PSYCHOL MED, V35, P1485, DOI 10.1017/S0033291705005362; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Medhin G, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-32; Motrico E, 2013, J AFFECT DISORDERS, V150, P931, DOI 10.1016/j.jad.2013.05.017; Pereira PK, 2014, CAD SAUDE PUBLICA, V30, P1654, DOI 10.1590/0102-311X00080213; Pereira PK, 2009, CAD SAUDE PUBLICA, V25, P2725, DOI 10.1590/S0102-311X2009001200019; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Rallis S, 2014, WOMEN BIRTH, V27, pE36, DOI 10.1016/j.wombi.2014.08.002; STEIN M, 1991, ARCH GEN PSYCHIAT, V48, P171; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; van Heyningen T, 2016, J AFFECT DISORDERS, V203, P121, DOI 10.1016/j.jad.2016.05.052	35	44	44	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161108	10.1371/journal.pone.0161108	http://dx.doi.org/10.1371/journal.pone.0161108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618181	Green Submitted, Green Published, gold			2022-12-26	WOS:000383653100004
J	Ghandchi, FP; Caetano-Anolles, G; Clough, SJ; Ort, DR				Ghandchi, Frederick P.; Caetano-Anolles, Gustavo; Clough, Steven J.; Ort, Donald R.			Investigating the Control of Chlorophyll Degradation by Genomic Correlation Mining	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; LEAF SENESCENCE; GENE-EXPRESSION; ARABIDOPSIS; BREAKDOWN; PROTEIN; PHEOPHORBIDE; CATABOLITES; OXYGENASE; ENZYMES	Chlorophyll degradation is an intricate process that is critical in a variety of plant tissues at different times during the plant life cycle. Many of the photoactive chlorophyll degradation intermediates are exceptionally cytotoxic necessitating that the pathway be carefully coordinated and regulated. The primary regulatory step in the chlorophyll degradation pathway involves the enzyme pheophorbide a oxygenase (PAO), which oxidizes the chlorophyll intermediate pheophorbide a, that is eventually converted to non-fluorescent chlorophyll catabolites. There is evidence that PAO is differentially regulated across different environmental and developmental conditions with both transcriptional and post-transcriptional components, but the involved regulatory elements are uncertain or unknown. We hypothesized that transcription factors modulate PAO expression across different environmental conditions, such as cold and drought, as well as during developmental transitions to leaf senescence and maturation of green seeds. To test these hypotheses, several sets of Arabidopsis genomic and bioinformatic experiments were investigated and re-analyzed using computational approaches. PAO expression was compared across varied environmental conditions in the three separate datasets using regression modeling and correlation mining to identify gene elements co-expressed with PAO. Their functions were investigated as candidate upstream transcription factors or other regulatory elements that may regulate PAO expression. PAO transcript expression was found to be significantly up-regulated in warm conditions, during leaf senescence, and in drought conditions, and in all three conditions significantly positively correlated with expression of transcription factor Arabidopsis thaliana activating factor 1 (ATAF1), suggesting that ATAF1 is triggered in the plant response to these processes or abiotic stresses and in result up-regulates PAO expression. The proposed regulatory network includes the freezing, senescence, and drought stresses modulating factor ATAF1 and various other transcription factors and pathways, which in turn act to regulate chlorophyll degradation by up-regulating PAO expression.	[Ghandchi, Frederick P.; Caetano-Anolles, Gustavo; Ort, Donald R.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ghandchi, Frederick P.; Caetano-Anolles, Gustavo; Clough, Steven J.; Ort, Donald R.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Clough, Steven J.] Univ Illinois, USDA ARS, Soybean Maize Germplasm Pathol & Genet Res Unit, Urbana, IL USA; [Ort, Donald R.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Ort, Donald R.] Univ Illinois, USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Ort, DR (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Ort, DR (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.; Ort, DR (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.; Ort, DR (corresponding author), Univ Illinois, USDA ARS, Global Change & Photosynthesis Res Unit, Urbana, IL 61801 USA.	d-ort@illinois.edu		Ort, Donald/0000-0002-5435-4387	Illinois Department of Crop Sciences and Institute for Genomic Biology	Illinois Department of Crop Sciences and Institute for Genomic Biology	We thank University of Illinois Department of Crop Sciences and Institute for Genomic Biology for their support.	Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cheng YD, 2012, FOOD CHEM, V135, P415, DOI 10.1016/j.foodchem.2012.05.017; Christ B, 2012, PLANT PHYSIOL, V158, P628, DOI 10.1104/pp.111.188870; Chung DW, 2006, PLANT PHYSIOL, V142, P88, DOI 10.1104/pp.106.084483; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang L, 2015, EXPRESSION VITIS AMU; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hortensteiner S, 2013, PLANT MOL BIOL, V82, P505, DOI 10.1007/s11103-012-9940-z; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Hortensteiner S, 1999, CELL MOL LIFE SCI, V56, P330, DOI 10.1007/s000180050434; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jensen MK, 2013, FEBS OPEN BIO, V3, P321, DOI 10.1016/j.fob.2013.07.006; Lai B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1433-4; Lee J, 2009, J FOOD SCI, V74, pC481, DOI 10.1111/j.1750-3841.2009.01242.x; Maracchi G, 2005, CLIMATIC CHANGE, V70, P117, DOI 10.1007/s10584-005-5939-7; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Ort DR, 2011, PLANT PHYSIOL, V155, P79, DOI 10.1104/pp.110.165886; Park S, 2015, PLANT J, V82, P193, DOI 10.1111/tpj.12796; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Qiu K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005399; Rosa RK, 2015, GLOBAL CHANGE BIOL, V21, P4520, DOI 10.1111/gcb.13040; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; WARD K, 1992, J AM OIL CHEM SOC, V69, P1039, DOI 10.1007/BF02541074; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xu C, 2016, GLOB CHANG BIOL; Zhang XL, 2011, J PLANT PHYSIOL, V168, P2081, DOI 10.1016/j.jplph.2011.06.011	27	12	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162327	10.1371/journal.pone.0162327	http://dx.doi.org/10.1371/journal.pone.0162327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618630	Green Submitted, Green Published, gold			2022-12-26	WOS:000383653100018
J	Staffas, A; Arabanian, LS; Wei, SY; Jansson, A; Stahlman, S; Johansson, P; Fogelstrand, L; Cammenga, J; Kuchenbauer, F; Palmqvist, L				Staffas, A.; Arabanian, L. S.; Wei, S. Y.; Jansson, A.; Stahlman, S.; Johansson, P.; Fogelstrand, L.; Cammenga, J.; Kuchenbauer, F.; Palmqvist, L.			Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice	ONCOGENE			English	Article							TYROSINE KINASE INHIBITOR; HEMATOPOIETIC STEM-CELL; BONE-MARROW-CELLS; HOXA9; GENE; EXPRESSION; MUTATION; RECEPTOR; LIGAND; AC220	HOXA9, MEIS1 and FLT3 are genes frequently upregulated in human acute myeloid leukemia. Hoxa9 and Meis1 also cooperate to induce aggressive AML with high Flt3 expression in mice, suggesting an important role for Flt3 in Hoxa9/Meis1-induced leukemogenesis. To define the role of Flt3 in AML with high Hoxa9/Meis1, we treated mice with Hoxa9/Meis1-induced AML with the Flt3 inhibitor AC220, used an Flt3-ligand (FL -/-) knockout model, and investigated whether overexpression of Flt3 could induce leukemia together with overexpression of Hoxa9. Flt3 inhibition by AC220 did not delay AML development in mice transplanted with bone marrow cells overexpressing Hoxa9 and Meis1. In addition, Hoxa9/Meis1 cells induced AML in FL -/- mice as rapid as in wild-type mice. However, FL -/- mice had reduced organ infiltration compared with wild-type mice, suggesting some Flt3 dependent effect on leukemic invasiveness. Interestingly, leukemic Hoxa9/Meis1 cells from sick mice expressed high levels of Flt3 regardless of presence of its ligand, showing that Flt3 is a passive marker on these cells. In line with this, combined engineered overexpression of Flt3 and Hoxa9 did not accelerate the progression to AML. We conclude that the Hoxa9- and Meis1-associated upregulation of Flt3 is not a requirement for leukemic progression induced by Hoxa9 and Meis1.	[Staffas, A.; Arabanian, L. S.; Wei, S. Y.; Stahlman, S.; Johansson, P.; Fogelstrand, L.; Palmqvist, L.] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Staffas, A.; Jansson, A.; Stahlman, S.; Johansson, P.; Fogelstrand, L.; Palmqvist, L.] Sahlgrens Univ Hosp, Dept Clin Chem, Bruna Straket 16, S-41345 Gothenburg, Sweden; [Wei, S. Y.] Sahlgrens Univ Hosp, Dept Med, Gothenburg, Sweden; [Cammenga, J.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Cammenga, J.] Linkoping Univ Hosp, Dept Hematol, Linkoping, Sweden; [Kuchenbauer, F.] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany	University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Linkoping University; Linkoping University; Ulm University	Palmqvist, L (corresponding author), Sahlgrens Univ Hosp, Dept Clin Chem, Bruna Straket 16, S-41345 Gothenburg, Sweden.	lars.palmqvist@clinchem.gu.se		Kuchenbauer, Florian/0000-0002-9820-3409	Swedish Cancer Society [CAN2014/525]; Vastra Gotalandsregionen [ALFGBG-431881]; Deutsche Krebshilfe [109420]; European Hematology Association; Deutsche Forschungsgemeinschaft [SFB 1074]; Assar Gabrielsson's foundation	Swedish Cancer Society(Swedish Cancer Society); Vastra Gotalandsregionen; Deutsche Krebshilfe(Deutsche Krebshilfe); European Hematology Association; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Assar Gabrielsson's foundation	We wish to thank Carina Wasslavik, Christina Nilsson, and Susanne Li for valuable technical assistance. This work was supported by grants to LP from the Swedish Cancer Society (CAN2014/525) and the Vastra Gotalandsregionen (ALFGBG-431881). FK was supported by grants from Deutsche Krebshilfe grant 109420 ( Max-Eder program), fellowship 2010/04 by the European Hematology Association, and by the Deutsche Forschungsgemeinschaft (SFB 1074, project A5). SYW was supported by a grant from Assar Gabrielsson's foundation.	Argiropoulos B, 2008, EXP HEMATOL, V36, P845, DOI 10.1016/j.exphem.2008.02.011; Balgobind BV, 2011, LEUKEMIA, V25, P1239, DOI 10.1038/leu.2011.90; BRASEL K, 1995, LEUKEMIA, V9, P1212; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Kampa-Schittenhelm KM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-19; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Konig H, 2015, EXPERT OPIN THER TAR, V19, P37, DOI 10.1517/14728222.2014.960843; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kuchenbauer F, 2005, HAEMATOLOGICA, V90, P1617; Li ZJ, 2013, BLOOD, V121, P1422, DOI 10.1182/blood-2012-07-442004; Lisovsky M, 1996, LEUKEMIA, V10, P1012; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Morgado E, 2007, BLOOD, V109, P4020, DOI 10.1182/blood-2006-01-039586; Nakao M, 1996, LEUKEMIA, V10, P1911; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Palmqvist L, 2006, BLOOD, V108, P1030, DOI 10.1182/blood-2005-12-007005; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; SB H, 2013, DESIGNING CLIN RES E; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Staffas A, 2011, BLOOD, V118, P5905, DOI 10.1182/blood-2011-05-353185; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Taylor SJ, 2012, BLOOD, V120, P4049, DOI 10.1182/blood-2012-06-436675; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Wang GG, 2005, BLOOD, V106, P254, DOI 10.1182/blood-2004-12-4664; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	33	10	10	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1516	1524		10.1038/onc.2016.318	http://dx.doi.org/10.1038/onc.2016.318			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27617578				2022-12-26	WOS:000397458100006
J	Gabriel, CH; Gross, F; Karl, M; Stephanowitz, H; Hennig, AF; Weber, M; Gryzik, S; Bachmann, I; Hecklau, K; Wienands, J; Schuchhardt, J; Herzel, H; Radbruch, A; Krause, E; Baumgrass, R				Gabriel, Christian H.; Gross, Fridolin; Karl, Martin; Stephanowitz, Heike; Hennig, Anna Floriane; Weber, Melanie; Gryzik, Stefanie; Bachmann, Ivo; Hecklau, Katharina; Wienands, Juergen; Schuchhardt, Johannes; Herzel, Hanspeter; Radbruch, Andreas; Krause, Eberhard; Baumgrass, Ria			Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP1 transcription factor (AP1); bioinformatics; cAMP-response element-binding protein (CREB); lymphocyte; mass spectrometry (MS); NFAT transcription factor; protein-protein interaction; RUNX transcription factor; SILAC	NF-KAPPA-B; TRANSCRIPTION FACTOR NFAT1; GENE-EXPRESSION; BINDING-PROTEIN; CALCINEURIN INHIBITORS; EFFECTOR FUNCTIONS; FOXP3; KINASE; FOS; JUN	Transcription factors of the nuclear factor of activated T cell (NFAT) family are essential for antigen-specific T cell activation and differentiation. Their cooperative DNA binding with other transcription factors, such as AP1 proteins (FOS, JUN, and JUNB), FOXP3, IRFs, and EGR1, dictates the gene regulatory action of NFATs. To identify as yet unknown interaction partners of NFAT, we purified biotin-tagged NFATc1/A, NFATc1/C, and NFATc2/C protein complexes and analyzed their components by stable isotope labeling by amino acids in cell culture-based mass spectrometry. We revealed more than 170 NFAT-associated proteins, half of which are involved in transcriptional regulation. Among them are many hitherto unknown interaction partners of NFATc1 and NFATc2 in T cells, such as Raptor, CHEK1, CREB1, RUNX1, SATB1, Ikaros, and Helios. The association of NFATc2 with several other transcription factors is DNA-dependent, indicating cooperative DNA binding. Moreover, our computational analysis discovered that binding motifs for RUNX and CREB1 are found preferentially in the direct vicinity of NFAT-binding motifs and in a distinct orientation to them. Furthermore, we provide evidence that mTOR and CHEK1 kinase activity influence NFAT's transcriptional potency. Finally, our dataset of NFAT-associated proteins provides a good basis to further study NFAT's diverse functions and how these are modulated due to the interplay of multiple interaction partners.	[Gabriel, Christian H.; Karl, Martin; Hennig, Anna Floriane; Weber, Melanie; Gryzik, Stefanie; Hecklau, Katharina; Radbruch, Andreas; Baumgrass, Ria] German Rheumatism Res Ctr DRFZ, Leibniz Inst, D-10117 Berlin, Germany; [Gross, Fridolin; Herzel, Hanspeter] Charite, Inst Theoret Biol, D-10015 Berlin, Germany; [Gross, Fridolin; Herzel, Hanspeter] Humboldt Univ, D-10015 Berlin, Germany; [Stephanowitz, Heike; Krause, Eberhard] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Bachmann, Ivo; Schuchhardt, Johannes] MicroDiscovery GmbH, D-10405 Berlin, Germany; [Wienands, Juergen] Georg August Univ Gottingen, Inst Cellular & Mol Immunol, D-37073 Gottingen, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Gottingen	Baumgrass, R (corresponding author), DRFZ Berlin, Charitepl 1, D-10117 Berlin, Germany.	baumgrass@drfz.de		Hennig, Anna Floriane/0000-0002-3942-3209; Gabriel, Christian/0000-0003-2081-1743; Hecklau, Katharina/0000-0002-7743-5366; Baumgrass, Ria/0000-0002-3289-1608; Gryzik, Stefanie/0000-0001-5871-539X; Radbruch, Andreas/0000-0001-5753-0000	"e:Bio-Innovationswettbewerb Systembiologie" Program from the German Federal Ministry of Education and Research Grant T-Sys; Deutsche Forschungsgemeinschaft [TR52, SFB650]	"e:Bio-Innovationswettbewerb Systembiologie" Program from the German Federal Ministry of Education and Research Grant T-Sys; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the "e:Bio-Innovationswettbewerb Systembiologie" Program from the German Federal Ministry of Education and Research Grant T-Sys (to R. B., H. H., J. S., and A. R.) and by Deutsche Forschungsgemeinschaft Grants TR52 and SFB650 (to R. B. and A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Banks CAS, 2014, MOL CELL PROTEOMICS, V13, P1510, DOI 10.1074/mcp.M113.033902; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benary M., 2013, COBINDR FINDING COOC; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Carneiro FRG, 2011, MOL CELL BIOL, V31, P2889, DOI 10.1128/MCB.00974-10; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Chuvpilo S, 1999, J IMMUNOL, V162, P7294; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Cobbold SP, 2013, IMMUNOLOGY, V140, P391, DOI 10.1111/imm.12162; Crisafuli FAP, 2015, EUR BIOPHYS J BIOPHY, V44, P1, DOI 10.1007/s00249-014-0995-4; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gomez-Casero E, 2007, CELL SIGNAL, V19, P1652, DOI 10.1016/j.cellsig.2007.02.010; Guzi TJ, 2011, MOL CANCER THER, V10, P591, DOI 10.1158/1535-7163.MCT-10-0928; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Hwang JS, 2015, J IMMUNOL, V194, P1963, DOI 10.4049/jimmunol.1401862; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Klein-Hessling S, 2008, J BIOL CHEM, V283, P31030, DOI 10.1074/jbc.M805929200; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Koos B, 2014, CURR TOP MICROBIOL, V377, P111, DOI 10.1007/82_2013_334; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Lee SH, 2009, BIOCHEM BIOPH RES CO, V381, P214, DOI 10.1016/j.bbrc.2009.02.026; Lee Yue-Hien, 2010, V22, P84; Leuchowius K., 2011, CURR PROTOC CYTOM, V56, P9, DOI [10.1002/0471142956.cy0936s56, DOI 10.1002/0471142956.CY0936S56]; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Marcilla M, 2011, TALANTA, V84, P430, DOI 10.1016/j.talanta.2011.01.050; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nayak A, 2009, J BIOL CHEM, V284, P10935, DOI 10.1074/jbc.M900465200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pages H., 2016, BIOSTRINGS STRING OB; Park HJ, 2015, J CELL PHYSIOL, V230, P667, DOI 10.1002/jcp.24790; Pasquinelli V, 2009, J INFECT DIS, V199, P661, DOI 10.1086/596742; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Rush D, 2013, TRANSPLANT REV-ORLAN, V27, P93, DOI 10.1016/j.trre.2013.04.003; RYSECK RP, 1991, ONCOGENE, V6, P533; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schaffer U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1178; Serfling E, 2006, EUR J IMMUNOL, V36, P2837, DOI 10.1002/eji.200536618; Serfling E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-16; Shin DS, 2014, EMBO REP, V15, P991, DOI 10.15252/embr.201338233; Shou JW, 2015, CANCER LETT, V361, P174, DOI 10.1016/j.canlet.2015.03.005; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Srikanth S, 2013, MOL CELLS, V35, P182, DOI 10.1007/s10059-013-0073-2; Stroud JC, 2003, J MOL BIOL, V334, P1009, DOI 10.1016/j.jmb.2003.09.065; Tan G, 2016, BIOINFORMATICS, V32, P1555, DOI 10.1093/bioinformatics/btw024; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tse AN, 2007, CLIN CANCER RES, V13, P591, DOI 10.1158/1078-0432.CCR-06-1424; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044; Vazquez-Cedeira M, 2012, J BIOL CHEM, V287, P42739, DOI 10.1074/jbc.M112.404285; Vihma H, 2008, GENOMICS, V92, P279, DOI 10.1016/j.ygeno.2008.06.011; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang F, 2000, J IMMUNOL, V165, P1762, DOI 10.4049/jimmunol.165.4.1762; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	99	22	23	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24172	24187		10.1074/jbc.M116.739326	http://dx.doi.org/10.1074/jbc.M116.739326			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27637333	Green Published, hybrid			2022-12-26	WOS:000388498100032
J	McMillan, DGG; Watanabe, R; Ueno, H; Cook, GM; Noji, H				McMillan, Duncan G. G.; Watanabe, Rikiya; Ueno, Hiroshi; Cook, Gregory M.; Noji, Hiroyuki			Biophysical Characterization of a Thermoalkaliphilic Molecular Motor with a High Stepping Torque Gives Insight into Evolutionary ATP Synthase Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; enzyme kinetics; enzyme mechanism; F1F0-ATPase; respiratory chain; single molecule biophysics; adaptation; rotation; thermoalkaliphile; torque	ESCHERICHIA-COLI F-1-ATPASE; BACILLUS-FIRMUS OF4; SP STRAIN TA2.A1; ENTEROCOCCUS-HIRAE; EPSILON-SUBUNIT; V-ATPASE; RING STOICHIOMETRY; F1FO-ATP SYNTHASE; F1F0-ATP SYNTHASE; ROTARY MECHANISM	F1F0 ATP synthases are bidirectional molecular motors that translocate protons across the cell membrane by either synthesizing or hydrolyzing ATP. Alkaliphile ATP synthases are highly adapted, performing oxidative phosphorylation at high pH against an inverted pH gradient (acid(in)/alkaline(out)). Unlike mesophilic ATP synthases, alkaliphilic enzymes have tightly regulated ATP hydrolysis activity, which can be relieved in the presence of lauryldimethylamine oxide. Here, we characterized the rotary dynamics of the Caldalkalibacillus thermarum TA2.A1 F-1 ATPase (TA2F(1)) with two forms of single molecule analysis, a magnetic bead duplex and a gold nanoparticle. TA2F(1) rotated in a counterclockwise direction in both systems, adhering to Michaelis-Menten kinetics with a maximum rotation rate (V-max) of 112.4 revolutions/s. TA2F(1) displayed 120 degrees unitary steps coupled with ATP hydrolysis. Torque measurements revealed the highest torque (52.4 piconewtons) derived from an F-1 molecule using fluctuation theorem. The implications of high torque in terms of extreme environment adaptation are discussed.	[McMillan, Duncan G. G.; Watanabe, Rikiya; Ueno, Hiroshi; Noji, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Cook, Gregory M.] Univ Otago, Dept Microbiol & Immunol, Otago Sch Med Sci, POB 56, Dunedin 9054, New Zealand	University of Tokyo; University of Otago	McMillan, DGG; Noji, H (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	duncan.mcmillan@nojilab.t.u-tokyo.ac.jp; hnoji@appchem.t.u-tokyo.ac.jp	McMillan, Duncan/AAT-7415-2021; Watanabe, Rikiya/AAO-1390-2021; Cook, Gregory/ABF-4208-2020	McMillan, Duncan/0000-0001-6614-4494; Watanabe, Rikiya/0000-0001-7146-2745; 	long term Japan Society for the Promotion of Sciences International Fellowship [P14383]; Grants-in-Aid for Scientific Research [26000011, 16K14706] Funding Source: KAKEN	long term Japan Society for the Promotion of Sciences International Fellowship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by long term Japan Society for the Promotion of Sciences International Fellowship P14383 (to D. G. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Albers SV, 2001, EXTREMOPHILES, V5, P285, DOI 10.1007/s007920100214; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Borsch M, 2011, CHEMPHYSCHEM, V12, P542, DOI 10.1002/cphc.201000702; Borsch M, 1998, FEBS LETT, V437, P251, DOI 10.1016/S0014-5793(98)01247-2; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cook GM, 2003, J BACTERIOL, V185, P4442, DOI 10.1128/JB.185.15.4442-4449.2003; Deckers-Hebestreit G, 2000, BBA-BIOENERGETICS, V1458, P364, DOI 10.1016/S0005-2728(00)00087-6; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dimroth P, 2004, ADV MICROB PHYSIOL, V49, P175, DOI 10.1016/S0065-2911(04)49004-3; GUFFANTI AA, 1994, J BIOL CHEM, V269, P21576; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; HICKS DB, 1990, J BIOL CHEM, V265, P20547; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOFFMANN A, 1990, EUR J BIOCHEM, V194, P423, DOI 10.1111/j.1432-1033.1990.tb15635.x; Hornung T, 2008, BBA-BIOENERGETICS, V1777, P579, DOI 10.1016/j.bbabio.2008.04.016; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kalamorz F, 2011, J BACTERIOL, V193, P4290, DOI 10.1128/JB.05035-11; KASHO VN, 1989, P NATL ACAD SCI USA, V86, P8708, DOI 10.1073/pnas.86.22.8708; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; Kishikawa J, 2014, EUR BIOPHYS J BIOPHY, V43, P415, DOI 10.1007/s00249-014-0973-x; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matthies D, 2009, J MOL BIOL, V388, P611, DOI 10.1016/j.jmb.2009.03.052; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; McMillan DGG, 2009, APPL ENVIRON MICROB, V75, P7649, DOI 10.1128/AEM.01639-09; Meier T, 2005, FEBS J, V272, P5474, DOI [10.1111/j.1742-4658.2005.04940.x, 10.1111/j.1742-4685.2005.04940.x]; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112; Muller DJ, 2001, FEBS LETT, V504, P219, DOI 10.1016/S0014-5793(01)02708-9; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; Murata T, 2008, P NATL ACAD SCI USA, V105, P8607, DOI 10.1073/pnas.0800992105; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Noji H, 1998, SCIENCE, V282, P1844, DOI 10.1126/science.282.5395.1844; PAIK SR, 1994, BIOCHEMISTRY-US, V33, P126, DOI 10.1021/bi00167a016; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Peddie CJ, 1999, J BACTERIOL, V181, P3172, DOI 10.1128/JB.181.10.3172-3177.1999; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2008, FEBS J, V275, P4850, DOI 10.1111/j.1742-4658.2008.06623.x; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Sambrook J., 2012, MOL CLONING LAB MANU, V4th, DOI DOI 10.1016/0003-2697(90)90595-Z; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2005, J STRUCT BIOL, V152, P140, DOI 10.1016/j.jsb.2005.08.005; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Svergun DI, 1998, BIOCHEMISTRY-US, V37, P17659, DOI 10.1021/bi982367a; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Ueno Hiroshi, 2014, J Biol Chem, V289, P31212, DOI 10.1074/jbc.M114.598177; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Watanabe R, 2008, EMBO REP, V9, P84, DOI 10.1038/sj.embor.7401135; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	78	16	16	5	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23965	23977		10.1074/jbc.M116.743633	http://dx.doi.org/10.1074/jbc.M116.743633			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27624936	Green Published, hybrid			2022-12-26	WOS:000388498100013
J	Yang, XD; Mudgett, J; Bou-About, G; Champy, MF; Jacobs, H; Monassier, L; Pavlovic, G; Sorg, T; Herault, Y; Petit-Demouliere, B; Lu, K; Feng, W; Wang, HW; Ma, LJ; Askew, R; Erion, MD; Kelley, DE; Myers, RW; Li, C; Guan, HP				Yang, Xiaodong; Mudgett, John; Bou-About, Ghina; Champy, Marie-France; Jacobs, Hugues; Monassier, Laurent; Pavlovic, Guillaume; Sorg, Tania; Herault, Yann; Petit-Demouliere, Benoit; Lu, Ku; Feng, Wen; Wang, Hongwu; Ma, Li-Jun; Askew, Roger; Erion, Mark D.; Kelley, David E.; Myers, Robert W.; Li, Cai; Guan, Hong-Ping			Physiological Expression of AMPK2(RG) Mutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; glycogen storage disease; insulin resistance; kidney metabolism; liver metabolism	ACTIVATED PROTEIN-KINASE; GLYCOGEN-STORAGE; ENERGY SENSOR; CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE; FATTY-ACID; AMPK ACTIVATION; DISEASE; SURVIVAL; GLUCOSE	Mutations of the AMP-activated kinase gamma 2 subunit (AMPK2), N488I (AMPK2(NI)) and R531G (AMPK2(RG)), are associated with Wolff-Parkinson-White (WPW) syndrome, a cardiac disorder characterized by ventricular pre-excitation in humans. Cardiac-specific transgenic overexpression of human AMPK2(NI) or AMPK2(RG) leads to constitutive AMPK activation and the WPW phenotype in mice. However, overexpression of these mutant proteins also caused profound, non-physiological increase in cardiac glycogen, which might abnormally alter the true phenotype. To investigate whether physiological levels of AMPK2(NI) or AMPK2(RG) mutation cause WPW syndrome and metabolic changes in other organs, we generated two knock-in mouse lines on the C57BL/6N background harboring mutations of human AMPK2(NI) and AMPK2(RG), respectively. Similar to the reported phenotypes of mice overexpressing AMPK2(NI) or AMPK2(RG) in the heart, both lines developed WPW syndrome and cardiac hypertrophy; however, these effects were independent of cardiac glycogen accumulation. Compared with AMPK2(WT) mice, AMPK2(NI) and AMPK2(RG) mice exhibited reduced body weight, fat mass, and liver steatosis when fed with a high fat diet (HFD). Surprisingly, AMPK2(RG) but not AMPK2(NI) mice fed with an HFD exhibited severe kidney injury characterized by glycogen accumulation, inflammation, apoptosis, cyst formation, and impaired renal function. These results demonstrate that expression of AMPK2(NI) and AMPK2(RG) mutations at physiological levels can induce beneficial metabolic effects but that this is accompanied by WPW syndrome. Our data also reveal an unexpected effect of AMPK2(RG) in the kidney, linking lifelong constitutive activation of AMPK to a potential risk for kidney dysfunction in the context of an HFD.	[Yang, Xiaodong; Lu, Ku; Feng, Wen; Ma, Li-Jun; Erion, Mark D.; Kelley, David E.; Myers, Robert W.; Li, Cai; Guan, Hong-Ping] Merck Res Labs, Dept Cardiometabol Dis, Kenilworth, NJ 07033 USA; [Mudgett, John; Askew, Roger] Merck Res Labs, Dept Genet Engn Models, Kenilworth, NJ 07033 USA; [Wang, Hongwu] Merck Res Labs, Dept Kenilworth Chem & Modeling Informat, Kenilworth, NJ 07033 USA; [Bou-About, Ghina; Champy, Marie-France; Jacobs, Hugues; Pavlovic, Guillaume; Sorg, Tania; Herault, Yann; Petit-Demouliere, Benoit] Univ Strasbourg, Inst Clin Souris, Ctr Europeen Rech Biol & Med GIE Groupement Inter, PHENOMIN,CNRS UMR 7104,INSERM U964, F-67404 Illkirch Graffenstaden, France; [Monassier, Laurent] Univ Strasbourg, Lab Neurobiol & Cardiovasc Pharmacol Dept, Federat Med Translationnelle, EA 7296, F-67000 Strasbourg, France	Merck & Company; Merck & Company; Merck & Company; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guan, HP (corresponding author), Merck Res Labs, Dept Cardiometabol Dis, Kenilworth, NJ 07033 USA.; Guan, HP (corresponding author), MRL, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	Hong-Ping_Guan@merck.com	Pavlovic, Guillaume/C-9907-2013; Monassier, Laurent/AAE-4446-2022; Herault, Yann/B-5500-2012	Pavlovic, Guillaume/0000-0001-9122-4592; Herault, Yann/0000-0001-7049-6900	Merck Research Laboratories	Merck Research Laboratories(Merck & Company)	This work was supported by the Merck Research Laboratories. The authors declare that they have no conflicts of interest with the contents of this article.	Accornero F, 2011, CIRC RES, V109, P272, DOI 10.1161/CIRCRESAHA.111.240820; Arad M, 2003, CIRCULATION, V107, P2850, DOI 10.1161/01.CIR.0000075270.13497.2B; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; BENDITT DG, 1978, CIRCULATION, V57, P454, DOI 10.1161/01.CIR.57.3.454; Birk JB, 2006, J PHYSIOL-LONDON, V577, P1021, DOI 10.1113/jphysiol.2006.120972; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; Cammisotto PG, 2008, AM J PHYSIOL-RENAL, V294, pF881, DOI 10.1152/ajprenal.00373.2007; Cardiff Robert D, 2014, Cold Spring Harb Protoc, V2014, P655, DOI 10.1101/pdb.prot073411; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Chopra I, 2008, CIRCULATION, V118, pS486; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Davies JK, 2006, AM J PHYSIOL-HEART C, V290, pH1942, DOI 10.1152/ajpheart.01020.2005; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Decleves AE, 2014, NEPHRON EXP NEPHROL, V128, P98, DOI 10.1159/000368932; Fraser S, 2005, AM J PHYSIOL-RENAL, V288, pF578, DOI 10.1152/ajprenal.00190.2004; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hallows KR, 2010, AM J PHYSIOL-RENAL, V298, pF1067, DOI 10.1152/ajprenal.00005.2010; Halse R, 2003, DIABETES, V52, P9, DOI 10.2337/diabetes.52.1.9; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jensen KK, 2012, AM J PHYSIOL-ENDOC M, V302, pE209, DOI 10.1152/ajpendo.00436.2011; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim M, 2014, CIRC RES, V114, P966, DOI 10.1161/CIRCRESAHA.114.302364; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kume S, 2012, DIABETES, V61, P23, DOI 10.2337/db11-0555; Light PE, 2003, CIRCULATION, V107, P1962, DOI 10.1161/01.CIR.0000069269.60167.02; Light Peter E, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS158, DOI 10.1111/j.1540-8167.2006.00399.x; Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Yung MMH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-327; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505	47	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23428	23439		10.1074/jbc.M116.738591	http://dx.doi.org/10.1074/jbc.M116.738591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621313	Green Published, hybrid			2022-12-26	WOS:000387884400006
J	Port, SA; Mendes, A; Valkova, C; Spillner, C; Fahrenkrog, B; Kaether, C; Kehlenbach, RH				Port, Sarah A.; Mendes, Adelia; Valkova, Christina; Spillner, Christiane; Fahrenkrog, Birthe; Kaether, Christoph; Kehlenbach, Ralph H.			The Oncogenic Fusion Proteins SET-Nup214 and Sequestosome-1 (SQSTM1)-Nup214 Form Dynamic Nuclear Bodies and Differentially Affect Nuclear Protein and Poly(A)(+) RNA Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; LEPTOMYCIN B; STRUCTURAL BASIS; BINDING-PROTEIN; SET-CAN; NUCLEOPORIN; LEUKEMIA; CRM1; TRANSCRIPTION	Genetic rearrangements are a hallmark of several forms of leukemia and can lead to oncogenic fusion proteins. One example of an affected chromosomal region is the gene coding for Nup214, a nucleoporin that localizes to the cytoplasmic side of the nuclear pore complex (NPC). We investigated two such fusion proteins, SET-Nup214 and SQSTM1 (sequestosome)Nup214, both containing C-terminal portions of Nup214. SETNup214 nuclear bodies containing the nuclear export receptor CRM1 were observed in the leukemia cell lines LOUCY and MEGAL. Overexpression of SET-Nup214 in HeLa cells leads to the formation of similar nuclear bodies that recruit CRM1, export cargo proteins, and certain nucleoporins and concomitantly affect nuclear protein and poly(A)(+) RNA export. SQSTM1-Nup214, although mostly cytoplasmic, also forms nuclear bodies and inhibits nuclear protein but not poly(A)(+) RNA export. The interaction of the fusion proteins with CRM1 is RanGTP-dependent, as shown in co-immunoprecipitation experiments and binding assays. Further analysis revealed that the Nup214 parts mediate the inhibition of nuclear export, whereas the SET or SQSTM1 part determines the localization of the fusion protein and therefore the extent of the effect. SETNup214 nuclear bodies are highly mobile structures, which are in equilibrium with the nucleoplasm in interphase and disassemble during mitosis or upon treatment of cells with the CRM1-inhibitor leptomycin B. Strikingly, we found that nucleoporins can be released from nuclear bodies and reintegrated into existing NPC. Our results point to nuclear bodies as a means of preventing the formation of potentially insoluble and harmful protein aggregates that also may serve as storage compartments for nuclear transport factors.	[Port, Sarah A.; Spillner, Christiane; Kehlenbach, Ralph H.] Georg August Univ, Fac Med, Dept Mol Biol, Humboldtallee 23, D-37073 Gottingen, Germany; [Port, Sarah A.; Spillner, Christiane; Kehlenbach, Ralph H.] Georg August Univ, Gottingen Ctr Mol Biosci GZMB, Humboldtallee 23, D-37073 Gottingen, Germany; [Mendes, Adelia; Fahrenkrog, Birthe] Univ Libre Bruxelles, Inst Mol Biol & Med, B-6041 Charleroi, Belgium; [Valkova, Christina; Kaether, Christoph] Fritz Lipmann Inst, Leibniz Inst Aging, Beutenbergstr 11, D-07745 Jena, Germany	University of Gottingen; University of Gottingen; Universite Libre de Bruxelles; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Kehlenbach, RH (corresponding author), Georg August Univ, Fac Med, Dept Mol Biol, Humboldtallee 23, D-37073 Gottingen, Germany.; Kehlenbach, RH (corresponding author), Georg August Univ, Gottingen Ctr Mol Biosci GZMB, Humboldtallee 23, D-37073 Gottingen, Germany.	rkehlen@gwdg.de	Port, Sarah A./J-7188-2019	Port, Sarah A./0000-0002-1897-0510; Kehlenbach, Ralph/0000-0003-4920-9916	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 860]; Sachbeihilfe [KA1751/4-2]; Fonds de la Recherche Scientifique (FNRS) Belgium [T.0082.14, J.0136, F3/5/5-MCF/XH/FC-18103]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sachbeihilfe; Fonds de la Recherche Scientifique (FNRS) Belgium(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 860 (to R. H. K.), Sachbeihilfe KA1751/4-2 (to C. K.), and Grants T.0082.14 and J.0136 (to B. F.) and F3/5/5-MCF/XH/FC-18103 (to A. M.) from Fonds de la Recherche Scientifique (FNRS) Belgium. The authors declare that they have no conflicts of interest with the contents of this article.	Ausubel F. M., 2003, CALCIUM PHOSPHATE TR; Bastos R, 1997, J CELL BIOL, V137, P989, DOI 10.1083/jcb.137.5.989; Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236; Brangwynne CP, 2013, J CELL BIOL, V203, P875, DOI 10.1083/jcb.201308087; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Conway AE, 2015, LEUKEMIA, V29, P423, DOI 10.1038/leu.2014.221; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dickmanns A, 2015, INT REV CEL MOL BIO, V320, P171, DOI 10.1016/bs.ircmb.2015.07.010; Dickmanns A, 2015, CELLS-BASEL, V4, P538, DOI 10.3390/cells4030538; Dolker N, 2013, STRUCTURE, V21, P1350, DOI 10.1016/j.str.2013.05.015; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Ernoult-Lange M, 2009, MOL BIOL CELL, V20, P176, DOI 10.1091/mbc.E08-09-0904; Fong KW, 2013, J CELL BIOL, V203, P149, DOI 10.1083/jcb.201303145; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; FORNEROD M, 1995, ONCOGENE, V10, P1739; Fornerod M, 1996, ONCOGENE, V13, P1801; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Fu GK, 1997, P NATL ACAD SCI USA, V94, P1811, DOI 10.1073/pnas.94.5.1811; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gorello P, 2010, HAEMATOL-HEMATOL J, V95, P2161, DOI 10.3324/haematol.2010.029769; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kirli K, 2015, ELIFE, V4, DOI 10.7554/eLife.11466; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Knockenhauer KE, 2016, CELL, V164, P1162, DOI 10.1016/j.cell.2016.01.034; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Laurell E, 2011, CELL, V144, P539, DOI 10.1016/j.cell.2011.01.012; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Milles S, 2013, EMBO REP, V14, P178, DOI 10.1038/embor.2012.204; Oka M, 2016, ELIFE, V5, DOI 10.7554/eLife.09540; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Port SA, 2015, CELL REP, V13, P690, DOI 10.1016/j.celrep.2015.09.042; Quentmeier H, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-3; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Roloff S, 2013, J BIOL CHEM, V288, P3952, DOI 10.1074/jbc.M112.433243; Romana S, 2016, CHROMOSOMA, V125, P789, DOI 10.1007/s00412-015-0567-0; Saito S, 2004, INT J CANCER, V111, P501, DOI 10.1002/ijc.20296; Saito S, 2016, MOL CELL BIOL, V36, P1820, DOI 10.1128/MCB.00158-16; Thakar K, 2013, MOL CELL PROTEOMICS, V12, P664, DOI 10.1074/mcp.M112.024877; Van Vlierberghe P, 2008, BLOOD, V111, P4668, DOI 10.1182/blood-2007-09-111872; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1990, MOL CELL BIOL, V10, P4016, DOI 10.1128/MCB.10.8.4016; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; Waldmann I, 2012, J CELL SCI, V125, P144, DOI 10.1242/jcs.090316; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhou MH, 2014, ONCOL LETT, V8, P959, DOI 10.3892/ol.2014.2263; Zwerger M, 2016, NUCLEUS-PHILA, V7, P1, DOI 10.1080/19491034.2015.1130197	66	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23068	23083		10.1074/jbc.M116.735340	http://dx.doi.org/10.1074/jbc.M116.735340			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613868	Green Published, hybrid			2022-12-26	WOS:000387224800019
J	Murakami, E; Shionoya, T; Komenoi, S; Suzuki, Y; Sakane, F				Murakami, Eri; Shionoya, Takao; Komenoi, Suguru; Suzuki, Yuji; Sakane, Fumio			Cloning and Characterization of Novel Testis-Specific Diacylglycerol Kinase eta Splice Variants 3 and 4	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; BIPOLAR-DISORDER; MALE-INFERTILITY; ISOZYMES DELTA; LIFE-STYLE; SAM DOMAIN; LOCALIZATION; EXPRESSION; KAPPA; DGKH	Diacylglycerol kinase (DGK) phosphorylates DG to generate phosphatidic acid. Recently, we found that a new alternative splicing product of the DGK. gene, DGK eta 3, which lacks exon 26 encoding 31 amino acid residues, was expressed only in the secondary spermatocytes and round spermatids of the testis. In this study, we cloned the full length DGK eta 3 gene and confirmedthe endogenous expression of its protein product. During the cloning procedure, we found a new testis-specific alternative splicing product of the DGK eta gene, DGK eta 4, which lacks half of the catalytic domain. We examined the DGK activity and subcellular localization of DGK eta 3 and eta 4. DGK eta 3 had almost the same activity as DGK eta 1, whereas the activity of DGK eta 4 was not detectable. In resting NEC8 cells (human testicular germcell tumor cell line), DGK eta 1, eta 3 and eta 4 were broadly distributed in the cytoplasm. When osmotically shocked, DGK eta 1 and eta 4 were distributed in punctate vesicles in the cytoplasm. In contrast, DGK eta 3 was partly translocated to the plasma membrane and co-localized with the actin cytoskeleton. These results suggest that DGK eta 3 and eta 4 have properties different from those of DGK eta 1 and that they play roles in the testis in a different manner.	[Murakami, Eri; Shionoya, Takao; Komenoi, Suguru; Suzuki, Yuji; Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan	Chiba University	Sakane, F (corresponding author), Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan.	sakane@faculty.chiba-u.jp	Sakane, Fumio/H-2693-2017	Sakane, Fumio/0000-0003-0857-0377	MEXT/JSPS KAKENHI Grant [22370047, 23116505, 25116704, 26291017, 15K14470]; Japan Science and Technology Agency [AS221Z00794F, AS231Z00139G, AS251Z01788Q, AS2621643Q]; Naito Foundation; Hamaguchi Foundation for the Advancement of Biochemistry; Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation; Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Venture Business Laboratory of Chiba University; Grants-in-Aid for Scientific Research [26291017, 16J06865] Funding Source: KAKEN	MEXT/JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Daiichi-Sankyo Foundation of Life Science; Terumo Life Science Foundation(Terumo Life Science Foundation); Futaba Electronic Memorial Foundation; Daiwa Securities Health Foundation; Ono Medical Research Foundation; Japan Foundation for Applied Enzymology; Food Science Institute Foundation; Skylark Food Science Institute; Venture Business Laboratory of Chiba University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grant Numbers 22370047 (Grant-in-Aid for Scientific Research (B)), 23116505 (Grant-in-Aid for Scientific Research on Innovative Areas), 25116704 (Grant-in-Aid for Scientific Research on Innovative Areas), 26291017 (Grant-in-Aid for Scientific Research (B)) and 15K14470 (Grant-in-Aid for Challenging Exploratory Research), the Japan Science and Technology Agency (AS221Z00794F, AS231Z00139G, AS251Z01788Q and AS2621643Q), the Naito Foundation, the Hamaguchi Foundation for the Advancement of Biochemistry, the Daiichi-Sankyo Foundation of Life Science, the Terumo Life Science Foundation, the Futaba Electronic Memorial Foundation, the Daiwa Securities Health Foundation, the Ono Medical Research Foundation, the Japan Foundation for Applied Enzymology, the Food Science Institute Foundation, the Skylark Food Science Institute and the Venture Business Laboratory of Chiba University (FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, BIOMED PHARMACOTHER, V62, P550, DOI 10.1016/j.biopha.2008.07.052; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Cheng Yan-Ho, 2011, Spermatogenesis, V1, P209, DOI 10.4161/spmg.1.3.17990; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Isozaki T, 2016, J NEUROCHEM, V138, P448, DOI 10.1111/jnc.13661; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; Knight MJ, 2010, BIOCHEMISTRY-US, V49, P9667, DOI 10.1021/bi101261x; Komenoi S, 2015, FEBS LETT, V589, P1272, DOI 10.1016/j.febslet.2015.03.032; Kume A, 2016, J BIOL CHEM, V291, P8150, DOI 10.1074/jbc.M115.648717; Matsutomo D, 2013, J BIOCHEM, V153, P179, DOI 10.1093/jb/mvs130; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; Nakano T, 2014, CLIN TRANSL ONCOL, V16, P29, DOI 10.1007/s12094-013-1036-y; Rittiner JE, 2014, MOL PHARMACOL, V85, P800, DOI 10.1124/mol.113.091280; Sakai H, 2012, J BIOCHEM, V152, P397, DOI 10.1093/jb/mvs104; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sharpe RM, 2000, BRIT MED BULL, V56, P630, DOI 10.1258/0007142001903436; Shionoya T, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0055-z; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Usuki T, 2015, J HISTOCHEM CYTOCHEM, V63, P57, DOI 10.1369/0022155414559130; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zeng Z, 2011, MOL PSYCHIATR, V16, P473, DOI 10.1038/mp.2010.86	31	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162997	10.1371/journal.pone.0162997	http://dx.doi.org/10.1371/journal.pone.0162997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643686	Green Published, gold, Green Submitted			2022-12-26	WOS:000383891900026
J	Erlendsson, AM; Thaysen-Petersen, D; Bay, C; Hald, A; Skak, K; Zibert, JR; Paasch, U; Wulf, HC; Haedersdal, M				Erlendsson, Andres Mar; Thaysen-Petersen, Daniel; Bay, Christiane; Hald, Andreas; Skak, Kresten; Zibert, John Robert; Paasch, Uwe; Wulf, Hans Christian; Haedersdal, Merete			Repeated Treatments with Ingenol Mebutate Prevents Progression of UV-Induced Photodamage in Hairless Mice	PLOS ONE			English	Article							PROTEIN-KINASE-C; SQUAMOUS-CELL CARCINOMAS; PEP005; NEUTROPHILS; PATTERNS; EXPOSURE; ANGELATE; THERAPY; REPAIR; DAMAGE	Background and Aim Ingenol mebutate (IngMeb) is an effective treatment for actinic keratosis. In this study, we hypothesized that repeated treatments with IngMeb may prevent progression of UV-induced photodamage, and that concurrent application of a corticosteroid may reduce IngMeb-induced local skin responses (LSR). Methods Hairless mice (n = 60; 3 groups of 20 mice) were irradiated with solar simulated ultraviolet radiation (UVR) throughout the study. Five single treatments with IngMeb were given at 4week intervals (Days 21, 49, 77, 105, and 133). Clobetasol propionate (CP) was applied once daily for 5 days prior to each IngMeb application, as well as 6 h and 1 day post treatment. One week after IngMeb treatment No. 1, 3, and 5 (Days 28, 84, and 140), biopsies from four mice in each group were collected for histological evaluation of UV-damage on a standardized UV-damage scale (0-12). LSR (0-24) were assessed once daily (Days 1-7) after each IngMeb treatment. Results IngMeb prevented progression of photodamage in terms of keratosis grade, epidermal hypertrophy, dysplasia, and dermal actinic damage with a lower composite UV-damage score on day 140 (UVR 10.25 vs. UVR+ IngMeb 6.00, p = 0.002) compared to UVR alone. IngMeb induced LSR, including erythema, flaking, crusting, bleeding, vesiculation, and ulceration. Concurrent CP increased LSR (max LSR Tx 1-5: UVR+IngMeb+CP 3.6-5.5 vs. UVR+IngMeb 2.6-4.3) and provided better prevention of photodamage compared to IngMeb alone (Day 140: UVR+IngMeb 6.00 vs. UVR+IngMeb+CP 3.00 p < 0.001). Conclusion Repeated field-directed treatments with IngMeb prevent progression of cutaneous photodamage in hairless mice, while CP cannot be used to alleviate IngMeb-induced LSR. The findings suggest that IngMeb may potentially serve as a prophylactic treatment for UV-induced tumors.	[Erlendsson, Andres Mar; Thaysen-Petersen, Daniel; Bay, Christiane; Wulf, Hans Christian; Haedersdal, Merete] Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark; [Hald, Andreas; Skak, Kresten; Zibert, John Robert] Leo Pharma AS, Ballerup, Denmark; [Paasch, Uwe] Univ Leipzig, Dept Dermatol, Div Aesthet & Laserdermatol, Leipzig, Germany	University of Copenhagen; Bispebjerg Hospital; LEO Pharma; Leipzig University	Erlendsson, AM (corresponding author), Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark.	andres.erlendsson@gmail.com	Thaysen-Petersen, Daniel/M-8423-2019; Zibert, John Robert/GRY-3584-2022; Bay, Christiane/H-2451-2013	Bay, Christiane/0000-0002-5176-8322	Leo Pharma A/S	Leo Pharma A/S	Leo Pharma A/S provided ingenol mebutate gel for the study and support in the form of salaries for authors AH, KS, and JRZ, but the funder had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BechThomsen N, 1997, DAN MED BULL, V44, P242; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Cozzi SJ, 2012, J INVEST DERMATOL, V132, P1263, DOI 10.1038/jid.2011.418; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; Erlendsson AM, 2016, J PHOTOCH PHOTOBIO B, V163, P144, DOI 10.1016/j.jphotobiol.2016.08.022; Erlendsson AM, 2016, J AM ACAD DERMATOL, V74, P709, DOI 10.1016/j.jaad.2015.11.034; Faurschou A, 2007, SKIN RES TECHNOL, V13, P202, DOI 10.1111/j.1600-0846.2007.00222.x; Freiberger SN, 2015, MOL CANCER THER, V14, P2132, DOI 10.1158/1535-7163.MCT-15-0023-T; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KAARSEN LL, 1995, PHOTODERMATOL PHOTO, V11, P1, DOI 10.1111/j.1600-0781.1995.tb00128.x; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; KLIGMAN LH, 1981, JNCI-J NATL CANCER I, V67, P1289; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Lerche CM, 2015, PHOTODERMATOL PHOTO, V31, P261, DOI 10.1111/phpp.12181; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; MONTAGNA W, 1954, J INVEST DERMATOL, V23, P259, DOI 10.1038/jid.1954.106; Mukhtar H, 1999, PHOTODERMATOL PHOTO, V15, P91, DOI 10.1111/j.1600-0781.1999.tb00065.x; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Rass K, 2008, ADV EXP MED BIOL, V624, P162, DOI 10.1007/978-0-387-77574-6_13; Rosen R, 2014, DERMATOLOGY THER, V4, P207, DOI 10.1007/s13555-014-0059-9; Rosso S, 1996, BRIT J CANCER, V73, P1447, DOI 10.1038/bjc.1996.275; Schafer-Korting M, 2005, SKIN PHARMACOL PHYS, V18, P103, DOI 10.1159/000084907; Serova M, 2008, MOL CANCER THER, V7, P915, DOI 10.1158/1535-7163.MCT-07-2060; Stahlhut M, 2012, J DRUGS DERMATOL, V11, P1181; WULF HC, 1982, J AM ACAD DERMATOL, V7, P194, DOI 10.1016/S0190-9622(82)70108-2; Yadav V, 2010, AM J PATHOL, V176, P1091, DOI 10.2353/ajpath.2010.090816	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162597	10.1371/journal.pone.0162597	http://dx.doi.org/10.1371/journal.pone.0162597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636884	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700011
J	Caporarello, N; Salmeri, M; Scalia, M; Motta, C; Parrino, C; Frittitta, L; Olivieri, M; Cristaldi, M; Avola, R; Bramanti, V; Toscano, MA; Anfuso, CD; Lupo, G				Caporarello, Nunzia; Salmeri, Mario; Scalia, Marina; Motta, Carla; Parrino, Cristina; Frittitta, Lucia; Olivieri, Melania; Cristaldi, Martina; Avola, Roberto; Bramanti, Vincenzo; Toscano, Maria Antonietta; Anfuso, Carmelina Daniela; Lupo, Gabriella			Cytosolic and Calcium-Independent Phospholipases A(2) Activation and Prostaglandins E-2 Are Associated with Escherichia coli-Induced Reduction of Insulin Secretion in INS-1E Cells	PLOS ONE			English	Article							INDUCED ACUTE-PANCREATITIS; HEMOLYTIC-UREMIC SYNDROME; BETA-CELL; PKC-ALPHA; DIABETES-MELLITUS; ARACHIDONIC-ACID; FATTY-ACID; GLUCOSE; ISLETS; INFECTION	It is suspected that microbial infections take part in the pathogenesis of diabetes mellitus type 1 (T1DM). Glucose-induced insulin secretion is accompanied by the release of free arachidonic acid (AA) mainly by cytosolic-and calcium independent phospholipases A(2) (cPLA(2) and iPLA(2)). Insulinoma cell line (INS-1E) was infected with E. coli isolated from the blood culture of a patient with sepsis. Invasion assay, Scanning Electron Microscopy and Transmission Electron Microscopy demonstrated the capacity of E. coli to enter cells, which was reduced by PLA(2) inhibitors. Glucose-induced insulin secretion was significantly increased after acute infection (8h) but significantly decreased after chronic infection (72h). PLA(2) activities, cPLA(2), iPLA(2), phospho-cPLA(2), and COX-2 expressions were increased after acute and, even more, after chronic E. coli infection. The silencing of the two isoforms of PLA(2)s, with specific cPLA(2)- or iPLA(2)-siRNAs, reduced insulin secretion after acute infection and determined a rise in insulin release after chronic infection. Prostaglandins E-2 (PGE(2)) production was significantly elevated in INS-1E after long-termE. coli infection and the restored insulin secretion in presence of L798106, a specific EP3 antagonist, and NS398, a COX-2 inhibitor, and the reduction of insulin secretion in presence of sulprostone, a specific EP3 agonist, revealed their involvement in the effects triggered by bacterial infection. The results obtained demonstrated that cPLA(2) and iPLA(2) play a key role in insulin secretion process after E. coli infection. The high concentration of AA released is transformed into PGE(2), which could be responsible for the reduced insulin secretion.	[Caporarello, Nunzia; Salmeri, Mario; Scalia, Marina; Motta, Carla; Olivieri, Melania; Cristaldi, Martina; Avola, Roberto; Bramanti, Vincenzo; Toscano, Maria Antonietta; Anfuso, Carmelina Daniela; Lupo, Gabriella] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Catania, Italy; [Parrino, Cristina; Frittitta, Lucia] Univ Catania, Sch Med, Dept Clin & Expt Med, Catania, Italy	University of Catania; University of Catania	Lupo, G (corresponding author), Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Catania, Italy.	lupogab@unict.it	Parrino, Cristina/H-4009-2018; Parrino, Cristina/ABA-7496-2020; frittitta, lucia/AAA-4733-2019; Bramanti, Vincenzo/L-8828-2019; frittitta, Lucia/J-2334-2012	Parrino, Cristina/0000-0002-1367-6208; Parrino, Cristina/0000-0002-1367-6208; frittitta, lucia/0000-0002-7941-5828; Bramanti, Vincenzo/0000-0002-9380-8062; Caporarello, Nunzia/0000-0002-3183-2868; ANFUSO, Carmelina Daniela/0000-0001-7951-1812	 [PON01-00110]		This work was supported by National Grant PON01-00110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina M, 2010, MICROVASC RES, V80, P280, DOI 10.1016/j.mvr.2010.03.013; Ali T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071748; Anfuso CD, 2007, J LIPID RES, V48, P782, DOI 10.1194/jlr.M600489-JLR200; Anfuso CD, 2014, BIOCHIMIE, V99, P77, DOI 10.1016/j.biochi.2013.11.013; ARENDT T, 1993, DIGEST DIS SCI, V38, P39, DOI 10.1007/BF01296771; Arendt T, 1998, INT J PANCREATOL, V24, P111; Arrellano-Valdez F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-549; Baker S, 2004, Crit Care Resusc, V6, P17; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bone RN, 2015, DIABETES, V64, P541, DOI 10.2337/db14-0097; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Caporarello N, 2015, FEBS LETT, V589, P3969, DOI 10.1016/j.febslet.2015.11.035; Crouzet J, 2011, INT J INFECT DIS, V15, pE601, DOI 10.1016/j.ijid.2011.05.003; Culetto A, 2015, DIGEST LIVER DIS, V47, P584, DOI 10.1016/j.dld.2015.03.009; D'Hertog W, 2011, PROTEOMICS, V11, P1365, DOI 10.1002/pmic.201000006; Dahan S, 2002, INFECT IMMUN, V70, P2304, DOI 10.1128/IAI.70.5.2304-2310.2002; DelGiorno KE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092807; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Du SC, 2012, CELL MOL BIOL, V58, P1654, DOI 10.1170/192; Faustino EV, 2005, J PEDIATR-US, V146, P30, DOI 10.1016/j.jpeds.2004.08.076; Frommel U, 2013, APPL ENVIRON MICROB, V79, P5814, DOI 10.1128/AEM.01384-13; GIANANTONIO CA, 1973, NEPHRON, V11, P174; Giurdanella G, 2011, MICROVASC RES, V81, P1, DOI 10.1016/j.mvr.2010.11.005; Hsieh PS, 2008, LIVER INT, V28, P1167, DOI 10.1111/j.1478-3231.2008.01714.x; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Iizuka K, 2002, BBA-MOL BASIS DIS, V1586, P23, DOI 10.1016/S0925-4439(01)00082-5; Ishida-Oku M, 2010, ISLETS, V2, P274, DOI 10.4161/isl.2.5.12728; Ismaili A, 1998, INFECT IMMUN, V66, P1688, DOI 10.1128/IAI.66.4.1688-1696.1998; Juhl K, 2003, AM J PHYSIOL-ENDOC M, V285, pE73, DOI 10.1152/ajpendo.00086.2003; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Keanei DC, 2011, CLIN SCI, V120, P195, DOI 10.1042/CS20100282; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Lammi N, 2005, MED SCI MONITOR, V11, pRA63; Milne HM, 2005, DIABETES, V54, P116, DOI 10.2337/diabetes.54.1.116; Myers MA, 2001, DIABETOLOGIA, V44, P1199; Nikolic DM, 2011, BRIT J BIOMED SCI, V68, P181, DOI 10.1080/09674845.2011.11730347; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Osto M, 2011, ENDOCRINOLOGY, V152, P804, DOI 10.1210/en.2010-0999; Patane G, 2013, ACTA DIABETOL, V50, P851, DOI 10.1007/s00592-013-0458-x; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Persaud SJ, 2002, DIABETES, V51, P98, DOI 10.2337/diabetes.51.1.98; Pezzilli Raffaele, 2003, JOP, V4, P200; Ramanadham S, 1998, BBA-LIPID LIPID MET, V1390, P301, DOI 10.1016/S0005-2760(97)00189-6; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Safi M, 2016, J INFECT CHEMOTHER, V22, P221, DOI 10.1016/j.jiac.2015.12.017; Salmeri M, 2013, CELL MICROBIOL, V15, P1367, DOI 10.1111/cmi.12121; Salmeri M, 2012, NEUROSCI LETT, V511, P33, DOI 10.1016/j.neulet.2012.01.031; Sanchez-Villamil J, 2015, FUTURE MICROBIOL, V10, P1009, DOI [10.2217/FMB.15.17, 10.2217/fmb.15.17]; Sansonetti P, 2002, GUT, V50, P2; Sass DA, 2003, DIGEST DIS SCI, V48, P415, DOI 10.1023/A:1021912518129; Sharma R, 2006, AM J PHYSIOL-GASTR L, V290, pG685, DOI 10.1152/ajpgi.00404.2005; Shen-Tu G, 2014, INFECT IMMUN, V82, P1648, DOI 10.1128/IAI.00534-13; Shunzhong B, 2008, AM J PHYSIOL-ENDOC M, V294, pE217; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Slavov E, 2010, VET RES COMMUN, V34, P205, DOI 10.1007/s11259-010-9345-x; Smith EJ, 2013, FUTURE MICROBIOL, V8, P1289, DOI 10.2217/fmb.13.94; Song HW, 2012, J BIOL CHEM, V287, P5528, DOI 10.1074/jbc.M111.285114; Suri RS, 2009, KIDNEY INT, V75, pS44, DOI 10.1038/ki.2008.619; Taser N, 2014, EUR J GASTROEN HEPAT, V26, P937, DOI 10.1097/MEG.0000000000000129; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; van Waardenburg DA, 2006, J CLIN ENDOCR METAB, V91, P3916, DOI 10.1210/jc.2006-0525; von Herrath MG, 2000, J NEUROIMMUNOL, V107, P154, DOI 10.1016/S0165-5728(00)00227-7; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711	67	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159874	10.1371/journal.pone.0159874	http://dx.doi.org/10.1371/journal.pone.0159874			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631977	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900004
J	Ebrahimi, L; Fotuhifar, KB; Nikkhah, MJ; Naghavi, MR; Baisakh, N				Ebrahimi, Leila; Fotuhifar, Khalil-Berdi; Nikkhah, Mohammad Javan; Naghavi, Mohammad-Reza; Baisakh, Niranjan			Population Genetic Structure of Apple Scab (Venturia inaequalis (Cooke) G. Winter) in Iran	PLOS ONE			English	Article							RESISTANCE; RACES; SOFTWARE; MALUS; ASIA	The population genetic structure of 278 Venturia inaequalis isolates, collected from different apple cultivars of eighteen different provinces in Iran, was investigated using 22 polymorphic microsatellite markers. Analysis of molecular variation, Bayesian clustering and Nei's genetic distance analyses based on 88 microsatellite alleles indicated substantial levels of gene flow among the collection sites. Ninety three percent of the variation was observed among the individuals within the populations and only 7% variation was observed among the populations. Structure analysis grouped the isolates into two populations. Maximum number of pathogen genotypes (44) was observed in the North of Iran that grows various different apple cultivars. Investigation on the variation of the pathogen on different cultivars in the North of Iran suggested a significant differentiation of the pathogen populations between wild apple and commercial cultivars. During sampling, varying ranges of scab infection were observed on various apple cultivars in forests, monoculture and mix orchards. Wild type apple (Malus orientalis) along the Caspian Sea Coast had the most infection in comparison with the Iranian endemic and commercial cultivars. Based on the genetic analysis and host tracking scenario of the pathogen, it was presumed that Iran could potentially be the center of origin of V. inaequalis, which requires further detailed studies with isolates collected from different parts of central Asia and world for confirmation.	[Ebrahimi, Leila; Fotuhifar, Khalil-Berdi; Nikkhah, Mohammad Javan] Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Plant Pathol, Karaj, Iran; [Naghavi, Mohammad-Reza] Univ Tehran, Coll Agr & Nat Resources, Fac Agr Sci & Engn, Dept Biotechnol, Karaj, Iran; [Ebrahimi, Leila; Baisakh, Niranjan] Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA	University of Tehran; University of Tehran; Louisiana State University System; Louisiana State University	Baisakh, N (corresponding author), Louisiana State Univ, Ctr Agr, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA.	nbaisakh@agcenter.lsu.edu	Naghavi, Mohammad Reza/L-8722-2017; Salehi, Maryam/AAD-3641-2019; Ebrahimi, Leila/S-4092-2018	Naghavi, Mohammad Reza/0000-0002-2427-3332; Salehi, Maryam/0000-0002-2427-3332; Ebrahimi, Leila/0000-0001-8021-9106				Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Boehm EWA, 2003, PHYTOPARASITICA, V31, P236, DOI 10.1007/BF02980833; BROWN AHD, 1980, GENETICS, V96, P523; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Clark Meredith, 2014, THESIS; Cornille A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002703; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ershad D., 2009, FUNGI IRAN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frantz A, 2006, J EVOLUTION BIOL, V19, P392, DOI 10.1111/j.1420-9101.2005.01025.x; Gao LQ, 2009, PEST MANAG SCI, V65, P1241, DOI 10.1002/ps.1816; Gharghani A, 2009, GENET RESOUR CROP EV, V56, P829, DOI 10.1007/s10722-008-9404-0; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Guerin F, 2004, MOL ECOL NOTES, V4, P268, DOI 10.1111/j.1471-8286.2004.00637.x; Hancock J.F., 2004, PLANT EVOLUTION ORIG; Leroy T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-64; MacHardy W.E, 1996, APPLE SCAB BIOL EPID; Martinez-Bilbao A, 2005, PLANT DIS, V89, P908, DOI 10.1094/PD-89-0908A; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; McDonald BA, 1997, PHYTOPATHOLOGY, V87, P448, DOI 10.1094/PHYTO.1997.87.4.448; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Melounova M, 2004, PLANT SOIL ENVIRON, V50, P416, DOI 10.17221/4053-PSE; Nei M., 1987, MOL EVOLUTIONARY GEN; Padder B. A., 2011, Asian Journal of Plant Pathology, V5, P75, DOI 10.3923/ajppaj.2011.75.83; PARISI L, 1993, PHYTOPATHOLOGY, V83, P533, DOI 10.1094/Phyto-83-533; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Sandskar B, 2005, ACTA AGR SCAND B-S P, V55, P143, DOI [10.1080/090647105100029042, 10.1080/09064710510029042]; Schenato PG, 2008, TROP PLANT PATHOL, V33, P281, DOI 10.1590/S1982-56762008000400004; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Tenzer I, 1999, PHYTOPATHOLOGY, V89, P748, DOI 10.1094/PHYTO.1999.89.9.748; Tenzer I, 1997, EUR J PLANT PATHOL, V103, P565, DOI 10.1023/A:1008636913211; Xu XM, 2008, PLANT DIS, V92, P247, DOI 10.1094/PDIS-92-2-0247; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zhang L., 2010, THESIS	36	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160737	10.1371/journal.pone.0160737	http://dx.doi.org/10.1371/journal.pone.0160737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631622	Green Submitted, gold, Green Published			2022-12-26	WOS:000383706900012
J	Lapadula, G; Bernasconi, DP; Casari, S; Maggiolo, F; Cauda, R; Di Pietro, M; Ladisa, N; Sighinolfi, L; Dal Zoppo, S; Sabbatini, F; Soria, A; Pezzoli, C; Mondi, A; Costarelli, S; Valsecchi, MG; Torti, C; Gori, A				Lapadula, Giuseppe; Bernasconi, Davide Paolo; Casari, Salvatore; Maggiolo, Franco; Cauda, Roberto; Di Pietro, Massimo; Ladisa, Nicoletta; Sighinolfi, Laura; Dal Zoppo, Sarah; Sabbatini, Francesca; Soria, Alessandro; Pezzoli, Chiara; Mondi, Annalisa; Costarelli, Silvia; Valsecchi, Maria Grazia; Torti, Carlo; Gori, Andrea		Italian MASTER Cohort	Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HIV-INFECTED PATIENTS; DISOPROXIL FUMARATE; INCOMPLETE REVERSIBILITY; POSITIVE PATIENTS; NAIVE PATIENTS; LARGE COHORT; EXPOSURE; SAFETY; ASSOCIATION	Background Tenofovir (TDF) can cause kidney injury through tubular dysfunction, with or without drop of estimated glomerular filtration rate (eGFR). Whether mild eGFR reductions during treatment should be considered a reason for prompt TDF discontinuation, however, remains unclear. Methods Patients with normal pre-TDF eGFR levels, who had developed mild renal impairment (i.e., two consecutive eGFR results between 89-60 ml/min) on TDF, were observed until onset of chronic kidney disease (CKD), defined as two eGFR< 60 ml/min 3 to 6 months apart. Multivariable Poisson regression analysis was used to investigate whether outcome was associated with current and cumulative use of TDF (modeled as time-varying covariates). Results 2023 (29%) out of 6984 patients developed mild renal impairment on TDF. Among them, 191 progressed to CKD. The incidence of CKD did not significantly differ during TDF treatment (2.6 per 100 PYFU; 95% CI 2.2-3.2) or after its discontinuation (2.2 per 100 PYFU; 95% CI 1.8-2.6). However, the rate of CKD was significantly higher among patients continuing with TDF treatment compared to those who had discontinued it within 6 months of occurrence of mild renal impairment (aIRR 4, 95% CI 2.4-6.8). In contrast, among patients who had maintained TDF > 6 months despite mild renal impairment, current TDF use was not associated with a significantly higher rate of CKD. Other significant predictors of CKD were older age, intravenous drug use, diabetes, hypertension, lower pre- TDF eGFR, higher eGFR drop since TDF introduction and longer exposure to TDF. Conclusions Prompt discontinuation of TDF among patients developing mild renal impairmentmay prevent further progression of renal damage.	[Lapadula, Giuseppe; Sabbatini, Francesca; Soria, Alessandro; Costarelli, Silvia; Gori, Andrea] San Gerardo Hosp, Monza, Italy; [Bernasconi, Davide Paolo; Valsecchi, Maria Grazia; Gori, Andrea] Univ Milano Bicocca, Milan, Italy; [Casari, Salvatore; Pezzoli, Chiara] Univ Brescia, Brescia, Italy; [Maggiolo, Franco] Papa Giovanni XXIII Hosp, Bergamo, Italy; [Cauda, Roberto; Mondi, Annalisa] Univ Cattolica Sacro Cuore, Rome, Italy; [Di Pietro, Massimo] Osped S Maria Annunziata, Florence, Italy; [Ladisa, Nicoletta] Osped Policlin, Bari, Italy; [Sighinolfi, Laura] Osped St Anna, Ferrara, Italy; [Dal Zoppo, Sarah] Ist Ospitalieri, Cremona, Italy; [Torti, Carlo] Magna Graecia Univ Catanzaro, Catanzaro, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Brescia; ASST Papa Giovanni XXIII; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Ferrara; Arcispedale Sant'Anna; Magna Graecia University of Catanzaro	Lapadula, G (corresponding author), San Gerardo Hosp, Monza, Italy.	giuseppe.lapadula@gmail.com	Casari, Salvatore/AAC-5790-2022; Valsecchi, Maria Grazia/K-8891-2016; Sighinolfi, Laura/AAH-1426-2020; Lapadula, Giuseppe/J-5163-2012; mondi, annalisa/AAA-8283-2019; Gori, Andrea/AAC-6078-2022; mondi, annalisa/HGC-9562-2022	Casari, Salvatore/0000-0001-5422-8754; Valsecchi, Maria Grazia/0000-0001-5574-3504; MONNO, Laura/0000-0002-2713-4258	Infectious Diseases and International Health (MISI) Foundation, Brescia, Italy	Infectious Diseases and International Health (MISI) Foundation, Brescia, Italy	The Italian MASTER cohort is sponsored by the Infectious Diseases and International Health (MISI) Foundation, Brescia, Italy (www.fondazionemisi.it). No specific funding was received for the present article.	Baxi SM, 2016, AIDS, V30, P609, DOI 10.1097/QAD.0000000000000958; Baxi SM, 2014, AIDS, V28, P59, DOI 10.1097/QAD.0000000000000033; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Cote HCF, 2006, ANTIVIR THER, V11, P79; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gupta SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092717; Herlitz LC, 2010, KIDNEY INT, V78, P1171, DOI 10.1038/ki.2010.318; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Izzedine H, 2005, NEPHROL DIAL TRANSPL, V20, P743, DOI 10.1093/ndt/gfh658; Izzedine H, 2004, AIDS, V18, P1074, DOI 10.1097/00002030-200404300-00019; Jose S, 2014, J INFECT DIS, V210, P363, DOI 10.1093/infdis/jiu107; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kearney BP, 2006, CLIN PHARMACOKINET, V45, P1115, DOI 10.2165/00003088-200645110-00005; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Rodriguez-Novoa S, 2010, AIDS, V24, P1064, DOI 10.1097/QAD.0b013e32833202e2; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Ryom L, 2014, AIDS, V28, P187, DOI 10.1097/QAD.0000000000000042; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Squires K, 2003, ANN INTERN MED, V139, P313, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00006; Torti C, 2015, INT J EPIDEMIOL; Vrouenraets SME, 2011, AIDS, V25, P2149, DOI 10.1097/QAD.0b013e32834bba87; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Yoshino M, 2012, J INFECT CHEMOTHER, V18, P169, DOI 10.1007/s10156-011-0310-6; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	27	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162320	10.1371/journal.pone.0162320	http://dx.doi.org/10.1371/journal.pone.0162320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632369	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900037
J	Carvalho, RCT; Vasconcellos, SEG; Issa, MD; Soares, PM; Mota, PMPC; de Araujo, FR; Carvalho, ACD; Gomes, HM; Suffys, PN; Figueiredo, EED; Paschoalin, VMF				Tavares Carvalho, Ricardo Cesar; Goncalves Vasconcellos, Sidra Ezidio; Issa, Marina de Azevedo; Soares Filho, Paulo Martins; Pinto Coelho Mota, Pedro Moacyr; de Araujo, Flabio Ribeiro; da Silva Carvalho, Ana Carolina; Gomes, Harrison Magdinier; Suffys, Philip Noel; de Souza Figueiredo, Eduardo Eustaquio; Flosi Paschoalin, Vania Margaret			Molecular Typing of Mycobacterium bovis from Cattle Reared in Midwest Brazil	PLOS ONE			English	Article							TUBERCULOSIS COMPLEX BACTERIA; LENGTH-POLYMORPHISM ANALYSIS; MATO-GROSSO; DISCRIMINATORY ABILITY; SPOLIGOTYPE DIVERSITY; GENETIC DIVERSITY; REPETITIVE UNITS; HIGH-RESOLUTION; TANDEM REPEATS; STRAINS	Mycobacterium bovis is the causative agent of bovine tuberculosis (BTB), the pathogen responsible for serious economic impact on the livestock sector. In order to obtain data on isolated M. bovis strains and assist in the control and eradication program for BTB, a cross sectional descriptive molecular epidemiology study in the Brazilian Midwest was conducted. Through spoligotyping and 24-loci MIRU-VNTR methods, 37 clinical isolates of M. bovis circulating in the region were analyzed, 10 isolated from the state of Mato Grosso, 12 from the state of Mato Grosso do Sul and 15 from the state of Goias. The spoligotyping analysis identified 10 distinct M. bovis profiles (SB0121 n = 14, SB0295 n = 6, SB0140 n = 6, SB0881 n = 3, SB1144 n = 2, SB1145 n = 2, SB0134 n = 1, SB1050 n = 1, SB1055 n = 1, SB1136 n = 1) grouped in six clusters and four orphan patterns. The MIRU-VNTR 24-loci grouped the same isolates in six clusters and 22 unique orphan patterns, showing higher discriminatory power than spoligotyping. When associating the results of both techniques, the isolates were grouped in five clusters and 24 unique M. bovis profiles. Among the 24-loci MIRUVNTR evaluated, two, ETR-A and QUB 11b loci, showed high discriminatory ability (h = >= 0.50), while MIRU 16, MIRU 27, ETR-B, ETR-C, Mtub21 and QUB 26 loci showed moderate ability (h = 0.33 or h = 0.49) and were the most effective in evaluating the genotypic similarities among the clinical M. bovis isolate samples. Herein, the 29 patterns found amongst the 37 isolates of M. bovis circulating in the Brazilian Midwest can be due to the animal movement between regions, municipalities and farms, thus causing the spread of various M. bovis strains in herds from Midwest Brazil.	[Tavares Carvalho, Ricardo Cesar; da Silva Carvalho, Ana Carolina; Flosi Paschoalin, Vania Margaret] Univ Fed Rio de Janeiro, Inst Quim, Rio de Janeiro, RJ, Brazil; [Goncalves Vasconcellos, Sidra Ezidio; Gomes, Harrison Magdinier; Suffys, Philip Noel] Fundacao Oswaldo Cruz FIOCRUZ, IOC, Lab Biol Mol Aplicado & Micobacterias, Rio De Janeiro, RJ, Brazil; [Suffys, Philip Noel] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Issa, Marina de Azevedo; Soares Filho, Paulo Martins; Pinto Coelho Mota, Pedro Moacyr] MAPA, Lab Nacl Agr LANAGRO, Pedro Leopoldo, MG, Brazil; [de Araujo, Flabio Ribeiro] Empresa Brasileira Pesquisa Agr EMBRAPA Gado Cort, Campo Grande, MS, Brazil; [da Silva Carvalho, Ana Carolina] Univ Fed Rio de Janeiro UFRJ Campus Macae, Macae, RJ, Brazil; [de Souza Figueiredo, Eduardo Eustaquio] Univ Fed Mato Grosso UFMT, Fac Nutr, Cuiaba, MT, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Institute of Tropical Medicine (ITM); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso do Sul	Figueiredo, EED (corresponding author), Univ Fed Mato Grosso UFMT, Fac Nutr, Cuiaba, MT, Brazil.	figueiredoeduardo@ufmt.br	Paschoalin, Vania/Q-4997-2019; suffys, philip/E-3009-2013; FIGUEIREDO, EDUARDO E S/I-2803-2013; vasconcellos, Sidra E G Ezidio gonçalves/H-9651-2014; Paschoalin, Vania M F/J-1746-2014; Carvalho, Ana Carolina/W-5365-2018; de Souza Figueiredo, Eduardo Eustaquio/J-4085-2014	vasconcellos, Sidra E G Ezidio gonçalves/0000-0001-6983-1310; Paschoalin, Vania M F/0000-0001-6093-134X; Carvalho, Ana Carolina/0000-0002-1163-3407; de Souza Figueiredo, Eduardo Eustaquio/0000-0002-2608-4324; Tavares Carvalho, Ricardo Cesar/0000-0002-0666-7135	PRONEM/FAPEMAT [472914/2011]; CNPq/Universal [14/2014 (443235/2014-7), 443235/2014-7]; EMBRAPA [02.13.16.002.00.00]; FUNDECT [085/2015]; CAPES/AUX-PE/PROCAD [2493/2008]; CAPES/PNPD [23038.007901/2010-81]; CNPq [140492/2013-5]; FAPEMAT/PRONEM [472914/2011]; FAPERJ; CAPES [AUX-PE PROCAD 2493/2008]; Brazilian Agricultural Research Corporation EMBRAPA [02.13.16.002.00.00]	PRONEM/FAPEMAT; CNPq/Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CAPES/AUX-PE/PROCAD; CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMAT/PRONEM(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Agricultural Research Corporation EMBRAPA(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	The authors thank the Brazilian funding agencies for support: PRONEM/FAPEMAT (472914/2011) Dr. Eduardo Eustaquio de Souza Figueiredo; CNPq/Universal 14/2014 (443235/2014-7) Dr. Flabio Ribeiro de Araujo; EMBRAPA (02.13.16.002.00.00) Dr. Flabio Ribeiro de Araujo; FUNDECT (085/2015) Dr. Flabio Ribeiro de Araujo; CAPES/AUX-PE/PROCAD (2493/2008) Dra. Vania Margaret Flosi Paschoalin; CAPES/PNPD (23038.007901/2010-81) Dra. Ana Carolina da Silva Carvalho; and CNPq PhD grant (140492/2013-5) Dr. Ricardo Cesar Tavares Carvalho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Brazilian funding agencies FAPEMAT/PRONEM (472914/2011), FAPERJ, FUNDECT (085/2015), CNPq/Universal (443235/2014-7), CAPES (AUX-PE PROCAD 2493/2008), CAPES/PNPD (23038.007901/2010-81), the Brazilian Agricultural Research Corporation EMBRAPA (project 02.13.16.002.00.00), and CNPq PhD grant (140492/2013-5) for financial support, and to National Agricultural Laboratory (LANAGRO/MAPA) and sequencing platform group (PDTIS-FIOCRUZ/RJ) for their assistance in research.	Acha PN, 2001, BACTERIOSES MYCOSES, P395; Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Alzamora F, 2014, PESQUI VET BRASIL, V34, P103, DOI 10.1590/S0100-736X2014000200001; Araujo CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091023; Boniotti MB, 2009, J CLIN MICROBIOL, V47, P636, DOI 10.1128/JCM.01192-08; Brazil, 2014, PROD PEC; Brazil, 2015, PROD PEC; Brazil, 2006, PROGR NAC CONTR ERR; Campos SR, 2013, J CLIN MICROBIOL, V51, P3658, DOI [10.1128/JCM.01271-13, DOI 10.1128/JCM.01271-13]; Carvalho RCT, 2015, TUBERCULOSIS EXPANDI, P191; Cazola DD, 2015, PESQUI VET BRASIL, V35, P141, DOI 10.1590/S0100-736X2015000200008; Christianson S, 2010, TUBERCULOSIS, V90, P31, DOI 10.1016/j.tube.2009.12.003; Cobos-Marin L, 2005, CAN J MICROBIOL, V51, P996, DOI [10.1139/w05-083, 10.1139/W05-083]; Costa A.C.F., 2010, Arq. Inst. Biol., V77, P233, DOI 10.1590/1808-1657v77p2332010; Costello E, 1999, J CLIN MICROBIOL, V37, P3217, DOI 10.1128/JCM.37.10.3217-3222.1999; Cousins D, 1998, J CLIN MICROBIOL, V36, P168, DOI 10.1128/JCM.36.1.168-178.1998; da Silva C F, 2001, Rev Inst Med Trop Sao Paulo, V43, P25, DOI 10.1590/S0036-46652001000100005; de Beer JL, 2012, J CLIN MICROBIOL, V50, P662, DOI 10.1128/JCM.00607-11; Figueiredo EED, 2012, UNDERSTANDING TUBERCULOSIS - GLOBAL EXPERIENCES AND INNOVATIVE APPROACHES TO THE DIAGNOSIS, P411; Figueiredo EED, 2012, VET J, V193, P296, DOI 10.1016/j.tvjl.2011.11.006; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Duarte EL, 2010, VET MICROBIOL, V143, P299, DOI 10.1016/j.vetmic.2009.11.027; Rocha VCF, 2013, VECTOR-BORNE ZOONOT, V13, P17, DOI 10.1089/vbz.2012.1035; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Furlanetto LV, 2012, ARQ BRAS MED VET ZOO, V64, P274, DOI 10.1590/S0102-09352012000200004; Gibson AL, 2004, J CLIN MICROBIOL, V42, P431, DOI 10.1128/JCM.42.1.431-434.2004; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Reyes JAG, 2012, PREV VET MED, V106, P1, DOI 10.1016/j.prevetmed.2012.05.008; Haddad N, 2001, J CLIN MICROBIOL, V39, P3623, DOI 10.1128/JCM.39.10.3623-3632.2001; Hauer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117103; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Hilty M, 2005, VET MICROBIOL, V109, P217, DOI 10.1016/j.vetmic.2005.05.017; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Leite CQF, 2003, MEM I OSWALDO CRUZ, V98, P319, DOI 10.1590/S0074-02762003000300005; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Medeiros LD, 2010, BRAZ J MICROBIOL, V41, P531, DOI 10.1590/S1517-83822010005000002; Michel AL, 2008, VET MICROBIOL, V126, P151, DOI 10.1016/j.vetmic.2007.07.015; Mignard S, 2006, EMERG INFECT DIS, V12, P1431, DOI 10.3201/eid1209.060209; Murakami P. S., 2009, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V12, P67; *OIE, 2007, WAHID INT; OIE-World Organisation for Animal Health, 2009, BOVINE TUBERCULOSIS; Parreiras PM, 2012, MEM I OSWALDO CRUZ, V107, P64, DOI 10.1590/S0074-02762012000100009; Ramos DF, 2014, BRAZ J MICROBIOL, V45, P657, DOI 10.1590/S1517-83822014000200039; Rodriguez C. A. R., 2004, Arquivos do Instituto Biologico (Sao Paulo), V71, P277; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Rodriguez-Campos S, 2011, J CLIN MICROBIOL, V49, P3361, DOI 10.1128/JCM.00301-11; Roring S, 2004, VET MICROBIOL, V101, P65, DOI 10.1016/j.vetmic.2004.02.013; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Roxo E, 2004, SITUACAO ATUAL TUBER; Sahraoui N, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-4; Serraino A, 1999, J CLIN MICROBIOL, V37, P2766, DOI 10.1128/JCM.37.9.2766-2771.1999; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Carvalho RCT, 2015, MEAT SCI, V106, P11, DOI 10.1016/j.meatsci.2015.03.017; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Viana-Niero C, 2006, J MED MICROBIOL, V55, P451, DOI 10.1099/jmm.0.46364-0; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; *WHO, 1996, WHOEMCZOO964; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zumarraga MJ, 2013, RES VET SCI, V94, P9, DOI 10.1016/j.rvsc.2012.07.012; Zumarraga MJ, 1999, J CLIN MICROBIOL, V37, P296	72	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162459	10.1371/journal.pone.0162459	http://dx.doi.org/10.1371/journal.pone.0162459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631383	Green Published, gold			2022-12-26	WOS:000383706900050
J	Wong, A; Lau, AYL; Yang, J; Wang, ZL; Liu, WY; Lam, BYK; Au, L; Shi, L; Wang, DF; Chu, WCW; Xiong, YY; Lo, ESK; Law, LSN; Leung, TWH; Lam, LCW; Chan, AYY; Soo, YOY; Leung, EYL; Wong, LKS; Mok, VCT				Wong, Adrian; Lau, Alexander Y. L.; Yang, Jie; Wang, Zhaolu; Liu, Wenyan; Lam, Bonnie Y. K.; Au, Lisa; Shi, Lin; Wang, Defeng; Chu, Winnie C. W.; Xiong, Yun-yun; Lo, Eugene S. K.; Law, Lorraine S. N.; Leung, Thomas W. H.; Lam, Linda C. W.; Chan, Anne Y. Y.; Soo, Yannie O. Y.; Leung, Eric Y. L.; Wong, Lawrence K. S.; Mok, Vincent C. T.			Neuropsychiatric Symptom Clusters in Stroke and Transient Ischemic Attack by Cognitive Status and Stroke Subtype: Frequency and Relationships with Vascular Lesions, Brain Atrophy and Amyloid	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; ALZHEIMERS-DISEASE; MRI SCANS; DEMENTIA; IMPAIRMENT; PREVALENCE; DEFINITIONS; RELIABILITY; INVENTORY; DIAGNOSIS	Background The objectives of this study are 1) to examine the frequencies of neuropsychiatric symptom clusters in patients with stroke or transient ischemic attack (TIA) by cognitive level and stroke subtype; and 2) to evaluate effect of demographic, clinical, and neuroimaging measures of chronic brain changes and amyloid upon neuropsychiatric symptom clusters. Methods Hospital-based, cross-sectional study. 518 patients were administered the Neuropsychiatric Inventory (NPI) 3-6 months post index admission. NPI symptoms were classified into four symptom clusters (Behavioral Problems, Psychosis, Mood Disturbance & Euphoria) derived from a confirmatoryfactor analysis of the 12 NPI items. Multivariable logistic regression was used to determine independent associations between demographic, clinical and neuroimaging measures of chronic brain changes (white matter changes, old infarcts, whole brain atrophy, medial temporal lobe atrophy [MTLA] and frontal lobe atrophy [FLA]) with the presence of NPI symptoms and all symptom clusters except euphoria. C-11-Pittsburg Compound B Positron Emission Tomography (C-11-PiB PET) was performed in 24 patients to measure amyloid retention for Alzheimer's Disease (AD) pathology. Results 50.6% of the whole sample, including 28.7% cognitively normal and 66.7% of patients with mild cognitive symptoms, had >= 1 NPI symptoms. Frequencies of symptom clusters were largely similar between stroke subtypes. Compared to patients with cardioembolic stroke and intracranial haemorrhage, those with TIA had less frequent mood disturbance. Stroke severity at admission and MTLA were the most robust correlates of symptoms. FLA was associated with behavioral problems cluster only. Frequency of symptom clusters did not differ between patients with and without significant amyloid retention. Conclusion Frequency of neuropsychiatric symptoms increased with level of cognitive impairment but was largely similar between stroke subtypes. Stroke severity and MTLA were associated with neuropsychiatric symptoms. AD pathology appeared to be unrelated to neuropsychiatric manifestations but further studies with larger sample size are required to substantiate this finding.	[Wong, Adrian; Lau, Alexander Y. L.; Wang, Zhaolu; Liu, Wenyan; Lam, Bonnie Y. K.; Au, Lisa; Shi, Lin; Lo, Eugene S. K.; Law, Lorraine S. N.; Leung, Thomas W. H.; Chan, Anne Y. Y.; Soo, Yannie O. Y.; Wong, Lawrence K. S.; Mok, Vincent C. T.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Wang, Defeng; Chu, Winnie C. W.] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Hong Kong, Hong Kong, Peoples R China; [Lam, Linda C. W.] Chinese Univ Hong Kong, Dept Psychiat, Lui Che Woo Inst Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Adrian; Lau, Alexander Y. L.; Liu, Wenyan; Lam, Bonnie Y. K.; Au, Lisa; Mok, Vincent C. T.] Chinese Univ Hong Kong, Therese Pei Fong Chow Res Ctr Prevent Dementia, Hong Kong, Hong Kong, Peoples R China; [Yang, Jie] Guangzhou Med Univ, Inst Neurosci, Guangzhou 510260, Guangdong, Peoples R China; [Yang, Jie] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou 510260, Guangdong, Peoples R China; [Yang, Jie] Key Lab Neurogenet & Channelopathies Guangdong Pr, Guangzhou 510260, Guangdong, Peoples R China; [Yang, Jie] Minist Educ China, Guangzhou 510260, Guangdong, Peoples R China; [Xiong, Yun-yun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Leung, Eric Y. L.] Hong Kong Sanat & Hosp, Dept Nucl Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Guangzhou Medical University; Guangzhou Medical University; Ministry of Education, China; Nanjing University	Mok, VCT (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.; Mok, VCT (corresponding author), Chinese Univ Hong Kong, Therese Pei Fong Chow Res Ctr Prevent Dementia, Hong Kong, Hong Kong, Peoples R China.	vctmok@cuhk.edu.hk	Lam, Bonnie Yin Ka/J-7578-2016; Chan, Yin Yan Anne/B-5093-2016; Lau, Alexander Y/N-2485-2015; Leung, Thomas W. H./O-8567-2015; Shi, Lin/K-5241-2014; liu, wen/HGE-3071-2022; Mok, Vincent/N-6421-2015; Leung, Thomas W/AAU-6475-2021; Wong, Vincent WS/K-3864-2014; Au, Chi Lisa/B-4218-2017; Wong, Ka Sing Lawrence/N-3434-2015; Wong, Adrian/K-4859-2014; Chu, Winnie CW/F-8449-2014	Lam, Bonnie Yin Ka/0000-0002-1656-2433; Lau, Alexander Y/0000-0002-5933-9290; Shi, Lin/0000-0003-2318-4669; Mok, Vincent/0000-0002-8102-8835; Leung, Thomas W/0000-0001-8193-0709; Wong, Vincent WS/0000-0003-2215-9410; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Wong, Adrian/0000-0002-7859-3956; Chu, Winnie CW/0000-0003-4962-4132	Health and Health Services Research Fund of the Food and Health Bureau [HHSRF 0708041]; Hong Kong Special Administrative Region; Therese Pei Fong Chow Research Centre for Prevention of Dementia; Neurology Research Fund of the Chinese University of Hong Kong	Health and Health Services Research Fund of the Food and Health Bureau; Hong Kong Special Administrative Region; Therese Pei Fong Chow Research Centre for Prevention of Dementia; Neurology Research Fund of the Chinese University of Hong Kong	This work was supported by Health and Health Services Research Fund (HHSRF 0708041) of the Food and Health Bureau, Hong Kong Special Administrative Region, The Therese Pei Fong Chow Research Centre for Prevention of Dementia and the Neurology Research Fund of the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Barker-Collo SL, 2007, ARCH CLIN NEUROPSYCH, V22, P519, DOI 10.1016/j.acn.2007.03.002; Brazzelli M, 2014, ANN NEUROL, V75, P67, DOI 10.1002/ana.24026; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; CASTILLO CS, 1993, J NERV MENT DIS, V181, P100, DOI 10.1097/00005053-199302000-00005; Chemerinski E, 2000, PSYCHOSOMATICS, V41, P5, DOI 10.1016/S0033-3182(00)71168-6; Cheng ST, 2012, INT PSYCHOGERIATR, V24, P1465, DOI 10.1017/S1041610212000609; Chiu H., 1994, HONG KONG J PSYCH S2, V4, P25; Chiu Pai-Yi, 2007, Acta Neurol Taiwan, V16, P86; de Groot JC, 2000, ANN NEUROL, V47, P145; Duara R, 2008, NEUROLOGY, V71, P1986, DOI 10.1212/01.wnl.0000336925.79704.9f; Geda YE, 2008, ARCH GEN PSYCHIAT, V65, P1193, DOI 10.1001/archpsyc.65.10.1193; Gupta M, 2013, ANN INDIAN ACAD NEUR, V16, P599, DOI 10.4103/0972-2327.120488; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hackett ML, 2014, LANCET NEUROL, V13, P525, DOI [10.1016/s1474-4422(14)70016-X, 10.1016/S1474-4422(14)70016-X]; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kim HJ, 2013, NEUROBIOL AGING, V34, P1913, DOI 10.1016/j.neurobiolaging.2013.01.002; Leung VPY, 2001, INT J GERIATR PSYCH, V16, P789, DOI 10.1002/gps.427.abs; Liu WY, 2015, STROKE, V46, P3074, DOI 10.1161/STROKEAHA.115.010449; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mayer LS, 2006, INT J GERIATR PSYCH, V21, P930, DOI 10.1002/gps.1583; Mok V, 2010, J NEUROL SCI, V290, P135, DOI 10.1016/j.jns.2009.12.014; Nys GMS, 2005, J NEUROL SCI, V228, P27, DOI 10.1016/j.jns.2004.09.031; O'Brien JT, 2006, AM J GERIAT PSYCHIAT, V14, P834, DOI 10.1097/01.JGP.0000214558.63358.94; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Peters ME, 2012, AM J GERIAT PSYCHIAT, V20, P416, DOI 10.1097/JGP.0b013e318211057d; Prabhakaran S, 2011, ARCH NEUROL-CHICAGO, V68, P85, DOI 10.1001/archneurol.2010.320; ROBINSON RG, 1988, STROKE, V19, P125, DOI 10.1161/01.STR.19.1.125; Rosen HJ, 2006, NEUROLOGY, V67, P1752, DOI 10.1212/01.wnl.0000247630.29222.34; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Samus QM, 2006, J GERONTOL B-PSYCHOL, V61, pP311, DOI 10.1093/geronb/61.5.P311; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2009, J INT NEUROPSYCH SOC, V15, P62, DOI 10.1017/S1355617708090061; Tang WK, 2009, J NEUROL; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Vataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925; VICTOROFF J, 1994, NEUROLOGY, V44, P2267, DOI 10.1212/WNL.44.12.2267; Xiong Y, 2011, EUR J NEUROL, V18, P744, DOI 10.1111/j.1468-1331.2010.03272.x; Yang J, 2015, ALZHEIMERS DEMENT, V11, P16, DOI 10.1016/j.jalz.2014.01.003	41	19	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162846	10.1371/journal.pone.0162846	http://dx.doi.org/10.1371/journal.pone.0162846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632159	Green Submitted, gold, Green Published			2022-12-26	WOS:000383706900085
J	Wong, RG; Wu, JR; Gloor, GB				Wong, Ruth G.; Wu, Jia R.; Gloor, Gregory B.			Expanding the UniFrac Toolbox	PLOS ONE			English	Article							RNA GENE DATABASE; DIVERSITY	The UniFrac distance metric is often used to separate groups in microbiome analysis, but requires a constant sequencing depth to work properly. Here we demonstrate that unweighted UniFrac is highly sensitive to rarefaction instance and to sequencing depth in uniform data sets with no clear structure or separation between groups. We show that this arises because of subcompositional effects. We introduce information UniFrac and ratio UniFrac, two new weightings that are not as sensitive to rarefaction and allow greater separation of outliers than classic unweighted and weighted UniFrac. With this expansion of the UniFrac toolbox, we hope to empower researchers to extract more varied information from their data.	[Wong, Ruth G.; Wu, Jia R.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Western University (University of Western Ontario)	Gloor, GB (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	ggloor@uwo.ca	Gloor, Greg B/D-1671-2013	Gloor, Gregory/0000-0001-5803-3380	National Research Council of Canada [RGPIN-2015-03878]; Canadian Institutes of Health Research [MOP123459]	National Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Discovery Grant from the National Research Council of Canada RGPIN-2015-03878 and Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca, MOP123459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; BEALS EW, 1984, ADV ECOL RES, V14, P1, DOI 10.1016/S0065-2504(08)60168-3; Callahan BJ, 2015, BIORXIV; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P8795, DOI 10.1128/AEM.05491-11; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egozcue J. J., 2011, P 4 INT WORKSH COMP, P1; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Lovell D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004075; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Oksanen J., 2007, COMMUN ECOL PACK, P631; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Simberloff D., 1978, BIOLOGICAL DATA WATE, P150; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Urbaniak C, 2016, MICROBIOME, V4, DOI 10.1186/s40168-015-0145-y; Wong RG, 2016, UNIFRAC WORKSH; Wong RG, 2016, SCRIPTS GENERATING P; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	42	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161196	10.1371/journal.pone.0161196	http://dx.doi.org/10.1371/journal.pone.0161196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632205	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900016
J	Barranco, I; Tvarijonaviciute, A; Perez-Patino, C; Vicente-Carrillo, A; Parrilla, I; Ceron, JJ; Martinez, EA; Rodriguez-Martinez, H; Roca, J				Barranco, Isabel; Tvarijonaviciute, Asta; Perez-Patino, Cristina; Vicente-Carrillo, Alejandro; Parrilla, Inmaculada; Ceron, Jose J.; Martinez, Emilio A.; Rodriguez-Martinez, Heriberto; Roca, Jordi			Glutathione Peroxidase 5 Is Expressed by the Entire Pig Male Genital Tract and Once in the Seminal Plasma Contributes to Sperm Survival and In Vivo Fertility	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; BOAR SPERM; OXIDATIVE STRESS; MOUSE EPIDIDYMIS; SPERMATOZOA; GPX5; INTEGRITY; QUALITY; SEMEN	Glutathione peroxidase-5 (GPX5) is an H2O2-scavenging enzyme identified in boar seminal plasma (SP). This study attempted to clarify its origin and role on sperm survival and fertility after artificial insemination (AI). GPX5 was expressed (Western blot and immunocytochemistry using a rabbit primary polyclonal antibody) in testes, epididymis and accessory sex glands (6 boars). SP-GPX5 concentration differed among boars (11 boars, P < 0.001), among ejaculates within boar (44 ejaculates, P < 0.001) and among portions within ejaculate (15 ejaculates). The first 10 mL of the spermrich fraction (SRF, sperm-peak portion) had a significantly lower concentration (8.87 +/- 0.78 ng/mL) than the rest of the SRF and the post-SRF (11.66 +/- 0.79 and 12.37 +/- 0.79 ng/mL, respectively, P < 0.005). Spermmotility of liquid-stored semen AI-doses (n = 44, at 15-17 degrees C during 72h) declined faster in AI-doses with low concentrations of SP-GPX5 compared to those with high-levels. Boars (n = 11) with high SP-GPX5 showed higher farrowing rates and litter sizes than those with low SP-GPX5 (a total of 5,275 inseminated sows). In sum, GPX5 is widely expressed in the boar genital tract and its variable presence in SP shows a positive relationship with sperm quality and fertility outcomes of liquid-stored semen AI-doses.	[Barranco, Isabel; Tvarijonaviciute, Asta; Perez-Patino, Cristina; Parrilla, Inmaculada; Ceron, Jose J.; Martinez, Emilio A.; Roca, Jordi] Univ Murcia, Fac Vet Sci, Dept Med & Anim Surg, Murcia, Spain; [Vicente-Carrillo, Alejandro; Rodriguez-Martinez, Heriberto] Linkoping Univ, Dept Clin & Expt Med IKE, Linkoping, Sweden	University of Murcia; Linkoping University	Roca, J (corresponding author), Univ Murcia, Fac Vet Sci, Dept Med & Anim Surg, Murcia, Spain.	roca@um.es	Barranco, Isabel/AAA-5368-2020; Martinez, Emilio A/I-1901-2015; Parrilla, Inmaculada/I-1045-2015; Rodriguez, Heriberto/G-2675-2012; Rodriguez-Martinez, Heriberto/AAG-4076-2020; Tvarijonaviciute, Asta/U-4303-2017; Ceron, Jose J/H-9043-2015	Barranco, Isabel/0000-0001-9873-814X; Martinez, Emilio A/0000-0003-1260-9721; Rodriguez, Heriberto/0000-0002-5194-2124; Rodriguez-Martinez, Heriberto/0000-0002-5194-2124; Tvarijonaviciute, Asta/0000-0002-5323-5001; Ceron, Jose J/0000-0002-8654-1793; Parrilla, Inmaculada/0000-0002-5121-758X; Vicente Carrillo, Alejandro/0000-0002-0256-1958	Ministerio de Economia y Competitividad Madrid (Spain) [AGL2012-39903, AGL2015-68738-R]; Seneca Foundation Murcia (Spain) [19892/GERM/15]; Swedish Research Council (VR) [521-2011-6353]; Swedish Research Council Formas [221-2011-512]; Research Council in Southeast Sweden (FORSS), Sweden [378091/312971]; Ministerio de Educacion, Cultura y Deporte, Spain; Fundacion Seneca, Murcia, Spain	Ministerio de Economia y Competitividad Madrid (Spain); Seneca Foundation Murcia (Spain)(Fundacion Seneca); Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Research Council in Southeast Sweden (FORSS), Sweden; Ministerio de Educacion, Cultura y Deporte, Spain; Fundacion Seneca, Murcia, Spain(Fundacion Seneca)	This work is supported by: Ministerio de Economia y Competitividad (AGL2012-39903, AGL2015-68738-R) Madrid (Spain); Seneca Foundation (19892/GERM/15) Murcia (Spain); The Swedish Research Council (VR, 521-2011-6353); The Swedish Research Council Formas (221-2011-512); The Research Council in Southeast Sweden (FORSS, 378091/312971), Sweden; Ministerio de Educacion, Cultura y Deporte, Spain (IB); and Fundacion Seneca, Murcia, Spain (CP-P).	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Barranco I, 2015, ANDROLOGY-US, V3, P315, DOI 10.1111/andr.309; Barranco I, 2015, SCI REP-UK, V5, DOI 10.1038/srep18538; Boe-Hansen GB, 2008, THERIOGENOLOGY, V69, P728, DOI 10.1016/j.theriogenology.2007.12.004; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Broekhuijse MLWJ, 2012, J ANIM SCI, V90, P4327, DOI 10.2527/jas.2012-5040; Chabory E, 2010, J ANIM SCI, V88, P1321, DOI 10.2527/jas.2009-2583; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Drevet JR, 2006, MOL CELL ENDOCRINOL, V250, P70, DOI 10.1016/j.mce.2005.12.027; Fraga CG, 2014, BBA-GEN SUBJECTS, V1840, P931, DOI 10.1016/j.bbagen.2013.06.030; Gharagozloo P, 2016, HUM REPROD, V31, P252, DOI 10.1093/humrep/dev302; Grignard E, 2005, THERIOGENOLOGY, V64, P1016, DOI 10.1016/j.theriogenology.2005.01.008; Guthrie HD, 2006, J ANIM SCI, V84, P2089, DOI 10.2527/jas.2005-766; Jelezarsky L, 2008, THERIOGENOLOGY, V69, P139, DOI 10.1016/j.theriogenology.2007.08.016; Juyena NS, 2012, J ANDROL, V33, P536, DOI 10.2164/jandrol.110.012583; Moreno SG, 2003, BIOL CHEM, V384, P635, DOI 10.1515/BC.2003.070; Noblanc A, 2011, J ANDROL, V32, P641, DOI 10.2164/jandrol.110.012823; Novak S, 2010, J ANDROL, V31, P188, DOI 10.2164/jandrol.109.007583; Okamura N, 1997, BBA-GEN SUBJECTS, V1336, P99, DOI 10.1016/S0304-4165(97)00016-0; Popwell JM, 2004, ANIM REPROD SCI, V81, P97, DOI 10.1016/j.anireprosci.2003.08.007; Radomil L, 2011, REPROD DOMEST ANIM, V46, P39, DOI 10.1111/j.1439-0531.2011.01865.x; Rejraji H, 2002, MOL REPROD DEV, V63, P96, DOI 10.1002/mrd.10136; Roca J, 2016, THERIOGENOLOGY, V86, P187, DOI 10.1016/j.theriogenology.2015.11.026; Roca J, 2016, ANIM REPROD SCI, V169, P24, DOI 10.1016/j.anireprosci.2016.02.028; Rodriguez-Martinez H, 2008, THERIOGENOLOGY, V70, P1242, DOI 10.1016/j.theriogenology.2008.06.007; Rodriguez-Martinez H, 2011, AM J REPROD IMMUNOL, V66, P11, DOI 10.1111/j.1600-0897.2011.01033.x; Tvrda E, 2011, ACTA VET HUNG, V59, P465, DOI 10.1556/AVet.2011.034; Vernet P, 1997, MOL REPROD DEV, V47, P87, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;87::AID-MRD12&gt;3.0.CO;2-X; Vicente-Carrillo A, 2016, MOL REPROD DEV, V83, P724, DOI 10.1002/mrd.22675; Vilagran I, 2015, ANDROLOGY-US, V3, P345, DOI 10.1111/andr.12009; Vilagran I, 2016, ANIM REPROD SCI, V165, P22, DOI 10.1016/j.anireprosci.2015.12.001; Williams K, 1998, MOL HUM REPROD, V4, P841, DOI 10.1093/molehr/4.9.841; Zhang T, 2008, REPROD FERT DEVELOP, V20, P615, DOI 10.1071/RD08008	34	31	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162958	10.1371/journal.pone.0162958	http://dx.doi.org/10.1371/journal.pone.0162958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627110	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600068
J	Rengier, F; Worz, S; Melzig, C; Ley, S; Fink, C; Benjamin, N; Partovi, S; von Tengg-Kobligk, H; Rohr, K; Kauczor, HU; Grunig, E				Rengier, Fabian; Woerz, Stefan; Melzig, Claudius; Ley, Sebastian; Fink, Christian; Benjamin, Nicola; Partovi, Sasan; von Tengg-Kobligk, Hendrik; Rohr, Karl; Kauczor, Hans-Ulrich; Gruenig, Ekkehard			Automated 3D Volumetry of the Pulmonary Arteries based on Magnetic Resonance Angiography Has Potential for Predicting Pulmonary Hypertension	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; QUANTIFICATION; ECHOCARDIOGRAPHY; HEMODYNAMICS; SEGMENTATION; DIAGNOSIS; UTILITY	Purpose To demonstrate feasibility of automated 3D volumetry of central pulmonary arteries based on magnetic resonance angiography (MRA), to assess pulmonary artery volumes in patients with pulmonary hypertension compared to healthy controls, and to investigate the potential of the technique for predicting pulmonary hypertension. Methods MRA of pulmonary arteries was acquired at 1.5T in 20 patients with pulmonary arterial hypertension and 21 healthy normotensive controls. 3D model-based image analysis software was used for automated segmentation of main, right and left pulmonary arteries (MPA, RPA and LPA). Volumes indexed to vessel length and mean, minimum and maximum diameters along the entire vessel course were assessed and corrected for body surface area (BSA). For comparison, diameters were also manually measured on axial reconstructions and double oblique multiplanar reformations. Analyses were performed by two cardiovascular radiologists, and by one radiologist again after 6 months. Results Mean volumes of MPA, RPA and LPA for patients/controls were 5508 +/- 1236/3438 +/- 749, 3522 +/- 934/1664 +/- 468 and 3093 +/- 692/1812 +/- 474 mu l/(cm length x m(2) BSA) (all p<0.001). Mean, minimum and maximum diameters along the entire vessel course were also significantly increased in patients compared to controls (all p<0.001). Intra-and interobserver agreement were excellent for both volume and diameter measurements using 3D segmentation (intraclass correlation coefficients 0.971-0.999, p<0.001). Area under the curve for predicting pulmonary hypertension using volume was 0.998 (95% confidence interval 0.990-1.0, p<0.001), compared to 0.967 using manually measured MPA diameter (95% confidence interval 0.910-1.0, p<0.001). Conclusions Automated MRA-based 3D volumetry of central pulmonary arteries is feasible and demonstrated significantly increased volumes and diameters in patients with pulmonary arterial hypertension compared to healthy controls. Pulmonary artery volume may serve as a superior predictor for pulmonary hypertension compared to manual measurements on axial images but verification in a larger study population is warranted.	[Rengier, Fabian; Melzig, Claudius; von Tengg-Kobligk, Hendrik; Kauczor, Hans-Ulrich] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Rengier, Fabian; Melzig, Claudius; Benjamin, Nicola; Kauczor, Hans-Ulrich; Gruenig, Ekkehard] Heidelberg Univ, TLRC, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Rengier, Fabian; Melzig, Claudius; Benjamin, Nicola; Kauczor, Hans-Ulrich; Gruenig, Ekkehard] Heidelberg Univ, German Ctr Lung Res DZL, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Rengier, Fabian; von Tengg-Kobligk, Hendrik; Kauczor, Hans-Ulrich] German Canc Res Ctr, Dept Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Woerz, Stefan; Rohr, Karl] Heidelberg Univ, BIOQUANT, IPMB, Dept Bioinformat & Funct Genom,Biomed Comp Vis Gr, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Woerz, Stefan; Rohr, Karl] German Canc Res Ctr, Neuenheimer Feld 110, D-69120 Heidelberg, Germany; [Ley, Sebastian] Radiol Isar Klinikum, Sonnenstr 22-24, D-80331 Munich, Germany; [Ley, Sebastian] Ludwig Maximilians Univ Hosp Munich, Clin Radiol, Marchioninistr 15, D-81377 Munich, Germany; [Fink, Christian] Univ Med Ctr Mannheim, Inst Clin Radiol & Nucl Med, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany; [Fink, Christian] AKH Celle, Dept Radiol, Siemenspl 4, D-29223 Celle, Germany; [Partovi, Sasan] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Dept Radiol, 11100 Euclid Ave, Cleveland, OH USA; [von Tengg-Kobligk, Hendrik] Inselspital Bern, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Freiburgstr 10, CH-3010 Bern, Switzerland; [Gruenig, Ekkehard] Univ Heidelberg Hosp, Thoraxklin, Ctr Pulm Hypertens, Rontgenstr 1, D-69126 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; Ruprecht Karls University Heidelberg; Case Western Reserve University; Case Western Reserve University Hospital; University of Bern; University Hospital of Bern; Ruprecht Karls University Heidelberg	Rengier, F (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.; Rengier, F (corresponding author), Heidelberg Univ, TLRC, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.; Rengier, F (corresponding author), Heidelberg Univ, German Ctr Lung Res DZL, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.; Rengier, F (corresponding author), German Canc Res Ctr, Dept Radiol, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	fabian.rengier@web.de	Kauczor, HU/AAX-6033-2021; von Tengg-Kobligk, Hendrik/N-6792-2019; Ley, Sebastian/I-3426-2013; Benjamin, Nicola/AAJ-4360-2021; Kauczor, Hans-Ulrich/AAU-5955-2021	von Tengg-Kobligk, Hendrik/0000-0003-3207-3223; Ley, Sebastian/0000-0001-9269-2670; Rengier, Fabian/0000-0001-9424-4652	German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF) [82DZL00401, 82DZL00402, 82DZL00404]; German Research Foundation (Deutsche Forschungsgemeinschaft); University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg)	German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg)	This study was supported by the German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF; 82DZL00401, 82DZL00402, 82DZL00404). We also acknowledge financial support by the German Research Foundation (Deutsche Forschungsgemeinschaft) and the University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the German Center for Lung Research (DZL) through grants from the German Ministry for Education and Science (BMBF; 82DZL00401, 82DZL00402, 82DZL00404). We also acknowledge financial support by the German Research Foundation (Deutsche Forschungsgemeinschaft) and the University of Heidelberg (Ruprecht-Karls-Universitat Heidelberg) within the funding programme Open Access Publishing.	Biesdorf A, 2012, MED IMAGE ANAL, V16, P1187, DOI 10.1016/j.media.2012.05.010; Corson N, 2014, ACAD RADIOL, V21, P523, DOI 10.1016/j.acra.2013.12.015; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Du Bois D, 1989, Nutrition, V5, P303; Froelich JJ, 2008, EUR J RADIOL, V67, P466, DOI 10.1016/j.ejrad.2007.08.022; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gerges M, 2015, CAN J CARDIOL, V31, P521, DOI 10.1016/j.cjca.2015.01.019; KURIYAMA K, 1984, INVEST RADIOL, V19, P16, DOI 10.1097/00004424-198401000-00005; Linguraru MG, 2014, PULM CIRC, V4, P319, DOI 10.1086/675997; Perez-Enguix D, 2007, TRANSPL P, V39, P2405, DOI 10.1016/j.transproceed.2007.07.055; Rajaram S, 2012, J RHEUMATOL, V39, P1265, DOI 10.3899/jrheum.110987; Shen YC, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000256; Sztrymf B, 2010, EUR RESPIR J, V35, P1286, DOI 10.1183/09031936.00070209; Tan RT, 1998, CHEST, V113, P1250, DOI 10.1378/chest.113.5.1250; Truong QA, 2012, CIRC-CARDIOVASC IMAG, V5, P147, DOI 10.1161/CIRCIMAGING.111.968610; Vachiery JL, 2012, EUR RESPIR REV, V21, P313, DOI 10.1183/09059180.00005412; Wang B, 2013, EUR REV MED PHARMACO, V17, P923; Worz S, 2007, IEEE T IMAGE PROCESS, V16, P1994, DOI 10.1109/TIP.2007.901204; Worz S, 2010, IEEE T BIO-MED ENG, V57, P2359, DOI 10.1109/TBME.2010.2053539	19	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162516	10.1371/journal.pone.0162516	http://dx.doi.org/10.1371/journal.pone.0162516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626802	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600039
J	Slattery, ML; Herrick, JS; Pellatt, AJ; Wolff, RK; Mullany, LE				Slattery, Martha L.; Herrick, Jennifer S.; Pellatt, Andrew J.; Wolff, Roger K.; Mullany, Lila E.			Telomere Length, TERT, and miRNA Expression	PLOS ONE			English	Article							B-DEPENDENT TRANSCRIPTION; COLON-CANCER; CELL LYMPHOMA; RISK; DEREGULATION; MECHANISMS; MICRORNAS	It has been proposed that miRNAs are involved in the control of telomeres. We test that hypothesis by examining the association between miRNAs and telomere length (TL). Additionally, we evaluate if genetic variation in telomerase reverse transcriptase (TERT) is associated with miRNA expression levels. We use data from a population-based study of colorectal cancer (CRC), where we have previously shown associations between TL and TERT and CRC, to test associations between TL and miRNA expression and TERT and miRNA expression. To gain insight into functions of miRNAs associated with TERT we tested linear associations between miRNAs and their targeted gene mRNAs. An Agilent platformthat contained information on over 2000 miRNAs was used. TL was measured using a multiplexed quantitative PCR (qPCR). RNAseq was used to assess gene expression. Our sample consisted of 1152 individuals with SNP data and miRNA expression data; 363 individuals with both TL and miRNA; and 148 individuals with miRNA and mRNA data. Thirty-three miRNAs were directly associated with TL after adjusting for age and sex (false discovery rate (FDR) of 0.05). TERT rs2736118 was associated with differences in miRNA expression between carcinoma and normal colonic mucosa for 75 miRNAs (FDR < 0.05). Genes regulated by these miRNAs, as indicated by mRNA/miRNA associations, were associated with major signaling pathways beyond their TL-related functions, including PTEN, and PI3K/AKT signaling. Our data support a direct association between miRNAs and TL; differences in miRNA expression levels by TERT genotype were observed. Based on miRNA and targeted mRNA associations our data suggest that TERT is involved in non-TL-related functions by acting through altered miRNA expression.	[Slattery, Martha L.; Herrick, Jennifer S.; Pellatt, Andrew J.; Wolff, Roger K.; Mullany, Lila E.] Univ Utah, Dept Med, 383 Colorow, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Slattery, ML (corresponding author), Univ Utah, Dept Med, 383 Colorow, Salt Lake City, UT 84108 USA.	Marty.Slattery@hsc.utah.edu		Herrick, Jennifer/0000-0001-9257-8843; Pellatt, Andrew/0000-0002-0127-9790	National Cancer Institute at the National Institutes of Health [CA163683, CA48998, CA61757]; NATIONAL CANCER INSTITUTE [R01CA163683] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI grants CA163683, CA48998 and CA61757 from the National Cancer Institute at the National Institutes of Health. NCI was not involved in any of the work described in this manuscript.	[Anonymous], 2014, QIAGENS INGENUITY PA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boardman LA, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2014.3; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonifacio LN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012519; Cao JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128829; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Cottliar ASH, 2009, EUR J HAEMATOL, V83, P433, DOI 10.1111/j.1600-0609.2009.01313.x; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Ding DQ, 2013, FASEB J, V27, P4375, DOI 10.1096/fj.13-230904; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; Hosnijeh FS, 2014, INT J CANCER, V135, P2910, DOI 10.1002/ijc.28934; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Jebaraj BMC, 2013, BLOOD, V121, P1184, DOI 10.1182/blood-2012-08-452649; Ladetto M, 2004, BLOOD, V103, P4644, DOI 10.1182/blood-2003-12-4412; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lassmann T, 2015, INT J MOL SCI, V16, P1192, DOI 10.3390/ijms16011192; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Li YH, 2014, CANCER RES, V74, P1639, DOI 10.1158/0008-5472.CAN-13-3568; Nabetani A, 2011, J BIOCHEM, V149, P5, DOI 10.1093/jb/mvq119; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Pellatt AJ, 2013, MOL CARCINOGEN, V52, P507, DOI 10.1002/mc.21885; Pellatt AJ, 2013, GENE CHROMOSOME CANC, V52, P595, DOI 10.1002/gcc.22056; Pellatt AJ, 2012, INT J MOL EPIDEMIOL, V3, P184; Pellatt DF, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.11; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Robaina MC, 2015, EXP MOL PATHOL, V98, P200, DOI 10.1016/j.yexmp.2015.03.006; Sestito Rosanna, 2014, RNA DIS; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Slattery ML, 2016, CARCINOGENESIS, V37, P245, DOI 10.1093/carcin/bgv249; Slattery ML, 2015, GENE CHROMOSOME CANC, V54, P527, DOI 10.1002/gcc.22265; Slattery ML, 2015, INT J CANCER, V137, P428, DOI 10.1002/ijc.29384; Slattery ML, 1997, CANCER RES, V57, P75; Uziel O, 2015, GENOMICS, V105, P5, DOI 10.1016/j.ygeno.2014.10.013	37	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162077	10.1371/journal.pone.0162077	http://dx.doi.org/10.1371/journal.pone.0162077			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627813	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600018
J	Hsiao, SH; Chiou, KR				Hsiao, Shih-Hung; Chiou, Kuan-Rau			Diastolic Heart Failure Predicted by Left Atrial Expansion Index in Patients with Severe Diastolic Dysfunction	PLOS ONE			English	Article							VENTRICULAR FILLING PRESSURE; PRESERVED EJECTION FRACTION; TISSUE DOPPLER; MYOCARDIAL-INFARCTION; FIBRILLATION; MORTALITY; VOLUME; ECHOCARDIOGRAPHY; CATHETERIZATION; COMMUNITY	Background Left atrial (LA) echocardiographic parameters are increasingly used to predict clinically relevant cardiovascular events. The study aims to evaluate the LA expansion index (LAEI) for predicting diastolic heart failure (HF) in patients with severe left ventricular (LV) diastolic dysfunction. Methods This prospective study enrolled 162 patients (65% male) with preserved LV systolic function and severe diastolic dysfunction (132 grade 2 patients, 30 grade 3 patients). All patients had sinus rhythm at enrollment. The LAEI was calculated as (Vol(max) - Vol(min)) x 100% / Vol(min), where Vol(max) was defined as maximal LA volume and Vol(min) was defined as minimal volume. The endpoint was hospitalization for HF withp reserved LV ejection fraction (HFpEF). Results The median follow-up duration was 2.9 years. Fifty-four patients had cardiovascular events, including 41 diastolic and 8 systolic HF hospitalizations. In these 54 patients, 13 in-hospital deaths and 5 sudden out-of-hospital deaths occurred. Multivariate analyses revealed that HFpEF was associated with LAEI. and atrial fibrillation during follow-up. For predicting HFpEF, the LAEI had a hazard ratio of 1.197per 10% decrease. In patients who had HFpEF events, the LAEI significantly (P< 0.0001) decreased from 69 +/- 18% to 39 +/- 11% during hospitalization. Although the LAEI improved during follow-up (53 +/- 13%), it did not return to baseline. Conclusions The LAEI predicts HFpEF in patients with severe diastolic dysfunction; it worsens during HFpEF events and partially recovers during followup.	[Hsiao, Shih-Hung; Chiou, Kuan-Rau] I Shou Univ, E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Hsiao, Shih-Hung; Chiou, Kuan-Rau] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chiou, Kuan-Rau] Kaohsiung Vet Gen Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan	E-Da Hospital; I Shou University; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital	Chiou, KR (corresponding author), I Shou Univ, E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.; Chiou, KR (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chiou, KR (corresponding author), Kaohsiung Vet Gen Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan.	krchiou@hotmail.com			Ministry of Science and Technology [102-2628-B-650-002-MY3]; Kaohsiung Veterans General Hospital [VGHKS102-010]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Veterans General Hospital	This work was funded by Ministry of Science and Technology (102-2628-B-650-002-MY3) and Kaohsiung Veterans General Hospital (VGHKS102-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlJaroudi W, 2012, CIRCULATION, V125, P782, DOI 10.1161/CIRCULATIONAHA.111.066423; [Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hsiao SH, 2013, CIRC J, V77, P2712, DOI 10.1253/circj.CJ-13-0463; Hsiao SH, 2013, EUR J HEART FAIL, V15, P1245, DOI 10.1093/eurjhf/hft087; Hsiao SH, 2012, AM J CARDIOL, V109, P748, DOI 10.1016/j.amjcard.2011.10.040; Hsiao SH, 2011, CIRC J, V75, P1942, DOI 10.1253/circj.CJ-11-0033; Hsiao SH, 2011, AM J CARDIOL, V107, P1117, DOI 10.1016/j.amjcard.2010.12.008; Hsiao SH, 2010, AM J CARDIOL, V105, P709, DOI 10.1016/j.amjcard.2009.10.052; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T; Liu JY, 2003, AM J CARDIOL, V91, P550, DOI 10.1016/S0002-9149(02)03304-0; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43; Ommen SR, 2000, CIRCULATION, V102, P1788; Ommen SR, 2000, MAYO CLIN PROC, V75, P24, DOI 10.4065/75.1.24; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Park HJ, 2011, CLIN CARDIOL, V34, P124, DOI 10.1002/clc.20850; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rivas-Gotz C, 2003, AM J CARDIOL, V91, P780, DOI 10.1016/S0002-9149(02)03433-1; Ujino K, 2006, AM J CARDIOL, V98, P1185, DOI 10.1016/j.amjcard.2006.05.040; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Wang WH, 2012, ANN THORAC SURG, V93, P796, DOI 10.1016/j.athoracsur.2011.11.007; Whalley GA, 2002, J AM COLL CARDIOL, V39, P1787, DOI 10.1016/S0735-1097(02)01868-5; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zakeri R, 2013, CIRCULATION, V128, P1085, DOI 10.1161/CIRCULATIONAHA.113.001475	32	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162599	10.1371/journal.pone.0162599	http://dx.doi.org/10.1371/journal.pone.0162599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622475	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000043
J	Miller, JRB; Jhala, YV; Schmitz, OJ				Miller, Jennifer R. B.; Jhala, Yadvendradev V.; Schmitz, Oswald J.			Human Perceptions Mirror Realities of Carnivore Attack Risk for Livestock: Implications for Mitigating Human-Carnivore Conflict	PLOS ONE			English	Article							TIGER RESERVE; SNOW LEOPARDS; CENTRAL INDIA; CONSERVATION; DEPREDATION; PREDATION; PATTERNS; WILDLIFE; WOLVES; FEAR	Human-carnivore conflict is challenging to quantify because it is shaped by both the realities and people's perceptions of carnivore threats. Whether perceptions align with realities can have implications for conflict mitigation: misalignments can lead to heightened and indiscriminant persecution of carnivores whereas alignments can offer deeper insights into human-carnivore interactions. We applied a landscape-scale spatial analysis of livestock killed by tigers and leopards in India to model and map observed attack risk, and surveyed owners of livestock killed by tigers and leopards for their rankings of threats across habitats to map perceived attack risk. Observed tiger risk to livestock was greatest near dense forests and at moderate distances from human activity while leopard risk was greatest near open vegetation. People accurately perceived spatial differences between tiger and leopard hunting patterns, expected greater threat in areas with high values of observed risk for both carnivores. Owners' perception of threats largely did not depend on environmental conditions surrounding their village (spatial location, dominant land-use or observed carnivore risk). Surveys revealed that owners who previously lost livestock to carnivores used more livestock protection methods than those who had no prior losses, and that owners who had recently lost livestock for the first time expressed greater interest in changing their protection methods than those who experienced prior losses. Our findings suggest that in systems where realities and perceptions of carnivore risk align, conservation programs and policies can optimize conservation outcomes by (1) improving the effectiveness of livestock protection methods and (2) working with owners who have recently lost livestock and are most willing to invest effort in adapting protection strategies to mitigate human-carnivore conflict.	[Miller, Jennifer R. B.; Schmitz, Oswald J.] Yale Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Miller, Jennifer R. B.; Jhala, Yadvendradev V.] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Miller, Jennifer R. B.] Panthera, New York, NY 10018 USA; [Miller, Jennifer R. B.] Univ Cape Town, Human Wildlife Inst, Dept Biol Sci, Private Bag X3, ZA-7701 Cape Town, South Africa; [Miller, Jennifer R. B.] Cornell Univ, Dept Nat Resources, 111 Fernow Hall, Ithaca, NY 14853 USA	Yale University; Wildlife Institute of India; University of Cape Town; Cornell University	Miller, JRB (corresponding author), Yale Sch Forestry & Environm Studies, New Haven, CT 06511 USA.; Miller, JRB (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.; Miller, JRB (corresponding author), Panthera, New York, NY 10018 USA.; Miller, JRB (corresponding author), Univ Cape Town, Human Wildlife Inst, Dept Biol Sci, Private Bag X3, ZA-7701 Cape Town, South Africa.; Miller, JRB (corresponding author), Cornell Univ, Dept Nat Resources, 111 Fernow Hall, Ithaca, NY 14853 USA.	jmiller@panthera.org	Jhala, Yadvendradev/AAL-9711-2020		American Institute for Indian Studies Junior Research Fellowship; American Philosophical Society Lewis and Clark Fund for Exploration and Field Research; Association of Zoos & Aquariums Conservation Endowment Fund; John Ball Zoo Society Wildlife Conservation Fund; Yale Tropical Resources Institute Fellowship; National Science Foundation Graduate Research Fellowship Program	American Institute for Indian Studies Junior Research Fellowship; American Philosophical Society Lewis and Clark Fund for Exploration and Field Research; Association of Zoos & Aquariums Conservation Endowment Fund; John Ball Zoo Society Wildlife Conservation Fund; Yale Tropical Resources Institute Fellowship; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	JRBM was funded by the American Institute for Indian Studies Junior Research Fellowship, American Philosophical Society Lewis and Clark Fund for Exploration and Field Research, Association of Zoos & Aquariums Conservation Endowment Fund; John Ball Zoo Society Wildlife Conservation Fund; Yale Tropical Resources Institute Fellowship; and National Science Foundation Graduate Research Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Bruskotter JT, 2014, CONSERV LETT, V7, P158, DOI 10.1111/conl.12072; Carter NH, 2012, ORYX, V46, P525, DOI 10.1017/S0030605312000245; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Dhanwatey HS, 2013, ORYX, V47, P221, DOI 10.1017/S0030605311001803; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Jhala Y. V, 2014, SPATIAL POPULATION E; Karanth KK, 2013, ENVIRON MANAGE, V52, P1320, DOI 10.1007/s00267-013-0162-1; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Karanth KU, 2000, J ZOOL, V250, P255; KELLERT SR, 1985, BIOL CONSERV, V31, P167, DOI 10.1016/0006-3207(85)90047-3; Kolowski J, BIOL CONSERV, V128, P529; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Linnell JDC, 2012, TECH ECOL CONSERVAT, P314; Miller JRB, 2016, REG ENVIRON CHANGE, V16, P17, DOI 10.1007/s10113-015-0871-5; Miller JRB, 2015, ECOL EVOL, V5, P1354, DOI 10.1002/ece3.1440; Miller JRB, 2014, J ANIM ECOL, V83, P214, DOI 10.1111/1365-2656.12111; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Negi Chandra Singh, 2005, International Journal of Biodiversity Science & Management, V1, P85; Negi H, 2012, TIGER CONSERVATION P; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Session G., 1987, ENV REV, V11, P105, DOI DOI 10.2307/3984023; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Suryawanshi KR, 2014, CONSERV BIOL, V28, P1657, DOI 10.1111/cobi.12320; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2017, BIOL REV, V92, P248, DOI 10.1111/brv.12227; Woodroffe R., 2005, CONSERV BIOL	34	30	30	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162685	10.1371/journal.pone.0162685	http://dx.doi.org/10.1371/journal.pone.0162685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617831	Green Submitted, Green Published, gold			2022-12-26	WOS:000383653100042
J	van der Lee, DI; Pont, MJ; Falkenburg, JHF; Griffioen, M				van der Lee, Dyantha I.; Pont, Margot J.; Falkenburg, J. H. Frederik; Griffioen, Marieke			The Value of Online Algorithms to Predict T-Cell Ligands Created by Genetic Variants	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; IDENTIFICATION; BINDING; TRANSPLANTATION; IMMUNOGENICITY; ASSOCIATION; NEOEPITOPES; REVEALS; PROTEIN; MHC	Allogeneic stem cell transplantation can be a curative treatment for hematological malignancies. After HLA-matched allogeneic stem cell transplantation, beneficial anti-tumor immunity as well as detrimental side-effects can develop due to donor-derived T-cells recognizing polymorphic peptides that are presented by HLA on patient cells. Polymorphic peptides on patient cells that are recognized by specific T-cells are called minor histocompatibility antigens (MiHA), while the respective peptides in donor cells are allelic variants. MiHA can be identified by reverse strategies in which large sets of peptides are screened for T-cell recognition. In these strategies, selection of peptides by prediction algorithms may be relevant to increase the efficiency of MiHA discovery. We investigated the value of online prediction algorithms for MiHA discovery and determined the in silico characteristics of 68 autosomal HLA class I-restricted MiHA that have been identified as natural ligands by forward strategies in which T-cells from in vivo immune responses after allogeneic stem cell transplantation are used to identify the antigen. Our analysis showed that HLA class I binding was accurately predicted for 87% of MiHA of which a relatively large proportion of peptides had strong binding affinity (56%). Weak binding affinity was also predicted for a considerable number of antigens (31%) and the remaining 13% of MiHA were not predicted as HLA class I binding peptides. Besides prediction for HLA class I binding, none of the other online algorithms significantly contributed to MiHA characterization. Furthermore, we demonstrated that the majority of MiHA do not differ from their allelic variants in in silico characteristics, suggesting that allelic variants can potentially be processed and presented on the cell surface. In conclusion, our analyses revealed the in silico characteristics of 68 HLA class I-restricted MiHA and explored the value of online algorithms to predict T-cell ligands that are created by genetic variants.	[van der Lee, Dyantha I.; Pont, Margot J.; Falkenburg, J. H. Frederik; Griffioen, Marieke] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Pont, Margot J.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Fred Hutchinson Cancer Center	van der Lee, DI (corresponding author), Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands.	d.i.van_der_lee@lumc.nl	van der Lee, Dyantha/Y-2568-2018; Griffioen, Marieke/ABA-1561-2021	van der Lee, Dyantha/0000-0002-0369-3856; Griffioen, Marieke/0000-0002-3001-4441				Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104; Broen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021266; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; Dolstra H, 2002, EUR J IMMUNOL, V32, P2748, DOI 10.1002/1521-4141(2002010)32:10<2748::AID-IMMU2748>3.0.CO;2-T; Duan F, 2014, J EXP MED, V211, P2231, DOI 10.1084/jem.20141308; Falkenburg JHF, 2011, BIOL BLOOD MARROW TR, V17, pS33, DOI 10.1016/j.bbmt.2010.11.009; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fritsch EF, 2014, CANCER IMMUNOL RES, V2, P522, DOI 10.1158/2326-6066.CIR-13-0227; Griffioen M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00100; Hombrink P, 2015, CLIN CANCER RES, V21, P2177, DOI 10.1158/1078-0432.CCR-14-2188; Hombrink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022523; Horowitz M M, 1990, Clin Transpl, P41; Jorgensen KW, 2014, IMMUNOLOGY, V141, P18, DOI 10.1111/imm.12160; Karosiene E, 2012, IMMUNOGENETICS, V64, P177, DOI 10.1007/s00251-011-0579-8; Kawase T, 2008, BLOOD, V111, P3286, DOI 10.1182/blood-2007-10-118950; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Pont MJ, 2016, CLIN CANC RES; Rapin Nicolas, 2010, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1817s88; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Spierings E, 2014, TISSUE ANTIGENS, V84, P347, DOI 10.1111/tan.12445; Stern M, 2014, LEUKEMIA, V28, P2235, DOI 10.1038/leu.2014.145; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; Warren EH, 2012, BLOOD, V120, P2796, DOI 10.1182/blood-2012-04-347286; Wolfel C, 2008, CANCER IMMUNOL IMMUN, V57, P849, DOI 10.1007/s00262-007-0421-1; Zilberberg J, 2015, BIOL BLOOD MARROW TR, V21, P1000, DOI 10.1016/j.bbmt.2014.11.001	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162808	10.1371/journal.pone.0162808	http://dx.doi.org/10.1371/journal.pone.0162808			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618304	Green Submitted, gold, Green Published			2022-12-26	WOS:000383653100055
J	Talamillo, A; Grande, L; Ruiz-Ontanon, P; Velasquez, C; Mollinedo, P; Torices, S; Sanchez-Gomez, P; Aznar, A; Esparis-Ogando, A; Lopez-Lopez, C; Lafita, C; Berciano, MT; Montero, JA; Vazquez-Barquero, A; Segura, V; Villagra, NT; Pandiella, A; Lafarga, M; Leon, J; Martinez-Climent, JA; Sanz-Moreno, V; Fernandez-Luna, JL				Talamillo, A.; Grande, L.; Ruiz-Ontanon, P.; Velasquez, C.; Mollinedo, P.; Torices, S.; Sanchez-Gomez, P.; Aznar, A.; Esparis-Ogando, A.; Lopez-Lopez, C.; Lafita, C.; Berciano, M. T.; Montero, J. A.; Vazquez-Barquero, A.; Segura, V.; Villagra, N. T.; Pandiella, A.; Lafarga, M.; Leon, J.; Martinez-Climent, J. A.; Sanz-Moreno, V.; Fernandez-Luna, J. L.			ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA	ONCOGENE			English	Article							TUMOR-INITIATING CELLS; IN-VIVO; INTRACELLULAR DOMAIN; GENE-EXPRESSION; C-MYC; CANCER GENOMICS; GLIOMA; INVASION; GTPASES; ACTIVATION	Long-term survival remains low for most patients with glioblastoma (GBM), which reveals the need for markers of disease outcome and novel therapeutic targets. We describe that ODZ1 (also known as TENM1), a type II transmembrane protein involved in fetal brain development, plays a crucial role in the invasion of GBM cells. Differentiation of glioblastoma stem-like cells drives the nuclear translocation of an intracellular fragment of ODZ1 through proteolytic cleavage by signal peptide peptidase-like 2a. The intracellular fragment of ODZ1 promotes cytoskeletal remodelling of GBM cells and invasion of the surrounding environment both in vitro and in vivo. Absence of ODZ1 by gene deletion or downregulation of ODZ1 by small interfering RNAs drastically reduces the invasive capacity of GBM cells. This activity is mediated by an ODZ1-triggered transcriptional pathway, through the E-box binding Myc protein, that promotes the expression and activation of Ras homolog family member A (RhoA) and subsequent activation of Rho-associated, coiled-coil containing protein kinase (ROCK). Overexpression of ODZ1 in GBM cells reduced survival of xenografted mice. Consistently, analysis of 122 GBM tumour samples revealed that the number of ODZ1-positive cells inversely correlated with overall and progression-free survival. Our findings establish a novel marker of invading GBM cells and consequently a potential marker of disease progression and a therapeutic target in GBM.	[Talamillo, A.; Grande, L.; Ruiz-Ontanon, P.; Mollinedo, P.; Torices, S.; Fernandez-Luna, J. L.] Hosp Valdecilla IDIVAl, Coll Genetica, Santander, Spain; [Velasquez, C.; Vazquez-Barquero, A.] Hosp Valdecilla IDIVAl, Neurosurg Serv, Santander, Spain; [Sanchez-Gomez, P.] Inst Salud Carlos lll, Unit Neuro Oncol, Madrid, Spain; [Aznar, A.; Segura, V.; Martinez-Climent, J. A.] CIMA, Pamplona, Spain; [Esparis-Ogando, A.] Ctr Investigo Canc, Salamanca, Spain; [Lopez-Lopez, C.] Hosp Valdecilla IDIVAL, Service Oncol Media, Santander, Spain; [Lafita, C.; Leon, J.] IBBTEC, CSIC, Coll Cantabria, Santander, Spain; [Berciano, M. T.; Montero, J. A.; Lafarga, M.] Coll Canatbria, Dept Anatomia & Biol Celular, Santander, Spain; [Villagra, N. T.] IDIVAL, Hosp Valdesilla, Serv Anatomia, Santander, Spain; [Sanz-Moreno, V.] Kings Coll london, Sch Biomed & Hlth Serv, Randall Div Cell & Mol Biophys, London, England; [Fernandez-Luna, J. L.] Hosp Valdecilla IDIVAL, Coll Gentica, 39008 Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of London; King's College London; Hospital Universitario Marques de Valdecilla (HUMV)	Fernandez-Luna, JL (corresponding author), Hosp Valdecilla IDIVAl, Coll Genetica, Santander, Spain.	fluna@humv.es	Leon, Javier/K-4615-2014; Sánchez-Gómez, Pilar/K-8256-2014; Martinez-Climent, Jose A/I-9199-2012; Lafarga, Miguel/K-3733-2014; Esparís-Ogando, Aucena/O-5326-2017; Talamillo, Ana/AAA-4633-2019; Pandiella, Atanasio/O-5180-2014; Velasquez, Carlos/N-6669-2016; Segura, Victor/E-4531-2010; Teran-Villagra, Nuria/P-3016-2016	Sánchez-Gómez, Pilar/0000-0002-0709-4973; Martinez-Climent, Jose A/0000-0002-7938-3950; Esparís-Ogando, Aucena/0000-0003-4550-4192; Talamillo, Ana/0000-0003-3089-7675; Pandiella, Atanasio/0000-0002-4704-8971; Leon, Javier/0000-0001-5803-0112; Berciano, Maria T./0000-0002-8225-6995; LOPEZ LOPEZ, CARLOS/0000-0002-8901-741X; Lafarga, Miguel/0000-0003-3402-1152; Velasquez, Carlos/0000-0002-4443-5888; Lafita Navarro, Maria del Carmen/0000-0002-7266-651X; Segura, Victor/0000-0002-7740-6290; Sanz-Moreno, Victoria/0000-0002-5096-9456; Teran-Villagra, Nuria/0000-0002-3746-455X	Instituto de Salud Carlos III (ISCIII) [PI13/01760, PI12/00775, SAF2014-53526R]; program Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD12/0036/0022, RD12/0036/0027, RD12/0036/0063, RD12/0036/0003, RD12-0036-0033]; Instituto de Investigacion Valdecilla (IDIVAL) grant [APG/03]; Cancer Research UK [C33043/A12065]; Royal Society [RG110591]; Cancer Research UK [12065] Funding Source: researchfish	Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); program Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Instituto de Investigacion Valdecilla (IDIVAL) grant; Cancer Research UK(Cancer Research UK); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK)	This work was supported by the Instituto de Salud Carlos III (ISCIII), grants PI13/01760 (JLF-L), PI12/00775 (PS-G) and SAF2014-53526R (JL), and program Red Tematica de Investigacion Cooperativa en Cancer (RTICC) grants RD12/0036/0022 (JLF-L), RD12/0036/0027 (PS-G), RD12/0036/0063 (JAM-C), RD12/0036/0003 (AP) and RD12-0036-0033 (JL), Instituto de Investigacion Valdecilla (IDIVAL) grant APG/03 to JLF-L, and Cancer Research UK C33043/A12065 and Royal Society RG110591 to VS-M. We thank R. Galli for kindly providing RG1 cell line. We also thank M.E. Fernandez-Valle for helping with magnetic resonance imaging experiments.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Bernard D, 2003, J CLIN INVEST, V112, P1724; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; Danussi C, 2013, CANCER RES, V73, P5140, DOI 10.1158/0008-5472.CAN-13-1168-T; Deng L, 2010, CANCER BIOL THER, V9, P875, DOI 10.4161/cbt.9.11.11634; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grande L, 2012, J BIOL CHEM, V287, P26495, DOI 10.1074/jbc.M112.376319; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Huang Y, 2001, P NATL ACAD SCI USA, V98, P15044, DOI 10.1073/pnas.251547398; Jacquemet G, 2013, J CELL BIOL, V202, P917, DOI 10.1083/jcb.201302041; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin X, 2013, CANCER LETT, V328, P235, DOI 10.1016/j.canlet.2012.09.005; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Lee KG, 2007, CELL CYCLE, V6, P1487; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pozo N, 2013, J CLIN INVEST, V123, P2475, DOI 10.1172/JCI63623; Roussel MF, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014308; Ruiz-Ontanon P, 2013, STEM CELLS, V31, P1075, DOI 10.1002/stem.1349; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Scholer J, 2015, J BIOL CHEM, V290, P8154, DOI 10.1074/jbc.M114.615922; Sherry MM, 2009, STEM CELLS, V27, P2383, DOI 10.1002/stem.185; Shervington A, 2006, MOL CELL BIOCHEM, V283, P1, DOI 10.1007/s11010-006-2495-z; SHINDO H, 1993, ACTA NEUROPATHOL, V86, P345, DOI 10.1007/BF00369446; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Timpson P, 2011, CANCER RES, V71, P747, DOI 10.1158/0008-5472.CAN-10-2267; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tucker RP, 2012, MOL BIOL EVOL, V29, P1019, DOI 10.1093/molbev/msr271; Wang H, 2014, ONCOGENE, V33, P1558, DOI 10.1038/onc.2013.97; Watsuji T, 1997, BIOCHEM BIOPH RES CO, V234, P769, DOI 10.1006/bbrc.1997.6705; Wong SY, 2015, CANCER RES, V75, P1113, DOI 10.1158/0008-5472.CAN-13-3426; Yan B, 2006, NEUROSCI LETT, V407, P124, DOI 10.1016/j.neulet.2006.08.032; Yan K, 2013, CURR OPIN NEUROL, V26, P701, DOI 10.1097/WCO.0000000000000032; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Ying Z, 2013, CANCER RES, V73, P990, DOI 10.1158/0008-5472.CAN-12-2895; Zhang M, 2006, EMBO J, V25, P5284, DOI 10.1038/sj.emboj.7601406; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248; Zhang W, 2014, MOL MED REP, V10, P113, DOI 10.3892/mmr.2014.2152; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	53	27	27	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1733	1744		10.1038/onc.2016.341	http://dx.doi.org/10.1038/onc.2016.341			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27641332	Green Submitted, Green Accepted			2022-12-26	WOS:000397460600012
J	Lalic, J; Marjanovic, MP; Palazzo, L; Perina, D; Sabljic, I; Zaja, R; Colby, T; Plese, B; Halasz, M; Jankevicius, G; Bucca, G; Ahel, M; Matic, I; Cetkovic, H; Luic, M; Mikoc, A; Ahel, I				Lalic, Jasna; Marjanovic, Melanija Posavec; Palazzo, Luca; Perina, Dragutin; Sabljic, Igor; Zaja, Rokoz; Colby, Thomas; Plese, Bruna; Halasz, Mirna; Jankevicius, Gytis; Bucca, Giselda; Ahel, Marijan; Matic, Ivan; Cetkovic, Helena; Luic, Marija; Mikoc, Andreja; Ahel, Ivan			Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATED PROTEINS; DNA-REPAIR; POLY(ADP-RIBOSE); IDENTIFICATION; FAMILY; GENE; DIFFERENTIATION; MECHANISM; RIBOSE; SITE	ADP-ribosylation is a post-translational modification that can alter the physical and chemical properties of target proteins and that controls many important cellular processes. Macrodomains are evolutionarily conserved structural domains that bind ADP-ribose derivatives and are found in proteins with diverse cellular functions. Some proteins from the macrodomain family can hydrolyze ADP-ribosylated substrates and therefore reverse this post-translational modification. Bacteria and Streptomyces, in particular, are known to utilize protein ADP-ribosylation, yet very little is known about their enzymes that synthesize and remove this modification. We have determined the crystal structure and characterized, both biochemically and functionally, the macrodomain protein SCO6735 from Streptomyces coelicolor. This protein is a member of an uncharacterized subfamily of macrodomain proteins. Its crystal structure revealed a highly conserved macrodomain fold. We showed that SCO6735 possesses the ability to hydrolyze PARP-dependent protein ADP-ribosylation. Furthermore, we showed that expression of this protein is induced upon DNA damage and that deletion of this protein in S. coelicolor increases antibiotic production. Our results provide the first insights into the molecular basis of its action and impact on Streptomyces metabolism.	[Lalic, Jasna; Marjanovic, Melanija Posavec; Perina, Dragutin; Plese, Bruna; Halasz, Mirna; Cetkovic, Helena; Mikoc, Andreja] Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10002, Croatia; [Sabljic, Igor] Rudjer Boskovic Inst, Div Phys Chem, Zagreb 10002, Croatia; [Zaja, Rokoz; Ahel, Marijan] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb 10002, Croatia; [Palazzo, Luca; Jankevicius, Gytis; Ahel, Ivan] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Colby, Thomas; Matic, Ivan] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Bucca, Giselda] Univ Brighton, Sch Pharm & Biomol Sci, Huxley Bldg, Brighton BN2 4GJ, E Sussex, England	Rudjer Boskovic Institute; Rudjer Boskovic Institute; Rudjer Boskovic Institute; University of Oxford; Max Planck Society; University of Brighton	Mikoc, A (corresponding author), Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10002, Croatia.; Ahel, I (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England.	mikoc@irb.hr; ivan.ahel@path.ox.ac.uk	Palazzo, Luca/Q-1084-2017; Matic, Ivan/F-7284-2010; Plese, Bruna/L-8289-2016	Palazzo, Luca/0000-0002-5556-5549; Matic, Ivan/0000-0003-0170-7991; Plese, Bruna/0000-0001-6690-3876; Ahel, Ivan/0000-0002-9446-3756; Zaja, Roko/0000-0003-3944-0153; Sabljic, Igor/0000-0001-9044-2678; Halasz, Mirna/0000-0003-1715-1625; Bucca, Giselda/0000-0001-5286-7771; Ahel, Marijan/0000-0001-6923-8461	Unity through Knowledge Fund Grant UKF [1B 2/13]; European Research Council [281739]; Wellcome Trust [101794]; Cancer Research UK [C35050/A22284]; European Community [283570]; Cancer Research UK [22284] Funding Source: researchfish	Unity through Knowledge Fund Grant UKF; European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); European Community(European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by Unity through Knowledge Fund Grant UKF 1B 2/13, European Research Council Grant 281739, Wellcome Trust Grant 101794, Cancer Research UK Grant C35050/A22284, and European Community's Seventh Framework Programme FP7/2007-2013 under BioStruct-X Grant 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguiar RCT, 2005, J BIOL CHEM, V280, P33756, DOI 10.1074/jbc.M505408200; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2002, FEMS MICROBIOL LETT, V209, P133, DOI 10.1111/j.1574-6968.2002.tb11121.x; BALTZ RH, 1985, MOL GEN GENET, V200, P351, DOI 10.1007/BF00425716; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Barkauskaite E, 2013, FEBS J, V280, P3491, DOI 10.1111/febs.12358; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Coze F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084151; EASTMAN D, 1994, MICROBIOL-UK, V140, P3167, DOI 10.1099/13500872-140-11-3167; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feijs KLH, 2013, NAT REV MOL CELL BIO, V14, P542, DOI 10.1038/nrm3623; Gamulin V, 2004, FEMS MICROBIOL LETT, V238, P57, DOI 10.1016/j.femsle.2004.07.017; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Golia B, 2015, FRONT BIOSCI-LANDMRK, V20, P440, DOI 10.2741/4318; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hawse WF, 2009, J BIOL CHEM, V284, P33654, DOI 10.1074/jbc.M109.024521; Hildebrandt K, 1997, MOL MICROBIOL, V23, P231, DOI 10.1046/j.1365-2958.1997.2111575.x; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Huh JW, 1996, J BACTERIOL, V178, P4935, DOI 10.1128/jb.178.16.4935-4941.1996; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kieser T., 2000, PRACTICAL STREPTOMYC, DOI DOI 10.2436/im.v3i4.9291; Kim T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-266; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Lambrecht MJ, 2015, J AM CHEM SOC, V137, P3558, DOI 10.1021/ja512528p; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; MALPARTIDA F, 1986, MOL GEN GENET, V205, P66, DOI 10.1007/BF02428033; Moure VR, 2015, CURR TOP MICROBIOL, V384, P89, DOI 10.1007/82_2014_380; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano T, 2013, TOXICON, V63, P55, DOI 10.1016/j.toxicon.2012.11.019; OCHI K, 1992, J GEN MICROBIOL, V138, P1745, DOI 10.1099/00221287-138-8-1745; Palazzo L, 2016, FEBS J, V283, P3371, DOI 10.1111/febs.13811; Palazzo L, 2015, BIOCHEM J, V468, P293, DOI 10.1042/BJ20141554; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P302, DOI 10.1016/S0966-842X(01)02074-1; PENYIGE A, 1992, GENE, V115, P181, DOI 10.1016/0378-1119(92)90557-6; Penyige A, 1996, MICROBIOL-UK, V142, P1937, DOI 10.1099/13500872-142-8-1937; Penyige A, 2009, J MICROBIOL, V47, P549, DOI 10.1007/s12275-009-0032-y; Perina D, 2014, DNA REPAIR, V23, P4, DOI 10.1016/j.dnarep.2014.05.003; Peterson FC, 2011, J BIOL CHEM, V286, P35955, DOI 10.1074/jbc.M111.276238; Pfaffl MW, 2004, A Z QUANTITATIVE PCR, P87; PIGAC J, 1995, APPL ENVIRON MICROB, V61, P352, DOI 10.1128/AEM.61.1.352-356.1995; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rack JGM, 2016, ANNU REV BIOCHEM, V85, P431, DOI 10.1146/annurev-biochem-060815-014935; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Rosenthal F, 2013, NAT STRUCT MOL BIOL, V20, P502, DOI 10.1038/nsmb.2521; Serres MH, 1996, J BACTERIOL, V178, P6074, DOI 10.1128/jb.178.20.6074-6077.1996; Sharifi R, 2013, EMBO J, V32, P1225, DOI 10.1038/emboj.2013.51; Shima J, 1996, J BACTERIOL, V178, P3785, DOI 10.1128/jb.178.13.3785-3790.1996; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Stallings CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021807; STONESIFER J, 1985, P NATL ACAD SCI USA, V82, P1180, DOI 10.1073/pnas.82.4.1180; Sugawara K, 2002, BIOSCI BIOTECH BIOCH, V66, P2292, DOI 10.1271/bbb.66.2292; Szirak K, 2012, J MICROBIOL, V50, P409, DOI 10.1007/s12275-012-1440-y; TAKADA T, 1993, J BIOL CHEM, V268, P17837; Tallis M, 2014, CHROMOSOMA, V123, P79, DOI 10.1007/s00412-013-0442-9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xiao YH, 2011, METHODS MOL BIOL, V687, P277, DOI 10.1007/978-1-60761-944-4_20	75	13	13	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23175	23187		10.1074/jbc.M116.721894	http://dx.doi.org/10.1074/jbc.M116.721894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27634042	hybrid, Green Published			2022-12-26	WOS:000387224800027
J	Velazquez-Villoria, A; Recalde, S; Anter, J; Bezunartea, J; Hernandez-Sanchez, M; Garcia-Garcia, L; Alonso, E; Ruiz-Moreno, JM; Araiz-Iribarren, J; Fernandez-Robredo, P; Garcia-Layana, A				Velazquez-Villoria, Alvaro; Recalde, Sergio; Anter, Jaouad; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Garcia-Garcia, Laura; Alonso, Elena; Marina Ruiz-Moreno, Jose; Araiz-Iribarren, Javier; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo			Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes	PLOS ONE			English	Article							COMPLEMENT FACTOR-I; MACULAR DEGENERATION; CANDIDATE GENE; RISK-FACTORS; COL1A1 GENE; SUSCEPTIBILITY GENE; PATHOLOGICAL MYOPIA; MOLECULAR-GENETICS; REFRACTIVE ERRORS; PREVALENCE	Choroidal neovascularization (CNV) commonly occurs in age related macular degeneration and pathological myopia patients. In this study we conducted a case-control prospective study including 431 participants. The aim of this study was to determine the potential association between 10 single nucleotide polymorphisms (SNPs) located in 4 different genetic regions (CFI, COL8A1, LIPC, and APOE), and choroidal neovascularization in age-related macular degeneration and the development of choroidal neovascularization in highly myopic eyes of a Caucasian population. Univariate and multivariate logistic regression analysis adjusted for age, sex and hypertension was performed for each allele, genotype and haplotype frequency analysis. We found that in the univariate analysis that both single-nucleotide polymorphisms in COL8A1 gene (rs13095226 and rs669676) together with age, sex and hypertension were significantly associated with myopic CNV development in Spanish patients (p<0.05). After correcting for multiple testing none of the polymorphisms studied remained significantly associated with myopic CNV (p>0.05); however, analysis of the axial length between genotypes of rs13095226 revealed an important influence of COL8A1 in the development of CNV in high myopia. Furthermore we conducted a meta-analysis of COL8A1, CFI and LIPC genes SNPs (rs669676, rs10033900 and rs10468017) and found that only rs669676 of these SNPs were associated with high myopia neovascularization.	[Velazquez-Villoria, Alvaro; Recalde, Sergio; Bezunartea, Jaione; Hernandez-Sanchez, Maria; Garcia-Garcia, Laura; Alonso, Elena; Fernandez-Robredo, Patricia; Garcia-Layana, Alfredo] Univ Navarra, Ophthalmol Expt Lab, Pamplona, Spain; [Velazquez-Villoria, Alvaro; Alonso, Elena; Garcia-Layana, Alfredo] Clin Univ Navarra, Dept Ophthalmol, Pamplona, Spain; [Anter, Jaouad] Ctr Invest Biol & Ciber Enfermedades Raras, Dept Celular & Mol Med, Madrid, Spain; [Marina Ruiz-Moreno, Jose] Castilla La Mancha Univ, Albacete & Baviera European Inst Retina, Dept Ophthalmol, Alicante, Spain; [Araiz-Iribarren, Javier] Univ Basque Country, Surg Clin Inst Ophthalmol, Bilbao, Spain; [Araiz-Iribarren, Javier] San Eloy Hosp, Bilbao, Spain	University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Basque Country	Recalde, S (corresponding author), Univ Navarra, Ophthalmol Expt Lab, Pamplona, Spain.	srecalde@unav.es	Recalde, Sergio/D-1815-2017	Recalde, Sergio/0000-0002-9328-9725; Ruiz-Moreno, Jose M/0000-0001-9636-0788	PN I + D + I; ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; European Program FEDER	PN I + D + I; ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; European Program FEDER	This work has been developed by members of the Spanish Vitreoretinal society (SERV), the RETICs: RD07-0062: "Age Related Ocular Diseases, Quality of Life, and Vision", and RETICS OFTARED (RD12/0034) "Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology" from the Instituto de Salud Carlos III from the Ministerio de Economia y Competitividad, Spain. This work has been partly funded by the PN I + D + I 20082011; the ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; and the European Program FEDER.; We greatly thank all the patients who participated in this study. This work has been developed by members of the Spanish Vitreoretinal society (SERV), the RETICs: RD07-0062: "Age Related Ocular Diseases, Quality of Life, and Vision", and RETICS OFTARED (RD12/0034) "Prevention, Early Detection, and Treatment of the Prevalent Degenerative and Chronic Ocular Pathology" from the Instituto de Salud Carlos III from the Ministerio de Economia y Competitividad, Spain. This work has been partly funded by the PN I + D + I 2008-2011; the ISCIII-Subdireccion General de Redes y Centros de Investigacion Cooperativa; and the European Program FEDER.	Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Chan NS, 2015, EYE CONTACT LENS; Chen SJ, 2012, INVEST OPHTH VIS SCI, V53, P4868, DOI 10.1167/iovs.12-9919; Cohen SY, 1996, OPHTHALMOLOGY, V103, P1241, DOI 10.1016/S0161-6420(96)30515-0; Dirani M, 2008, INVEST OPHTH VIS SCI, V49, P534, DOI 10.1167/iovs.07-1123; Ennis S, 2010, EUR J HUM GENET, V18, P15, DOI 10.1038/ejhg.2009.113; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Feldkamper M, 2003, DEV OPHTHALMOL, V37, P34; Fernandez-Robredo P, 2008, OPHTHALMOLOGY, V115, P1632, DOI 10.1016/j.ophtha.2008.03.004; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gorin MB, 2007, ARCH OPHTHALMOL-CHIC, V125, P21, DOI 10.1001/archopht.125.1.21; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Haghighi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112747; Hammond CJ, 2004, AM J HUM GENET, V75, P294, DOI 10.1086/423148; Han W, 2006, INVEST OPHTH VIS SCI, V47, P2291, DOI 10.1167/iovs.05-1344; Hayashi T, 2007, JPN J OPHTHALMOL, V51, P96, DOI 10.1007/s10384-006-0417-y; He MG, 2009, OPTOMETRY VISION SCI, V86, P40, DOI 10.1097/OPX.0b013e3181940719; Hrynchak PK, 2013, OPTOMETRY VISION SCI, V90, P1331, DOI 10.1097/OPX.0000000000000069; Hufnagel SB, 2014, AM J MED GENET A, V164, P2607, DOI 10.1002/ajmg.a.36688; Ikuno Y, 2008, RETINA-J RET VIT DIS, V28, P1124, DOI 10.1097/IAE.0b013e318174417a; Inamori Y, 2007, HUM GENET, V122, P151, DOI 10.1007/s00439-007-0388-1; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; Lechanteur YTE, 2012, INVEST OPHTH VIS SCI, V53, P5846, DOI 10.1167/iovs.11-7731; Leveziel N, 2012, INVEST OPHTH VIS SCI, V53, P5004, DOI 10.1167/iovs.12-9538; Liang CL, 2007, J HUM GENET, V52, P374, DOI 10.1007/s10038-007-0117-6; Lin HJ, 2010, EYE, V24, P1093, DOI 10.1038/eye.2009.254; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Lopes MC, 2009, INVEST OPHTH VIS SCI, V50, P126, DOI 10.1167/iovs.08-2385; Lu BY, 2011, INVEST OPHTH VIS SCI, V52, P8258, DOI 10.1167/iovs.11-7914; Metlapally R, 2009, INVEST OPHTH VIS SCI, V50, P4080, DOI 10.1167/iovs.08-3346; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Miyake M, 2013, INVEST OPHTH VIS SCI, V54, P4208, DOI 10.1167/iovs.13-12280; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Mutti DO, 2007, MOL VIS, V13, P1012; Nakanishi H, 2010, EYE, V24, P1078, DOI 10.1038/eye.2009.215; Nakanishi H, 2009, INVEST OPHTH VIS SCI, V50, P544, DOI 10.1167/iovs.08-2425; NOBLE KG, 1982, OPHTHALMOLOGY, V89, P1099; Pacella R, 1999, OPTOMETRY VISION SCI, V76, P381, DOI 10.1097/00006324-199906000-00017; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Percival S P, 1987, Dev Ophthalmol, V14, P42; Pertile KK, 2008, INVEST OPHTH VIS SCI, V49, P49, DOI 10.1167/iovs.07-0896; Saw Seang-Mei, 2003, Clin Exp Optom, V86, P289; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Scavello GS, 2004, INVEST OPHTH VIS SCI, V45, P2091, DOI 10.1167/iovs.03-0933; Seddon JM, 2015, INVEST OPHTH VIS SCI, V56, P2192, DOI 10.1167/iovs.14-15841; Seddon JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087047; Sergouniotis PI, 2015, EYE, V29, P475, DOI 10.1038/eye.2014.334; Shih YF, 2006, BRIT J OPHTHALMOL, V90, P546, DOI 10.1136/bjo.2005.081992; Shuttleworth CA, 1997, INT J BIOCHEM CELL B, V29, P1145, DOI 10.1016/S1357-2725(97)00033-2; Snead MP, 1999, J MED GENET, V36, P353; Soubrane G, 2008, SURV OPHTHALMOL, V53, P121, DOI 10.1016/j.survophthal.2007.12.004; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; TAMURA Y, 1991, INVEST OPHTH VIS SCI, V32, P2636; Tang WC, 2007, MOL VIS, V13, P534; TEIKARI JM, 1991, HUM HERED, V41, P151, DOI 10.1159/000153994; Terhal PA, 2015, AM J MED GENET A, V167, P461, DOI 10.1002/ajmg.a.36922; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wang PF, 2009, INVEST OPHTH VIS SCI, V50, P1546, DOI 10.1167/iovs.08-2537; Wolfram C, 2014, BRIT J OPHTHALMOL, V98, P857, DOI 10.1136/bjophthalmol-2013-304228; Wong TY, 2014, AM J OPHTHALMOL, V157, P9, DOI 10.1016/j.ajo.2013.08.010; Woo W W, 2004, Singapore Med J, V45, P470; Yu Y, 2015, INT J CLIN EXP PATHO, V8, P11635; Yu Y, 2011, HUM MOL GENET, V20, P3699, DOI 10.1093/hmg/ddr270; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070; Zayats T, 2009, MOL VIS, V15, P213; Zha Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P541, DOI 10.1001/archophthalmol.2008.623; Zhang DD, 2011, MOL VIS, V17, P3379; Zhang X, 2015, EURASIP J AUDIO SPEE, DOI 10.1186/s13636-015-0050-0	73	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162296	10.1371/journal.pone.0162296	http://dx.doi.org/10.1371/journal.pone.0162296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643879	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900010
J	Zhang, JL; Wu, SZ; Liu, YL; Qiao, L; Gao, WH; Zhang, WG; Liu, Z				Zhang, Jinlong; Wu, Shengzheng; Liu, Yongliang; Qiao, Lu; Gao, Wenhong; Zhang, Weiguo; Liu, Zheng			Disruption of Prostate Microvasculature by Combining Microbubble-Enhanced Ultrasound and Prothrombin	PLOS ONE			English	Article							MINIMALLY INVASIVE THERAPIES; INERTIAL CAVITATION; IN-VIVO; CONTRAST AGENTS; DRUG-DELIVERY; HYPERPLASIA; ANGIOGENESIS; ACTIVATION; BRAIN	Previous studies have shown a unique method to disrupt tumor vasculature using pulsed, high-pressure amplitude therapeutic ultrasound combined with microbubbles. In this study, we attempted to destroy the prostate vasculature of canine prostates using microbubble-enhanced ultrasound (MEUS) and prothrombin. The prostates of 43 male mongrel canines were surgically exposed. Twenty-two prostates were treated using MEUS (n = 11) or MEUS and prothrombin (PMEUS, n = 11). The other 21 prostates, which were treated using microbubbles (n = 7), ultrasound (n = 7) or prothrombin (n = 7) only, served as the controls. Prothrombin was intravenously infused at 20 IU/kg. MEUS was induced using a therapeutic ultrasound device at a peak negative pressure of 4.47 MPa and a microbubble injection. Contrast-enhanced ultrasound was performed to assess the blood perfusion of the prostates. Then, the prostate tissue was harvested immediately after treatment and at 48 hours later for pathological examination. The contrast-enhanced ultrasound peak value of the prostate decreased significantly from 36.2 +/- 5.6 to 27.1 +/- 6.3 after treatment in the PMEUS group, but it remained unchanged in the other groups. Histological examination found severe microvascular rupture, hemorrhage and thrombosis in both MEUS- and PMEUS-treated prostates immediately after treatment, while disruption in the PMEUS group was more severe than in the MEUS group. Forty-eight hours after treatment, massive necrosis and infiltration of white blood cells occurred in the PMEUS group. This study demonstrated that PMEUS disrupted the normal microvasculature of canine prostates and induced massive necrosis. PMEUS could potentially become a new noninvasive method used for the treatment of benign prostatic hyperplasia.	[Zhang, Jinlong; Zhang, Weiguo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China; [Wu, Shengzheng; Qiao, Lu; Gao, Wenhong; Liu, Zheng] Third Mil Med Univ, Xinqiao Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Liu, Yongliang] Third Mil Med Univ, Xinqiao Hosp, Dept Urol, Chongqing, Peoples R China; [Zhang, Weiguo] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Zhang, WG (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Radiol, Chongqing, Peoples R China.; Liu, Z (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Ultrasound, Chongqing, Peoples R China.; Zhang, WG (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	wgzhang01@163.com; liuzhengs@hotmail.com	zhang, jin/GXV-9154-2022		Natural Science Foundation of China [81227004]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was received from the Natural Science Foundation of China (Grant No. 81227004) (http://www.nsfc.gov.cn/). ZL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brujan EA, 2009, MED ENG PHYS, V31, P742, DOI 10.1016/j.medengphy.2009.03.007; Burgess A, 2016, ADV EXP MED BIOL, V880, P293, DOI 10.1007/978-3-319-22536-4_16; Cabelin M A, 2000, Curr Opin Urol, V10, P301, DOI 10.1097/00042307-200007000-00003; DEERING RE, 1995, PROSTATE, V26, P111, DOI 10.1002/pros.2990260302; Djavan B, 2012, CURR OPIN UROL, V22, P16, DOI 10.1097/MOU.0b013e32834d5469; Downs ME, 2015, SCI REP-UK, V5, DOI 10.1038/srep15076; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Hall TL, 2009, UROLOGY, V74, P932, DOI 10.1016/j.urology.2009.03.049; Hempel CR, 2011, J UROLOGY, V185, P1484, DOI 10.1016/j.juro.2010.11.044; Hwang JH, 2005, ULTRASOUND MED BIOL, V31, P553, DOI 10.1016/j.ultrasmedbio.2004.12.014; Hwang JH, 2006, ULTRASOUND MED BIOL, V32, P1611, DOI 10.1016/j.ultrasmedbio.2006.07.016; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kutty S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000689; Lake AM, 2008, UROLOGY, V72, P682, DOI 10.1016/j.urology.2008.01.037; Liu P, 2011, ULTRASONICS, V51, P210, DOI 10.1016/j.ultras.2010.07.008; Liu Z, 2012, ULTRASOUND MED BIOL, V38, P253, DOI 10.1016/j.ultrasmedbio.2011.11.007; Majeed A, 2012, THROMB RES, V129, P146, DOI 10.1016/j.thromres.2011.07.024; MCNEAL JE, 1978, INVEST UROL, V15, P340; MILLER DL, 1995, ULTRASOUND MED BIOL, V21, P1059, DOI 10.1016/0301-5629(95)93252-U; Miller DL, 2000, ULTRASOUND MED BIOL, V26, P307, DOI 10.1016/S0301-5629(99)00138-6; Miller DL, 2000, P NATL ACAD SCI USA, V97, P10179, DOI 10.1073/pnas.180294397; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; Ohigashi T, 2007, INT J UROL, V14, P326, DOI 10.1111/j.1442-2042.2007.01692.x; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123619; Sun N, 2014, INT UROL NEPHROL, V46, P1277, DOI 10.1007/s11255-014-0646-9; Tang Jie, 2007, Zhonghua Nan Ke Xue, V13, P584; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Tunuguntla HSGR, 2002, WORLD J UROL, V20, P197, DOI 10.1007/s00345-002-0283-2; Wheat JC, 2010, UROLOGY, V75, P207, DOI 10.1016/j.urology.2009.09.021; Wu SZ, 2014, INT J NANOMED, V9, P5639, DOI 10.2147/IJN.S73950; Xie F, 2009, CIRCULATION, V119, P1378, DOI 10.1161/CIRCULATIONAHA.108.825067; Yu XH, 2008, J UROLOGY, V180, P241, DOI 10.1016/j.juro.2008.03.039	34	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162398	10.1371/journal.pone.0162398	http://dx.doi.org/10.1371/journal.pone.0162398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643992	Green Submitted, gold, Green Published			2022-12-26	WOS:000383891900011
J	Berg, E; Sivertsen, A; Ariansen, AMS; Filip, C; Vindenes, HA; Feragen, KB; Moster, D; Lie, RT; Haaland, OA				Berg, Erik; Sivertsen, Ase; Ariansen, Anja Maria Steinsland; Filip, Charles; Vindenes, Halvard A.; Feragen, Kristin B.; Moster, Dag; Lie, Rolv Terje; Haaland, Oystein A.			Socio-Economic Status and Reproduction among Adults Born with an Oral Cleft: A Population-Based Cohort Study in Norway	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACADEMIC-ACHIEVEMENT; BIRTH-DEFECTS; BABIES BORN; LIP; PALATE; CHILDREN; RISK; RECURRENCE; SURVIVAL	Background It has been reported that people born with orofacial clefts do worse in life than their peers regarding a range of social markers, such as academic achievement and reproduction. We have compared otherwise healthy individuals with and without clefts, to investigate if these differences are due to the cleft or other background factors. Materials and Methods In a retrospective national cohort study, based on compulsory registers with data collected prospectively, we included everybody born in Norway between 1967 and 1992 (1490279 individuals, 2584 with clefts). This cohort was followed until the year 2010, when the youngest individuals were 18 years old. In order to ensure that the individuals were not affected by unknown syndromes or diseases, we excluded all individuals with any chronic medical condition, or who had other birth defects than clefts, hydroceles and dislocated hips. Individuals with oral clefts who were included in the study are said to have isolated clefts. Results Isolated cleft patients are similar to the general population regarding education, income and social class. Isolated cleft patients have lower fertility than the background population, but considering only married couples this difference in fertility disappeared. Conclusions An oral cleft did not appear to affect future socioeconomic status or chances of becoming a parent for children born in Norway. An exception was males with cleft lip and palate, but differences were small.	[Berg, Erik; Ariansen, Anja Maria Steinsland; Moster, Dag; Lie, Rolv Terje; Haaland, Oystein A.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Sivertsen, Ase; Vindenes, Halvard A.] Haukeland Hosp, Dept Plast Surg, Bergen, Norway; [Sivertsen, Ase; Filip, Charles; Vindenes, Halvard A.] Norwegian Qual Registry Cleft Lip & Palate, Bergen, Norway; [Filip, Charles] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Rikshosp, Oslo, Norway; [Feragen, Kristin B.] Oslo Univ Hosp, Ctr Rare Disorders, Oslo, Norway; [Moster, Dag; Lie, Rolv Terje] Norwegian Inst Publ Hlth, Bergen, Norway; [Haaland, Oystein A.] Haukeland Hosp, Dept Pediat, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; National Hospital Norway; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Bergen; Haukeland University Hospital	Berg, E (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	erik.berg@uib.no						Administration TT, NAT REG; Breen R, 2005, APPROACHES CLASS ANA, P31; Collett BR, 2014, J PEDIATR PSYCHOL, V39, P743, DOI 10.1093/jpepsy/jsu049; Herkrath APCD, 2015, CLEFT PALATE-CRAN J, V52, P157, DOI 10.1597/13-104; Erikson R, 2010, BRIT J SOCIOL, V61, P185, DOI 10.1111/j.1468-4446.2009.01246.x; Flemmen M, 2009, IMPLEMENTERING EGP K; Flynn T, 2014, CLEFT PALATE-CRAN J, V51, pE94, DOI 10.1597/12-288; Health NIoP, 2012, MED BIRTH REG NORW; Hunt O, 2005, EUR J ORTHODONT, V27, P274, DOI 10.1093/ejo/cji004; Koenker R., 2015, QUANTILE REGRESSION; Kubon C, 2007, ACTA OBSTET GYN SCAN, V86, P1453, DOI 10.1080/08037050701645090; Lie RT, 2001, JAMA-J AM MED ASSOC, V285, P755, DOI 10.1001/jama.285.6.755; Lindberg N, 2014, SCAND J CARING SCI, V28, P66, DOI 10.1111/scs.12048; Mani M, 2010, CLEFT PALATE-CRAN J, V47, P491, DOI 10.1597/08-281; Marcusson A, 2001, CLEFT PALATE-CRAN J, V38, P379, DOI 10.1597/1545-1569(2001)038<0379:QOLIAW>2.0.CO;2; Milerad J, 1997, PEDIATRICS, V100, P180, DOI 10.1542/peds.100.2.180; Morris JK, 2014, AM J MED GENET A, V164, P2979, DOI 10.1002/ajmg.a.36780; Mossey P A, 2011, Adv Dent Res, V23, P247, DOI 10.1177/0022034511402083; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Norway S., NASJONAL UTDANNINGSD; Persson M, 2008, SCAND J PLAST RECONS, V42, P14, DOI 10.1080/02844310701694472; Persson M, 2012, CLEFT PALATE-CRAN J, V49, P153, DOI 10.1597/09-047; PETER JP, 1975, CLEFT PALATE J, V12, P193; RAMSTAD T, 1995, SCAND J PLAST RECONS, V29, P251, DOI 10.3109/02844319509050135; Richman LC, 2012, CLEFT PALATE-CRAN J, V49, P387, DOI 10.1597/10-237; Roberts JE, 2004, PEDIATRICS, V113, pE238, DOI 10.1542/peds.113.3.e238; Roberts RM, 2012, J PEDIATR PSYCHOL, V37, P786, DOI 10.1093/jpepsy/jss052; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Skjaerven R, 1999, NEW ENGL J MED, V340, P1057, DOI 10.1056/NEJM199904083401401; StataCorp, CART STAT STAT SOFTW; Team RC, 2015, R LANG ENV STAT COMP; Wehby GL, 2014, PEDIATRICS, V133, P785, DOI 10.1542/peds.2013-3072; World Health Organization, INT CLASS DIS ICD; Yttri JE, 2011, CLEFT PALATE-CRAN J, V48, P601, DOI 10.1597/09-245; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162196	10.1371/journal.pone.0162196	http://dx.doi.org/10.1371/journal.pone.0162196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631472	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900031
J	Jiang, FZ; Jin, K; Huang, SY; Bao, Q; Shao, ZR; Hu, XQ; Ye, J				Jiang, Fangzhen; Jin, Kai; Huang, Shenyu; Bao, Qi; Shao, Zheren; Hu, Xueqing; Ye, Juan			Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; CANCER CELLS; IN-VITRO; GROWTH-INHIBITION; DEPHOSPHORYLATION; OSTEOSARCOMA; NANOLIPOSOME; C6-CERAMIDE; DEPENDENCE; PATHWAY	Melanoma is one common skin cancer. In the present study, the potential anti-melanoma activity by a liposomal C6 ceramide was tested in vitro. We showed that the liposomal C6 (ceramide) was cytotoxic and anti-proliferative against a panel of human melanoma cell lines (SK-Mel2, WM-266.4 and A-375 and WM-115). In addition, liposomal C6 induced caspase-dependent apoptotic death in the melanoma cells. Reversely, its cytotoxicity was attenuated by several caspase inhibitors. Intriguingly, liposomal C6 was non-cytotoxic to B10BR mouse melanocytes and primary human melanocytes. Molecularly, liposomal C6 activated protein phosphatase 1 (PP1) to inactivate Akt-mammalian target of rapamycin (mTOR) signaling in melanoma cells. On the other hand, PP1 shRNA knockdown or exogenous expression of constitutively activate Akt1 (CA-Akt1) restored Akt-mTOR activation and significantly attenuated liposomal C6-mediated cytotoxicity and apoptosis in melanoma cells. Our results suggest that liposomal C6 activates PP1 to inhibit melanoma cells.	[Jiang, Fangzhen; Bao, Qi; Shao, Zheren; Hu, Xueqing] Zhejiang Univ, Affiliated Hosp 2, Dept Plast & Reconstruct Surg, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China; [Jin, Kai; Huang, Shenyu; Ye, Juan] Zhejiang Univ, Affiliated Hosp 2, Dept Ophthalmol, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Jin, K (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Ophthalmol, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China.	drkaijinvip@sina.com			Zhejiang Key Laboratory fund of China [2011E10006]; Zhejiang Provincial Public Welfare Technical Program for Applied Research [2015C33180]	Zhejiang Key Laboratory fund of China; Zhejiang Provincial Public Welfare Technical Program for Applied Research	This work was generously supported by grants from Zhejiang Key Laboratory fund of China (2011E10006, to KJ) and Zhejiang Provincial Public Welfare Technical Program for Applied Research (2015C33180, to KJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah PP, 2013, CANCER LETT, V337, P254, DOI 10.1016/j.canlet.2013.04.034; Banerjee Hirendra Nath, 2012, J Cancer Sci Ther, V4, P12; Braeuer RR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12172; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chen MB, 2015, CARCINOGENESIS, V36, P1061, DOI 10.1093/carcin/bgv094; Chen MB, 2013, CELL SIGNAL, V25, P1993, DOI 10.1016/j.cellsig.2013.05.026; Dimanche-Boitrel MT, 2011, RECENT PAT ANTI-CANC, V6, P284, DOI 10.2174/157489211796957838; Eggermont AMM, 2014, NAT REV CLIN ONCOL, V11, P181, DOI 10.1038/nrclinonc.2014.36; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; Henry B., 2011, CANC LETT; Hu X, 2015, TUMOUR BIOL; Huo HZ, 2013, MOL CELL BIOCHEM, V378, P171, DOI 10.1007/s11010-013-1608-8; Hutchinson Lisa, 2015, Nat Rev Clin Oncol, V12, P1, DOI 10.1038/nrclinonc.2014.219; Hutchinson L, 2014, NAT REV CLIN ONCOL, V11, P299, DOI [10.1038/nrclinonc.2014.87, 10.1038/nrclinonc.2014.132]; Ilinykh PA, 2014, J BIOL CHEM, V289, P22723, DOI 10.1074/jbc.M114.575050; Ji C, 2010, ONCOGENE, V29, P6557, DOI 10.1038/onc.2010.379; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Kingwell K, 2014, NAT REV DRUG DISCOV, V13, P334, DOI 10.1038/nrd4314; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Mullen T. D., 2011, ANTICANCER AGENTS ME; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Populo H, 2012, EXPERT OPIN THER TAR, V16, P689, DOI 10.1517/14728222.2012.691472; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Ryland LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084648; Schadendorf D, 2014, NAT REV CLIN ONCOL, V11, P75, DOI 10.1038/nrclinonc.2013.246; Shen J, 2015, TUMOUR BIOL; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Sun H, 2011, CANCER LETT, V310, P118, DOI 10.1016/j.canlet.2011.06.010; Tagaram HRS, 2011, GUT, V60, P695, DOI 10.1136/gut.2010.216671; Tran MA, 2008, CLIN CANCER RES, V14, P3571, DOI 10.1158/1078-0432.CCR-07-4881; Ullal AJ, 2014, CLIN IMMUNOL, V154, P178, DOI 10.1016/j.clim.2014.05.007; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Webster RM, 2014, NAT REV DRUG DISCOV, V13, P491, DOI 10.1038/nrd4326; Wu L, 2015, BIOCHEM BIOPH RES CO, V466, P547, DOI 10.1016/j.bbrc.2015.09.068; Yang L, 2015, EXP CELL RES, V332, P47, DOI 10.1016/j.yexcr.2014.12.017; Yao C, 2012, MOL ONCOL, V6, P392, DOI 10.1016/j.molonc.2012.04.002; Yu T, 2010, CANCER CHEMOTH PHARM, V66, P999, DOI 10.1007/s00280-010-1374-1; Zhai L, 2015, BIOCHEM BIOPH RES CO, V468, P274, DOI 10.1016/j.bbrc.2015.10.113; Zhang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep09275; Zolnik BS, 2008, DRUG METAB DISPOS, V36, P1709, DOI 10.1124/dmd.107.019679	43	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0159849	10.1371/journal.pone.0159849	http://dx.doi.org/10.1371/journal.pone.0159849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631768	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900003
J	Sohn, SI; Oh, YJ; Lee, KR; Ko, HC; Cho, HS; Lee, YH; Chang, A				Sohn, Soo-In; Oh, Young-Ju; Lee, Kyeong-Ryeol; Ko, Ho-Cheol; Cho, Hyun-Suk; Lee, Yeon-Hee; Chang, Ancheol			Characteristics Analysis of F-1 Hybrids between Genetically Modified Brassica napus and B. rapa	PLOS ONE			English	Article							OILSEED RAPE; PLOIDY LEVEL; GENE FLOW; SEED OIL; FITNESS; INTROGRESSION; TRANSGENE; BACKCROSS; PLANTS; HYBRIDIZATION	A number of studies have been conducted on hybridization between transgenic Brassica napus and B. rapa or backcross of F-1 hybrid to their parents. However, trait changes must be analyzed to evaluate hybrid sustainability in nature. In the present study, B. rapa and transgenic (BrAGL20) B. napus were hybridized to verify the early flowering phenomenon of F-1 hybrids, and F-1 hybrid traits were analyzed to predict their impact on sustainability. Flowering of F-1 hybrid has been induced slightly later than that of the transgenic B. napus, but flowering was available in the greenhouse without low temperature treatment to young plant, similar to the transgenic B. napus. It is because the BrAGL20 gene has been transferred from transgenic B. napus to F-1 hybrid. The size of F-1 hybrid seeds was intermediate between those of B. rapa and transgenic B. napus, and similar to 40% of F-1 pollen exhibited abnormal size and morphology. The form of the F-1 stomata was also intermediate between that of B. rapa and transgenic B. napus, and the number of stomata was close to the parental mean. Among various fatty acids, the content of erucic acid exhibited the greatest change, owing to the polymorphism of parental FATTY ACID ELONGASE 1 alleles. Furthermore, F-2 hybrids could not be obtained. However, BC1 progeny were obtained by hand pollination of B. rapa with F-1 hybrid pollen, with an outcrossing rate of 50%.	[Sohn, Soo-In; Lee, Kyeong-Ryeol; Cho, Hyun-Suk; Lee, Yeon-Hee; Chang, Ancheol] Natl Inst Agr Sci, Dept Agr Biotechnol, 370 Nongsaengmyeong Ro, Jeonju 54874, North Jeolla Pr, South Korea; [Oh, Young-Ju] Inst Future Environm Ecol Co Ltd, 5,Palbok 1 Gil, Jeonju 54883, North Jeolla Pr, South Korea; [Ko, Ho-Cheol] Natl Inst Agr Sci, Natl Agrobiodivers Ctr, 370 Nongsaengmyeong Ro, Jeonju 54874, North Jeolla Pr, South Korea	National Institute of Agricultural Sciences; National Institute of Agricultural Sciences	Sohn, SI (corresponding author), Natl Inst Agr Sci, Dept Agr Biotechnol, 370 Nongsaengmyeong Ro, Jeonju 54874, North Jeolla Pr, South Korea.	sisohn@korea.kr	Lee, Kyeong-Ryeol/I-7389-2019		Research Program for Agricultural Science & Technology Development [PJ01186703]; National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea	Research Program for Agricultural Science & Technology Development; National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea	This study was conducted with the support of the Research Program for Agricultural Science & Technology Development (Project No. PJ01186703), National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea.	Allainguillaume J, 2006, MOL ECOL, V15, P1175, DOI 10.1111/j.1365-294X.2006.02856.x; Barthet VJ, 2008, PHYTOCHEMISTRY, V69, P411, DOI 10.1016/j.phytochem.2007.08.016; Beck SL, 2003, BOT J LINN SOC, V141, P177, DOI 10.1046/j.1095-8339.2003.00132.x; Bozcali E, 2009, INT J CLIN EXP MED, V2, P337; Broun P, 1999, ANNU REV NUTR, V19, P197, DOI 10.1146/annurev.nutr.19.1.197; CALDER R. A., 1937, New Zealand Journal of Agriculture, V55, P299; Cao D, 2014, PLANT SCI, V227, P45, DOI 10.1016/j.plantsci.2014.06.018; Chevre AM, 2003, ACTA AGR SCAND B-S P, V53, P22, DOI 10.1080/16519140310015102; DOWNEY RK, 1964, J AM OIL CHEM SOC, V41, P475, DOI 10.1007/BF02670026; ECKE W, 1995, THEOR APPL GENET, V91, P972, DOI 10.1007/BF00223908; Gregis V, 2006, PLANT CELL, V18, P1373, DOI 10.1105/tpc.106.041798; Gueritaine G, 2002, MOL ECOL, V11, P1419, DOI 10.1046/j.1365-294X.2002.01540.x; Halfhill Matthew D., 2002, Environmental Biosafety Research, V1, P19, DOI 10.1051/ebr:2002002; Halfhill MD, 2005, MOL ECOL, V14, P3177, DOI 10.1111/j.1365-294X.2005.02649.x; Halfhill MD, 2003, THEOR APPL GENET, V107, P1533, DOI 10.1007/s00122-003-1397-7; Hauser TP, 1998, HEREDITY, V81, P429, DOI 10.1046/j.1365-2540.1998.00424.x; Hauser TP, 1998, HEREDITY, V81, P436, DOI 10.1046/j.1365-2540.1998.00425.x; Hauser TP, 1999, HEREDITAS, V130, P89, DOI 10.1111/j.1601-5223.1999.00089.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hilbeck Angelika, 2011, Environmental Sciences Europe, V23, P13, DOI 10.1186/2190-4715-23-13; Hong JK, 2013, PLANT BIOTECHNOL REP, V7, P231, DOI 10.1007/s11816-012-0254-z; JORGENSEN RB, 1994, AM J BOT, V81, P1620, DOI 10.2307/2445340; Jorgensen RB, 1998, ACTA HORTIC, P211, DOI 10.17660/ActaHortic.1998.459.23; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Legere A, 2005, PEST MANAG SCI, V61, P292, DOI 10.1002/ps.975; Liu YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039705; Lu CM, 2001, BREEDING SCI, V51, P73, DOI 10.1270/jsbbs.51.73; Mandal S, 2002, GENET RESOUR CROP EV, V49, P551, DOI 10.1023/A:1021210800414; Meng J. L., 1990, Acta Agronomica Sinica, V16, P19; Mikkelsen TR, 1996, THEOR APPL GENET, V92, P492, DOI 10.1007/BF00223698; Mikkelsen TR, 1996, NATURE, V380, P31, DOI 10.1038/380031a0; Mishra MK, 1999, ANN BOT, V80, P689; Naidu MM, 2012, DRY TECHNOL, V30, P808, DOI 10.1080/07373937.2012.666607; Padoan D, 2013, THEOR EXP PLANT PHYS, V25, P283, DOI 10.1590/S2197-00252013000400006; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Phillips J, 1997, EMBO J, V16, P4489, DOI 10.1093/emboj/16.15.4489; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; ROGERS SO, 1994, PLANT MOL BIOL MANUA, P1, DOI DOI 10.1007/978-94-011-0511-8_12; Snow AA, 1997, BIOSCIENCE, V47, P86, DOI 10.2307/1313019; Snow AA, 1999, MOL ECOL, V8, P605, DOI 10.1046/j.1365-294x.1999.00596.x; STEFANSSON B. R., 1961, CANADIAN JOUR PLANT SCI, V41, P218; Tomiuk J, 2000, THEOR APPL GENET, V100, P750, DOI 10.1007/s001220051348; Tsuda M, 2014, BREEDING SCI, V64, P74, DOI 10.1270/jsbbs.64.74; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Warwick SI, 2003, THEOR APPL GENET, V107, P528, DOI 10.1007/s00122-003-1278-0; Wilkinson Mike, 2009, Environmental Biosafety Research, V8, P1, DOI 10.1051/ebr/2009003; Wilkinson MJ, 2003, TRENDS PLANT SCI, V8, P208, DOI 10.1016/S1360-1385(03)00057-8; Wu G, 2008, THEOR APPL GENET, V116, P491, DOI 10.1007/s00122-007-0685-z; Xiao L, 2009, TRANSGENIC RES, V18, P733, DOI 10.1007/s11248-009-9261-4; Yao K, 2005, PLANT PHYSIOL BIOCH, V43, P83, DOI 10.1016/j.plaphy.2004.12.006; Ye YM, 2010, SCI HORTIC-AMSTERDAM, V124, P95, DOI 10.1016/j.scienta.2009.12.016; Yuan SX, 2009, AGR SCI CHINA, V8, P939, DOI 10.1016/S1671-2927(08)60298-9	57	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162103	10.1371/journal.pone.0162103	http://dx.doi.org/10.1371/journal.pone.0162103			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632286	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900027
J	Baumann, FM; Yuzefpolskiy, Y; Sarkar, S; Kalia, V				Baumann, Florian M.; Yuzefpolskiy, Yevgeniy; Sarkar, Surojit; Kalia, Vandana			Dicer Regulates the Balance of Short-Lived Effector and Long-Lived Memory CD8 T Cell Lineages	PLOS ONE			English	Article							SELECTIVE EXPRESSION; IMMUNE-SYSTEM; DIFFERENTIATION; MIRNA; RESPONSES; FATES; INFECTIONS; ACTIVATION; MICRORNAS; PRECURSOR	MicroRNAs constitute a major post-transcriptional mechanism for controlling protein expression, and are emerging as key regulators during T cell development and function. Recent reports of augmented CD8 T cell activation and effector differentiation, and aberrant migratory properties upon ablation of Dicer/miRNAs in naive cells have established a regulatory role of miRNAs during priming. Whether miRNAs continue to exert similar functions or are dispensable during later stages of CD8 T cell expansion and memory differentiation remains unclear. Here, we report a critical role of Dicer/miRNAs in regulating the balance of long-lived memory and short-lived terminal effector fates during the post-priming stages when CD8 T cells undergo clonal expansion to generate a large cytotoxic T lymphocyte (CTL) pool and subsequently differentiate into a quiescent memory state. Conditional ablation of Dicer/miRNAs in early effector CD8 T cells following optimal activation and expression of granzyme B, using unique dicer(fl/fl) gzmb-cre mice, led to a strikingly diminished peak effector size relative to wild-type antigen-specific cells in the same infectious milieu. Diminished expansion of Dicer-ablated CD8 T cells was associated with lack of sustained antigen-driven proliferation and reduced accumulation of short-lived effector cells. Additionally, Dicer-ablated CD8 T cells exhibited more pronounced contraction after pathogen clearance and comprised a significantly smaller proportion of the memory pool, despite significantly higher proportions of CD127(Hi) memory precursors at the effector peak. Combined with previous reports of dynamic changes in miRNA expression as CD8 T cells differentiate from naive to effector and memory states, these findings support distinct stage-specific roles of miRNA-dependent gene regulation during CD8 T cell differentiation.	[Sarkar, Surojit; Kalia, Vandana] Univ Washington, Sch Med, Dept Pediat, Div Hematol & Oncol, Seattle, WA 98195 USA; [Sarkar, Surojit; Kalia, Vandana] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA; [Sarkar, Surojit] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Baumann, Florian M.; Yuzefpolskiy, Yevgeniy] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kalia, V (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Hematol & Oncol, Seattle, WA 98195 USA.; Kalia, V (corresponding author), Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA.	sarkarkalia@gmail.com			National Institutes of Health [AI113803, AI103748]; USDA AES project [4531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI103748, R03AI113803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA AES project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded, in part, by research grants from the National Institutes of Health to V.K. (AI113803) and S.S. (AI103748), and USDA AES project #4531 (Mechanisms of Immune Responses to Pathogens and Vaccines V.K. and S.S.).; The authors would like to thank Dr. Joshy Jacob (Emory University, Atlanta) for kindly providing the granzyme B-cre mice. This work was funded, in part, by research grants from the National Institutes of Health to VK (AI113803) and SS (AI103748), and USDA AES project #4531 (Mechanisms of Immune Responses to Pathogens and Vaccines V.K. and S.S.).	Andrade F, 2010, IMMUNOL REV, V235, P128, DOI 10.1111/j.0105-2896.2010.00909.x; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bannard O, 2009, SCIENCE, V323, P505, DOI 10.1126/science.1166831; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Bronevetsky Y, 2013, J EXP MED, V210, P417, DOI 10.1084/jem.20111717; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Castellano L, 2013, NUCLEIC ACIDS RES, V41, P3339, DOI 10.1093/nar/gks1474; Dai WP, 2015, LIVER INT, V35, P1234, DOI 10.1111/liv.12660; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Dudda JC, 2013, IMMUNITY, V38, P742, DOI 10.1016/j.immuni.2012.12.006; Feng Y, 2012, RNA, V18, P2083, DOI 10.1261/rna.033688.112; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Khan AA, 2013, BLOOD, V121, P4473, DOI 10.1182/blood-2012-06-435412; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00178; Lind EF, 2013, J IMMUNOL, V190, P1210, DOI 10.4049/jimmunol.1202700; Liu Juan, 2013, Cancer Biology Medicine, V10, P131, DOI 10.7497/j.issn.2095-3941.2013.03.002; Maris CH, 2003, J IMMUNOL, V171, P2393, DOI 10.4049/jimmunol.171.5.2393; Masopust D, 2007, J VIROL, V81, P2002, DOI 10.1128/JVI.01459-06; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Pepin G, 2012, NUCLEIC ACIDS RES, V40, P11603, DOI 10.1093/nar/gks903; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Soderquest K, 2011, J IMMUNOL, V186, P3304, DOI 10.4049/jimmunol.1004122; Stadnisky MD, 2011, BLOOD, V117, P5133, DOI 10.1182/blood-2010-12-324632; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; Tsai CY, 2013, J VIROL, V87, P2348, DOI 10.1128/JVI.01742-12; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang N, 2010, P NATL ACAD SCI USA, V107, P21629, DOI 10.1073/pnas.1016299107	41	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162674	10.1371/journal.pone.0162674	http://dx.doi.org/10.1371/journal.pone.0162674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627450	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600051
J	Hu, JH; Ye, F; Cui, M; Lee, P; Wei, CG; Hao, YY; Wang, XQ; Wang, YB; Lu, ZH; Galsky, M; McBride, R; Wang, L; Wang, DW; Cordon-Cardo, C; Wang, CX; Zhang, DY				Hu, Jinghai; Ye, Fei; Cui, Miao; Lee, Peng; Wei, Chengguo; Hao, Yuanyuan; Wang, Xiaoqing; Wang, Yanbo; Lu, Zhihua; Galsky, Matthew; McBride, Russell; Wang, Li; Wang, Dongwen; Cordon-Cardo, Carlos; Wang, Chunxi; Zhang, David Y.			Protein Profiling of Bladder Urothelial Cell Carcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RADICAL CYSTECTOMY; SIGNALING NETWORK; FACTOR RECEPTOR; CANCER; EXPRESSION; MUTATIONS; PROGNOSIS; CISPLATIN; SURVIVAL	This study aimed to detect protein changes that can assist to understand the underlying biology of bladder cancer. The data showed forty five proteins were found to be differentially expressed comparing tumors vs non-tumor tissues, of which EGFR and cdc2p34 were correlated with muscle invasion and histological grade. Ten proteins (beta-catenin, HSP70, autotaxin, Notch4, PSTPIP1, DPYD, ODC, cyclinB1, calretinin and EPO) were able to classify muscle invasive BCa (MIBC) into 2 distinct groups, with group 2 associated with poorer survival. Finally, 3 proteins (P2X7, cdc25B and TFIIH p89) were independent factors for favorable overall survival.	[Hu, Jinghai; Hao, Yuanyuan; Wang, Xiaoqing; Wang, Yanbo; Lu, Zhihua; Wang, Chunxi] Jilin Univ, Hosp 1, Dept Urol, Changchun 130021, Jilin, Peoples R China; [Ye, Fei; Cui, Miao; McBride, Russell; Cordon-Cardo, Carlos; Zhang, David Y.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY 10010 USA; [Wei, Chengguo] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA; [Galsky, Matthew] Mt Sinai Sch Med, Dept Med, Div Hematol & Oncol, New York, NY USA; [Wang, Li] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Wang, Li] Mt Sinai Sch Med, Dept Genom Sci, New York, NY USA; [Wang, Dongwen] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan 030002, Shanxi, Peoples R China	Jilin University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Shanxi Medical University	Wang, CX (corresponding author), Jilin Univ, Hosp 1, Dept Urol, Changchun 130021, Jilin, Peoples R China.; Zhang, DY (corresponding author), Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA.	chunxi_wang@126.com; david.zhang@mssm.edu	cui, miao/HCH-7244-2022		Science and Technology Department of Jilin Province, China [20140414003GH]	Science and Technology Department of Jilin Province, China	This work was supported by Science and Technology Department of Jilin Province, China (grant 20140414003GH) (http://www.jlkjxm.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Bellmunt J, 2007, ANN ONCOL, V18, P522, DOI 10.1093/annonc/mdl435; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Broggini M, 2000, ANTICANCER RES, V20, P4835; Canesin G, 2010, TUMOR BIOL, V31, P277, DOI 10.1007/s13277-010-0033-9; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Colquhoun AJ, 2002, POSTGRAD MED J, V78, P584, DOI 10.1136/pmj.78.924.584; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Fregoso M, 2007, MOL CELL BIOL, V27, P3640, DOI 10.1128/MCB.00030-07; Gala JL, 2000, CLIN CANCER RES, V6, P4049; Gore JL, 2010, JNCI-J NATL CANCER I, V102, P802, DOI 10.1093/jnci/djq121; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hakabayashi H, 2006, J CLIN PATHOL, V59, P725, DOI 10.1136/jcp.2005.029546; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Kaczmarek Piotr, 2006, Polish Journal of Pathology, V57, P41; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Lee BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035812; Lugli A, 2003, HUM PATHOL, V34, P994, DOI 10.1053/S0046-8177(03)00339-3; MacArthur BD, 2010, BIOINFORMATICS, V26, P143, DOI 10.1093/bioinformatics/btp628; MELLON K, 1995, J UROLOGY, V153, P919, DOI 10.1016/S0022-5347(01)67604-3; MESSING EM, 1987, J UROLOGY, V138, P1329, DOI 10.1016/S0022-5347(17)43593-2; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Raffaghello L, 2006, CANCER RES, V66, P907, DOI 10.1158/0008-5472.CAN-05-3185; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodel C, 2002, J CLIN ONCOL, V20, P3061, DOI 10.1200/JCO.2002.11.027; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slater M, 2004, HISTOPATHOLOGY, V44, P206, DOI 10.1111/j.0309-0167.2004.01798.x; Slater M, 2004, BREAST CANCER RES TR, V83, P1, DOI 10.1023/B:BREA.0000010670.85915.0f; Sonpavde G, 2010, LANCET ONCOL, V11, P861, DOI 10.1016/S1470-2045(10)70086-3; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Varga A, 2004, EUR UROL, V46, P462, DOI 10.1016/j.eururo.2004.04.014; Vashistha V, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-966; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wang DG, 2011, AM J PATHOL, V179, P1657, DOI 10.1016/j.ajpath.2011.06.010; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Ye F, 2009, NUTR CANCER, V61, P530, DOI 10.1080/01635580902803719; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Zhang DY, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-20; Zhang Z, 2014, TUMOR BIOL, V35, P2503, DOI 10.1007/s13277-013-1331-9	40	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161922	10.1371/journal.pone.0161922	http://dx.doi.org/10.1371/journal.pone.0161922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626805	Green Submitted, gold, Green Published			2022-12-26	WOS:000383680600012
J	Martinez-Torres, AO; Mosquera, MM; De Ory, F; Gonzalez-Praetorius, A; Echevarria, JE				Martinez-Torres, Alex O.; Mosquera, Maria M.; De Ory, Fernando; Gonzalez-Praetorius, Alejandro; Echevarria, Juan E.			Genetic Characterization of Rubella Virus Strains Detected in Spain, 1998-2014	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; OUTBREAK	The National Plan for the Elimination of Rubella was implemented in Spain in 2008 using the logistics of the National Plan for the Elimination of Measles that have been employed since year 2000. Molecular characterization of rubella virus (RUBV) is important for disease surveillance and for monitoring elimination of the disease throughout the world. We describe the first complete series of data regarding the circulation of RUBV genotypes in Spain. The 739-nucleotide fragment designated by the WHO for RUBV genotyping was sequenced in 88 selected cases collected from 1998 to 2014. Five genotypes were identified: 1E, 2B, 1J, 1I, and 1a. Genotype 1E was predominant between 1998 and 2003 but was replaced by genotype 2B, which was detected in sporadic cases in 2004, 2006, 2008, 2012, 2013 and 2014. There was an outbreak of genotype 2B in Algeciras (Andalusia) in 2008. Genotype 1J caused an outbreak in Madrid in 2004/2005 and sporadic cases in 2005 and 2007. Genotype 1I was found to have infected an immune-suppressed patient with neurological symptoms in 2008. Finally, vaccine strain RA 27/3 was detected in three sporadic cases, two of them immune-suppressed and without a recent history of vaccination. This suggests that during these years there were a series of imported sporadic cases and outbreaks, confirming the findings of epidemiological data analysis. The importation sources were generally consistent with our geographic and cultural ties, mainly with Europe (genotypes 1E, 2B, 1I) and Latin America (1J).	[Martinez-Torres, Alex O.; Mosquera, Maria M.; De Ory, Fernando; Echevarria, Juan E.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Martinez-Torres, Alex O.] Univ Panama, Lab Microbiol Expt & Aplicada, Vicerrectoria Invest & Postgrad, Ciudad De Panama, Panama; [Gonzalez-Praetorius, Alejandro] Hosp Univ Guadalajara, Secc Microbiol, Guadalajara, Spain; [Mosquera, Maria M.; De Ory, Fernando; Echevarria, Juan E.] CIBERESP, CIBER Epidemiol & Salud Publ, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad de Panama; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Martinez-Torres, AO (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.; Martinez-Torres, AO (corresponding author), Univ Panama, Lab Microbiol Expt & Aplicada, Vicerrectoria Invest & Postgrad, Ciudad De Panama, Panama.	amartinet13@hotmail.com	Echevarria, Juan E./F-7913-2016	Echevarria, Juan E./0000-0001-7522-850X; Gonzalez Praetorius, Alejandro/0000-0002-7886-0321; Martinez-Torres, Alex Omar/0000-0002-5001-6217; Mosquera Gutierrez, Maria del Mar/0000-0001-5863-7424	fellowship for Ph.D. Study by Republic of Panama; Acuerdo de Encomienda de Gestion entre la Direccion General de Salud Publica del Ministerio de Sanidad y Consumo y el Instituto de Salud Carlos III; Strategic Action on Health of the Instituto de Salud Carlos III [FIS PI12/02006]	fellowship for Ph.D. Study by Republic of Panama; Acuerdo de Encomienda de Gestion entre la Direccion General de Salud Publica del Ministerio de Sanidad y Consumo y el Instituto de Salud Carlos III(Instituto de Salud Carlos III); Strategic Action on Health of the Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work has received financial support from the fellowship for Ph.D. Study by Republic of Panama and Acuerdo de Encomienda de Gestion entre la Direccion General de Salud Publica del Ministerio de Sanidad y Consumo y el Instituto de Salud Carlos III. No expediente: DGVI-1429/05-3, and Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (IP12/02006). Also, has been developed under the Project FIS PI12/02006 funded by the Strategic Action on Health of the Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy ES, 2011, J INFECT DIS, V204, pS524, DOI 10.1093/infdis/jir099; Ahumada-Ruiz S, 2009, INFECT GENET EVOL, V9, P933, DOI 10.1016/j.meegid.2009.06.013; Amela Heras C., 2000, Boletin Epidemiologico Semanal, V8, P169; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P216; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P337; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; [Anonymous], 2005, B EP COM MADR, V11, P33; Calendario vacunal 1999, 1999, B EP COM MADR, V4, P50; CHANTLER J, 2001, FIELDS VIROLOGY, P963; Frey TK, 1998, J INFECT DIS, V178, P642, DOI 10.1086/515370; Hinman A R, 1998, Rev Panam Salud Publica, V4, P156; Martinez-Torres AO, 2009, J CLIN MICROBIOL, V47, P158, DOI 10.1128/JCM.00469-08; Masa J, 2009, INFORME ANUAL PLAN E, P1; Masa-Calles J, 2015, VIGILANCIA SARAMPION, P1; Mosquera MD, 2002, J CLIN MICROBIOL, V40, P111, DOI 10.1128/JCM.40.1.111-116.2002; Mosquera Mdel M., 2010, DESARROLLO DIAGNOSTI, P192; Mosquera MDM, 2006, ENFERM INFEC MICR CL, V24, P251, DOI 10.1016/S0213-005X(06)73771-5; Nuevo Calendario Vacunal, 1996, B EP COM MADR, V19, P25; Pena-Rey I, 2009, B EPIDEMIOL SEM, V17, P85; Rota P. A., 2005, Morbidity and Mortality Weekly Report, V54, P1100; Sanz JC, 2004, ENFERM INFEC MICR CL, V22, P197, DOI 10.1157/13058030; Torner N, 2005, EUROSURVEILLANCE, V11; Vauloup-Fellous C, 2010, J CLIN MICROBIOL, V48, P2530, DOI 10.1128/JCM.00181-10; World Health Organization, 2003, STRAT PLAN MEASL CON; Zheng DP, 2003, EMERG INFECT DIS, V9, P1523; Zheng DP, 2003, J INFECT DIS, V187, P1587, DOI 10.1086/374972	27	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162403	10.1371/journal.pone.0162403	http://dx.doi.org/10.1371/journal.pone.0162403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622271	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000031
J	Pitts, S; Pelser, E; Meeks, J; Smith, D				Pitts, Svetlana; Pelser, Elizabeth; Meeks, Julian; Smith, Dean			Odorant Responses and Courtship Behaviors Influenced by at4 Neurons in Drosophila	PLOS ONE			English	Article							PHEROMONE-SENSITIVE NEURONS; OR65A OLFACTORY NEURONS; CUTICULAR HYDROCARBONS; GUSTATORY NEURONS; MELANOGASTER; ATTRACTION; ACTIVATION; AGGRESSION; SUBUNIT; ACETATE	In insects, pheromones function as triggers to elicit complex behavior programs, such as courtship and mating behavior. In most species, the neurons tuned to pheromones are localized in a specific subset of olfactory sensilla located on the antenna called trichoid sensilla. In Drosophila there are two classes of trichoid sensilla, at1 sensilla that contain the dendrites of a single neuron that is specifically tuned to the male-specific pheromone 11-cis vaccenyl acetate (cVA), and at4 sensilla that contain three neurons with relatively poorly defined chemical specificity and function. Using a combination of odorant receptor mutant analysis, single sensillum electrophysiology and optogenetics, we have examined the chemical tuning and behavioral consequences of the three at4 olfactory neuron classes. Our results indicate that one class, Or65abc neurons, are unresponsive to cVA pheromone, and function to inhibit courtship behaviors in response to an unknown ligand, while the other two neuron classes, Or88a and Or47b neurons, are sensitive to a diverse array of fly and non-fly odors, and activation of these neurons has little direct impact on courtship behaviors.	[Pitts, Svetlana; Pelser, Elizabeth; Meeks, Julian; Smith, Dean] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Smith, Dean] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Smith, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Smith, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dean.smith@utsouthwestern.edu		Scheuermann, Elizabeth/0000-0002-7498-7130; Smith, Dean/0000-0002-4271-0436	National Institute on Deafness and Other Communication Disorders [R01DC011751]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015230, R01DC011751] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institute on Deafness and Other Communication Disorders, R01DC011751 to Dr. Dean Smith.	BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dweck HKM, 2015, P NATL ACAD SCI USA, V112, pE2829, DOI 10.1073/pnas.1504527112; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Elmore T, 2003, J NEUROSCIENCE IN PR; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hendrickson RC, 2008, J NEUROSCI, V28, P12523, DOI 10.1523/JNEUROSCI.2715-08.2008; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/nmeth.2765, 10.1038/NMETH.2765]; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lebreton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07119; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liu T, 2012, J NEUROSCI, V32, P11879, DOI 10.1523/JNEUROSCI.1376-12.2012; Liu WW, 2011, NAT NEUROSCI, V14, P896, DOI 10.1038/nn.2836; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Meeks JP, 2010, NAT NEUROSCI, V13, P723, DOI 10.1038/nn.2546; Munch D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21841; Ronderos DS, 2014, J NEUROSCI, V34, P3959, DOI 10.1523/JNEUROSCI.4582-13.2014; Ronderos DS, 2010, J NEUROSCI, V30, P2595, DOI 10.1523/JNEUROSCI.4819-09.2010; Starostina E, 2012, J NEUROSCI, V32, P4665, DOI 10.1523/JNEUROSCI.6178-11.2012; Thistle R, 2012, CELL, V149, P1140, DOI 10.1016/j.cell.2012.03.045; van der Goes van Naters W, 2007, CURR BIOL, V17, P606, DOI DOI 10.1016/J.CUB.2007.02.043; Vogt RG, 2005, PHYSL BIOCH PHARM MO, P753; Wang L. F., 2011, FOREIGN LANGUAGE WOR, V6, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022325; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	35	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162761	10.1371/journal.pone.0162761	http://dx.doi.org/10.1371/journal.pone.0162761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617442	Green Submitted, Green Published, gold			2022-12-26	WOS:000383653100050
J	Wang, C; Liu, QF; Chen, FF; Xu, WJ; Zhang, CQ; Xiao, W				Wang, Chao; Liu, Qingfa; Chen, Fangfang; Xu, Wenjuan; Zhang, Caiqing; Xiao, Wei			IL-25 Promotes Th2 Immunity Responses in Asthmatic Mice via Nuocytes Activation	PLOS ONE			English	Article							TYPE-2 IMMUNITY; AIRWAY HYPERREACTIVITY; THERAPEUTIC TARGETS; LYMPHOID-CELLS; INNATE; INTERLEUKIN-25; DISEASE; LUNG; INFLAMMATION; CYTOKINES	Background Interleukin-25 (IL-25) is a potent activator of type-2 immune responses, and is responsible for airway inflammation in asthma. Previous reports have shown that IL-25 expressed hyper-reactivity in an experimental mouse-model of asthma. In addition, the production of IL-13/IL-5 promoted by nuocytes induced airway inflammation. Thus, it has been questioned whether blocking IL-25 against its receptor IL-17BR could inhibit the expression of IL-13 and IL-5 via nuocytes, and further protect against inflammation in ovalbumin (OVA) induced mouse-model of asthma. Methods In this study, in order to investigate the correlation among IL-25, IL-5, IL-13 and nuocyte activities, we used OVA-sensitization and -challenging to induce the mouse model of asthma. The murine asthmatic model was validated by histology. The expressions of IL-5, IL-13 and IL-25 were detected by ELISA, quantitative real-time PCR, and western blotting of the lung tissue. Nuocyte activation was identified by the levels of ICOS (clone C398.4A) and T1/ST2 (cloneDJ8) (acting as nuocytes surface markers) in the bronchoalveolar lavage fluid (BALF). This, in turn, was done by means of flow cytometry. The expressions of IL-25, IL-5 and IL-13 in our murine model were detected in the BALF. Results The mice sensitized and challenged with OVA showed a high expression of IL-25 in both the mRNA and protein levels in lungs. The expressions of ICOS and T1/ST2 in BALF were increased. A significant correlation between IL-25 mRNA, protein, and other Th2-cell producing cytokines (such as IL-5 and IL-13) moreover were identified. Furthermore, when the asthmatic mice were treated with anti-IL-25, both the inflammatory cells' infiltration and the inflammatory cytokines' secretion were significantly decreased. The present findings indicate that IL-25 might be involved in a series of asthmatic immune responses, playing an important role in the increase of nuocytes, and that its activation is necessary in maintaining Th2 central memory and sustaining asthmatic inflammation. Conclusion This study showed that IL-25 promoted the accumulation of ICOS and T1/ST2 on nuocytes, further induced the pro-inflammatory Th2 cells, and promoted Th2 cytokine responses in OVA-induced airway inflammation.	[Wang, Chao; Chen, Fangfang; Xu, Wenjuan; Zhang, Caiqing] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China; [Liu, Qingfa] Shandong Univ, Sch Med Sci, Jinan, Shandong, Peoples R China; [Xiao, Wei] Shandong Univ, Qilu Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University	Zhang, CQ (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China.; Xiao, W (corresponding author), Shandong Univ, Qilu Hosp, Dept Resp Med, Jinan, Shandong, Peoples R China.	freezcq66@163.com; xiaoxingxingxh@163.com			Department of Science and Technology Foundation [2012 GSF 11830]; Natural and Science Foundation of Shandong Province, China [ZR2013HM046]	Department of Science and Technology Foundation; Natural and Science Foundation of Shandong Province, China	This work was supported by the Department of Science and Technology Foundation (2012 GSF 11830), and the Natural and Science Foundation of Shandong Province, China (ZR2013HM046).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Balazs Antus, 2012, Orvosi Hetilap, V153, P1847, DOI 10.1556/OH.2012.29494; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Barlow JL, 2011, J LEUKOCYTE BIOL, V90, P867, DOI 10.1189/jlb.0311160; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; Camelo A, 2012, J GASTROENTEROL, V47, P1198, DOI 10.1007/s00535-012-0591-2; Cully M, 2014, NAT REV DRUG DISCOV, V13, P810, DOI 10.1038/nrd4473; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gregory LG, 2013, THORAX, V68, P82, DOI 10.1136/thoraxjnl-2012-202003; Groves AM, 2012, AM J RESP CELL MOL, V47, P776, DOI 10.1165/rcmb.2011-0433OC; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Ji XY, 2014, INT J CLIN EXP PATHO, V7, P7554; Kaiko GE, 2011, CURR OPIN ALLERGY CL, V11, P39, DOI 10.1097/ACI.0b013e328342322f; Kang CM, 2005, AM J RESP CELL MOL, V33, P290, DOI 10.1165/rcmb.2005-0003OC; Kim JY, 2013, EXP DERMATOL, V22, P219, DOI 10.1111/exd.12092; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI 10.1016/j.mrfmmm.2009.09.005; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Petersen BC, 2012, FUTURE MED CHEM, V4, P833, DOI [10.4155/fmc.12.39, 10.4155/FMC.12.39]; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Shifren A, 2012, J ALLERGY, V2012, P1, DOI DOI 10.1155/2012/316049; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Silverman J, 2012, LAB ANIMAL, V41, P230, DOI 10.1038/laban0812-230; Stock P, 2009, J IMMUNOL, V182, P5116, DOI 10.4049/jimmunol.0804213; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Yang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059441; Yao XJ, 2015, RESPIROLOGY, V20, P730, DOI 10.1111/resp.12546	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162393	10.1371/journal.pone.0162393	http://dx.doi.org/10.1371/journal.pone.0162393			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617447	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100020
J	Alexandrino, AV; Goto, LS; Novo-Mansur, MTM				Alexandrino, Andre Vessoni; Goto, Leandro Seiji; Marques Novo-Mansur, Maria Teresa			treA Codifies for a Trehalase with Involvement in Xanthomonas citri subsp citri Pathogenicity	PLOS ONE			English	Article							ESCHERICHIA-COLI; METABOLISM; DNA	Citrus canker, caused by the bacterium Xanthomonas citri subsp. citri (Xcc), is a severe disease of citrus. Xcc presents broad spectrum of citrus hosts including economically important species whereas X. fuscans subsp. aurantifolii-type C (XauC) causes a milder disease and only infects Citrus aurantifolia. Trehalase catalyzes hydrolysis of the disaccharide trehalose, a sugar that has been reported to be related to Xcc pathogenicity. We expressed the recombinant gene product and assessed Xcc trehalase structural and kinetics data. The recombinant protein presented 42.7% of secondary structures in alpha-helix and 13% in beta-sheets, no quaternary structure in solution, and Michaelis-Menten constant (K-M) of 0.077 mM and V-max 55.308 mu Mol glucose.min(-1).mg protein(-1) for trehalose. A Xcc mutant strain (Xcc Delta treA) was produced by gene deletion from Xcc genome. Enzymatic activity of trehalase was determined in Xcc, XauC and Xcc Delta treA cellular lysates, showing the highest values for XauC in in vitro infective condition and no activity for Xcc Delta treA. Finally, leaves of Citrus aurantifolia infected with Xcc Delta treA showed much more drenching and necrosis than those infected by wild type Xcc. We concluded that trehalase contributes to alleviate bacterial virulence and that inability for trehalose hydrolysis may promote higher Xcc infectivity.	[Alexandrino, Andre Vessoni; Goto, Leandro Seiji; Marques Novo-Mansur, Maria Teresa] Univ Fed Sao Carlos, Dept Genet & Evolucao, LBBMA, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos	Alexandrino, AV (corresponding author), Univ Fed Sao Carlos, Dept Genet & Evolucao, LBBMA, Sao Carlos, SP, Brazil.	avalex@uol.com.br	Mansur, Maria Teresa Marques Novo/G-4779-2012; Alexandrino, André Vessoni/M-9295-2016	Mansur, Maria Teresa Marques Novo/0000-0003-0308-6287; Alexandrino, André Vessoni/0000-0002-0111-3491	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/50910-2]; Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil); Fundecitrus (Araraquara-SP, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES-PNPD [23038.006942/2011-31]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [131047/2013-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil); Fundecitrus (Araraquara-SP, Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES-PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Project 07/50910-2), Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil) and Fundecitrus (Araraquara-SP, Brazil). LSG is recipient of a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES-PNPD Institucional 23038.006942/2011-31. AVA received a scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Process 131047/2013-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Project 07/50910-2) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PNPD Institucional 23038.006942/2011-31) for financial support and to Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Process 131047/2013-2) for providing a scholarship to A.V.A. We also thank the support from Grupo de Biofisica Molecular "Sergio Mascarenhas" (USP-Sao Carlos-SP, Brazil) and Fundecitrus (Araraquara-SP, Brazil), especially to Dr. Franklin Behlau and Tamiris Garcia da Silva.	Ausubel F, 2002, SHORT PROTOCOLS MOL, V2; Bramucci MG, 1996, APPL ENVIRON MICROB, V62, P3948, DOI 10.1128/AEM.62.11.3948-3953.1996; Brodmann D, 2002, MOL PLANT MICROBE IN, V15, P693, DOI 10.1094/MPMI.2002.15.7.693; Civerolo E, 1984, J RIO GRANDE VALLEY; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Das A. K., 2003, Journal of Applied Horticulture (Lucknow), V5, P52; Djonovic S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003217; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Facincani AP, 2014, FUNCT INTEGR GENOMIC, V14, P205, DOI 10.1007/s10142-013-0340-5; FERREIRA H, 1995, APPL MICROBIOL BIOT, V43, P651, DOI 10.1007/BF00164769; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Goto LS, BIOCH BIOPHYSICA ACT; Goto M., 1992, Plant diseases of international importance. Volume III. Diseases of fruit crops., P170; Gottwald T. R., 2002, PLANT HLTH PROG, P10, DOI [10.1094/PHP2002-081201-RV, DOI 10.1094/PHP2002-081201-RV]; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Michaelis L, 1913, BIOCHEM Z, V49, P333; Moreira LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-238; Moreira LM, 2005, OMICS, V9, P43, DOI 10.1089/omi.2005.9.43; PADMANABHAN D, 1974, Indian Phytopathology, V27, P215; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Piazza A, 2015, J EXP BOT, V66, P2795, DOI 10.1093/jxb/erv095; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; TOURINHODOSSANTOS CF, 1994, BRAZ J MED BIOL RES, V27, P627; Trinder P., 1969, ANN CLIN BIOCH; Uhland K, 2000, J BIOL CHEM, V275, P23439, DOI 10.1074/jbc.M002793200	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162886	10.1371/journal.pone.0162886	http://dx.doi.org/10.1371/journal.pone.0162886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611974	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900182
J	Pope, NH; Salmon, M; Davis, JP; Chatterjee, A; Su, G; Conte, MS; Ailawadi, G; Upchurch, GR				Pope, Nicolas H.; Salmon, Morgan; Davis, John P.; Chatterjee, Anuran; Su, Gang; Conte, Michael S.; Ailawadi, Gorav; Upchurch, Gilbert R., Jr.			D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization	FASEB JOURNAL			English	Article						inflammation; proresolving mediators; vascular biology	PRORESOLVING LIPID MEDIATORS; MATRIX METALLOPROTEINASES; INFLAMMATION; RESOLUTION; ACTIVATION; RECEPTOR; HYPERPLASIA; PROTECTS; ASPIRIN; MODEL	The role of resolvins in abdominal aortic aneurysm (AAA) has not been established. We hypothesized that treatment with D-series resolvins (RvD2 or RvD1) would attenuate murine AAA formation through alterations in macrophage polarization and cytokine expression. Male C57/B6 mice (n = 9 per group) 8 to 12 wk old received RvD2 (100 ng/kg/treatment), RvD1 (100 ng/kg/treatment), or vehicle only every third day beginning 3 d before abdominal aortic perfusion with elastase as prevention. Aortas were collected 14d after elastase perfusion. Cytokine analysis (n = 5 per group) or confocal microscopy (n = 4 per group) was performed. In a separate experiment, RvD2 was provided to mice with small AAAs 3 d after elastase treatment (n = 8 per group). Additionally, apolipoprotein E knockout mice treated with angiotensin II (1000ng/kg) were treated with RvD2 or vehicle alone (n = 10 per group) in a nonsurgical model of AAA. To determine the effect of RvD2 on macrophage polarization, confocal staining for macrophages, M1 and M2 macrophage subtypes, alpha-actin, and DAPI was performed. Mean aortic dilation was 96 +/- 13% for vehicle-treated mice, 57 +/- 9.7% for RvD2-treated mice, and 61 +/- 11% for RvD1-treated mice (P < 0.0001). Proinflammatory cytokines macrophage chemotactic protein 1, C-X-C motif ligand 1, and IL-1 beta were significantly elevated in control animals compared to RvD2- and RvD1-treated animals (P < 0.05), resulting in a reduction of matrix metalloproteinase 2 and 9 activity in resolvin-treated mice in both elastase and angiotensin II models. Treatment of existing small AAAs with RvD2 demonstrated a 25% reduction in aneurysm size at d 14 compared to vehicle alone (P = 0.018). Confocal histology demonstrated a prevalence of M2 macrophages within the aortic medium in mice treated with RvD2. Resolvin D2 exhibits a potent protective effect against experimental AAA formation. Treatment with RvD2 significantly influences macrophage polarization and decreases several important proinflammatory cytokines. Resolvins and the alteration of macrophage polarization represent potential future targets for prevention of AAA.	[Pope, Nicolas H.; Salmon, Morgan; Davis, John P.; Su, Gang; Ailawadi, Gorav; Upchurch, Gilbert R., Jr.] Univ Virginia, Dept Surg, POB 800679, Charlottesville, VA 22908 USA; [Chatterjee, Anuran; Conte, Michael S.] Univ Calif San Francisco, Dept Surg, Div Vasc & Endovasc Surg, San Francisco, CA USA	University of Virginia; University of California System; University of California San Francisco	Pope, NH (corresponding author), Univ Virginia, Dept Surg, POB 800679, Charlottesville, VA 22908 USA.	np7g@virginia.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [K08-HL098560, R01-HL081629]; NIH NHLBI Award [T32-HL007849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098560, T32HL007849, R01HL119508, R01HL126668, R01HL081629] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NHLBI Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants K08-HL098560 (to G.A.) and R01-HL081629 (to G.R.U.). This project was supported by NIH NHLBI Award T32-HL007849 (to N.H.P., principal investigator: I.L. Kron). The content is solely the responsibility of the authors and does not necessarily represent the views of the NHLBI. The authors thank A. Herring, C. Dodson, and M. Bevard for their technical expertise.	Ailawadi G, 2003, J VASC SURG, V37, P1059, DOI 10.1067/mva.2003.163; Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Blomkalns AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000065; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Johnston W. F., 2014, J VASC SURG; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Kavazos K, 2015, HEART LUNG CIRC, V24, P377, DOI 10.1016/j.hlc.2014.11.005; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1724; Lindholt JS, 2008, VASC ENDOVASC SURG, V42, P329, DOI 10.1177/1538574408315205; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; NEWMAN KM, 1994, CONNECT TISSUE RES, V30, P265, DOI 10.3109/03008209409015042; NEWMAN KM, 1994, CIRCULATION, V90, P224; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Pillai PS, 2012, INFLAMMATION, V35, P98, DOI 10.1007/s10753-011-9294-8; Salmon M, 2013, CIRCULATION, V128, pS163, DOI 10.1161/CIRCULATIONAHA.112.000238; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Wang J.H., 2014, J APPL MATH, V2014; Woodrum DT, 2005, J AM COLL SURGEONS, V201, P398, DOI 10.1016/j.jamcollsurg.2005.04.002; Yoshihara T, 2015, CIRC J, V79, P1470, DOI 10.1253/circj.CJ-14-0471	45	70	71	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4192	4201		10.1096/fj.201600144RR	http://dx.doi.org/10.1096/fj.201600144RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27619672	Green Published			2022-12-26	WOS:000388201500025
J	Hoppstadter, J; Hachenthal, N; Valbuena-Perez, JV; Lampe, S; Astanina, K; Kunze, MM; Bruscoli, S; Riccardi, C; Schmid, T; Diesel, B; Kiemer, AK				Hoppstaedter, Jessica; Hachenthal, Nina; Valbuena-Perez, Jenny Vanessa; Lampe, Sebastian; Astanina, Ksenia; Kunze, Michael M.; Bruscoli, Stefano; Riccardi, Carlo; Schmid, Tobias; Diesel, Britta; Kiemer, Alexandra K.			Induction of Glucocorticoid-induced Leucine Zipper (GILZ) Contributes to Anti-inflammatory Effects of the Natural Product Curcumin in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN HUR; INFLAMMATORY-BOWEL-DISEASE; FACTOR-KAPPA-B; MESSENGER-RNA; NITRIC-OXIDE; TRANSLATIONAL CONTROL; TRANSGENIC MICE; HUMAN ALVEOLAR; CELL-DEATH; RECEPTOR 4	GILZ (glucocorticoid-induced leucine zipper) is inducible by glucocorticoids and plays a key role in their mode of action. GILZ attenuates inflammation mainly by inhibition of NF-kappa B and mitogen-activated protein kinase activation but does not seem to be involved in the severe side effects observed after glucocorticoid treatment. Therefore, GILZ might be a promising target for new therapeutic approaches. The present work focuses on the natural product curcumin, which has previously been reported to inhibit NF-kappa B. GILZ was inducible by curcumin in macrophage cell lines, primary human monocyte-derived macrophages, and murine bone marrow-derived macrophages. The up-regulation of GILZ was neither associated with glucocorticoid receptor activation nor with transcriptional induction or mRNA or protein stabilization but was a result of enhanced translation. Because the GILZ 3'-UTR contains AU-rich elements (AREs), we analyzed the role of the mRNA-binding protein HuR, which has been shown to promote the translation of ARE-containing mRNAs. Our results suggest that curcumin treatment induces HuR expression. An RNA immunoprecipitation assay confirmed that HuR can bind GILZ mRNA. In accordance, HuR overexpression led to increased GILZ protein levels but had no effect on GILZ mRNA expression. Our data employing siRNA in LPS-activated RAW264.7 macrophages show that curcumin facilitates its anti-inflammatory action by induction of GILZ in macrophages. Experiments with LPS-activated bone marrow-derived macrophages from wild-type and GILZ knock-out mice demonstrated that curcumin inhibits the activity of inflammatory regulators, such as NF-kappa B or ERK, and subsequent TNF-kappa production via GILZ. In summary, our data indicate that HuR-dependent GILZ induction contributes to the anti-inflammatory properties of curcumin.	[Hoppstaedter, Jessica; Hachenthal, Nina; Valbuena-Perez, Jenny Vanessa; Astanina, Ksenia; Diesel, Britta; Kiemer, Alexandra K.] Univ Saarland, Dept Pharm, Pharmaceut Biol, D-66041 Saarbrucken, Germany; [Lampe, Sebastian; Kunze, Michael M.; Schmid, Tobias] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60590 Frankfurt, Germany; [Bruscoli, Stefano; Riccardi, Carlo] Univ Perugia, Pharmacol Sect, Dept Med, I-06132 Perugia, Italy	Saarland University; Goethe University Frankfurt; University of Perugia	Kiemer, AK (corresponding author), Univ Saarland, Pharmaceut Biol, POB 15 11 50, D-66041 Saarbrucken, Germany.	pharm.bio.kiemer@mx.uni-saarland.de	Kiemer, Alexandra K./I-9300-2012; Riccardi, Carlo/N-4610-2014; Hoppstädter, Jessica/AAM-2548-2020	Kiemer, Alexandra K./0000-0002-7224-9900; Riccardi, Carlo/0000-0001-9257-3997; Valbuena Perez, J. Vanessa/0000-0001-7734-6251; Hoppstadter, Jessica/0000-0001-8758-1554; Schmid, Tobias/0000-0002-1952-5259	Deutsche Forschungsgemeinschaft, Bonn, Germany [KI702]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This work was supported, in part, by Deutsche Forschungsgemeinschaft, Bonn, Germany (Grant KI702). The authors declare that they have no conflicts of interest with the contents of this article.	Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4; Aggarwal B. B., 2013, British Journal of Pharmacology, V169, P1672, DOI 10.1111/bph.12131; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Astanina K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11453; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Brumatti LV, 2014, MOLECULES, V19, P21127, DOI 10.3390/molecules191221127; Bruscoli S, 2015, BLOOD, V126, P1790, DOI 10.1182/blood-2015-03-631580; Carroll R. E., 2011, CANCER PREV RES, DOI [10.1158/1940-6207, DOI 10.1158/1940-6207]; Chakravarti N., 2010, CANCER PREV RES, DOI [10.1158/1940-6207, DOI 10.1158/1940-6207]; Chen FY, 2014, J CARDIOVASC PHARM, V63, P544, DOI 10.1097/FJC.0000000000000079; Cheng AL, 2001, ANTICANCER RES, V21, P2895; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; de Oliveira LF, 2016, LANGMUIR, V32, P3217, DOI 10.1021/acs.langmuir.6b00214; Delfino DV, 2006, INT IMMUNOPHARMACOL, V6, P1126, DOI 10.1016/j.intimp.2006.02.001; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fejer G, 2015, IMMUNOBIOLOGY, V220, P169, DOI 10.1016/j.imbio.2014.11.005; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gao SS, 2015, J MOL CELL CARDIOL, V85, P131, DOI 10.1016/j.yjmcc.2015.04.025; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hahn RT, 2014, ATHEROSCLEROSIS, V234, P391, DOI 10.1016/j.atherosclerosis.2014.03.028; Hamdi H, 2007, HEPATOLOGY, V46, P1986, DOI 10.1002/hep.21880; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Hoppstadter J, 2015, ONCOTARGET, V6, P38446, DOI 10.18632/oncotarget.6197; Hoppstadter J, 2015, J IMMUNOL, V194, P6057, DOI 10.4049/jimmunol.1403207; Hoppstadter J, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00055; Hoppstadter J, 2012, EUR J IMMUNOL, V42, P1282, DOI 10.1002/eji.201142081; Hoppstadter J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-124; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Kiemer AK, 2002, IMMUNOL CELL BIOL, V80, P550, DOI 10.1046/j.1440-1711.2002.01124.x; Kiemer AK, 2001, IMMUNOL CELL BIOL, V79, P11, DOI 10.1046/j.1440-1711.2001.00969.x; Kiemer AK, 2009, J INNATE IMMUN, V1, P29, DOI 10.1159/000142731; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kunze MM, 2016, BBA-GENE REGUL MECH, V1859, P848, DOI 10.1016/j.bbagrm.2016.05.005; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2009, MOL CELL BIOL, V29, P2622, DOI 10.1128/MCB.01495-08; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Parodi FE, 2006, ANN VASC SURG, V20, P360, DOI 10.1007/s10016-006-9054-7; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Rodriguez-Pascual F, 2000, J BIOL CHEM, V275, P26040, DOI 10.1074/jbc.M910460199; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Simone LE, 2013, CURR OPIN GENET DEV, V23, P35, DOI 10.1016/j.gde.2012.12.006; Soetikno V., 2011, NUTR METAB LOND; Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Young NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111559; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou YY, 2015, CELL PHYSIOL BIOCHEM, V36, P631, DOI 10.1159/000430126; Zhou Y, 2016, J BIOL CHEM, V291, P291, DOI 10.1074/jbc.M115.693853; Ziaei A, 2015, J ETHNOPHARMACOL, V160, P94, DOI 10.1016/j.jep.2014.10.041	61	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22949	22960		10.1074/jbc.M116.733253	http://dx.doi.org/10.1074/jbc.M116.733253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27629417	Green Published, hybrid			2022-12-26	WOS:000387224800008
J	Quevedo, MF; Lucchesi, O; Bustos, MA; Pocognoni, CA; De la Iglesia, PX; Tomes, CN				Quevedo, Maria F.; Lucchesi, Ornella; Bustos, Matias A.; Pocognoni, Cristian A.; De la Iglesia, Paola X.; Tomes, Claudia N.			The Rab3A-22A Chimera Prevents Sperm Exocytosis by Stabilizing Open Fusion Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE GRANULE EXOCYTOSIS; ACROSOMAL EXOCYTOSIS; CA2+-TRIGGERED EXOCYTOSIS; SYNAPTIC VESICLE; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; HUMAN SPERMATOZOA; SNARE COMPLEX; RAB GTPASES; MECHANISM	At the final stage of exocytotis, a fusion pore opens between the plasma and a secretory vesicle membranes; typically, when the pore dilates the vesicle releases its cargo. Sperm contain a large dense-core secretory granule (the acrosome) whose contents are secreted by regulated exocytosis at fertilization. Minutes after the arrival of the triggering signal, the acrosomal and plasma membranes dock at multiple sites and fusion pores open at the contact points. It is believed that immediately afterward, fusion pores dilate spontaneously. Rab3A is an essential component of human sperm exocytotic machinery. Yet, recombinant, persistently active Rab3A halts calcium-triggered secretion when introduced after docking into streptolysin O-permeabilized cells; so does a Rab3A-22A chimera. Here, we applied functional assays, electron and confocal microscopy to show that the secretion blockage is due to the stabilization of open fusion pores. Other novel findings are that sperm SNAREs engage in alpha-SNAP/NSF-sensitive complexes at a post-fusion stage. Complexes are disentangled by these chaperons to achieve vesiculation and acrosomal contents release. Thus, post-fusion regulation of the pores determines their expansion and the success of the acrosome reaction.	[Quevedo, Maria F.; Lucchesi, Ornella; Bustos, Matias A.; Pocognoni, Cristian A.; De la Iglesia, Paola X.; Tomes, Claudia N.] Univ Nacl Cuyo, IHEM, CONICET, Fac Ciencias Med, CC56, RA-5500 Mendoza, Argentina; [Bustos, Matias A.] John Wayne Canc Inst, Dept Mol Oncol, Santa Monica, CA 90404 USA; [De la Iglesia, Paola X.] Hosp Italiano Buenos Aires, Serv Patol, C1199ABD, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; John Wayne Cancer Institute; Hospital Italiano de Buenos Aires; University of Buenos Aires	Tomes, CN (corresponding author), Univ Nacl Cuyo, IHEM, CONICET, Fac Ciencias Med, CC56, RA-5500 Mendoza, Argentina.	ctomes@fcm.uncu.edu.ar		Bustos, Matias A./0000-0001-9625-1127	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT2010-0342, PICT2013-1216]; Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo (Argentina) [06/J416]	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo (Argentina)	This study was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (Grant numbers PICT2010-0342 and PICT2013-1216, Argentina) and Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo (Grant number 06/J416, Argentina) (to C. N. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Belmonte SA, 2016, ADV ANAT EMBRYOL CEL, V220, P71, DOI 10.1007/978-3-319-30567-7_4; Binotti B, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010007; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Buffone MG, 2012, MOL REPROD DEV, V79, P4, DOI 10.1002/mrd.21393; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Bustos MA, 2014, J MOL CELL BIOL, V6, P286, DOI 10.1093/jmcb/mju021; Bustos MA, 2012, P NATL ACAD SCI USA, V109, pE2057, DOI 10.1073/pnas.1121173109; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chiang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4356; CROSS NL, 1986, GAMETE RES, V15, P213, DOI 10.1002/mrd.1120150303; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Dhara M, 2014, J CELL BIOL, V204, P1123, DOI 10.1083/jcb.201311085; Fang QH, 2014, PHYSIOLOGY, V29, P278, DOI 10.1152/physiol.00026.2013; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Graham ME, 2008, BIOCHEM J, V409, P407, DOI 10.1042/BJ20071094; Han X, 2006, J CELL BIOL, V172, P281, DOI 10.1083/jcb.200510012; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; KAO JPY, 1989, J BIOL CHEM, V264, P8179; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; Lai Y, 2013, P NATL ACAD SCI USA, V110, P1333, DOI 10.1073/pnas.1218818110; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Lucchesi O, 2016, BBA-MOL CELL RES, V1863, P544, DOI 10.1016/j.bbamcr.2015.12.007; Lui PPY, 1997, BIOL SIGNAL, V6, P45; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Zoppino FCM, 2012, FERTIL STERIL, V97, P1309, DOI 10.1016/j.fertnstert.2012.03.002; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Neuland K, 2014, J CELL SCI, V127, P5218, DOI 10.1242/jcs.153742; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pelletan LE, 2015, J BIOL CHEM, V290, P9823, DOI 10.1074/jbc.M114.629006; Pellizzari R, 1999, PHILOS T R SOC B, V354, P259, DOI 10.1098/rstb.1999.0377; Pocognoni CA, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132001; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rodriguez F, 2012, J BIOL CHEM, V287, P43825, DOI 10.1074/jbc.M112.409649; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Ruete MC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0043-0; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Sosa CM, 2015, MOL HUM REPROD, V21, P244, DOI 10.1093/molehr/gau110; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Tomes CN, 2015, BIOCHEM J, V465, P359, DOI 10.1042/BJ20141169; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Vardjan N, 2013, NEUROSCIENTIST, V19, P160, DOI 10.1177/1073858412461691; Wang XY, 2008, J PHYSIOL-LONDON, V586, P3949, DOI 10.1113/jphysiol.2008.151191; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; Zhao WD, 2016, NATURE, V534, P548, DOI 10.1038/nature18598	57	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23101	23111		10.1074/jbc.M116.729954	http://dx.doi.org/10.1074/jbc.M116.729954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613869	Green Published, hybrid			2022-12-26	WOS:000387224800021
J	Arras, SDM; Fraser, JA				Arras, Samantha D. M.; Fraser, James A.			Chemical Inhibitors of Non-Homologous End Joining Increase Targeted Construct Integration in Cryptococcus neoformans	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; DNA-PK; HOMOLOGOUS RECOMBINATION; ASPERGILLUS-FUMIGATUS; INFECTIOUS-DISEASES; PNEUMOCOCCAL TYPES; REPLICATION FORKS; HYBRID PLASMID; GENE DELETION	The development of a biolistic transformation protocol for Cryptococcus neoformans over 25 years ago ushered in a new era of molecular characterization of virulence in this previously intractable fungal pathogen. However, due to the low rate of homologous recombination in this species, the process of creating targeted gene deletions using biolistic transformation remains inefficient. To overcome the corresponding difficulty achieving molecular genetic modifications, members of the Cryptococcus community have investigated the use of specific genetic backgrounds or construct design strategies aimed at reducing ectopic construct integration via non-homologous end joining (NHEJ). One such approach involves deletion of components of the NHEJ-associated Ku heterodimer. While this strategy increases homologous recombination to nearly 100%, it also restricts strain generation to a ku80 Delta genetic background and requires subsequent complex mating procedures to reestablish wild-type DNA repair. In this study, we have investigated the ability of known inhibitors of mammalian NHEJ to transiently phenocopy the C. neoformans Ku deletion strains. Testing of eight candidate inhibitors revealed a range of efficacies in C. neoformans, with the most promising compound (W7) routinely increasing the rate of gene deletion to over 50%. We have successfully employed multiple inhibitors to reproducibly enhance the deletion rate at multiple loci, demonstrating a new, easily applied methodology to expedite acquisition of precise genetic alterations in C. neoformans. Based on this success, we anticipate that the use of these inhibitors will not only become widespread in the Cryptococcus community, but may also find use in other fungal species as well.	[Arras, Samantha D. M.; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.	jafraser@uq.edu.au	Fraser, James A/B-4918-2012	Fraser, James A/0000-0001-5724-5285	National Health and Medical Research Council [455980]; ARC Australian Postgraduate Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Australian Postgraduate Award(Australian Research Council)	This work was supported by the National Health and Medical Research Council (http://www.nhmrc.gov.au/) grant# 455980 to JAF and ARC Australian Postgraduate Award (https://www.education.gov.au/australian-postgraduate-awards) to SDMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2001, GENOME RES, V11, P1365, DOI 10.1101/gr.181001; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; ASANO M, 1989, J PHARMACOL EXP THER, V251, P764; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; Byrum J, 2004, NUCLEIC ACIDS RES, V32, P2776, DOI 10.1093/nar/gkh592; Calabrese CR, 2004, J NATL CANCER I, V96, P56, DOI 10.1093/jnci/djh005; CASE ME, 1979, P NATL ACAD SCI USA, V76, P5259, DOI 10.1073/pnas.76.10.5259; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; Chen Y, 2014, MBIO, V5, DOI 10.1128/mBio.01087-13; Chow EWL, 2012, MOL BIOL EVOL, V29, P1987, DOI 10.1093/molbev/mss066; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; De Soto JA, 2006, INT J BIOL SCI, V2, P179; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Durant S, 2003, NUCLEIC ACIDS RES, V31, P5501, DOI 10.1093/nar/gkg753; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; Institute. CaLS, 2005, M27A2 CLSI; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Karran P, 2006, BRIT MED BULL, V79-80, P153, DOI 10.1093/bmb/ldl020; Kooistra R, 2004, YEAST, V21, P781, DOI 10.1002/yea.1131; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lin XR, 2015, MED MYCOL, V53, P225, DOI 10.1093/mmy/myu083; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mwaba P, 2001, POSTGRAD MED J, V77, P769, DOI 10.1136/pmj.77.914.769; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Neal JA, 2011, MOL CELL BIOL, V31, P1719, DOI 10.1128/MCB.01298-10; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Singh P, 2015, GENETICS, V199, P1, DOI 10.1534/genetics.114.169771; SLEIGH MJ, 1976, NUCLEIC ACIDS RES, V3, P891, DOI 10.1093/nar/3.4.891; Srivastava M, 2012, CELL, V151, P1474, DOI 10.1016/j.cell.2012.11.054; Thompson EG, 2012, ENVIRON MOL MUTAGEN, V53, P32, DOI 10.1002/em.21674; TILBURN J, 1983, GENE, V26, P205, DOI 10.1016/0378-1119(83)90191-9; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417	52	20	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163049	10.1371/journal.pone.0163049	http://dx.doi.org/10.1371/journal.pone.0163049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643854	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900028
J	Ishikawa, Y; Fujii, T; Ishikawa, SK; Yukawa, N; Hashimoto, M; Furu, M; Ito, H; Ohmura, K; Mimori, T				Ishikawa, Yuki; Fujii, Takao; Ishikawa, Seiko Kondo; Yukawa, Naoichiro; Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Ohmura, Koichiro; Mimori, Tsuneyo			Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MONOCLONAL-ANTIBODY; CLINICAL-RESPONSE; DISEASE-ACTIVITY; THROMBOEMBOLIC EVENTS; ANTINUCLEAR ANTIBODY; ANTIDRUG ANTIBODIES; TNF; ADALIMUMAB; ERYTHEMATOSUS	Besides anti-drug antibodies, anti-nuclear antibodies and anti-DNA antibodies are often induced in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors. We examined the association between immunogenicity, autoantibody production, and serum cytokine profiles in patients with rheumatoid arthritis treated with infliximab. Japanese patients with rheumatoid arthritis (n = 57) were retrospectively examined. Serum trough levels of infliximab, anti-drug antibody, anti-nuclear antibody, and anti-DNA (Farr), anti-single-stranded DNA and anti-double-stranded DNA antibodies were measured. Interleukin-6, interferon-., interferon-a, and B-cell activating factor levels were also measured in the same sera. Then, we validated the association between anti-drug antibody and these serum markers along with clinical response to infliximab. Anti-drug antibodies developed in twenty-one patients (36.8%), whose serum trough levels of infliximab were significantly lower than those in anti-drug antibody-negative patients (0.09 +/- 0.03 vs. 2.48 +/- 0.326 mu g/mL, p < 0.0001). There were no significant differences in clinical backgrounds between the two groups. The anti-drug antibody-positive patients were more likely to develop antinuclear antibody titers of >= x160 compared to the negative patients (14 to 57% vs. 17 to 33%). In addition, anti-DNA antibodies (Farr) (from 1.5 +/- 0.4 to 35 +/- 17 IU/mL, p = 0.0001), especially IgM-anti-double stranded DNA antibody (from 5.1 +/- 0.7 to 41 +/- 8.9 IU/mL, p < 0.0001), and IgG-anti-single stranded DNA antibody (from 13 +/- 1.1 to 35 +/- 13, p = 0.0145) were significantly increased in anti-drug antibody-positive but not in negative patients. Moreover, the anti-drug antibody-positive, but not the negative patients, showed significant increased levels of interferon-a (from 248.7 +/- 102.3 to 466.8 +/- 135.1 pg/mL, p = 0.0353) and B-cell activating factor (from 1073 +/- 75.1 to 1387 +/- 136.5 pg/mL, p = 0.0208) following infliximab treatment. The development of anti-drug antibody against infliximab and lupus-like autoantibody production in patients with rheumatoid arthritis treated with infliximab can be linked each other along with increased lupus-associated cytokine levels including type I interferons.	[Ishikawa, Yuki; Fujii, Takao; Ishikawa, Seiko Kondo; Yukawa, Naoichiro; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Hashimoto, Motomu; Furu, Moritoshi] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Fujii, Takao] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan	Kyoto University; Kyoto University; Kyoto University; Wakayama Medical University	Fujii, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.; Fujii, T (corresponding author), Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan.	takfujii@wakayama-med.ac.jp	Ishikawa, Yuki/AAI-6721-2020	Ishikawa, Yuki/0000-0002-6514-8239	Grants-in-Aid for Scientific Research [16K09901] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anderson PJ, 2005, SEMIN ARTHRITIS RHEU, V34, P19, DOI 10.1016/j.semarthrit.2005.01.005; Andrade D, 2011, ARTHRITIS RHEUM-US, V63, P2764, DOI 10.1002/art.30424; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Becker-Merok A, 2013, LUPUS, V22, P155, DOI 10.1177/0961203312468964; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Bootsma H, 1997, ANN RHEUM DIS, V56, P661, DOI 10.1136/ard.56.11.661; Burmester GR, 2015, ANN RHEUM DIS, V74, P1037, DOI 10.1136/annrheumdis-2013-204769; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Charles PJ, 2000, ARTHRITIS RHEUM, V43, P2383, DOI 10.1002/1529-0131(200011)43:11<2383::AID-ANR2>3.3.CO;2-4; Choy EHS, 2002, RHEUMATOLOGY, V41, P1133, DOI 10.1093/rheumatology/41.10.1133; Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; De Rycke L, 2005, LUPUS, V14, P931, DOI 10.1191/0961203305lu2240rr; Dore RK, 2007, CLIN EXP RHEUMATOL, V25, P40; Ferraro-Peyret C, 2004, ARTHRITIS RES THER, V6, pR535, DOI 10.1186/ar1440; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Hall JC, 2015, ARTHRITIS RHEUMATOL, V67, P2437, DOI 10.1002/art.39204; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jamnitski A, 2012, ANN RHEUM DIS, V71, P88, DOI 10.1136/annrheumdis-2011-200184; Jamnitski A, 2011, ANN RHEUM DIS, V70, P284, DOI 10.1136/ard.2010.135111; Jullien D, 2012, ANN DERMATOL VENER, V139, pS58, DOI 10.1016/S0151-9638(12)70112-6; Kay J, 2015, ANN RHEUM DIS, V74, P538, DOI 10.1136/annrheumdis-2013-204195; Kneepkens EL, 2014, ANN RHEUM DIS, V73, P2217, DOI 10.1136/annrheumdis-2014-205983; Korswagen LA, 2011, ARTHRITIS RHEUM-US, V63, P877, DOI 10.1002/art.30209; Makol Ashima, 2010, J Med Case Rep, V4, P12, DOI 10.1186/1752-1947-4-12; Miyasaka N, 2008, MOD RHEUMATOL, V18, P252, DOI 10.1007/s10165-008-0045-0; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Moulis G, 2014, RHEUMATOLOGY, V53, P1864, DOI 10.1093/rheumatology/keu214; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pascual-Salcedo D, 2011, RHEUMATOLOGY, V50, P1445, DOI 10.1093/rheumatology/ker124; Petitpain N, 2009, BIO-MED MATER ENG, V19, P355, DOI 10.3233/BME-2009-0600; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Reizis B, 2011, NAT REV IMMUNOL, V11, P558, DOI 10.1038/nri3027; Smolen J, 2009, ANN RHEUM DIS, V68, P797, DOI 10.1136/ard.2008.101659; Svenson M, 2007, RHEUMATOLOGY, V46, P1828, DOI 10.1093/rheumatology/kem261; Takase K, 2014, ANN RHEUM DIS, V73, P1695, DOI 10.1136/annrheumdis-2014-205318; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Wolbink GJ, 2006, ARTHRITIS RHEUM-US, V54, P711, DOI 10.1002/art.21671; Xu Y, 2015, ARTHRITIS RHEUMATOL, V67, P225, DOI 10.1002/art.38882; Yukawa N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3546; Zhou HH, 2007, J CLIN PHARMACOL, V47, P383, DOI 10.1177/0091270006298188	45	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162896	10.1371/journal.pone.0162896	http://dx.doi.org/10.1371/journal.pone.0162896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643491	Green Submitted, gold, Green Published			2022-12-26	WOS:000383891900024
J	Shen, Y; Kim, AL; Du, R; Liu, L				Shen, Yao; Kim, Arianna L.; Du, Rong; Liu, Liang			Transcriptome Analysis Identifies the Dysregulation of Ultraviolet Target Genes in Human Skin Cancers	PLOS ONE			English	Article							HUMAN KERATINOCYTE; DAMAGE RESPONSE; SUN PROTECTION; BREAST-CANCER; RADIATION; EXPRESSION; EXPOSURE; IRRADIATION; GENOME; RISK	Exposure to ultraviolet radiation (UVR) is a major risk factor for both melanoma and non-melanoma skin cancers. In addition to its mutagenic effect, UVR can also induce substantial transcriptional instability in skin cells affecting thousands of genes, including many cancer genes, suggesting that transcriptional instability may be another important etiological factor in skin photocarcinogenesis. In this study, we performed detailed transcriptomic profiling studies to characterize the kinetic changes in global gene expression in human keratinocytes exposed to different UVR conditions. We identified a subset of UV-responsive genes as UV signature genes (UVSGs) based on 1) conserved UV-responsiveness of this subset of genes among different keratinocyte lines; and 2) UV-induced persistent changes in their mRNA levels long after exposure. Interestingly, 11 of the UVSGs were shown to be critical to skin cancer cell proliferation and survival. Through computational Gene Set Enrichment Analysis, we demonstrated that a significant portion of the UVSGs were dysregulated in human skin squamous cell carcinomas, but not in other human malignancies. This highlights the potential and specificity of the UVSGs in clinical diagnosis of UV damage and stratification of skin cancer risk.	[Shen, Yao] Columbia Univ, Dept Syst Biol, New York, NY USA; [Kim, Arianna L.; Du, Rong; Liu, Liang] Columbia Univ, Dept Dermatol, New York, NY 10027 USA	Columbia University; Columbia University	Liu, L (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10027 USA.	LL2697@columbia.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [K01AR064315]; Columbia University Skin Disease Research Center [P30AR44535]; Center for Environmental Health in Northern Manhattan [P30 ES009089]; American Skin Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535, K01AR064315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Columbia University Skin Disease Research Center; Center for Environmental Health in Northern Manhattan; American Skin Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number K01AR064315, the Columbia University Skin Disease Research Center grant P30AR44535, the Center for Environmental Health in Northern Manhattan P30 ES009089, and the American Skin Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, REPORTS SURG GEN; Batagelj V, 2004, MATH VIS, P77; Bens Guido, 2014, Adv Exp Med Biol, V810, P429; Boice JD, 2005, JNCI-J NATL CANCER I, V97, P703, DOI 10.1093/jnci/dji151; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Dawes JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093338; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; de la Fuente H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006735; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fartasch M, 2012, DTSCH ARZTEBL INT, V109, P715, DOI 10.3238/arztebl.2012.0715; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guy GP, 2015, AM J PREV MED, V48, P183, DOI 10.1016/j.amepre.2014.08.036; Gyorffy B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0514-2; Hacker E, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12157; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Heckman CJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50175; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson LG, 2010, MOL CARCINOGEN, V49, P619, DOI 10.1002/mc.20636; Kadekaro AL, 2010, FASEB J, V24, P3850, DOI 10.1096/fj.10-158485; Lautenschlager S, 2007, LANCET, V370, P528, DOI 10.1016/S0140-6736(07)60638-2; Lin SW, 2012, INT J CANCER, V131, pE1015, DOI 10.1002/ijc.27619; Osterwalder U, 2009, BRIT J DERMATOL, V161, P13, DOI 10.1111/j.1365-2133.2009.09506.x; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Robinson JK, 2005, JAMA-J AM MED ASSOC, V294, P1541, DOI 10.1001/jama.294.12.1541; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Seite S, 2010, BRIT J DERMATOL, V163, P903, DOI 10.1111/j.1365-2133.2010.10018.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XY, 2016, EXP DERMATOL, V25, P708, DOI 10.1111/exd.13057; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takao J, 2002, PHOTODERMATOL PHOTO, V18, P5, DOI 10.1034/j.1600-0781.2002.180102.x; Tripp CS, 2003, J INVEST DERMATOL, V121, P853, DOI 10.1046/j.1523-1747.2003.12495.x; van Eck NJ, 2010, J AM SOC INF SCI TEC, V61, P2405, DOI 10.1002/asi.21421; Wu SW, 2014, CANCER EPIDEM BIOMAR, V23, P1080, DOI 10.1158/1055-9965.EPI-13-0821; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; You YN, 2015, SURG ONCOL, V24, P61, DOI 10.1016/j.suronc.2015.02.001; Zanotti L, 2014, TUMOR BIOL, V35, P8461, DOI 10.1007/s13277-014-2366-2	39	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163054	10.1371/journal.pone.0163054	http://dx.doi.org/10.1371/journal.pone.0163054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643989	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900029
J	Chen, Y; Marino, J; Chen, Y; Tao, Q; Sullivan, CD; Shi, K; Macdonald, DW				Chen, Ying; Marino, Jorgelina; Chen, Yong; Tao, Qing; Sullivan, Casey D.; Shi, Kun; Macdonald, David W.			Predicting Hotspots of Human-Elephant Conflict to Inform Mitigation Strategies in Xishuangbanna, Southwest China	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION; COVER CHANGE; LAND-USE; CONSERVATION; BIODIVERSITY; PATTERNS; YUNNAN	Research on the spatial patterns of human-wildlife conflict is fundamental to understanding the mechanisms underlying it and to identifying opportunities for mitigation. In the state of Xishuangbanna, containing China's largest tropical forest, an imbalance between nature conservation and economic development has led to increasing conflicts between humans and Asian elephants (Elephas maximus), as both elephant numbers and conversion of habitable land to rubber plantations have increased over the last several decades. We analyzed government data on the compensation costs of elephant-caused damage in Xishuangbanna between 2008 and 2012 to understand the spatial and temporal patterns of conflict, in terms of their occurrence, frequency and distribution. More than 18,261 incidents were reported, including episodes involving damage to rubber trees (n = 10,999), damage to crops such as paddy, upland rice, corn, bananas and sugarcane (n = 11,020), property loss (n = 689) and attacks on humans (n = 19). The conflict data reconfirmed the presence of elephants in areas which have lacked records since the late 1990s. Zero Altered Negative Binomial models revealed that the risk of damage to crops and plantations increased with proximity to protected areas, increasing distance from roads, and lower settlement density. The patterns were constant across seasons and types of crop damaged. Damage to rubber trees was essentially incidental as elephants searched for crops to eat. A predictive map of risks revealed hotspots of conflict within and around protected areas, the last refuges for elephants in the region, and along habitat corridors connecting them. Additionally, we analyzed how mitigation efforts can best diminish the risk of conflict while minimizing financial costs and adverse biological impacts. Our analytical approach can be adopted, adjusted and expanded to other areas with historical records of human-wildlife conflict.	[Chen, Ying; Sullivan, Casey D.; Shi, Kun] Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing 100083, Peoples R China; [Chen, Ying; Marino, Jorgelina; Macdonald, David W.] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Oxford OX13 5QL, England; [Chen, Yong] Xishuangbanna Forestry Adm, Jinghong 666100, Yunnan, Peoples R China; [Tao, Qing] Xishuangbanna Natl Nat Reserve, Jinghong 666100, Yunnan, Peoples R China	Beijing Forestry University; University of Oxford	Shi, K (corresponding author), Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing 100083, Peoples R China.	kunshi@bjfu.edu.cn		Sullivan, Casey/0000-0001-7230-9574	Cambridge University; Recanati-Kaplan Foundation; Wildlife Conservation Network; State Forestry Administration; Yunnan Forest Administration	Cambridge University(University of Cambridge); Recanati-Kaplan Foundation; Wildlife Conservation Network; State Forestry Administration; Yunnan Forest Administration	The work was supported by the following: Cambridge University grant, http://www.cam.ac.uk; Recanati-Kaplan Foundation; Wildlife Conservation Network, http://wildnet.org; State Forestry Administration, http://www.forestry.gov.cn, China under the Program of Wildlife Survey, Monitoring and Management, with effective support by the Yunnan Forest Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand R, 2013, GEOGR ANAL, V45, P150, DOI 10.1111/gean.12008; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cai J, 2008, EUR J WILDLIFE RES, V54, P723, DOI 10.1007/s10344-008-0203-x; Carpenter J, 2000, BOOTSTRAP CONDENCE I; Chartier L, 2011, ORYX, V45, P528, DOI 10.1017/S0030605311000044; Chen Jin, 2006, Acta Ecologica Sinica, V26, P309, DOI 10.1016/S1872-2032(06)60006-1; Chen S, 2013, BIOL CONSERV, V168, P31, DOI 10.1016/j.biocon.2013.09.017; China Ministry of Agriculture State Forestry Administration, 2003, STAT COUNC B PEOPL R, V23; Das Jyoti P., 2012, Gajah, V37, P34; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Goswami VR, 2015, CONSERV BIOL, V29, P1100, DOI 10.1111/cobi.12475; Graham MD, 2010, SYST BIODIVERS, V8, P435, DOI 10.1080/14772000.2010.533716; Gubbi S, 2012, BIOL CONSERV, V148, P88, DOI 10.1016/j.biocon.2012.01.046; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; He QC, 2011, CHINESE GEOGR SCI, V21, P629, DOI 10.1007/s11769-011-0499-4; Hoare R, 2000, ORYX, V34, P34, DOI 10.1017/S0030605300030878; Hollander M., 1973, NONPARAMETRIC STAT M, P185; IUCN, IUCN RED LIST THREAT; Joshi R., 2008, J AM SCI, V4, P34; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Lacoeuilhe A, 2016, ACTA OECOL, V71, P61, DOI 10.1016/j.actao.2016.01.009; Lahkar B.P., 2007, STUDY HABITAT UTILIZ; Li C., 1999, CHINESE WILDLIFE, V20, P8; Li Zeng-Jia, 2008, Zhiwu Shengtai Xuebao, V32, P1091, DOI 10.3773/j.issn.1005-264x.2008.05.014; Lin Liu, 2011, Acta Theriologica Sinica, V31, P226; Liu J, 2010, J ENVIRON MANAGE, V91, P2254, DOI 10.1016/j.jenvman.2010.06.007; MacKinnon, 1987, ECOLOGIVAL GUIDELINE; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nyhus P, 2004, AGR ECOSYST ENVIRON, V104, P87, DOI 10.1016/j.agee.2004.01.009; Okabe A, 2009, INT J GEOGR INF SCI, V23, P7, DOI 10.1080/13658810802475491; Quantum GIS Development Team, 2013, QUANT GIS GEOGR INF; R Development Core Team R, 2014, R LANG ENV STAT COMP; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Senf C, 2013, REMOTE SENS-BASEL, V5, P2795, DOI 10.3390/rs5062795; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Songhurst A, 2014, ECOL EVOL, V4, P582, DOI 10.1002/ece3.837; Sukumar R., 2003, LIVING ELEPHANTS EVO; Sun G, 1997, J NE FORESTRY U, V26, P47; Tsinghua U., FINER RESOLUTION OBS; USGS NGA NASA, 2013, SHUTTL RAD TOP MISS; Webber CE, 2011, ORYX, V45, P243, DOI 10.1017/S0030605310000335; Wilson R., FREE GIS DATA 2014; Wilson S, 2013, ORYX, P1; XSBN-NNR N, 2010, MAST PLAN XISH NAT N; Xu JC, 2005, ENVIRON MANAGE, V36, P404, DOI 10.1007/s00267-003-0289-6; Xu JC, 2014, ECOL INDIC, V36, P749, DOI 10.1016/j.ecolind.2012.08.023; [杨文忠 YANG Wenzhong], 2009, [山地学报, Journal of Mountain Science], V27, P306; Yang Z, 2006, FOREST INVENTORY PLA, V31; Yi ZF, 2014, ECOL INDIC, V36, P788, DOI 10.1016/j.ecolind.2013.03.016; Yuan Zhiqiang, 2006, Acta Theriologica Sinica, V26, P359; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhang L., 2006, BIOL BULL, V42, P1; Zhang L., 2007, GAJAH, V35; Zhang L, 2006, INTEGR ZOOL, V1, P179, DOI 10.1111/j.1749-4877.2006.00031.x; Zomer RJ, 2014, BIOL CONSERV, V170, P264, DOI 10.1016/j.biocon.2013.11.028; Zong J, 2014, FOREST INVENORY PLAN, V39, P89; Zuur Alain F., 2009, P1	61	49	49	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162035	10.1371/journal.pone.0162035	http://dx.doi.org/10.1371/journal.pone.0162035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631976	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900024
J	Hueper, K; Gutberlet, M; Brasen, JH; Jang, MS; Thorenz, A; Chen, RJ; Hertel, B; Barrmeyer, A; Schmidbauer, M; Meier, M; von Vietinghoff, S; Khalifa, A; Hartung, D; Haller, H; Wacker, F; Rong, S; Gueler, F				Hueper, Katja; Gutberlet, Marcel; Braesen, Jan Hinrich; Jang, Mi-Sun; Thorenz, Anja; Chen, Rongjun; Hertel, Barbara; Barrmeyer, Amelie; Schmidbauer, Martina; Meier, Martin; von Vietinghoff, Sibylle; Khalifa, Abedalrazag; Hartung, Dagmar; Haller, Hermann; Wacker, Frank; Rong, Song; Gueler, Faikah			Multiparametric Functional MRI: Non-Invasive Imaging of Inflammation and Edema Formation after Kidney Transplantation in Mice	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; MAGNETIC-RESONANCE; RENAL-ALLOGRAFTS; RELAXATION-TIME; WATER-CONTENT; INJURY; INHIBITION; FIBROSIS; RECEPTOR	Background Kidney transplantation (ktx) in mice is used to learn about rejection and to develop new treatment strategies. Past studies have mainly been based on histological or molecular biological methods. Imaging techniques to monitor allograft pathology have rarely been used. Methods Here we investigated mice after isogenic and allogenic ktx over time with functional MRI with diffusion-weighted imaging (DWI) and mapping of T2-relaxation time (T2-mapping) to assess graft inflammation and edema formation. To characterize graft pathology, we used PAS-staining, counted CD3-positive T-lymphocytes, analyzed leukocytes by means flow cytometry. Results DWI revealed progressive restriction of diffusion of water molecules in allogenic kidney grafts. This was paralleled by enhanced infiltration of the kidney by inflammatory cells. Changes in tissue diffusion were not seen following isogenic ktx. T2-times in renal cortex were increased after both isogenic and allogenic transplantation, consistent with tissue edema due to ischemic injury following prolonged cold ischemia time of 60 minutes. Lack of T2 increase in the inner stripe of the inner medulla in allogenic kidney grafts matched loss of tubular autofluorescence and may result from rejection-driven reductions in tubular water content due to tubular dysfunction and renal functional impairment. Conclusions Functional MRI is a valuable non-invasive technique for monitoring inflammation, tissue edema and tubular function. It permits on to differentiate between acute rejection and ischemic renal injury in a mouse model of ktx.	[Hueper, Katja; Gutberlet, Marcel; Barrmeyer, Amelie; Schmidbauer, Martina; Hartung, Dagmar; Wacker, Frank] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Braesen, Jan Hinrich; Khalifa, Abedalrazag] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Jang, Mi-Sun; Thorenz, Anja; Chen, Rongjun; Hertel, Barbara; von Vietinghoff, Sibylle; Haller, Hermann; Rong, Song; Gueler, Faikah] Hannover Med Sch, Dept Nephrol, Hannover, Germany; [Meier, Martin] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Rong, Song] Zunyi Med Coll, Transplantat Ctr, Affiliated Hosp, Zunyi, Peoples R China; [Chen, Rongjun] Zhejiang Univ, Kidney Dis Ctr, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Zunyi Medical University; Zhejiang University	Hueper, K (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.	hueper.katja@mh-hannover.de		Meier, Martin/0000-0001-8642-0409; /0000-0001-9985-1515	German Research Foundation [HU2232/1-1, GU613/1-1]; "Junge Akademie" program of Hannover Medical School	German Research Foundation(German Research Foundation (DFG)); "Junge Akademie" program of Hannover Medical School	This work was supported by the German Research Foundation HU2232/1-1 (Hueper) and GU613/1-1 (Gueler) "Junge Akademie" program of Hannover Medical School (Hueper).	Blondin D, 2009, ROFO-FORTSCHR RONTG, V181, P1162, DOI 10.1055/s-0028-1109511; Eisenberger U, 2014, RADIOLOGY, V270, P800, DOI 10.1148/radiol.13122588; Eisenberger U, 2010, EUR RADIOL, V20, P1374, DOI 10.1007/s00330-009-1679-9; Fan WJ, 2016, EUR RADIOL, V26, P567, DOI 10.1007/s00330-015-3841-x; Gueler F, 2008, J IMMUNOL, V181, P1179, DOI 10.4049/jimmunol.181.2.1179; Gueler F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115709; Gueler F, 2008, J AM SOC NEPHROL, V19, P2302, DOI 10.1681/ASN.2007111267; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hueper K, 2016, J MAGN RESON IMAGING, V44, P112, DOI 10.1002/jmri.25158; Hueper K, 2016, INVEST RADIOL, V51, P58, DOI 10.1097/RLI.0000000000000205; Hueper K, 2015, AM J PHYSIOL-RENAL, V308, pF1444, DOI 10.1152/ajprenal.00064.2015; Hueper K, 2014, EUR RADIOL, V24, P2252, DOI 10.1007/s00330-014-3250-6; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; KIRICUTA IC, 1975, CANCER RES, V35, P1164; KUNDEL HL, 1986, INVEST RADIOL, V21, P12, DOI 10.1097/00004424-198601000-00002; Lanzman RS, 2013, RADIOLOGY, V266, P218, DOI 10.1148/radiol.12112522; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pohlmann A, 2014, INVEST RADIOL, V49, P547, DOI 10.1097/RLI.0000000000000054; Qayyum A, 2009, RADIOGRAPHICS, V29, P1797, DOI 10.1148/rg.296095521; Ren T, 2016, MAGN RESON IMAGING, V34, P908, DOI 10.1016/j.mri.2016.04.022; Rong S, 2014, AM J PHYSIOL-RENAL, V307, pF718, DOI 10.1152/ajprenal.00372.2013; Rong S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/127215; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Thoeny HC, 2006, RADIOLOGY, V241, P812, DOI 10.1148/radiol.2413060103; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Yang DW, 2004, RADIOLOGY, V231, P702, DOI 10.1148/radiol.2313021587	28	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162705	10.1371/journal.pone.0162705	http://dx.doi.org/10.1371/journal.pone.0162705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632553	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900068
J	Jee, YH; Lee, SJ; Jung, KJ; Jee, SH				Jee, Yon Ho; Lee, Sun Ju; Jung, Keum Ji; Jee, Sun Ha			Alcohol Intake and Serum Glucose Levels from the Perspective of a Mendelian Randomization Design: The KCPS-II Biobank	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENOTYPES; GENETIC EPIDEMIOLOGY; DRINKING BEHAVIOR; CONSUMPTION; MEN	Background Previous studies have suggested that alcohol intake is associated with increased fasting serumglucose (FSG), but the nature of the relationship remains unknown. We used Mendelian randomization analysis to assess the causal effect of alcohol intake on FSG in a middle-aged Korean population. Methods Clinical data including FSG and alcohol intake were collected from 156,386 Koreans aged 20 years or older who took part in the Korean Cancer Prevention Study-II (KCPS-II) Biobank Cohort. The single nucleotide polymorphism rs671 in ALDH2 was genotyped among 2,993 men and 1,374 women in 2016. This was a randomly selected subcohort of KCPS-II Biobank participants. Results Alcohol consumption was positively associated with FSG level in men, but not in women. The rs671 major G allele was associated with increased alcohol intake (F-statistic = 302.62) and an increase in FSG in men. Using Mendelian randomization analysis, alcohol intake increased FSG by 1.78 mg/dL per alcohol unit (10 g ethanol) per day (95% CI: 0.97-2.59) in men. The associations became stronger when we excluded heavy drinkers and the elderly. However, in women, no significant association between rs671 and alcohol or serumglucose was found. Conclusion Using Mendelian randomization analysis, we suggest a causal relationship between alcohol intake and FSG among Korean men. Moreover, we found that the ALDH2 variant rs671 was not associated with FSG among Korean women.	[Jee, Yon Ho; Lee, Sun Ju; Jung, Keum Ji; Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul, South Korea; [Jee, Sun Ha] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, KJ (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Inst Hlth Promot, Seoul, South Korea.	kjjung@yuhs.ac		Jee, Sun Ha/0000-0001-9519-3068; Jung, Keum Ji/0000-0003-4993-0666	grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2686]	grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was funded by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C2686). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breslow RA, 2003, J STUD ALCOHOL, V64, P884, DOI 10.15288/jsa.2003.64.884; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; GOEDDE HW, 1992, HUM GENET, V88, P344; Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x; Jee SH, 2014, EUR J PREV CARDIOL, V21, P1484, DOI 10.1177/2047487313497602; Kiage J. N., 2014, Current Nutrition Reports, V3, P213; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149321; Korean Statistics Information Service, STAT DAT; Li XH, 2016, AM J CLIN NUTR, V103, P818, DOI 10.3945/ajcn.115.114389; Moos RH, 2009, ADDICTION, V104, P1293, DOI 10.1111/j.1360-0443.2009.02604.x; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; NAKAJIMA T, 1994, AM J CLIN NUTR, V60, P87, DOI 10.1093/ajcn/60.1.87; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2011, GENES NUTR, V6, P27, DOI 10.1007/s12263-010-0181-y; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20691; Xu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137790; Yeung SLA, 2013, INT J EPIDEMIOL, V42, P318, DOI 10.1093/ije/dys221	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162930	10.1371/journal.pone.0162930	http://dx.doi.org/10.1371/journal.pone.0162930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632197	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900096
J	Duan, A; Bedggood, PA; Bui, BV; Metha, AB				Duan, Angelina; Bedggood, Phillip A.; Bui, Bang V.; Metha, Andrew B.			Evidence of Flicker-Induced Functional Hyperaemia in the Smallest Vessels of the Human Retinal Blood Supply	PLOS ONE			English	Article							OXYGEN-TENSION; INDUCED VASODILATATION; CAPILLARY PERICYTES; CARDIAC CYCLE; IN-VIVO; FLOW; DIAMETER; BRAIN; HETEROGENEITY; PRESSURE	Regional changes in blood flow are initiated within neural tissue to help fuel local differences in neural activity. Classically, this response was thought to arise only in larger arterioles and venules. However, recently, it has been proposed that a) the smallest vessels of the circulation make a comparable contribution, and b) the response should be localised intermittently along such vessels, due to the known distribution of contractile mural cells. To assess these hypotheses in human neural tissue in vivo, we imaged the retinal microvasculature (diameters 3-28 mu m) non-invasively, using adaptive optics, before and after delivery of focal (360 mu m) patches of flickering visible light. Our results demonstrated a definite average response in 35% of all vessel segments analysed. In these responding vessels, the magnitude of proportional dilation (mean +/- SEM for pre-capillary arterioles 13 +/- 5%, capillaries 31 +/- 8%, and post-capillary venules 10 +/- 3%) is generally far greater than the magnitudes we and others have measured in the larger retinal vessels, supporting proposition a) above. The dilations observed in venules were unexpected based on previous animal work, and may be attributed either to differences in stimulus or species. Response heterogeneity across the network was high; responses were also heterogeneous along individual vessels (45% of vessel segments showed demonstrable locality in their response). These observations support proposition b) above. We also observed a definite average constriction across 7% of vessel segments (mean +/- SEM constriction for capillaries -16 +/- 3.2%, and post-capillary venules -18 +/- 12%), which paints a picture of dynamic redistribution of flow throughout the smallest vessel networks in the retina in response to local, stimulus-driven metabolic demand.	[Duan, Angelina; Bedggood, Phillip A.; Bui, Bang V.; Metha, Andrew B.] Univ Melbourne, Dept Optometryand Vis Sci, Parkville, Vic, Australia	University of Melbourne	Metha, AB (corresponding author), Univ Melbourne, Dept Optometryand Vis Sci, Parkville, Vic, Australia.	ametha@unimelb.edu.au	Bui, Bang/AAD-2679-2021; Duan, Angelina/Y-5284-2019; Metha, Andrew/H-2401-2015	Bui, Bang/0000-0001-7298-1352; Duan, Angelina/0000-0002-6221-5782; Metha, Andrew/0000-0003-2997-4362; Bedggood, Phillip/0000-0001-5144-3694	Australian Research Council (ARC) Discovery Early Career Researcher Award [DE120101931]; ARC Future Fellowship Award [FT130100388]; ARC Discovery Project Grant [DP0984649]; Australian Postgraduate Award from the Australian Government; A.E. Rowden White Foundation benevolent bequest; Melbourne Neuroscience Institute (MNI) Interdisciplinary Seed Fund award from the University of Melbourne	Australian Research Council (ARC) Discovery Early Career Researcher Award(Australian Research Council); ARC Future Fellowship Award(Australian Research Council); ARC Discovery Project Grant(Australian Research Council); Australian Postgraduate Award from the Australian Government(Australian Research CouncilAustralian Government); A.E. Rowden White Foundation benevolent bequest; Melbourne Neuroscience Institute (MNI) Interdisciplinary Seed Fund award from the University of Melbourne	This research was supported by: an Australian Research Council (ARC) Discovery Early Career Researcher Award (DE120101931); an ARC Future Fellowship Award (FT130100388); an ARC Discovery Project Grant (DP0984649), an Australian Postgraduate Award from the Australian Government; an A.E. Rowden White Foundation benevolent bequest, and a Melbourne Neuroscience Institute (MNI) Interdisciplinary Seed Fund award from the University of Melbourne.	Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bedggood P, 2014, OPT LETT, V39, P610, DOI 10.1364/OL.39.000610; Bedggood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079251; Bedggood Phillip, 2012, Biomed Opt Express, V3, P3264, DOI 10.1364/BOE.3.003264; BRAUN RD, 1992, MICROVASC RES, V44, P73, DOI 10.1016/0026-2862(92)90103-V; CANHAM PB, 1968, CIRC RES, V22, P405, DOI 10.1161/01.RES.22.3.405; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chan G, 2012, INVEST OPHTH VIS SCI, V53, P5502, DOI 10.1167/iovs.12-10265; CHEN HC, 1994, EYE, V8, P97, DOI 10.1038/eye.1994.19; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Drasdo N, 2007, VISION RES, V47, P2901, DOI 10.1016/j.visres.2007.01.007; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fischer MJM, 2010, MICROVASC RES, V80, P258, DOI 10.1016/j.mvr.2010.04.004; Formaz F, 1997, CURR EYE RES, V16, P1252, DOI 10.1076/ceyr.16.12.1252.5021; Garhofer G, 2004, J GLAUCOMA, V13, P340, DOI 10.1097/00061198-200408000-00013; Garhofer G, 2004, VISION RES, V44, P833, DOI 10.1016/j.visres.2003.11.013; Garhofer G, 2003, INVEST OPHTH VIS SCI, V44, P5309, DOI 10.1167/iovs.03-0587; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Hao H, 2012, INVEST OPHTH VIS SCI, V53, P5799, DOI 10.1167/iovs.11-9326; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Humer MF, 1996, J APPL PHYSIOL, V81, P895, DOI 10.1152/jappl.1996.81.2.895; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kornfield TE, 2014, J NEUROSCI, V34, P11504, DOI 10.1523/JNEUROSCI.1971-14.2014; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; Mishra A, 2014, NAT PROTOC, V9, P323, DOI 10.1038/nprot.2014.019; Nagel E, 2004, INVEST OPHTH VIS SCI, V45, P1486, DOI 10.1167/iovs.03-0667; Newman EA, 2013, J CEREBR BLOOD F MET, V33, P1685, DOI 10.1038/jcbfm.2013.145; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Palkovits S, 2014, J CEREBR BLOOD F MET, V34, P1914, DOI 10.1038/jcbfm.2014.161; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Polak K, 2002, INVEST OPHTH VIS SCI, V43, P2721; Pournaras CJ, 2013, OPHTHALMOLOGICA, V229, P61, DOI 10.1159/000338186; RIVA CE, 1986, INVEST OPHTH VIS SCI, V27, P1706; Roy C S, 1890, J Physiol, V11, P85; Schallek J, 2013, INVEST OPHTH VIS SCI, V54, P8237, DOI 10.1167/iovs.13-12581; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; Seifertl B U, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P678, DOI 10.1515/bmte.2002.47.s1b.678; SIMS DE, 1986, TISSUE CELL, V18, P153, DOI 10.1016/0040-8166(86)90026-1; SKALAK R, 1969, SCIENCE, V164, P717, DOI 10.1126/science.164.3880.717; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Terai N, 2012, ACTA OPHTHALMOL, V90, pE524, DOI 10.1111/j.1755-3768.2012.02486.x	44	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162621	10.1371/journal.pone.0162621	http://dx.doi.org/10.1371/journal.pone.0162621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617960	gold, Green Published			2022-12-26	WOS:000383653100033
J	Ritz, L; Coulbault, L; Lannuzel, C; Boudehent, C; Segobin, S; Eustache, F; Vabret, F; Pitel, AL; Beaunieux, H				Ritz, Ludivine; Coulbault, Laurent; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene			Clinical and Biological Risk Factors for Neuropsychological Impairment in Alcohol Use Disorder	PLOS ONE			English	Article							BRAIN-DAMAGE; WERNICKES ENCEPHALOPATHY; COGNITIVE PERFORMANCE; PHOSPHATE-ESTERS; LIVER FIBROSIS; SCREENING TOOL; THIAMINE; DEFICITS; MEMORY; BLOOD	The effects of alcoholism on cognitive and motor functioning are heterogeneous. While the role of some factors (patterns of alcohol consumption, eating habits or associated liver disease) has been hypothesized, the origins of this heterogeneity remain difficult to establish. The goals of the present study were thus to identify the clinical and biological risk factors for alcohol-related neuropsychological impairments and to determine the threshold beyond which these risk factors can be considered significant. Thirty alcoholic patients and 15 healthy controls had a blood test and underwent a neuropsychological examination. Alcohol severity measures, and liver, thiamine and malnutrition variables, were included in logistic regression models to determine the risk factors for cognitive and motor impairments (executive functions, visuospatial abilities, verbal episodic memory, ataxia), as well as those related to the severity of patients' overall neuropsychological profile (moderate or severe impairments). Liver fibrosis was found to be a risk factor for executive impairments and also for ataxia, when it was associated with long-termalcohol misuse and symptoms of withdrawal. Altered thiamine metabolism was solely predictive of verbal episodic memory impairments. This combination of biological abnormalities was associated with a profile of moderate neuropsychological impairments. Malnutrition was associated with a profile of more severe impairments. Malnutrition, altered liver function and thiamine metabolism explain, at least partially, the heterogeneity of alcohol-related neuropsychological impairments. Our findings could allow clinicians to identify patients at particular risk of severe neuropsychological impairments before the onset of irreversible and debilitating neurological complications.	[Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] INSERM, U1077, Caen, France; [Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] Univ Caen Normandie, UMR S1077, Caen, France; [Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] Ecole Prat Hautes Etud, UMR S1077, Caen, France; [Ritz, Ludivine; Lannuzel, Coralie; Boudehent, Celine; Segobin, Shailendra; Eustache, Francis; Vabret, Francois; Pitel, Anne Lise; Beaunieux, Helene] Ctr Hosp Univ, U1077, Caen, France; [Boudehent, Celine; Vabret, Francois] Ctr Hosp Univ, Serv Addictol, Caen, France; [Coulbault, Laurent] Ctr Hosp Univ, Lab Biochim, Caen, France; [Coulbault, Laurent] Univ Caen Normandie, Lab EA4650, Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; CHU de Caen NORMANDIE; Universite de Caen Normandie	Beaunieux, H (corresponding author), INSERM, U1077, Caen, France.; Beaunieux, H (corresponding author), Univ Caen Normandie, UMR S1077, Caen, France.; Beaunieux, H (corresponding author), Ecole Prat Hautes Etud, UMR S1077, Caen, France.; Beaunieux, H (corresponding author), Ctr Hosp Univ, U1077, Caen, France.	helene.beaunieux@unicaen.fr	Eustache, Francis/J-9465-2015; Ritz, Ludivine/AAL-4269-2020	Eustache, Francis/0000-0003-4460-8686; BEAUNIEUX, HELENE/0000-0003-1354-6558; PITEL, Anne Lise/0000-0001-8573-9506; Segobin, Shailendra/0000-0003-1977-8210	French National Institute for Health and Medical Research (INSERM); French National Agency for Research (ANR); Postdoc Return (Retour Post-Doctorants, PDOC) program; Lower Normandy Regional Council; Mission Interministerielle de Lutte contre les Drogues Et les Conduites Addictives (MILDECA)	French National Institute for Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French National Agency for Research (ANR)(French National Research Agency (ANR)); Postdoc Return (Retour Post-Doctorants, PDOC) program; Lower Normandy Regional Council; Mission Interministerielle de Lutte contre les Drogues Et les Conduites Addictives (MILDECA)	This work was supported by the French National Institute for Health and Medical Research (INSERM), the French National Agency for Research (ANR), the Postdoc Return (Retour Post-Doctorants, PDOC) program, Lower Normandy Regional Council, and the Mission Interministerielle de Lutte contre les Drogues Et les Conduites Addictives (MILDECA).	ARRIA AM, 1991, ALCOHOL CLIN EXP RES, V15, P932, DOI 10.1111/j.1530-0277.1991.tb05192.x; Beatty WW, 2000, ALCOHOL CLIN EXP RES, V24, P149, DOI 10.1097/00000374-200002000-00003; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Caine D, 1997, J NEUROL NEUROSUR PS, V62, P51, DOI 10.1136/jnnp.62.1.51; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Ceccanti M, 2005, ALCOHOL ALCOHOLISM, V40, P283, DOI 10.1093/alcalc/agh162; Chanraud S, 2007, NEUROPSYCHOPHARMACOL, V32, P429, DOI 10.1038/sj.npp.1301219; CURRAN HV, 1991, PSYCHOPHARMACOLOGY, V105, P1; CUSHMAN P, 1985, ALCOHOL CLIN EXP RES, V9, P103, DOI 10.1111/j.1530-0277.1985.tb05527.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; der Collectif Linden MV, 2004, EVALUATION TROUBLES; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox AM, 2000, ALCOHOL ALCOHOLISM, V35, P52, DOI 10.1093/alcalc/35.1.52; Fregly AR, 1971, DTIC DOCUMENT; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Grefex G. O., 2008, FONCTIONS EXECUTIVES; Harper C, 2006, EUR J NEUROL, V13, P1078, DOI 10.1111/j.1468-1331.2006.01530.x; Harper C, 2009, ALCOHOL ALCOHOLISM, V44, P136, DOI 10.1093/alcalc/agn102; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HERVE C, 1995, CLIN CHIM ACTA, V234, P91, DOI 10.1016/0009-8981(94)05980-7; Ihara H, 2000, J NEUROL NEUROSUR PS, V68, P731, DOI 10.1136/jnnp.68.6.731; Junghanns K, 2004, ALCOHOL ALCOHOLISM, V39, P113, DOI 10.1093/alcalc/agh028; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; Losa R, 2005, J PHARMACEUT BIOMED, V37, P1025, DOI 10.1016/j.jpba.2004.08.038; Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077; Mancinelli R, 2009, ALCOHOL ALCOHOLISM, V44, P177, DOI 10.1093/alcalc/agn117; MOLINA JA, 1994, ACTA NEUROL SCAND, V89, P384; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; O'Mahony JF, 2005, ADDICT BEHAV, V30, P369, DOI 10.1016/j.addbeh.2004.05.008; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Pfefferbaum A, 2004, AM J PSYCHIAT, V161, P1190, DOI 10.1176/appi.ajp.161.7.1190; Pitel AL, 2011, NEUROPSYCHOPHARMACOL, V36, P580, DOI 10.1038/npp.2010.189; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Ritz L, 2015, ALCOHOL CLIN EXP RES, V39, P2249, DOI 10.1111/acer.12888; RYBACK RS, 1971, Q J STUD ALCOHOL, V32, P995; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan EV, 2000, ALCOHOL CLIN EXP RES, V24, P611, DOI 10.1097/00000374-200005000-00005; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; TALLAKSEN CME, 1992, ALCOHOL CLIN EXP RES, V16, P320, DOI 10.1111/j.1530-0277.1992.tb01384.x; Thomson A D, 2000, Alcohol Alcohol Suppl, V35, P2; Tsai GC, 1998, ANNU REV MED, V49, P173; Wechsler D, 2001, MEM 3 ECHELLE CLIN M; Wetterling T, 1998, ALCOHOL ALCOHOLISM, V33, P424; Zinn S, 2004, ALCOHOL CLIN EXP RES, V28, P1338, DOI 10.1097/01.ALC.0000139814.81811.62	50	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0159616	10.1371/journal.pone.0159616	http://dx.doi.org/10.1371/journal.pone.0159616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617840	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100002
J	Haller, M; Khalid, S; Kremser, L; Fresser, F; Furlan, T; Hermann, M; Guenther, J; Drasche, A; Leitges, M; Giorgio, M; Baier, G; Lindner, H; Troppmair, J				Haller, Martina; Khalid, Sana; Kremser, Leopold; Fresser, Friedrich; Furlan, Tobias; Hermann, Martin; Guenther, Julia; Drasche, Astrid; Leitges, Michael; Giorgio, Marco; Baier, Gottfried; Lindner, Herbert; Troppmair, Jakob			Novel Insights into the PKC-dependent Regulation of the Oxidoreductase p66Shc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; phosphotyrosine binding (PTB) domain; PKC; reactive oxygen species (ROS); redox signaling; p66shc; phosphorylation	ISCHEMIA-REPERFUSION INJURY; KINASE-C-BETA; INDUCED OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; N-ACETYLCYSTEINE; CELL-DEATH; MITOCHONDRIAL DYSFUNCTION; PROTEIN-PHOSPHORYLATION; SIGNALING PATHWAY; P66(SHC) ABLATION	Dysfunctional mitochondria contribute to the development of many diseases and pathological conditions through the excessive production of reactive oxygen species (ROS), and, where studied, ablation of p66Shc (p66) was beneficial. p66 translocates to the mitochondria and oxidizes cytochrome c to yield H2O2, which in turn initiates cell death. PKC-mediated phosphorylation of serine 36 in p66 has been implicated as a key regulatory step preceding mitochondrial translocation, ROS production, and cell death, and PKC thus may provide a target for therapeutic intervention. We performed a reassessment of PKC regulation of the oxidoreductase activity of p66. Although our experiments did not substantiate Ser(36) phosphorylation by PKC, they instead provided evidence for Ser(139) and Ser(213) as PKC phosphorylation sites regulating the pro-oxidant and pro-apoptotic function of p66. Mutation of another predicted PKC phosphorylation site also located in the phosphotyrosine binding domain, threonine 206, had no phenotype. Intriguingly, p66 with Thr(206) and Ser(213) mutated to glutamic acid showed a gain-of-function phenotype with significantly increased ROS production and cell death induction. Taken together, these data argue for a complex mechanism of PKC-dependent regulation of p66 activation involving Ser(139) and a motif surrounding Ser(213).	[Haller, Martina; Khalid, Sana; Furlan, Tobias; Guenther, Julia; Drasche, Astrid; Troppmair, Jakob] Med Univ Innsbruck, Daniel Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, Innrain 66, A-6020 Innsbruck, Austria; [Kremser, Leopold; Lindner, Herbert] Med Univ Innsbruck, Div Clin Biochem, Prot Microanal Facil, Innrain 66, A-6020 Innsbruck, Austria; [Fresser, Friedrich; Baier, Gottfried] Med Univ Innsbruck, Dept Pharmacol & Genet, Div Translat Cell Genet, Innrain 66, A-6020 Innsbruck, Austria; [Hermann, Martin] Med Univ Innsbruck, Dept Anesthesiol & Intens Care, Innrain 66, A-6020 Innsbruck, Austria; [Leitges, Michael] Biotechnol Ctr Oslo, N-0349 Oslo, Norway; [Giorgio, Marco] European Inst Oncol, I-20139 Milan, Italy	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; IRCCS European Institute of Oncology (IEO)	Troppmair, J (corresponding author), Med Univ Innsbruck, Daniel Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, Innrain 66, A-6020 Innsbruck, Austria.	jakob.troppmair@i-med.ac.at	Leitges, Michael/AAN-1953-2021; Giorgio, Marco/I-9425-2012; Guenther, Julia/T-9990-2017	Giorgio, Marco/0000-0002-5842-6042; Baier, Gottfried/0000-0002-2085-8325; Hermann, Martin/0000-0003-2213-3448; Guenther, Julia/0000-0002-2726-7982; Leitges, Michael/0000-0003-4203-6995	Jubilaumsfond der Oesterreichischen Nationalbank (OeNB) [13273]; Austrian Science Fund (FWF) [W1101]; Austrian Federal Ministries BMVIT/BMWFJ (via FFG); Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT); Osterreichische Krebshilfe Tirol	Jubilaumsfond der Oesterreichischen Nationalbank (OeNB); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Federal Ministries BMVIT/BMWFJ (via FFG); Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT); Osterreichische Krebshilfe Tirol	This work has been supported by grants from the Jubilaumsfond der Oesterreichischen Nationalbank (OeNB) Project 13273, Austrian Science Fund (FWF) W1101, Austrian Federal Ministries BMVIT/BMWFJ (via FFG), the Tiroler Zukunftsstiftung/Standortagentur Tirol (SAT), and the Osterreichische Krebshilfe Tirol. The authors declare that they have no conflicts of interest with the contents of this article.	Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Arany I, 2010, AM J PHYSIOL-RENAL, V298, pF1214, DOI 10.1152/ajprenal.00639.2009; Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021; Borkowska A, 2012, EUR J NUTR, V51, P817, DOI 10.1007/s00394-011-0260-x; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Cesselli D, 2001, CIRC RES, V89, P279, DOI 10.1161/hh1501.094115; Chambers JW, 2013, J BIOL CHEM, V288, P4000, DOI 10.1074/jbc.M112.406777; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Churchill EN, 2007, BIOCHEM SOC T, V35, P1040, DOI 10.1042/BST0351040; Di Stefano V, 2009, CARDIOVASC RES, V82, P421, DOI 10.1093/cvr/cvp082; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Faisal A, 2002, J BIOL CHEM, V277, P30144, DOI 10.1074/jbc.M203229200; Farooq A, 2003, STRUCTURE, V11, P905, DOI 10.1016/S0969-2126(03)00134-5; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Fuller TF, 2004, J UROLOGY, V171, P1296, DOI 10.1097/01.ju.0000103928.64939.6a; Galimov ER, 2010, ACTA NATURAE, V2, P44, DOI 10.32607/20758251-2010-2-4-44-51; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gruber T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000046; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Hermann Martin, 2008, Cell Commun Signal, V6, P4, DOI 10.1186/1478-811X-6-4; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Jegatheeswaran S, 2011, HPB, V13, P71, DOI 10.1111/j.1477-2574.2010.00263.x; Khalid S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20930; Khanday FA, 2006, MOL BIOL CELL, V17, P122, DOI 10.1091/mbc.e05-06-0570; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Koziel K, 2013, EXP CELL RES, V319, P2728, DOI 10.1016/j.yexcr.2013.07.029; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; Kulkarni AC, 2007, ANTIOXID REDOX SIGN, V9, P1717, DOI 10.1089/ars.2007.1724; Kumetsov AV, 2004, FEBS LETT, V577, P1, DOI 10.1016/j.febslet.2004.10.021; Kuznetsov AV, 2008, MOL CELL BIOL, V28, P2304, DOI 10.1128/MCB.00683-07; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; Malhotra A, 2009, AM J PHYSIOL-HEART C, V296, pH380, DOI 10.1152/ajpheart.00225.2008; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mckay A, 2008, J HEPATO-BILIARY-PAN, V15, P473, DOI 10.1007/s00534-007-1306-6; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Park JE, 2012, CELL DEATH DIFFER, V19, P153, DOI 10.1038/cdd.2011.82; Pellegrini M, 2007, CELL DEATH DIFFER, V14, P338, DOI 10.1038/sj.cdd.4401997; Piccoli C, 2006, FEBS LETT, V580, P4539, DOI 10.1016/j.febslet.2006.06.085; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rapino C, 2005, AGING CELL, V4, P177, DOI 10.1111/j.1474-9726.2005.00161.x; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; Sobieszek A, 2006, ARCH BIOCHEM BIOPHYS, V454, P197, DOI 10.1016/j.abb.2006.08.004; Sucher R, 2009, TRANSPL INT, V22, P922, DOI 10.1111/j.1432-2277.2009.00883.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vagnozzi RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006479; Wiltshire C, 2004, BIOCHEM SOC T, V32, P1075, DOI 10.1042/BST0321075; Yonekawa H, 2008, FEBS J, V275, P4005, DOI 10.1111/j.1742-4658.2008.06558.x; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; ZHOU MM, 1995, NATURE, V378, P584, DOI 10.1038/378584a0; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	68	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23557	23568		10.1074/jbc.M116.752766	http://dx.doi.org/10.1074/jbc.M116.752766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27624939	Green Published, hybrid			2022-12-26	WOS:000387884400017
J	De Laurentiis, EI; Mercier, E; Wieden, HJ				De Laurentiis, Evelina Ines; Mercier, Evan; Wieden, Hans-Joachim			The C-terminal Helix of Pseudomonas aeruginosa Elongation Factor Ts Tunes EF-Tu Dynamics to Modulate Nucleotide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; ANGSTROM RESOLUTION; KINETIC MECHANISM; GTP HYDROLYSIS; P-LOOP; RIBOSOME; COMPLEX; CONFORMATION	Little is known about the conservation of critical kinetic parameters and the mechanistic strategies of elongation factor (EF) Ts-catalyzed nucleotide exchange in EF-Tu in bacteria and particularly in clinically relevant pathogens. EF-Tu from the clinically relevant pathogen Pseudomonas aeruginosa shares over 84% sequence identity with the corresponding elongation factor from Escherichia coli. Interestingly, the functionally closely linked EF-Ts only shares 55% sequence identity. To identify any differences in the nucleotide binding properties, as well as in the EF-Ts-mediated nucleotide exchange reaction, we performed a comparative rapid kinetics and mutagenesis analysis of the nucleotide exchange mechanism for both the E. coli and P. aeruginosa systems, identifying helix 13 of EF-Ts as a previously unnoticed regulatory element in the nucleotide exchange mechanism with species-specific elements. Our findings support the base side-first entry of the nucleotide into the binding pocket of the EF-Tu.EF-Ts binary complex, followed by displacement of helix 13 and rapid binding of the phosphate side of the nucleotide, ultimately leading to the release of EF-Ts.	[De Laurentiis, Evelina Ines; Mercier, Evan; Wieden, Hans-Joachim] Univ Lethbridge, Alberta RNA Res & Training Inst, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Wieden, HJ (corresponding author), Univ Lethbridge, Dept Chem & Biochem, 4401 Univ Dr, Lethbridge, AB T1K 3M4, Canada.	hj.wieden@uleth.ca		Wieden, Hans-Joachim/0000-0001-5181-6059	National Science and Engineering Research Council [326979-2011]; Canada Foundation for Innovation [202588]; Alberta Innovates Technology Futures New Investigator Award; Alberta Innovates Technology Futures postgraduate scholarships	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Innovates Technology Futures New Investigator Award; Alberta Innovates Technology Futures postgraduate scholarships	This work was supported by National Science and Engineering Research Council Operating Grant 326979-2011 (to H.-J. W.), Canada Foundation for Innovation Grant 202588 (to H.-J. W.), an Alberta Innovates Technology Futures New Investigator Award (to H.-J. W.), and Alberta Innovates Technology Futures postgraduate scholarships (to E. M.), as well as resource allocations by Compute Canada and Westgrid. The authors declare that they have no conflicts of interest with the contents of this article.	Andersen GR, 2000, MOL CELL, V6, P1261, DOI 10.1016/S1097-2765(00)00122-2; Arike L, 2012, J PROTEOMICS, V75, P5437, DOI 10.1016/j.jprot.2012.06.020; BOON K, 1992, EUR J BIOCHEM, V210, P177, DOI 10.1111/j.1432-1033.1992.tb17406.x; CHAU V, 1981, J BIOL CHEM, V256, P5591; Dahl LD, 2006, J BIOL CHEM, V281, P21139, DOI 10.1074/jbc.M602068200; De Laurentiis EI, 2011, BBA-PROTEINS PROTEOM, V1814, P684, DOI 10.1016/j.bbapap.2011.02.007; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mercier E, 2015, SCI REP-UK, V5, DOI 10.1038/srep07677; Miller DL, 1977, MOL MECH PROTEIN BIO, P323; Nicholas K.B., 1997, EMBNET NEWS, V4, P4; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PINGOUD A, 1983, J BIOL CHEM, V258, P4200; RCoreTeam, 2013, R LANG ENV STAT COMP; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; Rosler KS, 2015, J BIOL CHEM, V290, P18650, DOI 10.1074/jbc.M114.598227; Schummer T, 2007, BIOCHEMISTRY-US, V46, P4977, DOI 10.1021/bi602486c; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shields MJ, 2009, BIOCHEMISTRY-US, V48, P10793, DOI 10.1021/bi901074h; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Wieden HJ, 2010, BIOPHYS J, V99, P3735, DOI 10.1016/j.bpj.2010.10.013; Wieden HJ, 2002, J BIOL CHEM, V277, P6032, DOI 10.1074/jbc.M110888200; Wilkins MR, 1999, METH MOL B, V112, P531; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Zhang YL, 1998, J BIOL CHEM, V273, P4556, DOI 10.1074/jbc.273.8.4556	38	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23136	23148		10.1074/jbc.M116.740381	http://dx.doi.org/10.1074/jbc.M116.740381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624934	hybrid, Green Published			2022-12-26	WOS:000387224800024
J	Lambert, PM; Nakata, PA				Lambert, Peter M.; Nakata, Paul A.			Determining the Biochemical Properties of the Oxalate BiosyntheticComponent (Obc) 1 from Burkholderia mallei	PLOS ONE			English	Article							OXALIC-ACID BIOSYNTHESIS; SCLEROTINIA-SCLEROTIORUM; COA SYNTHETASE; GRAIN ROT; GLUMAE; PATHOGEN; RICE; RESISTANCE; GLANDERS; OXIDASE	Oxalic acid is produced by a variety of organisms ranging from simple microbes to complex animals. This acid has been proposed to fulfill various physiological and pathological functions which vary between organisms. In bacteria from the Burkholderia genus, oxalate secretion has been shown to be quorum sensing dependent and to support pathogenicity and cell viability. In light of the critical roles of oxalate in Burkholderia as well as other organisms, it is surprising that our understanding of how this simple dicarboxylate is biosynthesized remains incomplete. Here we report the expression, purification, and partial characterization of the first intact bacterial oxalate biosynthetic enzyme, Obc1, from B. mallei. An N-terminal His-tagged Bmobc1 was cloned into pDUET, expressed in E. coli BLR (DE3), and the recombinant enzyme purified by affinity chromatography. Oxalate biosynthetic enzyme assays coupled with HPLC analysis revealed that BmObc1 catalyzed the biosynthesis of oxalate, acetoacetate, and free CoA from oxaloacetate and a short chain acyl-CoA following Michaelis- Menten kinetics. Optimal enzyme activity was measured at pH 8.0 and a temperature around 44 degrees C. Kinetic analysis conducted under conditions of saturating acetyl-CoA and varying oxaloacetate concentrations resulted in a calculated Km value for oxaloacetate of 94.3 +/- 9.2 mu M (mean +/- SE). Under conditions of saturating oxaloacetate concentration and varying acyl-CoA (acetyl- or propionyl-CoA) concentrations kinetic analysis generated a calculated Km value of 26.8 +/- 2.3 mu M (mean +/- SE) for acetyl-CoA and 104.4 +/- 12.7 mu M for propionyl-CoA. The significantly lower K-m for acetyl-CoA suggests that it is strongly favored as a substrate over propionyl-CoA.	[Lambert, Peter M.; Nakata, Paul A.] USDA ARS, Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA)	Nakata, PA (corresponding author), USDA ARS, Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA.	paul.nakata@ars.usda.gov		Nakata, Paul/0000-0002-6331-9700; Lambert, Peter/0000-0001-9427-638X	U.S. Department of Agriculture, Agricultural Research Service [58-3092-5-001]; ARS [ARS-0426342] Funding Source: Federal RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the U.S. Department of Agriculture, Agricultural Research Service under Cooperative agreement number 58-3092-5-001 to PAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The contents of this publication do not necessarily reflect the views or policies of the U.S. Department of Agriculture, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This research was supported in part by the U.S. Department of Agriculture, Agricultural Research Service, under Cooperative Agreement number 58-3092-5-001.	APPANNA VD, 1999, RRD MICROBIOL 2, V3, P615; BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P204; Chen C, 2010, J BIOL CHEM, V285, P26685, DOI 10.1074/jbc.M110.117804; DEMOZ A, 1995, J CHROMATOGR B, V667, P148, DOI 10.1016/0378-4347(94)00595-V; Donaldson PA, 2001, PHYSIOL MOL PLANT P, V59, P297, DOI 10.1006/pmpp.2001.0369; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Foster J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149850; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Gharieb MM, 2000, MYCOL RES, V104, P550, DOI 10.1017/S0953756299001707; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Green F, 2003, INT BIODETER BIODEGR, V51, P145, DOI 10.1016/S0964-8305(02)00099-9; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Hodgkinson A., 1977, OXALIC ACID BIOL MED; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jacob G, 2007, RECENT PAT ANTIINFEC, V2, P233; Jeong Y, 2003, PLANT DIS, V87, P890, DOI 10.1094/PDIS.2003.87.8.890; Kesarwani M, 2000, J BIOL CHEM, V275, P7230, DOI 10.1074/jbc.275.10.7230; Li HQ, 1999, J BIOCHEM, V126, P243, DOI 10.1093/oxfordjournals.jbchem.a022429; Livingstone DM, 2005, PLANT PHYSIOL, V137, P1354, DOI 10.1104/pp.104.057232; Munir E, 2001, P NATL ACAD SCI USA, V98, P11126, DOI 10.1073/pnas.191389598; Nakata PA, 2011, MICROBIOL RES, V166, P531, DOI 10.1016/j.micres.2010.11.002; Nakata PA, 2010, FEMS MICROBIOL LETT, V304, P177, DOI 10.1111/j.1574-6968.2010.01895.x; Nandakumar R, 2009, PLANT DIS, V93, P896, DOI 10.1094/PDIS-93-9-0896; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Oh J, 2014, J BIOL CHEM, V289, P11465, DOI 10.1074/jbc.M113.543462; SHIMADA M, 1994, FEMS MICROBIOL REV, V13, P285, DOI 10.1111/j.1574-6976.1994.tb00049.x; Tsushima Seiya, 1996, Annals of the Phytopathological Society of Japan, V62, P108, DOI 10.3186/jjphytopath.62.108; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Whitmore A, 1913, J HYG-CAMBRIDGE, V13, P1, DOI 10.1017/S0022172400005234	35	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163294	10.1371/journal.pone.0163294	http://dx.doi.org/10.1371/journal.pone.0163294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643499	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900042
J	Allwood, EG; Tyler, JJ; Urbanek, AN; Smaczynska-de Rooij, II; Ayscough, KR				Allwood, Ellen G.; Tyler, Joe J.; Urbanek, Agnieszka N.; Smaczynska-de Rooij, Iwona I.; Ayscough, Kathryn R.			Elucidating Key Motifs Required for Arp2/3-Dependent and Independent Actin Nucleation by Las17/WASP	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; WASP FAMILY PROTEINS; ARP2/3 COMPLEX; BINDING MOTIF; BUDDING YEAST; ENDOCYTOSIS; HOMOLOGY; DOMAINS; SPIRE	Actin nucleation is the key rate limiting step in the process of actin polymerization, and tight regulation of this process is critical to ensure actin filaments form only at specific times and at defined regions of the cell. Arp2/3 is a well-characterised protein complex that can promote nucleation of new filaments, though its activity requires additional nucleation promotion factors (NPFs). The best recognized of these factors are the WASP family of proteins that contain binding motifs for both monomeric actin and for Arp2/3. Previously we demonstrated that the yeast WASP homologue, Las17, in addition to activating Arp2/3 can also nucleate actin filaments de novo, independently of Arp2/3. This activity is dependent on its polyproline rich region. Through biochemical and in vivo analysis we have now identified key motifs within the polyproline region that are required for nucleation and elongation of actin filaments, and have addressed the role of the WH2 domain in the context of actin nucleation without Arp2/3. We have also demonstrated that full length Las17 is able to bind liposomes giving rise to the possibility of direct linkage of nascent actin filaments to specific membrane sites to which Las17 has been recruited. Overall, we propose that Las17 functions as the key initiator of de novo actin filament formation at endocytic sites by nucleating, elongating and tethering nascent filaments which then serve as a platformfor Arp2/3 recruitment and function.	[Allwood, Ellen G.; Tyler, Joe J.; Urbanek, Agnieszka N.; Smaczynska-de Rooij, Iwona I.; Ayscough, Kathryn R.] Univ Sheffield, Dept Biomed Sci, Court 5, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Ayscough, KR (corresponding author), Univ Sheffield, Dept Biomed Sci, Court 5, Sheffield S10 2TN, S Yorkshire, England.	k.ayscough@sheffield.ac.uk		Ayscough, Kathryn/0000-0003-3716-4490; Allwood, Ellen/0000-0003-3825-4789; Tyler, Joe/0000-0003-3940-876X	BBSRC [BB/J017094/1, BB/N007581/1, BB/J014443/1, BB/L013851/1]; Biotechnology and Biological Sciences Research Council [BB/L013851/1, BB/N007581/1, BB/J017094/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC project grant funding (BB/J017094/1 and BB/N007581/1) to KA. JT is a student funded by the BBSRC White Rose Doctoral training programme (BB/J014443/1). Thermophoresis was carried out in the Biomolecular Interaction suite at the University of Sheffield funded by support from BBSRC (BB/L013851/1). All funding bbsrc (http://www.bbsrc.ac.uk/). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Burianek LE, 2013, SEMIN CELL DEV BIOL, V24, P258, DOI 10.1016/j.semcdb.2012.12.005; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 2011, INT REV CEL MOL BIO, V290, P55, DOI 10.1016/B978-0-12-386037-8.00005-3; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Dominguez R, 2016, TRENDS BIOCHEM SCI, V41, P478, DOI 10.1016/j.tibs.2016.03.004; Feliciano D, 2015, TRAFFIC, V16, P379, DOI 10.1111/tra.12259; Galletta BJ, 2008, PLOS BIOL, V6, P72, DOI 10.1371/journal.pbio.0060001; Gaucher JF, 2012, J BIOL CHEM, V287, P34646, DOI 10.1074/jbc.M112.394361; Hagan IM, 2000, PRACT APPROACH SER, V218, P179; Kaiser C., 1994, METHODS YEAST GENETI; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Lewellyn EB, 2015, DEV CELL, V35, P281, DOI 10.1016/j.devcel.2015.10.007; Li R, 1997, J CELL BIOL, V136, P649, DOI 10.1083/jcb.136.3.649; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Robertson AS, 2009, MOL BIOL CELL, V20, P1618, DOI 10.1091/mbc.E08-09-0982; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Smaczynska-de Rooij II, 2010, J CELL SCI, V123, P3496, DOI 10.1242/jcs.070508; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Smith BA, 2013, P NATL ACAD SCI USA, V110, P1285, DOI 10.1073/pnas.1211164110; Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Urbanek AN, 2013, CURR BIOL, V23, P196, DOI 10.1016/j.cub.2012.12.024; Veltman DM, 2010, MOL BIOL CELL, V21, P2880, DOI 10.1091/mbc.E10-04-0372; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; WINDER SJ, 1995, J CELL SCI, V108, P63; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895	34	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163177	10.1371/journal.pone.0163177	http://dx.doi.org/10.1371/journal.pone.0163177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637067	Green Accepted, Green Published, gold			2022-12-26	WOS:000383723700039
J	Negahbani, E; Steyn-Ross, DA; Steyn-Ross, ML; Aguirre, LA				Negahbani, Ehsan; Steyn-Ross, D. Alistair; Steyn-Ross, Moira L.; Aguirre, Luis A.			Which System Variables Carry Robust Early Signs of Upcoming Phase Transition? An Ecological Example	PLOS ONE			English	Article							OBSERVABILITY	Growth of critical fluctuations prior to catastrophic state transition is generally regarded as a universal phenomenon, providing a valuable early warning signal in dynamical systems. Using an ecological fisheries model of three populations (juvenile prey J, adult prey A and predator P), a recent study has reported silent early warning signals obtained from P and A populations prior to saddle-node (SN) bifurcation, and thus concluded that early warning signals are not universal. By performing a full eigenvalue analysis of the same system we demonstrate that while J and P populations undergo SN bifurcation, A does not jump to a new state, so it is not expected to carry early warning signs. In contrast with the previous study, we capture a significant increase in the noise-induced fluctuations in the P population, but only on close approach to the bifurcation point; it is not clear why the P variance initially shows a decaying trend. Here we resolve this puzzle using observability measures from control theory. By computing the observability coefficient for the system from the recordings of each population considered one at a time, we are able to quantify their ability to describe changing internal dynamics. We demonstrate that precursor fluctuations are best observed using only the J variable, and also P variable if close to transition. Using observability analysis we are able to describe why a poorly observable variable (P) has poor forecasting capabilities although a full eigenvalue analysis shows that this variable undergoes a bifurcation. We conclude that observability analysis provides complementary information to identify the variables carrying early-warning signs about impending state transition.	[Negahbani, Ehsan; Steyn-Ross, D. Alistair; Steyn-Ross, Moira L.] Univ Waikato, Sch Engn, Hamilton, Waikato, New Zealand; [Aguirre, Luis A.] Univ Federeal Minas Gerais, Dept Elect Engn, Belo Horizonte, MG, Brazil	University of Waikato	Negahbani, E (corresponding author), Univ Waikato, Sch Engn, Hamilton, Waikato, New Zealand.	enegahbani@gmail.com	Aguirre, Luis A./A-2737-2008	Aguirre, Luis A./0000-0002-2746-5102	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Work of LAA is partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil: http://cnpq.br/. EN, DASR, and MLSR received no specific funding for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; L. A. Aguirre's research is partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Aguirre LA, 2005, J PHYS A-MATH GEN, V38, P6311, DOI 10.1088/0305-4470/38/28/004; AGUIRRE LA, 1995, IEEE T EDUC, V38, P33, DOI 10.1109/13.350218; Aguirre LA, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066209; Boerlijst MC, 2013, PLOS ONE, P1; Cairoli A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.264102; CHATURVEDI S, 1977, J STAT PHYS, V17, P469, DOI 10.1007/BF01014350; Gardiner C.W, 2004, HDB STOCHASTIC METHO, P80; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Laub AJ, 2005, MATRIX ANAL SCI ENG, P139; McQuarrie D. A., 2003, MATH METHODS SCI ENG; Negahbani E., 2014, THESIS; Negahbani E, 2015, J MATH NEUROSCI, V5, DOI 10.1186/s13408-015-0021-x; REICHL LE, 1980, MODERN COURSE STAT M; Steyn-Ross ML, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021902; van Kooten T, 2005, J THEOR BIOL, V237, P67, DOI 10.1016/j.jtbi.2005.03.032	15	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163003	10.1371/journal.pone.0163003	http://dx.doi.org/10.1371/journal.pone.0163003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631984	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900114
J	Lancefield, TF; Patel, SK; Freeman, M; Velkoska, E; Wai, B; Srivastava, PM; Horrigan, M; Farouque, O; Burrell, LM				Lancefield, Terase F.; Patel, Sheila K.; Freeman, Melanie; Velkoska, Elena; Wai, Bryan; Srivastava, Piyush M.; Horrigan, Mark; Farouque, Omar; Burrell, Louise M.			The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation	PLOS ONE			English	Article							ENDOGENOUS SECRETORY RECEPTOR; TYPE-2 DIABETES-MELLITUS; CORONARY-ARTERY-DISEASE; ENDOTHELIAL-CELLS; SOLUBLE RECEPTOR; HEART-FAILURE; GENE POLYMORPHISMS; CIRCULATING LEVELS; ENDPRODUCTS LEVELS; CLEAVED RECEPTOR	Objective Upregulation of the receptor for advanced glycation end products (RAGE) has been proposed as a pathophysiological mechanism underlying the development of atrial fibrillation (AF). We sought to investigate if soluble RAGE levels are associated with AF in Caucasian patients. Methods Patients (n = 587) were prospectively recruited and serum levels of soluble RAGE (sRAGE) and endogenous secretory RAGE (esRAGE) measured. The patients included 527 with sinus rhythm, 32 with persistent AF (duration > 7 days, n = 32) and 28 with paroxysmal AF (duration <7 days, n = 28). Results Patients with AF were older and had a greater prevalence of heart failure than patients in sinus rhythm. Circulating RAGE levels were higher in patients with persistent AF [median sRAGE 1190 (724-2041) pg/ml and median esRAGE 452 (288-932) pg/ml] compared with paroxysmal AF [sRAGE 799 (583-1033) pg/ml and esRAGE 279 (201-433) pg/ml, p <= 0.01] or sinus rhythm [sRAGE 782 (576-1039) pg/ml and esRAGE 289 (192-412) pg/ml, p < 0.001]. In multi-variable logistic regression analysis, independent predictors of persistent AF were age, heart failure, sRAGE [odds ratio 1.1 per 100 pg/ml, 95% confidence interval (CI) 1.0-1.1, p = 0.001] and esRAGE [odds ratio 1.3 per 100 pg/ml, 95% CI 1.1-1.4, p < 0.001]. Heart failure and age were the only independent predictors of paroxysmal AF. In AF patients, sRAGE [odds ratio 1.1 per 100 pg/ml, 95% CI 1.1-1.2, p = 0.007] and esRAGE [odds ratio 1.3 per 100 pg/ml, 95% CI 1.0-1.5, p = 0.017] independently predicted persistent compared with paroxysmal AF. Conclusions Soluble RAGE is elevated in Caucasian patients with AF, and both sRAGE and esRAGE predict the presence of persistent AF.	[Lancefield, Terase F.; Patel, Sheila K.; Freeman, Melanie; Velkoska, Elena; Wai, Bryan; Srivastava, Piyush M.; Farouque, Omar; Burrell, Louise M.] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia; [Lancefield, Terase F.; Wai, Bryan; Srivastava, Piyush M.; Horrigan, Mark; Farouque, Omar; Burrell, Louise M.] Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia; [Freeman, Melanie] Box Hill Hosp, Dept Cardiol, Box Hill, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Box Hill Hospital	Lancefield, TF (corresponding author), Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia.; Lancefield, TF (corresponding author), Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia.	terase.lancefield@austin.org.au			National Heart Foundation Clinical Research Scholarship; Pfizer Cardiovascular Lipid grant	National Heart Foundation Clinical Research Scholarship; Pfizer Cardiovascular Lipid grant	This work was supported by the National Heart Foundation Clinical Research Scholarship (http://heartfoundation.org.au) to TL and the Pfizer Cardiovascular Lipid grant (https://www.pfizergrants.com.au/grants/CardiovascularLipid.aspx) to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; Begieneman MPV, 2015, AM J PATHOL, V185, P2096, DOI 10.1016/j.ajpath.2015.04.018; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; BRETT J, 1993, AM J PATHOL, V143, P1699; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Candido R, 2003, CIRC RES, V92, P785, DOI 10.1161/01.RES.0000065620.39919.20; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chen MC, 2008, AM J CARDIOL, V102, P861, DOI 10.1016/j.amjcard.2008.05.038; Colhoun HM, 2011, DIABETES, V60, P2379, DOI 10.2337/db11-0291; Gao JX, 2010, J HUM GENET, V55, P668, DOI 10.1038/jhg.2010.85; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hudson BI, 2011, ATHEROSCLEROSIS, V216, P192, DOI 10.1016/j.atherosclerosis.2011.01.024; Huxley RR, 2011, AM J CARDIOL, V108, P56, DOI 10.1016/j.amjcard.2011.03.004; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Kalousova M, 2007, NEPHROL DIAL TRANSPL, V22, P2020, DOI 10.1093/ndt/gfm050; Katakami N, 2005, DIABETES CARE, V28, P2716, DOI 10.2337/diacare.28.11.2716; Kato T, 2008, J CARDIOVASC ELECTR, V19, P415, DOI 10.1111/j.1540-8167.2007.01037.x; Kato T, 2006, J CARDIOVASC ELECTR, V17, P890, DOI 10.1111/j.1540-8167.2006.00528.x; Koyama Y, 2008, J CARD FAIL, V14, P133, DOI 10.1016/j.cardfail.2007.10.019; Liu B, 2014, INT HEART J, V55, P499, DOI 10.1536/ihj.14-107; Lu L, 2010, CHINESE MED J-PEKING, V123, P594, DOI 10.3760/cma.j.issn.0366-6999.2010.05.017; Lu L, 2009, ATHEROSCLEROSIS, V206, P540, DOI 10.1016/j.atherosclerosis.2008.12.045; Nakamura K, 2005, MICROVASC RES, V70, P137, DOI 10.1016/j.mvr.2005.10.002; Nakamura K, 2008, MICROVASC RES, V76, P52, DOI 10.1016/j.mvr.2007.09.004; Peng WH, 2009, ARCH MED RES, V40, P393, DOI 10.1016/j.arcmed.2009.06.008; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Qu YC, 2009, SCAND CARDIOVASC J, V43, P292, DOI 10.1080/14017430802651803; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Raposeiras-Roubin S, 2012, INT J CARDIOL, V157, P397, DOI 10.1016/j.ijcard.2011.05.072; Raposeiras-Roubin S, 2010, EUR J HEART FAIL, V12, P1092, DOI 10.1093/eurjhf/hfq117; Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043; Selvin E, 2013, DIABETES, V62, P2116, DOI 10.2337/db12-1528; Tikellis C, 2008, AM J PHYSIOL-ENDOC M, V295, pE323, DOI 10.1152/ajpendo.00024.2008; Walker D, 2015, EXPERT OPIN INV DRUG, V24, P393, DOI 10.1517/13543784.2015.1001490; Wang LJ, 2011, EUR J HEART FAIL, V13, P440, DOI 10.1093/eurjhf/hfq231; Yan XX, 2013, INT J CARDIOL, V166, P242, DOI 10.1016/j.ijcard.2012.08.055; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371; Zhao DD, 2012, INT J CARDIOL, V158, P471, DOI 10.1016/j.ijcard.2012.05.042	41	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161715	10.1371/journal.pone.0161715	http://dx.doi.org/10.1371/journal.pone.0161715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627677	Green Published, gold			2022-12-26	WOS:000383680600007
J	Maricelli, JW; Lu, QL; Lin, DC; Rodgers, BD				Maricelli, Joseph W.; Lu, Qi L.; Lin, David C.; Rodgers, Buel D.			Trendelenburg-Like Gait, Instability and Altered Step Patterns in a Mouse Model for Limb Girdle Muscular Dystrophy 2i	PLOS ONE			English	Article							FUKUTIN-RELATED PROTEIN; 6-MINUTE WALK TEST; GENE-THERAPY; FUNCTIONAL GLYCOSYLATION; ALPHA-DYSTROGLYCAN; MDX MICE; MUSCLE; FORCE; MUTATIONS; HUMANS	Limb-girdlemuscular dystrophy type 2i (LGMD2i) affects thousands of lives with shortened life expectancy mainly due to cardiac and respiratory problems and difficulty with ambulation significantly compromising quality of life. Limited studies have noted impaired gait in patients and animal models of different muscular dystrophies, but not in animal models of LGMD2i. Our goal, therefore, was to quantify gait metrics in the fukutin-related protein P448L mutant (P448L) mouse, a recently developed model for LGMD2i. The Noldus Cat-Walk XT motion capture system was used to identify multiple gait impairments. An average galloping body speed of 35 cm/s for both P448L and C57BL/6 wild-type mice was maintained to ensure differences in gait were due only to strain physiology. Compared to wildtype mice, P448L mice reach maximum contact 10% faster and have 40% more paw surface area during stance. Additionally, force intensity at the time of maximum paw contact is roughly 2-fold higher in P448L mice. Paw swing time is reduced in P448L mice without changes in stride length as a faster swing speed compensates. Gait instability in P448L mice is indicated by 50% higher instances of 3 and 4 paw stance support and conversely, 2-fold fewer instances of single paw stance support and no instance of zero paw support. This leads to lower variation of normal step patterns used and a higher use of uncommon step patterns. Similar anomalies have also been noted in muscular dystrophy patients due to weakness in the hip abductor muscles, producing a Trendelenburg gait characterized by "waddling" and more pronounced shifts to the stance leg. Thus, gait of P448L mice replicates anomalies commonly seen in LGMD2i patients, which is not only potentially valuable for assessing drug efficacy in restoring movement biomechanics, but also for better understanding them.	[Maricelli, Joseph W.; Rodgers, Buel D.] Washington State Univ, Sch Mol Biol, Washington Ctr Muscle Biol, Pullman, WA 99164 USA; [Lu, Qi L.] Carolinas Med Ctr, Dept Neurol, Charlotte, NC 28203 USA; [Lin, David C.] Washington State Univ, Washington Ctr Muscle Biol, Dept Integrat Physiol & Neurosci, Voiland Sch Chem Engn & Bioengn, Pullman, WA 99164 USA	Washington State University; Carolinas Medical Center; Washington State University	Rodgers, BD (corresponding author), Washington State Univ, Sch Mol Biol, Washington Ctr Muscle Biol, Pullman, WA 99164 USA.	dan.rodgers@wsu.edu	lu, qi/HHS-2115-2022; Rodgers, Dan/AAA-5343-2020	Lin, David/0000-0003-4492-0944; Rodgers, Buel/0000-0003-0751-1105	LGMD2iFund; Carolinas Muscular Dystrophy Research Endowment	LGMD2iFund; Carolinas Muscular Dystrophy Research Endowment	LGMD2iFund http://www.lgmd2ifund.org and Carolinas Muscular Dystrophy Research Endowment http://www.givecarolinas.org/.	Adachi W, 2011, IEEE ENG MED BIO, P4022, DOI 10.1109/IEMBS.2011.6090999; Alexander RM, 2004, J ANAT, V204, P321, DOI 10.1111/j.0021-8782.2004.00289.x; ALEXANDER RM, 1982, LOCOMOTION ANIMALS, P81, DOI DOI 10.1007/978-94-011-6009-4_5; Avaria MDA, 1999, REV MED CHILE, V127, P65; Awano H, 2015, NEUROMUSCULAR DISORD, V25, P474, DOI 10.1016/j.nmd.2015.03.004; Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Blaeser A, 2013, HUM GENET, V132, P923, DOI 10.1007/s00439-013-1302-7; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; Fischer D, 2005, J NEUROL, V252, P538, DOI 10.1007/s00415-005-0684-4; Flynn J M, 2001, J Am Acad Orthop Surg, V9, P89; Ghaoui R, 2015, JAMA NEUROL, V72, P1424, DOI 10.1001/jamaneurol.2015.2274; Goddard MA, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.31; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hammaren E, 2015, NEUROMUSCULAR DISORD, V25, P141, DOI 10.1016/j.nmd.2014.11.004; HENSINGER RN, 1986, PEDIATR CLIN N AM, V33, P1355; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Izco FM, 2005, NEUROLOGIA, V20, P341; Krag TO, 2015, J NEUROPATH EXP NEUR, V74, P1137, DOI [10.1093/jnen/74.12.1137, 10.1097/NEN.0000000000000260]; Margeta M, 2009, MUSCLE NERVE, V40, P883, DOI 10.1002/mus.21432; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2012, NEUROSCI LETT, V527, P90, DOI 10.1016/j.neulet.2012.04.078; Mendell JR, 2009, ANN NEUROL, V66, P290, DOI 10.1002/ana.21732; Mendes CS, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0154-0; Mercuri E, 2005, PEDIATR ANN, V34, P560, DOI 10.3928/0090-4481-20050701-13; Mercuri E, 2003, ANN NEUROL, V53, P537, DOI 10.1002/ana.10559; Moller KA, 2008, J NEUROSCI METH, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Odom GL, 2011, MOL THER, V19, P36, DOI 10.1038/mt.2010.205; Pai VS, 1996, J ARTHROPLASTY, V11, P174, DOI 10.1016/S0883-5403(05)80013-0; Pane Marika, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.a93d9904d57dcb08936f2ea89bca6fe6; Papa R, PEDIAT NEUROLOGY; Papa R, 2016, PEDIATR NEUROL, V55, P58, DOI 10.1016/j.pediatrneurol.2015.11.004; Pegoraro E., 1993, GENEREVIEWS R; Petri H, 2015, INT J CARDIOL, V182, P403, DOI 10.1016/j.ijcard.2014.12.090; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; READ L, 1986, J BONE JOINT SURG BR, V68, P481, DOI 10.1302/0301-620X.68B3.3733820; Rijken NHM, 2015, GAIT POSTURE, V42, P295, DOI 10.1016/j.gaitpost.2015.06.005; Ropars J, 2015, COMPUT METHOD BIOMEC, V18, P2042, DOI 10.1080/10255842.2015.1069615; Rosales XQ, 2012, PEDIATR NEUROL, V46, P13, DOI 10.1016/j.pediatrneurol.2011.08.014; Shklyar I, 2015, PEDIATR NEUROL, V52, P202, DOI 10.1016/j.pediatrneurol.2014.09.014; Simoes GF, 2014, BRAIN BEHAV, V4, P738, DOI 10.1002/brb3.250; Smith BJH, 2015, J APPL PHYSIOL, V119, P704, DOI 10.1152/japplphysiol.01014.2014; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tsujiuchi N, 2014, IEEE ENG MED BIO, P2521, DOI 10.1109/EMBC.2014.6944135; Vasudevan PN, 1997, J BONE JOINT SURG BR, V79B, P462, DOI 10.1302/0301-620X.79B3.7495; de Albuquerque MAV, 2015, ARQ NEURO-PSIQUIAT, V73, P993, DOI 10.1590/0004-282X20150168; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Webb AA, 2011, JOVE-J VIS EXP, DOI 10.3791/2138; Xu L, 2013, MOL THER, V21, P1832, DOI 10.1038/mt.2013.156; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161984	10.1371/journal.pone.0161984	http://dx.doi.org/10.1371/journal.pone.0161984			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627455	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600015
J	Arai, K; Eguchi, T; Rahman, MM; Sakamoto, R; Masuda, N; Nakatsura, T; Calderwood, SK; Kozaki, K; Itoh, M				Arai, Kazuya; Eguchi, Takanori; Rahman, M. Mamunur; Sakamoto, Ruriko; Masuda, Norio; Nakatsura, Tetsuya; Calderwood, Stuart K.; Kozaki, Ken-ichi; Itoh, Manabu			A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-COLON-CARCINOMA; I RECEPTOR KINASE; OVARIAN-CANCER; TRANSFORMING GROWTH-FACTOR-BETA-1; SPHEROID FORMATION; CELL-CULTURE; STEM-CELLS; E-CADHERIN; EXPRESSION	Epithelial-mesenchymal transition (EMT) is a crucial pathological event in cancer, particularly in tumor cell budding and metastasis. Therefore, control of EMT can represent a novel therapeutic strategy in cancer. Here, we introduce an innovative three-dimensional (3D) high-throughput screening (HTS) system that leads to an identification of EMT inhibitors. For the establishment of the novel 3D-HTS system, we chose NanoCulture Plates (NCP) that provided a gel-free micro-patterned scaffold for cells and were independent of other spheroid formation systems using soft-agar. In the NCP-based 3D cell culture system, A549 lung cancer cells migrated, gathered, and then formed multiple spheroids within 7 days. Live cell imaging experiments showed that an established EMT-inducer TGF-beta promoted peripheral cells around the core of spheroids to acquire mesenchymal spindle shapes, loss of intercellular adhesion, and migration from the spheroids. Along with such morphological change, EMT-related gene expression signatures were altered, particularly alteration of mRNA levels of ECAD/CDH1, NCAD/CDH2, VIM and ZEB1/TCF8. These EMT-related phenotypic changes were blocked by SB431542, a TGF-beta receptor I (TGF beta R1) inhibitor. Inside of the spheroids were highly hypoxic; in contrast, spheroid-derived peripheral migrating cells were normoxic, revealed by visualization and quantification using Hypoxia Probe. Thus, TGF-beta-triggeredEMT caused spheroid hypoplasia and loss of hypoxia. Spheroid EMT inhibitory (SEMTIN) activity of SB431542 was calculated from fluorescence intensities of the Hypoxia Probe, and then was utilized in a drug screening of EMT-inhibitory small molecule compounds. In a pilot screening, 9 of 1,330 compounds were above the thresholds of the SEMTIN activity and cell viability. Finally, two compounds SB-525334 and SU9516 showed SEMTIN activities in a dose dependent manner. SB-525334 was a known TGF beta R1 inhibitor. SU9516 was a cyclin-dependent kinase 2 (CDK2) inhibitor, which we showed also had an EMT-inhibitory activity. The half maximal inhibitory concentration (IC50) of SB-525334 and SU9516 were 0.31 mu M and 1.21 mu M, respectively, while IC50 of SB431542 was 2.38 mu M. Taken together, it was shown that this 3D NCP-based HTS system was useful for screening of EMT-regulatory drugs.	[Arai, Kazuya; Sakamoto, Ruriko; Masuda, Norio; Itoh, Manabu] SCIVAX Life Sci Inc, Kawasaki, Kanagawa, Japan; [Arai, Kazuya; Rahman, M. Mamunur] SCIVAX USA Inc, Woburn, MA 01801 USA; [Eguchi, Takanori; Calderwood, Stuart K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA; [Eguchi, Takanori; Kozaki, Ken-ichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan; [Eguchi, Takanori] Okayama Univ, Sch Dent, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan; [Nakatsura, Tetsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Kashiwa, Chiba, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Okayama University; Okayama University; National Cancer Center - Japan	Arai, K (corresponding author), SCIVAX Life Sci Inc, Kawasaki, Kanagawa, Japan.; Arai, K (corresponding author), SCIVAX USA Inc, Woburn, MA 01801 USA.; Eguchi, T (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA.; Eguchi, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Pharmacol, Okayama, Japan.; Eguchi, T (corresponding author), Okayama Univ, Sch Dent, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan.	kazuya_arai@organogenix.com; eguchi@okayama-u.ac.jp		Eguchi, Takanori/0000-0002-3297-6126	SCIVAX Life Sciences Inc.; Joint Center for Radiation Therapy (JCRT) grant at Harvard Medical School; JSPS KAKENHI [JP16K11722]	SCIVAX Life Sciences Inc.; Joint Center for Radiation Therapy (JCRT) grant at Harvard Medical School; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	SCIVAX Life Sciences Inc. provided support in the form of salaries for authors KA, MMR, RS, NM and MI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by a Joint Center for Radiation Therapy (JCRT) grant at Harvard Medical School 2015 (to TE and SKC) and JSPS KAKENHI JP16K11722 (to TE). The specific roles of these authors are articulated in the "author contributions" section.	Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Brown KA, 2004, BREAST CANCER RES, V6, pR130, DOI 10.1186/bcr762; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Calone I., 2012, Experimental Oncology, V34, P9; Choi KS, 1999, J BIOL CHEM, V274, P31775, DOI 10.1074/jbc.274.45.31775; Chua KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033183; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Elsayed M, 2014, NANOMEDICINE-UK, V9, P349, DOI 10.2217/nnm.13.200; Floor S, 2011, ONCOGENE, V30, P4609, DOI 10.1038/onc.2011.184; Gao N, 2006, MOL PHARMACOL, V70, P645, DOI 10.1124/mol.106.024505; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ivascu A, 2007, INT J ONCOL, V31, P1403; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laping NJ, 2007, CLIN CANCER RES, V13, P3087, DOI 10.1158/1078-0432.CCR-06-1811; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Liu J, 2014, INT J CLIN EXP PATHO, V7, P6943; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Opyrchal M, 2014, INT J ONCOL, V45, P1193, DOI 10.3892/ijo.2014.2523; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pan JJ, 2011, J GASTROINTEST ONCOL, V2, P151, DOI 10.3978/j.issn.2078-6891.2011.022; Park MC, 2016, CANCER RES, V76, P1044, DOI 10.1158/0008-5472.CAN-14-2611; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Storch Katja, 2012, Chemother Res Pract, V2012, P319287, DOI 10.1155/2012/319287; SUTHERLAND RM, 1986, CANCER RES, V46, P5320; Takai M, 2014, J OVARIAN RES, V7, DOI [10.1186/1757-2215-7-38, 10.1186/1757-2215-7-76]; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xu S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05646; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Yu B, 2002, BIOCHEM PHARMACOL, V64, P1091, DOI 10.1016/S0006-2952(02)01264-9; Zang R., 2012, INT J BIOTECHNOL WEL, V1, P31, DOI DOI 10.6000/1927-3037.2012.01.01.02; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948	47	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162394	10.1371/journal.pone.0162394	http://dx.doi.org/10.1371/journal.pone.0162394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622654	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000029
J	Hernandez, CC; Klassen, TL; Jackson, LG; Gurba, K; Hu, NN; Noebels, JL; Macdonald, RL				Hernandez, Ciria C.; Klassen, Tara L.; Jackson, Laurel G.; Gurba, Katharine; Hu, Ningning; Noebels, Jeffrey L.; Macdonald, Robert L.			Deleterious Rare Variants Reveal Risk for Loss of GABA(A) Receptor Function in Patients with Genetic Epilepsy and in the General Population	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; AGONIST BINDING-SITE; MISSENSE MUTATIONS; STRUCTURAL DETERMINANTS; ENDOPLASMIC-RETICULUM; GATING MECHANISM; FEBRILE SEIZURES; BETA-2 SUBUNITS; A RECEPTORS; MOUSE MODEL	Genetic epilepsies (GEs) account for approximately 50% of all seizure disorders, and familial forms includemutations in single GABA(A) receptor subunit genes (GABRs). In 144 sporadic GE cases (GECs), exome sequencing of 237 ion channel genes identified 520 GABR variants. Among these variants, 33 rare variants in 11 GABR genes were present in 24 GECs. To assess functional risk of variants in GECs, we selected 8 variants found in GABRA, 3 in GABRB, and 3 in GABRG and compared them to 18 variants found in the general population for GABRA1 (n = 9), GABRB3 (n = 7), and GABRG2 (n = 2). To identify deleterious variants and gain insight into structure-function relationships, we studied the gating properties, surface expression and structural perturbations of the 32 variants. Significant reduction of GABAA receptor function was strongly associated with variants scored as deleterious and mapped within the N-terminal and transmembrane domains. In addition, 12 out of 17 variants mapped along the beta+/alpha- GABA binding interface, were associated with reduction in channel gating and were predicted to cause structural rearrangements of the receptor by in silico simulations. Missense or nonsensemutations of GABRA1, GABRB3 and GABRG2 primarily impair subunit biogenesis. In contrast, GABR variants affected receptor function by impairing gating, suggesting that different mechanisms are operating in GABR epilepsy susceptibility variants and disease-causingmutations. The functional impact of single GABR variants found in individuals with sporadic GEs warrants the use of molecular diagnosis and will ultimately improve the treatment of genetic epilepsies by using a personalized approach.	[Hernandez, Ciria C.; Hu, Ningning; Macdonald, Robert L.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA; [Klassen, Tara L.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6S 1Z3, Canada; [Jackson, Laurel G.; Gurba, Katharine] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA	Vanderbilt University; University of British Columbia; Vanderbilt University; Baylor College of Medicine	Hernandez, CC; Macdonald, RL (corresponding author), Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA.	ciria.hernandez@vanderbilt.edu; robert.macdonald@vanderbilt.edu			National Institutes of Health [R01 NS33300]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102924, UC2HL103010, RC2HL102923, UC2HL102923, RC2HL102925, UC2HL102926, UC2HL102925, RC2HL102926, UC2HL102924, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health via grant No. R01 NS33300 (to R. L. M.).; The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bianchi MT, 2002, J PHYSIOL-LONDON, V544, P3, DOI 10.1113/jphysiol.2002.020255; Bianchi MT, 2002, J NEUROSCI, V22, P5321; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Chung SK, 2010, J NEUROSCI, V30, P9612, DOI 10.1523/JNEUROSCI.1763-10.2010; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Dibbens LM, 2009, NEUROSCI LETT, V453, P162, DOI 10.1016/j.neulet.2009.02.038; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Gurba KN, 2012, J BIOL CHEM, V287, P12083, DOI 10.1074/jbc.M111.332528; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hernandez CC, 2011, J PHYSIOL-LONDON, V589, P5857, DOI 10.1113/jphysiol.2011.218883; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hirose S, 2005, EPILEPSIA, V46, P38, DOI 10.1111/j.0013-9580.2005.461011.x; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Huang X, 2014, NEUROBIOL DIS, V68, P167, DOI 10.1016/j.nbd.2014.04.015; James VM, 2013, NEUROBIOL DIS, V52, P137, DOI 10.1016/j.nbd.2012.12.001; Janve VS, 2016, ANN NEUROL, V79, P806, DOI 10.1002/ana.24631; Kang JQ, 2004, J NEUROSCI, V24, P8672, DOI 10.1523/JNEUROSCI.2717-04.2004; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Lo WY, 2014, NEUROCHEM RES, V39, P1088, DOI 10.1007/s11064-013-1187-9; Lo WY, 2010, J BIOL CHEM, V285, P31348, DOI 10.1074/jbc.M110.151449; Macdonald R.L., 2012, JASPERS BASIC MECH E, V4th, DOI 10.1093/med/9780199746545.003.0057; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; Marini C, 2004, EPILEPSIA, V45, P467, DOI 10.1111/j.0013-9580.2004.46803.x; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mulley JC, 2005, HUM MOL GENET, V14, pR243, DOI 10.1093/hmg/ddi355; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scimemi A, 2005, J NEUROSCI, V25, P10016, DOI 10.1523/JNEUROSCI.2520-05.2005; Shen XM, 2012, NEUROLOGY, V79, P449, DOI 10.1212/WNL.0b013e31825b5bda; Shen XM, 2012, J CLIN INVEST, V122, P2613, DOI 10.1172/JCI63415; SMART TG, 1991, BRIT J PHARMACOL, V103, P1837, DOI 10.1111/j.1476-5381.1991.tb12337.x; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Srivastava S, 2014, AM J MED GENET A, V164, P2914, DOI 10.1002/ajmg.a.36714; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Venkatachalan SP, 2012, J BIOL CHEM, V287, P6714, DOI 10.1074/jbc.M111.316836; Wallace RH, 2001, NAT GENET, V28, P49, DOI 10.1038/ng0501-49; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	54	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162883	10.1371/journal.pone.0162883	http://dx.doi.org/10.1371/journal.pone.0162883			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622563	gold, Green Submitted, Green Published			2022-12-26	WOS:000383681000066
J	Guo, YY; Deng, YJ; Li, XQ; Ning, Y; Lin, XP; Guo, SM; Chen, MX; Han, M				Guo, YanYan; Deng, YuanJun; Li, XiaoQing; Ning, Yong; Lin, XuePing; Guo, ShuiMing; Chen, MeiXue; Han, Min			Glutaminolysis Was Induced by TGF-beta 1 through PP2Ac Regulated Raf-MEK-ERK Signaling in Endothelial Cells	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; GLUTAMINASE EXPRESSION; TUMOR-CELLS; METABOLISM; CANCER; PROLIFERATION; DEPHOSPHORYLATION; INHIBITION; ACTIVATION; KINASE	Vascular endothelial cells can survive under hypoxic and inflammatory conditions by alterations of the cellular energy metabolism. In addition to high rates of glycolysis, glutaminolysis is another importantway of providing the required energy to support cellular sprouting in such situations. However, the exact mechanism in which endothelial cells upregulate glutaminolysis remains unclear. Here we demonstrated that protein phosphatase 2A (PP2A)-mediated Raf-MEK-ERK signaling was involved in glutaminolysis in endothelial cells. Using models of human umbilical vein endothelial cells (HUVECs) treated with transforming growth factor-beta 1 (TGF-beta 1), we observed a dramatic induction in cellular glutamate levels accompanied by Raf-MEK-ERK activation. By addition of U0126, the specific inhibitor of MEK1/2, the expression of kidney-type glutaminase (KGA, a critical glutaminase in glutaminolysis) was significantly decreased. Moreover, inhibition of PP2A by okadaic acid (OA), a specific inhibitor of PP2A phosphatase activity or by depletion of its catalytic subunit (PP2Ac), led to a significant inactivation of Raf-MEK-ERK signaling and reduced glutaminolysis in endothelial cells. Taken together, these results indicated that PP2A-dependent Raf-MEK-ERK activation was involved in glutaminolysis and inhibition of PP2A signals was sufficient to block Raf-MEK-ERK pathway and reduced glutamine metabolism in endothelial cells.	[Guo, YanYan; Deng, YuanJun; Li, XiaoQing; Ning, Yong; Lin, XuePing; Guo, ShuiMing; Chen, MeiXue; Han, Min] Huazhong Univ Sicence & Technol, Tongji Hosp, Dept Nephrol, Div Internal Med,Tongji Med Coll, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Han, M (corresponding author), Huazhong Univ Sicence & Technol, Tongji Hosp, Dept Nephrol, Div Internal Med,Tongji Med Coll, Wuhan, Hubei, Peoples R China.	minhan@tjh.tjmu.edu.cn			National Natural Science Foundation of China [81270770, 81370798, 81470948]; Natural Science Foundation of Hubei Province [2014CFB255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by grants of the National Natural Science Foundation of China (No. 81270770, 81370798, 81470948) and the Natural Science Foundation of Hubei Province (No. 2014CFB255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Aledo JC, 2004, BIOESSAYS, V26, P778, DOI 10.1002/bies.20063; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; Andratsch M, 2007, AM J PHYSIOL-RENAL, V293, pF846, DOI 10.1152/ajprenal.00139.2007; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeLaBarre B, 2014, CHEM BIOL, V21, P1143, DOI 10.1016/j.chembiol.2014.08.007; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Ferrari G, 2006, P NATL ACAD SCI USA, V103, P17260, DOI 10.1073/pnas.0605556103; Fukuda G, 2005, DIABETES-METAB RES, V21, P367, DOI 10.1002/dmrr.527; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Khan Zia Ali, 2003, Exp Diabesity Res, V4, P287, DOI 10.1155/EDR.2003.287; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lee YZ, 2014, ONCOTARGET, V5, P6087, DOI 10.18632/oncotarget.2173; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; Martin-Rufian M, 2014, J MOL MED, V92, P277, DOI 10.1007/s00109-013-1105-2; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Polet F, 2013, J INTERN MED, V273, P156, DOI 10.1111/joim.12016; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Unterluggauer H, 2008, BIOGERONTOLOGY, V9, P247, DOI 10.1007/s10522-008-9134-x; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Welbourne T, 2001, NEWS PHYSIOL SCI, V16, P157, DOI 10.1152/physiologyonline.2001.16.4.157; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Yu LG, 2004, J BIOL CHEM, V279, P41377, DOI 10.1074/jbc.M400017200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162658	10.1371/journal.pone.0162658	http://dx.doi.org/10.1371/journal.pone.0162658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612201	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900145
J	Zhang, S; Zhou, B; Wang, L; Li, P; Bennett, B; Snyder, R; Garantziotis, S; Fargo, D; Cox, A; Chen, L; Hu, G				Zhang, S.; Zhou, B.; Wang, L.; Li, P.; Bennett, Bd; Snyder, R.; Garantziotis, S.; Fargo, Dc; Cox, Ad; Chen, L.; Hu, G.			INO80 is required for oncogenic transcription and tumor growth in non-small cell lung cancer	ONCOGENE			English	Article							CHROMATIN REMODELING COMPLEX; AMPLIFICATION; PLURIPOTENCY; REPLICATION; MECHANISMS; LANDSCAPE; BIOLOGY; ENZYME; GENES	Epigenetic regulators are attractive targets for the development of new cancer therapies. Among them, the ATP-dependent chromatin remodeling complexes control the chromatin architecture and have important roles in gene regulation. They are often found to be mutated and de-regulated in cancers, but how they influence the cancer gene expression program during cancer initiation and progression is not fully understood. Here we show that the INO80 chromatin remodeling complex is required for oncogenic transcription and tumor growth in non-small-cell lung cancer (NSCLC). Ino80, the SWI/SNF ATPase in the complex, is highly expressed in NSCLC cells compared with normal lung epithelia cells. Further, its expression, as well as that of another subunit Ino80B, negatively correlates with disease prognosis in lung cancer patients. Functionally, INO80 silencing inhibits NSCLC cell proliferation and anchorage-independent growth in vitro and tumor formation in mouse xenografts. It occupies enhancer regions near lung cancer-associated genes, and its occupancy correlates with increased genome accessibility and enhanced expression of downstream genes. Together, our study defines a critical role of INO80 in promoting oncogenic transcription and NSCLC tumorigenesis, and reveals a potential treatment strategy for inhibiting the cancer transcription network by targeting the INO80 chromatin remodeling complex.	[Zhang, S.; Chen, L.] Chinese Peoples Liberat Army Gen Hosp, Dept Pulm & Crit Care Med, Beijing 100853, Peoples R China; [Zhou, B.; Cox, Ad] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Zhou, B.; Wang, L.] Fuwai Hosp, Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing, Peoples R China; [Zhou, B.; Wang, L.] Fuwai Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Wang, L.; Li, P.; Hu, G.] Natl Inst Environm Hlth Sci, Epigenet & Stem Cell Biol Lab, 111 TW Alexander Dr,Bldg 101,Room A314, Res Triangle Pk, NC 27709 USA; [Bennett, Bd; Fargo, Dc] Natl Inst Environm Hlth Sci, Integrat Bioinformat, Res Triangle Pk, NC USA; [Snyder, R.; Garantziotis, S.] Natl Inst Environm Hlth Sci, Clin Res Branch, Res Triangle Pk, NC USA	Chinese People's Liberation Army General Hospital; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chen, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Pulm & Crit Care Med, Beijing 100853, Peoples R China.; Hu, G (corresponding author), Natl Inst Environm Hlth Sci, Epigenet & Stem Cell Biol Lab, 111 TW Alexander Dr,Bldg 101,Room A314, Res Triangle Pk, NC 27709 USA.	CLA_301@163.com; hug4@niehs.nih.gov	Hu, Guang/E-7474-2016; Garantziotis, Stavros/A-6903-2009	Hu, Guang/0000-0003-0437-4723; Garantziotis, Stavros/0000-0003-4007-375X; Cox, Adrienne D./0000-0002-4901-2454; Chen, Liang-an/0000-0002-1829-3134	Intramural Research Program of the NIH; National Institute of Environmental Health Sciences [Z01ES102745]; National Institutes of Health Grants [CA042978, CA161494]; NATIONAL CANCER INSTITUTE [R01CA042978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIDES102465, ZIAES102605, ZIAES102745] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the NIEHS Animal, Epigenomics and Bioinformatics core facilities for assistance with various techniques and experiments. This study was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences Z01ES102745 (to GH) and by National Institutes of Health Grants CA042978 and CA161494 (to ADC).	Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baykara O, 2015, J CANCER, V6, P270, DOI 10.7150/jca.10638; Belinsky SA, 2015, ANNU REV PHYSIOL, V77, P453, DOI 10.1146/annurev-physiol-021014-072018; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bender E, 2014, NATURE, V513, pS2, DOI 10.1038/513S2a; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; El-Telbany Ahmed, 2012, Genes Cancer, V3, P467, DOI 10.1177/1947601912465177; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Helming KC, 2014, CANCER CELL, V26, P309, DOI 10.1016/j.ccr.2014.07.018; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Jakopovic M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00261; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kim J, 2011, GENOME MED, V3, DOI 10.1186/gm291; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laurette P, 2015, ELIFE, V4, DOI 10.7554/eLife.06857; Linxweiler M, 2012, AM J PATHOL, V180, P473, DOI 10.1016/j.ajpath.2011.10.039; Liu SV, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00135; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; Min JN, 2013, CELL RES, V23, P1396, DOI 10.1038/cr.2013.113; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Stewart DJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt356; Viktorsson K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.28; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Watanabe S, 2010, COLD SH Q B, V75, P35, DOI 10.1101/sqb.2010.75.063; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009	35	22	22	5	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1430	1439		10.1038/onc.2016.311	http://dx.doi.org/10.1038/onc.2016.311			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27641337	Green Accepted			2022-12-26	WOS:000395862500011
J	Xu, YJ; Pang, WJ; Lu, JS; Shan, AD; Zhang, Y				Xu, Yingjiao; Pang, Wenjie; Lu, Jishun; Shan, Aidong; Zhang, Yan			Polypeptide N-Acetylgalactosaminyltransferase 13 Contributes to Neurogenesis via Stabilizing the Mucin-type O-Glycoprotein Podoplanin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycosylation; glycosyltransferase; neurodifferentiation; protein stability; Galnt13; mucin-type O-glycoprotein; neuronal differentiation; podoplanin; ppGalNAc-T13	EMBRYONAL CARCINOMA-CELLS; AGGREGATION-INDUCING FACTOR; TRANSFERASE GENE FAMILY; TRIMERIC TN ANTIGEN; GALNAC-TRANSFERASE; LINKED GLYCOSYLATION; NEURONAL DIFFERENTIATION; NEURAL DEVELOPMENT; DEVELOPMENTAL-CHANGES; RECEPTOR EXPRESSION	Mucin-type O-glycosylation is initiated by an evolutionarily conserved family of polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-Ts). Previously, it was reported that ppGalNAc-T13 is restrictively expressed at a high level in the brain. Here we provide evidence for the critical role of ppGalNAc-T13 in neural differentiation. In detail, we show that the expression of ppGalNAc-T13 was dramatically up-regulated during early neurogenesis in mouse embryonic brains. Similar changes were also observed in cell models of neuronal differentiation by using either primary mouse cortical neural precursor cells or murine embryonal carcinoma P19 cells. Knockout of ppGalNAc-T13 in P19 cells suppressed not only neural induction but also neuronal differentiation. These effects are at least partly mediated by the mucin-type O-glycoprotein podoplanin (PDPN), as knockdown of PDPN led to a similar inhibition of neuronal differentiation and PDPN was significantly reduced at the posttranscriptional level after ppGalNAc-T13 knockout. Further data demonstrate that PDPN acts as a substrate of ppGalNAc-T13 and that the ppGalNAc-T13-mediated O-glycosylation on PDPN is important for its stability. Taken together, this study suggests that ppGalNAc-T13 contributes to neuronal differentiation through glycosylating and stabilizing PDPN, which provides insights into the regulatory roles of O-glycosylation in mammalian neural development.	[Xu, Yingjiao; Pang, Wenjie; Lu, Jishun; Shan, Aidong; Zhang, Yan] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University	Zhang, Y (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China.; Zhang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yanzhang2006@sjtu.edu.cn	Yang, Fang/AAF-3024-2019		National Basic Research Program of China [2012CB822103]; National High Technology Research and Development Program of China [2012AA020203]; National Natural Science Foundation [30970642, 31170771, 31370806, 31570796]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20130073110088]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020203] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Basic Research Program of China Grant 2012CB822103, National High Technology Research and Development Program of China Grant 2012AA020203, National Natural Science Foundation Grants 30970642, 31170771, 31370806, and 31570796, and Specialized Research Fund for the Doctoral Program of Higher Education Grant 20130073110088. The authors declare that they have no conflicts of interest with the contents of this article.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berois N, 2006, CLIN CHEM, V52, P1701, DOI 10.1373/clinchem.2006.067975; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Breen KC, 1998, MOL NEUROBIOL, V16, P163, DOI 10.1007/BF02740643; Dani N, 2014, J NEUROSCI, V34, P13047, DOI 10.1523/JNEUROSCI.1484-14.2014; Delgado-Esteban M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3879; Gerken TA, 2013, J BIOL CHEM, V288, P19900, DOI 10.1074/jbc.M113.477877; Grau SJ, 2015, INT J CLIN EXP PATHO, V8, P8663; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kotani M, 2003, J NEUROSCI RES, V73, P603, DOI 10.1002/jnr.10696; Kotani M, 2002, J NEUROSCI RES, V67, P595, DOI 10.1002/jnr.10150; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; MacPherson Paul A., 1995, Methods (Orlando), V7, P238, DOI 10.1006/meth.1995.1029; Matsumoto Y, 2013, J BIOL CHEM, V288, P24264, DOI 10.1074/jbc.M113.455006; Matsumoto Y, 2012, BIOCHEM BIOPH RES CO, V419, P7, DOI 10.1016/j.bbrc.2012.01.086; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Monlauzeur L, 1998, J BIOL CHEM, V273, P30263, DOI 10.1074/jbc.273.46.30263; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; Pan YF, 2014, BLOOD, V124, P3656, DOI 10.1182/blood-2014-04-572107; Park M, 2003, J CELL PHYSIOL, V196, P512, DOI 10.1002/jcp.10332; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; REDDY P, 1989, J BIOL CHEM, V264, P17329; Resende RR, 2007, NEUROSCIENCE, V146, P1169, DOI 10.1016/j.neuroscience.2007.02.041; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Scott Hilary, 2014, Adv Neurobiol, V9, P367, DOI 10.1007/978-1-4939-1154-7_17; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Suzuki M, 2003, J BIOL CHEM, V278, P49459, DOI 10.1074/jbc.M308316200; Suzuki-Inoue Katsue, 2009, Rinsho Ketsueki, V50, P389; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Takasaki N, 2014, P NATL ACAD SCI USA, V111, P1120, DOI 10.1073/pnas.1310777111; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Thompson JA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-62; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Voglmeir J, 2015, COMP BIOCHEM PHYS B, V180, P40, DOI 10.1016/j.cbpb.2014.10.003; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; White RB, 2008, PHYSIOL GENOMICS, V33, P41, DOI 10.1152/physiolgenomics.00256.2007; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; YAO M, 1995, J NEUROSCI RES, V41, P792, DOI 10.1002/jnr.490410610; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zamze S, 1999, GLYCOBIOLOGY, V9, P823, DOI 10.1093/glycob/9.8.823; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200; Ziman MR, 2001, EXP CELL RES, V268, P220, DOI 10.1006/excr.2001.5282	69	14	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23477	23488		10.1074/jbc.M116.743955	http://dx.doi.org/10.1074/jbc.M116.743955			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27629416	Green Published, hybrid			2022-12-26	WOS:000387884400010
J	Narendran, G; Kavitha, D; Karunaianantham, R; Gil-Santana, L; Almeida, JL; Reddy, SD; Kumar, MM; Hemalatha, H; Jayanthi, NN; Ravichandran, N; Krishnaraja, R; Prabhakar, A; Manoharan, T; Nithyananthan, L; Arjunan, G; Natrajan, M; Swaminathan, S; Andrade, BB				Narendran, Gopalan; Kavitha, Dhanasekaran; Karunaianantham, Ramesh; Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Reddy, Sirasanambatti Devarajulu; Kumar, Marimuthu Makesh; Hemalatha, Haribabu; Jayanthi, Nagesh Nalini; Ravichandran, Narayanan; Krishnaraja, Raja; Prabhakar, Angamuthu; Manoharan, Tamizhselvan; Nithyananthan, Lokeswaran; Arjunan, Gunasundari; Natrajan, Mohan; Swaminathan, Soumya; Andrade, Bruno B.			Role of LTA4H Polymorphism in Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome Occurrence and Clinical Severity in Patients Infected with HIV	PLOS ONE			English	Article							PREDICTION	Background Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is an inflammatory phenomenon complicating HIV management in coincidental tuberculosis (TB) infection, upon immune reconstitution driven by antiretroviral therapy (ART). Leukotriene A4 hydroxylase (LTA4H), an enzyme which converts LTA(4) to LTB4, regulates the balance between the anti-inflammatory lipoxins and pro-inflammatory LTB4, with direct implications in TB-driven inflammation. In humans, a single nucleotide polymorphism (SNP) in the LTA4H promoter which regulates its transcriptional activity (rs17525495) has been identified and described to impact clinical severity of TB presentation and response to corticosteroid therapy. Notably, the role of LTA4H on TB-IRIS has not been previously evaluated. Here, we performed an exploratory investigation testing the association of LTA4H polymorphism with respect to frequency of TB-IRIS occurrence and severity of TB-IRIS presentation in HIV-TB co-infected individuals. Methods Genotypic evaluation of the LTA4H enzyme from available samples was retrospectively correlated with clinical data captured in case sheets including IRIS details. The cohort included patients recruited from a prospective cohort study nested within a randomized clinical trial (NCT0933790) of ART-naive HIV+ patients with newly diagnosed rifampicin sensitive pulmonary TB in South India. Frequency of the wild type genotype (CC), as well as of the mutant genotypes (CT or TT) in the IRIS and non-IRIS patients was estimated. Comparative analyses were performed between wild genotype (CC) and the mutant genotypes (CT or TT) and tested for association between the LTA4H polymorphisms and IRIS incidence and clinical severity. Results A total of 142 eligible ART-naive patients were included in the analyses. Eighty-six individuals exhibited the wild genotype (CC) while 56 had mutant genotypes (43-CT and only 13-TT). Variant allele frequency was 0.23 and 0.26 in non-IRIS group and in IRIS group, respectively. Upon ART initiation, 51 patients developed IRIS while 91 did not. IRIS incidence was 34% and 37% in the wild (CC) and mutant type (CT/TT), respectively (p = 0.858) with a higher frequency of severe IRIS presentation in the mutant genotype group compared to the wild type genotype (p = 0.0006). A logistic regression model confirmed the association between the presence of CT/TT genotypes and occurrence of severe IRIS. Corticosteroid therapy successfully resolved IRIS in all cases irrespective of the LTA4H genotype. Conclusion A higher incidence of severe IRIS among patients with mutant LTA4H genotypes (CT and TT) was observed compared to the wild type, despite similar IRIS incidence and immune restoration in both groups. Steroids were effective in alleviating IRIS in all the genotypes.	[Narendran, Gopalan; Kavitha, Dhanasekaran; Karunaianantham, Ramesh; Reddy, Sirasanambatti Devarajulu; Kumar, Marimuthu Makesh; Hemalatha, Haribabu; Manoharan, Tamizhselvan; Nithyananthan, Lokeswaran; Arjunan, Gunasundari; Natrajan, Mohan; Swaminathan, Soumya] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Integrado Microbiol & Imunorregulacao, Unidade Med Investigat, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fundacao Jose Silveira, MONSTER Initiat, Salvador, BA, Brazil; [Gil-Santana, Leonardo; Almeida-Junior, Jilson L.; Andrade, Bruno B.] Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil; [Jayanthi, Nagesh Nalini; Ravichandran, Narayanan; Krishnaraja, Raja] Govt Hosp Thorac Med, Tambaram Sanat, Madras, Tamil Nadu, India; [Prabhakar, Angamuthu] Govt Vellore Med Coll & Hosp, Vellore, Tamil Nadu, India; [Swaminathan, Soumya] India Council Med Res Hlth Secretary, Dept Hlth Res, Minist Hlth & FamilyWelfare, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Fundacao Oswaldo Cruz	Andrade, BB (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Lab Integrado Microbiol & Imunorregulacao, Unidade Med Investigat, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, MONSTER Initiat, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil.	bruno.andrade@bahia.fiocruz.br	Andrade, Bruno/AAI-2248-2020	Dhanasekaran, Kavitha/0000-0002-3756-3419	Intramural-to-India Program, NIAID, NIH, USA; Indian Council of Medical Research, India; Fundacao de Amparo a Pesquisa do Estado da Bahia / Fundacao Oswaldo Cruz, Brazil	Intramural-to-India Program, NIAID, NIH, USA; Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR)); Fundacao de Amparo a Pesquisa do Estado da Bahia / Fundacao Oswaldo Cruz, Brazil	The work was supported by the Intramural-to-India Program, NIAID, NIH, USA and by the Indian Council of Medical Research, India. LG-S and JLA-J were supported by a scientific initiation fellowship from the Fundacao de Amparo a Pesquisa do Estado da Bahia / Fundacao Oswaldo Cruz, Brazil.	Andrade BB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004433; Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Departmentof Health & Human Services, 2015, MYC TUB DIS HIV COIN; Gopalan N, 2014, EXPERT REV CLIN IMMU, V10, P631, DOI 10.1586/1744666X.2014.892828; Haddow LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040623; Lai RPJ, 2016, SEMIN IMMUNOPATHOL, V38, P185, DOI 10.1007/s00281-015-0532-2; Lai RPJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9451; Marais S, 2013, CLIN INFECT DIS, V56, P450, DOI 10.1093/cid/cis899; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2012, AM J RESP CRIT CARE, V186, P369, DOI 10.1164/rccm.201201-0094OC; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Narendran G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063541; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Tadokera R, 2011, EUR RESPIR J, V37, P1248, DOI 10.1183/09031936.00091010; Tan HY, 2016, J IMMUNOL, V196, P4052, DOI 10.4049/jimmunol.1502203; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013	19	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163298	10.1371/journal.pone.0163298	http://dx.doi.org/10.1371/journal.pone.0163298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643598	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000383891900043
J	Poovorawan, K; Pan-ngum, W; White, LJ; Soonthornworasiri, N; Wilairatana, P; Wasitthankasem, R; Tangkijvanich, P; Poovorawan, Y				Poovorawan, Kittiyod; Pan-ngum, Wirichada; White, Lisa J.; Soonthornworasiri, Ngamphol; Wilairatana, Polrat; Wasitthankasem, Rujipat; Tangkijvanich, Pisit; Poovorawan, Yong			Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era	PLOS ONE			English	Article							VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; DRUG-USERS; EPIDEMIOLOGY; GENOTYPES; SURVIVAL; RISK; POPULATION; INTERFERON	Hepatitis C virus (HCV) infection is an important worldwide public health problem, and most of the global HCV burden is in low-to middle-income countries. This study aimed to estimate the future burden of chronic hepatitis C (CHC) and the impact of public health policies using novel antiviral agents in Thailand. A mathematical model of CHC transmission dynamics was constructed to examine the disease burden over the next 20 years using different treatment strategies. We compared and evaluated the current treatment (PEGylated interferon and ribavirin) with new treatments using novel direct-acting antiviral agents among various treatment policies. Thailand's CHC prevalence was estimated to decrease 1.09%-0.19% in 2015-2035. Expanding treatment coverage (i.e., a five-fold increment in treatment accessibility) was estimated to decrease cumulative deaths (33,007 deaths avoided, 25.5% reduction) from CHC-related decompensated cirrhosis and hepatocellular carcinoma (HCC). The yearly incidence of HCC-associated HCV was estimated to decrease from 2,305 to 1,877 cases yearly with expanding treatment coverage. A generalized treatment scenario (i.e., an equal proportional distribution of available treatment to individuals at all disease stages according to the number of cases at each stage) was predicted to further reduce death from HCC (9,170 deaths avoided, 11.3% reduction) and the annual incidence of HCC (i.e., a further decrease from 1,877 to 1,168 cases yearly, 37.7% reduction), but cumulative deaths were predicted to increase (by 3,626 deaths, 3.7% increase). Based on the extensive coverage scenario and the generalized treatment scenario, we estimated near-zero death from decompensated cirrhosis in 2031. In conclusion, CHC-related morbidity and mortality in Thailand are estimated to decrease dramatically over the next 20 years. Treatment coverage and allocation strategies are important factors that affect the future burden of CHC in resource-limited countries like Thailand.	[Poovorawan, Kittiyod; Wilairatana, Polrat] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Pan-ngum, Wirichada; Soonthornworasiri, Ngamphol] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Pan-ngum, Wirichada; White, Lisa J.] Mahidol Univ, Fac Trop Med, Math & Econ Modelling Grp, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [White, Lisa J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Wasitthankasem, Rujipat; Poovorawan, Yong] Chulalongkorn Univ, Dept Pediat, Ctr Excellence Clin Virol, Fac Med, Bangkok, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Res Unit Hepatitis & Liver Canc, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Chulalongkorn University; Chulalongkorn University	Poovorawan, K (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	kittiyod.poo@mahidol.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	pan-ngum, wirichada/0000-0002-9839-5359; White, Lisa/0000-0002-6523-185X; Poovorawan, Kittiyod/0000-0001-7016-7605	ICTM Grant of the Faculty of Tropical Medicine; Talent Management Fund, Mahidol University; NSTDA; Wellcome Trust Major Overseas Programme in SE Asia [106698/Z/14/Z]	ICTM Grant of the Faculty of Tropical Medicine; Talent Management Fund, Mahidol University; NSTDA; Wellcome Trust Major Overseas Programme in SE Asia(Wellcome Trust)	This research project was supported by an ICTM Grant of the Faculty of Tropical Medicine, the Talent Management Fund, Mahidol University, a Research Chair Grant, NSTDA and the Wellcome Trust Major Overseas Programme in SE Asia (grant number: 106698/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2014, J MED VIROL, V86, P1482, DOI 10.1002/jmv.23957; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Ansaldi F, 2014, WORLD J GASTROENTERO, V20, P9633, DOI 10.3748/wjg.v20.i29.9633; Avihingsanon A, 2014, J GASTROEN HEPATOL, V29, P1706, DOI 10.1111/jgh.12613; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Benvegnu L, 2001, GUT, V48, P110, DOI 10.1136/gut.48.1.110; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Cure S, 2015, J MED ECON, V18, P678, DOI 10.3111/13696998.2015.1040024; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Durier N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034548; Ford N, 2012, CLIN INFECT DIS, V54, P1465, DOI 10.1093/cid/cis227; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gutierrez JA, 2015, J VIRAL HEPATITIS, V22, P861, DOI 10.1111/jvh.12422; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hansurabhanon T, 2002, ANN TROP MED PARASIT, V96, P615, DOI 10.1179/000349802125001465; Hedskog C, 2015, J VIRAL HEPATITIS, V22, P871, DOI 10.1111/jvh.12405; Imran M, 2014, THEOR BIOSCI, V133, P91, DOI 10.1007/s12064-013-0197-0; Jatapai A, 2010, AM J TROP MED HYG, V83, P433, DOI 10.4269/ajtmh.2010.09-0749; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Pfeil AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126984; Pho MT, 2015, J VIRAL HEPATITIS, V22, P630, DOI 10.1111/jvh.12412; Quesada P, 2015, J CLIN VIROL, V68, P89, DOI 10.1016/j.jcv.2015.05.005; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Roy E, 2009, DRUG ALCOHOL DEPEN, V102, P158, DOI 10.1016/j.drugalcdep.2009.01.006; Solomon SS, 2015, LANCET INFECT DIS, V15, P36, DOI 10.1016/S1473-3099(14)71045-X; Somboon K, 2014, ASIAN PAC J CANCER P, V15, P3567, DOI 10.7314/APJCP.2014.15.8.3567; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Suthar AB, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001795; Thai Red Cross Organ Donation Center, 2015, ANN REPORT; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; Wasitthankasem R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149362; Wasitthankasem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126764; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; 2012, J HEPATOL, V56, P908, DOI DOI 10.1016/J.JHEP.2011.12.001S0168-8278(11)00873-7	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163095	10.1371/journal.pone.0163095	http://dx.doi.org/10.1371/journal.pone.0163095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631382	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900130
J	Dunker, KJ; Sepulveda, AJ; Massengill, RL; Olsen, JB; Russ, OL; Wenburg, JK; Antonovich, A				Dunker, Kristine J.; Sepulveda, Adam J.; Massengill, Robert L.; Olsen, Jeffrey B.; Russ, Ora L.; Wenburg, John K.; Antonovich, Anton			Potential of Environmental DNA to Evaluate Northern Pike (Esox lucius) Eradication Efforts: An Experimental Test and Case Study	PLOS ONE			English	Article							SOUTH-CENTRAL ALASKA; FISH; STREAM; EDNA; SALMONIDS; CONSUMPTION; SEDIMENTS; WATER; RIVER; TIME	Determining the success of invasive species eradication efforts is challenging because populations at very low abundance are difficult to detect. Environmental DNA (eDNA) sampling has recently emerged as a powerful tool for detecting rare aquatic animals; however, detectable fragments of DNA can persist over time despite absence of the targeted taxa and can therefore complicate eDNA sampling after an eradication event. This complication is a large concern for fish eradication efforts in lakes since killed fish can sink to the bottom and slowly decay. DNA released from these carcasses may remain detectable for long periods. Here, we evaluated the efficacy of eDNA sampling to detect invasive Northern pike (Esox lucius) following piscicide eradication efforts in southcentral Alaskan lakes. We used field observations and experiments to test the sensitivity of our Northern pike eDNA assay and to evaluate the persistence of detectable DNA emitted from Northern pike carcasses. We then used eDNA sampling and traditional sampling (i.e., gillnets) to test for presence of Northern pike in four lakes subjected to a piscicide-treatment designed to eradicate this species. We found that our assay could detect an abundant, free-roaming population of Northern pike and could also detect low-densities of Northern pike held in cages. For these caged Northern pike, probability of detection decreased with distance from the cage. We then stocked three lakes with Northern pike carcasses and collected eDNA samples 7, 35 and 70 days post-stocking. We detected DNA at 7 and 35 days, but not at 70 days. Finally, we collected eDNA samples similar to 230 days after four lakes were subjected to piscicide-treatments and detected Northern pike DNA in 3 of 179 samples, with a single detection at each of three lakes, though we did not catch any Northern pike in gillnets. Taken together, we found that eDNA can help to inform eradication efforts if used in conjunction with multiple lines of inquiry and sampling is delayed long enough to allow full degradation of DNA in the water.	[Dunker, Kristine J.; Antonovich, Anton] Alaska Dept Fish & Game, Sport Fish Div, 333 Raspberry Rd, Anchorage, AK 99518 USA; [Sepulveda, Adam J.] US Geol Survey, Northen Rocky Mt Sci Ctr, Bozeman, MT USA; [Massengill, Robert L.] Alaska Dept Fish & Game, Sport Fish Div, Soldotna, AK USA; [Olsen, Jeffrey B.; Russ, Ora L.; Wenburg, John K.] US Fish & Wildlife Serv, Conservat Genet Lab, Anchorage, AK USA	Alaska Department of Fish & Game; United States Department of the Interior; United States Geological Survey; Alaska Department of Fish & Game; United States Department of the Interior; US Fish & Wildlife Service	Sepulveda, AJ (corresponding author), US Geol Survey, Northen Rocky Mt Sci Ctr, Bozeman, MT USA.	asepulveda@usgs.gov	Wenburg, John/Y-4373-2019	Wenburg, John/0000-0001-9831-1672	Alaska Sustainable Salmon Fund; National Habitat Partnership; US Fish and Wildlife Service	Alaska Sustainable Salmon Fund; National Habitat Partnership; US Fish and Wildlife Service(US Fish & Wildlife Service)	Support was provided by Alaska Sustainable Salmon Fund (to KJM, RLM); National Habitat Partnership (Kenai Peninsula Chapter) to (to KJM, RLM); and US Fish and Wildlife Service (to JBO, OLR, JKW).	[Anonymous], 2006, SAS MIXED MODELS; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bradbury A., 1986, ROTENONE TROUT STOCK; Campbell K, 2004, ORYX, V38, P328, DOI 10.1017/S0030605304000572; Carim KJ, 2015, PROTOCOL COLLECTING; Casselman JM, 1996, CAN J FISH AQUAT SCI, V53, P161, DOI 10.1139/cjfas-53-S1-161; Clout M.N., 2002, TURNING TIDE ERADICA, P1; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; DAWSON V K, 1991, North American Journal of Fisheries Management, V11, P226, DOI 10.1577/1548-8675(1991)011<0226:RPIFPE>2.3.CO;2; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dunker KJ, 2013, ALEXANDER CREEK NO P; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Finlayson B, 2005, FISHERIES, V30, P10, DOI 10.1577/1548-8446(2005)30[10:NITRON]2.0.CO;2; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; INCE BW, 1976, J FISH BIOL, V8, P79, DOI 10.1111/j.1095-8649.1976.tb03909.x; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Johnson BM, 2008, N AM J FISH MANAGE, V28, P1941, DOI 10.1577/M07-199.1; Knapp RA, 1998, RESTOR ECOL, V6, P207, DOI 10.1111/j.1526-100X.1998.06212.x; Laramie MB, US GEOLOGICAL SURVEY, P15; Ling N, 2003, ROTENONE REV ITS TOX; Mack R. N, 2002, TURNING TIDE ERADICA, P164; Massengill RL, 2008, ALASKA DEP FISH GAME, V14-12; Massengill RL, 2011, FISHERY DATA SERIES, P11; Matisoo-Smith E, 2008, QUATERN INT, V184, P139, DOI 10.1016/j.quaint.2007.09.013; Morrison SA, 2007, FRONT ECOL ENVIRON, V5, P271, DOI 10.1890/1540-9295(2007)5[271:FTDAEE]2.0.CO;2; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Muhlfeld CC, 2008, N AM J FISH MANAGE, V28, P636, DOI 10.1577/M07-004.1; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Olsen JB, 2016, CONSERV GENET RESOUR, V8, P89, DOI 10.1007/s12686-016-0526-y; Olsen JB, 2015, CONSERV GENET RESOUR, V7, P615, DOI 10.1007/s12686-015-0459-x; Oslund S, 2011, RECREATIONAL FISHERI; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Rayner TS, 2006, NEW ZEAL J MAR FRESH, V40, P477, DOI 10.1080/00288330.2006.9517437; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rout TM, 2009, J APPL ECOL, V46, P782, DOI 10.1111/j.1365-2664.2009.01678.x; Sepulveda AJ, 2015, ECOL FRESHW FISH, V24, P519, DOI 10.1111/eff.12164; Sepulveda AJ, 2013, ECOL FRESHW FISH, V22, P268, DOI 10.1111/eff.12024; Simberloff D, 2009, BIOL INVASIONS, V11, P149, DOI 10.1007/s10530-008-9317-z; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thresher RE, 2008, FISHERIES, V33, P114, DOI 10.1577/1548-8446-33.3.114; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2015, CONSERV GENET, P1	49	50	53	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162277	10.1371/journal.pone.0162277	http://dx.doi.org/10.1371/journal.pone.0162277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626271	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600028
J	Grosse-Kreul, J; Busch, M; Winter, C; Pikos, S; Stephan, H; Dunker, N				Grosse-Kreul, Jan; Busch, Maike; Winter, Claudia; Pikos, Stefanie; Stephan, Harald; Duenker, Nicole			Forced Trefoil Factor Family Peptide 3 (TFF3) Expression Reduces Growth, Viability, and Tumorigenicity of Human Retinoblastoma Cell Lines	PLOS ONE			English	Article							GASTRIC-MUCOSAL EPITHELIUM; SIGNALING PATHWAY; MAMMARY-CARCINOMA; IN-VITRO; APOPTOSIS; DISEASE; CANCER; MIGRATION; DIFFERENTIATION; PROGRESSION	Trefoil factor family (TFF) peptides have been shown to effect cell proliferation, apoptosis, migration and invasion of normal cells and various cancer cell lines. In the literature TFF peptides are controversially discussed as tumor suppressors and potential tumor progression factors. In the study presented, we investigated the effect of TFF3 overexpression on growth, viability, migration and tumorigenicity of the human retinoblastoma cell lines Y-79, WERI-Rb1, RBL-13 and RBL-15. As revealed by WST-1 and TUNEL assays as well as DAPI and BrdU cell counts, recombinant human TFF3 significantly lowers retinoblastoma cell viability and increases apoptosis levels. Transient TFF3 overexpression likewise significantly increases RB cell apoptosis. Stable, lentiviral TFF3 overexpression lowers retinoblastoma cell viability, proliferation and growth and significantly increases cell death in retinoblastoma cells. Blockage experiments using a broad-spectrum caspase inhibitor and capase-3 immunocytochemistry revealed the involvement of caspases in general and of caspase-3 in particular in TFF3 induced apoptosis in retinoblastoma cell lines. Soft agarose and in ovo chicken chorioallantoic membrane (CAM) assays revealed that TFF3 overexpression influences anchorage independent growth and significantly decreases the size of tumors forming from retinoblastoma cells. Our study demonstrates that forced TFF3 expression exerts a significant pro-apoptotic, anti-proliferative, and tumor suppressive effect in retinoblastoma cells, setting a starting point for new additive chemotherapeutic approaches in the treatment of retinoblastoma.	[Grosse-Kreul, Jan; Busch, Maike; Winter, Claudia; Pikos, Stefanie; Duenker, Nicole] Univ Duisburg, Inst Anat 2, Fac Med, Dept Neuroanat, Essen, Germany; [Stephan, Harald] Univ Duisburg, Childrens Hosp, Div Haematol & Oncol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Busch, M; Dunker, N (corresponding author), Univ Duisburg, Inst Anat 2, Fac Med, Dept Neuroanat, Essen, Germany.	maike.busch@uk-essen.de; nicole.duenker@uk-essen.de	Stephan, Harald/AAT-6802-2021; Busch, Maike Anna/AGI-3929-2022	Busch, Maike Anna/0000-0001-9651-031X; Dunker, Nicole/0000-0003-1273-0644	Else Kroner Fresenius Stiftung foundation	Else Kroner Fresenius Stiftung foundation	This work was supported by the Else Kroner Fresenius Stiftung foundation (http://www.ekfs.de/de/die-stiftung/) to JG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abols A, 2015, NEOPLASMA, V62, P914, DOI 10.4149/neo_2015_111; Belovari T, 2015, BOSNIAN J BASIC MED, V15, P33, DOI 10.17305/bjbms.2015.251; Bernstein HG, 2015, AMINO ACIDS, V47, P1053, DOI 10.1007/s00726-015-1938-9; Bossenmeyer-Pourie C, 2002, J CELL BIOL, V157, P761, DOI 10.1083/jcb200108056; Busch M, 2014, HISTOCHEM CELL BIOL, V34, P1001; Busch Maike, 2015, BioMolecular Concepts, V6, P343, DOI 10.1515/bmc-2015-0020; Chen YH, 2000, BIOCHEM BIOPH RES CO, V274, P576, DOI 10.1006/bbrc.2000.3176; Dieckow J, 2016, INVEST OPHTH VIS SCI, V57, P56, DOI 10.1167/iovs.15-18129; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Emami S, 2004, PEPTIDES, V25, P885, DOI 10.1016/j.peptides.2003.10.019; Goke MN, 2001, EXP CELL RES, V264, P337, DOI 10.1006/excr.2000.5116; GRIEGEL S, 1990, INT J CANCER, V46, P125, DOI 10.1002/ijc.2910460123; Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016; Haubold M, 2010, INT J BIOL SCI, V6, P700; Hinz M, 2004, PEPTIDES, V25, P827, DOI 10.1016/j.peptides.2004.01.020; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; HOFFMANN W, 1993, TRENDS BIOCHEM SCI, V18, P239, DOI 10.1016/0968-0004(93)90170-R; Hoffmann W, 2013, HDB BIOL ACTIVE PEPT, P1338; Kannan N, 2010, NEOPLASIA, V12, P1041, DOI 10.1593/neo.10916; Khoury Thaer, 2005, Int J Gastrointest Cancer, V35, P171, DOI 10.1385/IJGC:35:3:171; Kinoshita K, 2000, MOL CELL BIOL, V20, P4680, DOI 10.1128/MCB.20.13.4680-4690.2000; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Lin JF, 2015, MOL CELL BIOCHEM, V404, P263, DOI 10.1007/s11010-015-2386-2; Lubka M, 2009, J APPL GENET, V50, P167, DOI 10.1007/BF03195669; MCFALL RC, 1977, CANCER RES, V37, P1003; Montoya V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138366; Palmer TD, 2011, JOVE-J VIS EXP, DOI 10.3791/2815; Pandey V, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0429-3; Paulsen FP, 2008, J BIOL CHEM, V283, P13418, DOI 10.1074/jbc.M800177200; Paunel-Gorgulu AN, 2011, HISTOCHEM CELL BIOL, V135, P461, DOI 10.1007/s00418-011-0810-6; Perera O, 2015, CANCER LETT, V361, P104, DOI 10.1016/j.canlet.2015.02.051; Perry JK, 2008, TRENDS ENDOCRIN MET, V19, P74, DOI 10.1016/j.tem.2007.10.003; Philippeit C, 2014, CELL PHYSIOL BIOCHEM, V34, P1001, DOI 10.1159/000366316; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Rickman DS, 2010, NEOPLASIA, V12, P1031, DOI 10.1593/neo.10866; Rosler S, 2010, ARTHRITIS RHEUM-US, V62, P815, DOI 10.1002/art.27295; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schulze U, 2014, INVEST OPHTH VIS SCI, V55, P3037, DOI 10.1167/iovs.13-13423; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Storesund T, 2009, EUR J ORAL SCI, V117, P511, DOI 10.1111/j.1600-0722.2009.00652.x; Sun ZR, 2014, INT J ONCOL, V45, P1123, DOI 10.3892/ijo.2014.2527; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; TOMITA M, 1995, BIOCHEM J, V311, P293, DOI 10.1042/bj3110293; Uchino H, 1999, Hum Cell, V12, P181; Uchino H, 2000, GASTROENTEROLOGY, V118, P60, DOI 10.1016/S0016-5085(00)70414-8; Weise A, 2013, HISTOCHEM CELL BIOL, V139, P323, DOI 10.1007/s00418-012-1028-y; Wright NA, 1997, FEBS LETT, V408, P121, DOI 10.1016/S0014-5793(97)00424-9; Yamachika T, 2002, CLIN CANCER RES, V8, P1092; Yio XY, 2005, CLIN EXP METASTAS, V22, P157, DOI 10.1007/s10585-005-6615-z; Zijlstra A, 2002, CANCER RES, V62, P7083	52	9	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0163025	10.1371/journal.pone.0163025	http://dx.doi.org/10.1371/journal.pone.0163025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626280	gold, Green Published, Green Submitted			2022-12-26	WOS:000383680600073
J	Maitre, J; Paillard, T				Maitre, Julien; Paillard, Thierry			Postural Effects of Vestibular Manipulation Depend on the Physical Activity Status	PLOS ONE			English	Article							PAROXYSMAL POSITIONAL VERTIGO; VESTIBULOOCULAR REFLEX; SELF-MOTION; GALVANIC STIMULATION; CUPULAR DEPOSITS; VISUAL CUES; BODY; HABITUATION; SYSTEM; RESPONSES	The purpose of this study was to compare the effects of galvanic vestibular stimulation (GVS) on postural control for participants of different physical activity status (i.e. active and non-active). Two groups of participants were recruited: one group of participants who regularly practised sports activities (active group, n = 17), and one group of participants who did not practise physical and/or sports activities (non-active group, n = 17). They were compared in a reference condition (i.e bipedal stance with eyes open) and four vestibular manipulation condition (i.e. GVS at 0.5 mA and 3 mA, in accordance with two designs) lasting 20 seconds. The centre of foot pressure displacement velocities were compared between the two groups. The main results indicate that the regular practice of sports activities counteracts postural control disruption caused by GVS. The active group demonstrated better postural control than the non-active group when subjected to higher vestibular manipulation. The active group may have developed their ability to reduce the influence of inaccurate vestibular signals. The active participants could identify the relevant sensory input, thought a better central integration, which enables them to switch faster between sensory inputs.	[Maitre, Julien; Paillard, Thierry] Univ Pau & Pays Adour, EA 4445, Dept STAPS, Lab Mouvement Equilibre Performance & Sante, Tarbes, France	Universite de Pau et des Pays de l'Adour	Maitre, J (corresponding author), Univ Pau & Pays Adour, EA 4445, Dept STAPS, Lab Mouvement Equilibre Performance & Sante, Tarbes, France.	maitre.julien@univ-pau.fr	Maitre, Julien/L-7972-2019	Maitre, Julien/0000-0001-9630-0240	Association Nationale de la Recherche et de la Technologie; Conseil General des Hautes Pyrenees	Association Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Conseil General des Hautes Pyrenees(Region Occitanie)	The investigation was supported by grants from the Association Nationale de la Recherche et de la Technologie and the Conseil General des Hautes Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpini D, 2009, SPORT SCI HLTH, V5, P129, DOI DOI 10.1007/S1S1332-009-00888-4; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Balter SGT, 2004, ACTA OTO-LARYNGOL, V124, P1015, DOI 10.1080/00016480410015730; Balter SGT, 2004, NEUROSCI LETT, V366, P71, DOI 10.1016/j.neulet.2004.05.015; Banfield GK, 2000, J LARYNGOL OTOL, V114, P501; Bonan IV, 2016, CLIN NEUROPHYSIOL, V127, P842, DOI 10.1016/j.clinph.2015.03.026; Bonan IV, 2013, CLIN NEUROPHYSIOL, V124, P713, DOI 10.1016/j.clinph.2012.09.019; Bringoux L, 2000, J VESTIBUL RES-EQUIL, V10, P251; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; BRONSTEIN AM, 1986, EXP BRAIN RES, V63, P655, DOI 10.1007/BF00237488; Cauquil AS, 1997, GAIT POSTURE, V6, P210, DOI 10.1016/S0966-6362(97)00011-8; Cauquil AS, 1998, NEUROSCI LETT, V245, P37, DOI 10.1016/S0304-3940(98)00161-X; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; Clement G, 2001, EUR J APPL PHYSIOL, V85, P539, DOI 10.1007/s004210100494; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; Clement G, 2007, J VESTIBUL RES-EQUIL, V17, P227; Clement G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111107; Clendaniel RA, 2010, J NEUROL PHYS THER, V34, P111, DOI 10.1097/NPT.0b013e3181deca01; CREMIEUX J, 1994, PERCEPT MOTOR SKILL, V78, P67, DOI 10.2466/pms.1994.78.1.67; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Denise P., 2005, SCI MOT, V55, P101, DOI [10.3917/sm.055.0101, DOI 10.3917/SM.055.0101]; Deshpande N, 2007, EXP BRAIN RES, V176, P43, DOI 10.1007/s00221-006-0593-5; Deveze A, 2014, NEUROPHYSIOL CLIN, V44, P49, DOI 10.1016/j.neucli.2013.10.138; Dilda V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112131; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Eikema DJA, 2014, NEUROSCI LETT, V561, P112, DOI 10.1016/j.neulet.2013.12.048; Ferre ER, 2013, NEUROSCI LETT, V550, P35, DOI 10.1016/j.neulet.2013.06.046; Ferre ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086379; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Forbes PA, 2015, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00094; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; Gibb R, 2011, AVIAT SPACE ENVIR MD, V82, P717, DOI 10.3357/ASEM.3048.2011; Grunfeld EA, 2000, J VESTIBUL RES-EQUIL, V10, P193; Hartmann M, 2014, EXP BRAIN RES, V232, P1249, DOI 10.1007/s00221-014-3841-0; Heroux ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124532; Hopper Diana M, 2014, J Dance Med Sci, V18, P67, DOI 10.12678/1089-313X.18.2.67; HORAK FB, 1994, EXP BRAIN RES, V100, P93; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Isableu B, 1998, HUM MOVEMENT SCI, V17, P367, DOI 10.1016/S0167-9457(98)00005-0; Kerrigan MA, 2013, PM&R, V5, P778, DOI 10.1016/j.pmrj.2013.05.010; Kiers H, 2013, SPORTS MED, V43, P1171, DOI 10.1007/s40279-013-0082-5; Kim KS, 2013, J INT ADV OTOL, V9, P175; Kusunoki T, 2005, J LARYNGOL OTOL, V119, P87, DOI 10.1258/0022215053420040; LACOUR M, 1974, ACTA OTO-LARYNGOL, V78, P399, DOI 10.3109/00016487409126372; Lee MY, 2004, LARYNGOSCOPE, V114, P897, DOI 10.1097/00005537-200405000-00021; Lopez C, 2015, MULTISENS RES, V28, P525, DOI 10.1163/22134808-00002490; Maitre J, 2015, SCAND J MED SCI SPOR, V25, pE82, DOI 10.1111/sms.12256; Maitre J, 2013, EUR J APPL PHYSIOL, V113, P1821, DOI 10.1007/s00421-013-2608-9; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; MERGNER T, 1995, MULTISENSORY CONTROL OF POSTURE, P157; MORIARTY B, 1992, LARYNGOSCOPE, V102, P56; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; Negahban H, 2013, GAIT POSTURE, V38, P226, DOI 10.1016/j.gaitpost.2012.11.016; Otsuka K, 2003, ACTA OTO-LARYNGOL, V123, P515, DOI 10.1080/0036554021000028094; Paillard T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/891390; Paillard T, 2011, EUR J APPL PHYSIOL, V111, P1619, DOI 10.1007/s00421-010-1782-2; PARNES LS, 1992, LARYNGOSCOPE, V102, P988; Schmidt L, 2013, NEUROPSYCHOLOGIA, V51, P893, DOI 10.1016/j.neuropsychologia.2013.02.013; Sharoni Z, 2001, ANN OTO RHINOL LARYN, V110, P127, DOI 10.1177/000348940111000207; SHELHAMER M, 1994, EXP BRAIN RES, V100, P328; Son GML, 2008, J APPL PHYSIOL, V105, P1210, DOI 10.1152/japplphysiol.01398.2006; St George RJ, 2011, J PHYSIOL-LONDON, V589, P807, DOI 10.1113/jphysiol.2010.197665; Tanguy S, 2008, EUR J APPL PHYSIOL, V104, P1031, DOI 10.1007/s00421-008-0859-7; Taube W, 2008, ACTA PHYSIOL, V193, P101, DOI 10.1111/j.1748-1716.2008.01850.x; TERAMOTO K, 1994, EUR ARCH OTO-RHINO-L, V251, P218, DOI 10.1007/BF00628427; TILIKET C, 1994, EXP BRAIN RES, V100, P316; Vrabec JT, 1998, ARCH OTOLARYNGOL, V124, P223, DOI 10.1001/archotol.124.2.223; Wardman DL, 2002, ADV EXP MED BIOL, V508, P119; Welling DB, 1997, LARYNGOSCOPE, V107, P90, DOI 10.1097/00005537-199701000-00018; Yang Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/567690; Yelnik AP, 2006, GAIT POSTURE, V24, P262, DOI 10.1016/j.gaitpost.2005.09.007	74	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162966	10.1371/journal.pone.0162966	http://dx.doi.org/10.1371/journal.pone.0162966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627441	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600069
J	Oelze, VM; Douglas, PH; Stephens, CR; Surbeck, M; Behringer, V; Richards, MP; Fruth, B; Hohmann, G				Oelze, Vicky M.; Douglas, Pamela Heidi; Stephens, Colleen R.; Surbeck, Martin; Behringer, Verena; Richards, Michael P.; Fruth, Barbara; Hohmann, Gottfried			The Steady State Great Ape? Long Term Isotopic Records Reveal the Effects of Season, Social Rank and Reproductive Status on Bonobo Feeding Behavior	PLOS ONE			English	Article							TAI-NATIONAL-PARK; PAN-PANISCUS; DIETARY VARIABILITY; WILD CHIMPANZEES; STABLE-ISOTOPES; LOMAKO FOREST; HAIR; CONSUMPTION; DELTA-N-15; RATIOS	Dietary ecology of extant great apes is known to respond to environmental conditions such as climate and food availability, but also to vary depending on social status and life history characteristics. Bonobos (Pan paniscus) live under comparatively steady ecological conditions in the evergreen rainforests of the Congo Basin. Bonobos are an ideal species for investigating influences of sociodemographic and physiological factors, such as female reproductive status, on diet. We investigate the long term dietary pattern in wild but fully habituated bonobos by stable isotope analysis in hair and integrating a variety of long-term sociodemographic information obtained through observations. We analyzed carbon and nitrogen stable isotopes in 432 hair sections obtained from 101 non-invasively collected hair samples. These samples represented the dietary behavior of 23 adult bonobos from 2008 through 2010. By including isotope and crude protein data from plants we could establish an isotope baseline and interpret the results of several general linear mixed models using the predictors climate, sex, social rank, reproductive state of females, adult age and age of infants. We found that low canopy foliage is a useful isotopic tracer for tropical rainforest settings, and consumption of terrestrial herbs best explains the temporal isotope patterns we found in carbon isotope values of bonobo hair. Only the diet of male bonobos was affected by social rank, with lower nitrogen isotope values in low-ranking young males. Female isotope values mainly differed between different stages of reproduction (cycling, pregnancy, lactation). These isotopic differences appear to be related to changes in dietary preference during pregnancy (high protein diet) and lactation (high energy diet), which allow to compensate for different nutritional needs during maternal investment.	[Oelze, Vicky M.; Douglas, Pamela Heidi; Stephens, Colleen R.; Surbeck, Martin; Behringer, Verena; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Saxony, Germany; [Oelze, Vicky M.] IDiv German Ctr Integrat Biodivers Res, Leipzig, Saxony, Germany; [Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Saxony, Germany; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver, BC, Canada; [Fruth, Barbara] Ludwig Maximilians Univ Munchen, Div Neurobiol, Bavaria, Germany; [Fruth, Barbara] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Flanders, Belgium	Max Planck Society; Max Planck Society; University of British Columbia; University of Munich	Oelze, VM (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Saxony, Germany.; Oelze, VM (corresponding author), IDiv German Ctr Integrat Biodivers Res, Leipzig, Saxony, Germany.	viktoria_oelze@eva.mpg.de	Richards, Michael/O-3717-2016; Behringer, Verena/AAE-9054-2022	Richards, Michael/0000-0001-5274-8887; Behringer, Verena/0000-0001-6338-7298	Wenner-Gren-Foundation (Grant "Isotope Ecology of the Salonga Bonobo - Tracing Dietary Variation and Seasonality by Stable isotope Analyses of Hair") [8573]	Wenner-Gren-Foundation (Grant "Isotope Ecology of the Salonga Bonobo - Tracing Dietary Variation and Seasonality by Stable isotope Analyses of Hair")	This project was generously funded by the Wenner-Gren-Foundation (Grant 8573 "Isotope Ecology of the Salonga Bonobo - Tracing Dietary Variation and Seasonality by Stable isotope Analyses of Hair", October 2011).	Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Blumenthal SA, 2012, P NATL ACAD SCI USA, V109, P21277, DOI 10.1073/pnas.1215782109; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P269, DOI 10.1017/CBO9780511542343.011; Brockman DK, 2005, SEASONALITY IN PRIMA; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Cerling TE, 2004, AFR J ECOL, V42, P88, DOI 10.1111/j.1365-2028.2004.00500.x; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Cernusak LA, 2009, FUNCT PLANT BIOL, V36, P199, DOI 10.1071/FP08216; Chapman Colin A., 1994, P41; CLEVELAND WS, 1984, AM STAT, V38, P261, DOI 10.2307/2683400; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Crowley BE, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22510; Deschner T, 2012, RAPID COMMUN MASS SP, V26, P69, DOI 10.1002/rcm.5312; Douglas PH, 2014, PRIMATES, V55, P533, DOI 10.1007/s10329-014-0436-0; Drews B, 2011, ZOO BIOL, V30, P241, DOI 10.1002/zoo.20304; Fahy GE, 2013, P NATL ACAD SCI USA, V110, P5829, DOI 10.1073/pnas.1221991110; Fruth B, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P231, DOI 10.1017/CBO9780511606397.023; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gehring C, 2004, BASIC APPL ECOL, V5, P567, DOI 10.1016/j.baae.2004.09.005; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; HOHMANN G, 1993, FOLIA PRIMATOL, V60, P225, DOI 10.1159/000156695; Hohmann G., 2006, FEEDING ECOLOGY APES; Hohmann G., 2003, PAN AFR NEWS, V10, P25, DOI DOI 10.5134/143430; Hohmann G, 2008, FOLIA PRIMATOL, V79, P103, DOI 10.1159/000110679; Hohmann Gottfried, 2006, P123; Hohmann G, 2010, AM J PHYS ANTHROPOL, V141, P476, DOI 10.1002/ajpa.21168; Hopkins JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028478; Kalhan SC, 2000, AM J CLIN NUTR, V71, p1249S, DOI 10.1093/ajcn/71.5.1249s; Kohn MJ, 1999, SCIENCE, V283, P335, DOI 10.1126/science.283.5400.335; Kristal MB, 2012, ECOL FOOD NUTR, V51, P177, DOI 10.1080/03670244.2012.661325; LEE PC, 1987, J ZOOL, V213, P409, DOI 10.1111/j.1469-7998.1987.tb03717.x; Loudon JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100758; MALENKY RK, 1991, AM J PRIMATOL, V23, P153, DOI 10.1002/ajp.1350230303; MALENKY RK, 1994, AM J PRIMATOL, V32, P1, DOI 10.1002/ajp.1350320102; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McClure PA, 1987, REPRODUCTIVE ENERGET, P241; McGrew WC, 1996, FOOD STATUS QUEST IN, P39; MEDINA E, 1980, OECOLOGIA, V45, P377, DOI 10.1007/BF00540209; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mundry R, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22499; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Oelze VM, 2016, AM J PRIMATOL, V78, DOI 10.1002/ajp.22497; Oelze VM, 2014, J HUM EVOL, V66, P95, DOI 10.1016/j.jhevol.2013.10.003; Oelze VM, 2011, P NATL ACAD SCI USA, V108, P9792, DOI 10.1073/pnas.1018502108; Oelze VM, 2016, J HUM EVOL UNPUB; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reitsema LJ, 2012, AM J PRIMATOL, V74, P926, DOI 10.1002/ajp.22045; Schoeninger MJ, 1997, AM J PHYS ANTHROPOL, V103, P69, DOI 10.1002/(SICI)1096-8644(199705)103:1<69::AID-AJPA5>3.0.CO;2-8; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Surbeck M, 2013, BEHAV ECOL SOCIOBIOL, V67, P1767, DOI 10.1007/s00265-013-1584-8; Surbeck M, 2009, AM J PRIMATOL, V71, P171, DOI 10.1002/ajp.20634; Thompson ME, 2012, BEHAV ECOL, V23, P1234, DOI 10.1093/beheco/ars107; Tobin DJ, 2005, ISS TOXICOL, P3; TUTIN CEG, 1993, J TROP ECOL, V9, P241, DOI 10.1017/S0266467400007239; Ungar PS, 2011, SCIENCE, V334, P190, DOI 10.1126/science.1207701; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Vogel ER, 2012, BIOL LETTERS, V8, P333, DOI 10.1098/rsbl.2011.1040; Walsh R.P.D., 1996, PW RICHARDS 1996 TRO, P159; Williams LJ, 2011, AM J PHYS ANTHROPOL, V145, P125, DOI 10.1002/ajpa.21479; Wolf N, 2009, FUNCT ECOL, V23, P17, DOI 10.1111/j.1365-2435.2009.01529.x	69	14	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162091	10.1371/journal.pone.0162091	http://dx.doi.org/10.1371/journal.pone.0162091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27626279	Green Published, Green Accepted, gold			2022-12-26	WOS:000383680600019
J	Phipps, ML; Lillo, AM; Shou, YL; Schmidt, EN; Paavola, CD; Naranjo, L; Bemdich, S; Swanson, BI; Bradbury, ARM; Martinez, JS				Phipps, M. Lisa; Lillo, Antoinetta M.; Shou, Yulin; Schmidt, Emily N.; Paavola, Chad D.; Naranjo, Leslie; Bemdich, Sara; Swanson, Basil I.; Bradbury, Andrew R. M.; Martinez, Jennifer S.			Beyond Helper Phage: Using "Helper Cells" to Select Peptide Affinity Ligands	PLOS ONE			English	Article							YEAST SURFACE DISPLAY; GENERAL STRATEGY; CAPSULAR ANTIGEN; LIBRARIES; ANTIBODY; PROTEINS; VECTORS; DOMAINS; SITES	Peptides are important affinity ligands for microscopy, biosensing, and targeted delivery. However, because they can have low affinity for their targets, their selection from large naive libraries can be challenging. When selecting peptidic ligands from display libraries, it is important to: 1) ensure efficient display; 2) maximize the ability to select high affinity ligands; and 3) minimize the effect of the display context on binding. The "helper cell" packaging system has been described as a tool to produce filamentous phage particles based on phagemid constructs with varying display levels, while remaining free of helper phage contamination. Here we report on the first use of this system for peptide display, including the systematic characterization and optimization of helper cells, their inefficient use in antibody display and their use in creating and selecting from a set of phage display peptide libraries. Our libraries were analyzed with unprecedented precision by standard or deep sequencing, and shown to be superior in quality than commercial gold standards. Using our helper cell libraries, we have obtained ligands recognizing Yersinia pestis surface antigen F1V and L-glutamine-binding periplasmic protein QBP. In the latter case, unlike any of the peptide library selections described so far, we used a combination of phage and yeast display to select intriguing peptide ligands. Based on the success of our selections we believe that peptide libraries obtained with helper cells are not only suitable, but preferable to traditional phage display libraries for selection of peptidic ligands.	[Phipps, M. Lisa; Martinez, Jennifer S.] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA; [Lillo, Antoinetta M.; Shou, Yulin; Schmidt, Emily N.; Naranjo, Leslie; Bemdich, Sara; Swanson, Basil I.; Bradbury, Andrew R. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Paavola, Chad D.] NASA, Space Biosci Div, Ames Res Ctr, Moffett Field, CA 94035 USA; [Martinez, Jennifer S.] Los Alamos Natl Lab, Inst Mat Sci, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of Energy (DOE); Los Alamos National Laboratory	Martinez, JS (corresponding author), Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA.; Martinez, JS (corresponding author), Los Alamos Natl Lab, Inst Mat Sci, Los Alamos, NM 87545 USA.	jenm@lanl.gov		Bradbury, Andrew/0000-0002-5567-8172	National Nuclear Security Administration of the U.S. Department of Energy [DE-AC52-06NA25396]	National Nuclear Security Administration of the U.S. Department of Energy(National Nuclear Security Administration)	Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the U.S. Department of Energy under contract DE-AC52-06NA25396.; This work was performed at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the U.S. Department of Energy under contract DE-AC52-06NA25396.	Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chasteen L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl772; Cherepanov P A, 1991, Mol Gen Mikrobiol Virusol, P19; Crochet AP, 2010, BIOSENS BIOELECTRON, V26, P55, DOI 10.1016/j.bios.2010.05.012; D'Angelo S, 2014, MABS-AUSTIN, V6, P160, DOI 10.4161/mabs.27105; Ferrara F, 2013, J IMMUNOL METHODS, V395, P83, DOI 10.1016/j.jim.2013.06.010; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; Goncharov A Iu, 1992, Mol Gen Mikrobiol Virusol, P10; Gonzalez-Techera A, 2007, ANAL CHEM, V79, P7799, DOI 10.1021/ac071323h; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Lillo AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027756; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Lubkowski J, 1998, NAT STRUCT BIOL, V5, P140, DOI 10.1038/nsb0298-140; McCafferty J, 2015, CURR OPIN CHEM BIOL, V26, P16, DOI 10.1016/j.cbpa.2015.01.003; Qi H, 2012, J MOL BIOL, V417, P129, DOI 10.1016/j.jmb.2012.01.038; ROBERTS D, 1993, GENE, V128, P67, DOI 10.1016/0378-1119(93)90154-U; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Siegel RW, 2004, GENOME RES, V14, P1119, DOI 10.1101/gr.1821804; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; STENGELE I, 1990, J MOL BIOL, V212, P143, DOI 10.1016/0022-2836(90)90311-9; Zwick MB, 1998, CURR OPIN BIOTECH, V9, P427, DOI 10.1016/S0958-1669(98)80017-7	25	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0160940	10.1371/journal.pone.0160940	http://dx.doi.org/10.1371/journal.pone.0160940			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626637	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600002
J	Zhu, SY; Henninger, K; McGrath, BC; Cavener, DR				Zhu, Siying; Henninger, Keely; McGrath, Barbara C.; Cavener, Douglas R.			PERK Regulates Working Memory and Protein Synthesis-Dependent Memory Flexibility	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; TRANSGENIC MICE; KINASE PERK; SPONTANEOUS-ALTERNATION; TRANSLATIONAL CONTROL; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; SHORT-TERM; EXPRESSION	PERK (EIF2AK3) is an ER-resident eIF2 alpha kinase required for memory flexibility and metabotropic glutamate receptor-dependent long-term depression, processes known to be dependent on new protein synthesis. Here we investigated PERK's role in working memory, a cognitive ability that is independent of new protein synthesis, but instead is dependent on cellular Ca2+ dynamics. We found that working memory is impaired in forebrain-specific Perk knockout and pharmacologically PERK-inhibited mice. Moreover, inhibition of PERK in wild-type mice mimics the fear extinction impairment observed in forebrain-specific Perk knockout mice. Our findings reveal a novel role of PERK in cognitive functions and suggest that PERK regulates both Ca2+ -dependent working memory and protein synthesis-dependent memory flexibility.	[Zhu, Siying; Henninger, Keely; McGrath, Barbara C.; Cavener, Douglas R.] Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cavener, DR (corresponding author), Penn State Univ, Dept Biol, Ctr Cellular Dynam, University Pk, PA 16802 USA.	drc9@psu.edu			National Institutes of Health [DK088140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant DK088140 (to DRC), http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Brown AP, 2000, CONTEMP TOP LAB ANIM, V39, P17; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Dash PK, 2007, LEARN MEMORY, V14, P554, DOI 10.1101/lm.558707; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; El-Hassar L, 2011, J PHYSIOL-LONDON, V589, P3211, DOI 10.1113/jphysiol.2011.209783; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; GULDIN WO, 1981, BRAIN BEHAV EVOLUT, V19, P93, DOI 10.1159/000121636; Gupta S, 2010, DIABETES, V59, P1937, DOI 10.2337/db09-1064; Hagenston AM, 2008, CEREB CORTEX, V18, P407, DOI 10.1093/cercor/bhm075; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hayashi K, 2007, NEUROREPORT, V18, P719, DOI 10.1097/WNR.0b013e3280d9e880; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Jacobsen CF, 1935, ARCH NEURO PSYCHIATR, V33, P558, DOI 10.1001/archneurpsyc.1935.02250150108009; Khan ZU, 2011, BEHAV BRAIN RES, V219, P329, DOI 10.1016/j.bbr.2010.12.039; Kolb B, 1990, THE CEREBRAL CORTEX, pxii; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Li YL, 2003, ENDOCRINOLOGY, V144, P3505, DOI 10.1210/en.2003-0236; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mikami A, 2007, EUR J PHARMACOL, V575, P82, DOI 10.1016/j.ejphar.2007.07.010; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; PENETAR DM, 1983, PHARMACOL BIOCHEM BE, V19, P963, DOI 10.1016/0091-3057(83)90399-4; Runyan JD, 2005, LEARN MEMORY, V12, P103, DOI 10.1101/lm.89405; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Trinh MA, 2014, LEARN MEMORY, V21, P298, DOI 10.1101/lm.032219.113; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wolf A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147733; Yamanaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084036; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang W, 2006, CELL METAB, V4, P491, DOI 10.1016/j.cmet.2006.11.002; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	52	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162766	10.1371/journal.pone.0162766	http://dx.doi.org/10.1371/journal.pone.0162766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627766	Green Submitted, gold, Green Published			2022-12-26	WOS:000383680600053
J	Gesesew, HA; Woldemichael, K; Massa, D; Mwanri, L				Gesesew, Hailay Abrha; Woldemichael, Kifle; Massa, Desalegn; Mwanri, Lillian			Farmers Knowledge, Attitudes, Practices and Health Problems Associated with Pesticide Use in Rural Irrigation Villages, Southwest Ethiopia	PLOS ONE			English	Article							SYMPTOMS; EXPOSURE; WORKERS; MANAGEMENT; TANZANIA	Background In Ethiopia, pesticides are widely used for a variety of purposes. The occurrence of contamination and poisoning for farmers is highly reporteddue to unsafe handling practices and their usage. We assessed knowledge, attitudes and experiences of previous pesticide exposure, and related health problems among farmers who use irrigation in Jimma Zone, Southwest Ethiopia. Methods A community based cross-sectional study was conducted among farmers living in the zone. Respondents were 796 irrigation farmers from 20 kebeles (lowest administration unit) in Jimma Zone. Data were collected using a pretested and structured questionnaire via face-to-face interviews. Both descriptive and inferential statistics analysis were performed. A binary logistic regression was used to identify factors associated with attitudes of farmers towards the safe use of pesticides at P value of <= 0.05 in the final model. Results Among the participants, 54.4% (95% CI, 50.7-58%) knew at least one pesticide control method and 53.7% had positive attitudes towards safe use of pesticide. The mean score of attitudes was found to be 3.9(+/- 0.4). Knowledge including each of the following: the names of the pesticides (AOR, 0.41; 95% CI, 0.25-0.67), methods of pest control and the use of gloves during pesticide exposure (AOR, 1.52; 95% CI, 1.07-2.16) was found to be independent predictor of the farmers' attitudes about safe use of pesticides. Past exposure of pesticide was reportedby 89.6% of farmers. Participants reported ingestion (88.9%) and inhalation (90.4%) as possible mechanisms of pesticide exposure. Nearly 42% of farmers had never used any personal protective equipment (PPE) to protect themselves against pesticide exposure. Farmers reported several health complications, which were perceived as complications of pesticide exposure, including: headache, nausea and vomiting, skin rash and irritation and abdominal pain. Conclusions The study exposed the existence of high probability of pesticide exposure, the low safe use of pesticide and the low use of PPE. However, but farmers had positive attitudes towards safe use of pesticides. These findings appeal for the development of effective public health strategies to improve farmers' awareness and safe use of PPE. In addition, there is a need to informfarmers about integrated pest management to prevent severe health complications, which may occur as a result of unsafe and inappropriate use of pesticides.	[Gesesew, Hailay Abrha; Woldemichael, Kifle; Massa, Desalegn] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Gesesew, Hailay Abrha; Mwanri, Lillian] Flinders Univ S Australia, Fac Med Nursing & Hlth Sci, Discipline Publ Hlth, Adelaide, SA, Australia	Jimma University; Flinders University South Australia	Gesesew, HA (corresponding author), Jimma Univ, Dept Epidemiol, Jimma, Ethiopia.; Gesesew, HA (corresponding author), Flinders Univ S Australia, Fac Med Nursing & Hlth Sci, Discipline Publ Hlth, Adelaide, SA, Australia.	hailushepi@gmail.com	Gesesew, Hailay/AAF-6486-2020; Mwanri, Lillian/AGG-3711-2022	Gesesew, Hailay/0000-0002-3531-4400; Mwanri, Lillian/0000-0002-5792-7785	Global Disaster Preparedness Center (GDPC); Response 2 Resilience (R2R)	Global Disaster Preparedness Center (GDPC); Response 2 Resilience (R2R)	We thank Global Disaster Preparedness Center (GDPC) and Response 2 Resilience (R2R) [http://preparecenter.org/activities/research-resilienceand-preparedness-%E2%80%93-small-grants-program] for funding this study. KW received the grant. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi OC, 2007, SCI RES ESSAYS, V2, P204; [Anonymous], 2015, PESTICIDES OUR HLTH; Bruce F, 2008, PESTICIDE APPL SAFET; Clarke EEK, 1997, OCCUP MED-OXFORD, V47, P301, DOI 10.1093/occmed/47.5.301; CSA, 2007, POP HOUS CENS REP ET; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; Daten Fakten, 2012, PESTICIDES HLTH HAZA; enHealth, 2010, ENV HLTH PRACT MAN R; EPA, 2004, EX EXP SCEN, P6; FAO, 2006, INT COD COND DISTR U; Faria N M, 2000, Cad Saude Publica, V16, P115, DOI 10.1590/S0102-311X2000000100012; Henry D., 2013, Journal of Agriculture and Rural Development in the Tropics and Subtropics, V114, P59; Ibitayo OO, 2006, RISK ANAL, V26, P989, DOI 10.1111/j.1539-6924.2006.00794.x; Issa Y, 2010, ENV HLTH, V9; Karunamoorthi K, 2012, ARCH ENVIRON OCCUP H, V67, P109, DOI 10.1080/19338244.2011.598891; Konradsen F, 2003, TOXICOLOGY, V192, P249, DOI 10.1016/S0300-483X(03)00339-1; Lekei EE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-389; Mekonnen Y, 2002, OCCUP MED-OXFORD, V52, P311, DOI 10.1093/occmed/52.6.311; Nalwanga E, 2011, J ENV PUBLIC HLTH, V200, P1; Negatu B, 2016, ANN OCCUP HYG, V60, P551, DOI 10.1093/annhyg/mew004; Ngowi A, 2002, HLTH IMPACTS PESTICI; Ngowi A, 2007, CROP PROT, V26, P1617, DOI 10.1016/j.cropro.2007.01.008; Parron T, 1996, HUM EXP TOXICOL, V15, P957, DOI 10.1177/096032719601501203; Rathinam X, 2005, Med J Malaysia, V60, P118; Rathinam X, 2005, MED J MALAYSIA, V60, P125; Recena MCP, 2006, ENVIRON RES, V102, P230, DOI 10.1016/j.envres.2006.01.007; Sa'ed H, 2008, KNOWLEDGE PRACTICES; Salameh PR, 2004, ENVIRON RES, V94, P1, DOI 10.1016/S0013-9351(03)00092-6; Sekiyama Makiko, 2007, Environmental Sciences, V14, P23; SIVAYOGANATHAN C, 1995, SOC SCI MED, V40, P431, DOI 10.1016/0277-9536(94)00143-H; Wheeler WB, 2002, J AGR FOOD CHEM, V50, P4151, DOI 10.1021/jf0256438; Wondgwichit D, 2012, J MED MED SCI, V3, P034; Yassin MM, 2002, OCCUP ENVIRON MED, V59, P387, DOI 10.1136/oem.59.6.387	33	41	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162527	10.1371/journal.pone.0162527	http://dx.doi.org/10.1371/journal.pone.0162527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622668	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000037
J	Tkatchenko, AV; Luo, XY; Tkatchenko, TV; Vaz, C; Tanavde, VM; Maurer-Stroh, S; Zauscher, S; Gonzalez, P; Young, TL				Tkatchenko, Andrei V.; Luo, Xiaoyan; Tkatchenko, Tatiana V.; Vaz, Candida; Tanavde, Vivek M.; Maurer-Stroh, Sebastian; Zauscher, Stefan; Gonzalez, Pedro; Young, Terri L.			Large-Scale microRNA Expression Profiling Identifies Putative Retinal miRNA-mRNA Signaling Pathways Underlying Form-Deprivation Myopia in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TREE SHREW SCLERA; EPITHELIAL-MESENCHYMAL TRANSITION; EYE GROWTH-REGULATION; GENE-EXPRESSION; MICROARRAY ANALYSIS; NONCODING RNAS; MOUSE RETINA; LINEAGE DIFFERENTIATION; PROTEIN EXPRESSION	Development of myopia is associated with large-scale changes in ocular tissue gene expression. Although differential expression of coding genes underlying development of myopia has been a subject of intense investigation, the role of non-coding genes such as microRNAs in the development of myopia is largely unknown. In this study, we explored myopia-associated miRNA expression profiles in the retina and sclera of C57Bl/6J mice with experimentally induced myopia using microarray technology. We found a total of 53 differentially expressed miRNAs in the retina and no differences in miRNA expression in the sclera of C57BL/6J mice after 10 days of visual form deprivation, which induced -6.93 +/- 2.44 D (p < 0.000001, n = 12) of myopia. We also identified their putative mRNA targets among mRNAs found to be differentially expressed in myopic retina and potential signaling pathways involved in the development of form-deprivation myopia using miRNA-mRNA interaction network analysis. Analysis of myopia-associated signaling pathways revealed that myopic response to visual form deprivation in the retina is regulated by a small number of highly integrated signaling pathways. Our findings highlighted that changes in microRNA expression are involved in the regulation of refractive eye development and predicted how they may be involved in the development of myopia by regulating retinal gene expression.	[Tkatchenko, Andrei V.; Tkatchenko, Tatiana V.] Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA; [Tkatchenko, Andrei V.] Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA; [Luo, Xiaoyan; Gonzalez, Pedro] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Luo, Xiaoyan] Duke Univ, Sch Med, Ctr Human Genet, Durham, NC USA; [Vaz, Candida; Tanavde, Vivek M.; Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Tanavde, Vivek M.] ASTAR, Inst Med Biol, Singapore, Singapore; [Zauscher, Stefan] Duke Univ, Dept Mech Engn & Mat Sci, Pratt Sch Engn, Durham, NC 27706 USA; [Young, Terri L.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA	Columbia University; Columbia University; Duke University; Duke University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Duke University; University of Wisconsin System; University of Wisconsin Madison	Tkatchenko, AV (corresponding author), Columbia Univ, Dept Ophthalmol, Coll Phys & Surg, New York, NY 10027 USA.; Tkatchenko, AV (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Coll Phys & Surg, New York, NY USA.; Young, TL (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.	avt2130@cumc.columbia.edu; tyoung6@wisc.edu	Maurer-Stroh, Sebastian/Q-9476-2019; Tanavde, Vivek/B-4758-2011; Vaz, Candida/HHZ-7196-2022	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Tanavde, Vivek/0000-0001-7404-5568; Zauscher, Stefan/0000-0002-2290-7178	National Institutes of Health/National Eye Institute grant [R01EY023839]; National Institutes of Health/National Eye Institute [R01EY023287, R01EY016228, R01EY014685, P30EY019007]; Duke Eye Center Exploring Grant; Research to Prevent Blindness (New York, NY); Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison; Acquavella Family Foundation; University of Wisconsin Centennial Scholar Fund; NATIONAL EYE INSTITUTE [R01EY023839, P30EY019007, R01EY016228, R01EY023287, R01EY014685] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute grant; National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Duke Eye Center Exploring Grant; Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison; Acquavella Family Foundation; University of Wisconsin Centennial Scholar Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was supported by National Institutes of Health/National Eye Institute grant R01EY023839, (www.nih.gov) (to AVT), National Institutes of Health/National Eye Institute grants R01EY023287 and R01EY016228, (www.nih.gov) (to PG), National Institutes of Health/National Eye Institute grant R01EY014685, (www.nih.gov) (to TLY), National Institutes of Health/National Eye Institute grant P30EY019007 (Core Support for Vision Research) (to AVT), Duke Eye Center Exploring Grant and unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, Columbia University and the Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison. These research was funded with support from the Acquavella Family Foundation, Joseph C. Connors, and the University of Wisconsin Centennial Scholar Fund.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexander LJ, 1994, PRIMARY CARE POSTERI; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Arora A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-1; Ashby R, 2010, MOL VIS, V16, P639; Ashby RS, 2010, INVEST OPHTH VIS SCI, V51, P3726, DOI 10.1167/iovs.09-4615; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Banerjee P, 2015, STEM CELLS; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Brand C, 2007, MOL VIS, V13, P920; Calissano M, 2010, MOL CELL NEUROSCI, V45, P317, DOI 10.1016/j.mcn.2010.06.015; Chase HB, 1942, GENETICS, V27, P0339; Chen HL, 2010, BIOCHEM BIOPH RES CO, V394, P921, DOI 10.1016/j.bbrc.2010.03.076; Chen JC, 2006, VISION RES, V46, P4096, DOI 10.1016/j.visres.2006.07.033; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040849; Chen KC, 2012, INVEST OPHTH VIS SCI, V53, P2732, DOI 10.1167/iovs.11-9272; Chivukula RR, 2009, CELL, V137, P606, DOI 10.1016/j.cell.2009.04.059; Conte I, 2013, CELL MOL LIFE SCI, V70, P4141, DOI 10.1007/s00018-013-1335-z; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Curtin BJ, 1985, MYOPIAS BASIC SCI CL; de Sousa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056908; Decembrini S, 2009, P NATL ACAD SCI USA, V106, P21179, DOI 10.1073/pnas.0909167106; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Di Bernardini E, 2014, J BIOL CHEM, V289, P3383, DOI 10.1074/jbc.M113.495531; Diaz-Martin J, 2014, J PATHOL, V232, P319, DOI 10.1002/path.4289; Engelsvold DH, 2013, EXP EYE RES, V115, P189, DOI 10.1016/j.exer.2013.07.003; Feldkaemper MP, 2009, INVEST OPHTH VIS SCI, V50, P13, DOI 10.1167/iovs.08-1702; Feldkaemper MP, 2002, VISUAL NEUROSCI, V19, P755, DOI 10.1017/S0952523802196064; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Fischer AJ, 1997, CAN J OPHTHALMOL, V32, P373; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Frost MR, 2012, INVEST OPHTH VIS SCI, V53, P322, DOI 10.1167/iovs.11-8354; Gao H, 2011, MOL VIS, V17, P903; Genini S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-172; Gonzalez P, 2014, J OCUL PHARMACOL TH, V30, P128, DOI 10.1089/jop.2013.0191; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hackler L, 2010, INVEST OPHTH VIS SCI, V51, P1823, DOI 10.1167/iovs.09-4657; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Hwang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046521; Iliff BW, 2012, INVEST OPHTH VIS SCI, V53, P348, DOI 10.1167/iovs.11-8783; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P611, DOI 10.1167/iovs.10-6115; Jin ZB, 2009, MOL VIS, V15, P523; KALTER H, 1968, TERATOLOGY, V1, P193, DOI 10.1002/tera.1420010208; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Koch FLP, 1939, ARCH PATHOL, V28, P171; Kovacs B, 2011, INVEST OPHTH VIS SCI, V52, P4402, DOI 10.1167/iovs.10-6879; Kushwaha R, 2014, STEM CELLS DEV, V23, P1149, DOI 10.1089/scd.2013.0262; La Torre A, 2013, P NATL ACAD SCI USA, V110, pE2362, DOI 10.1073/pnas.1301837110; Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18; Lee SKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021249; Li DD, 2015, GENE, V572, P198, DOI 10.1016/j.gene.2015.07.010; Li ZY, 2015, HUM REPROD, V30, P507, DOI 10.1093/humrep/dev001; Liang CL, 2011, INVEST OPHTH VIS SCI, V52, P3500, DOI 10.1167/iovs.10-5859; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Lu TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059397; Lumayag S, 2013, P NATL ACAD SCI USA, V110, pE507, DOI 10.1073/pnas.1212655110; Maiorano NA, 2012, INT J MOL SCI, V13, P558, DOI 10.3390/ijms13010558; Mathis U, 2007, GRAEF ARCH CLIN EXP, V245, P267, DOI 10.1007/s00417-006-0282-x; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McGarvey KM, 2015, MAMM GENOME, V26, P379, DOI 10.1007/s00335-015-9585-8; McGlinn AM, 2007, INVEST OPHTH VIS SCI, V48, P3430, DOI 10.1167/iovs.06-1538; Mei Y, 2013, J CELL BIOCHEM, V114, P1374, DOI 10.1002/jcb.24479; Metlapally R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078984; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Morgan Ian G, 2003, Clin Exp Optom, V86, P276; NGUYENLEGROS J, 1994, INVEST OPHTH VIS SCI, V35, P2906; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oyster CW., 1999, HUMAN EYE STRUCTURE; Pandi SPS, 2013, INVEST OPHTH VIS SCI, V54, P8140, DOI 10.1167/iovs.13-12631; Papadopoulos EI, 2015, GENE, V554, P174, DOI 10.1016/j.gene.2014.10.043; Pararajasegaram R, 1999, AM J OPHTHALMOL, V128, P359; Paschou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046189; Pattanayak Debasis, 2005, Indian Journal of Experimental Biology, V43, P7; Qi J, 2013, HUM GENET, V132, P1395, DOI 10.1007/s00439-013-1346-8; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Rada JAS, 2009, MOL VIS, V15, P778; Ryan D, 2006, MOL VIS, V12, P1175; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Schippert R, 2008, MOL VIS, V14, P1589; SELTNER RLP, 1995, VISION RES, V35, P1265, DOI 10.1016/0042-6989(94)00244-G; Shelton L, 2008, MOL VIS, V14, P1465; Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Siegwart JT, 2002, INVEST OPHTH VIS SCI, V43, P2067; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Singh SK, 2015, STEM CELL RES, V15, P305, DOI 10.1016/j.scr.2015.05.003; Sinha M, 2011, RNA BIOL, V8, P1005, DOI 10.4161/rna.8.6.16035; STONE RA, 1988, P NATL ACAD SCI USA, V85, P257, DOI 10.1073/pnas.85.1.257; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Tkatchenko AV, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005432; Tkatchenko AV, 2006, P NATL ACAD SCI USA, V103, P4681, DOI 10.1073/pnas.0600589103; Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P1297, DOI 10.1167/iovs.09-4153; Tkatchenko TV, 2010, INVEST OPHTH VIS SCI, V51, P21, DOI 10.1167/iovs.08-2767; Trumbach D, 2015, CELL TISSUE RES, V359, P161, DOI 10.1007/s00441-014-1911-z; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Vessey KA, 2005, INVEST OPHTH VIS SCI, V46, P3922, DOI 10.1167/iovs.04-1026; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang HC, 2014, CANCER INFORM, V13, P25, DOI 10.4137/CIN.S14074; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091199; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu SB, 2009, PROG RETIN EYE RES, V28, P87, DOI 10.1016/j.preteyeres.2008.11.003; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhong XW, 2004, INVEST OPHTH VIS SCI, V45, P2065, DOI 10.1167/iovs.03-1046	122	28	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162541	10.1371/journal.pone.0162541	http://dx.doi.org/10.1371/journal.pone.0162541			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622715	gold, Green Submitted, Green Published			2022-12-26	WOS:000383681000038
J	Bellet, MM; Masri, S; Astarita, G; Sassone-Corsi, P; Della Fazia, MA; Servillo, G				Bellet, Marina Maria; Masri, Selma; Astarita, Giuseppe; Sassone-Corsi, Paolo; Della Fazia, Maria Agnese; Servillo, Giuseppe			Histone Deacetylase SIRT1 Controls Proliferation, Circadian Rhythm, and Lipid Metabolism during Liver Regeneration in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-METABOLISM; IN-VIVO; CLOCK; TRANSCRIPTION; EXPRESSION; PROGRESSION; MECHANISM; SIRTUINS; RECEPTOR; CANCER	Liver regeneration offers a distinctive opportunity to study cell proliferation in vivo. Mammalian silent information regulator 1 (SIRT1), a NAD(+)-dependent histone deacetylase, is an important regulator of various cellular processes, including proliferation, metabolism, and circadian rhythms. In the liver, SIRT1 coordinates the circadian oscillation of clock-controlled genes, including genes that encode enzymes involved in metabolic pathways. We performed partial hepatectomy in WT and liver-specific Sirt1-deficient mice and analyzed the expression of cell cycle regulators in liver samples taken at different times during the regenerative process, by real time PCR, Western blotting analysis, and immunohistochemistry. Lipidomic analysis was performed in the same samples by MS/HPLC. We showed that G(1)/S progression was significantly affected by absence of SIRT1 in the liver, as well as circadian gene expression. This was associated to lipid accumulation due to defective fatty acid beta-oxidation. Our study revealed for the first time the importance of SIRT1 in the regulation of hepatocellular proliferation, circadian rhythms, and lipid metabolism during liver regeneration in mice. These results represent an additional step toward the characterization of SIRT1 function in the liver.	[Bellet, Marina Maria; Della Fazia, Maria Agnese; Servillo, Giuseppe] Univ Perugia, Dept Expt Med, Piazza Severi 1, I-06132 Perugia, Italy; [Masri, Selma; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Astarita, Giuseppe] Waters Corp, Hlth Sci, Milford, MA 01757 USA; [Astarita, Giuseppe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	University of Perugia; University of California System; University of California Irvine; Waters Corporation; Georgetown University	Bellet, MM; Servillo, G (corresponding author), Univ Perugia, Dept Expt Med, Piazza Severi 1, I-06132 Perugia, Italy.	marina_bellet@yahoo.com; giuseppe.servillo@unipg.it	Astarita, Giuseppe/AAD-1239-2019; Bellet, Marina Maria/K-7794-2016; Astarita, Giuseppe/N-7346-2014	Bellet, Marina Maria/0000-0001-7604-0189; Servillo, Giuseppe/0000-0001-7960-7689; Masri, Selma/0000-0002-8619-8331; Astarita, Giuseppe/0000-0001-6700-301X; Della Fazia, Maria Agnese/0000-0002-5373-8477	AUCC (Associazione Umbra per la lotta Contro il Cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro); Fondazione Umberto Veronesi; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	AUCC (Associazione Umbra per la lotta Contro il Cancro); AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by AUCC (Associazione Umbra per la lotta Contro il Cancro). The authors declare that they have no conflict of interest with the contents of this article.r Supported by a fellowship from AIRC (Associazione Italiana per la Ricerca sul Cancro) and Fondazione Umberto Veronesi. To whom correspondence may be addressed: Dept. of Experimental Medicine, University of Perugia, piazza Severi 1, 06132 Perugia, Italy. Tel.: 075 585 8109-12; E-mail: marina_bellet@yahoo.com.	Abel S, 2001, CARCINOGENESIS, V22, P795, DOI 10.1093/carcin/22.5.795; Aguilar-Arnal L, 2015, NAT STRUCT MOL BIOL, V22, P312, DOI 10.1038/nsmb.2990; Albrecht JH, 1998, ONCOGENE, V16, P2141, DOI 10.1038/sj.onc.1201728; Anderson SP, 2002, HEPATOLOGY, V36, P544, DOI 10.1053/jhep.2002.35276; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bartoli D, 2016, CELL CYCLE, P1; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Bellet MM, 2014, CELL CYCLE, V13, P1902, DOI 10.4161/cc.28760; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Della Fazia MA, 2005, J CELL SCI, V118, P3185, DOI 10.1242/jcs.02452; Della Fazia MA, 2001, J HEPATOL, V34, P555, DOI 10.1016/S0168-8278(00)00065-9; Farrell GC, 2004, HEPATOLOGY, V40, P1252, DOI 10.1002/hep.20522; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Garcia-Rodriguez JL, 2014, HEPATOLOGY, V59, P1972, DOI 10.1002/hep.26971; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Higgins GM, 1931, ARCH PATHOL, V12, P186; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rudnick DA, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/549241; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Servillo G, 1998, GENE DEV, V12, P3639, DOI 10.1101/gad.12.23.3639; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462	39	52	53	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23318	23329		10.1074/jbc.M116.737114	http://dx.doi.org/10.1074/jbc.M116.737114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27634039	Green Published, hybrid			2022-12-26	WOS:000387224800039
J	Gutierrez, MJ; Gomez, JL; Perez, GF; Pancham, K; Val, S; Pillai, DK; Giri, M; Ferrante, S; Freishtat, R; Rose, MC; Preciado, D; Nino, G				Gutierrez, Maria J.; Gomez, Jose L.; Perez, Geovanny F.; Pancham, Krishna; Val, Stephanie; Pillai, Dinesh K.; Giri, Mamta; Ferrante, Sarah; Freishtat, Robert; Rose, Mary C.; Preciado, Diego; Nino, Gustavo			Airway Secretory microRNAome Changes during Rhinovirus Infection in Early Childhood	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; EXTRACELLULAR VESICLES; INFLAMMATORY RESPONSE; EXPRESSION PROFILES; DENDRITIC CELLS; MESSENGER-RNAS; IN-VITRO; EXOSOMES; MIR-155; IMMUNE	Background Innate immune responses are fine-tuned by small noncoding RNA molecules termed microRNAs (miRs) that modify gene expression in response to the environment. During acute infections, miRs can be secreted in extracellular vesicles (EV) to facilitate cell-to-cell genetic communication. The purpose of this study was to characterize the baseline population of miRs secreted in EVs in the airways of young children (airway secretory microRNAome) and examine the changes during rhinovirus (RV) infection, the most common cause of asthma exacerbations and the most important early risk factor for the development of asthma beyond childhood. Methods Nasal airway secretions were obtained from children (<= 3 yrs. old) during PCR-confirmed RV infections (n = 10) and age-matched controls (n = 10). Nasal EVs were isolated with polymer-based precipitation and global miR profiles generated using NanoString microarrays. We validated our in vivo airway secretory miR data in an in vitro airway epithelium model using apical secretions from primaryhuman bronchial epithelial cells (HBEC) differentiated at air-liquid interface (ALI). Bioinformatics tools were used to determine the unified (nasal and bronchial) signature airway secretory miRNAome and changes during RV infection in children. Results Multiscale analysis identified four signature miRs comprising the baseline airway secretory miRNAome: hsa-miR-630, hsa-miR-302d-3p, hsa-miR-320e, hsa-miR-612. We identified hsa-miR-155 as the main change in the baseline miRNAome during RV infection in young children. We investigated the potential biological relevance of the airway secretion of hsa-mir-155 using in silico models derived from gene datasets of experimental in vivo human RV infection. These analyses confirmed that hsa-miR-155 targetome is an overrepresented pathway in the upper airways of individuals infected with RV. Conclusions Comparative analysis of the airway secretory microRNAome in children indicates that RV infection is associated with airway secretion of EVs containing miR-155, which is predicted in silico to regulate antiviral immunity. Further characterization of the airway secretory microRNAome during health and disease may lead to completely new strategies to treat and monitor respiratory conditions in all ages.	[Gutierrez, Maria J.] Johns Hopkins Univ, Sch Med, Div Pediat Allergy Immunol, Baltimore, MD USA; [Nino, Gustavo] Yale Univ, Sch Med, Div Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Rose, Mary C.; Nino, Gustavo] Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] George Washington Univ, Dept Integrat Syst Biol, Washington, DC 20052 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] George Washington Univ, Med Genet Res Ctr, Washington, DC 20052 USA; [Perez, Geovanny F.; Pillai, Dinesh K.; Giri, Mamta; Ferrante, Sarah; Freishtat, Robert; Rose, Mary C.; Nino, Gustavo] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Gomez, Jose L.; Pancham, Krishna] Univ Kentucky, Div Pediat Pulmonol, Lexington, KY USA; [Val, Stephanie; Preciado, Diego] Childrens Natl Med Ctr, Div Pediat Otolaryngol Head & Neck Surg, Washington, DC 20010 USA; [Freishtat, Robert] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA	Johns Hopkins University; Yale University; Children's National Health System; George Washington University; George Washington University; George Washington University; Children's National Health System; University of Kentucky; Children's National Health System; Children's National Health System	Nino, G (corresponding author), Yale Univ, Sch Med, Div Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA.; Nino, G (corresponding author), Childrens Natl Med Ctr, Div Pulm & Sleep Med, Washington, DC 20010 USA.; Nino, G (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.; Nino, G (corresponding author), George Washington Univ, Dept Integrat Syst Biol, Washington, DC 20052 USA.; Nino, G (corresponding author), George Washington Univ, Med Genet Res Ctr, Washington, DC 20052 USA.; Nino, G (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	gnino@childrensnational.org	giri, mamta/ABC-2895-2020; Gutierrez, Maria/AAK-2528-2021	Freishtat, Robert/0000-0002-7411-2342; Gutierrez, Maria Jimena/0000-0001-5494-5841; Perez, Geovanny/0000-0003-2843-6837; Gomez, Jose/0000-0002-6521-6318	National Heart, Lung and Blood Institute [NHLBI/HL090020, NHLBI/1K01HL125474-01]; National Institute for Child Health and Human Development [NICHC/HD001399]; National Center for Advancing Translational Sciences [KL2TR000076, UL1TR000075]; FAMRI: Young Clinical Scientist Award [113393]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125474] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); FAMRI: Young Clinical Scientist Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants: GN-National Heart, Lung and Blood Institute, NHLBI/HL090020 (K12 Genomics of Lung), http://www.nhlbi.nih.gov; JLG-National Heart, Lung and Blood Institute, NHLBI/1K01HL125474-01, http://www.nhlbi.nih.gov; GN-National Institute for Child Health and Human Development, NICHC/HD001399 (K12 Child Health Research Career Development Award), https://www.nichd.nih.gov; GN-National Center for Advancing Translational Sciences, KL2TR000076, https://www.nichd.nih.gov; GN-National Center for Advancing Translational Sciences, UL1TR000075, https://www.nichd.nih.gov; JLG-FAMRI: Young Clinical Scientist Award, 113393, http://www.famri.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala SE, 2014, AM J RESP CELL MOL, V51, P363, DOI 10.1165/rcmb.2013-0396OC; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Biosciences S., EXOQUICK EXOSOME PRE; Bondanese Victor Paky, 2014, World J Biol Chem, V5, P437, DOI 10.4331/wjbc.v5.i4.437; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Cao JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.386; Ceppi Maurizio, 2009, Immunome Res, V5, P5, DOI 10.1186/1745-7580-5-5; Challagundla KB, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv135; Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905; Cheng YQ, 2015, IMMUNOLOGY, V145, P485, DOI 10.1111/imm.12463; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Foster PS, 2013, IMMUNOL REV, V253, P198, DOI 10.1111/imr.12058; Friedlander SL, 2005, J ALLERGY CLIN IMMUN, V116, P267, DOI 10.1016/j.jaci.2005.06.003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fry RC, 2014, AM J PHYSIOL-LUNG C, V306, pL1129, DOI 10.1152/ajplung.00348.2013; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Graff JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044066; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hong JY, 2014, J ALLERGY CLIN IMMUN, V134, P429, DOI 10.1016/j.jaci.2014.04.020; Hsu S-D, 2010, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKQ1107; Inchley CS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0878-z; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kesimer M, 2015, METHODS, V87, P59, DOI 10.1016/j.ymeth.2015.03.013; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Kim YS, 2013, CLIN EXP ALLERGY, V43, P443, DOI 10.1111/cea.12085; Kulshreshtha A, 2013, J ALLERGY CLIN IMMUN, V131, P1194, DOI 10.1016/j.jaci.2012.12.1565; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Lossner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022146; Lu TX, 2013, J ALLERGY CLIN IMMUN, V132, P3, DOI 10.1016/j.jaci.2013.04.039; Malmhall C, 2014, J ALLERGY CLIN IMMUN, V133, P1429, DOI 10.1016/j.jaci.2013.11.008; Malmstrom K, 2015, ANN ALLERG ASTHMA IM, V114, P90, DOI 10.1016/j.anai.2014.09.019; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; NanoStringTechnologies I, 2012, NCOUNTER EXPR DAT AN; Nino G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115398; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Okoye IS, 2014, P NATL ACAD SCI USA, V111, pE3081, DOI 10.1073/pnas.1406322111; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Perez GF, 2015, PEDIAT ALLERG IMM-UK, V26, P145, DOI 10.1111/pai.12346; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Pillai DK, 2014, AM J RESP CELL MOL, V50, P292, DOI 10.1165/rcmb.2013-0188OC; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sessa R, 2013, PULM CIRC, V3, P315, DOI 10.4103/2045-8932.114758; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Su CH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-354; Thounaojam MC, 2014, J VIROL, V88, P4798, DOI 10.1128/JVI.02979-13; Tomankova T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-159; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057; Wahlgren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049723; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wu GP, 2015, ALLERGY ASTHMA IMMUN, V7, P449, DOI 10.4168/aair.2015.7.5.449; Wu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074190; Xi Y, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.27; Yang MM, 2013, EUR J CANCER, V49, P604, DOI 10.1016/j.ejca.2012.09.031; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110; Zech A, 2015, ALLERGY, V70, P1121, DOI 10.1111/all.12643; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001	69	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162244	10.1371/journal.pone.0162244	http://dx.doi.org/10.1371/journal.pone.0162244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643599	gold, Green Submitted, Green Published			2022-12-26	WOS:000383891900007
J	Hwang, OH; Cho, SB; Han, DW; Lee, SR; Kwag, JH; Park, SK				Hwang, Ok Hwa; Cho, Sung Back; Han, Deug Woo; Lee, Sang Ryoung; Kwag, Jeong Hoon; Park, Sung Kwon			Effect of Storage Period on the Changes of Odorous Compound Concentrations and Bacterial Ecology for Identifying the Cause of Odor Production from Pig Slurry	PLOS ONE			English	Article							FIELD SAMPLING METHOD; SWINE MANURE SLURRY; SP-NOV.; MICROBIAL-POPULATIONS; HUMAN COLON; GEN. NOV.; 16S RDNA; WASTE; FECES; ACID	Odor from buildings where pigs are housed is generated by anaerobic fermentation of undigested materials in pig slurry stored for several weeks in pit. The objective of this study was to investigate the effect of storage period on the level of odorous compounds in pig slurry and on its bacterial community. A slurry sample (15 L) was taken from the pit of a finisher pig building and incubated in acryl chambers for six-weeks. Slurry for analysis was sampled every two-week. Levels of odorous compounds in the slurry sample were drastically changed after two weeks of storage period; levels of phenols and short chain fatty acids (SCFAs) were decreased (P< 0.05), whereas indoles and branched-chain fatty acids (BCFAs) were increased (P< 0.05). Among dominant bacteria, Bacteroides and Porphyro-monadacese_uc_g revealed a strong positive correlation with the levels of phenols and SCFAs. Populations of AC160630_g, Acholeplasmatales_uc_g, Mollicutes_uc_g and Cloacamonas_f_uc_g positively correlated with indole and BCFAs content. Taken together, levels of odorous compounds were increased after two weeks of storage, possibly because of changes in the predominant bacterial groups to those that use protein as a carbon source in the hypo-carbohydrate conditions.	[Hwang, Ok Hwa; Cho, Sung Back; Han, Deug Woo; Lee, Sang Ryoung; Kwag, Jeong Hoon] Rural Dev Adm, Natl Inst Anim Sci, Wanju Gun, Jeollabuk Do, South Korea; [Park, Sung Kwon] Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Sejong University	Park, SK (corresponding author), Sejong Univ, Dept Food Sci & Technol, Seoul, South Korea.	sungkwonpark@sejong.ac.kr	Park, Sungkwon/AAJ-2209-2021; Lee, Sang-Ryong/C-2167-2017; Lee, Sang-Ryong/Q-7531-2019	Lee, Sang-Ryong/0000-0002-8672-301X; Lee, Sang-Ryong/0000-0002-8672-301X	National Institute of Animal Science, Rural Development Administration, Republic of Korea [PJ01026302]	National Institute of Animal Science, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was carried out with the support of "Practical use of odor reducing agent developed to symbiotic technology for pigpen (Project title: Practical research of odor reducing agent to add in pigpen slurry, Project No. PJ01026302)" by National Institute of Animal Science, Rural Development Administration, Republic of Korea.	Andrea IS, 2014, INT J SYST EVOL MICR, V64, P3936; [Anonymous], 1994, APPL ENV MICROB, V60, P1897; Boopathy R, 1995, BIORESOURCE TECHNOL, V54, P29, DOI 10.1016/0960-8524(95)00106-9; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975; Cotta MA, 2003, ENVIRON MICROBIOL, V5, P737, DOI 10.1046/j.1467-2920.2003.00467.x; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELSDEN SR, 1978, ARCH MICROBIOL, V117, P165, DOI 10.1007/BF00402304; Gaskins HR, 2001, INTESTINAL BACTERIA; Goux X, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0309-9; GUNDERSEN DE, 1994, J BACTERIOL, V176, P5244, DOI 10.1128/JB.176.17.5244-5254.1994; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HAMMOND EG, 1989, AGR ECOSYST ENVIRON, V25, P103, DOI 10.1016/0167-8809(89)90043-1; Hobbs PJ, 1999, J AGR ENG RES, V72, P291, DOI 10.1006/jaer.1998.0372; HOBSON PN, 1974, WATER RES, V8, P507, DOI 10.1016/0043-1354(74)90057-8; Hofstad T, 2000, INT J SYST EVOL MICR, V50, P2189, DOI 10.1099/00207713-50-6-2189; IANNOTTI EL, 1982, APPL ENVIRON MICROB, V43, P136, DOI 10.1128/AEM.43.1.136-143.1982; ISHAQUE M, 1985, AGR WASTES, V13, P229, DOI 10.1016/0141-4607(85)90037-X; JENSEN MT, 1995, APPL ENVIRON MICROB, V61, P3180, DOI 10.1128/AEM.61.8.3180-3184.1995; Ju F, 2014, MICROB ECOL, V68, P235, DOI 10.1007/s00248-014-0405-6; Kai P, 2004, AGR ENG INT GIGR J, pVI; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Klose V, 2010, VET MICROBIOL, V144, P515, DOI 10.1016/j.vetmic.2010.02.025; Kube M, 2014, J MOL MICROB BIOTECH, V24, P19, DOI 10.1159/000354322; Lazarev VN, 2011, J BACTERIOL, V193, P4943, DOI 10.1128/JB.05059-11; Le PD, 2008, LIVEST SCI, V114, P48, DOI 10.1016/j.livsci.2007.04.009; Le PD, 2005, NUTR RES REV, V18, P3, DOI 10.1079/NRR200592; Leung K, 2001, FEMS MICROBIOL ECOL, V38, P169, DOI 10.1111/j.1574-6941.2001.tb00895.x; Limam RD, 2014, MICROBIOLOGYOPEN, V3, P157, DOI 10.1002/mbo3.144; Mackie R., 1994, P INT ROUND TABL SWI, P13; Mackie RI, 1998, J ANIM SCI, V76, P1331; MAFRA, 2010, MIN AGR FOOD RUR AFF; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; MEV, 2011, LAW LIV EXCR MAN US; MEV, 2012, LAW OFF OD CONTR; Miller DN, 2003, J ANIM SCI, V81, P2131; Modak, 1958, BALWADIS RURAL AREAS; NIAS, 2012, KOR FEED STAND SWIN; ONEILL DH, 1992, J AGR ENG RES, V53, P23, DOI 10.1016/0021-8634(92)80072-Z; Parker DB, 2013, ATMOS ENVIRON, V66, P91, DOI 10.1016/j.atmosenv.2012.01.001; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Peu P, 2006, APPL ENVIRON MICROB, V72, P3578, DOI 10.1128/AEM.72.5.3578-3585.2006; Qiu YL, 2014, ARCH MICROBIOL, V196, P149, DOI 10.1007/s00203-013-0951-1; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; Rappert S, 2005, WASTE MANAGE, V25, P887, DOI 10.1016/j.wasman.2005.07.008; RIEPE SP, 1980, J CLIN INVEST, V66, P314, DOI 10.1172/JCI109859; Roustan J, 1980, TENTATIVE MEASUREMEN; Sakamoto M, 2009, INT J SYST EVOL MICR, V59, P1748, DOI 10.1099/ijs.0.007674-0; SALYERS AA, 1979, AM J CLIN NUTR, V32, P158, DOI 10.1093/ajcn/32.1.158; SAS, 2002, SAS STAT SOFTW VERS; Schiffman SS, 2001, AGR FOREST METEOROL, V108, P213, DOI 10.1016/S0168-1923(01)00239-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith EA, 1998, FEMS MICROBIOL ECOL, V25, P355, DOI 10.1016/S0168-6496(98)00004-X; Smith M. B, 2007, MARCHS ADV ORGANIC C; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Solli L, 2014, BIOTECHNOL BIOFUELS, V14, DOI 10.1186/s13068-014-0146-2; Song YL, 2005, J CLIN MICROBIOL, V43, P4522, DOI 10.1128/JCM.43.9.4522-4527.2005; SPOELSTRA SF, 1978, APPL ENVIRON MICROB, V35, P841, DOI 10.1128/AEM.35.5.841-846.1978; Spoelstra SF, 1978, MICROBIAL ASPECTS FO; Sutton AL, 1999, J ANIM SCI, V77, P430; Trabue S, 2008, ATMOS ENVIRON, V42, P3332, DOI 10.1016/j.atmosenv.2007.03.016; Trabue S, 2011, J ENVIRON QUAL, V40, P1510, DOI 10.2134/jeq2010.0522; Trabue S, 2011, ATMOS ENVIRON, V45, P4243, DOI 10.1016/j.atmosenv.2011.04.081; Trabue SL, 2008, ENVIRON SCI TECHNOL, V42, P3745, DOI 10.1021/es7031407; Ueki A, 2006, INT J SYST EVOL MICR, V56, P39, DOI 10.1099/ijs.0.63896-0; Van der Meulen R, 2008, INT J FOOD MICROBIOL, V124, P27, DOI 10.1016/j.ijfoodmicro.2008.02.013; Whitehead TR, 2001, ANAEROBE, V7, P181, DOI 10.1006/anae.2001.0388; WILLIAMS AG, 1981, AGR WASTES, V3, P311, DOI 10.1016/0141-4607(81)90017-2; Willig S, 2005, J AGR FOOD CHEM, V53, P1173, DOI 10.1021/jf048658+; Wu JJ, 1999, J AGR ENG RES, V72, P317, DOI 10.1006/jaer.1998.0378; Zahn JA, 1997, J ENVIRON QUAL, V26, P1687, DOI 10.2134/jeq1997.00472425002600060032x; Zhang S, 2010, INT S AIR QUAL MAN M; Zhu J, 1996, J ENVIRON SCI HEAL A, V31, P2487, DOI 10.1080/10934529609376505; Zhu J, 2000, AGR ECOSYST ENVIRON, V78, P93, DOI 10.1016/S0167-8809(99)00116-4; Ziemer CJ, 2009, J ENVIRON QUAL, V38, P2138, DOI 10.2134/jeq2008.0039; Ziganshin AM, 2011, APPL MICROBIOL BIOT, V89, P2039, DOI 10.1007/s00253-010-2981-9	79	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							0162714	10.1371/journal.pone.0162714	http://dx.doi.org/10.1371/journal.pone.0162714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642752	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900014
J	Vicentini, GE; Fracaro, L; de Souza, SRG; Martins, HA; Guarnier, FA; Zanoni, JN				Vicentini, Geraldo E.; Fracaro, Luciane; de Souza, Sara R. G.; Martins, Heber A.; Guarnier, Flavia A.; Zanoni, Jacqueline N.			Experimental Cancer Cachexia Changes Neuron Numbers and Peptide Levels in the Intestine: Partial Protective Effects after Dietary Supplementation with L-Glutamine	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; COLONIC ENDOCRINE-CELLS; OXIDATIVE STRESS; MYENTERIC NEURONS; TUMOR-GROWTH; RATS; GLUTATHIONE; CARCINOMA; INNERVATION; ILEUM	Gastrointestinal dysmotility frequently occurs in cancer cachexia and may result from damage to enteric innervation caused by oxidative stress, especially due to glutathione depletion. We assessed the effect of dietary supplementation with 20 g/kg L-glutamine (a glutathione precursor) on the intrinsic innervation of the enteric nervous system in healthy and Walker 256 tumor-bearing Wistar rats during the development of experimental cachexia (14 days), in comparison with non-supplemented rats, by using immunohistochemical methods and Western blotting. The total neural population and cholinergic subpopulation densities in the myenteric plexus, as well as the total population and VIPergic subpopulation in the submucosal plexus of the jejunum and ileum, were reduced in cachectic rats, resulting in adaptive morphometric alterations and an increase in vasoactive intestinal peptide (VIP) and calcitonin gene-related peptide (CGRP) expression, suggesting a neuroplastic response. L-glutamine supplementation prevented decrease in myenteric neuronal density in the ileum, morphometric alterations in the neurons and nerve fibers (in both the plexuses of the jejunum and ileum), and the overexpression of VIP and CGRP. Cancer cachexia severely affected the intrinsic innervation of the jejunum and ileum to various degrees and this injury seems to be associated with adaptive neural plasticity. L-glutamine supplementation presented partial protective effects on the enteric innervation against cancer cachexia, possibly by attenuating oxidative stress.	[Vicentini, Geraldo E.; Fracaro, Luciane; de Souza, Sara R. G.; Martins, Heber A.; Zanoni, Jacqueline N.] Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil; [Guarnier, Flavia A.] Univ Estadual Londrina, Dept Gen Pathol, Londrina, Parana, Brazil; [Vicentini, Geraldo E.] Univ Estadual Oeste Parana, Hlth Sci Ctr, Francisco Beltrao, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Londrina; Universidade Estadual do Oeste do Parana	Zanoni, JN (corresponding author), Univ Estadual Maringa, Dept Morphol Sci, Maringa, Parana, Brazil.	zanonijn@gmail.com	Guarnier, Flávia A/E-3800-2012; Cecchini, Rubens/D-9811-2013	Guarnier, Flávia A/0000-0001-9302-878X; Cecchini, Rubens/0000-0001-9941-2344	Fundacao Araucaria (Apoio ao desenvolvimento Cientifico e Tecnologico do Parana) [266/14]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil	Fundacao Araucaria (Apoio ao desenvolvimento Cientifico e Tecnologico do Parana)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project was funded by a grant from the Fundacao Araucaria (Apoio ao desenvolvimento Cientifico e Tecnologico do Parana) - 266/14, and from the CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Brazil to JNZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara S, 2008, ANN PHARMACOTHER, V42, P1481, DOI 10.1345/aph.1L179; Amores-Sanchez MI, 1999, MOL GENET METAB, V67, P100, DOI 10.1006/mgme.1999.2857; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Arias-Rotunno LR, 2007, THESIS; Alves EPB, 2010, NUTR NEUROSCI, V13, P43, DOI 10.1179/147683010X12611460763841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceyhan GO, 2009, AM J GASTROENTEROL, V104, P2555, DOI 10.1038/ajg.2009.380; Chen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033177; Chiocchetti R, 2006, CELL TISSUE RES, V323, P183, DOI 10.1007/s00441-005-0075-2; COSTA M, 1980, HISTOCHEMISTRY, V65, P157, DOI 10.1007/BF00493164; Cowen T, 2000, GUT, V47, P653, DOI 10.1136/gut.47.5.653; DiBaise JK, 1998, DIGEST DIS SCI, V43, P1369, DOI 10.1023/A:1018853106696; Ekblad E, 2004, NEUROGASTROENT MOTIL, V16, P123, DOI 10.1111/j.1743-3150.2004.00487.x; Ekblad E, 1998, GUT, V42, P836, DOI 10.1136/gut.42.6.836; Ekelund KM, 1999, GUT, V45, P236, DOI 10.1136/gut.45.2.236; El-Salhy M, 1998, EUR J GASTROEN HEPAT, V10, P517, DOI 10.1097/00042737-199806000-00015; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fenner FL, 2015, FOLIA NEUROPATHOL, V53, P139, DOI 10.5114/fn.2015.52410; Pereira RVF, 2011, DIGEST DIS SCI, V56, P3507, DOI 10.1007/s10620-011-1806-8; Fracaro L, 2015, NEUROGASTROENT MOTIL, DOI [10.1111/nmo.12702, DOI 10.1111/NMO.12702]; Freitas JJS, 2001, J NEUROCHEM, V77, P655, DOI 10.1046/j.1471-4159.2001.00280.x; Furness JB, 2006, ENTERIC NERVOUS SYST, Vxiii; Gamage P P K M, 2013, Neurogastroenterol Motil, V25, pe495; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Godlewski J, 2012, ANN ANAT, V194, P368, DOI 10.1016/j.aanat.2011.11.009; Godlewski J, 2010, FOLIA HISTOCHEM CYTO, V48, P475, DOI 10.2478/v10042-010-0079-y; Godlewski J, 2010, FOLIA HISTOCHEM CYTO, V48, P208, DOI 10.2478/v10042-010-0052-9; Godlewski J, 2010, FOLIA HISTOCHEM CYTO, V48, P157, DOI 10.2478/v10042-010-0029-8; GUAITANI A, 1982, ONCOLOGY, V39, P173, DOI 10.1159/000225631; Guarnier FA, 2010, MUSCLE NERVE, V42, P950, DOI 10.1002/mus.21798; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hay DL, 2011, ENDOCR-RELAT CANCER, V18, pC1, DOI 10.1677/ERC-10-0244; Hermes-Uliana C, 2014, DIGEST DIS SCI, V59, P937, DOI 10.1007/s10620-013-2993-2; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Iagher F, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-146; Johnson RJR, 1998, J ANAT, V192, P479, DOI 10.1046/j.1469-7580.1998.19240479.x; Kuhn KS, 2010, EUR J NUTR, V49, P197, DOI 10.1007/s00394-009-0082-2; Kurnik M, 2015, FOLIA HISTOCHEM CYTO, V53, P49, DOI 10.5603/FHC.a2015.0010; Levine B A, 1996, Surg Oncol Clin N Am, V5, P609; Lima MMR, 2002, CELL BIOCHEM FUNCT, V20, P107, DOI 10.1002/cbf.961; Machado AP, 2004, CELL TISSUE RES, V318, P503, DOI 10.1007/s00441-004-0987-2; Mann PT, 1999, CELL TISSUE RES, V297, P241, DOI 10.1007/s004410051352; Mantovani G, 2012, CURR PHARM DESIGN, V18, P4813, DOI 10.2174/138161212803216889; Materazzi S, 2012, PFLUG ARCH EUR J PHY, V463, P561, DOI 10.1007/s00424-011-1071-x; Michalak KP, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/964321; Paulino AS, 2011, DIGEST DIS SCI, V56, P2262, DOI 10.1007/s10620-011-1588-z; Pereira RVF, 2016, AN ACAD BRAS CIENC, V88, P609, DOI 10.1590/0001-3765201620150228; Phillips RJ, 2007, AUTON NEUROSCI-BASIC, V136, P1, DOI 10.1016/j.autneu.2007.04.005; Rasmussen TN, 2001, REGUL PEPTIDES, V98, P137, DOI 10.1016/S0167-0115(00)00242-1; Rebeca R, 2008, CELL BIOCHEM FUNCT, V26, P731, DOI 10.1002/cbf.1497; Rosa CV, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0143005, DOI 10.1371/JOURNAL.PONE.0143005]; Shin EJ, 2016, ARCH TOXICOL, V90, P937, DOI 10.1007/s00204-015-1516-7; Sitohy B, 2002, ACTA ONCOL, V41, P543; Sitohy B, 2001, HISTOL HISTOPATHOL, V16, P833, DOI 10.14670/HH-16.833; Soares A, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0228-z; SOUBA WW, 1988, THE JOURNAL OF SURGI, V44, P720; Tashima CM, 2007, DIGEST DIS SCI, V52, P1233, DOI 10.1007/s10620-006-9564-8; Toda M, 2008, P NATL ACAD SCI USA, V105, P13550, DOI 10.1073/pnas.0800767105; Tuncel N, 2012, J MOL NEUROSCI, V46, P51, DOI 10.1007/s12031-011-9618-z; Wang AL, 2015, INT J CLIN EXP PATHO, V8, P7896; Wu Y, 2015, NEUROSCI LETT, V598, P52, DOI 10.1016/j.neulet.2015.05.009; Zanoni Jacqueline Nelisis, 2011, Arq. Gastroenterol., V48, P66, DOI 10.1590/S0004-28032011000100014; Zhang F, 2008, INFLAMMATION, V31, P344, DOI 10.1007/s10753-008-9084-0	65	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162998	10.1371/journal.pone.0162998	http://dx.doi.org/10.1371/journal.pone.0162998			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27635657	gold, Green Published, Green Submitted			2022-12-26	WOS:000383723700023
J	Henry, KA; Sulea, T; van Faassen, H; Hussack, G; Purisima, EO; MacKenzie, CR; Arbabi-Ghahroudi, M				Henry, Kevin A.; Sulea, Traian; van Faassen, Henk; Hussack, Greg; Purisima, Enrico O.; MacKenzie, C. Roger; Arbabi-Ghahroudi, Mehdi			A Rational Engineering Strategy for Designing Protein A-Binding Camelid Single-Domain Antibodies	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; THERAPEUTIC ANTIBODIES; STRUCTURAL BASIS; IMMUNOGLOBULIN-BINDING; NEXT-GENERATION; FORCE-FIELD; ANTIGEN; PURIFICATION; AFFINITIES; NANOBODIES	Staphylococcal protein A (SpA) and streptococcal protein G (SpG) affinity chromatography are the gold standards for purifying monoclonal antibodies (mAbs) in therapeutic applications. However, camelid VHH single-domain Abs (sdAbs or V(H)Hs) are not bound by SpG and only sporadically bound by SpA. Currently, V(H)Hs require affinity tag-based purification, which limits their therapeutic potential and adds considerable complexity and cost to their production. Here we describe a simple and rapid mutagenesis-based approach designed to confer SpA binding upon a priori non-SpA-binding V(H)Hs. We show that SpA binding of V(H)Hs is determined primarily by the same set of residues as in human mAbs, albeit with an unexpected degree of tolerance to substitutions at certain core and non-core positions and some limited dependence on at least one residue outside the SpA interface, and that SpA binding could be successfully introduced into five V(H)Hs against three different targets with no adverse effects on expression yield or antigen binding. Next-generation sequencing of llama, alpaca and dromedary VHH repertoires suggested that species differences in SpA binding may result from frequency variation in specific deleterious polymorphisms, especially Ile57. Thus, the SpA binding phenotype of camelid V(H)Hs can be easily modulated to take advantage of tag-less purification techniques, although the frequency with which this is required may depend on the source species.	[Henry, Kevin A.; van Faassen, Henk; Hussack, Greg; MacKenzie, C. Roger; Arbabi-Ghahroudi, Mehdi] Natl Res Council Canada, Human Hlth Therapeut Portfolio, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Sulea, Traian; Purisima, Enrico O.] Natl Res Council Canada, Human Hlth Therapeut Portfolio, 6100 Royalmount Ave, Montreal, PQ H4P 2R2, Canada; [MacKenzie, C. Roger; Arbabi-Ghahroudi, Mehdi] Univ Guelph, Sch Environm Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada; [Arbabi-Ghahroudi, Mehdi] Carleton Univ, Dept Biol, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada	National Research Council Canada; National Research Council Canada; University of Guelph; Carleton University	Arbabi-Ghahroudi, M (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Portfolio, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.; Arbabi-Ghahroudi, M (corresponding author), Univ Guelph, Sch Environm Sci, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.; Arbabi-Ghahroudi, M (corresponding author), Carleton Univ, Dept Biol, 1125 Colonel By Dr, Ottawa, ON K1S 5B6, Canada.	mehdi.arbabi@nrc-cnrc.gc.ca			National Research Council Canada	National Research Council Canada	This work was supported by funding from the National Research Council Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A., 2011, Patent No. [US 8623369 B2, 8623369]; Alturki NA, 2015, METHODS MOL BIOL, V1348, P167, DOI 10.1007/978-1-4939-2999-3_16; Amor-Mahjoub M, 2006, J CHROMATOGR B, V844, P328, DOI 10.1016/j.jchromb.2006.07.031; Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; Baral Toya Nath, 2013, Curr Protoc Immunol, V103, DOI 10.1002/0471142735.im0217s103; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Bell A, 2010, CANCER LETT, V289, P81, DOI 10.1016/j.canlet.2009.08.003; BJORCK L, 1984, J IMMUNOL, V133, P969; Cary S, 1999, MOL IMMUNOL, V36, P769, DOI 10.1016/S0161-5890(99)00085-1; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chant A, 2005, PROTEIN EXPRES PURIF, V39, P152, DOI 10.1016/j.pep.2004.10.017; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; De Groeve K, 2010, J NUCL MED, V51, P782, DOI 10.2967/jnumed.109.070078; Deschacht N, 2010, J IMMUNOL, V184, P5696, DOI 10.4049/jimmunol.0903722; Fridy PC, 2015, ANAL BIOCHEM, V477, P92, DOI 10.1016/j.ab.2015.02.013; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hamilton S, 2003, HYBRIDOMA HYBRIDOM, V22, P347, DOI 10.1089/153685903771797048; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Henry KA, 2015, PROTEIN ENG DES SEL, V28, P379, DOI 10.1093/protein/gzv039; HILLSON JL, 1993, J EXP MED, V178, P331, DOI 10.1084/jem.178.1.331; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hussack G, 2011, J BIOL CHEM, V286, P8961, DOI 10.1074/jbc.M110.198754; Jain M, 2007, TRENDS BIOTECHNOL, V25, P307, DOI 10.1016/j.tibtech.2007.05.001; Khan F, 2012, BIOTECHNOL J, V7, P133, DOI 10.1002/biot.201100331; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kumaran Jyothi, 2012, Methods Mol Biol, V911, P105, DOI 10.1007/978-1-61779-968-6_7; Low D, 2007, J CHROMATOGR B, V848, P48, DOI 10.1016/j.jchromb.2006.10.033; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; OConchuir S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0130433, DOI 10.1371/JOURNAL.PONE.0130433]; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Potter KN, 1996, J IMMUNOL, V157, P2982; Richard G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069495; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; ROMAGNANI S, 1982, J IMMUNOL, V129, P596; SASANO M, 1993, J IMMUNOL, V151, P5822; SASSO EH, 1989, J IMMUNOL, V142, P2778; SASSO EH, 1991, J IMMUNOL, V147, P1877; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; SEPPALA I, 1990, J IMMUNOL, V145, P2989; Stanimirovic D, 2014, World Intellectual Property Organization patent application WO, Patent No. 2015131256; Sulea T, 2016, J CHEM INF MODEL, V56, P1292, DOI 10.1021/acs.jcim.6b00043; Sulea T, 2012, METHODS MOL BIOL, V819, P295, DOI 10.1007/978-1-61779-465-0_19; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; Woestenenk Esmeralda A., 2004, Journal of Structural and Functional Genomics, V5, P217, DOI 10.1023/B:jsfg.0000031965.37625.0e; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131; Zhang JB, 2004, J MOL BIOL, V341, P161, DOI 10.1016/j.jmb.2004.05.069; Zhang Jianbing, 2009, V525, P323, DOI 10.1007/978-1-59745-554-1_17	61	18	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163113	10.1371/journal.pone.0163113	http://dx.doi.org/10.1371/journal.pone.0163113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631624	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900132
J	Orue, A; Rieber, M				Orue, Andrea; Rieber, Manuel			Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR	PLOS ONE			English	Article							REAL-TIME PCR; METASTATIC COLORECTAL-CANCER; ASSAY; GENERATION; THERAPY; CETUXIMAB; MUTANT; GENE; RAS	Establishing the KRAS mutational status of tumor samples is essential to manage patients with colorectal or lung cancer, since these mutations preclude treatment with monoclonal anti-epidermal growth factor receptor (EGFR) antibodies. We report an inexpensive, rapid multiplex allele-specific qPCR method detecting the 7 most clinically relevant KRAS somatic mutations with concomitant amplification of non-mutated KRAS in tumor cells and tissues from CRC patients. Positive samples evidenced in the multiplex assay were further subjected to individual allele-specific analysis, to define the specific mutation. Reference human cancer DNA harbouring either G12A, G12C, G12D, G12R, G12S, G12V and G13D confirmed assay specificity with <= 1% sensitivity of mutant alleles. KRAS multiplex mutation analysis usefulness was also demonstrated with formalin-fixed paraffin embedded (FFPE) from CRC biopsies. Conclusion. Co-amplification of non-mutated DNA avoided false negatives from degraded samples. Moreover, this cost effective assay is compatible with mutation detection by DNA sequencing in FFPE tissues, but with a greater sensitivity when mutant DNA concentrations are limiting.	[Orue, Andrea; Rieber, Manuel] IVIC, Tumor Cell Biol Lab, Apartado 21827, Caracas 1020A, Venezuela	Venezuelan Institute Science Research	Rieber, M (corresponding author), IVIC, Tumor Cell Biol Lab, Apartado 21827, Caracas 1020A, Venezuela.	manuel.rieber@gmail.com			Fonacit-Mision Ciencia subproyecto SPNS 4-Cancer grant	Fonacit-Mision Ciencia subproyecto SPNS 4-Cancer grant	This research was funded by Fonacit-Mision Ciencia subproyecto SPNS 4-Cancer grant to Manuel Rieber. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mulla F, 1998, J PATHOL, V185, P130, DOI 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO;2-M; Amicarelli G, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm809; Borras E, 2016, CANCER PREV RES, V9, P417, DOI 10.1158/1940-6207.CAPR-16-0081; Chen CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055793; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; de Macedo MP, 2014, EXP MOL PATHOL, V96, P257, DOI 10.1016/j.yexmp.2014.02.014; Desai AN, 2012, CLIN GENET, V81, P503, DOI 10.1111/j.1399-0004.2012.01865.x; Domagala P, 2012, POL J PATHOL, V63, P145, DOI 10.5114/PJP.2012.31499; Fiala O, 2016, TUMOR BIOL, V37, P6823, DOI 10.1007/s13277-015-4523-7; Fiala O, 2013, CANCER GENET-NY, V206, P26, DOI 10.1016/j.cancergen.2012.12.003; Gaudet M, 2009, METHODS MOL BIOL, V578, P415, DOI 10.1007/978-1-60327-411-1_26; Halait H, 2012, DIAGN MOL PATHOL, V21, P1, DOI 10.1097/PDM.0b013e31823b216f; Han JY, 2014, LUNG CANCER, V85, P161, DOI 10.1016/j.lungcan.2014.04.009; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Huang Q, 2010, MOL CELL PROBE, V24, P376, DOI 10.1016/j.mcp.2010.07.010; Lang AH, 2011, J MOL DIAGN, V13, P23, DOI 10.1016/j.jmoldx.2010.11.007; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Little S, 2001, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0908s07; Mao C, 2013, CANCER-AM CANCER SOC, V119, P714, DOI 10.1002/cncr.27804; Milbury CA, 2011, EXPERT REV MOL DIAGN, V11, P159, DOI [10.1586/ERM.10.115, 10.1586/erm.10.115]; Morandi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036084; Naidoo J, 2016, ADV EXP MED BIOL, V893, P155, DOI 10.1007/978-3-319-24223-1_8; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ostrow SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21927; Plesec TP, 2009, ADV ANAT PATHOL, V16, P196, DOI 10.1097/PAP.0b013e3181a9d4ed; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Seekhuntod S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147672; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stintzing S, 2015, HEMATOL ONCOL CLIN N, V29, P43, DOI 10.1016/j.hoc.2014.09.009; Szankasi P, 2013, J MOL DIAGN, V15, P248, DOI 10.1016/j.jmoldx.2012.11.005; Tan C, 2012, WORLD J GASTROENTERO, V18, P5171, DOI 10.3748/wjg.v18.i37.5171; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Wang JF, 2013, CANCER BIOMARK, V13, P89, DOI 10.3233/CBM-130334; Wang T, 2015, EXP MOL PATHOL, V98, P152, DOI 10.1016/j.yexmp.2015.03.004; Weichert W, 2010, J MOL DIAGN, V12, P35, DOI 10.2353/jmoldx.2010.090079; Whitehall V, 2009, J MOL DIAGN, V11, P543, DOI 10.2353/jmoldx.2009.090057; Zhang HP, 2012, CELL BIOCHEM BIOPHYS, V62, P415, DOI 10.1007/s12013-011-9318-x	39	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163070	10.1371/journal.pone.0163070	http://dx.doi.org/10.1371/journal.pone.0163070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632281	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900127
J	Li, M; Huang, YB; Du, X; Li, SS; Ji, JC; Patel, A; Gao, RL; Wu, YF				Li, Min; Huang, Yubei; Du, Xin; Li, Shenshen; Ji, Jiachao; Patel, Anushka; Gao, Runlin; Wu, Yangfeng			Impact of Prior Use of Four Preventive Medications on Outcomes in Patients Hospitalized for Acute Coronary Syndrome-Results from CPACS-2 Study	PLOS ONE			English	Article							PRIOR ASPIRIN USE; GLOBAL REGISTRY; EVENTS GRACE; UNSTABLE ANGINA; STATIN THERAPY; ASSOCIATION; RISK	Background It is widely reported that long-term use of four preventive medications (antiplatelet agents, angiotensin converting enzyme inhibitor /angiotensin receptor blocker, statin and beta-blockers) reduce the risk of subsequent acute coronary syndromes (ACS). It is unclear whether these four medications benefit patients who develop ACS despite its use. Methods and Results Logistic regression and propensity-score was applied among 14790 ACS patients to assess the association between prior use of four preventive medications and in-hospital outcomes including severity of disease at presentation (type of ACS, systolic blood pressure <90 mmHg, and heart rate> = 100 beats/min), complicating arrhythmia and major adverse cardiovascular events (MACEs, including all deaths, non-fatal myocardial infarction or re-infarction, and non-fatal stroke). Prior use of each of the four medications was significantly associated with less severity of disease (ORs ranged from 0.40 to 0.82, all P<0.05), less arrhythmia (ORs ranged from 0.45 to 0.64, all P<0.05), and reduced risk of MACEs (ORs ranged from 0.59 to 0.73, all P<0.05) during hospitalization. Multiple variable-adjusted ORs of MACEs were 0.77, 0.67, 0.48 and 0.59 respectively in patients with 1, 2, 3 and 4 medications in comparison with patients with none, and other clinical outcomes showed the same trend (P for trend < 0.05). Conclusions Among ACS patients in our study, those with prior use of four preventive medications presented with less disease severity, developed less arrhythmia and had a lower risk of in-hospital MACEs. The value of taking these medications may beyond just preventing occurrence of the disease.	[Li, Min; Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing, Peoples R China; [Huang, Yubei] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Du, Xin; Li, Shenshen; Ji, Jiachao; Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China; [Du, Xin] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [Patel, Anushka] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Gao, Runlin] Chinese Acad Med Sci, Cardiovasc Inst, Dept Cardiol, Beijing, Peoples R China; [Gao, Runlin] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Gao, Runlin] Peking Union Med Coll, Beijing, Peoples R China	Peking University; Tianjin Medical University; Peking University; Capital Medical University; George Institute for Global Health; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, YF (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China.	ywu@georgeinstitute.org.cn	Huang, Yubei/AAE-8296-2020	Patel, Anushka/0000-0003-3825-4092	Sanofi, China	Sanofi, China(Sanofi-Aventis)	The source of funding used to support the CPACS-2 study is from Sanofi, China, through an unrestricted research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JH, 1999, AM J CARDIOL, V83, P1147, DOI 10.1016/S0002-9149(99)00049-1; Amad H, 2012, CAN J CARDIOL, V28, P48, DOI 10.1016/j.cjca.2011.09.003; Borzak S, 1998, AM J CARDIOL, V81, P678, DOI 10.1016/S0002-9149(97)01006-0; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; HERLITZ J, 1995, CARDIOLOGY, V86, P56, DOI 10.1159/000176831; Lancaster GI, 2001, INT J CARDIOL, V80, P201, DOI 10.1016/S0167-5273(01)00495-8; Portnay EL, 2005, J AM COLL CARDIOL, V46, P967, DOI 10.1016/j.jacc.2005.06.049; Rich JD, 2010, J AM COLL CARDIOL, V56, P1376, DOI 10.1016/j.jacc.2010.06.028; Rong Ye, 2010, Crit Pathw Cardiol, V9, P134, DOI 10.1097/HPC.0b013e3181f01eac; Santopinto J, 2001, AM HEART J, V141, P566, DOI 10.1067/mhj.2001.113994; Singh SM, 2012, AM J CARDIOL, V109, P332, DOI 10.1016/j.amjcard.2011.09.018; Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006; Spencer FA, 2002, AM J CARDIOL, V90, P1056, DOI 10.1016/S0002-9149(02)02769-8; Vedre A, 2009, AM J CARDIOL, V104, P1613, DOI 10.1016/j.amjcard.2009.07.045	15	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0163068	10.1371/journal.pone.0163068	http://dx.doi.org/10.1371/journal.pone.0163068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626640	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600074
J	Guzman-Perez, V; Bumke-Vogt, C; Schreiner, M; Mewis, I; Borchert, A; Pfeiffer, AFH				Guzman-Perez, Valentina; Bumke-Vogt, Christiane; Schreiner, Monika; Mewis, Inga; Borchert, Andrea; Pfeiffer, Andreas F. H.			Benzylglucosinolate Derived Isothiocyanate from Tropaeolum majus Reduces Gluconeogenic Gene and Protein Expression in Human Cells	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION PATHWAYS; TYPE-2 DIABETIC-PATIENTS; BLIND CLINICAL-TRIAL; HIGH-FAT DIET; OXIDATIVE STRESS; BROCCOLI SPROUTS; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; IN-VITRO	Nasturtium (Tropaeolum majus L.) contains high concentrations of benzylglcosinolate. We found that a hydrolysis product of benzyl glucosinolate-the benzyl isothiocyanate (BITC)modulates the intracellular localization of the transcription factor Forkhead box O 1 (FOXO1). FoxO transcription factors can antagonize insulin effects and trigger a variety of cellular processes involved in tumor suppression, longevity, development and metabolism. The current study evaluated the ability of BITC-extracted as intact glucosinolate from nasturtium and hydrolyzed with myrosinase-to modulate i) the insulin-signaling pathway, ii) the intracellular localization of FOXO1 and, iii) the expression of proteins involved in gluconeogenesis, antioxidant response and detoxification. Stably transfected human osteosarcoma cells (U-2 OS) with constitutive expression of FOXO1 protein labeled with GFP (green fluorescent protein) were used to evaluate the effect of BITC on FOXO1. Human hepatoma HepG2 cell cultures were selected to evaluate the effect on gluconeogenic, antioxidant and detoxification genes and protein expression. BITC reduced the phosphorylation of protein kinase B (AKT/PKB) and FOXO1; promoted FOXO1 translocation from cytoplasm into the nucleus antagonizing the insulin effect; was able to down-regulate the gene and protein expression of gluconeogenic enzymes; and induced the gene expression of antioxidant and detoxification enzymes. Knockdown analyses with specific siRNAs showed that the expression of gluconeogenic genes was dependent on nuclear factor (erythroid derived)-like2 (NRF2) and independent of FOXO1, AKT and NAD-dependent deacetylase sirtuin-1 (SIRT1). The current study provides evidence that BITC might have a role in type 2 diabetes T2D by reducing hepatic glucose production and increasing antioxidant resistance.	[Guzman-Perez, Valentina; Bumke-Vogt, Christiane; Borchert, Andrea; Pfeiffer, Andreas F. H.] German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany; [Guzman-Perez, Valentina] Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia; [Bumke-Vogt, Christiane; Pfeiffer, Andreas F. H.] Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Bumke-Vogt, Christiane; Schreiner, Monika; Mewis, Inga] Leibniz Inst Vegetable & Ornamental Crops Grossbe, Dept Plant Qual, Erfurt, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Pontificia Universidad Javeriana; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Guzman-Perez, V (corresponding author), German Inst Human Nutr, Dept Clin Nutr, Potsdam, Nuthetal, Germany.; Guzman-Perez, V (corresponding author), Pontificia Univ Javeriana, Fac Sci, Dept Biochem & Nutr, Bogota, Colombia.	vguzman@javeriana.edu.co	Guzmán-Pérez, Valentina/AAB-5471-2020; Pfeiffer, Andreas F.H./AAJ-2311-2020	Pfeiffer, Andreas F.H./0000-0002-6887-0016; Guzman-Perez, Valentina/0000-0002-6668-3161; Schreiner, Monika/0000-0002-5629-4429	"Investitionsbank Berlin" (IBB) [10140311]; "German Academic Exchange Service" (DAAD); Pontificia Universidad Javeriana Bogota DC (Colombia) [A/09/72490]	"Investitionsbank Berlin" (IBB); "German Academic Exchange Service" (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Pontificia Universidad Javeriana Bogota DC (Colombia)	CB-V was in part funded by "Investitionsbank Berlin" (IBB): http://www.ibb.de/Foerderangebote.aspx Project Titel: "Entwicklung einer biotechnologischen Methode zur Identifikation gesundheitlich vorteilhafter Pflanzeninhaltsstoffe zur Pravention von Diabetes Typ 2", Ref-No: 10140311. VG was funded by the "German Academic Exchange Service" (DAAD) and Pontificia Universidad Javeriana Bogota DC (Colombia): https://www.daad.de/de/index.html, Ref-No: A/09/72490, http://www.javeriana.edu.co/home. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2008, EUR J CLIN NUTR, V62, P324, DOI 10.1038/sj.ejcn.1602750; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Aleksunes LM, 2010, J PHARMACOL EXP THER, V333, P140, DOI 10.1124/jpet.109.162271; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Bahadoran Z, 2011, EUR J CLIN NUTR, V65, P972, DOI 10.1038/ejcn.2011.59; Bahadoran Z, 2013, J MED FOOD, V16, P375, DOI 10.1089/jmf.2012.2559; Bahadoran Z, 2012, INT J FOOD SCI NUTR, V63, P767, DOI 10.3109/09637486.2012.665043; Bahadoran Z, 2012, DIABETES RES CLIN PR, V96, P348, DOI 10.1016/j.diabres.2012.01.009; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Bumke-Vogt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104321; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Cheng ZY, 2012, NAT MED, V18, P351, DOI 10.1038/nm.2694; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Clore JN, 2000, DIABETES, V49, P969, DOI 10.2337/diabetes.49.6.969; Davis R, 2009, ONCOL REP, V22, P1473, DOI 10.3892/or_00000589; Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hanschen FS, 2014, ANGEW CHEM INT EDIT, DOI [10.1002/anie, 10.1002/ijc.24555, DOI 10.1002/ANIE.2009/07/09]; Jiao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041168; Ju YH, 2014, INT J ONCOL, V44, P1284, DOI 10.3892/ijo.2014.2269; Kim DH, 2013, J DIABETES, V5, P233, DOI 10.1111/1753-0407.12027; King GL, 2004, HISTOCHEM CELL BIOL, V122, P333, DOI 10.1007/s00418-004-0678-9; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Krajka-Kuzniak V, 2015, J PHYSIOL BIOCHEM, V71, P227, DOI 10.1007/s13105-015-0401-4; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lacroix IME, 2014, MOL NUTR FOOD RES, V58, P61, DOI 10.1002/mnfr.201300223; Lippmann D, 2014, FOOD FUNCT, V5, P1073, DOI 10.1039/c3fo60676g; Liu BN, 2013, CELL BIOCHEM BIOPHYS, V66, P81, DOI 10.1007/s12013-012-9456-9; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Martins LAM, 2014, CELL BIOCHEM BIOPHYS, V68, P247, DOI 10.1007/s12013-013-9703-8; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Oh KJ, 2013, ARCH PHARM RES, V36, P189, DOI 10.1007/s12272-013-0018-5; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Roy SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025166; Schreiner M, 2009, INNOV FOOD SCI EMERG, V10, P93, DOI 10.1016/j.ifset.2008.10.001; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; Smith GR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011092; Soane L, 2010, J NEUROSCI RES, V88, P1355, DOI 10.1002/jnr.22307; Son TG, 2008, NEUROMOL MED, V10, P236, DOI 10.1007/s12017-008-8037-y; Steinbrecher A, 2009, INT J CANCER, V125, P2179, DOI 10.1002/ijc.24555; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Verkerk R, 2009, MOL NUTR FOOD RES, V53, pS219, DOI 10.1002/mnfr.200800065; Waterman C, 2015, MOL NUTR FOOD RES, V59, P1013, DOI 10.1002/mnfr.201400679; Waterman C, 2014, PHYTOCHEMISTRY, V103, P114, DOI 10.1016/j.phytochem.2014.03.028; Xiao D, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032597, 10.1371/journal.pone.0046874]; Yuan ZQ, 2008, SCIENCE, V319, P1665, DOI 10.1126/science.1152337; Yun H, 2014, FEBS J, V281, P4421, DOI 10.1111/febs.12949; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; Zhang YS, 2000, CARCINOGENESIS, V21, P1175, DOI 10.1093/carcin/21.6.1175; Zhu Y, 2013, ASIAN PAC J CANCER P, V14, P2607, DOI 10.7314/APJCP.2013.14.4.2607	67	27	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162397	10.1371/journal.pone.0162397	http://dx.doi.org/10.1371/journal.pone.0162397			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622707	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000030
J	Horwitz, V; Davidson, B; Stern, D; Trope, CG; Re'em, TT; Reich, R				Horwitz, Vered; Davidson, Ben; Stern, Dganit; Trope, Claes G.; Re'em, Tali Tavor; Reich, Reuven			Ezrin Is Associated with Disease Progression in Ovarian Carcinoma	PLOS ONE			English	Article							PREDICTS POOR-PROGNOSIS; EXPRESSION; P130CAS; PHOSPHORYLATION; PROTEINS; SRC; PHENOTYPE; INVASION; HEALTH; TUMOR	Objective Ezrin and p130Cas are structural proteins with an important role in signaling pathways and have been shown to promote cancer dissemination. We previously reportedon overexpression of both ezrin and p130Cas in breast carcinoma effusions compared to primary carcinomas. Since ovarian and breast carcinomas share the ability to disseminate by forming malignant effusions, we sought to study the role of these molecules in ovarian carcinoma (OC). Methods OC cell lines were cultured in two different 3-dimensional conditions, on alginate scaffolds and as spheroids, which served as models for solid tumor and malignant effusions, respectively. shRNA was used to reduce protein expression in the cells. The malignant potential was evaluated by chemo-invasion assay, branching capacity on Matrigel and rate of proliferation. Subsequently, clinical specimens of high-grade serous carcinoma effusions, ovarian tumors and solid metastases were analyzed for ezrin and p130Cas expression. Results Higher ezrin expression was found in cells composing the spheroids compared to their counterparts cultured on alginate scaffold and in clinical samples of malignant effusions compared to solid tumors. In addition, reduced Ezrin expression impaired the invasion ability and the branching capacity of OC cells to a greater extent than reduced p130Cas expression. However, ezrin and p130Cas expression in effusions was unrelated to clinical outcome. Conclusions The 3-dimensional cell cultures were found to mimic the different tumor sites and be applicable as a model. The in vitro results concur with the clinical specimen analysis, suggesting that in OC, the role of ezrin in disease progression is more pronounced than that of p130Cas.	[Horwitz, Vered; Stern, Dganit; Reich, Reuven] Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, Jerusalem, Israel; [Horwitz, Vered] Israel Inst Biol Res, Dept Pharmacol, Ness Ziona, Israel; [Davidson, Ben] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Davidson, Ben; Trope, Claes G.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Davidson, Ben] Norwegian Radium Hosp, Gynecol Oncol Oslo Univ Hosp, Oslo, Norway; [Re'em, Tali Tavor] Azrieli Coll Engn, Dept Pharmaceut Engn, Jerusalem, Israel; [Reich, Reuven] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, Jerusalem, Israel; [Reich, Reuven] Hebrew Univ Jerusalem, Adolf & Klara Brettler Ctr Res Mol Pharmacol & Th, Jerusalem, Israel	Hebrew University of Jerusalem; University of Oslo; University of Oslo; University of Oslo; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Reich, R (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Sch Pharm, Fac Med, Jerusalem, Israel.; Davidson, B (corresponding author), Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway.; Davidson, B (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.; Davidson, B (corresponding author), Norwegian Radium Hosp, Gynecol Oncol Oslo Univ Hosp, Oslo, Norway.; Reich, R (corresponding author), Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, Jerusalem, Israel.; Reich, R (corresponding author), Hebrew Univ Jerusalem, Adolf & Klara Brettler Ctr Res Mol Pharmacol & Th, Jerusalem, Israel.	bend@medisin.uio.no; reich@cc.huji.ac.il			Inger and John Fredriksen Foundation for Ovarian Cancer Research	Inger and John Fredriksen Foundation for Ovarian Cancer Research	This work was supported by Inger and John Fredriksen Foundation for Ovarian Cancer Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada M, 2014, BBA-MOL CELL BIOL L, V1841, P727, DOI 10.1016/j.bbalip.2013.07.002; Banerjee A K, 1994, Eur J Surg Oncol, V20, P33; Barrett A, 2013, CELL SIGNAL, V25, P766, DOI 10.1016/j.cellsig.2012.12.019; Bruce A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140506; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Catalano V, 2013, SEMIN CANCER BIOL, V23, P522, DOI 10.1016/j.semcancer.2013.08.007; Chen ZC, 2001, CANCER-AM CANCER SOC, V92, P3068, DOI 10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5; Cho A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00245; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Davidson B., 2011, SEROUS EFFUSIONSETIO, V47-68, P167; DIETERICH M, 1994, ACTA CYTOL, V38, P945; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Gschwantler-Kaulich D, 2013, CELL ONCOL, V36, P485, DOI 10.1007/s13402-013-0153-5; Guiro K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118724; Heiska L, 2011, ONCOGENE, V30, P4953, DOI 10.1038/onc.2011.207; Hempel N, 2013, MOL CANCER RES, V11, P303, DOI 10.1158/1541-7786.MCR-12-0478; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Jacob A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00004; Jin TF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-191; Kobel M, 2006, INT J GYNECOL PATHOL, V25, P121, DOI 10.1097/01.pgp.0000185410.39050.ac; Kong JN, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-520; Konstantinovsky S, 2012, CLIN EXP METASTAS, V29, P527, DOI 10.1007/s10585-012-9468-2; Konstantinovsky S, 2010, J ONCOL, V2010, DOI 10.1155/2010/969084; Li QC, 2012, TUMOR BIOL, V33, P1493, DOI 10.1007/s13277-012-0400-9; Miao Y, 2012, FOLIA HISTOCHEM CYTO, V50, P392, DOI [10.5603/FHC.2012.0053, 10.5603/11957]; Moilanen J, 2003, GYNECOL ONCOL, V90, P273, DOI 10.1016/S0090-8258(03)00262-2; Nick AM, 2011, JNCI-J NATL CANCER I, V103, P1596, DOI 10.1093/jnci/djr372; Nikonova AS, 2014, IUBMB LIFE, V66, P387, DOI 10.1002/iub.1282; Ohtani K, 1999, CANCER LETT, V147, P31, DOI 10.1016/S0304-3835(99)00272-4; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; Piao JJ, 2015, EXP MOL PATHOL, V98, P1, DOI 10.1016/j.yexmp.2014.11.003; Ren L, 2014, ADV EXP MED BIOL, V804, P181, DOI 10.1007/978-3-319-04843-7_10; Sandercock AM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0415-0; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tatullo M, 2016, INT J IMMUNOPATH PH, V29, P3, DOI 10.1177/0394632015617951; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THIGPEN JT, 1994, J CLIN ONCOL, V12, P1748, DOI 10.1200/JCO.1994.12.9.1748; Tornillo G, 2011, EUR J CELL BIOL, V90, P237, DOI 10.1016/j.ejcb.2010.09.002	40	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162502	10.1371/journal.pone.0162502	http://dx.doi.org/10.1371/journal.pone.0162502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622508	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000034
J	Raikova, R; Krutki, P; Celichowski, J				Raikova, Rositsa; Krutki, Piotr; Celichowski, Jan			A General Mathematical Algorithm for Predicting the Course of Unfused Tetanic Contractions of Motor Units in Rat Muscle	PLOS ONE			English	Article							MEDIAL GASTROCNEMIUS-MUSCLE; FORCE OUTPUT; SUMMATION; CAT; DECOMPOSITION; STIMULATION; ACTIVATION; PATTERNS; BEHAVIOR	An unfused tetanus of a motor unit (MU) evoked by a train of pulses at variable interpulse intervals is the sum of non-equal twitch-like responses to these stimuli. A tool for a precise prediction of these successive contractions for MUs of different physiological types with different contractile properties is crucial for modeling the whole muscle behavior during various types of activity. The aim of this paper is to develop such a general mathematical algorithm for the MUs of the medial gastrocnemius muscle of rats. For this purpose, tetanic curves recorded for 30 MUs (10 slow, 10 fast fatigue-resistant and 10 fast fatigable) were mathematically decomposed into twitch-like contractions. Each contraction was modeled by the previously proposed 6-parameter analytical function, and the analysis of these six parameters allowed us to develop a prediction algorithm based on the following input data: parameters of the initial twitch, the maximum force of a MU and the series of pulses. Linear relationship was found between the normalized amplitudes of the successive contractions and the remainder between the actual force levels at which the contraction started and the maximum tetanic force. The normalization was made according to the amplitude of the first decomposed twitch. However, the respective approximation lines had different specific angles with respect to the ordinate. These angles had different and non-overlapping ranges for slow and fast MUs. A sensitivity analysis concerning this slope was performed and the dependence between the angles and the maximal fused tetanic force normalized to the amplitude of the first contraction was approximated by a power function. The normalized MU contraction and half-relaxation times were approximated by linear functions depending on the normalized actual force levels at which each contraction starts. The normalization was made according to the contraction time of the first contraction. The actual force levels were calculated initially from the recorded tetanic curves and subsequently from the modeled curves obtained from the summation of all models of the preceding contractions (the so called "full prediction"). The preciseness of the prediction was verified by two coefficients estimating the error between the modeled and the experimentally recorded curves. The proposed approach was tested for 30 MUs from the database and for three additional MUs, not included in the initial set. It was concluded that this general algorithm can be successfully used for modeling of a unfused tetanus course of a single MU of fast and slow type.	[Raikova, Rositsa] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Sofia, Bulgaria; [Krutki, Piotr; Celichowski, Jan] Univ Sch Phys Educ, Dept Neurobiol, Poznan, Poland	Bulgarian Academy of Sciences	Raikova, R (corresponding author), Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Sofia, Bulgaria.	rosi.raikova@biomed.bas.bg	Raikova, Rositsa/S-5718-2017; Krutki, Piotr/W-4011-2018; Celichowski, Jan/R-1162-2018	Krutki, Piotr/0000-0003-4193-5171; Celichowski, Jan/0000-0002-0394-3309	Bulgarian Academy of Sciences; Polish Academy of Sciences	Bulgarian Academy of Sciences; Polish Academy of Sciences	This study was partly supported by a bilateral agreement between the Bulgarian Academy of Sciences and the Polish Academy of Sciences.	Adam A, 1998, J NEUROPHYSIOL, V80, P1373, DOI 10.1152/jn.1998.80.3.1373; Boe SG, 2005, MUSCLE NERVE, V31, P365, DOI 10.1002/mus.20266; BURKE RE, 1976, BRAIN RES, V109, P515, DOI 10.1016/0006-8993(76)90031-7; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Celichowski J, 2014, J NEUROPHYSIOL, V112, P3116, DOI 10.1152/jn.00895.2013; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; HENNIG R, 1987, ACTA PHYSIOL SCAND, V130, P133, DOI 10.1111/j.1748-1716.1987.tb08119.x; Jones KE, 2005, J NEUROPHYSIOL, V94, P2255, DOI 10.1152/jn.00430.2005; KANDA K, 1992, J PHYSIOL-LONDON, V448, P677, DOI 10.1113/jphysiol.1992.sp019064; Krutki P, 2008, J PHYSIOL PHARMACOL, V59, P85; Krutki P, 2006, ARCH ITAL BIOL, V144, P11; MacIntosh BR, 2007, J BIOMECH, V40, P1066, DOI 10.1016/j.jbiomech.2006.04.009; MASUDA T, 1991, J ELECTROMYOGR KINES, V1, P116, DOI 10.1016/1050-6411(91)90005-P; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; PARRY DJ, 1990, CAN J PHYSIOL PHARM, V68, P51, DOI 10.1139/y90-007; Raikova R, 2010, J BIOMECH, V43, P1546, DOI 10.1016/j.jbiomech.2010.01.034; Raikova R, 2007, J ELECTROMYOGR KINES, V17, P121, DOI 10.1016/j.jelekin.2006.01.005; Raikova R, 2016, COMPUT METHOD BIOMEC, V19, P763, DOI 10.1080/10255842.2015.1062090; Raikova R, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/625427; Ralkova R, 2008, J ELECTROMYOGR KINES, V18, P741, DOI 10.1016/j.jelekin.2007.02.010; STEIN RB, 1979, BRAIN RES, V175, P372, DOI 10.1016/0006-8993(79)91019-9; STEIN RB, 1981, J GEN PHYSIOL, V78, P277, DOI 10.1085/jgp.78.3.277; Tansey KE, 1996, J NEUROPHYSIOL, V75, P38, DOI 10.1152/jn.1996.75.1.38; Westergaard RH, 2011, J NEUROPHYSIOL, V85, P1777	25	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162385	10.1371/journal.pone.0162385	http://dx.doi.org/10.1371/journal.pone.0162385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622581	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000028
J	Sanchez-Munoz, G; de Andres, AL; Jimenez-Garcia, R; Carrasco-Garrido, P; Hernandez-Barrera, V; Pedraza-Serrano, F; Puente-Maestu, L; de Miguel-Diez, J				Sanchez-Munoz, Gema; Lopez de Andres, Ana; Jimenez-Garcia, Rodrigo; Carrasco-Garrido, Pilar; Hernandez-Barrera, Valentin; Pedraza-Serrano, Fernando; Puente-Maestu, Luis; de Miguel-Diez, Javier			Time Trends in Hospital Admissions for Bronchiectasis: Analysis of the Spanish National Hospital Discharge Data (2004 to 2013)	PLOS ONE			English	Article							ORPHAN; DIAGNOSIS; DISEASE	Objective To analyze changes in the incidence, diagnostic procedures, comorbidity, length of hospital stay (LOHS), costs and in-hospital mortality (IHM) for patients with bronchiectasis who were hospitalized in Spain over a 10-year period. Methods We included all admissions for patients diagnosed with bronchiectasis as primary or secondary diagnosis during 2004-2013. Results 282,207 patients were admitted to the study. After controlling for possible confounders, we observed a significant increase in the incidence of hospitalizations over the study period when bronchiectasis was a secondary diagnosis. When bronchiectasis was the primary diagnosis we observed a significant decline in the incidence. In all cases, this pathology was more frequent in males, and the average age and comorbidity increased significantly during the study period (p< 0.001). When bronchiectasis was the primary diagnosis, the most frequent secondary diagnosis was Pseudomonas aeruginosa infection. When bronchiectasis was the secondary diagnosis, the most frequent primary diagnosis was COPD. IHM was low, tending to decrease from 2004 to 2013 (p< 0.05). The average LOHS decreased significantly during the study period in both cases (p< 0.001). The mean cost per patient decreased in patients with bronchiectasis as primary diagnosis, but it increased for cases of bronchiectasis as secondary diagnosis (p< 0.001). Conclusions Our results reveal an increase in the incidence of hospital admissions for patients with bronchiectasis as a secondary diagnosis from 2004 to 2013, as opposed to cases of bronchiectasis as the primary diagnosis. Although the average age and comorbidity significantly increased over time, both IHM and average LOHS significantly decreased.	[Sanchez-Munoz, Gema; Pedraza-Serrano, Fernando; Puente-Maestu, Luis; de Miguel-Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Fac Med,Resp Dept, Madrid, Spain; [Lopez de Andres, Ana; Jimenez-Garcia, Rodrigo; Carrasco-Garrido, Pilar; Hernandez-Barrera, Valentin] Univ Rey Juan Carlos, Dept Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain	Complutense University of Madrid; General University Gregorio Maranon Hospital; Universidad Rey Juan Carlos	de Miguel-Diez, J (corresponding author), Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon IiSGM, Fac Med,Resp Dept, Madrid, Spain.	javier.miguel@salud.madrid.org	Lopez-de-Andres, Ana/D-4498-2019; Lopez-de-Andres, Ana/AAD-8703-2019; Jimenez-Garcia, Rodrigo/D-4953-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; de Miguel-Diez, Javier/0000-0003-4543-573X; Hernandez-Barrera, Valentin/0000-0001-5790-1959; Puente-Maestu, Luis/0000-0001-8501-0117				Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; [Anonymous], 2004, HOSP EP STAT 2002 20, P203; [Anonymous], POPULATION ESTIMATES; BARKER AF, 1988, AM REV RESPIR DIS, V137, P969, DOI 10.1164/ajrccm/137.4.969; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Donat Y, 2008, ARCH BRONCONEUMOL, V44, P60; Garcia MAM, 2005, ARCH BRONCONEUMOL, V41, P407; Garcia-Vidal C, 2009, EUR RESPIR J, V34, P1072, DOI 10.1183/09031936.00003309; Goeminne PC, 2016, EUR RESPIR J, V47, P10, DOI 10.1183/13993003.01567-2015; Goeminne PC, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-21; Instituto Nacional de la Salud, 2001, CONJ MIN BAS DAT HOS; Instituto Nacional de la Salud. CMBD Insalud, 2000, CMBD INS AN GRDS; Joish VN, 2013, APPL HEALTH ECON HEA, V11, P299, DOI 10.1007/s40258-013-0027-z; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lara B, 2011, ARCH BRONCONEUMOL, V47, P389, DOI 10.1016/j.arbres.2011.04.002; De Souza-Galvao ML, 2010, ARCH BRONCONEUMOL, V46, P8, DOI 10.1016/S0300-2896(10)70003-X; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Martinez-Garcia MA, 2013, AM J RESP CRIT CARE, V187, P823, DOI 10.1164/rccm.201208-1518OC; Ministerio de Empleo y Seguridad Social, EXPL EST CONJ MIN BA; National Cancer Institute, 2013, JOINP REGR PROGR VER; Patel IS, 2004, AM J RESP CRIT CARE, V170, P400, DOI 10.1164/rccm.200305-648OC; Quint JK, 2016, EUR RESPIR J, V47, P186, DOI 10.1183/13993003.01033-2015; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071109; Roberts HJ, 2010, RESP MED, V104, P981, DOI 10.1016/j.rmed.2010.02.022; Saynajakangas O, 1997, RESP MED, V91, P395, DOI 10.1016/S0954-6111(97)90251-1; Seitz AE, 2012, CHEST, V142, P432, DOI 10.1378/chest.11-2209; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Tsang KW, 2004, INT J TUBERC LUNG D, V8, P691; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Vendrell M, 2008, ARCH BRONCONEUMOL, V44, P629, DOI 10.1016/S1579-2129(08)60117-2; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed	32	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162282	10.1371/journal.pone.0162282	http://dx.doi.org/10.1371/journal.pone.0162282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622273	gold, Green Published, Green Submitted			2022-12-26	WOS:000383681000021
J	Azzouz, DF; Martin, GV; Arnoux, F; Balandraud, N; Martin, T; Dubucquoi, S; Hachulla, E; Farge-Bancel, D; Tiev, K; Cabane, J; Bardin, N; Chiche, L; Martin, M; Caillet, EC; Kanaan, SB; Harle, JR; Granel, B; Diot, E; Roudier, J; Auger, I; Lambert, NC				Azzouz, Doua F.; Martin, Gabriel V.; Arnoux, Fanny; Balandraud, Nathalie; Martin, Thierry; Dubucquoi, Sylvain; Hachulla, Eric; Farge-Bancel, Dominique; Tiev, Kiet; Cabane, Jean; Bardin, Nathalie; Chiche, Laurent; Martin, Marielle; Caillet, Eleonore C.; Kanaan, Sami B.; Harle, Jean Robert; Granel, Brigitte; Diot, Elisabeth; Roudier, Jean; Auger, Isabelle; Lambert, Nathalie C.			Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus	PLOS ONE			English	Article							ALLOGRAFT INFLAMMATORY FACTOR-1; SYSTEMIC-SCLEROSIS; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; REVISED CRITERIA; ANGIOGENESIS; ERYTHEMATOSUS	In a pilot ProtoArray analysis, we identified 6 proteins out of 9483 recognized by autoantibodies (AAb) from patients with systemic sclerosis (SSc). We further investigated the 6 candidates by ELISA on hundreds of controls and patients, including patients with Systemic Lupus Erythematosus (SLE), known for high sera reactivity and overlapping AAb with SSc. Only 2 of the 6 candidates, Ephrin type-B receptor 2 (EphB2) and Three prime Histone mRNA EXonuclease 1 (THEX1), remained significantly recognized by sera samples from SSc compared to controls (healthy or with rheumatic diseases) with, respectively, 34% versus 14% (P = 2.10(-4)) and 60% versus 28% (P = 3.10(-8)). Above all, EphB2 and THEX1 revealed to be mainly recognized by SLE sera samples with respectively 56%, (P = 2.10(-10)) and 82% (P = 5.10(-13)). As anti-EphB2 and anti-THEX1 AAb were found in both diseases, an epitope mapping was realized on each protein to refine SSc and SLE diagnosis. A 15-mer peptide from EphB2 allowed to identify 35% of SLE sera samples (N = 48) versus only 5% of any other sera samples (N = 157), including SSc sera samples. AAb titers were significantly higher in SLE sera (P< 0.0001) and correlated with disease activity (p< 0.02). We could not find an epitope on EphB2 protein for SSc neither on THEX1 for SSc or SLE. We showed that patients with SSc or SLE have AAb against EphB2, a protein involved in angiogenesis, and THEX1, a 3'-5' exoribonuclease involved in histone mRNA degradation. We have further identified a peptide from EphB2 as a specific and sensitive tool for SLE diagnosis.	[Azzouz, Doua F.; Martin, Gabriel V.; Arnoux, Fanny; Balandraud, Nathalie; Martin, Marielle; Caillet, Eleonore C.; Kanaan, Sami B.; Roudier, Jean; Auger, Isabelle; Lambert, Nathalie C.] INSERM, UMRs 1097, Parc Sci Luminy, Marseille, France; [Azzouz, Doua F.; Martin, Gabriel V.; Arnoux, Fanny; Martin, Marielle; Caillet, Eleonore C.; Kanaan, Sami B.; Granel, Brigitte; Lambert, Nathalie C.] Aix Marseille Univ, Marseille, France; [Balandraud, Nathalie; Roudier, Jean; Auger, Isabelle] Hop St Marguerite, AP HM, IML, Rhumatol, Marseille, France; [Martin, Thierry] Hop Univ Strasbourg, Serv Immunol Clin, Strasbourg, France; [Martin, Thierry] CNRS, UPR 3572, Strasbourg, France; [Dubucquoi, Sylvain] Ctr Hosp Reg & Univ Lille, Inst Immunol, Lille, France; [Dubucquoi, Sylvain] Univ Lille, EA 2686, Lille, France; [Hachulla, Eric] Hop Claude Huriez, Ctr Natl Reference Sclerodermie Syst, Serv Med Interne, Lille, France; [Farge-Bancel, Dominique] Hop St Louis, Serv Med Interne & Pathol Vasc, Paris, France; [Farge-Bancel, Dominique] Hop St Louis, INSERM, U697, Paris, France; [Tiev, Kiet; Cabane, Jean] Hop St Louis, Serv Med Interne, Paris, France; [Bardin, Nathalie; Granel, Brigitte] Fac Pharm Marseille, UMR S Endothelium Pathol Vasc & Cibles Therapeut, Marseille, France; [Chiche, Laurent; Harle, Jean Robert; Granel, Brigitte] Ctr Competence PACA Ouest Prise Charge Malad Auto, Pole Med Interne, AP HM, Marseille, France; [Chiche, Laurent] Aix Marseille Univ, CIML, INSERM, CNRS UMR7280, Marseille, France; [Diot, Elisabeth] CHU Bretonneau, Serv Med Interne, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Tours	Lambert, NC (corresponding author), INSERM, UMRs 1097, Parc Sci Luminy, Marseille, France.; Lambert, NC (corresponding author), Aix Marseille Univ, Marseille, France.	nathalie.lambert@inserm.fr	Balandraud, Nathalie/ABD-6012-2020; Bardin, Nathalie/AAL-3663-2020; Lambert, Nathalie C/P-6816-2016; roudier, jean/A-8654-2011; Dubucquoi, Sylvain/I-5756-2018; HACHULLA, ERIC/R-8488-2018; AUGER, ISABELLE/P-6294-2016	Balandraud, Nathalie/0000-0002-3839-0185; Bardin, Nathalie/0000-0003-3680-082X; Lambert, Nathalie C/0000-0001-5817-8686; roudier, jean/0000-0001-5435-8567; Dubucquoi, Sylvain/0000-0002-8962-3719; HACHULLA, ERIC/0000-0001-7432-847X; AUGER, ISABELLE/0000-0002-1414-8095; Martin, Thierry/0000-0002-2776-2641	Groupe Francophone de Recherche sur la Sclerodermie (GFRS); Association des sclerodermiques de France; Arthritis Fondation Courtin; Societe Francaise de Rhumatologie; INSERM; Association des Sclerodermiques de France (ASF)	Groupe Francophone de Recherche sur la Sclerodermie (GFRS); Association des sclerodermiques de France; Arthritis Fondation Courtin; Societe Francaise de Rhumatologie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association des Sclerodermiques de France (ASF)	This study was supported by the Groupe Francophone de Recherche sur la Sclerodermie (GFRS), the Association des sclerodermiques de France but also Arthritis Fondation Courtin and the Societe Francaise de Rhumatologie and the INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Groupe Francophone de Recherche sur la Sclerodermie (GFRS); Association des Sclerodermiques de France (ASF), Arthritis Fondation Courtin, Societe Francaise de Rhumatologie and the INSERM. We are thankful to all participating subjects, to the Filiere des Maladies Autoimmunes et Autoinflammatoires Rares (FAI2R) for clinical data sharing with the help of Sarahe Dehimat and finally to Elisabeth Eynier for all the administrative management.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Alkassab F, 2007, RHEUMATOLOGY, V46, P1248, DOI 10.1093/rheumatology/kem057; Allanore Y, 2007, CLASSIFICATION EVALU; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Avouac J, 2011, RHEUMATOLOGY, V50, P1494, DOI 10.1093/rheumatology/keq448; Charpin C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3165; Cieslik Pawel, 2008, Pol Arch Med Wewn, V118, P57; Congi L, 2010, CLIN EXP RHEUMATOL, V28, P304; Del Galdo F, 2006, ARTHRITIS RHEUM-US, V54, P2616, DOI 10.1002/art.22010; Elhai M, 2016, ANN RHEUM DIS, V75, P163, DOI 10.1136/annrheumdis-2014-206386; Hachulla E, 2011, CLIN REV ALLERG IMMU, V40, P78, DOI 10.1007/s12016-010-8198-y; Ho KT, 2003, ARTHRITIS RES THER, V5, P80, DOI 10.1186/ar628; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hummers LK, 2009, J RHEUMATOL, V36, P576, DOI 10.3899/jrheum.080516; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mehra S, 2013, AUTOIMMUN REV, V12, P340, DOI 10.1016/j.autrev.2012.05.011; Nihtyanova SI, 2010, NAT REV RHEUMATOL, V6, P112, DOI 10.1038/nrrheum.2009.238; Otieno FG, 2007, TISSUE ANTIGENS, V69, P583, DOI 10.1111/j.1399-0039.2007.00830.x; PETERSON LS, 1995, MAYO CLIN PROC, V70, P1068, DOI 10.4065/70.11.1068; Reveille JD, 2006, AUTOIMMUN REV, V5, P389, DOI 10.1016/j.autrev.2005.10.012; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Sobanski V, 2014, ARTHRITIS RHEUMATOL, V66, P407, DOI 10.1002/art.38219; Song YC, 2008, EUR J IMMUNOL, V38, P3178, DOI 10.1002/eji.200838678; Sun KH, 2001, RHEUMATOLOGY, V40, P750, DOI 10.1093/rheumatology/40.7.750; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Thomas MF, 2014, TRENDS GENET, V30, P298, DOI 10.1016/j.tig.2014.05.003; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Walker UA, 2007, ANN RHEUMATIC DIS; Yang XC, 2006, J BIOL CHEM, V281, P30447, DOI 10.1074/jbc.M602947200; Zeidler H, 2011, ANN RHEUM DIS, V70, P1, DOI 10.1136/ard.2010.135889	33	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0160283	10.1371/journal.pone.0160283	http://dx.doi.org/10.1371/journal.pone.0160283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617966	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100003
J	Kurikawa, T; Kaneko, K				Kurikawa, Tomoki; Kaneko, Kunihiko			Dynamic Organization of Hierarchical Memories	PLOS ONE			English	Article							SPONTANEOUS CORTICAL ACTIVITY; NEURAL-NETWORKS; FINE INFORMATION; VISUAL-CORTEX; SENSORY INPUT; PATTERNS; NEURONS; STATES; MODEL	In the brain, external objects are categorized in a hierarchical way. Although it is widely accepted that objects are represented as static attractors in neural state space, this view does not take account interaction between intrinsic neural dynamics and external input, which is essential to understand how neural system responds to inputs. Indeed, structured spontaneous neural activity without external inputs is known to exist, and its relationship with evoked activities is discussed. Then, how categorical representation is embedded into the spontaneous and evoked activities has to be uncovered. To address this question, we studied bifurcation process with increasing input after hierarchically clustered associative memories are learned. We found a "dynamic categorization"; neural activity without input wanders globally over the state space including all memories. Then with the increase of input strength, diffuse representation of higher category exhibits transitions to focused ones specific to each object. The hierarchy of memories is embedded in the transition probability from one memory to another during the spontaneous dynamics. With increased input strength, neural activity wanders over a narrower state space including a smaller set of memories, showing more specific category or memory corresponding to the applied input. Moreover, such coarse-to-fine transitions are also observed temporally during transient process under constant input, which agrees with experimental findings in the temporal cortex. These results suggest the hierarchy emerging through interaction with an external input underlies hierarchy during transient process, as well as in the spontaneous activity.	[Kurikawa, Tomoki] RIKEN Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama 3510198, Japan; [Kaneko, Kunihiko] Univ Tokyo, Res Ctr Complex Syst Biol, Meguro Ku, Tokyo 1538902, Japan; [Kurikawa, Tomoki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan	RIKEN; University of Tokyo; Japan Society for the Promotion of Science	Kurikawa, T (corresponding author), RIKEN Brain Sci Inst, Lab Neural Circuit Theory, Wako, Saitama 3510198, Japan.; Kurikawa, T (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan.	tomoki.kurikawa@riken.jp			Ministry of Education, Culture, Sports, Science and Techonology and Japan society for the promotion of science [4103, 255431]; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science and Techonology and Japan society for the promotion of science; Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	The work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Neural creativity for communication (No. 4103)" and KAKENHI No. 255431 from The Ministry of Education, Culture, Sports, Science and Techonology and Japan society for the promotion of science, URL: https://www.jsps.go.jp/english/e-grants/, the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from Japan Agency for Medical Research and Development (AMED).	Abbott LF, 2009, INTERACTIONS INTRINS, P1; AMARI SI, 1977, BIOL CYBERN, V26, P175, DOI 10.1007/BF00365229; Amit Daniel J., 1992, MODELING BRAIN FUNCT; BACCI S, 1990, J PHYS A-MATH GEN, V23, P1801, DOI 10.1088/0305-4470/23/10/020; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Cartling B, 1996, BIOL CYBERN, V74, P63, DOI 10.1007/BF00199138; CORTES C, 1987, J PHYS A-MATH GEN, V20, P4449, DOI 10.1088/0305-4470/20/13/044; Dayan P, 2001, COMPUTATIONAL NEUROS; Deco G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002395; Engel A., 1990, PHYS REV A, V42; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Fusi S, 2002, BIOL CYBERN, V87, P459, DOI 10.1007/s00422-002-0356-8; Goldberg JA, 2004, NEURON, V42, P489, DOI 10.1016/S0896-6273(04)00197-7; GUTFREUND H, 1988, PHYS REV A, V37, P570, DOI 10.1103/PhysRevA.37.570; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kurikawa T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002943; Kurikawa T, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/48002; Luczak A, 2013, J NEUROSCI, V33, P1684, DOI 10.1523/JNEUROSCI.2928-12.2013; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Marre O, 2009, J NEUROSCI, V29, P14596, DOI 10.1523/JNEUROSCI.0753-09.2009; Matsumoto N, 2005, J COMPUT NEUROSCI, V18, P85, DOI 10.1007/s10827-005-5476-4; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Ohl FW, 2001, NATURE, V412, P733, DOI 10.1038/35089076; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Siri B, 2008, NEURAL COMPUT, V20, P2937, DOI 10.1162/neco.2008.05-07-530; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Toya K, 2000, J PHYS A-MATH GEN, V33, P2725, DOI 10.1088/0305-4470/33/14/308; VIRASORO MA, 1988, EUROPHYS LETT, V7, P293, DOI 10.1209/0295-5075/7/4/002; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162640	10.1371/journal.pone.0162640	http://dx.doi.org/10.1371/journal.pone.0162640			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618549	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100037
J	Sakai, S; Tanimoto, K; Imbe, A; Inaba, Y; Shishikura, K; Tanimoto, Y; Ushiroyama, T; Terasaki, J; Hanafusa, T				Sakai, Satoshi; Tanimoto, Keiji; Imbe, Ayumi; Inaba, Yuiko; Shishikura, Kanako; Tanimoto, Yoshimi; Ushiroyama, Takahisa; Terasaki, Jungo; Hanafusa, Toshiaki			Decreased beta-Cell Function Is Associated with Reduced Skeletal Muscle Mass in Japanese Subjects without Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; OLDER PERSONS; SECRETION; AGE; MELLITUS; HEALTH; INDIVIDUALS; SENSITIVITY; POPULATION; METABOLISM	Background Decreased insulin secretion has a great impact on the incidence of type 2 diabetes in Japanese subjects. It is not clear whether beta-cell function is related to muscle mass in subjects without diabetes. We investigated the relationship between beta-cell function and skeletal muscle mass in Japanese subjects without diabetes. Methods The study included 1098 subjects (538 men and 560 women) aged 40 to 79 years, without diabetes (fasting glucose lower than 126 mg/dL and glycosylated hemoglobin lower than 6.5%), who consulted Osaka Medical College Health Science Clinic for a medical examination. Appendicular muscle mass was measured by bioelectrical impedance analysis. Appendicular muscle mass index was calculated as appendicular muscle mass divided by height squared (kg/m(2)). The homeostatic model assessment of beta-cell function was used to assess beta-cell function. The homeostatic model assessment of insulin resistance was used as a measure of insulin resistance. The association between appendicular muscle mass index and clinical parameters of beta-cell function and insulin resistance was examined. Results Log-transformed homeostatic model assessment of beta-cell function and Log-transformed homeostatic model assessment of insulin resistance showed a normal distribution. In both men and women, there was a significant positive correlation between appendicular muscle mass index and clinical parameters of beta-cell function and insulin resistance. Tertile analysis, following stratification according to appendicular muscle mass index, found that low appendicular muscle mass index was significantly associated with the Log homeostatic model assessment of beta-cell function and Log-transformed homeostatic model assessment of insulin resistance. Conclusion This study shows that decreased beta cell function is associated with reduced skeletal muscle mass in Japanese subjects without diabetes.	[Sakai, Satoshi; Tanimoto, Keiji; Imbe, Ayumi; Inaba, Yuiko; Shishikura, Kanako; Tanimoto, Yoshimi; Terasaki, Jungo; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 5698686, Japan; [Ushiroyama, Takahisa] Osaka Med Coll, Hlth Sci Clin, Takatsuki, Osaka 5691121, Japan	Osaka Medical College; Osaka Medical College	Tanimoto, K (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka 5698686, Japan.	in1120@osaka-med.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [26860424]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 26860424.	Anbalagan VP, 2013, DIABETES TECHNOL THE, V15, P768, DOI 10.1089/dia.2013.0068; Bolanowski M, 2001, Med Sci Monit, V7, P1029; Chiu KC, 2000, CLIN ENDOCRINOL, V53, P569, DOI 10.1046/j.1365-2265.2000.01132.x; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Fujita S, 2007, DIABETES, V56, P1615, DOI 10.2337/db06-1566; Fukushima M, 2004, METABOLISM, V53, P831, DOI 10.1016/j.metabol.2004.02.012; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; Iozzo P, 1999, J CLIN ENDOCR METAB, V84, P863, DOI 10.1210/jc.84.3.863; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Katsanos CS, 2006, AM J PHYSIOL-ENDOC M, V291, pE381, DOI 10.1152/ajpendo.00488.2005; Katsuta H, 2015, ENDOCR J, V62, P485, DOI 10.1507/endocrj.EJ14-0611; Lee SW, 2015, DIABETES METAB J, V39, P37, DOI 10.4093/dmj.2015.39.1.37; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Li CL, 2003, DIABETES RES CLIN PR, V59, P225, DOI 10.1016/S0168-8227(02)00249-8; Metter EJ, 1999, J GERONTOL A-BIOL, V54, pB207, DOI 10.1093/gerona/54.5.B207; Morimoto A, 2013, DIABETOLOGIA, V56, P1671, DOI 10.1007/s00125-013-2932-y; Nagasaka S, 2007, DIABETES CARE, V30, pe43; Nagasaka Shoichiro, 2007, Diabetes Care, V30, pe43, DOI 10.2337/dc07-0016; Oya J, 2014, INTERNAL MED, V53, P941, DOI 10.2169/internalmedicine.53.1580; POLONSKY K, 1983, J CLIN INVEST, V72, P1114, DOI 10.1172/JCI111036; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Shishikura K, 2014, ENDOCR J, V61, P281, DOI 10.1507/endocrj.EJ13-0375; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Tanaka KI, 2015, CALCIF TISSUE INT; Tanimoto Y, 2013, GERIATR GERONTOL INT, V13, P958, DOI 10.1111/ggi.12037; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	31	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162603	10.1371/journal.pone.0162603	http://dx.doi.org/10.1371/journal.pone.0162603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612202	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900131
J	Martella, A; Sepe, RM; Silvestri, C; Zang, JJ; Fasano, G; Carnevali, O; De Girolamo, P; Neuhauss, SCF; Sordino, P; Di Marzo, V				Martella, Andrea; Sepe, Rosa M.; Silvestri, Cristoforo; Zang, Jingjing; Fasano, Giulia; Carnevali, Oliana; De Girolamo, Paolo; Neuhauss, Stephan C. F.; Sordino, Paolo; Di Marzo, Vincenzo			Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish	FASEB JOURNAL			English	Article						CB1; DAGL; MAGL; 2-arachidonoylglycerol; axonal pathfinding	LONG-TERM PLASTICITY; CANNABINOID RECEPTOR; LARVAL ZEBRAFISH; AXONAL GROWTH; MESSENGER-RNA; NITRIC-OXIDE; DANIO-RERIO; BRAIN; SYSTEM; ANANDAMIDE	The developmental role of the endocannabinoid system still remains to be fully understood. Here, we report the presence of a complete endocannabinoid system during zebrafish development and show that the genes that code for enzymes that catalyze the anabolism and catabolism (mgll and dagla) of the endocannabinoid, 2-AG (2-arachidonoylglycerol), as well as 2-AG main receptor in the brain, cannabinoid receptor type 1, are coexpressed in defined regions of axonal growth. By using morpholino-induced transient knockdown of the zebrafish Dagl alpha homolog and its pharmacologic rescue, we suggest that synthesis of 2-AG is implicated in the control of axon formation in the midbrain-hindbrain region and that animals that lack Dagl alpha display abnormal physiological behaviors in tests that measure stereotyped movement and motion perception. Our results suggest that the well-established role for 2-AG in axonal outgrowth has implications for the control of vision and movement in zebrafish and, thus, is likely common to all vertebrates.	[Martella, Andrea; Silvestri, Cristoforo; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy; [Sepe, Rosa M.; Fasano, Giulia; Sordino, Paolo] Staz Zool Anton Dohrn, Biol & Evolut Marine Organisms, I-80121 Naples, Italy; [Zang, Jingjing; Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Carnevali, Oliana] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [De Girolamo, Paolo] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Stazione Zoologica Anton Dohrn di Napoli; University of Zurich; Marche Polytechnic University; University of Naples Federico II	Sordino, P (corresponding author), Staz Zool Anton Dohrn, Biol & Evolut Marine Organisms, I-80121 Naples, Italy.; Di Marzo, V (corresponding author), CNR, Inst Biomol Chem, Via Campi Flegrei,34 Comprensorio Olivetti, I-80078 Pozzuoli, Italy.	paolo.sordino@szn.it; vdimarzo@icb.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019; Silvestri, Cristoforo/Y-2504-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Silvestri, Cristoforo/0000-0001-5635-1545; Martella, Andrea/0000-0002-4680-7702; de girolamo, paolo/0000-0003-1557-4763	Progetto Operativo Nazionale Grant [PONa3_00239]; Italian Ministry of Education, University and Research (MIUR) [RBFR12QW4I]; University of Naples "Federico II" Ph.D. fellowship; University of Sannio Ph.D. fellowship	Progetto Operativo Nazionale Grant; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Naples "Federico II" Ph.D. fellowship; University of Sannio Ph.D. fellowship	The authors thank Luigi Ippolito (Stazione Zoologica Anton Dohrn) for contributing to the early stages of the project, Fabiana Piscitelli for help with LC-MS analyses, and Enrico D'Aniello (both from the Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche) for critical reading of the manuscript. This work was supported by Progetto Operativo Nazionale Grant PONa3_00239, and a Fondo Italiano Ricerca di Base Grant RBFR12QW4I from the Italian Ministry of Education, University and Research (MIUR) (to P.S.), and a University of Naples "Federico II" Ph.D. fellowship (to R.M.S.) and a University of Sannio Ph.D. fellowship (to G.F.). P.S. and V.D.M. share senior authorship. The authors declare no conflicts of interest.	Alpar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5421; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Bisogno T, 1997, BBA-LIPID LIPID MET, V1345, P338, DOI 10.1016/S0005-2760(97)00009-X; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2007, PHARMACOL RES, V56, P428, DOI 10.1016/j.phrs.2007.09.002; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Brustein E, 2003, J PHYSIOL-PARIS, V97, P77, DOI 10.1016/j.jphysparis.2003.10.009; Cecyre B, 2013, INVEST OPHTH VIS SCI, V54, P8079, DOI 10.1167/iovs.13-12514; Cottone E, 2005, J COMP NEUROL, V485, P293, DOI 10.1002/cne.20502; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; El Manira A, 2010, PHYSIOLOGY, V25, P230, DOI 10.1152/physiol.00007.2010; Elphick MR, 2012, PHILOS T R SOC B, V367, P3201, DOI 10.1098/rstb.2011.0394; Elphick Maurice R., 2009, P123, DOI 10.1007/978-1-59745-503-9_5; Fride E, 2001, EUR J PHARMACOL, V419, P207, DOI 10.1016/S0014-2999(01)00953-0; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Godlewski G, 2009, PROSTAG OTH LIPID M, V89, P105, DOI 10.1016/j.prostaglandins.2009.07.001; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Haug MF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-8; Heap LA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00053; Jung KM, 2011, MOL PHARMACOL, V80, P60, DOI 10.1124/mol.110.070458; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Keimpema E, 2013, P NATL ACAD SCI USA, V110, P1935, DOI 10.1073/pnas.1212563110; Keimpema E, 2010, J NEUROSCI, V30, P13992, DOI 10.1523/JNEUROSCI.2126-10.2010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kyriakatos A, 2007, J NEUROSCI, V27, P12664, DOI 10.1523/JNEUROSCI.3174-07.2007; Lam CS, 2006, NEUROSCIENCE, V138, P83, DOI 10.1016/j.neuroscience.2005.10.069; Lindsay SM, 2004, CHEM SENSES, V29, P93, DOI 10.1093/chemse/bjh009; Maccarrone M, 2004, TRENDS PHARMACOL SCI, V25, P353, DOI 10.1016/j.tips.2004.05.002; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; McPartland JM, 2007, MOL GENET GENOMICS, V277, P555, DOI 10.1007/s00438-007-0207-3; McPartland JM, 2006, GENE, V370, P64, DOI 10.1016/j.gene.2005.11.004; Mechoulam R, 2006, INT J OBESITY, V30, pS24, DOI 10.1038/sj.ijo.0803274; Migharini B, 2009, MOL CELL ENDOCRINOL, V299, P172, DOI 10.1016/j.mce.2008.11.014; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Ryskamp Daniel A, 2014, Cells, V3, P914, DOI 10.3390/cells3030914; Sanudo-Pena MC, 2000, EUR J PHARMACOL, V391, P269, DOI 10.1016/S0014-2999(00)00044-3; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; Soderstrom K, 2001, J PHARMACOL EXP THER, V297, P189; Song JR, 2012, J NEUROSCI, V32, P5097, DOI 10.1523/JNEUROSCI.5850-11.2012; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Valenti M, 2005, J NEUROCHEM, V95, P662, DOI 10.1111/j.1471-4159.2005.03406.x; Wang X, 2003, NEUROSCIENCE, V118, P681, DOI 10.1016/S0306-4522(03)00020-4; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Williams EJ, 2003, J CELL BIOL, V160, P481, DOI 10.1083/jcb.200210164; Yoneda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053082; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	59	19	19	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4275	4288		10.1096/fj.201600602R	http://dx.doi.org/10.1096/fj.201600602R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27623930				2022-12-26	WOS:000388201500032
J	Lu, ZY; Reddy, MVVVS; Liu, JF; Kalichava, A; Liu, JK; Zhang, L; Chen, F; Wang, Y; Holthauzen, LMF; White, MA; Seshadrinathan, S; Zhong, XY; Ren, G; Rudenko, G				Lu, Zhuoyang; Reddy, M. V. V. V. Sekhar; Liu, Jianfang; Kalichava, Ana; Liu, Jiankang; Zhang, Lei; Chen, Fang; Wang, Yun; Holthauzen, Luis Marcelo F.; White, Mark A.; Seshadrinathan, Suchithra; Zhong, Xiaoying; Ren, Gang; Rudenko, Gabby			Molecular Architecture of Contactin-associated Protein-like 2 (CNTNAP2) and Its Interaction with Contactin 2 (CNTN2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell surface receptor; protein-protein interaction; structural biology; synapse; contactin; contactin-associated protein like; neuropsychiatric disorders; single particle analysis; synaptic organizer	NEGATIVE-STAINING PROTOCOL; MYELINATED AXONS; EXTRACELLULAR DOMAIN; ELECTRON-MICROSCOPY; SYNAPTIC CLEFT; CASPR2; SPECTRUM; REVEALS; VISUALIZATION; ABNORMALITIES	Contactin-associated protein-like 2 (CNTNAP2) is a large multidomain neuronal adhesion molecule implicated in a number of neurological disorders, including epilepsy, schizophrenia, autism spectrum disorder, intellectual disability, and language delay. We reveal here by electron microscopy that the architecture of CNTNAP2 is composed of a large, medium, and small lobe that flex with respect to each other. Using epitope labeling and fragments, we assign the F58C, L1, and L2 domains to the large lobe, the FBG and L3 domains to the middle lobe, and the L4 domain to the small lobe of the CNTNAP2 molecular envelope. Our data reveal that CNTNAP2 has a very different architecture compared with neurexin 1, a fellow member of the neurexin superfamily and a prototype, suggesting that CNTNAP2 uses a different strategy to integrate into the synaptic protein network. We show that the ectodomains of CNTNAP2 and contactin 2 (CNTN2) bind directly and specifically, with low nanomolar affinity. We show further that mutations in CNTNAP2 implicated in autism spectrum disorder are not segregated but are distributed over the whole ectodomain. The molecular shape and dimensions of CNTNAP2 place constraints on how CNTNAP2 integrates in the cleft of axo-glial and neuronal contact sites and how it functions as an organizing and adhesive molecule.	[Lu, Zhuoyang; Liu, Jianfang; Zhang, Lei; Ren, Gang] Lawrence Berkeley Natl Lab, Mol Foundry, Rm 2220,1 Cyclotron Rd,MS 67R2206, Berkeley, CA 94720 USA; [Lu, Zhuoyang; Liu, Jiankang] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Key Lab Biomed Informat Engn, Minist Educ,Sch Life Sci & Technol, Xian 710049, Peoples R China; [Lu, Zhuoyang; Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Peoples R China; [Reddy, M. V. V. V. Sekhar; Kalichava, Ana; Seshadrinathan, Suchithra; Zhong, Xiaoying; Rudenko, Gabby] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA; [Reddy, M. V. V. V. Sekhar; Kalichava, Ana; Holthauzen, Luis Marcelo F.; White, Mark A.; Seshadrinathan, Suchithra; Zhong, Xiaoying; Rudenko, Gabby] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA; [White, Mark A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Chen, Fang; Wang, Yun] Univ Michigan, Ann Arbor, MI 48109 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Xi'an Jiaotong University; Xi'an Jiaotong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Michigan System; University of Michigan	Ren, G (corresponding author), Lawrence Berkeley Natl Lab, Mol Foundry, Rm 2220,1 Cyclotron Rd,MS 67R2206, Berkeley, CA 94720 USA.; Rudenko, G (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.; Rudenko, G (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.	gren@lbl.gov; garudenk@utmb.edu	Rudenko, Gabrielle (Gabby)/O-7938-2018; Reddy, M. V. V. V. Sekhar/I-1093-2019; Liu, Jiankang/A-1610-2011; Ren, Gang/B-1567-2012; M, Sekharreddy/C-9428-2014; White, Mark Andrew/B-1723-2012; Zhang, Lei/G-6427-2012	Rudenko, Gabrielle (Gabby)/0000-0002-7372-0530; Ren, Gang/0000-0002-8036-2321; White, Mark Andrew/0000-0003-1057-4203; Zhang, Lei/0000-0002-4880-824X; manukonda, veera/0000-0002-9917-8778; Liu, Jianfang/0000-0001-6786-8873	NIMH, National Institutes of Health [R01MH077303]; Sealy Center for Structural Biology and Molecular Biophysics (University of Texas Medical Branch); Brain and Behavior Research Foundation; United States Department of Energy [DE-AC02-05CH11231]; National Basic Research Program of the Ministry of Science and Technology, China [2015CB553602]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077303] Funding Source: NIH RePORTER	NIMH, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sealy Center for Structural Biology and Molecular Biophysics (University of Texas Medical Branch); Brain and Behavior Research Foundation; United States Department of Energy(United States Department of Energy (DOE)); National Basic Research Program of the Ministry of Science and Technology, China; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH, National Institutes of Health, Grant R01MH077303 with additional support provided by the Sealy Center for Structural Biology and Molecular Biophysics (University of Texas Medical Branch) and the Brain and Behavior Research Foundation (to G. Rudenko). Work at the Molecular Foundry (G. Ren) was supported by the United States Department of Energy under Contract DE-AC02-05CH11231. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the National Basic Research Program of the Ministry of Science and Technology, China (Grant 2015CB553602).	Al-Murrani A, 2012, CASE REP GENET, V2012, DOI DOI 10.1155/2012/172408; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Anderson GR, 2012, P NATL ACAD SCI USA, V109, P18120, DOI 10.1073/pnas.1216398109; Arroyo EJ, 2001, CELL TISSUE RES, V305, P53, DOI 10.1007/s004410100403; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Banerjee S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025926; Becker EBE, 2012, J NEUROL NEUROSUR PS, V83, P437, DOI 10.1136/jnnp-2011-301506; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chen N, 2015, BBA-PROTEINS PROTEOM, V1854, P827, DOI 10.1016/j.bbapap.2015.02.008; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; de Arce KP, 2015, NEURON, V88, P1165, DOI 10.1016/j.neuron.2015.11.011; Faivre-Sarrailh C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00196; Falivelli G, 2012, HUM MOL GENET, V21, P4761, DOI 10.1093/hmg/dds320; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gdalyahu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125633; Gregor A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-106; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; High Brigit, 2015, Front Synaptic Neurosci, V7, P9, DOI 10.3389/fnsyn.2015.00009; Irani SR, 2012, ANN NEUROL, V72, P241, DOI 10.1002/ana.23577; Irani SR, 2012, ARQ NEURO-PSIQUIAT, V70, P300, DOI 10.1590/S0004-282X2012000400015; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Lancaster E, 2011, ANN NEUROL, V69, P303, DOI 10.1002/ana.22297; Linsalata AE, 2014, J COMP NEUROL, V522, P921, DOI 10.1002/cne.23453; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Melzer N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-160; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Murdoch JD, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004852; Nans A, 2011, J NEUROSCI RES, V89, P310, DOI 10.1002/jnr.22561; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Olsen AL, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000127; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinatel D, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00265, 10.3389/fncel.2015.00265]; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Rodenas-Cuadrado P, 2014, EUR J HUM GENET, V22, P171, DOI 10.1038/ejhg.2013.100; Rubio-Marrero EN, 2016, J BIOL CHEM, V291, P5788, DOI 10.1074/jbc.M115.705681; Salzer JL, 2008, GLIA, V56, P1532, DOI 10.1002/glia.20750; Sampath S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077906; Savvaki M, 2010, J NEUROSCI, V30, P13943, DOI 10.1523/JNEUROSCI.2574-10.2010; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Varea O, 2015, P NATL ACAD SCI USA, V112, P6176, DOI 10.1073/pnas.1423205112; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030249, 10.1371/journal.pone.0030592]; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102; Zweier C, 2011, MOL SYNDROMOL, V2, P181, DOI 10.1159/000331270; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	64	32	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24133	24147		10.1074/jbc.M116.748236	http://dx.doi.org/10.1074/jbc.M116.748236			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27621318	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000388498100029
J	Habeck, M; Tokhtaeva, E; Nadav, Y; Ben Zeev, E; Ferris, SP; Kaufman, RJ; Bab-Dinitz, E; Kaplan, JH; Dada, LA; Farfel, Z; Tal, DM; Katz, A; Sachs, G; Vagin, O; Karlish, SJD				Habeck, Michael; Tokhtaeva, Elmira; Nadav, Yotam; Ben Zeev, Efrat; Ferris, Sean P.; Kaufman, Randal J.; Bab-Dinitz, Elizabeta; Kaplan, Jack H.; Dada, Laura A.; Farfel, Zvi; Tal, Daniel M.; Katz, Adriana; Sachs, George; Vagin, Olga; Karlish, Steven J. D.			Selective Assembly of Na,K-ATPase alpha(2)beta(2) Heterodimers in the Heart DISTINCT FUNCTIONAL PROPERTIES AND ISOFORM-SELECTIVE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CARDIAC NA/K ATPASE; NA+/K+-ATPASE; PICHIA-PASTORIS; K-ATPASE; ADHESION MOLECULE; CRYSTAL-STRUCTURE; ALPHA-2 ISOFORM; BETA-SUBUNIT; INTRAOCULAR-PRESSURE	The Na, K-ATPase alpha(2) subunit plays a key role in cardiac muscle contraction by regulating intracellular Ca2+, whereas alpha(1) has a more conventional role of maintaining ion homeostasis. The beta subunit differentially regulates maturation, trafficking, and activity of alpha-beta heterodimers. It is not known whether the distinct role of alpha(2) in the heart is related to selective assembly with a particular one of the three beta isoforms. We show here by immunofluorescence and co-immunoprecipitation that alpha(2) is preferentially expressed with beta(2) in T-tubules of cardiac myocytes, forming alpha(2)beta(2) heterodimers. We have expressed human alpha(1)beta(1), alpha(2)beta(1), alpha(2)beta(2), and alpha(2)beta(3) in Pichia pastoris, purified the complexes, and compared their functional properties. alpha(2)beta(2) and alpha(2)beta(3) differ significantly from both alpha(2)beta(1) and alpha(1)beta(1) in having a higher K0.5K+ and lower K0.5Na+ for activating Na, K-ATPase. These features are the result of a large reduction in binding affinity for extracellular K+ and shift of the E1P-E2P conformational equilibrium toward E1P. A screen of perhydro-1,4-oxazepine derivatives of digoxin identified several derivatives (e.g. cyclobutyl) with strongly increased selectivity for inhibition of alpha(2)beta(2) and alpha(2)beta(3) over alpha(1)beta(1) (range 22-33-fold). Molecular modeling suggests a possible basis for isoform selectivity. The preferential assembly, specific T-tubular localization, and low K+ affinity of alpha(2)beta(2) could allow an acute response to raised ambient K+ concentrations in physiological conditions and explain the importance of alpha(2)beta(2) for cardiac muscle contractility. The high sensitivity of alpha(2)beta(2) to digoxin derivatives explains beneficial effects of cardiac glycosides for treatment of heart failure and potential of alpha(2)beta(2)-selective digoxin derivatives for reducing cardiotoxicity.	[Bab-Dinitz, Elizabeta; Farfel, Zvi; Tal, Daniel M.; Katz, Adriana; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biomol Sci, IL-7610001 Rehovot, Israel; [Ben Zeev, Efrat] Weizmann Inst Sci, Israel Natl Ctr Personalized Med, IL-7610001 Rehovot, Israel; [Farfel, Zvi] Tel Aviv Univ, Sch Med, IL-6997801 Tel Aviv, Israel; [Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; [Tokhtaeva, Elmira; Sachs, George; Vagin, Olga] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Ferris, Sean P.; Kaufman, Randal J.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaplan, Jack H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Dada, Laura A.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Ferris, Sean P.] Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,Hlth Sci West 451,Box 0102, San Francisco, CA 94143 USA; [Kaufman, Randal J.] Sanford Burnham Prebys Med Discovery Inst, Rm 7103,10901 N Torrey Pines Rd, La Jolla, CA 92037 USA	Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; Sanford Burnham Prebys Medical Discovery Institute	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-7610001 Rehovot, Israel.; Vagin, O (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA.; Vagin, O (corresponding author), Vet Adm Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA.	olgav@ucla.edu; Steven.Karlish@weizmann.ac.il		Habeck, Michael/0000-0002-4586-0499	Israel Science Foundation [789/12]; US-Israel Binational Science Foundation [711993]; National Institutes of Health [R37-HL48129, RO1HL113350]; USVA [2I01BX001006, 1RO1DK105156-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113350, R37HL048129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001006] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USVA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Israel Science Foundation (789/12) and US-Israel Binational Science Foundation (711993, to S. J. D. K.) and, in part, by National Institutes of Health Grants R37-HL48129 (to L. A. D.), RO1HL113350 (to L. A. D. and O. V.), USVA 2I01BX001006 (to G. S.), and 1RO1DK105156-01 (to G. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Berry RG, 2007, CARDIOVASC RES, V73, P92, DOI 10.1016/j.cardiores.2006.11.006; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BLANCO G, 1995, BIOCHEMISTRY-US, V34, P319, DOI 10.1021/bi00001a039; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Chan KE, 2010, J AM SOC NEPHROL, V21, P1550, DOI 10.1681/ASN.2009101047; Cirri E, 2011, BIOCHEMISTRY-US, V50, P3736, DOI 10.1021/bi2001714; Clausen T, 2008, AM J PHYSIOL-ENDOC M, V295, pE727, DOI 10.1152/ajpendo.90494.2008; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Correll RN, 2014, CIRC RES, V114, P249, DOI 10.1161/CIRCRESAHA.114.302293; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2007, AM J PHYSIOL-CELL PH, V293, pC321, DOI 10.1152/ajpcell.00597.2006; Despa S, 2012, CARDIOVASC RES, V95, P480, DOI 10.1093/cvr/cvs213; DiFranco M, 2015, J GEN PHYSIOL, V146, P281, DOI 10.1085/jgp.201511407; Dostanic I, 2005, AM J PHYSIOL-HEART C, V288, pH477, DOI 10.1152/ajpheart.00083.2004; EAKLE KA, 1994, J BIOL CHEM, V269, P6550; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; FORBUSH B, 1983, CURR TOP MEMBR TRANS, V19, P167; Gatto C, 1998, J BIOL CHEM, V273, P10578, DOI 10.1074/jbc.273.17.10578; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; Hoffman B. K., 1985, PHARMACOL BASIS THER, P716; Howie J, 2013, BIOCHEM SOC T, V41, P95, DOI 10.1042/BST20120269; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Juhaszova M, 1997, ANN NY ACAD SCI, V834, P524, DOI 10.1111/j.1749-6632.1997.tb52310.x; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; Katz A, 2015, P NATL ACAD SCI USA, V112, P13723, DOI 10.1073/pnas.1514569112; Katz A, 2014, J BIOL CHEM, V289, P21153, DOI 10.1074/jbc.M114.557629; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Larsen BR, 2014, GLIA, V62, P608, DOI 10.1002/glia.22629; Laursen M, 2015, P NATL ACAD SCI USA, V112, P1755, DOI 10.1073/pnas.1422997112; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Loreaux EL, 2008, J AM SOC NEPHROL, V19, P1947, DOI 10.1681/ASN.2008020174; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTSENKO S, 1993, BIOCHEMISTRY-US, V32, P6737, DOI 10.1021/bi00077a029; McDonough AA, 1996, AM J PHYSIOL-CELL PH, V270, pC1221, DOI 10.1152/ajpcell.1996.270.4.C1221; Mishra NK, 2015, J BIOL CHEM, V290, P28746, DOI 10.1074/jbc.M115.687913; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Pavlovic D, 2013, J MOL CELL CARDIOL, V61, P83, DOI 10.1016/j.yjmcc.2013.05.002; Rindler TN, 2011, AM J PHYSIOL-HEART C, V301, pH1396, DOI 10.1152/ajpheart.00121.2011; SCHMALZING G, 1992, J BIOL CHEM, V267, P20212; Schwinger RHG, 2003, CARDIOVASC RES, V57, P913, DOI 10.1016/S0008-6363(02)00767-8; Shattock MJ, 2015, J PHYSIOL-LONDON, V593, P1361, DOI 10.1113/jphysiol.2014.282319; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Stanley CM, 2015, BIOPHYS J, V109, P1852, DOI 10.1016/j.bpj.2015.09.015; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; SWEADNER KJ, 1994, CIRC RES, V74, P669, DOI 10.1161/01.RES.74.4.669; Swift F, 2007, CARDIOVASC RES, V75, P109, DOI 10.1016/j.cardiores.2007.03.017; Tal DM, 2016, MAGN RESON CHEM, V54, P260, DOI 10.1002/mrc.4380; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2007, J BIOENERG BIOMEMBR, V39, P367, DOI 10.1007/s10863-007-9103-0; Vagin O, 2007, CELL BIOCHEM BIOPHYS, V47, P376, DOI 10.1007/s12013-007-0033-6; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yang EH, 2012, AM J MED, V125, P337, DOI 10.1016/j.amjmed.2011.09.019	76	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23159	23174		10.1074/jbc.M116.751735	http://dx.doi.org/10.1074/jbc.M116.751735			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624940	hybrid, Green Published			2022-12-26	WOS:000387224800026
J	Guo, HT; Huo, HW; Yu, Q				Guo, Haitao; Huo, Hongwei; Yu, Qiang			SMCis: An Effective Algorithm for Discovery of Cis-Regulatory Modules	PLOS ONE			English	Article							MOTIF DISCOVERY; BINDING SITES; IDENTIFICATION; PREDICTION; ALIGNMENTS; DROSOPHILA; CLUSTERS; REGIONS; MODELS	The discovery of cis-regulatory modules (CRMs) is a challenging problem in computational biology. Limited by the difficulty of using an HMM to model dependent features in transcriptional regulatory sequences (TRSs), the probabilistic modeling methods based on HMMs cannot accurately represent the distance between regulatory elements in TRSs and are cumbersome to model the prevailing dependencies between motifs within CRMs. We propose a probabilistic modeling algorithm called SMCis, which builds a more powerful CRM discovery model based on a hidden semi-Markov model. Our model characterizes the regulatory structure of CRMs and effectively models dependencies between motifs at a higher level of abstraction based on segments rather than nucleotides. Experimental results on three benchmark datasets indicate that our method performs better than the compared algorithms.	[Guo, Haitao; Huo, Hongwei; Yu, Qiang] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China	Xidian University	Huo, HW (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	hwhuo@mail.xidian.edu.cn	Huo, Hongwei/AAM-1200-2020		National Natural Science Foundation of China [61173025, 61373044, 61502366]; China Postdoctoral Science Foundation [2015M582621]; Fundamental Research Funds for the Central Universities [JB150306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by the National Natural Science Foundation of China under Grant 61173025, 61373044, and 61502366, the China Postdoctoral Science Foundation under Grant 2015M582621, and the Fundamental Research Funds for the Central Universities under Grant JB150306. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2003, BIOINFORMATICS, V19, pII5, DOI 10.1093/bioinformatics/btg1052; Alkema WBL, 2004, NUCLEIC ACIDS RES, V32, pW195, DOI 10.1093/nar/gkh387; Arnold P, 2012, BIOINFORMATICS, V28, P487, DOI 10.1093/bioinformatics/btr695; Bilmes JA, 2006, IEICE T INF SYST, VE89D, P869, DOI 10.1093/ietisy/e89-d.3.869; Chan BY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-262; Davidson EH, 2006, REG GEN GEN REG; Fariselli P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S12; Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gan YL, 2014, IEEE ACM T COMPUT BI, V11, P73, DOI 10.1109/TCBB.2013.131; Gonzalez S, 2012, BIOINFORMATICS, V28, P763, DOI 10.1093/bioinformatics/bts024; Guns T, 2010, 2010 IEEE INT C BIOI; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hardison RC, 2012, NAT REV GENET, V13, P469, DOI 10.1038/nrg3242; Klepper K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-123; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Kulakovskiy I. V., 2009, Biophysics, V54, P667, DOI 10.1134/S0006350909060013; Lin TH, 2008, LECT N BIOINFORMAT, V4955, P66; Liu X, 2001, Pac Symp Biocomput, P127; Lott SE, 2007, P NATL ACAD SCI USA, V104, P10926, DOI 10.1073/pnas.0701359104; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mitchison, 1998, BIOLOGICAL SEQUENCE; Navarro C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108065; Nikulova AA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks235; Ostendorf M, 1996, IEEE T SPEECH AUDI P, V4, P360, DOI 10.1109/89.536930; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rouault H, 2014, NUCLEIC ACIDS RES, V42, P6128, DOI 10.1093/nar/gku209; Shaw WM, 1997, INFORM PROCESS MANAG, V33, P1, DOI 10.1016/S0306-4573(96)00043-X; Sinha S, 2007, PLOS COMPUT BIOL, V3, P2175, DOI 10.1371/journal.pcbi.0030216; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Su J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001020; Suryamohan K, 2015, WIRES DEV BIOL, V4, P59, DOI 10.1002/wdev.168; Thompson JA, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1022, DOI 10.1109/CEC.2014.6900542; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Van Loo P, 2009, BRIEF BIOINFORM, V10, P509, DOI 10.1093/bib/bbp025; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Yu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048442; Yu SZ, 2010, ARTIF INTELL, V174, P215, DOI 10.1016/j.artint.2009.11.011; Zambelli F, 2013, BRIEF BIOINFORM, V14, P225, DOI 10.1093/bib/bbs016; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	45	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162968	10.1371/journal.pone.0162968	http://dx.doi.org/10.1371/journal.pone.0162968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637070	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700021
J	Ayouni, S; Estienney, M; Hammami, S; Guediche, MN; Pothier, P; Aouni, M; Belliot, G; de Rougemont, A				Ayouni, Siwar; Estienney, Marie; Hammami, Sabeur; Guediche, Mohamed Neji; Pothier, Pierre; Aouni, Mahjoub; Belliot, Gael; de Rougemont, Alexis			Cosavirus, Salivirus and Bufavirus in Diarrheal Tunisian Infants	PLOS ONE			English	Article							REVERSE-TRANSCRIPTION-PCR; HUMAN ASTROVIRUSES; ENTERIC VIRUSES; GASTROENTERITIS; ROTAVIRUS; CHILDREN; IDENTIFICATION; KLASSEVIRUS; PICORNAVIRIDAE; INFECTIONS	Three newly discovered viruses have been recently described in diarrheal patients: Cosavirus (CosV) and Salivirus (SalV), two picornaviruses, and Bufavirus (BuV), a parvovirus. The detection rate and the role of these viruses remain to be established in acute gastroenteritis (AGE) in diarrheal Tunisian infants. From October 2010 through March 2012, stool samples were collected from 203 children < 5 years-old suffering from AGE and attending the Children's Hospital in Monastir, Tunisia. All samples were screened for CosV, SalV and BuV as well as for norovirus (NoV) and group A rotavirus (RVA) by molecular biology. Positive samples for the three screened viruses were also tested for astrovirus, sapovirus, adenovirus, and Aichi virus, then genotyped when technically feasible. During the study period, 11 (5.4%) samples were positive for one of the three investigated viruses: 2 (1.0%) CosV-A10, 7 (3.5%) SalV-A1 and 2 (1.0%) BuV-1, whereas 71 (35.0%) children were infected with NoV and 50 (24.6%) with RVA. No mixed infections involving the three viruses were found, but multiple infections with up to 4 classic enteric viruses were found in all cases. Although these viruses are suspected to be responsible for AGE in children, our data showed that this association was uncertain since all infected children also presented infections with several enteric viruses, suggesting here potential water-borne transmission. Therefore, further studies with large cohorts of healthy and diarrheal children will be needed to evaluate their clinical role in AGE.	[Ayouni, Siwar; Estienney, Marie; Pothier, Pierre; Belliot, Gael; de Rougemont, Alexis] CHU Dijon, Ctr Natl Reference Virus Enter, Lab Virol Serol, Pole Tech Biol, Dijon, France; [Ayouni, Siwar; Aouni, Mahjoub] Univ Monastir, Fac Pharm, Monastir, Tunisia; [Hammami, Sabeur; Guediche, Mohamed Neji] Hop Univ Fattouma Bourguiba, Serv Pediat, Monastir, Tunisia; [Hammami, Sabeur; Guediche, Mohamed Neji] Univ Monastir, Fac Med, Monastir, Tunisia; [Pothier, Pierre; Belliot, Gael; de Rougemont, Alexis] Univ Bourgogne Franche Comte AgroSup Dijon, UMR PAM A Proc Alimentaires & Microbiol 02 102, Dijon, France	CHU Dijon Bourgogne; Universite de Monastir; Universite de Monastir; Hopital Fattouma Bourguiba; Universite de Monastir; Institut Agro; AgroSup Dijon; Universite de Bourgogne	de Rougemont, A (corresponding author), CHU Dijon, Ctr Natl Reference Virus Enter, Lab Virol Serol, Pole Tech Biol, Dijon, France.; de Rougemont, A (corresponding author), Univ Bourgogne Franche Comte AgroSup Dijon, UMR PAM A Proc Alimentaires & Microbiol 02 102, Dijon, France.	alexis.de-rougemont@u-bourgogne.fr	de ROUGEMONT, Alexis/M-1090-2016; Belliot, Gaël/AAC-4649-2019	de ROUGEMONT, Alexis/0000-0002-3084-9414; BELLIOT, Gael/0000-0003-1161-9530	Campus France (PHC-UTIQUE program)	Campus France (PHC-UTIQUE program)	SA was awarded a fellowship from Campus France (PHC-UTIQUE program). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Siwar Ayouni was awarded a fellowship from Campus France (PHC-UTIQUE program). We would like to thank Philip Bastable for editorial assistance.	Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Altay A, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.06.006; Ayouni S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.015; Ayouni S, 2015, EMERG INFECT DIS, V21, P2055, DOI 10.3201/eid2111.141901; Boros A, 2016, ARCH VIROL, V161, P1671, DOI 10.1007/s00705-016-2824-9; Chieochansin T, 2015, ARCH VIROL, V160, P1781, DOI 10.1007/s00705-015-2441-z; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Dai XQ, 2010, J CLIN VIROL, V48, P228, DOI 10.1016/j.jcv.2010.03.024; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EuroRotaNet, 2009, EUR ROT DET TYP METH; GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992; Gomara MI, 2001, J CLIN MICROBIOL, V39, P3796, DOI 10.1128/JCM.39.10.3796-3798.2001; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Gutierrez-Aguirre I, 2008, J CLIN MICROBIOL, V46, P2547, DOI 10.1128/JCM.02428-07; Han TH, 2010, EMERG INFECT DIS, V16, P1623, DOI 10.3201/eid1610.100539; Holtz LR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-86; Huang DD, 2015, SCI REP-UK, V5, DOI 10.1038/srep13272; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; LeGuyader F, 1996, ARCH VIROL, V141, P2225, DOI 10.1007/BF01718228; Li LL, 2009, J VIROL, V83, P12002, DOI 10.1128/JVI.01241-09; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Noel JS, 1997, J MED VIROL, V52, P173, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;173::AID-JMV10&gt;3.0.CO;2-M; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Rezig D, 2015, J MED VIROL, V87, P940, DOI 10.1002/jmv.24076; Sdiri-Loulizi K, 2008, J CLIN MICROBIOL, V46, P1349, DOI 10.1128/JCM.02438-07; Shan TL, 2010, EMERG INFECT DIS, V16, P1303, DOI 10.3201/eid1608.100087; Smits SL, 2014, EMERG INFECT DIS, V20, P1218, DOI 10.3201/eid2007.140190; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Yahiro T, 2014, EMERG INFECT DIS, V20, P1037, DOI 10.3201/eid2006.131430; Yamashita T, 2000, J CLIN MICROBIOL, V38, P2955, DOI 10.1128/JCM.38.8.2955-2961.2000	36	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162255	10.1371/journal.pone.0162255	http://dx.doi.org/10.1371/journal.pone.0162255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631733	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900033
J	Durham, J; Warner, M; Phengsavanh, A; Sychareun, V; Vongxay, V; Rickart, K				Durham, Jo; Warner, Melissa; Phengsavanh, Alongkone; Sychareun, Vanphanom; Vongxay, Viengnakhone; Rickart, Keith			Stakeholder Analysis of Community Distribution of Misoprostol in Lao PDR: A Qualitative Study	PLOS ONE			English	Article							PREVENT POSTPARTUM HEMORRHAGE; HEALTH-SERVICES; OBSTETRIC CARE; COUNTRIES; FRAMEWORK; PAKISTAN; BIRTH; WOMEN	Background Globally, significant progress has been made in reducing maternal mortality, yet in many low-resource contexts it remains unacceptably high. Many of these deaths are due to postpartum haemorrhage and are preventable with access to essential obstetric care. Where there are barriers to access, maternal deaths could be prevented if community-level misoprostol was available. The purpose of this study was to explore perceptions of stakeholders regarding misoprostol use in the Lao People's Democratic Republic, a setting with high maternal mortality. Methods Semi-structured interviews were conducted with 35 stakeholders in the capital, Vientiane and in one northern province identified as a site for a possible intervention. The sample included international and national stakeholders involved in policy-making and providing maternal and reproductive health services. Findings Most stakeholders supported a pilot program for community distribution of misoprostol but levels of awareness of the drug's use in preventing postpartum haemorrhage and level of influence over policy direction varied considerably. Some international organizations, all identified as powerful in influencing policy, were ambivalent about the use of community distribution of misoprostol. Concerns related to the capacity of village health workers or lay people to safely administer misoprostol, whether its distribution would undermine efforts to improve access to safe delivery services and active management of the third stage of labour, the ease with which prescription drugs can be bought over the counter, and technical, logistical, and financial constraints. Conclusion Access to appropriate oxytocic drugs is a matter of health equity. In settings without access to essential obstetrical care, misoprostol represents a viable solution for the prevention of postpartum haemorrhage. Understanding stakeholders' perspectives and their legitimate concerns on misoprostol can inform interventions in order to assuage these concerns and enable disadvantaged women to access misoprostol and its potentially life-saving benefits.	[Durham, Jo; Warner, Melissa] Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld 4006, Australia; [Phengsavanh, Alongkone; Sychareun, Vanphanom; Vongxay, Viengnakhone] Univ Hlth Sci, Viangchan, Laos; [Rickart, Keith] Queensland Govt, Dept Hlth, Hlth Serv & Clin Innovat Div, Communicable Dis Unit,Chief Hlth Officer Branch, Brisbane, Qld 4006, Australia	University of Queensland; Queensland Health	Durham, J (corresponding author), Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld 4006, Australia.	m.durham@uq.edu.au	Durham, Jo/A-1977-2014	Durham, Jo/0000-0003-0544-9424				AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Akkhavong Kongsap Paphassarang C, 2014, HLTH SYSTEM REV; Blum J, 2010, LANCET, V375, P217, DOI 10.1016/S0140-6736(09)61923-1; Brugha R, 2000, HEALTH POLICY PLANN, V15, P239, DOI 10.1093/heapol/15.3.239; Bryman A., 2012, SOCIAL RES METHOD, V4th ed., P809; Buse K., 2012, MAKING HLTH POLICY; Carey G, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0207-6; Commission on information and accountability for Women's and Children's Health, 2000, KEEPING PROMISES MEA; Creswell J., 2009, RES DESIGN QUALITATI, V3; Douangphachanh X, 2010, BIOSCI TRENDS, V4, P318; Douangvichit Daovieng, 2012, Journal of the Medical Association of Thailand, V95, P1126; Ejembi C, 2010, PREVENTION OF POSTPA; Gynuity, 2006, POSTPARTUM HEMORRHAG; Hoa DT, 2012, BMC PUBLIC HEALTH, V12, P641, DOI [10.1186/1471-2458-12-641, DOI 10.1186/1471-2458-12-641]; Hyder A, 2010, PUBLIC HEALTH, V124, P159, DOI 10.1016/j.puhe.2009.12.006; Jacobs B, 2012, REPROD HEALTH MATTER, V20, P112, DOI 10.1016/S0968-8080(12)40649-8; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Lalonde A, 2012, INT J GYNECOL OBSTET, V117, P108, DOI 10.1016/j.ijgo.2012.03.001; Manithip C, 2013, MIDWIFERY, V29, P195, DOI 10.1016/j.midw.2011.12.010; Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740; Mertens DM, 2010, TRANSFORMATIVE RESEA; Mir AM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-120; Mobeen N, 2011, BJOG-INT J OBSTET GY, V118, P353, DOI 10.1111/j.1471-0528.2010.02807.x; MoH LSB/MPI MoES, 2012, LAO SOCIAL INDICATOR; National Institute of Statistics Directorate General for Health Macro, 2011, CAMBODIA DEMOGRAPHIC; Oladapo OT, 2012, INT J GYNECOL OBSTET, V119, P105, DOI 10.1016/j.ijgo.2012.08.004; Patton M.Q., 2008, ESSENTIALS UTILIZATI, V4th; Potts M, 2010, LANCET, V375, P459, DOI 10.1016/S0140-6736(10)60192-4; Prata N, 2013, HEALTH POLICY PLANN, V28, P339, DOI 10.1093/heapol/czs068; Rajbhandari S, 2010, INT J GYNECOL OBSTET, V108, P282, DOI 10.1016/j.ijgo.2009.11.006; Sanghvi H, 2010, INT J GYNECOL OBSTET, V108, P276, DOI 10.1016/j.ijgo.2009.12.003; Schmeer K., 1999, GUIDELINES FOR CONDU; Sihavong A, 2006, SEX TRANSM INFECT, V82, P182, DOI 10.1136/sti.2005.016352; Smith JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-44; Starrs A, 2012, INT J GYNECOL OBSTET, V116, P1, DOI 10.1016/j.ijgo.2011.10.005; Sychareun V, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-86; UNDP, 2012, COUNTRY ANALYSIS REP; Varvasovszky Z, 2000, HEALTH POLICY PLANN, V15, P338, DOI 10.1093/heapol/15.3.338; World Health Organization, 2012, WHO RECOMMENDATIONS; World Health Organization, 2014, MAT MORT; World Health Organization, 2014, THE COUNTRY COOPERAT	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162154	10.1371/journal.pone.0162154	http://dx.doi.org/10.1371/journal.pone.0162154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631089	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900029
J	Li, LL; Wang, PC; Chao, KH; Zhou, YT; Xie, Y				Li, Lingling; Wang, Pengchong; Chao, Kuei-Hsiang; Zhou, Yatong; Xie, Yang			Remaining Useful Life Prediction for Lithium-Ion Batteries Based on Gaussian Processes Mixture	PLOS ONE			English	Article							TIME-SERIES; PROGNOSTICS; FILTER	The remaining useful life (RUL) prediction of Lithium-ion batteries is closely related to the capacity degeneration trajectories. Due to the self-charging and the capacity regeneration, the trajectories have the property of multimodality. Traditional prediction models such as the support vector machines (SVM) or the Gaussian Process regression (GPR) cannot accurately characterize this multimodality. This paper proposes a novel RUL prediction method based on the Gaussian Process Mixture (GPM). It can process multimodality by fitting different segments of trajectories with different GPR models separately, such that the tiny differences among these segments can be revealed. The method is demonstrated to be effective for prediction by the excellent predictive result of the experiments on the two commercial and chargeable Type 1850 Lithium-ion batteries, provided by NASA. The performance comparison among the models illustrates that the GPM is more accurate than the SVM and the GPR. In addition, GPM can yield the predictive confidence interval, which makes the prediction more reliable than that of traditional models.	[Li, Lingling; Wang, Pengchong; Xie, Yang] Hebei Univ Technol, Prov Minist Joint Key Lab Electromagnet Field & E, Tianjin 300130, Peoples R China; [Li, Lingling; Chao, Kuei-Hsiang] Natl Chin Yi Univ Technol, Coll Elect Engn & Comp Sci, Taichung 41170, Taiwan; [Zhou, Yatong] Hebei Univ Technol, Sch Elect & Informat Engn, Tianjin 300130, Peoples R China	Hebei University of Technology; National Chin-Yi University of Technology; Hebei University of Technology	Chao, KH (corresponding author), Natl Chin Yi Univ Technol, Coll Elect Engn & Comp Sci, Taichung 41170, Taiwan.	zhengwentongzhi@126.com			National Natural Science Foundation of China [51475136]; Natural Science Foundation of Hebei Province of China [E2014202230]; Hebei Province Science and Technology Support Program [15212117]; University Innovation Team Leader Program of Hebei Province [LJRC003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Hebei Province Science and Technology Support Program; University Innovation Team Leader Program of Hebei Province	This work was supported by National Natural Science Foundation of China (Program No. 51475136), Lingling Li, http://www.nsfc.gov.cn/; Natural Science Foundation of Hebei Province of China (Program No. E2014202230), Lingling Li, http://www.hensf.gov.cn/; Hebei Province Science and Technology Support Program (Program No. 15212117), http://www.hebstd.gov.cn; and University Innovation Team Leader Program of Hebei Province (Program No. LJRC003), http://www.hee.gov.cn/.	Andre D, 2013, ENG APPL ARTIF INTEL, V26, P951, DOI 10.1016/j.engappai.2012.09.013; Bian MM, 2010, PROCEEDINGS OF 2010 INTERNATIONAL SYMPOSIUM ON IMAGE ANALYSIS AND SIGNAL PROCESSING, P1, DOI 10.1109/ICGPR.2010.5550226; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; [陈雄姿 Chen Xiongzi], 2013, [航空学报, Acta Aeronautica et Astronautica Sinica], V34, P2219; Chen Y, 2016, APPL SOFT COMPUT, V43, P357, DOI 10.1016/j.asoc.2016.02.045; Chen Y, 2013, ENERGIES, V6, P3082, DOI 10.3390/en6063082; Chen ZX, 2014, LECT NOTES COMP SCI, V98, P199, DOI 10.1007/978-3-319-05789-7_16; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; Goebel K, 2008, IEEE INSTRU MEAS MAG, V11, P33, DOI 10.1109/MIM.2008.4579269; He W, 2011, J POWER SOURCES, V196, P10314, DOI 10.1016/j.jpowsour.2011.08.040; Lazaro-Gredilla M, 2012, PATTERN RECOGN, V45, P1386, DOI 10.1016/j.patcog.2011.10.004; Liu Dan, 2012, Proceedings 2012 IEEE Symposium on Electrical & Electronics Engineering (EEESYM 2012), P1, DOI 10.1109/EEESym.2012.6258572; Liu Y, 2015, IEEE T RELIAB, V64, P1287, DOI 10.1109/TR.2015.2418294; Nguyen TV, 2014, PR MACH LEARN RES, V32; Nuhic A, 2013, J POWER SOURCES, V239, P680, DOI 10.1016/j.jpowsour.2012.11.146; Platanios EA, 2014, IEEE T PATTERN ANAL, V36, P888, DOI 10.1109/TPAMI.2013.183; Sun SL, 2013, INT CONF MACH LEARN, P1011, DOI 10.1109/ICMLC.2013.6890744; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Tayal A., 2012, P 26 ASS ADV ART INT, P1126; Zhou J., 2013, THESIS; Zhou YT, 2007, CHINESE PHYS LETT, V24, P42, DOI 10.1088/0256-307X/24/1/012; Zhou YT, 2006, LECT NOTES COMPUT SC, V4232, P513; Zhou ZW, 2014, PROGNOST SYST HEALT, P297, DOI 10.1109/PHM.2014.6988182	26	33	36	7	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163004	10.1371/journal.pone.0163004	http://dx.doi.org/10.1371/journal.pone.0163004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632176	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900115
J	Mester, T; Raychaudhuri, N; Gillespie, EF; Chen, H; Smith, TJ; Douglas, RS				Mester, Tuende; Raychaudhuri, Nupur; Gillespie, Erin F.; Chen, Hong; Smith, Terry J.; Douglas, Raymond S.			CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation	PLOS ONE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; ORBITAL FIBROBLASTS; GRAVES-DISEASE; CIRCULATING FIBROCYTES; RECEPTOR; CELLS; SUSCEPTIBILITY; MECHANISMS; GENERATION; FIBROSIS	Context Fibrocytes appear to participate in inflammation and tissue remodeling in patients with thyroid-associated ophthalmopathy (TAO). These patients have increased frequencies of circulating TSH receptor (TSHR)- and CD40-positive fibrocytes, suggesting TSHR and CD40 may play roles in proinflammatory cytokine production, which ultimately leads to orbital inflammation and tissue remodeling. Objective To investigate the potential interactions between the TSHR and CD40 signaling pathways and their roles in IL-6 and TNF-alpha production. Design and Outcome Measures CD40 expression on fibrocytes was assessed using flow cytometry; IL-6 and TNF-alpha protein release using Luminex technology; increased IL-6 and TNF-alpha mRNA abundance, using real-time PCR; TSH- and CD40 ligand (CD40L)-stimulated Akt phosphorylation in fibrocytes, by western blot analysis; TSHR-CD40 protein-protein interaction, using co-immunoprecipitation, and CD40-TSHR co-localization, using immunocytochemistry. Results TSH enhances CD40 expression at a pre-translational level in fibrocytes. Production of IL-6 and TNF-alpha after costimulation with TSH and CD40L was greater than that after TSH or CD40L stimulation alone. TSH and CD40L costimulation also resulted in greater Akt phosphorylation. Akt and nuclear factor (NF)-kappa B inhibitors significantly reduced cytokine production after TSH and CD40L costimulation. TSHR and CD40L are colocalized on the cell surface and forma complex. Conclusions TSHR and CD40 in fibrocytes appear to be physically and functionally related. TSH stimulates CD40 production on the fibrocyte surface. Cytokine expression upon simultaneous stimulation of TSHR and CD40 is greater than levels achieved with TSH or CD40L alone. Increased expression of CD40 by TSH is a potential mechanism for this process.	[Mester, Tuende; Raychaudhuri, Nupur; Gillespie, Erin F.; Chen, Hong; Smith, Terry J.; Douglas, Raymond S.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Chen, Hong] Huazhong Univ Sci & Technol, Dept Ophthalmol, Union Hosp, Coll Med, Wuhan 430022, Hubei, Peoples R China; [Smith, Terry J.] Univ Michigan, Sch Med, Internal Med, Ann Arbor, MI 48105 USA; [Douglas, Raymond S.] Ann Arbor Vet Adm Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; Huazhong University of Science & Technology; University of Michigan System; University of Michigan	Douglas, RS (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA.; Douglas, RS (corresponding author), Ann Arbor Vet Adm Med Ctr, Ann Arbor, MI 48105 USA.	raydougl@med.umich.edu	Gillespie, Erin/AAZ-8543-2021; Smith, Terry/ABG-1360-2020	Gillespie, Erin/0000-0002-1386-1542; Douglas, Raymond S./0000-0002-3435-8161; Smith, Terry/0000-0002-6279-9685	National Institutes of Health [EY008976, EY011708, DK063121, EY021197, EY007003]; Eye Core Grant; Bell Charitable Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY008976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye Core Grant; Bell Charitable Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health grants EY008976, EY011708, DK063121, EY021197, and EY007003; an Eye Core Grant; the Bell Charitable Foundation; and the following grants from Research to Prevent Blindness: a Career Development Award, a Lew Wasserman Merit Award, and a Physician Scientist Award.	Bahn RS, 2002, THYROID, V12, P193, DOI 10.1089/105072502753600124; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Buech TRH, 2008, J BIOL CHEM, V283, P20330, DOI 10.1074/jbc.M800211200; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; Chen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130322; Chen H, 2014, J CLIN ENDOCR METAB, V99, pE1635, DOI 10.1210/jc.2014-1580; Chesney J, 2000, Curr Rheumatol Rep, V2, P501, DOI 10.1007/s11926-000-0027-5; Dik WA, 2016, EXP EYE RES, V142, P83, DOI 10.1016/j.exer.2015.02.007; Douglas Raymond S, 2014, Trans Am Ophthalmol Soc, V112, P26; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; Foster N, 2012, J IMMUNOL, V189, P5632, DOI 10.4049/jimmunol.1202010; Galligan CL, 2010, RHEUMATOLOGY, V49, P640, DOI 10.1093/rheumatology/kep265; Gillespie EF, 2012, INVEST OPHTH VIS SCI, V53, P7746, DOI 10.1167/iovs.12-9861; Gillespie EF, 2012, J CLIN ENDOCR METAB, V97, pE740, DOI 10.1210/jc.2011-2514; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Kaufman J, 2004, J IMMUNOL, V172, P1862, DOI 10.4049/jimmunol.172.3.1862; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Li B, 2014, J CLIN ENDOCR METAB, V99, pE625, DOI 10.1210/jc.2013-3977; Liossis SNC, 2004, BIODRUGS, V18, P95, DOI 10.2165/00063030-200418020-00003; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Qi YC, 2014, CLIN ENDOCRINOL, V80, P128, DOI 10.1111/cen.12229; Raychaudhuri N, 2010, PLOS ONE, V5, DOI [10.1164/rccm.200810-1534OC, DOI 10.1164/RCCM.200810-1534OC]; Raychaudhuri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075100; SMITH BR, 1974, LANCET, V2, P427; Smith TJ, 2013, J CLIN ENDOCR METAB, V98, P515, DOI 10.1210/jc.2013-1004; Smith TJ, 2011, J CLIN ENDOCR METAB, V96, P3827, DOI 10.1210/jc.2011-1249; Tomer Y, 2010, THYROID, V20, P715, DOI 10.1089/thy.2010.1644; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Yamamoto K, 2012, THYROID, V22, P516, DOI 10.1089/thy.2011.0222; Yang DM, 1999, THYROID, V9, P305, DOI 10.1089/thy.1999.9.305	34	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162994	10.1371/journal.pone.0162994	http://dx.doi.org/10.1371/journal.pone.0162994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631497	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900111
J	Shitova, N; Roelofs, A; Schriefers, H; Bastiaansen, M; Schoffelen, JM				Shitova, Natalia; Roelofs, Ardi; Schriefers, Herbert; Bastiaansen, Marcel; Schoffelen, Jan-Mathijs			Using Brain Potentials to Functionally Localise Stroop-Like Effects in Colour and Picture Naming: Perceptual Encoding versus Word Planning	PLOS ONE			English	Article							TIME-COURSE ANALYSIS; SEMANTIC INTERFERENCE; COGNITIVE CONTROL; LEXICAL ACCESS; TEMPORAL COURSE; TASK; LANGUAGE; ERP; RESPONSES; CONFLICT	The colour-word Stroop task and the picture-word interference task (PWI) have been used extensively to study the functional processes underlying spoken word production. One of the consistent behavioural effects in both tasks is the Stroop-like effect: The reaction time (RT) is longer on incongruent trials than on congruent trials. The effect in the Stroop task is usually linked to word planning, whereas the effect in the PWI task is associated with either word planning or perceptual encoding. To adjudicate between the word planning and perceptual encoding accounts of the effect in PWI, we conducted an EEG experiment consisting of three tasks: a standard colour-word Stroop task (three colours), a standard PWI task (39 pictures), and a Stroop-like version of the PWI task (three pictures). Participants overtly named the colours and pictures while their EEG was recorded. A Stroop-like effect in RTs was observed in all three tasks. ERPs at centro-parietal sensors started to deflect negatively for incongruent relative to congruent stimuli around 350 ms after stimulus onset for the Stroop, Stroop-like PWI, and the Standard PWI tasks: an N400 effect. No early differences were found in the PWI tasks. The onset of the Stroop-like effect at about 350 ms in all three tasks links the effect to word planning rather than perceptual encoding, which has been estimated in the literature to be finished around 200-250 ms after stimulus onset. We conclude that the Stroop-like effect arises during word planning in both Stroop and PWI.	[Shitova, Natalia; Roelofs, Ardi; Schriefers, Herbert; Schoffelen, Jan-Mathijs] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Shitova, Natalia] Max Planck Inst Psycholinguist, Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Bastiaansen, Marcel] Acad Leisure, NHTV Breda Univ Appl Sci, Breda, Netherlands; [Schoffelen, Jan-Mathijs] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Breda University of Applied Sciences; Max Planck Society	Shitova, N (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.; Shitova, N (corresponding author), Max Planck Inst Psycholinguist, Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands.	n.shitova@donders.ru.nl	Schriefers, Herbert/D-8532-2012; Schoffelen, Jan-Mathijs/D-3716-2009; Roelofs, Ardi/A-5311-2010	Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Bastiaansen, Marcel/0000-0003-2865-7859	NWO [864.14.011]	NWO(Netherlands Organization for Scientific Research (NWO))	J-MS was funded by NWO (grant # 864.14.011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Ayora P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00057; Badzakova-Trajkov G, 2009, BRAIN RES, V1253, P139, DOI 10.1016/j.brainres.2008.11.069; Blackford T, 2012, COGNITION, V123, P84, DOI 10.1016/j.cognition.2011.12.007; Boersma Paul, 2002, GLOT INT, V5, P341; Damian MF, 1999, J EXP PSYCHOL LEARN, V25, P345, DOI 10.1037/0278-7393.25.2.345; De Houwer J, 2003, MEM COGNITION, V31, P353, DOI 10.3758/BF03194393; Dell GS, 2013, COGNITION, V128, P380, DOI 10.1016/j.cognition.2013.05.007; Dell'Acqua R, 2007, PSYCHON B REV, V14, P717, DOI 10.3758/BF03196827; Dell'Acqua R, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00177; Donohue SE, 2012, COGN AFFECT BEHAV NE, V12, P1, DOI 10.3758/s13415-011-0060-z; FAGOT C, 1992, J EXP PSYCHOL HUMAN, V18, P1058, DOI 10.1037/0096-1523.18.4.1058; Finkbeiner M, 2006, CORTEX, V42, P790, DOI 10.1016/S0010-9452(08)70419-2; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; GLASER MO, 1982, J EXP PSYCHOL HUMAN, V8, P875, DOI 10.1037/0096-1523.8.6.875; GLASER WR, 1989, J EXP PSYCHOL GEN, V118, P13, DOI 10.1037/0096-3445.118.1.13; GLASER WR, 1984, J EXP PSYCHOL HUMAN, V10, P640, DOI 10.1037/0096-1523.10.5.640; Hashimoto N, 2010, APHASIOLOGY, V24, P580, DOI 10.1080/02687030902777567; HOLCOMB PJ, 1993, LANG COGNITIVE PROC, V8, P379, DOI 10.1080/01690969308407583; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Janssen N, 2008, J EXP PSYCHOL LEARN, V34, P249, DOI 10.1037/0278-7393.34.1.249; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PASHLER H, 1984, J EXP PSYCHOL HUMAN, V10, P358, DOI 10.1037/0096-1523.10.3.358; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Piai V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088674; Piai V, 2014, J EXP PSYCHOL LEARN, V40, P147, DOI 10.1037/a0033745; Piai V, 2012, BRAIN RES, V1450, P87, DOI 10.1016/j.brainres.2012.02.050; Rapp B, 2000, PSYCHOL REV, V107, P460, DOI 10.1037/0033-295X.107.3.460; RAYNER K, 1986, BRIT J PSYCHOL, V77, P207, DOI 10.1111/j.2044-8295.1986.tb01995.x; Ries S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058197; Roelofs A, 2003, PSYCHOL REV, V110, P88, DOI 10.1037/0033-295X.110.1.88; ROELOFS A, 1992, J EXPT PSYCHOL LEARN, V42, P107, DOI DOI 10.1016/0010-0277(92)90041-F; Roelofs A, 2014, J EXP PSYCHOL LEARN, V40, P1332, DOI 10.1037/a0036575; Roelofs A, 2013, LANG COGNITIVE PROC, V28, P655, DOI 10.1080/01690965.2011.615663; ROSINSKI RR, 1975, CHILD DEV, V46, P247, DOI 10.2307/1128859; Schnur TT, 2012, PSYCHON B REV, V19, P301, DOI 10.3758/s13423-011-0190-x; SCHRIEFERS H, 1990, J MEM LANG, V29, P86, DOI 10.1016/0749-596X(90)90011-N; Seiger-Gardner L, 2008, INT J LANG COMM DIS, V43, P528, DOI 10.1080/13682820701768581; Thompson CK, 2012, BRAIN LANG, V120, P237, DOI 10.1016/j.bandl.2011.11.003; Ueno T, 2011, NEURON, V72, P385, DOI 10.1016/j.neuron.2011.09.013; van Casteren M, 2006, BEHAV RES METHODS, V38, P584, DOI 10.3758/BF03193889; van Maanen L, 2012, COGNITIVE SCI, V36, P62, DOI 10.1111/j.1551-6709.2011.01213.x; van Maanen L, 2009, PSYCHON B REV, V16, P987, DOI 10.3758/PBR.16.6.987; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Xiao X, 2010, NEUROREPORT, V21, P104, DOI 10.1097/WNR.0b013e32833499ff	52	11	11	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161052	10.1371/journal.pone.0161052	http://dx.doi.org/10.1371/journal.pone.0161052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27632171	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900015
J	Kaisaki, PJ; Cutts, A; Popitsch, N; Camps, C; Pentony, MM; Wilson, G; Page, S; Kaur, K; Vavoulis, D; Henderson, S; Gupta, A; Middleton, MR; Karydis, I; Talbot, DC; Schuh, A; Taylor, JC				Kaisaki, Pamela J.; Cutts, Anthony; Popitsch, Niko; Camps, Carme; Pentony, Melissa M.; Wilson, Gareth; Page, Suzanne; Kaur, Kulvinder; Vavoulis, Dimitris; Henderson, Shirley; Gupta, Avinash; Middleton, Mark R.; Karydis, Ioannis; Talbot, Denis C.; Schuh, Anna; Taylor, Jenny C.			Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for Diagnosis	PLOS ONE			English	Article							BIOPSY; HETEROGENEITY; TRIAL	Use of circulating tumour DNA (ctDNA) as a liquid biopsy has been proposed for potential identification and monitoring of solid tumours. We investigate a next-generation sequencing approach for mutation detection in ctDNA in two related studies using a targeted panel. The first study was retrospective, using blood samples taken from melanoma patients at diverse timepoints before or after treatment, aiming to evaluate correlation between mutations identified in biopsy and ctDNA, and to acquire a first impression of influencing factors. We found good concordance between ctDNA and tumour mutations of melanoma patients when blood samples were collected within one year of biopsy or before treatment. In contrast, when ctDNA was sequenced after targeted treatment in melanoma, mutations were no longer found in 9 out of 10 patients, suggesting the method might be useful for detecting treatment response. Building on these findings, we focused the second study on ctDNA obtained before biopsy in lung patients, i.e. when a tentative diagnosis of lung cancer had been made, but no treatment had started. The main objective of this prospective study was to evaluate use of ctDNA in diagnosis, investigating the concordance of biopsy and ctDNA-derived mutation detection. Here we also found positive correlation between diagnostic lung biopsy results and pre-biopsy ctDNA sequencing, providing support for using ctDNA as a cost-effective, non-invasive solution when the tumour is inaccessible or when biopsy poses significant risk to the patient.	[Kaisaki, Pamela J.; Popitsch, Niko; Camps, Carme; Pentony, Melissa M.; Wilson, Gareth; Kaur, Kulvinder; Vavoulis, Dimitris; Taylor, Jenny C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Kaisaki, Pamela J.; Popitsch, Niko; Camps, Carme; Pentony, Melissa M.; Wilson, Gareth; Kaur, Kulvinder; Vavoulis, Dimitris; Gupta, Avinash; Middleton, Mark R.; Karydis, Ioannis; Taylor, Jenny C.] NIHR Oxford BRC, Oxford, England; [Cutts, Anthony; Page, Suzanne; Vavoulis, Dimitris; Henderson, Shirley; Schuh, Anna] John Radcliffe Hosp, Oxford Univ Hosp, Natl Hlth Serv Translat Mol Diagnost Ctr, Biomed Res Ctr, Oxford, England; [Gupta, Avinash; Middleton, Mark R.; Karydis, Ioannis; Talbot, Denis C.] Univ Oxford, Churchill Hosp, Dept Oncol, Oxford, England; [Wilson, Gareth] Francis Crick Inst, London, England; [Kaur, Kulvinder] Millenium Hlth, San Diego, CA USA; [Karydis, Ioannis] Univ Southampton, Canc Sci Acad Unit, Southampton, Hants, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; Francis Crick Institute; University of Southampton	Kaisaki, PJ (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Kaisaki, PJ (corresponding author), NIHR Oxford BRC, Oxford, England.	pamela.kaisaki@well.ox.ac.uk	Herrero, Carlos Camps/L-3073-2017; wei, wei/HHR-8613-2022; Vavoulis, Dimitris/AAF-1690-2020	Herrero, Carlos Camps/0000-0002-0648-5403; Karydis, Ioannis/0000-0002-8308-3141; Anna, schuh/0000-0002-3938-8490; Karydis, Ioannis/0000-0003-0284-3549; Taylor, Jenny/0000-0003-3602-5704	Innovate UK [10809-62174]; National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust [090532/Z/09/Z]; Cancer Research UK [8466] Funding Source: researchfish	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust; University of Oxford; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK)	This study was supported by grants from: Technology Strategy Board (now called Innovate UK) (TP No: 10809-62174) (JCT and AS), https://www.gov.uk/government/organisations/innovate-uk; National Institute for Health Research Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford (JCT and AS), http://oxfordbrc.nihr.ac.uk/; The Wellcome Trust (090532/Z/09/Z) (JCT), http://www.wellcome.ac.uk/; Oxford Experimental Cancer Medicine Centre (MRM), http://www.ecmcnetwork.org.uk/. The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Brinza D, 2015, 106 ANN M AM ASS CAN; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Chang GA, 2016, MOL ONCOL, V10, P157, DOI 10.1016/j.molonc.2015.09.005; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Didelot A, 2012, EXP MOL PATHOL, V92, P275, DOI 10.1016/j.yexmp.2012.03.001; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Juratli MA, 2014, HEAD NECK-J SCI SPEC, V36, P1207, DOI 10.1002/hed.23439; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lebofsky R, 2015, MOL ONCOL, V9, P783, DOI 10.1016/j.molonc.2014.12.003; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Page K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077963; Patterson SE, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0061-7; Robertson EG, 2011, CLIN RADIOL, V66, P1007, DOI 10.1016/j.crad.2011.05.012; White HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045073; Xu S, 2016, CANCER LETT, V370, P324, DOI 10.1016/j.canlet.2015.11.005	23	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162809	10.1371/journal.pone.0162809	http://dx.doi.org/10.1371/journal.pone.0162809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626278	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600055
J	Warnke, P; Devide, A; Weise, M; Frickmann, H; Schwarz, NG; Schaffler, H; Ottl, P; Podbielski, A				Warnke, Philipp; Devide, Annette; Weise, Mirjam; Frickmann, Hagen; Schwarz, Norbert Georg; Schaeffler, Holger; Ottl, Peter; Podbielski, Andreas			Utilizing Moist or Dry Swabs for the Sampling of Nasal MRSA Carriers? An In Vivo and In Vitro Study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; INADEQUATE ANTIMICROBIAL TREATMENT; PORT-A-CUL; TRANSPORT-SYSTEMS; NEISSERIA-GONORRHOEAE; HOSPITAL ADMISSION; ANAEROBIC-BACTERIA; RAPID DETECTION; RECOVERY; RISK	This study investigates the quantitative bacterial recovery of Methicillin-resistant-Staphylococcus aureus (MRSA) in nasal screenings by utilizing dry or moistened swabs within an in vivo and an in vitro experimental setting. 135 nasal MRSA carriers were each swabbed in one nostril with a dry and in the other one with a moistened rayon swab. Quantitative bacterial recovery was measured by standard viable count techniques. Furthermore, an anatomically correct artificial nose model was inoculated with a numerically defined suspension of MRSA and swabbed with dry and moistened rayon, polyurethane-foam and nylon-flocked swabs to test these different settings and swab-materials under identical laboratory conditions. In vivo, quantities of MRSA per nostril in carriers varied between <10(1) and >10(7) colony forming units, with a median of 2.15x10(4) CFU. However, no statistically significant differences could be detected for the recovery of MRSA quantities when swabbing nasal carriers with moist or dry rayon swabs. In vitro testing confirmed the in vivo data for swabs with rayon, polyurethane and nylon-flocked tips, since pre-moistening of swabs did not significantly affect the quantities of retrieved bacteria. Therefore, pre-moistening of swabs prior to nasal MRSA sampling provides no advantage in terms of recovering greater bacterial quantities and therefore can be omitted. In addition, this situation can be mimicked in an in vitro model, thereby providing a useful basis for future in vitro testings of new swab types or target organisms for screening approaches.	[Warnke, Philipp; Devide, Annette; Weise, Mirjam; Frickmann, Hagen; Podbielski, Andreas] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Frickmann, Hagen] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Schwarz, Norbert Georg] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Hamburg, Germany; [Schaeffler, Holger] Univ Med Rostock, Div Gastroenterol & Endocrinol, Dept Internal Med, Rostock, Germany; [Ottl, Peter] Univ Med Rostock, Dept Prosthodont & Mat Sci, Rostock, Germany	University of Rostock; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; University of Rostock; University of Rostock	Warnke, P (corresponding author), Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de	Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837				Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Barber S, 1998, PATHOLOGY, V30, P179, DOI 10.1080/00313029800169196; Barenfanger J, 2000, J CLIN MICROBIOL, V38, P2824, DOI 10.1128/JCM.38.8.2824-2828.2000; Bartolitius L, 2014, EUR J MICROBIOL IMMU, V4, P159, DOI 10.1556/EUJMI-D-14-00020; BJURSTROM L, 1992, AM J VET RES, V53, P665; BROOK I, 1987, J CLIN MICROBIOL, V25, P2020, DOI 10.1128/JCM.25.10.2020-2022.1987; Citron DM, 2000, J CLIN MICROBIOL, V38, P892, DOI 10.1128/JCM.38.2.892-894.2000; Claro T, 2014, INFECT CONT HOSP EP, V35, P869, DOI 10.1086/676858; Codrington L, 2013, AM J INFECT CONTROL, V41, P469, DOI 10.1016/j.ajic.2012.09.011; Datta R, 2014, J CLIN MICROBIOL, V52, P312, DOI 10.1128/JCM.01606-13; Davis KA, 2004, CLIN INFECT DIS, V39, P776, DOI 10.1086/422997; Davis MF, 2012, APPL ENVIRON MICROB, V78, P2474, DOI 10.1128/AEM.06886-11; Dolan A, 2011, J HOSP INFECT, V79, P227, DOI 10.1016/j.jhin.2011.05.011; DONATELLI J, 1992, J CLIN MICROBIOL, V30, P138, DOI 10.1128/JCM.30.1.138-142.1992; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Farhat SE, 2001, J CLIN MICROBIOL, V39, P2958, DOI 10.1128/JCM.39.8.2958-2960.2001; Frickmann H, 2012, EUR J MICROBIOL IMMU, V2, P128, DOI 10.1556/EuJMI.2.2012.2.5; Frickmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063222; Goering RV, 2008, CLIN MICROBIOL INFEC, V14, P964, DOI 10.1111/j.1469-0691.2008.02073.x; Gupta K, 2011, INFECT CONT HOSP EP, V32, P791, DOI 10.1086/660362; Hagiya H, 2013, J INTENSIVE CARE, V1, DOI 10.1186/2052-0492-1-10; Hedin G, 2010, J HOSP INFECT, V75, P314, DOI 10.1016/j.jhin.2010.02.027; Hindiyeh M, 2001, J CLIN MICROBIOL, V39, P377, DOI 10.1128/JCM.39.1.377-380.2001; Hsu LY, 2005, J CLIN MICROBIOL, V43, P2923, DOI 10.1128/JCM.43.6.2923-2925.2005; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Johnson AP, 2001, J ANTIMICROB CHEMOTH, V48, P143, DOI 10.1093/jac/48.1.143; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2005, INFECTION, V33, P3, DOI 10.1007/s15010-005-4012-9; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Landers TF, 2010, J CLIN MICROBIOL, V48, P2235, DOI 10.1128/JCM.01958-09; Lemmen SW, 2001, INT J HYG ENVIR HEAL, V203, P245, DOI 10.1078/S1438-4639(04)70035-8; Melter O., 2006, EURO SURVEILL, V11; Mermel LA, 2010, INFECT CONT HOSP EP, V31, P592, DOI 10.1086/652778; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Obee P, 2007, J HOSP INFECT, V65, P35, DOI 10.1016/j.jhin.2006.09.010; Olsen CC, 1999, J CLIN MICROBIOL, V37, P3583, DOI 10.1128/JCM.37.11.3583-3585.1999; Osterblad M, 2003, J CLIN MICROBIOL, V41, P1894, DOI 10.1128/JCM.41.5.1894-1900.2003; Pang B. C. M., 2007, Legal Medicine, V9, P181, DOI 10.1016/j.legalmed.2006.12.003; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Roelofsen E, 1999, J CLIN MICROBIOL, V37, P3041, DOI 10.1128/JCM.37.9.3041-3043.1999; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Rossney AS, 2006, EUR J CLIN MICROBIOL, V25, P79, DOI 10.1007/s10096-006-0091-5; Shiferaw T, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-39; Stenehjem E, 2013, AM J INFECT CONTROL, V41, P405, DOI 10.1016/j.ajic.2012.07.017; Sweet D, 1997, J FORENSIC SCI, V42, P320; Thomasma SM, 2013, J FORENSIC SCI, V58, P465, DOI 10.1111/1556-4029.12036; VandenBergh MFQ, 1999, J CLIN MICROBIOL, V37, P3133, DOI 10.1128/JCM.37.10.3133-3140.1999; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111627; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102215; Warnke P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089667; Weidenmaier C, 2012, TRENDS MICROBIOL, V20, P243, DOI 10.1016/j.tim.2012.03.004; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	58	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0163073	10.1371/journal.pone.0163073	http://dx.doi.org/10.1371/journal.pone.0163073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626801	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600075
J	Fagundez, G; Perez-Freixo, H; Eyene, J; Momo, JC; Biye, L; Esono, T; Ayecab, MOM; Benito, A; Aparicio, P; Herrador, Z				Fagundez, Gabriela; Perez-Freixo, Hugo; Eyene, Juan; Carlos Momo, Juan; Biye, Lucia; Esono, Teodoro; Mba Ayecab, Marcial Ondo; Benito, Agustin; Aparicio, Pilar; Herrador, Zaida			Treatment Adherence of Tuberculosis Patients Attending Two Reference Units in Equatorial Guinea	PLOS ONE			English	Article							TREATMENT DEFAULT; TB; DETERMINANTS; NONADHERENCE; HIV; DISTRICTS; COUNTRIES; DISEASE	Equatorial Guinea has one of the highest burden of tuberculosis (TB) in Africa. Incomplete adherence to TB treatment has been identified as one of the most serious remaining problem in tuberculosis control. The following study is aimed at determining the adherence to anti-tuberculosis treatment in Equatorial Guinea and its determinants, as well as at assessing the knowledge of the people about the disease. In this cross-sectional study, participants were recruited by non-probabilistic consecutive sampling amongst patients who attended the reference units for TB in Bata and Malabo between March and July 2015. Socio-demographic and clinical data were collected. Adherence to treatment and knowledge about TB were assessed by Morisky-Green-Levine and Batalla tests and a questionnaire on adherence related factors specifically prepared for this research. Descriptive statistics were computed to summarize the data and bivariate analyses by adherence profile were performed with chi(2) test for categorical data. A total of 98 patients with TB were interviewed. 63.27% of interviewees had good knowledge about TB (Batalla test) while 78.57% of respondents were adherent according to the Morisky-Green-Levine test. A low educational level, lack of family support and lack of medical advice about the disease were significantly associated to lower adherence level. Patients with re-infection (due to relapse or treatment failure) and those who have suffered from drug shortageswere also less adherents. The National Programme for TB Control should consider improving the early diagnosis and follow-up of TB cases, as well as the implementation of all components of DOTS (Directly observed Treatment, short-course) strategy all over the country.	[Fagundez, Gabriela] Hosp Univ 12 Octubre, Dept Prevent Med, Madrid, Spain; [Perez-Freixo, Hugo] Hosp Clin Univ Santiago de Compostela, Dept Prevent Med, Santiago De Compostela, Spain; [Eyene, Juan; Carlos Momo, Juan; Biye, Lucia; Esono, Teodoro; Mba Ayecab, Marcial Ondo] Minist Hlth & Social Welf, Natl TB & Leprosy Control Program PNLP Spanish, Malabo, Equat Guinea; [Benito, Agustin; Aparicio, Pilar; Herrador, Zaida] Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Benito, Agustin; Aparicio, Pilar; Herrador, Zaida] Spanish Trop Dis Res Network RICET Spanish, Madrid, Spain	Hospital Universitario 12 de Octubre; Complexo Hospitalario Universitario de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT)	Herrador, Z (corresponding author), Inst Salud Carlos III, Natl Ctr Trop Med, Madrid, Spain.; Herrador, Z (corresponding author), Spanish Trop Dis Res Network RICET Spanish, Madrid, Spain.	zherrador@isciii.es		Perez Freixo, Hugo/0000-0002-0816-577X; Benito, Agustin/0000-0001-8229-5540; Herrador, Zaida/0000-0002-6508-3818				Alobu I, 2014, ASIAN PAC J TROP MED, V7, P977, DOI 10.1016/S1995-7645(14)60172-3; Barnestein-Fonseca P, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-6; Herrero MB, 2015, CAD SAUDE PUBLICA, V31, P1983, DOI 10.1590/0102-311X00024314; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; CIA, 2015, WORLD FACTB EQ GUIN; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Espinosa Garcia J, 2012, Semergen, V38, P292, DOI 10.1016/j.semerg.2012.01.001; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Harper M, 2003, T ROY SOC TROP MED H, V97, P506, DOI 10.1016/S0035-9203(03)80007-X; Hasker E, 2010, INT J TUBERC LUNG D, V14, P1132; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jimmy Beena, 2011, Oman Med J, V26, P155, DOI 10.5001/omj.2011.38; Khan MA, 2005, HEALTH POLICY PLANN, V20, P354, DOI 10.1093/heapol/czi047; Marquez Contreras E, 2006, ATEN PRIM, V38, P325, DOI DOI 10.1157/13093369; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; PNUD en Guinea Ecuatorial, 2011, ENC DEM SAL GUIN EC; Republica de Guinea Ecuatorial Sistema de las Naciones Unidas, 2009, 2 INF NAC OBJ DES MI; RIEDER HL, 2002, INTERVENTIONS TUBERC; Ross EA, 2002, INT J ARTIF ORGANS, V25, P1061, DOI 10.1177/039139880202501104; Salmanton-Garcia J, 2016, AIDS CARE, V28, P543, DOI 10.1080/09540121.2015.1124976; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; Tudo G, 2004, INT J TUBERC LUNG D, V8, P1458; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; Weltgesundheitsorganisation, 2003, ADH LONG THERM THER; WHO, 2015, EQ GUIN WHO STAT PRO; World Bank, 2014, WORLD DEV IND 2014; World Health Organisation, 2006, TUB AIR TRAV GUID PR; World Health Organization, TUB TRAD FOR POL DIP; World Health Organization, 2015, GLOB TUB REP 2015; Yone EWP, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000289; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	37	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161995	10.1371/journal.pone.0161995	http://dx.doi.org/10.1371/journal.pone.0161995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622461	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000012
J	Cai, GJ; Zhang, BF; Ma, CY; Shi, GW; Weng, WJ; Xue, SL				Cai, Gaojun; Zhang, Bifeng; Ma, Chunyan; Shi, Ganwei; Weng, Weijin; Xue, Sheliang			Associations of Rs3744841 and Rs3744843 Polymorphisms in Endothelial Lipase Gene with Risk of Coronary Artery Disease and Lipid Levels in a Chinese Population	PLOS ONE			English	Article							VARIANTS; LOCI		[Cai, Gaojun; Ma, Chunyan; Shi, Ganwei; Weng, Weijin; Xue, Sheliang] Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China; [Zhang, Bifeng] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada	Jiangsu University; McMaster University	Cai, GJ (corresponding author), Jiangsu Univ, Wujin Hosp, Dept Cardiol, Changzhou, Jiangsu, Peoples R China.	cgj982@126.com						Abd El-Aziz TA, 2014, J CLIN LIPIDOL, V8, P381, DOI 10.1016/j.jacl.2014.06.001; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Cai GJ, 2014, GENET MOL RES, V13, P1059, DOI 10.4238/2014.February.20.7; Cai GJ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0154-7; Cai GJ, 2012, MOL BIOL REP, V39, P9879, DOI 10.1007/s11033-012-1854-y; deLemos AS, 2002, CIRCULATION, V106, P1321, DOI 10.1161/01.CIR.0000028423.07623.6A; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Miksztowicz V, 2014, ARTERIOSCLER THROMB, V32, P3033; Sun L, 2014, J ATHEROSCLER THROMB, V21, P313, DOI 10.5551/jat.20131; Szpakowicz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129820; Toosi S, 2015, J CARDIOVASC THORAC, V7, P118, DOI 10.15171/jcvtr.2015.25; Wang XB, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0079-1; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Xie L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007621; Yamakawa-Kobayashi K, 2003, HUM GENET, V113, P311, DOI 10.1007/s00439-003-0985-6; Ye HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135683	19	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162727	10.1371/journal.pone.0162727	http://dx.doi.org/10.1371/journal.pone.0162727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612170	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900157
J	Catalan, V; Gomez-Ambrosi, J; Rodriguez, A; Ramirez, B; Izaguirre, M; Hernandez-Lizoain, JL; Baixauli, J; Marti, P; Valenti, V; Moncada, R; Silva, C; Salvador, J; Fruhbeck, G				Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Izaguirre, Maitane; Luis Hernandez-Lizoain, Jose; Baixauli, Jorge; Marti, Pablo; Valenti, Victor; Moncada, Rafael; Silva, Camilo; Salvador, Javier; Fruhbeck, Gema			Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; VISCERAL ADIPOSE-TISSUE; COLORECTAL-CANCER; GASTRIC BYPASS; BREAST-CANCER; LIPOCALIN 2; TUMOR PROGRESSION; PLASMA YKL-40; RECEPTOR 4; BODY-FAT	Background Excess adipose tissue represents a major risk factor for the development of colon cancer with inflammation and extracellular matrix (ECM) remodeling being proposed as plausible mechanisms. The aim of this study was to investigate whether obesity can influence circulating levels of inflammation-related extracellular matrix proteins in patients with colon cancer (CC), promoting a microenvironment favorable for tumor growth. Methods Serum samples obtained from 79 subjects [26 lean (LN) and 53 obese (OB)] were used in the study. Enrolled subjects were further subclassified according to the established diagnostic protocol for CC (44 without CC and 35 with CC). Anthropometric measurements as well as circulating metabolites and hormones were determined. Circulating concentrations of the ECM proteins osteopontin (OPN), chitinase-3-like protein 1 (YKL-40), tenascin C (TNC) and lipocalin-2 (LCN-2) were determined by ELISA. Results Significant differences in circulating OPN, YKL-40 and TNC concentrations between the experimental groups were observed, being significantly increased due to obesity (P<0.01) and colon cancer (P<0.05). LCN-2 levels were affected by obesity (P<0.05), but no differences were detected regarding the presence or not of CC. A positive association (P<0.05) with different inflammatory markers was also detected. Conclusions To our knowledge, we herein show for the first time that obese patients with CC exhibit increased circulating levels of OPN, YKL-40 and TNC providing further evidence for the influence of obesity on CC development via ECM proteins, representing promising diagnostic biomarkers or target molecules for therapeutics.	[Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Izaguirre, Maitane; Fruhbeck, Gema] Univ Navarra Clin, Metab Res Lab, Pamplona, Spain; [Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Izaguirre, Maitane; Valenti, Victor; Moncada, Rafael; Silva, Camilo; Salvador, Javier; Fruhbeck, Gema] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Pamplona, Spain; [Catalan, Victoria; Gomez-Ambrosi, Javier; Rodriguez, Amaia; Ramirez, Beatriz; Valenti, Victor; Moncada, Rafael; Silva, Camilo; Fruhbeck, Gema] Inst Invest Sanitaria Navarra IdiSNA, Obes & Adipobiol Grp, Pamplona, Spain; [Luis Hernandez-Lizoain, Jose; Baixauli, Jorge; Marti, Pablo; Valenti, Victor] Clin Univ Navarra, Dept Surg, Pamplona, Spain; [Moncada, Rafael] Clin Univ Navarra, Dept Anesthesia, Pamplona, Spain; [Silva, Camilo; Salvador, Javier; Fruhbeck, Gema] Clin Univ Navarra, Dept Endocrinol & Nutr, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra; University of Navarra; University of Navarra	Fruhbeck, G (corresponding author), Univ Navarra Clin, Metab Res Lab, Pamplona, Spain.; Fruhbeck, G (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Pamplona, Spain.; Fruhbeck, G (corresponding author), Inst Invest Sanitaria Navarra IdiSNA, Obes & Adipobiol Grp, Pamplona, Spain.; Fruhbeck, G (corresponding author), Clin Univ Navarra, Dept Endocrinol & Nutr, Pamplona, Spain.	gfruhbeck@unav.es	Catalan, Victoria/H-3566-2017; Martí Ciriquián, Pablo/C-4320-2015; Ramírez, Beatriz/I-1922-2017; Gómez-Ambrosi, Javier/D-2984-2017; Fons, Jorge Baixauli/F-1654-2011; Rodriguez, Amaia/D-3044-2019	Catalan, Victoria/0000-0002-7513-7509; Martí Ciriquián, Pablo/0000-0002-6877-784X; Ramírez, Beatriz/0000-0003-3381-7220; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Rodriguez, Amaia/0000-0002-2180-461X; valenti, victor/0000-0002-7074-2849; Silva Frojan, Camilo/0000-0002-3466-1291	Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII) [PI12/00515, PI13/00460, PI14/00950]; Department of Health of the Gobierno de Navarra of Spain [48/2011, 58/2011]; Fundacion Caja Navarra [20-2014]; ISCIII, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBEROBN, Spain	Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII); Department of Health of the Gobierno de Navarra of Spain; Fundacion Caja Navarra; ISCIII, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBEROBN, Spain	This work was supported by Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII) (PI12/00515, PI13/00460 and PI14/00950), by the Department of Health (48/2011 and 58/2011) of the Gobierno de Navarra of Spain, by Fundacion Caja Navarra (20-2014) and by the ISCIII, Centro de Investigacion Biomedica en Red Fisiopatologia de la Obesidad y Nutricion, CIBEROBN, Spain.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Allin KH, 2012, BRIT J CANCER, V106, P199, DOI 10.1038/bjc.2011.501; Berezin AE, 2013, ATHEROSCLEROSIS, V229, P475, DOI 10.1016/j.atherosclerosis.2013.06.003; Brellier F, 2012, J CELL MOL MED, V16, P32, DOI 10.1111/j.1582-4934.2011.01360.x; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Catalan V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00275; Catalan V, 2012, HISTOL HISTOPATHOL, V27, P1515, DOI 10.14670/HH-27.1515; Catalan V, 2012, J CLIN ENDOCR METAB, V97, pE1880, DOI 10.1210/jc.2012-1670; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fruhbeck G, 2015, NAT REV ENDOCRINOL, V11, P465, DOI 10.1038/nrendo.2015.84; Fruhbeck G, 2012, NAT REV ENDOCRINOL, V8, P570, DOI 10.1038/nrendo.2012.165; Fung KYC, 2013, CANCER BIOMARK, V13, P75, DOI 10.3233/CBM-130335; Ge T, 2015, MED ONCOL, V32, P367; Gomez-Ambrosi J, 2006, OBES SURG, V16, P262, DOI 10.1381/096089206776116525; Gomez-Ambrosi J, 2002, CLIN BIOCHEM, V35, P315, DOI 10.1016/S0009-9120(02)00320-X; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Haydon AMM, 2006, GUT, V55, P62, DOI 10.1136/gut.2005.068189; Hempen M, 2009, OBES SURG, V19, P1557, DOI 10.1007/s11695-009-9917-4; Johansen JS, 2015, CANC EPIDEMIOL BIOMA; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Kant P, 2011, NAT REV GASTRO HEPAT, V8, P224, DOI 10.1038/nrgastro.2011.23; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Matsumoto T, 2001, CLIN EXP RHEUMATOL, V19, P655; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nielsen AR, 2011, CYTOKINE, V55, P152, DOI 10.1016/j.cyto.2011.03.014; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Parekh N, 2012, ANNU REV NUTR, V32, P311, DOI 10.1146/annurev-nutr-071811-150713; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Perez-Hernandez AI, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00065; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pichler M, 2013, BRIT J CANCER, V109, P1123, DOI 10.1038/bjc.2013.443; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sung MK, 2011, ANN NY ACAD SCI, V1229, P61, DOI 10.1111/j.1749-6632.2011.06094.x; Tastekin D, 2014, TUMOR BIOL, V35, P6619, DOI 10.1007/s13277-014-1875-3; Wang LK, 2011, J GASTROINTEST SURG, V15, P652, DOI 10.1007/s11605-011-1445-6; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Wild N, 2010, CLIN CANCER RES, V16, P6111, DOI 10.1158/1078-0432.CCR-10-0119; Yang J, 2013, FASEB J, V27, P45, DOI 10.1096/fj.12-211730; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294	56	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162189	10.1371/journal.pone.0162189	http://dx.doi.org/10.1371/journal.pone.0162189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612200	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900054
J	Paul, PJ; Raghu, D; Chan, AL; Gulati, T; Lambeth, L; Takano, E; Herold, MJ; Hagekyriakou, J; Vessella, RL; Fedele, C; Shackleton, M; Williams, ED; Fox, S; Williams, S; Haupt, S; Gamell, C; Haupt, Y				Paul, P. J.; Raghu, D.; Chan, A-L; Gulati, T.; Lambeth, L.; Takano, E.; Herold, M. J.; Hagekyriakou, J.; Vessella, R. L.; Fedele, C.; Shackleton, M.; Williams, E. D.; Fox, S.; Williams, S.; Haupt, S.; Gamell, C.; Haupt, Y.			Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP	ONCOGENE			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; PML-INDUCED SENESCENCE; DRIVEN; CELLS; FIBROBLASTS; PROGRESSION; MOUSE; DEATH	Restoration of tumor suppression is an attractive onco-therapeutic approach. It is particularly relevant when a tumor suppressor is excessively degraded by an overactive oncogenic E3 ligase. We previously discovered that the E6-associated protein (E6AP; as classified in the human papilloma virus context) is an E3 ligase that has an important role in the cellular stress response, and it directly targets the tumor-suppressor promyelocytic leukemia protein (PML) for proteasomal degradation. In this study, we have examined the role of the E6AP-PML axis in prostate cancer (PC). We show that knockdown (KD) of E6AP expression attenuates growth of PC cell lines in vitro. We validated this finding in vivo using cell line xenografts, patient-derived xenografts and mouse genetics. We found that KD of E6AP attenuates cancer cell growth by promoting cellular senescence in vivo, which correlates with restoration of tumor suppression by PML. In addition, we show that KD of E6AP sensitizes cells to radiation-induced death. Overall, our findings demonstrate a role for E6AP in the promotion of PC and support E6AP targeting as a novel approach for PC treatment, either alone or in combination with radiation.	[Paul, P. J.; Raghu, D.; Gulati, T.; Haupt, Y.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Paul, P. J.; Raghu, D.; Chan, A-L; Gulati, T.; Lambeth, L.; Haupt, S.; Gamell, C.; Haupt, Y.] Peter MacCallum Canc Ctr, Tumor Suppress Lab, St Andrews Pl, Melbourne, Vic 3002, Australia; [Takano, E.; Fedele, C.; Shackleton, M.; Fox, S.] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Herold, M. J.] Walter & Eliza Hall Inst Med Res, Mol Genet Canc, Parkville, Vic, Australia; [Herold, M. J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Hagekyriakou, J.] Peter MacCallum Canc Ctr, Dept Phys Sci, Melbourne, Vic, Australia; [Vessella, R. L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Fedele, C.; Shackleton, M.] Peter MacCallum Canc Ctr, Canc Dev & Treatment Lab, Melbourne, Vic, Australia; [Fedele, C.; Shackleton, M.; Williams, S.; Haupt, Y.] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Melbourne, Vic, Australia; [Williams, E. D.] Queensland Univ Technol, Australian Prostate Canc Res Ctr, Brisbane, Qld, Australia; [Haupt, Y.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Haupt, Y.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Paul, P. J.] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Tumor Pathol Dept, Gliwice Branch, Gliwice, Poland; [Chan, A-L] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic, Australia; [Lambeth, L.] Murdoch Childrens Res Inst, Parkville, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; University of Washington; University of Washington Seattle; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Queensland University of Technology (QUT); Monash University; University of Melbourne; Maria Sklodowska-Curie National Research Institute of Oncology; Australian Regenerative Medicine Institute; Monash University; Murdoch Children's Research Institute	Gamell, C (corresponding author), Peter MacCallum Canc Ctr, Tumor Suppress Lab, St Andrews Pl, Melbourne, Vic 3002, Australia.	Cristina.Gamell@petermac.org	Williams, Elizabeth D/B-1538-2008; Herold, Marco J/C-8039-2013; Fox, Stephen/G-9719-2016	Williams, Elizabeth D/0000-0002-3364-6655; Herold, Marco J/0000-0001-7539-7581; Paul, Piotr Jan/0000-0002-2319-224X; Fox, Stephen/0000-0002-7648-8896; Raghu, Dinesh/0000-0002-8960-6222; Gulati, Twishi/0000-0003-3841-8392; Chan, Ai-Leen/0000-0003-3553-7249; Gamell, Cristina/0000-0003-0720-2652; Haupt, Ygal/0000-0001-5925-0096	NHMRC [1049179, 1063389, 9628426, 1049720]; PCF creativity grant; CCV grant [1085154]; VCA Richard Pratt Fellowship in Prostate Cancer Research; PCFA grant [NDDA-1811]; Pfizer Australia; Veski foundings; Foundation of the Peter MacCallum Cancer Centre	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); PCF creativity grant; CCV grant(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); VCA Richard Pratt Fellowship in Prostate Cancer Research; PCFA grant; Pfizer Australia(PfizerPfizer Australia); Veski foundings; Foundation of the Peter MacCallum Cancer Centre	This work was supported by NHMRC project grants (1049179 and 1063389) and NHMRC Fellowship to YH (9628426), NHMRC project grant to MJH (1049720), PCF creativity grant to SW and YH, CCV grant (1085154), VCA Richard Pratt Fellowship in Prostate Cancer Research to CG, the PCFA grant (NDDA-1811) to EW, Pfizer Australia, NHMRC and Veski foundings to MS, and a prostate initiative grant from the Foundation of the Peter MacCallum Cancer Centre. PrEC line was a generous gift from Dr Patrick Humbert and Helen Pearson at Peter MacCallum Cancer Centre.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Birch SE, 2014, ANN ONCOL, V25, P2392, DOI 10.1093/annonc/mdu454; Chen RH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-81; Christian PA, 2009, CANCER BIOL THER, V8, P73, DOI 10.4161/cbt.8.1.7132; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; de The H, 2012, J CELL BIOL, V198, P11, DOI 10.1083/jcb.201112044; Dreicer R, 2007, CLIN CANCER RES, V13, P1208, DOI 10.1158/1078-0432.CCR-06-2046; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gamell C, 2014, FEBS LETT, V588, P2653, DOI 10.1016/j.febslet.2014.02.007; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Hurwitz Arthur A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2005s45; Ivanschitz L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00171; Khan OY, 2006, MOL ENDOCRINOL, V20, P544, DOI 10.1210/me.2005-0110; Kraft AS, 2011, CANCER BIOL THER, V12, P119, DOI 10.4161/cbt.12.2.15723; Levav-Cohen Y, 2012, ONCOGENE, V31, P2199, DOI 10.1038/onc.2011.402; Li Z, 2013, ASIAN J ANDROL, V15, P328, DOI 10.1038/aja.2013.7; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Mallette FA, 2004, ONCOGENE, V23, P91, DOI 10.1038/sj.onc.1206886; Oh W, 2009, J CELL SCI, V122, P2613, DOI 10.1242/jcs.048066; Papandreou CN, 2004, J CLIN ONCOL, V22, P2108, DOI 10.1200/JCO.2004.02.106; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182; Price Nancy, 2004, Clin Prostate Cancer, V3, P141; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Srinivasan S, 2011, BBA-GENE REGUL MECH, V1809, P119, DOI 10.1016/j.bbagrm.2010.08.011; Steiner MS, 2000, ONCOGENE, V19, P1297, DOI 10.1038/sj.onc.1203428; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wolyniec K, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00124; Wolyniec K, 2012, CELL CYCLE, V11, P3705, DOI 10.4161/cc.22043; Wolyniec K, 2012, BLOOD, V120, P822, DOI 10.1182/blood-2011-10-387647; Yamagishi Y, 2011, CHEM BIOL, V18, P1562, DOI 10.1016/j.chembiol.2011.09.013	38	23	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 1	2016	35	48					6235	6245		10.1038/onc.2016.159	http://dx.doi.org/10.1038/onc.2016.159			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED4YH	27641331				2022-12-26	WOS:000388857700008
J	Casu, B; Smart, J; Hancock, MA; Smith, M; Sygusch, J; Baron, C				Casu, Bastien; Smart, Jonathan; Hancock, Mark A.; Smith, Mark; Sygusch, Jurgen; Baron, Christian			Structural Analysis and Inhibition of TraE from the pKM101 Type IV Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial conjugation; membrane protein; plasmid; protein secretion; protein-protein interaction; type IV secretion	BRUCELLA-SUIS VIRB8; AGROBACTERIUM-TUMEFACIENS VIRB8; CONJUGAL TRANSFER SYSTEM; INCN PLASMID PKM101; DNA TRANSPORT PORE; PERIPLASMIC DOMAIN; ESCHERICHIA-COLI; CORE COMPLEX; PROTEINS; COMPLEMENTATION	Gram-negative bacteria use type IV secretion systems (T4SSs) for a variety of macromolecular transport processes that include the exchange of genetic material. The pKM101 plasmid encodes a T4SS similar to the well-studied model systems from Agrobacterium tumefaciens and Brucella suis. Here, we studied the structure and function of TraE, a homolog of VirB8 that is an essential component of all T4SSs. Analysis by X-ray crystallography revealed a structure that is similar to other VirB8 homologs but displayed an altered dimerization interface. The dimerization interface observed in the X-ray structure was corroborated using the bacterial two-hybrid assay, biochemical characterization of the purified protein, and in vivo complementation, demonstrating that there are different modes of dimerization among VirB8 homologs. Analysis of interactions using the bacterial two-hybrid and cross-linking assays showed that TraE and its homologs from Agrobacterium, Brucella, and Helicobacter pylori form heterodimers. They also interact with heterologous VirB10 proteins, indicating a significant degree of plasticity in the protein-protein interactions of VirB8-like proteins. To further assess common features of VirB8-like proteins, we tested a series of small molecules derived from inhibitors of Brucella VirB8 dimerization. These molecules bound to TraE in vitro, docking predicted that they bind to a structurally conserved surface groove of the protein, and some of them inhibited pKM101 plasmid transfer. VirB8-like proteins thus share functionally important sites, and these can be exploited for the design of specific inhibitors of T4SS function.	[Casu, Bastien; Smart, Jonathan; Smith, Mark; Sygusch, Jurgen; Baron, Christian] Univ Montreal, Dept Biochem & Mol Med, Fac Med, Pavillon Roger Gaudry,CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Hancock, Mark A.] McGill Univ, Fac Med, SPR MS Facil, Montreal, PQ H3G 1Y6, Canada	Universite de Montreal; McGill University	Baron, C (corresponding author), Univ Montreal, Dept Biochem & Mol Med, Fac Med, Pavillon Roger Gaudry,CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	christian.baron@umontreal.ca		Baron, Christian/0000-0002-0132-2111; Sygusch, Jurgen/0000-0002-6629-2128; Casu, Bastien/0000-0003-3508-6804	Canadian Institutes of Health Research (CIHR) [MOP-84239]; Natural Sciences and Engineering Research Council (NSERC); NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (CDMC); Bristol Myers Smith Research Chair in Molecular Biology at Universite de Montreal; Groupe d'etudes des proteines membranaires (GEPROM); Canada Foundation for Innovation (CFI); Fonds de recherche du Quebec-Sante (FRQ-S)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (CDMC); Bristol Myers Smith Research Chair in Molecular Biology at Universite de Montreal; Groupe d'etudes des proteines membranaires (GEPROM); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de recherche du Quebec-Sante (FRQ-S)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-84239 and grants from the Natural Sciences and Engineering Research Council (NSERC), the NSERC-CREATE program on the Cellular Dynamics of Macromolecular Complexes (CDMC), the Bristol Myers Smith Research Chair in Molecular Biology at Universite de Montreal, the Groupe d'etudes des proteines membranaires (GEPROM), the Canada Foundation for Innovation (CFI), and the Fonds de recherche du Quebec-Sante (FRQ-S) (to C. B.). The McGill SPR-MS facility receives infrastructure support from CFI. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aguilar J, 2011, MBIO, V2, DOI 10.1128/mBio.00218-11; Aguilar J, 2010, P NATL ACAD SCI USA, V107, P3758, DOI 10.1073/pnas.0914940107; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bourg G, 2009, J BACTERIOL, V191, P2985, DOI 10.1128/JB.01426-08; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Das A, 2000, J BACTERIOL, V182, P758, DOI 10.1128/JB.182.3.758-763.2000; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Gillespie JJ, 2015, MBIO, V6, DOI 10.1128/mBio.01867-15; Giraldo AMV, 2015, FEBS LETT, V589, P1883, DOI 10.1016/j.febslet.2015.05.051; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Goessweiner-Mohr N, 2013, J BIOL CHEM, V288, P2018, DOI 10.1074/jbc.M112.428847; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kayama S, 2015, ANTIMICROB AGENTS CH, V59, P1356, DOI 10.1128/AAC.04759-14; Kumar RB, 2000, MOL MICROBIOL, V36, P608, DOI 10.1046/j.1365-2958.2000.01876.x; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Kumpar RB, 2001, J BACTERIOL, V183, P3636, DOI 10.1128/JB.183.12.3636-3641.2001; Kuroda T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10912; LANGER PJ, 1981, MOL GEN GENET, V182, P268, DOI 10.1007/BF00269669; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P979, DOI 10.1073/pnas.72.3.979; MORTELMANS KE, 1979, MOL GEN GENET, V167, P317, DOI 10.1007/BF00267425; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Paschos A, 2006, P NATL ACAD SCI USA, V103, P7252, DOI 10.1073/pnas.0600862103; Paschos A, 2011, INFECT IMMUN, V79, P1033, DOI 10.1128/IAI.00993-10; Patey G, 2006, INFECT IMMUN, V74, P4945, DOI 10.1128/IAI.00584-06; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; POHLMAN RF, 1994, MOL MICROBIOL, V14, P655, DOI 10.1111/j.1365-2958.1994.tb01304.x; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Sivanesan D, 2011, J BACTERIOL, V193, P2097, DOI 10.1128/JB.00907-10; Sivanesan D, 2010, BIOCHEMISTRY-US, V49, P4483, DOI 10.1021/bi902201y; Smith MA, 2012, CHEM BIOL, V19, P1041, DOI 10.1016/j.chembiol.2012.07.007; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Trokter M, 2014, CURR OPIN STRUC BIOL, V27, P16, DOI 10.1016/j.sbi.2014.02.006; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Valdes R Jr, 1979, Methods Enzymol, V61, P125; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Winans SC, 1996, TRENDS MICROBIOL, V4, P64, DOI 10.1016/0966-842X(96)81513-7; Yuan Q, 2005, J BIOL CHEM, V280, P26349, DOI 10.1074/jbc.M502347200; ZINONI F, 1990, P NATL ACAD SCI USA, V87, P4660, DOI 10.1073/pnas.87.12.4660	44	29	29	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23817	23829		10.1074/jbc.M116.753327	http://dx.doi.org/10.1074/jbc.M116.753327			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634044	hybrid, Green Published			2022-12-26	WOS:000387884400040
J	Azarpeykan, S; Dittmer, KE; Marshall, JC; Perera, KC; Gee, EK; Acke, E; Thompson, KG				Azarpeykan, Sara; Dittmer, Keren E.; Marshall, Jonathan C.; Perera, Kalyani C.; Gee, Erica K.; Acke, Els; Thompson, Keith G.			Evaluation and Comparison of Vitamin D Responsive Gene Expression in Ovine, Canine and Equine Kidney	PLOS ONE			English	Article							EPITHELIAL CA2+ CHANNEL; CALCIUM-TRANSPORT; TRPV5; PROTEINS; DUODENUM; SHEEP; ABSORPTION; MECHANISMS; PHOSPHATE; PMCA1B	The aim of this study was to determine the relative abundance and relationship of vitamin D responsive and calcium transporting transcripts (TRPV5, TRPV6, calD(9k), calD(28k), PMCA, NCX1, CYP27B1, CYP24A1, and VDR) in ovine, canine and, equine kidney using quantitative real-timePCR (RT-qPCR), and then performa comparison between the three species. Renal tissue samples were harvested post-mortemfrom 10 horses, 10 sheep, and five dogs. Primerswere designed for each gene. For each sample total RNA was extracted, cDNA synthesised, and RT-qPCR was performed. RT-qPCR data were normalised and statistical comparisonwas performed. Due to their consistent correlation with each other in each species, TRPV6, calD(9k)/calD(28k), and PMCA appeared to be the main pathways involved in active transepithelial calcium transport in the kidney of sheep, dogs and horses. The results indicate that all of the studied genes were expressed in the renal tissue of studied species, although the expression levels and correlation of transcripts with each other were different from species to species. All vitamin D responsive and calcium transporting transcripts were highly correlated with VDR in equine kidney, but not in sheep and dogs. The CYP27B1 and CYP24A1 mRNAs showed a different renal expression pattern and correlation in horses compared with sheep and dogs. Given the high urinary calcium concentration and low serum 1,25(OH)(2)D concentration in horses, it could be expected that CYP27B1 expression would be lower than CYP24A1 in the horse, and this did not appear to be the case. The findings suggest that despite low serum vitamin D concentrations, vitamin D still plays a significant role in calcium metabolism in horses, especially given the strong correlations between VDR and vitamin D responsive transcripts in these animals.	[Azarpeykan, Sara; Dittmer, Keren E.; Perera, Kalyani C.; Gee, Erica K.; Acke, Els; Thompson, Keith G.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Marshall, Jonathan C.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University	Azarpeykan, S (corresponding author), Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	S.Azarpeykan@massey.ac.nz	Dittmer, Keren/AAR-3148-2021; Gee, Erica/Y-1999-2018	Dittmer, Keren/0000-0002-1813-2197; Gee, Erica/0000-0001-5218-6589; Azarpeykan, Sara/0000-0003-4229-3115				Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Alexander RT, 2014, BIOCHEM CELL BIOL, V92, P467, DOI 10.1139/bcb-2014-0061; Azarpeykan S, 2016, J ANIM PHYSIOL AN N, V100, P1058, DOI 10.1111/jpn.12477; Azarpeykan S, 2016, DOMEST ANIM ENDOCRIN, V56, P75, DOI 10.1016/j.domaniend.2016.03.003; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blaine J, 2015, CLIN J AM SOC NEPHRO, V10, P1257, DOI 10.2215/CJN.09750913; Bonny O, 2013, AM J PHYSIOL-RENAL, V304, pF585, DOI 10.1152/ajprenal.00493.2012; BORKE JL, 1989, AM J PHYSIOL, V257, pF842, DOI 10.1152/ajprenal.1989.257.5.F842; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Breidenbach A, 1998, VET RES, V29, P173; COSTANZO LS, 1978, AM J PHYSIOL, V235, pF492, DOI 10.1152/ajprenal.1978.235.5.F492; Dittmer KE, 2011, VET PATHOL, V48, P389, DOI 10.1177/0300985810375240; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herm G, 2015, J ANIM SCI, V93, P1608, DOI 10.2527/jas.2014-8450; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Hoenderop JGJ, 2008, PHYSIOLOGY, V23, P32, DOI 10.1152/physiol.00039.2007; Hwang I, 2011, J VET MED SCI, V73, P1437, DOI 10.1292/jvms.11-0141; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kayis SA, 2011, ANIM REPROD SCI, V125, P124, DOI 10.1016/j.anireprosci.2011.02.019; Kim JA, 2011, IN VIVO, V25, P773; Kumar R, 2012, ARCH BIOCHEM BIOPHYS, V523, P77, DOI 10.1016/j.abb.2012.03.003; Lefebvre HP, 2008, VET CLIN PATH, V37, P4, DOI 10.1111/j.1939-165X.2008.00010.x; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; MAENPAA PH, 1988, J ANIM SCI, V66, P1418; Magyar CE, 2002, AM J PHYSIOL-RENAL, V283, pF29, DOI 10.1152/ajprenal.00252.2000; Mensenkamp A. R., 2007, V179, P207; PAK CYC, 1975, NEW ENGL J MED, V292, P497, DOI 10.1056/NEJM197503062921002; Palm C, 2010, ANAT REC, V293, P770, DOI 10.1002/ar.21104; Palviainen M, 2012, VET J, V193, P287, DOI 10.1016/j.tvjl.2011.10.004; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; R Core Team, 2021, R LANGUAGE ENV STAT; Radlovic N, 2012, SRP ARK CELOK LEK, V140, P110, DOI 10.2298/SARH1202110R; Rourke KM, 2010, GEN COMP ENDOCR, V167, P6, DOI 10.1016/j.ygcen.2010.02.022; Schoeber JPH, 2007, BIOCHEM SOC T, V35, P115, DOI 10.1042/BST0350115; Sprekeler N, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-65; Stockham SL., 2008, FUNDAMENTALS VET CLI, V2nd ed., P415; Strehler EE, 2015, BIOCHEM BIOPH RES CO, V460, P26, DOI 10.1016/j.bbrc.2015.01.121; van de Graaf SFJ, 2007, REV PHYSIOL BIOCH P, V158, P77, DOI 10.1007/11220060607; Wilkens MR, 2014, ANIM PROD SCI, V54, P1507, DOI 10.1071/AN14349; Wilkens MR, 2012, COMP BIOCHEM PHYS A, V163, P396, DOI 10.1016/j.cbpa.2012.06.011; Wilkens MR, 2009, VET J, V182, P294, DOI 10.1016/j.tvjl.2008.06.020	47	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162598	10.1371/journal.pone.0162598	http://dx.doi.org/10.1371/journal.pone.0162598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632366	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900057
J	Chen, YL; Cao, J; Zhang, XB				Chen, Yulei; Cao, Jiao; Zhang, Xiaobo			The Role of Cytokine PF4 in the Antiviral Immune Response of Shrimp	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; INNATE IMMUNITY; PENAEUS-JAPONICUS; ADAPTIVE IMMUNITY; VIRAL-INFECTION; IN-VIVO; PHAGOCYTOSIS; PLATELET-FACTOR-4; PROTEIN; CANCER	During viral infection in vertebrates, cytokines play important roles in the host defense against the virus. However, the function of cytokines in invertebrates has not been well characterized. In this study, shrimp cytokines involved in viral infection were screened using a cytokine antibody microarray. The results showed that three cytokines, the Fas receptor (Fas), platelet factor 4 (PF4) and interleukin-22 (IL-22), were significantly upregulated in the white spot syndrome virus (WSSV)-challenged shrimp, suggesting that these cytokines played positive regulatory roles in the immune response of shrimp against the virus. Further experiments revealed that PF4 had positive effects on the antiviral immunity of shrimp by enhancing the shrimp phagocytic activity and inhibiting the apoptotic activity of virus-infected hemocytes. Therefore, our study presented a novel mechanism of cytokines in the innate immunity of invertebrates.	[Chen, Yulei; Cao, Jiao; Zhang, Xiaobo] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, XB (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Zhang, Xiaobo/0000-0003-4606-212X	National Natural Science Foundation of China [41276152, 31430089]; National Program on the Key Basic Research Project [2015CB755903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on the Key Basic Research Project	This work was financially supported by National Natural Science Foundation of China (41276152, 31430089) and National Program on the Key Basic Research Project (2015CB755903).	Aidoudi S, 2010, THROMB HAEMOSTASIS, V104, P941, DOI 10.1160/TH10-03-0193; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Diana JS, 2009, BIOSCIENCE, V59, P27, DOI 10.1525/bio.2009.59.1.7; Fantuzzi G, 2011, THESCIENTIFICWORLDJO, V11, P2506, DOI 10.1100/2011/271206; Fiedler GM, 2009, CLIN CANCER RES, V15, P3812, DOI 10.1158/1078-0432.CCR-08-2701; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Han F, 2007, FISH SHELLFISH IMMUN, V23, P937, DOI 10.1016/j.fsi.2007.01.022; He YD, 2014, J VIROL, V88, P1104, DOI 10.1128/JVI.02455-13; Henneke P, 2004, J EXP MED, V199, P1, DOI 10.1084/jem.20031256; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014; Huang TZ, 2014, J VIROL, V88, P2544, DOI 10.1128/JVI.03575-13; Huang TZ, 2013, EUR J IMMUNOL, V43, P137, DOI 10.1002/eji.201242806; Huang TZ, 2012, J VIROL, V86, P12997, DOI 10.1128/JVI.01702-12; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaiser P, 2003, J VIROL, V77, P762, DOI 10.1128/JVI.77.1.762-768.2003; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kowalska MA, 2010, THROMB RES, V125, P292, DOI 10.1016/j.thromres.2009.11.023; Lambert MP, 2007, BLOOD, V110, P1153, DOI 10.1182/blood-2007-01-067116; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Li CY, 2010, FISH SHELLFISH IMMUN, V28, P1, DOI 10.1016/j.fsi.2009.09.003; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Liang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0275-7; Luo T, 2003, FEBS LETT, V551, P53, DOI 10.1016/S0014-5793(03)00891-3; Matte I, 2012, AM J CANCER RES, V2, P566; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pan D, 2005, DEV COMP IMMUNOL, V29, P103, DOI 10.1016/j.dci.2004.07.001; Peng XX, 2013, DEV COMP IMMUNOL, V39, P63, DOI 10.1016/j.dci.2012.03.017; Pervushina O, 2004, J IMMUNOL, V173, P2060, DOI 10.4049/jimmunol.173.3.2060; Rajeshkumar S, 2009, FISH SHELLFISH IMMUN, V26, P429, DOI 10.1016/j.fsi.2009.01.003; RUCINSKI B, 1990, THROMB HAEMOSTASIS, V63, P493; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Scheuerer B, 2000, BLOOD, V95, P1158, DOI 10.1182/blood.V95.4.1158.004k31_1158_1166; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Wang PH, 2014, ANTIVIR RES, V108, P129, DOI 10.1016/j.antiviral.2014.05.013; Wang ZW, 2016, DEV COMP IMMUNOL, V63, P111, DOI 10.1016/j.dci.2016.05.020; Witteveldt J, 2004, J VIROL, V78, P2057, DOI 10.1128/JVI.78.4.2057-2061.2004; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Ye T, 2012, J PROTEOME RES, V11, P4834, DOI 10.1021/pr300274k; Ye T, 2012, FISH SHELLFISH IMMUN, V33, P350, DOI 10.1016/j.fsi.2012.05.017; Zhao Z, 2011, FISH SHELLFISH IMMUN, V31, P1013, DOI 10.1016/j.fsi.2011.08.022; Zhu F, 2015, FISH SHELLFISH IMMUN, V47, P777, DOI 10.1016/j.fsi.2015.10.015; Zhu F, 2012, MAR BIOTECHNOL, V14, P63, DOI 10.1007/s10126-011-9387-2	47	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162954	10.1371/journal.pone.0162954	http://dx.doi.org/10.1371/journal.pone.0162954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631372	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900100
J	Scherer, L; Pfister, S				Scherer, Laura; Pfister, Stephan			Hydropower's Biogenic Carbon Footprint	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; MODEL SELECTION; RESOLUTION; WATER; RESERVOIRS	Global warming is accelerating and the world urgently needs a shift to clean and renewable energy. Hydropower is currently the largest renewable source of electricity, but its contribution to climate change mitigation is not yet fully understood. Hydroelectric reservoirs are a source of biogenic greenhouse gases and in individual cases can reach the same emission rates as thermal power plants. Little is known about the severity of their emissions at the global scale. Here we show that the carbon footprint of hydropower is far higher than previously assumed, with a global average of 173 kg CO2 and 2.95 kg CH4 emitted perMWh of electricity produced. This results in a combined average carbon footprint of 273 kg CO2e/MWh when using the global warming potential over a time horizon of 100 years (GWP100). Nonetheless, this is still below that of fossil energy sources without the use of carbon capture and sequestration technologies. We identified the dams most promising for capturing methane for use as alternative energy source. The spread among the similar to 1500 hydropower plants analysed in this study is large and highlights the importance of case-by-case examinations.	[Scherer, Laura; Pfister, Stephan] ETH, Inst Environm Engn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Scherer, L (corresponding author), ETH, Inst Environm Engn, Zurich, Switzerland.	scherer@ifu.baug.ethz.ch	Pfister, Stephan/B-1317-2011; Pfister, Stephan/AAE-8615-2019	Pfister, Stephan/0000-0001-8984-2041; Pfister, Stephan/0000-0001-8984-2041; Scherer, Laura/0000-0002-0194-9942				Baban SMJ, 2003, WATER RESOUR MANAG, V17, P1, DOI 10.1023/A:1023066705226; Bambace LAW, 2007, ENERGY, V32, P1038, DOI 10.1016/j.energy.2006.09.008; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Barton K., 2016, MUMIN MULTI MODEL IN; CARMA, 2015, CO2 EMISSIONS ENERGY; Chen H, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012410; Cherubini F, 2011, GCB BIOENERGY, V3, P413, DOI 10.1111/j.1757-1707.2011.01102.x; DelSontro T, 2011, ENVIRON SCI TECHNOL, V45, P9866, DOI 10.1021/es2005545; dos Santos MA, 2006, ENERG POLICY, V34, P481, DOI 10.1016/j.enpol.2004.06.015; FAO, 2016, AQUASTAT DAMS; Fearnside PM, 2012, NAT CLIM CHANGE, V2, P382, DOI 10.1038/nclimate1540; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Hertwich EG, 2013, ENVIRON SCI TECHNOL, V47, P9604, DOI 10.1021/es401820p; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kumar A., 2011, IPCC SPECIAL REPORT; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Mendonca R, 2012, NAT GEOSCI, V5, P838, DOI 10.1038/ngeo1653; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Nachtergaele F., 2012, HARMONIZED WORLD SOI; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Paish O, 2002, RENEW SUST ENERG REV, V6, P537, DOI 10.1016/S1364-0321(02)00006-0; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Scherer L, 2016, RENEW ENERG, V99, P711, DOI 10.1016/j.renene.2016.07.021; Scherer L, 2015, INT J LIFE CYCLE ASS, V20, P785, DOI 10.1007/s11367-015-0880-0; Scherer L, 2015, ENVIRON SCI TECHNOL, V49, P4971, DOI 10.1021/acs.est.5b00429; Schlomer S., 2014, CLIMATE CHANGE 2014; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; St Louis VL, 2000, BIOSCIENCE, V50, P766, DOI 10.1641/0006-3568(2000)050[0766:RSASOG]2.0.CO;2; Takeuchi K., 1997, IAHS PUBL, V240; Teodoru C.R., 2012, GLOB BIOGEOCHEM CYCL, V26; Turconi R, 2013, RENEW SUST ENERG REV, V28, P555, DOI 10.1016/j.rser.2013.08.013; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Yuksel I, 2010, RENEW SUST ENERG REV, V14, P462, DOI 10.1016/j.rser.2009.07.025	35	47	47	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0161947	10.1371/journal.pone.0161947	http://dx.doi.org/10.1371/journal.pone.0161947			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626943	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600013
J	Shih, HM; Hsu, TY; Chen, CY; Lin, CL; Kao, CH; Chen, CH; Yang, TY; Chen, WK				Shih, Hong-Mo; Hsu, Tai-Yi; Chen, Chih-Yu; Lin, Cheng-Li; Kao, Chia-Hung; Chen, Chao-Hsien; Yang, Tse-Yen; Chen, Wei-Kung			Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CALCIUM HOMEOSTASIS; DISEASE; EPIDEMIOLOGY; ASSOCIATION; GASTRITIS; WOMEN; MASS	Purpose Previous studies have reported conflicting results on the association between Helicobacter pylori infection and osteoporosis. A few studies have discussed the influence of H. pylori eradication therapy on bone mineral density. Methods We assessed the prevalence of osteoporosis among the H. pylori-infected population in Taiwan and the influence of early and late H. pylori eradication therapy on bone mineral density. Results Using data from Taiwan's National Health Insurance Research Database, we identified 5,447 patients who received H. pylori eradication therapy from 2000 to 2010 and 21,788 controls, frequency-matched according to age, sex, and year of receiving H. pylori eradication therapy. Those who received H. pylori eradication therapy were divided into two groups based on the time interval between the diagnosis of a peptic ulcer and commencement of eradication therapy. The risk of developing osteoporosis was higher in the early H. pylori treatment cohort (hazard ratio [HR] = 1.52, 95% confidence interval [CI] = 1.23-1.89) and late H. pylori treatment cohort (HR = 1.69, 95% CI = 1.39-2.05), compared with the risk in the control cohort. When followed for less than 5 years, both the early and late cohorts had a higher risk of developing osteoporosis (HR = 1.69, 95% CI = 1.32-2.16 and HR = 1.72, 95% CI = 1.38-2.14). However, when the follow-up period was over 5 years, only the late eradication group exhibited a higher incidence of osteoporosis (HR = 1.62, 95% CI = 1.06-2.47). Conclusion The development of osteoporosis is complex and multi-factorial. Via this population-based cohort study and adjustment of possible confounding variables, we found H. pylori infection may be associated with an increased risk of developing osteoporosis in Taiwan. Early eradication could reduce the influence of H. pylori infection on osteoporosis when the follow-up period is greater than 5 years. Further prospective studies are necessary to discover the connection of H. pylori and osteoporosis.	[Shih, Hong-Mo; Hsu, Tai-Yi; Chen, Chih-Yu; Chen, Wei-Kung] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Shih, Hong-Mo; Hsu, Tai-Yi; Chen, Chih-Yu; Lin, Cheng-Li; Chen, Wei-Kung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Chen, Chao-Hsien; Yang, Tse-Yen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Yang, Tse-Yen] China Med Univ, China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yang, TY (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.; Yang, TY (corresponding author), China Med Univ, China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan.	hardawayoung@hotmail.com; yang_t_y@yahoo.com.tw	, ChihYu/J-3855-2013; yang, zhe yan/C-4259-2015	, ChihYu/0000-0001-9986-8413; yang, zhe yan/0000-0002-3165-132X; Shih, Hong-Mo/0000-0001-7732-3594	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project [BM104010092]; NRPB Stroke Clinical Trial Consortium [MOST 103-2325-B-039 -006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	The Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039 -006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. Miss Cheng-Li Lin received her salary from The Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan for providing the service of statistical analysis, which is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002); China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Bio-signature Project (BM104010092); NRPB Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan.	Ali T, 2009, AM J MED, V122, P599, DOI 10.1016/j.amjmed.2009.01.022; Asaoka D, 2015, THER CLIN RISK MANAG, V11, P381, DOI 10.2147/TCRM.S80647; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Ayesh MH, 2013, BRAZ J INFECT DIS, V17, P629, DOI 10.1016/j.bjid.2013.01.009; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; BISBALLE S, 1991, GUT, V32, P1303, DOI 10.1136/gut.32.11.1303; Calvet X, 2013, HELICOBACTER, V18, P5, DOI 10.1111/hel.12071; Chang YP, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/175729; Crabtree JE, 1995, LAB INVEST, V73, P742; DeGerome JH, 1996, JAMA-J AM MED ASSOC, V276, P1034, DOI 10.1001/jama.1996.03540130032015; Del Valle Elisa, 2007, Hemodial Int, V11, P315, DOI 10.1111/j.1542-4758.2007.00186.x; Dolev E, 1997, Harefuah, V132, P511; Figura N, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201743; Fotouk-kiai M, 2015, CASP J INTERN MED, V6, P62; Fujita T, 2001, J BONE MINER METAB, V19, P131, DOI 10.1007/s007740170031; Gillen D, 1998, GASTROENTEROLOGY, V114, P50, DOI 10.1016/S0016-5085(98)70632-8; Hsu CW, 2016, INTENS CARE MED, V42, P38, DOI 10.1007/s00134-015-4044-2; Kakehasi Adriana M., 2007, Arq. Gastroenterol., V44, P266, DOI 10.1590/S0004-28032007000300016; Kalantarhormozi MR, 2016, J BONE MINER METAB, V34, P422, DOI 10.1007/s00774-015-0688-9; Keller J, 2013, OSTEOPOROSIS INT, V24, P2737, DOI 10.1007/s00198-013-2335-4; Kim HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101852; Kouda K, 2011, BONE, V49, P275, DOI 10.1016/j.bone.2011.04.010; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Lin SY, 2015, INT J CLIN PRACT, V69, P604, DOI 10.1111/ijcp.12602; Majumdar D, 2011, MEDICINE, V39, P154; Mangione RA, 2008, AM J HEALTH-SYST PH, V65, P1601, DOI 10.2146/ajhp080097; Maugeri D, 1998, ARCH GERONTOL GERIAT, V27, P159, DOI 10.1016/S0167-4943(98)00110-1; MOSS SF, 1994, GUT, V35, P1567, DOI 10.1136/gut.35.11.1567; Nabwera HM, 1999, J PHYSIOL PHARMACOL, V50, P711; Ngamruengphong S, 2011, AM J GASTROENTEROL, V106, P1209, DOI 10.1038/ajg.2011.113; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pavlovic Drasko, 2007, Lijec Vjesn, V129, P426; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; RECKER RR, 1985, NEW ENGL J MED, V313, P70, DOI 10.1056/NEJM198507113130202; Sawicki A, 2003, OSTEOPOROSIS INT, V14, P983, DOI 10.1007/s00198-003-1459-3; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Suzuki T, 2001, J BONE MINER METAB, V19, P133, DOI 10.1007/s007740170032; Tiwari Shridhar, 2005, Indian J Gastroenterol, V24, P193; TOVEY FI, 1991, BRIT J SURG, V78, P1335, DOI 10.1002/bjs.1800781122; Tucker KL, 2005, J BONE MINER RES, V20, P152, DOI [10.1359/jbmr.2005.20.1.152, 10.1359/JBMR.041018]; Wang CC, 2015, MEDICINE, V94, pe1585; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060	43	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162645	10.1371/journal.pone.0162645	http://dx.doi.org/10.1371/journal.pone.0162645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626940	gold, Green Submitted, Green Published			2022-12-26	WOS:000383680600049
J	Eriksson, O; Wall, A; Olsson, U; Marteinsdottir, I; Holstad, M; Agren, H; Hartvig, P; Langstrom, B; Naessen, T				Eriksson, Olle; Wall, Anders; Olsson, Ulf; Marteinsdottir, Ina; Holstad, Maria; Agren, Hans; Hartvig, Per; Langstrom, Bengt; Naessen, Tord			Women with Premenstrual Dysphoria Lack the Seemingly Normal Premenstrual Right-Sided Relative Dominance of 5-HTP-Derived Serotonergic Activity in the Dorsolateral Prefrontal Cortices - A Possible Cause of Disabling Mood Symptoms	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; REUPTAKE INHIBITORS; GONADAL-STEROIDS; RECEPTOR-BINDING; MENSTRUAL-CYCLE; CORTEX; BRAIN; ASYMMETRY; MODULATION; PET	Study Objective To investigate potential quantitative and qualitative differences in brain serotonergic activity between women with Premenstrual Dysphoria (PMD) and asymptomatic controls. Background Serotonin-augmenting drugs alleviate premenstrual mood symptoms in the majority of women with PMD while serotonin-depleting diets worsen PMD symptoms, both indicating intrinsic differences in brain serotonergic activity in women with PMD compared to asymptomatic women. Methods Positron-emission tomography with the immediate precursor of serotonin, 5-hydroxytryptophan (5-HTP), radiolabelled by 11C in the beta-3 position, was performed in the follicular and luteal phases for 12 women with PMD and 8 control women. Brain radioactivity-a proxy for serotonin precursor uptake and synthesis-was measured in 9 regions of interest (ROIs): the right and left sides of the medial prefrontal cortex, dorsolateral prefrontal cortex, putamen and caudate nucleus, and the single "whole brain". Results There were no significant quantitative differences in brain 5-HTP-derived activity between the groups in either of the menstrual phases for any of the 9 ROIs. However, multivariate analysis revealed a significant quantitative and qualitative difference between the groups. Asymptomatic control women showed a premenstrual right sided relative increase in dorsolateral prefrontal cortex 5-HTP derived activity, whereas PMD women displayed the opposite (p = 0.0001). Menstrual phase changes in this asymmetry (premenstrual-follicular) correlated with changes in self ratings of 'irritability' for the entire group (rs = -0.595, p = 0.006). The PMD group showed a strong inverse correlation between phase changes (pre-menstrual-follicular) in plasma levels of estradiol and phase changes in the laterality (dx/sin) of radiotracer activity in the dorsolateral prefrontal ROI (r(s) = -0.635; 0.027). The control group showed no such correlation. Conclusion Absence of increased premenstrual right-sided relative 5-HTP-derived activity of the dorsolateral prefrontal cortices was found to strongly correlate to premenstrual irritability. A causal relationship here seems plausible, and the findings give further support to an underlying frontal brain disturbance in hormonally influenced serotonergic activity in women with PMD. Because of the small number of subjects in the study, these results should be considered preliminary, requiring verification in larger studies.	[Eriksson, Olle; Naessen, Tord] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Obstet & Gynaecol, Uppsala, Sweden; [Wall, Anders] Univ Uppsala Hosp, Dept Surg Sci, Unit Nucl Med & PET, Uppsala, Sweden; [Olsson, Ulf] Swedish Univ Agr Sci, Unit Appl Stat & Math, Uppsala, Sweden; [Marteinsdottir, Ina] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Holstad, Maria] Univ Uppsala Hosp, Dept Neurosci, Psychiat Unit, Uppsala, Sweden; [Agren, Hans] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Hartvig, Per] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Langstrom, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Swedish University of Agricultural Sciences; Linkoping University; Uppsala University; Uppsala University Hospital; University of Gothenburg; University of Copenhagen; Uppsala University	Eriksson, O (corresponding author), Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Obstet & Gynaecol, Uppsala, Sweden.	olle.eriksson@kbh.uu.se			PET Foundation of the County of Uppsala; Amersham PET Fund; Swedish Medical Society; Soderstrom Konigska Foundation; Swedish Society for Medical Research; Family Planning Foundation of Uppsala University Hospital; Medical Faculty of the University of Uppsala	PET Foundation of the County of Uppsala; Amersham PET Fund; Swedish Medical Society; Soderstrom Konigska Foundation; Swedish Society for Medical Research; Family Planning Foundation of Uppsala University Hospital; Medical Faculty of the University of Uppsala	This study was financed by research grants from the PET Foundation of the County of Uppsala, the Amersham PET Fund, the Swedish Medical Society, the Soderstrom Konigska Foundation, the Swedish Society for Medical Research, and the Family Planning Foundation of Uppsala University Hospital. These were all the funding sources except for a total of about 12 months of salary to perform Clinical research at the Medical Faculty of the University of Uppsala provided to Olle Eriksson, in scattered monthly fractions, by the Medical Faculty of the University of Uppsala after yearly formal applications in competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2013, LATERALITY, V18, P437, DOI 10.1080/1357650X.2012.703206; Accortt EE, 2006, J ABNORM PSYCHOL, V115, P179, DOI 10.1037/0021-843X.115.1.179; Accortt EE, 2011, J AFFECT DISORDERS, V128, P178, DOI 10.1016/j.jad.2010.07.017; Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; AGREN H, 1994, PHARMACOPSYCHIATRY, V27, P2, DOI 10.1055/s-2007-1014265; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSSON JLR, 1995, J NUCL MED, V36, P670; Andrade R, 2011, NEUROPHARMACOLOGY, V61, P382, DOI 10.1016/j.neuropharm.2011.01.015; [Anonymous], 2006, SAS MIXED MODELS; Aznar S, 2013, MOL NEUROBIOL, V48, P841, DOI 10.1007/s12035-013-8472-0; Baller EB, 2013, AM J PSYCHIAT, V170, P305, DOI 10.1176/appi.ajp.2012.12030385; BERGER B, 1988, J COMP NEUROL, V273, P99, DOI 10.1002/cne.902730109; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Berman KF, 1997, P NATL ACAD SCI USA, V94, P8836, DOI 10.1073/pnas.94.16.8836; Berry MD, 1996, NEUROCHEM RES, V21, P1075, DOI 10.1007/BF02532418; Bismark AW, 2010, BIOL PSYCHOL, V83, P153, DOI 10.1016/j.biopsycho.2009.12.002; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brody A L, 2001, Semin Clin Neuropsychiatry, V6, P102, DOI 10.1053/scnp.2001.21837; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Celada P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00025; Davidson RJ, 2000, BIOL PSYCHIAT, V47, P85, DOI 10.1016/S0006-3223(99)00222-X; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Dimmock PW, 2000, LANCET, V356, P1131, DOI 10.1016/S0140-6736(00)02754-9; Donaldson ZR, 2013, CURR OPIN NEUROBIOL, V23, P399, DOI 10.1016/j.conb.2013.01.011; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Eriksson E, 1999, INT CLIN PSYCHOPHARM, V14, pS27; ERIKSSON E, 1990, ACTA PSYCHIAT SCAND, V81, P87, DOI 10.1111/j.1600-0447.1990.tb06455.x; Eriksson O, 2006, PSYCHIAT RES-NEUROIM, V146, P107, DOI 10.1016/j.pscychresns.2005.02.012; Eriksson O, 2006, PSYCHONEUROENDOCRINO, V31, P415, DOI 10.1016/j.psyneuen.2005.10.004; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 1997, SCID 2; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Hagberg GE, 2002, J CEREBR BLOOD F MET, V22, P1352, DOI 10.1097/01.WCB.0000040946.89393.9d; HAMMARBACK S, 1989, J PSYCHOSOM OBST GYN, V10, P25, DOI 10.3109/01674828909016676; Harlow SD, 2012, J CLIN ENDOCR METAB, V97, P1159, DOI 10.1210/jc.2011-3362; HARTVIG P, 1992, J NEURAL TRANSM-GEN, V88, P1, DOI 10.1007/BF01245032; Hecht David, 2013, Exp Neurobiol, V22, P173, DOI 10.5607/en.2013.22.3.173; Johansson J, 1994, SOUND RECORDING JAZZ; Johnson RA., 2007, APPL MULTIVARIATE ST; Jovanovic H, 2006, PSYCHIAT RES-NEUROIM, V148, P185, DOI 10.1016/j.pscychresns.2006.05.002; Kavoussi R, 1997, PSYCHIAT CLIN N AM, V20, P395, DOI 10.1016/S0193-953X(05)70319-1; Kim D R, 2004, Arch Womens Ment Health, V7, P37, DOI 10.1007/s00737-003-0027-3; Kranz GS, 2014, PSYCHONEUROENDOCRINO, V45, P1, DOI 10.1016/j.psyneuen.2014.03.004; Kugaya A, 2003, AM J PSYCHIAT, V160, P1522, DOI 10.1176/appi.ajp.160.8.1522; Landen M, 2001, PSYCHOPHARMACOLOGY, V155, P292, DOI 10.1007/s002130100718; LEARY PM, 1979, S AFR MED J, V55, P666; Leiser SC, 2015, ACS CHEM NEUROSCI, V6, P970, DOI 10.1021/cn500340j; Lindner KJ, 1997, NUCL MED BIOL, V24, P733, DOI 10.1016/S0969-8051(97)00114-5; LLOYD KG, 1972, J NEUROCHEM, V19, P1549, DOI 10.1111/j.1471-4159.1972.tb05099.x; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Marjoribanks J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001396.pub3; Mathersul D, 2008, EMOTION, V8, P560, DOI 10.1037/a0012811; Mengod G, 2015, ACS CHEM NEUROSCI, V6, P1089, DOI 10.1021/acschemneuro.5b00023; MENKES DB, 1994, J AFFECT DISORDERS, V32, P37, DOI 10.1016/0165-0327(94)90059-0; Moses EL, 2000, BIOL PSYCHIAT, V48, P854, DOI 10.1016/S0006-3223(00)00967-7; Moses-Kolko EL, 2003, FERTIL STERIL, V80, P554, DOI 10.1016/S0015-0282(03)00973-7; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; New AS, 2009, BIOL PSYCHIAT, V66, P1107, DOI 10.1016/j.biopsych.2009.07.015; NYBERG P, 1982, J NEURAL TRANSM, V54, P85, DOI 10.1007/BF01249281; Olivier B, 2015, EUR J PHARMACOL, V753, P2, DOI 10.1016/j.ejphar.2014.10.031; Olsson U., 2011, STAT LIFE SCI; Olsson U, 2011, STAT LIFE SCI, V2; Perach-Barzilay N, 2013, SOC NEUROSCI-UK, V8, P178, DOI 10.1080/17470919.2012.720602; Protopopescu X, 2005, P NATL ACAD SCI USA, V102, P16060, DOI 10.1073/pnas.0502818102; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Schmidt PJ, 1998, NEW ENGL J MED, V338, P209, DOI 10.1056/NEJM199801223380401; SUGERMAN A A, 1970, Research Communications in Chemical Pathology and Pharmacology, V1, P526; SUMNER BEH, 1995, J STEROID BIOCHEM, V54, P15, DOI 10.1016/0960-0760(95)00075-B; Visser AKD, 2011, EUR J NUCL MED MOL I, V38, P576, DOI 10.1007/s00259-010-1663-2; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yang YL, 2009, PSYCHIAT RES-NEUROIM, V174, P81, DOI 10.1016/j.pscychresns.2009.03.012; Yang YL, 2005, BIOL PSYCHIAT, V57, P1103, DOI 10.1016/j.biopsych.2005.01.021; Yonkers KA, 2008, LANCET, V371, P1200, DOI 10.1016/S0140-6736(08)60527-9	74	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0159538	10.1371/journal.pone.0159538	http://dx.doi.org/10.1371/journal.pone.0159538			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27617751	gold, Green Published, Green Submitted			2022-12-26	WOS:000383653100001
J	Kim, JE; Go, J; Koh, EK; Song, SH; Sung, JE; Lee, HA; Lee, YH; Hong, JT; Hwang, DY				Kim, Ji Eun; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Lee, Hyun Ah; Lee, Young Hee; Hong, Jin Tae; Hwang, Dae Youn			Gallotannin-Enriched Extract Isolated from Galla Rhois May Be a Functional Candidate with Laxative Effects for Treatment of Loperamide-Induced Constipation of SD Rats	PLOS ONE			English	Article							TANNINS; POMEGRANATE; INHIBITION; GROWTH; LEAVES; CELLS	Several natural products containing tannins are used as traditional medicines for treatment of constipation; however, their pharmacological mechanism is not well understood. The laxative effects of gallotannin-enriched extract isolated from Galla Rhois (GEGR) were investigated using a constipation model induced by loperamide (Lop) injection. After analysis for antioxidant activity of GEGR, alterations in the excretion parameters, histological structure, mucin secretion, and related protein levels were measured in the transverse colon of Sprague Dawley (SD) rats with Lop-induced constipation following treatment with 250, 500 and 1,000 mg/ml of GEGR. The number and weight of feces increased significantly by 48-79% and 128-159%, respectively, in the Lop+GEGR treated group relative to the Lop+vehicle treated group, while food intake and water consumption were maintained at a constant level. The thickness of mucosa, muscle and flat luminal surface, as well as the number of goblet cells and crypt of lieberkuhnwere enhanced in the Lop+GEGR treated group. Moreover, mucin secretion increased significantly in a dose dependent manner in the Lop+GEGR treated group. Furthermore, the downstream signaling pathway of the muscarinic acetylcholine receptors (mAChR) M2 and M3 was recovered by GEGR treatment, although the expression level varied. The levels of Ga expression and inositol triphosphate (IP3) concentration were also recovered in the Lop+GEGR treated group relative to the Lop+vehicle treated group. The results of the present study provide strong evidence that tannins distributed in various medicinal plants are important candidates for improving chronic constipation induced by Lop treatment in animal models.	[Kim, Ji Eun; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Lee, Hyun Ah; Hwang, Dae Youn] Pusan Natl Univ, Dept Biomat Sci, Coll Nat Resources & Life Sci, Life & Ind Convergence Res Inst, Miryang, South Korea; [Lee, Young Hee] Pusan Natl Univ, Dept Organ Mat Sci & Engn, Busan, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungju, South Korea	Pusan National University; Pusan National University; Chungbuk National University	Hwang, DY (corresponding author), Pusan Natl Univ, Dept Biomat Sci, Coll Nat Resources & Life Sci, Life & Ind Convergence Res Inst, Miryang, South Korea.	dyhwang@pusan.ac.kr	Lee, Young Hee/A-5424-2013		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2058360]; Korea Institute of Planning Evaluation for Technology of Food, Agriculture, Forestry and Fisheries [114034-03-1-HD030]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Institute of Planning Evaluation for Technology of Food, Agriculture, Forestry and Fisheries	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2058360).; We thank Jin Hyang Hwang and the animal technicians for directing the Animal Facility and Care at the Laboratory Animal Resources Center. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2058360) and the Korea Institute of Planning Evaluation for Technology of Food, Agriculture, Forestry and Fisheries (grant no. 114034-03-1-HD030).	Abbas S, 2012, PHYTOTHER RES, V26, P704, DOI 10.1002/ptr.3634; AHN T, 1994, BIOCHEM BIOPH RES CO, V203, P326, DOI 10.1006/bbrc.1994.2185; Ahn YJ, 1998, J APPL MICROBIOL, V84, P439, DOI 10.1046/j.1365-2672.1998.00363.x; [Anonymous], 1969, FOOD COSMET TOXICOL, V7, P364; Ata N, 1996, ONCOL RES, V8, P503; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Burleigh DE, 1998, EUR J PHARMACOL, V152, P39; CELIK AF, 1995, ALIMENT PHARM THER, V9, P63; Cha ChunNam, 2013, Journal of Veterinary Clinics, V30, P353; Chae HS, 2010, AM J CHINESE MED, V38, P973, DOI 10.1142/S0192415X10008391; Clinton C, 2009, NAT MED J, V1, P13; De Lillo AR, 2000, AM J GASTROENTEROL, V95, P901, DOI 10.1016/S0002-9270(00)00718-8; Go Jun, 2015, Lab Anim Res, V31, P101, DOI 10.5625/lar.2015.31.3.101; Guarize L, 2012, NAT PROD RES, V26, P331, DOI 10.1080/14786411003754264; Hs S Oz, 2005, J NUTR BIOCH, V16, P297; Karlsson NG, 1997, J BIOL CHEM, V272, P27025, DOI 10.1074/jbc.272.43.27025; 차준남, 2013, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V28, P95, DOI 10.13103/JFHS.2013.28.2.095; Khalif IL, 2005, DIGEST LIVER DIS, V37, P838, DOI 10.1016/j.dld.2005.06.008; Khan N, 2007, CANCER RES, V67, P3475, DOI 10.1158/0008-5472.CAN-06-3941; Kim JE, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-333; Kim SH, 2005, INT IMMUNOPHARMACOL, V5, P1820, DOI 10.1016/j.intimp.2005.06.007; Kumari M, 2012, RES J RECENT SCI, V1, P70; Lee HY, 2012, FOOD CHEM TOXICOL, V50, P895, DOI 10.1016/j.fct.2011.12.001; Lee JJ, 2012, AVIAN PATHOL, V41, P403, DOI 10.1080/03079457.2012.702888; Lee S. M., 1997, J APPL ENTOMOL, V36, P83; Lee TY, 2006, J PHARM PHARMACOL, V58, P659, DOI 10.1211/jpp.58.5.0011; Lee YH, 2015, TEXT RES J, V85, P1045, DOI 10.1177/0040517514559580; Lee YH, 2009, MATERIALS, V2, P10, DOI 10.3390/ma2010010; Meite S, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-7; Najeeb-ur-Rehman, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-16; Oh H, 2003, PHYTOTHER RES, V17, P417, DOI 10.1002/ptr.1148; Philippe D, 2003, J CLIN INVEST, V111, P1329, DOI 10.1172/JCI200316750; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V126, P203, DOI 10.1016/S1095-6433(00)00194-X; Voderholzer WA, 1997, AM J GASTROENTEROL, V92, P95; Walia R, 2009, CURR OPIN PEDIATR, V21, P661, DOI 10.1097/MOP.0b013e32832ff241; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Zoppi G, 1998, ACTA PAEDIATR, V87, P836, DOI 10.1080/080352598750013590	39	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161144	10.1371/journal.pone.0161144	http://dx.doi.org/10.1371/journal.pone.0161144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618438	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100006
J	Li, YL; Ning, ZY; Cui, D; Mao, W; Bi, JD; Zhao, XY				Li, Yulin; Ning, Zhiying; Cui, Duo; Mao, Wei; Bi, Jingdong; Zhao, Xueyong			Litter Decomposition in a Semiarid Dune Grassland: Neutral Effect of Water Supply and Inhibitory Effect of Nitrogen Addition	PLOS ONE			English	Article							LEAF-LITTER; FOLIAR LITTER; ROOT; RAINFALL; QUALITY; DESERT; PRECIPITATION; RESPONSES; DYNAMICS; RELEASE	Background The decomposition of plant material in arid ecosystems is considered to be substantially controlled by water and N availability. The responses of litter decomposition to external N and water, however, remain controversial, and the interactive effects of supplementary N and water also have been largely unexamined. Methodology/Principal Findings A 3.5-year field experiment with supplementary nitrogen and water was conducted to assess the effects of N and water addition on mass loss and nitrogen release in leaves and fine roots of three dominant plant species (i.e., Artemisia halondendron, Setaria viridis, and Phragmites australis) with contrasting substrate chemistry (e.g. N concentration, lignin content in this study) in a desertified dune grassland of Inner Mongolia, China. The treatments included N addition, water addition, combination of N and water, and an untreated control. The decomposition rate in both leaves and roots was related to the initial litter N and lignin concentrations of the three species. However, litter quality did not explain the slower mass loss in roots than in leaves in the present study, and thus warrant further research. Nitrogen addition, either alone or in combination with water, significantly inhibited dry mass loss and N release in the leaves and roots of the three species, whereas water input had little effect on the decomposition of leaf litter and fine roots, suggesting that there was no interactive effect of supplementary N and water on litter decomposition in this system. Furthermore, our results clearly indicate that the inhibitory effects of external N on dry mass loss and nitrogen release are relatively strong in high-lignin litter compared with low-lignin litter. Conclusion/Significance These findings suggest that increasing precipitation hardly facilitates ecosystem carbon turnover but atmospheric N deposition can enhance carbon sequestration and nitrogen retention in desertified dune grasslands of northern China. Additionally, litter quality of plant species should be considered when modelling the carbon cycle and nutrient dynamics of this system.	[Li, Yulin; Ning, Zhiying; Cui, Duo; Mao, Wei; Bi, Jingdong; Zhao, Xueyong] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, 320 Donggang West Rd, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Li, YL (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, 320 Donggang West Rd, Lanzhou 730000, Peoples R China.	liyl@lzb.ac.cn			China national key research and development plan [2016YFC0500907]; National natural Science Foundation of China [31270501, 41471083]; "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences [XDA05050406]	China national key research and development plan; National natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was financially supported by China national key research and development plan (2016YFC0500907), the National natural Science Foundation of China (31270501 and 41471083), and "Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences (XDA05050406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Araujo PI, 2012, OECOLOGIA, V168, P221, DOI 10.1007/s00442-011-2063-4; Austin AT, 2006, NATURE, V442, P555, DOI 10.1038/nature05038; Austin AT, 2011, TRENDS ECOL EVOL, V26, P229, DOI 10.1016/j.tree.2011.02.003; Austin AT, 2009, ECOLOGY, V90, P2642, DOI 10.1890/08-1804.1; Austin AT, 2000, J ECOL, V88, P129, DOI 10.1046/j.1365-2745.2000.00437.x; Brandt LA, 2010, ECOSYSTEMS, V13, P765, DOI 10.1007/s10021-010-9353-2; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Compton JE, 2004, FOREST ECOL MANAG, V196, P143, DOI 10.1016/j.foreco.2004.03.017; Cusack DF, 2009, GLOBAL CHANGE BIOL, V15, P1339, DOI 10.1111/j.1365-2486.2008.01781.x; Dence C.W., 1992, METHODS LIGNIN CHEM, P33, DOI [DOI 10.1007/978-3-642-74065-7_3, 10.1007/978-3-642-74065-7_3]; Fujii S, 2010, SOIL BIOL BIOCHEM, V42, P2224, DOI 10.1016/j.soilbio.2010.08.022; Gholz HL, 2000, GLOBAL CHANGE BIOL, V6, P751, DOI 10.1046/j.1365-2486.2000.00349.x; Giese M, 2009, APPL SOIL ECOL, V41, P8, DOI 10.1016/j.apsoil.2008.08.002; Hamadi Z, 2000, J ARID ENVIRON, V46, P281, DOI 10.1006/jare.2000.0672; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Kemp PR, 2003, J ARID ENVIRON, V53, P21, DOI 10.1006/jare.2002.1025; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Lee H, 2014, SOIL BIOL BIOCHEM, V72, P123, DOI 10.1016/j.soilbio.2014.01.027; Liu P, 2006, APPL SOIL ECOL, V34, P266, DOI 10.1016/j.apsoil.2005.12.009; Liu P, 2010, OECOLOGIA, V162, P771, DOI 10.1007/s00442-009-1506-7; Liu X. M., 1996, WIND SANDY ENV VEGET; Lue C., 2007, J GEOPHYS RES, V112, DOI [DOI 10.1029/2006JD007990, 10. 1029/2006JD007990]; Magill AH, 1998, PLANT SOIL, V203, P301, DOI 10.1023/A:1004367000041; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Osono T, 2006, SOIL BIOL BIOCHEM, V38, P2743, DOI 10.1016/j.soilbio.2006.04.028; Ostertag R, 1999, OECOLOGIA, V121, P564, DOI 10.1007/s004420050963; Papa S, 2008, APPL SOIL ECOL, V40, P401, DOI 10.1016/j.apsoil.2008.06.013; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Pucheta E, 2006, AUSTRAL ECOL, V31, P808, DOI 10.1111/j.1442-9993.2006.01635.x; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; STEINBERGER Y, 1990, OECOLOGIA, V82, P322, DOI 10.1007/BF00317478; Sullivan NH, 1999, BIOTROPICA, V31, P382, DOI 10.1111/j.1744-7429.1999.tb00380.x; Swift MJ, 1979, DECOMPOSITION IN TER; Throop Heather L., 2009, V70, P171, DOI 10.1007/978-3-540-68421-3_8; Treonis AM, 2000, FUNCT ECOL, V14, P460, DOI 10.1046/j.1365-2435.2000.00442.x; Vanderbilt KL, 2008, J ARID ENVIRON, V72, P696, DOI 10.1016/j.jaridenv.2007.10.010; Vivanco L, 2011, GLOBAL CHANGE BIOL, V17, P1963, DOI 10.1111/j.1365-2486.2010.02344.x; Wang XY, 2013, FRESEN ENVIRON BULL, V22, P12; WHITFORD WG, 1986, OECOLOGIA, V68, P512, DOI 10.1007/BF00378764; Yahdjian L, 2006, ECOSYSTEMS, V9, P128, DOI 10.1007/s10021-004-0118-7; Zhao HL, 2006, CATENA, V65, P71, DOI 10.1016/j.catena.2005.10.001; Zhou RL, 2008, GEODERMA, V145, P370, DOI 10.1016/j.geoderma.2008.04.003	48	19	22	15	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162663	10.1371/journal.pone.0162663	http://dx.doi.org/10.1371/journal.pone.0162663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617439	Green Submitted, gold, Green Published			2022-12-26	WOS:000383653100040
J	Wang, CY; Li, CX; Wei, H; Xie, YZ; Han, WJ				Wang, Chaoying; Li, Changxiao; Wei, Hong; Xie, Yingzan; Han, Wenjiao			Effects of Long-Term Periodic Submergence on Photosynthesis and Growth of Taxodium distichum and Taxodium ascendens Saplings in the Hydro-Fluctuation Zone of the Three Gorges Reservoir of China	PLOS ONE			English	Article							TAMARACK LARIX-LARICINA; SPRUCE PICEA-MARIANA; PLANT-RESPONSES; MORPHOLOGICAL RESPONSES; FLOODING TOLERANCE; ANOXIA TOLERANCE; SEEDLINGS; WATER; SURVIVAL; FOREST	Responses of bald cypress (Taxodium distichum) and pond cypress (Taxodium ascendens) saplings in photosynthesis and growth to long-termperiodic submergence in situ in the hydro-fluctuation zone of the Three Gorges Dam Reservoir (TGDR) were studied. Water treatments of periodic deep submergence (DS) and moderate submergence (MS) in situ were imposed on 2-year-old bald cypress and pond cypress saplings. The effects of periodic submergence on photosynthesis and growth were investigated after 3 years (i.e. 3 cycles) compared to a control (i.e. shallow submergence, abbreviated as SS). Results showed that pond cypress had no significant change in net photosynthetic rate (P-n) in response to periodic moderate and deep submergence in contrast to a significant decrease in Pn of bald cypress under both submergence treatments, when compared to that of SS. Ratios of Chlorophyll a/b and Chlorophylls/Carotenoid of pond cypress were significantly increased in periodic moderate submergence and deep submergence, while bald cypress showed no significant change. Diameter at breast height (DBH) and tree height of both species were significantly reduced along with submergence depth. Relative diameter and height growth rates of the two species were also reduced under deeper submergence. Moreover, bald cypress displayed higher relative diameter growth rate than pond cypress under deep submergence mainly attributed to higher productivity of the larger crown area of bald cypress. When subjected to deep subergence, both species showed significant reduction in primary branch number, while in moderate submergence, bald cypress but not pond cypress showed significant reduction in primary branch number. These results indicate that both bald cypress and pond cypress are suitbale candidates for reforestation in the TGDR region thanks to their submergence tolerance characteristics, but bald cypress can grow better than pond cypress under deep submergence overall.	[Wang, Chaoying; Li, Changxiao; Wei, Hong; Xie, Yingzan; Han, Wenjiao] Southwest Univ, Key Lab Ecoenvironm Gorges Reservoir Reg 3, Minist Educ,Sch Life Sci, Chongqing Key Lab Plant Ecol & Resources Gorges R, Chongqing 400715, Peoples R China	Southwest University - China	Li, CX (corresponding author), Southwest Univ, Key Lab Ecoenvironm Gorges Reservoir Reg 3, Minist Educ,Sch Life Sci, Chongqing Key Lab Plant Ecol & Resources Gorges R, Chongqing 400715, Peoples R China.	lichangx@swu.edu.cn	Changxiao, Li/ABF-6885-2020	WEI, Hong/0000-0001-9073-0928; Li, Changxiao/0000-0002-5090-6201	Chongqing Municipality Key Forestry Research Project [Yulinkeyan 2015-6, Yulinkeyan 2016-8]; International Sci-Tech Cooperation Project of Ministry of Science and Technology [2015DFA90900]; Forestry Extension Project of China Central Finance [Yulinketui 2014-10]	Chongqing Municipality Key Forestry Research Project; International Sci-Tech Cooperation Project of Ministry of Science and Technology; Forestry Extension Project of China Central Finance	This study was supported by Chongqing Municipality Key Forestry Research Project (Nos. Yulinkeyan 2015-6, 2016-8), International Sci-Tech Cooperation Project of Ministry of Science and Technology (No. 2015DFA90900) and Forestry Extension Project of China Central Finance (No. Yulinketui 2014-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PH, 1999, PHOTOSYNTHETICA, V37, P543, DOI 10.1023/A:1007163206642; Angelov MN, 1996, TREE PHYSIOL, V16, P477; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Berry J. A., 1982, Photosynthesis. Volume II. Development, carbon metabolism, and productivity, P263; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Conner WH., 1997, WETL ECOL MANAG, V5, P99, DOI [10.1023/A:1008251127131, DOI 10.1023/A:1008251127131]; Crawford RMM, 2003, CAN J BOT, V81, P1224, DOI [10.1139/B03-127, 10.1139/b03-127]; CRAWFORD RMM, 1992, ADV ECOL RES, V23, P93, DOI 10.1016/S0065-2504(08)60147-6; Das KK, 2005, PLANT SCI, V168, P131, DOI 10.1016/j.plantsci.2004.07.023; Das KK, 2009, ENVIRON EXP BOT, V66, P425, DOI 10.1016/j.envexpbot.2009.02.015; Dixon MD, 2015, ECOHYDROLOGY, V8, P812, DOI 10.1002/eco.1613; Effler RS, 2006, FOREST ECOL MANAG, V226, P330, DOI 10.1016/j.foreco.2006.02.011; Elcan JM, 2002, PHOTOSYNTHETICA, V40, P177, DOI 10.1023/A:1021381204684; Fan Da-Yong, 2015, Chinese Journal of Plant Ecology, V39, P416, DOI 10.17521/cjpe.2015.0041; FISHER HM, 1990, FOREST SCI, V36, P18; Striker GG, 2012, ECOL RES, V27, P983, DOI 10.1007/s11284-012-0978-9; Gardiner ES, 2001, TREE PHYSIOL, V21, P1103, DOI 10.1093/treephys/21.15.1103; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P1, DOI [10.1071/PP98095_ER, 10.1071/PP98095]; Gimeno V, 2012, ENVIRON EXP BOT, V78, P47, DOI 10.1016/j.envexpbot.2011.12.014; Gravatt DA, 1998, TREE PHYSIOL, V18, P411; Greenway H, 2003, FUNCT PLANT BIOL, V30, P999, DOI 10.1071/PP98096; Griffiths H, 2002, ANN BOT-LONDON, V89, P801, DOI 10.1093/aob/mcf159; Islam MA, 2004, TREES-STRUCT FUNCT, V18, P35, DOI 10.1007/s00468-003-0276-9; Islam MA, 2003, TREE PHYSIOL, V23, P545, DOI 10.1093/treephys/23.8.545; Ismail MR, 1996, SCI HORTIC-AMSTERDAM, V65, P229, DOI 10.1016/0304-4238(96)00897-7; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jackson MB, 2009, ANN BOT-LONDON, V103, P137, DOI 10.1093/aob/mcn242; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; KEELAND BD, 1995, CAN J FOREST RES, V25, P1084, DOI 10.1139/x95-120; Kozlowski TT, 2002, WETLANDS, V22, P550, DOI 10.1672/0277-5212(2002)022[0550:PEIOFO]2.0.CO;2; Kozlowski TT, 1997, TREE PHYSL MONOGR, V1, P1, DOI [DOI 10.1093/TREEPHYS/17.7.490, 10.1093/treephys/17.7.490]; Lavinsky AO, 2007, NEW FOREST, V34, P41, DOI 10.1007/s11056-006-9036-1; Lei ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091394; Li ChangXiao, 2010, Scientia Silvae Sinicae, V46, P144; Li CX, 2010, PLANT SOIL, V329, P481, DOI 10.1007/s11104-009-0174-z; Li ChangXiao, 2005, Scientia Silvae Sinicae, V41, P28; [李昌晓 Li Changxiao], 2005, [生态学报, Acta Ecologica Sinica], V25, P1953; Li CX, 2007, FRONT FOREST CHINA, V2, P310, DOI [10.1007/s11461-007-0050-z, DOI 10.1007/S11461-007-0050-Z]; Li X, 2011, ACTA ECOLOGICA SINIC, V31, P31, DOI DOI 10.1002/SIM.4341; Liu YF, 2006, J CHONGQING THREE GO, V22, P4; Liu ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107636; Lu ZJ, 2010, PLANT ECOL, V209, P153, DOI 10.1007/s11258-010-9732-y; Lundberg CJ, 2011, ECOL ENG, V37, P549, DOI 10.1016/j.ecoleng.2010.11.012; Luo FL, 2009, ANN BOT-LONDON, V104, P1435, DOI 10.1093/aob/mcp257; Lv Q, 2010, THESIS; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Masaka K, 2012, J FOREST RES-JPN, V17, P421, DOI 10.1007/s10310-011-0306-1; MEGONIGAL JP, 1992, ECOLOGY, V73, P1182, DOI 10.2307/1940668; Mielke MS, 2010, TREE PHYSIOL, V30, P45, DOI 10.1093/treephys/tpp095; Mielke MS, 2010, ENVIRON EXP BOT, V68, P113, DOI 10.1016/j.envexpbot.2009.11.007; New T, 2008, BIODIVERS CONSERV, V17, P3149, DOI 10.1007/s10531-008-9416-2; Ortuno MF, 2007, BIOL PLANTARUM, V51, P292, DOI 10.1007/s10535-007-0058-0; Palta MM, 2012, WETLANDS, V32, P59, DOI 10.1007/s13157-011-0245-9; Parad GA, 2013, TREES-STRUCT FUNCT, V27, P1387, DOI 10.1007/s00468-013-0886-9; Pena-Fronteras JT, 2009, ANN BOT-LONDON, V103, P295, DOI 10.1093/aob/mcn085; PEZESHKI S R, 1987, Wetlands, V7, P1; Pezeshki S.R., 1996, WETL ECOL MANAG, V4, P245; Pezeshki SR, 2007, ECOL ENG, V29, P56, DOI 10.1016/j.ecoleng.2006.07.014; Pezeshki SR, 2006, J AM WATER RESOUR AS, V42, P191, DOI 10.1111/j.1752-1688.2006.tb03833.x; Pezeshki SR, 1998, PHOTOSYNTHETICA, V35, P381, DOI 10.1023/A:1006912318352; PEZESHKI SR, 1994, PHOTOSYNTHETICA, V30, P59; Pezeshki SR, 1999, J PLANT NUTR, V22, P1481, DOI 10.1080/01904169909365729; [秦洪文 Qin Hongwen], 2014, [中国农学通报, Chinese Agricultural Science Bulletin], V30, P284; Ronzhina DA, 2004, RUSS J PLANT PHYSL+, V51, P21, DOI 10.1023/B:RUPP.0000011299.93961.8f; Scholes JD, 1997, OECOLOGIA, V109, P41, DOI 10.1007/s004420050056; Stiller V, 2009, ENVIRON EXP BOT, V67, P164, DOI 10.1016/j.envexpbot.2009.03.012; Striker GG, 2008, J AGRON CROP SCI, V194, P249, DOI 10.1111/j.1439-037X.2008.00317.x; Tan Shu-Duan, 2009, Wuhan Zhiwuxue Yanjiu, V27, P391; Tan SD, 2010, ACTA PHYSIOL PLANT, V32, P133, DOI 10.1007/s11738-009-0388-y; Tang JL, 2015, ENVIRON SCI POLLUT R, V22, P16709, DOI 10.1007/s11356-015-4805-z; van Eck WHJM, 2006, HYDROBIOLOGIA, V565, P59, DOI 10.1007/s10750-005-1905-7; van Eck WHJM, 2005, AQUAT BOT, V81, P253, DOI 10.1016/j.aquabot.2004.10.006; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Vann CD, 2002, ENVIRON POLLUT, V116, pS31, DOI 10.1016/S0269-7491(01)00244-5; Wang AF, 2013, ANN FOREST SCI, V70, P781, DOI 10.1007/s13595-013-0325-5; Xu ZZ, 2010, PLANT SIGNAL BEHAV, V5, P649, DOI 10.4161/psb.5.6.11398; Yordanov I, 2000, PHOTOSYNTHETICA, V38, P171, DOI 10.1023/A:1007201411474; Zhang ZhiYong, 2010, Acta Prataculturae Sinica, V19, P146; Zhu Ni-ni, 2015, Forest Research, V28, P109	79	16	22	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162867	10.1371/journal.pone.0162867	http://dx.doi.org/10.1371/journal.pone.0162867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618547	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100057
J	Danevcic, T; Vezjak, MB; Zorec, M; Stopar, D				Danevcic, Tjasa; Vezjak, Maja Boric; Zorec, Masa; Stopar, David			Prodigiosin - A Multifaceted Escherichia coli Antimicrobial Agent	PLOS ONE			English	Article							SERRATIA-MARCESCENS; BACTERIAL PRODIGININES; ADAPTIVE RESPONSES; BIOSYNTHESIS; ANTICANCER; EXPRESSION; PIGMENT; COLORANTS; CELLS; ATP	Despite a considerable interest in prodigiosin, the mechanism of its antibacterial activity is still poorly understood. In this work, Escherichia coli cells were treated with prodigiosin to determine its antimicrobial effect on bacterial physiology. The effect of prodigiosin was concentration dependent. In prodigiosin treated cells above MIC value no significant DNA damage or cytoplasmic membrane disintegration was observed. The outer membrane, however, becomes leaky. Cells had severely decreased respiration activity. In prodigiosin treated cells protein and RNA synthesis were inhibited, cells were elongated but could not divide. Pre-treatment with prodigiosin improved E. coli survival rate in media containing ampicillin, kanamycin and erythromycin but not phleomycin. The results suggest that prodigiosin acts as a bacteriostatic agent in E. coli cells. If prodigiosin was diluted, cells resumed growth. The results indicate that prodigiosin has distinct mode of antibacterial action in different bacteria.	[Danevcic, Tjasa; Vezjak, Maja Boric; Stopar, David] Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Microbiol Lab, Ljubljana, Slovenia; [Zorec, Masa] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Lab Microbiol & Microbial Biotechnol, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Stopar, D (corresponding author), Univ Ljubljana, Biotech Fac, Dept Food Sci & Technol, Microbiol Lab, Ljubljana, Slovenia.	david.stopar@bf.uni-lj.si			Slovenian Research Agency (ARRS grant) [1000-09-310208]; Slovenian Research Agency [P4-0116]	Slovenian Research Agency (ARRS grant); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The financial support from the Slovenian Research Agency (ARRS grant no. 1000-09-310208). This work was also supported by the Slovenian Research Agency grant P4-0116. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2004, J BACTERIOL, V186, P6133, DOI 10.1128/jb.186.18.6133-6141.2004; Ahn HJ, 2006, APPL ENVIRON MICROB, V72, P7383, DOI 10.1128/AEM.01246-06; Alihosseini F, 2008, BIOTECHNOL PROGR, V24, P742, DOI 10.1021/bp070481r; Alihosseini F, 2010, BIOTECHNOL PROGR, V26, P352, DOI 10.1002/btpr.346; Arivizhivendhan KV, 2015, RSC ADV, V5, P68621, DOI 10.1039/c5ra09172a; Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008; Boric M, 2011, MICROB ECOL, V62, P528, DOI 10.1007/s00248-011-9857-0; BURGER SR, 1985, APPL ENVIRON MICROB, V50, P487, DOI 10.1128/AEM.50.2.487-490.1985; Danevcic T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00027; Danevcic T, 2011, MICROB ECOL, V62, P198, DOI 10.1007/s00248-011-9870-3; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; GERBER N N, 1975, Critical Reviews in Microbiology, V3, P469, DOI 10.3109/10408417509108758; Haddix PL, 2008, J BACTERIOL, V190, P7453, DOI 10.1128/JB.00909-08; HOOD DW, 1992, GENE, V115, P5, DOI 10.1016/0378-1119(92)90533-U; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Ivancic T, 2009, MICROBIOL-SGM, V155, P3461, DOI 10.1099/mic.0.029637-0; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kawasaki T, 2009, J ANTIBIOT, V62, P271, DOI 10.1038/ja.2009.27; Konno H, 1998, J BIOCHEM-TOKYO, V124, P547, DOI 10.1093/oxfordjournals.jbchem.a022147; Lapenda JC, 2015, WORLD J MICROB BIOT, V31, P399, DOI 10.1007/s11274-014-1793-y; Lee JS, 2011, APPL ENVIRON MICROB, V77, P4967, DOI 10.1128/AEM.01986-10; Mansson M, 2011, MAR DRUGS, V9, P1440, DOI 10.3390/md9091440; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; Mensa B, 2011, ANTIMICROB AGENTS CH, V55, P5043, DOI 10.1128/AAC.05009-11; Meschke H, 2012, ENVIRON MICROBIOL, V14, P940, DOI 10.1111/j.1462-2920.2011.02665.x; Neissel OM, 1996, ESCHERICHIA COLI SAL, V2, P1683; Okamoto Hiroshi, 1998, Annals of the Phytopathological Society of Japan, V64, P294, DOI 10.3186/jjphytopath.64.294; Pandey R, 2009, CURR PHARM DESIGN, V15, P732, DOI 10.2174/138161209787582192; Perez-Tomas R, 2003, BIOCHEM PHARMACOL, V66, P1447, DOI 10.1016/S0006-2952(03)00496-9; Perez-Tomas R, 2010, CURR MED CHEM, V17, P2222, DOI 10.2174/092986710791331103; PURKAYASTHA M, 1960, NATURE, V187, P349, DOI 10.1038/187349a0; Radman M, 1974, MOL ENV ASPECTS MUTA, P128; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; RYAZANTSEVA IN, 1995, THERMOCHIM ACTA, V251, P63, DOI 10.1016/0040-6031(94)02148-H; Seganish JL, 2005, CHEM COMMUN, P5781, DOI 10.1039/b511847f; Shireen T, 2013, ANTIMICROB AGENTS CH, V57, P5134, DOI 10.1128/AAC.00780-13; Soto-Cerrato V, 2007, BIOCHEM PHARMACOL, V74, P1340, DOI 10.1016/j.bcp.2007.07.016; Stankovic N, 2014, APPL MICROBIOL BIOT, V98, P3841, DOI 10.1007/s00253-014-5590-1; Stankovic N, 2012, APPL MICROBIOL BIOT, V96, P1217, DOI 10.1007/s00253-012-4237-3; Staric N, 2010, MICROB ECOL, V60, P592, DOI 10.1007/s00248-010-9671-0; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; Szomolay B, 2005, ENVIRON MICROBIOL, V7, P1186, DOI 10.1111/j.1462-2920.2005.00797.x; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531	45	45	48	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162412	10.1371/journal.pone.0162412	http://dx.doi.org/10.1371/journal.pone.0162412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612193	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900092
J	de Sa, PM; Castro, HA; Lopes, AJ; de Melo, PL				de Sa, Paula Morisco; Castro, Hermano Albuquerque; Lopes, Agnaldo Jose; de Melo, Pedro Lopes			Early Diagnosis of Respiratory Abnormalities in Asbestos-Exposed Workers by the Forced Oscillation Technique	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASE; AIRWAY-OBSTRUCTION; IMPEDANCE MEASUREMENTS; INCREASING DEGREES; WESTERN-AUSTRALIA; INPUT IMPEDANCE; CYSTIC-FIBROSIS; MECHANICS; ACCURACY; SMOKING	Background The current reference test for the detection of respiratory abnormalities in asbestos-exposed workers is spirometry. However, spirometry has several shortcomings that greatly affect the efficacy of current asbestos control programs. The forced oscillation technique (FOT) represents the current state-of-the-art technique in the assessment of lung function. This method provides a detailed analysis of respiratory resistance and reactance at different oscillatory frequencies during tidal breathing. Here, we evaluate the FOT as an alternative method to standard spirometry for the early detection and quantification of respiratory abnormalities in asbestos-exposed workers. Methodology/Principalfindings Seventy-two subjects were analyzed. The control group was composed of 33 subjects with a normal spirometric exam who had no history of smoking or pulmonary disease. Thirty-nine subjects exposed to asbestos were also studied, including 32 volunteers in radiological category 0/0 and 7 volunteers with radiological categories of 0/1 or 1/1. FOT data were interpreted using classical parameters as well as integer (InOr) and fractional-order (FrOr) modeling. The diagnostic accuracy was evaluated by investigating the area under the receiver operating characteristic curve (AUC). Exposed workers presented increased obstruction (resistance p<0.001) and a reduced compliance (p<0.001), with a predominance of obstructive changes. The FOT parameter changes were correlated with the standard pulmonary function analysis methods (R = -0.52, p<0.001). Early respiratory abnormalities were identified with a high diagnostic accuracy (AUC = 0.987) using parameters obtained from the FrOr modeling. This accuracy was significantly better than those obtained with classical (p<0.001) and InOr (p<0.001) model parameters. Conclusions The FOT improved our knowledge about the biomechanical abnormalities in workers exposed to asbestos. Additionally, a high diagnostic accuracy in the diagnosis of early respiratory abnormalities in asbestos-exposed workers was obtained. This makes the FOT particularly useful as a screening tool in the context of asbestos control and elimination. Moreover, it can facilitate epidemiological research and the longitudinal follow-up of asbestos exposure and asbestos-related diseases.	[de Sa, Paula Morisco; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil; [de Sa, Paula Morisco; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil; [de Sa, Paula Morisco; de Melo, Pedro Lopes] Univ Estado Rio De Janeiro, Inst Biol, BioVasc Res Lab, Rio De Janeiro, Brazil; [Castro, Hermano Albuquerque] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Lopes, Agnaldo Jose] Univ Estado Rio De Janeiro, Pulm Funct Testing Lab, Fac Med Sci, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal de Juiz de Fora; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, Biomed Instrumentat Lab, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Fac Engn, Rio De Janeiro, Brazil.; de Melo, PL (corresponding author), Univ Estado Rio De Janeiro, Inst Biol, BioVasc Res Lab, Rio De Janeiro, Brazil.	plopes@uerj.br	Melo, Pedro/E-8440-2011; Lopes, Agnaldo José/AAB-5944-2019	Melo, Pedro/0000-0002-2081-6619; Lopes, Agnaldo José/0000-0001-8598-4878	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq); Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ)	The present study was funded by the Brazilian Council of Scientific and Technological Development (Conselho Brasileiro para o Desenvolvimento Cientifico e Tecnologico - CNPq) and the Rio de Janeiro Research Foundation (Fundacao de Apoio a Pesquisa do Estado do Rio de Janeiro - FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A A B, 2010, J OCCUPATIONAL MED T, V5; Alfonso HS, 2005, MED J AUSTRALIA, V183, P184, DOI 10.5694/j.1326-5377.2005.tb06990.x; Alfonso HS, 2005, J OCCUP ENVIRON MED, V47, P573, DOI 10.1097/01.jom.0000165750.54747.27; Alfonso HS, 2004, THORAX, V59, P1052, DOI 10.1136/thx.2004.022806; Ameille J, 2010, AM J RESP CRIT CARE, V182, P526, DOI 10.1164/rccm.200812-1815OC; Bates JHT, 2011, COMPR PHYSIOL, V1, P1233, DOI 10.1002/cphy.c100058; Bates JHT, 2009, LUNG MECHANICS: AN INVERSE MODELING APPROACH, P1, DOI 10.1017/CBO9780511627156; Becklake MR, 2007, INT J TUBERC LUNG D, V11, P356; Boros PW, 2004, RESPIRATION, V71, P374, DOI 10.1159/000079642; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Cavalcanti JV, 2006, RESP MED, V100, P2207, DOI 10.1016/j.rmed.2006.03.009; Croxton Thomas L., 2002, American Journal of Respiratory and Critical Care Medicine, V165, P838; de Melo PL, 2000, MED BIOL ENG COMPUT, V38, P102, DOI 10.1007/BF02344697; de Sa PM, 2013, CLINICS, V68, P644, DOI 10.6061/clinics/2013(05)11; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Di Mango AMGT, 2006, RESP MED, V100, P399, DOI 10.1016/j.rmed.2005.07.005; Faria ACD, 2010, CLINICS, V65, P1295, DOI 10.1590/S1807-59322010001200012; Dias RM, 2007, J BRAS PNEUMOL, V33, pxiii; Diong B, 2007, IEEE ENG MED BIOL, V26, P48, DOI 10.1109/MEMB.2007.289121; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; Faria ACD, 2009, RESPIRATION; Faria ACD, 2016, COMPUT METH PROG BIO, V128, P12, DOI 10.1016/j.cmpb.2016.02.010; Faria ACD, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-22; Faria ACD, 2009, RESPIRATION, V78, P93, DOI 10.1159/000213756; Felten MK, 2014, INT ARCH OCC ENV HEA, V87, P195, DOI 10.1007/s00420-013-0853-1; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FREDBERG JJ, 1989, J APPL PHYSIOL, V67, P2408, DOI 10.1152/jappl.1989.67.6.2408; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hotez PJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001859; International Labour Organization, 2002, GUID US ILO INT CLAS; International Social Security Association, 2010, DAT SOC SEC SOC PROT; Ionescu  C., 2006, ANN DUNAREA JOS U GA, P57; Ionescu C, 2013, HUMAN RESP SYSTEM AN; Ionescu C, 2011, COMPUT METH PROG BIO, V101, P315, DOI 10.1016/j.cmpb.2010.11.010; Ionescu C, 2010, COMPUT METH PROG BIO, V97, P78, DOI 10.1016/j.cmpb.2009.06.006; Ionescu CM, 2014, BIOMED SIGNAL PROCES, V11, P74, DOI 10.1016/j.bspc.2014.02.008; Ionescu CM, 2009, IEEE T BIO-MED ENG, V56, P978, DOI 10.1109/TBME.2008.2004966; JODOIN G, 1971, AM REV RESPIR DIS, V104, P525; Kaminsky DA, 2001, CURR OPIN ALLERGY CL, V1, P205; Langkulsen U, 2006, EUR J PUBLIC HEALTH, V16, P676, DOI 10.1093/eurpub/ckl061; LaPrad AS, 2008, RESP PHYSIOL NEUROBI, V163, P64, DOI 10.1016/j.resp.2008.04.015; Lima AN, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0007-7; Lopes Agnaldo José, 2008, J. bras. pneumol., V34, P264, DOI 10.1590/S1806-37132008000500004; Lopes AJ, 2006, JORNAL BRASILEIRO PN; Lorino AM, 1997, EUR RESPIR J, V10, P150, DOI 10.1183/09031936.97.10010150; Lutchen KR, 1996, J APPL PHYSIOL, V80, P1696, DOI 10.1152/jappl.1996.80.5.1696; MacLeod D, 2001, MED BIOL ENG COMPUT, V39, P505, DOI 10.1007/BF02345140; Magin Richard L., 2004, Critical Reviews in Biomedical Engineering, V32, P1, DOI 10.1615/CritRevBiomedEng.v32.10; Magin RL, 2010, COMPUT MATH APPL, V59, P1586, DOI 10.1016/j.camwa.2009.08.039; Marín Martínez B., 2005, Anales Sis San Navarra, V28, P37; Marsili D, 2013, ANN I SUPER SANITA, V49, P249, DOI 10.4415/ANN_13_03_03; Meraz EG, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-21; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miranda IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061657; Mizell Kelly N, 2009, J Occup Med Toxicol, V4, P14, DOI 10.1186/1745-6673-4-14; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; NAGELS J, 1980, J APPL PHYSIOL, V49, P408, DOI 10.1152/jappl.1980.49.3.408; NAKADATE T, 1995, OCCUP ENVIRON MED, V52, P368, DOI 10.1136/oem.52.6.368; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Nilsson AM, 2014, SCAND J RHEUMATOL, V43, P324, DOI 10.3109/03009742.2013.856466; Ohar J, 2004, CHEST, V125, P744, DOI 10.1378/chest.125.2.744; OOSTVEEN E, 1991, J APPL PHYSIOL, V71, P1813, DOI 10.1152/jappl.1991.71.5.1813; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Park EK, 2014, SAF HEALTH WORK, V5, P234, DOI 10.1016/j.shaw.2014.07.007; Pereira CAC, 1992, J PNEUMOL, V18, P10; PESLIN R, 1986, B EUR PHYSIOPATH RES, V22, P621; Peters U, 2016, APPL PHYSIOL NUTR ME, V41, P538, DOI 10.1139/apnm-2015-0473; PHAM QT, 1995, EUR RESPIR J, V8, P1307, DOI 10.1183/09031936.95.08081307; Pira E, 2009, OCCUP ENVIRON MED, V66, P805, DOI 10.1136/oem.2008.044693; Polkey MI, 2004, EUR RESPIR J, V24, P718, DOI 10.1183/09031936.04.00073104; Qi GS, 2013, J ASTHMA, V50, P45, DOI 10.3109/02770903.2012.743154; Reisch S, 1999, BIOL CYBERN, V81, P25, DOI 10.1007/s004220050542; Reisch S, 1998, Technol Health Care, V6, P245; Sa PM, 2010, IEEE ENG MED BIO, P398, DOI 10.1109/IEMBS.2010.5627284; Sa PM, 2014, 24 C BRAS ENG BIOM U, P73; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Sociedade Brasileira de Pneumologia e Tisiologia SBPT, 2009, J PNEUMOL SUPPL 3, V38; Sridhar D, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001487; STAPLES CA, 1989, AM REV RESPIR DIS, V139, P1502, DOI 10.1164/ajrccm/139.6.1502; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Van Noord J A, 1991, Eur Respir J, V4, P247; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Veiga J, 2009, CLINICS, V64, P649, DOI 10.1590/S1807-59322009000700008; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC; Wang XR, 2010, J OCCUP HEALTH, V52, P272, DOI 10.1539/joh.L10062; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, 2014, COMPR CERV CANC CONT, P1; World Healthy Organization, 2012, OUTL DEV NAT PROGR E; Yang Shieh-Ching, 2009, Chang Gung Med J, V32, P438; 1983, AM REV RESP DIS, V127, P725	90	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161981	10.1371/journal.pone.0161981	http://dx.doi.org/10.1371/journal.pone.0161981			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612198	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900041
J	Watanabe, M; Hashimoto, K; Abe, Y; Kodama, EN; Nabika, R; Oishi, S; Ohara, S; Sato, M; Kawasaki, Y; Fujii, N; Hosoya, M				Watanabe, Masahiro; Hashimoto, Koichi; Abe, Yusaku; Kodama, Eiichi N.; Nabika, Ryota; Oishi, Shinya; Ohara, Shinichiro; Sato, Masatoki; Kawasaki, Yukihiko; Fujii, Nobutaka; Hosoya, Mitsuaki			A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo	PLOS ONE			English	Article							MEASLES-VIRUS; PARAMYXOVIRUS FUSION; INTRAVENTRICULAR INTERFERON; EDMONSTON STRAIN; F-PROTEIN; ENFUVIRTIDE; RIBAVIRIN; RECEPTOR; REGIONS; BRAIN	Subacute sclerosing panencephalitis (SSPE) is a persistent, progressive, and fatal degenerative disease resulting from persistent measles virus (MV) infection of the central nervous system. Most drugs used to treat SSPE have been reported to have limited effects. Therefore, novel therapeutic strategies are urgently required. The SSPE virus, a variant MV strain, differs virologically from wild-type MV strain. One characteristic of the SSPE virus is its defective production of cell-free virus, which leaves cell-to-cell infection as the major mechanism of viral dissemination. The fusion protein plays an essential role in this cell-to-cell spread. It contains two critical heptad repeat regions that forma six-helix bundle in the trimer similar to most viral fusion proteins. In the case of human immunodeficiency virus type-1 (HIV-1), a synthetic peptide derived from the heptad repeat region of the fusion protein enfuvirtide inhibits viral replication and is clinically approved as an anti-HIV-1 agent. The heptad repeat regions of HIV-1 are structurally and functionally similar to those of the MV fusion protein. We therefore designed novel peptides derived from the fusion protein heptad repeat region of the MV and examined their effects on the measles and SSPE virus replication in vitro and in vivo. Some of these synthetic novel peptides demonstrated high antiviral activity against both the measles (Edmonston strain) and SSPE (Yamagata-1 strain) viruses at nanomolar concentrations with no cytotoxicity in vitro. In particular, intracranial administration of one of the synthetic peptides increased the survival rate from 0% to 67% in an SSPE virus-infected nude mouse model.	[Watanabe, Masahiro; Hashimoto, Koichi; Abe, Yusaku; Ohara, Shinichiro; Sato, Masatoki; Kawasaki, Yukihiko; Hosoya, Mitsuaki] Fukushima Med Univ, Dept Pediat, Fukushima, Japan; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Sendai, Miyagi, Japan; [Nabika, Ryota; Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan	Fukushima Medical University; Tohoku University; Kyoto University	Watanabe, M (corresponding author), Fukushima Med Univ, Dept Pediat, Fukushima, Japan.	nabe5658@fmu.ac.jp	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; xing zhi, shi zhi/0000-0003-3289-5681	Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare, Japan	Research Committee of Prion Disease and Slow Virus Infection; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	The work was supported by Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus Infection and from the Ministry of Health, Labour and Welfare, Japan, URL: http://prion.umin.jp/index.html, recipient: MH.; This work was supported by Grants-in-Aid from the Research Committee of Prion Disease and Slow Virus Infection and the Ministry of Health, Labor and Welfare, Japan.	Akiyama M, 2009, J MED MICROBIOL, V58, P638, DOI 10.1099/jmm.0.005439-0; AYATA M, 1991, VIROLOGY, V180, P166, DOI 10.1016/0042-6822(91)90020-C; Ayata M, 2010, J VIROL, V84, P11189, DOI 10.1128/JVI.01075-10; Baricevic M, 2007, VIRUS GENES, V35, P17, DOI 10.1007/s11262-006-0035-2; Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207; CATTANEO R, 1986, VIROLOGY, V154, P97, DOI 10.1016/0042-6822(86)90433-2; CHAMBERS P, 1990, J GEN VIROL, V71, P3075, DOI 10.1099/0022-1317-71-12-3075; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; FUKUYAMA Y, 1987, BRAIN DEV-JPN, V9, P270, DOI 10.1016/S0387-7604(87)80044-X; Gardner AE, 2007, BIOCHEMISTRY-US, V46, P5094, DOI 10.1021/bi6025648; Garg RK, 2008, J NEUROL, V255, P1861, DOI 10.1007/s00415-008-0032-6; GRIFFIN DE, 2007, FIELDS VIROLOGY; HOMMA M, 1982, MICROBIOL IMMUNOL, V26, P1195, DOI 10.1111/j.1348-0421.1982.tb00270.x; HONDA Y, 1994, ANTIMICROB AGENTS CH, V38, P653, DOI 10.1128/AAC.38.4.653; Hosoya M, 2001, ANTIMICROB AGENTS CH, V45, P943, DOI 10.1128/AAC.45.3.943-945.2001; Hosoya M, 2004, ANTIMICROB AGENTS CH, V48, P4631, DOI 10.1128/AAC.48.12.4631-4635.2004; Joly V, 2010, EXPERT OPIN PHARMACO, V11, P2701, DOI 10.1517/14656566.2010.522178; JONES CE, 1982, LANCET, V1, P1034; KOMASE K, 1990, Virus Genes, V4, P163, DOI 10.1007/BF00678407; KUROKI S, 1989, BRAIN DEV-JPN, V11, P65, DOI 10.1016/S0387-7604(89)80012-9; Lambert DM, 1996, P NATL ACAD SCI USA, V93, P2186, DOI 10.1073/pnas.93.5.2186; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Makhortova NR, 2007, VIROLOGY, V362, P235, DOI 10.1016/j.virol.2007.02.033; Moss WJ, 2006, NAT REV MICROBIOL, V4, P900, DOI 10.1038/nrmicro1550; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; OHUCHI R, 1984, MICROBIOL IMMUNOL, V28, P757, DOI 10.1111/j.1348-0421.1984.tb00731.x; Oishi S, 2008, J MED CHEM, V51, P388, DOI 10.1021/jm701109d; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Ozoemena LC, 2004, J MED VIROL, V73, P79, DOI 10.1002/jmv.20050; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; PAULABARBOSA MM, 1981, ANN NEUROL, V9, P400, DOI 10.1002/ana.410090414; Russell CJ, 2004, J VIROL, V78, P13727, DOI 10.1128/JVI.78.24.13727-13742.2004; Salditt A, 2010, J GEN VIROL, V91, P1464, DOI 10.1099/vir.0.018523-0; SCHEID A, 1977, VIROLOGY, V80, P54, DOI 10.1016/0042-6822(77)90380-4; STEINER I, 1989, J CHILD NEUROL, V4, P20, DOI 10.1177/088307388900400103; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Uhlmann V, 2002, J CLIN PATHOL-MOL PA, V55, P84, DOI 10.1136/mp.55.2.84; Wild TF, 1997, J GEN VIROL, V78, P107, DOI 10.1099/0022-1317-78-1-107; Zhu JQ, 2002, BIOCHEM BIOPH RES CO, V299, P897, DOI 10.1016/S0006-291X(02)02761-4	43	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162823	10.1371/journal.pone.0162823	http://dx.doi.org/10.1371/journal.pone.0162823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612283	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900171
J	Lv, Y; Zhang, SY; Liang, XY; Zhang, H; Xu, Z; Liu, B; Xu, MJ; Jiang, CT; Shang, J; Wang, X				Lv, Ying; Zhang, Song-Yang; Liang, Xianyi; Zhang, Heng; Xu, Zhi; Liu, Bo; Xu, Ming-Jiang; Jiang, Changtao; Shang, Jin; Wang, Xian			Adrenomedullin 2 Enhances Beiging in White Adipose Tissue Directly in an Adipocyte-autonomous Manner and Indirectly through Activation of M2 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; energy metabolism; macrophage; obesity; uncoupling protein	GENE-RELATED PEPTIDE; P38 MAP KINASE; INSULIN-RESISTANCE; PROTEIN-KINASE; BROWN ADIPOCYTES; APOLIPOPROTEIN-E; FAT-CELL; IN-VIVO; MICE; INTERMEDIN	Adrenomedullin 2 (ADM2) is an endogenous bioactive peptide belonging to the calcitonin gene-related peptide family. Our previous studies showed that overexpression of ADM2 in mice reduced obesity and insulin resistance by increasing thermogenesis in brown adipose tissue. However, the effects of ADM2 in another type of thermogenic adipocyte, beige adipocytes, remain to be understood. The plasma ADM2 levels were inversely correlated with obesity in humans, and adipo-ADM2-transgenic (tg) mice displayed resistance to high-fat diet-induced obesity with increased energy expenditure. Beiging of subcutaneous white adipose tissues (WAT) was more noticeably induced in high-fat diet-fed transgenic mice with adipocyte-ADM2 overexpression (adipo-ADM2-tg mice) than in WT animals. ADM2 treatment in primary rat subcutaneous adipocytes induced beiging with up-regulation of UCP1 and beiging-related marker genes and increased mitochondrial uncoupling respiration, which was mainly mediated by activation of the calcitonin receptor-like receptor (CRLR)<bold>receptor activity</bold>-modifying protein 1 (RAMP1) complex and PKA and p38 MAPK signaling pathways. Importantly, this adipocyte-autonomous beiging effect by ADM2 was translatable to human primary adipocytes. In addition, M2 macrophage activation also contributed to the beiging effects of ADM2 through catecholamine secretion. Therefore, our study reveals that ADM2 enhances subcutaneous WAT beiging via a direct effect by activating the CRLR<bold>RAMP</bold>1-cAMP/PKA and p38 MAPK pathways in white adipocytes and via an indirect effect by stimulating alternative M2 polarization in macrophages. Through both mechanisms, beiging of WAT by ADM2 results in increased energy expenditure and reduced obesity, suggesting ADM2 as a novel anti-obesity target.	[Lv, Ying; Zhang, Song-Yang; Liang, Xianyi; Liu, Bo; Xu, Ming-Jiang; Jiang, Changtao; Wang, Xian] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Key Lab Mol Cardiovascular Sci,Minist Educ, Beijing 100191, Peoples R China; [Lv, Ying; Zhang, Song-Yang; Liang, Xianyi; Liu, Bo; Xu, Ming-Jiang; Jiang, Changtao; Wang, Xian] Beijing Key Lab Cardiovasc Receptors Res, Beijing 100191, Peoples R China; [Zhang, Heng] Capital Med Univ, Dept Endocrinol, Beijing Chao Yang Hosp, Beijing 100020, Peoples R China; [Xu, Zhi] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100191, Peoples R China; [Shang, Jin] Merck & Co Inc, Dept Cardiometabol Dis, Merck Res Labs, Kenilworth, NJ 07033 USA	Peking University; Capital Medical University; Peking University; Merck & Company	Jiang, CT (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Key Lab Mol Cardiovascular Sci,Minist Educ, Beijing 100191, Peoples R China.; Jiang, CT (corresponding author), Beijing Key Lab Cardiovasc Receptors Res, Beijing 100191, Peoples R China.; Shang, J (corresponding author), Merck & Co Inc, Dept Cardiometabol Dis, Merck Res Labs, Kenilworth, NJ 07033 USA.; Jiang, CT (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100191, Peoples R China.; Shang, J (corresponding author), Merck Res Labs, Dept Cardiometabol Dis, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	jiangchangtao@bjmu.edu.cn; jin_shang@merck.com		Jiang, Changtao/0000-0002-5206-2372; Song-Yang, Zhang/0000-0002-4356-897X	National Natural Science Foundation of the People's Republic of China [31230035, 91439206, 81522007, 81470554]; National Basic Research Program (973 Program) of the People's Republic of China [2012CB518002]; 111 Project of the Chinese Ministry of Education [B07001]; Merck Sharp & Dohme R&D China postdoctoral fellowship	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of the People's Republic of China(National Basic Research Program of China); 111 Project of the Chinese Ministry of Education; Merck Sharp & Dohme R&D China postdoctoral fellowship	This work was supported by National Natural Science Foundation of the People's Republic of China Grants 31230035 and 91439206 (to X. W.) and 81522007 and 81470554 (to C. J.), National Basic Research Program (973 Program) of the People's Republic of China Grant 2012CB518002 (to M. J. X.), 111 Project of the Chinese Ministry of Education Grant B07001, and a Merck Sharp & Dohme R&D China postdoctoral fellowship (to Y. L.). J. S. is an employee of Merck & Co., Inc.	Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; COUSIN B, 1992, J CELL SCI, V103, P931; Dai XY, 2014, CARDIOVASC RES, V101, P297, DOI 10.1093/cvr/cvt254; Dai XY, 2012, J MOL CELL CARDIOL, V53, P509, DOI 10.1016/j.yjmcc.2012.07.006; Dunham-Snary KJ, 2014, REDOX BIOL, V2, P656, DOI 10.1016/j.redox.2014.04.005; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hong YG, 2012, BRIT J PHARMACOL, V166, P110, DOI 10.1111/j.1476-5381.2011.01530.x; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Kuwasako K, 2004, MOL PHARMACOL, V65, P207, DOI 10.1124/mol.65.1.207; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Lu WW, 2015, J HYPERTENS, V33, P1676, DOI 10.1097/HJH.0000000000000597; Lyu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117536; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Morimoto R, 2007, PEPTIDES, V28, P1095, DOI 10.1016/j.peptides.2007.01.018; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Pang YL, 2016, J BIOL CHEM, V291, P12336, DOI 10.1074/jbc.M115.702654; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Qiao X, 2015, NEPHROLOGY, V20, P820, DOI 10.1111/nep.12520; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Shostak A, 2013, ADIPOCYTE, V2, P201, DOI 10.4161/adip.26007; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; TRASFORINI G, 1991, J CLIN ENDOCR METAB, V73, P945, DOI 10.1210/jcem-73-5-945; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Wang C, 2010, BIOMED ENVIRON SCI, V23, P173, DOI 10.1016/S0895-3988(10)60049-9; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Xiang XX, 2015, DIABETES, V64, P519, DOI 10.2337/db14-0427; Zhang H, 2016, INT J OBESITY, V40, P852, DOI 10.1038/ijo.2016.2; Zhang SY, 2016, DIABETES, V65, P2342, DOI 10.2337/db15-1626; Zhang Y, 2014, DIABETES, V63, P514, DOI 10.2337/db13-1106	50	30	31	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23390	23402		10.1074/jbc.M116.735563	http://dx.doi.org/10.1074/jbc.M116.735563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621315	Green Published, hybrid			2022-12-26	WOS:000387884400003
J	Katoh, T; Katayama, T; Tomabechi, Y; Nishikawa, Y; Kumada, J; Matsuzaki, Y; Yamamoto, K				Katoh, Toshihiko; Katayama, Takane; Tomabechi, Yusuke; Nishikawa, Yoshihide; Kumada, Jyunichi; Matsuzaki, Yuji; Yamamoto, Kenji			Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; COMPLEX-TYPE OLIGOSACCHARIDES; TRANSGLYCOSYLATION ACTIVITY; CHEMOENZYMATIC SYNTHESIS; GLYCOSYNTHASE MUTANTS; MOLECULAR-CLONING; ACETYLGLUCOSAMINIDASE-D; CAENORHABDITIS-ELEGANS; HUMAN LACTOFERRIN; HIGH-MANNOSE	Endo-beta-N-acetylglucosaminidase M (Endo-M), an endoglycosidase from the fungus Mucor hiemalis, is a useful tool for chemoenzymatic synthesis of glycoconjugates, including glycoprotein-based therapeutics having a precisely defined glycoform, by virtue of its transglycosylation activity. Although Endo-M has been known to act on various N-glycans, it does not act on core-fucosylated N-glycans, which exist widely in mammalian glycoproteins, thus limiting its application. Therefore, we performed site-directed mutagenesis on Endo-M to isolate mutant enzymes that are able to act on mammalian-type core-1,6-fucosylated glycans. Among the Endo-M mutant enzymes generated, those in which the tryptophan at position 251 was substituted with alanine or asparagine showed altered substrate specificities. Such mutant enzymes exhibited increased hydrolysis of a synthetic alpha 1,6-fucosylated trimannosyl core structure, whereas their activity on the afucosylated form decreased. In addition, among the Trp-251 mutants, the W251N mutant was most efficient in hydrolyzing the core-fucosylated substrate. W251N mutants could act on the immunoglobulin G-derived core-fucosylated glycopeptides and human lactoferrin glycoproteins. This mutant was also capable of transferring the sialyl glycan from an activated substrate intermediate (sialyl glycooxazoline) onto an alpha 1,6-fucosyl-N-acetylglucosaminyl biotin. Furthermore, the W251N mutant gained a glycosynthase-like activity when a N175Q substitution was introduced and it caused accumulation of the transglycosylation products. These findings not only give insights into the substrate recognition mechanism of glycoside hydrolase family 85 enzymes but also widen their scope of application in preparing homogeneous glycoforms of core-fucosylated glycoproteins for the production of potent glycoprotein-based therapeutics.	[Katoh, Toshihiko; Katayama, Takane] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Katayama, Takane] Ishikawa Prefectural Univ, Host Microbe Interact Res Lab, Nonoichi, Ishikawa 9218836, Japan; [Tomabechi, Yusuke; Yamamoto, Kenji] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Nishikawa, Yoshihide; Kumada, Jyunichi; Matsuzaki, Yuji] Tokyo Chem Ind Co Ltd, Kita Ku, 6-15-9 Toshima, Tokyo 1140003, Japan	Kyoto University; Ishikawa Prefecture University; Ishikawa Prefecture University	Katoh, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Oiwake Cho, Kyoto 6068502, Japan.	tkatoh@lif.kyoto-u.ac.jp		Katayama, Takane/0000-0003-4009-7874	Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	We thank Dr. Yoshinobu Kimura (Okayama University) for valuable discussions. Part of this work was conducted in the Japan Advanced Institute of Science and Technology (JAIST), supported by the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Allhorn M, 2010, BLOOD, V115, P5080, DOI 10.1182/blood-2009-08-239020; Andre S, 2007, BIOCHEMISTRY-US, V46, P6984, DOI 10.1021/bi7000467; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; BOCK K, 1973, TETRAHEDRON LETT, P1037; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Eshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132859; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita K, 2004, BIOSCI BIOTECH BIOCH, V68, P1059, DOI 10.1271/bbb.68.1059; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Garbe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091035; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Giddens JP, 2016, J BIOL CHEM, V291, P9356, DOI 10.1074/jbc.M116.721597; Haneda K, 2006, CARBOHYD RES, V341, P181, DOI 10.1016/j.carres.2005.11.015; Huang CC, 2015, P NATL ACAD SCI USA, V112, P1398, DOI 10.1073/pnas.1414593112; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2011, CHEMBIOCHEM, V12, P932, DOI 10.1002/cbic.201000763; Huang W, 2009, J AM CHEM SOC, V131, P2214, DOI 10.1021/ja8074677; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; KADOWAKI S, 1990, AGR BIOL CHEM TOKYO, V54, P97, DOI 10.1080/00021369.1990.10869923; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Ling ZL, 2009, J MOL BIOL, V389, P1, DOI 10.1016/j.jmb.2009.03.050; Maeda M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00429; Murakami S, 2013, GLYCOBIOLOGY, V23, P736, DOI 10.1093/glycob/cwt012; Muramatsu H, 2001, J BIOCHEM, V129, P923, DOI 10.1093/oxfordjournals.jbchem.a002938; Nakamura K, 2009, BIOSCI BIOTECH BIOCH, V73, P461, DOI 10.1271/bbb.80889; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Parsons TB, 2016, ANGEW CHEM INT EDIT, V55, P2361, DOI 10.1002/anie.201508723; Sakaguchi K, 2016, BIOTECHNOL APPL BIOC, V63, P812, DOI 10.1002/bab.1433; Shang TQ, 2014, J PHARM SCI-US, V103, P1967, DOI 10.1002/jps.24004; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, BBA-GEN SUBJECTS, V1800, P1203, DOI 10.1016/j.bbagen.2010.07.003; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; Umemura M, 2008, J MED CHEM, V51, P4496, DOI 10.1021/jm8000967; vanBerkel PHC, 1996, BIOCHEM J, V319, P117, DOI 10.1042/bj3190117; Wang TT, 2015, CELL, V162, P160, DOI 10.1016/j.cell.2015.06.026; YAMAMOTO K, 1994, BIOSCI BIOTECH BIOCH, V58, P72, DOI 10.1271/bbb.58.72; Yamamoto S, 2005, GLYCOCONJUGATE J, V22, P35, DOI 10.1007/s10719-005-0847-7; Yin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004658; Yu TA, 2011, GLYCOBIOLOGY, V21, P206, DOI 10.1093/glycob/cwq151	55	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23305	23317		10.1074/jbc.M116.737395	http://dx.doi.org/10.1074/jbc.M116.737395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27629418	hybrid, Green Published			2022-12-26	WOS:000387224800038
J	Murphy, J; Kolandaivelu, S				Murphy, Joseph; Kolandaivelu, Saravanan			Palmitoylation of Progressive Rod-Cone Degeneration (PRCD) Regulates Protein Stability and Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINITIS-PIGMENTOSA; MUTATION; IDENTIFICATION; REVEALS; EXPRESSION; GENETICS; FAMILY; SITE; DOGS	Progressive rod-cone degeneration (PRCD) is a photoreceptor outer segment (OS) disc-specific protein with unknown function that is associated with retinitis pigmentosa (RP). The most common mutation in PRCD linked with severe RP phenotype is substitution of the only cysteine to tyrosine (C2Y). In this study, we find that PRCD is post-translationally modified by a palmitoyl lipid group at the cysteine residue linked with RP. Disrupting PRCD palmitoylation either chemically or by genetically eliminating the modified cysteine dramatically affects the stability of PRCD. Furthermore, in vivo electroporation of PRCD C2Y mutant in the mouse retina demonstrates that the palmitoylation of PRCD is important for its proper localization in the photoreceptor OS. Mutant PRCD C2Y was found in the inner segment in contrast to normal localization of WTPRCD in the OS. Our results also suggest that zDHHC3, a palmitoyl acyltransferase (PAT), catalyzes the palmitoylation of PRCD in the Golgi compartment. In conclusion, we find that the palmitoylation of PRCD is crucial for its trafficking to the photoreceptor OS and mislocalization of this protein likely leads to RP-related phenotypes.	[Murphy, Joseph; Kolandaivelu, Saravanan] West Virginia Univ, Inst Eye, Dept Ophthalmol, One Med Ctr Dr, Morgantown, WV 26506 USA	West Virginia University	Kolandaivelu, S (corresponding author), West Virginia Univ, Inst Eye, Dept Ophthalmol, One Med Ctr Dr, Morgantown, WV 26506 USA.	kolandaivelus@wvuhealthcare.com			West Virginia University (WVU); WVU internal Research Funding Development Grant (RFDG) [10018012.2.NT10076W]	West Virginia University (WVU); WVU internal Research Funding Development Grant (RFDG)	This work was supported by West Virginia University (WVU) startup funds (to S. K.) and WVU internal Research Funding Development Grant (RFDG) 10018012.2.NT10076W (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Addison JB, 2015, CANCER RES, V75, P344, DOI 10.1158/0008-5472.CAN-14-1561; AGUIRRE G, 1986, INVEST OPHTH VIS SCI, V27, P635; AGUIRRE G, 1982, INVEST OPHTH VIS SCI, V23, P610; Beltran WA, 2010, GENE THER, V17, P1162, DOI 10.1038/gt.2010.56; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Fahim A.T., 2000, GENEREVIEWS; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gelabert-Baldrich M, 2014, FASEB J, V28, P3023, DOI 10.1096/fj.13-241158; Gentilini F, 2009, J VET DIAGN INVEST, V21, P689, DOI 10.1177/104063870902100515; Goldstein O, 2006, GENOMICS, V88, P541, DOI 10.1016/j.ygeno.2006.05.013; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Guadagni V, 2015, PROG RETIN EYE RES, V48, P62, DOI 10.1016/j.preteyeres.2015.06.005; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kalloniatis M, 2016, EXP EYE RES, V150, P106, DOI 10.1016/j.exer.2015.10.019; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; Kohyama M, 2016, J VET MED SCI, V78, P481, DOI 10.1292/jvms.15-0279; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Majumder A, 2013, P NATL ACAD SCI USA, V110, P12468, DOI 10.1073/pnas.1222666110; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Maubaret C, 2005, J FR OPHTALMOL, V28, P71, DOI 10.1016/S0181-5512(05)81029-0; Murphy D, 2015, MOL CELL BIOL, V35, P1860, DOI 10.1128/MCB.00040-15; Nevet MJ, 2010, J MED GENET, V47, P533, DOI 10.1136/jmg.2009.073619; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; Pach J, 2013, MOL VIS, V19, P1350; Parmeggiani F, 2011, CURR GENOMICS, V12, P236, DOI 10.2174/138920211795860080; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Remez L, 2014, EXP EYE RES, V125, P217, DOI 10.1016/j.exer.2014.06.017; Roberts BJ, 2014, J CELL SCI, V127, P3782, DOI 10.1242/jcs.149849; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Skiba NP, 2013, J PROTEOME RES, V12, P3010, DOI 10.1021/pr4003678; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yeste-Velasco M, 2015, BBA-REV CANCER, V1856, P107, DOI 10.1016/j.bbcan.2015.06.004; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007	46	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23036	23046		10.1074/jbc.M116.742767	http://dx.doi.org/10.1074/jbc.M116.742767			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613864	Green Published, hybrid			2022-12-26	WOS:000387224800016
J	Schuebel, F; Rocker, A; Edelmann, D; Schessner, J; Brieke, C; Meinhart, A				Schuebel, Felix; Rocker, Andrea; Edelmann, Daniel; Schessner, Julia; Brieke, Clara; Meinhart, Anton			3 '-NADP and 3 '-NAADP, Two Metabolites Formed by the Bacterial Type III Effector AvrRxo1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; PLANT IMMUNITY; MALIC ENZYME; PYRIDINE-NUCLEOTIDES; SIGNALING PATHWAYS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CALCIUM-RELEASE; RESISTANCE	An arsenal of effector proteins is injected by bacterial pathogens into the host cell or its vicinity to increase virulence. The commonly used top-down approaches inferring the toxic mechanism of individual effector proteins from the host's phenotype are often impeded by multiple targets of different effectors as well as by their pleiotropic effects. Here we describe our bottom-up approach, showing that the bacterial type III effector AvrRxo1 of plant pathogens is an authentic phosphotransferase that produces two novel metabolites by phosphorylating nicotinamide/nicotinic acid adenine dinucleotide at the adenosine 3'-hydroxyl group. Both products of AvrRxo1, 3'-NADP and 3'-nicotinic acid adenine dinucleotide phosphate (3'-NAADP), are substantially different from the ubiquitous co-enzyme 2'-NADP and the calcium mobilizer 2'-NAADP. Interestingly, 3'-NADP and 3'-NAADP have previously been used as inhibitors or signaling molecules but were regarded as "artificial" compounds so far. Our findings now necessitate a shift in thinking about the biological importance of 3'-phosphorylated NAD derivatives.	[Schuebel, Felix; Rocker, Andrea; Edelmann, Daniel; Schessner, Julia; Brieke, Clara; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany; [Meinhart, Anton] CellNetworks, Heidelberg, Germany	Max Planck Society	Meinhart, A (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg, Germany.; Meinhart, A (corresponding author), CellNetworks, Heidelberg, Germany.	Anton.Meinhart@mpimf-heidelberg.mpg.de	Schessner, Julia Patricia/AFQ-4383-2022	Schessner, Julia Patricia/0000-0003-3361-9830	Max Planck Society; Chica and Heinz Schaller Foundation, Heidelberg	Max Planck Society(Max Planck Society); Chica and Heinz Schaller Foundation, Heidelberg	A member of CellNetworks, Heidelberg and supported by the Max Planck Society and the Chica and Heinz Schaller Foundation, Heidelberg. To whom correspondence should be addressed. E-mail: Anton.Meinhart@mpimf-heidelberg.mpg.de.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; ATKINSON MM, 1990, PLANT PHYSIOL, V92, P215, DOI 10.1104/pp.92.1.215; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bahadur RP, 2014, J BIOMOL STRUCT DYN, V32, P669, DOI 10.1080/07391102.2013.787370; BATIE CJ, 1986, J BIOL CHEM, V261, P1214; BERGHAUSER J, 1975, BIOCHIM BIOPHYS ACTA, V397, P370, DOI 10.1016/0005-2744(75)90126-6; BERNOFSKY C, 1975, ANAL BIOCHEM, V67, P611, DOI 10.1016/0003-2697(75)90336-X; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; CHINI EN, 1995, J BIOL CHEM, V270, P3216, DOI 10.1074/jbc.270.7.3216; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Drincovich MF, 2001, FEBS LETT, V490, P1, DOI 10.1016/S0014-5793(00)02331-0; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; GALIONE A, 1994, MOL CELL ENDOCRINOL, V98, P125, DOI 10.1016/0303-7207(94)90130-9; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Han Q, 2015, STRUCTURE, V23, P1900, DOI 10.1016/j.str.2015.06.030; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; IMSANDE J, 1961, J BIOL CHEM, V236, P1494; Jacobson MK, 1999, TRENDS BIOCHEM SCI, V24, P415, DOI 10.1016/S0968-0004(99)01481-4; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee HC, 1997, J BIOL CHEM, V272, P20378, DOI 10.1074/jbc.272.33.20378; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; LEE HJ, 1987, BIOCHEM J, V245, P407, DOI 10.1042/bj2450407; Liu HT, 2014, J CHINESE LINGUIST, V42, P1; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Navazio L, 2000, P NATL ACAD SCI USA, V97, P8693, DOI 10.1073/pnas.140217897; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224; OKUDA K, 1985, EUR J BIOCHEM, V147, P249, DOI 10.1111/j.1432-1033.1985.tb08744.x; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Potnis N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-146; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SHUSTER L, 1955, J BIOL CHEM, V215, P183; Singer AU, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003121; SPAMPINATO CP, 1991, PHOTOSYNTH RES, V28, P69, DOI 10.1007/BF00033716; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yu S, 2014, PROTEINS, V82, P2910, DOI 10.1002/prot.24656; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, THEOR APPL GENET, V109, P71, DOI 10.1007/s00122-004-1623-y; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	55	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22868	22880		10.1074/jbc.M116.751297	http://dx.doi.org/10.1074/jbc.M116.751297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27621317	hybrid, Green Published			2022-12-26	WOS:000387224800002
J	Shearer, AM; Rana, R; Austin, K; Baleja, JD; Nguyen, N; Bohm, A; Covic, L; Kuliopulos, A				Shearer, Andrew M.; Rana, Rajashree; Austin, Karyn; Baleja, James D.; Nguyen, Nga; Bohm, Andrew; Covic, Lidija; Kuliopulos, Athan			Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONALCOHOLIC FATTY LIVER; HEPATIC STELLATE CELLS; TISSUE FACTOR; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; SQUID RHODOPSIN; INTERLEUKIN-6; PATHWAYS	Chronic liver inflammation and fibrosis in nonalcoholic steatohepatitis can lead to cirrhosis and liver failure for which there are currently no approved treatments. Protease-activated receptor-2 (PAR2) is an emerging new target expressed on liver stellate cells and hepatocytes that regulates the response to liver injury and inflammation. Here, we identified a pepducin to block the deleterious actions of PAR2 in promoting liver fibrosis. Non-alcoholic fatty liver disease and early fibrosis were induced by the methionine-choline-deficient diet in mice. Fibrotic liver disease was induced by administering carbon tetrachloride for 8 weeks. Mice were treated with the pepducin PZ-235 either from onset of the experiment or after fibrosis was established. Hepatic fibrosis, collagen content, inflammatory cytokines, steatosis, triglycerides, and NAFLD activity score were assessed as primary outcome parameters depending on the model. The activity of the PAR2 pepducin on cultured stellate cell activation and hepatocyte reactive oxygen species production was evaluated. PZ-235 significantly suppressed liver fibrosis, collagen deposition, inflammatory cytokines, NAFLD activity score, steatosis, triglycerides, aspartate transaminase, alanine transaminase, and stellate cell proliferation by up to 50-100%. The PAR2 inhibitor afforded significant protective effects against hepatocellular necrosis and attenuated PAR2-mediated reactive oxygen species production in hepatocytes. PZ-235 was distributed to liver and other mouse tissues and was found to form a well structured alpha-helix that closely resembles the juxtamembrane helical region of the analogous TM6 and third intracellular region of the intact receptor that is critical for coupling to internal G proteins. The ability of PZ-235 to effectively suppress fibrosis, hepatocellular necrosis, reactive oxygen species production, steatosis, and inflammation indicates the potential for PAR2 pepducin inhibitors to be broadly efficacious in the treatment of liver fibrosis.	[Shearer, Andrew M.; Rana, Rajashree; Austin, Karyn; Nguyen, Nga; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Ctr Hemostasis & Thrombosis Res, Mol Oncol Res Inst,Tufts Med Ctr, Boston, MA 02111 USA; [Shearer, Andrew M.; Austin, Karyn; Baleja, James D.; Bohm, Andrew; Covic, Lidija; Kuliopulos, Athan] Tufts Univ, Sch Med, Sch Grad Biomed Sci Biochem Dev Mol & Chem Biol, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University	Kuliopulos, A (corresponding author), Tufts Med Ctr, Box 7510,800 Washington St, Boston, MA 02111 USA.	athan.kuliopulos@tufts.edu		Shearer, Andrew/0000-0003-2039-0934	NIDDK, National Institutes of Health [DK101240]; NHLBI, National Institutes of Health Ruth L. Kirschstein National Research Service Award [F31HL132419]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL132419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R42DK101240, R44DK101240] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health Ruth L. Kirschstein National Research Service Award; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIDDK, National Institutes of Health Grant DK101240 (to A. K. and L. C.). Dr. Kuliopulos and Dr. Covic report serving as Scientific Founders of Oasis Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by NHLBI, National Institutes of Health Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship F31HL132419.r Supported by an American Heart Association postdoctoral fellowship.	Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Borensztajn K, 2010, AM J PATHOL, V177, P2753, DOI 10.2353/ajpath.2010.091107; Borensztajn K, 2010, J CELL MOL MED, V14, P143, DOI 10.1111/j.1582-4934.2009.00980.x; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Chung H, 2013, J BIOL CHEM, V288, P37319, DOI 10.1074/jbc.M113.492793; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Gurbel PA, 2016, ARTERIOSCL THROM VAS, V36, P189, DOI 10.1161/ATVBAHA.115.306777; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Klausen P, 2000, ONCOGENE, V19, P3675, DOI 10.1038/sj.onc.1203707; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004; Kuliopulos A, 2003, LIFE SCI, V74, P255, DOI 10.1016/j.lfs.2003.09.012; KULIOPULOS A, 1994, J BIOL CHEM, V269, P21364; LaBrecque D, 2012, WORLD GASTROENTEROLO; Machado MV, 2016, GASTROENTEROLOGY, V150, P1769, DOI 10.1053/j.gastro.2016.02.066; Mak KM, 2013, ANAT REC, V296, P953, DOI 10.1002/ar.22694; Marra F, 1998, AM J PATHOL, V152, P423; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Michael ES, 2013, AM J PHYSIOL-GASTR L, V304, pG516, DOI 10.1152/ajpgi.00296.2012; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Michelotti GA, 2013, J CLIN INVEST, V123, P2380, DOI 10.1172/JCI66904; Murakami M, 2011, J MOL BIOL, V413, P615, DOI 10.1016/j.jmb.2011.08.044; Novo E, 2015, HISTOL HISTOPATHOL, V30, P1011, DOI 10.14670/HH-11-623; Nystedt S, 1996, J BIOL CHEM, V271, P14910, DOI 10.1074/jbc.271.25.14910; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rautou PE, 2014, HEPATOLOGY, V60, P1793, DOI 10.1002/hep.27033; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Ruf W, 2015, HAMOSTASEOLOGIE, V35, P279, DOI 10.5482/HAMO-14-11-0068; Sauvant P, 2011, J PHYSIOL BIOCHEM, V67, P487, DOI 10.1007/s13105-011-0101-7; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Sevigny LM, 2011, ARTERIOSCL THROM VAS, V31, pE100, DOI 10.1161/ATVBAHA.111.238261; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Su Z, 2016, CELL DEATH DIFFER, V23, P748, DOI 10.1038/cdd.2016.8; Sullivan BP, 2013, BLOOD, V121, P1868, DOI 10.1182/blood-2012-09-455436; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Tsuji M, 2013, ORG BIOMOL CHEM, V11, P3030, DOI 10.1039/c3ob27445d; Wielders SJH, 2007, J THROMB HAEMOST, V5, P571, DOI 10.1111/j.1538-7836.2007.02364.x; Wieser V, 2017, GUT, V66, P930, DOI 10.1136/gutjnl-2015-310344; Wygrecka M, 2011, AM J RESP CRIT CARE, V183, P1703, DOI 10.1164/rccm.201009-1479OC; Zhang P, 2015, J BIOL CHEM, V290, P15785, DOI 10.1074/jbc.M115.636316; Zhang P, 2012, CIRCULATION, V126, P83, DOI 10.1161/CIRCULATIONAHA.112.091918	60	33	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23188	23198		10.1074/jbc.M116.732743	http://dx.doi.org/10.1074/jbc.M116.732743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613872	hybrid, Green Published			2022-12-26	WOS:000387224800028
J	Braunholz, D; Saki, M; Niehr, F; Ozturk, M; Puertolas, BB; Konschak, R; Budach, V; Tinhofer, I				Braunholz, Diana; Saki, Mohammad; Niehr, Franziska; Oeztuerk, Merve; Puertolas, Berta Borras; Konschak, Robert; Budach, Volker; Tinhofer, Ingeborg			Spheroid Culture of Head and Neck Cancer Cells Reveals an Important Role of EGFR Signalling in Anchorage Independent Survival	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; GROWTH-FACTOR RECEPTOR; PROGRESSION-FREE; LUNG-CANCER; RESISTANCE; BLOOD; METASTASIS; CARCINOMA; MET; EXPRESSION	In solid tumours millions of cells are shed into the blood circulation each day. Only a subset of these circulating tumour cells (CTCs) survive, many of them presumable because of their potential to formmulti-cellular clusters also named spheroids. Tumour cells within these spheroids are protected from anoikis, which allows them to metastasize to distant organs or re-seed at the primary site. We used spheroid cultures of head and neck squamous cell carcinoma (HNSCC) cell lines as a model for such CTC clusters for determining the role of the epidermal growth factor receptor (EGFR) in cluster formation ability and cell survival after detachment from the extra-cellular matrix. The HNSCC cell lines FaDu, SCC-9 and UT-SCC-9 (UT-SCC-9P) as well as its cetuximab (CTX)-resistant sub-clone (UT-SCC-9R) were forced to grow in an anchorage-independent manner by coating culture dishes with the anti-adhesive polymer poly-2-hydroxyethylmethacrylate (poly-HEMA). The extent of apoptosis, clonogenic survival and EGFR signalling under such culture conditions was evaluated. The potential of spheroid formation in suspension culture was found to be positively correlated with the proliferation rate of HNSCC cell lines as well as their basal EGFR expression levels. CTX and gefitinib blocked, whereas the addition of EGFR ligands promoted anchorage-independent cell survival and spheroid formation. Increased spheroid formation and growth were associated with persistent activation of EGFR and its downstream signalling component (MAPK/ERK). Importantly, HNSCC cells derived from spheroid cultures retained their clonogenic potential in the absence of cell-matrix contact. Addition of CTX under these conditions strongly inhibited colony formation in CTX-sensitive cell lines but not their resistant subclones. Altogether, EGFR activation was identified as crucial factor for anchorage-independent survival of HNSCC cells. Targeting EGFR in CTC cluster formation might represent an attractive anti-metastatic treatment approach in HNSCC.	[Braunholz, Diana; Saki, Mohammad; Niehr, Franziska; Oeztuerk, Merve; Puertolas, Berta Borras; Konschak, Robert; Budach, Volker; Tinhofer, Ingeborg] Charite, Dept Radiooncol & Radiotherapy, Translat Radiooncol & Radiobiol Res Lab, Berlin, Germany; [Braunholz, Diana; Saki, Mohammad; Niehr, Franziska; Konschak, Robert; Tinhofer, Ingeborg] Charite, German Canc Consortium DKTK, Deutsch Krebsforschungszentrum DKFZ, Partner Site Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ)	Braunholz, D (corresponding author), Charite, Dept Radiooncol & Radiotherapy, Translat Radiooncol & Radiobiol Res Lab, Berlin, Germany.; Braunholz, D (corresponding author), Charite, German Canc Consortium DKTK, Deutsch Krebsforschungszentrum DKFZ, Partner Site Berlin, Berlin, Germany.	diana.braunholz@charite.de		Tinhofer, Ingeborg/0000-0002-0512-549X; Ozturk, Merve/0000-0003-2898-2176; Budach, Volker/0000-0002-2191-9871				Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Barriere G, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.10.04; Bernier J, 2009, NAT REV CLIN ONCOL, V6, P266, DOI 10.1038/nrclinonc.2009.40; Boeckx C, 2013, ONCOLOGIST, V18, P850, DOI 10.1634/theoncologist.2013-0013; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; BUTLER TP, 1975, CANCER RES, V35, P512; Chang MC, 2016, CLIN CHEM; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Denes V, 2015, INT J CANCER, V136, P1528, DOI 10.1002/ijc.29155; Duda DG, 2010, P NATL ACAD SCI USA, V107, P21677, DOI 10.1073/pnas.1016234107; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fehm T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2349; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Humtsoe JO, 2010, ONCOGENE, V29, P1214, DOI 10.1038/onc.2009.419; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kari C, 2003, CANCER RES, V63, P1; Krawczyk N, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.352; Krebs MG, 2014, NAT REV CLIN ONCOL, V11, P129, DOI 10.1038/nrclinonc.2013.253; Lee SH, 2009, CARCINOGENESIS, V30, P1997, DOI 10.1093/carcin/bgp233; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mascalchi M, 2016, J CANCER RES CLIN, V142, P195, DOI 10.1007/s00432-015-2021-3; Moitra K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/635745; Molnar B, 2001, CLIN CANCER RES, V7, P4080; MUELLERKLIESER W, 1987, J CANCER RES CLIN, V113, P101, DOI 10.1007/BF00391431; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Park Jae-Yeo, 2014, Evid Based Complement Alternat Med, V2014, P895272, DOI 10.1155/2014/895272; Payne RE, 2009, PHARMACOGENOMICS, V10, P51, DOI 10.2217/14622416.10.1.51; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rybak AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061716; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solic N, 1997, EXP CELL RES, V234, P465, DOI 10.1006/excr.1997.3635; Tinhofer I, 2014, INT J RADIAT BIOL, V90, P622, DOI 10.3109/09553002.2014.886798; Tinhofer I, 2012, INT J RADIAT ONCOL, V83, pE685, DOI 10.1016/j.ijrobp.2012.02.009; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Van Emburgh B.O., 2014, MOL ONCOL; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	50	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163149	10.1371/journal.pone.0163149	http://dx.doi.org/10.1371/journal.pone.0163149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643613	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900034
J	Mir, RA; Weppelmann, TA; Johnson, JA; Archer, D; Morris, JG; Jeong, KC				Mir, Raies A.; Weppelmann, Thomas A.; Johnson, Judith A.; Archer, Douglas; Morris, J. Glenn, Jr.; Jeong, KwangCheol Casey			Identification and Characterization of Cefotaxime Resistant Bacteria in Beef Cattle	PLOS ONE			English	Article							ESCHERICHIA-COLI; CTX-M; ENTEROBACTERIACEAE; EPIDEMIOLOGY; EMERGENCE; GENES; FARMS; SOIL	Third-generation cephalosporins are an important class of antibiotics that are widely used in treatment of serious Gram-negative bacterial infections. In this study, we report the isolation of bacteria resistant to the third-generation cephalosporin cefotaxime from cattle with no previous cefotaxime antibiotic exposure. The prevalence of cefotaxime-resistant bacteria was examined by a combination of culture based and molecular typing methods in beef cattle (n = 1341) from 8 herds located in North Central Florida. The overall prevalence of cefotaxime- resistant bacteria was 15.8% (95% CI: 13.9, 17.8), varied between farms, and ranged from 5.2% to 100%. A subset of isolates (n = 23) was further characterized for the cefotaxime minimum inhibitory concentration (MIC) and antibiotic susceptibility against 10 different antibiotics, sequencing of nine beta- lactamase genes, and species identification by 16S rRNA sequencing. Most of the bacterial isolates were resistant to cefotaxime (concentrations, > 64 mu g/mL) and showed high levels of multi-drug resistance. Full length 16S rRNA sequences (similar to 1300 bp) revealed that most of the isolates were not primary human or animal pathogens; rather were more typical of commensal, soil, or other environmental origin. Six extended spectrum beta-lactamase (ESBL) genes identical to those in clinical human isolates were identified. Our study highlights the potential for carriage of cefotaxime resistance (including "human" ESBL genes) by the bacterial flora of food animals with no history of cefotaxime antibiotic exposure. A better understanding of the origin and transmission of resistance genes in these pre-harvest settings will be critical to development of strategies to prevent the spread of antimicrobial resistant microorganisms to hospitals and communities.	[Mir, Raies A.; Jeong, KwangCheol Casey] Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA; [Mir, Raies A.; Weppelmann, Thomas A.; Johnson, Judith A.; Morris, J. Glenn, Jr.; Jeong, KwangCheol Casey] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Weppelmann, Thomas A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Johnson, Judith A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Archer, Douglas] Univ Florida, Inst Food & Agr Sci, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jeong, KC (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Anim Sci, Gainesville, FL 32611 USA.; Jeong, KC (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	kcjeong@ufl.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture [2015-68003-22971]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under the award number 2015-68003-22971 to KCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the farmers and livestock managers for the permission to collect fecal swab samples from the cattle housed on their farms for the purposes of scientific research. This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under the award number 2015-68003-22971 to KCJ.	[Anonymous], 2011, M2A9 CLSI, V32, P1; Anukool U, 2004, APPL ENVIRON MICROB, V70, P5222, DOI 10.1128/AEM.70.9.5222-5228.2004; Blossom D., 2008, INFECT DIS CLIN PRAC, V16, P1, DOI DOI 10.1097/IPC.0B013E3181635DEF; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Doi Y, 2012, DIAGN MICR INFEC DIS, V74, P34, DOI 10.1016/j.diagmicrobio.2012.05.020; Enoch DA, 2012, J HOSP INFECT, V81, P270, DOI 10.1016/j.jhin.2012.05.006; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Glupczynski Y, 2007, J CLIN MICROBIOL, V45, P501, DOI 10.1128/JCM.02221-06; Hiroi M, 2012, J VET MED SCI, V74, P1635, DOI 10.1292/jvms.11-0479; Johnson JR, 2009, J CLIN MICROBIOL, V47, P3721, DOI 10.1128/JCM.01581-09; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kiiru J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-155; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Mollenkopf DF, 2012, APPL ENVIRON MICROB, V78, P4552, DOI 10.1128/AEM.00373-12; Mollenkopf DF, 2011, FOODBORNE PATHOG DIS, V8, P333, DOI 10.1089/fpd.2010.0701; PAGE CP, 1993, ARCH SURG-CHICAGO, V128, P410; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Reglier-Poupet H, 2008, J MED MICROBIOL, V57, P310, DOI 10.1099/jmm.0.47625-0; Snow LC, 2012, PREV VET MED, V106, P225, DOI 10.1016/j.prevetmed.2012.03.009; STOUTENBEEK CP, 1987, J ANTIMICROB CHEMOTH, V19, P513, DOI 10.1093/jac/19.4.513; Sylvia L, 2010, CANVETJ, V51, P853; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian GB, 2009, FOODBORNE PATHOG DIS, V6, P297, DOI 10.1089/fpd.2008.0164; Tragesser LA, 2006, AM J VET RES, V67, P1696, DOI 10.2460/ajvr.67.10.1696; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Walsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065567; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1	30	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163279	10.1371/journal.pone.0163279	http://dx.doi.org/10.1371/journal.pone.0163279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642751	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900041
J	Alotaibi, NAS; Slater, NKH; Rahmoune, H				Alotaibi, Noha A. S.; Slater, Nigel K. H.; Rahmoune, Hassan			Salidroside as a Novel Protective Agent to Improve Red Blood Cell Cryopreservation	PLOS ONE			English	Article							HUMAN ERYTHROCYTES; OXIDATIVE STRESS; TREHALOSE; FROZEN; HEMOGLOBIN; SURVIVAL; ACP-215; STORAGE; RBCS	Glycerol and trehalose have been widely examined as protective agents in the cryopreservation of red blood cells (RBCs). However, the effectiveness of these reagents alone on cell viability is moderate. Here, the addition of salidroside attenuated oxidative damage of sheep RBCs prior to and post cryostorage. The supplementation of salidroside to the cryopreservation media containing 10% glycerol improved RBC survival by approximately 61.1+/-4.8% vs 37.9+/-4.6%. A smaller effect was seen in RBCs cryopreserved in 300 mM trehalose where the addition of salidroside improved survival by 7.6+/-0.3%. Furthermore, the addition of salidroside to cold storage solution demonstrated a significant reduction of haemolysis after 4 days for RBCs loaded with either glycerol or trehalose, compared to cells incubated without salidroside. RBCs survival was 2-fold greater following freezing in trehalose, compared with glycerol. After 10 days, salidroside enabled a lower haemolysis of 16.7+/-1.3% compared to 29.0+/-8.4% for cells incubated without salidroside. However, salidroside had no effect on RBCs which had been frozen in glycerol as the resulting haemolysis rate by day 10 was approximately 60%. Salidroside increased glutathione reductase activity and decreased lactate dehydrogenase activity. Furthermore, it led to reduced carbonylation of proteins in both glycerol and trehalose loaded cells. Finally, no effect on lipid peroxidation was found in the glycerol loaded RBCs although this was reduced in RBCs loaded with trehalose and salidroside. The present findings confirm the potential use of salidroside as a novel protective agent in cryopreservation and refrigerated storage of sheep RBCs.	[Alotaibi, Noha A. S.; Slater, Nigel K. H.; Rahmoune, Hassan] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England; [Alotaibi, Noha A. S.] King Abdulaziz City Sci & Technol Kingdom Saudi A, POB 6086, Riyadh 11442, Saudi Arabia	University of Cambridge	Rahmoune, H (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	hr228@cam.ac.uk			King AbdulAziz City for Science and Technology (KACST)	King AbdulAziz City for Science and Technology (KACST)	King AbdulAziz City for Science and Technology (KACST) funded NASA. The funder provided support in the form of salaries for authors [NASA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions'.	Acker J.P, 2006, ADV BIOPRESERVATION, P291; Baust JG, 2009, ORGANOGENESIS, V5, P90, DOI 10.4161/org.5.3.10021; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Bhowmick P, 2002, CRYOBIOLOGY, V45, P183, DOI 10.1016/S0011-2240(02)00126-8; Bosman GJCGM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00376; CHAO ES, 1988, CELL BIOL TOXICOL, V4, P1, DOI 10.1007/BF00141283; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; D'Alessandro A, 2013, MOL BIOSYST, V9, P1196, DOI 10.1039/c3mb25575a; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Henkelman S, 2015, VOX SANG, V108, P103, DOI 10.1111/vox.12218; Hess JR, 2004, TRANSFUSION MED, V14, P1, DOI 10.1111/j.0958-7578.2004.00472.x; Holovati JL, 2009, CRYOBIOLOGY, V58, P75, DOI 10.1016/j.cryobiol.2008.11.002; Kanias T, 2010, FEBS J, V277, P343, DOI 10.1111/j.1742-4658.2009.07472.x; Kelly G., 2001, ALTERN MED REV, V3, P293; Kriebardis AG, 2007, J CELL MOL MED, V11, P148, DOI 10.1111/j.1582-4934.2007.00008.x; Kucherenko YV, 2015, CELL PHYSIOL BIOCHEM, V35, P2055, DOI 10.1159/000374012; Lynch AL, 2010, ALTERN MED REV, V31, P6069, DOI [10.1016/j.biomaterials.2010.04.020, DOI 10.1016/J.BIOMATERIALS.2010.04.020]; Lynch AL, 2011, BIOMATERIALS, V32, P4443, DOI 10.1016/j.biomaterials.2011.02.062; Lynch AL, 2010, BIOMATERIALS, V31, P6096, DOI 10.1016/j.biomaterials.2010.04.020; Qian EW, 2012, J NAT PROD, V75, P531, DOI 10.1021/np200555s; Reed B.M., 2012, CRYOBIOLOGY, V65, P340, DOI [10.1016/j.cryobiol.2012.07.005, DOI 10.1016/J.CRYOBIOL.2012.07.005]; Satpathy GR, 2004, CRYOBIOLOGY, V49, P123, DOI 10.1016/j.cryobiol.2004.06.001; Scott K, 2004, CRYOBIOLOGY, V49, P304; Singbartl K, 1998, CRYOBIOLOGY, V36, P115, DOI 10.1006/cryo.1997.2072; Uchida T, 2012, CRYSTALLIZATION MAT, P203; Valeri CR, 2005, TRANSFUSION, V45, P1621, DOI 10.1111/j.1537-2995.2005.00588.x; Valeri CR, 2001, TRANSFUSION, V41, P933, DOI 10.1046/j.1537-2995.2001.41070933.x; Zhang XG, 2015, CRYOBIOLOGY, V70, P246, DOI 10.1016/j.cryobiol.2015.03.004; Zolla L, 2013, J INTEGRATED OMICS, V3, P11; Zolla L, 2015, BLOOD TRANSFUS-ITALY, V13, P21, DOI 10.2450/2014.0053-14	31	11	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162748	10.1371/journal.pone.0162748	http://dx.doi.org/10.1371/journal.pone.0162748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631782	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900073
J	Hilbert, A				Hilbert, Anja			Weight Stigma Reduction and Genetic Determinism	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; ANTI-FAT PREJUDICE; OVERWEIGHT INDIVIDUALS; OBESITY; ATTITUDES; BIAS; BELIEFS; HEALTH; IMPACT; PEOPLE	One major approach to weight stigma reduction consists of decreasing beliefs about the personal controllability of-and responsibility for-obesity by educating about its biogenetic causes. Evidence on the efficacy of this approach is mixed, and it remains unclear whether this would create a deterministic view, potentially leading to detrimental side-effects. Two independent studies from Germany using randomized designs with delayed-intervention control groups served to (1) develop and pilot a brief, interactive stigma reduction intervention to educate N = 128 university students on gene x environment interactions in the etiology of obesity; and to (2) evaluate this intervention in the general population (N = 128) and determine mechanisms of change. The results showed (1) decreased weight stigma and controllability beliefs two weeks post-intervention in a student sample; and (2) decreased internal attributions and increased genetic attributions, knowledge, and deterministic beliefs four weeks post-intervention in a population sample. Lower weight stigma was longitudinally predicted by a decrease in controllability beliefs and an increase in the belief in genetic determinism, especially in women. The results underline the usefulness of a brief, interactive intervention promoting an interactionist view of obesity to reduce weight stigma, at least in the short term, lending support to the mechanisms of change derived from attribution theory. The increase in genetic determinism that occurred despite the intervention's gene x environment focus had no detrimental side-effect on weight stigma, but instead contributed to its reduction. Further research is warranted on the effects of how biogenetic causal information influences weight management behavior of individuals with obesity.	[Hilbert, Anja] Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Dept Med Psychol & Med Sociol, Med Ctr, Leipzig, Germany	Leipzig University	Hilbert, A (corresponding author), Univ Leipzig, Integrated Res & Treatment Ctr Adipos Dis, Dept Med Psychol & Med Sociol, Med Ctr, Leipzig, Germany.	anja.hilbert@medizin.uni-leipzig.de			Bundesministerium fur Bildung und Forschung [01EO1501, 01GP0491]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	Bundesministerium fur Bildung und Forschung (https://www.bmbf.de/): Grants 01EO1501 and 01GP0491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON DB, 1991, INT J EAT DISORDER, V10, P599; Bannon KL, 2009, INT J EAT DISORDER, V42, P118, DOI 10.1002/eat.20588; Brauhardt A, 2014, J BEHAV THER EXP PSY, V45, P285, DOI 10.1016/j.jbtep.2014.01.001; Brewis AA, 2014, SOC SCI MED, V118, P152, DOI 10.1016/j.socscimed.2014.08.003; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRANDALL CS, 1995, BRIT J SOC PSYCHOL, V34, P67, DOI 10.1111/j.2044-8309.1995.tb01049.x; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 1996, PERS SOC PSYCHOL B, V22, P1165, DOI 10.1177/01461672962211007; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Danielsdottir S, 2010, OBESITY FACTS, V3, P47, DOI 10.1159/000277067; Dar-Nimrod I, 2014, APPETITE, V81, P269, DOI 10.1016/j.appet.2014.06.109; Dar-Nimrod I, 2011, PSYCHOL BULL, V137, P800, DOI 10.1037/a0021860; Diedrichs PC, 2011, BRIT J HEALTH PSYCH, V16, P846, DOI 10.1111/j.2044-8287.2011.02022.x; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Hague AL, 2005, J NUTR EDUC BEHAV, V37, P58, DOI 10.1016/S1499-4046(06)60017-1; Hilbert A, 2010, ESSANFALLE UND ADIPO; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Hilbert A, 2007, J EPIDEMIOL COMMUN H, V61, P585, DOI 10.1136/jech.2006.050906; Hilbert A, 2014, OBESITY, V22, P79, DOI 10.1002/oby.20561; Hoyt C.L., 2017, STIGMA HEALTH, V2, P53, DOI [10.1037/sah0000026, DOI 10.1037/SAH0000026]; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; Kvaale EP, 2013, CLIN PSYCHOL REV, V33, P782, DOI 10.1016/j.cpr.2013.06.002; Lebowitz MS, 2014, P NATL ACAD SCI USA, V111, P17786, DOI 10.1073/pnas.1414058111; Lee M, 2014, BODY IMAGE, V11, P251, DOI 10.1016/j.bodyim.2014.03.003; Lewis RJ, 1997, OBES RES, V5, P297, DOI 10.1002/j.1550-8528.1997.tb00555.x; Lippa NC, 2013, HUM HERED, V75, P186, DOI 10.1159/000353712; Lippa NC, 2012, OBESITY, V20, P2367, DOI 10.1038/oby.2012.144; Nelkin D., 2004, DNA MYSTIQUE GENE CU; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; O'Brien KS, 2010, OBESITY, V18, P2138, DOI 10.1038/oby.2010.79; Papadopoulos S, 2015, OBESITY, V23, P1743, DOI 10.1002/oby.21187; Pearl RL, 2014, PSYCHOL HEALTH, V29, P1176, DOI 10.1080/08870446.2014.916807; Persky S, 2011, ANN BEHAV MED, V41, P363, DOI 10.1007/s12160-010-9242-0; Phelan JC, 2005, J HEALTH SOC BEHAV, V46, P307, DOI 10.1177/002214650504600401; Puhl RM, 2015, INT J OBESITY, V39, P1166, DOI 10.1038/ijo.2015.32; Puhl RM, 2013, BEST PRACT RES CL EN, V27, P117, DOI 10.1016/j.beem.2012.12.002; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Puhl RM, 2005, HEALTH PSYCHOL, V24, P517, DOI 10.1037/0278-6133.24.5.517; Ruscio John, 2011, J Exp Psychopathol, V2, P170; Sheeran P, 2013, HEALTH PSYCHOL, V32, P460, DOI 10.1037/a0029203; Sikorski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046924; Stober J, 1999, DIAGNOSTICA, V45, P173, DOI 10.1026//0012-1924.45.4.173; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Swift JA, 2013, OBESITY FACTS, V6, P91, DOI 10.1159/000348714; Teachman BA, 2003, HEALTH PSYCHOL, V22, P68, DOI 10.1037/0278-6133.22.1.68; Teachman BA, 2001, INT J OBESITY, V25, P1525, DOI 10.1038/sj.ijo.0801745; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; WIESE HJC, 1992, INT J OBESITY, V16, P859; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	52	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162993	10.1371/journal.pone.0162993	http://dx.doi.org/10.1371/journal.pone.0162993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5SJ	27631384	Green Published, gold			2022-12-26	WOS:000383706900110
J	Liu, YL; Zhang, S; Zhao, YL; Du, J; Jin, GH; Shao, S; Lu, XQ				Liu, Yanli; Zhang, Sai; Zhao, Yali; Du, Juan; Jin, Guanghui; Shao, Shuang; Lu, Xiaoqin			Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							C VIRUS-INFECTION; GENERAL-PRACTITIONERS; EPIDEMIOLOGY; PREVENTION	Objective To develop the Chinese (Mainland) version of Chronic Liver Disease Questionnaire (CLDQ) and use it to assess the health-related quality of life (HRQoL) of chronic hepatitis B (CHB) patients in China and identify the determinants of HRQoL. Methods The Chinese (Mainland) CLDQ was developed by expert consultation, focus group interviews with patients, and pilot study. The final version of questionnaire was adopted to assess the HRQoL of chronic hepatitis B outpatients enrolled from two largest infectious hospitals in Beijing. Cronbach's alpha was used to measure the internal consistency reliability. The construct validity was measured by factor analysis. T-test, one-way analysis of variance (ANOVA), and multi-variable linear regression were used to analyze the data. Results Cronbach's alpha of the overall CLDQ is 0.935, ranging from 0.628 to 0.881 among six sub-scales. Six factors were identified via factor analysis, including a new factor sleeping(SL). A total of 519 patients with CHB were included in the investigation with the final version of questionnaire, 405 of them were only with CHB, 53 with compensated cirrhosis, and 61 with decompensated cirrhosis. The CHB group scored the highest in the overall score of CLDQ (p<0.05). The score of worry (WO) domain was significantly lower in the compensated group than the CHB group (p<0.05). Decompensated cirrhosis patients scored lower than the CHB group in all CLDQ domains and the overall score (p<0.05). Stages of illness, gender, regular visits to specialized hospitals, and work status in last year were determinants of HRQoL. Conclusion The psychometric properties of the Chinese(Mainland) CLDQ is acceptable. The HRQoL of CHB patients deteriorated with disease progression. Advanced stages of CHB, female, long time absence from work after illness, and no job or retirement were determinants of poor HRQoL. Regular visits to specialized hospitals was a positive determinant of HRQoL.	[Liu, Yanli; Zhang, Sai; Zhao, Yali; Du, Juan; Jin, Guanghui; Shao, Shuang; Lu, Xiaoqin] Capital Med Univ, Dept Gen Practice, Sch Gen Practice & Continuing Educ, Beijing 100069, Peoples R China; [Zhang, Sai] Cent S Univ, Xiangya Hosp, Inst Med Sci, Changsha 410008, Hunan, Peoples R China	Capital Medical University; Central South University	Lu, XQ (corresponding author), Capital Med Univ, Dept Gen Practice, Sch Gen Practice & Continuing Educ, Beijing 100069, Peoples R China.	xq6518@163.com		Liu, Yanli/0000-0003-3066-3668				Chang SC, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-97; Chinese Society Of Hepatology CMAC, 2011, CHINESE J EXPT CLIN, V5, P50; de Franchis R, 2003, COMMUNICATION; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Foster GR, 1998, HEPATOLOGY, V27, P209, DOI 10.1002/hep.510270132; Gao F, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-131; Giannini EG, 2009, J CLIN GASTROENTEROL, V43, P1001, DOI 10.1097/MCG.0b013e31818e876f; Gutteling JJ, 2006, ALIMENT PHARM THER, V23, P1629, DOI 10.1111/j.1365-2036.2006.02934.x; Hu M, 2009, VALUE HEALTH, V12, pS89, DOI 10.1111/j.1524-4733.2009.00636.x; Lam ETP, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-52; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lu FM, 2010, J VIRAL HEPATITIS, V17, P4, DOI 10.1111/j.1365-2893.2010.01266.x; Nokhodian Z, 2009, INDIAN J GASTROENTER, V28, P116, DOI 10.1007/s12664-009-0041-0; Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Ren JJ, 2014, HEPATOB PANCREAT DIS, V13, P495, DOI 10.1016/S1499-3872(14)60313-1; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Wai CT, 2005, ALIMENT PHARM THER, V21, P1255, DOI 10.1111/j.1365-2036.2005.02497.x; Wallace J, 2013, AUST NZ J PUBL HEAL, V37, P405, DOI 10.1111/1753-6405.12127; World Health Organization, 2014, HEP B FACT SHEETS; Younossi ZM, 1999, GUT, V45, P295, DOI 10.1136/gut.45.2.295; Zhuang GH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-101	22	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162763	10.1371/journal.pone.0162763	http://dx.doi.org/10.1371/journal.pone.0162763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631983	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900074
J	Lv, YY; Zhang, SB; Wang, JS; Hu, YS				Lv, Yangyong; Zhang, Shuaibing; Wang, Jinshui; Hu, Yuansen			Quantitative Proteomic Analysis of Wheat Seeds during Artificial Ageing and Priming Using the Isobaric Tandem Mass Tag Labeling	PLOS ONE			English	Article							CONTROLLED TUMOR PROTEIN; LIPID-TRANSFER PROTEINS; TRITICUM-AESTIVUM L.; FUSARIUM HEAD BLIGHT; POSTTRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; ANALYSIS REVEALS; GENE FAMILY; FATTY-ACID; GERMINATION	Wheat (Triticum aestivum L.) is an important crop worldwide. The physiological deterioration of seeds during storage and seed priming is closely associated with germination, and thus contributes to plant growth and subsequent grain yields. In this study, wheat seeds during different stages of artificial ageing (45 degrees C; 50% relative humidity; 98%, 50%, 20%, and 1% Germination rates) and priming (hydro-priming treatment) were subjected to proteomics analysis through a proteomic approach based on the isobaric tandem mass tag labeling. A total of 162 differentially expressed proteins (DEPs) mainly involved in metabolism, energy supply, and defense/stress responses, were identified during artificial ageing and thus validated previous physiological and biochemical studies. These DEPs indicated that the inability to protect against ageing leads to the incremental decomposition of the stored substance, impairment of metabolism and energy supply, and ultimately resulted in seed deterioration. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis revealed that the up-regulated proteins involved in seed ageing were mainly enriched in ribosome, whereas the down-regulated proteins were mainly accumulated in energy supply (starch and sucrose metabolism) and stress defense (ascorbate and aldarate metabolism). Proteins, including hemoglobin 1, oleosin, agglutinin, and non-specific lipid-transfer proteins, were first identified in aged seeds and might be regarded as new markers of seed deterioration. Of the identified proteins, 531 DEPs were recognized during seed priming compared with unprimed seeds. In contrast to the up-regulated DEPs in seed ageing, several up-regulated DEPs in priming were involved in energy supply (tricarboxylic acid cycle, glycolysis, and fatty acid oxidation), anabolism (amino acids, and fatty acid synthesis), and cell growth/division. KEGG and protein-protein interaction analysis indicated that the up-regulated proteins in seed priming were mainly enriched in amino acid synthesis, stress defense (plant-pathogen interactions, and ascorbate and aldarate metabolism), and energy supply (oxidative phosphorylation and carbonmetabolism). Therefore, DEPs associated with seed ageing and priming can be used to characterize seed vigor and optimize germination enhancement treatments. This work reveals new proteomic insights into protein changes that occur during seed deterioration and priming.	[Lv, Yangyong; Zhang, Shuaibing; Wang, Jinshui; Hu, Yuansen] Henan Univ Technol, Coll Biol Engn, Zhengzhou, Peoples R China	Henan University of Technology	Hu, YS (corresponding author), Henan Univ Technol, Coll Biol Engn, Zhengzhou, Peoples R China.	hys308@126.com	Lv, Yangyong/HDN-1832-2022		Natural Science Foundation of China [31371850, 31501575, 31401542]; Natural Science Foundation of Henan Provincial Education Department [13A210164]; Natural Science Foundation of Youth Support Plan of Henan University of Technology [2015QNJH06]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan Provincial Education Department; Natural Science Foundation of Youth Support Plan of Henan University of Technology	This research was financially supported by grants from the Natural Science Foundation of China grants (31371850, 31501575, and 31401542), Natural Science Foundation of Henan Provincial Education Department (13A210164) and Natural Science Foundation of Youth Support Plan of Henan University of Technology (2015QNJH06).	Abid G, 2009, GENE, V439, P1, DOI 10.1016/j.gene.2009.03.007; Bailly C, 2011, METHODS MOL BIOL, V773, P343, DOI 10.1007/978-1-61779-231-1_20; Bellani LM, 2012, ACTA PHYSIOL PLANT, V34, P1789, DOI 10.1007/s11738-012-0976-0; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; CAMMUE BRUNO PA, 1995, PLANT PHYSIOL, V109, P445, DOI 10.1104/pp.109.2.445; Cao BH, 2010, PLANT CELL TISS ORG, V103, P217, DOI 10.1007/s11240-010-9769-6; Caruso C, 1996, J PROTEIN CHEM, V15, P35, DOI 10.1007/BF01886809; Carvalho AO, 2001, PLANT PHYSIOL BIOCH, V39, P137, DOI 10.1016/S0981-9428(00)01230-4; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; CHHETRI DR, 1993, SEED SCI TECHNOL, V21, P31; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Christov NK, 2008, CELL BIOL INT, V32, P574, DOI 10.1016/j.cellbi.2007.11.014; Christova PK, 2006, PLANTA, V223, P1207, DOI 10.1007/s00425-005-0169-9; DAS G, 1988, PLANT PHYSIOL, V88, P983, DOI 10.1104/pp.88.4.983; Dell'Aquila A, 1994, SEED SCI RES, V4, P293, DOI 10.1017/S0960258500002324; Dong K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01017; Dong K, 2012, J CEREAL SCI, V56, P615, DOI 10.1016/j.jcs.2012.08.016; Dupont FM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-39; ELLIS RH, 1992, PLANT GROWTH REGUL, V11, P249, DOI 10.1007/BF00024563; Farajalla MR, 2007, GENOME, V50, P502, DOI 10.1139/G07-027; Feldman-Salit A, 2012, STRUCTURE, V20, P292, DOI 10.1016/j.str.2011.11.019; Ford KL, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00044; Fu ZY, 2011, PROTEOMICS, V11, P1462, DOI 10.1002/pmic.201000481; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Garcia-Olmedo Francisco, 1995, Trends in Microbiology, V3, P72, DOI 10.1016/S0966-842X(00)88879-4; Ge P, 2013, PROTEOMICS, V13, P3046, DOI 10.1002/pmic.201300042; Gnanasekar M, 2009, BIOCHEM BIOPH RES CO, V386, P333, DOI 10.1016/j.bbrc.2009.06.028; Goel A, 2003, J PLANT PHYSIOL, V160, P1093, DOI 10.1078/0176-1617-00881; Han J, 2014, J MICROBIOL BIOTECHN, V24, P1162, DOI 10.4014/jmb.1312.12076; He AY, 2014, GENE, V545, P30, DOI 10.1016/j.gene.2014.05.010; HEYDECKER W, 1973, NATURE, V246, P42, DOI 10.1038/246042a0; Hohm T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145247; Hu D, 2012, PLANT CELL ENVIRON, V35, P2045, DOI 10.1111/j.1365-3040.2012.02535.x; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Jin WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147586; Jones R., 2000, BIOCH MOL BIOL PLANT, P930; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Khlestkina EK, 2013, CEREAL RES COMMUN, V41, P185, DOI 10.1556/CRC.2013.0004; Kibinza S, 2011, PLANT SCI, V181, P309, DOI 10.1016/j.plantsci.2011.06.003; Kim ST, 2009, J PROTEOME RES, V8, P3598, DOI 10.1021/pr900358s; Kimura S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0460-2; Kondoh H, 2005, CANCER RES, V65, P177; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Lee J, 2012, PLANT BIOTECHNOL J, V10, P164, DOI 10.1111/j.1467-7652.2011.00650.x; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Lehninger AL, 2005, PRINCIPLES BIOCH; Lei L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073330; Li X, 2010, PHYTOPATHOLOGY, V100, P183, DOI 10.1094/PHYTO-100-2-0183; Lin XQ, 2013, J PROTEOMICS, V91, P58, DOI 10.1016/j.jprot.2013.06.031; Liu HT, 2003, PLANT PHYSIOL, V132, P1186, DOI 10.1104/pp.102.018564; Liu WJ, 2007, P NATL ACAD SCI USA, V104, P3627, DOI 10.1073/pnas.0611572104; Liu ZH, 2013, BIOTECHNOL LETT, V35, P1765, DOI 10.1007/s10529-013-1277-4; Lucyshyn D, 2007, MOL GENET GENOMICS, V277, P507, DOI 10.1007/s00438-006-0201-1; Ma CY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1029; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; Mak Y, 2009, CEREAL CHEM, V86, P281, DOI 10.1094/CCHEM-86-3-0281; Martineau Y, 2008, MOL CELL BIOL, V28, P6658, DOI 10.1128/MCB.00738-08; MATHUR M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P161, DOI 10.1016/0167-4838(91)99005-D; MCCUBBIN WD, 1985, CAN J BIOCHEM CELL B, V63, P803, DOI 10.1139/o85-102; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Miller J. David, 1997, Natural Toxins, V5, P234, DOI 10.1002/(SICI)1522-7189(1997)5:6<234::AID-NT3>3.0.CO;2-Q; MILLER JD, 1986, CAN J PLANT PATHOL, V8, P147; MIRELMAN D, 1975, NATURE, V256, P414, DOI 10.1038/256414a0; MOLINA A, 1993, FEBS LETT, V316, P119, DOI 10.1016/0014-5793(93)81198-9; Morscher F, 2015, ANN BOT-LONDON, V116, P669, DOI 10.1093/aob/mcv108; Nair RB, 1997, PLANT SCI, V122, P153, DOI 10.1016/S0168-9452(96)04543-8; Neal AL, 2013, J BIOL INORG CHEM, V18, P557, DOI 10.1007/s00775-013-1000-x; NI WT, 1991, PLANT CELL, V3, P737, DOI 10.1105/tpc.3.7.737; O'Sullivan NC, 2012, HUM MOL GENET, V21, P3356, DOI 10.1093/hmg/dds167; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Olea F, 2004, PLANT CELL PHYSIOL, V45, P770, DOI 10.1093/pcp/pch092; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Permyakova MD, 2010, APPL BIOCHEM MICRO+, V46, P87, DOI 10.1134/S0003683810010151; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Powell AA, 2000, J EXP BOT, V51, P2031, DOI 10.1093/jexbot/51.353.2031; Qin DD, 2015, PLANT MOL BIOL, V87, P31, DOI 10.1007/s11103-014-0259-9; Qu ZL, 2005, BBA-GENE STRUCT EXPR, V1730, P103, DOI 10.1016/j.bbaexp.2005.06.009; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; REBEILLE F, 1994, BIOCHEM J, V302, P223, DOI 10.1042/bj3020223; Seebauer JR, 2004, PLANT PHYSIOL, V136, P4326, DOI 10.1104/pp.104.043778; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoeva OY, 2014, GENE, V538, P334, DOI 10.1016/j.gene.2014.01.008; Song YH, 2007, TRENDS FOOD SCI TECH, V18, P132, DOI 10.1016/j.tifs.2006.11.003; Sramkova Z., 2009, ACTA CHIM SLOVACA, V2, P115; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; TZEN JTC, 1992, J CELL BIOL, V117, P327, DOI 10.1083/jcb.117.2.327; Uematsu K, 2012, J EXP BOT, V63, P3001, DOI 10.1093/jxb/ers004; Van den Ende W, 2003, PLANT PHYSIOL, V131, P621, DOI 10.1104/pp.015305; van Ulsen P, 2009, PROTEOMICS, V9, P1771, DOI 10.1002/pmic.200800642; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walters C, 1998, SEED SCI RES, V8, P223, DOI 10.1017/S096025850000413X; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Weyler C, 2016, BIOTECHNOL LETT, V38, P477, DOI 10.1007/s10529-015-1995-x; Whittle E, 2005, J BIOL CHEM, V280, P28169, DOI 10.1074/jbc.M504205200; WONG YS, 1981, PHYTOCHEMISTRY, V20, P1831, DOI 10.1016/0031-9422(81)84014-9; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xin X, 2014, J PLANT PHYSIOL, V171, P140, DOI 10.1016/j.jplph.2013.09.016; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Xu AM, 1999, BIOCHEM J, V342, P683, DOI 10.1042/0264-6021:3420683; Yacoubi R, 2011, J PROTEOME RES, V10, P3891, DOI 10.1021/pr101274f; Yan X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076914; Yang P, 2007, PLANT J, V51, P441, DOI 10.1111/j.1365-313X.2007.03154.x; [杨伟飞 Yang Weifei], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1878; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yu YL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2416-9; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng J, 2011, MOLECULES, V16, P10570, DOI 10.3390/molecules161210570	112	33	34	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162851	10.1371/journal.pone.0162851	http://dx.doi.org/10.1371/journal.pone.0162851			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632285	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900086
J	Ogita, M; Miyauchi, K; Onishi, A; Tsuboi, S; Wada, H; Konishi, H; Naito, R; Dohi, T; Kasai, T; Kojima, Y; Schwartz, RS; Daida, H				Ogita, Manabu; Miyauchi, Katsumi; Onishi, Akira; Tsuboi, Shuta; Wada, Hideki; Konishi, Hirokazu; Naito, Ryo; Dohi, Tomotaka; Kasai, Takatoshi; Kojima, Yuko; Schwartz, Robert S.; Daida, Hiroyuki			Development of Accelerated Coronary Atherosclerosis Model Using Low Density Lipoprotein Receptor Knock-Out Swine with Balloon Injury	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FAMILIAL HYPERCHOLESTEROLEMIA; INTERVENTIONAL RESEARCH; VULNERABLE PLAQUE; APOLIPOPROTEIN-B; PORCINE MODEL; PIG; LESIONS; CHOLESTEROL; ALLELES	Background Several animal models have facilitated the evaluation and pathological understanding of atherosclerosis, but a definitive animal model of coronary atherosclerosis is not available. We therefore developed low density lipoprotein receptor knockout (LDLR-KO) pigs with hypercholesterolemia, a model which rapidly developed coronary atherosclerosis following balloon injury. Methods and Results We deleted LDLR exon regions from cultured porcine fetal fibroblasts and cloned LDLR knockout (LDLR-KO) embryos microinjecting fetal fibroblast nuclei into enucleated oocytes. Twelve LDLR-KO pigs were fed a 2.0% cholesterol and 20% fat diet. Baseline serum LDL cholesterol level was 510.0 +/- 86.1 mg/dL. Balloon injury was created in 46 coronary segments and necropsy were obtained 2, 4, 8 and 12 weeks later. Coronary artery sections were reviewed to evaluate lesion progression. We found lipid accumulation with foam cells and inflammatory cells beginning four weeks after balloon injury. The mean ratio of macrophages to plaque area was significantly higher in the four-weeks and eight-week animals compared with those at 2-weeks (8.79% +/- 5.98% and 17.00% +/- 10.38% vs. 1.14% +/- 1.88%, P < 0.0001). At 12 weeks the ratio decreased toward the level at 2 week level (4.00% +/- 4.56%, P = 0.66 vs. baseline). Advanced coronary atherosclerotic lesions contained lipid pools at eight-weeks with fibrous components beginning at 12 weeks. Conclusions We developed a model of rapid coronary atherosclerosis using LDLR KO pigs with balloon injury. This model may be useful for preclinical evaluation of medication or devices, and may also help investigate mechanisms of plaque progression.	[Ogita, Manabu; Miyauchi, Katsumi; Tsuboi, Shuta; Wada, Hideki; Konishi, Hirokazu; Naito, Ryo; Dohi, Tomotaka; Kasai, Takatoshi; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Onishi, Akira] Natl Inst Agrobiol Sci, Transgen Anim Res Ctr, Tsukuba, Ibaraki, Japan; [Kojima, Yuko] Juntendo Univ, Div Biomed Imaging Res, Biomed Res Ctr, Grad Sch Med, Tokyo, Japan; [Schwartz, Robert S.] Minneapolis Heart Inst & Fdn, Minneapolis, MN USA	Juntendo University; National Institute of Agrobiological Sciences - Japan; Juntendo University; Minneapolis Heart Institute Foundation	Miyauchi, K (corresponding author), Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan.	ktmmy@juntendo.ac.jp	Dohi, Tomotaka/ABH-3047-2021	Dohi, Tomotaka/0000-0002-6646-468X				Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Bentzon JF, 2007, CIRCULATION, V116, P2053, DOI 10.1161/CIRCULATIONAHA.107.722355; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Davis BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093457; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Gradada JF, 2007, ARTERIOSCLER THROMB, V27, P387; Granada JF, 2005, CORONARY ARTERY DIS, V16, P217, DOI 10.1097/00019501-200506000-00002; Granada JF, 2009, EUROINTERVENTION, V5, P140, DOI 10.4244/EIJV5I1A22; Hasler-Rapacz J, 1998, AM J MED GENET, V76, P379, DOI 10.1002/(SICI)1096-8628(19980413)76:5<379::AID-AJMG3>3.0.CO;2-I; Jensen TW, 2010, ANIM BIOTECHNOL, V21, P179, DOI 10.1080/10495398.2010.490693; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Li Y, 2016, J AM HEART ASS, V5; Maeng M, 2001, CORONARY ARTERY DIS, V12, P285, DOI 10.1097/00019501-200106000-00004; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ozawa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132155; PRESCOTT MF, 1995, ANN NY ACAD SCI, V748, P283; PRESCOTT MF, 1991, AM J PATHOL, V139, P139; RAPACZ J, 1986, SCIENCE, V234, P1573, DOI 10.1126/science.3787263; REITMAN JS, 1982, ATHEROSCLEROSIS, V43, P119, DOI 10.1016/0021-9150(82)90104-6; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Shiomi M, 2009, ATHEROSCLEROSIS, V207, P1, DOI 10.1016/j.atherosclerosis.2009.03.024; Suzuki Y, 2009, JACC-CARDIOVASC INTE, V2, P373, DOI 10.1016/j.jcin.2009.03.004; Thim Troels, 2010, Dan Med Bull, V57, pB4161; Thim T, 2010, EUROINTERVENTION, V6, P261, DOI 10.4244/; Thorpe PE, 1996, ANGIOLOGY, V47, P849, DOI 10.1177/000331979604700903; Virmani R, 2007, ARTERIOSCL THROM VAS, V27, P1666, DOI 10.1161/ATVBAHA.107.143198; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870	29	9	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163055	10.1371/journal.pone.0163055	http://dx.doi.org/10.1371/journal.pone.0163055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631974	gold, Green Submitted, Green Published			2022-12-26	WOS:000383706900124
J	Park, S; Han, S; Choi, I; Kim, B; Park, SP; Joe, EH; Suh, YH				Park, Sangwook; Han, Seulki; Choi, Insup; Kim, Beomsue; Park, Seung Pyo; Joe, Eun-Hye; Suh, Young Ho			Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy	PLOS ONE			English	Article							PROTEIN-DEGRADATION PATHWAYS; PARKINSONS-DISEASE; RECEPTOR OPTINEURIN; ALPHA-SYNUCLEIN; CELL-DEATH; P62; PHOSPHORYLATION; CLEARANCE; ADAPTER; UBIQUITINATION	The deposit of polyubiquitinated aggregates has been implicated in the pathophysiology of Parkinson's disease (PD), and growing evidence indicates that selective autophagy plays a critical role in the clearance of ubiquitin-positive protein aggregates by autophagosomes. The selective autophagic receptor p62/SQSTM-1, which associates directly with both ubiquitin and LC3, transports ubiquitin conjugates to autophagosomes for degradation. Leucine-rich repeat kinase 2 (LRRK2), a PD-associated protein kinase, is tightly controlled by autophagy-lysosome degradation as well as by the ubiquitin-proteasome pathway. However, little is known about the degradation of ubiquitinated LRRK2 via selective autophagy. In the present study, we found that p62/SQSTM-1 physically interacts with LRRK2 as a selective autophagic receptor. The overexpression of p62 leads to the robust degradation of LRRK2 through the autophagy-lysosome pathway. In addition, LRRK2 indirectly regulates Ser351 and Ser403 phosphorylation of p62. Of particular interest, the interaction between phosphorylated p62 and Keap1 is reduced by LRRK2 overexpression. Therefore, we propose that the interplay between LRRK2 and p62 may contribute to the pathophysiological function and homeostasis of LRRK2 protein.	[Park, Sangwook] Kyungwoon Univ, Coll Hlth, Dept Biomed Lab Sci, Gumi 39160, South Korea; [Choi, Insup; Kim, Beomsue; Joe, Eun-Hye] Ajou Univ, Sch Med, Dept Pharmacol, Suwon 16499, South Korea; [Choi, Insup; Kim, Beomsue; Joe, Eun-Hye] Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, Suwon 16499, South Korea; [Han, Seulki; Park, Seung Pyo; Suh, Young Ho] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea; [Han, Seulki; Park, Seung Pyo; Suh, Young Ho] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul 03080, South Korea	Kyungwoon University; Ajou University; Ajou University; Seoul National University (SNU); Seoul National University (SNU)	Park, S (corresponding author), Kyungwoon Univ, Coll Hlth, Dept Biomed Lab Sci, Gumi 39160, South Korea.; Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea.; Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul 03080, South Korea.	spark367@iikw.ac.kr; suhyho@snu.ac.kr	Suh, Young Ho/AAJ-6405-2021; Kim, Beomsue/X-3045-2019	Suh, Young Ho/0000-0003-3979-1615; Kim, Beomsue/0000-0003-1207-7876; CHOI, INSUP/0000-0001-8314-8067	National Research Foundation of Korea (NRF) [2013R1A1A2058079, NRF-2011-0011694, 2015048055]; Brain Korea 21 PLUS program; Seoul National University Hospital	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Korea 21 PLUS program; Seoul National University Hospital	This study was supported by the National Research Foundation of Korea (NRF) grant (http://nrf.re.kr/) to S.P. (2013R1A1A2058079) and to Y.H.S. (NRF-2011-0011694, 2015048055); by the Brain Korea 21 PLUS program (https://bkplus.nrf.re.kr/) to S.H.; and by a grant from Seoul National University Hospital (2016) (http://www.snuh.org/) to Y.H.S.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; Esteves AR, 2014, EXP NEUROL, V261, P206, DOI 10.1016/j.expneurol.2014.05.025; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Joung I, 1996, P NATL ACAD SCI USA, V93, P5991, DOI 10.1073/pnas.93.12.5991; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lichtenberg M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.81; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Pan JA, 2013, J BIOL CHEM, V288, P2952, DOI 10.1074/jbc.M112.441063; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Qi D, 2008, J VIROL METHODS, V149, P85, DOI 10.1016/j.jviromet.2008.01.002; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012	43	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163029	10.1371/journal.pone.0163029	http://dx.doi.org/10.1371/journal.pone.0163029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631370	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900120
J	Tan, PY; Chang, CW; Duan, KB; Poidinger, M; Ng, KL; Chong, YS; Gluckman, PD; Stunkel, W				Tan, Peck Yean; Chang, Cheng Wei; Duan, Kaibo; Poidinger, Michael; Kai Lyn Ng; Chong, Yap Seng; Gluckman, Peter D.; Stunkel, Walter			E2F1 Orchestrates Transcriptomics and Oxidative Metabolism in Wharton's Jelly-Derived Mesenchymal Stem Cells from Growth-Restricted Infants	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; INTRAUTERINE GROWTH; HISTONE MODIFICATIONS; CANCER-CELLS; HUMAN GENOME; DISEASE; HEALTH; LIFE; RETARDATION; APPROPRIATE	Wharton's jelly-derived Mesenchymal Stem Cells (MSCs) isolated from newborns with intrauterine fetal growth restriction were previously shown to exert anabolic features including insulin hypersensitivity. Here, we extend these observations and demonstrate that MSCs from small for gestational age (SGA) individuals have decreased mitochondrial oxygen consumption rates. Comparing normally grown and SGA MSCs using next generation sequencing studies, we measured global transcriptomic and epigenetic profiles and identified E2F1 as an over-expressed transcription factor regulating oxidative metabolism in the SGA group. We further show that E2F1 regulates the differential transcriptome found in SGA derived MSCs and is associated with the activating histone marks H3K27ac and H3K4me3. One of the key genes regulated by E2F1 was found to be the fatty acid elongase ELOVL2, a gene involved in the endogenous synthesis of docosahexaenoic acid (DHA). Finally, we shed light on how the E2F1-ELOVL2 pathway may alter oxidative respiration in the SGA condition by contributing to the maintenance of cellular metabolic homeostasis.	[Tan, Peck Yean; Chang, Cheng Wei; Chong, Yap Seng; Gluckman, Peter D.; Stunkel, Walter] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Duan, Kaibo; Poidinger, Michael] ASTAR, Singapore Immunol Network, Singapore, Singapore; [Kai Lyn Ng; Chong, Yap Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland, New Zealand	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; University of Auckland	Stunkel, W (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	walter_stunkel@sics.a-star.edu.sg		Chong, Yap Seng/0000-0002-7232-8473; Poidinger, Michael/0000-0002-1047-2277	Singapore National Research Foundation under Translational and Clinical Research (TCR) Flagship Programme; Agency for Science Technology and Research (A*STAR);  [NMRC/TCR/004-NUS/2008];  [NMRC/TCR/012-NUHS/ 2014]	Singapore National Research Foundation under Translational and Clinical Research (TCR) Flagship Programme(National Research Foundation, Singapore); Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); ; 	This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC; www.nmrc.gov.sg), Singapore-NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/ 2014. SICS Investigators are supported through Agency for Science Technology and Research (A*STAR; www.a-star.edu.sg) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bazaes RA, 2003, PEDIATRICS, V111, P804, DOI 10.1542/peds.111.4.804; Beauchamp B, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150007; Benveniste D, 2014, P NATL ACAD SCI USA, V111, P13367, DOI 10.1073/pnas.1412081111; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blanchet E, 2011, NAT CELL BIOL, V13, P1146, DOI 10.1038/ncb2309; Bol VV, 2008, OBESITY, V16, P2760, DOI 10.1038/oby.2008.417; Budden DM, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-36; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; Dogan N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0009-5; Fajas L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00004; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662; Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jorgensen SW, 2015, DIABETOLOGIA, V58, P178, DOI 10.1007/s00125-014-3406-6; Joseph R, 2015, MOL ENDOCRINOL, V29, P909, DOI 10.1210/me.2015-1020; Joung KE, 2015, METABOLISM, V64, P1507, DOI 10.1016/j.metabol.2015.07.019; Kuzawa CW, 1998, YEARB PHYS ANTHROPOL, V41, P177; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Minjong, 2015, World J Biol Chem, V6, P148, DOI 10.4331/wjbc.v6.i3.148; Llanos A, 2005, PEDIATR RES, V58, P735, DOI 10.1203/01.PDR.0000180542.68526.A2; McCarthy F, 2015, LANCET, V385, P67, DOI 10.1016/S0140-6736(15)60382-8; McLeay RC, 2012, BIOINFORMATICS, V28, P2789, DOI 10.1093/bioinformatics/bts529; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Mericq V, 2009, J PEDIATR ENDOCR MET, V22, P1041; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Padmanabhan V, 2016, ENDOCRINOLOGY, V157, P1328, DOI 10.1210/en.2016-1003; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Salama GSA, 2015, CLIN MED INSIGHTS-PE, V9, P25, DOI 10.4137/CMPed.S21161; Gonzalez RS, 2014, GENE, V549, P7, DOI 10.1016/j.gene.2014.06.057; Sukarieh R, 2014, HUM REPROD, V29, P2287, DOI 10.1093/humrep/deu209; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; WARBURG O, 1956, SCIENCE, V124, P269; Wu MH, 2015, ONCOTARGET, V6, P11252, DOI 10.18632/oncotarget.3594; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772	43	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163035	10.1371/journal.pone.0163035	http://dx.doi.org/10.1371/journal.pone.0163035			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631473	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900121
J	Yadav, G; Goldberg, HR; Barense, MD; Bell, CM				Yadav, Geeta; Goldberg, Hanna R.; Barense, Morgan D.; Bell, Chaim M.			A Cross-Sectional Survey of Population-Wide Wait Times for Patients Seeking Medical vs. Cosmetic Dermatologic Care	PLOS ONE			English	Article							WORKFORCE SHORTAGE; SERVICES; CANADA; ACCESS; LONG; TOO	Background Though previous work has examined some aspects of the dermatology workforce shortage and access to dermatologic care, little research has addressed the effect of rising interest in cosmetic procedures on access to medical dermatologic care. Our objective was to determine the wait times for Urgent and Non-Urgent medical dermatologic care and Cosmetic dermatology services at a population level and to examine whether wait times for medical care are affected by offering cosmetic services. Methods A population-wide survey of dermatology practices using simulated calls asking for the earliest appointment for a Non-Urgent, Urgent and Cosmetic service. Results Response rates were greater than 89% for all types of care. Wait times across all types of care were significantly different from each other (all P < 0.05). Cosmetic care was associated with the shortestwait times (3.0 weeks; Interquartile Range (IQR) = 0.4-3.4), followed by Urgent care (9.0 weeks; IQR = 2.1-12.9), then Non-Urgent Care (12.7 weeks; IQR = 4.4-16.4). Wait times for practices offering only Urgent care were not different from practices offering both Urgent and Cosmetic care (10.3 vs. 7.0 weeks). Interpretation Longer wait times and greater variation for Urgent and Non-Urgent dermatologic care and shorter wait times and less variation for Cosmetic care. Wait times were significantly longer in regions with lower dermatologist density. Provision of Cosmetic services did not increase wait times for Urgent care. These findings suggest an overall dermatology workforce shortage and a need for a more streamlined referral system for dermatologic care.	[Yadav, Geeta; Goldberg, Hanna R.; Bell, Chaim M.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Yadav, Geeta] Womens Coll Hosp, Div Dermatol, Toronto, ON, Canada; [Barense, Morgan D.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Bell, Chaim M.] Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada; [Bell, Chaim M.] Univ Toronto, Dept Med & Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Bell, CM (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Bell, CM (corresponding author), Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada.; Bell, CM (corresponding author), Univ Toronto, Dept Med & Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Bell, CM (corresponding author), Mt Sinai Hosp, Dept Med, Toronto, ON, Canada.	cbell@mtsinai.on.ca	Bell, Chaim/C-4611-2015; Barense, Morgan/H-7451-2019; Yadav, Geeta/HHZ-1529-2022	Bell, Chaim/0000-0002-3778-9469; Barense, Morgan/0000-0002-4008-9201; 				[Anonymous], 2014, POSITION PAPER OCCAS; Bercovici Eduard, 2008, Healthc Policy, V4, P59; Burton A, 2008, LANCET ONCOL, V9, P825, DOI 10.1016/S1470-2045(08)70225-0; Campbell RJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P1384, DOI 10.1001/archophthalmol.2009.275; Canadian Medical Association, 2010, 2010 NAT PHYS SURV; Canadian Skin Patient Alliance, 2012, SKIN DEEP REP CARD A; Cancer Care Ontario, 2014, SKIN SYST WAIT TIM R; Chow EY, 2010, J CUTAN MED SURG, V14, P71, DOI 10.2310/7750.2010.09025; Dall TM, 2013, HEALTH AFFAIR, V32, P2013, DOI 10.1377/hlthaff.2013.0714; Esmail N, 2008, FRASER FORUM     DEC, P22; Health Council of Canada, 2014, CANADIAN HLTH CARE M, V8; Heughan C, 2008, J CUTAN MED SURG, V12, P217, DOI 10.2310/7750.2008.07071; Kimball AB, 2008, J AM ACAD DERMATOL, V59, P741, DOI 10.1016/j.jaad.2008.06.037; Maguiness S, 2004, J CUTAN MED SURG, V8, P141, DOI 10.1007/s10227-004-0107-7; Martin AR, 2011, CAN J SURG, V54, P154, DOI 10.1503/cjs.048909; Piggott Katrina L, 2013, Healthc Policy, V9, P65; Pong RW, 2005, OTTAWA CAN I HLTH IN, P11; Resneck J, 2004, J AM ACAD DERMATOL, V50, P50, DOI 10.1016/j.jaad.2003.07.001; Resneck J, 2001, ARCH DERMATOL, V137, P1295; Resneck JS, 2008, J AM ACAD DERMATOL, V58, P211, DOI 10.1016/j.jaad.2007.09.032; Resneck JS, 2007, J AM ACAD DERMATOL, V57, P985, DOI 10.1016/j.jaad.2007.07.020; Revah Giselle, 2007, Healthc Policy, V2, P49; Robert JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035179; Salsberg E, 2006, ACAD MED, V81, P782, DOI 10.1097/00001888-200609000-00003; Sibley LM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-20; Siciliani L, 2009, HEALTH ECON, V18, P1295, DOI 10.1002/hec.1429; Suneja T, 2001, ARCH DERMATOL, V137, P1303; Tsang MW, 2006, J AM ACAD DERMATOL, V55, P54, DOI 10.1016/j.jaad.2006.04.001	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162767	10.1371/journal.pone.0162767	http://dx.doi.org/10.1371/journal.pone.0162767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632206	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900076
J	Yamaguchi, N; Sekine, S; Naguro, I; Sekine, Y; Ichijo, H				Yamaguchi, Namiko; Sekine, Shiori; Naguro, Isao; Sekine, Yusuke; Ichijo, Hidenori			KLHDC10 Deficiency Protects Mice against TNF alpha-Induced Systemic Inflammation	PLOS ONE			English	Article							KINASE DOMAIN-LIKE; NONAPOPTOTIC CELL-DEATH; ISCHEMIC BRAIN-INJURY; INDUCED LETHAL SHOCK; REACTIVE OXYGEN; NADPH OXIDASE; INDUCED ACTIVATION; RESPONSE SYNDROME; OXIDATIVE STRESS; INDUCED NECROSIS	Systemic inflammatory response syndrome (SIRS) is a form of fatal acute inflammation for which there is no effective treatment. Here, we revealed that the ablation of Kelch domain containing 10 (KLHDC10), which we had originally identified as an activator of Apoptosis Signal-regulating Kinase 1 (ASK1), protects mice against TNF alpha-induced SIRS. The disease development of SIRS is mainly divided into two stages. The early stage is characterized by TNF alpha-induced systemic necroptosis, a regulated form of necrosis mediated by Receptor-interacting protein (RIP) 1/3 kinases. The later stage presents with an over-production of inflammatory cytokines induced by damage-associated molecular patterns (DAMPs), which are immunogenic cellular contents released from cells that underwent necroptosis. Analysis of TNF alpha-challenged mice revealed that KLHDC10-deficient mice show a reduction in the inflammatory response, but not in early systemic necroptosis. In vitro analysis suggested that the reduced inflammatory response observed in KLHDC10-deficient mice might be caused, in part, by enhanced necroptosis of inflammatory cells encountering DAMPs. Interestingly, the enhancement of necroptosis induced by KLHDC10 deficiency was selectively observed in inflammatory cells. Our results suggest that KLHDC10 is a cell-type specific regulator of necroptosis that ultimately contributes to the development of TNF alpha-induced SIRS.	[Yamaguchi, Namiko; Sekine, Shiori; Naguro, Isao; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan; [Sekine, Yusuke] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	University of Tokyo; University of Cambridge	Ichijo, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan.	ichijo@mol.f.u-tokyo.ac.jp	Sekine, Yusuke/AHI-8340-2022; Naguro, Isao/P-1337-2019	Ichijo, Hidenori/0000-0002-5005-6438; Naguro, Isao/0000-0002-0338-8026; Sekine, Yusuke/0000-0003-0345-1416	KAKENHI from Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25221302]; Grants-in-Aid for Scientific Research [26114009] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science (JSPS) and the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (Grant number; 25221302 to H. Ichijo). URL; https://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Cauwels A, 2000, IMMUNITY, V13, P223, DOI 10.1016/S1074-7613(00)00022-4; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dewas C, 2003, J IMMUNOL, V171, P4392, DOI 10.4049/jimmunol.171.8.4392; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; EVERAERDT B, 1994, J IMMUNOL, V152, P5041; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Maruyama J, 2016, SCI REP-UK, V6, DOI 10.1038/srep18710; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Sekine Y, 2012, MOL CELL, V48, P692, DOI 10.1016/j.molcel.2012.09.018; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; STARNES HF, 1990, J IMMUNOL, V145, P4185; Takahashi N, 2008, J EXP MED, V205, P1755, DOI 10.1084/jem.20080588; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Wakabayashi M, 2013, CELL REP, V3, P858, DOI 10.1016/j.celrep.2013.02.024; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109	42	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163118	10.1371/journal.pone.0163118	http://dx.doi.org/10.1371/journal.pone.0163118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631783	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900133
J	Chao, YJ; Chan, JF; Hsu, YHH				Chao, Yu-Jen; Chan, Jui-Fen; Hsu, Yuan-Hao Howard			Chemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin Fluctuation	PLOS ONE			English	Article							CELL-CYCLE; PHOSPHOLIPASE A(2); CANCER; BIOGENESIS; METABOLISM; MECHANISMS; EXPRESSION; ASYMMETRY; APOPTOSIS; DYNAMICS	Chemotherapy drugs have been prescribed for the systemic treatment of cancer. We selected three chemotherapy drugs, including methotrexate, mitomycine C and vincristine to inhibit the proliferation of HT1080 human fibrosarcoma cells in S, G2 and M phases of the cell cycle respectively. These chemotherapy drugs showed significant toxicity and growth inhibition to the cancer cells measured by MTT assay. After treated with a 50% inhibitory dosage for 48 hours, these cancer cells showed significant accumulation of cardiolipin (CL), which was a reverse trend of the nutritional deficiency induced arrest at G1 phase. The quantity of each CL species was further semi-quantitated by HPLC-ion trap mass spectrometer. Methotraxate treatment caused unique increases of acyl chain length on CL, which were the opposite of the serum starvation, mitomycine C and vincristine treatments. Although mitomycine C and vincristine have different mechanisms to induce cell cycle arrest, these two drugs displayed similar effects on decreasing chain length of CL. Continuation of CL synthesis during cell cycle arrest indicated the chemotherapy drugs resulting in the discoordination of the mitochondrial life cycle from the cell cycle and thus caused the accumulation of CL. These finding reveals that the pre-remodeling nascent CL accumulates during the methotraxate induced arrest; however, the post-remodeling mature CL accumulates during the mitomycine C and vincristine induced arrest after the synthesis phase.	[Chao, Yu-Jen; Chan, Jui-Fen; Hsu, Yuan-Hao Howard] Tunghai Univ, Dept Chem, Taichung, Taiwan; [Hsu, Yuan-Hao Howard] Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan	Tunghai University; Tunghai University	Hsu, YHH (corresponding author), Tunghai Univ, Dept Chem, Taichung, Taiwan.; Hsu, YHH (corresponding author), Tunghai Univ, Life Sci Res Ctr, Taichung, Taiwan.	howardhsu@thu.edu.tw	hsu, yuan-hao/B-5744-2009		Ministry of Science and Technology, R.O.C. [MOST 103-2113-M-029-002-MY2]; National Health Research Institutes, Taiwan [NHRI-EX104-10236SC]	Ministry of Science and Technology, R.O.C.; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Ministry of Science and Technology, R.O.C. (MOST 103-2113-M-029-002-MY2) and the National Health Research Institutes, Taiwan (NHRI-EX104-10236SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, ONCOLOGIST, DOI [DOI 10.1002/STEM.140005, DOI 10.1634/THEONCOLOGIST.1-4-223]; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Ascenzi P, 2011, IUBMB LIFE, V63, P160, DOI 10.1002/iub.440; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113680; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Collins I, 2005, CURR OPIN PHARMACOL, V5, P366, DOI 10.1016/j.coph.2005.04.009; Costantini P, 2000, J NATL CANCER I, V92, P1042, DOI 10.1093/jnci/92.13.1042; Genestier L, 2000, IMMUNOPHARMACOLOGY, V47, P247, DOI 10.1016/S0162-3109(00)00189-2; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jordan A, 1998, MED RES REV, V18, P259, DOI 10.1002/(SICI)1098-1128(199807)18:4<259::AID-MED3>3.3.CO;2-T; Kagan VE, 2015, ANTIOXID REDOX SIGN, V22, P1667, DOI 10.1089/ars.2014.6219; Kagan VE, 2014, CHEM PHYS LIPIDS, V179, P64, DOI 10.1016/j.chemphyslip.2013.11.010; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pamplona R, 1998, J LIPID RES, V39, P1989; PANGBORN MC, 1947, J BIOL CHEM, V168, P351; PETRU E, 1995, GYNECOL ONCOL, V58, P48, DOI 10.1006/gyno.1995.1182; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Ray NB, 2010, NAT MED, V16, P1120, DOI 10.1038/nm.2213; RICHARDSON VB, 1994, CYTOGENET CELL GENET, V66, P126, DOI 10.1159/000133682; SAKAI T, 1989, CANCER RES, V49, P1193; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Ting HC, 2015, J NUTR BIOCHEM, V26, P769, DOI 10.1016/j.jnutbio.2015.02.005; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Verweij J, 1999, Cancer Chemother Biol Response Modif, V18, P46; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Weinberg F, 2009, ANN NY ACAD SCI, V1177, P66, DOI 10.1111/j.1749-6632.2009.05039.x; Xiong W, 2012, ACTA BIOCH BIOPH SIN, V44, P347, DOI 10.1093/abbs/gms006; Ye C, 2014, J BIOENERG BIOMEMBR; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	51	4	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162457	10.1371/journal.pone.0162457	http://dx.doi.org/10.1371/journal.pone.0162457			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627658	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600034
J	Fracanzani, AL; Pisano, G; Consonni, D; Tiraboschi, S; Baragetti, A; Bertelli, C; Norata, GD; Dongiovanni, P; Valenti, L; Grigore, L; Tonella, T; Catapano, A; Fargion, S				Fracanzani, Anna Ludovica; Pisano, Giuseppina; Consonni, Dario; Tiraboschi, Silvia; Baragetti, Andrea; Bertelli, Cristina; Norata, Giuseppe Danilo; Dongiovanni, Paola; Valenti, Luca; Grigore, Liliana; Tonella, Tatiana; Catapano, Alberico; Fargion, Silvia			Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; TERM-FOLLOW-UP; ARTERIAL STIFFNESS; METABOLIC SYNDROME; HEPATIC STEATOSIS; BODY-SIZE; FIBROSIS; RISK; SYSTEM; NAFLD	Background and Aims Epicardial adipose tissue (EAT) has been proposed as a cardiometabolic and hepatic fibrosis risk factor in patients with non alcoholic fatty liver disease (NAFLD). Aim of this study was to evaluate the role of EAT in NAFLD by analyzing 1) the association between EAT, the other metabolic parameters and the severity of steatosis 2) the relationship between cardiovascular (cIMT, cplaques, E/A), liver (presence of NASH and significant fibrosis) damage and metabolic risk factors including EAT 3) the relationship between EAT and genetic factors strongly influencing liver steatosis. Methods In a cross-sectional study, we considered 512 consecutive patients with NAFLD (confirmed by biopsy in 100). EAT, severity of steatosis, carotid intima-media thickness (cIMT) and plaques were evaluated by ultrasonography and results analysed by multiple linear and logistic regression models. Variables independently associated with EAT (mm) were female gender (p = 0.003), age (p = 0.001), BMI (p = 0.01), diastolic blood pressure (p = 0.009), steatosis grade 2 (p = 0.01) and 3 (p = 0.04), fatty liver index (p = 0.001) and statin use (p = 0.03). Variables independently associated with carotid IMT were age (p = 0.0001), hypertension (p = 0.009), diabetes (p = 0.04), smoking habits (p = 0.04) and fatty liver index (p = 0.02), with carotid plaques age (p = 0.0001), BMI (p = 0.03), EAT (p = 0.02),) and hypertension (p = 0.02), and with E/A age (p = 0.0001), diabetes (p = 0.005), hypertension (p = 0.04) and fatty liver index (p = 0.004). In the 100 patients with available liver histology non alcoholic steatohepatitis (NASH) was independently associated with EAT (p = 0.04) and diabetes (p = 0.054) while significant fibrosis with EAT (p = 0.02), diabetes (p = 0.01) and waist circumference (p = 0.05). No association between EAT and PNPLA3 and TM6SF2 polymorphisms was found. Conclusion In patients with NAFLD, EAT is associated with the severity of liver and vascular damage besides with the known metabolic risk factors.	[Fracanzani, Anna Ludovica; Pisano, Giuseppina; Tiraboschi, Silvia; Bertelli, Cristina; Dongiovanni, Paola; Valenti, Luca; Fargion, Silvia] Univ Milan, Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Dept Pathophysiol & Transplantat, Milan, Italy; [Consonni, Dario] Univ Milan, Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Epidemiol Unit, Milan, Italy; [Baragetti, Andrea; Norata, Giuseppe Danilo] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Baragetti, Andrea; Norata, Giuseppe Danilo] Ctr Studi Aterosclerosi Milan, Milan, Italy; [Grigore, Liliana] Bassini Hosp, Ctr Studi Aterosclerosi, Milan, Italy; [Tonella, Tatiana] Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Cardiovasc Med Unit, Milan, Italy; [Catapano, Alberico] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Catapano, Alberico] Multimed IRCCS, Milan, Italy	University of Milan; University of Milan; University of Milan; University of Milan; IRCCS Multimedica	Fracanzani, AL (corresponding author), Univ Milan, Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Dept Pathophysiol & Transplantat, Milan, Italy.	anna.fracanzani@unimi.it	Consonni, Dario/AAM-2947-2020; Dongiovanni, Paola/AAC-9965-2019; Catapano, alberico/AAC-2827-2019; Fracanzani, Anna Ludovica/J-8986-2018; Norata, Giuseppe Danilo/AAC-2863-2019; Valenti, Luca/B-3695-2009	Consonni, Dario/0000-0002-8935-3843; Dongiovanni, Paola/0000-0003-4343-7213; Catapano, alberico/0000-0002-7593-2094; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Valenti, Luca/0000-0001-8909-0345; Norata, Giuseppe Danilo/0000-0002-6081-1257				Alp H, 2013, CAN J CARDIOL, V29, P1118, DOI 10.1016/j.cjca.2012.07.846; Altin C, 2016, ANGIOLOGY, V67, P961, DOI 10.1177/0003319716643669; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Baker AR, 2009, J CLIN ENDOCR METAB, V94, P261, DOI 10.1210/jc.2007-2579; Baragetti A, 2016, NUTR METAB CARDIOVAS, V26, P141, DOI 10.1016/j.numecd.2015.10.013; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Colak Y, 2012, EUR J GASTROEN HEPAT, V24, P613, DOI 10.1097/MEG.0b013e3283513f19; Corrao S, 2015, J HEPATOL, V62, P1212, DOI 10.1016/j.jhep.2015.01.010; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; Drapkina J, 2014, Endosc Ultrasound, V3, pS2; Echouffo-Tcheugui J-B, 2013, Diabetes Metab, V39, P389, DOI 10.1016/j.diabet.2013.07.002; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; FOLSOM AR, 1994, STROKE, V25, P66, DOI 10.1161/01.STR.25.1.66; Garber AJ, 2006, DIABETES CARE, V29, P1955, DOI 10.2337/dc06-9913; Graner M, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.001979; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Iacobellis G, 2016, CURR OPIN PHARMACOL, V27, P13, DOI 10.1016/j.coph.2016.01.004; Iacobellis G, 2014, OBESITY, V22, P332, DOI 10.1002/oby.20624; Iacobellis G, 2011, INT J BIOCHEM CELL B, V43, P1651, DOI 10.1016/j.biocel.2011.09.006; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Kaya H, 2013, J CARDIOL, V62, P343, DOI 10.1016/j.jjcc.2013.05.009; Khawaja T, 2011, AM J CARDIOL, V108, P397, DOI 10.1016/j.amjcard.2011.03.058; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; LICATA G, 1995, J HYPERTENS, V13, P611, DOI 10.1097/00004872-199506000-00006; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Luna-Luna M, 2015, ARCH MED RES, V46, P392, DOI 10.1016/j.arcmed.2015.05.007; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Malavazos AE, 2010, AM J CARDIOL, V105, P1831, DOI 10.1016/j.amjcard.2010.01.368; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mukherjee D, 2002, AM HEART J, V144, P753, DOI 10.1067/mhj.2002.124865; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nakazato R, 2012, ATHEROSCLEROSIS, V221, P422, DOI 10.1016/j.atherosclerosis.2011.12.018; Natale F, 2009, EUR J ECHOCARDIOGR, V10, P549, DOI 10.1093/ejechocard/jep002; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Perseghin G, 2008, HEPATOLOGY, V47, P51, DOI 10.1002/hep.21983; Petta S, 2015, J HEPATOL, V62, P928, DOI 10.1016/j.jhep.2014.11.030; Petta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074089; Psychari SN, 2016, ANGIOLOGY, V67, P41, DOI 10.1177/0003319715576672; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Serfaty L, 2008, DIABETES METAB, V34, P634, DOI 10.1016/S1262-3636(08)74597-X; Shulman GI, 2014, NEW ENGL J MED, V371, P2237; Sinha Santosh Kumar, 2016, J Clin Med Res, V8, P410, DOI 10.14740/jocmr2468w; Sookoian S, 2008, J HEPATOL, V49, P600, DOI 10.1016/j.jhep.2008.06.012; Stein JH, 2004, CLIN CARDIOL, V27, P388, DOI 10.1002/clc.4960270704; Sunbul M, 2014, ATHEROSCLEROSIS, V237, P490, DOI 10.1016/j.atherosclerosis.2014.10.004; Targher G, 2006, DIABETES CARE, V29, P1178, DOI 10.2337/dc06-0233; Targher G, 2010, CLIN J AM SOC NEPHRO, V5, P2166, DOI 10.2215/CJN.05050610; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Topuz M, 2014, Clin Ter, V165, pe46, DOI 10.7417/CT.2014.1671; Ulucan S, 2015, J HEPATOL, V62, P1214, DOI 10.1016/j.jhep.2015.01.008; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Xia MF, 2016, ALIMENT PHARM THER, V43, P631, DOI 10.1111/apt.13521	63	31	33	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162473	10.1371/journal.pone.0162473	http://dx.doi.org/10.1371/journal.pone.0162473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627804	Green Published, gold			2022-12-26	WOS:000383680600036
J	Huang, YJ; Li, Y; Wang, FF; Lv, WG; Xie, X; Cheng, XD				Huang, YongJie; Li, Yang; Wang, Fen F.; Lv, WeiGuo; Xie, Xing; Cheng, Xiaodong			Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; UP-REGULATION; LUNG-CANCER; SMALL RNAS; GENES; CELLS; IDENTIFICATION; MECHANISMS; FAMILY	Cervical cancer is the most common cause of cancer-related deaths in women from developing countries. Identification of novel prognostic predictors or therapeutic targets may improve patient prognosis. In the current study, we demonstrated by real-timePCR that miR-224 expression was significantly upregulated (1.82-fold, P = 0.0025) in cervical cancer tissues (n = 126) compared with in normal cervical tissues (n = 64). Higher expression of miR-224 was significantly associated with poorer prognostic factors, including advanced FIGO stage, nodal metastasis, larger tumor size, vascular involvement and deep stromal invasion (all P < 0.05). Enforced expression of miR-224 promoted cell proliferation, migration and invasion in SiHa and CaSki cancer cell lines. Bioinformatic analysis indicated that RASSF8 (RAS-association domain family 8) was a potential target of miR-224. Western blot analysis and luciferase reporter assay showed that overexpressed miR-224 inhibited RASSF8 protein expression and decreased the activity of a luciferase reporter containing the 3' untranslated region (UTR) of RASSF8, respectively. Further, RASSF8 knockdown by specific RNAi showed similar effects in cervical cancer cells transfected with miR-224 mimic. Our findings suggest that miR-224 directly targets RASSF8 and thereby acts as a tumor promoter in cervical cancer progression.	[Huang, YongJie] Zhejiang Univ, Sch Med, Womens Hosp, Womens Reprod Hlth Lab Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Li, Yang; Wang, Fen F.; Lv, WeiGuo; Xie, Xing; Cheng, Xiaodong] Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cheng, XD (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol Oncol, Hangzhou, Zhejiang, Peoples R China.	chengxd@zju.edu.cn	Huang, yongjie/ABD-4114-2021		National Natural Science Foundation of China [81301687, 81302248]; Zhejiang Provincial Natural Science Foundation of China [LQ13H160003]; Ministry of Education of the People's Republic of China [20120101110019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Ministry of Education of the People's Republic of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (Grant No. 81301687, http://www.nsfc.gov.cn) to Y. Li, Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ13H160003, http://www.zjnsf.gov.cn), Ministry of Education of the People's Republic of China (Grant No. 20120101110019) to X. Xie, National Natural Science Foundation of China (Grant No 81302248) to Dr Fen f Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amankwatia EB, 2015, BRIT J CANCER, V112, P1480, DOI 10.1038/bjc.2015.125; An FM, 2015, J CLIN MED, V4, P1713, DOI 10.3390/jcm4091713; ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Cui R, 2015, ONCOTARGET, V6, P21802, DOI 10.18632/oncotarget.5224; Cui R, 2015, P NATL ACAD SCI USA, V112, pE4288, DOI 10.1073/pnas.1502068112; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Falvella FS, 2006, ONCOGENE, V25, P3934, DOI 10.1038/sj.onc.1209422; Falvella FS, 2007, LUNG CANCER, V56, P1, DOI 10.1016/j.lungcan.2006.11.008; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Garland SM, 2008, VACCINE, V26, pM89, DOI 10.1016/j.vaccine.2008.06.020; Hartmann C, 2004, M S-MED SCI, V20, P894, DOI 10.1051/medsci/20042010894; Huang L, 2012, BIOCHEM BIOPH RES CO, V425, P127, DOI 10.1016/j.bbrc.2012.07.025; KANAVOS P, 2006, EUROPEAN SOC MEDICAL, V8, P15, DOI DOI 10.1093/ANNONC/MDL983; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langton PF, 2009, CURR BIOL, V19, P1969, DOI 10.1016/j.cub.2009.10.027; Lea JS, 2012, OBSTET GYN CLIN N AM, V39, P233, DOI 10.1016/j.ogc.2012.02.008; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Lock FE, 2010, ONCOGENE, V29, P4307, DOI 10.1038/onc.2010.192; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma DL, 2012, ONCOL LETT, V4, P483, DOI 10.3892/ol.2012.742; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Mavridis K, 2013, CLIN CHEM, V59, P261, DOI 10.1373/clinchem.2012.191502; Mencia N, 2011, BIOCHEM PHARMACOL, V82, P1572, DOI 10.1016/j.bcp.2011.08.009; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Shen SN, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-69; Sherwood V, 2010, BIOCHEM J, V425, P303, DOI 10.1042/BJ20091318; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wang Y, 2012, FASEB J, V26, P3032, DOI 10.1096/fj.11-201855	36	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162378	10.1371/journal.pone.0162378	http://dx.doi.org/10.1371/journal.pone.0162378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626930	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600031
J	Tang, DL; del Nido, PJ; Yang, C; Zuo, H; Huang, XY; Rathod, RH; Gooty, V; Tang, A; Wu, ZY; Billiar, KL; Geva, T				Tang, Dalin; del Nido, Pedro J.; Yang, Chun; Zuo, Heng; Huang, Xueying; Rathod, Rahul H.; Gooty, Vasu; Tang, Alexander; Wu, Zheyang; Billiar, Kristen L.; Geva, Tal			Patient-Specific MRI-Based Right Ventricle Models Using Different Zero-Load Diastole and Systole Geometries for Better Cardiac Stress and Strain Calculations and Pulmonary Valve Replacement Surgical Outcome Predictions	PLOS ONE			English	Article							REPAIRED TETRALOGY; MECHANICAL-PROPERTIES; MAGNETIC-RESONANCE; CROSS-VALIDATION; FALLOT; HEART; MYOCARDIUM; SURGERY; CLASSIFICATION; CONTRACTION	Background Accurate calculation of ventricular stress and strain is critical for cardiovascular investigations. Sarcomere shortening in active contraction leads to change of ventricular zero-stress configurations during the cardiac cycle. A new model using different zero-load diastole and systole geometries was introduced to provide more accurate cardiac stress/strain calculations with potential to predict post pulmonary valve replacement (PVR) surgical outcome. Methods Cardiac magnetic resonance (CMR) data were obtained from 16 patients with repaired tetralogy of Fallot prior to and 6 months after pulmonary valve replacement (8 male, 8 female, mean age 34.5 years). Patients were divided into Group 1 (n = 8) with better post PVR outcome and Group 2 (n = 8) with worse post PVR outcome based on their change in RV ejection fraction (EF). CMR-based patient-specific computational RV/LV models using one zero-load geometry (1G model) and two zero-load geometries (diastole and systole, 2G model) were constructed and RV wall thickness, volume, circumferential and longitudinal curvatures, mechanical stress and strain were obtained for analysis. Pairwise T-test and Linear Mixed Effect (LME) model were used to determine if the differences from the 1G and 2G models were statistically significant, with the dependence of the pair-wise observations and the patient-slice clustering effects being taken into consideration. For group comparisons, continuous variables (RV volumes, WT, C-and L-curvatures, and stress and strain values) were summarized as mean +/- SD and compared between the outcome groups by using an unpaired Student t-test. Logistic regression analysis was used to identify potential morphological and mechanical predictors for post PVR surgical outcome. Results Based on results from the 16 patients, mean begin-ejection stress and strain from the 2G model were 28% and 40% higher than that from the 1G model, respectively. Using the 2G model results, RV EF changes correlated negatively with stress (r = -0.609, P = 0.012) and with pre-PVR RV end-diastole volume (r = -0.60, P = 0.015), but did not correlate with WT, C-curvature, L-curvature, or strain. At begin-ejection, mean RV stress of Group 2 was 57.4% higher than that of Group 1 (130.1 +/- 60.7 vs. 82.7 +/- 38.8 kPa, P = 0.0042). Stress was the only parameter that showed significant differences between the two groups. The combination of circumferential curvature, RV volume and the difference between begin-ejection stress and end-ejection stress was the best predictor for post PVR outcome with an area under the ROC curve of 0.855. The begin-ejection stress was the best single predictor among the 8 individual parameters with an area under the ROC curve of 0.782. Conclusion The new 2G model may be able to provide more accurate ventricular stress and strain calculations for potential clinical applications. Combining morphological and mechanical parameters may provide better predictions for post PVR outcome.	[Tang, Dalin] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Tang, Dalin; Yang, Chun; Zuo, Heng; Huang, Xueying; Wu, Zheyang] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA; [del Nido, Pedro J.] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiac Surg, Dept Surg, Boston, MA USA; [Yang, Chun] China Informat Tech Designing & Consulting Inst C, Beijing, Peoples R China; [Huang, Xueying] Xiamen Univ, Sch Math Sci, Xiamen, Fujian, Peoples R China; [Rathod, Rahul H.; Gooty, Vasu; Tang, Alexander; Geva, Tal] Harvard Med Sch, Boston Childrens Hosp, Dept Cardiol, Dept Pediat, Boston, MA USA; [Billiar, Kristen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Billiar, Kristen L.] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA USA	Southeast University - China; Worcester Polytechnic Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Xiamen University; Harvard University; Boston Children's Hospital; Harvard Medical School; Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Worcester	Tang, DL (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.; Tang, DL (corresponding author), Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA.	dtang@wpi.edu	Gooty, Vasu/AAL-4132-2020	Gooty, Vasu/0000-0002-1826-3568; Wu, Zheyang/0000-0003-0641-0791	National Heart, Lung and Blood Institute [1R01-HL 089269, R01-HL63095, 5P50HL074734]; National Sciences Foundation of China [11171030, 1571691, 11672001]	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: National Heart, Lung and Blood Institute, 1R01-HL 089269, PIs: del Nido, Tang, Geva; National Heart, Lung and Blood Institute, R01-HL63095, del Nido; National Heart, Lung and Blood Institute, 5P50HL074734, Geva, del Nido; National Sciences Foundation of China 11171030 Yang; National Sciences Foundation of China, 1571691, Tang; and National Sciences Foundation of China, 11672001, Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner L, 2015, BIOMECH MODEL MECHAN; Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Chiu SN, 2012, CIRC-CARDIOVASC QUAL, V5, P120, DOI 10.1161/CIRCOUTCOMES.111.963603; Choi YJ, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00140; Costa KD, 1999, AM J PHYSIOL-HEART C, V276, pH595, DOI 10.1152/ajpheart.1999.276.2.H595; Das A, 2015, MED IMAGE ANAL, V19, P121, DOI 10.1016/j.media.2014.09.001; Fomovsky GM, 2011, J CARDIOVASC TRANSL, V4, P82, DOI 10.1007/s12265-010-9241-3; Gan Y, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S1-S9; Geva T, 2014, CIRC-CARDIOVASC IMAG, V7, P190, DOI 10.1161/CIRCIMAGING.113.000553; Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9; Geva T, 2010, CIRCULATION, V122, pS201, DOI 10.1161/CIRCULATIONAHA.110.951178; Goetz WA, 2005, AM J PHYSIOL-HEART C, V289, pH196, DOI 10.1152/ajpheart.00867.2004; GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P82, DOI 10.1115/1.2895474; Hastie T., 2009, THE ELEMENTS OF STAT, DOI DOI 10.1007/B94608; Holmes Jeffery W, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1545; HUMPHREY JD, 1990, AM J PHYSIOL, V259, pH101, DOI 10.1152/ajpheart.1990.259.1.H101; Hunter PJ, 2003, ANNU REV BIOMED ENG, V5, P147, DOI 10.1146/annurev.bioeng.5.040202.121537; Kerckhoffs RCP, 2007, ANN BIOMED ENG, V35, P1, DOI 10.1007/s10439-006-9212-7; Kerckhoffs RCP, 2009, IEEE ENG MED BIO, P4281, DOI 10.1109/IEMBS.2009.5332708; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Krishnamurthy A, 2013, J COMPUT PHYS, V244, P4, DOI 10.1016/j.jcp.2012.09.015; MCCULLOCH A, 1992, CRIT REV BIOMED ENG, V20, P427; McKenzie ED, 2014, J THORAC CARDIOV SUR, V148, P1450, DOI 10.1016/j.jtcvs.2014.02.060; NOVAK VP, 1994, J BIOMECH, V27, P403, DOI 10.1016/0021-9290(94)90016-7; Ooi A, 2006, EUR J CARDIO-THORAC, V30, P917, DOI 10.1016/j.ejcts.2006.08.022; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; Pfeiffer ER, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026221; Saber NR, 2001, ANN BIOMED ENG, V29, P275, DOI 10.1114/1.1359452; SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122; SanchezQuintana D, 1996, HEART, V76, P280, DOI 10.1136/hrt.76.3.280; Tang DL, 2016, J THORAC CARDIOV SUR, V151, P687, DOI 10.1016/j.jtcvs.2015.09.106; Tang DL, 2014, J THORAC CARDIOV SUR, V147, P537, DOI 10.1016/j.jtcvs.2013.08.054; Tang DL, 2011, COMPUT STRUCT, V89, P1059, DOI 10.1016/j.compstruc.2010.12.012; Tang DL, 2010, PROG PEDIATR CARDIOL, V30, P51, DOI 10.1016/j.ppedcard.2010.09.007; Tang DL, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913339; Valdez-Jasso D, 2012, J PHYSIOL-LONDON, V590, P4571, DOI 10.1113/jphysiol.2012.233015; Nguyen VT, 2015, CARDIOVASC ENG TECHN, V6, P412, DOI 10.1007/s13239-015-0244-8; WAIEN SA, 1992, J AM COLL CARDIOL, V20, P295, DOI 10.1016/0735-1097(92)90093-3	39	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162986	10.1371/journal.pone.0162986	http://dx.doi.org/10.1371/journal.pone.0162986			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627806	gold, Green Submitted, Green Published			2022-12-26	WOS:000383680600072
J	Krafft, BA; Krag, LA; Engas, A; Nordrum, S; Bruheim, I; Herrmann, B				Krafft, Bjorn A.; Krag, Ludvig A.; Engas, Arill; Nordrum, Sigve; Bruheim, Inge; Herrmann, Bent			Quantifying the Escape Mortality of Trawl Caught Antarctic Krill (Euphausia superba)	PLOS ONE			English	Article							BEAM-TRAWL; SURVIVAL; DISCARDS; CODEND; MODEL; SEA; FISHERIES; SELECTION; ECOSYSTEM; CAPTURE	Antarctic krill (Euphausia superba) is an abundant fishery resource, the harvest levels of which are expected to increase. However, many of the length classes of krill can escape through commonly used commercial trawl mesh sizes. A vital component of the overall management of a fishery is to estimate the total fishing mortalityand quantify the mortality rate of individuals that escape from fishing gear. The methods for determining fishing mortality in krill are still poorly developed. We used a covered codend sampling technique followed by onboard observations made in holding tanks to monitor mortality rates of escaped krill. Haul duration, hydrological conditions, maximum fishing depth and catch composition all had no significant effect on mortality of krill escaping 16 mm mesh size nets, nor was any further mortality associated with the holding tank conditions. A non-parametric Kaplan-Meier analysis was used to model the relationship between mortality rates of escapees and time. There was a weak tendency, though not significant, for smaller individuals to suffer higher mortality than larger individuals. The mortality of krill escaping the trawl nets in our study was 4.4 +/- 4.4%, suggesting that krill are fairly tolerant of the capture-and-escape process in trawls.	[Krafft, Bjorn A.; Engas, Arill] Inst Marine Res, Bergen, Norway; [Krag, Ludvig A.] Tech Univ Denmark, DTU Aqua, Hirtshals, Denmark; [Nordrum, Sigve] Aker BioMarineAS, Oslo, Norway; [Bruheim, Inge] RimfrostAS, Fosnavag, Norway; [Herrmann, Bent] Fishing Gear Technol, SINTEF Fisheries & Aquaculture, Hirtshals, Denmark	Institute of Marine Research - Norway; Technical University of Denmark; SINTEF	Krafft, BA (corresponding author), Inst Marine Res, Bergen, Norway.	bjorn.krafft@imr.no		Herrmann, Bent/0000-0003-1325-6198; Krag, Ludvig Ahm/0000-0002-1531-1499	Research Council of Norway [243619, 222798]; Rimfrost AS; Aker BioMarine AS	Research Council of Norway(Research Council of Norway); Rimfrost AS; Aker BioMarine AS	The Research Council of Norway, grant number 243619 and 222798, funded travel costs and expedition equipment; grant number 243619 funded in addition salary and publication costs. The contribution by author BH, from SINTEF Fisheries and Aquaculture, was funded by the grant number 243619. Rimfrost AS sponsored shiptime and crew. Rimfrost AS and Aker BioMarine AS provided support in the form of salaries for authors IB and SN. Rimfrost AS provided valuable practical input regarding the framework needed for execution of the field experiments. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Atkinson A, 2001, MAR ECOL PROG SER, V216, P279, DOI 10.3354/meps216279; Broadhurst MK, 2007, FISHERIES MANAG ECOL, V14, P353, DOI 10.1111/j.1365-2400.2007.00563.x; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Broadhurst MK, 2002, MAR FRESHWATER RES, V53, P1189, DOI 10.1071/MF02082; Budzinski E., 1985, 268 FAO, P46; Cabral HN, 2002, HYDROBIOLOGIA, V475, P449, DOI 10.1023/A:1020359913694; Chernick M., 2007, WILEY SERIES PROBABI; Chopin F, 1996, FISH RES, V25, P377, DOI 10.1016/0165-7836(95)00417-3; Efron B, 1982, SIAM MONOG, V38; Everson I., 2000, KRILL BIOL ECOLOGY F, P63; FAO, 2005, 457 FAO, P235; Garcia SM, 2010, PHILOS T R SOC B, V365, P2869, DOI 10.1098/rstb.2010.0171; Grant SM, 2013, ANTARCT SCI, V25, P603, DOI 10.1017/S0954102013000308; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; HILL BJ, 1990, AUST J MAR FRESH RES, V41, P53; Ingolfsson OA, 2007, ICES J MAR SCI, V64, P1836, DOI 10.1093/icesjms/fsm150; JEAN Y, 1963, J FISH RES BOARD CAN, V20, P497, DOI 10.1139/f63-038; KAISER MJ, 1995, MAR ECOL PROG SER, V126, P31, DOI 10.3354/meps126031; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Krafft BA, 2015, POLAR BIOL, V38, P1687, DOI 10.1007/s00300-015-1735-7; Krafft BA, 2015, FISH RES, V170, P102, DOI 10.1016/j.fishres.2015.05.019; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102168; Madsen N, 2012, AQUAT LIVING RESOUR, V25, P231, DOI 10.1051/alr/2012021; Marr J, 1962, 32 NAT I OC, P17; MCLOUGHLIN RJ, 1991, FISH RES, V11, P1, DOI 10.1016/0165-7836(91)90030-J; Metin C, 2004, FISH RES, V70, P49, DOI 10.1016/j.fishres.2004.06.013; Naidu K. S., 1988, J SHELLFISH RES, V7, P61; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Sangster GI, 1996, FISH RES, V25, P323, DOI 10.1016/0165-7836(95)00430-0; Siegel V, 2007, WGEMM0728 CCAMLR; Soldal AV, 1997, ICES J MAR SCI, V54, P117; Stoot LJ, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou011; Suuronen P, 1996, ICES J MAR SCI, V53, P691, DOI 10.1006/jmsc.1996.0088; Suuronen P, 1996, FISH RES, V25, P305, DOI 10.1016/0165-7836(95)00446-7; Suuronen P., 2005, FAO FISH TECHN PAP, V478, P72; VANBEEK FA, 1990, NETH J SEA RES, V26, P151, DOI 10.1016/0077-7579(90)90064-N; Vinogradov NN, 1960, CM1960F ICES, V172; WASSENBERG TJ, 1993, FISH RES, V17, P343, DOI 10.1016/0165-7836(93)90134-S; Wileman D.A., 1996, 1126 ICES COOP	41	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162311	10.1371/journal.pone.0162311	http://dx.doi.org/10.1371/journal.pone.0162311			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622510	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000383681000024
J	Leotta, GA; Brusa, V; Galli, L; Adriani, C; Linares, L; Etcheverria, A; Sanz, M; Sucari, A; Garcia, PP; Signorini, M				Leotta, Gerardo A.; Brusa, Victoria; Galli, Lucia; Adriani, Cristian; Linares, Luciano; Etcheverria, Analia; Sanz, Marcelo; Sucari, Adriana; Peral Garcia, Pilar; Signorini, Marcelo			Comprehensive Evaluation and Implementation of Improvement Actions in Butcher Shops	PLOS ONE			English	Article							ESCHERICHIA-COLI O157; RETAIL GROUND-BEEF; LISTERIA-MONOCYTOGENES; BIOFILM FORMATION; FOOD; SALMONELLA; PREVALENCE; STATE; CUTS; CARCASSES	Foodborne pathogens can cause acute and chronic diseases and produce a wide range of symptoms. Since the consumption of ground beef is a risk factor for infections with some bacterial pathogens, we performed a comprehensive evaluation of butcher shops, implemented improvement actions for both butcher shops and consumers, and verified the impact of those actions implemented. A comprehensive evaluation was made and risk was quantified on a 1-100 scale as high-risk (1-40), moderate-risk (41-70) or low-risk (71-100). A total of 172 raw ground beef and 672 environmental samples were collected from 86 butcher shops during the evaluation (2010-2011) and verification (2013) stages of the study. Ground beef samples were analyzed for mesophilic aerobic organisms, Escherichia coli and coagulase-positive Staphylococcus aureus enumeration. Salmonella spp., E. coli O157:H7, non-O157 Shiga toxin-producing E. coli (STEC), and Listeria monocytogenes were detected and isolated from all samples. Risk quantification resulted in 43 (50.0%) high-risk, 34 (39.5%) moderate-risk, and nine (10.5%) low-risk butcher shops. Training sessions for 498 handlers and 4,506 consumers were held. Re-evaluation by risk quantification and microbiological analyses resulted in 19 (22.1%) high-risk, 42 (48.8%) moderate-risk and 25 (29.1%) low-risk butcher shops. The count of indicator microorganisms decreased with respect to the 2010-2011 period. After the implementation of improvement actions, the presence of L. monocytogenes, E. coli O157: H7 and stx genes in ground beef decreased. Salmonella spp. was isolated from 10 (11.6%) ground beef samples, without detecting statistically significant differences between both study periods (evaluation and verification). The percentage of pathogens in environmental samples was reduced in the verification period (Salmonella spp., 1.5%; L. monocytogenes, 10.7%; E. coli O157: H7, 0.6%; non-O157 STEC, 6.8%). Risk quantification was useful to identify those relevant facts in butcher shops. The reduction of contamination in ground beef and the environment was possible after training handlers based on the problems identified in their own butcher shops. Our results confirm the feasibility of implementing a comprehensive risk management program in butcher shops, and the importance of information campaigns targeting consumers. Further collaborative efforts would be necessary to improve foodstuffs safety at retail level and at home.	[Leotta, Gerardo A.; Brusa, Victoria; Galli, Lucia; Peral Garcia, Pilar] UNLP, Fac Ciencias Vet, CONICET LA PLATA, IGEVET Inst Genet Vet Ing Fernando N Dulout, La Plata, Buenos Aires, Argentina; [Brusa, Victoria; Linares, Luciano] UNLP, Fac Ciencias Vet, Lab Microbiol Alimentos, La Plata, Buenos Aires, Argentina; [Adriani, Cristian] Municipalidad Berisso, Dept Seguridad Alimentaria, Berisso, Buenos Aires, Argentina; [Etcheverria, Analia; Sanz, Marcelo] UNCPBA, Fac Ciencias Vet, CICPBA, CONICET,Ctr Invest Vet Tandil CIVETAN, Buenos Aires, DF, Argentina; [Sucari, Adriana] Ctr Estudios Infectol Dr Daniel Stamboulian, Div Alimentos, Buenos Aires, DF, Argentina; [Signorini, Marcelo] INTA, CONICET EEA Rafaela, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Leotta, GA (corresponding author), UNLP, Fac Ciencias Vet, CONICET LA PLATA, IGEVET Inst Genet Vet Ing Fernando N Dulout, La Plata, Buenos Aires, Argentina.	gerardo.leotta@gmail.com	Etcheverría, Analía/ABC-5883-2021; Signorini, Marcelo/B-7097-2009	Signorini, Marcelo/0000-0001-6537-8782; Peral-Garcia, Pilar/0000-0003-3015-4628	Argentine Beef Promotion Institute (IPCVA); PIP grant from CONICET (Argentina) [0266]; Science and Technology Agency (Argentina) [PICTO-2010-0082]	Argentine Beef Promotion Institute (IPCVA); PIP grant from CONICET (Argentina); Science and Technology Agency (Argentina)	The present study was supported by Argentine Beef Promotion Institute (IPCVA), PIP grant #0266 from CONICET (Argentina), PICTO-2010-0082 from Science and Technology Agency (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3138; Andrews W.H., 2011, BACTERIOLOGICAL ANAL; [Anonymous], 2016, B INT EP, V298; Antman J, 2014, INFORME ESPECIAL; Arnedo-Pena A, 2016, ENFERM INFEC MICR CL, V34, P544, DOI 10.1016/j.eimc.2015.11.016; Barlow RS, 2006, INT J FOOD MICROBIOL, V111, P1, DOI 10.1016/j.ijfoodmicro.2006.04.039; Beauchamp CS, 2012, J FOOD SCI, V77, pM343, DOI 10.1111/j.1750-3841.2012.02695.x; Berger S, 2016, SALMONELLOSIS GLOBAL; Bogard AK, 2013, J FOOD PROTECT, V76, P2132, DOI 10.4315/0362-028X.JFP-13-126; Bosilevac JM, 2007, J FOOD PROTECT, V70, P440, DOI 10.4315/0362-028X-70.2.440; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brusa V, 2016, FOODBORNE PATHOG DIS, V13, P163, DOI 10.1089/fpd.2015.2034; Brusa V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00171; Camargo AC, 2014, J FOOD PROTECT, V77, P1148, DOI 10.4315/0362-028X.JFP-13-434; de Paula CMD, 2014, VIGIL SANIT DEBATE, V2, P23, DOI 10.3395/vd.v2i4.442; Erickson MC, 2007, J FOOD PROTECT, V70, P2426, DOI 10.4315/0362-028X-70.10.2426; Etcheverria AI, 2010, MEAT SCI, V86, P418, DOI 10.1016/j.meatsci.2010.05.027; EU Reference Laboratory for E. coli Department of Veterinary Public Health and Food Safety Unit of Foodborne Zoonoses, 2013, EU REF LAB E COL; Giaouris E, 2012, SALMONELLA DANGEROUS; Gounadaki AS, 2008, FOOD MICROBIOL, V25, P313, DOI 10.1016/j.fm.2007.10.001; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; International Organization for Standardization, 1664922001 ISO; International Organization for Standardization, 1129012004 ISO; International Organization for Standardization, 688811999 ISO; Jourdan N, 2008, EUROSURVEILLANCE, V13, P39; Ju WT, 2012, FOOD MICROBIOL, V32, P371, DOI 10.1016/j.fm.2012.07.017; KARCH H, 1993, J CLIN MICROBIOL, V31, P1200, DOI 10.1128/JCM.31.5.1200-1205.1993; Leotta G.A., 2005, Rev. argent. microbiol., V37, P1; Leotta GA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-46; Llorente P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/795104; Mangen MJJ, 2015, INT J FOOD MICROBIOL, V196, P84, DOI 10.1016/j.ijfoodmicro.2014.11.022; Manios SG, 2014, METHODS MOL BIOL, V1157, P251, DOI 10.1007/978-1-4939-0703-8_21; Masana MO, 2010, J FOOD PROTECT, V73, P649, DOI 10.4315/0362-028X-73.4.649; Maturin L, 2001, BACTERIOLOGICAL ANAL; Mora A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-13; Organizacion Panamericana de la Salud (OPS)-Instituto Panamericano de Proteccion de Alimentos y Zoonosis (INPPAZ), 2001, HACCP HERR ES IN AL; Papadopoulou OS, 2012, MEAT SCI, V90, P865, DOI 10.1016/j.meatsci.2011.11.008; Perez-Rodriguez F, 2010, MEAT SCI, V86, P479, DOI 10.1016/j.meatsci.2010.05.038; Phang HS, 2011, J FOOD PROTECT, V74, P1708, DOI 10.4315/0362-028X.JFP-10-417; Rhoades JR, 2009, FOOD MICROBIOL, V26, P357, DOI 10.1016/j.fm.2008.10.012; Rivas M, 2010, PATHOGENIC ESCHERICH, P142; Rodolpho D, 2007, BRAZ J MICROBIOL, V38, P599, DOI 10.1590/S1517-83822007000400004; Samadpour M, 2006, J FOOD PROTECT, V69, P441, DOI 10.4315/0362-028X-69.2.441; Sirsat SA, 2014, JOVE-J VIS EXP, DOI 10.3791/51402; Srednik ME, 2013, INVET, V15, P23; Stepanovic S, 2004, LETT APPL MICROBIOL, V38, P428, DOI 10.1111/j.1472-765X.2004.01513.x; Taylor EV, 2012, J FOOD PROTECT, V75, P341, DOI 10.4315/0362-028X.JFP-11-333; Todd ECD, 2008, J FOOD PROTECT, V71, P2339, DOI 10.4315/0362-028X-71.11.2339; Torso LM, 2015, J FOOD PROTECT, V78, P1272, DOI 10.4315/0362-028X.JFP-14-545; United States Department of Agriculture, 2011, MLG505 USDA; Vipham JL, 2012, J FOOD PROTECT, V75, P2110, DOI 10.4315/0362-028X.JFP-12-077; Wagner VR, 2013, BRAZ J MICROBIOL, V44, P723, DOI 10.1590/S1517-83822013005000064; Wang JJ, 2015, FOODBORNE PATHOG DIS, V12, P151, DOI 10.1089/fpd.2014.1837; Wasilenko JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00081; *WHO GLOB SALM SUR, 2006, PROGR REP 2000 2005; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Yang BW, 2010, INT J FOOD MICROBIOL, V141, P63, DOI 10.1016/j.ijfoodmicro.2010.04.015	57	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162635	10.1371/journal.pone.0162635	http://dx.doi.org/10.1371/journal.pone.0162635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618439	Green Published, gold			2022-12-26	WOS:000383653100036
J	Hoshina, S; Sekizuka, T; Kataoka, M; Hasegawa, H; Hamada, H; Kuroda, M; Katano, H				Hoshina, Shiho; Sekizuka, Tsuyoshi; Kataoka, Michiyo; Hasegawa, Hideki; Hamada, Hiromichi; Kuroda, Makoto; Katano, Harutaka			Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; PRIMARY EFFUSION LYMPHOMA; KAPOSIS-SARCOMA; RETICULOCYTE MATURATION; TRANSFERRIN RECEPTOR; VIRUS; IDENTIFICATION; DNA; IMPORT; PLASMA	Exosomes are small vesicles released from cells, into which microRNAs (miRNA) are specifically sorted and accumulated. Two gamma-herpesviruses, Kaposi sarcoma-associated herpesvirus(KSHV) and Epstein-Barr virus (EBV), encode miRNAs in their genomes and express virus-encoded miRNAs in cells and exosomes. However, there is little information about the detailed distribution of virus-encoded miRNAs in cells and exosomes. In this study, we thus identified virus-and host-encoded miRNAs in exosomes released from KSHV- or EBV-infected lymphoma cell lines and compared them with intracellular miRNAs using a next-generation sequencer. Sequencing analysis demonstrated that 48% of the annotated miRNAs in the exosomes from KSHV- infected cells originated from KSHV. Human mir-10b-5p and mir-143-3p were much more highly concentrated in exosomes than in cells. Exosomes contained more nonexact mature miRNAs that did not exactly match those in miR Base than cells. Among the KSHV-encoded miRNAs, miRK12-3-5p was the most abundant exact mature miRNA in both cells and exosomes that exactly matched those in miR ]Base. Recently identified EXO motifs, nucleotide motifs that control the loading of miRNAs into exosomes were frequently found within the sequences of KSHV- encoded miRNAs, and the presence of the EXO motif CCCT or CCCG was associated with the localization of miRNA in exosomes in KSHV- infected cells. These observations suggest that specific virus-encoded miRNAs are sorted by EXO motifs and accumulate in exosomes in virus-infected cells.	[Hoshina, Shiho; Kataoka, Michiyo; Hasegawa, Hideki; Katano, Harutaka] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan; [Hoshina, Shiho; Hamada, Hiromichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, 477-96 Owada Shinden, Chiba 2760046, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Tokyo Women's Medical University	Katano, H (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	katano@nih.go.jp	Hasegawa, Hideki/C-7978-2014	Katano, Harutaka/0000-0002-5332-4434; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Research Program on HIV/AIDS [15fk00410017h0101, 15fk041000h0103, 15fk0108011h0003, 16fk0410209j0102, 16fk0410108j0101, 16fk0410107j0001]; Research Program on Emerging and Re-emerging Infectious Diseases from the Agency for Medical Research and Development [15fk0108011h0503, 16fk0108119j0001]; Japan Society for the Promotion of Science [15K08509]	Research Program on HIV/AIDS; Research Program on Emerging and Re-emerging Infectious Diseases from the Agency for Medical Research and Development; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by Research Program on HIV/AIDS (grant numbers 15fk00410017h0101, 15fk041000h0103, 15fk0108011h0003, 16fk0410209j0102, 16fk0410108j0101, and 16fk0410107j0001) and Research Program on Emerging and Re-emerging Infectious Diseases (grant numbers 15fk0108011h0503 and 16fk0108119j0001) from the Agency for Medical Research and Development, and Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (grant number 15K08509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099163; Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Amoroso R, 2011, J VIROL, V85, P996, DOI 10.1128/JVI.01528-10; Baran-Marszak F, 2002, LAB INVEST, V82, P1463, DOI 10.1097/01.LAB.0000035025.51772.2B; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Chugh PE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003484; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Feederle R, 2011, J VIROL, V85, P9801, DOI 10.1128/JVI.05100-11; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Katano H, 1999, J MED VIROL, V58, P394, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;394::AID-JMV12&gt;3.0.CO;2-H; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Liu ZQ, 2014, BIOCHEM BIOPH RES CO, V455, P218, DOI 10.1016/j.bbrc.2014.10.146; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Osawa M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0086-5; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Rocca A, 2015, J CLIN VIROL, V70, P1, DOI 10.1016/j.jcv.2015.06.104; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; UHARA H, 1990, JPN J CANCER RES, V81, P272, DOI 10.1111/j.1349-7006.1990.tb02561.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035	34	33	35	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162574	10.1371/journal.pone.0162574	http://dx.doi.org/10.1371/journal.pone.0162574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611973	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900129
J	Ke, P; Shao, BZ; Xu, ZQ; Wei, W; Han, BZ; Chen, XW; Su, DF; Liu, C				Ke, Ping; Shao, Bo-Zong; Xu, Zhe-Qi; Wei, Wei; Han, Bin-Ze; Chen, Xiong-Wen; Su, Ding-Feng; Liu, Chong			Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages	PLOS ONE			English	Article							CB2 RECEPTOR; NITRIC-OXIDE; MOUSE MODEL; MICE; EXPRESSION; AUTOPHAGY; PATHWAY; CELLS; DISEASE; SUPPRESSION	Activation of cannabinoid receptor 2 (CB2R) ameliorates inflammation, but the underlying mechanism remains unclear. In the present study, we examined whether activation of CB2R could suppress the nucleotide-binding domain and leucine-rich repeat protein 3 (NLRP3) inflammasome. In peritoneal macrophages isolated from C57BL/6 mice, LPS/DSS challenge for 24 h increased the expression of the components of NLRP3 inflammasome NLRP3, Casp-1 p20/Casp-1 p45 ratio, proIL-1 beta and IL-1 beta and also enhanced autophagy (LC3-II/LC3-I ratio, Beclin-1 and SQSTM1). Pretreatment of peritoneal macrophages with HU 308, a selective CB2R agonist, attenuated LPS/DSS-induced NLRP3 inflammasome activation, but further enhanced autophagy. In comparison with wild-type (WT) control, peritoneal macrophages from CB2R knockout (KO) mice had more robust NLRP3 inflammasome activation and attenuated autophagy upon LPS/DSS challenge. Knockdown autophagy-related gene 5 (Atg5) with a siRNA in peritoneal macrophages attenuated the inhibitory effects of HU 308 on LPS/DSS-induced NLRP3 inflammasome activation in vitro. In vivo, HU308 treatment attenuated DSS-induced colitis mice associated with reduced colon inflammation and inhibited NLRP3 inflammasome activation in wild-type mice. In CB2R KO mice, DSS-induced inflammation and NLRP3 inflammasome activation were more pronounced than those in WT control. Finally, we demonstrated that AMPK-mTOR-P70S6K signaling pathway was involved in this CB2R-mediated process. We conclude that activation of CB2R ameliorates DSS-induced colitis through enhancing autophagy that may inhibit NLRP3 inflammasome activation in macrophages.	[Ke, Ping; Shao, Bo-Zong; Xu, Zhe-Qi; Han, Bin-Ze; Su, Ding-Feng; Liu, Chong] Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Wei, Wei] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiong-Wen] Temple Univ, Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA	Naval Medical University; Zhejiang Academy of Agricultural Sciences; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Su, DF; Liu, C (corresponding author), Second Mil Med Univ, Sch Pharm, Dept Pharmacol, Shanghai, Peoples R China.	dfsu2008@gmail.com; wanlc2004@aliyun.com	Chen, Xiongwen/D-5988-2012; Xu, Zhe-Qi/GXV-8629-2022	Chen, Xiongwen/0000-0002-3829-5815; 	Shanghai Natural Science Foundation of China [13ZR1448400]; State Key Program of National Natural Science of China [81230083]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088243] Funding Source: NIH RePORTER	Shanghai Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Shanghai Natural Science Foundation of China (13ZR1448400) received by CL and the State Key Program of National Natural Science of China (Grant No. 81230083) received by DFS. CL and D-FS contributed to the designing of the experiments and the analysis of data. CL made decision of submission and D-FS gave his valuable suggestion in organizing this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Berger ND, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-77; Budai MM, 2013, MOL IMMUNOL, V56, P471, DOI 10.1016/j.molimm.2013.05.005; Carbone F, 2014, CURR MED CHEM, V21, P4046, DOI 10.2174/0929867321666140915141332; Casarejos MJ, 2013, J ALZHEIMERS DIS, V35, P525, DOI 10.3233/JAD-130050; Cheluvappa R, 2014, INFLAMM BOWEL DIS, V20, P847, DOI 10.1097/MIB.0000000000000034; Cho DH, 2014, FREE RADICAL BIO MED, V76, P96, DOI 10.1016/j.freeradbiomed.2014.07.043; Cho MH, 2014, AUTOPHAGY, V10, P1761, DOI 10.4161/auto.29647; Dando I, 2013, CELL DEATH DIS, P4; Gao Y, 2014, FREE RADICAL BIO MED, V72, P104, DOI 10.1016/j.freeradbiomed.2014.04.001; Gherbi K, 2014, BRIT J PHARMACOL, V171, P5431, DOI 10.1111/bph.12858; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gu JX, 2013, INT J CLIN EXP PATHO, V6, P2396; Guo WJ, 2014, AUTOPHAGY, V10, P972, DOI 10.4161/auto.28374; Harvey BS, 2013, CYTOKINE, V63, P209, DOI 10.1016/j.cyto.2013.04.032; Islam MS, 2014, BRIT J PHARMACOL, V171, P375, DOI 10.1111/bph.12452; Kong WM, 2014, CELL IMMUNOL, V287, P1, DOI 10.1016/j.cellimm.2013.11.002; Liu C, 2013, FREE RADICAL BIO MED, V65, P658, DOI 10.1016/j.freeradbiomed.2013.07.045; Liu C, 2009, CRIT CARE MED, V37, P634, DOI 10.1097/CCM.0b013e31819598f5; Liu H, 2015, GEN COMP ENDOCR, V210, P124, DOI 10.1016/j.ygcen.2014.09.006; Liu X, 2015, BRAIN BEHAV IMMUN, V46, P121, DOI 10.1016/j.bbi.2015.01.011; Liu Y, 2015, INNATE IMMUN-LONDON, V21, P587, DOI 10.1177/1753425914566205; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Maiuri MC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/584715; Menon D, 2014, FREE RADICAL BIO MED, V73, P318, DOI 10.1016/j.freeradbiomed.2014.05.020; Mitrovic M, 2010, BRIT J PHARMACOL, V160, P1430, DOI 10.1111/j.1476-5381.2010.00794.x; Pannuru P, 2014, CELL SIGNAL, V26, P2193, DOI 10.1016/j.cellsig.2014.06.014; Sanchez AJ, 2012, CLIN IMMUNOL, V142, P57, DOI 10.1016/j.clim.2011.02.010; Santoni G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0239-2; Schepetkin IA, 2015, J PHARMACOL EXP THER, V353, P505, DOI 10.1124/jpet.114.220251; Shao BZ, 2014, CNS NEUROSCI THER, V20, P1021, DOI 10.1111/cns.12349; Singh UP, 2012, TOXICOL APPL PHARM, V258, P256, DOI 10.1016/j.taap.2011.11.005; Tun X, 2014, FREE RADICAL BIO MED, V74, P108, DOI 10.1016/j.freeradbiomed.2014.06.020; Wild EJ, 2014, MOVEMENT DISORD, V29, P1434, DOI 10.1002/mds.26007; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Zhang B, 2015, J CARD FAIL, V21, P426, DOI 10.1016/j.cardfail.2015.01.002; Zhong Y, 2013, FRONT IMMUNOL, P4; Zoppi S, 2014, BRIT J PHARMACOL, V171, P2814, DOI 10.1111/bph.12607	41	60	66	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0155076	10.1371/journal.pone.0155076	http://dx.doi.org/10.1371/journal.pone.0155076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611972	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900001
J	Verheul, RC; van Deutekom, JCT; Datson, NA				Verheul, Ruurd C.; van Deutekom, Judith C. T.; Datson, Nicole A.			Digital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)Clinical Development for Duchenne Muscular Dystrophy	PLOS ONE			English	Article							GENE; RELIABILITY; TRANSCRIPT; EXPRESSION; EFFICACY; MUTATION; DELETION; MODEL	Antisense oligonucleotides (AONs) in clinical development for Duchenne muscular dystrophy (DMD) aim to induce skipping of a specific exon of the dystrophin transcript during pre-mRNA splicing. This results in restoration of the open reading frame and consequently synthesis of a dystrophin protein with a shorter yet functional central rod domain. To monitor the molecular therapeutic effect of exon skip-inducing AONs in clinical studies, accurate quantification of pre- and post-treatment exon skip levels is required. With the recent introduction of 3rd generation digital droplet PCR (ddPCR), a state-of-the-arttechnology became available which allows absolute quantification of transcript copy numbers with and without specific exon skip with high precision, sensitivity and reproducibility. Using Taqman assays with probes targeting specific exon-exon junctions, we here demonstrate that ddPCR reproducibly quantified cDNA fragments with and without exon 51 of the DMD gene over a 4-log dynamic range. In a comparison of conventional nested PCR, qPCR and ddPCR using cDNA constructs with and without exon 51 mixed in different molar ratios using, ddPCR quantification came closest to the expected outcome over the full range of ratios (0-100%), while qPCR and in particular nested PCR overestimated the relative percentage of the construct lacking exon 51. Highest accuracy was similarly obtained with ddPCR in DMD patient-derived muscle cells treated with an AON inducing exon 51 skipping. We therefore recommend implementation of ddPCR for quantification of exon skip efficiencies of AONs in (pre)clinical development for DMD.	[Verheul, Ruurd C.; van Deutekom, Judith C. T.; Datson, Nicole A.] BioMarin NederlandBV, Leiden, Netherlands		Datson, NA (corresponding author), BioMarin NederlandBV, Leiden, Netherlands.	nicole.datson@bmrn.com	Datson, Nicole A./O-8797-2014	Datson, Nicole/0000-0003-2887-0238	BioMarin Nederland BV, Leiden, The Netherlands	BioMarin Nederland BV, Leiden, The Netherlands(Netherlands Government)	Funding was provided by BioMarin Nederland BV, Leiden, The Netherlands. The funder provided support in the form of salaries, equipment and facilities for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Anthony K, 2014, NEUROLOGY, V83, P2062, DOI 10.1212/WNL.0000000000001025; Anthony K, 2012, HUM GENE THER METHOD, V23, P336, DOI 10.1089/hgtb.2012.117; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Havenga MJE, 2002, J VIROL, V76, P4612, DOI 10.1128/JVI.76.9.4612-4620.2002; Heemskerk H, 2009, ANN NY ACAD SCI, V1175, P71, DOI 10.1111/j.1749-6632.2009.04973.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; McDonald CM, 2013, MUSCLE NERVE, V48, P357, DOI 10.1002/mus.23905; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mirabella M, 1998, NEUROLOGY, V51, P592, DOI 10.1212/WNL.51.2.592; Mitrpant C, 2009, J GENE MED, V11, P46, DOI 10.1002/jgm.1265; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Murphy J, 2009, EXPERT REV MOL DIAGN, V9, P187, DOI 10.1586/14737159.9.2.187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sironi M, 2002, FEBS LETT, V517, P163, DOI 10.1016/S0014-5793(02)02613-3; Spitali P, 2013, FASEB J, V27, P4909, DOI 10.1096/fj.13-232025; Spitali P, 2010, LAB INVEST, V90, P1396, DOI [10.1038/labinvest.2010.98, 10.1038/labinvest.labinvest201098]; Tanganyika-de Winter CL, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.38; van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P747, DOI 10.1136/jnnp-2013-306350; van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P92, DOI 10.1136/jnnp-2012-304729; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; Verhaart IEC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.1; Verhaart IEC, 2013, NUCLEIC ACID THER, V23, P228, DOI 10.1089/nat.2012.0398; Vila MC, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0070-6; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Vulin A, 2012, MOL THER, V20, P2120, DOI 10.1038/mt.2012.181; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; Wilton SD, 2015, TRENDS MOL MED, V21, P417, DOI 10.1016/j.molmed.2015.04.006; Wilton SD, 2014, NEUROMUSCULAR DISORD, V24, P463, DOI 10.1016/j.nmd.2014.03.007; Yokota T, 2011, METHODS MOL BIOL, V709, P299, DOI 10.1007/978-1-61737-982-6_20; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	41	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162467	10.1371/journal.pone.0162467	http://dx.doi.org/10.1371/journal.pone.0162467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612288	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900106
J	Dinnes, DLM; White, MY; Kockx, M; Traini, M; Hsieh, V; Kim, MJ; Hou, LM; Jessup, W; Rye, KA; Thaysen-Andersen, M; Cordwell, SJ; Kritharides, L				Dinnes, Donna Lee M.; White, Melanie Y.; Kockx, Maaike; Traini, Mathew; Hsieh, Victar; Kim, Mi-Jurng; Hou, Liming; Jessup, Wendy; Rye, Kerry-Anne; Thaysen-Andersen, Morten; Cordwell, Stuart J.; Kritharides, Leonard			Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser(228) severely impairs antiatherogenic capacity	FASEB JOURNAL			English	Article						atherosclerosis; coronary artery disease; high-density lipoprotein; proteolysis	LECITHIN-CHOLESTEROL ACYLTRANSFERASE; HIGH-DENSITY-LIPOPROTEINS; MAST-CELL CHYMASE; FOAM CELLS; LIPID-FREE; APOA-I; ATHEROSCLEROTIC PLAQUES; PLASMA-MEMBRANE; EFFLUX CAPACITY; HUMAN-SERUM	Apolipoprotein A-I (apoA-I) is the major component of HDL and central to the ability of HDL to stimulate ATP-binding cassette transporter A1 (ABCA1)-dependent, antiatherogenic export of cholesterol from macrophage foam cells, a key player in the pathology of atherosclerosis. Cell-mediated modifications of apoA-I, such as chlorination, nitration, oxidation, and proteolysis, can impair its antiatherogenic function, although it is unknown whether macrophages themselves contribute to such modifications. To investigate this, human monocyte-derived macrophages (HMDMs) were incubated with human apoA-I under conditions used to induce cholesterol export. Two-dimensional gel electrophoresis and Western blot analysis identified that apoA-I is cleaved (similar to 20-80%) by HMDMs in a time-dependent manner, generating apoA-I of lower MW and isoelectric point. Mass spectrometry analysis identified a novel C-terminal cleavage site of apoA-I between Ser(228)-Phe(229). Recombinant apoA-I truncated at Ser(228) demonstrated profound loss of capacity to solubilize lipid and to promote ABCA1-dependent cholesterol efflux. Protease inhibitors, small interfering RNA knockdown in HMDMs, mass spectrometry analysis, and cathepsin B activity assays identified secreted cathepsin B as responsible for apoA-I cleavage at Ser(228). Importantly, C-terminal cleavage of apoA-I was also detected in human carotid plaque. Cleavage at Ser(228) is a novel, functionally important post-translational modification of apoA-Imediated by HMDMs that limits the antiatherogenic properties of apo A-I.	[Dinnes, Donna Lee M.; Kockx, Maaike; Traini, Mathew; Jessup, Wendy; Kritharides, Leonard] Univ Sydney, Atherosclerosis Lab, ANZAC Res Inst, Sydney, NSW, Australia; [White, Melanie Y.; Cordwell, Stuart J.] Univ Sydney, Sch Mol Biosci, Discipline Pathol, Sch Med Sci, Sydney, NSW, Australia; [White, Melanie Y.; Cordwell, Stuart J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Hsieh, Victar] St George Hosp, Dept Cardiol, Sydney, NSW, Australia; [Kim, Mi-Jurng] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Hou, Liming; Rye, Kerry-Anne] Univ New South Wales, Lipid Res Grp, Sch Med Sci, Sydney, NSW, Australia; [Thaysen-Andersen, Morten] Macquarie Univ, Fac Sci & Engn, Dept Chem & Biomol Sci, Sydney, NSW, Australia; [Kritharides, Leonard] Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University; Concord Repatriation General Hospital	Kritharides, L (corresponding author), Concord Repatriat Gen Hosp, Dept Cardiol, Concord, NSW 2137, Australia.	leonard.kritharides@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Kritharides, Leonard/AAQ-2720-2020; Ekanayake, Kanchana/P-8817-2016	White, Melanie/0000-0003-2571-2816; Cordwell, Stuart/0000-0002-0995-0171; Hsieh, Victar/0000-0003-0085-5933; Hou, Liming/0000-0002-4551-5636; Thaysen-Andersen, Morten/0000-0001-8327-6843; Traini, Mathew/0000-0002-9423-5294	National Health and Medical Research Council of Australia [1037903]; Natural Sciences and Engineering Research Council of Canada [PDF-358145-2008]; Australian Research Council [DE120102556]; Cancer Institute NSW	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council); Cancer Institute NSW	This work was supported by National Health and Medical Research Council of Australia Program Grant 1037903 (to L.K., W.J., K.-A.R.), Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship PDF-358145-2008 (to D.L.D.), and Australian Research Council Discovery Early Career Researcher Award DE120102556 (to M.Y.W.). M.T.-A. was supported by a fellowship from the Cancer Institute NSW. The authors thank D. Nawara (Atherosclerosis Research Group) for assisting with monocyte isolations. K. Shearston (Lipid Research Group) provided apoA-IV. M. Patel (Lipid Research Group) prepared lipid-free apoA-I. MS analyses were facilitated by access to the University of SydneyMass Spectrometry Core Facility. The authors acknowledge B. Brown and C. Hawkins (Heart Research Institute) for guidance with establishing CTSB activity assays. The authors declare no conflicts of interest.	Albrecht C, 2004, STROKE, V35, P2801, DOI 10.1161/01.STR.0000147036.07307.93; Bhatt A, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-015-0554-1; Bielicki JK, 1999, J LIPID RES, V40, P85; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cordwell SJ, 2002, METHOD ENZYMOL, V358, P207; DEAN RT, 1979, EXP CELL BIOL, V47, P454; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Eberini I, 2002, BIOCHEM J, V362, P627, DOI 10.1042/0264-6021:3620627; EBISUI C, 1994, BIOCHEM MOL BIOL INT, V32, P515; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Gelissen IC, 1999, J LIPID RES, V40, P1636; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Headlam HA, 2006, FREE RADICAL BIO MED, V40, P1539, DOI 10.1016/j.freeradbiomed.2005.12.036; Hsieh V, 2014, J BIOL CHEM, V289, P7524, DOI 10.1074/jbc.M113.515890; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Hwang IK, 2004, BBA-PROTEINS PROTEOM, V1702, P79, DOI 10.1016/j.bbapap.2004.08.001; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; JONAS A, 1989, J BIOL CHEM, V264, P4818; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Kim DE, 2010, ARTERIOSCL THROM VAS, V30, P449, DOI 10.1161/ATVBAHA.109.194613; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Lee M, 2000, J LIPID RES, V41, P975; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Lee-Rueckert M, 2011, CURR OPIN LIPIDOL, V22, P394, DOI 10.1097/MOL.0b013e32834a3d24; LIANG HQ, 1994, J LIPID RES, V35, P1187; Lindstedt L, 2003, BIOCHEM BIOPH RES CO, V312, P1019, DOI 10.1016/j.bbrc.2003.11.020; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Liu HT, 2008, IMMUNOL LETT, V117, P70, DOI 10.1016/j.imlet.2007.12.012; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Murray P.J., 2014, FRONT IMMUNOL, V41, P14, DOI DOI 10.1016/J.IMMUNI.2014.06.008; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rohatgi A, 2015, PROG CARDIOVASC DIS, V58, P32, DOI 10.1016/j.pcad.2015.05.004; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Rothblat GH, 1999, J LIPID RES, V40, P781; RYE KA, 1990, BIOCHIM BIOPHYS ACTA, V1042, P227, DOI 10.1016/0005-2760(90)90013-N; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; STEINMETZ A, 1989, J CHROMATOGR-BIOMED, V487, P154, DOI 10.1016/S0378-4347(00)83018-2; Nguyen SD, 2016, ARTERIOSCL THROM VAS, V36, P274, DOI 10.1161/ATVBAHA.115.306827; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Usami Y, 2011, J IMMUNOL METHODS, V369, P51, DOI 10.1016/j.jim.2011.04.002; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Weinberg RB, 1996, METHOD ENZYMOL, V263, P282	58	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4239	4255		10.1096/fj.201600508R	http://dx.doi.org/10.1096/fj.201600508R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27630170				2022-12-26	WOS:000388201500029
J	Mulvaney, KM; Matson, JP; Siesser, PF; Tamir, TY; Goldfarb, D; Jacobs, TM; Cloer, EW; Harrison, JS; Vaziri, C; Cook, JG; Major, MB				Mulvaney, Kathleen M.; Matson, Jacob P.; Siesser, Priscila F.; Tamir, Tigist Y.; Goldfarb, Dennis; Jacobs, Timothy M.; Cloer, Erica W.; Harrison, Joseph S.; Vaziri, Cyrus; Cook, Jeanette G.; Major, Michael B.			Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; E3 ubiquitin ligase; nuclear factor 2; erythroid-derived 2-like factor; NFE2L2; Nrf2; oxidative stress; proteomics; KEAP1; MCM3	ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; UBIQUITIN LIGASE COMPLEX; DNA-REPLICATION; OXIDATIVE STRESS; NRF2-KEAP1 PATHWAY; PROTEOMICS REVEALS; ENDOPLASMIC-RETICULUM; NEGATIVE REGULATION; CYSTEINE RESIDUES	KEAP1 is a substrate adaptor protein for a CUL3-based E3 ubiquitin ligase. Ubiquitylation and degradation of the antioxidant transcription factor NRF2 is considered the primary function of KEAP1; however, few other KEAP1 substrates have been identified. Because KEAP1 is altered in a number of human pathologies and has been proposed as a potential therapeutic target therein, we sought to better understand KEAP1 through systematic identification of its substrates. Toward this goal, we combined parallel affinity capture proteomics and candidate-based approaches. Substrate-trapping proteomics yielded NRF2 and the related transcription factor NRF1 as KEAP1 substrates. Our targeted investigation of KEAP1-interacting proteins revealed MCM3, an essential subunit of the replicative DNA helicase, as a new substrate. We show that MCM3 is ubiquitylated by the KEAP1-CUL3-RBX1 complex in cells and in vitro. Using ubiquitin remnant profiling, we identify the sites of KEAP1-dependent ubiquitylation in MCM3, and these sites are on predicted exposed surfaces of the MCM2-7 complex. Unexpectedly, we determined that KEAP1 does not regulate total MCM3 protein stability or subcellular localization. Our analysis of a KEAP1 targeting motif in MCM3 suggests that MCM3 is a point of direct contact between KEAP1 and the MCM hexamer. Moreover, KEAP1 associates with chromatin in a cell cycle-dependent fashion with kinetics similar to the MCM2-7 complex. KEAP1 is thus poised to affect MCM2-7 dynamics or function rather than MCM3 abundance. Together, these data establish new functions for KEAP1 within the nucleus and identify MCM3 as a novel substrate of the KEAP1-CUL3-RBX1 E3 ligase.	[Mulvaney, Kathleen M.; Cloer, Erica W.; Major, Michael B.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Matson, Jacob P.; Harrison, Joseph S.; Cook, Jeanette G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Tamir, Tigist Y.; Major, Michael B.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Goldfarb, Dennis; Major, Michael B.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA; [Vaziri, Cyrus] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [Mulvaney, Kathleen M.; Siesser, Priscila F.; Tamir, Tigist Y.; Goldfarb, Dennis; Cloer, Erica W.; Harrison, Joseph S.; Vaziri, Cyrus; Cook, Jeanette G.; Major, Michael B.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Jacobs, Timothy M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cook, JG (corresponding author), Dept Biochem & Biophys, 120 Mason Farm Rd,Campus Box 7260, Chapel Hill, NC 27599 USA.; Major, MB (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Lineberger Comprehens Canc Ctr, 450 West Dr,Lineberger Bldg,CB 7295, Chapel Hill, NC 27599 USA.	jgcook@email.unc.edu; benmajor@med.unc.edu		Harrison, Joseph/0000-0002-2118-6524; Cook, Jeanette/0000-0003-0849-7405; Matson, Jacob/0000-0002-9375-1676; Major, Michael/0000-0002-6753-8513; Tamir, Tigist/0000-0002-8194-8754	Sidney Kimmel Cancer Foundation; American Cancer Society [RSG-14-068-01-TBE]; National Science Foundation [DGE-1144081]; NIGMS, National Institutes of Health [R01GM102413]; NATIONAL CANCER INSTITUTE [T32CA071341, U54CA156733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040, R01GM102413] Funding Source: NIH RePORTER	Sidney Kimmel Cancer Foundation; American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Sidney Kimmel Cancer Foundation (to M. B. M.), by American Cancer Society Grant RSG-14-068-01-TBE (to M. B. M.), by National Science Foundation Graduate Research Fellowship DGE-1144081 (to J. P. M.), and by NIGMS, National Institutes of Health Grant R01GM102413 (to J. G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baird L, 2013, BIOCHEM BIOPH RES CO, V433, P58, DOI 10.1016/j.bbrc.2013.02.065; Barone MC, 2011, DIS MODEL MECH, V4, P701, DOI 10.1242/dmm.007575; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Camp ND, 2012, J BIOL CHEM, V287, P6539, DOI 10.1074/jbc.M111.316471; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085744; Cheng IH, 2002, J BIOL CHEM, V277, P41706, DOI 10.1074/jbc.M205793200; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Deegan TD, 2016, CURR OPIN STRUC BIOL, V37, P145, DOI 10.1016/j.sbi.2016.01.014; Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Drissi R, 2015, MOL CELL PROTEOMICS, V14, P2002, DOI 10.1074/mcp.M115.048991; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goldfarb D, 2014, J PROTEOME RES, V13, P5944, DOI 10.1021/pr5008416; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jiang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075076; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kim JH, 2012, FREE RADICAL BIO MED, V53, P629, DOI 10.1016/j.freeradbiomed.2012.04.019; Kim MS, 2016, MOL CELLS, V39, P258, DOI 10.14348/molcells.2016.2310; Kim TY, 2015, MOL CELL BIOL, V35, P167, DOI 10.1128/MCB.00857-14; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Lam SKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082177; Lecona E, 2016, NAT STRUCT MOL BIOL, V23, P270, DOI 10.1038/nsmb.3185; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Maculins T, 2015, CURR BIOL, V25, P2254, DOI 10.1016/j.cub.2015.07.012; Mann GE, 2009, CURR OPIN PHARMACOL, V9, P139, DOI 10.1016/j.coph.2008.12.012; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Mathew R, 2014, MOL CELL, V55, P916, DOI 10.1016/j.molcel.2014.07.019; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Moreno SP, 2014, SCIENCE, V346, P477, DOI 10.1126/science.1253585; Musahl C, 1998, EXP CELL RES, V241, P260, DOI 10.1006/excr.1998.4041; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ogura T, 2010, P NATL ACAD SCI USA, V107, P2842, DOI 10.1073/pnas.0914036107; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Samel SA, 2014, GENE DEV, V28, P1653, DOI 10.1101/gad.242404.114; Siddiqui K., 2013, COLD SPRING HARB PER, V5, P9, DOI DOI 10.1101/CSHPERSPECT.A012930; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; Takei Y, 2002, J BIOL CHEM, V277, P43121, DOI 10.1074/jbc.C200442200; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wei L, 2016, NAT STRUCT MOL BIOL, V23, P209, DOI 10.1038/nsmb.3173; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yankulov K, 1999, MOL CELL BIOL, V19, P6154; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725	77	50	53	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23719	23733		10.1074/jbc.M116.729418	http://dx.doi.org/10.1074/jbc.M116.729418			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621311	Green Published, hybrid			2022-12-26	WOS:000387884400032
J	Singh, Y; Zhou, YT; Shi, XL; Zhang, SQ; Umbach, AT; Salker, MS; Lang, KS; Lang, F				Singh, Yogesh; Zhou, Yuetao; Shi, Xiaolong; Zhang, Shaqiu; Umbach, Anja T.; Salker, Madhuri S.; Lang, Karl S.; Lang, Florian			Alkaline Cytosolic pH and High Sodium Hydrogen Exchanger 1 (NHE1) Activity in Th9 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cellular regulation; interleukin; pH regulation; T helper cells; NHE1; Th9 cells; iTregs	REGULATORY T-CELLS; NA+/H+ EXCHANGER; IN-VIVO; DENDRITIC CELLS; CANCER-CELLS; T(H)9 CELLS; HELPER 9; DIFFERENTIATION; IMMUNITY; ACTIVATION	CD4(+) T helper 9 (Th9) cells are a newly discovered Th cell subset that produce the pleiotropic cytokine IL-9. Th9 cells can protect against tumors and provide resistance against helminth infections. Given their pivotal role in the adaptive immune system, understanding Th9 cell development and the regulation of IL-9 production could open novel immunotherapeutic opportunities. The Na+/H+ exchanger 1 (NHE1; gene name Slc91)) is critically important for regulating intracellular pH (pH(i)), cell volume, migration, and cell survival. The pH(i) influences cytokine secretion, activities of membrane-associated enzymes, ion transport, and other effector signaling molecules such as ATP and Ca2+ levels. However, whether NHE1 regulates Th9 cell development or IL-9 secretion has not yet been defined. The present study explored the role of NHE1 in Th9 cell development and function. Th cell subsets were characterized by flow cytometry and pH(i) was measured using 2,7-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein-acetoxymethyl ester (BCECF-AM) dye. NHE1 functional activity was estimated from the rate of realkalinization following an ammonium pulse. Surprisingly, in Th9 cells pH(i) and NHE1 activity were significantly higher than in all other Th cell subsets (Th1/Th2/Th17 and induced regulatory T cells (iTregs)). NHE1 transcript levels and protein abundance were significantly higher in Th9 cells than in other Th cell subsets. Inhibition of NHE1 by siRNA-NHE1 or with cariporide in Th9 cells down-regulated IL-9 and ATP production. NHE1 activity, Th9 cell development, and IL-9 production were further blunted by pharmacological inhibition of protein kinase Akt1/Akt2. Our findings reveal that Akt1/Akt2 control of NHE1 could be an important physiological regulator of Th9 cell differentiation, IL-9 secretion, and ATP production.	[Singh, Yogesh; Zhou, Yuetao; Shi, Xiaolong; Zhang, Shaqiu; Umbach, Anja T.; Salker, Madhuri S.; Lang, Florian] Eberhard Karls Tubingen Univ, Dept Cardiol Cardiovasc Med & Physiol, Gmelinstr 5, D-72076 Tubingen, Germany; [Zhang, Shaqiu] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu 611130, Sichuan, Peoples R China; [Lang, Karl S.] Univ Duisburg Essen, Inst Immunol, Fac Med, Hufelandstr 55, D-45147 Essen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Sichuan Agricultural University; University of Duisburg Essen	Singh, Y; Lang, F (corresponding author), Eberhard Karls Tubingen Univ, Dept Cardiol Cardiovasc Med & Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	ysinghbt@gmail.com; florian.lang@uni-tuebingen.de	Singh, Yogesh/T-8230-2017; Zhou, Yuetao/U-9384-2019	Singh, Yogesh/0000-0001-6919-6273; Zhou, Yuetao/0000-0003-1870-3276; Salker, Madhuri Sonal/0000-0002-7939-289X; Lang, Karl/0000-0001-9783-7605	Deutsche Forschungsgemeinschaft [LA 315]; EMBO Long Term Postdoctoral Fellowship [ATLF 20-2013]; China Scholarship Council (CSC), China Ph.D. studentships	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO Long Term Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); China Scholarship Council (CSC), China Ph.D. studentships(China Scholarship Council)	This work was supported by grants from Deutsche Forschungsgemeinschaft LA 315 (to F. L.), EMBO Long Term Postdoctoral Fellowship ATLF 20-2013 (to M. S. S.), and China Scholarship Council (CSC), China Ph.D. studentships (to Y. Z., X. S., and S. Z.). The authors declare that they have no conflicts of interest with the content of this article.	Abu Jawdeh BG, 2011, J BIOL CHEM, V286, P42435, DOI 10.1074/jbc.M110.212845; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; BOITEUX A, 1981, PHILOS T ROY SOC B, V293, P5, DOI 10.1098/rstb.1981.0056; Bruhn S, 2012, ALLERGY, V67, P33, DOI 10.1111/j.1398-9995.2011.02707.x; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Cairns RA, 2015, CANCER J, V21, P56, DOI 10.1097/PPO.0000000000000106; Chang CP, 2010, J CELL PHYSIOL, V223, P679, DOI 10.1002/jcp.22070; Chatterjee S, 2014, FEBS LETT, V588, P1571, DOI 10.1016/j.febslet.2014.02.040; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Chien EJ, 2007, J CELL PHYSIOL, V211, P544, DOI 10.1002/jcp.20962; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dardalhon V, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.01.28; De, 2006, CELL IMMUNOL, V240, P69; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Harguindey S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-282; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heinrich R, 1999, BIOCHEM SOC T, V27, P294, DOI 10.1042/bst0270294; Horka H, 2012, J IMMUNOL, V188, P2669, DOI 10.4049/jimmunol.1100529; Hosseinzadeh Z, 2015, CELL PHYSIOL BIOCHEM, V36, P727, DOI 10.1159/000430133; Jabeen R, 2013, J CLIN INVEST, V123, P4641, DOI 10.1172/JCI69489; Kaplan MH, 2015, NAT REV IMMUNOL, V15, P295, DOI 10.1038/nri3824; Kaplan MH, 2013, IMMUNOL REV, V252, P104, DOI 10.1111/imr.12028; Kara EE, 2013, J IMMUNOL, V191, P1110, DOI 10.4049/jimmunol.1203089; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Kim IK, 2015, NAT MED, V21, P1010, DOI 10.1038/nm.3922; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kudo M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00263; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Meima ME, 2009, J BIOL CHEM, V284, P26666, DOI 10.1074/jbc.M109.019448; MILLS GB, 1986, J IMMUNOL, V136, P1150; Nagai S, 2013, ANN NY ACAD SCI, V1280, P30, DOI 10.1111/nyas.12059; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Niedbala W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5575; Odunewu A, 2013, AM J PHYSIOL-RENAL, V305, pF370, DOI 10.1152/ajprenal.00598.2012; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Pierau M, 2009, J IMMUNOL, V183, P6124, DOI 10.4049/jimmunol.0900246; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Putney LK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-46; Qadri SM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0134-7; Rotte A, 2010, CELL PHYSIOL BIOCHEM, V26, P553, DOI 10.1159/000322323; Salker MS, 2015, BIOCHEM BIOPH RES CO, V460, P845, DOI 10.1016/j.bbrc.2015.03.120; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Singh Y, 2016, IMMUNOLOGY, V149, P74, DOI 10.1111/imm.12631; Singh Y, 2015, J IMMUNOL, V195, P5667, DOI 10.4049/jimmunol.1401875; Singh Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17723; Singh Y, 2011, IMMUNOL LETT, V140, P21, DOI 10.1016/j.imlet.2011.05.011; Soroosh P, 2009, IMMUNOLOGY, V127, P450, DOI 10.1111/j.1365-2567.2009.03114.x; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Vegran F, 2015, CANCER RES, V75, P475, DOI 10.1158/0008-5472.CAN-14-2748; Vegran F, 2014, NAT IMMUNOL, V15, P758, DOI 10.1038/ni.2925; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wang Y, 2016, IMMUNITY, V44, P1337, DOI 10.1016/j.immuni.2016.05.009; Xiao X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9266; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou YT, 2015, CELL PHYSIOL BIOCHEM, V36, P1237, DOI 10.1159/000430293; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	73	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23662	23671		10.1074/jbc.M116.730259	http://dx.doi.org/10.1074/jbc.M116.730259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27629415	Green Published, hybrid			2022-12-26	WOS:000387884400026
J	Garwain, O; Scarlata, S				Garwain, Osama; Scarlata, Suzanne			Phospholipase C beta-TRAX Association Is Required for PC12 Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; MEMBRANE INTERACTIONS; RNA INTERFERENCE; RISC ACTIVATION; FACTOR-X; PROTEIN; C-BETA-1; C3PO; COMPLEX; BINDING	When treated with nerve growth factor, PC12 cells will differentiate over the course of several days. Here, we have followed changes during differentiation in the cellular levels of phosphoinositide-specific phospholipase C beta (PLC beta) and its activator, G alpha(q), which together mediate Ca2+ release. We also followed changes in the level of the novel PLC beta binding partner TRAX (translin-associated factor X), which promotes RNA-induced gene silencing. We find that the level of PLC beta increases 4-fold within 24 h, whereas G alpha(q) increases only 1.4-fold, and this increase occurs similar to 24 h later than PLC beta. Alternately, the level of TRAX remains constant over the 72 h tested. When PLC beta 1 or TRAX is down-regulated, differentiation does not occur. The impact of PLC beta on differentiation appears independent of G alpha(q) as down-regulating G alpha(q) at constant PLC beta does not affect differentiation. Forster resonance energy transfer studies after PLC beta association with its partners indicate that PLC beta induced soon after nerve growth factor treatment associates with TRAX rather than G alpha(q). Functional measurements of Ca2+ signals to assess the activity of PLC beta-G alpha(q) complexes and measurements of the reversal of siRNA(GAPDH) to assess the activity of PLC beta-TRAX complexes additionally suggest that the newly synthesized PLC beta associates with TRAX to impact RNA-induced silencing. Taken together, our studies show that PLC beta, through its ability to bind TRAX and reverse RNA silencing of specific genes, plays a key role in switching PC12 cells to their differentiated state.	[Garwain, Osama; Scarlata, Suzanne] Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA	Worcester Polytechnic Institute	Scarlata, S (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	sfscarlata@wpi.edu			National Institutes of Health [RO1GM116187, RO172853]; Richard Whitcomb endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard Whitcomb endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1GM116187 and RO172853. This work was also supported by the Richard Whitcomb endowment. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aisiku O, 2011, ARCH BIOCHEM BIOPHYS, V509, P186, DOI 10.1016/j.abb.2011.02.006; Aisiku OR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015001; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bortul R, 2002, J CELL BIOCHEM, V84, P56, DOI 10.1002/jcb.1266; Ciruela A, 2000, BIOCHEM J, V346, P587, DOI 10.1042/0264-6021:3460587; Cocco L, 2002, ADV ENZYME REGUL, V42, P181, DOI 10.1016/S0065-2571(01)00030-9; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Golebiewska U, 2011, BIOCHEMISTRY-US, V50, P2829, DOI 10.1021/bi101701x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; KIM UH, 1991, J BIOL CHEM, V266, P1359; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Li Z, 2008, BBA-GENE REGUL MECH, V1779, P479, DOI 10.1016/j.bbagrm.2008.03.008; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Marchetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113708; Philip F, 2016, FASEB J, V30, P1958, DOI 10.1096/fj.201500140; Philip Finly, 2013, Advances in Biological Regulation, V53, P319, DOI 10.1016/j.jbior.2013.07.002; Philip F, 2012, FASEB J, V26, P4903, DOI 10.1096/fj.12-213934; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Sahu S, 2014, J BIOL CHEM, V289, P5134, DOI 10.1074/jbc.M113.531467; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Toni T, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.48; Weinstein H, 2011, BBA-BIOMEMBRANES, V1808, P2940, DOI 10.1016/j.bbamem.2011.08.028; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200; Ye XC, 2011, NAT STRUCT MOL BIOL, V18, P650, DOI 10.1038/nsmb.2032	28	13	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22970	22976		10.1074/jbc.M116.744953	http://dx.doi.org/10.1074/jbc.M116.744953			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27624933	Green Published, hybrid			2022-12-26	WOS:000387224800010
J	Benso, B; Franchin, M; Massarioli, AP; Paschoal, JAR; Alencar, SM; Franco, GCN; Rosalen, PL				Benso, Bruna; Franchin, Marcelo; Massarioli, Adna Prado; Rizzato Paschoal, Jonas Augusto; Alencar, Severino Matias; Nobre Franco, Gilson Cesar; Rosalen, Pedro Luiz			Anti-Inflammatory, Anti-Osteoclastogenic and Antioxidant Effects of Malva sylvestris Extract and Fractions: In Vitro and In Vivo Studies	PLOS ONE			English	Article							RANKL-INDUCED OSTEOCLASTOGENESIS; PAW EDEMA; FREE-RADICALS; RAT; INFLAMMATION; INHIBITION; DECREASES; IL-1-BETA; MECHANISM; MIGRATION	Given their medical importance, natural products represent a tremendous source of drug discovery. The aim of this study was to investigate Malva sylvestris L. extract and fractions and their pharmacological activities followed by chemical identification. The aqueous fraction (AF) was identified as the bioactive fraction in the in vitro and in vivo assays. The AF controlled the neutrophil migration to the peritoneal cavity by 66%, inhibited the antiedematogenic activity by 58.8%, and controlled IL-1 beta cytokine expression by 54%. The in vitro viability tests showed a concentration-dependent effect, where the MSE and fractions at concentrations under 10 mu g/ mL were non-toxic to cells. Transcriptional factors of carbonic anhydrase II (CAII), cathepsin K (Ctsk) and tartrate-resistant acid phosphatase (TRAP) were analyzed by qPCR in RAW 264.7 cell lines. The gene expression analysis showed that the AF was the only treatment that could downregulate all the study genes: CAII, Ctsk and TRAP (p<0.05). TRAP staining was used to evaluate osteoclast formation. AF treatments reduced the number of osteoclastogenesis 2.6-fold compared to the vehicle control group. Matrix metalloproteinase 9 (MMP-9) activity decreased 75% with the AF treatment. Moreover, the bioactive fraction had the ability to regulate the oxidation pathway in the ABTS (2,2-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) assay with an activity equivalent to 1.30 mu mol Trolox/g and DPPH (2,2-diphenyl-1-picrylhydrazyl) radicals 1.01 g/L. Positive ion ESI-mass spectrometry for molecular ions at m/z 611 and 633 confirmed rutin as the major compound in the AF. The AF of M. sylvestris presented anti-inflammatory, controlled osteoclastogenic mechanisms and antioxidant abilities in different in vitro and in vivo methods. In addition, we suggest that given its multi-target activity the bioactive fraction may be a good candidate in the therapy of chronic inflammatory diseases.	[Benso, Bruna; Franchin, Marcelo; Rosalen, Pedro Luiz] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil; [Benso, Bruna] Univ Austral Chile, Fac Med, Sch Dent, Valdivia, Chile; [Massarioli, Adna Prado; Alencar, Severino Matias] Univ Sao Paulo, Dept Agri Food Ind Food & Nutr, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil; [Rizzato Paschoal, Jonas Augusto] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Ribeirao Preto, SP, Brazil; [Nobre Franco, Gilson Cesar] Univ Estadual Ponta Grossa, Dept Gen Biol, Lab Physiol & Pathophysiol, Ponta Grossa, PR, Brazil	Universidade Estadual de Campinas; Universidad Austral de Chile; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Ponta Grossa	Benso, B; Rosalen, PL (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil.; Benso, B (corresponding author), Univ Austral Chile, Fac Med, Sch Dent, Valdivia, Chile.	bruna.benso@uach.cl; rosalen@fop.unicamp.br	Paschoal, Jonas Augusto Rizzato/F-4260-2012; Franchin, Marcelo/M-7636-2017; Benso, Bruna/L-1010-2015; Massarioli, Adna Prado/I-4840-2013; Rosalen, Pedro Luiz/I-3718-2012; Alencar, Severino Matias/B-7743-2012	Paschoal, Jonas Augusto Rizzato/0000-0002-7372-0936; Franchin, Marcelo/0000-0001-5613-2756; Benso, Bruna/0000-0002-4425-5174; Massarioli, Adna Prado/0000-0002-2747-0788; Rosalen, Pedro Luiz/0000-0003-0812-4027; Alencar, Severino Matias/0000-0002-6637-7973	Sao Paulo Research Foundation (FAPESP) [2011/23980-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Grant #2011/23980-5, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Sao Paulo Research Foundation (FAPESP) (Grant #2011/23980-5) for financial support. We also would like to thank Dr. Helen Lowry for the very careful review of the English in this work.	Al Mamun MA, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0043-6, 10.1186/S40659-015-0043-6]; Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012; Bocci V, 2013, CURR MED CHEM, V20, P3397, DOI 10.2174/0929867311320270005; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Bruna Benso, 2015, PLOS ONE; Cataldo DD, 2003, CELL MOL BIOL, V49, P875; Choi KS, 2014, ARCH BIOCHEM BIOPHYS, V559, P38, DOI 10.1016/j.abb.2014.05.016; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; Coxon A, 2002, ARTHRITIS RHEUM, V46, P2604, DOI 10.1002/art.10546; Cragg GM, 2014, J NAT PROD, V77, P703, DOI 10.1021/np5000796; Crotti TN, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/281287; Dal Secco D, 2006, NITRIC OXIDE-BIOL CH, V15, P77, DOI 10.1016/j.niox.2006.02.004; Franchin M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/907041; Franchin M, 2012, J ETHNOPHARMACOL, V143, P709, DOI 10.1016/j.jep.2012.07.040; Franco GCN, 2011, EXP CELL RES, V317, P1454, DOI 10.1016/j.yexcr.2011.03.014; Gasparetto JC, 2012, J PHARM PHARMACOL, V64, P172, DOI 10.1111/j.2042-7158.2011.01383.x; Georgakopoulou EA, 2014, ORAL DIS, V20, P127, DOI 10.1111/odi.12132; Hardy RS, 2014, ANN NY ACAD SCI, V1318, P18, DOI 10.1111/nyas.12389; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; Ishtiaq Muhammad, 2007, Pak J Biol Sci, V10, P2241, DOI 10.3923/pjbs.2007.2241.2256; Javanmardi J, 2003, FOOD CHEM, V83, P547, DOI 10.1016/S0308-8146(03)00151-1; Kauss T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2372; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Kim HS, 2012, INT J MOL MED, V29, P169, DOI 10.3892/ijmm.2011.822; Koeberle A, 2014, DRUG DISCOV TODAY, V19, P1871, DOI 10.1016/j.drudis.2014.08.006; Kohli P, 2009, BRIT J PHARMACOL, V158, P960, DOI 10.1111/j.1476-5381.2009.00290.x; LEVY L, 1969, LIFE SCI PT 1 PHYSI, V8, P601, DOI 10.1016/0024-3205(69)90021-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Brien CA, 2010, BONE, V46, P911, DOI 10.1016/j.bone.2009.08.050; Ohshiba T, 2003, BRIT J CANCER, V88, P1318, DOI 10.1038/sj.bjc.6600858; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Posadas I, 2004, BRIT J PHARMACOL, V142, P331, DOI 10.1038/sj.bjp.0705650; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Rainsford K. D., 2007, V42, P3; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Seleem D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157188; Shim KS, 2011, J MED FOOD, V14, P1439, DOI 10.1089/jmf.2010.1502; Syggelos SA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/230805; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tiveron AP, 2012, INT J MOL SCI, V13, P8943, DOI 10.3390/ijms13078943; van den Berg WB, 2001, SEMIN ARTHRITIS RHEU, V30, P7, DOI 10.1053/sarh.2001.23704; WARD PA, 1974, ANN NY ACAD SCI, V221, P290, DOI 10.1111/j.1749-6632.1974.tb28228.x; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Wu CL, 2015, BIOCHEM PHARMACOL, V93, P59, DOI 10.1016/j.bcp.2014.10.019; Yan B, 2014, J IMMUNOL, V192, P5998, DOI 10.4049/jimmunol.1301645; Zhang F, 2011, BIOCHIMIE, V93, P296, DOI 10.1016/j.biochi.2010.10.001	48	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162728	10.1371/journal.pone.0162728	http://dx.doi.org/10.1371/journal.pone.0162728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643502	Green Published, Green Submitted, gold			2022-12-26	WOS:000383891900015
J	Fregin, T; Bickmeyer, U				Fregin, Torsten; Bickmeyer, Ulf			Electrophysiological Investigation of Different Methods of Anesthesia in Lobster and Crayfish	PLOS ONE			English	Article							CARBON-DIOXIDE; CRUSTACEANS; BEHAVIOR; TEMPERATURE; NEURONS; CRABS; MODULATION; ANIMALS; CIRCUIT; PAIN	Objectives In search for methods of anesthesia of crustaceans, an implanted electrode into lobster and crayfish CNS enabled us to monitor signal propagation in the nerve system of animals undergoing different protocols. Results Cooling (tap water 0 degrees C, sea water -1,8 degrees C) and anesthesia with MgCl2 (10%) were both discarded as anesthetic procedures because responses to external stimuli were still detectable under treatment. Contrarily, bubbling the aquarium water with CO2 can be considered a "partially successful" anesthesia, because signal propagation is inhibited but before that the animals show discomfort. The procedure of "electro-stunning" induces epileptic-form seizures in the crustacean CNS (lobster, crayfish), which overlay but do not mitigate the response to external stimuli. After several minutes the activity declines before the nervous system starts to recover. A feasible way to sacrifice lobsters is to slowly raise the water temperature (1 degrees C min(-1)), as all electrical activities in the CNS cease at temperatures above similar to 30 degrees C, whereas below this temperature the animals do not show signs of stress or escape behavior (e.g. tail flips) in the warming water. Conclusion CO2 is efficient to anaesthetize lobster and crayfish but due to low pH in water is stressful to the animals previous to anesthesia. Electrical stunning induces epileptiform seizures but paralyses the animals and leads to a reversible decline of nerve system activity after seizure. Electric stunning or slowly warming just before preparation may meet ethical expectations regarding anaesthesia and to sacrifice crustaceans.	[Fregin, Torsten; Bickmeyer, Ulf] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Handelshafen 12, D-27570 Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Bickmeyer, U (corresponding author), Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Handelshafen 12, D-27570 Bremerhaven, Germany.	Ulf.Bickmeyer@awi.de		Bickmeyer, Ulf/0000-0002-5351-2902	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE) [2812HS009]	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE)	German Federal Ministry of Food and Agriculture (BMEL) through the Federal Office for Agriculture and Food (BLE), grant number 2812HS009.	Aaser CS, 1949, NORDISK VET MEDISIN, V1, P221; BAKER JR, 1955, J MAR BIOL ASSOC UK, V34, P15, DOI 10.1017/S0025315400008572; BAKER JR, 1962, SCIENCE, V135, P587, DOI 10.1126/science.135.3503.587-a; Barr S, 2008, ANIM BEHAV, V75, P745, DOI 10.1016/j.anbehav.2007.07.004; BENARDE MA, 1962, SCIENCE, V135, P587, DOI 10.1126/science.135.3503.587; Bickmeyer U, 2012, MAR DRUGS, V10, P223, DOI 10.3390/md10010223; Bierbower SM, 2010, J EXP ZOOL PART A, V313A, P484, DOI 10.1002/jez.620; Bierbower SM, 2013, J EXP ZOOL PART A, V319A, P340, DOI 10.1002/jez.1798; Chung Y.S., 2012, OPEN J MOL INTEGR PH, V2, P75, DOI DOI 10.4236/OJMIP.2012.23011; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Edwards DH, 1999, TRENDS NEUROSCI, V22, P153, DOI 10.1016/S0166-2236(98)01340-X; Elwood RW, 2012, ANIM WELFARE, V21, P23, DOI 10.7120/096272812X13353700593365; Fish F. R., 1943, Transactions of the American Fisheries Society, V1942, P25; FORWARD RB, 1990, BIOL BULL-US, V178, P195, DOI 10.2307/1541819; GREGORY NG, 1988, BRIT VET J, V144, P573, DOI 10.1016/0007-1935(88)90027-9; GREGORY NG, 1987, BRIT VET J, V143, P175, DOI 10.1016/0007-1935(87)90009-1; Gruhn M, 2002, J NEUROSCI METH, V118, P33, DOI 10.1016/S0165-0270(02)00127-9; GUNTER G, 1962, SCIENCE, V135, P588, DOI 10.1126/science.135.3503.588; GUNTER G, 1961, SCIENCE, V133, P327, DOI 10.1126/science.133.3449.327; Hamilton JL, 2007, J EXP BIOL, V210, P1025, DOI 10.1242/jeb.02717; HOBBS H H JR, 1981, Smithsonian Contributions to Zoology, P1; Hoenderken R, 1978, ELEKT BEDWELMING SLA, VXI; KERKUT G. A., 1958, BEHAVIOR, V13, P259, DOI 10.1163/156853957X00047; KERKUT GA, 1956, NATURE, V178, P426, DOI 10.1038/178426a0; KRAVITZ EA, 1988, SCIENCE, V241, P1775, DOI 10.1126/science.2902685; Lagerspetz KYH, 2006, BIOL REV, V81, P237, DOI 10.1017/S1464793105006998; Liu YC, 2010, J NEUROPHYSIOL, V104, P675, DOI 10.1152/jn.00391.2010; Makowska IJ, 2009, APPL ANIM BEHAV SCI, V121, P230, DOI 10.1016/j.applanim.2009.10.001; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; MESSENGER JB, 1985, COMP BIOCHEM PHYS C, V82, P203, DOI 10.1016/0742-8413(85)90230-0; Pantin C. F. A., 1962, NOTES MICROSCOPICAL; Payette AL, 2003, COMP BIOCHEM PHYS A, V136, P539, DOI 10.1016/S1095-6433(03)00203-4; POST G, 1979, PROG FISH CULT, V41, P142, DOI 10.1577/1548-8659(1979)41[142:CAAFAO]2.0.CO;2; Reimers U., 2008, THESIS; Roth B, 2010, ANIM WELFARE, V19, P287; RUNHAM N. W., 1965, MALCOLOGIA, V2, P231; Smaldon G., 1979, SYNOPSIS METHODS NAR; Sneddon LU, 2015, J EXP BIOL, V218, P967, DOI 10.1242/jeb.088823; Southward A.J., 1963, CATALOGUE MAIN MARIN; Steneck RS, 2013, CAN J FISH AQUAT SCI, V70, P1612, DOI 10.1139/cjfas-2013-0094; Tang LS, 2012, J NEUROSCI, V32, P10075, DOI 10.1523/JNEUROSCI.1443-12.2012; Tang LS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000469; Tani M, 1998, COMP BIOCHEM PHYS A, V119, P845, DOI 10.1016/S1095-6433(98)01025-3; Wiese KE., 2002, CRUSTACEAN NERVOUS S, Vxxi; Wiese KE, 2002, CRUSTACEAN EXPT SYST, Vxiv	45	18	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162894	10.1371/journal.pone.0162894	http://dx.doi.org/10.1371/journal.pone.0162894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642755	Green Published, gold, Green Submitted			2022-12-26	WOS:000383891900023
J	Park, SJ; Yoon, DM; Yoon, KB; Moon, JA; Kim, SH				Park, Sang Jun; Yoon, Duck Mi; Yoon, Kyung Bong; Moon, Ji Ae; Kim, Shin Hyung			Factors Associated with Higher Reported Pain Levels in Patients with Chronic Musculoskeletal Pain: A Cross-Sectional, Correlational Analysis	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL-PROCESSES; INSOMNIA SEVERITY INDEX; POOR SLEEP; NECK PAIN; BACK-PAIN; DEPRESSION; POPULATION; QUALITY; OSTEOARTHRITIS; HYPERALGESIA	Background Chronic musculoskeletal pain is highly prevalent, disabling, and costly, and has many negative effects on quality of life. The aim of this study was to investigate factors associated with higher reported pain levels in patients with chronic musculoskeletal pain among demographic, clinical, and psychological factors, and to evaluate whether insomnia is independently associated with pain intensity in this population. Methods A total of 357 patients with chronic musculoskeletal pain (pain duration >= six months) satisfied the study inclusion criteria and were included in the analyses. Patient demographics, clinical, and psychological factors were evaluated with hierarchical multivariate logistic analysis to identify factors associated with severe pain (NRS [numeric rating scale] >= 7). Hierarchical linear regression analysis also performed to identify factors associated with pain intensity (0 to 10 NRS). Results Multivariate logistic analyses revealed older age (OR [odds ratio] = 1.017, 95% CI [confidence interval] 1.001-1.032, P = 0.034), high anxiety level (OR = 1.162, 95% CI 1.020-1.324, P = 0.024), high pain catastrophizing (OR = 1.043, 95% CI 1.007-1.081, P = 0.018), and severe insomnia (OR = 1.112, 95% CI 1.057-1.170, P < 0.001) were significantly associated with severe pain. Hierarchical linear regression analysis showed age (beta = 0.106, P = 0.041), pain catastrophizing (beta = 0.249, P< 0.001), and insomnia (beta = 0.286, P < 0.001) were significantly associated with pain intensity. The variance in pain intensity explained by the final model was 32.2%. Conclusions Older age, severe insomnia, and high pain catastrophizing were significantly associated with higher reported pain levels. Insomnia was independently associated with pain intensity, even after controlling for various demographic and clinical factors. These factors should be considered when devising pain management strategies for this population.	[Park, Sang Jun; Yoon, Duck Mi; Yoon, Kyung Bong; Moon, Ji Ae; Kim, Shin Hyung] Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Anesthesia & Pain Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System	Kim, SH (corresponding author), Yonsei Univ, Coll Med, Dept Anesthesiol & Pain Med, Anesthesia & Pain Res Inst, Seoul, South Korea.	tessar@yuhs.ac		Park, Sang Jun/0000-0002-2496-7764; Yoon, Kyung Bong/0000-0002-4167-1375; Kim, Shin Hyung/0000-0003-4058-7697				Artner J, 2013, J PAIN RES, V6, P1, DOI 10.2147/JPR.S36386; Asih S, 2014, SPINE J, V14, P2000, DOI 10.1016/j.spinee.2013.11.052; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Buenaver LF, 2012, PAIN, V153, P1159, DOI 10.1016/j.pain.2012.01.023; Byers HD, 2016, J BEHAV MED, V39, P233, DOI 10.1007/s10865-015-9687-5; Campbell CM, 2015, ARTHRIT CARE RES, V67, P1387, DOI 10.1002/acr.22609; Chiu YH, 2005, PAIN, V115, P316, DOI 10.1016/j.pain.2005.03.009; Chung KF, 2010, SLEEP MED, V11, P752, DOI 10.1016/j.sleep.2009.09.005; Farrell M, 2007, PAIN MED, V8, P514, DOI 10.1111/j.1526-4637.2007.00282.x; Finan PH, 2013, SLEEP MED REV, V17, P173, DOI 10.1016/j.smrv.2012.03.003; Fishbain DA, 2008, J PAIN SYMPTOM MANAG, V36, P639, DOI 10.1016/j.jpainsymman.2007.12.012; Frondini C, 2007, ARCH GERONTOL GERIAT, V44, P167, DOI 10.1016/j.archger.2007.01.024; Gibson SJ, 2004, CLIN J PAIN, V20, P227, DOI 10.1097/00002508-200407000-00004; Gustavsson C, 2006, J REHABIL MED, V38, P100, DOI 10.1080/16501970510044025; Haack M, 2012, EUR J PAIN, V16, P522, DOI 10.1016/j.ejpain.2011.07.007; Jourdan D, 2000, EUR J PAIN, V4, P291, DOI 10.1053/eujp.2000.0188; Kelly GA, 2011, CLIN J PAIN, V27, P169, DOI 10.1097/AJP.0b013e3181f3bdd5; Kim SH, 2015, KOREAN J PAIN, V28, P137, DOI 10.3344/kjp.2015.28.2.137; Kovacs FM, 2015, CLIN J PAIN, V31, P713, DOI 10.1097/AJP.0000000000000147; Linton SJ, 2011, EUR J PAIN, V15, P416, DOI 10.1016/j.ejpain.2010.08.009; MacDonald S, 2008, INT J BEHAV MED, V15, P201, DOI 10.1080/10705500802222675; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Palermo TM, 2011, PAIN, V152, P89, DOI 10.1016/j.pain.2010.09.035; Power JD, 2005, ARTHRIT RHEUM-ARTHR, V53, P911, DOI 10.1002/art.21584; Quartana PJ, 2015, BRAIN BEHAV IMMUN, V47, P228, DOI 10.1016/j.bbi.2014.12.010; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Sayar K, 2002, CAN J PSYCHIAT, V47, P844, DOI 10.1177/070674370204700905; Schuh-Hofer S, 2013, PAIN, V154, P1613, DOI 10.1016/j.pain.2013.04.046; Smith MT, 2004, CLIN J PAIN, V20, P111, DOI 10.1097/00002508-200403000-00008; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Strine TW, 2007, ARTHRIT RHEUM-ARTHR, V57, P656, DOI 10.1002/art.22684; Sturgeon JA, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-012-0317-4; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Tang Nicole K Y, 2008, Rev Pain, V2, P2, DOI 10.1177/204946370800200102; Tang NKY, 2012, CLIN J PAIN, V28, P428, DOI 10.1097/AJP.0b013e31823711bc; Vitiello MV, 2014, PAIN, V155, P1547, DOI 10.1016/j.pain.2014.04.032; Wong WS, 2014, QUAL LIFE RES, V23, P2333, DOI 10.1007/s11136-014-0683-y; Zheng Z, 2000, PAIN, V85, P51, DOI 10.1016/S0304-3959(99)00247-X	39	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163132	10.1371/journal.pone.0163132	http://dx.doi.org/10.1371/journal.pone.0163132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636367	gold, Green Submitted, Green Published			2022-12-26	WOS:000383723700035
J	Guven, G; Lohmann, E; Bras, J; Gibbs, JR; Gurvit, H; Bilgic, B; Hanagasi, H; Rizzu, P; Heutink, P; Emre, M; Erginel-Unaltuna, N; Just, W; Hardy, J; Singleton, A; Guerreiro, R				Guven, Gamze; Lohmann, Ebba; Bras, Jose; Gibbs, J. Raphael; Gurvit, Hakan; Bilgic, Basar; Hanagasi, Hasmet; Rizzu, Patrizia; Heutink, Peter; Emre, Murat; Erginel-Unaltuna, Nihan; Just, Walter; Hardy, John; Singleton, Andrew; Guerreiro, Rita			Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients	PLOS ONE			English	Article							HEXANUCLEOTIDE REPEAT EXPANSION; LOBAR DEGENERATION; NULL MUTATIONS; TAU-MUTATIONS; PROGRANULIN; RECOMMENDATIONS; ASSOCIATION; GUIDELINES; DIAGNOSIS; DISEASE	'Microtubule-associated protein tau' (MAPT), 'granulin' (GRN) and 'chromosome 9 open reading frame72' (C9ORF72) genemutations are the major known genetic causes of frontotemporal dementia (FTD). Recent studies suggest that mutations in these genes may also be associated with other forms of dementia. Therefore we investigated whether MAPT, GRN and C9ORF72 genemutations are major contributors to dementia in a random, unselected Turkish cohort of dementia patients. A combination of whole-exome sequencing, Sanger sequencing and fragment analysis/Southern blot was performed in order to identify pathogenic mutations and novel variants in these genes as well as other FTD-related genes such as the 'charged multivesicular body protein 2B' (CHMP2B), the 'FUS RNA binding protein' (FUS),the 'TAR DNA binding protein' (TARDBP), the 'sequestosome1' (SQSTM1), and the 'valosin containing protein' (VCP). We determined one pathogenic MAPT mutation (c. 1906C> T, p. P636L) and one novel missense variant (c. 38A> G, p. D13G). In GRN we identified a probably pathogenic TGAG deletion in the splice donor site of exon 6. Three patients were found to carry the GGGGCC expansions in the non-coding region of the C9ORF72 gene. In summary, a complete screening for mutations in MAPT, GRN and C9ORF72 genes revealed a frequency of 5.4% of pathogenicmutations in a random cohort of 93 Turkish index patients with dementia.	[Guven, Gamze; Erginel-Unaltuna, Nihan] Istanbul Univ, Inst Expt Med, Dept Genet, Istanbul, Turkey; [Lohmann, Ebba; Gurvit, Hakan; Bilgic, Basar; Hanagasi, Hasmet; Emre, Murat] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Behav Neurol & Movement Disorders Unit, Istanbul, Turkey; [Lohmann, Ebba; Heutink, Peter] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Lohmann, Ebba; Rizzu, Patrizia; Heutink, Peter] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Bras, Jose; Hardy, John] UCL, Inst Neurol, Dept Mol Neurosci, London, England; [Bras, Jose; Guerreiro, Rita] Univ Aveiro, Dept Med Sci, P-3810193 Aveiro, Portugal; [Bras, Jose; Guerreiro, Rita] Univ Aveiro, Inst Biomed iBiMED, P-3810193 Aveiro, Portugal; [Gibbs, J. Raphael; Singleton, Andrew] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Just, Walter] Univ Ulm, Inst Human Genet, Ulm, Germany	Istanbul University; Istanbul University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of London; University College London; Universidade de Aveiro; Universidade de Aveiro; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Ulm University	Lohmann, E (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Neurol, Behav Neurol & Movement Disorders Unit, Istanbul, Turkey.; Lohmann, E (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany.; Lohmann, E (corresponding author), German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany.	ebbalohmann@gmx.net	Gurvit, Hakan/A-7646-2019; Hanagasi, Hasmet A./AAT-9501-2020; Hardy, John/C-2451-2009; Guven, Gamze/AAB-7548-2020; Gibbs, J. Raphael/A-3984-2010; Erginel-Unaltuna, Nihan/A-4885-2018; Singleton, Andrew B/C-3010-2009; Guerreiro, Rita J L/A-1327-2011; Bilgic, Basar/E-4821-2012; Bras, Jose MT/A-1428-2011; Guven, Gamze/Q-4560-2016	Gurvit, Hakan/0000-0003-2908-8475; Hardy, John/0000-0002-3122-0423; Gibbs, J. Raphael/0000-0002-6985-0658; Erginel-Unaltuna, Nihan/0000-0003-0562-0455; Bilgic, Basar/0000-0001-6032-0856; Heutink, Peter/0000-0001-5218-1737; Guerreiro, Rita/0000-0001-5879-3486; Bras, Jose/0000-0001-8186-0333	Alzheimer's Research UK (ARUK); Wellcome Trust/MRC [WT089698]; National Institute on Aging; National Institute of Neurological Disease and Stroke, National Institutes of Health, Department Of Health and Human Services [ZO1 AG000950-10]; ARUK Alzheimer's Society; European Social Fund; Ministry of Science Research and the Arts Baden-Wurttemberg; Alzheimer's Society; Alzheimer's Research UK; National Institute on Aging, National Institutes of Health, Department of Health and Human Services; MRC [G0701075, G0901254] Funding Source: UKRI; Alzheimers Research UK [ARUK-TRFUS2012-3] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG000951, ZIAAG000957] Funding Source: NIH RePORTER	Alzheimer's Research UK (ARUK)(Alzheimer's Research UK (ARUK)); Wellcome Trust/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disease and Stroke, National Institutes of Health, Department Of Health and Human Services; ARUK Alzheimer's Society; European Social Fund(European Social Fund (ESF)); Ministry of Science Research and the Arts Baden-Wurttemberg; Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); National Institute on Aging, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Alzheimer's Research UK (ARUK) by an anonymous donor, by the Wellcome Trust/MRC Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium whose members are from the UCL/Institute of Neurology, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee; by the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health, Department Of Health and Human Services, Project number ZO1 AG000950-10; and by Research Fellowships from ARUK Alzheimer's Society to Dr. Guerreiro and Dr Bras. This project was supported by the European Social Fund and by the Ministry of Science Research and the Arts Baden-Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all patients and their families for taking part in this study. Ebru Ozer and Meltem Pak helped with obtaining the samples. Jose Bras and Rita Guerreiro are supported by Fellowships from the Alzheimer's Society. This work was partially funded by Alzheimer's Research UK, Alzheimer's Society and by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services and the European Social Fund and the Ministry of Science Research and the Arts Baden-Wurttemberg.	Bernardi L, 2009, NEUROBIOL AGING, V30, P1825, DOI 10.1016/j.neurobiolaging.2008.01.005; Bit-Ivan EN, 2014, J NEUROPATH EXP NEUR, V73, P467, DOI 10.1097/NEN.0000000000000070; Bronner IF, 2007, EUR J HUM GENET, V15, P369, DOI 10.1038/sj.ejhg.5201772; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cruchaga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031039; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Fabre SF, 2001, EXP NEUROL, V168, P413, DOI 10.1006/exnr.2000.7613; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Galimberti D, 2015, BIOL PSYCHIAT, V78, P684, DOI 10.1016/j.biopsych.2015.03.028; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Gomez-Tortosa E, 2013, NEUROLOGY, V80, P366, DOI 10.1212/WNL.0b013e31827f08ea; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.009; Hayashi S, 2002, ANN NEUROL, V51, P525, DOI 10.1002/ana.10163; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Huey ED, 2006, ANN NEUROL, V60, P374, DOI 10.1002/ana.20969; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Kertesz A, 2003, NEUROLOGIST, V9, P311, DOI 10.1097/01.nrl.0000094943.84390.cf; Kowalska A, 2001, DEMENT GERIATR COGN, V12, P387, DOI 10.1159/000051285; Le Ber I, 2007, HUM MUTAT, V28, P846, DOI 10.1002/humu.20520; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohmann E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.02.020; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Masellis M, 2006, BRAIN, V129, P3115, DOI 10.1093/brain/awl276; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Murray ME, 2011, ACTA NEUROPATHOL, V122, P673, DOI 10.1007/s00401-011-0907-y; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Poorkaj P, 2001, ARCH NEUROL-CHICAGO, V58, P383, DOI 10.1001/archneur.58.3.383; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohrer JD, 2011, CURR OPIN NEUROL, V24, P542, DOI 10.1097/WCO.0b013e32834cd442; Skoglund L, 2011, ALZ DIS ASSOC DIS, V25, P173, DOI 10.1097/WAD.0b013e3181fbc22c; Stanford PM, 2004, J NEUROL, V251, P1098, DOI 10.1007/s00415-004-0489-x; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wojtas Aleksandra, 2012, Am J Neurodegener Dis, V1, P107; Zekanowski C, 2003, DEMENT GERIATR COGN, V16, P126, DOI 10.1159/000070999	49	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162592	10.1371/journal.pone.0162592	http://dx.doi.org/10.1371/journal.pone.0162592			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632209	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900056
J	de Freitas-Blanco, VS; Franz-Montan, M; Groppo, FC; de Carvalho, JE; Figueira, GM; Serpe, L; Sousa, IMO; Damasio, VAG; Yamane, LT; de Paula, E; Rodrigues, RAF				de Freitas-Blanco, Veronica Santana; Franz-Montan, Michelle; Groppo, Francisco Carlos; de Carvalho, Joao Ernesto; Figueira, Glyn Mara; Serpe, Luciano; Oliveira Sousa, Ilza Maria; Guilherme Damasio, Viviane Aparecida; Yamane, Lais Thiemi; de Paula, Eneida; Ferreira Rodrigues, Rodney Alexandre			Development and Evaluation of a Novel Mucoadhesive Film Containing Acmella oleracea Extract for Oral Mucosa Topical Anesthesia	PLOS ONE			English	Article							IN-VITRO ASSAYS; SPILANTHES-ACMELLA; DENTAL ANXIETY; HELIOPSIS-LONGIPES; ANALGESIC ACTIVITY; SYSTEMIC TOXICITY; DELIVERY-SYSTEMS; SKIN PENETRATION; VIVO; PERMEATION	Purpose To develop an anesthetic mucoadhesive film containing Acmella oleracea (jambu) extract for topical use on oral mucosa. Methods Ethanolic extracts from aerial parts of jambu were prepared by maceration. Pigment removal was obtained by adsorption with activated carbon. Three mucoadhesive films were developed using a film casting method: 10 or 20% of crude jambu extract (10% JB and 20% JB), and 10% of crude jambu extract treated with activated carbon (10% JBC). The mucoadhesive films were characterized regarding their uniformity, thickness, pH, and spilanthol content, and their stability was evaluated during 120 days. Gas chromatography was used to quantify the amount of spilanthol. In vitro tests determined the permeation of spilanthol across pig esophageal epithelium mucosa in Franz diffusion cells. Topical anesthetic efficacy was assessed in vivo using a tail flick test in mice. Results The three mucoadhesive films showed physical stability and visual appearances suitable for use on oral mucosa. The permeation study revealed that the spilanthol from 10% JBC presented higher flux and permeability coefficient values, compared to 10% or 20% JB (p < 0.001). Moreover, 10% JBC showed better topical anesthetic efficacy than the other films (p < 0.01). Conclusion Mucoadhesive film containing crude extract of jambu treated with activated carbon is a potential alternative for oral, topical use, encouraging future clinical studies.	[de Freitas-Blanco, Veronica Santana; Franz-Montan, Michelle; Groppo, Francisco Carlos; de Carvalho, Joao Ernesto; Serpe, Luciano; Ferreira Rodrigues, Rodney Alexandre] Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, Brazil; [de Freitas-Blanco, Veronica Santana; de Carvalho, Joao Ernesto; Figueira, Glyn Mara; Oliveira Sousa, Ilza Maria; Yamane, Lais Thiemi; Ferreira Rodrigues, Rodney Alexandre] Univ Estadual Campinas, Chem Biol & Agr Res Ctr CPQBA, Paulinia, Brazil; [de Carvalho, Joao Ernesto] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP, Brazil; [Guilherme Damasio, Viviane Aparecida; de Paula, Eneida] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Rodrigues, RAF (corresponding author), Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, Brazil.; Rodrigues, RAF (corresponding author), Univ Estadual Campinas, Chem Biol & Agr Res Ctr CPQBA, Paulinia, Brazil.	rodney@cpqba.unicamp.br	groppo, francisco carlos/HIK-2053-2022; Franz-Montan, Michelle/E-2865-2010; Figueira, Glyn/C-9605-2017; de Olivei Sousa, Ilza Maria/AAK-7866-2020; Franz-Montan, Michelle/V-3301-2019; de Paula, Eneida/C-3031-2013; Franz-Montan, Michelle/AAN-1071-2021	groppo, francisco carlos/0000-0002-8513-773X; Figueira, Glyn/0000-0002-0159-9735; Franz-Montan, Michelle/0000-0003-0760-1389; de Paula, Eneida/0000-0003-4504-5723; Franz-Montan, Michelle/0000-0003-0760-1389; Rodrigues, Rodney A. F./0000-0001-5631-0970	Brazilian National Council for Scientific and Technological Development (CNPq) [133666/2012-3]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq, #133666/2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Melh M, 2007, ORAL SURG ORAL MED O, V103, pE16, DOI 10.1016/j.tripleo.2006.11.033; Aksungur P, 2004, J CONTROL RELEASE, V98, P269, DOI 10.1016/j.jconrel.2004.05.002; Al-Melh Manal Abu, 2008, J Clin Dent, V19, P43; [Anonymous], 2003, GUIDE VALIDATION ANA; [Anonymous], 2007, FDA PUBLIC HEALTH AD; [Anonymous], 2008, PLANTAS MED BRASIL N; [Anonymous], 2010, PRODUCT MONOGRAPH EM; Anvisa, 2010, BRAZILIAN PHARMACOPO, P56; Armfield JM, 2013, COMMUNITY DENT ORAL, V41, P279, DOI 10.1111/cdoe.12005; Arrau S, 2011, J ETHNOPHARMACOL, V133, P164, DOI 10.1016/j.jep.2010.09.016; Bae SS, 2010, PHYTOCHEM ANALYSIS, V21, P438, DOI 10.1002/pca.1215; Bansal RC, 2005, ACTIVATED CARBON ADS, P1, DOI DOI 10.1201/9781420028812; Barman S., 2009, PHARM ONLINE, V1, P1027; Baruah R. N., 1993, Journal of Essential Oil Research, V5, P693; Bolognesi C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3995; Boonen J, 2010, J PHARMACEUT BIOMED, V53, P243, DOI 10.1016/j.jpba.2010.02.010; Briggs M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001177.pub3; Chakraborty A., 2004, Indian Journal of Pharmacology, V36, P148; Chakraborty A, 2010, INDIAN J PHARMACOL, V42, P277, DOI 10.4103/0253-7613.70106; Cilia-Lopez VG, 2010, PHARM BIOL, V48, P195, DOI 10.3109/13880200903078495; CORNWELL PA, 1994, J PHARM PHARMACOL, V46, P261, DOI 10.1111/j.2042-7158.1994.tb03791.x; de Araujo DR, 2010, PHARM RES-DORDR, V27, P1677, DOI 10.1007/s11095-010-0151-5; Del Consuelo ID, 2005, J PHARM SCI-US, V94, P2777, DOI 10.1002/jps.20409; del Consuelo ID, 2005, PHARM RES-DORDR, V22, P1525, DOI 10.1007/s11095-005-6020-y; Di Stasi LC, 2002, PLANTAS MEDICINAIS A, P472; Dias AMA, 2012, J SUPERCRIT FLUID, V61, P62, DOI 10.1016/j.supflu.2011.09.020; Diaz-del-Consuelo I, 2005, ARCH ORAL BIOL, V50, P981, DOI 10.1016/j.archoralbio.2005.04.008; Donaldson D, 1995, Anesth Prog, V42, P7; Eitner S, 2006, J ORAL REHABIL, V33, P588, DOI 10.1111/j.1365-2842.2005.01589.x; Fang C, 2008, EUR J PHARM BIOPHARM, V68, P735, DOI 10.1016/j.ejpb.2007.02.007; Fosquiera E, 2012, EFFECTIVENESS ACMELL; Franz TJ, 2009, SKIN PHARMACOL PHYS, V22, P276, DOI 10.1159/000235828; Franz-Montan M, 2015, J LIPOSOME RES, V25, P11, DOI 10.3109/08982104.2014.911315; Franz-Montan M, 2013, J LIPOSOME RES, V23, P54, DOI 10.3109/08982104.2012.742536; Godin B, 2007, ADV DRUG DELIVER REV, V59, P1152, DOI 10.1016/j.addr.2007.07.004; Gordon D, 2013, J ANXIETY DISORD, V27, P365, DOI 10.1016/j.janxdis.2013.04.002; GRANT GJ, 1993, J PHARMACOL TOXICOL, V29, P223, DOI 10.1016/1056-8719(93)90029-E; Hmud R, 2009, DENT ANXIETY CAUSES; HOLST A, 1985, SWED DENT J, V9, P185; Hutchins H S Jr, 1997, Anesth Prog, V44, P87; Jirovetz L, 2005, J ESSENT OIL RES, V17, P429, DOI 10.1080/10412905.2005.9698952; Kolesnikov Y, 2008, EUR J PHARMACOL, V579, P126, DOI 10.1016/j.ejphar.2007.10.014; Kulkarni U, 2010, J PHARM SCI-US, V99, P1265, DOI 10.1002/jps.21907; Kulkarni UD, 2011, AAPS PHARMSCITECH, V12, P579, DOI 10.1208/s12249-011-9624-z; Lehman PA, 2011, SKIN PHARMACOL PHYS, V24, P224, DOI 10.1159/000324884; Lemos T. L. G., 1991, Journal of Essential Oil Research, V3, P369; Ley Jakob P., 2006, V43, P21; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Malamed SF, 2013, MANUAL ANESTESIA LOC, V3; Marra DE, 2006, ARCH DERMATOL, V142, P1024, DOI 10.1001/archderm.142.8.1024; McGrath C, 2004, COMMUNITY DENT ORAL, V32, P67, DOI 10.1111/j.1600-0528.2004.00119.x; McMillan AS, 2000, BRIT J ORAL MAX SURG, V38, P58, DOI 10.1054/bjom.1999.0143; Meechan J G, 2005, Anesth Prog, V52, P91, DOI 10.2344/0003-3006(2005)52[91:FITDOI]2.0.CO;2; Meechan JG, 1996, BRIT DENT J, V181, P333, DOI 10.1038/sj.bdj.4809252; Miyazawa T, 2006, Agent for enhancing flavor of food/beverage products such as fish paste, milk beverages and snacks, contains plant extract or plant essential oil containing spilanthol, or spilanthol patent, Patent No. [JP2006296356-A 02, 2006296356]; Miyazawa T, 2006, Agent for enhancing flavor of food/beverage products such as fish paste, milk beverages and snacks, contains plant extract or plant essential oil containing spilanthol, or spilanthol patent, P17, Patent No. [JP2006296356-A 02, JP4530906-B2, JP2006296356-A, 4530906]; Miyazawa T, 2006, Agent for enhancing flavor of food/beverage products such as fish paste, milk beverages and snacks, contains plant extract or plant essential oil containing spilanthol, or spilanthol patent, P17, Patent No. [JP4530906-B2, 4530906]; Mohammed D, 2014, PHARM RES-DORDR, V31, P394, DOI 10.1007/s11095-013-1169-2; Morales JO, 2011, EUR J PHARM BIOPHARM, V77, P187, DOI 10.1016/j.ejpb.2010.11.023; Morris GA, 2010, BIOTECHNOL GENET ENG, V27, P257, DOI 10.1080/02648725.2010.10648153; Naik AD, 2012, J CHROMATOGR A, V1260, P61, DOI 10.1016/j.chroma.2012.08.043; Nokhodchi A, 2007, INT J PHARMACEUT, V335, P97, DOI 10.1016/j.ijpharm.2006.10.041; OECD, 2004, 428 ORG EC COOP DEV, DOI DOI 10.1787/9789264071087-EN; Nomura ECO, 2013, J ETHNOPHARMACOL, V150, P583, DOI 10.1016/j.jep.2013.09.007; Ogle Orrett E, 2012, Dent Clin North Am, V56, P133, DOI 10.1016/j.cden.2011.08.003; Ozsoy HD, 2010, J FOOD ENG, V101, P106, DOI 10.1016/j.jfoodeng.2010.06.018; Parirokh M, 2012, J ENDODONT, V38, P1553, DOI 10.1016/j.joen.2012.08.011; Prachayasittikul S, 2009, MOLECULES, V14, P850, DOI 10.3390/molecules14020850; Prachayasittikul V, 2013, EXCLI J, V12, P291; Ramsewak RS, 1999, PHYTOCHEMISTRY, V51, P729, DOI 10.1016/S0031-9422(99)00101-6; Rios MY, 2007, J ETHNOPHARMACOL, V110, P364, DOI 10.1016/j.jep.2006.09.041; Rodrigues R, 2014, INVENTORSPROCESSO PU; Rodrigues RAF, 2006, QUIM NOVA, V29, P368, DOI 10.1590/S0100-40422006000200030; Rodriguez-Reinoso F, 2001, ENCY MAT SCI TECHNOL, P22; Scheepers JC, 2011, AFR J BIOTECHNOL, V10, P16976, DOI 10.5897/AJB11.1999; Schuller AA, 2003, COMMUNITY DENT ORAL, V31, P116, DOI 10.1034/j.1600-0528.2003.00026.x; Sharma V, 2011, PHYTOMEDICINE, V18, P1161, DOI 10.1016/j.phymed.2011.06.001; Shin SC, 2004, INT J PHARMACEUT, V287, P73, DOI 10.1016/j.ijpharm.2004.08.012; States FaEMotU, 2000, SAFETY ASSESSMENT JA; Svensson P, 1992, Anesth Prog, V39, P79; Tran AN, 2014, J DRUGS DERMATOL, V13, P1118; van Wijk AJ, 2009, J DENT, V37, P700, DOI 10.1016/j.jdent.2009.05.023; Woolfson AD, 1998, INT J PHARM, V169, P83, DOI 10.1016/S0378-5173(98)00109-4; Wu LC, 2008, J AGR FOOD CHEM, V56, P2341, DOI 10.1021/jf073057e; Yadav R., 2011, INT J PHARM PHARM SC, V3, P245; Yang Z, 2013, INT J PHARMACEUT, V447, P231, DOI 10.1016/j.ijpharm.2013.02.048; Yu HY, 2002, J PHARM PHARMACOL, V54, P1221, DOI 10.1211/002235702320402062; Zhao W, 2011, INTRO NATURAL PRODUC, P5	88	21	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162850	10.1371/journal.pone.0162850	http://dx.doi.org/10.1371/journal.pone.0162850			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626796	gold, Green Submitted, Green Published			2022-12-26	WOS:000383680600057
J	Iqbal, Z; Wilson, NE; Keller, MA; Michalik, DE; Church, JA; Nielsen-Saines, K; Deville, J; Souza, R; Brecht, ML; Thomas, MA				Iqbal, Zohaib; Wilson, Neil E.; Keller, Margaret A.; Michalik, David E.; Church, Joseph A.; Nielsen-Saines, Karin; Deville, Jaime; Souza, Raissa; Brecht, Mary-Lynn; Thomas, M. Albert			Pilot Assessment of Brain Metabolism in Perinatally HIV-Infected Youths Using Accelerated 5D Echo Planar J-Resolved Spectroscopic Imaging	PLOS ONE			English	Article							H-1 MR SPECTROSCOPY; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN-IMMUNODEFICIENCY-VIRUS; GROUP SPARSE RECONSTRUCTION; PROTON SPECTROSCOPY; N-ACETYLASPARTATE; NMR-SPECTROSCOPY; CHEMICAL-SHIFT; GLUTAMATE; CHILDREN	Purpose To measure cerebral metabolite levels in perinatally HIV-infected youths and healthy controls using the accelerated five dimensional (5D) echo planar J-resolved spectroscopic imaging (EP-JRESI) sequence, which is capable of obtaining two dimensional (2D) J-resolved spectra from three spatial dimensions (3D). Materials and Methods After acquisition and reconstruction of the 5D EP-JRESI data, T-1-weighted MRIs were used to classify brain regions of interest for HIV patients and healthy controls: right frontal white (FW), medial frontal gray (FG), right basal ganglia (BG), right occipital white (OW), and medial occipital gray (OG). From these locations, respective J-resolved and TE-averaged spectra were extracted and fit using two different quantitation methods. The J-resolved spectra were fit using prior knowledge fitting (ProFit) while the TE-averaged spectra were fit using the advanced method for accurate robust and efficient spectral fitting (AMARES). Results Quantitation of the 5D EP-JRESI data using the ProFit algorithm yielded significant metabolic differences in two spatial locations of the perinatally HIV-infected youths compared to controls: elevated NAA/(Cr+Ch) in the FW and elevated Asp/(Cr+Ch) in the BG. Using the TE-averaged data quantified by AMARES, an increase of Glu/(Cr+Ch) was shown in the FW region. A strong negative correlation (r < -0.6) was shown between tCh/(Cr+Ch) quantified using ProFit in the FW and CD4 counts. Also, strong positive correlations (r > 0.6) were shown between Asp/(Cr+Ch) and CD4 counts in the FG and BG. Conclusion The complimentary results using ProFit fitting of J-resolved spectra and AMARES fitting of TE-averaged spectra, which are a subset of the 5D EP-JRESI acquisition, demonstrate an abnormal energy metabolism in the brains of perinatally HIV-infected youths. This may be a result of the HIV pathology and long-term combinational anti-retroviral therapy (cART). Further studies of larger perinatally HIV-infected cohorts are necessary to confirm these findings.	[Iqbal, Zohaib; Wilson, Neil E.; Souza, Raissa; Thomas, M. Albert] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA; [Keller, Margaret A.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pediat, Torrance, CA 90502 USA; [Keller, Margaret A.; Nielsen-Saines, Karin; Deville, Jaime] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Michalik, David E.] Miller Childrens Hosp Long Beach, Dept Pediat, Long Beach, CA 90806 USA; [Church, Joseph A.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Brecht, Mary-Lynn] Univ Calif Los Angeles, David Geffen Sch Med, Dept Behav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Thomas, MA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol, Los Angeles, CA 90095 USA.	athomas@mednet.ucla.edu	Thomas, M. Albert/A-6176-2012; Thomas, M. Albert/J-7210-2019	Thomas, M. Albert/0000-0001-9037-2585; Thomas, M. Albert/0000-0001-9037-2585; Iqbal, Zohaib/0000-0002-5024-7509	National Institute of Health [R21-NS080649-02]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institute of Health R21-NS080649-02 awarded to Dr. Michael Albert Thomas (https://projectreporter.nih.gov/project_info_description.cfm?aid=8551779&icde=28687176).	Adalsteinsson E, 1999, MAGNET RESON MED, V41, P8, DOI 10.1002/(SICI)1522-2594(199901)41:1<8::AID-MRM3>3.0.CO;2-D; Banakar S, 2008, J MAGN RESON IMAGING, V27, P710, DOI 10.1002/jmri.21251; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; BROWN TR, 1982, P NATL ACAD SCI-BIOL, V79, P3523, DOI 10.1073/pnas.79.11.3523; Burns B, 2014, NMR BIOMED, V27, P191, DOI 10.1002/nbm.3052; Burns BL, 2014, ALGORITHMS, V7, P276, DOI 10.3390/a7030276; CHONG WK, 1993, RADIOLOGY, V188, P119, DOI 10.1148/radiology.188.1.8099750; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; Ernst T, 2010, J MAGN RESON IMAGING, V32, P1045, DOI 10.1002/jmri.22366; Eslami R, 2010, IEEE T MED IMAGING, V29, P1297, DOI 10.1109/TMI.2010.2046673; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Fuchs A, 2014, MAGN RESON MED, V71, P458, DOI 10.1002/mrm.24703; Furuyama JK, 2012, MAGN RESON MED, V67, P1499, DOI 10.1002/mrm.24265; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Hurd R, 2004, MAGNET RESON MED, V51, P435, DOI 10.1002/mrm.20007; Iqbal Z, 2016, P ISMRM SUNT CIT SIN; Iqbal Z, 2016, NMR BIOMED, V29, P329, DOI 10.1002/nbm.3469; Keller MA, 2006, NEUROLOGY, V66, P874, DOI 10.1212/01.wnl.0000203339.69771.d8; Keller MA, 2004, NEUROLOGY, V62, P1810, DOI 10.1212/01.WNL.0000125492.57419.25; KLOSE U, 1990, MAGNET RESON MED, V14, P26, DOI 10.1002/mrm.1910140104; Kreis R, 1996, J MAGN RESON SER B, V113, P103, DOI 10.1006/jmrb.1996.0163; Kreis R, 2016, MAGN RESON MED, V75, P15, DOI 10.1002/mrm.25568; Laubenberger J, 1996, RADIOLOGY, V199, P805, DOI 10.1148/radiology.199.3.8638009; Lu DF, 1996, RADIOLOGY, V199, P423, DOI 10.1148/radiology.199.2.8668788; MACURA S, 1983, J MAGN RESON, V53, P529, DOI 10.1016/0022-2364(83)90227-5; MANSFIELD P, 1984, MAGNET RESON MED, V1, P370, DOI 10.1002/mrm.1910010308; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mohamed MA, 2010, MAGN RESON IMAGING, V28, P1251, DOI 10.1016/j.mri.2010.06.007; Moller HE, 1999, J MAGN RESON IMAGING, V9, P10, DOI 10.1002/(SICI)1522-2586(199901)9:1<10::AID-JMRI2>3.0.CO;2-W; Nagarajan R, 2012, J NEUROIMMUNE PHARM, V7, P981, DOI 10.1007/s11481-012-9407-7; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Patel K, 2009, AIDS, V23, P1893, DOI 10.1097/QAD.0b013e32832dc041; PAVLAKIS SG, 1995, PEDIATR NEUROL, V12, P277, DOI 10.1016/0887-8994(95)00048-K; Pavlakis SG, 1998, AM J NEURORADIOL, V19, P383; POSSE S, 1995, MAGN RESON MED, V33, P34, DOI 10.1002/mrm.1910330106; Potter MC, 2013, J NEUROIMMUNE PHARM, V8, P594, DOI 10.1007/s11481-013-9442-z; RYNER LN, 1995, MAGN RESON IMAGING, V13, P853, DOI 10.1016/0730-725X(95)00031-B; Sailasuta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049272; Sailasuta N, 2009, NMR BIOMED, V22, P326, DOI 10.1002/nbm.1329; Salvan AM, 1998, PEDIATR RES, V44, P755, DOI 10.1203/00006450-199811000-00019; Schulte RF, 2006, NMR BIOMED, V19, P264, DOI 10.1002/nbm.1027; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Tardieu M, 2000, NEUROLOGY, V54, P1089, DOI 10.1212/WNL.54.5.1089; Thomas MA, 1996, JMRI-J MAGN RESON IM, V6, P453, DOI 10.1002/jmri.1880060307; Thomas MA, 2001, MAGNET RESON MED, V46, P58, DOI 10.1002/mrm.1160; Tisell A, 2013, MAGN RESON MED, V70, P905, DOI 10.1002/mrm.24554; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wilson NE, 2016, MAGN RESON MED, V75, P42, DOI 10.1002/mrm.25605; Wilson NE, 2015, MAGN RESON MED, V74, P1199, DOI 10.1002/mrm.25988; Winston A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118608	56	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162810	10.1371/journal.pone.0162810	http://dx.doi.org/10.1371/journal.pone.0162810			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622551	gold, Green Published			2022-12-26	WOS:000383681000057
J	Aung, T; Wei, CY; McFarland, W; Aung, YK; Khin, HSS				Aung, Tin; Wei, Chongyi; McFarland, Willi; Aung, Ye Kyaw; Khin, Hnin Su Su			Ownership and Use of Insecticide-Treated Nets among People Living in Malaria Endemic Areas of Eastern Myanmar	PLOS ONE			English	Article								Background Myanmar has the highest burden of malaria in the Greater Mekong. However, there is limited information on ownership and use of insecticide-treated nets (ITNs) in areas of Myanmar most severely affected by malaria. We describe ownership and use of ITNs among people in the malaria-endemic eastern parts of Myanmar and factors associated with ITN use. Methods A cross-sectional household survey using a multi-stage cluster design was conducted in malaria-endemic townships in eastern Myanmar during the high malaria season of August to September, 2014. An effective ITN was defined as 1) a long-lasting insecticide-treated net obtained within the past three years, or 2) any net treated with insecticide within the past year. Results In 4,679 households, the average number of ITNs per household was higher in rural compared to urban areas (0.6 vs. 0.4, p < 0.001) as well as the proportion of households owning at least one ITN (27.3% vs. 15.5%, p < 0.001). The proportion of households in which all members slept under an ITN was also higher in rural compared to urban areas (15.3% vs 6.9%, p < 0.001). In multivariate analysis, rural households (adjusted odds ratio [aOR] 1.78, 95% CI: 1.43-2.21, p<0.001), households in which respondents knew malaria is transmitted by mosquitoes (aOR 1.35, 95% CI: 1.10-1.65, p = 0.004), and in which respondents knew malaria can be prevented by ITN use (aOR 1.86, 95% CI: 1.28-2.70, p<0.001) were more likely to have all members sleep under an ITN. Compared to the lowest socio- economic quintile, households in the richest quintile were less likely to have all members sleep under an ITN (aOR 0.47; 95% CI: 0.33-0.66, p<0.001). Households in which the main income earner was a skilled worker or a businessman were less likely to have all members sleep under an ITN (aOR, 0.70, 95% CI: 0.52-0.96, p<0.025) compared to those headed by farmers or fishermen. Households in which all children slept under an ITN were more likely to be in rural areas (aOR 1.58, 95% CI: 1.19-2.09, p = 0.002) and have a household head who knew malaria can be prevented by ITN use (aOR 2.13, 95% CI: 1.30-3.50, p = 0.003). Children were less likely to have slept under an ITN in houses headed by skilled workers or businessmen (aOR 0.50, 95% CI: 0.33-0.75, p = 0.001) or unskilled workers (aOR 0.66, 95% CI: 0.49-0.89, p = 0.006) compared to households with farmers or fishermen. Higher socio-economic level was associated with lower ITN use by children (aOR 0.56, 95% CI: 0.36-0.88, p = 0.012, highest vs. lowest quintile). Conclusions The study found ownership of ITNs was low in Myanmar in comparison to the goal of one for every two household members. Use of ITNs was low even when present. Findings are of concern given the study areas were part of enhanced efforts to reduce artemisinin-resistant malaria. Nonetheless, groups vulnerable to malaria such as individuals in rural settings, lower socio-economic households, and workers in high mosquito exposure jobs, had higher rates of ITN ownership. Malaria knowledge was linked to effective ITN use suggesting that distribution campaigns should be complemented by behavior change communications.	[Aung, Tin; Aung, Ye Kyaw; Khin, Hnin Su Su] Populat Serv Int Myanmar, Yangon, Myanmar; [Wei, Chongyi; McFarland, Willi] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	McFarland, W (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	Willi.McFarland@ucsf.edu	Aung, Ye Kyaw/AAC-7192-2022	Aung, Ye Kyaw/0000-0001-7488-6412	Department for International Development [202759-101, 40049299]; Bill and Melinda Gates Foundation [OPP1024757]	Department for International Development; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Department for International Development (Project Component no: 202759-101, Purchase Order no: 40049299) and the Bill and Melinda Gates Foundation (Grant no OPP1024757). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Global Malaria Programme, 2014, STAT REP ART RES; Liu H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0727-y; MOH, 2014, UN MYANM NAT STRAT P; MOH, 2014, UN MYANM ANN REP NAT; MOH, 2012, UN MYANM NAT POL VEC; Nyunt MH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-211; Nyunt MH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1047-y; WHO, 2013, WORLD MALARIA REPORT 2013, P1	8	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162292	10.1371/journal.pone.0162292	http://dx.doi.org/10.1371/journal.pone.0162292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618440	gold, Green Submitted, Green Published			2022-12-26	WOS:000383653100016
J	Chen, HC; Chen, PY; Wu, MJ; Tai, MH; Yen, JH				Chen, Hung-Chen; Chen, Pei-Yi; Wu, Ming-Jiuan; Tai, Mi-Hsueh; Yen, Jui-Hung			Tanshinone IIA Modulates Low Density Lipoprotein Uptake via Down-Regulation of PCSK9 Gene Expression in HepG2 Cells	PLOS ONE			English	Article							LDL RECEPTOR; TARGET GENES; CHOLESTEROL HOMEOSTASIS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; DEGRADATION; DISEASE; BINDING; MODEL; MICE	Tanshinone IIA, one of the most pharmacologically bioactive phytochemicals isolated from Salvia miltiorrhiza Bunge, possesses several biological activities such as anti-inflammation, anti-cancer, neuroprotection and hypolipidemic activities. In this study, we aim to investigate the hypocholesterolemic effect of tanshinone IIA in hepatic cells. We demonstrated that tanshinone IIA significantly increased the amount of low-density lipoprotein receptor (LDLR) and LDL uptake activity in HepG2 cells at the post-transcriptional regulation. We further demonstrated that tanshinone IIA inhibited the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA and mature protein, which may lead to an increase the cell-surface LDLR in hepatic cells. We further identified a regulatory DNA element involved in the tanshinone IIA-mediated PCSK9 down-regulation, which is located between the -411 and -336 positions of the PCSK9 promoter. Moreover, we found that tanshinone IIA markedly increased the nuclear forkhead box O3a (FoxO3a) level, enhanced FoxO3a/PCSK9 promoter complexes formation and decreased the PCSK9 promoter binding capacity of hepatocyte nuclear factor 1 alpha (HNF-1 alpha), resulting in suppression of PCSK9 gene expression. Finally, we found that the statin-induced PCSK9 overexpression was attenuated and the LDLR activity was elevated in a synergic manner by combination of tanshinone IIA treatment in HepG2 cells. Overall, our results reveal that the tanshinone IIA modulates LDLR level and activity via down-regulation of PCSK9 expression in hepatic cells. Our current findings provide a molecular basis of tanshinone IIA to develop PCSK9 inhibitors for cholesterol management.	[Chen, Hung-Chen; Tai, Mi-Hsueh; Yen, Jui-Hung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan; [Wu, Ming-Jiuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Chia Nan University of Pharmacy & Science	Yen, JH (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	imyenjh@mail.tcu.edu.tw			Ministry of Science and Technology, Taiwan [NSC-102-2313-B-320-001-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant NSC-102-2313-B-320-001-MY3 (to Dr. J-H Yen) from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaggia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124587; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cariou B, 2011, ATHEROSCLEROSIS, V216, P258, DOI 10.1016/j.atherosclerosis.2011.04.018; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Chen PY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071282, 10.1371/journal.pone.0083227]; Chen WY, 2012, EUR J PHARMACOL, V674, P359, DOI 10.1016/j.ejphar.2011.10.040; Chen Z., 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/267976; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Costet P, 2008, TRENDS BIOCHEM SCI, V33, P426, DOI 10.1016/j.tibs.2008.06.005; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Ellison RC, 2005, AM J CARDIOL, V95, P1180, DOI 10.1016/j.amjcard.2005.01.046; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Giunzioni L, 2015, VASC HEALTH RISK MAN, V11, P493, DOI 10.2147/VHRM.S74692; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Grundy SM, 1998, CIRCULATION, V97, P1436; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Harwood HJ, 1997, BIOCHEM J, V323, P649, DOI 10.1042/bj3230649; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lagace TA, 2014, CURR OPIN LIPIDOL, V25, P387, DOI 10.1097/MOL.0000000000000114; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liu ZP, 2014, J LIPID RES, V55, P201, DOI 10.1194/jlr.M040394; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez D, 2008, DRUG NEWS PERSPECT, V21, P323, DOI 10.1358/dnp.2008.21.6.1246795; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Miller PE, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0578-1; Nho Richard Seonghun, 2014, World J Biol Chem, V5, P346, DOI 10.4331/wjbc.v5.i3.346; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Rallidis LS, 2012, INT J CARDIOL, V159, P169, DOI 10.1016/j.ijcard.2011.07.048; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Smith BA, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-015-0550-5; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Tai MH, 2014, MOL NUTR FOOD RES, V58, P2133, DOI 10.1002/mnfr.201400366; Tang FT, 2007, VASC PHARMACOL, V46, P427, DOI 10.1016/j.vph.2007.01.001; Tao RY, 2013, J BIOL CHEM, V288, P29252, DOI 10.1074/jbc.M113.481473; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; van der Vos KE, 2011, ANTIOXID REDOX SIGN, V14, P579, DOI 10.1089/ars.2010.3419; Xu SW, 2012, TRANSL RES, V160, P114, DOI 10.1016/j.trsl.2012.01.008; Yen JH, 2011, MOL NUTR FOOD RES, V55, P733, DOI 10.1002/mnfr.201000226; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	56	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162414	10.1371/journal.pone.0162414	http://dx.doi.org/10.1371/journal.pone.0162414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617748	Green Submitted, gold, Green Published			2022-12-26	WOS:000383653100021
J	Zanin, M; Albernaz, ALM				Zanin, Marina; Mangabeira Albernaz, Ana Luisa			Impacts of Climate Change on Native Landcover: Seeking Future Climatic Refuges	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; AMAZON BASIN; BIODIVERSITY; FOREST; VULNERABILITY; CONSERVATION; DYNAMICS; HABITAT; DEFORESTATION; DISTRIBUTIONS	Climate change is a driver for diverse impacts on global biodiversity. We investigated its impacts on native landcover distribution in South America, seeking to predict its effect as a new force driving habitat loss and population isolation. Moreover, we mapped potential future climatic refuges, which are likely to be key areas for biodiversity conservation under climate change scenarios. Climatically similar native landcovers were aggregated using a decision tree, generating a reclassified landcover map, from which 25% of the map's coverage was randomly selected to fuel distribution models. We selected the best geographical distribution models among twelve techniques, validating the predicted distribution for current climate with the landcover map and used the best technique to predict the future distribution. All landcover categories showed changes in area and displacement of the latitudinal/longitudinal centroid. Closed vegetation was the only landcover type predicted to expand its distributional range. The range contractions predicted for other categories were intense, even suggesting extirpation of the sparse vegetation category. The landcover refuges under future climate change represent a small proportion of the South American area and they are disproportionately represented and unevenly distributed, predominantly occupying five of 26 South American countries. The predicted changes, regardless of their direction and intensity, can put biodiversity at risk because they are expected to occur in the near future in terms of the temporal scales of ecological and evolutionary processes. Recognition of the threat of climate change allows more efficient conservation actions.	[Zanin, Marina; Mangabeira Albernaz, Ana Luisa] Emilio Goeldi Museum Para, Earth Sci & Ecol Ctr, Av Perimetral,1901 Terra Firme, BR-66077830 Belem, PA, Brazil; [Zanin, Marina] Univ Fed Espirito Santo, Nat & Human Ctr Sci, Dept Biol, Vitoria, Espirito Santo, Brazil	Museu Paraense Emilio Goeldi; Universidade Federal do Espirito Santo	Zanin, M (corresponding author), Emilio Goeldi Museum Para, Earth Sci & Ecol Ctr, Av Perimetral,1901 Terra Firme, BR-66077830 Belem, PA, Brazil.; Zanin, M (corresponding author), Univ Fed Espirito Santo, Nat & Human Ctr Sci, Dept Biol, Vitoria, Espirito Santo, Brazil.	marinazaning@gmail.com	Zanin, Marina/AAN-6327-2020; Zanin, Marina/D-7139-2015; Albernaz, Ana Luisa KM/K-5226-2012	Zanin, Marina/0000-0001-7112-7381; Zanin, Marina/0000-0001-7112-7381; Albernaz, Ana Luisa KM/0000-0001-9299-4361	CAPES fellowship through the INCT Biodiversity [574008/2008-0]; Land Use in the Amazon Project	CAPES fellowship through the INCT Biodiversity(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Land Use in the Amazon Project	MZ was supported by CAPES fellowship number 574008/2008-0 through the INCT Biodiversity and Land Use in the Amazon Project.	Aber J. D., 2001, TERRESTRIAL ECOSYSTE; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anhuf D, 2006, PALAEOGEOGR PALAEOCL, V239, P510, DOI 10.1016/j.palaeo.2006.01.017; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Banks WE, 2011, J ANTHROPOL ARCHAEOL, V30, P359, DOI 10.1016/j.jaa.2011.05.003; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L., 2017, CLASSIFICATION REGRE; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Cardozo FD, 2011, REMOTE SENS-BASEL, V3, P2110, DOI 10.3390/rs3102110; Carmel Y, 2001, ECOL APPL, V11, P268, DOI 10.1890/1051-0761(2001)011[0268:SPMOMV]2.0.CO;2; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Cuyckens GAE, 2015, J ARID ENVIRON, V115, P14, DOI 10.1016/j.jaridenv.2014.12.009; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P519, DOI 10.1111/j.1529-8817.2003.00779.x; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Descombes P, 2015, GLOBAL CHANGE BIOL, V21, P2479, DOI 10.1111/gcb.12868; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Eigenbrod F, 2015, GLOBAL CHANGE BIOL, V21, P275, DOI 10.1111/gcb.12669; ELITH J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI [DOI 10.1146/ANNUREV.EC0LSYS.110308.120159, 10.1146/annurev.ecolsys.110308.120159, DOI 10.1146/ANNUREV.ECOLSYS.110308.120159]; Ermert V, 2012, ENVIRON HEALTH PERSP, V120, P77, DOI 10.1289/ehp.1103681; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Fei SL, 2016, LANDSCAPE ECOL, V31, P31, DOI 10.1007/s10980-015-0272-7; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fordham DA, 2013, ECOGRAPHY, V36, P956, DOI 10.1111/j.1600-0587.2013.00147.x; Forrest JL, 2012, BIOL CONSERV, V150, P129, DOI 10.1016/j.biocon.2012.03.001; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Fyllas NM, 2009, GLOBAL ECOL BIOGEOGR, V18, P64, DOI 10.1111/j.1466-8238.2008.00419.x; Gimona A, 2015, LANDSCAPE ECOL, V30, P771, DOI 10.1007/s10980-015-0158-8; Harper EB, 2011, ECOL APPL, V21, P1225, DOI 10.1890/10-0506.1; Hastie T., 1986, STAT SCI, V1, P297; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hortal J, 2008, OIKOS, V117, P847, DOI 10.1111/j.0030-1299.2008.16434.x; Hortal J, 2007, CONSERV BIOL, V21, P853, DOI 10.1111/j.1523-1739.2007.00686.x; Huberty C.J., 1994, APPL DISCRIMINANT AN; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2004, MAP VEG BRAS, P1; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Lapola DM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003357; Legendre P., 2012, NUMERICAL ECOLOGY; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Luzzi R, 2001, J MATH SOCIOL, V25, P179, DOI 10.1080/0022250X.2001.9990250; Machado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072283; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marino J, 2011, DIVERS DISTRIB, V17, P311, DOI 10.1111/j.1472-4642.2011.00744.x; McCullagh P., 1989, GEN LINEAR MODELS, DOI [10. 1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6, 10.1007/978-1-4899-3242-6]; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; OLIVEIRA G, 2012, BIODIVERS CONSERV, V21, P2913, DOI DOI 10.1007/S10531-012-0346-7; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; RICHARDS P. W., 1952, The tropical rain forest. An ecological study.; Riitters K, 2016, LANDSCAPE ECOL, V31, P137, DOI 10.1007/s10980-015-0270-9; Rosa IMD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077231; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Silverio DV, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0427; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tessarolo G, 2014, DIVERS DISTRIB, V20, P1258, DOI 10.1111/ddi.12236; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; VanDerWal J, 2009, J BIOGEOGR, V36, P291, DOI 10.1111/j.1365-2699.2008.01993.x; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Zanin M, 2015, J NAT CONSERV, V23, P90, DOI 10.1016/j.jnc.2014.06.003; Zomer RJ, 2014, CLIMATIC CHANGE, V125, P445, DOI 10.1007/s10584-014-1176-2	82	4	4	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162500	10.1371/journal.pone.0162500	http://dx.doi.org/10.1371/journal.pone.0162500			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27618445	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100026
J	Sarkisjan, D; Julsing, JR; Smid, K; de Klerk, D; van Kuilenburg, ABP; Meinsma, R; Lee, YB; Kim, DJ; Peters, GJ				Sarkisjan, Dzjemma; Julsing, Joris R.; Smid, Kees; de Klerk, Daniel; van Kuilenburg, Andre B. P.; Meinsma, Rutger; Lee, Young B.; Kim, Deog J.; Peters, Godefridus J.			The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2	PLOS ONE			English	Article							HUMAN CANCER-CELLS; ANTITUMOR-ACTIVITY; NUCLEOSIDE ANALOGS; LUNG-CANCER; GEMCITABINE; EXPRESSION; METHYLATION; CHEMOTHERAPY; AZACITIDINE; SENSITIVITY	Fluorocyclopentenylcytosine (RX-3117) is an orally available cytidine analog, currently in Phase I clinical trial. RX-3117 has promising antitumor activity in various human tumor xenografts including gemcitabine resistant tumors. RX-3117 is activated by uridine-cytidine kinase (UCK). Since UCK exists in two forms, UCK1 and UCK2, we investigated which form is responsible for RX-3117 phosphorylation. For that purpose we transfected A549 and SW1573 cell lines with UCK-siRNAs. Transfection of UCK1-siRNA efficiently downregulated UCK1-mRNA, but not UCK2-mRNA expression, and did not affect sensitivity to RX-3117. However, transfection of UCK2-siRNA completely downregulated UCK2-mRNA and protein and protected both A549 and SW1573 against RX-3117. UCK enzyme activity in two panels of tumor cell lines and xenograft cells correlated only with UCK2-mRNA expression (r = 0.803 and 0.915, respectively), but not with UCK1-mRNA. Moreover, accumulation of RX-3117 nucleotides correlated with UCK2 expression. In conclusion, RX-3117 is activated by UCK2 which may be used to select patients potentially sensitive to RX-3117.	[Sarkisjan, Dzjemma; Julsing, Joris R.; Smid, Kees; de Klerk, Daniel; Peters, Godefridus J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [van Kuilenburg, Andre B. P.; Meinsma, Rutger] Acad Med Ctr, Dept Clin Chem, Lab Genet Metab Dis, Amsterdam, Netherlands; [Lee, Young B.; Kim, Deog J.] Rexahn Pharmaceut Inc, Rockville, MD USA	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Peters, GJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	gj.peters@vumc.nl	; Peters, Godefridus J/C-7562-2013	van Kuilenburg, Andre/0000-0002-7989-4910; Peters, Godefridus J/0000-0002-5447-2877	Rexahn Pharmaceuticals, Inc.	Rexahn Pharmaceuticals, Inc.	GJP received a grant from Rexahn Pharmaceuticals, Inc. This study was supported by Rexahn Pharmaceuticals, Inc. Employees (the 19 coauthors) participated in the design of the studies and the execution, discussed data and commented on the manuscript, and approved final submission.; This study was supported by Rexahn Pharmaceuticals, Inc. Employees (the coauthors) participated in the design of the studies and the execution, discussed data and commented on the manuscript, and approved final submission.	Backus HHJ, 2001, ANN ONCOL, V12, P779, DOI 10.1023/A:1011112227044; Bergman AM, 2002, DRUG RESIST UPDATE, V5, P19, DOI 10.1016/S1368-7646(02)00002-X; Choi WJ, 2012, J MED CHEM, V55, P4521, DOI 10.1021/jm3004009; Davidsson J, 2007, HUM MOL GENET, V16, P2215, DOI 10.1093/hmg/ddm173; Galvani E, 2013, NEOPLASIA, V15, P61, DOI 10.1593/neo.121434; Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010; KEEPERS YP, 1991, EUR J CANCER, V27, P897, DOI 10.1016/0277-5379(91)90142-Z; Le Chevalier T, 2005, LUNG CANCER, V47, P69, DOI 10.1016/j.lungcan.2004.10.014; Murata D, 2004, DRUG METAB DISPOS, V32, P1178, DOI 10.1124/dmd.104.000737; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peters GJ, 2014, NUCLEOS NUCLEOT NUCL, V33, P358, DOI 10.1080/15257770.2014.894197; Peters GJ, 2014, NUCLEOS NUCLEOT NUCL, V33, P403, DOI 10.1080/15257770.2014.894196; Peters GJ, 2013, INVEST NEW DRUG, V31, P1444, DOI 10.1007/s10637-013-0025-x; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; Shimamoto Y, 2002, JPN J CANCER RES, V93, P825, DOI 10.1111/j.1349-7006.2002.tb01325.x; Sripayap P, 2014, EXP HEMATOL, V42, P294, DOI 10.1016/j.exphem.2013.12.004; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; Valencia A, 2014, LEUKEMIA, V28, P621, DOI 10.1038/leu.2013.330; van Kuilenburg ABP, 2016, BBA-MOL BASIS DIS, V1862, P1504, DOI 10.1016/j.bbadis.2016.05.012; Van Rompay AR, 2001, MOL PHARMACOL, V59, P1181, DOI 10.1124/mol.59.5.1181; Yang MY, 2014, ANTICANCER RES, V34, P6951	24	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162901	10.1371/journal.pone.0162901	http://dx.doi.org/10.1371/journal.pone.0162901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612203	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900184
J	Salk, HM; Simon, WL; Lambert, ND; Kennedy, RB; Grill, DE; Kabat, BF; Poland, GA				Salk, Hannah M.; Simon, Whitney L.; Lambert, Nathaniel D.; Kennedy, Richard B.; Grill, Diane E.; Kabat, Brian F.; Poland, Gregory A.			Taxa of the Nasal Microbiome Are Associated with Influenza-SpecificIgA Response to Live Attenuated Influenza Vaccine	PLOS ONE			English	Article							UPPER RESPIRATORY TRACTS; VIRUS-INFECTION; GUT MICROBIOTA; IMMUNE-RESPONSES; INTESTINAL MICROBIOTA; SPECIES RICHNESS; NATURAL ADJUVANT; DOUBLE-BLIND; ADULTS; PROBIOTICS	Live attenuated influenza vaccine (LAIV) has demonstrated varying levels of efficacy against seasonal influenza; however, LAIV may be used as a tool to measure interactions between the human microbiome and a live, replicating virus. To increase our knowledge of this interaction, we measured changes to the nasal microbiome in subjects who received LAIV to determine if associations between influenza-specific IgA production and the nasal microbiome exist after immunization with a live virus vaccine. The anterior nares of 47 healthy subjects were swabbed pre- (Day 0) and post- (Days 7 and 28) LAIV administration, and nasal washes were conducted on Days 0 and 28. We performed next-generation sequencing on amplified 16s rRNA genes and measured mucosal influenza-specific IgA titers via enzyme-linked immunosorbent assay (ELISA). A significant increase in alpha diversity was identified (Observed, CHAO, and ACE) between Days 7 vs 0 (p-values = 0.017, 0.005, 0.005, respectively) and between Days 28 vs 0 (p-values = 0.054, 0.030, 0.050, respectively). Several significant associations between the presence of different microbial species, including Lactobacillus helveticus, Prevotella melaninogenica, Streptococcus infantis, Veillonella dispar, and Bacteroides ovatus, and influenza-specific H1 and H3 IgA antibody response were demonstrated. These data suggest that LAIV alters the nasal microbiome, allowing several less-abundant OTUs to establish a community niche. Additionally, specific alterations in the nasal microbiome are significantly associated with variations in influenza-specific IgA antibody production and could be clinically relevant.	[Salk, Hannah M.; Simon, Whitney L.; Lambert, Nathaniel D.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; [Grill, Diane E.; Kabat, Brian F.] Mayo Clin, Div Biostat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967	Mayo Clinic Center for Individualized Medicine	Mayo Clinic Center for Individualized Medicine	Research reported in this publication was supported by The Mayo Clinic Center for Individualized Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Akatsu H, 2016, GERIATR GERONTOL INT, V16, P205, DOI 10.1111/ggi.12454; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barria MI, 2013, J INFECT DIS, V207, P115, DOI 10.1093/infdis/jis641; Bek-Thomsen M, 2008, INFECT IMMUN, V76, P1889, DOI 10.1128/IAI.01511-07; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chiu CH, 2014, BIOMETRICS, V70, P671, DOI 10.1111/biom.12200; Chowdhury MYE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094051; Davidson LE, 2011, EUR J CLIN NUTR, V65, P501, DOI 10.1038/ejcn.2010.289; Diaz-Ropero MP, 2007, J APPL MICROBIOL, V102, P337, DOI 10.1111/j.1365-2672.2006.03102.x; Dong HL, 2012, BRIT J NUTR, V108, P459, DOI 10.1017/S0007114511005824; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI [10.2217/fmb.10.146, 10.2217/FMB.10.146]; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hori T, 2002, CLIN DIAGN LAB IMMUN, V9, P105, DOI 10.1128/CDLI.9.1.105-108.2002; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jeraldo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114804; Koeppel AF, 2013, NUCLEIC ACIDS RES, V41, P5175, DOI 10.1093/nar/gkt241; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li R, 2015, VET MICROBIOL, V179, P250, DOI 10.1016/j.vetmic.2015.07.020; MacDonald TT, 2010, P NUTR SOC, V69, P442, DOI 10.1017/S0029665110001758; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mina MJ, 2014, MBIO, V5, P5; Minton K, 2014, NAT REV IMMUNOL, V14, P650, DOI 10.1038/nri3745; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; O'Flaherty S, 2010, GUT MICROBES, V1, P293, DOI 10.4161/gmic.1.5.12924; O'Hara RB, 2005, J ANIM ECOL, V74, P375, DOI 10.1111/j.1365-2656.2005.00940.x; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Pabst O, 2014, IMMUNITY, V41, P349, DOI 10.1016/j.immuni.2014.09.002; Piters WAAD, 2016, ISME J, V10, P97, DOI 10.1038/ismej.2015.99; Planet PJ, 2016, MBIO, V7, DOI 10.1128/mBio.01939-15; Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007; Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; Rizzardini G, 2012, BRIT J NUTR, V107, P876, DOI 10.1017/S000711451100420X; Samuelson DR, 2015, FRONT MICROBIOL, V6, DOI [10.5389/fmicb.2015.01085, 10.3389/fmicb.2015.01085]; Seto CT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-42; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shida K, 2008, TRENDS IMMUNOL, V29, P565, DOI 10.1016/j.it.2008.07.011; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Tarabichi Y, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0133-2; Tojo R, 2014, WORLD J GASTROENTERO, V20, P15163, DOI 10.3748/wjg.v20.i41.15163; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Yaqoob P, 2014, P NUTR SOC, V73, P309, DOI 10.1017/S0029665113003777; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004; Yi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0583-3; Zhang KY, 2015, CELL MICROBIOL, V17, P1561, DOI 10.1111/cmi.12501	53	52	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162803	10.1371/journal.pone.0162803	http://dx.doi.org/10.1371/journal.pone.0162803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643883	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900019
J	Tukenmez, H; Magnussen, HM; Kovermann, M; Bystrom, A; Wolf-Watz, M				Tukenmez, Hasan; Magnussen, Helge Magnus; Kovermann, Michael; Bystrom, Anders; Wolf-Watz, Magnus			Linkage between Fitness of Yeast Cells and Adenylate Kinase Catalysis	PLOS ONE			English	Article							DYNAMICS; MOTIONS; INHIBITOR; STABILITY; COMPLEX; RESOLUTION; PATHWAY; DOMAIN	Enzymes have evolved with highly specific values of their catalytic parameters kcat and KM. This poses fundamental biological questions about the selection pressures responsible for evolutionary tuning of these parameters. Here we are address these questions for the enzyme adenylate kinase (Adk) in eukaryotic yeast cells. A plasmid shuffling system was developed to allow quantification of relative fitness (calculated from growth rates) of yeast in response to perturbations of Adk activity introduced through mutations. Biophysical characterization verified that all variants studied were properly folded and that the mutations did not cause any substantial differences to thermal stability. We found that cytosolic Adk is essential for yeast viability in our strain background and that viability could not be restored with a catalytically dead, although properly folded Adk variant. There exist a massive overcapacity of Adk catalytic activity and only 12% of the wild type kcat is required for optimal growth at the stress condition 20 degrees C. In summary, the approach developed here has provided new insights into the evolutionary tuning of kcat for Adk in a eukaryotic organism. The developed methodology may also become useful for uncovering new aspects of active site dynamics and also in enzyme design since a large library of enzyme variants can be screened rapidly by identifying viable colonies.	[Tukenmez, Hasan; Bystrom, Anders] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Magnussen, Helge Magnus; Kovermann, Michael; Wolf-Watz, Magnus] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Kovermann, Michael] Univ Konstanz, Dept Chem, D-78457 Constance, Germany	Umea University; Umea University; University of Konstanz	Bystrom, A (corresponding author), Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden.; Wolf-Watz, M (corresponding author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.	anders.bystrom@umu.se; magnus.wolf-watz@umu.se		Bystrom, Anders/0000-0003-1281-3888; Magnussen, Helge Magnus/0000-0002-1104-2973	Swedish Research Council [621-2013-5954, 621-2012-3576]; Swedish Cancer Foundation [13 0301]; Karin and Harald Silvanders Foundation [223-2808-12]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Karin and Harald Silvanders Foundation	This work was financially supported by the Swedish Research Council (grants 621-2013-5954 to M.W.W. and 621-2012-3576 to A.B.). A.B. was also supported by the Swedish Cancer Foundation (13 0301) and Karin and Harald Silvanders Foundation (223-2808-12).; This work was financially supported by the Swedish Research Council (grants 621-2013-5954 to M.W.W. and 621-2012-3576 to A.B.). A.B. was also supported by the Swedish Cancer Foundation (13 0301) and Karin and Harald Silvanders Foundation (223-2808-12). The NMR experiments were conducted at NMR4life and we thank the Wallenberg and Kempe foundations for supporting this infrastructure. Parts of this work were planned and performed by the Ume Protein Expertise Platform.	ABELE U, 1995, PROTEIN SCI, V4, P1262, DOI 10.1002/pro.5560040702; Aden J, 2007, J AM CHEM SOC, V129, P14003, DOI 10.1021/ja075055g; Aden J, 2012, J AM CHEM SOC, V134, P16562, DOI 10.1021/ja3032482; Beach H, 2005, J AM CHEM SOC, V127, P9167, DOI 10.1021/ja0514949; Bearne SL, 1997, BIOCHEMISTRY-US, V36, P1646, DOI 10.1021/bi9620722; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; BRINDLE K, 1990, BIOCHEMISTRY-US, V29, P3295, DOI 10.1021/bi00465a021; Burke D., 2000, METHODS YEAST GENETI; Cheng X, 2010, J BIOL CHEM, V285, P29974, DOI 10.1074/jbc.M110.161455; Consalvi V, 2000, PROTEIN ENG, V13, P501, DOI 10.1093/protein/13.7.501; Danielsson J, 2015, P NATL ACAD SCI USA, V112, P12402, DOI 10.1073/pnas.1511308112; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Eames M, 2012, SCIENCE, V336, P911, DOI 10.1126/science.1219083; Ebbinghaus S, 2010, NAT METHODS, V7, P319, DOI [10.1038/NMETH.1435, 10.1038/nmeth.1435]; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fersht A. K, 2000, STRUCTURE MECH PROTE; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; KONRAD M, 1988, J BIOL CHEM, V263, P19468; Kovermann M, 2016, Q REV BIOPHYS, V49, DOI 10.1017/S0033583516000019; Kovermann M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8644; Lee SY, 2014, J MOL BIOL, V426, P1377, DOI 10.1016/j.jmb.2013.10.042; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Olsson U, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1106; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; REINSTEIN J, 1988, BIOCHEMISTRY-US, V27, P4712, DOI 10.1021/bi00413a020; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thongwichian R, 2015, J AM CHEM SOC, V137, P6468, DOI 10.1021/jacs.5b02987; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	41	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163115	10.1371/journal.pone.0163115	http://dx.doi.org/10.1371/journal.pone.0163115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27642758	Green Published, gold, Green Submitted			2022-12-26	WOS:000383891900032
J	Obert, D; Helms, G; Sattler, MB; Jung, K; Kretzschmar, B; Bahr, M; Dechent, P; Diem, R; Hein, K				Obert, Dorothea; Helms, Gunther; Saettler, Muriel B.; Jung, Klaus; Kretzschmar, Benedikt; Baehr, Mathias; Dechent, Peter; Diem, Ricarda; Hein, Katharina			Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; APPEARING WHITE-MATTER; AXONAL DAMAGE; H-1-MRS QUANTIFICATION; MR SPECTROSCOPY; LESIONS; DISABILITY; DISEASE; NEURODEGENERATION; DEMYELINATION	Magnetic resonance spectroscopy (MRS) provides the unique ability to monitor several disease-related pathological processes via their characteristic metabolic markers in vivo. In the present study metabolic compositions were assessed every six months over the period of two years in 36 patients with Multiple Sclerosis (MS) including 21 relapsing-remitting (RR), 15 secondary progressive (SP) patients and 12 normal subjects. The concentrations of the main MRS-detectable metabolites N-acetylaspartate and N-acetylaspartylglutamate (tNAA), creatine and phosphocreatine (tCr), choline containing compounds (Cho), myo-Inositol (Ins), glutamine and glutamate (Glx) and their ratios were calculated in the normal appearing white matter (NAWM) and in selected non-enhancing white matter (WM) lesions. Association between metabolic concentrations in the NAWM and disability were investigated. Concentration of tNAA, a marker for neuroaxonal integrity, did not show any difference between the investigated groups. However, the patients with SPMS showed significant reduction of tNAA in the NAWM over the investigation period of two years indicating diffuse neuroaxonal loss during the disease course. Furthermore, we found a significant increase of Ins, Ins/tCr and Ins/tNAA in WM lesions independently from the course of the disease suggesting ongoing astrogliosis in silent-appearing WM lesions. Analyzing correlations between MRS metabolites in the NAWM and patients clinical status we found the positive correlation of Ins/tNAA with disability in patients with RRMS. In SPMS positive correlation of Cho with disability was found.	[Obert, Dorothea; Saettler, Muriel B.; Kretzschmar, Benedikt; Baehr, Mathias; Hein, Katharina] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany; [Helms, Gunther; Dechent, Peter] Univ Med Ctr Gottingen, Dept Cognit Neurol, Gottingen, Germany; [Jung, Klaus] Univ Med Ctr Gottingen, Dept Med Stat, Gottingen, Germany; [Jung, Klaus] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Diem, Ricarda] Univ Clin Heidelberg, Dept Neurol, Heidelberg, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Veterinary Medicine Hannover, Foundation; Ruprecht Karls University Heidelberg	Hein, K (corresponding author), Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany.	k.hein@uni-goettingen.de	; Helms, Gunther/A-9114-2010	Jung, Klaus/0000-0001-9955-748X; Helms, Gunther/0000-0002-1371-5123	Bayer Vital GmbH, Leverkusen, Germany; Merck Serono GmbH, Darmstadt	Bayer Vital GmbH, Leverkusen, Germany(Bayer AG); Merck Serono GmbH, Darmstadt	This study was supported by research grants from Bayer Vital GmbH, Leverkusen, Germany, and Merck Serono GmbH, Darmstadt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagory M, 2012, IEEE T BIO-MED ENG, V59, P2687, DOI 10.1109/TBME.2011.2161609; Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brex PA, 2000, J NEUROL NEUROSUR PS, V68, P627, DOI 10.1136/jnnp.68.5.627; Caramanos Z, 2005, BRAIN, V128, P2483, DOI 10.1093/brain/awh640; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; DAVIE CA, 1994, BRAIN, V117, P49, DOI 10.1093/brain/117.1.49; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; De Stefano N, 2007, J NEUROIMAGING, V17, p31S, DOI 10.1111/j.1552-6569.2007.00134.x; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Griffin JL, 2001, FEBS LETT, V509, P263, DOI 10.1016/S0014-5793(01)03175-1; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Helms G, 2000, MAGNET RESON MED, V43, P102, DOI 10.1002/(SICI)1522-2594(200001)43:1<102::AID-MRM12>3.0.CO;2-I; Hostenbach S, 2014, NEUROSCI LETT, V565, P39, DOI 10.1016/j.neulet.2013.10.012; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Llufriu S, 2014, JAMA NEUROL, V71, P840, DOI 10.1001/jamaneurol.2014.895; Ludwin SK, 2000, NEUROIMAG CLIN N AM, V10, P625; Matthews PM, 1998, SEMIN NEUROL, V18, P327, DOI 10.1055/s-2008-1040884; Narayana PA, 2005, J NEUROIMAGING, V15, p46S, DOI 10.1177/1051228405284200; Narayana PA, 2004, MULT SCLER J, V10, pS73, DOI 10.1191/1352458504ms1035oa; Natt O, 2005, MAGN RESON MED, V53, P3, DOI 10.1002/mrm.20337; Pan JW, 2002, MULT SCLER J, V8, P200, DOI 10.1191/1352458502ms802oa; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rovaris M, 2001, J NEUROL SCI, V186, pS3, DOI 10.1016/S0022-510X(01)00485-3; Sastre-Garriga J, 2005, NEUROLOGY, V65, P633, DOI 10.1212/01.wnl.0000173061.12776.1f; Summers M, 2008, J NEUROL NEUROSUR PS, V79, P955, DOI 10.1136/jnnp.2007.138685; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vigeveno RM, 2012, J MAGN RESON IMAGING, V36, P1, DOI 10.1002/jmri.23578; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366	40	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162583	10.1371/journal.pone.0162583	http://dx.doi.org/10.1371/journal.pone.0162583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636543	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700009
J	Fukada, I; Araki, K; Kobayashi, K; Shibayama, T; Takahashi, S; Horii, R; Akiyama, F; Iwase, T; Ohno, S; Hatake, K; Hozumi, Y; Sata, N; Ito, Y				Fukada, Ippei; Araki, Kazuhiro; Kobayashi, Kokoro; Shibayama, Tomoko; Takahashi, Shunji; Horii, Rie; Akiyama, Futoshi; Iwase, Takuji; Ohno, Shinji; Hatake, Kiyohiko; Hozumi, Yasuo; Sata, Naohiro; Ito, Yoshinori			Predictive Factors and Value of ypN plus after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PREOPERATIVE CHEMOTHERAPY; PRIMARY THERAPY; RECOMMENDATIONS; PACLITAXEL; HIGHLIGHTS; DOCETAXEL; SUBTYPES; UPDATE; TRIAL	Background Pathological complete response (pCR) with neoadjuvant chemotherapy (NAC) has been regarded as a surrogate endpoint for disease-free survival (DFS) and overall survival (OS) of patients with breast cancer. No consensus regarding the definition of pCR has been established; there are several definitions according to a variety of classifications. Eradication of cancer cells in both breast and lymph nodes has been better associated with improved prognosis than in the breast alone. Even in patients diagnosed as having clinically node-negative cancer before NAC, postoperative pathological examination often shows axillary lymph node metastases. Patients and Methods Of the 771 patients with breast cancer who underwent NAC in the Cancer Institute Hospital between January 2000 and May 2009, 146 patients preoperatively diagnosed as having node-negative breast cancer were retrospectively evaluated. We have made the definition of clinically lymph node-negative (N0) as follows: first, ultrasonography before NAC did not show any lymphadenopathy. Second, a cytological procedure confirmed negative study for each patient when ultrasonography suggested lymphadenopathy. Results The median observation period was 79.7 months, and the median age of the subjects was 51 years. Pathological examination at the time of the surgery showed lymph node metastases (ypN+) in 46 patients (31.5%). Histological therapeutic effects revealed ypT0/is in 9 patients (6.2%) and ypTinv in 137 (93.8%). Multivariate analysis demonstrated that younger age (49>), large tumor size, NG3, and ypN+ were significant poor prognostic factors for DFS (p = 0.020, p = 0.008, P = 0.022 and p = 0.010, respectively). Moreover, ypN+ was the only significant poor prognostic factor for OS (p = 0.022). The predictive factors of ypN+ in clinically lymph node-negative breast cancer were ypTinv (p = 0.036) and the luminal type (HR+ and HER2-) (p = 0.029). Conclusion The prognosis of clinically lymph node negative breast cancer depended on ypN+, which was associated with ypTinv and luminal subtype.	[Fukada, Ippei; Araki, Kazuhiro; Kobayashi, Kokoro; Shibayama, Tomoko; Ito, Yoshinori] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Med Oncol, Tokyo, Japan; [Takahashi, Shunji] Japanese Fdn Canc Res, Canc Inst Hosp, Med Oncol, Tokyo, Japan; [Horii, Rie] Japanese Fdn Canc Res, Canc Inst Hosp, Div Pathol, Tokyo, Japan; [Akiyama, Futoshi] Japanese Fdn Canc Res, Inst Canc, Div Pathol, Tokyo, Japan; [Iwase, Takuji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Breast Surg Oncol, Tokyo, Japan; [Ohno, Shinji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan; [Hatake, Kiyohiko] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hematol & Oncol, Tokyo, Japan; [Hozumi, Yasuo] Ibaraki Cent Hosp, Dept Surg, Ibaraki, Japan; [Sata, Naohiro] Jichi Med Univ, Dept Gastrointestinal Surg, Shimotsuke, Tochigi, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Jichi Medical University	Fukada, I (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Breast Med Oncol, Tokyo, Japan.	ippei.fukada@jfcr.or.jp	Araki, kazuhiro/AAD-5658-2019	Araki, kazuhiro/0000-0001-7623-7715				Alvarez S, 2006, AM J ROENTGENOL, V186, P1342, DOI 10.2214/AJR.05.0936; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Green MC, 2005, J CLIN ONCOL, V23, P5983, DOI 10.1200/JCO.2005.06.232; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Kaufmann M, 2006, J CLIN ONCOL, V24, P1940, DOI 10.1200/JCO.2005.02.6187; Kobayashi K, 2016, PATHOL INT, V66, P8, DOI 10.1111/pin.12365; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Loo CE, 2011, J CLIN ONCOL, V29, P660, DOI 10.1200/JCO.2010.31.1258; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Sakamoto G, 2005, BREAST CANC, V12, P1, DOI DOI 10.1007/BF02967379; Sparano JA, 2015, J CLIN ONCOL, V33, P2353, DOI 10.1200/JCO.2015.60.9271; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162616	10.1371/journal.pone.0162616	http://dx.doi.org/10.1371/journal.pone.0162616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631393	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900060
J	Stilianakis, NI; Syrris, V; Petroliagkis, T; Part, P; Gewehr, S; Kalaitzopoulou, S; Mourelatos, S; Baka, A; Pervanidou, D; Vontas, J; Hadjichristodoulou, C				Stilianakis, Nikolaos I.; Syrris, Vasileios; Petroliagkis, Thomas; Part, Peeter; Gewehr, Sandra; Kalaitzopoulou, Stella; Mourelatos, Spiros; Baka, Agoritsa; Pervanidou, Danai; Vontas, John; Hadjichristodoulou, Christos			Identification of Climatic Factors Affecting the Epidemiology of Human West Nile Virus Infections in Northern Greece	PLOS ONE			English	Article							DROUGHT-INDUCED AMPLIFICATION; UNITED-STATES; TRANSMISSION; DISEASE; MOSQUITOS; EUROPE; SURVEILLANCE; ENCEPHALITIS; TEMPERATURE; VARIABILITY	Climate can affect the geographic and seasonal patterns of vector-borne disease incidence such as West Nile Virus (WNV) infections. We explore the association between climatic factors and the occurrence of West Nile fever (WNF) or West Nile neuro-invasive disease (WNND) in humans in Northern Greece over the years 2010-2014. Time series over a period of 30 years (1979-2008) of climatic data of air temperature, relative humidity, soil temperature, volumetric soil water content, wind speed, and precipitation representing average climate were obtained utilising the ECMWF's (European Centre for Medium-Range-Weather Forecasts) Re-Analysis (ERA-Interim) system allowing for a homogeneous set of data in time and space. We analysed data of reported human cases of WNF/WNND and Culex mosquitoes in Northern Greece. Quantitative assessment resulted in identifying associations between the above climatic variables and reported human cases of WNF/WNND. A substantial fraction of the cases was linked to the upper percentiles of the distribution of air and soil temperature for the period 1979-2008 and the lower percentiles of relative humidity and soil water content. A statistically relevant relationship between the mean weekly value climatic anomalies of wind speed (negative association), relative humidity (negative association) and air temperature (positive association) over 30 years, and reported human cases of WNF/WNND during the period 2010-2014 could be shown. A negative association between the presence of WNV infected Culex mosquitoes and wind speed could be identified. The statistically significant associations could also be confirmed for the week the WNF/WNND human cases appear and when a time lag of up to three weeks was considered. Similar statistically significant associations were identified with the weekly anomalies of the maximum and minimum values of the above climatic factors. Utilising the ERA-Interim re-analysis methodology it could be shown that besides air temperature, climatic factors such as soil temperature, relative humidity, soil water content and wind speed may affect the epidemiology of WNV.	[Stilianakis, Nikolaos I.; Syrris, Vasileios; Petroliagkis, Thomas; Part, Peeter] European Commiss, Joint Res Ctr, Ispra, VA, Italy; [Stilianakis, Nikolaos I.] Univ Erlangen Nurnberg, Dept Biometry & Epidemiol, Erlangen, Germany; [Baka, Agoritsa; Pervanidou, Danai] Hellen Ctr Dis Control & Prevent KEELPNO, Athens, Greece; [Gewehr, Sandra; Kalaitzopoulou, Stella; Mourelatos, Spiros] EcoDev SA, Thessaloniki, Greece; [Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Hadjichristodoulou, Christos] Univ Thessaly, Fac Med, Dept Hyg & Epidemiol, Larisa, Greece	European Commission Joint Research Centre; EC JRC ISPRA Site; University of Erlangen Nuremberg; Foundation for Research & Technology - Hellas (FORTH); University of Thessaly	Stilianakis, NI (corresponding author), European Commiss, Joint Res Ctr, Ispra, VA, Italy.; Stilianakis, NI (corresponding author), Univ Erlangen Nurnberg, Dept Biometry & Epidemiol, Erlangen, Germany.	nikolaos.stilianakis@jrc.ec.europa.eu	Vontas, John/X-5112-2018	Vontas, John/0000-0002-8704-2574; Mourelatos, Spiros/0000-0001-9276-0135; KALAITZOPOULOU, STELLA/0000-0002-7932-3157; Gewehr, Sandra/0000-0001-5236-9537; Hadjichristodoulou, Christos/0000-0002-4769-8376	European Union Regional Development Fund	European Union Regional Development Fund(European Commission)	The epidemiological data acquisition was supported by the Operational Program entitled 'Human Resources Development of National Strategic Reference Framework' (NSRF) 2007-2013 co-funded by Greece and the European Union Regional Development Fund. There was no funding by Ecodevelopment S.A. that provided the entomological data. Members of Ecodevelopment S.A. (SG, SK, SM) collected, analyzed data and contributed to the interpretation of the data.	Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Berrisford P, 2009, ERA REP SER, P1; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cardenas R, 2008, ANN NY ACAD SCI, V1149, P326, DOI 10.1196/annals.1428.094; Chevalier V, 2014, INT J ENV RES PUB HE, V11, P67, DOI 10.3390/ijerph110100067; Chung WM, 2013, JAMA-J AM MED ASSOC, V310, P297, DOI 10.1001/jama.2013.8267; Coelho CAS, 2008, J CLIMATE, V21, P2072, DOI 10.1175/2007JCLI1781.1; Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12; Crowder DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055006; Darsie RF, 1997, J AM MOSQUITO CONTR, V13, P247; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Deichmeister JM, 2011, J VECTOR ECOL, V36, P75, DOI 10.1111/j.1948-7134.2011.00143.x; Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869; Hahn MB, 2015, AM J TROP MED HYG, V92, P1013, DOI 10.4269/ajtmh.14-0737; Hartley DM, 2012, AM J TROP MED HYG, V86, P884, DOI 10.4269/ajtmh.2012.11-0342; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Johnson BJ, 2013, J MED ENTOMOL, V50, P195, DOI 10.1603/ME12035; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Mann BR, 2013, EMERG INFECT DIS, V19, P1418, DOI 10.3201/eid1909.130377; Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700; Marka A, 2013, INT J ENV RES PUB HE, V10, P6534, DOI 10.3390/ijerph10126534; Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5; National Oceanic and Atmospheric Administration USA, 2015, NCDC CLIM DAT ONL; Papa A, 2013, VECTOR-BORNE ZOONOT, V13, P682, DOI 10.1089/vbz.2012.1212; Papa A, 2013, PARASITOL RES, V112, P1551, DOI 10.1007/s00436-013-3302-x; Paz S, 2006, INT J ENVIRON HEAL R, V16, P1, DOI 10.1080/09603120500392400; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Soverow JE, 2009, ENVIRON HEALTH PERSP, V117, P1049, DOI 10.1289/ehp.0800487; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Takeda T, 2003, J AM MOSQUITO CONTR, V19, P179; Wang GM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-38; Wimberly MC, 2014, AM J TROP MED HYG, V91, P677, DOI 10.4269/ajtmh.14-0239; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1	41	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161510	10.1371/journal.pone.0161510	http://dx.doi.org/10.1371/journal.pone.0161510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631082	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900019
J	Tomotsune, D; Hirashima, K; Fujii, M; Yue, FM; Matsumoto, K; Takizawa-Shirasawa, S; Yokoyama, T; Sasaki, K				Tomotsune, Daihachiro; Hirashima, Kanji; Fujii, Masako; Yue, Fengming; Matsumoto, Ken; Takizawa-Shirasawa, Sakiko; Yokoyama, Tadayuki; Sasaki, Katsunori			Enrichment of Pluripotent Stem Cell-Derived Hepatocyte-Like Cells by Ammonia Treatment	PLOS ONE			English	Article							HUMAN ES CELLS; GLUTAMINE-SYNTHETASE; MOUSE; LIVER; DIFFERENTIATION; EXPRESSION; COLONIES; CULTURE	Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are potential resources for the regeneration of defective organs, including the liver. However, some obstaclesmust be overcome before this becomes reality. Undifferentiated cells that remain following differentiation have teratoma-forming potential. Additionally, practical applications require a large quantity of differentiated cells, so the differentiation processmust be economical. Here we describe a DNA microarray-based global analysis of the gene expression profiles of differentiating human pluripotent stem cells. We identified differences and commonalities among six human pluripotent stem cell lines: the hESCs KhES1, KhES2, KhES3, and H1, and the iPSCs 201B7 and 243G1. Embryoid bodies (EBs) formed without requiring supplementation with inducing factors. EBs also expressed some liver-specific metabolic genes including the ammonia-metabolizing enzymes glutamine synthetase and carbamoyl-phosphate synthase 1. Real-time PCR analysis revealed hepatocyte-like differentiation of EBs treated with ammonia in Lanford medium. Analysis of DNA microarray data suggested that hepatocyte-like cells were the most abundant population in ammonia-treated cells. Furthermore, expression levels of undifferentiated pluripotent stem cell markers were drastically reduced, suggesting a reduced teratoma-forming capacity. These results indicate that treatment of EBs with ammonia in Lanford medium may be an effective inducer of hepatic differentiation in absence of expensive inducing factors.	[Tomotsune, Daihachiro; Yue, Fengming; Sasaki, Katsunori] Shinshu Univ Matsumoto, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Dept Biotechnol & Biomed Engn, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Hirashima, Kanji; Fujii, Masako; Yue, Fengming; Sasaki, Katsunori] Shinshu Univ, Sch Med, Dept Histol & Embryol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan; [Matsumoto, Ken] Nissui Pharmaceut Co Ltd, 1075-2 Hokunanmoro, Yuki, Ibaraki 3070036, Japan; [Takizawa-Shirasawa, Sakiko; Yokoyama, Tadayuki] Bourbon Corp, 4-2-14 Matsunami, Kashiwazaki, Niigata 9458611, Japan	Shinshu University; Shinshu University	Tomotsune, D (corresponding author), Shinshu Univ Matsumoto, Inst Biomed Sci, Interdisciplinary Cluster Cutting Edge Res, Dept Biotechnol & Biomed Engn, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	dtomo@shinshu-u.ac.jp; katsmd@shinshu-u.ac.jp	Hirashima, Kanji/AAX-1696-2020		Ministry of Education, Culture, Sports, Science and Technology [22500425, 15K01280, 24240076, 15H01803]; Nissui Pharmaceutical Co., Ltd.; Bourbon Corporation; JSPS KAKENHI [JP22500425, JP24240076, JP15H01803, JP15K01280]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nissui Pharmaceutical Co., Ltd.; Bourbon Corporation; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Daihachiro Tomotsune received Grant-in-Aid for Scientific Research (c) 22500425 and 15K01280 from The Ministry of Education, Culture, Sports, Science and Technology. (https://kaken.nii.ac.jp/d/p/22500425.ja.html, https://kaken.nii.ac.jp/d/p/15K01280.ja.html). Katsunori Sasaki received Grant-in-Aid for Scientific Research(A) 24240076 and 15H01803 from The Ministry of Education, Culture, Sports, Science and Technology. (https://kaken.nii.ac.jp/d/p/24240076.ja.html, https://kaken.nii.ac.jp/d/p/15H01803.ja.html). Ken Matsumoto is employed by Nissui Pharmaceutical Co., Ltd. and Sakiko Takizawa-Shirasawa and Tadayuki Yokoyama are employed by Bourbon Corporation. Nissui Pharmaceutical Co., Ltd. and Bourbon Corporation provided support in the form of salaries for authors KM, ST-S, and TY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We gratefully thank Akiko Yoshitome for assistance with real-time PCR analysis. We also thank Yumi Uedai and Ikuei Hiraka at DNA Chip Research, Inc., for supporting the processing of microarray data. This work was supported by JSPS KAKENHI Grant Number JP22500425 and JP24240076, JP15H01803 and JP15K01280.	Bartlett DC, 2015, EXPERT REV GASTROENT, V9, P1261, DOI 10.1586/17474124.2015.1073106; Behbahan IS, 2011, STEM CELL REV REP, V7, P748, DOI 10.1007/s12015-010-9216-4; CAMPBELL JW, 1985, SCIENCE, V228, P349, DOI 10.1126/science.228.4697.349; Fleming KE, 2013, LIVER INT, V33, P525, DOI 10.1111/liv.12099; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; He Y, 2007, DEV DYNAM, V236, P1865, DOI 10.1002/dvdy.21185; Hirschi KK, 2014, ANNU REV BIOMED ENG, V16, P277, DOI 10.1146/annurev-bioeng-071813-105108; Ichikawa H, 2011, CRYOPRESERVATION PLU, P1; Ichikawa H, 2013, ANN ANAT, V195, P50, DOI 10.1016/j.aanat.2012.05.004; Ichikawa H, 2012, CRYOBIOLOGY, V64, P12, DOI 10.1016/j.cryobiol.2011.11.005; Johkura K, 2004, J ANAT, V205, P247, DOI 10.1111/j.0021-8782.2004.00336.x; Kondo Y, 2014, DRUG METAB PHARMACOK, V29, P407, DOI 10.2133/dmpk.DMPK-14-RG-022; LANFORD RE, 1989, IN VITRO CELL DEV B, V25, P174; Lee SY, 2015, INT J STEM CELLS, V8, P36, DOI 10.15283/ijsc.2015.8.1.36; Mogi A, 2009, TISSUE CELL, V41, P79, DOI 10.1016/j.tice.2008.06.005; Mogi A, 2014, J MED BIOL ENG, V34, P101, DOI [10.5405/jmbe.2225, 10.5405/jmbe.1356]; Notenboom RGE, 1997, MICROSC RES TECHNIQ, V39, P413, DOI 10.1002/(SICI)1097-0029(19971201)39:5<413::AID-JEMT4>3.0.CO;2-H; PACKARD GC, 1983, SCIENCE, V221, P1049, DOI 10.1126/science.221.4615.1049; Sampaziotis F, 2015, HEPATOLOGY, V62, P303, DOI 10.1002/hep.27651; Sasaki K, 2009, THESCIENTIFICWORLDJO, V9, P884, DOI 10.1100/tsw.2009.97; Sauer V, 2014, CURR PATHOBIOL REP, V1, P11; Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4; SCHUMPP B, 1992, CYTOTECHNOLOGY, V8, P39, DOI 10.1007/BF02540028; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Takei S, 2009, AM J PHYSIOL-HEART C, V296, pH1793, DOI 10.1152/ajpheart.01288.2008; Takizawa-Shirasawa S, 2013, CELL TISSUE RES, V354, P751, DOI 10.1007/s00441-013-1695-6; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Tomizawa Minoru, 2015, World J Methodol, V5, P108, DOI 10.5662/wjm.v5.i3.108; Tomizawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071897; Tomotsune D, 2011, ADVANCES IN REGENERATIVE MEDICINE, P145; Ueno M, 2006, P NATL ACAD SCI USA, V103, P9554, DOI 10.1073/pnas.0600104103; Vermeulen T, 2008, ARCH BIOCHEM BIOPHYS, V478, P96, DOI 10.1016/j.abb.2008.07.009; Yoshie S, 2010, BIOCHEM BIOPH RES CO, V391, P1477, DOI 10.1016/j.bbrc.2009.12.097; Yue FM, 2013, REGENERATIVE MEDICINE AND TISSUE ENGINEERING, P117, DOI 10.5772/56000	35	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162693	10.1371/journal.pone.0162693	http://dx.doi.org/10.1371/journal.pone.0162693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632182	Green Submitted, Green Published, gold			2022-12-26	WOS:000383706900065
J	Zhao, ZQ; Liu, XX; Xing, XM; Lu, Y; Sun, Y; Ou, XY; Su, XL; Jiang, J; Yang, YR; Chen, JL; Shen, BL; He, Y				Zhao, Zhiqiang; Liu, Xinxia; Xing, Xiumei; Lu, Yao; Sun, Yi; Ou, Xiaoyan; Su, Xiaolin; Jiang, Jun; Yang, Yarui; Chen, Jingli; Shen, Biling; He, Yun			The Activation Effects of Low Level Isopropyl Alcohol Exposure on Arterial Blood Pressures Are Associated with Decreased 5-Hydroxyindole Acetic Acid in Urine	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; CARDIOVASCULAR-DISEASE; DEVELOPMENTAL TOXICITY; INTOXICATION; INGESTION; SEROTONIN; HEALTH; METABOLISM; ABSORPTION; MECHANISMS	Purposes The objectives of this paper are to study the impact of low level isopropyl alcohol exposure on blood pressure and to explore its potential mechanism. Methods This cross-sectional study was based on a prospective occupational cohort in south China, which focusing on occupational risk factors related cardiovascular health problems. A total of 283 participants (200 low isopropyl alcohol exposed workers and 83 controls) was finally enrolled in this study. Linear regression models were used to analyze the relationship between arterial blood pressures and low level isopropyl alcohol exposure. We used mediation method to explore possible mediated roles of neurogenic factors. Results Systolic blood pressure (SBP, 123 +/- 10 vs. 118 +/- 11), diastolic blood pressure (DBP, 79 +/- 7 vs. 74 +/- 7) and mean blood pressure (MBP, 93 +/- 8 vs. 89 +/- 9) were different between the exposed group and the control group (p < 0.01). After adjusting for covariates, the difference was still significant. Besides, isopropyl alcohol and smoking had an interactive effect on DBP and MBP (p < 0.05). Furthermore, we observed a mediated effect of 5-hydroxyindole acetic acid (5-HIAA) on isopropyl alcohol exposure induced arterial blood pressure increase, which accounted for about 25%. Conclusions Our results suggest that low level isopropyl alcohol exposure is a potential risk factor for the increased arterial blood pressure and 5-HIAA partly mediates the association between low level isopropyl alcohol exposure and arterialblood pressures.	[Zhao, Zhiqiang; Xing, Xiumei; Lu, Yao; Sun, Yi; Ou, Xiaoyan; Su, Xiaolin; Jiang, Jun; Yang, Yarui; Chen, Jingli; Shen, Biling; He, Yun] Sun Yat Sen Univ, Guangzhou Key Lab Environm Pollut & Risk Assessme, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Xinxia] Zhongshan Ctr Dis Control & Prevent, Prevent & Control Ctr Occupat Dis, Zhongshan, Guangdong, Peoples R China	Sun Yat Sen University	He, Y (corresponding author), Sun Yat Sen Univ, Guangzhou Key Lab Environm Pollut & Risk Assessme, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.	heyun_jane@163.com			Natural Science Foundation of China [81273097, 81472998]; One Hundred Talents Program of Sun Yat-sen University [18801031]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Talents Program of Sun Yat-sen University	This research was supported by the Natural Science Foundation of China (No. 81273097, 81472998) and by the One Hundred Talents Program of Sun Yat-sen University (No. 18801031).	ADELSON L, 1962, AM J CLIN PATHOL, V38, P144; Allen B, 1998, REGUL TOXICOL PHARM, V28, P38, DOI 10.1006/rtph.1998.1226; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Calabrese EJ, 2011, REGUL TOXICOL PHARM, V61, P73, DOI 10.1016/j.yrtph.2011.06.003; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Carignan D, 2012, TOXICOL SCI, V125, P144, DOI 10.1093/toxsci/kfr283; Carrasco G, 1998, LIFE SCI, V62, P1323, DOI 10.1016/S0024-3205(98)00066-6; Clark JD, 2010, J EMERG NURS, V36, P81, DOI 10.1016/j.jen.2009.10.006; Cosselman KE, 2015, NAT REV CARDIOL, V12, P627, DOI 10.1038/nrcardio.2015.152; Cote F, 2004, TRENDS MOL MED, V10, P232, DOI 10.1016/j.molmed.2004.03.007; DALZIEL K, 1966, BIOCHEM J, V100, P34, DOI 10.1042/bj1000034; DANIEL DR, 1981, J ANAL TOXICOL, V5, P110, DOI 10.1093/jat/5.3.110; Desy O, 2008, J IMMUNOL, V181, P2348, DOI 10.4049/jimmunol.181.4.2348; Emadi A, 2007, NEW ENGL J MED, V356, P530, DOI 10.1056/NEJMc063237; Faber WD, 2008, BIRTH DEFECTS RES B, V83, P459, DOI 10.1002/bdrb.20167; FILSHIE GM, 1992, BRIT MED J, V304, P1223, DOI 10.1136/bmj.304.6836.1223; FREIREICH AW, 1967, NEW ENGL J MED, V277, P699, DOI 10.1056/NEJM196709282771308; Grammer TB, 2013, EUR HEART J, V34, P1298, DOI 10.1093/eurheartj/eht001; GUJRATI VR, 1994, LIFE SCI, V55, P327, DOI 10.1016/0024-3205(94)00735-7; Hyland K, 2008, CLIN CHEM, V54, P633, DOI 10.1373/clinchem.2007.099986; Iavicoli I, 2007, G Ital Med Lav Ergon, V29, P271; JELEN I, 1979, BRIT J OBSTET GYNAEC, V86, P468, DOI 10.1111/j.1471-0528.1979.tb10791.x; Jiang Kaiyou, 2014, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V32, P140; Jones AW, 2000, J ANAL TOXICOL, V24, P8, DOI 10.1093/jat/24.1.8; Leeper SC, 2000, VET HUM TOXICOL, V42, P15; Leow MKS, 2015, HYPERTENS RES, V38, P299, DOI 10.1038/hr.2015.7; Lewis RJ, 2012, SAXS DANGEROUS PROPE, V1-5; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Palermo AM, 2011, MUTAT RES-GEN TOX EN, V726, P215, DOI 10.1016/j.mrgentox.2011.09.016; MARTINEZ TT, 1986, VET HUM TOXICOL, V28, P233; Martz W, 2010, J ANAL TOXICOL, V34, P49, DOI 10.1093/jat/34.1.49; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906; Mueller-Kronast N, 2003, NEUROLOGY, V61, P1456, DOI 10.1212/01.WNL.0000094205.26168.43; Nascimento BR, 2014, HEART, V100, P1743, DOI 10.1136/heartjnl-2014-306026; NATOWICZ M, 1985, CLIN CHEM, V31, P326; NELSON BK, 1988, FOOD CHEM TOXICOL, V26, P247, DOI 10.1016/0278-6915(88)90126-3; NORDMANN R, 1973, LIFE SCI, V13, P919, DOI 10.1016/0024-3205(73)90082-9; Nwosu ME, 2009, J CHILD NEUROL, V24, P349, DOI 10.1177/0883073808322664; ONeil MJ, 2013, MERCK INDEX ENCY CHE, V15th; Peng LW, 2006, AM J MED, V119, pE9, DOI 10.1016/j.amjmed.2005.12.024; PERSSON B, 1988, J CARDIOVASC PHARM, V11, pS22; Rapisarda V, 2016, TOXICOL IND HEALTH, V32, P1729, DOI 10.1177/0748233715576616; Sethre T, 2000, INT ARCH OCC ENV HEA, V73, P528, DOI 10.1007/s004200000178; Sethre T, 2000, INT ARCH OCC ENV HEA, V73, P105, DOI 10.1007/s004200050015; Slaughter RJ, 2014, CLIN TOXICOL, V52, P470, DOI 10.3109/15563650.2014.914527; Stremski E, 2000, PEDIATR EMERG CARE, V16, P238, DOI 10.1097/00006565-200008000-00005; VICAS IMO, 1993, J TOXICOL-CLIN TOXIC, V31, P473, DOI 10.3109/15563659309000415; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Wood JN, 2007, J PERINATOL, V27, P183, DOI 10.1038/sj.jp.7211646; Zahra A, 2015, PUBLIC HEALTH, V129, P385, DOI 10.1016/j.puhe.2015.01.013	52	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162762	10.1371/journal.pone.0162762	http://dx.doi.org/10.1371/journal.pone.0162762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622502	gold, Green Submitted, Green Published			2022-12-26	WOS:000383681000053
J	Kaseva, N; Pyhala, R; Pesonen, AK; Raikkonen, K; Jarvenpaa, AL; Andersson, S; Eriksson, JG; Hovi, P; Kajantie, E				Kaseva, Nina; Pyhala, Riikka; Pesonen, Anu-Katriina; Raikkonen, Katri; Jarvenpaa, Anna-Liisa; Andersson, Sture; Eriksson, Johan G.; Hovi, Petteri; Kajantie, Eero			Diurnal Cortisol Patterns and Dexamethasone Suppression Test Responses in Healthy Young Adults Born Preterm at Very Low Birth Weight	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; CIRCADIAN-RHYTHM; INFANTS BORN; STRESS; DETERMINANTS; PROFILES; CHILDREN; BEHAVIOR; AGE	Background Early life stress, such as painful and stressful procedures during neonatal intensive care after pretermbirth, can permanently affect physiological, hormonal and neurobiological systems. This may contribute to altered programming of the hypothalamic-pituitary-adrenal axis (HPAA) and provoke changes in HPAA function with long-term health impacts. Previous studies suggest a lower HPAA response to stress in young adults born preterm compared with controls born at term. We assessed whether these differences in HPAA stress responsiveness are reflected in everyday life HPAA functioning, i.e. in diurnal salivary cortisol patterns, and reactivity to a low-dose dexamethasone suppression test (DST), in unimpaired young adults born preterm at very low birth weight (VLBW; <1500 g). Methods The participants were recruited from the Helsinki Study of Very Low Birth Weight Adults cohort study. At mean age 23.3 years (2.1 SD), 49 VLBW and 36 controls born at term participated in the study. For cortisol analyzes, saliva samples were collected on two consecutive days at 0, 15, 30 and 60 min after wake-up, at 12: 00 h, 17: 00 h and 22: 00 h. After the last salivary sample of the first study day the participants were instructed to take a 0.5 mg dexamethasone tablet. Results With mixed-effects model no difference was seen in overall diurnal salivary cortisol between VLBW and control groups [13.9% (95% CI: -11.6, 47.0), P = 0.31]. Salivary cortisol increased similarly after awakening in both VLBW and control participants[mean difference -2.9% (29.2, 33.0), P = 0.85]. Also reactivity to the low-dose DST (awakening cortisol ratio day2/day1) was similar between VLBW and control groups [-1.1% (-53.5, 103.8), P = 0.97)]. Conclusions Diurnal cortisol patterns and reactivity to a low-dose DST in young adulthood were not associated with preterm birth.	[Kaseva, Nina; Eriksson, Johan G.; Hovi, Petteri; Kajantie, Eero] Natl Inst Hlth & Welfare, Dept Hlth, Chron Dis Prevent Unit, Helsinki, Finland; [Pyhala, Riikka; Pesonen, Anu-Katriina; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Pyhala, Riikka; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Jarvenpaa, Anna-Liisa; Andersson, Sture; Hovi, Petteri; Kajantie, Eero] Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland; [Jarvenpaa, Anna-Liisa; Andersson, Sture; Hovi, Petteri] Univ Helsinki, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Hosp, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Kajantie, Eero] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Grp, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; University of Oulu; University of Oulu	Kaseva, N (corresponding author), Natl Inst Hlth & Welfare, Dept Hlth, Chron Dis Prevent Unit, Helsinki, Finland.	nina.kaseva@fimnet.fi	Kaseva, Nina/O-7918-2019; Pyhälä, Riikka/AAG-1947-2021	Pesonen, Anu-Katriina/0000-0002-0662-6261; Raikkonen, Katri/0000-0003-3124-3470; Kaseva, Nina/0000-0003-4648-0022	Medical Societies of Finland; Finnish Foundation of Paediatric Research, Academy of Finland [127437, 129306, 130326, 134791, 263924]; Emil Aaltonen Foundation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Novo Nordisk Fonden [NNF12OC1016374, NNF15OC0016362] Funding Source: researchfish	Medical Societies of Finland; Finnish Foundation of Paediatric Research, Academy of Finland; Emil Aaltonen Foundation; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by grants from the Medical Societies of Finland (Duodecim and Finska Lakaresallskapet to NK), the Finnish Foundation of Paediatric Research (to EK), Academy of Finland (grants 127437, 129306, 130326, 134791 and 263924 to EK), the Emil Aaltonen Foundation (to EK), the Jalmari and Rauha Ahokas Foundation (to EK), the Juho Vainio Foundation, the Novo Nordisk Foundation, the Signe and Ane Gyllenberg Foundation (to NK), the Sigrid Juselius Foundation (to EK) and the Yrjo Jahnsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelte S, 2011, DEV PSYCHOBIOL, V53, P184, DOI 10.1002/dev.20511; Buske-Kirschbaum A, 2007, J CLIN ENDOCR METAB, V92, P3429, DOI 10.1210/jc.2006-2223; de Graaf J, 2014, J PEDIATR-US, V165, P459, DOI 10.1016/j.jpeds.2014.05.047; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; de Weerth C, 2003, EARLY HUM DEV, V73, P39, DOI 10.1016/S0378-3782(03)00074-4; Grunau RE, 2007, J PEDIATR-US, V150, P151, DOI 10.1016/j.jpeds.2006.10.053; Grunau RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073926; Grunau RE, 2010, CLIN J PAIN, V26, P698, DOI 10.1097/AJP.0b013e3181e5bb00; Gustafsson PE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-346; Hovi P, 2007, NEW ENGL J MED, V356, P2053, DOI 10.1056/NEJMoa067187; Hovi P, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-57; Hovi P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000135; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Kaseva N, 2014, CLIN ENDOCRINOL, V80, P101, DOI 10.1111/cen.12251; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Lee J, 2014, AM J HUM BIOL, V26, P598, DOI 10.1002/ajhb.22569; Matthews SG, 2002, TRENDS ENDOCRIN MET, V13, P373, DOI 10.1016/S1043-2760(02)00690-2; McEwen BS, 1998, NEW ENGL J MED, P338; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Pihkala J, 1989, Duodecim, V105, P1540; Raikkonen K, 2010, PSYCHONEUROENDOCRINO, V35, P1587, DOI 10.1016/j.psyneuen.2010.04.010; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1843, DOI 10.1016/j.psyneuen.2013.05.018; Rosmalen JGM, 2005, PSYCHONEUROENDOCRINO, V30, P483, DOI 10.1016/j.psyneuen.2004.12.007; SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439; Smith CM, 2011, CLIN ENDOCRINOL, V75, P443, DOI 10.1111/j.1365-2265.2011.04118.x; Tollenaar MS, 2010, EARLY HUM DEV, V86, P13, DOI 10.1016/j.earlhumdev.2009.12.003	27	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162650	10.1371/journal.pone.0162650	http://dx.doi.org/10.1371/journal.pone.0162650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618620	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100038
J	Tan, CW; Tee, HK; Lee, MHP; Sam, IC; Chan, YF				Tan, Chee Wah; Tee, Han Kang; Lee, Michelle Hui Pheng; Sam, I-Ching; Chan, Yoke Fun			Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic Tool	PLOS ONE			English	Article							MESSENGER-RNA; IN-VITRO; CDNA-CLONES; INITIATES REPLICATION; CLINICAL-FEATURES; IMMUNE-RESPONSE; POLIOVIRUS CDNA; PLASMID DNA; HNRNP A1; VIRUS	Enterovirus A71 (EV-A71) causes major outbreaks of hand, foot and mouth disease, and is occasionally associated with neurological complications and death in children. Reverse genetics is widely used in the field of virology for functional study of viral genes. For EV-A71, such tools are limited to clones that are transcriptionally controlled by T7/SP6 bacteriophage promoter. This is often time-consuming and expensive. Here, we describe the development of infectious plasmid DNA-based EV-A71 clones, for which EV-A71 genome expression is under transcriptional control by the CMV-intermediate early promoter and SV40 transcriptional-termination signal. Transfection of this EV-A71 infectious DNA produces good virus yield similar to in vitro-transcribed EV-A71 infectious RNA, 6.4 and 5.8 log(10)PFU/ml, respectively. Infectious plasmid with enhanced green fluorescence protein and Nano luciferase reportergenes also produced good virus titers, with 4.3 and 5.0 log(10) PFU/ml, respectively. Another infectious plasmid with both CMV and T7 promoters was also developed for easy manipulation of in vitro transcription or direct plasmid transfection. Transfection with either dual-promoter infectious plasmid DNA or infectious RNA derived from this dual-promoter clone produced infectious viral particles. Incorporation of hepatitis delta virus ribozyme, which yields precise 3' ends of the DNA-launched EV-A71 genomic transcripts, increased infectious viral production. In contrast, the incorporation of hammerhead ribozyme in the DNA-launched EV-A71 resulted in lower virus yield, but improved the virus titers for T7 promoter-derived infectious RNA. This study describes rapid and robust reverse genetic tools for EV-A71.	[Tan, Chee Wah; Tee, Han Kang; Lee, Michelle Hui Pheng; Sam, I-Ching; Chan, Yoke Fun] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Tan, CW; Chan, YF (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.	tcwah@um.edu.my; chanyf@um.edu.my	Tee, Han Kang/GOK-1453-2022; Sam, Jamal I-Ching/B-8688-2010; Chan, Yoke Fun/B-5351-2010	Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510; Tan, Chee Wah/0000-0001-9837-1413; Tee, Han Kang/0000-0002-8975-0945	University of Malaya [UM.C/625/1/HIR/MOHE/MED/41, BK046-2015]	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya High Impact Research Grant (UM.C/625/1/HIR/MOHE/MED/41) and University of Malaya Research Fund Assistance (BK046-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton DJ, 2001, EMBO J, V20, P1439, DOI 10.1093/emboj/20.6.1439; BOYER JC, 1994, VIROLOGY, V198, P415, DOI 10.1006/viro.1994.1053; Chambers TJ, 2006, J GEN VIROL, V87, P3131, DOI 10.1099/vir.0.81909-0; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Du N, 2014, J VIROL, V88, P5816, DOI 10.1128/JVI.03826-13; Dubensky TW, 1996, J VIROL, V70, P508, DOI 10.1128/JVI.70.1.508-519.1996; Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13; Han JF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-116; Hayashi T, 2010, DEV DYNAM, V239, P2034, DOI 10.1002/dvdy.22344; Herold J, 2000, J VIROL, V74, P6394, DOI 10.1128/JVI.74.14.6394-6400.2000; Izaurralde E, 1997, J CELL BIOL, V137, P27, DOI 10.1083/jcb.137.1.27; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; KEAN KM, 1986, J VIROL, V59, P490, DOI 10.1128/JVI.59.2.490-493.1986; Kim TK, 2010, ANAL BIOANAL CHEM, V397, P3173, DOI 10.1007/s00216-010-3821-6; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KUHN RJ, 1987, VIROLOGY, V157, P560, DOI 10.1016/0042-6822(87)90302-3; Lazouskaya NV, 2014, J VIROL METHODS, V197, P67, DOI 10.1016/j.jviromet.2013.12.005; Lian KQ, 2015, VIRUS RES, V208, P73, DOI 10.1016/j.virusres.2015.06.008; Lilley DMJ, 2005, CURR OPIN STRUC BIOL, V15, P313, DOI 10.1016/j.sbi.2005.05.002; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Liu F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-534; Liu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001066; Meng T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-238; Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9; Nishimura Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003511; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; Pu SY, 2014, J GEN VIROL, V95, P1493, DOI 10.1099/vir.0.064915-0; RACANIELLO VR, 1981, P NATL ACAD SCI-BIOL, V78, P4887, DOI 10.1073/pnas.78.8.4887; RACANIELLO VR, 1981, SCIENCE, V214, P916, DOI 10.1126/science.6272391; SARNOW P, 1989, J VIROL, V63, P467, DOI 10.1128/JVI.63.1.467-470.1989; Shang BD, 2013, ANTIVIR RES, V97, P198, DOI 10.1016/j.antiviral.2012.12.010; Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Song YT, 2012, J VIROL, V86, P1999, DOI 10.1128/JVI.05871-11; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Tan CW, 2014, ANTIVIR RES, V107, P35, DOI 10.1016/j.antiviral.2014.04.004; Tan CW, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-14; Tan CW, 2013, J VIROL, V87, P611, DOI 10.1128/JVI.02226-12; Tan CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034589; Tretyakova I, 2014, VIROLOGY, V468, P28, DOI 10.1016/j.virol.2014.07.050; Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114; Tretyakova I, 2013, VACCINE, V31, P1019, DOI 10.1016/j.vaccine.2012.12.050; Usme-Ciro JA, 2014, VIRUS RES, V180, P12, DOI 10.1016/j.virusres.2013.12.001; Van de Parre TJL, 2005, BIOCHEM BIOPH RES CO, V327, P356, DOI 10.1016/j.bbrc.2004.12.027; VANDERWERF S, 1986, P NATL ACAD SCI USA, V83, P2330; Varnavski AN, 2000, J VIROL, V74, P4394, DOI 10.1128/JVI.74.9.4394-4403.2000; Wickramasinghe VO, 2015, NAT REV MOL CELL BIO, V16, P431, DOI 10.1038/nrm4010; Xu LL, 2015, J VIROL METHODS, V219, P62, DOI 10.1016/j.jviromet.2015.03.020; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yang SL, 2011, J VIROL, V85, P11809, DOI 10.1128/JVI.00297-11; Yeh MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027082; ZHANG HC, 1995, VIROLOGY, V212, P686, DOI 10.1006/viro.1995.1526	59	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162771	10.1371/journal.pone.0162771	http://dx.doi.org/10.1371/journal.pone.0162771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617744	Green Published, Green Submitted, gold			2022-12-26	WOS:000383653100051
J	Taniguchi, T; Maruyama, N; Ogata, T; Kasahara, T; Nakanishi, N; Miyagawa, K; Naito, D; Hamaoka, T; Nishi, M; Matoba, S; Ueyama, T				Taniguchi, Takuya; Maruyama, Naoki; Ogata, Takehiro; Kasahara, Takeru; Nakanishi, Naohiko; Miyagawa, Kotaro; Naito, Daisuke; Hamaoka, Tetsuro; Nishi, Masahiro; Matoba, Satoaki; Ueyama, Tomomi			PTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac Fibrosis	PLOS ONE			English	Article							LONG-QT SYNDROME; INFANT-DEATH-SYNDROME; COILED-COIL PROTEIN; LATE SODIUM CURRENT; KNOCKOUT MICE; GENERALIZED LIPODYSTROPHY; PTRF MUTATIONS; CAVEOLAE; MUSCLE; CAVIN	Mutations in the PTRF/Cavin-1 gene cause congenital generalized lipodystrophy type 4 (CGL4) associated with myopathy. Additionally, long-QT syndrome and fatal cardiac arrhythmia are observed in patients with CGL4 who have homozygous PTRF/Cavin-1 mutations. PTRF/Cavin-1 deficiency shows reductions of caveolae and caveolin-3 (Cav3) protein expression in skeletal muscle, and Cav3 deficiency in the heart causes cardiac hypertrophy with loss of caveolae. However, it remains unknown how loss of PTRF/Cavin-1 affects cardiac morphology and function. Here, we present a characterization of the hearts of PTRF/Cavin-1-null (PTRF-/-) mice. Electron microscopy revealed the reduction of caveolae in cardiomyocytes of PTRF-/- mice. PTRF-/- mice at 16 weeks of age developed a progressive cardiomyopathic phenotype with wall thickening of left ventricles and reduced fractional shortening evaluated by echocardiography. Electrocardiography revealed that PTRF-/- mice at 24 weeks of age had low voltages and wide QRS complexes in limb leads. Histological analysis showed cardiomyocyte hypertrophy accompanied by progressive interstitial/perivascular fibrosis. Hypertrophy-related fetal gene expression was also induced in PTRF-/- hearts. Western blotting analysis and quantitative RT-PCR revealed that Cav3 expression was suppressed in PTRF-/- hearts compared with that in wild-type (WT) ones. ERK1/2 was activated in PTRF-/- hearts compared with that in WT ones. These results suggest that loss of PTRF/Cavin-1 protein expression is sufficient to induce a molecular program leading to cardiomyocyte hypertrophy and cardiomyopathy, which is partly attributable to Cav3 reduction in the heart.	[Taniguchi, Takuya; Maruyama, Naoki; Ogata, Takehiro; Kasahara, Takeru; Nakanishi, Naohiko; Miyagawa, Kotaro; Naito, Daisuke; Hamaoka, Tetsuro; Nishi, Masahiro; Matoba, Satoaki; Ueyama, Tomomi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan	Kyoto Prefectural University of Medicine	Ueyama, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan.	toueyama-circ@umin.ac.jp	Nishi, Masahiro/HDM-4433-2022; Taniguchi, Takuya/AAD-9103-2022		Japan Society for the Promotion of Science (JSPS) KAKENHI [26670407]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 26670407, https://www.jsps.go.jp/index.html.	[Anonymous], 2014, BRAUNWALDS HEART DIS; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Berul CI, 2003, PHYSIOL GENOMICS, V13, P207, DOI 10.1152/physiolgenomics.00183.2002; Brenyo A, 2011, CARDIOL J, V18, P8; Briand N, 2011, BIOCHIMIE, V93, P71, DOI 10.1016/j.biochi.2010.03.022; Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; Cronk LB, 2007, HEART RHYTHM, V4, P161, DOI 10.1016/j.hrthm.2006.11.030; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Feiner EC, 2011, J CARD FAIL, V17, P253, DOI 10.1016/j.cardfail.2010.10.008; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hayashi T, 2004, BIOCHEM BIOPH RES CO, V313, P178, DOI 10.1016/j.bbrc.2003.11.101; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hedley PL, 2013, CIRC-CARDIOVASC GENE, V6, P452, DOI 10.1161/CIRCGENETICS.113.000137; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Karbalaei MS, 2012, EUR J PHARMACOL, V689, P179, DOI 10.1016/j.ejphar.2012.05.023; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Nassoy P, 2012, TRENDS CELL BIOL, V22, P381, DOI 10.1016/j.tcb.2012.04.007; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Ogata T, 2014, P NATL ACAD SCI USA, V111, P3811, DOI 10.1073/pnas.1315359111; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Pfleger C, 2012, HISTOCHEM CELL BIOL, V138, P231, DOI 10.1007/s00418-012-0961-0; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Satomi-Kobayashi S, 2009, HYPERTENSION, V54, P825, DOI 10.1161/HYPERTENSIONAHA.109.130443; Sellers SL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00280; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sward K., 2013, PHYSL REP, V1, DOI DOI 10.1002/PHY2.8; Sward K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092428; Tagawa M, 2008, AM J PHYSIOL-CELL PH, V295, pC490, DOI 10.1152/ajpcell.00188.2008; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Wang L, 1997, CIRC RES, V81, P120, DOI 10.1161/01.RES.81.1.120; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Yarbrough TL, 2002, CIRC RES, V90, P443, DOI 10.1161/hh0402.105177; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	49	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162513	10.1371/journal.pone.0162513	http://dx.doi.org/10.1371/journal.pone.0162513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612189	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900119
J	Hulsurkar, M; Li, Z; Zhang, Y; Li, X; Zheng, D; Li, W				Hulsurkar, M.; Li, Z.; Zhang, Y.; Li, X.; Zheng, D.; Li, W.			Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1	ONCOGENE			English	Article							CORONARY-HEART-DISEASE; PROTEIN-KINASE-A; HISTONE DEACETYLASE; CARDIAC-HYPERTROPHY; HDAC INHIBITORS; VALPROIC ACID; IN-VITRO; CELLS; RECEPTOR; GENOMICS	Chronic behavioral stress and beta-adrenergic signaling have been shown to promote cancer progression, whose underlying mechanisms are largely unclear, especially the involvement of epigenetic regulation. Histone deacetylase-2 (HDAC2), an epigenetic regulator, is critical for stress-induced cardiac hypertrophy. It is unknown whether it is necessary for beta-adrenergic signaling promoted cancer progression. Using xenograft models, we showed that chronic behavioral stress and beta-adrenergic signaling promote angiogenesis and prostate cancer progression. HDAC2 was induced by beta-adrenergic signaling in vitro and in mouse xenografts. We next uncovered that HDAC2 is a direct target of cAMP response element-binding protein (CREB) that is activated by beta-adrenergic signaling. Notably, HDAC2 is necessary for beta-adrenergic signaling to induce angiogenesis. We further demonstrated that, upon CREB activation, HDAC2 represses thrombospondin-1 (TSP1), a potent angiogenesis inhibitor, through epigenetic regulation. Together, these data establish a novel pathway that HDAC2 and TSP1 act downstream of CREB activation in beta-adrenergic signaling to promote cancer progression.	[Hulsurkar, M.; Li, Z.; Zhang, Y.; Li, X.; Zheng, D.; Li, W.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Texas Therapeut Inst, SRB 537C,1825 Pressler St, Houston, TX 77030 USA; [Hulsurkar, M.; Li, W.] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA; [Li, Z.] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Breast & Thyroid Surg Ctr, Wuhan 430074, Peoples R China; [Zhang, Y.] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Li, X.] Taishan Med Univ, Liaocheng Clin Sch, Liaocheng Peoples Hosp, Liaocheng, Peoples R China; [Zheng, D.] Southern Med Univ, Nanfang Hosp, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Southern Medical University - China	Li, W (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Texas Therapeut Inst, SRB 537C,1825 Pressler St, Houston, TX 77030 USA.	wenliang.li@uth.tmc.edu	Hulsurkar, Mohit/L-9946-2019	Hulsurkar, Mohit/0000-0003-0595-6661	University of Texas System	University of Texas System	We are grateful to Dr Rebecca Berdeaux for providing us the CREB cDNA constructs. We are thankful to Drs Isaiah Fidler and Vihang Narkar for providing us PC3 and SVEC4-10 cells, respectively. We also would like to thank Dr Kendra Carmon for critical reading of this paper. This work was supported by a Rising STARS Award from University of Texas System (W Li).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Armaiz-Pena GN, 2013, BRAIN BEHAV IMMUN, V30, pS19, DOI 10.1016/j.bbi.2012.06.005; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Braadland PR, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00375; Byler TK, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-21; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; de Graaf C, 2008, J MED CHEM, V51, P4978, DOI 10.1021/jm800710x; Dishy V, 2001, NEW ENGL J MED, V345, P1030, DOI 10.1056/NEJMoa010819; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Duvic M, 2007, BLOOD, V109, P31, DOI 10.1182/blood-2006-06-025999; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Govindan MV, 2010, J BIOL CHEM, V285, P4489, DOI 10.1074/jbc.M109.072728; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Grytli HH, 2013, PROSTATE, V73, P250, DOI 10.1002/pros.22564; Hassan S, 2013, J CLIN INVEST, V123, P874, DOI 10.1172/JCI63324; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Krantz DS, 2002, ANNU REV PSYCHOL, V53, P341, DOI 10.1146/annurev.psych.53.100901.135208; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Li LN, 2014, ONCOTARGET, V5, P10840, DOI 10.18632/oncotarget.2535; Lia WL, 2014, P NATL ACAD SCI USA, V111, P1521, DOI 10.1073/pnas.1320638111; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Manna PP, 2004, CANCER RES, V64, P1026, DOI 10.1158/0008-5472.CAN-03-1708; Manna PP, 2003, J IMMUNOL, V170, P3544, DOI 10.4049/jimmunol.170.7.3544; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Roberts W, 2010, BLOOD, V116, P4297, DOI 10.1182/blood-2010-01-265561; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sang M, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9359.; Staton CA, 2004, INT J EXP PATHOL, V85, P233, DOI 10.1111/j.0959-9673.2004.00396.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thaker PH, 2006, NAT MED, V12, P939, DOI 10.1038/nm1447; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Walchli T, 2015, NAT PROTOC, V10, P53, DOI 10.1038/nprot.2015.002; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang HM, 2013, ANN ONCOL, V24, P1312, DOI 10.1093/annonc/mds616; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Wojtukiewicz MZ, 2001, NEOPLASIA, V3, P371, DOI 10.1038/sj.neo.7900184; Yang QW, 2007, CANCER RES, V67, P1716, DOI 10.1158/0008-5472.CAN-06-2595; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043	50	49	54	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1525	1536		10.1038/onc.2016.319	http://dx.doi.org/10.1038/onc.2016.319			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27641328				2022-12-26	WOS:000397458100007
J	Makinodan, M; Ikawa, D; Miyamoto, Y; Yamauchi, J; Yamamuro, K; Yamashita, Y; Toritsuka, M; Kimoto, S; Okumura, K; Yamauchi, T; Fukami, S; Yoshino, H; Wanaka, A; Kishimoto, T				Makinodan, Manabu; Ikawa, Daisuke; Miyamoto, Yuki; Yamauchi, Junji; Yamamuro, Kazuhiko; Yamashita, Yasunori; Toritsuka, Michihiro; Kimoto, Sohei; Okumura, Kazuki; Yamauchi, Takahira; Fukami, Shin-ichi; Yoshino, Hiroki; Wanaka, Akio; Kishimoto, Toshifumi			Social isolation impairs remyelination in mice through modulation of IL-6	FASEB JOURNAL			English	Article						oligodendrocyte; prefrontal cortex; social experience; cytokines; multiple sclerosis	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LATE OLIGODENDROCYTE PROGENITORS; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; STRUCTURAL CONNECTIVITY; PREFRONTAL CORTEX; INTERLEUKIN-6; MYELINATION; STRESS	Recent studies have revealed that social experience affects myelination. These findings have important implications for disorders that feature abnormal myelination, such as multiple sclerosis ( MS), as previous studies have shown that psychosocial stress exacerbates the pathobiology of MS. However, most studies have focused on psychosocial stress during the demyelination phase of MS and have not investigated the effects of social experience on remyelination. Thus, the current study sought to determine whether social experience can alter remyelination after myelin depletion. Myelin in the mouse medial prefrontal cortex was depleted with cuprizone, and the effects of subsequent social isolation on remyelination were evaluated. Remyelination was severely impaired in socially isolated mice. Social isolation also increased IL-6 levels in the medial prefrontal cortex, and administration of an IL-6 inhibitor (ND50 = 0.01-0.03 mu g for 0.25 ng/ml IL-6) ameliorated remyelination impairments. Consistent with this result, IL-6 administration (ED50 = 0.02-0.06 ng/ml) disturbed remyelination. In addition, neuron-oligodendrocyte coculture experiments showed that IL-6 treatment (ED50 <= 0.02 ng/ml) markedly impeded myelination, which was recovered with IL-6 inhibitor administration (ND50 = 0.01-0.03 mg for 0.25 ng/ml IL-6). This study provides the first direct evidence, to our knowledge, that social experience influences remyelination via modulation of IL-6 expression. These findings indicate that psychosocial stress may disturb remyelination through regulation of IL-6 expression in patients with such demyelinating diseases that involve remyelination as MS.	[Makinodan, Manabu; Ikawa, Daisuke; Yamamuro, Kazuhiko; Yamashita, Yasunori; Toritsuka, Michihiro; Kimoto, Sohei; Okumura, Kazuki; Yamauchi, Takahira; Fukami, Shin-ichi; Yoshino, Hiroki; Kishimoto, Toshifumi] Nara Med Univ, Sch Med, Dept Psychiat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan; [Wanaka, Akio] Nara Med Univ, Sch Med, Dept Anat & Neurosci, Nara, Japan; [Miyamoto, Yuki; Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan	Nara Medical University; Nara Medical University; National Center for Child Health & Development - Japan	Makinodan, M (corresponding author), Nara Med Univ, Sch Med, Dept Psychiat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	mmm@naramed-u.ac.jp	Wanaka, Akio/ABE-4671-2020; Wanaka, Akio/GPW-8926-2022; Okumura, Kazuki/AAH-8945-2020; Wanaka, Akio/AAC-9754-2019	Okumura, Kazuki/0000-0002-3019-7049; Wanaka, Akio/0000-0001-9951-9862; Kimoto, Sohei/0000-0002-3148-690X	Uehara Memorial Foundation; Naito Foundation; Takeda Science Foundation;  [15K15432]	Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); 	The authors thank Kouji Okuda for tissue sectioning for the electron microscopy study. This work was supported by The Uehara Memorial Foundation, the Naito Foundation, the Takeda Science Foundation, and Grant-in-Aid for Scientific Research 15K15432.	Agis-Balboa RC, 2007, P NATL ACAD SCI USA, V104, P18736, DOI 10.1073/pnas.0709419104; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; BANKS WA, 1989, BRAIN RES BULL, V23, P433, DOI 10.1016/0361-9230(89)90185-8; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Ben Menachem-Zidon O, 2008, NEUROPSYCHOPHARMACOL, V33, P2251, DOI 10.1038/sj.npp.1301606; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bogosian A, 2015, MULT SCLER J, V21, P1184, DOI 10.1177/1352458515576261; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; ERMISCH A, 1985, J CEREBR BLOOD F MET, V5, P350, DOI 10.1038/jcbfm.1985.49; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fang XX, 2013, CELL MOL NEUROBIOL, V33, P241, DOI 10.1007/s10571-012-9891-6; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; FREI K, 1991, J NEUROIMMUNOL, V31, P147; Gananca L, 2016, PSYCHONEUROENDOCRINO, V63, P296, DOI 10.1016/j.psyneuen.2015.10.008; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Ireland SJ, 2015, CYTOKINE, V73, P236, DOI 10.1016/j.cyto.2015.01.009; Jankord R, 2010, AM J PHYSIOL-REG I, V299, pR343, DOI 10.1152/ajpregu.00131.2010; Krugel U, 2014, ARCH TOXICOL, V88, P853, DOI 10.1007/s00204-014-1203-0; Li YY, 2012, HUM BRAIN MAPP, V33, P349, DOI 10.1002/hbm.21215; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lovera J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0398-4; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Makinodan M, 2009, PROG NEURO-PSYCHOPH, V33, P978, DOI 10.1016/j.pnpbp.2009.05.006; Malmestrom C, 2006, J NEUROIMMUNOL, V175, P176, DOI 10.1016/j.jneuroim.2006.03.004; Mandolesi G, 2015, CEREBELLUM, V14, P19, DOI 10.1007/s12311-014-0613-0; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Mohr DC, 2000, NEUROLOGY, V55, P55, DOI 10.1212/WNL.55.1.55; Mohr DC, 2004, BMJ-BRIT MED J, V328, P731, DOI 10.1136/bmj.38041.724421.55; Mohr DC, 2002, PSYCHOSOM MED, V64, P803, DOI 10.1097/01.PSY.0000024238.11538.EC; Morita S, 2014, NEUROCHEM RES, V39, P59, DOI 10.1007/s11064-013-1190-1; Nave KA, 2014, JAMA PSYCHIAT, V71, P582, DOI 10.1001/jamapsychiatry.2014.189; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Rothwell N J, 1994, Adv Pharmacol, V25, P1, DOI 10.1016/S1054-3589(08)60428-7; Schiavone S, 2017, MOL NEUROBIOL, V54, P2031, DOI 10.1007/s12035-016-9791-8; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simpson R, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-15; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Yamauchi J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002802; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang PL, 2006, MOL CELL NEUROSCI, V31, P387, DOI 10.1016/j.mcn.2005.10.014	53	17	17	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4267	4274		10.1096/fj.201600537R	http://dx.doi.org/10.1096/fj.201600537R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27613805				2022-12-26	WOS:000388201500031
J	Akhter, N; Takeda, Y; Nara, H; Araki, A; Ishii, N; Asao, N; Asao, H				Akhter, Nasrin; Takeda, Yuji; Nara, Hidetoshi; Araki, Akemi; Ishii, Naoto; Asao, Naoki; Asao, Hironobu			Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 (Ape1/Ref-1) Modulates Antigen Presenting Cell-mediated T Helper Cell Type 1 Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; dendritic cell; differentiation; redox regulation; T helper cells; Ape1; Ref-1; IL-12; antigen presenting cell	DNA-REPAIR; INTERLEUKIN-6 RECEPTOR; PROTEIN APE1/REF-1; IL-12; PROLIFERATION; MACROPHAGES; EXPRESSION; DOMAIN; ALPHA; APE1	Apurinic/apyrimidinic endonuclease 1/redox factor-1 (Ape1/Ref-1) is a multifunctional protein possessing DNA repair, redox control, and transcriptional regulatory activities. Although Ape1/Ref-1 plays multiple roles in the immune system, its functions in helper T (Th) cell activation and differentiation are largely unknown. In this study, the function of Ape1/Ref-1 in Th cell activation was analyzed using an Ape1/Ref-1 redox-specific inhibitor, E3330. When splenocytes from OT-II mice, which are ovalbumin (OVA)-specific T-cell receptor transgenic mice, were activated with OVA in the presence of E3330, the induction of IFN--producing OT-II T cells was significantly increased. In contrast, E3330 did not enhance IFN- production from plate-bound anti-CD3 antibody-stimulated CD4(+) T cells in the absence of antigen presenting cells (APCs). Furthermore, E3330-pretreated and OVA-pulsed APCs also enhanced the IFN- production from OT-II T cells. These results suggested that E3330 enhances Th1 responses by modifying APC function. E3330 did not alter the surface expression of MHC-II or the co-stimulatory molecules CD80 and CD86 on APCs. On the other hand, E3330 up-regulated the IL-12 p35 and p40 gene expression, and IL-12 surface retention, but decreased the IL-12 secretion from Toll-like receptor (TLR) ligand-stimulated APCs. These results were confirmed with Ape1/Ref-1 knockdown experiments. Taken together, our findings indicated that the suppression of Ape1/Ref-1 redox function leads to an increased cell surface retention of IL-12 and enhances Th1 responses. This is the first study to demonstrate that Ape1/Ref-1 modulates the IL-12 production and secretion from APCs and controls Th1 immune responses.	[Akhter, Nasrin; Takeda, Yuji; Nara, Hidetoshi; Araki, Akemi; Asao, Hironobu] Yamagata Univ, Dept Immunol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan; [Ishii, Naoto] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808075, Japan; [Asao, Naoki] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Yamagata University; Tohoku University; Tohoku University	Asao, H (corresponding author), Yamagata Univ, Dept Immunol, Fac Med, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	asao-h@med.id.yamagata-u.ac.jp		Ishii, Naoto/0000-0002-0549-8245	Seizankai Medical Welfare Group; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan;  [22590432]	Seizankai Medical Welfare Group; Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; 	This work was supported in part by Grant-in-Aid for Scientific Research (C) 22590432 and a grant from the Seizankai Medical Welfare Group and the Nanotechnology Platform Program (Molecule and Material Synthesis) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Araki A, 2013, CYTOKINE, V62, P262, DOI 10.1016/j.cyto.2013.03.006; Asao H, 2000, J BIOL CHEM, V275, P867, DOI 10.1074/jbc.275.2.867; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Chakrabarti R, 2004, VACCINE, V22, P1199, DOI 10.1016/j.vaccine.2003.09.023; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Fan XH, 1996, BIOCHEM BIOPH RES CO, V225, P1063, DOI 10.1006/bbrc.1996.1295; Feng GJ, 1999, J IMMUNOL, V163, P6403; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; GEARING DP, 1991, CELL, V66, P9, DOI 10.1016/0092-8674(91)90131-H; Ji JF, 2004, J GENE MED, V6, P777, DOI 10.1002/jgm.547; Juliana FM, 2012, BIOCHEM BIOPH RES CO, V420, P628, DOI 10.1016/j.bbrc.2012.03.051; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; Lee HM, 2009, J IMMUNOL, V183, P6839, DOI 10.4049/jimmunol.0901856; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liu Jianguo, 2005, Curr Immunol Rev, V1, P119, DOI 10.2174/1573395054065115; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; Merluzzi S, 2004, J BIOL CHEM, V279, P1777, DOI 10.1074/jbc.M305418200; Onoda T, 2007, INT IMMUNOL, V19, P1191, DOI 10.1093/intimm/dxm090; Quinones M, 2000, J EXP MED, V192, P507, DOI 10.1084/jem.192.4.507; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Takeda Y, 2013, INFLAMM RES, V62, P951, DOI 10.1007/s00011-013-0650-z; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Zhu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041260; Zou GM, 2007, BLOOD, V109, P1917, DOI 10.1182/blood-2006-08-044172	31	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23672	23680		10.1074/jbc.M116.742353	http://dx.doi.org/10.1074/jbc.M116.742353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27637330	hybrid, Green Published			2022-12-26	WOS:000387884400027
J	Campos, BM; Liberato, MV; Alvarez, TM; Zanphorlin, LM; Ematsu, GC; Barud, H; Polikarpov, I; Ruller, R; Gilbert, HJ; Zeri, ACD; Squina, FM				Campos, Bruna Medeia; Liberato, Marcelo Vizona; Alvarez, Thabata Maria; Zanphorlin, Leticia Maria; Ematsu, Gabriela Cristina; Barud, Hernane; Polikarpov, Igor; Ruller, Roberto; Gilbert, Harry J.; de Mattos Zeri, Ana Carolina; Squina, Fabio Marcio			A Novel Carbohydrate-binding Module from Sugar Cane Soil Metagenome Featuring Unique Structural and Carbohydrate Affinity Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; cellulose; glycoside hydrolase; metagenomics; X-ray crystallography	CELLULOSE-BINDING; ENZYMATIC-HYDROLYSIS; X-RAY; CRYSTALLINITY; RECOGNITION; SPECIFICITY; CHITINASE; XYLANASE; QUALITY; DOMAIN	Carbohydrate-binding modules (CBMs) are appended to glycoside hydrolases and can contribute to the degradation of complex recalcitrant substrates such as the plant cell wall. For application in bioethanol production, novel enzymes with high catalytic activity against recalcitrant lignocellulosic material are being explored and developed. In this work, we report the functional and structural study of CBM_E1, which was discovered through a metagenomics approach and is the founding member of a novel CBM family, CBM81. CBM_E1, which is linked to an endoglucanase, displayed affinity for mixed linked 1,3-1,4-glucans, xyloglucan, Avicel, and cellooligosaccharides. The crystal structure of CBM_E1 in complex with cellopentaose displayed a canonical -sandwich fold comprising two -sheets. The planar ligand binding site, observed in a parallel orientation with the -strands, is a typical feature of type A CBMs, although the expected affinity for bacterial crystalline cellulose was not detected. Conversely, the binding to soluble glucans was enthalpically driven, which is typical of type B modules. These unique properties of CBM_E1 are at the interface between type A and type B CBMs.	[Campos, Bruna Medeia] CNPEM, Lab Nacl Biociencias LNBio, BR-13083970 Sao Paulo, Brazil; [Liberato, Marcelo Vizona; Alvarez, Thabata Maria; Zanphorlin, Leticia Maria; Ematsu, Gabriela Cristina; Ruller, Roberto; Squina, Fabio Marcio] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CNBE, Postal 6192, BR-13083970 Sao Paulo, Brazil; [de Mattos Zeri, Ana Carolina] CNPEM, Lab Nacl Luz Sincrotron LNLS, BR-13083970 Sao Paulo, Brazil; [Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13566590 Sao Paulo, Brazil; [Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE 4HH, Tyne & Wear, England; [Barud, Hernane] BioPolMat, Ctr Univ Araraquara UNIARA, BR-14801340 Araraquara, SP, Brazil	Universidade de Sao Paulo; Newcastle University - UK	Squina, FM (corresponding author), CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CNBE, Postal 6192, BR-13083970 Sao Paulo, Brazil.	fabio.squina@bioetanol.org.br	Squina, Fabio/J-8130-2012; Polikarpov, Igor/D-2575-2012; Zeri, Ana/AAY-4799-2021; Liberato, Marcelo V/J-3606-2014	Squina, Fabio/0000-0002-8154-7459; Zeri, Ana/0000-0003-4169-4523; Liberato, Marcelo V/0000-0002-7609-7844; Ruller, Roberto/0000-0001-7501-5176; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Process [2013/06336-0, 2014/04105-4, 2010/11469-1, 2008/58037-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Process; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Process Grants 2013/06336-0, 2014/04105-4, 2010/11469-1, and 2008/58037-9 and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083635; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Borges JC, 2006, ARCH BIOCHEM BIOPHYS, V452, P46, DOI 10.1016/j.abb.2006.05.006; Campos BM, 2014, ACTA CRYSTALLOGR F, V70, P1232, DOI 10.1107/S2053230X14015520; Cohen RL, 2008, MOL BIOL CELL, V19, P4480, DOI 10.1091/mbc.E08-03-0297; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malecki PH, 2013, ACTA CRYSTALLOGR D, V69, P821, DOI 10.1107/S0907444913002011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean BW, 2002, J BIOL CHEM, V277, P50245, DOI 10.1074/jbc.M204433200; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2008, J MOL BIOL, V381, P670, DOI 10.1016/j.jmb.2008.06.006; Okazaki F, 2002, J BACTERIOL, V184, P2399, DOI 10.1128/JB.184.9.2399-2403.2002; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Petkun S, 2015, PEERJ, V3, DOI 10.7717/peerj.1126; Pinto ERP, 2015, J MATER CHEM C, V3, P11581, DOI 10.1039/c5tc02359a; Ponyi T, 2000, BIOCHEMISTRY-US, V39, P985, DOI 10.1021/bi9921642; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	41	13	14	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23734	23743		10.1074/jbc.M116.744383	http://dx.doi.org/10.1074/jbc.M116.744383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27621314	Green Published, hybrid			2022-12-26	WOS:000387884400033
J	Bastos, HN; Osorio, NS; Castro, AG; Ramos, A; Carvalho, T; Meira, L; Araujo, D; Almeida, L; Boaventura, R; Fragata, P; Chaves, C; Costa, P; Portela, M; Ferreira, I; Magalhaes, SP; Rodrigues, F; Sarmento-Castro, R; Duarte, R; Guimaraes, JT; Saraiva, M				Bastos, Helder Novais; Osorio, Nuno S.; Castro, Antonio Gil; Ramos, Angelica; Carvalho, Teresa; Meira, Leonor; Araujo, David; Almeida, Leonor; Boaventura, Rita; Fragata, Patricia; Chaves, Catarina; Costa, Patricio; Portela, Miguel; Ferreira, Ivo; Magalhaes, Sara Pinto; Rodrigues, Fernando; Sarmento-Castro, Rui; Duarte, Raquel; Guimaraes, Joao Tiago; Saraiva, Margarida			A Prediction Rule to Stratify Mortality Risk of Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; DIABETES-MELLITUS; VALIDATION; INPATIENTS; COHORT; ADULTS	Tuberculosis imposes high human and economic tolls, including in Europe. This study was conducted to develop a severity assessment tool for stratifying mortality risk in pulmonary tuberculosis (PTB) patients. A derivation cohort of 681 PTB cases was retrospectively reviewed to generate a model based on multiple logistic regression analysis of prognostic variables with 6-month mortality as the outcome measure. A clinical scoring system was developed and tested against a validation cohort of 103 patients. Five risk features were selected for the prediction model: hypoxemic respiratory failure (OR 4.7, 95% CI 2.8-7.9), age >= 50 years (OR 2.9, 95% CI 1.7-4.8), bilateral lung involvement (OR 2.5, 95% CI 1.44.4), >= 1 significant comorbidity-HIV infection, diabetes mellitus, liver failure or cirrhosis, congestive heart failure and chronic respiratory disease-(OR 2.3, 95% CI 1.3-3.8), and hemoglobin < 12 g/dL (OR 1.8, 95% CI 1.1-3.1). A tuberculosis risk assessment tool (TReAT) was developed, stratifying patients with low (score <= 2), moderate (score 3-5) and high (score >= 6) mortality risk. The mortality associated with each group was 2.9%, 22.9% and 53.9%, respectively. The model performed equally well in the validation cohort. We provide a new, easy-to-use clinical scoring system to identify PTB patients with high-mortality risk in settings with good healthcare access, helping clinicians to decide which patients are in need of closer medical care during treatment.	[Bastos, Helder Novais; Meira, Leonor; Araujo, David; Almeida, Leonor; Boaventura, Rita] Ctr Hosp Sao Joao, Dept Pneumol, Oporto, Portugal; [Bastos, Helder Novais; Osorio, Nuno S.; Castro, Antonio Gil; Chaves, Catarina; Costa, Patricio; Rodrigues, Fernando; Sarmento-Castro, Rui; Saraiva, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Bastos, Helder Novais; Osorio, Nuno S.; Castro, Antonio Gil; Costa, Patricio; Rodrigues, Fernando; Sarmento-Castro, Rui; Saraiva, Margarida] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Ramos, Angelica; Carvalho, Teresa; Guimaraes, Joao Tiago] Ctr Hosp Sao Joao, Dept Clin Pathol, Oporto, Portugal; [Ramos, Angelica; Carvalho, Teresa; Guimaraes, Joao Tiago] Univ Porto, Inst Publ Hlth, Oporto, Portugal; [Fragata, Patricia] Hosp Santo Espirito Ilha Terceira, Dept Internal Med, Angra Do Heroismo, Portugal; [Costa, Patricio] Univ Porto, Fac Psychol & Educ Sci, Oporto, Portugal; [Portela, Miguel] Univ Minho, Sch Econ & Management, Braga, Portugal; [Ferreira, Ivo; Magalhaes, Sara Pinto] Ctr Hosp Porto, Dept Radiol, Oporto, Portugal; [Sarmento-Castro, Rui] Ctr Hosp Porto, Hosp Joaquim Urbano Unit, Dept Infect Dis, Oporto, Portugal; [Duarte, Raquel] Ctr Hosp Vila Nova De Gaia Espinho, Dept Pneumol, Vila Nova De Gaia, Portugal; [Duarte, Raquel] Chest Dis Ctr Vila Nova Gaia, Referral Ctr Multidrug Resistant TB Northern Reg, Vila Nova De Gaia, Portugal; [Duarte, Raquel] Gen Directorate Hlth, Lisbon, Portugal; [Guimaraes, Joao Tiago] Univ Porto, Fac Med, Dept Biochem, Oporto, Portugal; [Saraiva, Margarida] Univ Porto, I3S Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal; [Saraiva, Margarida] Univ Porto, IBMC, Oporto, Portugal	Sao Joao Hospital; Universidade do Minho; Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Universidade do Minho; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Bastos, HN (corresponding author), Ctr Hosp Sao Joao, Dept Pneumol, Oporto, Portugal.; Bastos, HN (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.; Bastos, HN (corresponding author), ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.	hnovaisbastos@ecsaude.uminho.pt	Rodrigues, Fernando/T-5299-2018; Costa, Patrício/A-3072-2013; Novais e Bastos, Helder/F-5722-2011; Osório, Nuno S./D-4773-2013; Portela, Miguel/C-4509-2008; Chaves, Catarina/AAM-9455-2020; Guimarães, João Tiago/T-3079-2017; Osório, Nuno S./AAF-4307-2020; Castro, Gil/T-7584-2018; Saraiva, Margarida/E-8781-2011; Novais Bastos, Helder/E-5191-2017	Rodrigues, Fernando/0000-0001-8436-9398; Costa, Patrício/0000-0002-1201-9177; Novais e Bastos, Helder/0000-0002-1412-4202; Osório, Nuno S./0000-0003-0949-5399; Portela, Miguel/0000-0002-4721-2081; Chaves, Catarina/0000-0003-0131-5728; Guimarães, João Tiago/0000-0003-4836-6311; Osório, Nuno S./0000-0003-0949-5399; Castro, Gil/0000-0002-4684-4183; Saraiva, Margarida/0000-0002-8180-1293; Novais Bastos, Helder/0000-0002-1412-4202; Duarte, Raquel/0000-0003-2257-3099; da Costa Ramos, Angelica/0000-0002-0763-7843; Mendonca Almeida, Leonor/0000-0002-9235-9453	Sociedade Portuguesa de Pneumologia (SPP); Northern Portugal Regional Operational Programme (NORTE), under European Regional Development Fund (FEDER) [NORTE-01-0145-FEDER-000013]; Fundacao Amelia de Mello/Jose de Mello Saude	Sociedade Portuguesa de Pneumologia (SPP); Northern Portugal Regional Operational Programme (NORTE), under European Regional Development Fund (FEDER); Fundacao Amelia de Mello/Jose de Mello Saude	This work was supported by Fundacao Amelia de Mello/Jose de Mello Saude and Sociedade Portuguesa de Pneumologia (SPP). This work was developed under the scope of the project NORTE-01-0145-FEDER-000013, supported by the Northern Portugal Regional Operational Programme (NORTE 2020), under the Portugal 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). NSO is a FCT (Fundacao para a Ciencia e Tecnologia) investigator. MS is an Associate FCT Investigator. The fundershad no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2012, CLIN INFECT DIS, V54, P818, DOI 10.1093/cid/cir939; Balkema CA, 2014, INT J TUBERC LUNG D, V18, P824, DOI 10.5588/ijtld.13.0044; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fournet N, 2006, PUBLIC HEALTH, V120, P976, DOI 10.1016/j.puhe.2006.06.004; Franco I, 2016, REV PORT PNEUMOL, V22, P50, DOI 10.1016/j.rppnen.2015.08.006; Horita N, 2013, INT J TUBERC LUNG D, V17, P54, DOI 10.5588/ijtld.12.0476; Horne DJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-258; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Lanoix JP, 2014, INT J TUBERC LUNG D, V18, P581, DOI 10.5588/ijtld.13.0901; Lee PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092623; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Low S, 2009, INT J TUBERC LUNG D, V13, P328; Lui G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092077; MacIntyre CR, 2001, INT J TUBERC LUNG D, V5, P266; Marcy O, 2014, CLIN INFECT DIS, V59, P435, DOI 10.1093/cid/ciu283; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; Millet JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025315; Moons KGM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001744; NUNN P, 1992, AM REV RESPIR DIS, V146, P849, DOI 10.1164/ajrccm/146.4.849; Pontali E, 2015, REV PORT PNEUMOL, V21, P295, DOI 10.1016/j.rppnen.2015.10.007; Reina S, 2015, INT J TUBERC LUNG D, V19, P1554, DOI 10.5588/ijtld.0632; Sales Anne E, 2004, Health Qual Life Outcomes, V2, P49, DOI 10.1186/1477-7525-2-49; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; Perrechi MCT, 2011, J BRAS PNEUMOL, V37, P783, DOI 10.1590/S1806-37132011000600012; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Valade S, 2012, CAN J INFECT DIS MED, V23, P173, DOI 10.1155/2012/361292; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Walpola HC, 2003, INT J TUBERC LUNG D, V7, P742; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; WHO, 2010, GUID TREATM TUB; Wisnivesky JP, 2005, ARCH INTERN MED, V165, P453, DOI 10.1001/archinte.165.4.453; World Health Organization, 2015, GLOB TUB REP 2015; Yen YF, 2012, T ROY SOC TROP MED H, V106, P303, DOI 10.1016/j.trstmh.2012.01.011	40	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162797	10.1371/journal.pone.0162797	http://dx.doi.org/10.1371/journal.pone.0162797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636095	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700015
J	Afzal, SM; Razvi, MAN; Khan, SA; Osman, OI; Bakry, AH; Asiri, AM				Afzal, S. M.; Razvi, M. A. N.; Khan, Salman A.; Osman, Osman I.; Bakry, Ahmed H.; Asiri, Abdullah M.			Physicochemical and Nonlinear Optical Properties of Novel Environmentally Benign Heterocyclic Azomethine Dyes: Experimental and Theoretical Studies	PLOS ONE			English	Article							STATE DIPOLE-MOMENTS; REVERSE SATURABLE ABSORPTION; MICROWAVE-ASSISTED SYNTHESIS; SOLVENT POLARITY PARAMETER; Z-SCAN; EXCITED-STATE; SCHIFF-BASE; MOLECULAR-STRUCTURE; LIMITING PROPERTIES; HYPERPOLARIZABILITIES	Novel heterocyclic azomethine dyes were prepared by the reaction of anthracene-9-carbaldehyde with different heterocyclic amines under microwave irradiation. Structures of the azomethine dyes were confirmed by the elemental analysis, mass spectrometry and several spectroscopic techniques. We studied absorbance and fluorescence spectra of the azomethine dyes in various solvents. They are found to be good absorbers and emitters. We also report photophysical properties like, extinction coefficient, oscillator strength, stokes shift and transition dipole moment. This reflects physicochemical behaviors of synthesized dyes. In addition, their intramolecular charge transfer and nonlinear optical properties, supported by natural bond orbital technique, were also studied computationally by density functional theory. The negative nonlinear refractive index and nonlinear absorption coefficient were measured for these dyes using the closed and open aperture Z-scan technique with a continuous wave helium-neon laser. These are found to vary linearly with solution concentration.	[Afzal, S. M.; Razvi, M. A. N.; Bakry, Ahmed H.] King Abdulaziz Univ, Fac Sci, Dept Phys, POB 80203, Jeddah 21589, Saudi Arabia; [Khan, Salman A.; Osman, Osman I.; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, POB 80203, Jeddah 21589, Saudi Arabia; [Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat, POB 80203, Jeddah 21589, Saudi Arabia; [Afzal, S. M.] Aligarh Muslim Univ, Dept Phys, Aligarh 202002, Uttar Pradesh, India; [Osman, Osman I.] Univ Khartoum, Fac Sci, Dept Chem, POB 321, Khartoum 11111, Sudan	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Aligarh Muslim University; University of Khartoum	Afzal, SM (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Phys, POB 80203, Jeddah 21589, Saudi Arabia.; Afzal, SM (corresponding author), Aligarh Muslim Univ, Dept Phys, Aligarh 202002, Uttar Pradesh, India.	drsmafzal62@gmail.com	Asiri, Abdullah M./C-3458-2009; RAZVI, MIR ALI NAQI/D-5601-2013; I.Osman, Osman/F-1032-2010	Asiri, Abdullah M./0000-0001-7905-3209; RAZVI, MIR ALI NAQI/0000-0003-2729-0813; I.Osman, Osman/0000-0003-4436-276X; Khan, Salman Ahmad/0000-0002-3892-2241	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [130-857-D1435]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. (130-857-D1435). The authors, therefore, acknowledge the DSR technical and financial support (SMA).	ACREE WE, 1994, J PHYS CHEM-US, V98, P2537, DOI 10.1021/j100061a007; Afzal SM, 2016, J FLUORESC, V26, P559, DOI 10.1007/s10895-015-1740-9; Asiri A.M., 2010, ORG CHEM INSIGHT, V3, P1; Asiri AM, 2012, B KOREAN CHEM SOC, V33, P1900, DOI 10.5012/bkcs.2012.33.6.1900; Asiri AM, 2010, MOLECULES, V15, P6850, DOI 10.3390/molecules15106850; Aurell MJ, 2004, TETRAHEDRON, V60, P11503, DOI 10.1016/j.tet.2004.09.057; BIONDIC MC, 1994, J PHOTOCH PHOTOBIO A, V77, P149, DOI 10.1016/1010-6030(94)80038-3; Chattaraj PK, 2003, J AM CHEM SOC, V125, P2705, DOI 10.1021/ja0276063; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Dworczak R, 1997, DYES PIGMENTS, V34, P13, DOI 10.1016/S0143-7208(96)00055-1; Frisch G. W., 2013, GAUSSIAN 09; Frisch MJ, 2007, GAUSSVIEW REFERENCE; Gao Y, 2007, APPL PHYS B-LASERS O, V88, P255, DOI 10.1007/S00340-007-2687-6; Garza AJ, 2015, J PHYS CHEM B, V119, P1202, DOI 10.1021/jp507226v; Garza AJ, 2013, THEOR CHEM ACC, V132, DOI 10.1007/s00214-013-1384-2; Gayathri C, 2008, SPECTROCHIM ACTA A, V69, P980, DOI 10.1016/j.saa.2007.05.060; Geethakrishnan T, 2007, OPT COMMUN, V270, P424, DOI 10.1016/j.optcom.2006.09.035; Geronikaki Athina, 2003, Farmaco (Lausanne), V58, P489, DOI 10.1016/S0014-827X(03)00065-X; Grivani G, 2012, INORG CHEM COMMUN, V18, P15, DOI 10.1016/j.inoche.2011.12.044; Hamryszak L, 2012, J MOL LIQ, V165, P12, DOI 10.1016/j.molliq.2011.10.001; IIJIMA T, 1973, B CHEM SOC JPN, V46, P2311, DOI 10.1246/bcsj.46.2311; Iwan A, 2011, PROG POLYM SCI, V36, P1277, DOI 10.1016/j.progpolymsci.2011.05.001; Jacquemin D, 2007, J MOL STRUC-THEOCHEM, V804, P31, DOI 10.1016/j.theochem.2006.10.012; Jeux V, 2015, DYES PIGMENTS, V113, P402, DOI 10.1016/j.dyepig.2014.09.012; Jiao T, 2006, J COLLOID INTERF SCI, V299, P815, DOI 10.1016/j.jcis.2006.02.037; Kaatz P, 1998, J CHEM PHYS, V108, P849, DOI 10.1063/1.475448; Karabacak M, 2012, SPECTROCHIM ACTA A, V86, P590, DOI 10.1016/j.saa.2011.11.022; Kaya I, 2010, SYNTHETIC MET, V160, P911, DOI 10.1016/j.synthmet.2010.01.044; Khan S.A., 2013, EUR J MED CHEM, V4, P454, DOI [10.5155/eurjchem.4.4.454-458.784, DOI 10.5155/EURJCHEM.4.4.454-458.784]; Khan SA, 2015, SPECTROCHIM ACTA A, V137, P1100, DOI 10.1016/j.saa.2014.08.065; Khanmohammadi H, 2012, DYES PIGMENTS, V94, P163, DOI 10.1016/j.dyepig.2011.12.013; Kiran AJ, 2006, J PHYS B-AT MOL OPT, V39, P3747, DOI 10.1088/0953-4075/39/18/005; Kong LY, 2005, CHEM PHYS LETT, V416, P176, DOI 10.1016/j.cplett.2005.09.074; Krawczyk P, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2651-z; Kumar S, 2001, SPECTROCHIM ACTA A, V57, P41, DOI 10.1016/S1386-1425(00)00330-9; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LI CF, 1994, PHYS REV A, V49, P1149, DOI 10.1103/PhysRevA.49.1149; Liu XD, 2001, OPT COMMUN, V197, P431, DOI 10.1016/S0030-4018(01)01406-7; MANCINI PME, 1995, J PHYS ORG CHEM, V8, P617, DOI 10.1002/poc.610080908; Mendis BAS, 2004, J MOL STRUC-THEOCHEM, V678, P31, DOI 10.1016/j.theochem.2004.02.027; Nalwa H.S, 1997, HDB ORGANIC CONDUCTI, V1st ed.; NISHIKAWA T, 1955, J CHEM PHYS, V23, P1735, DOI 10.1063/1.1742444; Niu HJ, 2004, MATER LETT, V58, P2979, DOI 10.1016/j.matlet.2004.05.007; Patel NB, 2010, ACTA POL PHARM, V67, P45; Pearson RG, 2005, J CHEM SCI, V117, P369, DOI 10.1007/BF02708340; Pramodini S, 2014, OPT LASER TECHNOL, V62, P12, DOI 10.1016/j.optlastec.2014.02.003; RAVI M, 1995, J CHEM SOC FARADAY T, V91, P2739, DOI 10.1039/ft9959102739; RAVI M, 1994, J PHYS CHEM-US, V98, P9133, DOI 10.1021/j100088a007; Razvi MAN, 2015, MATER LETT, V144, P131, DOI 10.1016/j.matlet.2015.01.036; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; REED AE, 1983, J CHEM PHYS, V78, P4066, DOI 10.1063/1.445134; Reis H, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2211611; Ronchi A, 2003, SYNTHETIC MET, V139, P831, DOI 10.1016/S0379-6779(03)00274-1; SAID AA, 1992, J OPT SOC AM B, V9, P405, DOI 10.1364/JOSAB.9.000405; Sendhil K, 2006, OPT LASER TECHNOL, V38, P512, DOI 10.1016/j.optlastec.2004.12.005; Sharbati MT, 2011, J LUMIN, V131, P553, DOI 10.1016/j.jlumin.2010.10.016; SHEIKBAHAE M, 1989, OPT LETT, V14, P955, DOI 10.1364/OL.14.000955; SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394; Sheikhshoaie I, 2006, DYES PIGMENTS, V70, P91, DOI 10.1016/j.dyepig.2005.04.011; Shin CK, 2000, J KOREAN PHYS SOC, V36, P356; Silverstein R., 1977, SPECTROMETRIC IDENTI; Solomon VR, 2009, BIOORGAN MED CHEM, V17, P7585, DOI 10.1016/j.bmc.2009.08.068; Souza RF, 2006, ADV MAT STRUCTURES; Sriram D, 2006, BIOORG MED CHEM LETT, V16, P2127, DOI 10.1016/j.bmcl.2006.01.050; STAHELIN M, 1993, J CHEM PHYS, V98, P5595, DOI 10.1063/1.464904; Sukumaran VS, 2006, PHYS LETT A, V359, P467, DOI 10.1016/j.physleta.2006.06.079; Sun WF, 2000, P SOC PHOTO-OPT INS, V4106, P280, DOI 10.1117/12.408515; Thanthiriwatte KS, 2002, J MOL STRUC-THEOCHEM, V617, P169, DOI 10.1016/S0166-1280(02)00419-0; Turro NJ, 1965, MOL PHOTOCHEMISTRY F; Vydrov OA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2409292; WILLETTS A, 1992, J CHEM PHYS, V97, P7590, DOI 10.1063/1.463479; Yu BL, 1997, OPT MATER, V7, P103, DOI 10.1016/S0925-3467(96)00067-5	72	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0161613	10.1371/journal.pone.0161613	http://dx.doi.org/10.1371/journal.pone.0161613			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631371	Green Submitted, gold, Green Published			2022-12-26	WOS:000383706900020
J	Butler, J; Stewart, CR; Layton, DS; Phommachanh, P; Harper, J; Payne, J; Evans, RM; Valdeter, S; Walker, S; Harvey, G; Shan, SH; Bruce, MP; Rootes, CL; Gough, TJ; Rohringer, A; Peck, GR; Fardy, SJ; Karpala, AJ; Johnson, D; Wang, JN; Douangngeun, B; Morrissy, C; Wong, FYK; Bean, AGD; Bingham, J; Williams, DT				Butler, Jeffrey; Stewart, Cameron R.; Layton, Daniel S.; Phouvong Phommachanh; Harper, Jennifer; Payne, Jean; Evans, Ryan M.; Valdeter, Stacey; Walker, Som; Harvey, Gemma; Shan, Songhua; Bruce, Matthew P.; Rootes, Christina L.; Gough, Tamara J.; Rohringer, Andreas; Peck, Grantley R.; Fardy, Sarah J.; Karpala, Adam J.; Johnson, Dayna; Wang, Jianning; Douangngeun, Bounlom; Morrissy, Christopher; Wong, Frank Y. K.; Bean, Andrew G. D.; Bingham, John; Williams, David T.			Novel Reassortant H5N6 Influenza A Virus from the Lao People's Democratic Republic Is Highly Pathogenic in Chickens	PLOS ONE			English	Article							AVIAN INFLUENZA; CHINA; HEMAGGLUTININ; INFECTION; FERRETS; DUCKS; PATHOBIOLOGY; TRANSMISSION; SUBLINEAGES; APOPTOSIS	Avian influenza viruses of H5 subtype can cause highly pathogenic disease in poultry. In March 2014, a new reassortant H5N6 subtype highly pathogenic avian influenza virus emerged in Lao People's Democratic Republic. We have assessed the pathogenicity, pathobiology and immunological responses associated with this virus in chickens. Infection caused moderate to advanced disease in 6 of 6 chickens within 48 h of mucosal inoculation. High virus titers were observed in blood and tissues (kidney, spleen, liver, duodenum, heart, brain and lung) taken at euthanasia. Viral antigen was detected in endothelium, neurons, myocardium, lymphoid tissues and other cell types. Pro-inflammatory cytokines were elevated compared to non-infected birds. Our study confirmed that this new H5N6 reassortant is highly pathogenic, causing disease in chickens similar to that of Asian H5N1 viruses, and demonstrated the ability of such clade 2.3.4-originH5 viruses to reassort with non-N1 subtype viruses while maintaining a fit and infectious phenotype. Recent detection of influenza H5N6 poultry infections in Lao PDR, China and Viet Nam, as well as six fatal human infections in China, demonstrate that these emergent highly pathogenic H5N6 viruses may be widely established in several countries and represent an emerging threat to poultry and human populations.	[Butler, Jeffrey; Stewart, Cameron R.; Layton, Daniel S.; Harper, Jennifer; Payne, Jean; Evans, Ryan M.; Valdeter, Stacey; Walker, Som; Harvey, Gemma; Shan, Songhua; Bruce, Matthew P.; Rootes, Christina L.; Gough, Tamara J.; Rohringer, Andreas; Peck, Grantley R.; Fardy, Sarah J.; Karpala, Adam J.; Johnson, Dayna; Wang, Jianning; Morrissy, Christopher; Wong, Frank Y. K.; Bean, Andrew G. D.; Bingham, John; Williams, David T.] CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia; [Phouvong Phommachanh; Douangngeun, Bounlom] Natl Anim Hlth Lab, Viangchan, Laos	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Williams, DT (corresponding author), CSIRO Australian Anim Hlth Lab, Geelong, Vic, Australia.	d.williams@csiro.au	Stewart, Cameron R/E-6823-2011; Rootes, Christina/AAS-6972-2021; Gough, Tamara/P-2107-2015; Layton, Daniel S/J-6117-2017; Bean, Andrew G/H-8664-2013; Williams, David T/H-6750-2013; Bingham, John/H-8591-2013; shan, songhua/H-8650-2013; Bruce, Matthew/AAU-5684-2021; Rootes, Christina L/H-4905-2013; Wong, Frank/H-1950-2013	Rootes, Christina/0000-0002-7448-8307; Bean, Andrew G/0000-0002-4585-3811; Williams, David T/0000-0002-7169-149X; Bingham, John/0000-0003-2360-3827; Rootes, Christina L/0000-0002-7448-8307; Wong, Frank/0000-0003-2471-9549; Stewart, Cameron/0000-0002-3395-7859; Butler, Jeff/0000-0001-7971-9904; Rohringer, Andreas/0000-0003-4351-7184	Australian Government Department of Agriculture; Commonwealth Scientific and Industrial Research Organisation; National CollaborativeResearch Infrastructure Strategy through the AAHL Collaborative Biosecurity Research Facility	Australian Government Department of Agriculture(Australian Government); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); National CollaborativeResearch Infrastructure Strategy through the AAHL Collaborative Biosecurity Research Facility	This study was funded by the Australian Government Department of Agriculture (http://www.agriculture.gov.au; JB, JH, JP, RME, SV, SW, GH, SS, DJ, JW, CM, FYKW, JB, DTW), the Commonwealth Scientific and Industrial Research Organisation (http://www.csiro.au; CRS, DSL, CLR, TJG, AR, SJF, AJK, AGDB) and the National CollaborativeResearch Infrastructure Strategy (https://www.education.gov.au/national-collaborative-research-infrastructure-strategy-ncris) through the AAHL Collaborative Biosecurity Research Facility (MPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Bi YH, 2015, J GEN VIROL, V96, P975, DOI 10.1099/vir.0.000056; Boonnak K, 2014, J IMMUNOL, V192, P5906, DOI 10.4049/jimmunol.1302992; Burggraaf S, 2014, VIRUS RES, V185, P23, DOI 10.1016/j.virusres.2014.03.012; Burggraaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014561; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Curran JM, 2014, AVIAN DIS, V58, P53, DOI 10.1637/10531-031513-Reg.1; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Food and Agricultural Organization of the United Nations, 2014, AV INFL H5N6 LAT ADD; Food and Agriculture Organization of the United Nations, 2011, 171 FAO UN; Heine HG, 2007, AVIAN DIS, V51, P370, DOI 10.1637/7587-040206R.1; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Hurt AC, 2010, J VIROL, V84, P9427, DOI 10.1128/JVI.00373-10; Kim YI, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.75; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; Lee YJ, 2014, EMERG INFECT DIS, V20, P1087, DOI 10.3201/eid2006.140233; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; NHMRC, 2013, AUSTR COD CAR US AN, V8th; OIE, 2015, AVIAN INFLUENZA; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Qi X, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00706-14; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shen HQ, 2015, EMERG INFECT DIS, V21, P1261, DOI 10.3201/eid2107.140838; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; VANCAMPEN H, 1989, J GEN VIROL, V70, P467, DOI 10.1099/0022-1317-70-2-467; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; Wibawa H, 2013, COMP IMMUNOL MICROB, V36, P175, DOI 10.1016/j.cimid.2012.12.001; Wong FYK, 2015, EMERG INFECT DIS, V21, P511, DOI 10.3201/eid2103.141488; World Health Organization, INFL HUM AN INT SUMM; World Health Organization, 2016, INFL HUM AN INT SUMM; World Organization for Animal Health, UPD HIGHL PATH AV IN; Wu HB, 2015, INFECT GENET EVOL, V31, P64, DOI 10.1016/j.meegid.2015.01.019; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yamamoto Y, 2007, AVIAN DIS, V51, P744, DOI 10.1637/0005-2086(2007)51[744:PICDII]2.0.CO;2; Zhao G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046183; Zhao KK, 2013, VET MICROBIOL, V163, P351, DOI 10.1016/j.vetmic.2012.12.025	41	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162375	10.1371/journal.pone.0162375	http://dx.doi.org/10.1371/journal.pone.0162375			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631618	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900042
J	Modjeski, KL; Ture, SK; Field, DJ; Cameron, SJ; Morrell, CN				Modjeski, Kristina L.; Ture, Sara K.; Field, David J.; Cameron, Scott J.; Morrell, Craig N.			Glutamate Receptor Interacting Protein 1 Mediates Platelet Adhesion and Thrombus Formation	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FRASER-SYNDROME; AMPA RECEPTORS; MICE LACKING; GRIP1; GPIB; IDENTIFICATION; TRAFFICKING; ACTIVATION; MECHANISMS	Thrombosis-associated pathologies, such as myocardial infarction and stroke, are major causes of morbidity and mortality worldwide. Because platelets are necessary for hemostasis and thrombosis, platelet directed therapies must balance inhibiting platelet function with bleeding risk. Glutamate receptor interacting protein 1 (GRIP1) is a large scaffolding protein that localizes and organizes interacting proteins in other cells, such as neurons. We have investigated the role of GRIP1 in platelet function to determine its role as a molecular scaffold in thrombus formation. Platelet-specific GRIP1(-/-) mice were used to determine the role of GRIP1 in platelets. GRIP1(-/-) mice had normal platelet counts, but a prolonged bleeding time and delayed thrombus formation in a FeCl3-induced vessel injury model. In vitro stimulation of WT and GRIP1(-/-) platelets with multiple agonists showed no difference in platelet activation. However, in vivo platelet rolling velocity after endothelial stimulation was significantly greater in GRIP1(-/-) platelets compared to WT platelets, indicating a potential platelet adhesion defect. Mass spectrometry analysis of GRIP1 platelet immunoprecipitation revealed enrichment of GRIP1 binding to GPIb-IX complex proteins. Western blots confirmed the mass spectrometry findings that GRIP1 interacts with GPIb alpha, GPIb beta, and 14-3-3. Additionally, in resting GRIP1(-/-) platelets, GPIba and 14-3-3 have increased interaction compared to WT platelets. GRIP1 interactions with the GPIb-IX binding complex are necessary for normal platelet adhesion to a stimulated endothelium.	[Modjeski, Kristina L.; Ture, Sara K.; Field, David J.; Cameron, Scott J.; Morrell, Craig N.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Modjeski, Kristina L.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Morrell, CN (corresponding author), Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	Craig_Morrell@urmc.rochester.edu	Cameron, Scott/AAW-8429-2021	Cameron, Scott/0000-0002-9616-1540	American Heart Association [13EIA14250023]; National Institutes of Health [R01HL124018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124018] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (13EIA14250023) and the National Institutes of Health (R01HL124018).	Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Baier PC, 2009, J PSYCHIATR RES, V43, P585, DOI 10.1016/j.jpsychires.2008.07.005; Baig A, 2009, PLATELETS, V20, P446, DOI 10.3109/09537100903137314; Bergmeier W, 2006, P NATL ACAD SCI USA, V103, P16900, DOI 10.1073/pnas.0608207103; Bladt F, 2002, P NATL ACAD SCI USA, V99, P6816, DOI 10.1073/pnas.092130099; Bryckaert M, 2015, CELL MOL LIFE SCI, V72, P307, DOI 10.1007/s00018-014-1743-8; Charych EI, 2006, J NEUROCHEM, V97, P884, DOI 10.1111/j.1471-4159.2006.03795.x; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Chater TE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00401; De Cuyper IM, 2013, BLOOD, V121, pE70, DOI 10.1182/blood-2012-06-437723; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dong HL, 1999, J NEUROSCI, V19, P6930, DOI 10.1523/JNEUROSCI.19-16-06930.1999; Estevez B, 2016, BLOOD, V127, P626, DOI 10.1182/blood-2015-04-638387; Geiger JC, 2014, DEV CELL, V28, P381, DOI 10.1016/j.devcel.2014.01.018; Gitz E, 2013, HAEMATOLOGICA, V98, P1810, DOI 10.3324/haematol.2013.087221; Goubau C, 2014, DEV MED CHILD NEUROL, V56, P724, DOI 10.1111/dmcn.12421; Hammond JC, 2010, NEUROPSYCHOPHARMACOL, V35, P2110, DOI 10.1038/npp.2010.87; HARDISTY RM, 1955, J PHYSIOL-LONDON, V130, P711, DOI 10.1113/jphysiol.1955.sp005437; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; Hoffman LM, 2003, MOL CELL BIOL, V23, P70, DOI 10.1128/MCB.23.1.70-79.2003; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628; Jones CI, 2014, J THROMB HAEMOST, V12, P1342, DOI 10.1111/jth.12620; Mangin P, 2004, BLOOD, V104, P420, DOI 10.1182/blood-2003-08-2881; Mejias R, 2011, P NATL ACAD SCI USA, V108, P4920, DOI 10.1073/pnas.1102233108; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Morrell CN, 2008, J EXP MED, V205, P575, DOI 10.1084/jem.20071474; Ni HY, 2000, J CLIN INVEST, V106, P385, DOI 10.1172/JCI9896; Polgar J, 1999, BLOOD, V94, P1313, DOI 10.1182/blood.V94.4.1313.416k27_1313_1318; Schanze D, 2014, AM J MED GENET A, V164, P837, DOI 10.1002/ajmg.a.36343; Sun H, 2009, CIRC RES, V105, P595, DOI 10.1161/CIRCRESAHA.109.198861; Swaim AF, 2010, J IMMUNOL, V185, P6999, DOI 10.4049/jimmunol.1000929; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Vogel MJ, 2012, J MED GENET, V49, P303, DOI 10.1136/jmedgenet-2011-100590; Wang L, 2014, THROMB HAEMOSTASIS, V111, P873, DOI 10.1160/TH13-09-0738; Ware J, 2000, P NATL ACAD SCI USA, V97, P2803, DOI 10.1073/pnas.050582097; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0160638	10.1371/journal.pone.0160638	http://dx.doi.org/10.1371/journal.pone.0160638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631377	gold, Green Published, Green Submitted			2022-12-26	WOS:000383706900010
J	Sun, XL; Yang, LL; Yan, XF; Sun, YY; Zhao, DL; Ji, Y; Wang, K; Chen, XY; Shen, BZ				Sun, Xilin; Yang, Lili; Yan, Xuefeng; Sun, Yingying; Zhao, Dongliang; Ji, Yang; Wang, Kai; Chen, Xiaoyuan; Shen, Baozhong			DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin	PLOS ONE			English	Article							ALBUMIN-BOUND PACLITAXEL; METASTATIC BREAST-CANCER; SQUAMOUS-CELL CARCINOMA; NAB-PACLITAXEL; ANTIANGIOGENIC THERAPY; LUNG-CANCER; CHEMOTHERAPY; EFFICACY; STAGE; ANTITUMOR	Our previous studies revealed molecular alterations of tumor vessels, varying from immature to mature alterations, resulting from Abraxane, and demonstrated that the integrin-specific PET tracer F-18-FPPRGD2 can be used to noninvasively monitor such changes. However, changes in the tumor vasculature at functional levels such as perfusion and permeability are also important for monitoring Abraxane treatment outcomes in patients with cancer. The purpose of this study is to further investigate the vascular response during Abraxane therapy and the effectiveness of its synergistic interaction with cisplatin using Dynamic contrast enhanced-magnetic resonance imaging (DCE-MRI). Thirty MDA-MB-435 tumor mice were randomized into three groups: PBS control (C group), Abraxane only (A group), and sequential treatment with Abraxane followed by cisplatin (A-P group). Tumor volume was monitored based on caliper measurements. A DCE-MRI protocol was performed at baseline and day 3. The K-trans, K-ep and V-e were calculated and compared with CD31, alpha-SMA, and Ki67 histology data. Sequential treatment with Abraxane followed by cis-platin produced a significantly greater inhibition of tumor growth during the three weeks of the observation period. Decreases in K-trans and K-ep for the A and A-P groups were observed on day 3. Immunohistological staining suggested vascular remodeling during the Abraxane therapy. The changes in K-trans and K-ep values were correlated with alterations in the permeability of the tumor vasculature induced by the Abraxane treatment. In conclusion, Abraxane- mediated permeability variations in tumor vasculature can be quantitatively visualized by DCE-MRI, making this a useful method for studying the effects of early cancer treatment, especially the early vascular response. Vascular remodeling by Abraxane improves the efficiency of cisplatin delivery and thus results in a favorable treatment outcome.	[Sun, Xilin; Yan, Xuefeng; Sun, Yingying; Zhao, Dongliang; Ji, Yang; Wang, Kai; Shen, Baozhong] Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China; [Sun, Xilin; Yang, Lili; Yan, Xuefeng; Sun, Yingying; Zhao, Dongliang; Ji, Yang; Wang, Kai; Shen, Baozhong] Harbin Med Univ, Mol Imaging Res Ctr, Harbin, Heilongjiang, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	Harbin Medical University; Harbin Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Shen, BZ (corresponding author), Harbin Med Univ, Hosp 4, Dept Radiol, Harbin, Heilongjiang, Peoples R China.; Shen, BZ (corresponding author), Harbin Med Univ, Mol Imaging Res Ctr, Harbin, Heilongjiang, Peoples R China.	shenbzh@vip.sina.com	chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; Yan, Xuefeng/I-9936-2019	Yan, Xuefeng/0000-0002-9803-5222	National Basic Research Program of China [2015CB931800]; National Natural Science Foundation of China [81101088, 81471724, 81130028, 31210103913]; Natural Science Foundation of Heilongjiang Province of China [LC2013C26]; Reserved Medical Imaging and Nuclear medicine Talent Team Foundation of Heilongjiang Province; Heilongjiang Province Department of Education Science and Technology Research Projects [12521184]; Innovation Talents Foundation of Harbin Science and Technology Bureau [2014RFQGJ011]; Youth Science WU LIANDE Foundation of Harbin Medical University [WLD-QN1119]; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Reserved Medical Imaging and Nuclear medicine Talent Team Foundation of Heilongjiang Province; Heilongjiang Province Department of Education Science and Technology Research Projects; Innovation Talents Foundation of Harbin Science and Technology Bureau; Youth Science WU LIANDE Foundation of Harbin Medical University; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Basic Research Program of China (2015CB931800), the National Natural Science Foundation of China (81101088, 81471724,81130028, 31210103913), Natural Science Foundation of Heilongjiang Province of China (LC2013C26), Reserved Medical Imaging and Nuclear medicine Talent Team Foundation of Heilongjiang Province, Heilongjiang Province Department of Education Science and Technology Research Projects (12521184), Innovation Talents Foundation of Harbin Science and Technology Bureau (2014RFQGJ011), The Youth Science WU LIANDE Foundation of Harbin Medical University (WLD-QN1119), and the Intramural Research Program, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fang Y, 2014, ASIAN PAC J CANCER P, V15, P7453, DOI 10.7314/APJCP.2014.15.17.7453; Gambini D, 2009, TUMORI, V95, P828, DOI 10.1177/030089160909500631; Harries M, 2005, J CLIN ONCOL, V23, P7768, DOI 10.1200/JCO.2005.08.002; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jensen LR, 2010, NMR BIOMED, V23, P56, DOI 10.1002/nbm.1426; Kaiser CG, 2015, EUR RADIOL, V25, P1793, DOI 10.1007/s00330-014-3580-4; Loong HH, 2014, EUR J CANCER, V50, P2263, DOI 10.1016/j.ejca.2014.05.021; Loveless ME, 2012, NEOPLASIA, V14, P54, DOI 10.1593/neo.111478; Myoung H, 2001, CANCER LETT, V163, P191, DOI 10.1016/S0304-3835(00)00701-1; O'Shaughnessy J, 2013, BREAST CANCER RES TR, V138, P829, DOI 10.1007/s10549-013-2447-8; Riham H, 2011, AM J ROENTGENOL, V197, P1498; Rizvi NA, 2008, J CLIN ONCOL, V26, P639, DOI 10.1200/JCO.2007.10.8605; Sun S, 2014, INT J NANOMED, V9, P1443, DOI 10.2147/IJN.S58275; Sun XL, 2011, J NUCL MED, V52, P140, DOI 10.2967/jnumed.110.080606; Volk LD, 2008, NEOPLASIA, V10, P613, DOI 10.1593/neo.08302; Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003; Yang Q, 2015, MED PHYS, V42, P103, DOI 10.1118/1.4903280; Yardley DA, 2013, J CONTROL RELEASE, V170, P365, DOI 10.1016/j.jconrel.2013.05.041; Zheng DC, 2014, J MAGN RESON IMAGING, V39, P940, DOI 10.1002/jmri.24249	21	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162601	10.1371/journal.pone.0162601	http://dx.doi.org/10.1371/journal.pone.0162601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632532	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900058
J	Buffarini, R; Restrepo-Mendez, MC; Silveira, VM; Miranda, JJ; Goncalves, HD; Oliveira, IO; Horta, BL; Gigante, DP; Menezes, AM; Assuncao, MCF				Buffarini, Romina; Restrepo-Mendez, Maria Clara; Silveira, Vera M.; Miranda, Jaime J.; Goncalves, Helen D.; Oliveira, Isabel O.; Horta, Bernardo L.; Gigante, Denise P.; Menezes, Ana Maria; Assuncao, Maria Cecilia F.			Distribution of Glycated Haemoglobin According to Early-Life and Contemporary Characteristics in Adolescents and Adults without Diabetes: The 1982 and 1993 Pelotas Birth Cohorts	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR RISK-FACTORS; 3RD NATIONAL-HEALTH; BODY-MASS INDEX; NONDIABETIC INDIVIDUALS; ATHEROSCLEROSIS RISK; WAIST CIRCUMFERENCE; ETHNIC-DIFFERENCES; BLOOD-PRESSURE; GROWTH	Aim Glycated haemoglobin (HbA(1c)), a marker of glucose control in individuals with diabetes mellitus, is also related with the incidence of cardiometabolic risk in populations free of disease. The aim of this study was to describe the distribution of HbA(1c) levels according to early-life and contemporary factors in adolescents and adults without diabetes mellitus. Methods HbA(1c) was measured in adults aged 30 years and adolescents aged 18 years who are participants in the 1982 and 1993 Pelotas Birth Cohorts, respectively. Bivariate and multivariate analyses were performed to describe the HbA(1c) mean values according to early-life and contemporary characteristics collected prospectively since birth. Results The distribution of the HbA(1c) was approximately normal in both cohorts, with a mean (SD) 5.10% (0.43) in the 1982 cohort, and 4.89% (0.50) in the 1993 cohort. HbA(1c) mean levels were significantly higher in individuals self-reportedas black/brown skin color compared to those self-reportedas white in both cohorts. Parental history of diabetes was associated with higher HbA(1c) mean in adults, while stunting at one year old presented an inverse relation with the outcome in adolescents. No other early and contemporary factors were associated with HbA(1c) levels in adults or adolescents. Conclusions We found a consistent relationship between HbA1c and skin color in both cohorts. Further research is needed to understand the role of genomic ancestry on levels of HbA1c concentrations which may informpolicies and preventive actions for diabetes mellitus and cardiometabolic risk.	[Buffarini, Romina; Goncalves, Helen D.; Horta, Bernardo L.; Gigante, Denise P.; Menezes, Ana Maria] Univ Fed Pelotas, Postgrad Program Epidemiol, Marechal Deodoro 1160,3rd Floor, BR-96020220 Pelotas, Brazil; [Restrepo-Mendez, Maria Clara] Univ Fed Pelotas, Int Ctr Equity Hlth, Rua Marechal Deodoro,1160 3rd Floor, BR-96020220 Pelotas, Brazil; [Silveira, Vera M.] Univ Fed Pelotas, Fac Med, Dept Clin Med, Rua Felix Cunha 614, BR-96010000 Pelotas, Brazil; [Miranda, Jaime J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Oliveira, Isabel O.] Univ Fed Pelotas, Dept Physiol & Pharmacol, Campus Univ S-N, BR-96010900 Pelotas, Brazil; [Assuncao, Maria Cecilia F.] Univ Fed Pelotas, Sch Nutr, Dept Nutr, Campus Anglo,Gomes Carneiro 1, BR-96010900 Pelotas, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidade Federal de Pelotas; Universidad Peruana Cayetano Heredia; Universidade Federal de Pelotas; Universidade Federal de Pelotas	Buffarini, R (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Marechal Deodoro 1160,3rd Floor, BR-96020220 Pelotas, Brazil.	romibuffarini@gmail.com	Gonçalves, Helen/P-2381-2018; Horta, Bernardo/A-7604-2008; Menezes, Ana MB/G-7266-2012; Gonçalves, Helen/M-1603-2017	Horta, Bernardo/0000-0001-9843-412X; Menezes, Ana MB/0000-0002-2996-9427; Gonçalves, Helen/0000-0001-6470-3352; Reis, AlessanRSS/0000-0001-8486-7469; Restrepo-Mendez, Maria Clara/0000-0001-7714-7340	International Development Research Center (Canada); World Health Organization (WHO); Overseas Development Administration (U.K.); Brazilian Council for Scientific and Technological Development (CNPq); Rio Grande do Sul State Research Foundation (FAPERGS); Wellcome Trust [072403/Z/03/Z]; European Union; National Program for Centers of Excellence (Brazil); National Research Council (Brazil); Ministry of Health (Brazil)	International Development Research Center (Canada)(CGIAR); World Health Organization (WHO)(World Health Organization); Overseas Development Administration (U.K.); Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio Grande do Sul State Research Foundation (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Wellcome Trust(Wellcome Trust); European Union(European Commission); National Program for Centers of Excellence (Brazil); National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (Brazil)	The 1982 cohort study, in its many stages, was supported by the International Development Research Center (Canada), the World Health Organization (WHO), the Overseas Development Administration (U.K.), the Brazilian Council for Scientific and Technological Development (CNPq), and the Rio Grande do Sul State Research Foundation (FAPERGS). The 1993 cohort study was supported by the Wellcome Trust initiative entitled 'Major Awards for Latin America on Health Consequences of Population Change' (process 072403/Z/03/Z). Earlier phases of the 1993 cohort study were funded by the European Union, the National Program for Centers of Excellence (Brazil), the National Research Council (Brazil), and the Ministry of Health (Brazil).	Adair LS, 2003, HYPERTENSION, V41, P451, DOI 10.1161/01.HYP.0000054212.23528.B2; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barros AJD, 2008, CAD SAUDE PUBLICA, V24, pS371, DOI 10.1590/S0102-311X2008001500002; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bleyer AJ, 2009, DIABETIC MED, V26, P128, DOI 10.1111/j.1464-5491.2008.02646.x; Boeing H, 2000, AM J CLIN NUTR, V71, P1115; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Brewer N, 2008, DIABETES CARE, V31, P1144, DOI 10.2337/dc07-2374; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eskesen K, 2013, J INTERN MED, V273, P94, DOI 10.1111/j.1365-2796.2012.02594.x; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; Forrester TE, 1996, BRIT MED J, V312, P156; Goncalves H, 2014, INT J EPIDEMIOL; Gulliford MC, 2001, EUR J CLIN NUTR, V55, P615, DOI 10.1038/sj.ejcn.1601233; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; Howe LD, 2012, INT J EPIDEMIOL, V41, P871, DOI 10.1093/ije/dys037; Jorgensen L, 2004, CIRCULATION, V110, P466, DOI 10.1161/01.CIR.0000136809.55141.3B; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921; Meigs JB, 1996, J CLIN EPIDEMIOL, V49, P411, DOI 10.1016/0895-4356(95)00513-7; Nakanishi S, 2005, DIABETOLOGIA, V48, P230, DOI 10.1007/s00125-004-1643-9; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Nazmi A, 2007, EUR J CLIN NUTR, V61, P434, DOI 10.1038/sj.ejcn.1602535; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Nguyen QM, 2008, METABOLISM, V57, P1487, DOI 10.1016/j.metabol.2008.04.011; Nightingale CM, 2015, DIABETOLOGIA, V58, P474, DOI 10.1007/s00125-014-3474-7; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Saydah S, 2009, DIABETES CARE, V32, P1440, DOI 10.2337/dc09-0117; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; SIMON D, 1989, DIABETOLOGIA, V32, P864, DOI 10.1007/BF00297451; Syed IAA, 2011, J PAK MED ASSOC, V61, P690; Szostak-Wegierek Dorota, 2007, Pol Arch Med Wewn, V117, P13; Victora Cesar G., 2003, Cad. Saúde Pública, V19, P1241, DOI 10.1590/S0102-311X2003000500003; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Victora CG, 1993, INT J EPIDEMIOL, V2008, P704, DOI DOI 10.1093/IJEIDYRN277; Vitelli LL, 1997, DIABETES CARE, V20, P1454, DOI 10.2337/diacare.20.9.1454; World Health Organization, 2010, Global recommendations on physical activity for health; Yoshida D, 2009, J ATHEROSCLER THROMB, V16, P431, DOI 10.5551/jat.No539	55	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162614	10.1371/journal.pone.0162614	http://dx.doi.org/10.1371/journal.pone.0162614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626274	Green Published, gold, Green Submitted			2022-12-26	WOS:000383680600046
J	Fan, LC; Jeng, YM; Lu, YT; Lien, HC				Fan, Li-Ching; Jeng, Yung-Ming; Lu, Yueh-Tong; Lien, Huang-Chun			SPOCK1 Is a Novel Transforming Growth Factor-beta-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; IMMUNOHISTOCHEMICAL ANALYSIS; TUMOR PROGRESSION; CELL-FATE; DIFFERENTIATION; EXPRESSION; CARCINOMA; IDENTIFICATION; MYOFIBROBLAST; PROMOTES	In addition to contraction, myoepithelia have diverse paracrine effects, including a tumor suppression effect. However, certain myoepithelial markers have been shown to contribute to tumor progression. Transforming growth factor-beta (TGF-beta) is involved in the transdifferentiation of fibroblasts to contractile myofibroblasts. We investigated whether TGF-beta can upregulate potential myoepithelial markers, which may have functional and clinicopathological significance in breast cancer. We found that TGF-beta induced SPOCK1 expression in MCF10A, MCF12A, and M10 breast cells and demonstrated SPOCK1 as a novel myoepithelial marker that was immunolocalized within or beneath myoepithelia lining ductolobular units. A functional study showed that overexpression of SPOCK1 enhanced invasiveness in mammary immortalized and cancer cells. To further determine the biological significance of SPOCK1 in breast cancer, we investigated the expression of SPOCK1 in 478 invasive ductal carcinoma (IDC) cases through immunohistochemistry and correlated the expression with clinicopathological characteristics. SPOCK1 expression was significantly correlated with high pathological tumor size (P = 0.012), high histological grade (P = 0.013), the triple-negative phenotype (P = 0.022), and the basal-like phenotype (P = 0.026) and was correlated with a significantly poorer overall survival on univariate analysis (P = 0.001, log-rank test). Multivariate Cox regression analysis demonstrated that SPOCK1 expression maintained an independent poor prognostic factor of overall survival. Analysis of SPOCK1 expression on various non-IDC carcinoma sub-types showed an enrichment of SPOCK1 expression in metaplastic carcinoma, which is pathogenetically closely related to epithelial-mesenchymal transition (EMT). In conclusion, we identified SPOCK1 as a novel TGF-beta-induced myoepithelial marker and furtherdemon-strated that SPOCK1 enhanced invasion in breast cancer cells and correlated with poor prognosis in breast cancer clinical samples. The enrichment of SPOCK1 expression in metaplastic carcinoma and the correlation between SPOCK1 expression and high histological grading and basal-like phenotypes in IDC evidence an association between SPOCK1 and EMT.	[Fan, Li-Ching; Jeng, Yung-Ming; Lu, Yueh-Tong; Lien, Huang-Chun] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Fan, Li-Ching; Jeng, Yung-Ming; Lu, Yueh-Tong; Lien, Huang-Chun] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lien, HC (corresponding author), Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan.; Lien, HC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei, Taiwan.	huangchunlien@ntu.edu.tw		LIEN, HUANG-CHUN/0000-0003-1472-1231; JENG, YUNG-MING/0000-0002-3878-4491	National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIEL PM, 1993, EUR J BIOCHEM, V214, P347, DOI 10.1111/j.1432-1033.1993.tb17930.x; Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Carter MR, 2006, AM J SURG PATHOL, V30, P300; Colin C, 2006, ONCOGENE, V25, P2818, DOI 10.1038/sj.onc.1209305; Dugina V, 2001, J CELL SCI, V114, P3285; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Huang FI, 2012, CARCINOGENESIS, V33, P1142, DOI 10.1093/carcin/bgs131; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kim HP, 2014, ONCOGENE, V33, P3334, DOI 10.1038/onc.2013.285; Lachapelle J, 2011, CURR ONCOL, V18, P161; Li Y, 2013, GASTROENTEROLOGY, V144, P179, DOI 10.1053/j.gastro.2012.09.042; Lien HC, 2007, ONCOGENE, V26, P7859, DOI 10.1038/sj.onc.1210593; Lien HC, 2014, HISTOPATHOLOGY, V65, P328, DOI 10.1111/his.12390; Miao LY, 2013, BIOCHEM BIOPH RES CO, V440, P792, DOI 10.1016/j.bbrc.2013.10.024; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Moumen M, 2011, INT J DEV BIOL, V55, P763, DOI 10.1387/ijdb.113385mm; Pandey PR, 2010, FRONT BIOSCI-LANDMRK, V15, P226, DOI 10.2741/3617; Porter DA, 2001, CANCER RES, V61, P5697; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Reis JS, 2006, HISTOPATHOLOGY, V49, P10, DOI 10.1111/j.1365-2559.2006.02467.x; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savage K, 2008, BREAST CANCER RES TR, V110, P245, DOI 10.1007/s10549-007-9718-1; Schwartz TL, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-31; Shu YJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0276-y; Song XP, 2015, J MOL HISTOL, V46, P347, DOI 10.1007/s10735-015-9627-2; Yang C, 2015, TUMOR BIOL, V36, P9567, DOI 10.1007/s13277-015-3628-3	34	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162933	10.1371/journal.pone.0162933	http://dx.doi.org/10.1371/journal.pone.0162933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27626636	Green Published, Green Submitted, gold			2022-12-26	WOS:000383680600065
J	Ishii, S; Chang, C; Tanaka, T; Kuroda, A; Tsuji, T; Akishita, M; Iijima, K				Ishii, Shinya; Chang, Chang; Tanaka, Tomoki; Kuroda, Aki; Tsuji, Tetsuo; Akishita, Masahiro; Iijima, Katsuya			The Association between Sarcopenic Obesity and Depressive Symptoms in Older Japanese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL PERFORMANCE; BLOOD-PRESSURE; MUSCLE MASS; MORTALITY; DISABILITY; LEPTIN; ONSET	The effects of sarcopenic obesity, the co-existence of sarcopenia and obesity, on mood disorders have not been studies extensively. Our objective was to examine the association of depressive symptoms with sarcopenia and obesity status in older Japanese adults. We analyzed data from 1731 functionally-independent, community-dwelling Japanese adults aged 65 years or older (875 men, 856 women) randomly selected from the resident register of Kashiwa city, Chiba, Japan in 2012. Sarcopenia was defined based on appendicular skeletal muscle mass, grip strength and usual gait speed. Obesity was defined as the highest sex-specific quintile of the percentage body fat. Depressive symptoms were defined as a Geriatric Depression Scale 15-item score >= 6. Multiple logistic regression was employed to examine the association of depressive symptoms with four groups defined by the presence/absence of sarcopenia and obesity. The prevalence of depressive symptoms was 10.1% and the proportions of sarcopenia/obesity, sarcopenia/non-obesity, non-sarcopenia/obesity, non-sarcopenia/non-obesity were 3.7%, 13.6%, 16.9% and 65.8%, respectively. After adjustment for potential confounders, sarcopenia/obesity was positively associated with depressive symptoms compared with non-sarcopenia/non-obesity, whereas either sarcopenia or obesity alone was not associated with depressive symptoms. The association was particularly pronounced in those aged 65 to 74 years in age-stratified analysis. We conclude that our findings suggest a synergistic impact exerted by sarcopenic obesity on the risk of depressive symptoms, particularly in those aged 65 to 74 years.	[Ishii, Shinya; Chang, Chang; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Tanaka, Tomoki; Kuroda, Aki; Tsuji, Tetsuo; Iijima, Katsuya] Univ Tokyo, Inst Gerontol, Tokyo, Japan	University of Tokyo; University of Tokyo	Iijima, K (corresponding author), Univ Tokyo, Inst Gerontol, Tokyo, Japan.	iijima@iog.u-tokyo.ac.jp		Ishii, Shinya/0000-0001-5762-4066	Ministry osf Health, Labor, and Welfare of Japan [H24-Choju-Ippan-002]	Ministry osf Health, Labor, and Welfare of Japan	KI received a Health and Labor Sciences Research Grant (H24-Choju-Ippan-002) from the Ministry osf Health, Labor, and Welfare of Japan http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h24/gaiyo/16.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Everson-Rose SA, 2005, PSYCHOSOM MED, V67, P609, DOI 10.1097/01.psy.0000170334.77508.35; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Forman-Hoffman VL, 2007, J GERONTOL B-PSYCHOL, V62, pS43, DOI 10.1093/geronb/62.1.S43; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Ishii S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036062; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Kawano Y, 2011, AM J HYPERTENS, V24, P1250, DOI 10.1038/ajh.2011.138; Kim JH, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/634289; Kim NH, 2011, J AM GERIATR SOC, V59, P2062, DOI 10.1111/j.1532-5415.2011.03664.x; Kurimoto Ayumi, 2011, Nihon Ronen Igakkai Zasshi, V48, P149; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; Laudisio A, 2014, CLIN NUTR, V33, P626, DOI 10.1016/j.clnu.2013.08.005; Light JM, 1996, GERONTOLOGIST, V36, P165, DOI 10.1093/geront/36.2.165; Milaneschi Y, 2012, J CLIN PSYCHIAT, V73, P1205, DOI 10.4088/JCP.11m07552; Mitchell AJ, 2010, J AFFECT DISORDERS, V125, P10, DOI 10.1016/j.jad.2009.08.019; Nagasaki H, 1996, PERCEPT MOTOR SKILL, V82, P435, DOI 10.2466/pms.1996.82.2.435; Noh JW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1663-z; Odden MC, 2012, ARCH INTERN MED, V172, P1162, DOI 10.1001/archinternmed.2012.2555; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Schreiner AS, 2003, INT J GERIATR PSYCH, V18, P498, DOI 10.1002/gps.880; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Tanimoto Y, 2012, ARCH GERONTOL GERIAT, V54, pE230, DOI 10.1016/j.archger.2011.06.015; Wada T, 2004, ARCH GERONTOL GERIAT, V39, P15, DOI 10.1016/j.archger.2003.12.003; Waters DL, 2008, J GERONTOL A-BIOL, V63, P536, DOI 10.1093/gerona/63.5.536; World Health Organization,, 2015, OB OV; Xiang XL, 2015, J PSYCHOSOM RES, V78, P242, DOI 10.1016/j.jpsychores.2014.12.008; Yanagita M, 2006, AM J GERIAT PSYCHIAT, V14, P1060, DOI 10.1097/01.JGP.0000224364.70515.12	40	40	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162898	10.1371/journal.pone.0162898	http://dx.doi.org/10.1371/journal.pone.0162898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JO	27627756	Green Submitted, gold, Green Published			2022-12-26	WOS:000383680600062
J	Schroder, H; Gomez, SF; Ribas-Barba, L; Perez-Rodrigo, C; Bawaked, RA; Fito, M; Serra-Majem, L				Schroeder, Helmut; Gomez, Santiago F.; Ribas-Barba, Lourdes; Perez-Rodrigo, Carmen; Ahmed Bawaked, Rowaedh; Fito, Montserrat; Serra-Majem, Lluis			Monetary Diet Cost, Diet Quality, and Parental Socioeconomic Status in Spanish Youth	PLOS ONE			English	Article							MEDITERRANEAN DIET; CHILDREN; INDEX; SAMPLE; ADOLESCENTS; ADHERENCE; PATTERNS; HEALTH; SCORE	Background Using a food-based analysis, healthy dietary patterns in adults are more expensive than less healthy ones; studies are needed in youth. Therefore, the objective of the present study was to determine relationships between monetary daily diet cost, diet quality, and parental socioeconomic status. Design and Methods Data were obtained from a representative national sample of 3534 children and young people in Spain, aged 2 to 24 years. Dietary assessment was performed with a 24-hour recall. Mediterranean diet adherence was measured by the KIDMED questionnaire. Average food cost was calculated from official Spanish government data. Monetary daily diet cost was expressed as euros per day ((sic)/d) and euros per day standardized to a 1000kcal diet ((sic)/1000kcal/d). Results Mean monetary daily diet cost was 3.16 +/- 1.57(sic)/d (1.56 +/- 0.72(sic)/1000kcal/d). Socioeconomic status was positively associated with monetary daily diet cost and diet quality measured by the KIDMED index ((sic)/d and (sic)/1000kcal/d, p<0.019). High Mediterranean diet adherence (KIDMED score 8-12) was 0.71 (sic)/d (0.28(sic)/1000kcal/d) more expensive than low compliance (KIDMED score 0-3). Analysis for nonlinear association between the KIDMED index and monetary daily diet cost per1000kcal showed no further cost increases beyond a KIDMED score of 8 (linear p<0.001; nonlinear p = 0.010). Conclusion Higher monetary daily diet cost is associated with healthy eating in Spanish youth. Higher socioeconomic status is a determinant for higher monetary daily diet cost and quality.	[Schroeder, Helmut; Gomez, Santiago F.; Ahmed Bawaked, Rowaedh; Fito, Montserrat] IMIM Hosp del Mar Med Res Inst, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain; [Schroeder, Helmut] Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Gomez, Santiago F.] Generalitat Catalunya, Dept Salut, AQuAS ASPCAT, Barcelona, Spain; [Gomez, Santiago F.] Univ Pompeu Fabra, PhD Programme Biomed, Barcelona, Spain; [Ribas-Barba, Lourdes; Serra-Majem, Lluis] Nutr Res Fdn, Barcelona, Spain; [Ribas-Barba, Lourdes; Fito, Montserrat; Serra-Majem, Lluis] Inst Salud Carlos III, CIBER Physiopathol Obes & Nutr CIBEROBN, Madrid, Spain; [Perez-Rodrigo, Carmen] Univ Basque Country, FIDEC Fdn, Bilbao, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Reseach Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Basque Country; Universidad de Las Palmas de Gran Canaria	Schroder, H (corresponding author), IMIM Hosp del Mar Med Res Inst, Cardiovasc Risk & Nutr Res Grp CARIN, Barcelona, Spain.; Schroder, H (corresponding author), Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.	hschroeder@imim.es	Serra-Majem, Lluis/I-6708-2019; Bawaked, Rowaedh/AAX-6292-2020; Schroder, Helmut/G-2586-2015; Fito, Montserrat/C-1822-2012; Perez-Rodrigo, Carmen/N-3251-2018; Santos, Santiago Felipe Gómez/H-9478-2017	Serra-Majem, Lluis/0000-0002-9658-9061; Bawaked, Rowaedh/0000-0002-8161-0454; Schroder, Helmut/0000-0003-2231-5081; Fito, Montserrat/0000-0002-1817-483X; Santos, Santiago Felipe Gómez/0000-0003-3352-2510; Perez-Rodrigo, Carmen/0000-0002-4554-6184	Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain; Kellogg's Espana SA and Kellogg's Company; Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacio'n Nutricional; King Abdullah scholarship program [ID 2631]; Instituto de Salud Carlos III FEDER [CB06/02/0029]; AGAUR [2014 SGR 240]	Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain(Spanish Government); Kellogg's Espana SA and Kellogg's Company; Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria; Fundacion para la Investigacio'n Nutricional; King Abdullah scholarship program; Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos IIIEuropean Commission); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported by grants from the Spanish Ministry of Health [RED: Alimentacion saludable en la prevencion primaria de enfermedades cronicas: la Red Predimed, one of the Redes Tematicas de Investigacion Cooperativa Sanitaria (RETICs)] Fundacion Dieta Mediterranea, Spain; and Kellogg's Espana SA and Kellogg's Company, Battle Creek, USA via the Fundacion Universitaria de Las Palmas de Gran Canaria and the Fundacion para la Investigacio'n Nutricional and by King Abdullah scholarship program [2014, ID 2631], Instituto de Salud Carlos III FEDER (CB06/02/0029), AGAUR (2014 SGR 240). The CIBERESP and the CIBEROBN and the RETIC Predimed are initiatives of the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy U, 2014, EUR J CLIN NUTR, V68, P1175, DOI 10.1038/ejcn.2014.101; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Carlson A, 2012, EIB96 USDA EC RES SE; Cunado J, 2012, SOC INDIC RES, V108, P185, DOI 10.1007/s11205-011-9874-x; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Frazao E, 2011, AM J CLIN NUTR, V93, P861, DOI 10.3945/ajcn.110.009639; French SA, 2003, J NUTR, V133, p841S, DOI 10.1093/jn/133.3.841S; Giannini C, 2014, NUTR METAB CARDIOVAS, V24, P75, DOI 10.1016/j.numecd.2013.04.005; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Kontogianni MD, 2008, J NUTR, V138, P1951, DOI 10.1093/jn/138.10.1951; Lydakis C, 2012, EUR J PEDIATR, V171, P1373, DOI 10.1007/s00431-012-1735-3; Monsivais P, 2012, J EPIDEMIOL COMMUN H, V66, P530, DOI 10.1136/jech.2010.122333; NELSON M, 1989, AM J CLIN NUTR, V50, P155, DOI 10.1093/ajcn/50.1.155; O'Neil A, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2014.302110; OECD, 2015, INEQUALITY; Rao M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004277; Ryden PJ, 2011, PUBLIC HEALTH NUTR, V14, P1680, DOI 10.1017/S1368980010003642; Sahingoz SA, 2011, APPETITE, V57, P272, DOI 10.1016/j.appet.2011.05.307; Santomauro F, 2014, NUTRITION, V30, P1379, DOI 10.1016/j.nut.2014.04.008; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Schroder H, 2006, INT J OBESITY, V30, P1574, DOI 10.1038/sj.ijo.0803308; Schroder H, 2007, J NUTR BIOCHEM, V18, P149, DOI 10.1016/j.jnutbio.2006.05.006; Schroder H, 2014, EUR J PEDIATR, V173, P1169, DOI 10.1007/s00431-014-2302-x; Schroder H, 2013, NUTRITION, V29, P1350, DOI 10.1016/j.nut.2013.05.019; Schroder H, 2010, INT J PEDIATR OBES, V5, P516, DOI 10.3109/17477161003777417; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Serra-Majem L, 2003, EUR J CLIN NUTR, V57, pS35, DOI 10.1038/sj.ejcn.1601812; Serra-Majem L, 2004, PUBLIC HEALTH NUTR, V7, P931, DOI 10.1079/PHN2004556; Steffen LM, 2014, BRIT J NUTR, V112, P1654, DOI 10.1017/S0007114514002633; Torun B, 1996, EUR J CLIN NUTR, V50, pS37	30	18	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161422	10.1371/journal.pone.0161422	http://dx.doi.org/10.1371/journal.pone.0161422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5JR	27622518	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000005
J	Welsh, K; Milutinovic, S; Ardecky, RJ; Gonzalez-Lopez, M; Ganji, SR; Teriete, P; Finlay, D; Riedl, S; Matsuzawa, S; Pinilla, C; Houghten, R; Vuori, K; Reed, JC; Cosford, NDP				Welsh, Kate; Milutinovic, Snezana; Ardecky, Robert J.; Gonzalez-Lopez, Marcos; Ganji, Santhi Reddy; Teriete, Peter; Finlay, Darren; Riedl, Stefan; Matsuzawa, Shu-ichi; Pinilla, Clemencia; Houghten, Richard; Vuori, Kristiina; Reed, John C.; Cosford, Nicholas D. P.			Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ALPHA-DEPENDENT APOPTOSIS; MOLECULE IAP ANTAGONISTS; XIAP INHIBITS CASPASE-3; PROTEIN XIAP; BIR3 DOMAIN; SIGNALING COMPLEX; ML-IAP; CIAP1	Members of the Inhibitor of APoptosis (IAP) protein family suppress apoptosis within tumor cells, particularly in the context of immune cell-mediated killing by the tumor necrosis factor (TNF) superfamily cytokines. Most IAPs are opposed endogenously by the second mitochondrial activator of caspases (SMAC), which binds to selected baculovirus IAP repeat (BIR) domains of IAPs to displace interacting proteins. The development of SMAC mimetics as novel anticancer drugs has gained impetus, with several agents now in human clinical trials. To further understand the cellular mechanisms of SMAC mimetics, we focused on IAP family members cIAP1 and cIAP2, which are recruited to TNF receptor complexes where they support cell survival through NF-kappa B activation while suppressing apoptosis by preventing caspase activation. We established fluorescence polarization (FP) assays for the BIR2 and BIR3 domains of human cIAP1 and cIAP2 using fluorochrome-conjugated SMAC peptides as ligands. A library of SMAC mimetics was profiled using the FP assays to provide a unique structure activity relationship (SAR) analysis compared to previous assessments of binding to XIAP. Potent compounds displayed mean inhibitory binding constants (K-i) of 9 to 27 nM against the BIR3 domains of cIAP1 and cIAP2, respectively. Selected compounds were then characterized using cytotoxicity assays in which a cytokine-resistant human tumor cell line was sensitized to either TNF or lymphotoxin-alpha (LT-alpha). Cytotoxicity correlated closely with cIAP1 and cIAP2 BIR3 binding activity with the most potent compounds able to reduce cell viability by 50%. Further testing demonstrated that active compounds also inhibit RIP1 binding to BIR3 of cIAP1 and cIAP2 in vitro and reduce steady-state cIAP1 protein levels in cells. Altogether, these data inform the SAR for our SMAC mimetics with respect to cIAP1 and cIAP2, suggesting that these IAP family members play an important role in tumor cell resistance to cytotoxicity mediated by TNF and LT-alpha.	[Welsh, Kate; Milutinovic, Snezana; Ardecky, Robert J.; Gonzalez-Lopez, Marcos; Ganji, Santhi Reddy; Teriete, Peter; Finlay, Darren; Riedl, Stefan; Matsuzawa, Shu-ichi; Vuori, Kristiina; Reed, John C.; Cosford, Nicholas D. P.] Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Pinilla, Clemencia; Houghten, Richard] Torrey Pines Inst Mol Studies, 3550 Gen Atomics Ct, San Diego, CA 92121 USA; [Pinilla, Clemencia; Houghten, Richard] 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA; [Gonzalez-Lopez, Marcos] Ignyta Inc, 11111 Flintkote Ave, San Diego, CA 92121 USA; [Reed, John C.] Hoffmann La Roche AG, Grenzacherstr 124, CH-4070 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; Torrey Pines Institute for Molecular Studies, California; Roche Holding	Cosford, NDP (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ncosford@sbpdiscovery.org		Cosford, Nic/0000-0001-7228-4709	National Institute of Health [CA163743, HG003916, CA195227]; NATIONAL CANCER INSTITUTE [R01CA195227, P30CA030199] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by National Institute of Health: CA163743 (JCR), National Institute of Health: HG003916 (JCR), and National Institute of Health: CA195227 (NDPC).	Ardecky RJ, 2013, BIOORG MED CHEM LETT, V23, P4253, DOI 10.1016/j.bmcl.2013.04.096; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Benetatos CA, 2014, MOL CANCER THER, V13, P867, DOI 10.1158/1535-7163.MCT-13-0798; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022356; Beug ST, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28541; Beug ST, 2014, NAT BIOTECHNOL, V32, P182, DOI 10.1038/nbt.2806; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Condon SM, 2014, J MED CHEM, V57, P3666, DOI 10.1021/jm500176w; Corrie JET, 2001, BIOCONJUGATE CHEM, V12, P186, DOI 10.1021/bc0000785; Cossu F, 2010, PROTEIN SCI, V19, P2418, DOI 10.1002/pro.523; Darding M, 2011, CELL DEATH DIFFER, V18, P1376, DOI 10.1038/cdd.2011.10; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Etemadi N, 2013, FEBS J, V280, P5283, DOI 10.1111/febs.12419; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Finlay D, 2014, MOL CANCER THER, V13, P5, DOI 10.1158/1535-7163.MCT-13-0153; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gonzalez-Lopez M, 2011, BIOORG MED CHEM LETT, V21, P4332, DOI 10.1016/j.bmcl.2011.05.049; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kulathila R, 2009, ACTA CRYSTALLOGR D, V65, P58, DOI 10.1107/S0907444908039243; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Lorusso D, 2012, BRIT J CANCER, V107, P37, DOI 10.1038/bjc.2012.233; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Ndubaku C, 2009, ACS CHEM BIOL, V4, P557, DOI 10.1021/cb900083m; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Samuel T, 2005, CANCER RES, V65, P210; Schilling R, 2014, METHOD ENZYMOL, V545, P83, DOI 10.1016/B978-0-12-801430-1.00004-4; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Son JK, 2010, CELL DEATH DIFFER, V17, P1288, DOI 10.1038/cdd.2010.9; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Suzuki Y, 2001, J BIOL CHEM, V276, P27058, DOI 10.1074/jbc.M102415200; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Vamos M, 2013, ACS CHEM BIOL, V8, P725, DOI 10.1021/cb3005512; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2012, BIOCHEM J, V447, P427, DOI 10.1042/BJ20121103; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2001, GENOME BIOL, V2; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046	61	15	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161952	10.1371/journal.pone.0161952	http://dx.doi.org/10.1371/journal.pone.0161952			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617834	gold, Green Published, Green Submitted			2022-12-26	WOS:000383653100012
J	Miao, XY; Zhang, W; Huang, ZS; Li, NL				Miao, Xinyan; Zhang, Wei; Huang, Zhangsen; Li, Nailin			Unaltered Angiogenesis-Regulating Activities of Platelets in Mild Type 2 Diabetes Mellitus despite a Marked Platelet Hyperreactivity	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ALPHA-GRANULES; ACTIVATION; PROTEINS; RELEASE; THROMBOSPONDIN-1; MICROANGIOPATHY; MOBILIZATION; ADHESION; REVEALS	Type 2 diabetes mellitus (T2DM) is associated with platelet dysfunction and impaired angiogenesis. Aim of the study is to investigate if platelet dysfunction might hamper platelet angiogenic activities in T2DM patients. Sixteen T2DM patients and gender/age-matched non-diabetic controls were studied. Flow cytometry and endothelial colony forming cell (ECFC) tube formation on matrigelwere used to assess platelet reactivity and angiogenic activity, respectively. Thrombin receptor PAR1-activating peptide (PAR1-AP) induced higher platelet P-selectin expression, and evoked more rapid and intense platelet annexin V binding in T2DM patients, seen as a more rapid increase of annexin V+ platelets (24.3 +/- 6.4% vs 12.6 +/- 3.8% in control at 2 min) and a higher elevation (30.9 +/- 5.1% vs 24.3 +/- 3.0% at 8 min). However, PAR1-AP and PAR4-AP induced similar releases of angiogenic regulators from platelets, and both stimuli evoked platelet release of platelet angiogenic regulators to similar extents in T2DM and control subjects. Thus, PAR1-stimulated platelet releasate (PAR1-PR) and PAR4-PR similarly enhanced capillary-like network/tube formation of ECFCs, and the enhancements did not differ between T2DM and control subjects. Direct supplementation of platelets to ECFCs at the ratio of 1: 200 enhanced ECFC tube formation even more markedly, leading to approximately 100% increases of the total branch points of ECFC tube formation, for which the enhancements were also similar between patients and controls. In conclusion, platelets from T2DM subjects are hyperreactive. Platelet activation induced by high doses of PAR1-AP, however, results in similar releases of angiogenic regulators in mild T2DM and control subjects. Platelets from T2DM and control subjects also demonstrate similar enhancements on ECFC angiogenic activities.	[Miao, Xinyan; Zhang, Wei; Huang, Zhangsen; Li, Nailin] Karolinska Univ Hosp Solna, Clin Pharmacol, Dept Med Solna, Karolinska Inst, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Li, NL (corresponding author), Karolinska Univ Hosp Solna, Clin Pharmacol, Dept Med Solna, Karolinska Inst, S-17176 Stockholm, Sweden.	Nailin.Li@ki.se	Huang, Zhangsen/AAJ-5425-2021	Li, Nailin/0000-0002-3848-7251	Swedish Heart-Lung Foundation; Swedish Research Council; China Scholarship Council; Karolinska Institutet; Stockholm County Council	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	The study was supported by grants from the Swedish Heart-Lung Foundation, the Swedish Research Council, the China Scholarship Council, Karolinska Institutet, and the Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bikfalvi A, 2004, SEMIN THROMB HEMOST, V30, P379, DOI 10.1055/s-2004-831051; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Cines DB, 1998, BLOOD, V91, P3527; Dernbach E, 2008, BASIC RES CARDIOL, V103, P572, DOI 10.1007/s00395-008-0734-z; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferroni P, 2004, J THROMB HAEMOST, V2, P1282, DOI 10.1111/j.1538-7836.2004.00836.x; Fox CS, 2015, CIRCULATION, V132, P691, DOI 10.1161/CIR.0000000000000230; Gawaz M, 2013, BLOOD, V122, P2550, DOI 10.1182/blood-2013-05-468694; Hu H, 2004, J THROMB HAEMOST, V2, P58, DOI 10.1111/j.1538-7836.2003.00525.x; Huang Z, 2016, J THROMB HAEMOST, V14, P606, DOI 10.1111/jth.13248; Huang Z, 2015, J THROMB HAEMOST, V13, P465, DOI 10.1111/jth.12815; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kamykowski J, 2011, BLOOD, V118, P1370, DOI 10.1182/blood-2011-01-330910; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Li NL, 2003, THROMB RES, V111, P165, DOI 10.1016/j.thromres.2003.08.026; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; Patzelt J, 2012, CURR VASC PHARMACOL, V10, P570, DOI 10.2174/157016112801784648; Razmara M, 2008, J THROMB HAEMOST, V6, P2186, DOI 10.1111/j.1538-7836.2008.03185.x; Redondo PC, 2005, BIOCHEM BIOPH RES CO, V333, P794, DOI 10.1016/j.bbrc.2005.05.178; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Santilli F, 2015, PROSTAG OTH LIPID M, V120, P28, DOI 10.1016/j.prostaglandins.2015.05.002; Schneider DJ, 2009, DIABETES CARE, V32, P525, DOI 10.2337/dc08-1865; Spinetti G, 2008, CARDIOVASC RES, V78, P265, DOI 10.1093/cvr/cvn039; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; van Holten TC, 2014, CARDIOVASC RES, V103, P140, DOI 10.1093/cvr/cvu113; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Yngen M, 2004, DIABETOLOGIA, V47, P537, DOI 10.1007/s00125-004-1352-4; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162405	10.1371/journal.pone.0162405	http://dx.doi.org/10.1371/journal.pone.0162405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612088	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900091
J	Sankella, S; Garg, A; Agarwal, AK				Sankella, Shireesha; Garg, Abhimanyu; Agarwal, Anil K.			Characterization of the Mouse and Human Monoacylglycerol O-Acyltransferase 1 (Mogat1) Promoter in Human Kidney Proximal Tubule and Rat Liver Cells	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; INDUCED HEPATIC STEATOSIS; INSULIN-RESISTANCE; FATTY-ACIDS; LIPID-ACCUMULATION; GENOME TOPOLOGY; PPAR-GAMMA; MICE; GENE; DNA	Monoacylglycerol acyltransferase 1 (Mogat1) catalyzes the conversion of monoacylglycerols (MAG) to diacylglycerols (DAG), the precursor of several physiologically important lipids such as phosphatidylcholine, phosphatidylethanolamine and triacylglycerol (TAG). Expression of Mogat1 is tissue restricted and it is highly expressed in the kidney, stomach and adipose tissue but minimally in the normal adult liver. To understand the transcriptional regulation of Mogat1, we characterized the mouse and human Mogat1 promoters in human kidney proximal tubule-2 (HK-2) cells. In-silico analysis revealed several peroxisome proliferator response element (PPRE) binding sites in the promoters of both human and mouse Mogat1. These sites responded to all three peroxisome proliferator activated receptor (PPAR) isoforms such that their respective agonist or antagonist activated or inhibited the expression of Mogat1. PPRE site mutagenesis revealed that sites located at -592 and -2518 are very effective in decreasing luciferase reporter gene activity. Chromatin immunoprecipitation (ChIP) assay using PPARa antibody further confirmed the occupancy of these sites by PPARa. While these assays revealed the core promoter elements necessary for Mogat1 expression, there are additional elements required to regulate its tissue specific expression. Chromosome conformation capture (3C) assay revealed additional cis-elements located similar to 10-15 kb upstream which interact with the core promoter. These chromosomal regions are responsive to both PPARa agonist and antagonist.	[Agarwal, Anil K.] UT Southwestern Med Ctr, Div Nutr & Metab Dis, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; UT Southwestern Med Ctr, Ctr Human Nutr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agarwal, AK (corresponding author), UT Southwestern Med Ctr, Div Nutr & Metab Dis, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Anil.Agarwal@utsouthwestern.edu			National Institutes of Health [R01-DK54387]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from National Institutes of Health; R01-DK54387.; Authors thank Katie Tunison for copy editing. This work was supported by a grant from National Institutes of Health; R01-DK54387	Agarwal AK, 2016, J LIPID RES, V57, P616, DOI 10.1194/jlr.M065896; [Anonymous], 2005, NATURE METHODS, V2, P997; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; BARDOT O, 1995, FEBS LETT, V360, P183, DOI 10.1016/0014-5793(95)00097-S; Chan SMH, 2013, DIABETES, V62, P2095, DOI 10.2337/db12-1397; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Daguenet E, 2015, EMBO REPORTS, DOI 10.15252/embr.201541116; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hayashi Y, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.4; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Li JH, 2015, J MOL CELL BIOL, V7, P284, DOI 10.1093/jmcb/mjv016; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; MOSTAFA N, 1993, BIOCHIM BIOPHYS ACTA, V1169, P189, DOI 10.1016/0005-2760(93)90205-N; Mudaliar Sunder, 2003, Endocr Pract, V9, P406; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Pappas A, 2002, J INVEST DERMATOL, V118, P164, DOI 10.1046/j.0022-202x.2001.01612.x; Sankella S, 2014, J BIOL CHEM, V289, P4762, DOI 10.1074/jbc.M113.530998; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Soufi N, 2014, J BIOL CHEM, V289, P30177, DOI 10.1074/jbc.M114.595850; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Xie Y, 2002, J BIOL CHEM, V277, P11802, DOI 10.1074/jbc.M109296200; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Yu JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29352; Yu JH, 2015, BIOCHEM BIOPH RES CO, V460, P715, DOI 10.1016/j.bbrc.2015.03.095; Zhao XM, 2002, CELL, V108, P615, DOI 10.1016/S0092-8674(02)00648-7	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162504	10.1371/journal.pone.0162504	http://dx.doi.org/10.1371/journal.pone.0162504			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611931	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900117
J	Karwad, MA; Macpherson, T; Wang, B; Theophilidou, E; Sarmad, S; Barrett, DA; Larvin, M; Wright, KL; Lund, JN; O'Sullivan, SE				Karwad, Mustafa A.; Macpherson, Tara; Wang, Bo; Theophilidou, Elena; Sarmad, Sarir; Barrett, David A.; Larvin, Michael; Wright, Karen L.; Lund, Jonathan N.; O'Sullivan, Saoirse E.			Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPAR alpha	FASEB JOURNAL			English	Article						gut; cannabinoid; nuclear receptor	TIGHT JUNCTION PERMEABILITY; INFLAMMATORY-BOWEL-DISEASE; BARRIER FUNCTION; FOOD-INTAKE; ENDOCANNABINOID SYSTEM; CROHNS-DISEASE; CB1 RECEPTORS; BODY-WEIGHT; C-SRC; MECHANISMS	Cannabinoids modulate intestinal permeability through cannabinoid receptor 1 (CB1). The endocannabinoid-like compounds oleoylethanolamine (OEA) and palmitoylethanolamine (PEA) play an important role in digestive regulation, and we hypothesized they would also modulate intestinal permeability. Transepithelial electrical resistance (TEER) was measured in human Caco-2 cells to assess permeability after application of OEA and PEA and relevant antagonists. Cells treated with OEA and PEA were stained for cytoskeletal F-actin changes and lysed for immunoassay. OEA and PEA were measured by liquid chromatography-tandem mass spectrometry. OEA (applied apically, logEC(50) -5.4) and PEA (basolaterally, logEC(50) -4.9; apically logEC(50) -5.3) increased Caco-2 resistance by 20-30% via transient receptor potential vanilloid (TRPV)-1 and peroxisome proliferator-activated receptor (PPAR)-. Preventing their degradation (by inhibiting fatty acid amide hydrolase) enhanced the effects of OEA and PEA. OEA and PEA induced cytoskeletal changes and activated focal adhesion kinase and ERKs 1/2, and decreased Src kinases and aquaporins 3 and 4. In Caco-2 cells treated with IFN and TNF, OEA (via TRPV1) and PEA (via PPAR) prevented or reversed the cytokine-induced increased permeability compared to vehicle (0.1% ethanol). PEA (basolateral) also reversed increased permeability when added 48 or 72 h after cytokines (P < 0.001, via PPAR). Cellular and secreted levels of OEA and PEA (P < 0.001-0.001) were increased in response to inflammatory mediators. OEA and PEA have endogenous roles and potential therapeutic applications in conditions of intestinal hyperpermeability and inflammation.Karwad, M. A., Macpherson, T., Wang, B., Theophilidou, E., Sarmad, S., Barrett, D. A., Larvin, M., Wright, K. L., Lund, J. N., O'Sullivan, S. E. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitrovia TRPV1 and PPAR alpha.	[Karwad, Mustafa A.; Theophilidou, Elena; Lund, Jonathan N.; O'Sullivan, Saoirse E.] Univ Nottingham, Royal Derby Hosp, Sch Med, Nottingham NG7 2RD, England; [Sarmad, Sarir; Barrett, David A.] Univ Nottingham, Ctr Analyt Biosci, Sch Pharm, Nottingham NG7 2RD, England; [Macpherson, Tara; Wang, Bo; Wright, Karen L.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YW, England; [Larvin, Michael] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Larvin, Michael; O'Sullivan, Saoirse E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland	University of Nottingham; University of Nottingham; Lancaster University; University of Limerick; University of Limerick	O'Sullivan, SE (corresponding author), Univ Nottingham, Royal Derby Hosp, Sch Med, Derby DE22 3DT, England.	saoirse.osullivan@nottingham.ac.uk	Larvin, Michael/AAE-4674-2019; Lund, Jonathan/K-6631-2019; Wright, Karen Leslie/C-7959-2011; Barrett, David/C-9922-2011	Lund, Jonathan/0000-0001-5195-2181; Wright, Karen Leslie/0000-0003-0040-9247; O'Sullivan, Saoirse Elizabeth/0000-0002-1672-6610; Barrett, David/0000-0001-6900-9474				Adami M, 2002, BRIT J PHARMACOL, V135, P1598, DOI 10.1038/sj.bjp.0704625; Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Alhamoruni A, 2010, J PHARMACOL EXP THER, V335, P92, DOI 10.1124/jpet.110.168237; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; AlSuleimani YM, 2013, EUR J PHARMACOL, V702, P1, DOI 10.1016/j.ejphar.2013.01.006; Astarita G, 2006, AM J PHYSIOL-REG I, V290, pR1407, DOI 10.1152/ajpregu.00664.2005; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Bischoff SC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-24; Borrelli F, 2015, BRIT J PHARMACOL, V172, P142, DOI 10.1111/bph.12907; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; Brandtzaeg P, 2011, EUR J PHARMACOL, V668, pS16, DOI 10.1016/j.ejphar.2011.07.006; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Capasso R, 2014, BRIT J PHARMACOL, V171, P4026, DOI 10.1111/bph.12759; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Di Carlo G., 2005, EXPERT OPIN INV DRUG, V12, P39; Di Marzo V, 2006, GUT, V55, P1373, DOI 10.1136/gut.2005.090472; Di Paola R, 2012, J LEUKOCYTE BIOL, V91, P911, DOI 10.1189/jlb.0911485; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Esposito G, 2014, GUT, V63, P1300, DOI 10.1136/gutjnl-2013-305005; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Hansen JJ, 2009, INFLAMM BOWEL DIS, V15, P890, DOI 10.1002/ibd.20850; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Kitchen P, 2015, BIOCH BIOPHYSICA, V12, P2410; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma YJ, 2013, BBA-MOL BASIS DIS, V1832, P151, DOI 10.1016/j.bbadis.2012.10.006; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Massa F, 2006, J MOL MED, V84, P142, DOI 10.1007/s00109-005-0016-2; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R., 1986, CANNABINOIDS THERAPE; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Pasantes-Morales H, 2016, MOL PHARMACOL, V90, P358, DOI 10.1124/mol.116.104158; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Rao JN, 2002, AM J PHYSIOL-CELL PH, V282, pC885, DOI 10.1152/ajpcell.00361.2001; Ricanek P, 2015, CLIN EXP GASTROENTER, V8, P49, DOI 10.2147/CEG.S70119; Richardson D, 2007, ANAL BIOCHEM, V360, P216, DOI 10.1016/j.ab.2006.10.039; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Samak G, 2014, AM J PHYSIOL-GASTR L, V306, pG947, DOI 10.1152/ajpgi.00396.2013; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schifilliti C, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/849623; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Van Sickle MD, 2001, GASTROENTEROLOGY, V121, P767, DOI 10.1053/gast.2001.28466; Wang JR, 2014, DIGEST DIS SCI, V59, P2693, DOI 10.1007/s10620-014-3212-5; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG463, DOI 10.1152/ajpgi.2000.279.2.G463; Welcker K, 2004, EUR J MED RES, V9, P456; Wheal AJ, 2010, BRIT J PHARMACOL, V160, P701, DOI 10.1111/j.1476-5381.2010.00770.x; Wyatt J, 1997, AM J GASTROENTEROL, V92, P1891; Zhang WJ, 2011, FEBS LETT, V585, P3113, DOI 10.1016/j.febslet.2011.08.045; Zhou Y, 2012, NEUROPHARMACOLOGY, V63, P242, DOI 10.1016/j.neuropharm.2012.03.008	72	55	55	0	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					469	481		10.1096/fj.201500132	http://dx.doi.org/10.1096/fj.201500132			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27623929	Green Accepted			2022-12-26	WOS:000394235400004
J	Ferrari, AR; Rozeboom, HJ; Dobruchowska, JM; van Leeuwen, SS; Vugts, ASC; Koetsier, MJ; Visser, J; Fraaije, MW				Ferrari, Alessandro R.; Rozeboom, Henriette J.; Dobruchowska, Justyna M.; van Leeuwen, Sander S.; Vugts, Aniek S. C.; Koetsier, Martijn J.; Visser, Jaap; Fraaije, Marco W.			Discovery of a Xylooligosaccharide Oxidase from Myceliophthora thermophila C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; crystal structure; flavin adenine dinucleotide (FAD); oligosaccharide; oxidase; CAZy; xylan; xylose; oxidase; carbohydrate processing	GLUCOOLIGOSACCHARIDE OXIDASE; CHITOOLIGOSACCHARIDE OXIDASE; CELLOBIOSE DEHYDROGENASE; ACCEPTOR OXIDOREDUCTASE; FUSARIUM-GRAMINEARUM; CRYSTAL-STRUCTURE; LACTOBIONIC ACID; OXIDATION; CARBOHYDRATE; PURIFICATION	By inspection of the predicted proteome of the fungus Myceliophthora thermophila C1 for vanillyl-alcohol oxidase (VAO)-type flavoprotein oxidases, a putative oligosaccharide oxidase was identified. By homologous expression and subsequent purification, the respective protein could be obtained. The protein was found to contain a bicovalently bound FAD cofactor. By screening a large number of carbohydrates, several mono- and oligosaccharides could be identified as substrates. The enzyme exhibits a strong substrate preference toward xylooligosaccharides; hence it is named xylooligosaccharide oxidase (XylO). Chemical analyses of the product formed upon oxidation of xylobiose revealed that the oxidation occurs at C1, yielding xylobionate as product. By elucidation of several XylO crystal structures (in complex with a substrate mimic, xylose, and xylobiose), the residues that tune the unique substrate specificity and regioselectivity could be identified. The discovery of this novel oligosaccharide oxidase reveals that the VAO-type flavoprotein family harbors oxidases tuned for specific oligosaccharides. The unique substrate profile of XylO hints at a role in the degradation of xylan-derived oligosaccharides by the fungus M. thermophila C1.	[Ferrari, Alessandro R.; Rozeboom, Henriette J.; Fraaije, Marco W.] Univ Groningen, Mol Enzymol Grp, NL-9747 AG Groningen, Netherlands; [Dobruchowska, Justyna M.; van Leeuwen, Sander S.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Microbial Physiol Grp, NL-9747 AG Groningen, Netherlands; [Vugts, Aniek S. C.; Koetsier, Martijn J.] Dupont Ind Biosci, NL-6709 PA Wageningen, Netherlands; [Visser, Jaap] Fungal Genet & Technol Consultancy, NL-6700 AJ Wageningen, Netherlands	University of Groningen; University of Groningen	Fraaije, MW (corresponding author), Univ Groningen, Mol Enzymol Grp, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl	DOBRUCHOWSKA, JUSTYNA/AAY-1409-2021; van Leeuwen, Sander/C-7140-2012	van Leeuwen, Sander/0000-0003-0017-2841; Rozeboom, Henriette/0000-0002-1656-6477; Fraaije, Marco/0000-0001-6346-5014	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organisation for Scientific Research (NWO) in the framework of the Technology Areas for Sustainable Chemistry (TASC) Technology Area Biomass. The authors declare that they have no conflicts of interest with the contents of this article.	Baminger U, 2001, APPL ENVIRON MICROB, V67, P1766, DOI 10.1128/AEM.67.4.1766-1774.2001; Baumann MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-45; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniel B, 2015, J BIOL CHEM, V290, P18770, DOI 10.1074/jbc.M115.659631; Dijkman WP, 2014, APPL ENVIRON MICROB, V80, P1082, DOI 10.1128/AEM.03740-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Ferrari AR, 2015, BIOTECHNOL BIOENG, V112, P1074, DOI 10.1002/bit.25532; Ferrari AR, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-37; Foumani M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125398; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Heuts DPHM, 2007, FEBS LETT, V581, P4905, DOI 10.1016/j.febslet.2007.09.019; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; HUANG CH, 2008, J BIOL CHEM, V0283; Huang TH, 2012, ACTA CRYSTALLOGR D, V68, P1303, DOI 10.1107/S0907444912027552; Jain I, 2015, INDIAN J EXP BIOL, V53, P131; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karnaouri A, 2013, PEERJ, V1, DOI 10.7717/peerj.46; KASPRZAK AA, 1983, BIOCHEM J, V211, P535, DOI 10.1042/bj2110535; Kiryu T, 2008, BIOSCI BIOTECH BIOCH, V72, P833, DOI 10.1271/bbb.70701; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; Kolbusz MA, 2014, FUNGAL GENET BIOL, V72, P10, DOI 10.1016/j.fgb.2014.05.006; Kopacz MM, 2014, BIOORGAN MED CHEM, V22, P5621, DOI 10.1016/j.bmc.2014.05.051; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee MH, 2005, APPL ENVIRON MICROB, V71, P8881, DOI 10.1128/AEM.71.12.8881-8887.2005; Leferink NGH, 2008, ARCH BIOCHEM BIOPHYS, V474, P292, DOI 10.1016/j.abb.2008.01.027; LIN SF, 1991, BIOCHIM BIOPHYS ACTA, V1118, P41, DOI 10.1016/0167-4838(91)90439-7; Ludwig R, 2004, APPL MICROBIOL BIOT, V64, P213, DOI 10.1007/s00253-003-1501-6; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NISHIKIMI M, 1977, FEBS LETT, V81, P323, DOI 10.1016/0014-5793(77)80545-0; Nordkvist M, 2007, BIOTECHNOL BIOENG, V97, P694, DOI 10.1002/bit.21273; Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qing Q, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-18; ROYER JC, 1991, EUR J BIOCHEM, V202, P521, DOI 10.1111/j.1432-1033.1991.tb16404.x; Samanta A. K., 2015, Bioactive Carbohydrates and Dietary Fibre, V5, P62; Schallmey M, 2013, CHEMBIOCHEM, V14, P870, DOI 10.1002/cbic.201300005; Schou C, 1998, BIOCHEM J, V330, P565, DOI 10.1042/bj3300565; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; THEANDER O, 1989, ANIM FEED SCI TECH, V23, P205, DOI 10.1016/0377-8401(89)90098-9; Topakas E, 2012, APPL MICROBIOL BIOT, V94, P399, DOI 10.1007/s00253-011-3612-9; van Gool MP, 2012, BIORESOURCE TECHNOL, V119, P123, DOI 10.1016/j.biortech.2012.05.117; van Hellemond EW, 2006, ADV APPL MICROBIOL, V60, P17, DOI 10.1016/S0065-2164(06)60002-6; Verdoes J.C., 2007, IND BIOTECHNOL, V3, P48, DOI [10.1089/ind.2007.3.048, DOI 10.1089/IND.2007.3.048]; Verdoes J. C., 2010, Patent, Patent No. [WO 2010107 303 A2, 2010107303]; Visser H., 2011, IND BIOTECHNOL, V7, P214, DOI [10.1089/ind.2011.7.214, DOI 10.1089/IND.2011.7.214]; Vuong TV, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-148; Winkler A, 2006, J BIOL CHEM, V281, P21276, DOI 10.1074/jbc.M603267200; Xu F, 2001, EUR J BIOCHEM, V268, P1136, DOI 10.1046/j.1432-1327.2001.01982.x; Zafred D, 2015, FEBS J, V282, P3060, DOI 10.1111/febs.13212	56	17	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23709	23718		10.1074/jbc.M116.741173	http://dx.doi.org/10.1074/jbc.M116.741173			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27629413	hybrid, Green Published			2022-12-26	WOS:000387884400031
J	Lykken, EA; Li, QJ				Lykken, Erik Allen; Li, Qi-Jing			The MicroRNA miR-191 Supports T Cell Survival Following Common Chain Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; cytokine induction; homeostasis; immunodeficiency; microRNA mechanism; T cell biology	INSULIN-RECEPTOR SUBSTRATE-1; NORMAL IMMUNE FUNCTION; IN-VIVO; HOMEOSTATIC PROLIFERATION; TH1 RESPONSES; C-ELEGANS; MEMORY; STAT5; NAIVE; EXPRESSION	To ensure lifelong immunocompetency, naive and memory T cells must be adequately maintained in the peripheral lymphoid tissues. Homeostatic maintenance of T cells is controlled by tonic signaling through T cell antigen receptors and common chain cytokine receptors. In this study, we identify the highly expressed microRNA miR-191 as a key regulator of naive, memory, and regulatory T cell homeostasis. Conditional deletion of miR-191 using LckCre resulted in preferential loss of peripheral CD4(+) regulatory T cells as well as naive and memory CD8(+) T cells. This preferential loss stemmed from reduced survival following deficient cytokine signaling and STAT5 activation. Mechanistically, insulin receptor substrate 1 (Irs1) is a direct target of miR-191, and dysregulated IRS1 expression antagonizes STAT5 activation. Our study identifies a novel role for microRNAs in fine-tuning immune homeostasis and thereby maintaining the lymphocyte reservoir necessary to mount productive immune responses.	[Lykken, Erik Allen; Li, Qi-Jing] Duke Univ, Dept Immunol, Med Ctr, Box 3010, Durham, NC 27710 USA	Duke University	Li, QJ (corresponding author), Duke Univ, Dept Immunol, Med Ctr, Box 3010, Durham, NC 27710 USA.	qi-jing.li@dm.duke.edu		Lykken, Erik/0000-0002-1458-5885	American Diabetes Association [1-10-JF-28]; National Institutes of Health [R01AI091878]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091878, T32AI052077] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Diabetes Association Grant 1-10-JF-28 and National Institutes of Health Grant R01AI091878 (to Q. J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Buckley RH, 2000, IMMUNOL RES, V22, P237, DOI 10.1385/IR:22:2-3:237; Cerwenka A, 1998, J IMMUNOL, V161, P97; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Decaluwe H, 2010, P NATL ACAD SCI USA, V107, P9311, DOI 10.1073/pnas.0913729107; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; JOHNSTON JA, 1995, J BIOL CHEM, V270, P28527, DOI 10.1074/jbc.270.48.28527; Kang JS, 2004, J IMMUNOL, V173, P2307, DOI 10.4049/jimmunol.173.4.2307; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lin R, 2014, J CLIN INVEST, V124, P5352, DOI 10.1172/JCI76561; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; Masuda K, 2007, J IMMUNOL, V179, P3699, DOI 10.4049/jimmunol.179.6.3699; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Metz HE, 2016, P NATL ACAD SCI USA, V113, P8795, DOI 10.1073/pnas.1601989113; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Mitchell DM, 2013, J IMMUNOL, V190, P3390, DOI 10.4049/jimmunol.1202674; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ramezani A, 2000, MOL THER, V2, P458, DOI 10.1006/mthe.2000.0190; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sharfe N, 1997, J IMMUNOL, V159, P1107; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Snow JW, 2003, J IMMUNOL, V171, P5042, DOI 10.4049/jimmunol.171.10.5042; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tripathi P, 2010, J IMMUNOL, V185, P2116, DOI 10.4049/jimmunol.1000842; Tsuruzoe K, 2001, MOL CELL BIOL, V21, P26, DOI 10.1128/MCB.21.1.26-38.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zou T, 2012, J IMMUNOL, V189, P28, DOI 10.4049/jimmunol.1200507	49	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23532	23544		10.1074/jbc.M116.741264	http://dx.doi.org/10.1074/jbc.M116.741264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634043	Green Published, hybrid			2022-12-26	WOS:000387884400015
J	Qi, ST; Ma, JY; Wang, ZB; Guo, L; Hou, Y; Sun, QY				Qi, Shu-Tao; Ma, Jun-Yu; Wang, Zhen-Bo; Guo, Lei; Hou, Yi; Sun, Qing-Yuan			N-6-Methyladenosine Sequencing Highlights the Involvement of mRNA Methylation in Oocyte Meiotic Maturation and Embryo Development by Regulating Translation in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC POLYADENYLATION; GENOME ACTIVATION; DNA-REPLICATION; ZYGOTIC GENOME; NUCLEAR-RNA; PROTEIN; MOS; CPEB; N6-METHYLADENOSINE; PHOSPHORYLATION	During the oogenesis of Xenopus laevis, oocytes accumulate maternal materials for early embryo development. As the transcription activity of the oocyte is silenced at the fully grown stage and the global genome is reactivated only by the mid-blastula embryo stage, the translation of maternal mRNAs accumulated during oocyte growth should be accurately regulated. Previous evidence has illustrated that the poly(A) tail length and RNA binding elements mediate RNA translation regulation in the oocyte. Recently, RNA methylation has been found to exist in various systems. In this study, we sequenced the N-6-methyladenosine (m(6)A) modified mRNAs in fully grown germinal vesicle-stage and metaphase II-stage oocytes. As a result, we identified 4207 mRNAs with m(6)A peaks in germinal vesicle-stage or metaphase II-stage oocytes. When we integrated the mRNA methylation data with transcriptome and proteome data, we found that the highly methylated mRNAs showed significantly lower protein levels than those of the hypomethylated mRNAs, although the RNA levels showed no significant difference. We also found that the hypomethylated mRNAs were mainly enriched in the cell cycle and translation pathways, whereas the highly methylated mRNAs were mainly associated with protein phosphorylation. Our results suggest that oocyte mRNA methylation can regulate cellular translation and cell division during oocyte meiotic maturation and early embryo development.	[Qi, Shu-Tao; Wang, Zhen-Bo; Guo, Lei; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China; [Ma, Jun-Yu; Sun, Qing-Yuan] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao 266109, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Qingdao Agricultural University	Sun, QY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.	sunqy@ioz.ac.cn		Qi, Shutao/0000-0002-4073-1161; Sun, Qing-Yuan/0000-0002-0148-2414	Ministry of Science and Technology of China [JFYS2016ZY05001886]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work is supported by Ministry of Science and Technology of China Grant JFYS2016ZY05001886. The authors declare that they have no conflicts of interest with the contents of this article.	Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Bellier S, 1997, MOL CELL BIOL, V17, P1434, DOI 10.1128/MCB.17.3.1434; Cao GC, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160003; Charlier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-560; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Feng Jianxing, 2011, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0214s34; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Graf A, 2014, ANIM REPROD SCI, V149, P46, DOI 10.1016/j.anireprosci.2014.05.016; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Miyara F, 2003, MOL REPROD DEV, V64, P458, DOI 10.1002/mrd.10233; Narasimhachar Y, 2009, J BIOL CHEM, V284, P27235, DOI 10.1074/jbc.M109.008854; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Peshkin L, 2015, DEV CELL, V35, P383, DOI 10.1016/j.devcel.2015.10.010; Peter M, 2002, DEVELOPMENT, V129, P2129; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Prather R. S., 2010, MOL REPROD DEV, V77; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Smits AH, 2014, NUCLEIC ACIDS RES, V42, P9880, DOI 10.1093/nar/gku661; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Yoshitome S, 2012, BIOCHEM BIOPH RES CO, V422, P770, DOI 10.1016/j.bbrc.2012.05.080; Yu C, 2016, NAT STRUCT MOL BIOL, V23, P387, DOI 10.1038/nsmb.3204; Yu C, 2016, CELL RES, V26, P275, DOI 10.1038/cr.2016.20; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	42	44	47	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23020	23026		10.1074/jbc.M116.748889	http://dx.doi.org/10.1074/jbc.M116.748889			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27613873	Green Published, hybrid			2022-12-26	WOS:000387224800014
J	Alnazzawi, N; Thompson, P; Ananiadou, S				Alnazzawi, Noha; Thompson, Paul; Ananiadou, Sophia			Mapping Phenotypic Information in Heterogeneous Textual Sources to a Domain-Specific Terminological Resource	PLOS ONE			English	Article							OF-THE-ART; CONCEPT RECOGNITION; CLINICAL TEXT; NORMALIZATION; EXTRACTION; ONTOLOGY; CORPUS; GENES; UMLS; TASK	Biomedical literature articles and narrative content from Electronic Health Records (EHRs) both constitute rich sources of disease-phenotype information. Phenotype concepts may be mentioned in text in multiple ways, using phrases with a variety of structures. This variability stems partly from the different backgrounds of the authors, but also from the different writing styles typically used in each text type. Since EHR narrative reports and literature articles contain different but complementary types of valuable information, combining details from each text type can help to uncover new disease-phenotype associations. However, the alternative ways in which the same concept may be mentioned in each source constitutes a barrier to the automatic integration of information. Accordingly, identification of the unique concepts represented by phrases in text can help to bridge the gap between text types. We describe our development of a novel method, PhenoNorm, which integrates a number of different similarity measures to allow automatic linking of phenotype concept mentions to known concepts in the UMLS Metathesaurus, a biomedical terminological resource. PhenoNorm was developed using the PhenoCHF corpus D a collection of literature articles and narratives in EHRs, annotated for phenotypic information relating to congestive heart failure (CHF). We evaluate the performance of PhenoNorm in linking CHF-related phenotype mentions to Metathesaurus concepts, using a newly enriched version of PhenoCHF, in which each phenotype mention has an expert-verified link to a concept in the UMLS Metathesaurus. We show that PhenoNorm outperforms a number of alternative methods applied to the same task. Furthermore, we demonstrate PhenoNorm's wider utility, by evaluating its ability to link mentions of various other types of medically-related information, occurring in texts covering wider subject areas, to concepts in different terminological resources. We show that PhenoNorm can maintain performance levels, and that its accuracy compares favourably to other methods applied to these tasks.	[Alnazzawi, Noha; Thompson, Paul; Ananiadou, Sophia] Univ Manchester, Natl Ctr Text Min, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester	Alnazzawi, N (corresponding author), Univ Manchester, Natl Ctr Text Min, Manchester Inst Biotechnol, Manchester, Lancs, England.	alnazzan@cs.man.ac.uk	Alnazzaawi, Noha/ABG-9130-2021	Alnazzaawi, Noha/0000-0003-3265-0297	Medical Research Council [MR/L01078X/1]; Defense Advanced Research Projects Agency [DARPA-BAA-14-14]; MRC [MR/N00583X/1, MR/L01078X/1] Funding Source: UKRI; Medical Research Council [MR/N00583X/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council (Supporting Evidence-based Public Health Interventions using Text Mining [Grant MR/L01078X/1]) and by the Defense Advanced Research Projects Agency (Big Mechanism [Grant DARPA-BAA-14-14]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnazzawi N, 2014, P 5 INT WORKSH HLTH, P69; Alnazzawi N, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/1472-6947-15-S2-S3; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Baumgartner WA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S9; Bello S, 2015, P PHEN DAY ISMB 2015, P16; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Chapman WW, 2011, J AM MED INFORM ASSN, V18, P540, DOI 10.1136/amiajnl-2011-000465; Cohen William W., 2003, P IJCAI 03 WORKSH IN, P73; Collier N, 2015, P PHEN DAY 2015 ISMB; Collier N, 2014, P PHEN DAY ISMB 2014; Collier N, 2015, J BIOMED SEMANT, V6, DOI 10.1186/s13326-015-0019-z; Dai M, 2008, P AMIA SUMM TRANSL B; Davis AP, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar065; de Bruijn B, 2011, J AM MED INFORM ASSN, V18, P557, DOI 10.1136/amiajnl-2011-000150; De La Higuera C, 2008, 1 INT WORKSH SIM SEA; Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006; Donnelly K, 2006, STUD HEALTH TECHNOL, V121, P279; Elhadad N, 2015, P 9 INT WORKSH SEM E, P303; Fan J, 2013, P SHARE CLEF EV LAB; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Franz P, 2000, J AM MED INFORM ASSN, P250; Friedman C, 2000, P AMIA S; Friedman C, 1996, P AMIA ANN FALL S, P938; Fu X, 2014, PROCEED PHENOTYPE DA, V2014, P1; Garla VN, 2013, J AM MED INFORM ASSN, V20, P882, DOI 10.1136/amiajnl-2012-001350; Goeuriot L, 2015, LECT NOTES COMPUT SC, V9283, P429, DOI 10.1007/978-3-319-24027-5_44; Golbeck J, 2011, WEB SEMANTICS SCI SE, V1; Goudey B, 2007, P AUSTR LANG TECHN W, P143; Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; HERSH WR, 1990, COMPUT BIOMED RES, V23, P410, DOI 10.1016/0010-4809(90)90031-7; Hettne K, 2015, P PHEN DAY ISMB 2015, P36; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Islamaj Dogan R, 2012, P 2012 AAAI FALL S S; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jaro MA, 1995, J AM MED INFORM ASSN, V14, DOI DOI 10.1136/AMIAJNL-2011-000203; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Kate RJ, 2016, J AM MED INFORM ASSN, V23, P380, DOI 10.1093/jamia/ocv108; Kessler JS, 2010, P INT AAAI C WEBL SO; Khordad M, 2012, P COLING, P1425; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim J-D, 2004, P INT JOINT WORKSH N, P70; Kim JD, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S1; Kim JD, 2011, COMPUT INTELL-US, V27, P513, DOI 10.1111/j.1467-8640.2011.00398.x; Kondrak G, 2005, LECT NOTES COMPUT SC, V3772, P115; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Leaman R, 2013, P SHARE CLEF EV LAB; Leaman R, 2009, P 2009 S LANG BIOL M; Leaman Robert, 2008, Pac Symp Biocomput, P652; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Lu ZY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S2; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Man, 2014, P 8 INT WORKSH SEM E, P54, DOI DOI 10.3115/V1/S14-2007; Miller R A, 1992, Proc Annu Symp Comput Appl Med Care, P86; Moreau E, 2008, P 22 INT C COMP LING, P593, DOI DOI 10.3115/1599081.1599156; Myers EW, 1986, ALGORITHMICA, V1, P251, DOI 10.1007/BF01840446; Nunes T, 2013, BIOINFORMATICS, V29, P1915, DOI 10.1093/bioinformatics/btt317; Oellrich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116040; Orly A, 2015, P PHEN DAY ISMB 2015, P35; Patrick J, 2007, P 5 AUSTR S ACSW FRO, P219; Patrick J, 2006, P 2006 AUSTR LANG TE, P75; Pradhan S, 2015, J AM MED INFORM ASSN, V22, P143, DOI 10.1136/amiajnl-2013-002544; Pyysalo S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S11-S2; Ramanan S, 2013, P SHARE CLEF EV LAB; Richesson R, 2015, ELECT HLTH RECORDS B; Rudniy A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-187; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Simpson Matthew S, 2012, MINING TEXT DATA, P465, DOI DOI 10.1007/978-1-4614-3223-4_14; Suominen H, 2013, LECT NOTES COMPUT SC, V8138, P212, DOI 10.1007/978-3-642-40802-1_24; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Tseytlin E, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0871-y; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Uzuner O, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Uzuner O, 2007, J AM MED INFORM ASSN, V14, P550, DOI 10.1197/jamia.M2444; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Vasant D, 2014, P PHEN DAY ISMB 2014, P49; Vasant D, 2015, P PHEN DAY ISMB 2015, P24; Wang CX, 2013, SCI WORLD J, DOI 10.1155/2013/968432; Wang LQ, 2016, ARTIF INTELL MED, V68, P47, DOI 10.1016/j.artmed.2016.02.003; Wei Q, P 5 BIOCREATIVE CHAL, P327; Winkler WE, 1999, STATE RECORD LINKAGE; Winnenburg R, 2014, JOINT BIOONT BIOLINK, P41; Woo H, 2015, INT J MOL SCI, V16, P9017, DOI 10.3390/ijms16049017; Zhou XH, 2006, LECT NOTES ARTIF INT, V4099, P1145, DOI 10.1007/978-3-540-36668-3_150; Zou Qinghua, 2003, AMIA Annu Symp Proc, P763; Zuccon G, 2013, P SHARE CLEF EV LAB	91	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0162287	10.1371/journal.pone.0162287	http://dx.doi.org/10.1371/journal.pone.0162287			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW8GC	27643689	Green Submitted, Green Published, gold			2022-12-26	WOS:000383891900008
J	Chung, SD; Huang, CY; Wu, ST; Lin, HC; Huang, CC; Kao, LT				Chung, Shiu-Dong; Huang, Chao-Yuan; Wu, Sheng-Tang; Lin, Herng-Ching; Huang, Chung-Chien; Kao, Li-Ting			Nephrectomy Type Was Not Associated with a Subsequent Risk of Coronary Heart Disease: A Population-Based Study	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; RADICAL NEPHRECTOMY; FUNCTIONAL OUTCOMES; SURVIVAL BENEFIT; ARTERY-DISEASE; KIDNEY-DISEASE; TUMORS; CM; EPIDEMIOLOGY; MORTALITY	Previous studies investigated the impacts of a partial nephrectomy (PN) or radical nephrectomy (RN) on cardiovascular events and death. However, the association between the type of nephrectomy (PN vs. RN) and cardiovascular disease is still equivocal. This retrospective cohort study aimed to compare the risk of coronary heart disease (CHD) between patients who underwent a PN and those who underwent an RN. We used data from the Taiwan Longitudinal Health Insurance Database 2005. In total, 60 patients who underwent a PN and 545 patients who underwent an RN were included. Each patient was tracked for 1-, 2-, 3-, and 5-year periods to identify those who were subsequently diagnosed with CHD. Cox proportional hazard regression analyses were used to calculate hazard ratios (HRs) for CHD during 1-, 2-, 3-, and 5-year follow-up periods between these two cohorts. For the 1-year follow-up period, the adjusted HR was 0.39 (95% CI: 0.05 similar to 2.90, p = 0.355) for patients who underwent a PN compared to those who underwent an RN. Additionally, the adjusted HRs of CHD in patients who underwent a PN for 2-, 3-and 5-year follow-up periods were 1.40 (95% CI: 0.62 similar to 3.16, p = 0.417), 1.09 (95% CI: 0.52 similar to 2.31, p = 0.814), and 1.02 (95% CI: 0.48 similar to 2.18, p = 0.961), respectively, compared to those who underwent an RN. We concluded that there was no significant difference in the risk of CHD between patients who underwent a PN and those who underwent an RN.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Div Urol, Dept Surg, Banciao, Taiwan; [Chung, Shiu-Dong] Yuan Ze Univ, Coll Informat, Grad Program Biomed Informat, Chungli, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching; Kao, Li-Ting] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Huang, Chao-Yuan] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Huang, Chao-Yuan] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Urol, Taipei, Taiwan; [Wu, Sheng-Tang] Triserv Gen Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Wu, Sheng-Tang] Natl Def Med Ctr, Taipei, Taiwan; [Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Far Eastern Memorial Hospital; Yuan Ze University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Tri-Service General Hospital; National Defense Medical Center; Taipei Medical University; National Defense Medical Center	Kao, LT (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.; Kao, LT (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	kaoliting@gmail.com	Huang, CC/AAX-5872-2021; Kao, Li-Ting/W-9287-2018	Huang, CC/0000-0003-0818-7175; Kao, Li-Ting/0000-0003-0692-7408; HUANG, CHAO-YUAN/0000-0002-9322-6062				Cai QJ, 2013, CURR CARDIOL REV, V9, P331, DOI 10.2174/1573403X10666140214122234; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Daugherty M, 2014, UROL ONCOL-SEMIN ORI, V32, P549, DOI 10.1016/j.urolonc.2013.11.009; Edwards L, 2016, KIDNEY CANC NURSE PR, P333; Eskicorapci SY, 2007, THESCIENTIFICWORLDJO, V7, P825, DOI 10.1100/tsw.2007.153; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Huang WC, 2009, J UROLOGY, V181, P55, DOI 10.1016/j.juro.2008.09.017; Kates M, 2011, J UROLOGY, V186, P1247, DOI 10.1016/j.juro.2011.05.054; Kim SP, 2012, J UROLOGY, V188, P51, DOI [10.1016/j.juro.2012.10.026, 10.1016/j.juro.2012.03.006]; Kopp RP, 2015, UROLOGY, V86, P312, DOI 10.1016/j.urology.2015.02.067; Krabbe L-M, 2016, COCHRANE DATABASE SY; Lane BR, 2008, J UROLOGY, V180, P2363, DOI 10.1016/j.juro.2008.08.036; Lane BR, 2011, J UROLOGY, V186, P1229, DOI 10.1016/j.juro.2011.05.081; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Mack M, 2014, CARDIOL CLIN, V32, P323, DOI 10.1016/j.ccl.2014.04.003; McCullough PA, 2007, CLIN J AM SOC NEPHRO, V2, P611, DOI 10.2215/CJN.03871106; Miller DC, 2008, CANCER-AM CANCER SOC, V112, P511, DOI 10.1002/cncr.23218; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Silberstein JL, 2012, J UROLOGY, V187, P429, DOI 10.1016/j.juro.2011.09.150; Smaldone MC, 2012, J UROLOGY, V188, P2089, DOI 10.1016/j.juro.2012.07.099; Sun M, 2012, EUR UROL, V61, P725, DOI 10.1016/j.eururo.2011.11.047; Takagi T, 2015, BJU INT; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Weight CJ, 2010, UROLOGY, V76, P631, DOI 10.1016/j.urology.2009.11.087; Weight CJ, 2010, EUR UROL, V58, P293, DOI 10.1016/j.eururo.2010.04.033; Weight CJ, 2010, J UROLOGY, V183, P1317, DOI 10.1016/j.juro.2009.12.030; Yokoyama M, 2011, J UROLOGY, V185, P2066, DOI 10.1016/j.juro.2011.02.005	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163253	10.1371/journal.pone.0163253	http://dx.doi.org/10.1371/journal.pone.0163253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636094	gold, Green Published, Green Submitted			2022-12-26	WOS:000383723700042
J	Shin, SH; Kim, SC; Song, KB; Hwang, DW; Lee, JH; Park, KM; Lee, YJ				Shin, Sang Hyun; Kim, Song Cheol; Song, Ki Byung; Hwang, Dae Wook; Lee, Jae Hoon; Park, Kwang-Min; Lee, Young-Joo			Appraisal of Laparoscopic Distal Pancreatectomy for Left-Sided Pancreatic Cancer: A Large Volume Cohort Study of 152 Consecutive Patients	PLOS ONE			English	Article							ANTEGRADE MODULAR PANCREATOSPLENECTOMY; PYLORUS-PRESERVING PANCREATICODUODENECTOMY; RANDOMIZED CONTROLLED-TRIAL; INTERNATIONAL STUDY-GROUP; DUCTAL ADENOCARCINOMA; CLINICAL-OUTCOMES; ADJUVANT CHEMOTHERAPY; SINGLE-INSTITUTION; RESECTION; SURGERY	Background The aim of this study was to appraise the value of laparoscopic distal pancreatectomy (LDP) for left-sided pancreatic cancer based on a large volume cohort study. Methods We reviewed data for all consecutive patients undergoing LDP for left-sided pancreatic cancer at Asan Medical Center (Seoul, Korea) between December 2006 and December 2014. Results A total of 91 male and 61 female patients, with a median age of 62.7 years were included in this study. The median operative duration was 234 minutes. Pathological reports revealed the following: a median tumor size of 3.0 cm (range, 0.4-10.0), T stages (T1 in 7.9%, T2 in 5.3%, T3 in 86.8%, and no T4), the tumor differentiation (well differentiated in 16.4%, moderately differentiated in 75.4%, and poorly differentiated in 8.2%), and R0 resection in 126 patients (82.9%). After pancreatectomy, 96 patients (63.2%) received adjuvant chemotherapy, and the median time to chemotherapy was 30 days. The median length of hospital stay was 8 days (range, 5-31), and the median time to diet resumption was 1 day. Grade B or C postoperative pancreatic fistula occurred in 14 patients (9.2%) and grade II or III complications occurred in 27 (17.7%). The median overall survival was 43.0 months. A Cox proportional hazards model showed that tumor size, N1 stage, combined resection, and incompleteness of planned adjuvant chemotherapy affect patient survival. Conclusions LDP for left-sided pancreatic cancer is reasonable within selected indications. An international consensus on laparoscopic surgery for pancreatic cancer would be desirable and timely.	[Shin, Sang Hyun; Kim, Song Cheol; Song, Ki Byung; Hwang, Dae Wook; Lee, Jae Hoon; Park, Kwang-Min; Lee, Young-Joo] Univ Ulsan, Coll Med, Asan Med Ctr, Div Hepato Biliary & Pancreat Surg,Dept Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kim, SC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Hepato Biliary & Pancreat Surg,Dept Surg, Seoul, South Korea.	drksc@amc.seoul.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C2640]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant number: HI14C2640). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. (grant number: HI14C2640)	Asbun HJ, 2012, J AM COLL SURGEONS, V215, P810, DOI 10.1016/j.jamcollsurg.2012.08.006; Ashfaq A, 2014, J GASTROINTEST SURG, V18, P1929, DOI 10.1007/s11605-014-2566-5; BARKUN JS, 1992, LANCET, V340, P1116, DOI 10.1016/0140-6736(92)93148-G; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Correa-Gallego C, 2014, J AM COLL SURGEONS, V218, P129, DOI 10.1016/j.jamcollsurg.2013.09.005; Croome KP, 2014, ANN SURG, V260, P633, DOI 10.1097/SLA.0000000000000937; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eom BW, 2008, SURG ENDOSC, V22, P1334, DOI 10.1007/s00464-007-9660-7; Gagner M, 1996, SURGERY, V120, P1051, DOI 10.1016/S0039-6060(96)80054-7; Gagner M, 1997, ANN SURG, V226, P238, DOI 10.1097/00000658-199709000-00003; Giessing M, 2005, TRANSPLANT P, V37, P2011, DOI 10.1016/j.transproceed.2005.03.007; Gigot JF, 2002, ANN SURG, V236, P90, DOI 10.1097/00000658-200207000-00014; Hofstetter G, 2013, GYNECOL ONCOL, V131, P15, DOI 10.1016/j.ygyno.2013.07.086; Kawaguchi Y, 2015, SURGERY, V157, P1106, DOI 10.1016/j.surg.2014.12.015; Kim SC, 2008, SURG ENDOSC, V22, P2261, DOI 10.1007/s00464-008-9973-1; Kim SC, 2013, SURG ENDOSC, V27, P95, DOI 10.1007/s00464-012-2427-9; Kooby DA, 2010, J AM COLL SURGEONS, V210, P779, DOI 10.1016/j.jamcollsurg.2009.12.033; Kooby DA, 2010, SURG CLIN N AM, V90, P427, DOI 10.1016/j.suc.2009.12.011; Latorre M, 2013, AM SURGEON, V79, P1154; Limongelli P, 2012, SURG ENDOSC, V26, P1830, DOI 10.1007/s00464-011-2141-z; Mabrut JY, 2005, SURGERY, V137, P597, DOI 10.1016/j.surg.2005.02.002; Magge D, 2013, JAMA SURG, V148, P525, DOI 10.1001/jamasurg.2013.1673; Melotti G, 2007, ANN SURG, V246, P77, DOI 10.1097/01.sla.0000258607.17194.2b; Mitchem JB, 2012, J AM COLL SURGEONS, V214, P46, DOI 10.1016/j.jamcollsurg.2011.10.008; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Park HJ, 2014, WORLD J SURG, V38, P186, DOI 10.1007/s00268-013-2254-8; Paye F, 2015, BRIT J SURG, V102, P229, DOI 10.1002/bjs.9708; Rehman S, 2014, WORLD J SURG, V38, P476, DOI 10.1007/s00268-013-2268-2; Sharpe SM, 2015, AM J SURG, V209, P557, DOI 10.1016/j.amjsurg.2014.11.001; Shin SH, 2015, J AM COLL SURGEONS, V220, P177, DOI 10.1016/j.jamcollsurg.2014.10.014; Song KB, 2015, ANN SURG, V262, P146, DOI 10.1097/SLA.0000000000001079; Song KB, 2011, SURG ENDOSC, V25, P3364, DOI 10.1007/s00464-011-1727-9; Strasberg SM, 2003, SURGERY, V133, P521, DOI 10.1067/msy.2003.146; Tol JAMG, 2014, SURGERY, V156, P591, DOI 10.1016/j.surg.2014.06.016; Valle JW, 2014, J CLIN ONCOL, V32, P504, DOI 10.1200/JCO.2013.50.7657; Veldkamp R, 2004, SURG ENDOSC, V18, P1163, DOI 10.1007/s00464-003-8253-3; Vijan SS, 2010, ARCH SURG-CHICAGO, V145, P616, DOI 10.1001/archsurg.2010.120; Yamamoto J, 2010, JPN J CLIN ONCOL, V40, P530, DOI 10.1093/jjco/hyq015	39	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0163266	10.1371/journal.pone.0163266	http://dx.doi.org/10.1371/journal.pone.0163266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636547	Green Published, gold, Green Submitted			2022-12-26	WOS:000383723700045
J	Astolfi, L; Simoni, E; Valente, F; Ghiselli, S; Hatzopoulos, S; Chicca, M; Martini, A				Astolfi, Laura; Simoni, Edi; Valente, Filippo; Ghiselli, Sara; Hatzopoulos, Stavros; Chicca, Milvia; Martini, Alessandro			Coenzyme Q10 plus Multivitamin Treatment Prevents Cisplatin Ototoxicity in Rats	PLOS ONE			English	Article							INDUCED HEARING-LOSS; HAIR CELL LOSS; OXIDATIVE STRESS; GUINEA-PIG; D-METHIONINE; IN-VIVO; MICE; PROTECTS; NEPHROTOXICITY; MECHANISMS	Cisplatin (Cpt) is known to induce a high level of oxidative stress, resulting in an increase of reactive oxygen species damaging the inner ear and causing hearing loss at high frequencies. Studies on animal models show that antioxidants may lower Cpt-induced ototoxicity. The aim of this study is to evaluate the ototoxic effects of two different protocols of Cpt administration in a Sprague-Dawley rat model, and to test in the same model the synergic protective effects of a solution of coenzyme Q10 terclatrate and Acuval 4001, a multivitamin supplement containing antioxidant agents and minerals (Acu-Qter). The Cpt was administered intraperitoneally in a single dose (14 mg/kg) or in three daily doses (4.6 mg/kg/day) to rats orally treated or untreated with Acu-Qter for 5 days. The auditory function was assessed by measuring auditory brainstem responses from 2 to 32 kHz at day 0 and 5 days after treatment. Similar hearing threshold and body weight alterations were observed in both Cpt administration protocols, but mortality reduced to zero when Cpt was administered in three daily doses. The Acu-Qter treatment was able to prevent and completely neutralize ototoxicity in rats treated with three daily Cpt doses, supporting the synergic protective effects of coenzyme Q terclatrate and Acuval 4001 against Cpt-induced oxidative stress. The administration protocol involving three Cpt doses is more similar to common human chemotherapy protocols, therefore it appears more useful for long-term preclinical studies on ototoxicity prevention.	[Astolfi, Laura; Simoni, Edi; Valente, Filippo; Martini, Alessandro] Univ Padua, Bioacoust Res Lab, Dept Neurosci, Padua, Italy; [Astolfi, Laura; Martini, Alessandro] Fdn Onlus Staminali & Vita, Padua, Italy; [Ghiselli, Sara; Martini, Alessandro] Univ Padua, ENT Surg Dept Neurosci, Padua, Italy; [Hatzopoulos, Stavros] Univ Ferrara, Clin ENT, Ferrara, Italy; [Chicca, Milvia] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy	University of Padua; University of Padua; University of Ferrara; University of Ferrara	Astolfi, L (corresponding author), Univ Padua, Bioacoust Res Lab, Dept Neurosci, Padua, Italy.; Astolfi, L (corresponding author), Fdn Onlus Staminali & Vita, Padua, Italy.	laura.astolfi@unipd.it	Astolfi, Laura/H-2846-2012; Astolfi, Laura/GLU-1045-2022; Hatzopoulos, Stavros/B-6999-2016; Ghiselli, Sara/D-8042-2016; Martini, Alessandro/K-2513-2018	Astolfi, Laura/0000-0002-3291-8567; Astolfi, Laura/0000-0002-3291-8567; Hatzopoulos, Stavros/0000-0002-9509-9722; Ghiselli, Sara/0000-0002-1214-0807; Valente, Filippo/0000-0001-5760-5949; SIMONI, EDI/0000-0001-7336-5041; Martini, Alessandro/0000-0002-2003-6348	Scharper Healthcare Srl. (Milan, Italy)	Scharper Healthcare Srl. (Milan, Italy)	The work was supported by the Scharper Healthcare Srl. (Milan, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi L., 2008, AUDIOL MED, V6, P251, DOI [10.1080/16513860802527930, DOI 10.1080/16513860802527930]; Astolfi L, 2013, ONCOL REP, V29, P1285, DOI 10.3892/or.2013.2279; Bhadri N, 2013, SCI WORLD J, DOI 10.1155/2013/565813; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Cardinaal RM, 2000, HEARING RES, V144, P135, DOI 10.1016/S0378-5955(00)00059-9; Cascella V, 2012, MED SCI MONITOR, V18, pBR1, DOI 10.12659/MSM.882180; Chirtes F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925485; Choi SJ, 2013, NEUROSCIENCE, V244, P49, DOI 10.1016/j.neuroscience.2013.04.001; Conklin KA, 2000, NUTR CANCER, V37, P1, DOI 10.1207/S15327914NC3701_1; Corvi Mora P, 2005, OXYGEN SOCIETY OF CA, P97; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Ding DL, 2012, ANAT REC, V295, P1851, DOI 10.1002/ar.22577; Ekborn A, 2003, HEARING RES, V181, P109, DOI 10.1016/S0378-5955(03)00181-3; Ekborn A, 2002, HEARING RES, V165, P53, DOI 10.1016/S0378-5955(02)00277-0; Fang B, 2014, BIOCHEM BIOPH RES CO, V448, P443, DOI 10.1016/j.bbrc.2014.04.123; Fetoni AR, 2014, OTOL NEUROTOL, V35, pE169, DOI 10.1097/MAO.0000000000000302; Fetoni AR, 2009, BRAIN RES, V1257, P108, DOI 10.1016/j.brainres.2008.12.027; Fetoni AR, 2004, ACTA OTO-LARYNGOL, V124, P421, DOI 10.1080/00016480410016559; Fouad AA, 2010, TOXICOLOGY, V274, P49, DOI 10.1016/j.tox.2010.05.007; Giordano P, 2006, Acta Otorhinolaryngol Ital, V26, P198; Guthrie OW, 2008, HEARING RES, V239, P79, DOI 10.1016/j.heares.2008.01.013; Harrison RT, 2015, LARYNGOSCOPE, V125, pE78, DOI 10.1002/lary.24948; He JC, 2009, ACTA OTO-LARYNGOL, V129, P1359, DOI 10.3109/00016480902856604; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Jun HJ, 2009, J PHARM PHARMACOL, V61, P1391, DOI 10.1211/jpp/61.10.0017; Karasawa T, 2015, TOXICOL LETT, V237, P219, DOI 10.1016/j.toxlet.2015.06.012; Li GM, 2002, LAB INVEST, V82, P585, DOI 10.1038/labinvest.3780453; Li GM, 2001, NEUROTOXICOLOGY, V22, P163, DOI 10.1016/S0161-813X(00)00010-3; Li YQ, 2011, NEUROTOX RES, V20, P307, DOI 10.1007/s12640-011-9244-0; Lorito G, 2011, MED SCI MONITOR, V17, pBR179, DOI 10.12659/MSM.881894; Ma WJ, 2015, CANCER CHEMOTH PHARM, V75, P949, DOI 10.1007/s00280-015-2716-9; Melamed SB, 2000, AUDIOLOGY, V39, P24; MORA PC, 2007, Patent No. 2007009997; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Rybak LP, 2000, AM J OTOL, V21, P513; Salami A, 2010, ACTA OTO-LARYNGOL, V130, P1154, DOI 10.3109/00016481003727590; Sohet FM, 2009, BIOCHEM PHARMACOL, V78, P1391, DOI 10.1016/j.bcp.2009.07.008; Sun CL, 2015, INT J NANOMED, V10, P3567, DOI 10.2147/IJN.S77912; Teranishi M, 2003, INT J PEDIATR OTORHI, V67, P133, DOI 10.1016/S0165-5876(02)00353-1; Tokgoz SA, 2012, J LARYNGOL OTOL, V126, P464, DOI 10.1017/S0022215112000382; Tsuneki H, 2007, EUR J PHARMACOL, V566, P1, DOI 10.1016/j.ejphar.2007.03.006; Yazici ZM, 2012, EUR ARCH OTO-RHINO-L, V269, P45, DOI 10.1007/s00405-011-1582-2; Youn CK, 2015, INT J PEDIATR OTORHI, V79, P1814, DOI 10.1016/j.ijporl.2015.08.012	44	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162106	10.1371/journal.pone.0162106	http://dx.doi.org/10.1371/journal.pone.0162106			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632426	Green Published, gold			2022-12-26	WOS:000383706900028
J	Frejd, D; Dunaway, K; Hill, J; Van Maanen, J; Carlson, C				Frejd, Derek; Dunaway, Kiera; Hill, Jennifer; Van Maanen, Jesse; Carlson, Clayton			The Genomic and Morphological Effects of Bisphenol A on Arabidopsis thaliana	PLOS ONE			English	Article							GERMINATION	The environmental toxin bisphenol A (BPA) is a known mammalian hormone disrupter but its effects on plants have not been well established. The effect of BPA on gene expression in Arabidopsis thaliana was determined using microarray analysis and quantitative gene PCR. Many hormone responsive genes showed changes in expression after BPA treatment. BPA disrupted flowering by a mechanism that may involve disruption of auxin signaling. The results presented here indicate that BPA is a plant hormone disrupter.	[Frejd, Derek; Dunaway, Kiera; Hill, Jennifer; Van Maanen, Jesse; Carlson, Clayton] Trinity Christian Coll, Dept Biol, Palos Hts, IL USA; [Dunaway, Kiera] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Hill, Jennifer] Univ New Hampshire, Mol Cellular & Biomed Sci Dept, Durham, NH 03824 USA; [Van Maanen, Jesse] Univ South Dakota, Dept Surg, Sanford Sch Med, Vermillion, SD USA	University System Of New Hampshire; University of New Hampshire; University of South Dakota	Carlson, C (corresponding author), Trinity Christian Coll, Dept Biol, Palos Hts, IL USA.	clayton.carlson@trnty.edu			VanderVelde Research Fellowship; Trinity Christian College	VanderVelde Research Fellowship; Trinity Christian College	This work was supported by the VanderVelde Research Fellowship and the Trinity Summer Research Grant from Trinity Christian College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamakis IDS, 2013, MUTAT RES-GEN TOX EN, V750, P111, DOI 10.1016/j.mrgentox.2012.10.012; Barnes KK, 2008, SCI TOTAL ENVIRON, V402, P192, DOI 10.1016/j.scitotenv.2008.04.028; Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008; Flint S, 2012, J ENVIRON MANAGE, V104, P19, DOI 10.1016/j.jenvman.2012.03.021; Han SJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-179; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jayasri K, 2016, ASIAN J WATER ENVIRO, V13, P107, DOI 10.3233/AJW-160021; KOPCEWICZ J, 1970, Acta Societatis Botanicorum Poloniae, V39, P339, DOI 10.5586/asbp.1970.026; Latorre A, 2003, CHROMATOGRAPHIA, V57, P111, DOI 10.1007/BF02497486; LEOPOLD AC, 1958, ANNU REV PLANT PHYS, V9, P281, DOI 10.1146/annurev.pp.09.060158.001433; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Mohapatra DP, 2011, J XENOBIOTICS, V1, P9, DOI 10.4081/xeno.2011.e3; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Speranza A, 2011, PLANT BIOLOGY, V13, P209, DOI 10.1111/j.1438-8677.2010.00330.x; Staples C, 2010, ENVIRON TOXICOL CHEM, V29, P467, DOI 10.1002/etc.49; Terouchi N, 2004, PLANT BIOTECHNOL, V21, P307, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.21.307; Terouchi N, 2010, PLANT BIOTECHNOL-NAR, V27, P115, DOI 10.5511/plantbiotechnology.27.115; Tian YS, 2014, J TOXICOL SCI, V39, P671, DOI 10.2131/jts.39.671; Tsuchisaka A, 2004, PLANT PHYSIOL, V136, P2982, DOI 10.1104/pp.104.049999; US Environmental Protection Agency, 2010, BISPH A ACT PLAN; US Environmental Protection Agency, 2014, BISPH A ALT THEM PAP; Williams SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055698	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0163028	10.1371/journal.pone.0163028	http://dx.doi.org/10.1371/journal.pone.0163028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631104	gold, Green Submitted, Green Published			2022-12-26	WOS:000383706900119
J	Zhao, YZ; Liu, XY; Wang, WP				Zhao, Yuzhen; Liu, Xiyu; Wang, Wenping			Spiking Neural P Systems with Neuron Division and Dissolution	PLOS ONE			English	Article							PRE-COMPUTED RESOURCES; SOLVING SUBSET SUM; STRUCTURAL PLASTICITY; COMPUTATIONAL POWER; UNIFORM SOLUTIONS; SYNAPSES WORKING; RULES; STRATEGY; SPIKES; SAT	Spiking neural P systems are a new candidate in spiking neural network models. By using neuron division and budding, such systems can generate/produce exponential working space in linear computational steps, thus provide a way to solve computational hard problems in feasible (linear or polynomial) time with a "time-spacetrade-off" strategy. In this work, a new mechanism called neuron dissolution is introduced, by which redundant neurons produced during the computation can be removed. As applications, uniform solutions to two NP-hard problems: SAT problem and Subset Sum problem are constructed in linear time, working in a deterministic way. The neuron dissolution strategy is used to eliminate invalid solutions, and all answers to these two problems are encoded as indices of output neurons. Our results improve the one obtained in Science China Information Sciences, 2011, 1596-1607 by Pan et al.	[Zhao, Yuzhen; Liu, Xiyu; Wang, Wenping] Shandong Normal Univ, Sch Management Sci & Engn, Jinan, Peoples R China	Shandong Normal University	Liu, XY (corresponding author), Shandong Normal Univ, Sch Management Sci & Engn, Jinan, Peoples R China.	sdxyliu@163.com		Zhao, Yuzhen/0000-0003-4902-1120	National Natural Science Foundation of China [61472231, 61170038, 61402187, 61502283]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) 61472231 to XL, 61170038 to XL, 61402187 (not applicable) and 61502283 (not applicable). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, COMPUTERS INTRACTABI; Brown D., 2014, APOPTOSIS ENCY TOXIC, V3, P598; Cabarle F G C, 2012, THEORY PRACTICE COMP, V7, P82, DOI [10.1007/978-4-431-54436-4_6, DOI 10.1007/978-4-431-54436-4_6]; Cabarle F G C, 2012, S MATH ASPECTS COMPU, V12, P25; Cabarle FGC, 2016, NEURAL COMPUT APPL, V27, P1337, DOI 10.1007/s00521-015-1937-5; Cabarle FGC, 2015, LECT NOTES COMPUT SC, V9504, P106, DOI 10.1007/978-3-319-28475-0_8; Cabarle FGC, 2015, NEURAL COMPUT APPL, V26, P1905, DOI 10.1007/s00521-015-1857-4; Chen H., 2006, 4H BRAINSTORMING WEE, V1, P195; Diaz-Pernil D, 2013, PATTERN RECOGN LETT, V34, P846, DOI 10.1016/j.patrec.2012.10.014; Galli R, 2003, CIRC RES, V92, P598, DOI 10.1161/01.RES.0000065580.02404.F4; Ionescu M, 2006, FUND INFORM, V71, P279; Ishdorj Tseren-Onolt, 2008, Natural Computing, V7, P519, DOI 10.1007/s11047-008-9081-0; Leporati A, 2007, LECT NOTES COMPUT SC, V4860, P336; Leporati Alberto, 2009, Natural Computing, V8, P681, DOI 10.1007/s11047-008-9091-y; Leporati A, 2009, INT J UNCONV COMPUT, V5, P459; Leporati A, 2008, FUND INFORM, V87, P61; Pan LQ, 2016, THEOR COMPUT SCI, V623, P83, DOI 10.1016/j.tcs.2015.10.027; Pan LQ, 2012, NEURAL PROCESS LETT, V35, P13, DOI 10.1007/s11063-011-9201-1; Pan LQ, 2011, SCI CHINA INFORM SCI, V54, P1596, DOI 10.1007/s11432-011-4303-y; Paun G, 2000, J COMPUT SYST SCI, V61, P108, DOI 10.1006/jcss.1999.1693; Paun G, 2006, FUND INFORM, V73, P213; Pun G, 2010, OXFORD HDB ELEGY; Song T, 2016, INFORM SCIENCES, V372, P380, DOI 10.1016/j.ins.2016.08.055; Song T, 2016, NEUROCOMPUTING, V193, P193, DOI 10.1016/j.neucom.2016.02.023; Song T, 2015, IEEE T NANOBIOSCI, V14, P960, DOI 10.1109/TNB.2015.2503603; Song T, 2015, NEURAL PROCESS LETT, V42, P633, DOI 10.1007/s11063-014-9378-1; Song T, 2015, IEEE T NANOBIOSCI, V14, P465, DOI 10.1109/TNB.2015.2402311; Song T, 2015, IEEE T NANOBIOSCI, V14, P38, DOI 10.1109/TNB.2014.2367506; Song T, 2015, NEURAL PROCESS LETT, V42, P199, DOI 10.1007/s11063-014-9352-y; Song T, 2015, NEUROCOMPUTING, V151, P1439, DOI 10.1016/j.neucom.2014.10.044; Song T, 2014, APPL MATH INFORM SCI, V8, P333; Song T, 2014, APPL MATH INFORM SCI, V8, P327; Tu M, 2014, CHINESE J ELECTRON, V23, P87; Wang J, 2011, MEMBRANE COMPUTING, P361; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep27624; Zeng XX, 2015, J COMPUT THEOR NANOS, V12, P2023, DOI 10.1166/jctn.2015.3981; Zhang XY, 2015, IEEE T NEUR NET LEAR, V26, P2816, DOI 10.1109/TNNLS.2015.2396940; Zhang Y, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500038	38	28	28	0	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2016	11	9							e0162882	10.1371/journal.pone.0162882	http://dx.doi.org/10.1371/journal.pone.0162882			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JO	27627104	Green Submitted, Green Published, gold			2022-12-26	WOS:000383680600059
J	Douglas, SM; Chubiz, LM; Harcombe, WR; Ytreberg, FM; Marx, CJ				Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Ytreberg, F. Marty; Marx, Christopher J.			Parallel Mutations Result in a Wide Range of Cooperation and Community Consequences in a Two-Species Bacterial Consortium	PLOS ONE			English	Article							LONG-TERM EXPERIMENT; ESCHERICHIA-COLI; METHIONINE BIOSYNTHESIS; SALMONELLA-TYPHIMURIUM; BENEFICIAL MUTATIONS; SPECIES INTERACTIONS; EVOLUTION; POPULATIONS; MUTANTS; EXPRESSION	Multi-species microbial communities play a critical role in human health, industry, and waste remediation. Recently, the evolution of synthetic consortia in the laboratory has enabled adaptation to be addressed in the context of interacting species. Using an engineered bacterial consortium, we repeatedly evolved cooperative genotypes and examined both the predictability of evolution and the phenotypes that determine community dynamics. Eight Salmonella enterica serovar Typhimurium strains evolved methionine excretion sufficient to support growth of an Escherichia coli methionine auxotroph, from whom they required excreted growth substrates.Non-synonymous mutations in metA, encoding homoserine trans-succinylase (HTS), were detected in each evolved S. enterica methionine cooperator and were shown to be necessary for cooperative consortia growth. Molecular modeling was used to predict that most of the non-synonymous mutations slightly increase the binding affinity for HTS homodimer formation. Despite this genetic parallelism and trend of increasing protein binding stability, these metA alleles gave rise to a wide range of phenotypic diversity in terms of individual versus group benefit. The cooperators with the highest methionine excretion permitted nearly two-fold faster consortia growth and supported the highest fraction of E. coli, yet also had the slowest individual growth rates compared to less cooperative strains. Thus, although the genetic basis of adaptation was quite similar across independent origins of cooperative phenotypes, quantitative measurements of metabolite production were required to predict either the individual-level growth consequences or how these propagate to community-level behavior.	[Douglas, Sarah M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA; [Douglas, Sarah M.; Chubiz, Lon M.; Harcombe, William R.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID USA; [Ytreberg, F. Marty; Marx, Christopher J.] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Marx, Christopher J.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Chubiz, Lon M.] Univ Missouri St Louis, Dept Biol, St Louis, MO USA; [Harcombe, William R.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Harvard University; Harvard University; Harvard University; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; University of Missouri System; University of Missouri Saint Louis; University of Minnesota System; University of Minnesota Twin Cities	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Marx, CJ (corresponding author), Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA.; Marx, CJ (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Marx, CJ (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.	cmarx@uidaho.edu			NIH NRSA Award; DOE award [DE-SC0006731]	NIH NRSA Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE award(United States Department of Energy (DOE))	This work was funded with an NIH (www.nih.gov) NRSA Award to WRH and a DOE (www.energy.gov) award to CJM (DE-SC0006731). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Dominguez A, 2014, ISME J, V8, P1041, DOI 10.1038/ismej.2013.208; [Anonymous], PYMOL MOL GRAPHICS S; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Biran D, 2000, MOL MICROBIOL, V37, P1436, DOI 10.1046/j.1365-2958.2000.02097.x; Chou HH, 2012, CELL REP, V1, P133, DOI 10.1016/j.celrep.2011.12.003; Chubiz L, 2014, METHODS MOL BIOL, V1151, P39, DOI 10.1007/978-1-4939-0554-6_3; Chubiz LM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00271; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delaney NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062957; Delaney NF, 2013, JALA-J LAB AUTOM, V18, P171, DOI 10.1177/2211068212460237; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; HOBSON AC, 1973, MOL GEN GENET, V126, P7, DOI 10.1007/BF00333477; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; KASCER H, 1973, S SOC EXP BIOL, V27, P65; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim W, 2014, P NATL ACAD SCI USA, V111, pE1639, DOI 10.1073/pnas.1323632111; Kinnersley M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004430; Kummerli R, 2015, J EVOLUTION BIOL, V28, P2264, DOI 10.1111/jeb.12751; LAWRENCE DA, 1968, GENETICS, V58, P473; LAWRENCE DA, 1972, J BACTERIOL, V109, P8, DOI 10.1128/JB.109.1.8-11.1972; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Lee KH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025640; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Liow LH, 2011, TRENDS ECOL EVOL, V26, P349, DOI 10.1016/j.tree.2011.03.016; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; MacLean RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000406; Marx CJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001487; Miller CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112988; Momeni B, 2013, ELIFE, V2, DOI 10.7554/eLife.00230; Mordukhova EA, 2008, APPL ENVIRON MICROB, V74, P7660, DOI 10.1128/AEM.00654-08; OLD IG, 1991, PROG BIOPHYS MOL BIO, V56, P145, DOI 10.1016/0079-6107(91)90012-H; Paliwal V, 2012, APPL BIOCHEM BIOTECH, V166, P903, DOI 10.1007/s12010-011-9479-5; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shyu C, 2011, TOXICOL APPL PHARM, V250, P322, DOI 10.1016/j.taap.2010.11.005; Smid EJ, 2013, CURR OPIN BIOTECH, V24, P148, DOI 10.1016/j.copbio.2012.11.007; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Usuda Y, 2005, APPL ENVIRON MICROB, V71, P3228, DOI 10.1128/AEM.71.6.3228-3234.2005; Wagner M, 2002, ANTON LEEUW INT J G, V81, P665, DOI 10.1023/A:1020586312170; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58; Zhan YA, 2013, PROTEINS, V81, P1738, DOI 10.1002/prot.24310	55	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161837	10.1371/journal.pone.0161837	http://dx.doi.org/10.1371/journal.pone.0161837			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617746	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100011
J	Bauer, PM; Zalis, MC; Abdshill, H; Deierborg, T; Johansson, F; Englund-Johansson, U				Bauer, Patrik Maximilian; Zalis, Marina Castro; Abdshill, Hodan; Deierborg, Tomas; Johansson, Fredrik; Englund-Johansson, Ulrica			Inflamed In Vitro Retina: Cytotoxic Neuroinflammationand Galectin-3 Expression	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MICROGLIAL CELL RESPONSES; NEURODEGENERATIVE DISEASES; ORGANOTYPIC CULTURES; MOUSE RETINA; MULLER CELLS; RAT RETINA; DEATH; INFLAMMATION; ACTIVATION	Background Disease progression in retinal neurodegeneration is strongly correlated to immune cell activation, which may have either a neuroprotective or neurotoxic effect. Increased knowledge about the immune response profile and retinal neurodegeneration may lead to candidate targets for treatments. Therefore, we have used the explanted retina as a model to explore the immune response and expression of the immune modulator galectin-3 (Gal-3), induced by the cultivation per se and after additional immune stimulation with lipopolysaccharide (LPS), and how this correlates with retinal neurotoxicity. Methods Post-natal mouse retinas were cultured in a defined medium. One group was stimulated with LPS (100 ng/ml, 24 h). Retinal architecture, apoptotic cell death, and micro-and macroglial activity were studied at the time of cultivation (0 days in vitro (DIV)) and at 3, 4 and 7 DIV using morphological staining, biochemical-and immunohistochemical techniques. Results Our results show that sustained activation of macro-and microglia, characterized by no detectable cytokine release and limited expression of Gal-3, is not further inducing apoptosis additional to the axotomy-induced apoptosis in innermost nuclear layer. An elevated immune response was detected after LPS stimulation, as demonstrated primarily by release of immune mediators (i.e. interleukin 2 (IL-2), IL-6, KC/GRO (also known as CLCX1) and tumour necrosis factor-alpha (TNF-alpha)), increased numbers of microglia displaying morphologies of late activation stages as well as Gal-3 expression. This was accompanied with increased apoptosis in the two additional nuclear layers, and damage to retinal gross architecture. Conclusion We demonstrate that an immune response characterized by sustained and increased release of cytokines, along with an increase in Gal-3 expression, is accompanied by significant increased neurotoxicity in the explanted retina. Further investigations using the current setting may lead to increased understanding on the mechanisms involved in neuronal loss in retinal neurodegenerations.	[Bauer, Patrik Maximilian; Johansson, Fredrik] Lund Univ, Dept Biol, Sect Funct Zool, Lund, Sweden; [Bauer, Patrik Maximilian; Zalis, Marina Castro; Abdshill, Hodan; Englund-Johansson, Ulrica] Lund Univ, Div Ophthalmol, Dept Clin Sci Lund, Lund, Sweden; [Deierborg, Tomas] Lund Univ, Dept Expt Med Sci, Expt Neuroinflammat Lab, Lund, Sweden	Lund University; Lund University; Lund University	Englund-Johansson, U (corresponding author), Lund Univ, Div Ophthalmol, Dept Clin Sci Lund, Lund, Sweden.	ulrica.englund_johansson@med.lu.se	Deierborg, Tomas/P-6345-2015	Deierborg, Tomas/0000-0002-3651-3444	Crafoord Foundation; Olle Engqvist Foundation; Olle and Edla Johansson Foundation; VELUX stiftung; Claes Groschinsky Foundation; Crown Princess Margaretas Fund for Vision Disabled; Fund for Vision disabled in Southern Sweden; Clas Groschinsky Foundation	Crafoord Foundation; Olle Engqvist Foundation; Olle and Edla Johansson Foundation; VELUX stiftung; Claes Groschinsky Foundation; Crown Princess Margaretas Fund for Vision Disabled; Fund for Vision disabled in Southern Sweden; Clas Groschinsky Foundation	This work was funded by The Crafoord Foundation, The Olle Engqvist Foundation, The Olle and Edla Johansson Foundation, The VELUX stiftung, The Claes Groschinsky Foundation, Crown Princess Margaretas Fund for visually disabled, and Fund for Vision disabled in Southern Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For funding we gratefully thank the Crafoord Foundation, VELUX stiftung, Olle Engqvist Foundation, Edla and Olle Johanssons Foundation, Clas Groschinsky Foundation, Crown Princess Margaretas Fund for Vision Disabled, Fund for vision disabled in Southern Sweden. We also thank Birgitta Stenstrom for excellent technical assistance, Dr Lars Raberg (Dept Biology, Lund University) for advice on the statistical analysis, and Dr Christopher Dunning for proof-reading the manuscript.	Ahl M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0618-3; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Boza-Serrano A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0156-0; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Burguillos M. A., 2015, CELL REPORTS; Caffe AR, 2001, J CHEM NEUROANAT, V22, P263; Canning P, 2007, EXP DIABETES RES, DOI 10.1155/2007/51837; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; DUNLOP SA, 1987, J COMP NEUROL, V264, P14, DOI 10.1002/cne.902640103; Engelsberg K, 2004, GRAEF ARCH CLIN EXP, V242, P229, DOI 10.1007/s00417-003-0780-z; Fakhoury M, 2015, NEURODEGENER DIS, V15, P63, DOI 10.1159/000369933; Farinelli P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.512; Ferrer-Martin RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135238; Ferrer-Martin RM, 2014, EXP EYE RES, V121, P42, DOI 10.1016/j.exer.2014.02.015; GUERIN CJ, 1990, INVEST OPHTH VIS SCI, V31, P1474; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hakansson Gisela, 2010, J Ocul Biol Dis Infor, V3, P20, DOI 10.1007/s12177-010-9050-6; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jang S, 2007, NEUROCHEM RES, V32, P1, DOI 10.1007/s11064-006-9215-7; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Johnson EC, 2009, J GLAUCOMA, V18, P341, DOI 10.1097/IJG.0b013e31818c6ef6; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim J, 2009, MOL VIS, V15, P1971; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; Liu GH, 2014, MICROCIRCULATION, V21, P478, DOI 10.1111/micc.12121; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Madeira MH, MEDIATORS INFLAMMATI; Manouchehrian O, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0312-x; McKernan DP, 2006, INVEST OPHTH VIS SCI, V47, P807, DOI 10.1167/iovs.05-0520; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Mertsch K, 2001, J COMP NEUROL, V431, P217; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Nickells RW, 2007, CAN J OPHTHALMOL, V42, P278, DOI 10.3129/canjophthalmol.i07-036; Pajoohesh-Ganji A, 2012, BRAIN RES, V1475, P96, DOI 10.1016/j.brainres.2012.07.058; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Pfister F, 2013, PFLUG ARCH EUR J PHY, V465, P789, DOI 10.1007/s00424-013-1272-6; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; SANYAL S, 1973, Z ANAT ENTWICKLUNGS, V142, P219, DOI 10.1007/BF00519723; SCHNITZER J, 1990, J COMP NEUROL, V302, P779, DOI 10.1002/cne.903020410; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Shin T, 2013, ACTA HISTOCHEM, V115, P407, DOI 10.1016/j.acthis.2012.11.010; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Smith SWMJ Richard S., 2001, SYSTEMATIC EVALUATIO, P195; Soderstjerna E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105359; Soto I, 2014, COLD SPRING HARB PER, V4; Sriram K, 2006, J NEUROCHEM, V96, P706, DOI 10.1111/j.1471-4159.2005.03566.x; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Uehara F, 2001, INVEST OPHTH VIS SCI, V42, P2164; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Whitcup SM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/724648; Wilson GN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0399-0; Zhang FJ, 2015, NEUROPSYCH DIS TREAT, V11, P243, DOI 10.2147/NDT.S75546	72	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161723	10.1371/journal.pone.0161723	http://dx.doi.org/10.1371/journal.pone.0161723			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612287	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900028
J	Emmert, S; Haenssle, HA; Zibert, JR; Schon, M; Hald, A; Hansen, MH; Litman, T; Schon, MP				Emmert, Steffen; Haenssle, Holger A.; Zibert, John R.; Schoen, Margarete; Hald, Andreas; Hansen, Maria H.; Litman, Thomas; Schoen, Michael P.			Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate	PLOS ONE			English	Article							PROTEIN-KINASE-C; SOLAR KERATOSIS; GENE-EXPRESSION; DOUBLE-BLIND; HUMAN SKIN; CARCINOMA; GEL; CANCER; PEP005; INGENOL-3-ANGELATE	The rapid and strong clinical efficacy of the first-in-class, ingenol mebutate, against actinic keratosis (AK) has resulted in its recent approval. We conducted the first comprehensive analysis of the cellular and molecular mode of action of topical ingenol mebutate 0.05% gel in both AK and uninvolved skin of 26 patients in a phase I, single-center, open-label, within-patient comparison. As early as 1 day after application, ingenol mebutate induced profound epidermal cell death, along with a strong infiltrate of CD4(+) and CD8(+) T-cells, neutrophils, and macrophages. Endothelial ICAM-1 activation became evident after 2 days. The reaction pattern was significantly more pronounced in AK compared with uninvolved skin, suggesting a tumor-preferential mode of action. Extensive molecular analyses and transcriptomic profiling of mRNAs and microRNAs demonstrated alterations in gene clusters functionally associated with epidermal development, inflammation, innate immunity, and response to wounding. Ingenol mebutate reveals a unique mode of action linking directly to anti-tumoral effects.	[Emmert, Steffen; Haenssle, Holger A.; Schoen, Margarete; Schoen, Michael P.] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany; [Zibert, John R.; Hald, Andreas; Hansen, Maria H.; Litman, Thomas] LEO Pharma AS, Ballerup, Denmark; [Emmert, Steffen] Univ Med Ctr Rostock, Dept Dermatol, Rostock, Germany; [Haenssle, Holger A.] Univ Med Ctr Heidelberg, Dept Dermatol Venereol & Allergol, Heidelberg, Germany	University of Gottingen; LEO Pharma; University of Rostock; Ruprecht Karls University Heidelberg	Schon, MP (corresponding author), Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, Gottingen, Germany.	michael.schoen@med.uni-goettingen.de	Zibert, John Robert/GRY-3584-2022	Litman, Thomas/0000-0002-6068-901X	LEO Pharma A/S	LEO Pharma A/S	This work was funded by LEO Pharma A/S. The funder provided support in the form of salaries for authors (JRZ, AH, MHH, TL). The funder was responsible for the study according to the law. LEO Pharma A/S did contribute to: the study design, the electronic case report system and analysis of the data, the monitoring according to GCP, preparation of the manuscript, and, in collaboration with the PI, the decision to publish the work. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson L, 2009, J AM ACAD DERMATOL, V60, P934, DOI 10.1016/j.jaad.2009.01.008; Babilas R, 2003, HAUTARZT, V54, P551, DOI 10.1007/s00105-003-0543-0; Berman B, 2014, J DRUGS DERMATOL, V13, P741; Berman B, 2012, CLIN COSMET INVESTI, V5, P111, DOI 10.2147/CCID.S28905; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Chu TH, 2013, CANCER LETT, V337, P115, DOI 10.1016/j.canlet.2013.05.032; Cockerell CJ, 2000, J AM ACAD DERMATOL, V42, pS11, DOI 10.1067/mjd.2000.103344; Cohen Joel L, 2010, J Clin Aesthet Dermatol, V3, P39; Cozzi SJ, 2012, J INVEST DERMATOL, V132, P1263, DOI 10.1038/jid.2011.418; Criscione VD, 2009, CANCER-AM CANCER SOC, V115, P2523, DOI 10.1002/cncr.24284; Czarnecki D, 2002, J CUTAN MED SURG, V6, P207, DOI 10.1007/s10227-001-0041-x; Dayem MA, 2003, COMP FUNCT GENOM, V4, P47, DOI 10.1002/cfg.239; Divekar AA, 2011, J IMMUNOL, V186, P924, DOI 10.4049/jimmunol.1002218; Einspahr JG, 2002, CRIT REV ONCOL HEMAT, V41, P269, DOI 10.1016/S1040-8428(01)00185-8; Esmann S, 2013, BRIT J DERMATOL, V168, P277, DOI 10.1111/bjd.12036; Fernandez-Figueras MT, 2015, J EUR ACAD DERMATOL, V29, P991, DOI 10.1111/jdv.12848; Flohil SC, 2013, J INVEST DERMATOL, V133, P1971, DOI 10.1038/jid.2013.134; Freiberger SN, 2015, MOL CANCER THER, V14, P2132, DOI 10.1158/1535-7163.MCT-15-0023-T; Fu W, 2003, ARCH DERMATOL, V139, P66, DOI 10.1001/archderm.139.1.66; Gillespie SK, 2004, MOL CANCER THER, V3, P1651; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; HURWITZ RM, 1995, DERMATOL SURG, V21, P184, DOI 10.1111/j.1524-4725.1995.tb00141.x; Jorgensen L, 2013, SCIENCE, V341, P878, DOI 10.1126/science.1241606; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kelada S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003451; Le TTT, 2009, VACCINE, V27, P3053, DOI 10.1016/j.vaccine.2009.03.025; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Liang PF, 2012, BURNS, V38, P534, DOI 10.1016/j.burns.2011.10.014; Makino K, 2012, CLIN EXP DERMATOL, V37, P34, DOI 10.1111/j.1365-2230.2011.04158.x; Memon AA, 2000, BRIT J DERMATOL, V142, P1154, DOI 10.1046/j.1365-2133.2000.03541.x; Mittelbronn MA, 1998, INT J DERMATOL, V37, P677, DOI 10.1046/j.1365-4362.1998.00467.x; Nissan X, 2011, DEV BIOL, V356, P506, DOI 10.1016/j.ydbio.2011.06.004; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Olsnes AM, 2009, BRIT J HAEMATOL, V145, P761, DOI 10.1111/j.1365-2141.2009.07691.x; Ortonne JP, 2002, BRIT J DERMATOL, V146, P20, DOI 10.1046/j.1365-2133.146.s61.6.x; Padilla RS, 2010, ARCH DERMATOL, V146, P288, DOI 10.1001/archdermatol.2009.378; Ramsay JR, 2011, BRIT J DERMATOL, V164, P633, DOI 10.1111/j.1365-2133.2010.10184.x; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Rosen RH, 2012, J AM ACAD DERMATOL, V66, P486, DOI 10.1016/j.jaad.2010.12.038; Rosen T, 2013, J AM ACAD DERMATOL, V68, pS2, DOI 10.1016/j.jaad.2012.09.052; Salvesen HG, 2002, ESSAYS BIOCHEM, V39, P9; Sanmartin O, 2008, NEW ENGL J MED, V358, pE21, DOI 10.1056/NEJMicm071130; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Siller G, 2009, AUSTRALAS J DERMATOL, V50, P16, DOI 10.1111/j.1440-0960.2008.00497.x; Stahlhut M, 2012, J DRUGS DERMATOL, V11, P1181; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004; Zidar N, 2011, DIS MARKERS, V31, P259, DOI [10.1155/2011/247654, 10.3233/DMA-2011-0827]	53	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160096	10.1371/journal.pone.0160096	http://dx.doi.org/10.1371/journal.pone.0160096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612149	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900002
J	Gimenez-Lirola, LG; Mur, L; Rivera, B; Mogler, M; Sun, YX; Lizano, S; Goodell, C; Harris, DLH; Rowland, RRR; Gallardo, C; Sanchez-Vizcaino, JM; Zimmerman, J				Gimenez-Lirola, Luis G.; Mur, Lina; Rivera, Belen; Mogler, Mark; Sun, Yaxuan; Lizano, Sergio; Goodell, Christa; Harris, D. L. Hank; Rowland, Raymond R. R.; Gallardo, Carmina; Manuel Sanchez-Vizcaino, Jose; Zimmerman, Jeff			Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; HIGH-LEVEL EXPRESSION; POTENTIAL USE; SAMPLES; SERODIAGNOSIS; SURVEILLANCE; DIAGNOSIS; PRRSV; PIGS	In the absence of effective vaccine(s), control of African swine fever caused by African swine fever virus (ASFV) must be based on early, efficient, cost-effective detection and strict control and elimination strategies. For this purpose, we developed an indirect ELISA capable of detecting ASFV antibodies in either serum or oral fluid specimens. The recombinant protein used in the ELISA was selected by comparing the early serum antibody response of ASFV-infected pigs (NHV-p68 isolate) to three major recombinant polypeptides (p30, p54, p72) using a multiplex fluorescent microbead-based immunoassay (FMIA). Nonhazardous (non-infectious) antibody-positive serum for use as plate positive controls and for the calculation of sample-to-positive (S:P) ratios was produced by inoculating pigs with a replicon particle (RP) vaccine expressing the ASFV p30 gene. The optimized ELISA detected anti-p30 antibodies in serum and/or oral fluid samples from pigs inoculated with ASFV under experimental conditions beginning 8 to 12 days post inoculation. Tests on serum (n = 200) and oral fluid (n = 200) field samples from an ASFV-free population demonstrated that the assay was highly diagnostically specific. The convenience and diagnostic utility of oral fluid sampling combined with the flexibility to test either serum or oral fluid on the same platform suggests that this assay will be highly useful under the conditions for which OIE recommends ASFV antibody surveillance, i.e., in ASFV-endemic areas and for the detection of infections with ASFV isolates of low virulence.	[Gimenez-Lirola, Luis G.; Zimmerman, Jeff] Iowa State Univ, Coll Vet Med, Ames, IA 50011 USA; [Mur, Lina; Rivera, Belen; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, VISAVET Ctr, E-28040 Madrid, Spain; [Mur, Lina; Rivera, Belen; Manuel Sanchez-Vizcaino, Jose] Univ Complutense Madrid, Dept Anim Hlth, E-28040 Madrid, Spain; [Mogler, Mark; Harris, D. L. Hank] Harrisvaccines Inc, Ames, IA USA; [Sun, Yaxuan] Iowa State Univ, Coll Liberal Arts & Sci, Ames, IA USA; [Lizano, Sergio; Goodell, Christa] IDEXX Labs, Westbrook, ME USA; [Rowland, Raymond R. R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Gallardo, Carmina] CISA INIA, Madrid, Spain	Iowa State University; Complutense University of Madrid; Complutense University of Madrid; Iowa State University; Kansas State University	Gimenez-Lirola, LG (corresponding author), Iowa State Univ, Coll Vet Med, Ames, IA 50011 USA.	luisggl@iastate.edu	Zimmerman, Jeff/ABC-6361-2020; Gallardo+Frontaura, Carmina/ABE-6878-2021; Mur, Lina/AAC-8860-2022; gallardo, Carmina/AAB-2386-2019	Zimmerman, Jeff/0000-0002-8107-2422; gallardo, Carmina/0000-0003-3293-306X	Pork Checkoff funds through the National Pork Board, Des Moines, Iowa USA [13-048]; Iowa State University; Pork Checkoff funds through the National Pork Board (Des Moines, Iowa USA)	Pork Checkoff funds through the National Pork Board, Des Moines, Iowa USA; Iowa State University; Pork Checkoff funds through the National Pork Board (Des Moines, Iowa USA)	This work was supported by Pork Checkoff funds distributed through the National Pork Board (#13-048), Des Moines, Iowa USA 50306, and by internal funding through Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Pork Checkoff funds distributed through the National Pork Board (PO Box 9114, Des Moines, Iowa USA 50306).	Carrascosa Angel L, 2011, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2614s53; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cubillos C, 2013, VIRUS RES, V173, P159, DOI 10.1016/j.virusres.2012.10.021; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; Dixon L.K., 2005, VIRUS TAXONOMY, P135, DOI DOI 10.1186/1743-422X-2-64; EFSA, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4228; Gallardo C, 2006, J CLIN MICROBIOL, V44, P950, DOI 10.1128/JCM.44.3.950-956.2006; Gallardo C, 2013, VET MICROBIOL, V162, P32, DOI 10.1016/j.vetmic.2012.08.011; Gallardo C, 2009, CLIN VACCINE IMMUNOL, V16, P1012, DOI 10.1128/CVI.00408-08; Gimenez-Lirola LG, 2014, CLIN VACCINE IMMUNOL, V21, P85, DOI 10.1128/CVI.00451-13; Hooper JW, 2009, VACCINE, V28, P494, DOI 10.1016/j.vaccine.2009.09.133; Kamrud KI, 2007, VIROLOGY, V360, P376, DOI 10.1016/j.virol.2006.10.049; Kittawornrat A, 2014, VET MICROBIOL, V168, P331, DOI 10.1016/j.vetmic.2013.11.035; Kittawornrat A, 2012, J VET DIAGN INVEST, V24, P262, DOI 10.1177/1040638711435679; Kittawornrat A, 2010, VIRUS RES, V154, P170, DOI 10.1016/j.virusres.2010.07.025; MCVICAR JW, 1984, AM J VET RES, V45, P1535; Mur L, 2016, TRANSBOUND EMERG DIS, V63, pE436, DOI 10.1111/tbed.12304; Mur L, 2013, VET MICROBIOL, V165, P135, DOI 10.1016/j.vetmic.2012.12.034; Olsen C, 2013, J VET DIAGN INVEST, V25, P328, DOI 10.1177/1040638713481471; Oura CAL, 2012, MANUAL DIAGNOSTIC TE; Oviedo JM, 1997, J VIROL METHODS, V64, P27, DOI 10.1016/S0166-0934(96)02140-4; Pang S, 2005, J IMMUNOL METHODS, V302, P1, DOI 10.1016/j.jim.2005.04.007; Panyasing Y, 2016, TRANSBOUND EMERG DIS, V63, pE328, DOI 10.1111/tbed.12307; Perez-Filgueira DA, 2006, J CLIN MICROBIOL, V44, P3114, DOI 10.1128/JCM.00406-06; Prickett JR, 2011, TRANSBOUND EMERG DIS, V58, P121, DOI 10.1111/j.1865-1682.2010.01189.x; Prickett JR, 2008, J SWINE HEALTH PROD, V16, P86; Prickett John R., 2010, Animal Health Research Reviews, V11, P207, DOI 10.1017/S1466252310000010; Rayner JO, 2002, REV MED VIROL, V12, P279, DOI 10.1002/rmv.360; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Sanchez-Vizcaino JM, 2012, TRANSBOUND EMERG DIS, V59, P27, DOI 10.1111/j.1865-1682.2011.01293.x; Sanchez-Vizcaino M., 2012, DIS SWINE, P396; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4	32	43	55	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161230	10.1371/journal.pone.0161230	http://dx.doi.org/10.1371/journal.pone.0161230			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611939	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900013
J	Kim, YW; Jeoung, JW; Girard, MJA; Mari, JM; Park, KH				Kim, Yong Woo; Jeoung, Jin Wook; Girard, Michael J. A.; Mari, Jean Martial; Park, Ki Ho			Positional and Curvature Difference of Lamina Cribrosa According to the Baseline Intraocular Pressure in Primary Open-Angle Glaucoma: A Swept-Source Optical Coherence Tomography (SS-OCT) Study	PLOS ONE			English	Article							RETINAL VESSEL TRUNK; NERVE HEAD; REGIONAL DIFFERENCES; NEURORETINAL RIM; VISUAL-FIELD; DISC; ENHANCEMENT; AGE; DISPLACEMENT; VISIBILITY	Purpose To investigate the variation of lamina cribrosa (LC) structure based on the baseline intraocular pressure (IOP) in eyes with primary open-angle glaucoma (POAG) and healthy individuals using swept-source optical coherence tomography. Methods A total of 108 eyes with POAG and 61 healthy eyes were recruited. Based on the baseline IOP, the POAG eyes were divided into higher-baseline IOP (HTG; baseline IOP > 21 mmHg, n = 38 eyes) and lower-baseline IOP (NTG; baseline IOP <= 21 mmHg, n = 70 eyes). The anterior laminar insertion depth (ALID), mean LC depth (mLCD), and the LC curvature index (mLCD-ALID) were measured, and compared among the three groups. The regional variation of LC structure was evaluated by vertical-horizontal ALID difference. Results The mLCD and LC curvature index were greatest in HTG eyes (520.3 +/- 123.0 and 80.9 +/- 30.7 mu m), followed by NTG (463.2 +/- 110.5 and 64.5 +/- 30.7 mu m) and healthy eyes (382.9 +/- 107.6 and 47.6 +/- 25.7 mu m, all P < 0.001). However, there were no significant difference in ALID between HTG and NTG eyes. The vertical-horizontal ALID difference was larger in NTG eyes (72.8 +/- 56.2 mu m) than in HTG (32.7 +/- 61.4 mu m, P = 0.004) and healthy eyes (25.5 +/- 34.8 mu m, P < 0.001). Conclusions Lamina cribrosa position and curvature differed in POAG eyes with low and high IOP. This would support the theory that IOP induced biomechanical effects on the optic play a role on glaucoma.	[Kim, Yong Woo] Armed Forces Capital Hosp, Dept Ophthalmol, Songnam, South Korea; [Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Girard, Michael J. A.] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Girard, Michael J. A.] Singapore Eye Res Inst, Singapore, Singapore; [Mari, Jean Martial] Univ French Polynesia, Tahiti, France	Seoul National University (SNU); Seoul National University Hospital; National University of Singapore; National University of Singapore; Singapore National Eye Center	Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea.	kihopark@snu.ac.kr	Girard, Michael/F-9323-2015	Girard, Michael/0000-0003-4408-5918; Mari, Jean Martial/0000-0002-1169-6547	NUS Young Investigator Award [NUSYIA_FY13_P03, R-397-000-174-133]	NUS Young Investigator Award	This work was supported by a grant of NUS Young Investigator Award (NUSYIA_FY13_P03, R-397-000-174-133). The funding organizations had no role in the design or conduct of this research.	Albon J, 2000, BRIT J OPHTHALMOL, V84, P318, DOI 10.1136/bjo.84.3.318; Amini N, 2014, INVEST OPHTH VIS SCI, V55, P7332, DOI 10.1167/iovs.14-14962; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chauhan BC, 2013, AM J OPHTHALMOL, V156, P218, DOI 10.1016/j.ajo.2013.04.016; DANDONA L, 1990, ARCH OPHTHALMOL-CHIC, V108, P393, DOI 10.1001/archopht.1990.01070050091039; Danthurebandara VM, 2015, INVEST OPHTH VIS SCI, V56, P98, DOI 10.1167/iovs.14-15375; Edwards ME, 2001, CURR EYE RES, V23, P215, DOI 10.1076/ceyr.23.3.215.5460; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Girard MJA, 2015, INVEST OPHTH VIS SCI, V56, P865, DOI 10.1167/iovs.14-14903; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; He L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092225; Huang HL, 2013, BRIT J OPHTHALMOL, V97, P96, DOI 10.1136/bjophthalmol-2012-302068; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; JONAS JB, 1994, BRIT J OPHTHALMOL, V78, P99, DOI 10.1136/bjo.78.2.99; Jonas JB, 2001, OPHTHALMOLOGY, V108, P1059, DOI 10.1016/S0161-6420(01)00571-1; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim YW, 2015, EYE, V29, P1368, DOI 10.1038/eye.2015.162; Kim YK, 2016, ACTA OPHTHALMOL, V94, pE468, DOI 10.1111/aos.12903; Kim YK, 2016, INVEST OPHTH VIS SCI, V57, P899, DOI 10.1167/iovs.15-18389; Kim YW J J, 2016, PLOS ONE IN PRESS; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Mwanza JC, 2016, AM J OPHTHALMOL, V161, P12, DOI 10.1016/j.ajo.2015.09.019; Nadler Z, 2014, INVEST OPHTH VIS SCI, V55, P6459, DOI 10.1167/iovs.14-15177; Park SC, 2012, INVEST OPHTH VIS SCI, V53, P1610, DOI 10.1167/iovs.11-7577; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P478; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Ren RJ, 2014, INVEST OPHTH VIS SCI, V55, P1531, DOI 10.1167/iovs.13-13382; Rho CR, 2012, CLIN EXP OPHTHALMOL, V40, pE183, DOI 10.1111/j.1442-9071.2011.02669.x; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; Sigal IA, 2009, INVEST OPHTH VIS SCI, V50, P2785, DOI 10.1167/iovs.08-3095; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Sigal IA, 2009, BIOMECH MODEL MECHAN, V8, P85, DOI 10.1007/s10237-008-0120-7; Sigal IA, 2009, BIOMECH MODEL MECHAN, V8, P99, DOI 10.1007/s10237-008-0119-0; Tatham AJ, 2014, OPHTHALMOLOGY, V121, P110, DOI 10.1016/j.ophtha.2013.08.018; Zhang L, 2015, INVEST OPHTH VIS SCI, V56, P2031, DOI 10.1167/iovs.14-15734	36	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162182	10.1371/journal.pone.0162182	http://dx.doi.org/10.1371/journal.pone.0162182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611970	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900052
J	Castagnoli, L; Ghedini, GC; Koschorke, A; Triulzi, T; Dugo, M; Gasparini, P; Casalini, P; Palladini, A; Iezzi, M; Lamolinara, A; Lollini, P; Nanni, P; Chiodoni, C; Tagliabue, E; Pupa, SM				Castagnoli, L.; Ghedini, G. C.; Koschorke, A.; Triulzi, T.; Dugo, M.; Gasparini, P.; Casalini, P.; Palladini, A.; Iezzi, M.; Lamolinara, A.; Lollini, Pl; Nanni, P.; Chiodoni, C.; Tagliabue, E.; Pupa, S. M.			Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MAMMARY-TUMORS; HER2; CELLS; NOTCH; CARCINOMA; MECHANISMS; PATHWAYS; GROWTH; MICE	We have previously shown that the d16HER2 splice variant is linked to HER2-positive breast cancer (BC) tumorigenesis, progression and response to Trastuzumab. However, the mechanisms by which d16HER2 contributes to HER2-driven aggressiveness and targeted therapy susceptibility remain uncertain. Here, we report that the d16HER2-positive mammary tumor cell lines MI6 and MI7, derived from spontaneous lesions of d16HER2 transgenic (tg) mice and resembling the aggressive features of primary lesions, are enriched in the expression of Wnt, Notch and epithelial-mesenchymal transition pathways related genes compared with full-length wild-type (WT) HER2-positive cells (WTHER2_1 and WTHER2_2) derived from spontaneous tumors arising in WTHER2 tg mice. MI6 cells exhibited increased resistance to anoikis and significantly higher mammosphere-forming efficiency (MFE) and self-renewal capability than the WTHER2-positive counterpart. Furthermore, d16HER2-positive tumor cells expressed a higher fraction of CD29(High)/CD24(+)/SCA1(Low) cells and displayed greater in vivo tumor engraftment in serial dilution conditions than WTHER2_1 cells. Accordingly, NOTCH inhibitors impaired mammosphere formation only in MI6 cells. A comparative analysis of stemness-related features driven by d16HER2 and WTHER2 in ad hoc engineered human BC cells (MCF7 and T47D) revealed a higher MFE and aldehyde dehydrogenase-positive staining in d16HER2-vs WTHER2-infected cells, sustaining consistent BC-initiating cell enrichment in the human setting. Moreover, marked CD44 expression was found in MCF7_d16 and T47D_d16 cells vs their WTHER2 and Mock counterparts. Clinically, BC cases from two distinct HER2-positive cohorts characterized by high levels of expression of the activated-d16HER2 metagene were significantly enriched in the Notch family and signal transducer genes vs those with low levels of the metagene.	[Castagnoli, L.; Ghedini, G. C.; Koschorke, A.; Triulzi, T.; Tagliabue, E.; Pupa, S. M.] Fondazione IRCCS Inst Naz Tumori, Mol Targeting Unit, Dept Expt Oncol & Mol Med, Milan, Italy; [Dugo, M.] Fondazione IRCCS Inst Naz Tumori, Funct Genom & Bioinformat Core Facility, Dep Expt Oncol & Mol Med, Milan, Italy; [Gasparini, P.] Fondazione IRCCS Inst Naz Tumori, Tumor Genom, Dep Expt Oncol & Mol Med, Milan, Italy; [Palladini, A.; Lollini, Pl; Nanni, P.] Univ Bologna, Diagnostic & Specialty Med, Dept Expt, Lab Immunol & Biol Metastases, Bologna, Italy; [Iezzi, M.; Lamolinara, A.] Univ G dAnnunzio, Dept Med & Aging Sci, CESI Aging Res Ctr, Chieti, Italy; [Chiodoni, C.] Fondazione IRCSS Inst Natl, Dept Expt Oncol & mol med, Mol Immunol, Milan, Italy	University of Bologna; G d'Annunzio University of Chieti-Pescara	Pupa, SM (corresponding author), Fondazione IRCCS Inst Naz Tumori, Mol Targeting Unit, Dept Expt Oncol & Mol Med, Milan, Italy.	serenella.pupa@istitutotumori.mi.it	Iezzi, Manuela/AAB-7939-2019; Gasparini, Patrizia/Q-7626-2016; Tagliabue, Elda/B-9377-2017; Triulzi, Tiziana/C-1070-2017; Pupa, Serenella/K-6388-2016; Castagnoli, Lorenzo/J-1893-2014; lamolinara, alessia/AAB-8833-2019; Lollini, Pier Luigi/A-7644-2008; Chiodoni, Claudia/C-2172-2017; Koschorke, Ada/C-5576-2017; Dugo, Matteo/H-6860-2014	Iezzi, Manuela/0000-0002-6296-6498; Gasparini, Patrizia/0000-0002-9548-3724; Tagliabue, Elda/0000-0001-9877-2903; Triulzi, Tiziana/0000-0003-3050-8676; Pupa, Serenella/0000-0002-4592-6830; Castagnoli, Lorenzo/0000-0002-0220-6497; lamolinara, alessia/0000-0002-7421-4509; Lollini, Pier Luigi/0000-0003-1702-4108; Chiodoni, Claudia/0000-0002-7644-9969; Koschorke, Ada/0000-0002-4828-7405; Dugo, Matteo/0000-0001-9786-2763	Associazione Italiana Ricerca Cancro (AIRC) [10352, 16918, AIRC 15324]; Ministero Italiano della Salute [RF-2009-1532281];  [15002]	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute(Ministry of Health, Italy); 	We thank Mrs Ghirelli and Mrs Ratti for technical assistance, the Functional Genomics Core Facility and the Flow Cytometry and Cell Sorting Facility of the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan for their support in gene expression profile analyses and in the multiparametric cytofluorimetric analyses, and Mrs Mameli for secretarial assistance. This work was funded by grants from the Associazione Italiana Ricerca Cancro (AIRC) 10352 and 16918 to SM Pupa and AIRC 15324 to PL Lollini; Fellowship 15002 to L Castagnoli; and Ministero Italiano della Salute RF-2009-1532281 to SM Pupa.	Alajati A, 2013, CANCER RES, V73, P5320, DOI 10.1158/0008-5472.CAN-12-3186; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Campiglio M, 2013, BREAST CANCER RES TR, V141, P101, DOI 10.1007/s10549-013-2658-z; Castagnoli L, 2014, CANCER RES, V74, P6248, DOI 10.1158/0008-5472.CAN-14-0983; Castiglioni F, 2006, ENDOCR-RELAT CANCER, V13, P221, DOI 10.1677/erc.1.01047; Chen J, 2015, ONCOGENE, V34, P1, DOI 10.1038/onc.2013.570; De Giovanni C, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3602; Farahani E, 2014, CARCINOGENESIS, V35, P747, DOI 10.1093/carcin/bgu045; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Farnie G, 2014, CELL CYCLE, V13, P418, DOI 10.4161/cc.27201; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Harrison H, 2010, CANCER RES, V70, P709, DOI 10.1158/0008-5472.CAN-09-1681; Jackson Claire, 2013, Int J Cell Biol, V2013, P973584, DOI 10.1155/2013/973584; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260; Korkaya H, 2009, CLIN CANCER RES, V15, P1845, DOI 10.1158/1078-0432.CCR-08-3087; Kwong KY, 1998, MOL CARCINOGEN, V23, P62, DOI 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Latorre IJ, 2000, MADAME CURIE BIOSCIE; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Marchini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018727; Mitra D, 2009, MOL CANCER THER, V8, P2152, DOI 10.1158/1535-7163.MCT-09-0295; Monteiro J, 2014, CARCINOGENESIS, V35, P2, DOI 10.1093/carcin/bgt279; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Prat A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju152; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Shaw FL, 2012, J MAMMARY GLAND BIOL, V17, P111, DOI 10.1007/s10911-012-9255-3; Shiu KK, 2014, ONCOGENE, V33, P619, DOI 10.1038/onc.2012.625; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Triulzi T, 2015, ONCOTARGET, V6, P28173, DOI 10.18632/oncotarget.4405; Turpin J, 2016, ONCOGENE, V35, P6053, DOI 10.1038/onc.2016.129; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Weigelt B, 2013, CANCER DISCOV, V3, P145, DOI 10.1158/2159-8290.CD-12-0585; Zagozdzon R, 2011, DRUG DISCOV TODAY, V16, P810, DOI 10.1016/j.drudis.2011.06.003; Zhang XJ, 2015, INT J ONCOL, V46, P1141, DOI 10.3892/ijo.2014.2809	45	27	27	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1721	1732		10.1038/onc.2016.338	http://dx.doi.org/10.1038/onc.2016.338			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27641338	Green Published, hybrid			2022-12-26	WOS:000397460600011
J	Haase, G; Gavert, N; Brabletz, T; Ben-Ze'ev, A				Haase, G.; Gavert, N.; Brabletz, T.; Ben-Ze'ev, A.			A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10	ONCOGENE			English	Article							ADHESION MOLECULE L1; NEUTRAL ENDOPEPTIDASE; LIVER METASTASIS; EXPRESSION; BINDING; GENE; OUTGROWTH; TARGET; CAM; ENKEPHALINASE	The neural L1 transmembrane cell adhesion receptor of the immunoglobulin-like family is a target gene of Wnt-beta-catenin signaling in human colorectal cancer (CRC) cells and is expressed at the invasive edge of the tumor tissue. L1 overexpression in cultured CRC cells confers enhanced proliferation, motility and liver metastasis. We have analyzed the mechanisms of L1-mediated signaling in CRC cells by using various point mutations in the L1 ectodomain that are known to cause severe genetically inherited mental retardation disorders in patients. We found that all such L1 ectodomain mutations abolish the ability of L1 to confer metastatic properties in CRC cells. Using gene array analysis, we identified L1-mutation-specific gene expression signatures for the L1/H210Q and L1/D598N mutations. We identified CD10, a metalloprotease (neprilysin, neutral endopeptidase) and a gene that is specifically induced in CRC cells by L1 in an L1/H210Q mutation-specific manner. CD10 expression was required for the L1-mediated induction of cell proliferation, motility and metastasis, as suppression of CD10 levels in L1-expressing CRC cells abolished the L1 effects on CRC progression. The signaling from L1 to CD10 was mediated through the L1-ezrin-NF-.B pathway. In human CRC tissue L1 and CD10 were localized in partially overlapping regions in the more invasive areas of the tumor tissue. The results suggest that CD10 is a necessary component conferring the L1 effects in CRC cells. The identification of gene expression patterns of L1-domain-specific point mutations may provide novel markers and targets for interfering with L1-mediated CRC progression.	[Haase, G.; Brabletz, T.; Ben-Ze'ev, A.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Brabletz, T.] Univ Erlangen Nuernberg, Dept Expt Med, Erlangen, Germany	Weizmann Institute of Science; University of Erlangen Nuremberg	Ben-Ze'ev, A (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	avri.ben-zeev@weizmann.ac.il		Gavert, Nancy/0000-0003-1639-4684; ben-ze'ev, avri/0000-0001-6113-3921	Israel Science Foundation (ISF); Israel Cancer Research Fund (ICRF)	Israel Science Foundation (ISF)(Israel Science Foundation); Israel Cancer Research Fund (ICRF)	We thank Drs N Iwata, M Shtutman, F Rathjen and V Lemmon for providing reagents. This study was supported by grants from the Israel Science Foundation (ISF) and from the Israel Cancer Research Fund (ICRF). A B-Z is the incumbent of the Lunenfeld-Kunin professorial chair in genetics and cell biology.	Beer S, 1999, J CELL SCI, V112, P2667; Ben-Shmuel A, 2013, ONCOGENE, V32, P3220, DOI 10.1038/onc.2012.340; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; ERDOS EG, 1989, FASEB J, V3, P145, DOI 10.1096/fasebj.3.2.2521610; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2007, CANCER RES, V67, P7703, DOI 10.1158/0008-5472.CAN-07-0991; Gavert N, 2013, CANCER RES, V73, P5754, DOI 10.1158/0008-5472.CAN-13-0576; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Grumet M, 1991, Curr Opin Neurobiol, V1, P370, DOI 10.1016/0959-4388(91)90055-C; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Kamiguchi H, 1998, MOL CELL NEUROSCI, V12, P48, DOI 10.1006/mcne.1998.0702; Koga Y, 2008, HISTOPATHOLOGY, V52, P569, DOI 10.1111/j.1365-2559.2008.02996.x; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; MALFROY B, 1988, FEBS LETT, V229, P206, DOI 10.1016/0014-5793(88)80828-7; Ogawa H, 2002, HUM PATHOL, V33, P806, DOI 10.1053/hupa.2002.125773; Ohji Y, 2007, ONCOL REP, V17, P525; Oleszewski M, 1999, J BIOL CHEM, V274, P24602, DOI 10.1074/jbc.274.35.24602; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Shapiro B, 2015, ONCOTARGET, V6, P34389, DOI 10.18632/oncotarget.5360; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6; Yao T, 2002, PATHOLOGY, V34, P556, DOI 10.1080/0031302021000035965-4	33	11	11	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1597	1606		10.1038/onc.2016.329	http://dx.doi.org/10.1038/onc.2016.329			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27641335				2022-12-26	WOS:000397458100013
J	Matsukawa, K; Hashimoto, T; Matsumoto, T; Ihara, R; Chihara, T; Miura, M; Wakabayashi, T; Iwatsubo, T				Matsukawa, Koji; Hashimoto, Tadafumi; Matsumoto, Taisei; Ihara, Ryoko; Chihara, Takahiro; Miura, Masayuki; Wakabayashi, Tomoko; Iwatsubo, Takeshi			Familial Amyotrophic Lateral Sclerosis-linked Mutations in Profilin 1 Exacerbate TDP-43-induced Degeneration in the Retina of Drosophila melanogaster through an Increase in the Cytoplasmic Localization of TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); Drosophila; fused in sarcoma (FUS); neurodegeneration; neurodegenerative disease; profilin; TAR DNA-binding protein 43 (TDP-43) (TARDBP)	FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; STRESS GRANULE DYNAMICS; HEXANUCLEOTIDE REPEAT; VCP MUTATIONS; GENE; ALS; DISEASE; RNA; DEMENTIA	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive and selective loss of motor neurons. Causative genes for familial ALS (fALS), e.g. TARDBP or FUS/TLS, have been found, among which mutations within the profilin 1 (PFN1) gene have recently been identified in ALS18. To elucidate the mechanism whereby PFN1 mutations lead to neuronal death, we generated transgenic Drosophila melanogaster overexpressing human PFN1 in the retinal photoreceptor neurons. Overexpression of wild-type or fALS mutant PFN1 caused no degenerative phenotypes in the retina. Double overexpression of fALS mutant PFN1 and human TDP-43 markedly exacerbated the TDP-43-induced retinal degeneration, i.e. vacuolation and thinning of the retina, whereas co-expression of wild-type PFN1 did not aggravate the degenerative phenotype. Notably, co-expression of TDP-43 with fALS mutant PFN1 increased the cytoplasmic localization of TDP-43, the latter remaining in nuclei upon co-expression with wild-type PFN1, whereas co-expression of TDP-43 lacking the nuclear localization signal with the fALS mutant PFN1 did not aggravate the retinal degeneration. Knockdown of endogenous Drosophila PFN1 did not alter the degenerative phenotypes of the retina in flies overexpressing wild-type TDP-43. These data suggest that ALS-linked PFN1 mutations exacerbate TDP-43-induced neurodegeneration in a gain-of-function manner, possibly by shifting the localization of TDP-43 from nuclei to cytoplasm.	[Matsukawa, Koji; Hashimoto, Tadafumi; Matsumoto, Taisei; Ihara, Ryoko; Wakabayashi, Tomoko; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Matsumoto, Taisei; Iwatsubo, Takeshi] Univ Tokyo, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Chihara, Takahiro; Miura, Masayuki] Univ Tokyo, Dept Genet, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol & Neurosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.; Iwatsubo, T (corresponding author), Univ Tokyo, Dept Neuropathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iwatsubo@m.u-tokyo.ac.jp	Chihara, Takahiro/G-7639-2019; Wakabayashi, Tomoko/GSD-1544-2022	Chihara, Takahiro/0000-0001-9989-3619; Hashimoto, Tadafumi/0000-0001-5442-4800	Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [15H04375] Funding Source: KAKEN	Nakabayashi Trust for ALS Research; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Nakabayashi Trust for ALS Research (to T. H.) and Grants-in-Aid for Scientific Research (C) (to T. H.) and for JSPS Fellows (to K. M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; BRAND AH, 1993, DEVELOPMENT, V118, P401; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; De Conti L, 2015, NUCLEIC ACIDS RES, V43, P8990, DOI 10.1093/nar/gkv814; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Fiesel FC, 2012, NUCLEIC ACIDS RES, V40, P2668, DOI 10.1093/nar/gkr1082; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Figley MD, 2014, J NEUROSCI, V34, P8083, DOI 10.1523/JNEUROSCI.0543-14.2014; Fratta P, 2014, J NEUROL NEUROSUR PS, V85, P506, DOI 10.1136/jnnp-2013-306761; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gitcho MA, 2009, J BIOL CHEM, V284, P12384, DOI 10.1074/jbc.M900992200; Ihara R, 2013, HUM MOL GENET, V22, P4474, DOI 10.1093/hmg/ddt296; Ingre C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.009; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Kobayashi Z, 2010, J NEUROL SCI, V293, P6, DOI 10.1016/j.jns.2010.03.029; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Miguel L, 2011, NEUROBIOL DIS, V41, P398, DOI 10.1016/j.nbd.2010.10.007; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; Shao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032802; Smith BN, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.10.032; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tanaka Y, 2016, HUM MOL GENET, V25, P1420, DOI 10.1093/hmg/ddw024; van Blitterswijk M, 2013, AMYOTROPH LAT SCL FR, V14, P463, DOI 10.3109/21678421.2013.787630; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	49	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23464	23476		10.1074/jbc.M116.729152	http://dx.doi.org/10.1074/jbc.M116.729152			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634045	hybrid, Green Published			2022-12-26	WOS:000387884400009
J	Morris, JS; Facchini, PJ				Morris, Jeremy S.; Facchini, Peter J.			Isolation and Characterization of Reticuline N-Methyltransferase Involved in Biosynthesis of the Aporphine Alkaloid Magnoflorine in Opium Poppy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme catalysis; functional genomics; plant biochemistry; secondary metabolism; N-methyltransferase; aporphine alkaloid; benzylisoquinoline alkaloid; biochemical genomics; magnoflorine	ADENOSYL-L-METHIONINE; COPTIS-JAPONICA CELLS; MOLECULAR-CLONING; O-METHYLTRANSFERASES; TINOSPORA-CORDIFOLIA; PARTIAL-PURIFICATION; DENSITY-LIPOPROTEIN; GENE-EXPRESSION; CULTURED-CELLS; RHIZOMA	Benzylisoquinoline alkaloids are a large group of plant-specialized metabolites displaying an array of biological and pharmacological properties associated with numerous structural scaffolds and diverse functional group modification. N-Methylation is one of the most common tailoring reactions, yielding tertiary and quaternary pathway intermediates and products. Two N-methyltransferases accepting (i) early 1-benzylisoquinoline intermediates possessing a secondary amine and leading to the key branch-point intermediate (S)-reticuline and (ii) downstream protoberberines containing a tertiary amine and forming quaternary intermediates destined for phthalideisoquinolines and antimicrobial benzo[c]phenanthridines were previously characterized. We report the isolation and characterization of a phylogenetically related yet functionally distinct N-methyltransferase (NMT) from opium poppy (Papaver somniferum) that primarily accepts 1-benzylisoquinoline and aporphine substrates possessing a tertiary amine. The preferred substrates were the R and S conformers of reticuline and the aporphine (S)-corytuberine, which are proposed intermediates in the biosynthesis of magnoflorine, a quaternary aporphine alkaloid common in plants. Suppression of the gene encoding reticuline N-methyltransferase (RNMT) using virus-induced gene silencing in opium poppy resulted in a significant decrease in magnoflorine accumulation and a concomitant increase in corytuberine levels in roots. RNMT transcript levels were also most abundant in roots, in contrast to the distribution of transcripts encoding other NMTs, which occur predominantly in aerial plant organs. The characterization of a third functionally unique NMT involved in benzylisoquinoline alkaloid metabolism will facilitate the establishment of structure-function relationships among a large group of related enzymes.	[Morris, Jeremy S.; Facchini, Peter J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Facchini, PJ (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada.	pfacchin@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (to P. J. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Austin RS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-191; BHAKUNI DS, 1980, TETRAHEDRON, V36, P2525, DOI 10.1016/0040-4020(80)80233-X; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chen JH, 2009, ARCH PHARM RES, V32, P3, DOI 10.1007/s12272-009-1111-7; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; Choi KB, 2001, PHYTOCHEMISTRY, V56, P649, DOI 10.1016/S0031-9422(00)00481-7; Dang TTT, 2012, PLANT PHYSIOL, V159, P618, DOI 10.1104/pp.112.194886; de la Pena JBI, 2013, J NAT MED-TOKYO, V67, P814, DOI 10.1007/s11418-013-0754-3; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; Farrow SC, 2012, PHYTOCHEMISTRY, V77, P79, DOI 10.1016/j.phytochem.2012.02.014; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRENZEL T, 1990, PHYTOCHEMISTRY, V29, P3491, DOI 10.1016/0031-9422(90)85263-F; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0596-0; Hagel JM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0594-2; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2012, J BIOL CHEM, V287, P42972, DOI 10.1074/jbc.M112.420414; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Hung TM, 2007, PLANTA MED, V73, P1281, DOI 10.1055/s-2007-981615; Hung TM, 2007, BIOL PHARM BULL, V30, P1157, DOI 10.1248/bpb.30.1157; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Kato M, 2000, NATURE, V406, P956, DOI 10.1038/35023072; Khamidov II, 1997, CHEM NAT COMPD, V33, p323 , DOI DOI 10.1007/BF02234886; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lam KC, 2007, GENOME, V50, P1001, DOI 10.1139/G07-077; Levac D, 2016, PLANT PHYSIOL, V170, P1935, DOI 10.1104/pp.15.01813; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liscombe DK, 2010, P NATL ACAD SCI USA, V107, P18793, DOI 10.1073/pnas.1009003107; Liscombe DK, 2009, PLANT J, V60, P729, DOI 10.1111/j.1365-313X.2009.03980.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOEFFLER S, 1995, PHYTOCHEMISTRY, V38, P1387, DOI 10.1016/0031-9422(94)00813-9; Marques JV, 2014, MOL BIOSYST, V10, P2838, DOI 10.1039/c4mb00403e; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; McCarthy AA, 2007, PLANT PHYSIOL, V144, P879, DOI 10.1104/pp.106.094854; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Patel MB, 2012, PHYTOTHER RES, V26, P1342, DOI 10.1002/ptr.3721; Priestap HA, 2012, BIOCHEM SYST ECOL, V40, P126, DOI 10.1016/j.bse.2011.10.006; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RUEFFER M, 1990, PHYTOCHEMISTRY, V29, P3727, DOI 10.1016/0031-9422(90)85321-6; Shulgin A.T., 2002, SIMPLE PLANT ISOQUIN; Torres MA, 2016, J BIOL CHEM, V291, P23403, DOI 10.1074/jbc.M116.747261; WAT CK, 1986, Z NATURFORSCH C, V41, P126; Willaman JJ, 1961, ALKALOID BEARING PLA; Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852	51	25	29	6	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23416	23427		10.1074/jbc.M116.750893	http://dx.doi.org/10.1074/jbc.M116.750893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27634038	Green Published, hybrid			2022-12-26	WOS:000387884400005
J	Vieira, BA; Luft, VC; Schmidt, MI; Chambless, LE; Chor, D; Barreto, SM; Duncan, BB				Vieira, Bruna Angelo; Luft, Vivian Cristine; Schmidt, Maria Ines; Chambless, Lloyd Ellwood; Chor, Dora; Barreto, Sandhi Maria; Duncan, Bruce Bartholow			Timing and Type of Alcohol Consumption and the Metabolic Syndrome - ELSA-Brasil	PLOS ONE			English	Article							KOREAN NATIONAL-HEALTH; DRINKING PATTERNS; RISK-FACTOR; RED WINE; ASSOCIATION; METAANALYSIS; BEER; ORGANIZATION; PREVALENCE; BIOMARKERS	The prevalence of the metabolic syndrome is rising worldwide. Its association with alcohol intake, a major lifestyle factor, is unclear, particularly with respect to the influence of drinking with as opposed to outside of meals. We investigated the associations of different aspects of alcohol consumption with the metabolic syndrome and its components. In cross-sectional analyses of 14,375 active or retired civil servants (aged 35-74 years) participating in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), we fitted logistic regression models to investigate interactions between the quantity of alcohol, the timing of its consumption with respect to meals, and the predominant beverage type in the association of alcohol consumption with the metabolic syndrome. In analyses adjusted for age, sex, educational level, income, socioeconomic status, ethnicity, smoking, body mass index, and physical activity, light consumption of alcoholic beverages with meals was inversely associated with the metabolic syndrome (<= 4 drinks/week: OR = 0.85, 95% CI 0.74-0.97; 4 to 7 drinks/week: OR = 0.75, 95% CI 0.61-0.92), compared to abstention/occasional drinking. On the other hand, greater consumption of alcohol consumed outside of meals was significantly associated with the metabolic syndrome (7 to 14 drinks/week: OR = 1.32, 95% CI 1.11-1.57; >= 14 drinks/week: OR = 1.60, 95% CI 1.29-1.98). Drinking predominantly wine, which occurred mostly with meals, was significantly related to a lower syndrome prevalence; drinking predominantly beer, most notably when outside of meals and in larger quantity, was frequently associated with a greater prevalence. In conclusion, the alcohol-metabolic syndrome association differs markedly depending on the relationship of intake to meals. Beverage preference-wine or beer-appears to underlie at least part of this difference. Notably, most alcohol was consumed in metabolically unfavorable type and timing. If further investigations extend these findings to clinically relevant endpoints, public policies should recommend that alcohol, when taken, should be preferably consumed with meals.	[Vieira, Bruna Angelo; Luft, Vivian Cristine; Schmidt, Maria Ines; Duncan, Bruce Bartholow] Fed Univ Rio Grande Sul UFRGS, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil; [Vieira, Bruna Angelo; Luft, Vivian Cristine; Schmidt, Maria Ines; Duncan, Bruce Bartholow] Fed Univ Rio Grande Sul UFRGS, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Luft, Vivian Cristine] HCPA UFRGS, Food & Nutr Res Ctr, Porto Alegre, RS, Brazil; [Chambless, Lloyd Ellwood] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Chor, Dora] Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Dept Epidemiol, Rio De Janeiro, Brazil; [Barreto, Sandhi Maria] Fed Univ Minas Gerais UFMG, Grad Studies Program Publ Hlth, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Luft, VC (corresponding author), Fed Univ Rio Grande Sul UFRGS, Grad Studies Program Epidemiol, Porto Alegre, RS, Brazil.; Luft, VC (corresponding author), Fed Univ Rio Grande Sul UFRGS, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.; Luft, VC (corresponding author), HCPA UFRGS, Food & Nutr Res Ctr, Porto Alegre, RS, Brazil.	vcluft@hcpa.edu.br	Schmidt, Maria Inês/AGT-5691-2022; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria/V-3196-2019; Barreto, Sandhi M/D-2855-2014; Vieira, Bruna/AAA-2594-2020; Luft, Vivian/U-2141-2019; Duncan, Bruce B/L-4140-2016	Schmidt, Maria Inês/0000-0002-3837-0731; Barreto, Sandhi M/0000-0001-7383-7811; Duncan, Bruce B/0000-0002-7491-2630; Angelo Vieira, Bruna/0000-0002-7078-6251	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos) [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]; Brazilian Ministry of Science and Technology (National Council for Scientific and Technological Development - CNPq) [01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos); Brazilian Ministry of Science and Technology (National Council for Scientific and Technological Development - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian Ministry of Health (Science and Technology Department -http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/sctie/decit-departamento-de-ciencia-e-tecnologia) and the Brazilian Ministry of Science and Technology (Financiadora de Estudos e Projetos - http://www.finep.gov.br/- and the National Council for Scientific and Technological Development - CNPq - http://cnpq.br/) [grant numbers 01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Athyros VG, 2007, ANGIOLOGY, V58, P689, DOI 10.1177/0003319707306146; Augustin LSA, 2004, EPIDEMIOLOGY, V15, P767, DOI 10.1097/01.ede.0000142146.36594.9a; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Barrio-Lopez MT, 2013, CLIN NUTR, V32, P797, DOI 10.1016/j.clnu.2012.12.002; Bendsen NT, 2013, NUTR REV, V71, P67, DOI 10.1111/j.1753-4887.2012.00548.x; Bensenor IM, 2013, REV SAUDE PUBL, V47, P37, DOI 10.1590/S0034-8910.2013047003780; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Brand-Miller JC, 2007, AM J CLIN NUTR, V85, P1545, DOI 10.1093/ajcn/85.6.1545; Brinton EA, 2012, CURR ATHEROSCLER REP, V14, P108, DOI 10.1007/s11883-012-0230-7; Canadian Centre on Substance Abuse (CCSA), CAN LOW RISK ALC DRI; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen CC, 2012, NUTR RES, V32, P24, DOI 10.1016/j.nutres.2011.11.004; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Chor D, 2013, REV SAUDE PUBL, V47, P27, DOI 10.1590/S0034-8910.2013047003835; Costanzo S, 2011, EUR J EPIDEMIOL, V26, P833, DOI 10.1007/s10654-011-9631-0; Della Valle E, 2009, NUTR METAB CARDIOVAS, V19, P115, DOI 10.1016/j.numecd.2008.03.006; Dima-Cozma C, 2014, EUR J SCI THEOL, V10, P111; DUNCAN BB, 1995, AM J EPIDEMIOL, V142, P1034, DOI 10.1093/oxfordjournals.aje.a117556; Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807; Foppa M, 2002, J STUD ALCOHOL, V63, P247, DOI 10.15288/jsa.2002.63.247; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; Fujita N, 2011, HEPATOL RES, V41, P287, DOI 10.1111/j.1872-034X.2011.00787.x; Galan I, 2014, NUTR METAB CARDIOVAS, V24, P189, DOI 10.1016/j.numecd.2013.07.002; Government Australian. Department of Health and Ageing, NEW NAT GUID ALC CON; Hampton SM, 2010, J HUM NUTR DIET, V23, P120, DOI 10.1111/j.1365-277X.2009.01021.x; Huang C, 2014, MAYO CLIN PROC, V89, P1201, DOI 10.1016/j.mayocp.2014.05.014; Imhof A, 2004, EUR HEART J, V25, P2092, DOI 10.1016/j.ehj.2004.09.032; IPAQ-International Physical Activity Questionnaire, GUID DAT PROC AN INT; Kim BJ, 2012, CIRC J, V76, P2363, DOI 10.1253/circj.CJ-12-0315; Lee KW, 2011, ALCOHOL, V45, P499, DOI 10.1016/j.alcohol.2011.01.001; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Munoz A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/610950; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Sacanella E, 2003, ADDICT BIOL, V8, P371, DOI 10.1080/13556210310001656376; Santos AC, 2007, PREV MED, V44, P328, DOI 10.1016/j.ypmed.2006.11.016; Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027; Schmidt MI, 2013, REV SAUDE PUBL, V47, P105, DOI 10.1590/S0034-8910.2013047003889; Schrieks IC, 2013, ALCOHOL ALCOHOLISM, V48, P153, DOI 10.1093/alcalc/ags086; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stoutenberg M, 2013, BRIT J NUTR, V110, P901, DOI 10.1017/S0007114512005764; Sun K, 2014, CLIN NUTR, V33, P596, DOI 10.1016/j.clnu.2013.10.003; Toda N, 2010, ALCOHOL ALCOHOLISM, V45, P347, DOI 10.1093/alcalc/agq028; Trevisan M, 2001, ANN EPIDEMIOL, V11, P312, DOI 10.1016/S1047-2797(00)00183-6; US Department of Health and Human Services and US Department of Agriculture, 2015, 2015 2020 DIET GUID; Wakabayashi I, 2011, J ATHEROSCLER THROMB, V18, P684, DOI 10.5551/jat.7435; Wandler A, 2008, MOL CELL ENDOCRINOL, V296, P26, DOI 10.1016/j.mce.2008.09.006; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Yokoyama H, 2007, INTERNAL MED, V46, P1345, DOI 10.2169/internalmedicine.46.6196; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Zhang C., 2014, P 51 ANN DES AUT C D, P1, DOI [DOI 10.1145/2593069.2593124, 10.1109/BTAS.2014.6996295]	55	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2016	11	9							e0163044	10.1371/journal.pone.0163044	http://dx.doi.org/10.1371/journal.pone.0163044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW8GC	27643787	gold, Green Published, Green Submitted			2022-12-26	WOS:000383891900027
J	Li, XJ; Augustine, A; Chen, S; Fliegel, L				Li, Xiuju; Augustine, Aruna; Chen, Shuo; Fliegel, Larry			Stop Codon Polymorphisms in the Human SLC9A1 Gene Disrupt or Compromise Na+/H+ Exchanger Function	PLOS ONE			English	Article							TRANSMEMBRANE SEGMENT-IV; AMINO-ACIDS SER(770); NHE1 ISOFORM; PHOSPHORYLATION; REGION; IDENTIFICATION; KINASE; ATAXIA; TAIL	The NHE1 isoform of the mammalian Na+/H+ exchanger is a ubiquitous plasma membrane protein that regulates intracellular pH in mammalian cells by removing one intracellular proton in exchange for one extracellular sodium. Deletion of the NHE1 gene (SLC9A1) affects the growth and motor ability of mice and humans but mutations and polymorphisms of the gene are only beginning to be characterized. NHE1 has a cytosolic C-terminal regulatory tail of approximately 315 amino acids and a 500 amino acid membrane domain. We examined the functional effects of three human stop codon mutations at amino acids 321, 449 and 735 in comparison with a mutant that had a shortened tail region (543 stop codon). The short mutants, 321, 449 and 543 stop codon mutant proteins, lost NHE1 activity and expression, and did not target to the plasma membrane. Protein for these short mutants was more rapidly degraded than the wild type and 735 ending proteins. The 735 terminating mutant, with the membrane domain and much of the cytosolic tail, had reduced protein expression and activity. The results demonstrate that early stop codon polymorphisms have significant and deleterious effects on the activity of the SLC9A1 protein product. The 735-NHE1 mutant, without the last 80 amino acids, had more minor defects. Surprisingly, retention of a proximal 43 amino acids adjacent to the membrane domain did little to maintain NHE1 expression, targeting and activity.	[Li, Xiuju; Augustine, Aruna; Chen, Shuo; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca			Canadian Institute of Health Research [MOP 97816]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institute of Health Research MOP 97816.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alves C, 2014, BIOCHEM CELL BIOL, V92, P524, DOI 10.1139/bcb-2014-0071; Amith SR, 2015, INT J DEV BIOL, V59, P367, DOI 10.1387/ijdb.140336lf; Amith SR, 2013, CANCER RES, V73, P1259, DOI 10.1158/0008-5472.CAN-12-4031; Amith SR, 2016, ONCOTARGET, V7, P21091, DOI 10.18632/oncotarget.8520; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; Boedtkjer E, 2012, CURR PHARM DESIGN, V18, P1345, DOI 10.2174/138161212799504830; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; FLIEGEL L, 1993, BIOCHEM J, V289, P101, DOI 10.1042/bj2890101; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Guissart C, 2015, HUM MOL GENET, V24, P463, DOI 10.1093/hmg/ddu461; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; Hendus-Altenburger R, 2014, CURR TOP MEMBR, V73, P69, DOI 10.1016/B978-0-12-800223-0.00002-5; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; Karki P, 2011, J BIOL CHEM, V286, P13096, DOI 10.1074/jbc.M110.165134; Karmazyn M, 2008, J MOL CELL CARDIOL, V44, P647, DOI 10.1016/j.yjmcc.2008.01.005; Lee BL, 2009, J BIOL CHEM, V284, P11546, DOI 10.1074/jbc.M809201200; Lee YCG, 2012, GENOME BIOL EVOL, V4, P533, DOI 10.1093/gbe/evr113; Li XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119453; Li XJ, 2013, J MOL CELL CARDIOL, V61, P153, DOI 10.1016/j.yjmcc.2013.04.007; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Liu YS, 2015, BBA-BIOMEMBRANES, V1848, P2385, DOI 10.1016/j.bbamem.2015.07.011; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Reshkin SJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0100; Silva NLCL, 1997, PFLUG ARCH EUR J PHY, V433, P792, DOI 10.1007/s004240050347; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tzeng J, 2010, J BIOL CHEM, V285, P36656, DOI 10.1074/jbc.M110.161471; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162902	10.1371/journal.pone.0162902	http://dx.doi.org/10.1371/journal.pone.0162902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27636896	Green Submitted, gold, Green Published			2022-12-26	WOS:000383723700020
J	Sansoe, G; Aragno, M; Mastrocola, R; Mengozzi, G; Novo, E; Parola, M				Sansoe, Giovanni; Aragno, Manuela; Mastrocola, Raffaella; Mengozzi, Giulio; Novo, Erica; Parola, Maurizio			Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; RENIN-ANGIOTENSIN SYSTEM; RENAL-FUNCTION; PORTAL-HYPERTENSION; CONVERTING ENZYME; VASCULAR TISSUES; RECEPTOR BLOCKER; CARDIAC-FUNCTION; FIBROSIS; CALCIUM	Background Tissue Angiotensin II (Ang-II), produced through local non ACE-dependent pathways, stimulates liver fibrogenesis, renal vasoconstriction and sodium retention. Aim To highlight chymase-dependent pathway of Ang-II production in liver and kidney during cirrhosis development. Methods Liver histology, portal pressure, liver and kidney function, and hormonal status were investigated in rat liver cirrhosis induced through 13 weeks of CCl4, with or without chymase inhibitor SF2809E, administered between 4th and 13th CCl4 weeks; liver and kidney chymase immunolocation and Ang-II content were assessed. Chymase immunohistochemistry was also assessed in normal and cirrhotic human liver, and chymase mRNA transcripts were measured in human HepG2 cells and activated hepatic stellate cells (HSC/MFs) in vitro. Results Rats receiving both CCl4 and SF2809E showed liver fibrotic septa focally linking portal tracts but no cirrhosis, as compared to ascitic cirrhotic rats receiving CCl4. SF2809E reduced portal pressure, plasma bilirubin, tissue content of Ang-II, plasma renin activity, norepinephrine and vasopressin, and increased glomerular filtration rate, water clearance, urinary sodium excretion. Chymase tissue content was increased and detected in alpha-SMA-positive liver myofibroblasts and in kidney tubular cells of cirrhotic rats. In human cirrhosis, chymase was located in hepatocytes of regenerative nodules. Human HepG2 cells and HSC/MFs responded to TGF-beta 1 by up-regulating chymase mRNA transcription. Conclusions Chymase, through synthesis of Ang-II and other mediators, plays a role in the derangement of liver and kidney function in chronic liver diseases. In human cirrhosis, chymase is well-represented and apt to become a future target of pharmacological treatment.	[Sansoe, Giovanni] Humanitas Gradenigo Hosp, Div Gastroenterol, Turin, Italy; [Aragno, Manuela; Mastrocola, Raffaella; Novo, Erica; Parola, Maurizio] Univ Torino, Dept Clin & Biol Sci, Turin, Italy; [Mengozzi, Giulio] San Giovanni Battista Hosp, Clin Biochem Lab, Turin, Italy	Humanitas Hospital Gradenigo; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Sansoe, G (corresponding author), Humanitas Gradenigo Hosp, Div Gastroenterol, Turin, Italy.	giovannisan@iol.it	Mengozzi, Giulio/AAY-5322-2020	Mengozzi, Giulio/0000-0003-0431-8369; ARAGNO, Manuela/0000-0002-0453-5235; novo, erica/0000-0003-2586-4246; Sansoe', Giovanni/0000-0003-2328-1768	Italian Ministry of University and of Scientific Research	Italian Ministry of University and of Scientific Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the Italian Ministry of University and of Scientific Research (60%), 2011.	Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bernardi M, 1996, J HEPATOL, V24, P161, DOI 10.1016/S0168-8278(96)80025-0; Carey RM, 2003, ENDOCR REV, V24, P261, DOI 10.1210/er.2003-0001; Chappell MC, 2001, NEPHROL DIAL TRANSPL, V16, P22, DOI 10.1093/ndt/16.suppl_1.22; COLE BR, 1972, NEW ENGL J MED, V287, P1109, DOI 10.1056/NEJM197211302872202; Dostal DE, 1999, CIRC RES, V85, P643, DOI 10.1161/01.RES.85.7.643; GANDHI CR, 1995, LIFE SCI, V58, P55, DOI 10.1016/0024-3205(95)02255-4; GENTILINI P, 1993, GASTROENTEROLOGY, V104, P588, DOI 10.1016/0016-5085(93)90431-B; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Huss S, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-10; ICHIKAWA I, 1984, CIRC RES, V55, P669, DOI 10.1161/01.RES.55.5.669; Jin D, 2003, CARDIOVASC RES, V60, P413, DOI 10.1016/S0008-6363(03)00535-2; Jin D, 1998, J HYPERTENS, V16, P657, DOI 10.1097/00004872-199816050-00013; Jonsson JR, 2001, GASTROENTEROLOGY, V121, P148, DOI 10.1053/gast.2001.25480; Kamada Y, 2003, HEPATOL RES, V25, P296, DOI 10.1016/S1386-6346(02)00306-6; Kohan DE, 1997, AM J KIDNEY DIS, V29, P2, DOI 10.1016/S0272-6386(97)90004-4; Komeda K, 2008, HEPATOL RES, V38, P501, DOI 10.1111/j.1872-034X.2007.00271.x; Komeda K, 2010, HEPATOL RES, V40, P832, DOI 10.1111/j.1872-034X.2010.00672.x; Miyazaki MA, 2001, HYPERTENS RES, V24, P189, DOI 10.1291/hypres.24.189; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Nishiyama A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000026610.48842.CB; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Parola M, 1996, FREE RADICAL BIO MED, V20, P351, DOI 10.1016/0891-5849(96)02055-2; PINZANI M, 1992, J CLIN INVEST, V90, P642, DOI 10.1172/JCI115905; Rockey DC, 1996, J CLIN INVEST, V98, P1381, DOI 10.1172/JCI118925; ROSE BD, 2001, CLIN PHYSL ACID BASE, P285; Sansoe G, 2007, GUT, V56, P1117, DOI 10.1136/gut.2006.109728; Sansoe G, 2006, AM J PHYSIOL-RENAL, V290, pF1337, DOI 10.1152/ajprenal.00435.2005; Sansoe G, 2005, J HEPATOL, V43, P791, DOI 10.1016/j.jhep.2005.04.017; Sansoe G, 2010, J HEPATOL, V53, P856, DOI 10.1016/j.jhep.2010.05.021; Schepke M, 2001, GASTROENTEROLOGY, V121, P389, DOI 10.1053/gast.2001.26295; SCHEUER PJ, 1995, J HEPATOL, V22, P112, DOI 10.1016/0168-8278(95)80269-X; Sheehan D.C., 1987, THEORY PRACTICE HIST; Simard E, 2009, J PHARMACOL EXP THER, V328, P540, DOI 10.1124/jpet.108.142992; Takai S, 2001, CLIN CHIM ACTA, V305, P191, DOI 10.1016/S0009-8981(01)00379-5; Takai S, 2012, J PHARMACOL SCI, V118, P311, DOI 10.1254/jphs.11R11CP; Tani M, 2004, J ANTIBIOT, V57, P83, DOI 10.7164/antibiotics.57.83; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2016	11	9							e0162644	10.1371/journal.pone.0162644	http://dx.doi.org/10.1371/journal.pone.0162644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5YN	27637026	Green Published, Green Submitted, gold			2022-12-26	WOS:000383723700012
J	Di Pasquale, G; Alaux, C; Le Conte, Y; Odoux, JF; Pioz, M; Vaissiere, BE; Belzunces, LP; Decourtye, A				Di Pasquale, Garance; Alaux, Cedric; Le Conte, Yves; Odoux, Jean-Francois; Pioz, Maryline; Vaissiere, Bernard E.; Belzunces, Luc P.; Decourtye, Axel			Variations in the Availability of Pollen Resources Affect Honey Bee Health	PLOS ONE			English	Article							MELLIFERA L HYMENOPTERA; APIS-MELLIFERA; NUTRITIVE-VALUE; BOMBUS-TERRESTRIS; JUVENILE-HORMONE; APIDAE; WORKERS; LARVAE; DIET; VITELLOGENIN	Intensive agricultural systems often expose honey bees (Apis mellifera L.) to large temporal variations in the availability (quantity, quality and diversity) of nutritional resources. Such nutritional irregularity is expected to affect honey bee health. We therefore tested under laboratory conditions the effect of such variation in pollen availability on honey bee health (survival and nursing physiology-hypopharyngeal gland development and vitellogenin expression). We fed honey bees with different diets composed of pollen pellets collected by honey bees in an agricultural landscape of western France. Slight drops (5-10%) in the availability of oilseed rape (Brassica napus L.) pollen resulted in significant reductions of all tested variables. Despite some variations in taxonomic diversity and nutritional quality, the pollen mixes harvested over the season had a similar positive influence on honey bee health, except for the one collected in late July that induced poor survival and nursing physiology. This period coincided with the mass-flowering of maize (Zea mays L.), an anemophilous crop which produces poor-quality pollen. Therefore, changes in bee health were not connected to variations in pollen diversity but rather to variations in pollen depletion and quality, such as can be encountered in an intensive agricultural system of western France. Finally, even though pollen can be available ad libitum during the mass-flowering of some crops (e.g. maize), it can fail to provide bees with diet adequate for their development.	[Di Pasquale, Garance; Alaux, Cedric; Le Conte, Yves; Pioz, Maryline; Vaissiere, Bernard E.; Belzunces, Luc P.; Decourtye, Axel] UMT PrADE, Avignon, France; [Di Pasquale, Garance; Decourtye, Axel] ACTA, Avignon, France; [Alaux, Cedric; Le Conte, Yves; Pioz, Maryline; Vaissiere, Bernard E.; Belzunces, Luc P.] INRA, UR Abeilles & Environm 406, Avignon, France; [Odoux, Jean-Francois] INRA, Unite Expt Entomol, Le Magneraud, France; [Decourtye, Axel] ITSAP Inst Abeille, Avignon, France	INRAE; INRAE	Di Pasquale, G (corresponding author), UMT PrADE, Avignon, France.; Di Pasquale, G (corresponding author), ACTA, Avignon, France.	garancedipasquale@gmail.com	, Belzunces/P-7061-2019; Le Conte, Yves/M-4442-2018; Alaux, Cedric/B-4667-2013; Le Conte, Yves M/B-3246-2016; ODOUX, Jean-François/AAB-3596-2019; Pioz, Maryline/AAI-3325-2020; Le Conte, Yves/AAP-2379-2021	, Belzunces/0000-0003-1798-9962; Le Conte, Yves/0000-0002-8466-5370; Alaux, Cedric/0000-0002-3045-2599; Le Conte, Yves M/0000-0002-8466-5370; ODOUX, Jean-François/0000-0002-6264-4376; Le Conte, Yves/0000-0002-8466-5370; Pioz, Maryline/0000-0003-0331-4403	European Agricultural Guarantee Fund [797/2004]; Conventions Industrielles de Formation par la Recherche (ANRT)	European Agricultural Guarantee Fund; Conventions Industrielles de Formation par la Recherche (ANRT)(French National Research Agency (ANR))	This work was funded by a grant from the European Agricultural Guarantee Fund (797/2004) and GDP was supported by a fellowship from the Conventions Industrielles de Formation par la Recherche (ANRT).	Alaux C, 2014, J EXP BIOL, V217, P3416, DOI 10.1242/jeb.105783; Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; [Anonymous], ISO5983; [Anonymous], 2009, AFNOR15662; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bitondi MMG, 1996, J APICULT RES, V35, P27, DOI 10.1080/00218839.1996.11100910; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Cane JH, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P99; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; COX DR, 1972, J R STAT SOC B, V34, P187; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; DIETZ A, 1980, APIDOLOGIE, V11, P143, DOI 10.1051/apido:19800204; Dimou M, 2009, APIDOLOGIE, V40, P124, DOI 10.1051/apido/2008066; FERNANDESDASILVA PG, 1993, APIDOLOGIE, V24, P73, DOI 10.1051/apido:19930109; Fischer P, 2008, NATURWISSENSCHAFTEN, V95, P723, DOI 10.1007/s00114-008-0378-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Girard M, 2012, BOTANY, V90, P545, DOI [10.1139/B2012-049, 10.1139/b2012-049]; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hocherl N, 2012, J INSECT PHYSIOL, V58, P278, DOI 10.1016/j.jinsphys.2011.12.001; Jacobs F, 2004, COMPT REND 1 C TECHN, P57; Keller I, 2005, BEE WORLD, V86, P3, DOI 10.1080/0005772X.2005.11099641; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; LOPER GM, 1980, APIDOLOGIE, V11, P351, DOI 10.1051/apido:19800403; LOPER GM, 1980, APIDOLOGIE, V11, P181, DOI 10.1051/apido:19800208; Louveaux J, 1959, ANN ABEILLE, V2; Manning R, 2001, BEE WORLD, V82, P60, DOI 10.1080/0005772X.2001.11099504; Mattila HR, 2006, APIDOLOGIE, V37, P533, DOI 10.1051/apido:2006037; Maurizio A., 1950, BEE WORLD, V31, P9, DOI 10.1080/0005772X.1950.11094617; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Odoux JF, 2012, APIDOLOGIE, V43, P561, DOI 10.1007/s13592-012-0125-1; Otis GW, 2007, AM BEE J, V147, P1033; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; Ravoet J, 2015, B ENVIRON CONTAM TOX, V94, P543, DOI 10.1007/s00128-015-1511-y; Requier F, 2015, ECOL APPL, V25, P881, DOI 10.1890/14-1011.1; RINDERER TE, 1977, J ECON ENTOMOL, V70, P431, DOI 10.1093/jee/70.4.431; RINDERER TE, 1974, J INVERTEBR PATHOL, V23, P347, DOI 10.1016/0022-2011(74)90100-1; Schmickl T, 2003, INSECT SOC, V50, P174, DOI 10.1007/s00040-003-0644-x; SCHMIDT JO, 1984, J KANSAS ENTOMOL SOC, V57, P323; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5201; Shannon C. E., 1949, MATH THEORY COMMUNIC; Smeets P, 2003, APIDOLOGIE, V34, P333, DOI 10.1051/apido:2003026; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; VAISSIERE BE, 1994, GRANA, V33, P128, DOI 10.1080/00173139409428989; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Wang H, 2014, APIDOLOGIE, V45, P618, DOI 10.1007/s13592-014-0276-3; Willard LE, 2011, APIDOLOGIE, V42, P508, DOI 10.1007/s13592-011-0006-z; Winston M., 1987, The biology of the honey bee.; Wratten SD, 2012, AGR ECOSYST ENVIRON, V159, P112, DOI 10.1016/j.agee.2012.06.020	67	85	87	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162818	10.1371/journal.pone.0162818	http://dx.doi.org/10.1371/journal.pone.0162818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631605	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900082
J	Dong, CJ; Wu, AM; Du, SJ; Tang, K; Wang, Y; Liu, JY				Dong, Chun-Juan; Wu, Ai-Min; Du, Shao-Jun; Tang, Kai; Wang, Yun; Liu, Jin-Yuan			GhMCS1, the Cotton Orthologue of Human GRIM-19, Is a Subunit of Mitochondrial Complex I and Associated with Cotton Fibre Growth	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED PROTEINS; ARABIDOPSIS-THALIANA; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; CELLULOSE SYNTHASE; CELL ELONGATION; EAR-MOTIF; MYB GENE; IDENTIFICATION; INSIGHTS	GRIM-19 (Gene associated with Retinoid-Interferon-induced Mortality 19) is a subunit of mitochondrial respiratory complex I in mammalian systems, and it has been demonstrated to be a multifunctional protein involved in the cell cycle, cell motility and innate immunity. However, little is known about the molecular functions of its homologues in plants. Here, we characterised GhMCS1, an orthologue of human GRIM-19 from cotton (Gossypium hirsutum L.), and found that it was essential for maintaining complex integrity and mitochondrial function in cotton. GhMCS1 was detected in various cotton tissues, with high levels expressed in developing fibres and flowers and lower levels in leaves, roots and ovules. In fibres at different developmental stages, GhMCS1 expression peaked at 5-15 days post anthesis (dpa) and then decreased at 20 dpa and diminished at 25 dpa. By Western blot analysis, GhMCS1 was observed to be localised to the mitochondria of cotton leaves and to colocalise with complex I. In Arabidopsis, GhMCS1 overexpression enhanced the assembly of complex I and thus respiratory activity, whereas the GhMCS1 homologue (At1g04630) knockdown mutants showed significantly decreased respiratory activities. Furthermore, the mutants presented with some phenotypic changes, such as smaller whole-plant architecture, poorly developed seeds and fewer trichomes. More importantly, in the cotton fibres, both the GhMCS1 transcript and protein levels were correlated with respiratory activity and fibre developmental phase. Our results suggest that GhMCS1, a functional ortholog of the human GRIM-19, is an essential subunit of mitochondrial complex I and is involved in cotton fibre development. The present data may deepen our knowledge on the potential roles of mitochondria in fibre morphogenesis.	[Dong, Chun-Juan; Wu, Ai-Min; Du, Shao-Jun; Tang, Kai; Wang, Yun; Liu, Jin-Yuan] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing, Peoples R China	Tsinghua University	Liu, JY (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Plant Mol Biol Lab, Beijing, Peoples R China.	liujy@mail.tsinghua.edu.cn	Wu, Aimin/AAG-9747-2020	Wu, Aimin/0000-0001-8322-8833	State Key Basic Research and Development Plan [2010CB126003]; National Transgenic Animals and Plants Research Project [2009ZX08005-026B, 2011ZX08005-003, 2011ZX08009-003]	State Key Basic Research and Development Plan; National Transgenic Animals and Plants Research Project	This work was supported by the State Key Basic Research and Development Plan (2010CB126003) and the National Transgenic Animals and Plants Research Project (2009ZX08005-026B, 2011ZX08005-003 and 2011ZX08009-003).	Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Applequist WL, 2001, EVOL DEV, V3, P3, DOI 10.1046/j.1525-142x.2001.00079.x; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Chen Y, 2007, MOL CELL BIOL, V27, P6420, DOI 10.1128/MCB.01946-06; Chen Y, 2012, J BIOL CHEM, V287, P27227, DOI 10.1074/jbc.M112.340315; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deng T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26829; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; Dong CJ, 2010, FUNCT PLANT BIOL, V37, P64, DOI 10.1071/FP09100; Dong DJ, 2012, AMINO ACIDS, V42, P1297, DOI 10.1007/s00726-010-0824-8; Du SJ, 2013, J PROTEOMICS, V82, P113, DOI 10.1016/j.jprot.2013.02.020; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; GABRIDGE MG, 1976, INFECT IMMUN, V13, P84, DOI 10.1128/IAI.13.1.84-91.1976; Garmier M, 2008, PLANT PHYSIOL, V148, P1324, DOI 10.1104/pp.108.125880; Gonzalez-Halphen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.107; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Kalvakolanu DV, 2010, CYTOKINE, V52, P128, DOI 10.1016/j.cyto.2010.03.009; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li T, 2016, MOL PLANT, V9, P650, DOI 10.1016/j.molp.2016.02.010; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Liu BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116272; Lu H, 2008, MOL BIOL CELL, V19, P1893, DOI 10.1091/mbc.E07-07-0683; Lu SY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P85, DOI 10.1134/S0006297910010116; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Pang Y, 2010, PLANT BIOLOGY, V12, P903, DOI 10.1111/j.1438-8677.2009.00313.x; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Remacle C, 2008, MOL GENET GENOMICS, V280, P93, DOI 10.1007/s00438-008-0350-5; Ruan YL, 1998, PLANT PHYSIOL, V118, P399, DOI 10.1104/pp.118.2.399; Shangguan XX, 2008, J EXP BOT, V59, P3533, DOI 10.1093/jxb/ern204; Shi Y, 2013, FISH SHELLFISH IMMUN, V34, P273, DOI 10.1016/j.fsi.2012.11.017; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; Smart LB, 1998, PLANT PHYSIOL, V116, P1539, DOI 10.1104/pp.116.4.1539; Sweetlove Lee J, 2007, Methods Mol Biol, V372, P125, DOI 10.1007/978-1-59745-365-3_9; Tang K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156281; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Whittaker DJ, 1999, PLANT PHYSIOL, V121, P181, DOI 10.1104/pp.121.1.181; Wu AM, 2007, CELL RES, V17, P174, DOI 10.1038/sj.cr.7310119; Yang XD, 2006, PLANT MOL BIOL, V62, P951, DOI 10.1007/s11103-006-9068-0; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Yao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117049; Zhang B, 2013, PROTEOMICS, V13, P1159, DOI 10.1002/pmic.201200176; Zhang HM, 2005, J INTEGR PLANT BIOL, V47, P223, DOI 10.1111/j.1744-7909.2005.00019.x; Zhao GR, 2001, BIOSCI BIOTECH BIOCH, V65, P2789, DOI 10.1271/bbb.65.2789; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t; Zhou L, 2011, J INTEGR PLANT BIOL, V53, P347, DOI 10.1111/j.1744-7909.2011.01034.x	59	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162928	10.1371/journal.pone.0162928	http://dx.doi.org/10.1371/journal.pone.0162928			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27632161	Green Published, Green Submitted, gold			2022-12-26	WOS:000383706900095
J	Khan, AA; Qureshi, JA; Afzal, M; Stansly, PA				Khan, Azhar A.; Qureshi, Jawwad A.; Afzal, Muhammad; Stansly, Philip A.			Two-Spotted Ladybeetle Adalia bipunctata L. (Coleoptera: Coccinellidae): A Commercially Available Predator to Control Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae)	PLOS ONE			English	Article							SAO-PAULO-STATE; SUITABILITY; DISEASE; BEETLE; BRAZIL; EGGS; PREY	The Asian citrus psyllid Diaphorina citri Kuwayama (Hemiptera: Liviidae) is an economically important pest of citrus because it serves as a vector of the causal pathogens of huanglongbing (HLB) also known as citrus greening disease. The increased use of insecticides for control of D. citri negatively impacts several natural enemies including some effective ladybeetle species which are not available commercially. The two-spotted ladybeetle, Adalia bipunctata (Coleoptera: Coccinellidae) is found in some crop and forest ecosystems of Asia, Europe and North America and available commercially. It is known to attack aphids and mealybugs but there are no published records of feeding on psyllids. We evaluated suitability and preference of A. bipunctata for nymphs of D. citri compared to corn leaf aphid Rhopalosiphum maidis (Hemiptera: Aphididae) a global pest of cereal crops and prey for many predaceous insects. We also compared development and reproduction of A. bipunctata on these two species with frozen eggs of the Mediterranean flour moth Ephestia kuehniella (Lepidoptera: Pyralidae) at 25 degrees C. Initially, more D. citri than R. maidis nymphs were consumed in the no-choice tests although final consumption by larva and adult of A. bipunctata did not differ in the choice and no-choice tests. Larval development was prolonged by one day on D. citri compared to R. maidis nymphs but did not differ between either of these diets and E. kuehniella. Larval survival to adult averaged 93-100% and was not impacted by diet. Adult life span did not differ between diets although those on D. citri and R. maidis nymphs weighed less and produced fewer but more fertile eggs than on E. kuehniella eggs. Significant reduction of D. citri nymphs averaging 54% was observed in colonies caged with adult A. bipunctata on field planted citrus. R degrees (net reproductive rate) was least for beetles fed R. maidis, but otherwise there were no significant differences in demographic parameters. Successful feeding, development and reproductive performance of A. bipunctata suggest its usefulness as biological control agent of D. citri as well as aphid species exemplified by R. maidis.	[Khan, Azhar A.; Qureshi, Jawwad A.; Stansly, Philip A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA; [Khan, Azhar A.; Afzal, Muhammad] Univ Sargodha, Dept Entomol, Sargodha, Pakistan; [Khan, Azhar A.] Bahauddin Zakariya Univ, Coll Agr, Bahadur Campus, Layyah, Pakistan; [Qureshi, Jawwad A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL 34945 USA	State University System of Florida; University of Florida; University of Sargodha; State University System of Florida; University of Florida	Qureshi, JA (corresponding author), Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA.; Qureshi, JA (corresponding author), Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL 34945 USA.	jawwadq@ufl.edu	Alotaibi, Majed/GZG-1828-2022; Khan, Azhar/AAQ-6876-2020; Khan, Azhar Abbas/ABH-1865-2020; Afzal, Muhammad/G-2699-2011	Khan, Azhar Abbas/0000-0002-3227-5186; Afzal, Muhammad/0000-0003-1511-816X	Higher Education Commission of Pakistan	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the Higher Education Commission of Pakistan, for funding the PhD research work of Azhar A Khan part of which was conducted at UF-SWFREC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the Higher Education Commission of Pakistan, for funding the PhD research work of Azhar A. Khan part of which was conducted at UF-SWFREC.	[Anonymous], 1925, J ECON ENTOMOL; CATLING HD, 1970, FAO PLANT PROTECT B, V18, P8; De Clercq P, 2005, PEST MANAG SCI, V61, P1129, DOI 10.1002/ps.1111; FRAZER B D, 1976, Journal of the Entomological Society of British Columbia, V73, P33; Halbert S.E., 2005, PEST ALERT CITRUS GR; HALBERT SE, 1998, TRIOLOGY, V37, P6; Hodek I, 1973, BIOL COCCINELLIDAE; Hodek I., 1996, ECOLOGY COCCINELLIDA, V54; Hussain MA, 1927, ENTOMOLOGICAL SERIES, V10, P1; Juan-Blasco M, 2012, FLA ENTOMOL, V95, P543, DOI 10.1653/024.095.0302; Kanga LHB, 2016, J ECON ENTOMOL, V109, P832, DOI 10.1093/jee/tov348; Khan I, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.0701; Kuwayama S., 1908, T SOPPORO NAT HIST S, V2, P149; Lanzoni A, 2004, J APPL ENTOMOL, V128, P298, DOI 10.1111/j.1439-0418.2004.00847.x; Lima AC, 1947, SER DIDAT ESC NAC AG, V3, P327; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Majerus M. E. N, 1994, LADYBIRDS; McCoy C. W., 1985, Biological control in agricultural IPM systems, P481; Michaud JP, 2004, BIOCONTROL, V49, P417, DOI 10.1023/B:BICO.0000034605.53030.db; Michaud JP, 2004, BIOL CONTROL, V29, P260, DOI 10.1016/S1049-9644(03)00161-0; Monzo C, 2015, ACTA HORTIC, V1065, P1137; Qureshi JA, 2007, PROC FL STATE HORTIC, V120, P110; Qureshi JA, 2011, ENVIRON ENTOMOL, V40, P1503, DOI 10.1603/EN11171; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Texeira DC, 2005, PLANT DIS, V89, P107, DOI 10.1094/PD-89-0107A; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Wyss E, 1999, ENTOMOL EXP APPL, V90, P167, DOI 10.1023/A:1003564714363; Zahoor M. Kashif, 2003, International Journal of Agriculture and Biology, V5, P555	30	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2016	11	9							e0162843	10.1371/journal.pone.0162843	http://dx.doi.org/10.1371/journal.pone.0162843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5SJ	27631730	Green Published, gold, Green Submitted			2022-12-26	WOS:000383706900083
J	Deschodt-Arsac, V; Arsac, L; Magat, J; Naulin, J; Quesson, B; Dos Santos, P				Deschodt-Arsac, Veronique; Arsac, Laurent; Magat, Julie; Naulin, Jerome; Quesson, Bruno; Dos Santos, Pierre			Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo P-31-MR Spectroscopy Follow-Up Study	PLOS ONE			English	Article							CARDIAC-FUNCTION; DILATED CARDIOMYOPATHY; HYPERTROPHIED HEARTS; VENTRICULAR MYOCYTES; PHOSPHATE-METABOLISM; RESPIRATORY CONTROL; OXYGEN-CONSUMPTION; BEATING HEART; FAILING HEART; ENERGETICS	Introduction Gradual alterations in cardiac energy balance, as assessed by the myocardial PCr/ATP-ratio, are frequently associated with the development of cardiac disease. Despite great interest for the follow-up of myocardial PCr and ATP content, cardiac MR-spectroscopy in rat models in vivo is challenged by sensitivity issues and cross-contamination from other organs. Methods Here we combined MR-Imaging and MR-Spectroscopy (Bruker BioSpec 9.4T) to follow-up for the first time in vivo the cardiac energy balance in the SHR, a genetic rat model of cardiac hypertrophy known to develop early disturbances in cytosolic calcium dynamics. Results We obtained consistent P-31-spectra with high signal/noise ratio from the left ventricle in vivo by using a double-tuned (P-31/H-1) surface coil. Reasonable acquisition time (< 3.2min) allowed assessing the PCr/ATP-ratio comparatively in SHR and age-matched control rats (WKY): i) weekly from 12 to 21 weeks of age; ii) in response to a bolus injection of the beta-adrenoreceptor agonist isoproterenol at age 21 weeks. Discussion Along weeks, the cardiac PCr/ATP-ratio was highly reproducible, steady and similar (2.35 +/- 0.06) in SHR and WKY, in spite of detectable ventricular hypertrophy in SHR. At the age 21 weeks, PCr/ATP dropped more markedly (-17.1%+/- 0.8% vs. -3,5%+/- 1.4%, P< 0.001) after isoproterenol injection in SHR and recovered slowly thereafter (time constant 21.2min vs. 6.6min, P< 0.05) despite similar profiles of tachycardia among rats. Conclusion The exacerbated PCr/ATP drop under beta-adrenergic stimulation indicates a defect in cardiac energy regulation possibly due to calcium-mediated abnormalities in the SHR heart. Of note, defects in energy regulation were present before detectable abnormalities in cardiac energy balance at rest.	[Deschodt-Arsac, Veronique; Arsac, Laurent; Magat, Julie; Naulin, Jerome; Quesson, Bruno; Dos Santos, Pierre] Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Pessac, France; [Deschodt-Arsac, Veronique; Arsac, Laurent; Magat, Julie; Naulin, Jerome; Quesson, Bruno; Dos Santos, Pierre] Univ Bordeaux, Inserm CRCTB U1045, Bordeaux, France; [Dos Santos, Pierre] CHU Bordeaux, Hop Cardiol Haut Leveque, Pessac, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Deschodt-Arsac, V (corresponding author), Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Pessac, France.; Deschodt-Arsac, V (corresponding author), Univ Bordeaux, Inserm CRCTB U1045, Bordeaux, France.	veronique.arsac@u-bordeaux.fr	NAULIN, Jérôme/AAP-4488-2021; Magat, Julie/ABC-5523-2021	NAULIN, Jérôme/0000-0002-9402-4200; Deschodt-Arsac, Veronique/0000-0002-9244-9862; quesson, bruno/0000-0001-6434-3684; Dos Santos, Pierre/0000-0002-0811-3099; Magat, Julie/0000-0002-0967-9625	ANR "Investissement d'Avenir" [ANR-10-IAHU-04]; "Investissement d'Avenir" Grant from French Government through Agence Nationale de la Recherche [ANR-10-IAHU-04]	ANR "Investissement d'Avenir"(French National Research Agency (ANR)); "Investissement d'Avenir" Grant from French Government through Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by ANR "Investissement d'Avenir": ANR-10-IAHU-04. The Liryc creation was supported by the "Investissement d'Avenir" Grant, ANR-10-IAHU-04 from the French Government through the Agence Nationale de la Recherche.	Atlante A, 2011, MECH AGEING DEV, V132, P488, DOI 10.1016/j.mad.2011.07.009; Bashir A, 2014, NMR BIOMED, V27, P663, DOI 10.1002/nbm.3103; Bollano E, 2007, INT J CARDIOL, V114, P195, DOI 10.1016/j.ijcard.2006.01.027; Chen-Izu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3301, DOI 10.1152/ajpheart.00259.2007; Cui WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135000; DAS AM, 1990, AM J PHYSIOL, V259, pH1264, DOI 10.1152/ajpheart.1990.259.4.H1264; De Sousa E, 1999, CIRC RES, V85, P68; Deschodt-Arsac V, 2013, INT J BIOCHEM CELL B, V45, P4, DOI 10.1016/j.biocel.2012.07.007; Diolez P, 2007, AM J PHYSIOL-REG I, V293, pR13, DOI 10.1152/ajpregu.00189.2006; Diolez Philippe, 2015, Methods Mol Biol, V1264, P289, DOI 10.1007/978-1-4939-2257-4_26; Dupont S, 2012, AM J PHYSIOL-HEART C, V302, pH1524, DOI 10.1152/ajpheart.00955.2010; Endoh M, 2006, J PHARMACOL SCI, V100, P525, DOI 10.1254/jphs.CPJ06009X; Frey N, 2012, NAT REV CARDIOL, V9, P91, DOI 10.1038/nrcardio.2011.159; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Gupta A, 2009, AM J PHYSIOL-HEART C, V297, pH59, DOI 10.1152/ajpheart.00178.2009; Holloway CJ, 2012, HEART, V98, P1083, DOI 10.1136/heartjnl-2012-302145; Houser SR, 2000, TRENDS CARDIOVAS MED, V10, P101, DOI 10.1016/S1050-1738(00)00057-8; Iemitsu M, 2008, AM J PHYSIOL-HEART C, V295, pH136, DOI 10.1152/ajpheart.01417.2006; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; INGWALL JS, 1985, NEW ENGL J MED, V313, P1050, DOI 10.1056/NEJM198510243131704; Jang A, 2016, MAGN RESON MED, V75, P1859, DOI 10.1002/mrm.26162; KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265; Korzeniewski B, 2008, BIOCHEM J, V413, P343, DOI 10.1042/BJ20080162; Kushmerick MJ, 2002, BIOCHEM SOC T, V30, P227, DOI 10.1042/bst0300227; Maslov MY, 2007, AM J PHYSIOL-HEART C, V292, pH387, DOI 10.1152/ajpheart.00737.2006; Nahrendorf M, 2003, AM J PHYSIOL-HEART C, V285, pH2712, DOI 10.1152/ajpheart.00233.2003; Naumova AV, 2003, AM J PHYSIOL-HEART C, V285, pH1976, DOI 10.1152/ajpheart.00474.2003; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 1999, J MOL CELL CARDIOL, V31, P1845, DOI 10.1006/jmcc.1999.1016; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; ORDIDGE RJ, 1988, MAGNET RESON MED, V8, P323, DOI 10.1002/mrm.1910080309; Perings SM, 2000, HEART VESSELS, V15, P197, DOI 10.1007/PL00007270; Portman MA, 2000, CIRCULATION, V102, P1323, DOI 10.1161/01.CIR.102.11.1323; Portman MA, 1997, AM J PHYSIOL-HEART C, V273, pH1977; SHIMAMOTO N, 1982, BASIC RES CARDIOL, V77, P359, DOI 10.1007/BF02005337; Vendelin M, 2010, J BIOL CHEM, V285, P37240, DOI 10.1074/jbc.M110.147116; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Whalen EJ, 1999, EUR J PHARMACOL, V382, P207, DOI 10.1016/S0014-2999(99)00631-7; WU ST, 1992, CELL CALCIUM, V13, P235, DOI 10.1016/0143-4160(92)90012-H; Xiong QA, 2011, CIRC RES, V108, P653, DOI 10.1161/CIRCRESAHA.110.231456	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162677	10.1371/journal.pone.0162677	http://dx.doi.org/10.1371/journal.pone.0162677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622548	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000045
J	Kim, DH; Hong, YK; Jeun, SS; Park, JS; Jung, KH; Kim, SW; Cho, JH; Park, YJ; Kang, YJ; Kim, SW				Kim, Do Hyun; Hong, Yong-Kil; Jeun, Sin-Soo; Park, Jae-Sung; Jung, Ki Hwan; Kim, Soo Whan; Cho, Jin Hee; Park, Yong Jin; Kang, Yun Jin; Kim, Sung Won			Invagination of the Sphenoid Sinus Mucosa after Endoscopic Endonasal Transsphenoidal Approach and Its Significance	PLOS ONE			English	Article							CEREBROSPINAL-FLUID LEAKS; PITUITARY MACROADENOMAS; GRADED REPAIR; RECONSTRUCTION; SURGERY; IMPLANTS; CLOSURE; SELLAR; FLAPS; PLATE	Objective To describe the clinical features of invagination of the sphenoid sinus mucosa (ISM) and compare them with other similar cases using a visual analog scale (VAS) to assess the various nasal symptoms and to discuss its clinical significance and means of prevention. Study Design Retrospective chart review at a tertiary referral center. Methods Between 2010 and 2015, 8 patients who had undergone EETSA surgery displayed postoperative ISM. The comparison group consisted of 147 patients who underwent the same surgical procedures and were diagnosed with the same diseases. Pre- or postoperative paranasal sinus computed tomography (PNS CT) and VAS were performed and subsequently analyzed. Results The clinical features of ISM of the sphenoid sinus showed sellar floor invagination and regenerated inverted ingrowing sphenoid mucosa on endoscopic imaging. PNS CT also showed a bony defect and invaginated air densities at the sellar turcica. Pre- and postoperative VAS scores revealed that the ISM group had much less of an improvement in headaches after surgery than that of the comparison group (p = 0.049). Conclusion ISM may occur because of a change in pressure, sphenoid mucosal status, or arachnoid membrane status. Moreover, ISM is related to improvements in headaches. Therefore, EETSA patients should avoid activities that cause rapid pressure changes during the healing process. In addition, sellar reconstruction that is resistant to physical pressure changes should be mandated despite the absence of an intraoperative CSF leak.	[Kim, Do Hyun; Jung, Ki Hwan; Kim, Soo Whan; Cho, Jin Hee; Park, Yong Jin; Kang, Yun Jin; Kim, Sung Won] Catholic Univ Korea, Seoul St Marys Hosp, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Hong, Yong-Kil; Jeun, Sin-Soo; Park, Jae-Sung] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Neurosurg, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, SW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	kswent@catholic.ac.kr	Kim, Do Hyun/AAA-2792-2021	Kim, Do Hyun/0000-0002-9248-5572; Park, Jae-Sung/0000-0002-9827-9913	National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT, and Future Planning [2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT, and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT, and Future Planning (No. 2014R1A2A2A01004325) and the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare (HI14C3228). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2016, NEUROSURG REV, V39, P123, DOI 10.1007/s10143-015-0667-6; Arita K, 1999, J NEUROSURG, V91, P1055, DOI 10.3171/jns.1999.91.6.1055; Chen X, 2011, AM J NEURORADIOL, V32, P785, DOI 10.3174/ajnr.A2364; Couldwell William T, 2006, Neurosurg Focus, V20, pE11, DOI 10.3171/foc.2006.20.3.12; Esposito F, 2007, NEUROSURGERY, V60, P295, DOI 10.1227/01.NEU.0000255354.64077.66; FREIDBERG SR, 1994, NEUROSURGERY, V35, P159, DOI 10.1227/00006123-199407000-00027; Balanzar GG, 2011, WORLD NEUROSURG, V75, P286, DOI 10.1016/j.wneu.2010.08.002; Kabuto M, 1998, J NEUROSURG, V88, P949, DOI 10.3171/jns.1998.88.6.0949; Kaptain GJ, 2001, NEUROSURGERY, V48, P232, DOI 10.1097/00006123-200101000-00048; Kelly DF, 2001, NEUROSURGERY, V49, P885, DOI 10.1097/00006123-200110000-00020; Kim BY, 2013, LARYNGOSCOPE, V123, P2605, DOI 10.1002/lary.24098; Kim do H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151531; KOBAYASHI S, 1987, NEUROSURGERY, V21, P751, DOI 10.1227/00006123-198711000-00032; Locatelli D, 2009, ACTA NEUROCHIR, V151, P1431, DOI 10.1007/s00701-009-0428-9; Mak HKF, 2015, PITUITARY, V18, P509, DOI 10.1007/s11102-014-0603-8; Park JH, 2015, J KOREAN NEUROSURG S, V58, P36, DOI 10.3340/jkns.2015.58.1.36; SPAZIANTE R, 1989, J NEUROSURG, V71, P864, DOI 10.3171/jns.1989.71.6.0864; Stadlbauer A, 2008, J NEUROSURG, V109, P306, DOI 10.3171/JNS/2008/109/8/0306; Yoon TM, 2008, ACTA OTO-LARYNGOL, V128, P785, DOI 10.1080/00016480701730752; Yu B, 2017, CEPHALALGIA, V37, P348, DOI 10.1177/0333102416648347	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162836	10.1371/journal.pone.0162836	http://dx.doi.org/10.1371/journal.pone.0162836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622454	Green Published, gold, Green Submitted			2022-12-26	WOS:000383681000062
J	Lu, Y; Wang, AH; Shi, P; Zhang, H; Li, ZS				Lu, Yang; Wang, Aihua; Shi, Peng; Zhang, Hui; Li, ZeSheng			Kinetic Reaction Mechanism of Sinapic Acid Scavenging NO2 and OH Radicals: A Theoretical Study	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; CHEMICAL-REACTION RATES; ANTIOXIDANT ACTIVITY; NITROGEN-DIOXIDE; FERULIC ACID; PHENOLIC-COMPOUNDS; RATE CONSTANTS; CAFFEIC ACID; GALLIC ACID; DERIVATIVES	The mechanism and kinetics underlying reactions between the naturally-occurring antioxidant sinapic acid (SA) and the very damaging center dot NO2 and center dot OH were investigated through the density functional theory (DFT). Two most possible reaction mechanisms were studied: hydrogen atom transfer (HAT) and radical adduct formation (RAF). Different reaction channels of neutral and anionic sinapic acid (SA-) scavenging radicals in both atmosphere and water medium were traced independently, and the thermodynamic and kinetic parameters were calculated. We find the most active site of SA/SA-scavenging center dot NO2 and center dot OH is the -OH group in benzene ring by HAT mechanism, while the RAF mechanism for SA/SA-scavenging center dot NO2 seems thermodynamically unfavorable. In water phase, at 298 K, the total rate constants of SA eliminating center dot NO2 and center dot OH are 1.30x108 and 9.20x109 M-1 S-1 respectively, indicating that sinapic acid is an efficient scavenger for both center dot NO2 and center dot OH.	[Lu, Yang; Wang, Aihua; Shi, Peng] Harbin Univ Sci & Technol, Coll Mat Sci & Engn, Harbin, Peoples R China; [Zhang, Hui] Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Key Lab Cluster Sci, Minist Educ, Beijing, Peoples R China; [Li, ZeSheng] Beijing Inst Technol, Sch Chem, Beijing, Peoples R China	Harbin University of Science & Technology; Harbin University of Science & Technology; Beijing Institute of Technology; Beijing Institute of Technology	Zhang, H (corresponding author), Harbin Univ Sci & Technol, Coll Chem & Environm Engn, Harbin, Peoples R China.	hust_zhanghui11@hotmail.com						Agnihotri N, 2011, J PHYS CHEM A, V115, P14221, DOI 10.1021/jp209318f; Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758; Ardura D, 2005, J PHYS CHEM B, V109, P23618, DOI 10.1021/jp0540499; ARUOMA OI, 1993, J AGR FOOD CHEM, V41, P1880, DOI 10.1021/jf00035a014; Bakalbassis EG, 2001, LIPIDS, V36, P181, DOI 10.1007/s11745-001-0705-9; Black G, 2010, J COMPUT CHEM, V31, P1236, DOI 10.1002/jcc.21410; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Chen WJ, 2006, BIOORG MED CHEM LETT, V16, P3582, DOI 10.1016/j.bmcl.2006.03.091; Chen YZ, 2015, EURASIP J WIREL COMM, DOI 10.1186/s13638-015-0327-0; Cheng JC, 2007, FOOD CHEM, V104, P132, DOI 10.1016/j.foodchem.2006.11.012; CHISOLM GM, 1991, CLIN CARDIOL, V14, P25, DOI 10.1002/clc.4960141304; Chuang YY, 1998, INT J QUANTUM CHEM, V70, P887, DOI 10.1002/(SICI)1097-461X(1998)70:4/5<887::AID-QUA34>3.0.CO;2-W; Corchado J.C., 2007, POLYRATE VERSION 9 7; CSALLANY AS, 1978, ARCH ENVIRON HEALTH, V33, P285, DOI 10.1080/00039896.1978.10667349; CUVELIER ME, 1992, BIOSCI BIOTECH BIOCH, V56, P324, DOI 10.1271/bbb.56.324; Di Meo F, 2013, J PHYS CHEM A, V117, P2082, DOI 10.1021/jp3116319; Draganic I, 1971, RAD CHEM WATER; Filipovic M, 2015, CR CHIM, V18, P492, DOI 10.1016/j.crci.2014.09.001; FORNI LG, 1986, J CHEM SOC PERK T 2, P1, DOI 10.1039/p29860000001; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Furuncuoglu T, 2010, MACROMOLECULES, V43, P1823, DOI 10.1021/ma902803p; Galano A, 2013, J COMPUT CHEM, V34, P2430, DOI 10.1002/jcc.23409; Galano A, 2011, PHYS CHEM CHEM PHYS, V13, P11199, DOI 10.1039/c1cp20722a; Galano A, 2009, ORG LETT, V11, P5114, DOI 10.1021/ol901862h; Gao JY, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1108-z; GARRETT BC, 1980, J PHYS CHEM-US, V84, P805, DOI 10.1021/j100444a020; Garzon A, 2014, J AGR FOOD CHEM, V62, P9705, DOI 10.1021/jf5011148; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; HERRMANN K, 1989, CRIT REV FOOD SCI, V28, P315, DOI 10.1080/10408398909527504; Kono Y, 1997, BBA-GEN SUBJECTS, V1335, P335, DOI 10.1016/S0304-4165(96)00151-1; Leopoldini M, 2004, J PHYS CHEM A, V108, P92, DOI 10.1021/jp035901j; Leopoldini M, 2011, J CHEM THEORY COMPUT, V7, P4218, DOI 10.1021/ct200572p; LU DH, 1992, COMPUT PHYS COMMUN, V71, P235, DOI 10.1016/0010-4655(92)90012-N; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Marino T, 2014, J PHYS CHEM B, V118, P10380, DOI 10.1021/jp505589b; Mohajeri A, 2009, J MOL STRUCT, V930, P15, DOI 10.1016/j.molstruc.2009.04.031; Nenadis N, 2012, FOOD RES INT, V48, P538, DOI 10.1016/j.foodres.2012.05.014; Niwa T, 1999, FEBS LETT, V459, P43, DOI 10.1016/S0014-5793(99)01216-8; Okuno Y, 1997, CHEM-EUR J, V3, P212, DOI 10.1002/chem.19970030208; Perez-Gonzalez A, 2011, J PHYS CHEM B, V115, P1306, DOI 10.1021/jp110400t; PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5; PRYOR WA, 1981, SCIENCE, V214, P435, DOI 10.1126/science.214.4519.435; PRYOR WA, 1982, J AM CHEM SOC, V104, P6685, DOI 10.1021/ja00388a035; RiceEvans CA, 1997, TRENDS PLANT SCI, V2, P152, DOI 10.1016/S1360-1385(97)01018-2; Saqib M, 2016, INT J FOOD PROP, V19, P745, DOI 10.1080/10942912.2015.1042588; Saqib M, 2013, PAK J PHARM SCI, V26, P1209; SCOTT BC, 1993, FREE RADICAL RES COM, V19, P241, DOI 10.3109/10715769309056512; Silva FAM, 2000, J AGR FOOD CHEM, V48, P2122, DOI 10.1021/jf9913110; Smyk B, 2003, J FLUORESC, V13, P349, DOI 10.1023/A:1025334029406; SMYK B, 1989, ANALYST, V114, P723, DOI 10.1039/an9891400723; STREET DA, 1994, CIRCULATION, V90, P1154, DOI 10.1161/01.CIR.90.3.1154; Thiyam U, 2006, EUR J LIPID SCI TECH, V108, P239, DOI 10.1002/ejlt.200500292; Urbaniak A, 2012, CMST, V18, P1; Urbaniak A., 2012, COMPUT METHODS SCI T, V18, P117, DOI [DOI 10.12921/CMST.2012.18.02.117-128, 10.12921/cmst.2012.18.02.117-128]; Urbaniak A, 2013, COMPUT THEOR CHEM, V1012, P33, DOI 10.1016/j.comptc.2013.02.018; Valentao P, 2001, J AGR FOOD CHEM, V49, P3476, DOI 10.1021/jf001145s; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vallet V, 2001, J AM CHEM SOC, V123, P11999, DOI 10.1021/ja015935+; vanAcker SABE, 1996, CHEM RES TOXICOL, V9, P1305, DOI 10.1021/tx9600964; Vega-Rodriguez A, 2009, PHYS CHEM CHEM PHYS, V11, P7649, DOI 10.1039/b906692f; Velez E, 2009, J PHYS ORG CHEM, V22, P971, DOI 10.1002/poc.1547; WANG WF, 1993, RADIAT PHYS CHEM, V42, P985, DOI 10.1016/0969-806X(93)90417-S; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Wright JS, 2001, J AM CHEM SOC, V123, P1173, DOI 10.1021/ja002455u; Yoon BH, 2007, LIFE SCI, V81, P234, DOI 10.1016/j.lfs.2007.05.007; Yun KJ, 2008, J AGR FOOD CHEM, V56, P10265, DOI 10.1021/jf802095g; Zavala-Oseguera C, 2009, J PHYS CHEM A, V113, P13913, DOI 10.1021/jp906144d; Zhang ZE, 1998, FREE RADICAL RES, V29, P13, DOI 10.1080/10715769800300021; Zhao Y, 2006, J CHEM THEORY COMPUT, V2, P364, DOI 10.1021/ct0502763; Zhao Y, 2008, J PHYS CHEM A, V112, P1095, DOI 10.1021/jp7109127; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n; Zou YN, 2002, J AGR FOOD CHEM, V50, P5884, DOI 10.1021/jf020496z	72	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162729	10.1371/journal.pone.0162729	http://dx.doi.org/10.1371/journal.pone.0162729			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622460	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000052
J	Thompson, S; Avent, T; Doughty, LS				Thompson, S.; Avent, T.; Doughty, L. S.			Range Analysis and Terrain Preference of Adult Southern White Rhinoceros (Ceratotherium simum) in a South African Private Game Reserve: Insights into Carrying Capacity and Future Management	PLOS ONE			English	Article							HOME-RANGE; MEGA-GRAZER; PATTERNS; FOOD; TERRITORIALITY; SELECTION; SIZE	The Southern white rhinoceros (Ceratotherium simum) is a threatened species, central to the tourism appeal of private game reserves in South Africa. Privately owned reserves in South Africa tend to be smaller than government run reserves such as Kruger National Park. Because of their relatively small size and the often heterogeneous nature of the landscape private game reserve managers benefit from detailed knowledge of white rhinoceros terrain selection preferences, which can be assessed from their ranging behaviours. We collected adult and sub-adult white rhinoceros distribution data over a 15 month period, calculating individual range size using kernel density estimation analysis within a GIS. From this, terrain selectivity was calculated using 50% and 95% kernels to extract terrain composition values. Jacob's correction of the Ivlev's selectivity index was subsequently applied to the terrain composition of each individual to identify trends in selectivity. Results reveal that adult males hold exclusive territories considerably smaller than those found in previous work conducted in "open" or large reserves. Similarly, results for the size of male versus female territories were also not in keeping with those from previous field studies, with males, rather than females, having the larger territory requirement. Terrain selection for both genders and age classes (adult and sub-adult) showed a strong preference for open grassland and avoidance of hill slope and riparian terrains. This research reveals white rhinoceros terrain selection preferences and how they influence range requirements in small, closed reserves. We conclude that this knowledge will be valuable in future white rhinoceros conservation management in small private game reserves, particularly in decisions surrounding removal of surplus individuals or augmentation of existing populations, calculation of reserve carrying capacity and future private reserve acquisition.	[Thompson, S.; Avent, T.; Doughty, L. S.] Oxford Brookes Univ, Spatial Ecol & Landuse Unit, Gipsy Lane, Oxford OX3 0BP, England; [Avent, T.] WWT, Conservat & Dev, Slimbridge, Glos, England	Oxford Brookes University	Thompson, S (corresponding author), Oxford Brookes Univ, Spatial Ecol & Landuse Unit, Gipsy Lane, Oxford OX3 0BP, England.	sthompson@brookes.ac.uk			Operation Wallacea & WEI: Provision of students; Welgevonden Game Reserve; Operation Wallacea	Operation Wallacea & WEI: Provision of students; Welgevonden Game Reserve; Operation Wallacea	This work was supported by Operation Wallacea & WEI: Provision of students to collect data.; We would like to thank the lodge owners of Welgevonden Game Reserve for access to their properties and for their support for this project. We are indebted to the conservation management staff of the reserve in general and Gerhardt Lorist in particular, for provision of on the ground knowledge of individual rhino identification and distribution. This study was supported by Operation Wallacea. We would like to thank their volunteers who assisted in the field.	Acocks J. P. H., 1988, VELD TYPES S AFRICA; Bro-Jorgensen J, 2008, ANIM BEHAV, V75, P1229, DOI 10.1016/j.anbehav.2007.06.010; Callaghan CC, 1993, GEOLOGY WATERBERG GR; Chytry M, 2008, VEGETATION S AFRICA; CONWAY AJ, 1989, BIOL CONSERV, V47, P109, DOI 10.1016/0006-3207(89)90094-3; Emslie RH, 1995, FINE TUNING RHINO MA; Environmental Systems Research Institute, 2011, ESRI ARCGIS DESKT RE; FRITZ H, 1994, P ROY SOC B-BIOL SCI, V256, P77, DOI 10.1098/rspb.1994.0052; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Hitchins PM, 1970, LAMMERGEYER, V12, P48; Hopcraft JGC, 2012, J ANIM ECOL, V81, P201, DOI 10.1111/j.1365-2656.2011.01885.x; Horne JS, 2008, ECOL MODEL, V214, P338, DOI 10.1016/j.ecolmodel.2008.02.042; IVIEV VS, 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Kettles R, 2009, S AFR J WILDL RES, V39, P23, DOI 10.3957/056.039.0103; Knight M, 2013, PACHYDERM, P7; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; McLeod SR, 1997, OIKOS, V79, P529, DOI 10.2307/3546897; MURRAY MG, 1982, AFR J ECOL, V20, P253, DOI 10.1111/j.1365-2028.1982.tb00301.x; Mysterud A, 2006, WILDLIFE BIOL, V12, P129, DOI 10.2981/0909-6396(2006)12[129:TCOOAI]2.0.CO;2; Oudtshoorn FV, 2002, GUIDE GRASSES SO AFR; OWEN-SMITH R N, 1975, Zeitschrift fuer Tierpsychologie, V38, P337; Owen-Smith R.N., 1973, THESIS; OWENSMIT.N, 1971, NATURE, V231, P294, DOI 10.1038/231294a0; Perrin MR, 1999, S AFR J WILDL RES, V29, P72; Pienaar D. J., 1993, Koedoe, V36, P79; Pienaar D. J., 1992, Koedoe, V35, P1; PIENAAR DJ, 1993, J ZOOL, V229, P641, DOI 10.1111/j.1469-7998.1993.tb02661.x; Pienaar DJ, 1994, P S RHIN GAM RANCH A; Rachlow JL, 1999, AFR J ECOL, V37, P295, DOI 10.1046/j.1365-2028.1999.00175.x; Save the Rhino, 2016, POACH STAT; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Sims-Castley R., 2005, PARKS, V15, P6; Slater K, 2012, OPERATION WALLACEA W; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Timko JA, 2009, BIOL CONSERV, V142, P676, DOI 10.1016/j.biocon.2008.11.022; Trollope W. S. W., 1998, Koedoe, V41, P103; US Geological Survey, 2016, LAND PROC DISTR ACT; van Aarde RJ, 2006, S AFR J SCI, V102, P385; Waldram MS, 2008, ECOSYSTEMS, V11, P101, DOI 10.1007/s10021-007-9109-9; Wallgren M, 2009, AFR J ECOL, V47, P20, DOI 10.1111/j.1365-2028.2007.00904.x; White AM, 2007, ANIM BEHAV, V74, P349, DOI 10.1016/j.anbehav.2006.12.011; Wronski T, 2006, BEHAV ECOL SOCIOBIOL, V59, P819, DOI 10.1007/s00265-005-0128-2	44	7	7	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0161724	10.1371/journal.pone.0161724	http://dx.doi.org/10.1371/journal.pone.0161724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622566	Green Published, Green Submitted, gold			2022-12-26	WOS:000383681000007
J	Yao, KZ; Wu, YY; Chen, Q; Zhang, ZH; Chen, X; Zhang, Y				Yao, Kezhen; Wu, Yongyan; Chen, Qi; Zhang, Zihan; Chen, Xin; Zhang, Yong			The Arginine/Lysine-Rich Element within the DNA-Binding Domain Is Essential for Nuclear Localization and Function of the Intracellular Pathogen Resistance 1	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; REGULATOR PROTEIN; TUBERCULOSIS; SP110; GENE; TRANSCRIPTION; SIGNALS; IMPORT; SUSCEPTIBILITY; IDENTIFICATION	The mouse intracellular pathogen resistance 1 (Ipr1) gene plays important roles in mediating host immunity and previous work showed that it enhances macrophage apoptosis upon mycobacterium infection. However, to date, little is known about the regulation pattern of Ipr1 action. Recent studies have investigated the protein-coding genes and microRNAs regulated by Ipr1 in mouse macrophages, but the structure and the functional motif of the Ipr1 protein have yet to be explored. In this study, we analyzed the domains and functional motif of the Ipr1 protein. The resulting data reveal that Ipr1 protein forms a homodimer and that the Sp100-like domain mediates the targeting of Ipr1 protein to nuclear dots (NDs). Moreover, we found that an Ipr1mutant lacking the classic nuclear localization signal (cNLS) also translocated into the nuclei, suggesting that the cNLS is not the only factor that directs Ipr1 nuclear localization. Additionally, mechanistic studies revealed that an arginine/lysinerich element within the DNA-binding domain (SAND domain) is critical for Ipr1 binding to the importin protein receptor NPI-1, demonstrating that this element plays an essential role in mediating the nuclear localization of Ipr1 protein. Furthermore, our results show that this arginine/lysine-rich element contributes to the transcriptional regulation and apoptotic activity of Ipr1. These findings highlight the structural foundations of Ipr1 action and provide new insights into the mechanism of Ipr1-mediated resistance to mycobacterium.	[Yao, Kezhen; Wu, Yongyan; Chen, Qi; Zhang, Zihan; Chen, Xin; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yao, Kezhen; Wu, Yongyan; Chen, Qi; Zhang, Zihan; Chen, Xin; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.; Zhang, Y (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China.	yongzhlab@hotmail.com	chen, xiner/GVU-3933-2022; Wu, Yongyan/AAH-1471-2019	Wu, Yongyan/0000-0003-1669-3860	National Natural Science Foundation of China [31530075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 31530075).	Abhimanyu, 2011, HUM IMMUNOL, V72, P576, DOI 10.1016/j.humimm.2011.03.014; Banerjee RR, 2001, J BIOL CHEM, V276, P25970, DOI 10.1074/jbc.M103109200; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Cai L, 2013, HUM GENET, V132, P265, DOI 10.1007/s00439-012-1244-5; Cai L, 2010, MOL BIOL REP, V37, P3863, DOI 10.1007/s11033-010-0042-1; Christensen J, 1999, MOL CELL BIOL, V19, P7741; de la Fuente J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-110; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Fox GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099496; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; He XN, 2011, SCAND J IMMUNOL, V74, P438, DOI 10.1111/j.1365-3083.2011.02596.x; Huggenvik JI, 1998, MOL ENDOCRINOL, V12, P1619, DOI 10.1210/me.12.10.1619; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647; Leszczyniecka M, 2004, MOL PHYLOGENET EVOL, V31, P123, DOI 10.1016/j.ympev.2003.07.012; Li LZ, 2016, MOL GENET GENOMICS; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Melen K, 2001, J BIOL CHEM, V276, P16447, DOI 10.1074/jbc.M008821200; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nicewonger J, 2004, J VIROL, V78, P9412, DOI 10.1128/JVI.78.17.9412-9422.2004; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ruiz-Larranaga O, 2010, J DAIRY SCI, V93, P5950, DOI 10.3168/jds.2010-3340; Saito T, 2004, BIOCHEM BIOPH RES CO, V317, P335, DOI 10.1016/j.bbrc.2004.03.056; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Sekimoto T, 1997, EMBO J, V16, P7067, DOI 10.1093/emboj/16.23.7067; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Wu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22041	35	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2016	11	9							e0162832	10.1371/journal.pone.0162832	http://dx.doi.org/10.1371/journal.pone.0162832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5JR	27622275	Green Submitted, Green Published, gold			2022-12-26	WOS:000383681000061
J	Bosseler, AN; Teinonen, T; Tervaniemi, M; Huotilainen, M				Bosseler, Alexis N.; Teinonen, Tuomas; Tervaniemi, Mari; Huotilainen, Minna			Infant Directed Speech Enhances Statistical Learning in Newborn Infants: An ERP Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; AUDITORY-EVOKED POTENTIALS; MISMATCH NEGATIVITY; CEREBRAL SPECIALIZATION; LANGUAGE EXPERIENCE; 9-MONTH-OLD INFANTS; BRAIN POTENTIALS; NATIVE-LANGUAGE; VISUAL-CORTEX; SEGMENTATION	Statistical learning and the social contexts of language addressed to infants are hypothesized to play important roles in early language development. Previous behavioral work has found that the exaggerated prosodic contours of infant-directed speech (IDS) facilitate statistical learning in 8-month-old infants. Here we examined the neural processes involved in on-line statistical learning and investigated whether the use of IDS facilitates statistical learning in sleeping newborns. Event-related potentials (ERPs) were recorded while newborns were exposed to 12 pseudo-words, six spoken with exaggerated pitch contours of IDS and six spoken without exaggerated pitch contours (ADS) in ten alternating blocks. We examined whether ERP amplitudes for syllable position within a pseudo-word (word-initial vs. word-medial vs. word-final, indicating statistical word learning) and speech register (ADS vs. IDS) would interact. The ADS and IDS registers elicited similar ERP patterns for syllable position in an early 0-100 ms component but elicited different ERP effects in both the polarity and topographical distribution at 200-400 ms and 450-650 ms. These results provide the first evidence that the exaggerated pitch contours of IDS result in differences in brain activity linked to on-line statistical learning in sleeping newborns.	[Bosseler, Alexis N.; Teinonen, Tuomas; Tervaniemi, Mari; Huotilainen, Minna] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Bosseler, Alexis N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Tervaniemi, Mari; Huotilainen, Minna] Univ Helsinki, Cicero Learning, Helsinki, Finland	University of Helsinki; University of Washington; University of Washington Seattle; University of Helsinki	Bosseler, AN (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland.; Bosseler, AN (corresponding author), Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA.	bosseler@u.washington.edu		Tervaniemi, Mari/0000-0002-9651-2929; Huotilainen, Minna/0000-0002-7251-6984	Erasmus Mundus Mobility Auditory Cognitive Neuroscience; Academy of Finland	Erasmus Mundus Mobility Auditory Cognitive Neuroscience; Academy of Finland(Academy of Finland)	This work was supported by Erasmus Mundus Mobility Auditory Cognitive Neuroscience, http://research.uni-leipzig.de/acn/ (ANB); and Academy of Finland, http://www.aka.fi/en/ (ANB).	Abla D, 2008, J COGNITIVE NEUROSCI, V20, P952, DOI 10.1162/jocn.2008.20058; ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Baldeweg T, 2006, TRENDS COGN SCI, V10, P93, DOI 10.1016/j.tics.2006.01.010; Best CC, 2003, LANG SPEECH, V46, P183, DOI 10.1177/00238309030460020701; Boersma P, PRAAT DONING PHONETI; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Bosseler AN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00690; Callan DE, 2004, NEUROIMAGE, V22, P1182, DOI 10.1016/j.neuroimage.2004.03.006; CHEOURLUHTANEN M, 1995, HEARING RES, V82, P53, DOI 10.1016/0378-5955(94)00164-L; Conboy BT, 2006, DEVELOPMENTAL SCI, V9, pF1, DOI 10.1111/j.1467-7687.2005.00453.x; Cunillera T, 2006, BRAIN RES, V1123, P168, DOI 10.1016/j.brainres.2006.09.046; Cunillera T, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-23; de Gardelle V, 2013, CEREB CORTEX, V23, P2235, DOI 10.1093/cercor/bhs211; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; Friederici AD, 2007, CURR BIOL, V17, P1208, DOI 10.1016/j.cub.2007.06.011; Friedrich M, 2009, CORTEX, V45, P662, DOI 10.1016/j.cortex.2008.06.014; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garcia-Sierra A, 2011, J PHON, V39, P456; Golestani N, 2004, NEUROIMAGE, V21, P494, DOI 10.1016/j.neuroimage.2003.09.071; GOODSITT JV, 1993, J CHILD LANG, V20, P229, DOI 10.1017/S0305000900008266; Grimm S, 2007, RESTOR NEUROL NEUROS, V25, P241; Guenther FH, 2004, J SPEECH LANG HEAR R, V47, P46, DOI 10.1044/1092-4388(2004/005); Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hinojosa JA, 2005, NEUROSCI LETT, V378, P34, DOI 10.1016/j.neulet.2004.12.010; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Kooijman V, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00025; Kudo N, 2011, DEVELOPMENTAL SCI, V14, P1100, DOI 10.1111/j.1467-7687.2011.01056.x; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; MASSARO DW, 1983, PERCEPT PSYCHOPHYS, V34, P338, DOI 10.3758/BF03203046; Massaro DW, 1993, PERCEIVING TALKING F; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Maye J, 2008, DEVELOPMENTAL SCI, V11, P122, DOI 10.1111/j.1467-7687.2007.00653.x; Meyer MC, 2009, NAT LANG LINGUIST TH, V27, P139, DOI 10.1007/s11049-008-9060-2; Mills D L, 1997, Semin Pediatr Neurol, V4, P125, DOI 10.1016/S1071-9091(97)80029-0; MILLS DL, 1993, J COGNITIVE NEUROSCI, V5, P317, DOI 10.1162/jocn.1993.5.3.317; Mills DL, 2004, J COGNITIVE NEUROSCI, V16, P1452, DOI 10.1162/0898929042304697; Mills DL, 1997, DEV NEUROPSYCHOL, V13, P397, DOI 10.1080/87565649709540685; Morr ML, 2002, EAR HEARING, V23, P118, DOI 10.1097/00003446-200204000-00005; Muller NG, 2013, CEREB CORTEX, V23, P315, DOI 10.1093/cercor/bhs009; Purdy SC, 2001, AUDIOL NEURO-OTOL, V6, P211, DOI 10.1159/000046835; Reinke KS, 2003, COGNITIVE BRAIN RES, V17, P781, DOI 10.1016/S0926-6410(03)00202-7; Rescorla R.A., 1966, PSYCHON SCI, V4, P383, DOI [10.3758/BF03342350, DOI 10.3758/BF03342350]; Rivera-Gaxiola M, 2005, NEUROREPORT, V16, P495, DOI 10.1097/00001756-200504040-00015; Saffran JR, 2001, COGNITION, V81, P149, DOI 10.1016/S0010-0277(01)00132-9; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2005, DEVELOPMENTAL SCI, V8, P1, DOI 10.1111/j.1467-7687.2005.00387.x; Saffran JR, 2002, J MEM LANG, V47, P172, DOI 10.1006/jmla.2001.2839; Saito Y, 2007, ARCH DIS CHILD-FETAL, V92, pF113, DOI 10.1136/adc.2006.097949; Saito Y, 2007, EARLY HUM DEV, V83, P225, DOI 10.1016/j.earlhumdev.2006.05.017; Sanders LD, 2002, NAT NEUROSCI, V5, P700, DOI 10.1038/nn873; Sanders LD, 2003, COGNITIVE BRAIN RES, V15, P214, DOI 10.1016/S0926-6410(02)00194-5; Santesso DL, 2007, BRAIN COGNITION, V65, P14, DOI 10.1016/j.bandc.2007.02.008; Shafer LV, 2011, J PHONETICS, V39, P527; Shahin A, 2003, J NEUROSCI, V23, P5545; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Teinonen T, 2012, J PSYCHOLINGUIST RES, V41, P71, DOI 10.1007/s10936-011-9182-2; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; Thiessen ED, 2005, INFANCY, V7, P53, DOI 10.1207/s15327078in0701_5; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Tremblay P, 2013, NEUROIMAGE, V66, P318, DOI 10.1016/j.neuroimage.2012.10.055; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Werker JF, 2005, LANG LEARN DEV, V1, P197, DOI 10.1080/15475441.2005.9684216; WERKER JF, 1994, INFANT BEHAV DEV, V17, P323, DOI 10.1016/0163-6383(94)90012-4; Zangl R, 2007, INFANCY, V11, P31, DOI 10.1207/s15327078in1101_2; Zhang Y, 2005, NEUROIMAGE, V26, P703, DOI 10.1016/j.neuroimage.2005.02.040; Zhang Y, 2011, DEVELOPMENTAL SCI, V14, P566, DOI 10.1111/j.1467-7687.2010.01004.x; Zhang Y, 2009, NEUROIMAGE, V46, P226, DOI 10.1016/j.neuroimage.2009.01.028	75	31	33	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162177	10.1371/journal.pone.0162177	http://dx.doi.org/10.1371/journal.pone.0162177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DW5AC	27617967	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100013
J	Grounta, A; Harizanis, P; Mylonakis, E; Nychas, GJE; Panagou, EZ				Grounta, Athena; Harizanis, Paschalis; Mylonakis, Eleftherios; Nychas, George-John E.; Panagou, Efstathios Z.			Investigating the Effect of Different Treatments with Lactic Acid Bacteria on the Fate of Listeria monocytogenes and Staphylococcus aureus Infection in Galleria mellonella Larvae	PLOS ONE			English	Article							IMMUNOGLOBULIN-E PRODUCTION; TABLE OLIVES; LACTOBACILLUS-PLANTARUM; CAENORHABDITIS-ELEGANS; CANDIDA-ALBICANS; IN-VITRO; BIOFILM FORMATION; FERMENTED OLIVES; IMMUNE-RESPONSES; STARTER CULTURES	The use of Galleria mellonella as a model host to elucidate microbial pathogenesis and search for novel drugs and therapies has been well appreciated over the past years. However, the effect of microorganisms with functional appeal in the specific host remains scarce. The present study investigates the effect of treatment with selected lactic acid bacteria (LAB) with probiotic potential, as potential protective agents by using live or heat-killed cells at 6 and 24 h prior to infection with Listeria monocytogenes and Staphylococcus aureus or as potential therapeutic agents by using cell-free supernatants (CFS) after infection with the same pathogens. The employed LAB strains were Lactobacillus pentosus B281 and Lactobacillus plantarum B282 (isolated from table olive fermentations) along with Lactobacillus rhamnosusGG (inhabitant of human intestinal tract). Kaplan-Meier survival curves were plotted while the pathogen's persistence in the larval hemolymph was determined by microbiological analysis. It was observed that the time (6 or 24 h) and type (live or heat-killed cells) of challenge period with LAB prior to infection greatly affected the survival of infected larvae. The highest decrease of L. monocytogenes population in the hemolymph was observed in groups challenged for 6 h with heat-killed cells by an average of 1.8 log units compared to non challenged larvae for strains B281 (p 0.0322), B282 (p 0.0325), and LGG (p 0.0356). In the case of S. aureus infection, the population of the pathogen decreased in the hemolymph by 1 log units at 8 h post infection in the groups challenged for 6 h with heat-killed cells of strains B281 (p 0.0161) and B282 (p 0.0096) and by 1.8 log units in groups challenged with heat-killed cells of LGG strain (p 0.0175). Further use of CFS of each LAB strain did not result in any significant prolonged survival but interestingly it resulted in pronounced decrease of L. monocytogenes in the hemolymph at 24 h and 48 h after infection by more than 1 log unit (p < 0.05) depending on the strain. The results of the present work support the broader use of G. mellonella larvae as a low cost in vivo tool for screening for probiotic properties.	[Grounta, Athena; Nychas, George-John E.; Panagou, Efstathios Z.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Microbiol & Biotechnol, Athens, Greece; [Harizanis, Paschalis] Agr Univ Athens, Fac Crop Sci, Lab Sericulture & Apiculture, Athens, Greece; [Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	Agricultural University of Athens; Agricultural University of Athens; Brown University	Panagou, EZ (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Food Microbiol & Biotechnol, Athens, Greece.	stathispanagou@aua.gr	Nychas, George/B-2734-2009; Panagou, Efstathios/I-6537-2019	Nychas, George/0000-0002-2673-6425; Panagou, Efstathios/0000-0002-0317-1177	EU [243471/FP7-SME-2008-2]	EU(European Commission)	The present study was funded by the EU project PROBIOLIVES (No 243471/FP7-SME-2008-2).	Abriouel H, 2012, FOOD MICROBIOL, V32, P308, DOI 10.1016/j.fm.2012.07.006; Andrejko M, 2009, COMP BIOCHEM PHYS B, V152, P118, DOI 10.1016/j.cbpb.2008.10.008; Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005; Bautista-Gallego J, 2013, FOOD RES INT, V50, P135, DOI 10.1016/j.foodres.2012.10.004; Bergin D, 2006, MICROBES INFECT, V8, P2105, DOI 10.1016/j.micinf.2006.03.005; Beristain-Bauza SC, 2016, FOOD CONTROL, V62, P44, DOI 10.1016/j.foodcont.2015.10.007; Bevilacqua A, 2010, J FOOD SCI, V75, pM536, DOI 10.1111/j.1750-3841.2010.01793.x; Blana VA, 2014, FOOD MICROBIOL, V38, P208, DOI 10.1016/j.fm.2013.09.007; Botta C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094457; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Champion OL, 2009, MICROBIOL-SGM, V155, P1516, DOI 10.1099/mic.0.026823-0; Commane D, 2005, MUTAT RES-FUND MOL M, V591, P276, DOI 10.1016/j.mrfmmm.2005.02.027; Cotter G, 2000, FEMS IMMUNOL MED MIC, V27, P163, DOI 10.1111/j.1574-695X.2000.tb01427.x; Cross ML, 2002, FEMS IMMUNOL MED MIC, V34, P245, DOI 10.1111/j.1574-695X.2002.tb00632.x; Cytrynska M, 2007, PEPTIDES, V28, P533, DOI 10.1016/j.peptides.2006.11.010; De Bellis P, 2010, INT J FOOD MICROBIOL, V140, P6, DOI 10.1016/j.ijfoodmicro.2010.02.024; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Doulgeraki AI, 2013, ANTON LEEUW INT J G, V103, P821, DOI 10.1007/s10482-012-9864-2; Doulgeraki AI, 2013, LWT-FOOD SCI TECHNOL, V50, P353, DOI 10.1016/j.lwt.2012.07.003; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; FAO/WHO, 2002, PROB FOOD HLTH NUTR; Forestier C, 2001, RES MICROBIOL, V152, P167, DOI 10.1016/S0923-2508(01)01188-3; Fuchs BB, 2010, MICROBES INFECT, V12, P488, DOI 10.1016/j.micinf.2010.03.001; Gibreel TM, 2013, J ANTIMICROB CHEMOTH, V68, P2269, DOI 10.1093/jac/dkt195; Glavis-Bloom J, 2012, ADV EXP MED BIOL, V710, P11, DOI 10.1007/978-1-4419-5638-5_2; Grounta A, 2016, FOOD MICROBIOL, V56, P35, DOI 10.1016/j.fm.2015.12.002; Gupta S, 2012, CRIT REV FOOD SCI, V52, P183, DOI 10.1080/10408398.2010.499779; Ishikawa H, 2010, BIOSCI BIOTECH BIOCH, V74, P1338, DOI 10.1271/bbb.90871; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224; Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11; Kobayashi N, 2011, INT IMMUNOPHARMACOL, V11, P199, DOI 10.1016/j.intimp.2010.11.019; Komura T, 2013, BIOGERONTOLOGY, V14, P73, DOI 10.1007/s10522-012-9411-6; Latimer J, 2012, ANTIMICROB AGENTS CH, V56, P3092, DOI 10.1128/AAC.05904-11; Lavermicocca P, 2005, APPL ENVIRON MICROB, V71, P4233, DOI 10.1128/AEM.71.8.4233-4240.2005; Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003; Lin WH, 2007, J APPL MICROBIOL, V102, P22, DOI 10.1111/j.1365-2672.2006.03073.x; Maeda N, 2009, INT IMMUNOPHARMACOL, V9, P1122, DOI 10.1016/j.intimp.2009.04.015; MATSUZAKI T, 1990, MED MICROBIOL IMMUN, V179, P161; Matsuzaki T, 1998, J DAIRY SCI, V81, P48, DOI 10.3168/jds.S0022-0302(98)75549-3; Michaux C, 2011, INFECT IMMUN, V79, P2638, DOI 10.1128/IAI.01132-10; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Mowlds P, 2008, MICROBES INFECT, V10, P628, DOI 10.1016/j.micinf.2008.02.011; Mukherjee K, 2011, APPL ENVIRON MICROB, V77, P4237, DOI 10.1128/AEM.02435-10; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Ramos AN, 2010, INT IMMUNOPHARMACOL, V10, P247, DOI 10.1016/j.intimp.2009.11.007; Salminen S, 1998, INT DAIRY J, V8, P563, DOI 10.1016/S0958-6946(98)00077-6; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Saxami G, 2016, J FUNCT FOODS, V24, P461, DOI 10.1016/j.jff.2016.04.036; Segawa S, 2008, INT J FOOD MICROBIOL, V121, P1, DOI 10.1016/j.ijfoodmicro.2007.10.004; Tang MLK, 2010, CURR OPIN PEDIATR, V22, P626, DOI 10.1097/MOP.0b013e32833d9728; Upadhyay A, 2016, J MED MICROBIOL, V65, P443, DOI 10.1099/jmm.0.000251; Vilela SFG, 2015, VIRULENCE, V6, P29, DOI 10.4161/21505594.2014.981486; Villena J, 2009, MICROBIOL IMMUNOL, V53, P636, DOI 10.1111/j.1348-0421.2009.00171.x; Vintini EO, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-46; Wollowski I, 2001, AM J CLIN NUTR, V73, p451S, DOI 10.1093/ajcn/73.2.451s	60	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161263	10.1371/journal.pone.0161263	http://dx.doi.org/10.1371/journal.pone.0161263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27618619	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100008
J	Shah, P; Lueschen, N; Ardestani, A; Oberholzer, J; Olerud, J; Carlsson, PO; Maedler, K				Shah, Payal; Lueschen, Navina; Ardestani, Amin; Oberholzer, Jose; Olerud, Johan; Carlsson, Per-Ola; Maedler, Kathrin			Angiopoetin-2 Signals Do Not Mediate the Hypervascularization of Islets in Type 2 Diabetes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BETA-CELL APOPTOSIS; IN-VIVO; VEGF-A; EXTRACELLULAR-MATRIX; INSULIN-SECRETION; ANGIOPOIETIN-2; TIE2; RECEPTOR; VASCULARIZATION	Aims Changes in the islet vasculature have been implicated in the regulation of beta-cell survival and function during the progression to type 2 diabetes (T2D). Failure of the beta-cell to compensate for the increased insulin demand in obesity eventually leads to diabetes; as a result of the complex interplay of genetic and environmental factors (e.g. ongoing inflammation within the islets) and impaired vascular function. The Angiopoietin/Tie (Ang/Tie) angiogenic system maintains vasculature and is closely related to organ inflammation and angiogenesis. In this study we aimed to identify whether the vessel area within the islets changes in diabetes and whether such changes would be triggered by the Tie-antagonist Ang-2. Methods Immunohistochemical and qPCR analyses to follow islet vascularization and Ang/Tie levels were performed in human pancreatic autopsies and isolated human and mouse islets. The effect of Ang-2 was assessed in beta-cell-specific Ang-2 overexpressing mice during high fat diet (HFD) feeding. Results Islet vessel area was increased in autopsy pancreases from patients with T2D. The vessel markers Tie-1, Tie-2 and CD31 were upregulated in mouse islets upon HFD feeding from 8 to 24 weeks. Ang-2 was transiently upregulated in mouse islets at 8 weeks of HFD and under glucolipotoxic conditions (22.2mMglucose/0.5 mMpalmitate) in vitro in human and mouse islets, in contrast to its downregulation by cytokines (IL-1 beta, IFN-gamma and TNF-alpha). Ang-1 on the other hand was oppositely regulated, with a significant loss under glucolipotoxic condition, a trend to reduce in islets from patients with T2D and an upregulation by cytokines. Modulation of such changes in Ang-2 by its overexpression or the inhibition of its receptor Tie-2 impaired beta-cell function at basal conditions but protected islets from cytokine induced apoptosis. In vivo, beta-cell-specific Ang-2 overexpression in mice induced hypervascularization under normal diet but contrastingly led to hypovascularized islets in response to HFD together with increased apoptosis and reduced beta-cell mass. Conclusions Islet hypervascularization occurs in T2D. A balanced expression of the Ang1/Ang2 system is important for islet physiology. Ang-2 prevents beta-cell mass and islet vascular adaptation in response to HFD feeding with no major influence on glucose homeostasis.	[Shah, Payal; Lueschen, Navina; Ardestani, Amin; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact, Bremen, Germany; [Oberholzer, Jose] Univ Illinois, Div Transplantat, Chicago, IL USA; [Olerud, Johan] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Carlsson, Per-Ola] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Carlsson, Per-Ola] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Maedler, Kathrin] Univ Bremen, German Ctr Diabet Res DZD Project Partner, Bremen, Germany	University of Bremen; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Uppsala University; Uppsala University; Uppsala University; University of Bremen	Maedler, K (corresponding author), Univ Bremen, Ctr Biomol Interact, Bremen, Germany.; Maedler, K (corresponding author), Univ Bremen, German Ctr Diabet Res DZD Project Partner, Bremen, Germany.	kmaedler@uni-bremen.de	Maedler, Kathrin/ABE-3022-2021	Maedler, Kathrin/0000-0002-7436-1197; Ardestani, Amin/0000-0002-0685-8564	European Research Council (ERC); German Research Foundation (DFG); German Diabetes Center grant (DZD) from the BMBF; EFSD; JDRF award [31-2008-413]; NIDDK; integrated islet distribution program (IIDP)	European Research Council (ERC)(European Research Council (ERC)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Diabetes Center grant (DZD) from the BMBF; EFSD; JDRF award; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); integrated islet distribution program (IIDP)	This work was supported by the European Research Council (ERC), the German Research Foundation (DFG), by the German Diabetes Center grant (DZD) from the BMBF (to KM) and by an Albert Renold travel grant from the EFSD (to PS). Human is lets were provided through the JDRF award 31-2008-413 (ECIT Islet for Basic Research program) and by the integrated islet distribution program (IIDP). Autopsy pancreases were provided by the National Disease Research Interchange NDRI, supported from the NIDDK.; We thank J. Kerr-Conte and Francois Pattou (European Genomic Institute for Diabetes, Lille) and ProdoLabs for the high quality human islet isolations, Marcella Brissova and Alvin C. Powers (Vanderbilt University, Nashville) for providing the RIP-rtTA<SUP>tg/tg</SUP> and Tet-O-Ang-2<SUP>tg/wt</SUP> mice, Katrischa Hennekens and Jennifer Bergemann for technical assistance, Wei He (all University of Bremen) for human islet RNA processing and Hellmut Augustin (Dkfz-Heidelberg) for the Ang2-adenovirus. Autopsy pancreases were provided by the National Disease Research Interchange NDRI, supported from the NIDDK. Human islets were provided through an approved protocol by the Integrated Islet Distribution Program (IIDP) for human islets for research.	Agudo J, 2012, DIABETES, V61, P2851, DOI 10.2337/db12-0134; Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482; Ardestani A, 2011, J BIOL CHEM, V286, P17144, DOI 10.1074/jbc.M110.210526; Banerjee M, 2012, MOL CELL ENDOCRINOL, V355, P78, DOI 10.1016/j.mce.2012.01.020; Benest AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070459; Bonner-Weir S, 2015, J HISTOCHEM CYTOCHEM, V63, P604, DOI 10.1369/0022155415570969; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Brissova M, 2015, J HISTOCHEM CYTOCHEM, V63, P637, DOI 10.1369/0022155415573324; Cai Q, 2012, DEV BIOL, V367, P40, DOI 10.1016/j.ydbio.2012.04.022; Calderari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029438; Dai CH, 2013, DIABETES, V62, P4144, DOI 10.2337/db12-1657; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; Eberhard D, 2010, TRENDS ENDOCRIN MET, V21, P457, DOI 10.1016/j.tem.2010.03.003; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Feng ZC, 2015, DIABETES, V64, P3852, DOI 10.2337/db15-0054; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2009, EXP MOL MED, V41, P133, DOI 10.3858/emm.2009.41.3.016; Hasenstein JR, 2012, NEOPLASIA, V14, P131, DOI 10.1593/neo.111770; HENDERSON JR, 1985, Q J EXP PHYSIOL CMS, V70, P347, DOI 10.1113/expphysiol.1985.sp002920; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Iwashita N, 2007, DIABETOLOGIA, V50, P380, DOI 10.1007/s00125-006-0512-0; Jabs N, 2008, EXP CLIN ENDOCR DIAB, V116, pS46, DOI 10.1055/s-2008-1081486; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; KAISER N, 1988, ENDOCRINOLOGY, V123, P834, DOI 10.1210/endo-123-2-834; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Lim HS, 2004, DIABETES CARE, V27, P2918, DOI 10.2337/diacare.27.12.2918; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Manavski Y, 2014, CIRC RES, V114, P1077, DOI 10.1161/CIRCRESAHA.114.303452; Meyer A, 2015, DIABETES, V64, P2138, DOI 10.2337/db14-0864; Moldovan S, 2001, WORLD J SURG, V25, P468, DOI 10.1007/s002680020339; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Owyang AM, 2010, ENDOCRINOLOGY, V151, P2515, DOI 10.1210/en.2009-1124; Rasul S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-55; Roviezzo F, 2005, J PHARMACOL EXP THER, V314, P738, DOI 10.1124/jpet.105.086553; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653; Scholz A, 2015, ANN NY ACAD SCI, V1347, P45, DOI 10.1111/nyas.12726; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Semones M, 2007, BIOORG MED CHEM LETT, V17, P4756, DOI 10.1016/j.bmcl.2007.06.068; Singh H, 2010, MICROVASC RES, V79, P121, DOI 10.1016/j.mvr.2010.01.005; Spelios MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072260; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Toyofuku Y, 2009, BIOCHEM BIOPH RES CO, V383, P303, DOI 10.1016/j.bbrc.2009.03.138; WEIR GC, 1990, J CLIN INVEST, V85, P983, DOI 10.1172/JCI114574; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0161834	10.1371/journal.pone.0161834	http://dx.doi.org/10.1371/journal.pone.0161834			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617438	gold, Green Published, Green Submitted			2022-12-26	WOS:000383653100010
J	Wurtzler, EM; Wendell, D				Wurtzler, Elizabeth M.; Wendell, David			Selective Photocatalytic Disinfection by Coupling StrepMiniSog to the Antibody Catalyzed Water Oxidation Pathway	PLOS ONE			English	Article							TITANIUM-DIOXIDE; PSEUDOMONAS-AERUGINOSA; DRINKING-WATER; STAPHYLOCOCCUS-AUREUS; IN-VITRO; TIO2; INACTIVATION; PHOTOSENSITIZER; LIGHT; BACTERIOPHAGES	For several decades reactive oxygen species have been applied to water quality engineering and efficient disinfection strategies; however, these methods are limited by disinfection byproduct and catalyst-derived toxicity concerns which could be improved by selectively targeting contaminants of interest. Here we present a targeted photocatalytic system based on the fusion protein StrepMiniSOG that uses light within the visible spectrum to produce reactive oxygen species at a greater efficiency than current photosensitizers, allowing for shorter irradiation times from a fully biodegradable photocatalyst. The StrepMiniSOG photodisinfection system is unable to cross cell membranes and like other consumed proteins, can be degraded by endogenous digestive enzymes in the human gut, thereby reducing the consumption risks typically associated with other disinfection agents. We demonstrate specific, multi-log removal of Listeria monocytogenes from a mixed population of bacteria, establishing the StrepMiniSOG disinfection system as a valuable tool for targeted pathogen removal, while maintaining existing microbial biodiversity.	[Wurtzler, Elizabeth M.; Wendell, David] Univ Cincinnati, Coll Engn & Appl Sci, Dept Biol Chem & Environm Engn, Cincinnati, OH 45220 USA	University of Cincinnati	Wendell, D (corresponding author), Univ Cincinnati, Coll Engn & Appl Sci, Dept Biol Chem & Environm Engn, Cincinnati, OH 45220 USA.	wendeldw@uc.edu			National Science Foundation; Chemical, Bioengineering, Environmental, and Transport Systems Division; CBET [1552456, 1509022]; Div Of Chem, Bioeng, Env, & Transp Sys [1552456] Funding Source: National Science Foundation	National Science Foundation; Chemical, Bioengineering, Environmental, and Transport Systems Division; CBET; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation; Chemical, Bioengineering, Environmental, and Transport Systems Division; http://www.nsf.gov/div/index.jsp?div=CBET; CBET# 1552456; CBET# 1509022.	Abu-Yousif AO, 2012, CANCER LETT, V321, P120, DOI 10.1016/j.canlet.2012.01.014; Afaq F, 1998, J APPL TOXICOL, V18, P307, DOI 10.1002/(SICI)1099-1263(1998090)18:5<307::AID-JAT508>3.0.CO;2-K; Alrousan DMA, 2009, WATER RES, V43, P47, DOI 10.1016/j.watres.2008.10.015; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; Babior BM, 2003, P NATL ACAD SCI USA, V100, P3031, DOI 10.1073/pnas.0530251100; Bertoloni G, 1984, PORPHYRINS TUMOR PHO, P177; Bhatti M, 2000, ANTIMICROB AGENTS CH, V44, P2615, DOI 10.1128/AAC.44.10.2615-2618.2000; Bruynoghe R, 1921, CR SOC BIOL, V85, P1120; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Bundschuh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048956; Centers for Disease Control and Prevention, 2015, MULT OUTBR LIST LINK; Centers for Disease Control and Prevention, 2012, MULT OUTBR LIST LINK; Chick H, 1908, J HYG-CAMBRIDGE, V8, P92, DOI 10.1017/S0022172400006987; Choi Y, 2006, CHEMMEDCHEM, V1, P458, DOI 10.1002/cmdc.200500036; Colombo MJ, 2011, IMMUNOL RES, V51, P249, DOI 10.1007/s12026-011-8260-8; Datta D, 2002, P NATL ACAD SCI USA, V99, P2636, DOI 10.1073/pnas.052709399; De Gusseme B, 2010, APPL ENVIRON MICROB, V76, P1082, DOI 10.1128/AEM.02433-09; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Ede S, 2012, PHOTOCHEM PHOTOBIOL, V88, P728, DOI 10.1111/j.1751-1097.2012.01104.x; Embleton ML, 2005, ANTIMICROB AGENTS CH, V49, P3690, DOI 10.1128/AAC.49.9.3690-3696.2005; Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12; Hope CK, 2009, J ANTIMICROB CHEMOTH, V64, P59, DOI 10.1093/jac/dkp157; Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045; Huang L, 2010, ANTIMICROB AGENTS CH, V54, P3834, DOI 10.1128/AAC.00125-10; Ibanez JA, 2003, J PHOTOCH PHOTOBIO A, V157, P81, DOI 10.1016/S1010-6030(03)00074-1; IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668, DOI 10.1128/AEM.59.5.1668-1670.1993; Kessel D., 1987, LASER MED SCI, V2, P95; Kuhn KP, 2003, CHEMOSPHERE, V53, P71, DOI 10.1016/S0045-6535(03)00362-X; Kuznetsova NA, 2007, J HAZARD MATER, V146, P487, DOI 10.1016/j.jhazmat.2007.04.064; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Laksanalamai P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042448; LAOT N, 1999, J ADV OXID TECHNOL, V4, P97; Lee JH, 2004, WATER RES, V38, P713, DOI 10.1016/j.watres.2003.10.011; Liga MV, 2013, ENVIRON SCI TECHNOL, V47, P6463, DOI 10.1021/es400196p; Lin SH, 2013, WATER RES, V47, P3959, DOI 10.1016/j.watres.2012.09.005; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; MALIK Z, 1990, J PHOTOCH PHOTOBIO B, V5, P281, DOI 10.1016/1011-1344(90)85044-W; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211, DOI 10.1111/j.1574-6968.1985.tb00864.x; MERKEL PB, 1972, J AM CHEM SOC, V94, P7244, DOI 10.1021/ja00776a003; MEW D, 1985, CANCER RES, V45, P4380; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; Pal B., 2000, TOXICOL ENVIRON CHEM, V78, P233; Parthasarathy A, 2013, ACS APPL MATER INTER, V5, P4516, DOI 10.1021/am400282p; Pellieux C, 2000, METHOD ENZYMOL, V319, P197; Pilloni A., 2012, LASER MED SCI, V2, P1; Praetorius A, 2012, ENVIRON SCI TECHNOL, V46, P6705, DOI 10.1021/es204530n; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; RICCHELLI F, 1995, J PHOTOCH PHOTOBIO B, V29, P109, DOI 10.1016/1011-1344(95)07155-U; Rice TB, 1930, AM J MED SCI, V179, P345; Ryu H, 2008, WATER RES, V42, P1523, DOI 10.1016/j.watres.2007.10.037; Ryumina AP, 2013, BBA-GEN SUBJECTS, V1830, P5059, DOI 10.1016/j.bbagen.2013.07.015; SAITO T, 1992, J PHOTOCH PHOTOBIO B, V14, P369, DOI 10.1016/1011-1344(92)85115-B; Schless RA, 1932, AM J DIS CHILD, V44, P813, DOI 10.1001/archpedi.1932.01950110115011; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Sigstam T, 2013, APPL ENVIRON MICROB, V79, P3455, DOI 10.1128/AEM.00663-13; SJOGREN JC, 1994, APPL ENVIRON MICROB, V60, P344, DOI 10.1128/AEM.60.1.344-347.1994; Uehara Y, 2006, J INFECT DIS, V194, P98, DOI 10.1086/504439; Usacheva MN, 2001, LASER SURG MED, V29, P165, DOI 10.1002/lsm.1105; Waite GN, 2005, BIOCHEM BIOPH RES CO, V338, P1110, DOI 10.1016/j.bbrc.2005.10.037; WATTS RJ, 1995, WATER RES, V29, P95, DOI 10.1016/0043-1354(94)E0122-M; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; Wurtzler EM, 2014, BIOMACROMOLECULES, V15, P228, DOI 10.1021/bm401511a; Xia DH, 2013, ENVIRON SCI TECHNOL, V47, P11166, DOI 10.1021/es402170b; Xie XM, 2010, J IMMUNOL, V184, P3725, DOI 10.4049/jimmunol.0902732; Yamashita K, 2008, P NATL ACAD SCI USA, V105, P16912, DOI 10.1073/pnas.0807952105; Zhang YY, 2013, WATER RES, V47, P4507, DOI 10.1016/j.watres.2013.05.014; Zhang YY, 2013, BIOTECHNOL BIOENG, V110, P286, DOI 10.1002/bit.24630; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu XY, 2004, P NATL ACAD SCI USA, V101, P2247, DOI 10.1073/pnas.0307311101	72	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2016	11	9							e0162577	10.1371/journal.pone.0162577	http://dx.doi.org/10.1371/journal.pone.0162577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW5AC	27617441	Green Published, gold, Green Submitted			2022-12-26	WOS:000383653100030
J	Andrews, CJ; Kempf, M; Kimble, R; Cuttle, L				Andrews, Christine J.; Kempf, Margit; Kimble, Roy; Cuttle, Leila			Development of a Consistent and Reproducible Porcine Scald Burn Model	PLOS ONE			English	Article							THICKNESS BURN; HISTOPATHOLOGICAL EVALUATION; OPTIMAL DURATION; AID TREATMENT; DEPTH; TEMPERATURE; INJURY; PIG; PROGRESSION; VALIDATION	There are very few porcine burn models that replicate scald injuries similar to those encountered by children. We have developed a robust porcine burn model capable of creating reproducible scald burns for a wide range of burn conditions. The study was conducted with juvenile Large White pigs, creating replicates of burn combinations; 50 degrees C for 1, 2, 5 and 10 minutes and 60 degrees C, 70 degrees C, 80 degrees C and 90 degrees C for 5 seconds. Visual wound examination, biopsies and Laser Doppler Imaging were performed at 1, 24 hours and at 3 and 7 days post-burn. A consistent water temperature was maintained within the scald device for long durations (49.8 +/- 0.1 degrees C when set at 50 degrees C). The macroscopic and histologic appearance was consistent between replicates of burn conditions. For 50 degrees C water, 10 minute duration burns showed significantly deeper tissue injury than all shorter durations at 24 hours post-burn (p <= 0.0001), with damage seen to increase until day 3 post-burn. For 5 second duration burns, by day 7 post-burn the 80 degrees C and 90 degrees C scalds had damage detected significantly deeper in the tissue than the 70 degrees C scalds (p <= 0.001). A reliable and safe model of porcine scald burn injury has been successfully developed. The novel apparatus with continually refreshed water improves consistency of scald creation for long exposure times. This model allows the pathophysiology of scald burn wound creation and progression to be examined.	[Andrews, Christine J.; Kempf, Margit; Kimble, Roy] Univ Queensland, Ctr Childrens Burns & Trauma Res, Ctr Childrens Hlth Res, South Brisbane, Qld, Australia; [Cuttle, Leila] Queensland Univ Technol, Ctr Childrens Burns & Trauma Res, Sch Biomed Sci, Inst Hlth & Biomed Innovat,Ctr Childrens Hlth Res, South Brisbane, Qld, Australia	University of Queensland; Queensland University of Technology (QUT)	Andrews, CJ (corresponding author), Univ Queensland, Ctr Childrens Burns & Trauma Res, Ctr Childrens Hlth Res, South Brisbane, Qld, Australia.	c.andrews@uq.edu.au	Andrews, Christine/J-4891-2015; Cuttle, Leila/U-9376-2017	Andrews, Christine/0000-0003-4513-1349; Cuttle, Leila/0000-0002-2282-4815	National Health and Medical Research Council [APP1035907]; Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant [50083]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant	This work was financially supported by the National Health and Medical Research Council (Fellowship for LC (APP1035907) and Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant funding (50083)).; The authors would like to acknowledge Dr Gael Phillips for her invaluable advice and providing training in dermatohistopathology. We would also like to thank Mr Blair McEwan for his technical assistance with the animal studies and Mr Anthony Smith for his input on early scald burn device prototypes. This work was financially supported by the National Health and Medical Research Council (Fellowship for LC (APP1035907) and Queensland Children's Medical Research Institute/Children's Health Queensland Program Grant funding (50083)).	Abdullahi A, 2014, CELL MOL LIFE SCI, V71, P3241, DOI 10.1007/s00018-014-1612-5; Abraham JP, 2011, INT COMMUN HEAT MASS, V38, P1169, DOI 10.1016/j.icheatmasstransfer.2011.07.004; Abraham JP, 2016, INT J HYPERTHER, V32, P900, DOI 10.1080/02656736.2016.1211752; Abraham JP, 2016, BURNS, V42, P715, DOI 10.1016/j.burns.2016.01.003; Abraham JP, 2015, BURNS, V41, P1741, DOI 10.1016/j.burns.2015.06.002; Andrews CJ, 2016, INT J HEAT MASS TRAN, V101, P542, DOI 10.1016/j.ijheatmasstransfer.2016.05.070; Barker R, 2005, BURNS SCALDS QUEENSL; Bartlett N, 2008, J BURN CARE RES, V29, P828, DOI 10.1097/BCR.0b013e3181855c9a; Bourdon RT, 2016, AUSTIN J EMERGENCY C, V3, P1043; BRANS TA, 1994, BURNS, V20, pS48, DOI 10.1016/0305-4179(94)90090-6; Branski LK, 2008, BURNS, V34, P1119, DOI 10.1016/j.burns.2008.03.013; Braue EH, 2007, J BURN CARE RES, V28, P275, DOI 10.1097/BCR.0B013E318031A1A8; Cuttle L, 2008, WOUND REPAIR REGEN, V16, P626, DOI 10.1111/j.1524-475X.2008.00413.x; Cuttle L, 2006, BURNS, V32, P806, DOI 10.1016/j.burns.2006.02.023; Cuttle L, 2010, BURNS, V36, P673, DOI 10.1016/j.burns.2009.08.002; Dahiya P, 2009, FRONT BIOSCI, V14, P4962, DOI 10.2741/3580; Diller KR, 2011, J BURN CARE RES, V32, pE33, DOI 10.1097/BCR.0b013e31820ab159; Duke J, 2011, PEDIATRICS, V127, pE971, DOI 10.1542/peds.2010-3136; FELDMAN KW, 1978, PEDIATRICS, V62, P1; Fourman MS, 2015, BURNS, V41, P1043, DOI 10.1016/j.burns.2014.11.001; Fourman MS, BURNS; Gaines C, 2013, BURNS, V39, P311, DOI 10.1016/j.burns.2012.06.011; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Henze U, 1997, BURNS, V23, P473, DOI 10.1016/S0305-4179(97)00019-3; Hirth DA, 2012, WOUND REPAIR REGEN, V20, P918, DOI 10.1111/j.1524-475X.2012.00847.x; Hoeksema H, 2009, BURNS, V35, P36, DOI 10.1016/j.burns.2008.08.011; HOEKSTRA MJ, 1993, BRIT J PLAST SURG, V46, P585, DOI 10.1016/0007-1226(93)90111-N; JACKSON DM, 1953, BRIT J SURG, V40, P588, DOI 10.1002/bjs.18004016413; Jandera V, 2000, BURNS, V26, P265, DOI 10.1016/S0305-4179(99)00133-3; Johnson N. N., 2011, Journal of Thermal Science and Engineering Applications, V3, DOI 10.1115/1.4003610; KELLEY KW, 1973, J ANIM SCI, V36, P927; Kempf M, 2009, BURNS, V35, P454, DOI 10.1016/j.burns.2008.06.013; Kim JY, 2016, BURNS, V42, P384, DOI 10.1016/j.burns.2015.08.027; Meyer W, 1978, Curr Probl Dermatol, V7, P39; Middelkoop E, 2004, BIOMATERIALS, V25, P1559, DOI 10.1016/S0142-9612(03)00502-7; MONTAGNA W, 1964, J INVEST DERMATOL, V43, P11, DOI 10.1038/jid.1964.5; MORITZ AR, 1947, AM J PATHOL, V23, P915; MORITZ AR, 1947, AM J PATHOL, V23, P695; O'Reilly T J, 1989, J Burn Care Rehabil, V10, P1, DOI 10.1097/00004630-198901000-00001; Papp A, 2004, BURNS, V30, P684, DOI 10.1016/j.burns.2004.03.021; Public Health Association Australia, 2012, HOT TAP WAT TEMP SCA; Radke A, 2000, CRIT CARE MED, V28, P3224, DOI 10.1097/00003246-200009000-00018; Rayner R, 2011, WOUND PRACT RES, V19, P39; Ring Lisa M, 2007, J Pediatr Health Care, V21, P192, DOI 10.1016/j.pedhc.2007.02.001; Sheu SY, 2014, BURNS, V40, P1679, DOI 10.1016/j.burns.2014.04.023; Singer AJ, 2011, J BURN CARE RES, V32, P638, DOI 10.1097/BCR.0b013e31822dc439; Singer AJ, 2009, AM J EMERG MED, V27, P285, DOI 10.1016/j.ajem.2008.02.019; Singer AJ, 2003, METH MOLEC MED, V78, P107; Stetinsky J, 2015, LASER SURG MED, V47, P196, DOI 10.1002/lsm.22291; Stockton KA, 2015, BURNS, V41, P476, DOI 10.1016/j.burns.2014.09.018; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Wang XQ, 2009, BURNS, V35, P264, DOI 10.1016/j.burns.2008.05.030; Watts AMI, 2001, BURNS, V27, P154, DOI 10.1016/S0305-4179(00)00079-6; Yuan J, 2007, J BURN CARE RES, V28, P514, DOI 10.1097/BCR.0B013E318053DB13	54	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162888	10.1371/journal.pone.0162888	http://dx.doi.org/10.1371/journal.pone.0162888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612153	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900183
J	Donley, DW; Olson, AR; Raisbeck, MF; Fox, JH; Gigley, JP				Donley, David W.; Olson, Andrew R.; Raisbeck, Merl F.; Fox, Jonathan H.; Gigley, Jason P.			Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+T-Cell Responses, and Premature Mortality	PLOS ONE			English	Article							INTERFERON-GAMMA; MICROGLIAL ACTIVATION; T-CELLS; REACTIVATION; DYSFUNCTION; ENZYME; BRAIN; MODEL; ONSET	Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a polyglutamine-repeat expansion in the huntingtin protein. Activation of the kynurenine pathway of tryptophan degradation is implicated in the pathogenesis of HD. Indoleamine-2,3-dioxygenase (IDO) catalyzes the oxidation of tryptophan to kynurenine, the first step in this pathway. The prevalent, neuroinvasive protozoal pathogen To xoplasma gondii (T. gondii) results in clinically silent life-long infection in immune-competent individuals. T. gondii infection results in activation of IDO which provides some protection against the parasite by depleting tryptophan which the parasite cannot synthesize. The kynurenine pathway may therefore represent a point of synergism between HD and T. gondii infection. We show here that IDO activity is elevated at least four-fold in frontal cortex and striata of non-infected N171-82Q HD mice at 14-weeks corresponding to early-advanced HD. T. gondii infection at 5 weeks resulted in elevation of cortical IDO activity in HD mice. HD-infected mice died significantly earlier than wild-type infected and HD control mice. Prior to death, infected HD mice demonstrated decreased CD8+ T-lymphocyte proliferation in brain and spleen compared to wild-type infected mice. We demonstrate for the first time that HD mice have an altered response to an infectious agent that is characterized by premature mortality, altered immune responses and early activation of IDO. Findings are relevant to understanding how T. gondii infection may interact with pathways mediating neurodegeneration in HD.	[Donley, David W.; Raisbeck, Merl F.; Fox, Jonathan H.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Donley, David W.; Fox, Jonathan H.] Univ Wyoming, Grad Program Neurosci, Laramie, WY 82071 USA; [Olson, Andrew R.] Univ Wyoming, Dept Psychol, Laramie, WY 82071 USA; [Gigley, Jason P.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming; University of Wyoming; University of Wyoming	Gigley, JP (corresponding author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.	jgigley@uwyo.edu			University of Wyoming Neuroscience Center [5P30GM103398-03]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103398] Funding Source: NIH RePORTER	University of Wyoming Neuroscience Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided as a pilot project from the University of Wyoming Neuroscience Center Grant 5P30GM103398-03. (https://www.nigms.nih.gov/Pages/default.aspx) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhadra R, 2012, J INFECT DIS, V206, P125, DOI 10.1093/infdis/jis304; Bhadra R, 2011, P NATL ACAD SCI USA, V108, P9196, DOI 10.1073/pnas.1015298108; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boussicault L, 2016, BRAIN, V139, P953, DOI 10.1093/brain/awv384; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carter CJ, 2013, J PATHOG, V2013, DOI 10.1155/2013/965046; Celik T, 2010, SCAND J INFECT DIS, V42, P604, DOI 10.3109/00365541003716500; Chew WK, 2012, EXP PARASITOL, V130, P22, DOI 10.1016/j.exppara.2011.10.004; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Fujigaki S, 2002, INFECT IMMUN, V70, P779, DOI 10.1128/IAI.70.2.779-786.2002; Gigley JP, 2009, INFECT IMMUN, V77, P5380, DOI 10.1128/IAI.00649-09; Gigley JP, 2009, J IMMUNOL, V182, P1069, DOI 10.4049/jimmunol.182.2.1069; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; GUPTA SL, 1994, INFECT IMMUN, V62, P2277, DOI 10.1128/IAI.62.6.2277-2284.1994; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Khan IA, 1999, INFECT IMMUN, V67, P5869, DOI 10.1128/IAI.67.11.5869-5876.1999; Kusbeci OY, 2011, ALZ DIS ASSOC DIS, V25, P1, DOI 10.1097/WAD.0b013e3181f73bc2; Lu Z, 2014, NEUROBIOL DIS, V71, P34, DOI 10.1016/j.nbd.2014.06.022; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacKenzie CR, 1999, ADV EXP MED BIOL, V467, P533; Mazarei G, 2013, J NEUROCHEM, V127, P852, DOI 10.1111/jnc.12350; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller JRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141793; Miman O, 2010, NEUROSCI LETT, V475, P129, DOI 10.1016/j.neulet.2010.03.057; Perry CE, 2016, ALZ DIS ASSOC DIS, V30, P123, DOI 10.1097/WAD.0000000000000108; Politis M, 2015, NEUROBIOL DIS, V83, P115, DOI 10.1016/j.nbd.2015.08.011; Politis M, 2011, HUM BRAIN MAPP, V32, P258, DOI 10.1002/hbm.21008; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schilling G, 2004, EXP NEUROL, V187, P137, DOI 10.1016/j.expneurol.2004.01.003; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sutterland AL, 2015, ACTA PSYCHIAT SCAND, V132, P161, DOI 10.1111/acps.12423; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; THOMAS SR, 1994, J BIOL CHEM, V269, P14457; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Trager U, 2015, NEUROBIOL DIS, V73, P388, DOI 10.1016/j.nbd.2014.10.012; Weiss A, 2012, J CLIN INVEST, V122, P3731, DOI 10.1172/JCI64565; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	44	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162404	10.1371/journal.pone.0162404	http://dx.doi.org/10.1371/journal.pone.0162404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611938	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900090
J	Hewawasam, RP; Liu, D; Casarotto, MG; Board, PG; Dulhunty, AF				Hewawasam, Ruwani P.; Liu, Dan; Casarotto, Marco G.; Board, Philip G.; Dulhunty, Angela F.			The GSTM2 C-Terminal Domain Depresses Contractility and Ca2+ Transients in Neonatal Rat Ventricular Cardiomyocytes	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASE GSTM2-2; RYANODINE RECEPTORS; MALEYLACETOACETATE ISOMERASE; STRIATED-MUSCLE; MYOCYTES; LOCATION; CHANNELS; RELEASE; SIGNALS; CULTURE	The cardiac ryanodine receptor (RyR2) is an intracellular ion channel that regulates Ca2+ release from the sarcoplasmic reticulum (SR) during excitation-contraction coupling in the heart. The glutathione transferases (GSTs) are a family of phase II detoxification enzymes with additional functions including the selective inhibition of RyR2, with therapeutic implications. The C-terminal half of GSTM2 (GSTM2C) is essential for RyR2 inhibition, and mutations F157A and Y160A within GSTM2C prevent the inhibitory action. Our objective in this investigation was to determine whether GSTM2C can enter cultured rat neonatal ventricular cardiomyocytes and influence contractility. We show that oregon green-tagged GSTM2C (at 1 mu M) is internalized into the myocytes and it reduces spontaneous contraction frequency and myocyte shortening. Field stimulation of myocytes evoked contraction in the same percentage of myocytes treated either with media alone or media plus 15 mu M GSTM2C. Myocyte shortening during contraction was significantly reduced by exposure to 15 mu MGSTM2C, but not 5 and 10 mu M GSTM2C and was unaffected by exposure to 15 mu M of the mutants Y160A or F157A. The amplitude of the Ca2+ transient in the 15 mu MGSTM2C-treatedmyocytes was significantly decreased, the rise time was significantly longer and the decay time was significantly shorter than in controlmyocytes. The Ca2+ transient was not altered by exposure to Y160A or F157A. The results are consistent with GSTM2C entering themyocytes and inhibiting RyR2, in a manner that indicates a possible therapeutic potential for treatment of arrhythmia in the neonatal heart.	[Hewawasam, Ruwani P.; Liu, Dan; Casarotto, Marco G.; Board, Philip G.; Dulhunty, Angela F.] Australian Natl Univ, John Curtin Sch Med Res, GPO Box 334, Canberra, ACT 2600, Australia; [Hewawasam, Ruwani P.] Univ Ruhuna, Fac Med, Dept Biochem, Labuduwa Rd, Galle, Sri Lanka	Australian National University; John Curtin School of Medical Research; University Ruhuna	Dulhunty, AF (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, GPO Box 334, Canberra, ACT 2600, Australia.	Angela.dulhunty@anu.edu.au	Hewawasam, Ruwani/ABF-2161-2020; Dulhunty, Angela/AAO-5421-2020	Casarotto, Marco/0000-0002-0571-7671; Hewawasam, Ruwani/0000-0001-6349-4755; Dulhunty, Angela/0000-0001-9493-4944	Australian National Health and Medical Research Council [471462, 1008477]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by The Australian National Health and Medical Research Council (https://www.nhmrc.gov.au/) APP #471462 to P. G. Board, A. F. Dulhunty, M. G. Casarotto and APP #1008477 to P. G. Board, A. F. Dulhunty, M. G. Casarotto and L. Arnolda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif Y, 2007, CELL CALCIUM, V41, P429, DOI 10.1016/j.ceca.2006.08.004; Aceto A, 1997, BIOCHEM J, V322, P229, DOI 10.1042/bj3220229; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Blackburn AC, 1998, CYTOGENET CELL GENET, V83, P109, DOI 10.1159/000015145; BOARD PG, 1988, BIOCHIM BIOPHYS ACTA, V953, P214, DOI 10.1016/0167-4838(88)90027-1; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Dulhunty AF, 2002, PROG BIOPHYS MOL BIO, V79, P45, DOI 10.1016/S0079-6107(02)00013-5; Er F, 2003, CIRCULATION, V107, P485, DOI 10.1161/01.CIR.0000045672.32920.CB; Fernandez-Canon JM, 1999, GENOMICS, V58, P263, DOI 10.1006/geno.1999.5832; FIELD AC, 1988, J PHYSIOL-LONDON, V406, P277, DOI 10.1113/jphysiol.1988.sp017380; GOMEZ JP, 1994, CELL CALCIUM, V15, P265, DOI 10.1016/0143-4160(94)90066-3; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hewawasam R, 2010, BIOCHEM PHARMACOL, V80, P381, DOI 10.1016/j.bcp.2010.04.019; Jaconi M, 2000, MOL BIOL CELL, V11, P1845, DOI 10.1091/mbc.11.5.1845; Janowski E, 2010, AM J PHYSIOL-HEART C, V298, pH1939, DOI 10.1152/ajpheart.00607.2009; Johansson AS, 2001, J BIOL CHEM, V276, P33061, DOI 10.1074/jbc.M104539200; KOMIYAMA M, 1990, J MUSCLE RES CELL M, V11, P419, DOI 10.1007/BF01739762; Korhonen T, 2009, BIOPHYS J, V96, P1189, DOI 10.1016/j.bpj.2008.10.026; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Liu D, 2012, BIOCHEM PHARMACOL, V83, P1523, DOI 10.1016/j.bcp.2012.02.020; Liu D, 2009, BIOCHEM PHARMACOL, V77, P1181, DOI 10.1016/j.bcp.2008.12.024; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Maltsev VA, 2006, J PHARMACOL SCI, V100, P338, DOI 10.1254/jphs.CR0060018; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Morris MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017864; Morris MJ, 2009, BBA-BIOMEMBRANES, V1788, P676, DOI 10.1016/j.bbamem.2008.10.018; RAGHUNATHAN S, 1994, J MOL BIOL, V238, P815, DOI 10.1006/jmbi.1994.1336; Rapila R, 2008, J GEN PHYSIOL, V132, P397, DOI 10.1085/jgp.200809960; Samarasinghe K, 2015, BIOCHEM PHARMACOL, V97, P269, DOI 10.1016/j.bcp.2015.08.004; Sasse P, 2007, J GEN PHYSIOL, V130, P133, DOI 10.1085/jgp.200609575; Trafford AW, 2000, CELL CALCIUM, V28, P269, DOI 10.1054/ceca.2000.0156; Wu Y, 2006, ONCOGENE, V25, P5787, DOI 10.1038/sj.onc.1209576	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162415	10.1371/journal.pone.0162415	http://dx.doi.org/10.1371/journal.pone.0162415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27612301	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900093
